Citrus Sinensis ID: 046586
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 763 | 2.2.26 [Sep-21-2011] | |||||||
| Q9XID3 | 829 | G-type lectin S-receptor- | yes | no | 0.842 | 0.775 | 0.340 | 1e-101 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.897 | 0.785 | 0.299 | 5e-90 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.874 | 0.816 | 0.318 | 7e-89 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.681 | 0.628 | 0.336 | 6e-81 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.625 | 0.598 | 0.340 | 2e-79 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.389 | 0.361 | 0.466 | 3e-79 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.880 | 0.770 | 0.290 | 3e-79 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.614 | 0.563 | 0.322 | 4e-70 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.442 | 0.533 | 0.377 | 6e-64 | |
| Q8VYT3 | 648 | Probable LRR receptor-lik | no | no | 0.373 | 0.439 | 0.418 | 3e-63 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 370 bits (949), Expect = e-101, Method: Compositional matrix adjust.
Identities = 269/790 (34%), Positives = 381/790 (48%), Gaps = 147/790 (18%)
Query: 48 SPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQL 107
SPNSTF+ F+P P S N F +V + + IWSA V GSL + T+G L
Sbjct: 44 SPNSTFSVSFVPSP-SPNSFLAAVSFAG----SVPIWSAG---TVDSRGSLRLH-TSGSL 94
Query: 108 RLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYGN------WQSFNLPTDTILPNQT 161
RL N S + +W + G + + ++D G + N W SF+ PTDTI+ +Q
Sbjct: 95 RLTNGSGTTVWDSKTDRLGVTSGS---IEDTGEFILLNNRSVPVWSSFDNPTDTIVQSQN 151
Query: 162 LNGPPLVSKNGKFSF--------------------------------------------- 176
++ ++G +SF
Sbjct: 152 FTAGKIL-RSGLYSFQLERSGNLTLRWNTSAIYWNHGLNSSFSSNLSSPRLSLQTNGVVS 210
Query: 177 ------LNASELVFV-----SANRSYWNIDDDGNLRIYS-YDDNGDRWTVVWQAVQEICT 224
L +E+V+ S + +DDDGNLRIYS N W AV + C
Sbjct: 211 IFESNLLGGAEIVYSGDYGDSNTFRFLKLDDDGNLRIYSSASRNSGPVNAHWSAVDQ-CL 269
Query: 225 IPDLCGENAICISDGLSRSTSCVCPP---GFKNSTRQDKSCQRKIELKNLR-NTKFLQLD 280
+ CG IC + + C CP F + + K C+RK+EL + NT L L
Sbjct: 270 VYGYCGNFGICSYN--DTNPICSCPSRNFDFVDVNDRRKGCKRKVELSDCSGNTTMLDLV 327
Query: 281 YVNFSRGNLSDLEADNF----SACKANCSANPKCVAFGFKYDGKRYC--VLVDQLLYGYW 334
+ D +++F S C+ANC ++ C+A DG C GY
Sbjct: 328 HTRLFTYE-DDPNSESFFAGSSPCRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQ 386
Query: 335 SPGTEMATFLRVD--------ESENDVSNFTGMTNLLVTTCPVNISLPLPPDESSTTARN 386
P ++++V E + +L + V
Sbjct: 387 WPSVPSTSYVKVCGPVVANTLERATKGDDNNSKVHLWIVAVAV----------------- 429
Query: 387 IAIIVTLFAAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGPKRFTHAELRAATNG 446
IA ++ L A E+ G W W +K ++ ++ L +G P +FT+ EL+ T
Sbjct: 430 IAGLLGLVAVEI--GLW--WCCCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKS 485
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
F +G GGFG VY+G LT+ VVAVK L+ + G+ +F EV I+ HHLNLVRL GF
Sbjct: 486 FKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQGEKQFRMEVATISSTHHLNLVRLIGF 545
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
C++ R LVYE++ NGSL ++LF + D K L W R+
Sbjct: 546 CSQGRHRLLVYEFMRNGSLDNFLFTT--------------------DSAK-FLTWEYRFN 584
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSMSR 625
IALG A+ I YLHEEC + ++HCDIKPENIL+ D+F K+SDFGLAK L K++ +MS
Sbjct: 585 IALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSS 644
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685
+RGTRGY+APEWL + IT K+DVYS+GMVLLE+VSG RNF++ ++ F WA+
Sbjct: 645 VRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVS---EKTNHKKFSIWAY 701
Query: 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745
E+ +E+ + ILD + S D V + V RMVKT+ WCIQ++P RP+MGKV +MLEG
Sbjct: 702 EE-FEKGNTKAILDTRL--SEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG 758
Query: 746 TVEITEPKKP 755
EI P P
Sbjct: 759 ITEIKNPLCP 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (852), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 259/865 (29%), Positives = 393/865 (45%), Gaps = 180/865 (20%)
Query: 5 FFFFFIFILSPSPSLQQQQKPQYMSSFSSSDSPWLPNQNRILLSPNSTFAAGFLP-KPNS 63
FF FF+ L+ P + K + + P NR +S N TFA GF KP
Sbjct: 16 FFCFFLVSLATEPHIGLGSKLK-------ASEP-----NRAWVSANGTFAIGFTRFKPTD 63
Query: 64 RNLFTFSVWYHNL--------------------------------SEPTTVIWSANDKFP 91
R F S+W+ L S+ TV+W++N
Sbjct: 64 R--FLLSIWFAQLPGDPTIVWSPNRNSPVTKEAVLELEATGNLVLSDQNTVVWTSN---- 117
Query: 92 VAGNG-SLAIAATTGQLRLLNSS--------------NSNLWPN-PKTA----TGNPNST 131
+ +G A+ + +G LL + + L PN P T T NP+ +
Sbjct: 118 TSNHGVESAVMSESGNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPS 177
Query: 132 RL------FLQDAGNLVYGNWQSFNLP--------TDTILPNQTLNGPPLVSKNGKFSFL 177
R LQ +L G + NL + + N T + ++ G F +
Sbjct: 178 RHGHYSLKMLQQHTSLSLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKIV 237
Query: 178 NASELVF--------VSANRSYWN----------------IDDDGNLRIYSYDDN---GD 210
+ V NR+Y N ++++GNLR+Y +D++
Sbjct: 238 YGESSIGAVYVYKNPVDDNRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRWDNDMNGSS 297
Query: 211 RWTVVWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGFKNSTRQD----------- 259
+W W AV C I +CG N +C D ++ C+C PG Q+
Sbjct: 298 QWVPEWAAVSNPCDIAGICG-NGVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSL 356
Query: 260 -KSCQRKIELKNLRNTKFLQLDYVNFSR----GNLSDLEADNFSACKANCSANPKCVAFG 314
+ C+ I +Q FS N+SD+ N C C ++ KCVA
Sbjct: 357 VQECESNINRNGSFKISTVQETNYYFSERSVIENISDIS--NVRKCGEMCLSDCKCVASV 414
Query: 315 FKYDGKR-YCVLVDQLLYG-YWSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNIS 372
+ D ++ YC ++ L +G + PG+ + R +ES SN +
Sbjct: 415 YGLDDEKPYCWILKSLNFGGFRDPGSTLFVKTRANESYPSNSNNNDSKS----------- 463
Query: 373 LPLPPDESSTTARNIAIIVTLFAAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGP 432
S R +++ + L+ A + R + R L+ P
Sbjct: 464 ------RKSHGLRQKVLVIPIVVGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDSP 517
Query: 433 KRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCL-KNVTGGDAEFWAEVTI 491
FT+ +L+ TN FS L+G GGFG VYKG + +VAVK L + ++ G+ EF EV
Sbjct: 518 VSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNT 577
Query: 492 IARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGP 551
I MHH+NLVRL G+C+E R LVYEY+ NGSL ++F S + +
Sbjct: 578 IGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTAN-------------- 623
Query: 552 HDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL 611
+LDW R+ IA+ A+ IAY HE+C ++HCDIKPENILL D+FCPK+SDFGL
Sbjct: 624 ------LLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGL 677
Query: 612 AKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671
AK+ +E ++ IRGTRGY+APEW+ + IT KADVYS+GM+LLEIV G RN ++
Sbjct: 678 AKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMS-- 735
Query: 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPE 731
+++++++P WA++++ ++ + D+ ++ + + V + +K A WCIQD
Sbjct: 736 -YDAEDFFYPGWAYKELTNGTSLKAV-DKRLQGVAEE----EEVVKALKVAFWCIQDEVS 789
Query: 732 LRPSMGKVAKMLEGTV-EITEPKKP 755
+RPSMG+V K+LEGT EI P P
Sbjct: 790 MRPSMGEVVKLLEGTSDEINLPPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 329 bits (843), Expect = 7e-89, Method: Compositional matrix adjust.
Identities = 256/804 (31%), Positives = 374/804 (46%), Gaps = 137/804 (17%)
Query: 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPT----TVIWSANDKFPVAGNGS 97
++ L S + TF++GF + FTFSVWY T++WSAN PV S
Sbjct: 44 ESSTLQSSDGTFSSGFYEVYT--HAFTFSVWYSKTEAAAANNKTIVWSANPDRPVHARRS 101
Query: 98 LAIAATTGQLRLLNSSNSNLWPNPKTATGN--PNSTRLFLQDAGNLVY----GN--WQSF 149
G + L + + +W A GN R L D GNLV GN WQSF
Sbjct: 102 ALTLQKDGNMVLTDYDGAAVW----RADGNNFTGVQRARLLDTGNLVIEDSGGNTVWQSF 157
Query: 150 NLPTDTILPNQTLNG-----PPLVSKNG-----KFSFLNASELVFVSANRS--YW----- 192
+ PTDT LP Q + P S++ +FS L+ L++ S YW
Sbjct: 158 DSPTDTFLPTQLITAATRLVPTTQSRSPGNYIFRFSDLSVLSLIYHVPQVSDIYWPDPDQ 217
Query: 193 NIDDDG------------------------------------------------NLRIYS 204
N+ DG NLR+YS
Sbjct: 218 NLYQDGRNQYNSTRLGMLTDSGVLASSDFADGQALVASDVGPGVKRRLTLDPDGNLRLYS 277
Query: 205 YDDNGDRWTVVWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGF--KNSTRQDKSC 262
+D+ W+V A+ + C I LCG N IC S + +C CPPG+ +N + C
Sbjct: 278 MNDSDGSWSVSMVAMTQPCNIHGLCGPNGIC---HYSPTPTCSCPPGYATRNPGNWTEGC 334
Query: 263 QRKIELK----NLRNTKFLQLDYVNFSRGNLSDLEADNFSACKANCSANPKCVAFGFKY- 317
+ + R+ +F++L +F + L + + C+ C ++ C GF+Y
Sbjct: 335 MAIVNTTCDRYDKRSMRFVRLPNTDFWGSDQQHLLSVSLRTCRDICISD--CTCKGFQYQ 392
Query: 318 DGKRYCVLVDQLLYGYWSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCP-------VN 370
+G C L G P +++ T + VSN + + + P +N
Sbjct: 393 EGTGSCYPKAYLFSGRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMN 452
Query: 371 ISLPLP-PDESSTTARN------IAIIVTLFAAEL--ISGAWFFWAFLKKYIKYRDM-AR 420
S+ P PD T I F E+ IS AWFF LK+ ++ ++ A
Sbjct: 453 KSIREPFPDVHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWFF--VLKRELRPSELWAS 510
Query: 421 TLGLELLPAGGPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG 480
G + + + +R+++ EL AT F +GRG G VYKG L D R VAVK L+NV
Sbjct: 511 EKGYKAMTSNF-RRYSYRELVKATRKFKVELGRGESGTVYKGVLEDDRHVAVKKLENVRQ 569
Query: 481 GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSP 540
G F AE+++I R++H+NLVR+WGFC+E R LV EYV NGSLA+ LF
Sbjct: 570 GKEVFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILF---------- 619
Query: 541 AREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600
+GG +LDW R+ IALGVA+ +AYLH ECLEWV+HCD+KPENILL
Sbjct: 620 -----------SEGGNILLDWEGRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQ 668
Query: 601 DFCPKISDFGLAK-LRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI 659
F PKI+DFGL K L + ++S +RGT GY+APEW+ S IT K DVYS+G+VLLE+
Sbjct: 669 AFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLEL 728
Query: 660 VSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMV 719
++G+R E+ G E + + +D ++ + + V++ ++
Sbjct: 729 LTGTRVSELVGGTDEVHSMLRKLVRMLSAKLEGEEQSWIDGYLDSKLNRPVNYVQARTLI 788
Query: 720 KTAMWCIQDRPELRPSMGKVAKML 743
K A+ C+++ RP+M + L
Sbjct: 789 KLAVSCLEEDRSKRPTMEHAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 6e-81, Method: Compositional matrix adjust.
Identities = 196/582 (33%), Positives = 294/582 (50%), Gaps = 62/582 (10%)
Query: 183 VFVSANRSYWNIDDDGNLRIYSYDDNGDRWTVVWQAVQEICTIPDLCGENAICISDGLSR 242
++ N S + +D G ++ +++ + W + W ++ C + CG IC SD
Sbjct: 250 IYNQLNVSRFVMDVSGQIKQFTWLEGNKAWNLFWSQPRQQCQVYRYCGSFGIC-SD--KS 306
Query: 243 STSCVCPPGFKNSTRQD-------KSCQRKIELKNLRN--TKFLQLDYVNFSRGNLSDLE 293
C CP GF+ +++D C RK EL+ R +F +L + + N L
Sbjct: 307 EPFCRCPQGFRPMSQKDWDLKDYSAGCVRKTELQCSRGDINQFFRLPNMKLAD-NSEVLT 365
Query: 294 ADNFSACKANCSANPKCVAFGFKYDGKRYCVLVDQLLYGYWSPGTEMATFLRVDESENDV 353
+ S C + C + C A+ + +G C++ WS L + SE ++
Sbjct: 366 RTSLSICASACQGDCSCKAYAYD-EGSSKCLV--------WSKDVLNLQQLEDENSEGNI 416
Query: 354 SNFTGMTNLLVTTCPVNISLPLPPDESSTTARNIAIIVTLFAAELISGAWFFWAFLKKYI 413
L + P N+ +S + N +I F A L S L +
Sbjct: 417 FYL----RLAASDVP-NVG-------ASGKSNNKGLI---FGAVLGSLGVIVLVLLVVIL 461
Query: 414 KYRDMARTLGLELLPAGGPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVK 473
R R G F++ EL+ AT FS+ +G GGFG V+KG L D +AVK
Sbjct: 462 ILRYRRRKRMRGEKGDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVK 521
Query: 474 CLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSG 533
L+ ++ G+ +F EV I + H+NLVRL GFC+E ++ LVY+Y+PNGSL +LF
Sbjct: 522 RLEGISQGEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLF--- 578
Query: 534 RVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593
++E K VL W +R++IALG AR +AYLH+EC + ++HCDIKP
Sbjct: 579 -------LNQVEE---------KIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKP 622
Query: 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFG 653
ENILL FCPK++DFGLAKL ++ ++ +RGTRGY+APEW+ IT KADVYS+G
Sbjct: 623 ENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYG 682
Query: 654 MVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFD 713
M+L E+VSG RN E N +FP WA + ++ + ++D ++ V +
Sbjct: 683 MMLFELVSGRRNTE---QSENEKVRFFPSWAATILTKDGDIRSLVDPRLEG---DAVDIE 736
Query: 714 MVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITEPKKP 755
V R K A WCIQD RP+M +V ++LEG +E+ P P
Sbjct: 737 EVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 297 bits (761), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 193/567 (34%), Positives = 278/567 (49%), Gaps = 90/567 (15%)
Query: 194 IDDDGNLRIYSYDDNGDRWTVVWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGFK 253
+ +G L+ Y++D W + W ++ C + +LCG+ C S+ L C C GF+
Sbjct: 249 VGANGQLKQYTWDPQTQSWNMFWLQPEDPCRVYNLCGQLGFCSSELLK---PCACIRGFR 305
Query: 254 -------NSTRQDKSCQRKIELKNLRNTKFLQLDYVNFSRG-NLSDLEADNFSACKANCS 305
S C+R+ ++ F + + + +S L+ S+C C
Sbjct: 306 PRNDAAWRSDDYSDGCRRENGDSGEKSDTFEAVGDLRYDGDVKMSRLQVSK-SSCAKTCL 364
Query: 306 ANPKCVAFGFKYDGKRYCVLVDQLLYGYWSPGTEMATFLRVDESENDVSNFTG-MTNLLV 364
N CV F K +L+ ES N++ N G ++ ++
Sbjct: 365 GNSSCVGFYHKEKSNLCKILL---------------------ESPNNLKNSKGNISKSII 403
Query: 365 TTCPVNISLPLPPDESSTTARNIAIIVTLFAAELISGAWFFWAFLKKYIKYRDMARTLGL 424
C V S + ++V L + K + D L L
Sbjct: 404 ILCSV---------VGSISVLGFTLLVPLILLKRSR------KRKKTRKQDEDGFAVLNL 448
Query: 425 ELLPAGGPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRV-VAVKCLKNVTGGDA 483
K F+ EL++ATNGFS+ +G GGFG V+KG L VAVK L+ G++
Sbjct: 449 --------KVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGES 500
Query: 484 EFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPARE 543
EF AEV I + H+NLVRL GFC+E R LVY+Y+P GSL+ YL R+ SP
Sbjct: 501 EFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRT------SPK-- 552
Query: 544 MEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603
+L W R+RIALG A+ IAYLHE C + ++HCDIKPENILL D+
Sbjct: 553 --------------LLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYN 598
Query: 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS 663
K+SDFGLAKL ++ ++ +RGT GY+APEW+ IT KADVYSFGM LLE++ G
Sbjct: 599 AKVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGR 658
Query: 664 RNFEIQGSMMNSDE-----WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRM 718
RN + + E W+FP WA ++ + V+ ++D + Y++ + V RM
Sbjct: 659 RNVIVNSDTLGEKETEPEKWFFPPWAAREIIQG-NVDSVVDSRLNGEYNT----EEVTRM 713
Query: 719 VKTAMWCIQDRPELRPSMGKVAKMLEG 745
A+WCIQD E+RP+MG V KMLEG
Sbjct: 714 ATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (759), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 151/324 (46%), Positives = 210/324 (64%), Gaps = 27/324 (8%)
Query: 429 AGGPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAE 488
+G P RF + +L++ATN FS +G+GGFG VY+G L D +AVK L+ + G EF AE
Sbjct: 477 SGMPIRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAE 536
Query: 489 VTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSG 548
V+II +HHL+LVRL GFCAE R L YE++ GSL ++FR
Sbjct: 537 VSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFR----------------- 579
Query: 549 VGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISD 608
G +LDW R+ IALG A+ +AYLHE+C ++HCDIKPENILL D+F K+SD
Sbjct: 580 ---KKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSD 636
Query: 609 FGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEI 668
FGLAKL +E + +RGTRGY+APEW+ + I+ K+DVYS+GMVLLE++ G +N++
Sbjct: 637 FGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDP 696
Query: 669 QGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQD 728
+ S++ +FP +AF+K+ EE K+ DI+D +KN V + V R +KTA+WCIQ+
Sbjct: 697 SET---SEKCHFPSFAFKKM-EEGKLMDIVDGKMKN---VDVTDERVQRAMKTALWCIQE 749
Query: 729 RPELRPSMGKVAKMLEGTVEITEP 752
+ RPSM KV +MLEG + +P
Sbjct: 750 DMQTRPSMSKVVQMLEGVFPVVQP 773
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 296 bits (759), Expect = 3e-79, Method: Compositional matrix adjust.
Identities = 239/824 (29%), Positives = 363/824 (44%), Gaps = 152/824 (18%)
Query: 41 NQNRILLSPNSTFAAGFLP--KPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSL 98
++ LLS NS F AG +S F FSV + + + IWS+N PV+ +G++
Sbjct: 45 SKGAFLLSRNSIFKAGLFSPGGDDSSTGFYFSVVH---VDSGSTIWSSNRDSPVSSSGTM 101
Query: 99 AIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYGN------WQSFNLP 152
+ + S +W P A+ P + L L DAGNL+ + W+SF+ P
Sbjct: 102 NLTPQGISVIEDGKSQIPVWSTPVLAS--PVKS-LRLTDAGNLLLLDHLNVSLWESFDFP 158
Query: 153 TDTILPNQTLNGPPLVS--------KNGKFSFL-NASELVFVSANRSYW--------NID 195
TD+I+ Q L +S G + FL S+ + ++YW N+D
Sbjct: 159 TDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGESDGLMQWRGQNYWKLRMHIRANVD 218
Query: 196 DD--------------------------------GNLRIYSYDDNGD---------RWTV 214
+ + R+ D +G
Sbjct: 219 SNFPVEYLTVTTSGLALMARNGTVVVVRVALPPSSDFRVAKMDSSGKFIVSRFSGKNLVT 278
Query: 215 VWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGFKNSTRQDKSCQRKIELK----- 269
+ + C IP +CG+ +C D S + SC CP + + L
Sbjct: 279 EFSGPMDSCQIPFVCGKLGLCNLDNASENQSCSCPDEMRMDAGKGVCVPVSQSLSLPVSC 338
Query: 270 NLRNTKFLQLDY-VNFSRGNLSDLEADNFS--ACKANCSANPKCVAFGFKYDGKRYCVLV 326
RN +L+L V++ + +D AC CS N C+ F + R C LV
Sbjct: 339 EARNISYLELGLGVSYFSTHFTDPVEHGLPLLACHDICSKNCSCLGV-FYENTSRSCYLV 397
Query: 327 DQLLYGYWSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDESSTTARN 386
+F + +N N + + ++ N P + ++
Sbjct: 398 KD-------------SFGSLSLVKNSPENHDLIGYVKLSIRKTNAQPPGNNNRGGSSFPV 444
Query: 387 IAIIVT----LFAAELISGAWFFWAFLKKYIKYRDMART---------LGLELLPAGGPK 433
IA+++ F + W+ + +Y R+ T LG +P G P+
Sbjct: 445 IALVLLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQVTRPGSFESGDLGSFHIP-GLPQ 503
Query: 434 RFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNV-TGGDAEFWAEVTII 492
+F EL AT F IG GGFG VYKG L D ++AVK + N G EF E+ II
Sbjct: 504 KFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCTEIAII 563
Query: 493 ARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPH 552
+ H NLV+L GFCA + LVYEY+ +GSL LF
Sbjct: 564 GNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF---------------------- 601
Query: 553 DGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612
G PVL+W R+ IALG AR +AYLH C + ++HCD+KPENILL D F PKISDFGL+
Sbjct: 602 SGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLS 661
Query: 613 KLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRN--FEIQG 670
KL +E+ + +RGTRGY+APEW+ + I+ KADVYS+GMVLLE+VSG +N F +
Sbjct: 662 KLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRS 721
Query: 671 SMMNSDE--------------WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVN 716
+ + D YFP +A + ++E+ + ++ D + + RV
Sbjct: 722 NSVTEDNNQNHSSTTTTSTGLVYFPLYALD-MHEQGRYMELADPRL----EGRVTSQEAE 776
Query: 717 RMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITEPKKPTIYFL 760
++V+ A+ C+ + P LRP+M V M EG++ + P+ ++ FL
Sbjct: 777 KLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNPRMESLNFL 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (680), Expect = 4e-70, Method: Compositional matrix adjust.
Identities = 181/562 (32%), Positives = 272/562 (48%), Gaps = 93/562 (16%)
Query: 229 CGENAICISDGLSRSTSCVCPPGF--KNSTRQDKSCQRKIELKNLRNT-----------K 275
CG N IC S G ++ C CP F K+ + + C E++ R +
Sbjct: 314 CGYNNIC-SLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPENQTANSDVNLYE 372
Query: 276 FLQLDYVNFSRGNLSDLEADNFSACKANCSANPKCVAFGFKYDGKRYCVLVD-QLLYGYW 334
F+ L+ N+ G+ + CKA+C ++ C A F + C L +G
Sbjct: 373 FITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKCWKKKFPLSHGER 432
Query: 335 SPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDESSTTARNIAIIVTLF 394
SP + TF++V N + PV + A+ + ++
Sbjct: 433 SPRGDSDTFIKV-------------RNRSIADVPV----------TGNRAKKLDWLIIAC 469
Query: 395 AAELISGAWFFWAFLKKYIKY-----------RDMARTLGLELLPAGGPKRFTHAELRAA 443
+ L + A+ + Y K RD+ RT + FT+ EL A
Sbjct: 470 SVLLGTSAFVIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEA 529
Query: 444 TNGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHL 498
T F+ +GRG FG VYKG L VAVK L + + EF EV +I ++HH
Sbjct: 530 TRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHK 589
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
NLVRL GFC E + +VYE++P G+LA++LFR +P
Sbjct: 590 NLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFR------------------------RPR 625
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
W R IA+ +AR I YLHEEC E ++HCDIKP+NILL + + P+ISDFGLAKL
Sbjct: 626 PSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMN 685
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678
+++ IRGT+GY+APEW R+ IT K DVYS+G++LLEIV + +++ +++
Sbjct: 686 QTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDLEDNVI----- 740
Query: 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDM--VNRMVKTAMWCIQDRPELRPSM 736
WA++ + + ++ED+ + DS DM V R VK A+WCIQ+ +RP+M
Sbjct: 741 -LINWAYD-CFRQGRLEDLTED------DSEAMNDMETVERYVKIAIWCIQEEHGMRPNM 792
Query: 737 GKVAKMLEGTVEITEPKKPTIY 758
V +MLEG +++ +P P+ Y
Sbjct: 793 RNVTQMLEGVIQVFDPPNPSPY 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (627), Expect = 6e-64, Method: Compositional matrix adjust.
Identities = 151/400 (37%), Positives = 219/400 (54%), Gaps = 62/400 (15%)
Query: 364 VTTCPVNISLPLPPDESSTTARNIAIIVTL-----FAAELISGAWFFWAFLKKYIKYRDM 418
++ P+++SL SS+ R + V L FA +I F W YR
Sbjct: 215 ISASPLSVSL-----RSSSGRRTNILAVALGVSLGFAVSVILSLGFIW--------YRKK 261
Query: 419 ARTLGL---------ELLPAGGPKRFTHAELRAATNGFSN--LIGRGGFGDVYKGELTDH 467
R L + LL G + FT EL AT+GFS+ ++G GGFG+VY+G+ D
Sbjct: 262 QRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVATDGFSSKSILGAGGFGNVYRGKFGDG 321
Query: 468 RVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525
VVAVK LK+V G G+++F E+ +I+ H NL+RL G+CA ER LVY Y+ NGS+
Sbjct: 322 TVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRNLLRLIGYCASSSERLLVYPYMSNGSV 381
Query: 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEW 585
A L KP LDW+ R +IA+G AR + YLHE+C
Sbjct: 382 ASRL------------------------KAKPALDWNTRKKIAIGAARGLFYLHEQCDPK 417
Query: 586 VLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITP 645
++H D+K NILL + F + DFGLAKL ED + +RGT G++APE+L + Q +
Sbjct: 418 IIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLSTGQSSE 477
Query: 646 KADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNS 705
K DV+ FG++LLE+++G R E S+ S + +W K+++EMKVE+++DR + +
Sbjct: 478 KTDVFGFGILLLELITGMRALEFGKSV--SQKGAMLEWV-RKLHKEMKVEELVDRELGTT 534
Query: 706 YDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745
YD R+ V M++ A+ C Q P RP M +V +MLEG
Sbjct: 535 YD-RIE---VGEMLQVALLCTQFLPAHRPKMSEVVQMLEG 570
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 244 bits (622), Expect = 3e-63, Method: Compositional matrix adjust.
Identities = 134/320 (41%), Positives = 190/320 (59%), Gaps = 35/320 (10%)
Query: 430 GGPKRFTHAELRAATNGFS--NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG--GDAEF 485
G + FT EL T+GFS N++G GGFG+VY+G+L D +VAVK LK++ G GD++F
Sbjct: 286 GNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQF 345
Query: 486 WAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREME 545
E+ +I+ H NL+RL G+CA GER LVY Y+PNGS+A L
Sbjct: 346 RMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKL---------------- 389
Query: 546 MSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605
KP LDW++R RIA+G AR + YLHE+C ++H D+K NILL + F
Sbjct: 390 --------KSKPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAV 441
Query: 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRN 665
+ DFGLAKL D + +RGT G++APE+L + Q + K DV+ FG++LLE+++G R
Sbjct: 442 VGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRA 501
Query: 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWC 725
E ++ S + +W K++EEMKVE++LDR + +YD V M++ A+ C
Sbjct: 502 LEFGKTV--SQKGAMLEWV-RKLHEEMKVEELLDRELGTNYDK----IEVGEMLQVALLC 554
Query: 726 IQDRPELRPSMGKVAKMLEG 745
Q P RP M +V MLEG
Sbjct: 555 TQYLPAHRPKMSEVVLMLEG 574
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 763 | ||||||
| 255573210 | 800 | ATP binding protein, putative [Ricinus c | 0.984 | 0.938 | 0.655 | 0.0 | |
| 147770298 | 788 | hypothetical protein VITISV_005324 [Viti | 0.969 | 0.939 | 0.662 | 0.0 | |
| 225424428 | 788 | PREDICTED: G-type lectin S-receptor-like | 0.969 | 0.939 | 0.661 | 0.0 | |
| 297737599 | 820 | unnamed protein product [Vitis vinifera] | 0.937 | 0.871 | 0.644 | 0.0 | |
| 356521169 | 805 | PREDICTED: G-type lectin S-receptor-like | 0.963 | 0.913 | 0.623 | 0.0 | |
| 449450145 | 825 | PREDICTED: G-type lectin S-receptor-like | 0.976 | 0.903 | 0.570 | 0.0 | |
| 449506871 | 825 | PREDICTED: G-type lectin S-receptor-like | 0.976 | 0.903 | 0.570 | 0.0 | |
| 449506879 | 795 | PREDICTED: G-type lectin S-receptor-like | 0.951 | 0.913 | 0.566 | 0.0 | |
| 449450221 | 795 | PREDICTED: G-type lectin S-receptor-like | 0.951 | 0.913 | 0.565 | 0.0 | |
| 414868018 | 815 | TPA: putative S-locus-like receptor prot | 0.958 | 0.896 | 0.513 | 0.0 |
| >gi|255573210|ref|XP_002527534.1| ATP binding protein, putative [Ricinus communis] gi|223533084|gb|EEF34843.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1044 bits (2700), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/810 (65%), Positives = 620/810 (76%), Gaps = 59/810 (7%)
Query: 1 MSLFFFFFFIFILS-PSPSLQQQQKPQYMSSFSSSDSPWLPNQNRILLSPNSTFAAGFLP 59
MSLF+ F + + + P PSLQQ ++SFSSS++ WLPNQN+ILLSPNSTFAAGF P
Sbjct: 1 MSLFYLIFALLLCTNPLPSLQQNNS---LTSFSSSNTSWLPNQNQILLSPNSTFAAGFRP 57
Query: 60 KPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLN-SSNSNLW 118
P S NLFTFS+WY+ L + T++WSA+ + + + ++TG+LRL N SS +NLW
Sbjct: 58 LPRSPNLFTFSIWYYKLPD-KTIVWSASKDSTPLSSSASLVISSTGELRLTNGSSGTNLW 116
Query: 119 PNPKTATGNPNSTRLFLQDAGNLVYGNWQSFNLPTDTILPNQTLNG-PPLVSKNGKFSFL 177
P +T T N NST LFLQ+ GNLVYGNW SF+ PT T LP Q + G LVS NGKFSF
Sbjct: 117 PGNQT-TANSNSTSLFLQEIGNLVYGNWDSFDYPTHTFLPTQNITGRTKLVSNNGKFSFS 175
Query: 178 NASELVFVSANRSYW-----------------------------------------NIDD 196
++ LVF + Y+ +DD
Sbjct: 176 DSKNLVFDLDSEIYYTATSQFLQLRTDGSVAQANGFSIISADFNPNQTSDPKLRRLTLDD 235
Query: 197 DGNLRIYSYDDNGDRWTVVWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGFKNST 256
DG LR+YS D + D+W +VWQAVQE+C + CG NAIC+ + S S SC CPPGF+ ++
Sbjct: 236 DGVLRVYSSDQSQDQWFIVWQAVQEVCKVHGTCGPNAICMPED-SNSRSCACPPGFRKNS 294
Query: 257 RQDKSCQRKIELKNLRNTKFLQLDYVNFSRG-NLSDLEADNFSACKANCSANPKCVAFGF 315
+C RKI L NTKFL+LDYVNF+ G + S L N S C++ C + KC F F
Sbjct: 295 TNSDACDRKIPLSG--NTKFLRLDYVNFTGGLDQSSLRVGNLSVCQSRCLNDRKCQGFMF 352
Query: 316 KYDGKRYCVL-VDQLLYGYWSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLP 374
KYDG+ YCVL ++++ YGYWSPGTE A FLRVD E+D SNFTGMT++L TTCPV ISLP
Sbjct: 353 KYDGQGYCVLQLEKMPYGYWSPGTETAFFLRVDIKESDESNFTGMTSVLETTCPVRISLP 412
Query: 375 LPPDESSTTARNIAIIVTLFAAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGPKR 434
PP+ES+TT RNIAII TLFAAELISG FFWAFLKKYIKYRDMARTLGLE LPAGGPKR
Sbjct: 413 FPPEESNTTTRNIAIICTLFAAELISGILFFWAFLKKYIKYRDMARTLGLEFLPAGGPKR 472
Query: 435 FTHAELRAATNGFS--NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTII 492
FT+AEL+ ATN FS N IG+GGFGDVY+GELTD R+VAVKCLKNVTGGDAEFWAEVTII
Sbjct: 473 FTYAELKVATNDFSNANAIGKGGFGDVYRGELTDKRIVAVKCLKNVTGGDAEFWAEVTII 532
Query: 493 ARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPH 552
ARMHHLNLVRLWGFCAEKG+R LVYEYVPNGSL YLF +G++ SS EMEM G
Sbjct: 533 ARMHHLNLVRLWGFCAEKGQRILVYEYVPNGSLDKYLFPAGQLASS--GSEMEM-GPLAI 589
Query: 553 DGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612
DG KP+LDW IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA
Sbjct: 590 DGPKPILDWGIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 649
Query: 613 KLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672
KLRKKEDMVSMSRIRGTRGYMAPEW++ D ITPKADVYSFGMVLLEIV+GSRNFE+QGS+
Sbjct: 650 KLRKKEDMVSMSRIRGTRGYMAPEWVKMDPITPKADVYSFGMVLLEIVTGSRNFEMQGSI 709
Query: 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPEL 732
M+S++WYFP+WAF+KV++EMKV+DILDR IK+ YD+R+HFDMV+RMVKTAMWC+QDRPE
Sbjct: 710 MDSEDWYFPRWAFDKVFKEMKVDDILDRKIKHCYDARLHFDMVDRMVKTAMWCLQDRPEA 769
Query: 733 RPSMGKVAKMLEGTVEITEPKKPTIYFLGD 762
RPSMGKVAKMLEGTVE+TEPKKPTI+FLGD
Sbjct: 770 RPSMGKVAKMLEGTVEMTEPKKPTIFFLGD 799
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147770298|emb|CAN62476.1| hypothetical protein VITISV_005324 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1035 bits (2677), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 528/797 (66%), Positives = 614/797 (77%), Gaps = 57/797 (7%)
Query: 5 FFFFFIFILSPSPSLQQQQKPQYMSSFSSSDSPWLPNQNRILLSPNSTFAAGFLPKPNSR 64
F F+F P S Q QQ +S+FSSSDSPW P+Q +ILLSPNSTFAAGF P P S
Sbjct: 10 LIFTFLFCNPPPLSAQXQQN---ISNFSSSDSPWRPSQGQILLSPNSTFAAGFWPTPXSP 66
Query: 65 NLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTA 124
NL+ FS+WYHN+S T IWSAN PV+GNG+++I A+ G+LRL++SS NLWP A
Sbjct: 67 NLYIFSIWYHNISVHTD-IWSANANSPVSGNGTVSITAS-GELRLVDSSGKNLWPG--NA 122
Query: 125 TGNPNSTRLFLQDAGNLVYGNWQSFNLPTDTILPNQTLNGPPLVSKNGKFSFLNASELVF 184
TGNPNST+L L++ G LVYG W SF PTDTILPNQ +NG LVS+NGK+ F N+ +LVF
Sbjct: 123 TGNPNSTKLVLRNDGVLVYGXWSSFGSPTDTILPNQQINGTELVSRNGKYKFKNSMKLVF 182
Query: 185 VSANRSYWN------------------------------------IDDDGNLRIYSYDDN 208
+++ SYW+ +DDDGNLR+YS+
Sbjct: 183 NNSD-SYWSTGNAFQKLDEYGNVWQENGEKQISSDLGAAWLRRLTLDDDGNLRVYSFQGG 241
Query: 209 GDRWTVVWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGFKNSTRQDKSCQRKIEL 268
D W VVW AV EIC I CG N+IC++DG ST C+CPPGF+ ++ SC RKI++
Sbjct: 242 VDGWVVVWLAVPEICXIYGRCGANSICMNDG-GNSTRCICPPGFQ---QRGDSCDRKIQM 297
Query: 269 KNLRNTKFLQLDYVNFSRG-NLSDLEADNFSACKANCSANPKCVAFGFKYDGKRYCVL-V 326
+NTKFL+LDYVNFS G + +L NF+ C++ C AN C+ FGFKYDG YCVL +
Sbjct: 298 T--QNTKFLRLDYVNFSGGADQXNLGVQNFTICESKCLANRDCLGFGFKYDGSGYCVLQL 355
Query: 327 DQLLYGYWSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDESSTTARN 386
+LLYGYWSPGTE A +LRVD SE+D SNFTGMT+LL TTCPV ISLPLPP+ES+TT RN
Sbjct: 356 KRLLYGYWSPGTETAMYLRVDNSESDQSNFTGMTDLLETTCPVRISLPLPPEESNTTTRN 415
Query: 387 IAIIVTLFAAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGPKRFTHAELRAATNG 446
I II TLFAAELISG FF AFLKKYIKYRDMARTLGLE LPAGGPKRFT+AEL+AATN
Sbjct: 416 IVIICTLFAAELISGVLFFSAFLKKYIKYRDMARTLGLEFLPAGGPKRFTYAELKAATND 475
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
FS+ +G+GGFGDVYKGEL DHR+VAVKCLKNVTGGD EFWAEVTIIARMHHLNLVRLWGF
Sbjct: 476 FSDCVGKGGFGDVYKGELPDHRIVAVKCLKNVTGGDPEFWAEVTIIARMHHLNLVRLWGF 535
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRS-GRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
CAEKG R LVYEYVP GSL +LF + G + S E E+ + P P+LDW+IRY
Sbjct: 536 CAEKGRRILVYEYVPKGSLDKFLFPARGILKSEEDDAEDEL--LDPSR--PPMLDWNIRY 591
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL+KKEDMVSMSR
Sbjct: 592 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLKKKEDMVSMSR 651
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685
IRGTRGYMAPEW++ D ITPKADVYSFGMVLLEIVSG RN EIQ S+ S++WYFP+WAF
Sbjct: 652 IRGTRGYMAPEWVKMDPITPKADVYSFGMVLLEIVSGRRNNEIQDSLTQSEDWYFPRWAF 711
Query: 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745
+KV++EM+VEDILD I + YDSR+HFDMV+RMVKTAMWC+QDRPE+RPSMGKVAKMLEG
Sbjct: 712 DKVFKEMRVEDILDSQIIHCYDSRLHFDMVDRMVKTAMWCLQDRPEMRPSMGKVAKMLEG 771
Query: 746 TVEITEPKKPTIYFLGD 762
TVE+ EPKKPTI+FL D
Sbjct: 772 TVEMMEPKKPTIFFLAD 788
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225424428|ref|XP_002281523.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1030 bits (2664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 527/797 (66%), Positives = 613/797 (76%), Gaps = 57/797 (7%)
Query: 5 FFFFFIFILSPSPSLQQQQKPQYMSSFSSSDSPWLPNQNRILLSPNSTFAAGFLPKPNSR 64
F F+F P S Q QQ +S+FSSSDSPW P+Q +ILLSPNSTFAAGF P P S
Sbjct: 10 LIFTFLFCNPPPLSAQPQQN---ISNFSSSDSPWRPSQGQILLSPNSTFAAGFWPTPTSP 66
Query: 65 NLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTA 124
NL+ FS+WY N+S T IWSAN PV+GNG+++I A+ G+LRL++SS NLWP A
Sbjct: 67 NLYIFSIWYLNISVHTD-IWSANANSPVSGNGTVSITAS-GELRLVDSSGKNLWPG--NA 122
Query: 125 TGNPNSTRLFLQDAGNLVYGNWQSFNLPTDTILPNQTLNGPPLVSKNGKFSFLNASELVF 184
TGNPNST+L L++ G LVYG+W SF PTDTILPNQ +NG LVS+NGK+ F N+ LVF
Sbjct: 123 TGNPNSTKLVLRNDGVLVYGDWSSFGSPTDTILPNQQINGTRLVSRNGKYKFKNSMRLVF 182
Query: 185 VSANRSYWN------------------------------------IDDDGNLRIYSYDDN 208
++ SYW+ +D+DGNLR+YS+
Sbjct: 183 NDSD-SYWSTANAFQKLDEYGNVWQENGEKQISSDLGAAWLRRLTLDNDGNLRVYSFQGG 241
Query: 209 GDRWTVVWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGFKNSTRQDKSCQRKIEL 268
D W VVW AV EICTI CG N+IC++DG ST C CPPGF+ ++ SC RKI++
Sbjct: 242 VDGWVVVWLAVPEICTIYGRCGANSICMNDG-GNSTRCTCPPGFQ---QRGDSCDRKIQM 297
Query: 269 KNLRNTKFLQLDYVNFSRG-NLSDLEADNFSACKANCSANPKCVAFGFKYDGKRYCVL-V 326
+NTKFL+LDYVNFS G + ++L NF+ C++ C AN C+ FGFKYDG YCVL +
Sbjct: 298 T--QNTKFLRLDYVNFSGGADQNNLGVQNFTICESKCLANRDCLGFGFKYDGSGYCVLQL 355
Query: 327 DQLLYGYWSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDESSTTARN 386
+LLYGYWSPGTE A +LRVD SE+D SNFTGMT+LL TTCPV ISLPLPP+ES+TT RN
Sbjct: 356 KRLLYGYWSPGTETAMYLRVDNSESDQSNFTGMTDLLETTCPVRISLPLPPEESNTTTRN 415
Query: 387 IAIIVTLFAAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGPKRFTHAELRAATNG 446
I II TLFAAELISG FF AFLKKYIKYRDMARTLGLE LPAGGPKRFT+AEL+AATN
Sbjct: 416 IVIICTLFAAELISGVLFFSAFLKKYIKYRDMARTLGLEFLPAGGPKRFTYAELKAATND 475
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
FS+ +G+GGFGDVYKGEL DHR+VAVKCLKNVTGGD EFWAEVTIIARMHHLNLVRLWGF
Sbjct: 476 FSDCVGKGGFGDVYKGELPDHRIVAVKCLKNVTGGDPEFWAEVTIIARMHHLNLVRLWGF 535
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRS-GRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
CAEKG R LVYEYVP GSL +LF + G + S E E+ + P P+LDW+IRY
Sbjct: 536 CAEKGRRILVYEYVPKGSLDKFLFPARGILKSEEDYAEDEL--LDPSR--PPMLDWNIRY 591
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL+KKEDMVSMSR
Sbjct: 592 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLKKKEDMVSMSR 651
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685
IRGTRGYMAPEW++ D ITPKADVYSFGMVLLEIVSG RN EIQ S+ S++WYFP+WAF
Sbjct: 652 IRGTRGYMAPEWVKMDPITPKADVYSFGMVLLEIVSGRRNNEIQDSLTQSEDWYFPRWAF 711
Query: 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745
+KV++EM+VEDILD I + YDSR+HFDMV+RMVKTAMWC+QDRPE+RPSMGKVAKMLEG
Sbjct: 712 DKVFKEMRVEDILDSQIIHCYDSRLHFDMVDRMVKTAMWCLQDRPEMRPSMGKVAKMLEG 771
Query: 746 TVEITEPKKPTIYFLGD 762
TVE+ EPKKPTI+FL D
Sbjct: 772 TVEMMEPKKPTIFFLAD 788
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297737599|emb|CBI26800.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 991 bits (2563), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/794 (64%), Positives = 592/794 (74%), Gaps = 79/794 (9%)
Query: 5 FFFFFIFILSPSPSLQQQQKPQYMSSFSSSDSPWLPNQNRILLSPNSTFAAGFLPKPNSR 64
F F+F P S Q QQ +S+FSSSDSPW P+Q +ILLSPNSTFAAGF P P S
Sbjct: 10 LIFTFLFCNPPPLSAQPQQN---ISNFSSSDSPWRPSQGQILLSPNSTFAAGFWPTPTSP 66
Query: 65 NLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTA 124
NL+ FS+WY N+S T IWSAN PV+GNG+++I A+ G+LRL++SS NLWP A
Sbjct: 67 NLYIFSIWYLNISVHTD-IWSANANSPVSGNGTVSITAS-GELRLVDSSGKNLWPG--NA 122
Query: 125 TGNPNSTRLFLQDAGNLVYGNWQSFNLPTDTILPNQTLNGPPLVSKNGKFSFLNASELVF 184
TGNPNST+L L++ G LVYG+W SF PTDTILPNQ +NG LVS+NGK+ F N+ LVF
Sbjct: 123 TGNPNSTKLVLRNDGVLVYGDWSSFGSPTDTILPNQQINGTRLVSRNGKYKFKNSMRLVF 182
Query: 185 VSANRSYWN------------------------------------IDDDGNLRIYSYDDN 208
++ SYW+ +D+DGNLR+YS+
Sbjct: 183 NDSD-SYWSTANAFQKLDEYGNVWQENGEKQISSDLGAAWLRRLTLDNDGNLRVYSFQGG 241
Query: 209 GDRWTVVWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGFKNSTRQDKSCQRKIEL 268
D W VVW AV EICTI CG N+IC++DG ST C CPPGF+ ++ SC RKI++
Sbjct: 242 VDGWVVVWLAVPEICTIYGRCGANSICMNDG-GNSTRCTCPPGFQ---QRGDSCDRKIQM 297
Query: 269 KNLRNTKFLQLDYVNFSRG-NLSDLEADNFSACKANCSANPKCVAFGFKYDGKRYCVL-V 326
+NTKFL+LDYVNFS G + ++L NF+ C++ C AN C+ FGFKYDG YCVL +
Sbjct: 298 T--QNTKFLRLDYVNFSGGADQNNLGVQNFTICESKCLANRDCLGFGFKYDGSGYCVLQL 355
Query: 327 DQLLYGYWSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDESSTTARN 386
+LLYGYWSPGTE A +LRVD SE+D SNFTGMT+LL TTCPV ISLPLPP+ES+TT RN
Sbjct: 356 KRLLYGYWSPGTETAMYLRVDNSESDQSNFTGMTDLLETTCPVRISLPLPPEESNTTTRN 415
Query: 387 IAIIVTLFAAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGPKRFTHAELRAATNG 446
I II TLFAAELISG FF AFLKKYIKYRDMARTLGLE LPAGGPKRFT+AEL+AATN
Sbjct: 416 IVIICTLFAAELISGVLFFSAFLKKYIKYRDMARTLGLEFLPAGGPKRFTYAELKAATND 475
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
FS+ +G+GGFGDVYKGEL DHR+VAVKCLKNVTGGD EFWAEVTIIARMHHLNLVRLWGF
Sbjct: 476 FSDCVGKGGFGDVYKGELPDHRIVAVKCLKNVTGGDPEFWAEVTIIARMHHLNLVRLWGF 535
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
CAEKG R LVYEYVP GSL +LF PA W+IRYR
Sbjct: 536 CAEKGRRILVYEYVPKGSLDKFLF---------PAH------------------WNIRYR 568
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL+KKEDMVSMSRI
Sbjct: 569 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLKKKEDMVSMSRI 628
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686
RGTRGYMAPEW++ D ITPKADVYSFGMVLLEIVSG RN EIQ S+ S++WYFP+WAF+
Sbjct: 629 RGTRGYMAPEWVKMDPITPKADVYSFGMVLLEIVSGRRNNEIQDSLTQSEDWYFPRWAFD 688
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746
KV++EM+VEDILD I + YDSR+HFDMV+RMVKTAMWC+QDRPE+RPSMGKVAKMLEGT
Sbjct: 689 KVFKEMRVEDILDSQIIHCYDSRLHFDMVDRMVKTAMWCLQDRPEMRPSMGKVAKMLEGT 748
Query: 747 VEITEPKKPTIYFL 760
+ P I L
Sbjct: 749 KILPLPPHLIIISL 762
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521169|ref|XP_003529230.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2497), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/791 (62%), Positives = 591/791 (74%), Gaps = 56/791 (7%)
Query: 17 PSLQQQQKPQYMSSFSSSDSPWLPNQNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNL 76
PS+ QQQ +SF+ S SPWLP QN+ LLSPN F AGF P PNS N+FTFS+WY +
Sbjct: 25 PSVSQQQ----FTSFNISHSPWLPAQNKTLLSPNKNFTAGFFPLPNSSNVFTFSIWYSKV 80
Query: 77 SEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQ 136
P+ + N V +GSL I G+L LLN S N T NST+L LQ
Sbjct: 81 P-PSANPFVWNATVQVNTSGSLEITP-KGEL-LLNGSPFQSAEN-ATTNSTSNSTQLLLQ 136
Query: 137 DAGNLVYGNWQSFNLPTDTILPNQTLN-GPPLVSKNGKFSFLNASELVFVSANRSYWN-- 193
+ GNLV+G W SF PT T+LPNQ + G L S NGKF F+ + LV S + Y+N
Sbjct: 137 NDGNLVFGEWSSFKNPTSTVLPNQNFSTGFELHSNNGKFRFIKSQNLVLSSTSDQYYNTP 196
Query: 194 ---------------------------------IDDDGNLRIYS-YDDNGDRWTVVWQAV 219
+DDDGNLRIYS Y + ++W VW+ +
Sbjct: 197 SQLLNMDDNGKMSMQGNSFLTSDYGDPRFRKLVLDDDGNLRIYSFYPEQKNQWVEVWKGI 256
Query: 220 QEICTIPDLCGENAICI-SDGLSRSTSCVCPPGFKNSTRQD--KSCQRKIELKNLRNTKF 276
E+C I CG NAIC+ + LS ST CVCP GF + + D K C+RKI L +NT+F
Sbjct: 257 WEMCRIKGKCGPNAICVPKEDLSTSTYCVCPSGFTPAIQNDPEKGCRRKIPLS--QNTQF 314
Query: 277 LQLDYVNFSR-GNLSDLEADNFSACKANCSANPKCVAFGFKYDGKRYCVLVD--QLLYGY 333
L+LDYVN S G+L++++ADNF+ C+ANCS C+ FGFKYDG YC+LV+ L YG+
Sbjct: 315 LRLDYVNCSSDGHLNEIKADNFAMCEANCSREKTCLGFGFKYDGSGYCMLVNGTNLQYGF 374
Query: 334 WSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDESSTTARNIAIIVTL 393
WSPGTE A F++VD+SE+ VSNF GMT ++ TTCPVNISLPLPP +S+ TARNIAII TL
Sbjct: 375 WSPGTEAALFVKVDKSESSVSNFIGMTEVMQTTCPVNISLPLPPKDSNATARNIAIICTL 434
Query: 394 FAAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGPKRFTHAELRAATNGFSNLIGR 453
FAAELI+G FFW+FLK+YIKYRDMA TLGLELLPAGGPKRFT++E++AAT FSNLIG+
Sbjct: 435 FAAELIAGVAFFWSFLKRYIKYRDMATTLGLELLPAGGPKRFTYSEIKAATKDFSNLIGK 494
Query: 454 GGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513
GGFGDVYKGEL DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG+R
Sbjct: 495 GGFGDVYKGELPDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGQR 554
Query: 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPH--DGGKPVLDWSIRYRIALGV 571
LVYE++P GSL YLFR + +++ +E + S + P+ + VLDWS+RYRIALG+
Sbjct: 555 ILVYEHIPGGSLDKYLFRVNKSHNNNHLKE-QSSSLNPNTPQQERHVLDWSMRYRIALGM 613
Query: 572 ARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRG 631
ARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV+MSR RGT G
Sbjct: 614 ARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVTMSRRRGTPG 673
Query: 632 YMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEE 691
YMAPEW+ +D IT KADVYSFGMVLLE+VSG RNFEIQGS++ S+EWYFP WAF+K+++E
Sbjct: 674 YMAPEWITADPITSKADVYSFGMVLLELVSGIRNFEIQGSVVRSEEWYFPGWAFDKMFKE 733
Query: 692 MKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITE 751
M+VE+ILD I+++YDSR HF+MVNRMVKTAMWC+QDRPELRP+MGKVAKMLEGTVEITE
Sbjct: 734 MRVEEILDGQIRDAYDSRAHFEMVNRMVKTAMWCLQDRPELRPTMGKVAKMLEGTVEITE 793
Query: 752 PKKPTIYFLGD 762
PKKPT++FLG+
Sbjct: 794 PKKPTVFFLGE 804
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450145|ref|XP_004142824.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 863 bits (2231), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/806 (57%), Positives = 565/806 (70%), Gaps = 61/806 (7%)
Query: 1 MSLFFFFFFIFILS-PSPSLQQQQKPQYMSSFSSSDSPWLPNQNRILLSPNSTFAAGFLP 59
MSL F +F+L PSP+ Q KP S+FS S SPW P+ N +LLSPNS FAAGF P
Sbjct: 1 MSLAVAFSALFLLFFPSPAAAQSPKPTNFSAFSISQSPWRPSHNLLLLSPNSLFAAGFHP 60
Query: 60 KPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWP 119
PN+ NLF FSVWY N+S ++WSAN PV + +L I A TGQLRL ++S NLWP
Sbjct: 61 LPNNSNLFIFSVWYFNIST-DNIVWSANRLHPVTRSAALVITA-TGQLRLNDASGRNLWP 118
Query: 120 NPKTATGNPNSTRLFLQDAGNLVYGNWQSFNLPTDTILPNQTLNGPPLVSKNGKFSFLNA 179
+ + N NSTRL L+D G+L+YG W+SF PT+TILPNQTLNG ++S NGK+SF+N+
Sbjct: 119 S-NNVSANSNSTRLILRDDGDLIYGTWESFQFPTNTILPNQTLNGTTIISNNGKYSFVNS 177
Query: 180 SELVFVSANRSYWN-----------------------------------IDDDGNLRIYS 204
L F R +W +DDDGNL+I S
Sbjct: 178 VNLTF-GTERYWWTDNPFKNFENTGQINRDNQNPIYPTDFNSTRLRKLVVDDDGNLKILS 236
Query: 205 YDDNGDRWTVVWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGFKNSTR--QDKSC 262
++ N RW +VWQA E+C I CG N++C+S G ST CVC PGF R + C
Sbjct: 237 FNPNSPRWDMVWQAHVELCQIFRTCGPNSVCMSSGSYNSTYCVCAPGFSPDPRGGARQGC 296
Query: 263 QRKIELKNLRNTKFLQLDYVNFSRG-NLSDLEADNFSACKANCSANPKCVAFGFKYDGKR 321
RK+ + N +KFLQLD+VNF G N +E N S C+ANC N CV + F ++G
Sbjct: 297 NRKLNVSN--KSKFLQLDFVNFRGGANQIFMETPNISVCQANCLKNSSCVGYTFSFEGND 354
Query: 322 YCVL-VDQLLYGYWSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDES 380
CVL +D L G+WSPG + A F++VD SE D SNFTGM L TTCPV+ISL PPD
Sbjct: 355 QCVLQLDILSNGFWSPGMKTAAFVKVDNSETDQSNFTGMMYKLQTTCPVHISLRPPPDNK 414
Query: 381 STTARNIAIIVTLFAAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGPKRFTHAEL 440
T RNI IIVT+F AELISGA FF AFLK++IKYRDMARTLG E LPAGGPKRF++ EL
Sbjct: 415 DNTTRNIWIIVTIFIAELISGAVFFCAFLKRFIKYRDMARTLGFESLPAGGPKRFSYDEL 474
Query: 441 RAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL 500
+ ATN FSN +G+GGFG+V+KGEL D RV+AVKCLKNV+GGD +FWAEVT+IARMHHLNL
Sbjct: 475 KIATNDFSNPVGKGGFGEVFKGELPDKRVIAVKCLKNVSGGDGDFWAEVTVIARMHHLNL 534
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+RLWGFCAEKG+R LVYEY+PNGSL +LF SS + +E+ DG P+LD
Sbjct: 535 LRLWGFCAEKGQRMLVYEYIPNGSLDKFLFV-----KSSFSDSIEI------DGENPLLD 583
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
W IRYRIA+GVARAIAYLHEECLEWVLH DIKPENILL +DFCPK++DFGL+KL++ +
Sbjct: 584 WGIRYRIAIGVARAIAYLHEECLEWVLHRDIKPENILLDNDFCPKLADFGLSKLKENDGT 643
Query: 621 -VSMSRIRGTRGYMAPEWLR--SDQITPKADVYSFGMVLLEIVSGSRNFEI-QGSMMNSD 676
VSMSRIRGT GY+APE ++ S+ ITPKADVYSFGMVLLEI+SG+RNF+ +GS + S
Sbjct: 644 AVSMSRIRGTPGYVAPELVKLGSNSITPKADVYSFGMVLLEIISGTRNFDTKEGSTVESA 703
Query: 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
WYFP WAFEK + E K+E++LD I+N YDS HF +VNRMV+TAMWC+Q +PE+RPSM
Sbjct: 704 FWYFPSWAFEKAFVEEKIEEVLDSRIRNEYDSGGHFAIVNRMVQTAMWCLQSQPEMRPSM 763
Query: 737 GKVAKMLEGTVEITEPKKPTIYFLGD 762
GKV KMLEG +EI P+KP+IYFL +
Sbjct: 764 GKVVKMLEGKLEIPNPEKPSIYFLSE 789
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449506871|ref|XP_004162871.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 863 bits (2231), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/806 (57%), Positives = 565/806 (70%), Gaps = 61/806 (7%)
Query: 1 MSLFFFFFFIFILS-PSPSLQQQQKPQYMSSFSSSDSPWLPNQNRILLSPNSTFAAGFLP 59
MSL F +F+L PSP+ Q KP S+FS S SPW P+ N +LLSPNS FAAGF P
Sbjct: 1 MSLAVAFSALFLLFFPSPAAAQSPKPTNFSAFSISQSPWRPSHNLLLLSPNSLFAAGFRP 60
Query: 60 KPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWP 119
PN+ NLF FSVWY N+S ++WSAN PV + +L I A TGQLRL ++S NLWP
Sbjct: 61 LPNNSNLFIFSVWYFNIST-DNIVWSANRLHPVTRSAALVITA-TGQLRLNDASGRNLWP 118
Query: 120 NPKTATGNPNSTRLFLQDAGNLVYGNWQSFNLPTDTILPNQTLNGPPLVSKNGKFSFLNA 179
+ + N NSTRL L+D G+L+YG W+SF PT+TILPNQTLNG ++S NGK+SF+N+
Sbjct: 119 S-NNVSANSNSTRLILRDDGDLIYGTWESFQFPTNTILPNQTLNGTTIISNNGKYSFVNS 177
Query: 180 SELVFVSANRSYWN-----------------------------------IDDDGNLRIYS 204
L F R +W +DDDGNL+I S
Sbjct: 178 VNLTF-GTERYWWTDNPFKNFENTGQINRDNQNPIYPTDFNSTRLRKLVVDDDGNLKILS 236
Query: 205 YDDNGDRWTVVWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGFKNSTR--QDKSC 262
++ N RW +VWQA E+C I CG N++C+S G ST CVC PGF R + C
Sbjct: 237 FNPNSPRWDMVWQAHVELCQIFRTCGPNSVCMSSGSYNSTYCVCAPGFSPDPRGGARQGC 296
Query: 263 QRKIELKNLRNTKFLQLDYVNFSRG-NLSDLEADNFSACKANCSANPKCVAFGFKYDGKR 321
RK+ + N +KFLQLD+VNF G N +E N S C+ANC N CV + F ++G
Sbjct: 297 NRKLNVSN--KSKFLQLDFVNFRGGANQIFMETPNISVCQANCLKNSSCVGYTFSFEGND 354
Query: 322 YCVL-VDQLLYGYWSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDES 380
CVL +D L G+WSPG + A F++VD SE D SNFTGM L TTCPV+ISL PPD
Sbjct: 355 QCVLQLDILSNGFWSPGMKTAAFVKVDNSETDQSNFTGMMYKLQTTCPVHISLRPPPDNK 414
Query: 381 STTARNIAIIVTLFAAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGPKRFTHAEL 440
T RNI IIVT+F AELISGA FF AFLK++IKYRDMARTLG E LPAGGPKRF++ EL
Sbjct: 415 DNTTRNIWIIVTIFIAELISGAVFFCAFLKRFIKYRDMARTLGFESLPAGGPKRFSYDEL 474
Query: 441 RAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL 500
+ ATN FSN +G+GGFG+V+KGEL D RV+AVKCLKNV+GGD +FWAEVT+IARMHHLNL
Sbjct: 475 KIATNDFSNPVGKGGFGEVFKGELPDKRVIAVKCLKNVSGGDGDFWAEVTVIARMHHLNL 534
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+RLWGFCAEKG+R LVYEY+PNGSL +LF SS + +E+ DG P+LD
Sbjct: 535 LRLWGFCAEKGQRMLVYEYIPNGSLDKFLFV-----KSSFSDSIEI------DGENPLLD 583
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
W IRYRIA+GVARAIAYLHEECLEWVLH DIKPENILL +DFCPK++DFGL+KL++ +
Sbjct: 584 WGIRYRIAIGVARAIAYLHEECLEWVLHRDIKPENILLDNDFCPKLADFGLSKLKENDGT 643
Query: 621 -VSMSRIRGTRGYMAPEWLR--SDQITPKADVYSFGMVLLEIVSGSRNFEI-QGSMMNSD 676
VSMSRIRGT GY+APE ++ S+ ITPKADVYSFGMVLLEI+SG+RNF+ +GS + S
Sbjct: 644 AVSMSRIRGTPGYVAPELVKLGSNSITPKADVYSFGMVLLEIISGTRNFDTKEGSTVESA 703
Query: 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
WYFP WAFEK + E K+E++LD I+N YDS HF +VNRMV+TAMWC+Q +PE+RPSM
Sbjct: 704 FWYFPSWAFEKAFVEEKIEEVLDSRIRNEYDSGGHFAIVNRMVQTAMWCLQSQPEMRPSM 763
Query: 737 GKVAKMLEGTVEITEPKKPTIYFLGD 762
GKV KMLEG +EI P+KP+IYFL +
Sbjct: 764 GKVVKMLEGKLEIPNPEKPSIYFLSE 789
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449506879|ref|XP_004162873.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 853 bits (2205), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/789 (56%), Positives = 539/789 (68%), Gaps = 63/789 (7%)
Query: 20 QQQQKPQYMSSFSSSDSPWLPNQNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEP 79
Q P+ SSFS S SPW P QN LLSPNS FAAGF P PN+ NLF FSVWY N+S
Sbjct: 20 QPTTNPRKFSSFSISQSPWRPTQNLTLLSPNSLFAAGFHPLPNNSNLFIFSVWYFNIST- 78
Query: 80 TTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAG 139
V+WSAN PV + +L I A TGQLRL ++S NLWP+ + + NST+L L+D G
Sbjct: 79 DNVVWSANRLHPVNRSAALVITA-TGQLRLNDASGRNLWPS-NNVSAHSNSTQLILRDDG 136
Query: 140 NLVYGNWQSFNLPTDTILPNQTLNGPPLVSKNGKFSFLNASELVFVSANRSYWN------ 193
+L+YG W+SF PT+T LPN T NG +VS NGK+SF+N++ L F +YW+
Sbjct: 137 DLIYGTWESFQFPTNTFLPNHTFNGTSIVSNNGKYSFVNSANLTF--GTETYWSSGNPFQ 194
Query: 194 ------------------------------IDDDGNLRIYSYDDNGDRWTVVWQAVQEIC 223
+DDDGNLRI+S++ N RW VVWQA E+C
Sbjct: 195 NFQIDGQIIINNQIPVIPSDFNSTRFRKLVLDDDGNLRIFSFNPNWPRWDVVWQAHVELC 254
Query: 224 TIPDLCGENAICISDGLSRSTSCVCPPGFKNSTR--QDKSCQRKIELKNLRNTKFLQLDY 281
I D CG N++C+S G ST CVC PGF + R + C RK+ + N KFLQLD+
Sbjct: 255 QILDTCGPNSVCMSSGSYNSTYCVCAPGFSPNPRGGARQGCHRKLNVSN--KPKFLQLDF 312
Query: 282 VNFSRGNLSD--LEADNFSACKANCSANPKCVAFGFKYDG----KRYCVL-VDQLLYGYW 334
VNF RG + L+ N S C+A+C N CV + F +DG CVL +D L G W
Sbjct: 313 VNF-RGGVKQISLQTPNISVCQADCLKNSSCVGYTFSFDGNGNAHAQCVLQLDILSNGLW 371
Query: 335 SPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDESSTTARNIAIIVTLF 394
SPG + A F++VD SE D SNFTGM L TTCPV I+L PP T RNI II T+F
Sbjct: 372 SPGMKAAAFVKVDNSETDRSNFTGMMYKLQTTCPVRITLRPPPVNKDNTTRNILIISTIF 431
Query: 395 AAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGPKRFTHAELRAATNGFSNLIGRG 454
AELI+GA FFWAFLK+++KYRDMARTLGLE LPAGGPKRF +AEL+ ATN FS IGRG
Sbjct: 432 VAELITGAVFFWAFLKRFVKYRDMARTLGLESLPAGGPKRFNYAELKTATNDFSTCIGRG 491
Query: 455 GFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514
GFG+V+KGEL D RVVAVKCLKNV GGD +FWAEVTIIARMHHLNL+RLWGFCAEKG+R
Sbjct: 492 GFGEVFKGELPDKRVVAVKCLKNVAGGDRDFWAEVTIIARMHHLNLLRLWGFCAEKGQRI 551
Query: 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARA 574
LVYE++PNGSL +LF S P LDWSIRYRIA+GVARA
Sbjct: 552 LVYEHIPNGSLDKFLFVKHSPSDSEKEERETEEERSP-------LDWSIRYRIAIGVARA 604
Query: 575 IAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED-MVSMSRIRGTRGYM 633
IAYLHEECLEWVLH DIKPENILL +DFCPK+SDFGL+KLRK E+ VSMSRIRGT GY+
Sbjct: 605 IAYLHEECLEWVLHRDIKPENILLDNDFCPKLSDFGLSKLRKNEETTVSMSRIRGTPGYV 664
Query: 634 APEWLR--SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEE 691
APE ++ S+ IT KADVYSFGMVLLEI+SG+RNFEI+ + S +WYFP WAFEK + E
Sbjct: 665 APELVKLGSNSITTKADVYSFGMVLLEIISGTRNFEIKRWTVESADWYFPGWAFEKAFVE 724
Query: 692 MKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITE 751
K+++ILD I+ Y+ + +VNRMV+TAMWC+Q++PE RPSMGKV KMLEG +EI
Sbjct: 725 EKMKEILDGRIREEYERGGNVCIVNRMVETAMWCLQNQPEKRPSMGKVVKMLEGKLEIPP 784
Query: 752 PKKPTIYFL 760
P+KP+IYFL
Sbjct: 785 PEKPSIYFL 793
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450221|ref|XP_004142862.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2196), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/789 (56%), Positives = 538/789 (68%), Gaps = 63/789 (7%)
Query: 20 QQQQKPQYMSSFSSSDSPWLPNQNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEP 79
Q P+ SSFS S SPW P QN LLSPNS FAAGF P PN+ NLF FSVWY N+S
Sbjct: 20 QPTTNPRKFSSFSISQSPWRPTQNLTLLSPNSLFAAGFHPLPNNSNLFIFSVWYFNIST- 78
Query: 80 TTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAG 139
V+WSAN PV + +L I A TGQLRL ++S NLWP+ + + NST+L L+D G
Sbjct: 79 DNVVWSANRLHPVNRSAALVITA-TGQLRLNDASGRNLWPS-NNVSAHSNSTQLILRDDG 136
Query: 140 NLVYGNWQSFNLPTDTILPNQTLNGPPLVSKNGKFSFLNASELVFVSANRSYWN------ 193
+L+YG W+SF PT+T LPN T NG +VS NGK+SF+N++ L F +YW+
Sbjct: 137 DLIYGTWESFQFPTNTFLPNHTFNGTSIVSNNGKYSFVNSANLTF--GTETYWSSGNPFQ 194
Query: 194 ------------------------------IDDDGNLRIYSYDDNGDRWTVVWQAVQEIC 223
+DDDGNLRI+S++ N RW VVWQA E+C
Sbjct: 195 NFQIDGQIIINNQIPVIPSDFNSTRFRKLVLDDDGNLRIFSFNPNWPRWDVVWQAHVELC 254
Query: 224 TIPDLCGENAICISDGLSRSTSCVCPPGFKNSTR--QDKSCQRKIELKNLRNTKFLQLDY 281
I CG N++C+S G ST CVC PGF + R + C RK+ + N KFLQLD+
Sbjct: 255 QIFRTCGPNSVCMSSGSYNSTYCVCAPGFSPNPRGGARQGCHRKLNVSN--KPKFLQLDF 312
Query: 282 VNFSRGNLSD--LEADNFSACKANCSANPKCVAFGFKYDG----KRYCVL-VDQLLYGYW 334
VNF RG + L+ N S C+A+C N CV + F +DG CVL +D L G W
Sbjct: 313 VNF-RGGVKQISLQTPNISVCQADCLKNSSCVGYTFSFDGNGNAHAQCVLQLDILSNGLW 371
Query: 335 SPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDESSTTARNIAIIVTLF 394
SPG + A F++VD SE D SNFTGM L TTCPV I+L PP T RNI II T+F
Sbjct: 372 SPGMKAAAFVKVDNSETDRSNFTGMMYKLQTTCPVRITLRPPPVNKDNTTRNILIISTIF 431
Query: 395 AAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGPKRFTHAELRAATNGFSNLIGRG 454
AELI+GA FFWAFLK+++KYRDMARTLGLE LPAGGPKRF +AEL+ ATN FS IGRG
Sbjct: 432 VAELITGAVFFWAFLKRFVKYRDMARTLGLESLPAGGPKRFNYAELKTATNDFSTCIGRG 491
Query: 455 GFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514
GFG+V+KGEL D RVVAVKCLKNV GGD +FWAEVTIIARMHHLNL+RLWGFCAEKG+R
Sbjct: 492 GFGEVFKGELPDKRVVAVKCLKNVAGGDRDFWAEVTIIARMHHLNLLRLWGFCAEKGQRI 551
Query: 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARA 574
LVYE++PNGSL +LF S P LDWSIRYRIA+GVARA
Sbjct: 552 LVYEHIPNGSLDKFLFVKHSPSDSEKEERETEEERSP-------LDWSIRYRIAIGVARA 604
Query: 575 IAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED-MVSMSRIRGTRGYM 633
IAYLHEECLEWVLH DIKPENILL +DFCPK+SDFGL+KLRK E+ VSMSRIRGT GY+
Sbjct: 605 IAYLHEECLEWVLHRDIKPENILLDNDFCPKLSDFGLSKLRKNEETTVSMSRIRGTPGYV 664
Query: 634 APEWLR--SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEE 691
APE ++ S+ IT KADVYSFGMVLLEI+SG+RNFEI+ + S +WYFP WAFEK + E
Sbjct: 665 APELVKLGSNSITTKADVYSFGMVLLEIISGTRNFEIKRWTVESADWYFPGWAFEKAFVE 724
Query: 692 MKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITE 751
K+++ILD I+ Y+ + +VNRMV+TAMWC+Q++PE RPSMGKV KMLEG +EI
Sbjct: 725 EKMKEILDGRIREEYERGGNVCIVNRMVETAMWCLQNQPEKRPSMGKVVKMLEGKLEIPP 784
Query: 752 PKKPTIYFL 760
P+KP+IYFL
Sbjct: 785 PEKPSIYFL 793
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|414868018|tpg|DAA46575.1| TPA: putative S-locus-like receptor protein kinase family protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1991), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/799 (51%), Positives = 515/799 (64%), Gaps = 68/799 (8%)
Query: 26 QYMSSFSSSDSPWLP-NQNRILLSPNSTFAAGFLPKPNSRNLFTFSVWY-HNLSEPTTVI 83
Q MSSFS+++S W P N NRIL+S N FAAGF+ ++R+ + F+VW + S I
Sbjct: 22 QQMSSFSANNSTWSPTNSNRILVSINREFAAGFVASTSARDRYHFAVWVVGSNSTDKAFI 81
Query: 84 WSANDKF---PVAGNGS--LAIAATTGQLRLLNSSNSN--LWPNPKTATGNPNSTRLFLQ 136
W A+D P GN + LAI A G+L N+N +W P A L L
Sbjct: 82 WYAHDTASYSPYEGNDTSKLAIDAA-GRLTWTAGGNNNATIWSLPPPANTTTTPAVLQLN 140
Query: 137 DAGNLVYGN-WQSFNLPTDTILPNQTL----NGPPLVSKNGKFSFLNASELVF------- 184
D G+LVYG W SF PT+T++P Q + N L S NG + +N++ L F
Sbjct: 141 DTGSLVYGAAWSSFAEPTNTLMPGQAMPKGGNDTTLQSVNGHYRVVNSATLQFNNSMMYA 200
Query: 185 -VSANRSYWNI-----------------------------DDDGNLRIYSYDDNGDRWTV 214
+S + N+ DDDGNLR+YS +W V
Sbjct: 201 NISGGSALLNLTADGKLQFSGSQLIASDQGTTNRVRRLTLDDDGNLRLYSLVPKTRKWLV 260
Query: 215 VWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGFKNSTRQDKSCQRKIELKNLRNT 274
VWQ VQE+CTI C IC+ G+ ST+CVCPPG++N+T D +K +
Sbjct: 261 VWQVVQELCTIRGTCANGRICVPVGVD-STTCVCPPGYRNATPTDPCTPKKRYSGRGDDD 319
Query: 275 KFLQLDYVNFSRGN----------LSDLEADNFSACKANCSANPKCVAFGFKYDGKRYCV 324
F+++D+V+FS ++ L N + C+ C +N CVAFG+K+ G R C+
Sbjct: 320 TFVRMDFVSFSGAANSSASDPGPLMTKLTPQNLADCERLCRSNSTCVAFGYKFGGDRTCL 379
Query: 325 LVDQLLYGYWSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDESSTTA 384
L+ GYWSP TEM+T+LRV S+ND + FTGMT ++ T CPV ++LP+PP ES TT
Sbjct: 380 QFTGLVDGYWSPATEMSTYLRVVASDNDSNPFTGMTTMIETVCPVQLALPVPPKESQTTI 439
Query: 385 RNIAIIVTLFAAELISGAWFFWAFLKKYIKYRDMARTLGLELLPAGGPKRFTHAELRAAT 444
+N+AII LF EL++G FWAFL+KY +YR+MARTLGLE LPAGGP+RF+HAEL+ AT
Sbjct: 440 QNVAIITALFVVELLAGVLSFWAFLRKYSQYREMARTLGLEYLPAGGPRRFSHAELKQAT 499
Query: 445 NGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLW 504
FSN++GRG +G VY+GEL D R VAVK L+ V GG+AEFWAEVTIIARMHHLNLVR+W
Sbjct: 500 KDFSNVVGRGAYGTVYRGELPDRRAVAVKQLQGVGGGEAEFWAEVTIIARMHHLNLVRMW 559
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
GFCAEK +R LVYEYVPNGSL YLF G E +P+LD R
Sbjct: 560 GFCAEKEQRMLVYEYVPNGSLDKYLF----AGGGGGGGSGEEDSSAEQQQQQPLLDLHTR 615
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
YRIALGVARAIAYLHEECLEWVLHCDIKPENILL DDFCPK+SDFGL+KL K++ V+MS
Sbjct: 616 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLEDDFCPKVSDFGLSKLTSKKEKVTMS 675
Query: 625 RIRGTRGYMAPEW-LRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683
RIRGTRGYMAPEW + + IT KADVYSFGMVLLEIVSG RN+ + + S++WYFPKW
Sbjct: 676 RIRGTRGYMAPEWVIHREPITAKADVYSFGMVLLEIVSGRRNYGFRQESVGSEDWYFPKW 735
Query: 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743
A+EKVY E +++DILD I +YD V RMVKTAMWC+QDR E+RPSMGKV+KML
Sbjct: 736 AYEKVYVERRIDDILDPRIAATYDDAASVATVERMVKTAMWCLQDRAEMRPSMGKVSKML 795
Query: 744 EGTVEITEPKKPTIYFLGD 762
EG+VEITEP KPTI+ + D
Sbjct: 796 EGSVEITEPVKPTIFCVQD 814
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 763 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.256 | 0.236 | 0.529 | 4.6e-103 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.250 | 0.232 | 0.5 | 1.5e-85 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.737 | 0.645 | 0.312 | 3.2e-77 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.254 | 0.234 | 0.475 | 1.8e-76 | |
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.255 | 0.228 | 0.431 | 4.6e-60 | |
| TAIR|locus:2020583 | 799 | AT1G70250 [Arabidopsis thalian | 0.389 | 0.371 | 0.395 | 5.4e-59 | |
| TAIR|locus:2147635 | 452 | AT5G20050 [Arabidopsis thalian | 0.399 | 0.674 | 0.412 | 1.9e-58 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.242 | 0.228 | 0.372 | 2.4e-58 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.252 | 0.290 | 0.409 | 4.4e-58 | |
| TAIR|locus:2197704 | 831 | AT1G61390 [Arabidopsis thalian | 0.243 | 0.223 | 0.368 | 4.2e-57 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 4.6e-103, Sum P(3) = 4.6e-103
Identities = 108/204 (52%), Positives = 140/204 (68%)
Query: 553 DGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612
D K L W R+ IALG A+ I YLHEEC + ++HCDIKPENIL+ D+F K+SDFGLA
Sbjct: 572 DSAK-FLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLA 630
Query: 613 KL-RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671
KL K++ +MS +RGTRGY+APEWL + IT K+DVYS+GMVLLE+VSG RNF++
Sbjct: 631 KLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVS-E 689
Query: 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPE 731
N + F WA+E+ +E+ + ILD + S D V + V RMVKT+ WCIQ++P
Sbjct: 690 KTNHKK--FSIWAYEE-FEKGNTKAILDTRL--SEDQTVDMEQVMRMVKTSFWCIQEQPL 744
Query: 732 LRPSMGKVAKMLEGTVEITEPKKP 755
RP+MGKV +MLEG EI P P
Sbjct: 745 QRPTMGKVVQMLEGITEIKNPLCP 768
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 504 (182.5 bits), Expect = 1.5e-85, Sum P(4) = 1.5e-85
Identities = 99/198 (50%), Positives = 140/198 (70%)
Query: 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL 614
G +LDW R+ IALG A+ +AYLHE+C ++HCDIKPENILL D+F K+SDFGLAKL
Sbjct: 583 GDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKL 642
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674
+E + +RGTRGY+APEW+ + I+ K+DVYS+GMVLLE++ G +N++ +
Sbjct: 643 MTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSET--- 699
Query: 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734
S++ +FP +AF+K+ EE K+ DI+D +KN D V + V R +KTA+WCIQ+ + RP
Sbjct: 700 SEKCHFPSFAFKKM-EEGKLMDIVDGKMKN-VD--VTDERVQRAMKTALWCIQEDMQTRP 755
Query: 735 SMGKVAKMLEGTVEITEP 752
SM KV +MLEG + +P
Sbjct: 756 SMSKVVQMLEGVFPVVQP 773
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 672 (241.6 bits), Expect = 3.2e-77, Sum P(2) = 3.2e-77
Identities = 203/649 (31%), Positives = 308/649 (47%)
Query: 150 NLPTDTILPNQTLNGPPLVSKNGKFSFLNASELVFVSANRSYWNIDDDGNLRIYSYDDNG 209
N P + + T +G L+++NG + + + S++ +D G + + +G
Sbjct: 220 NFPVEYL--TVTTSGLALMARNGTVVVVRVA--LPPSSDFRVAKMDSSGKFIVSRF--SG 273
Query: 210 DRWTVVWQAVQEICTIPDLCGENAICISDGLSRSTSCVCPPGFKNSTRQDKSC--QRKIE 267
+ + C IP +CG+ +C D S + SC CP + + + +
Sbjct: 274 KNLVTEFSGPMDSCQIPFVCGKLGLCNLDNASENQSCSCPDEMRMDAGKGVCVPVSQSLS 333
Query: 268 LK---NLRNTKFLQLDY-VNFSRGNLSDLEADNFS--ACKANCSANPKCVAFGFKYDGKR 321
L RN +L+L V++ + +D AC CS N C+ F + R
Sbjct: 334 LPVSCEARNISYLELGLGVSYFSTHFTDPVEHGLPLLACHDICSKNCSCLGV-FYENTSR 392
Query: 322 YCVLVDQLLYGYWSPGTEMATFLRVDESENDVSNFTGMTNLLVTTCPVNISLPLPPDESS 381
C LV +G S L + EN + G L + N P +
Sbjct: 393 SCYLVKDS-FGSLS--------LVKNSPENH--DLIGYVKLSIRK--TNAQPPGNNNRGG 439
Query: 382 TTARNIAIIVT----LFAAELISGAWFFWAFLKKYIKYRDMART---------LGLELLP 428
++ IA+++ F + W+ + +Y R+ T LG +P
Sbjct: 440 SSFPVIALVLLPCSGFFLLIALGLLWWRRCAVMRYSSIREKQVTRPGSFESGDLGSFHIP 499
Query: 429 AGGPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNV-TGGDAEFWA 487
G P++F EL AT F IG GGFG VYKG L D ++AVK + N G EF
Sbjct: 500 -GLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFCT 558
Query: 488 EVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMS 547
E+ II + H NLV+L GFCA + LVYEY+ +GSL LF S
Sbjct: 559 EIAIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLF----------------S 602
Query: 548 GVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKIS 607
G GP VL+W R+ IALG AR +AYLH C + ++HCD+KPENILL D F PKIS
Sbjct: 603 GNGP------VLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKIS 656
Query: 608 DFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRN-- 665
DFGL+KL +E+ + +RGTRGY+APEW+ + I+ KADVYS+GMVLLE+VSG +N
Sbjct: 657 DFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCS 716
Query: 666 FEIQGSMMNSDE--------------WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVH 711
F + + + D YFP +A + ++E+ + ++ D + + RV
Sbjct: 717 FRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALD-MHEQGRYMELADPRL----EGRVT 771
Query: 712 FDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITEPKKPTIYFL 760
++V+ A+ C+ + P LRP+M V M EG++ + P+ ++ FL
Sbjct: 772 SQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNPRMESLNFL 820
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 1.8e-76, Sum P(3) = 1.8e-76
Identities = 95/200 (47%), Positives = 132/200 (66%)
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
K VL W +R++IALG AR +AYLH+EC + ++HCDIKPENILL FCPK++DFGLAKL
Sbjct: 585 KIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLV 644
Query: 616 KKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675
++ ++ +RGTRGY+APEW+ IT KADVYS+GM+L E+VSG RN E Q N
Sbjct: 645 GRDFSRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTE-QSE--NE 701
Query: 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735
+FP WA + ++ + ++D ++ D+ V + V R K A WCIQD RP+
Sbjct: 702 KVRFFPSWAATILTKDGDIRSLVDPRLEG--DA-VDIEEVTRACKVACWCIQDEESHRPA 758
Query: 736 MGKVAKMLEGTVEITEPKKP 755
M +V ++LEG +E+ P P
Sbjct: 759 MSQVVQILEGVLEVNPPPFP 778
|
|
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 4.6e-60, Sum P(3) = 4.6e-60
Identities = 88/204 (43%), Positives = 128/204 (62%)
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL-RKK 617
++W Y IA+GVAR + YLH C+ ++H DIKP+NIL+ +D CPKISDFGLAKL +KK
Sbjct: 613 IEWKTLYNIAVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKK 672
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQ--ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675
E ++SM RGT GY+APE + ++ K+DVYS+GMV+LE++ ++ E++ S +
Sbjct: 673 ESIISMLDARGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATKREEVETSATDK 732
Query: 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735
YFP W +E + E + +L+ HI + +V RM +WCIQ P RP
Sbjct: 733 SSMYFPDWVYEDL-ERKETMRLLEDHIIEEEEEE---KIVKRMTLVGLWCIQTNPSDRPP 788
Query: 736 MGKVAKMLEGT-VEITE-PKKPTI 757
M KV +MLEG+ +E + P KP +
Sbjct: 789 MRKVVEMLEGSRLEALQVPPKPLL 812
|
|
| TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 584 (210.6 bits), Expect = 5.4e-59, Sum P(2) = 5.4e-59
Identities = 131/331 (39%), Positives = 193/331 (58%)
Query: 433 KRFTHAELRAATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTI 491
KRF++ +++ T F N++G+GGFG VYKG+L D R VAVK LK +F E+
Sbjct: 447 KRFSYVQVKKMTKSFENVLGKGGFGTVYKGKLPDGSRDVAVKILKESNEDGEDFINEIAS 506
Query: 492 IARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGP 551
++R H N+V L GFC E ++ ++YE +PNGSL ++ S + + +ME
Sbjct: 507 MSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFI-------SKNMSAKME------ 553
Query: 552 HDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL 611
W Y IA+GV+ + YLH C+ ++H DIKP+NIL+ D CPKISDFGL
Sbjct: 554 ---------WKTLYNIAVGVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGL 604
Query: 612 AKLRKK-EDMVSMSRIRGTRGYMAPEWLRSD--QITPKADVYSFGMVLLEIVSGSRNF-E 667
AKL K E ++SM RGT GY+APE + ++ K+DVYS+GMV+LE++ G+RN
Sbjct: 605 AKLCKNNESIISMLHARGTIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEMI-GARNIGR 663
Query: 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQ 727
Q + ++ YFP W ++ + E+ ++ L I D ++ V +MV +WCIQ
Sbjct: 664 AQNAGSSNTSMYFPDWIYKDL-EKGEIMSFLADQITEEEDEKI----VKKMVLVGLWCIQ 718
Query: 728 DRPELRPSMGKVAKMLEGTVEITE-PKKPTI 757
P RP M KV +MLEG++E + P KP +
Sbjct: 719 TNPYDRPPMSKVVEMLEGSLEALQIPPKPLL 749
|
|
| TAIR|locus:2147635 AT5G20050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 600 (216.3 bits), Expect = 1.9e-58, P = 1.9e-58
Identities = 136/330 (41%), Positives = 201/330 (60%)
Query: 429 AGGPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAE 488
AG P +F +L AT+GF +LIG+GG G V+KG L D VAVK ++ G+ EF +E
Sbjct: 87 AGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKGVLKDGSQVAVKRIEGEEKGEREFRSE 146
Query: 489 VTIIARMHHLNLVRLWGFCAEKGE---RTLVYEYVPNGSLADYLFRSGRVGSSSPAREME 545
V IA + H NLVRL+G+ + R LVY+Y+ N SL ++F P R
Sbjct: 147 VAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDYIVNSSLDIWIF---------PDR--- 194
Query: 546 MSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605
G GG L W RY++A+ VA+A+AYLH +C +LH D+KPENILL ++F
Sbjct: 195 -GNRGRSGGG--CLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENFRAV 251
Query: 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRN 665
++DFGL+KL +++ ++ IRGTRGY+APEWL I+ K+DVYS+G+VLLE++ G R+
Sbjct: 252 VTDFGLSKLIARDESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMIGGRRS 311
Query: 666 F---EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA 722
E++ + E YFP+ +K+ E K+ +I+D+ + + V + V ++V A
Sbjct: 312 ISRVEVKETKKKKLE-YFPRIVNQKM-RERKIMEIVDQRLIEV--NEVDEEEVMKLVCVA 367
Query: 723 MWCIQDRPELRPSMGKVAKMLEGTVEITEP 752
+WCIQ++ + RP M V +MLEG V + EP
Sbjct: 368 LWCIQEKSKKRPDMTMVIEMLEGRVPVNEP 397
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 319 (117.4 bits), Expect = 2.4e-58, Sum P(4) = 2.4e-58
Identities = 76/204 (37%), Positives = 118/204 (57%)
Query: 559 LDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK- 616
+DW R+ I G+AR + YLH + CL V+H D+K NILL + PKISDFGLA++ +
Sbjct: 590 IDWPKRFNIIEGIARGLHYLHRDSCLR-VIHRDLKVSNILLDEKMNPKISDFGLARMYQG 648
Query: 617 KEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR----NFEIQGSM 672
E + R+ GT GYMAPE+ + + K+D+YSFG++LLEI++G + ++ QG
Sbjct: 649 TEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRFSYGRQGKT 708
Query: 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPEL 732
+ + W W E + D+LD+ + +S H V R V+ + C+Q +P
Sbjct: 709 LLAYAW--ESWC-----ESGGI-DLLDKDVADS----CHPLEVERCVQIGLLCVQHQPAD 756
Query: 733 RPSMGKVAKMLEGTVEITEPKKPT 756
RP+ ++ ML T ++T PK+PT
Sbjct: 757 RPNTMELLSMLTTTSDLTSPKQPT 780
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 4.4e-58, Sum P(2) = 4.4e-58
Identities = 84/205 (40%), Positives = 132/205 (64%)
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK-K 617
++W Y +A+G++R + YLH C+ ++H DIKP+NIL+ ++ CPKISDFGLAKL K K
Sbjct: 424 MEWERLYDVAVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNK 483
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSD--QITPKADVYSFGMVLLEIVSGSRNFE-IQGSMMN 674
E ++SM +RGT GY+APE + ++ K+DVYS+GMV+LE++ G++N E ++ S N
Sbjct: 484 ESIISMLHMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMI-GAKNIEKVEYSGSN 542
Query: 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734
+ YFP+W + K +E+ ++ I I + + + ++V A+WCIQ P RP
Sbjct: 543 NGSMYFPEWVY-KDFEKGEITRIFGDSITDEEEK-----IAKKLVLVALWCIQMNPSDRP 596
Query: 735 SMGKVAKMLEGTVEITE-PKKPTIY 758
M KV +MLEG +E + P P ++
Sbjct: 597 PMIKVIEMLEGNLEALQVPPNPLLF 621
|
|
| TAIR|locus:2197704 AT1G61390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 311 (114.5 bits), Expect = 4.2e-57, Sum P(4) = 4.2e-57
Identities = 74/201 (36%), Positives = 112/201 (55%)
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK-K 617
+DW R+ I GVAR + YLH + V+H D+K NILL + PKISDFGLA++ +
Sbjct: 614 IDWQKRFNIIQGVARGLLYLHRDSRLRVIHRDLKVSNILLDEKMIPKISDFGLARMSQGT 673
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR--NFEIQGSMMNS 675
+ + R+ GT GYMAPE+ + + K+D+YSFG++LLEI+ G + F +G + +
Sbjct: 674 QYQDNTRRVVGTLGYMAPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSEEGKTLLA 733
Query: 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735
W W E K D+LD+ + +S H V R V+ + C+Q +P RP+
Sbjct: 734 YAW--ESWC------ETKGVDLLDQALADSS----HPAEVGRCVQIGLLCVQHQPADRPN 781
Query: 736 MGKVAKMLEGTVEITEPKKPT 756
++ ML E+ PK+PT
Sbjct: 782 TLELMSMLTTISELPSPKQPT 802
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 763 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-26 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-22 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-22 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-15 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 8e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-14 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 5e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-13 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-13 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 5e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-05 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-05 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 1e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-04 | |
| cd00053 | 36 | cd00053, EGF, Epidermal growth factor domain, foun | 5e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.003 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 2e-52
Identities = 85/265 (32%), Positives = 119/265 (44%), Gaps = 43/265 (16%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGF 506
+G G FG VYK ++VAVK LK + D E+ I+ R+ H N+VRL
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+K LV EY G L DYL R G L +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP------------------------LSEDEAKK 102
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
IAL + R + YLH ++H D+KPENILL ++ KI+DFGLAK K S++
Sbjct: 103 IALQILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTF 158
Query: 627 RGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSG-----SRNFEIQGSMMNSD---E 677
GT YMAPE L PK DV+S G++L E+++G N Q ++
Sbjct: 159 VGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPP 218
Query: 678 WYFPKWAFEKVYEEMK--VEDILDR 700
F + + EE K ++ L++
Sbjct: 219 LEFDEPKWSSGSEEAKDLIKKCLNK 243
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 8e-49
Identities = 67/214 (31%), Positives = 99/214 (46%), Gaps = 32/214 (14%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVRLWGFC 507
+G GGFG VY + VA+K +K E E+ I+ +++H N+V+L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
++ LV EY GSL D L + L RI
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE-----------------------NEGKLSEDEILRI 97
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLG-DDFCPKISDFGLAKLRKKEDMVSMSRI 626
L + + YLH ++H D+KPENILL D+ K++DFGL+K D + I
Sbjct: 98 LLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSK-LLTSDKSLLKTI 153
Query: 627 RGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEI 659
GT YMAPE L + K+D++S G++L E+
Sbjct: 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 3e-46
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 449 NLIGRGGFGDVYKG-ELTDHRVVAVKCLK--NVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+G G FG VY + ++VA+K +K + E+ I+ ++ H N+VRL+
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
++ + LV EY G L D L + GR+ E E R+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRL------SEDE-----------------ARF 101
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ A+ YLH + ++H D+KPENILL +D K++DFGLA+ +
Sbjct: 102 -YLRQILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTF 156
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ GT YMAPE L D++S G++L E+++G
Sbjct: 157 V-GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTG 192
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 4e-46
Identities = 89/307 (28%), Positives = 135/307 (43%), Gaps = 62/307 (20%)
Query: 447 FSNLIGRGGFGDVYKGELTD-----HRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLN 499
+G G FG+VYKG+L VAVK LK EF E I+ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+V+L G C E+ +V EY+ G L YL R+ +P L
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL------------RKN-----------RPKL 99
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
S AL +AR + YL + +H D+ N L+G++ KISDFGL++ +D
Sbjct: 100 SLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 156
Query: 620 MVSMSRIRGTRG---YMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676
R RG + +MAPE L+ + T K+DV+SFG++L EI + G
Sbjct: 157 YY---RKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL-------GEQ---- 202
Query: 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
P Y M E++L ++KN Y + + + C + PE RP+
Sbjct: 203 ----P-------YPGMSNEEVL-EYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTF 250
Query: 737 GKVAKML 743
++ ++L
Sbjct: 251 SELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 8e-46
Identities = 87/308 (28%), Positives = 130/308 (42%), Gaps = 63/308 (20%)
Query: 447 FSNLIGRGGFGDVYKGELTD-----HRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLN 499
+G G FG+VYKG L VAVK LK EF E I+ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+V+L G C E+ +V EY+P G L DYL L
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL----------------------RKNRPKEL 100
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
S AL +AR + YL + +H D+ N L+G++ KISDFGL++ +D
Sbjct: 101 SLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157
Query: 620 MVSMSR----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675
+ IR +MAPE L+ + T K+DV+SFG++L EI + G
Sbjct: 158 YYKVKGGKLPIR----WMAPESLKEGKFTSKSDVWSFGVLLWEIFTL-------GEE--- 203
Query: 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735
P Y M ++L ++K Y + + K + C + PE RP+
Sbjct: 204 -----P-------YPGMSNAEVL-EYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPT 250
Query: 736 MGKVAKML 743
++ ++L
Sbjct: 251 FSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 90/311 (28%), Positives = 135/311 (43%), Gaps = 64/311 (20%)
Query: 449 NLIGRGGFGDVYKGELTD----HRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVR 502
+G G FG+VYKG+L VAVK LK + +F E ++ ++ H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L G C E+ LV EY+ G L DYL R R SP K L
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYL-RKSRPVFPSP--------------EKSTLSLK 105
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
A+ +A+ + YL + +H D+ N L+G+D KISDFGL++ +D
Sbjct: 106 DLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYR 162
Query: 623 MSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
IR +MAPE L+ T K+DV+SFG++L EI + G+
Sbjct: 163 KKTGGKLPIR----WMAPESLKDGIFTSKSDVWSFGVLLWEIFTL-------GA------ 205
Query: 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSY----DSRVHFDMVNRMVKTAMWCIQDRPELR 733
P Y + E++L +++ Y ++ M+ C Q PE R
Sbjct: 206 --TP-------YPGLSNEEVL-EYLRKGYRLPKPEYCPDELYELMLS----CWQLDPEDR 251
Query: 734 PSMGKVAKMLE 744
P+ ++ + LE
Sbjct: 252 PTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 84/321 (26%), Positives = 132/321 (41%), Gaps = 89/321 (27%)
Query: 447 FSNLIGRGGFGDVYKGELTD-----HRVVAVKCLKNVTGGD--AEFWAEVTIIARMHHLN 499
+G G FG+VYKG L VAVK LK + EF E +I+ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+VRL G C + +V EY+P G L D+L + L
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH-----------------------GEKL 99
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL----- 614
++AL +A+ + YL + +H D+ N L+ ++ KISDFGL++
Sbjct: 100 TLKDLLQMALQIAKGMEYLESKNF---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD 156
Query: 615 --RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672
RK+ I+ +MAPE L+ + T K+DV+SFG++L EI + G
Sbjct: 157 YYRKRGG--GKLPIK----WMAPESLKDGKFTSKSDVWSFGVLLWEIFTL-------GEQ 203
Query: 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRM---------VKTAM 723
P Y M E++L+ +++ Y R+ + M
Sbjct: 204 --------P-------YPGMSNEEVLE-LLEDGY----------RLPRPENCPDELYELM 237
Query: 724 -WCIQDRPELRPSMGKVAKML 743
C PE RP+ ++ + L
Sbjct: 238 LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 3e-37
Identities = 67/232 (28%), Positives = 108/232 (46%), Gaps = 34/232 (14%)
Query: 449 NLIGRGGFGDVYKGELTDH-RVVAVKCLKNVTGGDAEFWA---EVTIIARMHHLNLVRLW 504
L+GRG FG VY D ++AVK ++ + E A E+ I++ + H N+VR +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 505 GFC--AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
G EK + EYV GSL+ L + G++ E +
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKL------PEPVIR--------------- 104
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
+Y + +AYLH ++H DIK NIL+ D K++DFG AK +
Sbjct: 105 -KY--TRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158
Query: 623 MSR-IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673
+ +RGT +MAPE +R ++ AD++S G ++E+ +G + G+ M
Sbjct: 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 86/308 (27%), Positives = 132/308 (42%), Gaps = 73/308 (23%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG+G FGDV G+ + VAVKCLK+ + F AE +++ + H NLV+L G
Sbjct: 10 LGATIGKGEFGDVMLGDYRG-QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ +V EY+ GSL DYL RS G+ V+ + +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYL-RSR---------------------GRAVITLAQQLG 106
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
AL V + YL E+ +H D+ N+L+ +D K+SDFGLAK + +
Sbjct: 107 FALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV 163
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686
+ T APE LR + + K+DV+SFG++L EI S R P
Sbjct: 164 KWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRV---------------P----- 199
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRM----------VKTAMWCIQDRPELRPSM 736
Y + ++D++ H++ Y RM K C + P RP+
Sbjct: 200 --YPRIPLKDVVP-HVEKGY----------RMEAPEGCPPEVYKVMKDCWELDPAKRPTF 246
Query: 737 GKVAKMLE 744
++ + L
Sbjct: 247 KQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (321), Expect = 6e-32
Identities = 81/301 (26%), Positives = 120/301 (39%), Gaps = 52/301 (17%)
Query: 450 LIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWA----EVTIIARM-HHLNLVRLW 504
+G G FG+VY D ++VA+K L ++ E+ I+A + H N+V+L+
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
F ++G LV EYV GSL D L + GR G S S
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE---------------------SEA 103
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLG-DDFCPKISDFGLAKLRKKEDMVS- 622
I + A+ YLH + ++H DIKPENILL D K+ DFGLAKL S
Sbjct: 104 LFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160
Query: 623 ----MSRIRGTRGYMAPEWLRS---DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675
S GT GYMAPE L + +D++S G+ L E+++G FE + + +
Sbjct: 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT 220
Query: 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735
+ + + + + P+ R S
Sbjct: 221 SQTLKIILELP------------TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
Query: 736 M 736
Sbjct: 269 S 269
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 34/221 (15%)
Query: 447 FSNL--IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFW-AEVTIIARMHHLNLVR 502
F L IG+GGFG+VYK + VA+K +K + E E+ I+ + H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+G +K E +V E+ GSL D L L S
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL-----------------------KSTNQTLTES 98
Query: 563 -IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
I Y + + + + YLH ++H DIK NILL D K+ DFGL+ + D
Sbjct: 99 QIAY-VCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTK 152
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ + + GT +MAPE + KAD++S G+ +E+ G
Sbjct: 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 77/302 (25%), Positives = 136/302 (45%), Gaps = 60/302 (19%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKC--LKNVTGGDAEF-WAEVTIIARMHHLNLVRLW 504
IG+G FG VY +D ++ +K L N++ + E EV I+ +++H N+++ +
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
EKG+ +V EY G L+ + + + G P + +LDW ++
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQ--------------ILDWFVQ 111
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSM 623
+ L A+ YLH +LH DIKP+NI L + K+ DFG++K L D+
Sbjct: 112 --LCL----ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK- 161
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683
+ + GT Y++PE ++ K+D++S G VL E+ + F +G +
Sbjct: 162 TVV-GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF--EGENL---------- 208
Query: 684 AFEKVYEEMKVEDILDRH---IKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740
IL I + Y S + ++V+ + +Q PE RPS+ ++
Sbjct: 209 -------LELALKILKGQYPPIPSQYSSELR-NLVSSL-------LQKDPEERPSIAQIL 253
Query: 741 KM 742
+
Sbjct: 254 QS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 32/237 (13%)
Query: 439 ELRAATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTGGDAE--FWAEVT 490
++ T +G G FG V+ GE D +VAVK LK DA F E
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 491 IIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVG 550
++ H N+V+ +G C E +V+EY+ +G L +L G + + + M G
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM---G 117
Query: 551 PHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFG 610
L S +IA+ +A + YL + +H D+ N L+G D KI DFG
Sbjct: 118 E-------LTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFG 167
Query: 611 LAKLRKKEDMVSMS--RIRGTR----GYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+++ D+ + R+ G +M PE + + T ++DV+SFG+VL EI +
Sbjct: 168 MSR-----DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 447 FSNLIGRGGFGDVYKGE-LTDHRVVAVKCLK--NVTGGD-AEFWAEVTIIARMHHLNLVR 502
+LIGRG FG VYKG L VA+K + + E+ ++ + H N+V+
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
G ++ EY NGSL + + G S A +
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV------------------ 105
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-KLRKKEDMV 621
Y++ G +AYLHE+ V+H DIK NIL D K++DFG+A KL
Sbjct: 106 --YQVLQG----LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-- 154
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ + GT +MAPE + + +D++S G ++E+++G
Sbjct: 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 71/228 (31%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 447 FSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHL 498
F +G G FG VYKGELT VA+K LK EF E +++ + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
N+V L G C ++ +++EY+ +G L ++L R +SP ++ + K
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVR------NSPHSDVGAESGD--ETVKSS 120
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
LD S IA+ +A + YL +H D+ N L+G+ KISDFGL++
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 619 DMVSM-SR----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
D + S+ +R +M PE + + T ++D++SFG+VL EI S
Sbjct: 178 DYYRVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 75/215 (34%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAE- 509
IG+G FGDV G+ ++V AVKC+KN A F AE +++ ++ H NLV+L G E
Sbjct: 14 IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 510 KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIAL 569
KG +V EY+ GSL DYL GR VL + +L
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGR----------------------SVLGGDCLLKFSL 109
Query: 570 GVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGT 629
V A+ YL +H D+ N+L+ +D K+SDFGL K ++ T
Sbjct: 110 DVCEAMEYLEANNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 166
Query: 630 RGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664
APE LR + + K+DV+SFG++L EI S R
Sbjct: 167 ----APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 37/226 (16%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR-----VVAVKCLKNVTGGD--AEFWAEVTIIARMHHLN 499
F +G G FG V VAVK L + ++F E+ I+ + H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 500 LVRLWGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
+V+ G C + G R+ L+ EY+P+GSL DYL R +
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-----------------------RD 104
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL--R 615
++ + + + + YL + +H D+ NIL+ + KISDFGLAK+
Sbjct: 105 QINLKRLLLFSSQICKGMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPE 161
Query: 616 KKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
K+ + APE LR+ + + +DV+SFG+ L E+ +
Sbjct: 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510
+G G FG+V+ G VAVK LK T F E I+ ++ H LV+L+ C+E+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
+V EY+ GSL D+L SG G ++D +A
Sbjct: 74 EPIYIVTEYMSKGSLLDFL----------------KSGEGKKLRLPQLVD------MAAQ 111
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
+A +AYL +H D+ NIL+G++ KI+DFGLA+L + ++ + +
Sbjct: 112 IAEGMAYLESRNY---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI 168
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664
+ APE + T K+DV+SFG++L EIV+ R
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510
+G G FG V+ G+ VA+K ++ + +F E ++ ++ H NLV+L+G C ++
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
+V EY+ NG L +YL RE G L +
Sbjct: 72 RPIFIVTEYMANGCLLNYL------------RER------KGKLGTEWL-----LDMCSD 108
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
V A+ YL +H D+ N L+G+D K+SDFGLA+ + S +
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV 165
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR-------NFEIQGSMMNSDEWYFPKW 683
+ PE + + K+DV+SFG+++ E+ S + N E+ S+ Y PK
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL 225
Query: 684 AFEKVYEEMK 693
A +VY M
Sbjct: 226 APTEVYTIMY 235
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 77/304 (25%), Positives = 130/304 (42%), Gaps = 63/304 (20%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG G FG V+ G + R VA+K ++ + +F E ++ ++ H LV+L+G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
C E+ LV+E++ +G L+DYL R+ R G S + M
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL-RAQR-GKFSQETLLGM-------------------- 105
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
L V +AYL V+H D+ N L+G++ K+SDFG+ + + S +
Sbjct: 106 -CLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR-------NFEIQGSMMNSDEWY 679
+ + +PE + + K+DV+SFG+++ E+ S + N E+ ++ Y
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY 221
Query: 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739
P+ A + VYE M+ C ++RPE RPS +
Sbjct: 222 KPRLASQSVYELMQ------------------------------HCWKERPEDRPSFSLL 251
Query: 740 AKML 743
L
Sbjct: 252 LHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 85/295 (28%), Positives = 131/295 (44%), Gaps = 57/295 (19%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLK-NVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAE 509
IG G FG V +GE T +V AVK +K +VT F E ++ ++HH NLVRL G
Sbjct: 14 IGEGEFGAVLQGEYTGQKV-AVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 510 KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIAL 569
G +V E + G+L ++L GR S + +L
Sbjct: 71 NG-LYIVMELMSKGNLVNFLRTRGRALVSVIQ----------------------LLQFSL 107
Query: 570 GVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGT 629
VA + YL + L +H D+ NIL+ +D K+SDFGLA++ S ++ T
Sbjct: 108 DVAEGMEYLESKKL---VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT 164
Query: 630 RGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVY 689
APE L+ + + K+DV+S+G++L E+ S R +PK + ++V
Sbjct: 165 ----APEALKHKKFSSKSDVWSYGVLLWEVFSYGRA-------------PYPKMSLKEVK 207
Query: 690 EEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744
E VE + V+ M + C + P+ RPS K+ + LE
Sbjct: 208 EC--VEKGYRMEPPEGCPADVYVLMTS--------CWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510
+G G FG+V++G + VAVK LK T +F AE I+ ++ H L++L+ C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
+V E + GSL +YL G L +A
Sbjct: 74 EPIYIVTELMKYGSLLEYL----------------------QGGAGRALKLPQLIDMAAQ 111
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
VA +AYL + +H D+ N+L+G++ K++DFGLA++ K++ + +
Sbjct: 112 VASGMAYLEAQNY---IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPI 168
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664
+ APE ++ + K+DV+SFG++L EIV+ R
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 61/230 (26%), Positives = 94/230 (40%), Gaps = 37/230 (16%)
Query: 448 SNLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWA---EVTIIARMHHLNLVRL 503
N IG G FG VY L ++AVK ++ E+ ++ + H NLV+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+G + + + EY G+L + L GR+ LD +
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL-EHGRI-----------------------LDEHV 100
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
L + +AYLH ++H DIKP NI L + K+ DFG A K
Sbjct: 101 IRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157
Query: 624 SRIRGTRG---YMAPEWLRSDQITPK---ADVYSFGMVLLEIVSGSRNFE 667
++ G YMAPE + + AD++S G V+LE+ +G R +
Sbjct: 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 72/265 (27%), Positives = 111/265 (41%), Gaps = 54/265 (20%)
Query: 451 IGRGGFGDVYK-GELTDHRVVAVKCLK----NVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+G+G FG V + ++ A+K LK E I++R++H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 506 FCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
A + E L V EY P G L +L + GR + +
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS----------------------EERAR 96
Query: 564 RY--RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
Y I L A+ YLH +++ D+KPENILL D K++DFGLAK E
Sbjct: 97 FYAAEIVL----ALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR 149
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQGSMMNS 675
+ + GT Y+APE L D +S G++L E+++G F EI ++
Sbjct: 150 TNTFC-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208
Query: 676 DEWYFPKWAFEKVYEEMKVEDILDR 700
FP E + E + D++
Sbjct: 209 PL-RFP----EFLSPEAR--DLISG 226
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 35/219 (15%)
Query: 450 LIGRGGFGDVYKGELTDHRVVAVK-CLKNVTGGD-AEFWAEVTIIARMHHLNLVRLWGFC 507
IG+G FGDVYKG L + VAVK C + +F E I+ + H N+V+L G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+K +V E VP GSL +L + + + ++MS
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKK--NRLTVKKLLQMS-------------------- 99
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR 627
L A + YL + +H D+ N L+G++ KISDFG++ R++E +
Sbjct: 100 -LDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMS--REEEGGIYTVS-D 152
Query: 628 GTR----GYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
G + + APE L + T ++DV+S+G++L E S
Sbjct: 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 27/212 (12%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLK-NVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAE 509
+G G FG+V++G + VA+K LK + +F EV + R+ H +L+ L+ C+
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 510 KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIAL 569
++ E + GSL +L S + + ++ ++D +A
Sbjct: 74 GEPVYIITELMEKGSLLAFL-------RSPEGQVLPVA---------SLID------MAC 111
Query: 570 GVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGT 629
VA +AYL E+ +H D+ NIL+G+D K++DFGLA+L KED+ S +
Sbjct: 112 QVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARL-IKEDVYLSSDKKIP 167
Query: 630 RGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ APE + K+DV+SFG++L E+ +
Sbjct: 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 449 NLIGRGGFGDVYKGELTDH-RVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFC 507
+ +G G +G+VY+G + VAVK LK T EF E ++ + H NLV+L G C
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+ ++ E++ G+L DYL R A + +
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNR--QEVNA--------------------VVLLYM 109
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR 627
A ++ A+ YL ++ +H D+ N L+G++ K++DFGL++L + + + +
Sbjct: 110 ATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 166
Query: 628 GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ APE L ++ + K+DV++FG++L EI +
Sbjct: 167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 1e-22
Identities = 87/315 (27%), Positives = 135/315 (42%), Gaps = 56/315 (17%)
Query: 447 FSNLIGRGGFGDVYKGELT---DHRVVAVKCLKNVTGGD--AEFWAEVTIIARM-HHLNL 500
F ++IG G FG V + + A+K LK + +F E+ ++ ++ HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+ L G C +G + EY P G+L D+L R RV + PA E G L
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKE-------HGTASTLT 117
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
+ A VA + YL E+ +H D+ N+L+G++ KI+DFGL+ R +E
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLS--RGEEVY 172
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-------GSRNFEIQGSMM 673
V + R +MA E L T K+DV+SFG++L EIVS G E+ +
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232
Query: 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELR 733
P+ ++VYE M+ C +DRP R
Sbjct: 233 QGYRMEKPRNCDDEVYELMR------------------------------QCWRDRPYER 262
Query: 734 PSMGKVAKMLEGTVE 748
P +++ L +E
Sbjct: 263 PPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 19/221 (8%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRV---VAVKCLKNVTGGD--AEFWAEVTIIARM-HHLNL 500
F ++IG G FG V K + + A+K +K D +F E+ ++ ++ HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+ L G C +G L EY P+G+L D+L R RV + PA + S L
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTAS-------TLS 122
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
A VAR + YL ++ +H D+ NIL+G+++ KI+DFGL+ R +E
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLS--RGQEVY 177
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
V + R +MA E L T +DV+S+G++L EIVS
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 64/220 (29%), Positives = 91/220 (41%), Gaps = 34/220 (15%)
Query: 450 LIGRGGFGDVYKGELT----DHRVVAVKCLK--NVTGGDAEFWAEVTIIARMHHLNLVRL 503
+G G FG V +GE + VAVKCLK ++ +F E I+ + H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+G +V E P GSL D L S
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRL----------------------RKDALGHFLIST 98
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVS 622
A+ +A + YL + +H D+ NILL D KI DFGL + L + ED
Sbjct: 99 LCDYAVQIANGMRYLESKRF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155
Query: 623 MSRIRGTR-GYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
M + APE LR+ + +DV+ FG+ L E+ +
Sbjct: 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-22
Identities = 83/305 (27%), Positives = 139/305 (45%), Gaps = 39/305 (12%)
Query: 451 IGRGGFGDVYKGELTD------HRVVAVKCLKNVTGGDAEFWA---EVTIIARMHHLNLV 501
+G G FG V K + VAVK LK +E E ++ +++H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSS-PAREMEMSGVGPHDGGKPVLD 560
+L+G C++ G L+ EY GSL +L S +VG S + S + + L
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA-LT 125
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED- 619
A ++R + YL E L +H D+ N+L+ + KISDFGL++ +ED
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKL---VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679
V S+ R +MA E L T ++DV+SFG++L EIV+ N
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN-------------P 229
Query: 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739
+P A E+++ +K ++R S + + ++ T C + P+ RP+ +
Sbjct: 230 YPGIAPERLFNLLKTGYRMERPENCS-------EEMYNLMLT---CWKQEPDKRPTFADI 279
Query: 740 AKMLE 744
+K LE
Sbjct: 280 SKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 451 IGRGGFGDVYK-GELTDHRVVAVK--CLKNVTGGDAEFWA-EVTIIARMHHLNLVRLWGF 506
IG G G V+K + VA+K L+ + GG E+ + H +V+L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
LV EY+P L++ L D +P+ + ++
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVL----------------------RDEERPLPEAQVK-S 103
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+ + +AY+H ++H D+KP N+L+ D KI+DFGLA+L +E+ S
Sbjct: 104 YMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160
Query: 627 RGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSGS 663
TR Y APE L + + P D+++ G + E+++GS
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 40/227 (17%)
Query: 451 IGRGGFGDVYKGEL----TDHRV--VAVKCL-KNVTGGD-AEFWAEVTIIARMHHLNLVR 502
+G+G FG VY+G VA+K + +N + + EF E +++ + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 503 LWGFCAEKGERTLV-YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L G + G+ TLV E + G L YL RS R P E ++ G
Sbjct: 74 LLGVVS-TGQPTLVVMELMAKGDLKSYL-RSRR-----PEAE--------NNPGLGPPTL 118
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL------- 614
++A +A +AYL ++V H D+ N ++ +D KI DFG+ +
Sbjct: 119 QKFIQMAAEIADGMAYLAA--KKFV-HRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
RK + +R +MAPE L+ T K+DV+SFG+VL E+ +
Sbjct: 176 RK--GGKGLLPVR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-22
Identities = 87/307 (28%), Positives = 141/307 (45%), Gaps = 48/307 (15%)
Query: 449 NLIGRGGFGDVYKGELTDHRV---VAVKCLKNVTGGD--AEFWAEVTIIARM-HHLNLVR 502
++IG G FG V K + + A+K +K D +F E+ ++ ++ HH N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L G C +G L EY P+G+L D+L R RV + PA + + L
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIA-------NSTASTLSSQ 112
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
A VAR + YL ++ +H D+ NIL+G+++ KI+DFGL+ R +E V
Sbjct: 113 QLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLS--RGQEVYVK 167
Query: 623 MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFP 681
+ R +MA E L T +DV+S+G++L EIVS G + M E Y
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY----CGMTCAELY-- 221
Query: 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA- 740
EK+ + ++E D V +++ C +++P RPS ++
Sbjct: 222 ----EKLPQGYRLE-----------KPLNCDDEVYDLMRQ---CWREKPYERPSFAQILV 263
Query: 741 ---KMLE 744
+MLE
Sbjct: 264 SLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 69/242 (28%), Positives = 108/242 (44%), Gaps = 49/242 (20%)
Query: 449 NLIGRGGFGDVYKGELT----DHRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVR 502
+IG G FG+V +G L VA+K LK + +F E +I+ + H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L G + ++ EY+ NGSL +L RE +DG
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL------------RE--------NDGK---FTVG 106
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMV 621
+ G+A + YL E +H D+ NIL+ + K+SDFGL++ L E
Sbjct: 107 QLVGMLRGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163
Query: 622 SMSRIRGTRG------YMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674
+ T+G + APE + + T +DV+SFG+V+ E++S G R + M N
Sbjct: 164 T------TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY---WDMSN 214
Query: 675 SD 676
D
Sbjct: 215 QD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510
+G G FG+V+ G H VA+K LK + F AE ++ ++ H LVRL+ +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72
Query: 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
++ EY+ NGSL D+L + ++ ++ ++D +A
Sbjct: 73 EPIYIITEYMENGSLVDFL-------KTPEGIKLTIN---------KLID------MAAQ 110
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
+A +A++ + +H D++ NIL+ + C KI+DFGLA+L + + + +
Sbjct: 111 IAEGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI 167
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664
+ APE + T K+DV+SFG++L EIV+ R
Sbjct: 168 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 70/225 (31%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 451 IGRGGFGDVYKGEL------TDHRVVAVKCLKNVTGGD--AEFWAEVTIIARMHHLNLVR 502
IG+G FG V++ +VAVK LK D A+F E ++A H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYL-FRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L G CA L++EY+ G L ++L RS R S L
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS---ARKCGLNPLPLSC 129
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
+ + IA VA +AYL E +H D+ N L+G++ KI+DFGL++ D
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 622 SMSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
S IR +M PE + ++ T ++DV+++G+VL EI S
Sbjct: 187 KASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 68/249 (27%), Positives = 111/249 (44%), Gaps = 33/249 (13%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510
+G G FG V G+ VA+K +K + + EF E ++ ++ H LV+L+G C ++
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
+V EY+ NG L +YL R P++ +EM
Sbjct: 72 RPIYIVTEYMSNGCLLNYL-REHGKR-FQPSQLLEM---------------------CKD 108
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
V +AYL + +H D+ N L+ D C K+SDFGL++ ++ S +
Sbjct: 109 VCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR-------NFEIQGSMMNSDEWYFPKW 683
+ PE L + + K+DV++FG+++ E+ S + N E + Y P
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHL 225
Query: 684 AFEKVYEEM 692
A EKVY M
Sbjct: 226 ASEKVYAIM 234
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 40/228 (17%)
Query: 451 IGRGGFGDVYKG----ELTDHRV-VAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVRL 503
+G G FG VYKG E ++ VA+K L+ T A E E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 504 WGFCAEKGER-TLVYEYVPNGSLADYLFR-SGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
G C + L+ + +P G L DY+ +GS +L+W
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQY------------------LLNW 114
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDM 620
++ +A+ ++YL E+ L +H D+ N+L+ KI+DFGLAK L E
Sbjct: 115 CVQ------IAKGMSYLEEKRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFE 667
+ +MA E + T K+DV+S+G+ + E+++ G++ +E
Sbjct: 166 YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 48/224 (21%)
Query: 451 IGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEF----WAEVTIIARMHHLNLVRLWG 505
+G+G G VYK ++ A+K + GD EF E+ + +V+ +G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
++GE ++V EY+ GSLAD L + G++ +PVL I
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKI-------------------PEPVLA-YIAR 106
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+I G + YLH + ++H DIKP N+L+ KI+DFG++K +
Sbjct: 107 QILKG----LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISK--------VLEN 152
Query: 626 IR-------GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT YM+PE ++ + + AD++S G+ LLE G
Sbjct: 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 70/228 (30%), Positives = 112/228 (49%), Gaps = 33/228 (14%)
Query: 450 LIGRGGFGDVYKGEL--TDHR----VVAVKCLK-NVTGGD-AEFWAEVTIIARM-HHLNL 500
+G G FG V K E D+ VAVK LK + T D ++ +E+ ++ + H N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+ L G C ++G +V EY +G+L D+L R+ R S P + +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARR------PPGEYASPDDPRPPEETLTQ 131
Query: 561 WSIRYRIALGVARAIAYL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
+ A VAR + +L ++C+ H D+ N+L+ +D KI+DFGLA+ D
Sbjct: 132 KDL-VSFAYQVARGMEFLASKKCI----HRDLAARNVLVTEDHVMKIADFGLAR-----D 181
Query: 620 MVSMSRIRG-TRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ + R T G +MAPE L T ++DV+SFG++L EI +
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 77/292 (26%), Positives = 116/292 (39%), Gaps = 54/292 (18%)
Query: 449 NLIGRGGFGDVYKGELTD-------HRVVAVKCLKN--VTGGDAEFWAEVTIIARMHHLN 499
N +G G FG+VY+G TD VAVK L+ EF E +++ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+V+L G C + ++ E + G L YL R RV P P+L
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGP----------------PLL 103
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG--DDFCP---KISDFGLAKL 614
I L VA+ YL + +H D+ N L+ KI DFGLA+
Sbjct: 104 TLKELLDICLDVAKGCVYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160
Query: 615 RKKEDMVSMSRIRGTR----GYMAPEWLRSDQITPKADVYSFGMVLLEIVS-------GS 663
K D R G +MAPE L + T ++DV+SFG+++ EI++
Sbjct: 161 IYKSDYY---RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217
Query: 664 RNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMV 715
N E+ + P+ +K+Y ++ R FD +
Sbjct: 218 NNQEVLQHVTAGGRLQKPENCPDKIY------QLMTNCWAQDPSERPTFDRI 263
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 76/239 (31%), Positives = 116/239 (48%), Gaps = 34/239 (14%)
Query: 439 ELRAATNGFSNLIGRGGFGDVYKGEL----TDH-RVVAVKCLKNVTGGD--AEFWAEVTI 491
EL + F +G FG +YKG L DH ++VA+K LK++ EF E ++
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 492 IARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYL-FRS--GRVGSSSPAREMEMSG 548
+A +HH N+V L G ++ +++EY+ G L ++L RS VG SS
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS--------- 111
Query: 549 VGPHDGG-KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKIS 607
DG K LD IA+ +A + YL + +H D+ NIL+G+ KIS
Sbjct: 112 --DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKIS 166
Query: 608 DFGLAKLRKKEDMV-----SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
D GL++ D S+ IR +M PE + + + +D++SFG+VL EI S
Sbjct: 167 DLGLSREIYSADYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 67/305 (21%), Positives = 123/305 (40%), Gaps = 65/305 (21%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
F +G G FG V+ G+ VA+K + + +F E ++ ++ H LV+L+G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 507 CAEKGERTLVYEYVPNGSLADYLF-RSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
C ++ +V E++ NG L +YL R G++ ++M +S
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLS-----KDMLLS------------------ 104
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ V + YL +H D+ N L+ K+SDFG+ + ++ S S
Sbjct: 105 -MCQDVCEGMEYLERNSF---IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR-------NFEIQGSMMNSDEW 678
+ + PE + + K+DV+SFG+++ E+ + + N+E+ +
Sbjct: 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL 220
Query: 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGK 738
Y PK A VYE M C ++PE RP+ +
Sbjct: 221 YRPKLASMTVYEVM------------------------------YSCWHEKPEGRPTFAE 250
Query: 739 VAKML 743
+ + +
Sbjct: 251 LLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510
+G G FG+V+ G + VAVK LK T F E I+ ++ H LV+L+ +E+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
+V EY+ GSL D+L DG L +A
Sbjct: 74 -PIYIVTEYMSKGSLLDFL----------------------KDGEGRALKLPNLVDMAAQ 110
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
VA +AY+ E + ++ H D++ NIL+GD KI+DFGLA+L + + + +
Sbjct: 111 VAAGMAYI--ERMNYI-HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPI 167
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664
+ APE + T K+DV+SFG++L E+V+ R
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 450 LIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAE--FWAEVTIIARMHHLNLVRLWGFC 507
L+G+G FG+V+KG L D VAVK K + + F +E I+ + H N+V+L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
++ +V E VP G +L + K L +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK-----------------------KDELKTKQLVKF 98
Query: 568 ALGVARAIAYLH-EECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSR 625
AL A +AYL + C +H D+ N L+G++ KISDFG++ R+++D + S S
Sbjct: 99 ALDAAAGMAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMS--RQEDDGIYSSSG 152
Query: 626 IRGTR-GYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
++ + APE L + + ++DV+S+G++L E S
Sbjct: 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 451 IGRGGFGDVYK-GELTDHRVVAVKCLKNVTGGDAE---FWAEVTIIARMHHLNLVRLWGF 506
IG+G FG V K +D +++ K + + E +EV I+ + H N+VR +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 507 CAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
++ +TL V EY G LA + + + + W I
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI----------------WRIL 111
Query: 565 YRIALGVARAIAYLH--EECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
++ L A+ H + VLH D+KP NI L + K+ DFGLAK+ + +
Sbjct: 112 TQLLL----ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 623 MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
+ + GT YM+PE L K+D++S G ++ E+ + S F
Sbjct: 168 KTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 32/250 (12%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510
+G G FG+V+ G + VAVK LK T F E ++ + H LVRL+ ++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
++ EY+ GSL D+L +GGK +L I + +
Sbjct: 74 EPIYIITEYMAKGSLLDFL--------------------KSDEGGKVLLPKLIDF--SAQ 111
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
+A +AY+ + +H D++ N+L+ + KI+DFGLA++ + + + +
Sbjct: 112 IAEGMAYIERKNY---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI 168
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVS-------GSRNFEIQGSMMNSDEWYFPKW 683
+ APE + T K+DV+SFG++L EIV+ G N ++ ++ +
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN 228
Query: 684 AFEKVYEEMK 693
+++Y+ MK
Sbjct: 229 CPDELYDIMK 238
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 32/226 (14%)
Query: 449 NLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDA----EFWAEVTIIARMHHLNLVRL 503
N IG+G FG V+K D RV A+K + +++ + E E ++A++ ++R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQI-DLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ +KG+ +V EY NG L L R + V W
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLL-------KMQRGRPLPEDQV-----------WRF 106
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
+I LG +A+LH + +LH DIK N+ L KI D G+AKL +
Sbjct: 107 FIQILLG----LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669
+ I GT Y++PE K+DV++ G+VL E +G F+
Sbjct: 160 T-IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 63/251 (25%), Positives = 99/251 (39%), Gaps = 72/251 (28%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL-----------KNVTGGDAEFWAEVTIIAR 494
F +IG G F V E ++ A+K L K V E ++ R
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVK-------IEKEVLTR 57
Query: 495 M-HHLNLVRLWGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGP 551
+ H +++L + + E L V EY PNG L Y+ + G
Sbjct: 58 LNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGS----------------- 98
Query: 552 HDGGKPVLDW-SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFG 610
LD R+ A + A+ YLH + ++H D+KPENILL D KI+DFG
Sbjct: 99 -------LDEKCTRFYAAE-ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFG 147
Query: 611 LAKLRKKEDMVS--------------MSRIR-----GTRGYMAPEWLRSDQITPKADVYS 651
AK+ +R R GT Y++PE L +D+++
Sbjct: 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWA 207
Query: 652 FGMVLLEIVSG 662
G ++ ++++G
Sbjct: 208 LGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 67/234 (28%), Positives = 105/234 (44%), Gaps = 50/234 (21%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCL---KNVTGGDAE--------FWAEVTIIARMHH 497
LIG+G +G VY +T ++AVK + + G +E+ + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 498 LNLVRLWGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGG 555
LN+V+ GF E E L EYVP GS+ L GR
Sbjct: 68 LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGR--------------------- 104
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
+ + V +AYLH + +LH D+K +N+L+ D KISDFG++K
Sbjct: 105 ---FEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK-- 156
Query: 616 KKEDM---VSMSRIRGTRGYMAPEWLRSDQ--ITPKADVYSFGMVLLEIVSGSR 664
K +D+ ++G+ +MAPE + S + K D++S G V+LE+ +G R
Sbjct: 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 34/219 (15%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDA---EFWAEVTIIARMHHLNLVRLWG 505
++G G +G V K +VA+K K + EV ++ ++ H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
KG LV+EYV +L + L E G+ P ++R
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELL-------------EASPGGLPPD---------AVR- 103
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSMS 624
+ +AIAY H ++H DIKPENIL+ + K+ DFG A+ LR +
Sbjct: 104 SYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160
Query: 625 RIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSG 662
+ TR Y APE L D DV++ G ++ E++ G
Sbjct: 161 YV-ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 451 IGRGGFGDVYKGEL------TDHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRL 503
+G G FG V+ E D +VAVK LK + +F E ++ + H ++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+G C E +V+EY+ +G L +L G + E G L
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGP--DAKILAGGEDVAPGQ-------LTLGQ 123
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
IA +A + YL L +V H D+ N L+G KI DFG+++ D+ S
Sbjct: 124 MLAIASQIASGMVYL--ASLHFV-HRDLATRNCLVGQGLVVKIGDFGMSR-----DIYST 175
Query: 624 SRIR-GTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
R G R +M PE + + T ++D++SFG+VL EI +
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVK----CLKNVTGGDA--EFWAEVTIIARMHHLNLVR 502
L+G G FG VY+G L D AVK TG +A + E+ +++++ H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
G E+ + E VP GSLA L + G E PV+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYG------SFPE-------------PVIRLY 107
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
R +I LG + YLH+ +H DIK NIL+ + K++DFG+AK +
Sbjct: 108 TR-QILLG----LEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF-- 157
Query: 623 MSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSG 662
+G+ +MAPE + AD++S G +LE+ +G
Sbjct: 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 45/229 (19%)
Query: 449 NLIGRGGFGDVYKGELTDHRVVAVKCL----KNVTGGDAEF---WAEVTIIARMHHLNLV 501
++G+G +G VY G +++AVK + NV + E+ EV ++ + H+N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+ G C + ++ E+VP GS++ L R G P E
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFG------PLPEP----------------- 102
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
+ + + +AYLH C V+H DIK N++L + K+ DFG A ++ V
Sbjct: 103 -VFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCA---RRLAWV 155
Query: 622 SMS--------RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ + GT +MAPE + K+D++S G + E+ +G
Sbjct: 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-17
Identities = 72/307 (23%), Positives = 134/307 (43%), Gaps = 52/307 (16%)
Query: 449 NLIGRGGFGDVYKGELTDHRV-VAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFC 507
N+I RG G YKG+ + + VK + +V + A+ + ++ H N+V+L G C
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQHPNIVKLIGLC 752
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+ L++EY+ +L++ L L W R +I
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN---------------------------LSWERRRKI 785
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR 627
A+G+A+A+ +LH C V+ ++ PE I++ P + L L + +S
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-- 842
Query: 628 GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR----NFEIQGSMMNSDEWYFPKW 683
Y+APE + IT K+D+Y FG++L+E+++G F + GS++ EW ++
Sbjct: 843 ---AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV---EW--ARY 894
Query: 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743
+ + +M ++ + + + + V ++ A+ C P RP V K L
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVE------VMNLALHCTATDPTARPCANDVLKTL 948
Query: 744 EGTVEIT 750
E +
Sbjct: 949 ESASRSS 955
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 64/220 (29%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEF---WAEVTIIARMHHLNLVRLWGF 506
IG G VY L ++ VA+K + ++ EV +++ +H N+V+ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
E LV Y+ GSL D + S G LD +I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRG---------------------GLDEAIIAT 106
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL-AKLRKKEDMVSMSR 625
+ V + + YLH +H DIK NILLG+D KI+DFG+ A L D R
Sbjct: 107 VLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 626 --IRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSG 662
GT +MAPE + KAD++SFG+ +E+ +G
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510
+G+G FG+V+ G VA+K LK T F E ++ ++ H LV+L+ +E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
+V EY+ GSL D+L G +G L +A
Sbjct: 74 -PIYIVTEYMSKGSLLDFL--KGEMGK--------------------YLRLPQLVDMAAQ 110
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
+A +AY+ E + +V H D++ NIL+G++ K++DFGLA+L + + + +
Sbjct: 111 IASGMAYV--ERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 167
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664
+ APE + T K+DV+SFG++L E+ + R
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 36/222 (16%)
Query: 447 FSNL--IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWA-EVTIIARMHHLNLVR 502
+ NL IG G G+VYK + + VA+K ++ + + E E+ I+ H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVD 79
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ E +V EY+ GSL D + ++ E +++
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIA--------------- 119
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL-AKLRKKEDM- 620
+ V + + YLH + V+H DIK +NILL D K++DFG A+L K++
Sbjct: 120 ---YVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
S+ GT +MAPE ++ PK D++S G++ +E+ G
Sbjct: 174 NSVV---GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510
+G+G FG+V+ G VA+K LK T F E I+ ++ H LV L+ +E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
+V E++ GSL D+L G G + ++D +A
Sbjct: 74 -PIYIVTEFMGKGSLLDFL----------------KEGDGKYLKLPQLVD------MAAQ 110
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
+A +AY+ E + ++ H D++ NIL+GD+ KI+DFGLA+L + + + +
Sbjct: 111 IADGMAYI--ERMNYI-HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI 167
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664
+ APE + T K+DV+SFG++L E+V+ R
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 450 LIGRGGFGDVYKGELTDHR----VVAVK-CLKNVTGGDAE-FWAEVTIIARMHHLNLVRL 503
IG G FGDVY+G VAVK C + E F E I+ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
G E +V E P G L YL + K LD +
Sbjct: 73 IGVITEN-PVWIVMELAPLGELRSYLQVN-----------------------KYSLDLAS 108
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
+ ++ A+AYL + +H DI N+L+ C K+ DFGL++ + E
Sbjct: 109 LILYSYQLSTALAYLESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA 165
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
S+ + +MAPE + + T +DV+ FG+ + EI+
Sbjct: 166 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 70/225 (31%), Positives = 100/225 (44%), Gaps = 48/225 (21%)
Query: 451 IGRGGFGDVYKG--ELTDHRV--VAVKCLKN--VTGGDAEFWAEVTIIARMHHLNLVRLW 504
+G G FG V KG + + VAVK LK + G EF E +++A++ H +VRL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 505 GFCAEKGER-TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
G C KGE LV E P G L YL + + S + +
Sbjct: 63 GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSD------------------LKEL-- 100
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVS 622
A VA +AYL E +V H D+ N+LL + KISDFG+++ L D
Sbjct: 101 ----AHQVAMGMAYL-ESK-HFV-HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY- 152
Query: 623 MSRIRGTRG------YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
R T + APE + + + K+DV+S+G+ L E S
Sbjct: 153 ----RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 55/227 (24%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEF--WA------EVTIIARM-HHLNL 500
+G G FG VY +VA+K +K +F W EV + ++ H N+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK------KFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLAD-YLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
V+L E E V+EY+ G+L R G+ S S R
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR----------------- 102
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKE 618
SI Y+I G +A++H+ H D+KPEN+L+ KI+DFGLA+ +R +
Sbjct: 103 --SIIYQILQG----LAHIHKHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153
Query: 619 ---DMVSMSRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVS 661
D VS TR Y APE LRS + D+++ G ++ E+ +
Sbjct: 154 PYTDYVS------TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 4e-17
Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 44/215 (20%)
Query: 465 TDHRVVAVKCLKNVTGGD----AEFWAEVTIIARMHHLNLVRLW--GFCAEKGERTLVYE 518
T H V A+K L+ + A F E + AR++H N+V L G G V+E
Sbjct: 2 TGHEV-AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYL 578
YVP +L + L G + + R M VLD A+A
Sbjct: 60 YVPGRTLREVLAADGALPAGETGRLMLQ-----------VLD-------------ALACA 95
Query: 579 HEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKL---RKKEDMVSMSR---IRGT 629
H + ++H D+KP+NI++ G K+ DFG+ L + D+ +++R + GT
Sbjct: 96 HNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152
Query: 630 RGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664
Y APE LR + +TP +D+Y++G++ LE ++G R
Sbjct: 153 PTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 70/230 (30%), Positives = 93/230 (40%), Gaps = 42/230 (18%)
Query: 449 NLIGRGGFGDVYKGELTDHRV------VAVKCLKNVTGGDAE--FWAEVTIIARMHHLNL 500
+G G FG+VY+G VAVK L E F E I+++ +H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
VRL G E+ R ++ E + G L +L R R P L
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFL-RENR----------------PRPERPSSLT 114
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKK 617
A VA+ YL E +H DI N LL G KI+DFG+A+
Sbjct: 115 MKDLLFCARDVAKGCKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMAR---- 167
Query: 618 EDMVSMSRIR-GTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
D+ S R G R +M PE T K DV+SFG++L EI S
Sbjct: 168 -DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 53/231 (22%)
Query: 451 IGRGGFGDVY---KGELTDHRVVAVKCL-------KNVTGGDAEFWAEVTIIARMHHLNL 500
I +G +G V+ K D + A+K + KN + E I+++ +
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQV---DQVLTERDILSQAQSPYV 55
Query: 501 VRLWGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
V+L + + +G++ L V EY+P G LA L E G D
Sbjct: 56 VKL--YYSFQGKKNLYLVMEYLPGGDLASLL---------------ENVGSLDED----- 93
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
R IA V A+ YLH ++H D+KP+NIL+ + K++DFGL+K+
Sbjct: 94 ---VARIYIAEIVL-ALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146
Query: 619 DMVSMS-------RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
++++ RI GT Y+APE + + D +S G +L E + G
Sbjct: 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 44/223 (19%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGD--AEFWAEVTIIARMHHLNLVRLWGF 506
IG+G FG+VYK + ++VVA+K + D + E+ +++ + + +G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG- 66
Query: 507 CAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
KG + ++ EY GS D L + G++ E ++ + +R
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLD-LLKPGKLD------ETYIAFI-------------LRE 106
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-----KLRKKEDM 620
V + YLHEE +H DIK NILL ++ K++DFG++ + K+
Sbjct: 107 -----VLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS 663
V GT +MAPE ++ KAD++S G+ +E+ G
Sbjct: 159 V------GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 71/294 (24%), Positives = 135/294 (45%), Gaps = 54/294 (18%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKC--LKNVTGGD-AEFWAEVTIIARMHHLNLVRLWG 505
+G+G +G VYK + L+D++ A+K L +++ + + E+ I+A ++H N++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ + +V EY P G L+ + + + P +E+ +
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI--------------------W 106
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
RI + + R + LHE+ +LH D+K NILL + KI D G++K+ KK ++ ++
Sbjct: 107 RIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK--NMAKTQ 161
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685
I GT YMAPE + + K+D++S G +L E+ + + FE + SM
Sbjct: 162 I-GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SM------------- 206
Query: 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739
+D+ + + Y + + +Q +P+LRP+ K+
Sbjct: 207 ---------QDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 36/218 (16%)
Query: 451 IGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGD--AEFWAEVTIIARMHHLNLVRLWGFC 507
IGRG FG+V+ G L D+ VAVK + D A+F E I+ + H N+VRL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+K +V E V G +L GP K ++ ++
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL-----------------RTEGPRLKVKELI------QM 99
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR 627
A + YL + +H D+ N L+ + KISDFG++ R++ED V S
Sbjct: 100 VENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMS--REEEDGVYAST-G 153
Query: 628 GTR----GYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
G + + APE L + + ++DV+SFG++L E S
Sbjct: 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 39/219 (17%)
Query: 451 IGRGGFGDVYKGELTDHR----VVAVKCLKNVTGGDAEFWA---EVTIIARMHHLNLVRL 503
+G G G V K HR ++AVK ++ + +A E+ I+ + + +V
Sbjct: 9 LGAGNSGVVSK---VLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+G G+ ++ EY+ GSL L E+ G P I
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKIL--------------KEVQGRIPER---------I 101
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
+IA+ V + + YLHE+ ++H D+KP NIL+ K+ DFG++ + + ++
Sbjct: 102 LGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVS--GQLVNSLAK 157
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ + GT YMAPE ++ + + K+D++S G+ L+E+ +G
Sbjct: 158 TFV-GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 31/229 (13%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWA----EVTIIARMHHLNLVRLWG 505
IG+G F VYK L D RVVA+K ++ DA+ E+ ++ ++ H N+++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E E +V E G L+ + + P R + W
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI----------------WKYFV 113
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
++ A+ ++H + ++H DIKP N+ + K+ D GL + + + S
Sbjct: 114 QL----CSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674
+ GT YM+PE + + K+D++S G +L E+ + F G MN
Sbjct: 167 V-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY--GDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 75/309 (24%), Positives = 132/309 (42%), Gaps = 63/309 (20%)
Query: 450 LIGRGGFGDVYKGELTDH--RVVAVKCLKNVT----GGDA--------EFWAEVTII-AR 494
+G G FG VYK ++ ++A+K + NV G D + +EVTII +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEI-NVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 495 MHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDG 554
+ H N+VR + E +V + + L ++ +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---------- 115
Query: 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL 614
W+I ++ L A+ YLH+E + ++H D+ P NI+LG+D I+DFGLAK
Sbjct: 116 ------WNIFVQMVL----ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674
++ E ++ + GT Y PE ++++ KADV++FG +L ++ + +Q +
Sbjct: 164 KQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYS 215
Query: 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734
++ E VYE + E + Y V C+ E RP
Sbjct: 216 TNMLSLATKIVEAVYEPLP-EGM--------YSEDVTD--------VITSCLTPDAEARP 258
Query: 735 SMGKVAKML 743
+ +V+ M+
Sbjct: 259 DIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 69/261 (26%), Positives = 116/261 (44%), Gaps = 37/261 (14%)
Query: 451 IGRGGFGDVYKGEL------TDHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRL 503
+G G FG V+ E D +VAVK LK+ + +F E ++ + H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+G C E +V+EY+ +G L +L G P + G P + L S
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHG------PDAVLMAEGNRPAE-----LTQSQ 121
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-- 621
IA +A + YL + +H D+ N L+G++ KI DFG+++ D
Sbjct: 122 MLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
Query: 622 ---SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR-------NFEIQGS 671
+M IR +M PE + + T ++DV+S G+VL EI + + N E+
Sbjct: 179 GGHTMLPIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234
Query: 672 MMNSDEWYFPKWAFEKVYEEM 692
+ P+ ++VY+ M
Sbjct: 235 ITQGRVLQRPRTCPKEVYDLM 255
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 38/235 (16%)
Query: 449 NLIGRGGFGDVYKGELTDHR-VVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRL 503
+IG+G FG V + D + + A+K + G E I+ ++H LV L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 504 W-GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
W F E+ LV + + G L +L + +
Sbjct: 66 WYSFQDEE-NMYLVVDLLLGGDLRYHLSQKVKFSEEQ----------------------- 101
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-KLRKKEDMV 621
+++ I + A+ YLH + ++H DIKP+NILL + I+DF +A K+
Sbjct: 102 VKFWIC-EIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676
S S GT GYMAPE L + D +S G+ E + G R + +
Sbjct: 158 STS---GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 451 IGRGGFGDVYKGE------LTDHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRL 503
+G G FG V+ E D +VAVK LK+ T +F E ++ + H ++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+G C + +V+EY+ +G L +L G P + + G G+ L S
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHG------PDAMILVDGQPRQAKGE--LGLSQ 124
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-- 621
IA +A + YL + +H D+ N L+G + KI DFG+++ D
Sbjct: 125 MLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 622 ---SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+M IR +M PE + + T ++DV+SFG++L EI +
Sbjct: 182 GGHTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 5e-16
Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGD---AEFWAEVTIIARMHHLNLVRLWGF 506
+G G +G VYK + +VA+K ++ + + E++++ + H N+V+L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ + LV+EY L YL + + + K
Sbjct: 67 IHTERKLYLVFEYCDM-DLKKYL--------DKRPGPLSPNLI------K---------S 102
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-----LRKKEDMV 621
I + R +AY H +LH D+KP+NIL+ D K++DFGLA+ LR V
Sbjct: 103 IMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159
Query: 622 SMSRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSGS 663
T Y APE L S + D++S G + E+++G
Sbjct: 160 V------TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 68/227 (29%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 447 FSNLIGRGGFGDVYK---GELTDH--RVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNL 500
F +G+G FG V L D+ VVAVK L++ T F E+ I+ + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 501 VRLWGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
V+ G C G R LV EY+P GSL DYL + +
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-----------------------RER 104
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
LD A + + + YL + +H D+ NIL+ + KI DFGL K+ ++
Sbjct: 105 LDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161
Query: 619 DMVSMSRIRGTRG--YMAPEWLRSDQITPKADVYSFGMVLLEIVSGS 663
R G + APE L + + +DV+SFG+VL E+ + S
Sbjct: 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-16
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 451 IGRGGFGDV--YKGELTDH---RVVAVKCLKNVTGGD-AEFW-AEVTIIARMHHLNLVRL 503
+G G FG V Y + + +VAVK LK G W E+ I+ ++H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 504 WGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
G C+E+G + L+ EYVP GSL DYL P ++ ++ +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHKLNLAQL------------ 109
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
A + +AYLH + +H D+ N+LL +D KI DFGLAK +
Sbjct: 110 ---LLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163
Query: 622 SMSRIRGTRG--YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
R G + A E L+ ++ + +DV+SFG+ L E+++
Sbjct: 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510
+G G FG+V+ H VAVK +K + F AE ++ + H LV+L K
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K 72
Query: 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
++ E++ GSL D+L GS P ++ +D+S +
Sbjct: 73 EPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKL--------------IDFSAQ------ 110
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
+A +A++ + +H D++ NIL+ KI+DFGLA++ + + + +
Sbjct: 111 IAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 167
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664
+ APE + T K+DV+SFG++L+EIV+ R
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 28/221 (12%)
Query: 450 LIGRGGFGDVYKGELT------DHRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLV 501
+GRG FG+V+ + +V VK L+ + EF E+ + ++ H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRS-GRVGSSSPAREMEMSGVGPHDGGKPVLD 560
RL G C E ++ EY G L +L + + P P L
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKP----------------PPLS 115
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
+ + +A + +L +H D+ N L+ K+S L+K +
Sbjct: 116 TKQKVALCTQIALGMDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ ++APE ++ D + K+DV+SFG+++ E+ +
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 62/264 (23%), Positives = 110/264 (41%), Gaps = 42/264 (15%)
Query: 450 LIGRGGFGDVYKGEL----TDHRVVAVKCLK--NVTGGDAE-FWAEVTIIARMHHLNLVR 502
++G G FG V +G+L VAVK +K T + E F +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 503 LWGFCAEKGER------TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
L G C E ++ ++ +G L +L S R+G ++
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQT---------- 114
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK 616
+ + +A + YL +H D+ N +L +D ++DFGL+K
Sbjct: 115 -------LLKFMVDIALGMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIY 164
Query: 617 KEDMVSMSRI-RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-------GSRNFEI 668
D RI + ++A E L T K+DV++FG+ + EI + G N EI
Sbjct: 165 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224
Query: 669 QGSMMNSDEWYFPKWAFEKVYEEM 692
+ + + P+ +++Y+ M
Sbjct: 225 YDYLRHGNRLKQPEDCLDELYDLM 248
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 67/248 (27%), Positives = 102/248 (41%), Gaps = 64/248 (25%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKN----VTGGDAEFWAEVTIIARMHHLNLVRLW 504
+IGRG FG+V+ + +V A+K L+ A AE I+A +V+L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 505 GFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ + + E L V EY+P G L + L R E +
Sbjct: 67 -YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVF------PE----------------ET- 102
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK--------- 613
R+ IA V A+ +H+ L ++ H DIKP+NIL+ D K++DFGL K
Sbjct: 103 ARFYIAELVL-ALDSVHK--LGFI-HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158
Query: 614 -------------------LRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGM 654
K+ V + GT Y+APE LR + D +S G+
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218
Query: 655 VLLEIVSG 662
+L E++ G
Sbjct: 219 ILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 36/223 (16%)
Query: 449 NLIGRGGFGDVYKGELTD----HRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVR 502
+IG+G FG VY G L D AVK L +T +F E I+ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 503 LWGFC-AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L G C +G +V Y+ +G L +++ R + +P + ++ G G
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFI----RSETHNPTVK-DLIGFG----------- 104
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
L VA+ + YL + +H D+ N +L + F K++DFGLA+ ++
Sbjct: 105 -------LQVAKGMEYLASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154
Query: 622 SMSRIRGTR---GYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
S+ G + +MA E L++ + T K+DV+SFG++L E+++
Sbjct: 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 78/310 (25%), Positives = 129/310 (41%), Gaps = 62/310 (20%)
Query: 451 IGRGGFGDVYKGE---LTDHRVVAVKCLKNVTGGDAE--FWAEVTIIARMHHLNLVRLWG 505
IG G FG V GE V VK L+ D + F EV ++H N+++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
C E LV E+ P G L +YL RS R + A++ +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKD------------------VLQ 103
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
R+A VA + +LH+ +H D+ N L D KI D+GLA + ED
Sbjct: 104 RMACEVASGLLWLHQADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160
Query: 626 -----IRGTRGYMAPEWLRSDQ-------ITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673
+R ++APE + T K++++S G+ + E+ F
Sbjct: 161 CHAVPLR----WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL------FT------ 204
Query: 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELR 733
+D+ Y P + E+V +++ + ++ IK ++ +R + +C D PE R
Sbjct: 205 AADQPY-PDLSDEQVLKQV----VREQDIKLP-KPQLDLKYSDRWYEVMQFCWLD-PETR 257
Query: 734 PSMGKVAKML 743
P+ +V ++L
Sbjct: 258 PTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 46/226 (20%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGD--AEFWAEVTIIARMHHL---NLVRL 503
LIGRG +G VY+G + RVVA+K + T D ++ EV +++++ N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 504 WGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+G KG R ++ EY GS+ L ++G P E +S +
Sbjct: 68 YG-SYLKGPRLWIIMEYAEGGSVRT-LMKAG------PIAEKYISVI------------- 106
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
IR V A+ Y+H+ V+H DIK NIL+ + K+ DFG+A L +
Sbjct: 107 IRE-----VLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAAL-----LNQ 153
Query: 623 MSRIR----GTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGS 663
S R GT +MAPE + + KAD++S G+ + E+ +G+
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGN 199
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 75/306 (24%), Positives = 135/306 (44%), Gaps = 63/306 (20%)
Query: 450 LIGRGGFGDVYKGELT----DHRVVAVKCLKN--VTGGDAEFWAEVTIIARMHHLNLVRL 503
+IG G FG+V++G L VA+K LK +F +E +I+ + H N++RL
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
G + ++ EY+ NG+L YL R+ HDG ++S
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYL------------RD--------HDG-----EFSS 106
Query: 564 RYRIAL--GVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK--ED 619
+ + G+A + YL + + +V H D+ NIL+ + K+SDFGL+++ + E
Sbjct: 107 YQLVGMLRGIAAGMKYLSD--MNYV-HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEW 678
+ S + + APE + + T +DV+SFG+V+ E++S G R
Sbjct: 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER-------------- 209
Query: 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGK 738
P W +M +++ + I + + D + + + + C Q RP
Sbjct: 210 --PYW-------DMSNHEVM-KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVD 259
Query: 739 VAKMLE 744
+ +L+
Sbjct: 260 IVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 39/223 (17%)
Query: 451 IGRGGFGDVY------KGELTDHRVVAVKCLKNVTGGD--AEFWAEVTIIARMHHLNLVR 502
+G G FG V +G+ T +V AVK LK +GG+ A+ E+ I+ ++H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQV-AVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 503 LWGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
G C E G L+ E++P+GSL +YL P + K L
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL---------------------PRNKNKINLK 109
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK--KE 618
++Y A+ + + + YL ++V H D+ N+L+ + KI DFGL K + KE
Sbjct: 110 QQLKY--AVQICKGMDYLGSR--QYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ + APE L + +DV+SFG+ L E+++
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 66/238 (27%), Positives = 112/238 (47%), Gaps = 34/238 (14%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR-----------------VVAVKCLKNVTGGDA--EFWA 487
F +G G FG+V+ E+ + + +VAVK L+ +A +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 488 EVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMS 547
EV I++R+ N++RL G C ++ ++ EY+ NG L +L S +E +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL--SSHHLDD---KEENGN 123
Query: 548 GVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKIS 607
P P + +S +AL +A + YL L +V H D+ N L+G++ KI+
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSLNFV-HRDLATRNCLVGENLTIKIA 180
Query: 608 DFGLAKLRKKEDMVSMSRIRGTR----GYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
DFG+++ D RI+G +MA E + + T +DV++FG+ L EI+
Sbjct: 181 DFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 8e-15
Identities = 36/118 (30%), Positives = 54/118 (45%), Gaps = 12/118 (10%)
Query: 41 NQNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAI 100
+ + L+S S F GF K ++ + Y S TV+W AN P + +L +
Sbjct: 5 SSGQTLVSSGSLFELGFF-KLIMQSRDYNLILYKGSSR--TVVWVANRDNPSGSSCTLTL 61
Query: 101 AATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLV-YGN-----WQSFNLP 152
+ G L + + S + +W + T N N L L D GNLV Y + WQSF+ P
Sbjct: 62 Q-SDGNLVIYDGSGTVVW-SSNTTRVNGN-YVLVLLDDGNLVLYDSDGNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 69/224 (30%), Positives = 106/224 (47%), Gaps = 25/224 (11%)
Query: 451 IGRGGFGDVYKGEL-------TDHRV-VAVKCLK-NVTGGD-AEFWAEVTIIARM-HHLN 499
+G G FG V + E D V VAVK LK N T D A+ +E+ ++ + H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
++ L G C ++G ++ EY G+L ++L R+ R P + + L
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARR----PPGPDYTFDITKVPEE---QL 131
Query: 560 DWSIRYRIALGVARAIAYLH-EECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
+ A VAR + YL C +H D+ N+L+ +D KI+DFGLA+
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 619 DMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
D S R +MAPE L T ++DV+SFG+++ EI +
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 79/308 (25%), Positives = 132/308 (42%), Gaps = 59/308 (19%)
Query: 451 IGRGGFGDVYKGELTD------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVR 502
+G+G FG VY+G D VAVK + EF E +++ ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 503 LWGFCAEKGERTLV-YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L G + KG+ TLV E + +G L YL RS R + + G+P
Sbjct: 74 LLGVVS-KGQPTLVVMELMAHGDLKSYL-RSLRPEAENNP-------------GRPPPTL 118
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
++A +A +AYL+ + +H D+ N ++ DF KI DFG+ + + D
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 175
Query: 622 SMSRIRGTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676
+G +G +MAPE L+ T +D++SFG+VL EI S +
Sbjct: 176 R----KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA------------- 218
Query: 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
E+ Y+ + E +L + Y + + R+ C Q P++RP+
Sbjct: 219 ---------EQPYQGLSNEQVLKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTF 268
Query: 737 GKVAKMLE 744
++ +L+
Sbjct: 269 LEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 78/267 (29%), Positives = 113/267 (42%), Gaps = 59/267 (22%)
Query: 447 FSNLIGRGGFGDVYKGELTDH------RVVAVKCLKNVTGGDAEFWA---EVTIIARM-H 496
+GRG FG V + R VAVK LK +E+ A E+ I+ + H
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLK-EGATASEYKALMTELKILIHIGH 69
Query: 497 HLNLVRLWGFCAEKGERTLV-YEYVPNGSLADYL------------------------FR 531
HLN+V L G C + G +V EY G+L++YL +
Sbjct: 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129
Query: 532 SGRVGSSSPAREMEMSGVGPHDGGKPV---------------LDWSIRYRIALGVARAIA 576
R+ S S ++ SG V L+ I Y + VAR +
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISY--SFQVARGME 187
Query: 577 YL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSMSRIRGTRGYMA 634
+L +C+ H D+ NILL ++ KI DFGLA+ + K D V R +MA
Sbjct: 188 FLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243
Query: 635 PEWLRSDQITPKADVYSFGMVLLEIVS 661
PE + T ++DV+SFG++L EI S
Sbjct: 244 PESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 35/220 (15%)
Query: 450 LIGRGGFGDVYKG----ELTDHRV-VAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVR 502
++G G FG VYKG E ++ VA+K L TG + EF E I+A M H +LVR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L G C + LV + +P+G L DY+ + G + +L+W
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEH-----------------KDNIGSQLLLNWC 115
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK-KEDMV 621
++ +A+ + YL E L +H D+ N+L+ KI+DFGLA+L + E
Sbjct: 116 VQ------IAKGMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ + +MA E + + T ++DV+S+G+ + E+++
Sbjct: 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 79/319 (24%), Positives = 137/319 (42%), Gaps = 69/319 (21%)
Query: 440 LRAATNGFSNLIGRGGFGDVYKG--ELTDHRVVAVKCLKNVTGGDAE-----FWAEVTII 492
+ A+ +IG G FG+V G +L R + V +K + G E F +E +I+
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPV-AIKTLKAGYTEKQRRDFLSEASIM 59
Query: 493 ARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPH 552
+ H N++ L G + +V EY+ NGSL +L + H
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK--------------------H 99
Query: 553 DGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612
DG V+ R G+A + YL + + +V H D+ NIL+ + K+SDFGL+
Sbjct: 100 DGQFTVIQLVGMLR---GIASGMKYLSD--MGYV-HRDLAARNILVNSNLVCKVSDFGLS 153
Query: 613 KLRKKEDMVSMSRIRGTRG------YMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRN 665
++ + + + + TRG + APE + + T +DV+S+G+V+ E++S G R
Sbjct: 154 RVLEDDPEAAYT----TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER- 208
Query: 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWC 725
P W EM +D++ + I+ Y D + + + C
Sbjct: 209 ---------------PYW-------EMSNQDVI-KAIEEGYRLPAPMDCPAALHQLMLDC 245
Query: 726 IQDRPELRPSMGKVAKMLE 744
Q RP ++ +L+
Sbjct: 246 WQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 42/228 (18%)
Query: 450 LIGRGGFGDVY--KGELTDHRVVAVKCLKNVTG--GDAEFWA--EVTIIARMHHLNLVRL 503
++GRG FG V+ + D ++V +K V D A E ++ + H N++
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIK-QIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ E +V EY P G+LA+Y+ + S E +L + +
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCN----SLLDE------------DTILHFFV 108
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD-DFCPKISDFGLAKLRKKEDMVS 622
+ +AL ++H + +LH D+K +NILL KI DFG++K+ + S
Sbjct: 109 QILLAL------HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSS 154
Query: 623 MSR---IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
S+ + GT Y++PE K+D+++ G VL E+ S R FE
Sbjct: 155 KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 52/192 (27%), Positives = 83/192 (43%), Gaps = 40/192 (20%)
Query: 488 EVTIIARMHHLNLVRLWGFCAEKGERTL--VYEYVPNGSLADYLF-----RSGRVGSSSP 540
E+ I +V+ +G ++ ++ EY GSL D ++ R GR+G
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGE--- 104
Query: 541 AREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600
K + +IA V + ++YLH ++H DIKP NILL
Sbjct: 105 ---------------KVLG------KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTR 140
Query: 601 DFCPKISDFGLAKLRKKEDMVSM-SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI 659
K+ DFG++ E + S+ GT YMAPE ++ + +DV+S G+ LLE+
Sbjct: 141 KGQVKLCDFGVSG----ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
Query: 660 VSGSRNFEIQGS 671
F +G
Sbjct: 197 AQNRFPFPPEGE 208
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 42/225 (18%)
Query: 448 SNLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHL------NL 500
IG G +G VYK +L R VA+K ++ + + + IA + L N+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 501 VRLWGFCAEK-GER----TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGG 555
VRL C +R TLV+E+V + LA YL S P G+ P
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-------SKCPK-----PGLPP---- 106
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
+I+ + + R + +LH ++H D+KP+NIL+ D KI+DFGLA++
Sbjct: 107 -----ETIK-DLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY 157
Query: 616 KKEDMVSMSRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEI 659
E ++++ + T Y APE L+S TP D++S G + E+
Sbjct: 158 SFE--MALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 37/226 (16%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFC 507
+IG G +G VYK ++VA+K + + + E E I+ + +H N+ +G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 508 AEKGERT------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+K LV E GS+ D L + G GK + +
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTD-LVK------------------GLRKKGKRLKEE 113
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
I Y I R +AYLHE V+H DIK +NILL + K+ DFG++
Sbjct: 114 WIAY-ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169
Query: 622 SMSRIRGTRGYMAPEWLRSDQ-----ITPKADVYSFGMVLLEIVSG 662
+ I GT +MAPE + D+ ++DV+S G+ +E+ G
Sbjct: 170 RNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 39/222 (17%)
Query: 450 LIGRGGFGDVYKG----ELTDHRV-VAVKCLKNVTGGDAEFWAEVT----IIARMHHLNL 500
L+G G FG V+KG E ++ VA+K +++ +G + + E+T + + H +
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEITDHMLAMGSLDHAYI 71
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
VRL G C LV + P GSL D++ R R S P R +L+
Sbjct: 72 VRLLGICP-GASLQLVTQLSPLGSLLDHV-RQHR-DSLDPQR---------------LLN 113
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED- 619
W ++ +A+ + YL E + +H ++ NILL D +I+DFG+A L +D
Sbjct: 114 WCVQ------IAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
S + +MA E + + T ++DV+S+G+ + E++S
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 55/224 (24%), Positives = 96/224 (42%), Gaps = 45/224 (20%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE---FWAEVTIIARMHHLNLVRLWGF 506
IG G +G VYK + +VA+K +K + E+ ++ ++H N+++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVG-PHDGGKPVLDWSIRY 565
KG+ LV+E++ + + ++ G P K S Y
Sbjct: 67 FRHKGDLYLVFEFM----------------DTDLYKLIKDRQRGLPESLIK-----SYLY 105
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL-----RKKEDM 620
++ + +A+ H +LH D+KPEN+L+ + K++DFGLA+ R
Sbjct: 106 QLL----QGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158
Query: 621 VSMSRIRGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSGS 663
V TR Y APE L + D++S G + E++S
Sbjct: 159 VV------TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 64/241 (26%), Positives = 108/241 (44%), Gaps = 31/241 (12%)
Query: 431 GPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLK-NVT-GGDAEFWAE 488
G +F L +G + + + +VAVK L+ + + +F E
Sbjct: 14 GEGQFGEVHL-CEADGLQDFSEKAFAENDNADA---PVLVAVKVLRPDASDNAREDFLKE 69
Query: 489 VTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSG 548
V I++R+ N+ RL G C ++ EY+ NG L +L + E SG
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK----------HVAETSG 119
Query: 549 VGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISD 608
+ L +S +A +A + YL E L +V H D+ N L+G ++ KI+D
Sbjct: 120 LA---CNSKSLSFSTLLYMATQIASGMRYL--ESLNFV-HRDLATRNCLVGKNYTIKIAD 173
Query: 609 FGLAKLRKKEDMVSMSRIRGT-----RGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS 663
FG+++ D R++G R +MA E + + T K+DV++FG+ L EI++
Sbjct: 174 FGMSRNLYSSD---YYRVQGRAPLPIR-WMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229
Query: 664 R 664
R
Sbjct: 230 R 230
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 61/235 (25%), Positives = 107/235 (45%), Gaps = 47/235 (20%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGG-----------DAEFWAEVTIIARMHH 497
LIG G FG VY G + ++AVK ++ + DA E+ ++ + H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDA-LAREIALLKELQH 65
Query: 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
N+V+ G + + EYVP GS+A L G +
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALL---------------NNYGAFE----ET 106
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
++ +R + + + YLH ++H DIK NIL+ + KISDFG++K + +
Sbjct: 107 LVRNFVRQ-----ILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK-KLE 157
Query: 618 EDMVSMSR------IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
+ +S ++G+ +MAPE ++ T KAD++S G +++E+++G F
Sbjct: 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 5e-14
Identities = 32/93 (34%), Positives = 44/93 (47%), Gaps = 12/93 (12%)
Query: 79 PTTVIWSAN-DKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTAT-GNPNSTRLFLQ 136
TV+W AN + +L + + G L L + + +W + T G + LQ
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQ-SDGNLVLYDGNGRVVW---SSNTSGKGSGCVAVLQ 56
Query: 137 DAGNLV-YGN-----WQSFNLPTDTILPNQTLN 163
D GNLV Y N WQSF+ PTDT+LP Q
Sbjct: 57 DDGNLVLYDNSGKVLWQSFDHPTDTLLPGQKDG 89
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 66/239 (27%), Positives = 110/239 (46%), Gaps = 34/239 (14%)
Query: 439 ELRAATNGFSNLIGRGGFGDVYKGEL------TDHRVVAVKCLKNVTGGD--AEFWAEVT 490
E+ +T F +G FG VYKG L + VA+K LK+ G EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 491 IIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYL-FRS--GRVGSSSPAREMEMS 547
+ +R+ H N+V L G ++ ++++ Y + L ++L RS VGS+ + ++ S
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK-S 119
Query: 548 GVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKIS 607
+ P D I +A + +L V+H D+ N+L+ D KIS
Sbjct: 120 TLEPAD----------FVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKIS 166
Query: 608 DFGLAKLRKKEDMV-----SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
D GL + D S+ IR +M+PE + + + +D++S+G+VL E+ S
Sbjct: 167 DLGLFREVYAADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 6e-14
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG G +G VYK +VA+K ++ G E+ ++ ++ H N+VRL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 507 CAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
KG+ + +V+EY+ + L L SP + S + K
Sbjct: 67 VTSKGKGSIYMVFEYMDH-DLTGLL--------DSPEVKFTESQI------K-----CYM 106
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
++ G+ YLH +LH DIK NIL+ +D K++DFGLA+ K + +
Sbjct: 107 KQLLEGLQ----YLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
Query: 625 RIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSG 662
T Y PE L + + P+ D++S G +L E+ G
Sbjct: 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 60/228 (26%), Positives = 89/228 (39%), Gaps = 56/228 (24%)
Query: 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAE----FWA--EVTIIARMHHLNLV 501
+G G + VYK R+VA+K +K +A+ F A E+ ++ + H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L K LV+E+ M D K + D
Sbjct: 66 GLLDVFGHKSNINLVFEF--------------------------MET----DLEKVIKDK 95
Query: 562 SIRYR------IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
SI L R + YLH W+LH D+KP N+L+ D K++DFGLA+
Sbjct: 96 SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR-- 150
Query: 616 KKEDMVSMSRIRG----TRGYMAPEWL-RSDQITPKADVYSFGMVLLE 658
S +R TR Y APE L + D++S G + E
Sbjct: 151 ---SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 50/243 (20%)
Query: 450 LIGRGGFGDVYKGELT----DHRVVAVKCLKNVTGGDAE-----FWAEVTIIARMHHLNL 500
+IG G FG+V +G L VA+K LK G E F +E +I+ + H N+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLK---SGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+ L G + ++ E++ NG+L +L ++ DG V+
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQN--------------------DGQFTVIQ 107
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
R G+A + YL E + +V H D+ NIL+ + K+SDFGL+ R ED
Sbjct: 108 LVGMLR---GIAAGMKYLSE--MNYV-HRDLAARNILVNSNLVCKVSDFGLS--RFLEDD 159
Query: 621 VSMSRIRGTRG------YMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673
S + G + APE + + T +DV+S+G+V+ E++S G R + M
Sbjct: 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY---WDMS 216
Query: 674 NSD 676
N D
Sbjct: 217 NQD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-13
Identities = 64/236 (27%), Positives = 98/236 (41%), Gaps = 42/236 (17%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDA----EFWAEVTIIARMHHLNLVRLW 504
LIG+GG G+VY + R VA+K ++ + F E I A + H +V ++
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 505 GFCAEKGERTLVYEYVP--NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
C++ VY +P G L +S S E + VG
Sbjct: 69 SICSDG---DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF---------- 115
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED--- 619
I + I Y+H + VLH D+KP+NILLG I D+G A +K E+
Sbjct: 116 --LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 620 --------------MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
M +I GT YMAPE L + D+Y+ G++L ++++
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 67/247 (27%), Positives = 99/247 (40%), Gaps = 49/247 (19%)
Query: 451 IGRGGFGDVYKGELTDH-RVVAVKCL--------KNVTGGDAEFWAEVTIIARMHHLNLV 501
+G G FG V + A+K L K V E I+ + H LV
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQV----EHVLNEKRILQSIRHPFLV 64
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L+G + LV EYVP G L +L +SGR
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFP----------------------EPV 102
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
+ Y A V A+ YLH + ++ D+KPEN+LL D KI+DFG AK R K
Sbjct: 103 ARFY--AAQVVLALEYLHSLDI---VYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTY 156
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN-----SD 676
++ GT Y+APE + S D ++ G+++ E+++G F +
Sbjct: 157 TLC---GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213
Query: 677 EWYFPKW 683
+ FP +
Sbjct: 214 KVRFPSF 220
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 45/228 (19%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNV--TGGDAE-----FWAEVTIIARMHHLNLV 501
+G G F Y+ ++ ++AVK + V T + E E+ ++AR++H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
R+ G E L E++ GS++ L + G +E
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG------AFKE------------------ 102
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKE 618
++ + R ++YLHE ++H D+K N+L+ G +I+DFG A R
Sbjct: 103 AVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAA-ARLAA 156
Query: 619 DMVSMSRIRG----TRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+G T +MAPE LR +Q DV+S G V++E+ +
Sbjct: 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 44/219 (20%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEF-WAEVTIIARMHHLNLVRLWGFCA 508
IG G +GDVYK ++ +VA+K +K G D E E++++ H N+V +G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY--R 566
+ + +V EY GSL D P+ + I Y R
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIY----------------------QVTRGPLSELQIAYVCR 108
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
L + +AYLHE +H DIK NILL +D K++DFG++ ++++
Sbjct: 109 ETL---KGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA----TIAK- 157
Query: 627 R----GTRGYMAPEWL---RSDQITPKADVYSFGMVLLE 658
R GT +MAPE R K D+++ G+ +E
Sbjct: 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 78/268 (29%), Positives = 113/268 (42%), Gaps = 63/268 (23%)
Query: 451 IGRGGFGDVYKGE------LTDHRVVAVKCLKNVTGGDAEFW----AEVTIIARM-HHLN 499
+GRG FG V + + R VAVK LK G +E+ I+ + HHLN
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKILIHIGHHLN 72
Query: 500 LVRLWGFCAEKGERTLV-YEYVPNGSLADYL----------------FRSGRVG------ 536
+V L G C + G +V E+ G+L++YL FR G+ G
Sbjct: 73 VVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISE 132
Query: 537 ----------------SSSPAREMEMSGVGPHDGG-----KPVLDWSIRYRIALGVARAI 575
SS E +S V + K VL + VA+ +
Sbjct: 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGM 192
Query: 576 AYL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSMSRIRGTRGYM 633
+L +C+ H D+ NILL ++ KI DFGLA+ + K D V R +M
Sbjct: 193 EFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 248
Query: 634 APEWLRSDQITPKADVYSFGMVLLEIVS 661
APE + T ++DV+SFG++L EI S
Sbjct: 249 APETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCA 508
+G G +G VYK +VVA+K + V E E++I+ + +V+ +G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
+ + +V EY GS++D + + + + E E++ +I Y+
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLT-----EEEIA--------------AILYQTL 109
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-----KLRKKEDMVSM 623
G + YLH +H DIK NILL ++ K++DFG++ + K+ ++
Sbjct: 110 KG----LEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-- 160
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE ++ KAD++S G+ +E+ G
Sbjct: 161 ----GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 42/237 (17%)
Query: 451 IGRGGFGDVYKGELTDH-RVVAVKCLKN----VTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+G+GGFG+V ++ ++ A K L G+ E I+ ++ +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
K + LV + G L +++ G G +I Y
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR--------------------AIFY 100
Query: 566 --RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
+I G + +LH+ +++ D+KPEN+LL D +ISD GLA ++
Sbjct: 101 AAQIICG----LEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAV-----ELKGG 148
Query: 624 SRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
+I+ GT GYMAPE L+ + D ++ G L E+++G F + + +E
Sbjct: 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGFC 507
++G+G +G VY +L+ +A+K + + E+ + + + H N+V+ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+E G + E VP GSL+ L S GP + + + +
Sbjct: 75 SENGFFKIFMEQVPGGSLSALL----------------RSKWGPLKDNEQTIIFYTKQ-- 116
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGD-DFCPKISDFGLAKLRKKEDMVSMSRI 626
+ + YLH+ ++H DIK +N+L+ KISDFG +K + +
Sbjct: 117 ---ILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT-ETF 169
Query: 627 RGTRGYMAPEWLRSDQ--ITPKADVYSFGMVLLEIVSGSRNF----EIQGSM 672
GT YMAPE + AD++S G ++E+ +G F E Q +M
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 42/225 (18%)
Query: 451 IGRGGFGDVYKGEL-TDHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWG 505
+G GGFG V ++ + +R A+KC+K TG ++E I+ +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 506 FCAEKGERTLVY---EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ K ++ +Y EY G L L G +++
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFD-----------------------EYT 94
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMV 621
R+ IA V A YLH +++ D+KPEN+LL + K+ DFG AK L+ +
Sbjct: 95 ARFYIA-CVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW 150
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
+ GT Y+APE + + D +S G++L E+++G F
Sbjct: 151 T---FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 39/114 (34%), Positives = 65/114 (57%), Gaps = 7/114 (6%)
Query: 552 HDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL 611
++ K V+ I +IA+ +A+ YL EE L+ ++H D+KP NILL + K+ DFG+
Sbjct: 97 YEVLKSVIPEEILGKIAVATVKALNYLKEE-LK-IIHRDVKPSNILLDRNGNIKLCDFGI 154
Query: 612 AKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITP---KADVYSFGMVLLEIVSG 662
+ + D ++ +R G R YMAPE + ++DV+S G+ L E+ +G
Sbjct: 155 SG--QLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 36/224 (16%)
Query: 451 IGRGGFGD--VYKGELTDHRVV----AVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLW 504
+G+G FG+ +Y+ D VV + L DA E+ I++ + H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL--NEIVILSLLQHPNIIAYY 65
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+ + EY G+L D + R G + VL + +
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQK----------------GQLFEEEMVLWYLFQ 109
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
+ A++Y+H+ +LH DIK NI L K+ DFG++K+ E SM+
Sbjct: 110 ------IVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSMA 158
Query: 625 R-IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
+ GT YM+PE + + K+D+++ G VL E+++ R F+
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 5e-13
Identities = 37/115 (32%), Positives = 53/115 (46%), Gaps = 13/115 (11%)
Query: 41 NQNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAI 100
+ + L+S NS F GF +N + Y + S TV+W AN PV+ + +L +
Sbjct: 5 SSGQTLVSGNSLFELGFF-TLIMQN-DYNLILYKSSSR--TVVWVANRDNPVSDSCTLTL 60
Query: 101 AATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLV-YGN-----WQSF 149
+ G L L + +W + T N N L L D GNLV Y + WQSF
Sbjct: 61 Q-SDGNLVLYDGDGRVVW-SSNTTGANGN-YVLVLLDDGNLVIYDSDGNFLWQSF 112
|
Length = 114 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 41/237 (17%)
Query: 447 FSNLIGRGGFGDVYKGELT-------------DHR--VVAVKCLKNVTGGDA--EFWAEV 489
+G G FG+V+ E D + +VAVK L+ A +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 490 TIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGV 549
I++R+ + N++RL G C ++ EY+ NG L +L + E+
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL------------SQREIEST 116
Query: 550 GPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDF 609
H P + + +A+ +A + YL L +V H D+ N L+G+ + KI+DF
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYL--ASLNFV-HRDLATRNCLVGNHYTIKIADF 173
Query: 610 GLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI-----TPKADVYSFGMVLLEIVS 661
G+++ D RI+G R + W+ + I T +DV++FG+ L E+ +
Sbjct: 174 GMSRNLYSGDYY---RIQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 33/235 (14%)
Query: 439 ELRAATNGFSNLIGRGGFGDVYKG--ELTDHR--VVAVKCLKNVTGGDAE--FWAEVTII 492
EL + ++G G FG++ +G +L R VA+ L+ F AE +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 493 ARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPH 552
+ H N+VRL G +V EY+ NG+L +L + G + M M
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK--HEGQLVAGQLMGM------ 112
Query: 553 DGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612
G+A + YL E +H + +L+ D KIS F
Sbjct: 113 ---------------LPGLASGMKYLSEMGY---VHKGLAAHKVLVNSDLVCKISGFRRL 154
Query: 613 KLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNF 666
+ K E + + + + APE ++ + +DV+SFG+V+ E++S G R +
Sbjct: 155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 31/176 (17%)
Query: 488 EVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMS 547
EV I+ H N+V ++ E +V E++ G+L D + R+ A
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAT----- 119
Query: 548 GVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKIS 607
+ L V +A+++LH + V+H DIK ++ILL D K+S
Sbjct: 120 -------------------VCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLS 157
Query: 608 DFGL-AKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
DFG A++ +++ + GT +MAPE + + D++S G++++E+V G
Sbjct: 158 DFGFCAQV--SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 40/219 (18%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVK-CLKNVTGGDAE----FWAEVTIIARMHHLNLVRLWG 505
+G G FG VYK H+ + K + E F E+ I++ H N+V L+
Sbjct: 13 LGDGAFGKVYK---AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE 69
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ + ++ E+ G+L + E+E + + + IRY
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIML------------ELE----------RGLTEPQIRY 107
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ + A+ +LH V+H D+K NILL D K++DFG++ K +
Sbjct: 108 -VCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF 163
Query: 626 IRGTRGYMAPEWL-----RSDQITPKADVYSFGMVLLEI 659
I GT +MAPE + + + KAD++S G+ L+E+
Sbjct: 164 I-GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 36/217 (16%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAE-----FWAEVTIIARMHHLNLVRLWG 505
IG+G FG+V+KG D+R V +K + +AE E+T++++ + + +G
Sbjct: 12 IGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ + ++ EY+ GS D L R+G P E +++ + K +L
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLRAG------PFDEFQIATML-----KEIL------ 111
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ + YLH E +H DIK N+LL + K++DFG+A + + + +
Sbjct: 112 -------KGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNT 160
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE ++ KAD++S G+ +E+ G
Sbjct: 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 39/113 (34%), Positives = 62/113 (54%), Gaps = 9/113 (7%)
Query: 572 ARAIAYLHEECL-------EWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
RA+ Y E C E +++ D+KPENILL D +ISD GLA + E
Sbjct: 102 GRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKG 160
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
R+ GT GYMAPE +++++ T D ++ G +L E+++G F+ + + +E
Sbjct: 161 RV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 84/315 (26%), Positives = 141/315 (44%), Gaps = 52/315 (16%)
Query: 451 IGRGGFGDVYKGELTD------HRV--VAVKCLK-NVTGGD-AEFWAEVTIIARM-HHLN 499
+G G FG V E +RV VAVK LK + T D ++ +E+ ++ + H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
++ L G C + G ++ EY G+L +YL R+ R P ME P
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARR----PPG--MEYCYNPTQV---PEE 135
Query: 560 DWSIRYRI--ALGVARAIAYL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LR 615
S + + A VAR + YL ++C+ H D+ N+L+ +D KI+DFGLA+ +
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDIH 191
Query: 616 KKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675
+ + R +MAPE L T ++DV+SFG++L EI F + GS
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI------FTLGGSP--- 242
Query: 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735
+P E++++ +K +D+ + N + C P RP+
Sbjct: 243 ----YPGVPVEELFKLLKEGHRMDKPS----------NCTNELYMMMRDCWHAVPSQRPT 288
Query: 736 MGKVAKMLEGTVEIT 750
++ + L+ + +T
Sbjct: 289 FKQLVEDLDRILALT 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVRLWGFC 507
IG+G FG+VYKG + VVA+K + D + E+T++++ + R +G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+ + ++ EY+ GS D L P E ++ I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-------KPGPLEETYIA------------------TI 106
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR 627
+ + + YLH E +H DIK N+LL + K++DFG+A + + + +
Sbjct: 107 LREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFV 162
Query: 628 GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE ++ KAD++S G+ +E+ G
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 451 IGRGGFGDVYKG---ELTDHRVVAVKCLK----NVTGGDAEFWAEVTIIARMHHLNLVRL 503
IGRG +G VYK D + A+K K TG E+ ++ + H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 504 WGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
E +++ L+++Y + F S P ++
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK---------------- 111
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-GDDF---CPKISDFGLAKLRKK 617
S+ ++I G + YLH WVLH D+KP NIL+ G+ KI D GLA+L
Sbjct: 112 SLLWQILNG----VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
Query: 618 --EDMVSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVS 661
+ + + + T Y APE L + T D+++ G + E+++
Sbjct: 165 PLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 31/153 (20%)
Query: 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
GE ++ E++ GSL L ++GR+ P + I +I++
Sbjct: 72 GEISICMEHMDGGSLDQVLKKAGRI---------------PEN---------ILGKISIA 107
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR-IRGT 629
V R + YL E+ ++H D+KP NIL+ K+ DFG++ + + SM+ GT
Sbjct: 108 VLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGT 161
Query: 630 RGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
R YM+PE L+ T ++D++S G+ L+E+ G
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 41/228 (17%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRV--------VAVKCLKNVTGGDAE--FWAEVTIIARM- 495
F +G G FG V E T + + VAVK LK +E+ I++ +
Sbjct: 39 FGKTLGAGAFGKVV--EATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96
Query: 496 HHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGG 555
+H N+V L G C G ++ EY G L ++L R
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES-------------------- 136
Query: 556 KPVLDWSIRYRIALGVARAIAYL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK- 613
L + VA+ +A+L + C+ H D+ N+LL KI DFGLA+
Sbjct: 137 --FLTLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNVLLTHGKIVKICDFGLARD 190
Query: 614 LRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ + V R +MAPE + + T ++DV+S+G++L EI S
Sbjct: 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 50/297 (16%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWA----EVTIIARMHHLNLVRLWG 505
IGRG F +VY+ L D VA+K ++ DA+ A E+ ++ +++H N+++ +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E E +V E G L+ + + P + + W +Y
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV----------------W--KY 111
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ L A+ ++H V+H DIKP N+ + K+ D GL + + + S
Sbjct: 112 FVQL--CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685
+ GT YM+PE + + K+D++S G +L E+ + F G MN ++
Sbjct: 167 V-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNL-------YSL 216
Query: 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742
K E+ + H S + R +M CI PE RP + V +
Sbjct: 217 CKKIEQCDYPPLPSDHY--SEELRQLVNM----------CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 44/239 (18%)
Query: 447 FSNLIGRGGFGDVYKGEL-----------------TDHRVVAVKCLKNVTGGDA--EFWA 487
F +G G FG+V+ E +VAVK L+ +A +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 488 EVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMS 547
E+ I++R+ N++RL C ++ EY+ NG L +L R E + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSR----------HEPQEA 118
Query: 548 GVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKIS 607
+ +S +A +A + YL L +V H D+ N L+G ++ KI+
Sbjct: 119 AE---KADVVTISYSTLIFMATQIASGMKYL--SSLNFV-HRDLATRNCLVGKNYTIKIA 172
Query: 608 DFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI-----TPKADVYSFGMVLLEIVS 661
DFG+++ D RI+G R + W+ + I T +DV++FG+ L EI++
Sbjct: 173 DFGMSRNLYSGDYY---RIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 70/252 (27%), Positives = 109/252 (43%), Gaps = 53/252 (21%)
Query: 450 LIGRGGFGDVYKGEL--TDHRVVAVKCLKN---VTGGDAEF-WAEVTIIARM-HHLNLVR 502
++G+G FG V EL TD + AVK LK + D E E ++A H L +
Sbjct: 2 VLGKGSFGKVLLAELKGTD-ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 503 LWGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L C + +R V EYV G L ++ RSGR
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPR---------------------- 97
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-GDDFCPKISDFGLAKLRKKEDM 620
+ Y A + + +LHE +++ D+K +N+LL + KI+DFG+ K E +
Sbjct: 98 ARFY--AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHI-KIADFGMCK----EGI 147
Query: 621 VSMSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG------S 671
+ GT Y+APE L P D ++ G++L E+++G FE S
Sbjct: 148 LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS 207
Query: 672 MMNSDEWYFPKW 683
++ DE +P+W
Sbjct: 208 ILE-DEVRYPRW 218
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 41/219 (18%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWA-EVTIIARMHHLNLVRLWGFCA 508
IG+G G VY ++ + VA+K + E E+ ++ H N+V
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
E +V EY+ GSL D V + + E +++ V
Sbjct: 87 VGDELWVVMEYLAGGSLTD-------VVTETCMDEGQIAAV------------------C 121
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL-AKL----RKKEDMVSM 623
+A+ +LH V+H DIK +NILLG D K++DFG A++ K+ MV
Sbjct: 122 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-- 176
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE + PK D++S G++ +E+V G
Sbjct: 177 ----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 35/101 (34%), Positives = 56/101 (55%), Gaps = 8/101 (7%)
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
++ + + +A+ YL E+ V+H D+KP NILL K+ DFG++ R + + +R
Sbjct: 118 KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISG-RLVDSK-AKTR 173
Query: 626 IRGTRGYMAPEWLRSDQITPK----ADVYSFGMVLLEIVSG 662
G YMAPE + PK ADV+S G+ L+E+ +G
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG 214
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 7e-12
Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 36/217 (16%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAE-----FWAEVTIIARMHHLNLVRLWG 505
IG+G FG+V+KG D+R V +K + +AE E+T++++ + + +G
Sbjct: 12 IGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ + ++ EY+ GS D L P E +++
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIA------------------ 104
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
I + + + YLH E +H DIK N+LL + K++DFG+A + + + +
Sbjct: 105 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKRNT 160
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE ++ KAD++S G+ +E+ G
Sbjct: 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 8e-12
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 33/223 (14%)
Query: 451 IGRGGFGDVY--KGEL-TDHRVVAVKCLKNVTGGDAEFWA-EVTIIARMHHLNLVRLWGF 506
IG G FG +Y K + ++H V+ L + + E EV ++A+M H N+V +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
E G +V EY G L + R V S +L W + +
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSE----------------DQILSWFV--Q 109
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDD-FCPKISDFGLAKLRKKEDMVSMSR 625
I+LG + ++H+ +LH DIK +NI L + K+ DFG+A R+ D + ++
Sbjct: 110 ISLG----LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIA--RQLNDSMELAY 160
Query: 626 I-RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
GT Y++PE ++ K D++S G VL E+ + FE
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 62/231 (26%), Positives = 112/231 (48%), Gaps = 44/231 (19%)
Query: 450 LIGRGGFGDVYKG----ELTDHRV-VAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVR 502
++G G FG VYKG E ++ VA+K L+ T A E E ++A + + ++ R
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L G C + L+ + +P G L DY+ RE + + G + +L+W
Sbjct: 74 LLGICLTSTVQ-LITQLMPFGCLLDYV------------REHK-----DNIGSQYLLNWC 115
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
++ +A+ + YL E L +H D+ N+L+ KI+DFGLAKL ++
Sbjct: 116 VQ------IAKGMNYLEERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGADE--- 163
Query: 623 MSRIRGTRGYMAPEWLRSDQI-----TPKADVYSFGMVLLEIVS-GSRNFE 667
G + +W+ + I T ++DV+S+G+ + E+++ GS+ ++
Sbjct: 164 -KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 449 NLIGRGGFGDVYKG-ELTDHRVVAVKCLK--NVTGG-DAEFWAEVTIIARMHHLNLVRLW 504
N IG G +G VY+ + T +VA+K ++ N G E+T++ + H N+V L
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 505 GFCAEKGERT----LVYEYVPN--GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
G+ LV EY SL D + +P E ++
Sbjct: 73 EVVV--GKHLDSIFLVMEYCEQDLASLLDNM--------PTPFSESQVKC---------- 112
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
+ L + R + YLHE +++H D+K N+LL D C KI+DFGLA R
Sbjct: 113 --------LMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLA--RTYG 159
Query: 619 DMV-SMSRIRGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSG 662
M+ T Y APE L T D+++ G +L E+++
Sbjct: 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 42/222 (18%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDA---EFWAEVTIIARMHHL---NLVRL 503
IG G +G VYK + VA+K ++ T D EV ++ R+ N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 504 WGFCA-----EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
CA + + TLV+E+V + L YL P + + D +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYL-------DKVPPPGLPAETI--KDLMRQF 117
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
L R + +LH C ++H D+KPENIL+ K++DFGLA++ +
Sbjct: 118 L-------------RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ 161
Query: 619 DMVSMSRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEI 659
++++ + T Y APE L+S TP D++S G + E+
Sbjct: 162 --MALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 37/220 (16%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEF-----WAEVTIIARMHHLNLVRL 503
L+G G +G V K + + ++VA+K K + D + E+ ++ ++ H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIK--KFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
K LV+E+V + L D +E G LD S
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDD----------------LEKYPNG--------LDESR 101
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
+ + R I + H ++H DIKPENIL+ K+ DFG A+ V
Sbjct: 102 VRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158
Query: 624 SRIRGTRGYMAPEWLRSDQITPKA-DVYSFGMVLLEIVSG 662
+ TR Y APE L D +A D+++ G ++ E+++G
Sbjct: 159 DYV-ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 72/265 (27%), Positives = 109/265 (41%), Gaps = 60/265 (22%)
Query: 450 LIGRGGFGDVYKGELTDH------RVVAVKCLKNVTGGDAE----FWAEVTIIARM-HHL 498
++G G FG V + VAVK LK G A +E+ I+ + +HL
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKE--GATASEHKALMSELKILIHIGNHL 71
Query: 499 NLVRLWGFCAE-KGERTLVYEYVPNGSLADYLFRSGRVGSS-----SP------------ 540
N+V L G C + G ++ E+ G+L+++L R+ R S SP
Sbjct: 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFL-RAKREFFSPYREKSPKQRGRFRAMVEQ 130
Query: 541 --AREMEMSGVG--------PHDGGKPVLD------WSIRYRI------ALGVARAIAYL 578
+G P G W + + VAR + +L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190
Query: 579 -HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSMSRIRGTRGYMAPE 636
+C+ H D+ NILL ++ KI DFGLA+ + K D V R +MAPE
Sbjct: 191 ASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246
Query: 637 WLRSDQITPKADVYSFGMVLLEIVS 661
+ T ++DV+SFG++L EI S
Sbjct: 247 SIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 29/188 (15%)
Query: 488 EVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMS 547
EV +++ M H N+V+ E G +V +Y G L Y + + G P +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL--YKKINAQRGVLFPEDQ---- 102
Query: 548 GVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKIS 607
+LDW ++ +AL ++H+ +LH DIK +NI L D K+
Sbjct: 103 ----------ILDWFVQICLAL------KHVHDR---KILHRDIKSQNIFLTKDGTIKLG 143
Query: 608 DFGLAKLRKKEDMVSMSRI-RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
DFG+A++ V ++R GT Y++PE + K+D+++ G VL E+ + F
Sbjct: 144 DFGIARVL--NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF 201
Query: 667 EIQGSMMN 674
E G+M N
Sbjct: 202 E-AGNMKN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 451 IGRGGFGDVY----KGELTDH--RVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVR 502
+G+G FG VY KG + D VA+K + EF E +++ + ++VR
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L G ++ ++ E + G L YL RS R P P L
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYL-RSLR------PEMENNPVQAP-----PSLKKM 121
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
I+ +A +A +AYL+ +H D+ N ++ +DF KI DFG+ + + D
Sbjct: 122 IQ--MAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176
Query: 623 MSRIRGTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+G +G +M+PE L+ T +DV+SFG+VL EI +
Sbjct: 177 ----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 39/224 (17%)
Query: 451 IGRGGFGDVYKGE----LTDHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLW 504
IG G FG V GE T +VV VK L+ +F E + H NL++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
G C E LV E+ P G L YL RS R D +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTP------------------DPTTL 102
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED-MVSM 623
R+A +A + +LH+ +H D+ N LL D KI D+GL+ + KED V+
Sbjct: 103 QRMACEIALGLLHLHKNNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159
Query: 624 SRIRGTRGYMAPEWLRS--------DQITPKADVYSFGMVLLEI 659
++ ++APE + DQ T +++V+S G+ + E+
Sbjct: 160 DQLWVPLRWIAPELVDEVHGNLLVVDQ-TKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 72/228 (31%), Positives = 103/228 (45%), Gaps = 52/228 (22%)
Query: 447 FSNL--IGRGGFGDVYKGELTDHR---VVAVKCLKNVTGGDA-EFW----AEVTIIARMH 496
F++L IG G FG VY D R VVA+K + + +G + E W EV + ++
Sbjct: 17 FTDLREIGHGSFGAVYFA--RDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 497 HLNLVRLWGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDG 554
H N + G C + E T LV EY GS +D L + P +E+E++
Sbjct: 74 HPNTIEYKG-CYLR-EHTAWLVMEYCL-GSASDILEVHKK-----PLQEVEIAA------ 119
Query: 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL 614
I G + +AYLH +H DIK NILL + K++DFG A L
Sbjct: 120 ------------ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL 164
Query: 615 RKKEDMVSMSRIRGTRGYMAPE-WLRSD--QITPKADVYSFGMVLLEI 659
+ + GT +MAPE L D Q K DV+S G+ +E+
Sbjct: 165 -----VSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 59/237 (24%), Positives = 107/237 (45%), Gaps = 47/237 (19%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLK-NVTGG-DAEFWAEVTIIARMHHLNLVRL 503
+ ++G G G VYK L R++AVK + ++T + +E+ I+ + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+G + ++ E++ GSL Y P + VL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY--------RKIP---------------EHVLG--- 98
Query: 564 RYRIALGVARAIAYLHEECLEW---VLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
RIA+ V + + YL W +LH D+KP N+L+ K+ DFG++ + +
Sbjct: 99 --RIAVAVVKGLTYL------WSLKILHRDVKPSNMLVNTRGQVKLCDFGVS--TQLVNS 148
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS----RNFEIQGSMM 673
++ + + GT YMAPE + +Q +DV+S G+ +E+ G + + QGS+M
Sbjct: 149 IAKTYV-GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM 204
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 65/263 (24%), Positives = 108/263 (41%), Gaps = 43/263 (16%)
Query: 451 IGRGGFGDVYKGELT-DHRV--VAVKCLKNVTGGDAE---FWAEVTIIARMHHLNLVRLW 504
+G G FG V +G+L D + VAVK +K +E F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 505 GFCAEKGER------TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
G C + E ++ ++ +G L +L S R+G P
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RLGDC------------------PQ 107
Query: 559 -LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
L + + +A + YL + +H D+ N +L ++ ++DFGL+K
Sbjct: 108 YLPTQMLVKFMTDIASGMEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKIYN 164
Query: 618 EDMVSMSRI-RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-------GSRNFEIQ 669
D RI + ++A E L T K+DV+SFG+ + EI + G N EI
Sbjct: 165 GDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
Query: 670 GSMMNSDEWYFPKWAFEKVYEEM 692
+ + P + +Y M
Sbjct: 225 DYLRQGNRLKQPPDCLDGLYSLM 247
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 451 IGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEF-WAEVTIIARMHHLNLVRLWGFCA 508
IG G G V + + ++VAVK + E + EV I+ H N+V ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
E +V E++ G+L D + + + E +++ V
Sbjct: 88 VGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAV------------------C 122
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRG 628
L V +A++ LH + V+H DIK ++ILL D K+SDFG KE + + G
Sbjct: 123 LAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSLVG 178
Query: 629 TRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
T +MAPE + P+ D++S G++++E+V G
Sbjct: 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 67/228 (29%), Positives = 111/228 (48%), Gaps = 33/228 (14%)
Query: 451 IGRGGFGDVYKGEL--------TDHRVVAVKCLK-NVTGGD-AEFWAEVTIIARM-HHLN 499
+G G FG V E + VAVK LK + T D ++ +E+ ++ + H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
++ L G C + G ++ EY G+L +YL R+ R ME S +D + V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYL-RARR------PPGMEYS----YDIAR-VP 130
Query: 560 DWSIRYRIALG----VARAIAYL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL 614
D + ++ + VAR + YL ++C +H D+ N+L+ ++ KI+DFGLA+
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 615 RKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
D + R +MAPE L T ++DV+SFG+++ EI +
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 65/243 (26%), Positives = 105/243 (43%), Gaps = 43/243 (17%)
Query: 434 RFTHAELRAATN----------GFSNL--IGRGGFGDV-YKGELTDHRVVAVKCLKNVTG 480
R +H + RAA + IG G G V E + VAVK +
Sbjct: 1 RVSHEQFRAALQLVVSPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ 60
Query: 481 GDAEF-WAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSS 539
E + EV I+ HH N+V ++ E +V E++ G+L D + + +
Sbjct: 61 QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV-------THT 113
Query: 540 PAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599
E +++ V L V RA++YLH + V+H DIK ++ILL
Sbjct: 114 RMNEEQIATV------------------CLSVLRALSYLHNQ---GVIHRDIKSDSILLT 152
Query: 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI 659
D K+SDFG KE + + GT +MAPE + + D++S G++++E+
Sbjct: 153 SDGRIKLSDFGFCAQVSKE-VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
Query: 660 VSG 662
+ G
Sbjct: 212 IDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 70/251 (27%), Positives = 113/251 (45%), Gaps = 51/251 (20%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLK-NVTGGDAEFWAEVTIIAR------MHHLNLV 501
++G+G FG V EL + A+K LK +V D + E T++ R H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD--VECTMVERRVLALAWEHPFLT 59
Query: 502 RLWGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
L FC + + L V EY+ G L ++ SGR +
Sbjct: 60 HL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA--------------------- 96
Query: 560 DWSIRYRI-ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
R R A + + +LH++ +++ D+K +N+LL D KI+DFG+ K
Sbjct: 97 ----RARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG 149
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQGSM 672
+ + S GT Y+APE L+ + D +SFG++L E++ G F E+ S+
Sbjct: 150 EGKA-STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
Query: 673 MNSDEWYFPKW 683
+N D +FP+W
Sbjct: 209 LN-DRPHFPRW 218
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 47/231 (20%)
Query: 450 LIGRGGFGDVYKGELTDHR----VVAVKCLKN---VTGGD-AEFWAEVTIIARMHHLNLV 501
+IGRG FG+V +L H+ V A+K L + D A FW E I+A + +V
Sbjct: 50 VIGRGAFGEV---QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIV 106
Query: 502 RLWGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+L A + ++ L V EY+P G L + + S+ E
Sbjct: 107 QL--HYAFQDDKYLYMVMEYMPGGDLVNLM-------SNYDIPE---------------- 141
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
W+ Y V A+ +H +H D+KP+N+LL K++DFG
Sbjct: 142 KWARFY--TAEVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196
Query: 620 MVSMSRIRGTRGYMAPEWLRSD----QITPKADVYSFGMVLLEIVSGSRNF 666
MV GT Y++PE L+S + D +S G+ L E++ G F
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 67/259 (25%), Positives = 117/259 (45%), Gaps = 47/259 (18%)
Query: 450 LIGRGGFGDVYKGEL-TDHRVVAVKCLK-NVTGGDAEFWAEVT-----IIARMHHLNLVR 502
++G+G FG V L R+ AVK LK +V D + +T +AR H L +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF-LTQ 60
Query: 503 LWGFCAEKGERTL-VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L+ C + +R V E+V G L ++ +S R +
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA----------------------- 96
Query: 562 SIRYRI-ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
R R A + A+ +LH++ +++ D+K +N+LL + K++DFG+ K +
Sbjct: 97 --RARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNG 150
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG------SMMN 674
+ S GT Y+APE L+ P D ++ G++L E++ G FE + +++N
Sbjct: 151 KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
Query: 675 SDEWYFPKWAFEKVYEEMK 693
DE +P W + + +K
Sbjct: 211 -DEVVYPTWLSQDAVDILK 228
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 450 LIGRGGFGDVYKGELTDH-RVVAVKCLK------NVTGGDAEFWAEVTIIARMHHLNLVR 502
L+G+G FG VY D R +A K ++ + + E+ ++ + H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 503 LWGFCAEKGERTLV--YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+G ++ E+TL EY+P GS+ D L G L
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG------------------------ALT 104
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
S+ + + ++YLH ++H DIK NIL K+ DFG +K + M
Sbjct: 105 ESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161
Query: 621 --VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ + GT +M+PE + + KADV+S G ++E+++
Sbjct: 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 31/229 (13%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDA----EFWAEVTIIARMHHLNLVRLWG 505
IGRG F +VY+ L D + VA+K ++ DA + E+ ++ +++H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E E +V E G L+ + + P R + W +Y
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV----------------W--KY 111
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ L A+ ++H V+H DIKP N+ + K+ D GL + + + S
Sbjct: 112 FVQL--CSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674
+ GT YM+PE + + K+D++S G +L E+ + F G MN
Sbjct: 167 V-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 77/295 (26%), Positives = 118/295 (40%), Gaps = 60/295 (20%)
Query: 451 IGRGGFGDVY-KGELTDHRVVAVKCLKNVTGGDAEFW----AEVTIIARMHHLNLVRLWG 505
IG G FG VY + VVAVK + E W EV + ++ H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
++ LV EY GS +D L + P +E+E++
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAA----------------- 125
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
I G + +AYLH + +H DIK NILL + K++DFG A +
Sbjct: 126 -ITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-----S 176
Query: 626 IRGTRGYMAPE---WLRSDQITPKADVYSFGMVLLEIV----------SGSRNFEI---Q 669
GT +MAPE + Q K DV+S G+ +E+ + S + I
Sbjct: 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND 236
Query: 670 GSMMNSDEWY-----FPKWAFEKVYEEMKVEDILDRH--IKNSYDSRVHFDMVNR 717
+ S+EW F + +K+ +E L RH ++ +RV D++ R
Sbjct: 237 SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQR 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 67/231 (29%), Positives = 104/231 (45%), Gaps = 39/231 (16%)
Query: 451 IGRGGFGDVYKGEL--------TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH----HL 498
+G G FG V E VAVK LK+ D + V+ + M H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD-DATDKDLSDLVSEMEMMKMIGKHK 78
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVG-PHDGGKP 557
N++ L G C + G ++ EY G+L +YL R+ R P + P +
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYL-RARR----PPGMDYSFDTCKLPEE---- 129
Query: 558 VLDWSIRYRIALGVARAIAYL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK 616
L + A VAR + YL ++C+ H D+ N+L+ +D KI+DFGLA+
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIADFGLAR--- 182
Query: 617 KEDMVSMSRIRGTRG------YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
D+ ++ + T +MAPE L T ++DV+SFG++L EI +
Sbjct: 183 --DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 36/221 (16%)
Query: 450 LIGRGGFGDVYKGELTDH-RVVAVKCL---KNVTGGDAEFWA---EVTIIARMHHLNLVR 502
L+G+G FG VY D R +AVK + + E A E+ ++ + H +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+G + ++ EY+P GS+ D L G + + + R+
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGAL-TETVTRKYT----------------- 110
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-- 620
+I GV YLH ++H DIK NIL K+ DFG +K +
Sbjct: 111 --RQILEGVE----YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
M + GT +M+PE + + KADV+S G ++E+++
Sbjct: 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 56/228 (24%)
Query: 450 LIGRGGFGDVY--KGELTDH----------RVVAVKCLKNVTGGDAEFWAEVTIIARMHH 497
+G G FG V+ + +++H V+ +K ++V E ++ + H
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN-------EKRVLKEVSH 60
Query: 498 LNLVRLWGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGG 555
++RL F E +R L + EYVP G L YL SGR +S+
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNST---------------- 102
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-L 614
+ Y A + A+ YLH + +++ D+KPENILL + K++DFG AK L
Sbjct: 103 ------GLFY--ASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
R + + GT Y+APE ++S D ++ G+++ E++ G
Sbjct: 152 RDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+IA+ V + YL+ ++H DIKP NIL+ K+ DFG++ E + S++
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSG----ELINSIAD 160
Query: 626 -IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT YM+PE ++ + T K+DV+S G+ ++E+ G
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
R + YLH +LH DIKP N+L+ + KI DFGLA++ + ++ M++ T+ Y
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 633 MAPEWLR-SDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670
APE L S T D++S G + E++ F+ Q
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 61/233 (26%), Positives = 104/233 (44%), Gaps = 34/233 (14%)
Query: 451 IGRGGFGDV------YKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLW 504
+G+GGFG+V G++ + + K LK G+ E I+ +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
K LV + G L +++ G G +EM V I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-------LEMERV-------------IH 99
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
Y + + I +LH +++ D+KPEN+LL D ++SD GLA K D +++
Sbjct: 100 Y--SAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELK--DGKTIT 152
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
+ GT GYMAPE L+ + + D ++ G + E+V+G F+ + +E
Sbjct: 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 58/230 (25%), Positives = 89/230 (38%), Gaps = 52/230 (22%)
Query: 451 IGRGGFGDVYKGELTDHRVV----AVKCLK--------NVTGGDAEFWAEVTIIARMHHL 498
I +G FG VY L R A+K LK VT AE ++ +
Sbjct: 4 ISKGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE---RAIMMIQGESP 57
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
+ +L+ K LV EY+ G A + + G P
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLI---------------KTLGGLP------- 95
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
DW+ +Y V + LH+ ++H DIKPEN+L+ K++DFGL++
Sbjct: 96 EDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR----- 145
Query: 619 DMVSMS-RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
+ + GT Y+APE + +D +S G V+ E + G F
Sbjct: 146 -NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 47/171 (27%), Positives = 84/171 (49%), Gaps = 32/171 (18%)
Query: 495 MHHLN---LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGP 551
+H N +V +G GE ++ E++ GSL L + R+ P
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRI---------------P 101
Query: 552 HDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL 611
+ I ++++ V R +AYL E+ ++H D+KP NIL+ K+ DFG+
Sbjct: 102 EE---------ILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGV 150
Query: 612 AKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ + D ++ S + GTR YM+PE L+ + ++D++S G+ L+E+ G
Sbjct: 151 SG--QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 41/117 (35%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK- 613
G+P+ D + I + + Y+H VLH D+KP N+L+ D KI DFGLA+
Sbjct: 99 GQPLTDAHFQSFI-YQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154
Query: 614 --LRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKA-DVYSFGMVLLEIVSGSRNFE 667
E+ M+ TR Y APE + S Q KA DV+S G +L E++ F+
Sbjct: 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 62/238 (26%)
Query: 451 IGRGGFGDVYKGELTDHRV--------------VAVKCLKNVTGGDAEFWAEVTIIARMH 496
+G+G F ++YKG RV V +K L + F+ ++++++
Sbjct: 3 LGQGTFTNIYKG---VLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS 59
Query: 497 HLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
H +LV+L+G C E +V EYV G L +L R
Sbjct: 60 HKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHRE---------------------KNN 97
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-------GDDFCPKISDF 609
L W + +A +A A+ YL ++ L +H ++ +NIL+ G K+SD
Sbjct: 98 VSLHW--KLDVAKQLASALHYLEDKKL---VHGNVCGKNILVARYGLNEGYVPFIKLSDP 152
Query: 610 GLAK--LRKKEDMVSMSRIRGTRGYMAPEWLRSDQ--ITPKADVYSFGMVLLEIVSGS 663
G+ L ++E + RI ++APE +R+ Q +T AD +SFG LLEI S
Sbjct: 153 GIPITVLSREE---RVERIP----WIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 64/228 (28%), Positives = 96/228 (42%), Gaps = 46/228 (20%)
Query: 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNV-TGGDAEFWA-----EVTIIARMHHLNLVR 502
IG G +G VYK D + LK V + E + E+ I+ +++H N+V
Sbjct: 13 GQIGEGTYGQVYKAR--DKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVN 70
Query: 503 L----------WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPH 552
L F +KG LV+EY+ + + L SG V S + M
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVHFSEDHIKSFM------ 122
Query: 553 DGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612
K +L+ + Y H++ LH DIK NILL + K++DFGLA
Sbjct: 123 ---KQLLE-------------GLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLA 163
Query: 613 KLRKKEDMVSMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEI 659
+L E+ + T Y PE L ++ P DV+S G +L E+
Sbjct: 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 34/106 (32%), Positives = 59/106 (55%), Gaps = 18/106 (16%)
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+IA+ + +A+ YLH + V+H D+KP N+L+ + K+ DFG++ D V+ +
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISG--YLVDSVAKTI 162
Query: 626 IRGTRGYMAPEWLRSDQITP---------KADVYSFGMVLLEIVSG 662
G + YMAPE +I P K+DV+S G+ ++E+ +G
Sbjct: 163 DAGCKPYMAPE-----RINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 61/230 (26%), Positives = 113/230 (49%), Gaps = 42/230 (18%)
Query: 450 LIGRGGFGDVYKG----ELTDHRV-VAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVR 502
++G G FG VYKG + + ++ VA+K L+ T A E E ++A + + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRS-GRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L G C + LV + +P G L DY+ + R+GS + +L+W
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGS------------------QDLLNW 114
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL---RKKE 618
++ +A+ ++YL E L +H D+ N+L+ KI+DFGLA+L + E
Sbjct: 115 CVQ------IAKGMSYLEEVRL---VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFE 667
++ +MA E + + T ++DV+S+G+ + E+++ G++ ++
Sbjct: 166 YHADGGKV--PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 572 ARAIAYLHEECL-------EWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
RA+ Y E E +++ D+KPENILL D +ISD GLA + E
Sbjct: 102 ERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRG 160
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
R+ GT GYMAPE +++++ T D + G ++ E++ G F
Sbjct: 161 RV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 42/223 (18%)
Query: 447 FSNL--IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFW----AEVTIIARMHHLN 499
FS+L IG G FG VY ++ + VVA+K + E W EV + ++ H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
++ G + LV EY GS +D L + P +E+E++
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAA----------- 119
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
+ G + +AYLH + +H D+K NILL + K+ DFG A +
Sbjct: 120 -------VTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASI----- 164
Query: 620 MVSMSRIRGTRGYMAPE---WLRSDQITPKADVYSFGMVLLEI 659
M + GT +MAPE + Q K DV+S G+ +E+
Sbjct: 165 MAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 35/235 (14%)
Query: 451 IGRGGFGDVY------KGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLW 504
+G+GGFG+V G+L + + K LK G + E I+A++H +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM-VEKRILAKVHSRFIVSLA 59
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
K + LV + G L +++ V +P G +
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYN---VDEENP-------GFPEPR--------ACF 101
Query: 565 Y--RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
Y +I G + +LH+ +++ D+KPEN+LL +D +ISD GLA + K+
Sbjct: 102 YTAQIISG----LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSK 153
Query: 623 MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
GT G+MAPE L+ ++ D ++ G+ L E+++ F +G + + E
Sbjct: 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 42/131 (32%), Positives = 64/131 (48%), Gaps = 19/131 (14%)
Query: 573 RAIAYLHEECL-------EWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
RA+ Y E E ++ D+KPENILL D +ISD GLA ++ E R
Sbjct: 103 RALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGR 161
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF----------EIQGSMMNS 675
+ GT GYMAPE L + + T D + G ++ E++ G F E+ ++ +
Sbjct: 162 V-GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET 220
Query: 676 DEWYFPKWAFE 686
+E Y K++ E
Sbjct: 221 EEVYSAKFSEE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 44/223 (19%)
Query: 451 IGRGGFGDVYKG---ELTDHRVVAVKCLKNVTGGDA---EFWAEVTIIARMHHLNLVRLW 504
+G G FG V KG + VAVK LKN A E E ++ ++ + +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDG----GKPVLD 560
G C E LV ME++ +GP + K V +
Sbjct: 63 GIC-EAESWMLV---------------------------MELAELGPLNKFLQKNKHVTE 94
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
+I + V+ + YL E +H D+ N+LL KISDFGL+K ++
Sbjct: 95 KNIT-ELVHQVSMGMKYLEETNF---VHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150
Query: 621 VSMSRIRGT--RGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
++ G + APE + + + K+DV+SFG+++ E S
Sbjct: 151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 32/220 (14%)
Query: 451 IGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWA--EVTIIARMHHLNLVRLWGFC 507
+G G + VYKG+ + ++VA+K ++ F A E +++ + H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
K TLV+EYV + L Y+ + G+ P + K L
Sbjct: 73 HTKETLTLVFEYV-HTDLCQYM-------------DKHPGGLHP-ENVKLFL-------- 109
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR 627
+ R ++Y+H+ ++LH D+KP+N+L+ D K++DFGLA+ + + +
Sbjct: 110 -FQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165
Query: 628 GTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
T Y P+ L S + + D++ G + +E++ G F
Sbjct: 166 -TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 65/227 (28%), Positives = 98/227 (43%), Gaps = 53/227 (23%)
Query: 451 IGRGGFGDVYKGELTDH-RVVAVKCLKNVTGGDAEF-----WAEVTIIARMHHLNLVRLW 504
IG G +G V+K + ++VA+K K V D E+ ++ ++ H NLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREME--MSGVGPHDGGKPVLDWS 562
K + LV+EY + L E+E GV H
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVL----------------NELEKNPRGVPEH---------L 101
Query: 563 IRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENILLGDDFCPKISDFGLAKL-----RK 616
I+ +I +A+ + H+ C+ H D+KPENIL+ K+ DFG A++
Sbjct: 102 IK-KIIWQTLQAVNFCHKHNCI----HRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156
Query: 617 KEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSG 662
D V+ TR Y APE L D Q P DV++ G V E+++G
Sbjct: 157 YTDYVA------TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 9/112 (8%)
Query: 573 RAIAYLHEECL-------EWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
RAI Y E C E +++ D+KPENILL D +ISD GLA ++ E R
Sbjct: 103 RAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGR 161
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
+ GT GYMAPE + +++ T D + G ++ E++ G F + + +E
Sbjct: 162 V-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 33/215 (15%)
Query: 451 IGRGGFGDV-YKGELTDHRVVAVKCLKNVTGGDAEF-WAEVTIIARMHHLNLVRLWGFCA 508
IG G G V E R VAVK + E + EV I+ H N+V ++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
E ++ E++ G+L D + S + E +++ V
Sbjct: 89 VGEELWVLMEFLQGGALTDIV-------SQTRLNEEQIATV------------------C 123
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL-AKLRKKEDMVSMSRIR 627
V +A+ YLH + V+H DIK ++ILL D K+SDFG A++ K D+ +
Sbjct: 124 ESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLV 178
Query: 628 GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE + + D++S G++++E+V G
Sbjct: 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 59/223 (26%), Positives = 87/223 (39%), Gaps = 48/223 (21%)
Query: 451 IGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWA--------EVTIIARMHHLNLV 501
+G+GG+G V+ + D +VA+K +K F E I+ LV
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSL----LFKLNEVRHVLTERDILTTTKSEWLV 64
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+L + L EYVP G L G +
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA--------------------- 103
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK--LRKKED 619
R+ +A A+ LHE L ++ H D+KPEN L+ K++DFGL+K +
Sbjct: 104 --RFYMAEMFE-AVDALHE--LGYI-HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS 157
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+V G+ YMAPE LR D +S G +L E + G
Sbjct: 158 VV------GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 49/242 (20%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR------VVAVKCLKNVTGGD---AEFWAEVTIIARMHH 497
F ++G+G +G+V L HR V+ L+N + + AE E +++++ H
Sbjct: 4 FVRVVGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKH 58
Query: 498 LNLVRL---WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDG 554
N+V W E G +V + G L L + G P +
Sbjct: 59 PNIVAYRESWE--GEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQ----------- 103
Query: 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK- 613
V++W ++ +A A+ YLHE+ +LH D+K +N+ L K+ D G+A+
Sbjct: 104 ---VVEWFVQ------IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV 151
Query: 614 LRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673
L + DM S + GT YM+PE + K+DV++ G + E+ + F + M
Sbjct: 152 LENQCDMAST--LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--M 207
Query: 674 NS 675
NS
Sbjct: 208 NS 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 64/223 (28%), Positives = 96/223 (43%), Gaps = 42/223 (18%)
Query: 447 FSNL--IGRGGFGDVY-KGELTDHRVVAVKCLKNVTGGDAEFW----AEVTIIARMHHLN 499
F++L IG G FG VY ++ + VVA+K + E W EV + R+ H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+ G + LV EY GS +D L + P +E+E++
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAA----------- 129
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
I G + +AYLH + +H DIK NILL + K++DFG A + +
Sbjct: 130 -------ITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179
Query: 620 MVSMSRIRGTRGYMAPE---WLRSDQITPKADVYSFGMVLLEI 659
GT +MAPE + Q K DV+S G+ +E+
Sbjct: 180 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 32/171 (18%)
Query: 495 MHHLN---LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGP 551
+H N +V +G GE ++ E++ GSL L ++GR+ P +
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI----PEQ--------- 103
Query: 552 HDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL 611
I ++++ V + + YL E+ ++H D+KP NIL+ K+ DFG+
Sbjct: 104 -----------ILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV 150
Query: 612 AKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ + D ++ S + GTR YM+PE L+ + ++D++S G+ L+E+ G
Sbjct: 151 SG--QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 52/231 (22%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWA------EVTIIARMHHLNLVRL 503
+G G + VYKG T +VA+K + DAE E++++ + H N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHL----DAEEGTPSTAIREISLMKELKHENIVRL 63
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGG-KPVLDWS 562
+ + LV+EY+ + L Y M+ G G P S
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKY---------------MDTHG---VRGALDPNTVKS 104
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL------RK 616
Y++ G IA+ HE VLH D+KP+N+L+ K++DFGLA+
Sbjct: 105 FTYQLLKG----IAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157
Query: 617 KEDMVSMSRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
++V T Y AP+ L S + D++S G ++ E+++G F
Sbjct: 158 SNEVV-------TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 40/221 (18%)
Query: 451 IGRGGFGDVYKG--ELTDHRV-VAVKCLKNVTGGDA--EFWAEVTIIARMHHLN---LVR 502
+G G FG V KG ++ ++ VA+K LKN E E I MH L+ +VR
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEI---MHQLDNPYIVR 59
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ G C E LV E G L +L S E+ +S V
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFL--------SGKKDEITVSNVV-----------E 99
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
+ +++++G + YL + +H D+ N+LL + KISDFGL+K +D
Sbjct: 100 LMHQVSMG----MKYLEGKNF---VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152
Query: 623 MSRIRGT--RGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+R G + APE + + + ++DV+S+G+ + E S
Sbjct: 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 70/277 (25%), Positives = 110/277 (39%), Gaps = 63/277 (22%)
Query: 447 FSNLIGRGGFGDVYK------GELTDHRVVAVKCLKNVTGGDAE--FWAEVTIIARM-HH 497
F +G G FG V + G+ + VAVK LK D +E+ I++ + H
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFR-------------------------- 531
N+V L G C G ++ EY G L ++L +
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT 161
Query: 532 ---------SG------------RVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALG 570
SG R SSS ++ + + P LD R +
Sbjct: 162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWP-LDLDDLLRFSSQ 220
Query: 571 VARAIAYL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSMSRIRG 628
VA+ + +L + C+ H D+ N+LL D KI DFGLA+ + + V R
Sbjct: 221 VAQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 629 TRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRN 665
+MAPE + T ++DV+S+G++L EI S ++
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 52/225 (23%)
Query: 451 IGRGGFGDVYK------GELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLW 504
+G G FG VYK G L +V+ K + + ++ E+ I+A +H +V+L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE----DYMVEIEILATCNHPYIVKLL 75
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
G G+ ++ E+ P G++ + R G + P ++
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQV-------------------- 114
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-----KLRKKED 619
I + A+ YLH ++H D+K N+LL D K++DFG++ L++++
Sbjct: 115 --ICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS 169
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQI--TP---KADVYSFGMVLLEI 659
+ GT +MAPE + + + TP KAD++S G+ L+E+
Sbjct: 170 FI------GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 72/298 (24%), Positives = 120/298 (40%), Gaps = 68/298 (22%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLK---NVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG G +G VYKG ++VA+K ++ G + E++++ + H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
++ L++E++ + L YL S + M+ V S Y+
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYL------DSLPKGQYMDAELVK-----------SYLYQ 109
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
I G I + H VLH D+KP+N+L+ + K++DFGLA+ V +
Sbjct: 110 ILQG----ILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEV 162
Query: 627 RGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSGS-------------RNFEIQGSM 672
T Y APE L S + + D++S G + E+ + R F I G+
Sbjct: 163 V-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT- 220
Query: 673 MNSDEW-----------YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMV 719
D W FPKW + L +KN + D++ +M+
Sbjct: 221 PTEDVWPGVTSLPDYKNTFPKWK----------KGSLRSAVKNLDED--GLDLLEKML 266
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 38/229 (16%)
Query: 451 IGRGGFGDVYKGELTDHRVVA---VKCLKNVTGGD------AEFWAEVTIIARMHHLNLV 501
+G+G FG VY + D + VA +K LK + G+ + E +++++ H +V
Sbjct: 8 LGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+ E+ ++ EY L L G + + V +W
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ--------------VCEW 111
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE-DM 620
I+ + LGV Y+H+ +LH D+K +NI L ++ KI DFG+++L D+
Sbjct: 112 FIQ--LLLGVH----YMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDL 161
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669
+ GT YM+PE L+ K+D++S G +L E+ + FE Q
Sbjct: 162 ATT--FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 36/218 (16%)
Query: 451 IGRGGFGDVYKG--ELTDHRVVAVK--CLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+G G + V+KG +LT++ +VA+K L++ G EV+++ + H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
TLV+EY+ + L Y+ G + M M V +
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNI--------MSMHNV----------------K 107
Query: 567 IAL-GVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
I L + R +AY H VLH D+KP+N+L+ + K++DFGLA+ + +
Sbjct: 108 IFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE 164
Query: 626 IRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSG 662
+ T Y P+ L S + + + D++ G + E+ SG
Sbjct: 165 VV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 67/248 (27%), Positives = 106/248 (42%), Gaps = 47/248 (18%)
Query: 433 KRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHR----VVAVKCLKNVT----GGDAE 484
++ +++A +IGRG FG+V +L H+ V A+K L A
Sbjct: 33 RKIRKLQMKAEDYDVVKVIGRGAFGEV---QLVRHKSSQKVYAMKLLSKFEMIKRSDSAF 89
Query: 485 FWAEVTIIARMHHLNLVRLWGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAR 542
FW E I+A + +V+L FCA + ++ L V EY+P G L + + S+
Sbjct: 90 FWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLM-------SNYDVP 140
Query: 543 EMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602
E W+ Y V A+ +H L +H D+KP+N+LL
Sbjct: 141 E----------------KWAKFYTAE--VVLALDAIHSMGL---IHRDVKPDNMLLDKHG 179
Query: 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD----QITPKADVYSFGMVLLE 658
K++DFG + MV GT Y++PE L+S + D +S G+ L E
Sbjct: 180 HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFE 239
Query: 659 IVSGSRNF 666
++ G F
Sbjct: 240 MLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 40/224 (17%)
Query: 450 LIGRGGFGDVYKGELTDH-RVVAVKCLK------NVTGGDAEFWAEVTIIARMHHLNLVR 502
L+G+G FG VY D R +AVK ++ + E+ ++ + H +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 503 LWGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+G + ERTL E++P GS+ D L G L
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG------------------------ALT 104
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
++ + + ++YLH ++H DIK NIL K+ DFG +K R +
Sbjct: 105 ENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK-RLQTIC 160
Query: 621 VS---MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+S M + GT +M+PE + + KAD++S G ++E+++
Sbjct: 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFC 507
++G G +G VYKG + ++ A+K + + E E+ ++ + HH N+ +G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 508 AEKG------ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+K + LV E+ GS+ D + + G DW
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--------------------KGNALKEDW 122
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL-AKLRKKEDM 620
I Y I + R +A+LH V+H DIK +N+LL ++ K+ DFG+ A+L + +
Sbjct: 123 -IAY-ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--V 175
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITP------KADVYSFGMVLLEIVSGS 663
+ GT +MAPE + D+ P ++D++S G+ +E+ G+
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDE-NPDATYDYRSDIWSLGITAIEMAEGA 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 35/109 (32%), Positives = 63/109 (57%), Gaps = 8/109 (7%)
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK--LRKKEDMVSMSRIRG 628
++ A+ YLHE +++ D+K +N+LL + K++D+G+ K LR + + S G
Sbjct: 105 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCG 158
Query: 629 TRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
T Y+APE LR + D ++ G+++ E+++G F+I GS N D+
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
+A+ +LH V+H DIK +NILLG D K++DFG E S + GT +
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYW 182
Query: 633 MAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
MAPE + PK D++S G++ +E++ G
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 42/220 (19%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLK---NVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG G +G VYK + +VA+K ++ G + E++++ ++H N+VRL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ + LV+E++ + L Y M P G P L S Y+
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKY-----------------MDSS-PLTGLDPPLIKSYLYQ 107
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-----LRKKEDMV 621
+ + IAY H VLH D+KP+N+L+ + K++DFGLA+ +R V
Sbjct: 108 L----LQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV 160
Query: 622 SMSRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIV 660
T Y APE L S Q + D++S G + E+V
Sbjct: 161 V------TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 32/82 (39%), Positives = 52/82 (63%), Gaps = 1/82 (1%)
Query: 586 VLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITP 645
+++ D+KPENILL ++ K++DFGL+K + + S GT YMAPE + T
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQ 177
Query: 646 KADVYSFGMVLLEIVSGSRNFE 667
AD +SFG+++ E+++GS F+
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 450 LIGRGGFGDVYKGELTD----HRVVAVKCLKNVT-----GGDAEFWAEVTIIARMHHLNL 500
++G+GG+G V++ ++ A+K LK T A AE I+ + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
V L G+ L+ EY+ G L +L R G ME D
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIF--------ME--------------D 100
Query: 561 WSIRY--RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
+ Y I+L A+ +LH++ +++ D+KPENILL K++DFGL K E
Sbjct: 101 TACFYLSEISL----ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
V+ + GT YMAPE L D +S G ++ ++++G+ F
Sbjct: 154 GTVTHT-FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
+A+ +LH V+H DIK +NILLG D K++DFG E S + GT +
Sbjct: 126 QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYW 181
Query: 633 MAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
MAPE + PK D++S G++ +E+V G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 69/269 (25%), Positives = 107/269 (39%), Gaps = 58/269 (21%)
Query: 416 RDMARTLGLELLPAGGPKRFTHA-----ELRAATNGFSNL-----IGRGGFGDVYKGELT 465
RD + + L L P + + +A S L IG G G VYK
Sbjct: 37 RDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYK---V 93
Query: 466 DHRVVA-VKCLKNVTGG--DA---EFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519
HR + LK + G D + E+ I+ ++H N+V+ GE ++ E+
Sbjct: 94 IHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153
Query: 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH 579
+ GSL G H + L +A + IAYLH
Sbjct: 154 MDGGSLE-----------------------GTHIADEQFLA-----DVARQILSGIAYLH 185
Query: 580 EECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSMSRIRGTRGYMAPEWL 638
++H DIKP N+L+ KI+DFG+++ L + D + S GT YM+PE +
Sbjct: 186 RR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERI 240
Query: 639 RSDQITPK-----ADVYSFGMVLLEIVSG 662
+D D++S G+ +LE G
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 45/222 (20%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEF--WAEVTIIARM-HHLNLVRLWGF 506
IG G F +V K + A+KC+K + E+ + R+ H N++RL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 507 CAEK--GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
++ G LV+E + + +L + + GR R S
Sbjct: 67 LFDRKTGRLALVFELM-DMNLYELI--KGRKRPLPEKRVK-----------------SYM 106
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKE---DM 620
Y++ +++ ++H + H DIKPENIL+ DD K++DFG + + K +
Sbjct: 107 YQLL----KSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEY 158
Query: 621 VSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVS 661
+S TR Y APE L +D PK D+++ G V EI+S
Sbjct: 159 IS------TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 10/98 (10%)
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV---SMS 624
A +A A+ YLH +++ D+KPENILL ++DFGL KE + + S
Sbjct: 102 AAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLC----KEGIEHSKTTS 154
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT Y+APE LR D + G VL E++ G
Sbjct: 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 46/229 (20%)
Query: 451 IGRGGFGDVYK-GELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWG--F 506
IG+G +G VYK D + AVK L ++ D E AE I+ + +H N+V+ +G +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 507 CAEK---GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
A+K G+ LV E GS+ + + G LD ++
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR--------------------LDEAM 129
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
I G + +LH ++H D+K NILL + K+ DFG++ ++
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSA------QLTS 180
Query: 624 SRIR-----GTRGYMAPEWLRSDQ-----ITPKADVYSFGMVLLEIVSG 662
+R+R GT +MAPE + +Q + DV+S G+ +E+ G
Sbjct: 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 59/229 (25%), Positives = 108/229 (47%), Gaps = 43/229 (18%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARM-HHLNLVRLWGF 506
L+G G +G VYKG + ++ A+K + +VTG + E E+ ++ + HH N+ +G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 507 CAEKG------ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+K + LV E+ GS+ D + + G + +
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLI---------------------KNTKGNTLKE 110
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
I Y I + R +++LH+ V+H DIK +N+LL ++ K+ DFG++ + +
Sbjct: 111 EWIAY-ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTV 165
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITP------KADVYSFGMVLLEIVSGS 663
+ GT +MAPE + D+ P K+D++S G+ +E+ G+
Sbjct: 166 GRRNTFIGTPYWMAPEVIACDE-NPDATYDFKSDLWSLGITAIEMAEGA 213
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 53/188 (28%), Positives = 81/188 (43%), Gaps = 30/188 (15%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGD-AEFWAEVTIIARMHHLNLVRLWGFCA 508
+G G +GDVYK L + AVK +K G D + E+ ++ H N+V +G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
+ + + EY GSL D +G P+ + I Y +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG-----------------------PLSELQIAY-VC 112
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRG 628
+ +AYLH + +H DIK NILL D+ K++DFG+A + + G
Sbjct: 113 RETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAA-KITATIAKRKSFIG 168
Query: 629 TRGYMAPE 636
T +MAPE
Sbjct: 169 TPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 31/167 (18%)
Query: 451 IGRGGFGDVYKGELTD-HRVVAVKCLK---NVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG G +G V+K + + H +VA+K ++ + G + E+ ++ + H N+VRL+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ TLV+EY + L Y D +D I
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKYF-----------------------DSCNGDIDPEIVKS 103
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK 613
+ + +A+ H VLH D+KP+N+L+ + K++DFGLA+
Sbjct: 104 FMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS--MSRIRGTR 630
R + Y+H VLH D+KP N+LL + KI DFGLA++ E + ++ TR
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 631 GYMAPE-WLRSDQITPKADVYSFGMVLLEIVSGS 663
Y APE L S T D++S G +L E++S
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 42/127 (33%), Positives = 64/127 (50%), Gaps = 17/127 (13%)
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
+ A+ YLH E + V++ D+K EN++L D KI+DFGL K K D +M GT
Sbjct: 104 IVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKTFCGTP 160
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYE 690
Y+APE L + D + G+V+ E++ G F N D EK++E
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF------YNQDH--------EKLFE 206
Query: 691 EMKVEDI 697
+ +E+I
Sbjct: 207 LILMEEI 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED-MVSMSRIRGTRG 631
+A+LH+ W+LH D+K N+LL + KI DFGLA R+ + +++ T
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLA--REYGSPLKPYTQLVVTLW 171
Query: 632 YMAPE-WLRSDQITPKADVYSFGMVLLEIVSG 662
Y APE L + + + D++S G + E+++
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 63/242 (26%), Positives = 97/242 (40%), Gaps = 64/242 (26%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEF----WAEVTIIARMHHLNLVRLWG 505
+G G FG+VYK ++ RVVA+K + D F E+ I+ ++ H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPL-- 72
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGV--GPHDGGKPVLDWSI 563
+ E + G V +P + ++SG+ P S+
Sbjct: 73 -------IDMAVERPDKSK-----RKRGSVYMVTPYMDHDLSGLLENP----------SV 110
Query: 564 RYR------IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL--- 614
+ L + I YLHE +LH DIK NIL+ + KI+DFGLA+
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 615 -------------RKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIV 660
RK ++V TR Y PE L + + T D++ G V E+
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVV------TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
Query: 661 SG 662
+
Sbjct: 222 TR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 49/230 (21%)
Query: 451 IGRGGFGDVYKG---ELTD----HRV-VAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLV 501
+G+G F ++KG E+ D H+ V +K L +E F+ ++++++ H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+G C E +V EYV GSL YL ++ + + S W
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS---------------------W 101
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCP-----KISDFGLAK 613
+ +A +A A+ +L ++ L H ++ +N+LL D K+SD G++
Sbjct: 102 KL--EVAKQLAWALHFLEDKGL---THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156
Query: 614 LRKKEDMVSMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSG 662
++++ + RI ++ PE + + Q ++ AD +SFG L EI SG
Sbjct: 157 TVLPKEIL-LERIP----WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 59/230 (25%), Positives = 103/230 (44%), Gaps = 34/230 (14%)
Query: 443 ATNGFSNL--IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWA--EVTIIARMHH 497
A + NL +G G + VYKG + ++VA+K + T F A E +++ + H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
N+V L K T V+EY+ + LA Y+ P G+ P++
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM-------IQHPG------GLHPYN---- 104
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
+R + R +AY+H + +LH D+KP+N+L+ K++DFGLA+ +
Sbjct: 105 -----VRL-FMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155
Query: 618 EDMVSMSRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
S + T Y P+ L + + D++ G + +E++ G F
Sbjct: 156 PSQTYSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 70/249 (28%), Positives = 111/249 (44%), Gaps = 47/249 (18%)
Query: 450 LIGRGGFGDVYKGEL--TDHRVVAVKCLKN---VTGGDAE-FWAEVTIIA-RMHHLNLVR 502
++G+G FG V EL TD V A+K LK + D + E I+A H L
Sbjct: 2 VLGKGSFGKVMLAELKGTDE-VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 503 LWGFCAEKGERTL-VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L C + +R V EYV G D +F+ R +R+ +
Sbjct: 61 LHC-CFQTKDRLFFVMEYVNGG---DLMFQIQR------SRKFDEP-------------- 96
Query: 562 SIRYRI-ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
R R A V A+ +LH V++ D+K +NILL + K++DFG+ K +
Sbjct: 97 --RSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG------SMMN 674
+ + GT Y+APE L+ + P D ++ G+++ E+++G FE S+++
Sbjct: 152 TT-TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210
Query: 675 SDEWYFPKW 683
D Y P W
Sbjct: 211 DDVLY-PVW 218
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 34/217 (15%)
Query: 451 IGRGGFGDVYKG--ELTDHRVVAVK--CLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+G G + VYKG +LTD+ +VA+K L++ G EV+++ + H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ TLV+EY+ + L YL G + M V K L
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNS--------INMHNV------KLFL------- 110
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+ R + Y H VLH D+KP+N+L+ + K++DFGLA+ + + +
Sbjct: 111 --FQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEV 165
Query: 627 RGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSG 662
T Y P+ L S + + D++ G + E+ +G
Sbjct: 166 V-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 37/219 (16%)
Query: 451 IGRGGFGDVYKGELTD-HRVVAVKCLKN---VTGGDAEF-WAEVTIIARMHHLNLVRLWG 505
IG+G FG V + D R+ A+K ++ V+ + AE T++A+++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ LV ++ G L +L R GR S R+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA-----------------------RF 97
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKIS--DFGLAKLRKKEDMVSM 623
A + A+ LH+ V++ D+KPENILL D+ I+ DFGL KL K+D +
Sbjct: 98 YTA-ELLCALENLHKFN---VIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKT- 150
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ GT Y+APE L T D ++ G++L E+++G
Sbjct: 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 7/92 (7%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL---RKKEDMVSMSRIRGT 629
R + Y+H V+H D+KP N+L+ +D +I DFG+A+ E M+ T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 630 RGYMAPEWLRS-DQITPKADVYSFGMVLLEIV 660
R Y APE L S + T D++S G + E++
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 41/222 (18%)
Query: 451 IGRGGFGDVYKGELTDH--RVVAVKCLKNVTGGDAEFWAEVTIIARMHHL------NLVR 502
IG G +G V+K + R VA+K ++ TG + + + +A + HL N+VR
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 503 LWGFCA-----EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
L+ C + + TLV+E+V + L YL + P G
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKV------------------PEPGVPT 109
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
+ +++ R + +LH V+H D+KP+NIL+ K++DFGLA++
Sbjct: 110 ETIKDMMFQLL----RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 162
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI 659
+ ++ + T Y APE L D++S G + E+
Sbjct: 163 QMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 40/237 (16%)
Query: 450 LIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEF--WAEV---TIIARMHHLNLVRL 503
+IGRG + V EL R+ A+K +K D E W + +H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 504 WGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
C + R V E+V G L ++ R ++ P +
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKL---------------PEEHA------- 98
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK--LRKKEDM 620
R+ A ++ A+ +LHE +++ D+K +N+LL + K++D+G+ K +R +
Sbjct: 99 -RFYSA-EISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-- 151
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
+ S GT Y+APE LR + D ++ G+++ E+++G F+I G N D+
Sbjct: 152 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 451 IGRGGFGDVYKG--ELTDHRVVAVK--CLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+G G + V+KG +LT++ +VA+K L++ G EV+++ + H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ TLV+EY+ + L YL G + M M V
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNL--------MSMHNVKI--------------- 107
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+ R ++Y H+ +LH D+KP+N+L+ + K++DFGLA+ K + S
Sbjct: 108 FMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNE 163
Query: 627 RGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
T Y P+ L S + + D++ G +L E+ +G F
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 450 LIGRGGFGDVYKGELTDH-RVVAVKCL------KNVTGGDAEFWAEVTIIARMHHLNLVR 502
L+GRG FG+VY D R +AVK + + + E+ ++ + H +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 503 LWGFCAEKGER--TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+G + E+ ++ EY+P GS+ D L G L
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG------------------------ALT 104
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
++ R + + ++YLH ++H DIK NIL K+ DFG +K + M
Sbjct: 105 ENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161
Query: 621 --VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ + GT +M+PE + + KADV+S ++E+++
Sbjct: 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 47/231 (20%)
Query: 450 LIGRGGFGDVYKGELTDHR----VVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLV 501
+IGRG FG+V +L H+ V A+K L A FW E I+A + +V
Sbjct: 50 VIGRGAFGEV---QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 502 RLWGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+L F A + +R L V EY+P G L + + P K
Sbjct: 107 QL--FYAFQDDRYLYMVMEYMPGGDLVNLM-----SNYDVP--------------EKWAR 145
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
++ +AL ++ ++H D+KP+N+LL K++DFG KE
Sbjct: 146 FYTAEVVLALDAIHSMGFIHR---------DVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196
Query: 620 MVSMSRIRGTRGYMAPEWLRSD----QITPKADVYSFGMVLLEIVSGSRNF 666
MV GT Y++PE L+S + D +S G+ L E++ G F
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
+A+ +LH V+H DIK +N+LLG D K++DFG E S + GT +
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYW 181
Query: 633 MAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
MAPE + PK D++S G++ +E+V G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 24/171 (14%)
Query: 575 IAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR---GTRG 631
+ +LH + +++ D+K +N++L D KI+DFG+ K E++ +R GT
Sbjct: 109 LQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDNRASTFCGTPD 161
Query: 632 YMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF--EIQGSMMNS---DEWYFPKWAFE 686
Y+APE L+ + T D +SFG++L E++ G F + + + S D ++P+W
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRW--- 218
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFD---MVNRMVKTAMWCIQDRPELRP 734
+ +E K DIL++ + R+ + KT W ++ EL P
Sbjct: 219 -ITKESK--DILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDP 266
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 6e-08
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 8/96 (8%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK----LRKKEDMVSMSRIRG 628
+A+ Y+H V+H D+KP NILL D K++DFGLA+ L + + ++
Sbjct: 118 KALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 629 TRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSGS 663
TR Y APE L S + T D++S G +L E++ G
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 41/240 (17%)
Query: 451 IGRGGFGDVY----KGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIAR--MHHLN----L 500
+G G +G V+ G ++ A+K LK T AE T R + + L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 501 VRL-WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
V L + F + + L+ +YV G L +L++ E E
Sbjct: 68 VTLHYAFQTDT-KLHLILDYVNGGELFTHLYQREHF------TESE-------------- 106
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
+R IA + A+ +LH+ +++ DIK ENILL + ++DFGL+K E+
Sbjct: 107 ---VRVYIA-EIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159
Query: 620 MVSMSRIRGTRGYMAPEWLR--SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
GT YMAPE +R S D +S G++ E+++G+ F + G + E
Sbjct: 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 7e-08
Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 18/99 (18%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-----LRKKEDM---VSMS 624
R + YLH V+H D+KP NIL+ + KI DFGLA+ +K + V
Sbjct: 114 RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-- 168
Query: 625 RIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSG 662
TR Y APE L S + T D++S G + E+++
Sbjct: 169 ----TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 69/221 (31%), Positives = 93/221 (42%), Gaps = 38/221 (17%)
Query: 450 LIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT----GGDAEFWAEVTIIAR-MHHLNLVRL 503
+IG+G FG V + +D AVK L+ T AE ++ + + H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 504 -WGF-CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+ F AEK V +YV G L +L R R AR
Sbjct: 62 HYSFQTAEK--LYFVLDYVNGGELFFHLQRE-RCFLEPRAR------------------- 99
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
A VA AI YLH +++ D+KPENILL ++DFGL K E
Sbjct: 100 ----FYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEE 151
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ S GT Y+APE LR + D + G VL E++ G
Sbjct: 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 42/222 (18%)
Query: 449 NLIGRGGFGDVYKGELTDHR----VVAVKCLKN----VTGGDAEFWAEVTIIARMHHLNL 500
+G G FG V + H+ A+KCLK E +I+ + H +
Sbjct: 24 ETLGTGSFGRV---RIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
V + ++ + E+V G L +L ++GR P+D K
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRF---------------PNDVAK---- 121
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
+ A YLH + +++ D+KPEN+LL + K++DFG AK + +
Sbjct: 122 -----FYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRT 172
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
++ GT Y+APE ++S D ++ G++L E ++G
Sbjct: 173 FTLC---GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 15/111 (13%)
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
+P+ I+Y + R + Y+H V+H D+KP NIL+ ++ KI DFGLA+++
Sbjct: 103 RPLEKQFIQY-FLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ 158
Query: 616 KKEDMVSMSRIRGTRGYMAPE----WLRSDQITPKADVYSFGMVLLEIVSG 662
+ M+ TR Y APE W + D + D++S G + E++ G
Sbjct: 159 DPQ----MTGYVSTRYYRAPEIMLTWQKYDV---EVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 9e-08
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 14/94 (14%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
R + Y+H ++H D+KP NI + +D KI DFGLA+ E M+ TR Y
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWY 181
Query: 633 MAPE----WLRSDQITPKADVYSFGMVLLEIVSG 662
APE W+ +Q D++S G ++ E+++G
Sbjct: 182 RAPEIMLNWMHYNQT---VDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 64/238 (26%), Positives = 111/238 (46%), Gaps = 46/238 (19%)
Query: 449 NLIGRGGFGDVYKGELTD--HRVVAVKCLKNVTGGDAEFW-AEVTIIARMHHLNLVRLWG 505
N+IG G FG VY+ D +V K L+ D ++ E+ I+ ++H+N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQ-----DPQYKNRELLIMKNLNHINIIFLKD 126
Query: 506 F----CAEKGERTL----VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
+ C +K E+ + V E++P ++ Y+ R + P +++
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKL----------- 174
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG-DDFCPKISDFGLAK-LR 615
Y L RA+AY+H + ++ H D+KP+N+L+ + K+ DFG AK L
Sbjct: 175 -------YSYQL--CRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222
Query: 616 KKEDMVSMSRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672
+ VS +R Y APE L + T D++S G ++ E++ G F Q S+
Sbjct: 223 AGQRSVSYI---CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 70/253 (27%), Positives = 99/253 (39%), Gaps = 47/253 (18%)
Query: 450 LIGRGGFGDV-YKGELTDHRVVAVKCLKN--VTGGD--AEFWAEVTIIARMHHLNLVRLW 504
L+G+G FG V E + A+K LK + D A E ++ H L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
K V EYV G L +L R RV S R
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAE----------------- 103
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
+ A+ YLH +++ D+K EN++L D KI+DFGL K D +M
Sbjct: 104 ------IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMK 153
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWA 684
GT Y+APE L + D + G+V+ E++ G F N D
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF------YNQDH------- 200
Query: 685 FEKVYEEMKVEDI 697
EK++E + +EDI
Sbjct: 201 -EKLFELILMEDI 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 31/221 (14%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDA---EFWAEVTIIARMHHLNLVRLWG 505
++G G +G V K + +VA+K K+ + E+ ++ + N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+G+ LV+EYV L E +GV P +R
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE--------------LLEEMPNGVPPE---------KVRS 104
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
I + +AI + H+ ++H DIKPEN+L+ + K+ DFG A+ + + +
Sbjct: 105 YI-YQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
TR Y +PE L D++S G +L E+ G F
Sbjct: 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 34/98 (34%), Positives = 56/98 (57%), Gaps = 4/98 (4%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYM 633
A+ +LH+ +++ DIK ENILL + ++DFGL+K E+ GT YM
Sbjct: 117 ALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 634 APEWLRSDQITPKA-DVYSFGMVLLEIVSGSRNFEIQG 670
APE +R KA D +S G+++ E+++G+ F ++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 43/219 (19%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGD-AEFWAEVTIIARMHHLNLVRLWGFCA 508
IG G +GDVYK + + A+K +K G D A E+ ++ H N+V +G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
+ + + E+ GSL D +G P+ + I Y ++
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG-----------------------PLSESQIAY-VS 112
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL-----AKLRKKEDMVSM 623
+ + YLH + +H DIK NILL D+ K++DFG+ A + K++ +
Sbjct: 113 RETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-- 167
Query: 624 SRIRGTRGYMAPEWL---RSDQITPKADVYSFGMVLLEI 659
GT +MAPE R D+++ G+ +E+
Sbjct: 168 ----GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 42/221 (19%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG G +G VYK VVA+K ++ T G + E++++ ++H N+V+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ + LV+E++ + L ++ +SP + + + S ++
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFM-------DASPLSGIPLPLIK-----------SYLFQ 108
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-----LRKKEDMV 621
+ G +A+ H VLH D+KP+N+L+ + K++DFGLA+ +R V
Sbjct: 109 LLQG----LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 161
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKA-DVYSFGMVLLEIVS 661
T Y APE L + A D++S G + E+V+
Sbjct: 162 V------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 33/111 (29%), Positives = 63/111 (56%), Gaps = 10/111 (9%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK--LRKKEDMVSMSRIRGTRG 631
A+ +LHE +++ D+K +N+LL D K++D+G+ K L + + S GT
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPN 161
Query: 632 YMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEI--QGSMMNSDEWYF 680
Y+APE LR ++ D ++ G+++ E+++G F+I MN++++ F
Sbjct: 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWA--EVTIIARMHHLNLVRLWGFCA 508
+GRG +G VYK + D + LK + G A E+ ++ + H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 509 EKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+R L+++Y + F + P M++ P K +L Y+
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKP---MQL----PRSMVKSLL-----YQ 116
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP----KISDFGLAKLRKK--EDM 620
I G I YLH WVLH D+KP NIL+ + KI+D G A+L + +
Sbjct: 117 ILDG----IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKA-DVYSFGMVLLEIVSGSRNF 666
+ + T Y APE L + KA D+++ G + E+++ F
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYM 633
I +LH ++H D+KP NI++ D KI DFGLA R M+ TR Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYVVTRYYR 184
Query: 634 APEWLRSDQITPKADVYSFGMVLLEIVSGS 663
APE + D++S G ++ E++ G+
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 39/231 (16%)
Query: 449 NLIGRGGFGDVY-KGELTDHRVVAVKCLKNVTGGDAE----FWAEVTIIARMHHLNLVRL 503
+L+GRG FG+V E + A+K +K E F E I++ + + +L
Sbjct: 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS- 562
+K LV EY P G L L R ++ D
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNR--------------------YED---QFDEDM 103
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
++ +A + AI +H+ + +V H DIKPEN+L+ K++DFG A MV+
Sbjct: 104 AQFYLA-ELVLAIHSVHQ--MGYV-HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159
Query: 623 MSRIRGTRGYMAPEWLRSDQITPKA------DVYSFGMVLLEIVSGSRNFE 667
GT Y+APE L + K D +S G++ E++ G F
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 30/227 (13%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWA--EVTIIARMHHLNLVRLWGFCA 508
+GRG +G VYK + D + LK + G A E+ ++ + H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 509 EKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+R L+++Y + F + P + P K +L Y+
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQL-------PRGMVKSLL-----YQ 116
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP----KISDFGLAKLRKK--EDM 620
I G I YLH WVLH D+KP NIL+ + KI+D G A+L + +
Sbjct: 117 ILDG----IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKA-DVYSFGMVLLEIVSGSRNF 666
+ + T Y APE L + KA D+++ G + E+++ F
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 34/88 (38%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
R + Y+H VLH D+KP N+LL + KI DFGLA+ E M+ TR Y
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTRWY 174
Query: 633 MAPE-WLRSDQITPKADVYSFGMVLLEI 659
APE L + T DV+S G + E+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 34/94 (36%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK--LRKKEDMVSMSRIRGTR 630
RA+ Y+H V H D+KP+NIL D KI DFGLA+ + + TR
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 631 GYMAPEWLRS--DQITPKADVYSFGMVLLEIVSG 662
Y APE S + TP D++S G + E+++G
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 56/236 (23%), Positives = 108/236 (45%), Gaps = 54/236 (22%)
Query: 448 SNLIGRGGFGDVYKGELTDH-----RVVAVKCLKNVTGGDAE-----FWAEVTIIARMHH 497
S+L+ G FG ++ G L D V VK +K+ +E E ++ + H
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLLYGLSH 67
Query: 498 LNLVRLWGFCAEKGERTLV-YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
N++ + C E GE V Y Y+ G+L +L + R+G ++ +
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL-QQCRLGEANNPQ-------------- 112
Query: 557 PVLDWSIRYR----IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612
++ + +A+ +A ++YLH+ V+H DI N ++ ++ KI+D L+
Sbjct: 113 -----ALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALS 164
Query: 613 KLRKKEDMVSM-------SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ D+ M + R + +MA E L + + + +DV+SFG++L E+++
Sbjct: 165 R-----DLFPMDYHCLGDNENRPVK-WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 40/127 (31%), Positives = 61/127 (48%), Gaps = 18/127 (14%)
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
+ A+ YLH V++ DIK EN++L D KI+DFGL K D +M GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 159
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYE 690
Y+APE L + D + G+V+ E++ G F N D E+++E
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF------YNQDH--------ERLFE 205
Query: 691 EMKVEDI 697
+ +E+I
Sbjct: 206 LILMEEI 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 34/168 (20%)
Query: 451 IGRGGFGDVYKG--ELTDHRVVAVKCLKNVTGGDAEFWA--EVTIIARMHHLNLVRLWGF 506
+G G + VYKG +LT ++VA+K ++ A F A E +++ + H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
K TLV+EY+ + L Y+ G + M V R
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYMDDCGGG--------LSMHNV----------------R 106
Query: 567 IAL-GVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK 613
+ L + R +AY H+ VLH D+KP+N+L+ + K++DFGLA+
Sbjct: 107 LFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 64/265 (24%), Positives = 108/265 (40%), Gaps = 55/265 (20%)
Query: 450 LIGRGGFGDVYKGELT-DHRVVAVKCLK-NVTGGDAEFWAEVTIIARM------HHLNLV 501
++G+G FG V+ EL ++ A+K LK +V D + E T++ + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFLT 59
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L+ K V EY+ G L ++ + D
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK------------------------FDL 95
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
A + + +LH + +++ D+K +NILL D KI+DFG+ K E+M+
Sbjct: 96 PRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK----ENML 148
Query: 622 SMSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS-----MM 673
++ GT Y+APE L + D +SFG++L E++ G F +
Sbjct: 149 GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
Query: 674 NSDEWYFPKWAFEKVYEEMKVEDIL 698
D +P+W + +DIL
Sbjct: 209 RMDNPCYPRWL------TREAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 71/253 (28%), Positives = 100/253 (39%), Gaps = 47/253 (18%)
Query: 450 LIGRGGFGDV-YKGELTDHRVVAVKCLKN--VTGGD--AEFWAEVTIIARMHHLNLVRLW 504
L+G+G FG V E + A+K LK + D A E ++ H L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
V EY G L +L R RV S AR G + V
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFY---------GAEIVS----- 106
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
A+ YLH V++ D+K EN++L D KI+DFGL K D +M
Sbjct: 107 ---------ALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMK 153
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWA 684
GT Y+APE L + D + G+V+ E++ G F N D
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF------YNQDH------- 200
Query: 685 FEKVYEEMKVEDI 697
EK++E + +E+I
Sbjct: 201 -EKLFELILMEEI 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 34/216 (15%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVRLWGFCA 508
+G G FG VYK + + V+A + + + ++ E+ I+A H N+V+L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
+ ++ E+ G++ + E+E +P+ + IR +
Sbjct: 73 YENNLWILIEFCAGGAVDAVML------------ELE----------RPLTEPQIRV-VC 109
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRG 628
A+ YLHE ++H D+K NIL D K++DFG++ + S I G
Sbjct: 110 KQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-G 165
Query: 629 TRGYMAPEWL--RSDQITP---KADVYSFGMVLLEI 659
T +MAPE + + + P KADV+S G+ L+E+
Sbjct: 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 33/85 (38%), Positives = 47/85 (55%), Gaps = 6/85 (7%)
Query: 585 WVLHCDIKPENILLGDDFCPKISDFGLA-KLRKKEDMVSMSRIRGTRGYMAPEWL-RSDQ 642
+V++ D+KP NILL + +ISD GLA KK+ S+ GT GYMAPE L +
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGVA 172
Query: 643 ITPKADVYSFGMVLLEIVSGSRNFE 667
AD +S G +L +++ G F
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 48/185 (25%), Positives = 86/185 (46%), Gaps = 43/185 (23%)
Query: 485 FWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREM 544
F+ ++++++ H++L + G C E +V E+V +G L D R
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRK------------ 109
Query: 545 EMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL-----LG 599
+ G+ + W I +A +A A++YL ++ L +H ++ +NIL L
Sbjct: 110 --------EKGRVPVAWKI--TVAQQLASALSYLEDKNL---VHGNVCAKNILLARLGLA 156
Query: 600 DDFCP--KISDFG--LAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGM 654
+ P K+SD G L ++E + RI ++APE + + ++ AD +SFG
Sbjct: 157 EGTSPFIKLSDPGVSFTALSREE---RVERIP----WIAPECVPGGNSLSTAADKWSFGT 209
Query: 655 VLLEI 659
LLEI
Sbjct: 210 TLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 33/84 (39%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 585 WVLHCDIKPENILLGDDFCPKISDFGLA-KLRKKEDMVSMSRIRGTRGYMAPEWL-RSDQ 642
+V++ D+KP NILL + +ISD GLA KK+ S+ GT GYMAPE L +
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKGTA 172
Query: 643 ITPKADVYSFGMVLLEIVSGSRNF 666
AD +S G +L +++ G F
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 66/309 (21%), Positives = 119/309 (38%), Gaps = 81/309 (26%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-----FWAEVTIIARMHHLN-LVRL 503
IG G +G VYK + ++VA+K K D E E++++ + +VRL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 504 WGFCAEKGERT-------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
E E LV+EY+ + L ++ +GR P R + +
Sbjct: 67 --LDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGR----GPGRPLPAKTIK------ 113
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD-FCPKISDFGLAK-- 613
S Y++ GVA + H+ V+H D+KP+N+L+ KI+D GL +
Sbjct: 114 -----SFMYQLLKGVA----HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
Query: 614 ---LRKKEDMVSMSRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVS-------- 661
++ + T Y APE L S + D++S G + E+
Sbjct: 162 SIPVKSYTHEIV------TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215
Query: 662 -------------GSRNFEIQGSMMNSDEWY-FPKWA---FEKVYEEMKVE--DILDRHI 702
G+ ++ + +W+ FP+W + ++ E D+L + +
Sbjct: 216 SELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKML 275
Query: 703 KNSYDSRVH 711
+ R+
Sbjct: 276 RYDPAKRIS 284
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 37/105 (35%), Positives = 54/105 (51%), Gaps = 8/105 (7%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYM 633
I +LH ++H D+KP NI++ D KI DFGLA+ M M+ TR Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYYR 189
Query: 634 APEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678
APE + D++S G ++ E+V GS F QG+ + D+W
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIF--QGT-DHIDQW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 18/141 (12%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYM 633
AI +H+ L +V H DIKP+N+LL + +++DFG ++ V S GT Y+
Sbjct: 114 AIHSIHQ--LHYV-HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYI 170
Query: 634 APEWLRS-----DQITPKADVYSFGMVLLEIVSGSRNF------EIQGSMMNSDEWY-FP 681
+PE L++ + P+ D +S G+ + E++ G F E G +MN +E + FP
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230
Query: 682 KWAFEKVYEEMKVEDILDRHI 702
V EE K D++ R I
Sbjct: 231 S-HITDVSEEAK--DLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 12/106 (11%)
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM- 623
Y+I L A+ +H + +H D+K NI L K+ DFG +K + D VS+
Sbjct: 176 YQIVL----ALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSVSLD 226
Query: 624 --SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
S GT Y+APE + + KAD++S G++L E+++ R F+
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 14/100 (14%)
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
+ R + Y+H ++H D+KP N+ + +D KI DFGLA+ E M+ TR
Sbjct: 129 ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATR 181
Query: 631 GYMAPE----WLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
Y APE W+ +Q D++S G ++ E+++G F
Sbjct: 182 WYRAPEIMLNWMHYNQTV---DIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 43/225 (19%)
Query: 451 IGRGGFGDVYKGELTDHR----VVAVKCLKNVTGGDAEF---WAEVTIIARMHHLNLVRL 503
+G+G +G VYK HR +A+K ++ + +++F E+ I+ + +V
Sbjct: 9 LGKGNYGSVYK---VLHRPTGVTMAMKEIR-LELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+G +G + EY+ GSL D L+ G P + VL
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIP---------------EDVLR--- 105
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
RI V + + +L EE ++H D+KP N+L+ + K+ DFG++ ++
Sbjct: 106 --RITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAK 159
Query: 624 SRIRGTRGYMAPEWLRSDQI------TPKADVYSFGMVLLEIVSG 662
+ I G + YMAPE ++S T ++DV+S G+ +LE+ G
Sbjct: 160 TNI-GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 54/233 (23%)
Query: 451 IGRGGFGDVYK-GELTDHRVVAVKCLKNVTGGDAEFWAEVTII-ARMHHLNLVRLWGFCA 508
IG+G +G V+K + AVK L + D E AE I+ A H N+V+ +G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 509 EKGERT-----LVYEYVPNGSLAD----YLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+K + LV E GS+ D +L R R+ +P++
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME-------------------EPII 126
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
+ I + +G + +LH +H D+K NILL + K+ DFG++
Sbjct: 127 AY-ILHEALMG----LQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSA------ 172
Query: 620 MVSMSRIR-----GTRGYMAPEWLRSDQ-----ITPKADVYSFGMVLLEIVSG 662
++ +R+R GT +MAPE + +Q + DV+S G+ +E+ G
Sbjct: 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 61/266 (22%), Positives = 108/266 (40%), Gaps = 46/266 (17%)
Query: 450 LIGRGGFGDVYKGELTDH----RVVAVKCLK---NVTGGDAEFWAEVTIIARMHHLNLVR 502
++G+G FG V + +L + VAVK LK + EF E + H N+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 503 LWGFCAEKGER------TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
L G + ++ ++ +G L +L MS +G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL---------------MSRIGEEPFTL 110
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK 616
P+ R + +A + YL + +H D+ N +L ++ ++DFGL+K
Sbjct: 111 PL---QTLVRFMIDIASGMEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSKKIY 164
Query: 617 KEDMV---SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-------GSRNF 666
D S++ ++A E L + T +DV++FG+ + EI++ G N
Sbjct: 165 SGDYYRQGCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222
Query: 667 EIQGSMMNSDEWYFPKWAFEKVYEEM 692
EI ++ + P E VYE M
Sbjct: 223 EIYNYLIKGNRLKQPPDCLEDVYELM 248
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 40/116 (34%), Positives = 56/116 (48%), Gaps = 14/116 (12%)
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGD--DFCPKISDFGLAKLRKKEDMVSMS 624
I V RAI YLHE ++H DIK ENI + D C + DFG A ++ +
Sbjct: 187 IERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVC--LGDFGAACFPVD---INAN 238
Query: 625 RIRGTRGYMA---PEWLRSDQITPKADVYSFGMVLLEIVSGSRN-FEIQGSMMNSD 676
+ G G +A PE L D P D++S G+VL E+ + + FE G + D
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294
|
Length = 391 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 29/221 (13%)
Query: 450 LIGRGGFGD--VYKGELTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGF 506
++G G FG + + +D + + + E E ++A+M H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
G +V EY G L + +++ + P D +L W ++
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKI-------------KLQRGKLFPED---TILQWFVQ-- 108
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+ LGV ++HE+ VLH DIK +NI L + K+ DFG A+L + + +
Sbjct: 109 MCLGVQ----HIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV 161
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
GT Y+ PE + K+D++S G +L E+ + F+
Sbjct: 162 -GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 14/98 (14%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
R + Y+H + +H D+KP N+ + +D +I DFGLA R+ +D M+ TR Y
Sbjct: 129 RGLKYIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLA--RQADD--EMTGYVATRWY 181
Query: 633 MAPE----WLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
APE W+ +Q D++S G ++ E++ G F
Sbjct: 182 RAPEIMLNWMHYNQTV---DIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
+ + YLH + ++H D+K ENI + D I D G A+ + GT
Sbjct: 166 ILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA--FLGLAGTV 220
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
APE L D+ KAD++S G+VL E+++
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 32/85 (37%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 586 VLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR---GTRGYMAPEWLRSDQ 642
++H DIK NILL + K+ DFG +K+ VS R GT Y+APE R
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYA--ATVSDDVGRTFCGTPYYVAPEIWRRKP 221
Query: 643 ITPKADVYSFGMVLLEIVSGSRNFE 667
+ KAD++S G++L E+++ R F+
Sbjct: 222 YSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 71/268 (26%), Positives = 109/268 (40%), Gaps = 68/268 (25%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLK---NVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG G +G VYK + + +A+K ++ G + E++++ M H N+VRL
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ LV+EY+ D + + M+ S P P L + Y+
Sbjct: 70 VHSEKRLYLVFEYL------DLDLK----------KHMDSS---PDFAKNPRLIKTYLYQ 110
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLG-DDFCPKISDFGLAK-----LRKKEDM 620
I R IAY H VLH D+KP+N+L+ K++DFGLA+ +R
Sbjct: 111 IL----RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
Query: 621 VSMSRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSGS-------------RNF 666
V T Y APE L S + D++S G + E+V+ + F
Sbjct: 164 VV------TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217
Query: 667 EIQGSMMNSDEW-----------YFPKW 683
I G+ N + W FPKW
Sbjct: 218 RILGT-PNEETWPGVTSLPDYKSAFPKW 244
|
Length = 294 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 40/224 (17%)
Query: 451 IGRGGFGDVYKGEL-TDHRV--VAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVRLWG 505
IG G FG V E+ TD V V VK LK EF + + H N+++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
C E LV+EY G L YL ++E + +L
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYL-----------SQEQWHRR----NSQLLLLQ----- 102
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS- 624
R+A +A + ++H+ LH D+ N L D K+ D+G+ R KED +
Sbjct: 103 RMACEIAAGVTHMHKHNF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159
Query: 625 -RIRGTRGYMAPEW--------LRSDQITPKADVYSFGMVLLEI 659
+ R ++APE + ++Q P ++V++ G+ L E+
Sbjct: 160 DKCVPLR-WLAPELVGEFHGGLITAEQTKP-SNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 62/239 (25%), Positives = 96/239 (40%), Gaps = 42/239 (17%)
Query: 518 EYVP-----NGSLADYLFRS--GRVGSSSPAREMEMSGVGPHDG--GKPVLDW-SIRYRI 567
+YVP S + RS R S + + E+ + DG G LD S Y+
Sbjct: 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQ- 245
Query: 568 ALGVARAIAYL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSMSR 625
VAR + +L + C+ H D+ N+LL KI DFGLA+ + + VS
Sbjct: 246 ---VARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685
+MAPE + + T +DV+S+G++L EI F + G+
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI------FSLGGTP------------- 339
Query: 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744
Y M V+ IK+ Y + + C PE RPS ++ ++E
Sbjct: 340 ---YPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 17/120 (14%)
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR--- 627
V + YLHE +++ D+K +N+LL + KI+DFGL KE M R
Sbjct: 110 VVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLC----KEGMGFGDRTSTFC 162
Query: 628 GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQGSMMNSDEWYFP 681
GT ++APE L T D + G+++ E++ G F E+ S++N DE +P
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-DEVRYP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 14/99 (14%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
+ + Y+H ++H D+KP N+ + +D KI DFGLA+ E M+ TR Y
Sbjct: 129 KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWY 181
Query: 633 MAPE----WLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
APE W+ Q D++S G ++ E+++G F+
Sbjct: 182 RAPEVILNWMHYTQTV---DIWSVGCIMAEMLTGKPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 67/263 (25%), Positives = 102/263 (38%), Gaps = 74/263 (28%)
Query: 451 IGRGGFGDVYKGELTD-HRVVAVKCL--KNVTGGD--AEFWAEVTIIARMHHLNLVRLWG 505
IG G FG+V D + + A+K L +V + A AE I+A + +V+L+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+K V +Y+P G + L R G + D R+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLG---------------IFEEDLA--------RF 105
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL---------AKLRK 616
IA + AI +H+ +H DIKP+NIL+ D K++DFGL +K +
Sbjct: 106 YIA-ELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 617 KED--------------------MVSMSRIR-------------GTRGYMAPEWLRSDQI 643
K D + + R R GT Y+APE L
Sbjct: 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221
Query: 644 TPKADVYSFGMVLLEIVSGSRNF 666
T D +S G++L E++ G F
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 36/228 (15%)
Query: 447 FSNLIGRGGFGDVYKGEL--TDHRVVAVKCLKN---VTGGDAE-FWAEVTIIARMHHLNL 500
F ++G+G FG V E TD + A+K LK + D E E ++A
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDE-LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 501 VRLWGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+ C + +R V EYV G L + + GR PH
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE-------------PH------- 102
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
++ Y A +A + +LH + +++ D+K +N++L + KI+DFG+ K D
Sbjct: 103 --AVFY--AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWD 154
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
V+ GT Y+APE + D ++FG++L E+++G FE
Sbjct: 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 33/99 (33%), Positives = 58/99 (58%), Gaps = 5/99 (5%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYM 633
A+ +LH+ +++ DIK ENILL + ++DFGL+K ++++ GT YM
Sbjct: 117 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 634 APEWLR-SDQITPKA-DVYSFGMVLLEIVSGSRNFEIQG 670
AP+ +R D KA D +S G+++ E+++G+ F + G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 53/251 (21%), Positives = 88/251 (35%), Gaps = 70/251 (27%)
Query: 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWA---------------EVTII 492
+G G +G V K T ++VA+K +K + + E+ I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 493 ARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPH 552
+ H N++ L E LV + + L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDL--------------------------- 106
Query: 553 DGGKPVLDWSIRYR------IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKI 606
K V+D IR I L + + LH+ + +H D+ P NI + KI
Sbjct: 107 ---KKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160
Query: 607 SDFGLAK-------LRKKEDMVSMSRIRG------TRGYMAPEWLR-SDQITPKADVYSF 652
+DFGLA+ +M R T Y APE L +++ D++S
Sbjct: 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220
Query: 653 GMVLLEIVSGS 663
G + E+++G
Sbjct: 221 GCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 5/106 (4%)
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
+P+L R I + A+ Y+H++ L +H DIK ENI L D + DFG A
Sbjct: 263 RPLL-KQTR-AIMKQLLCAVEYIHDKKL---IHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
Query: 616 KKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+KE GT +PE L D D++S G++LL+++S
Sbjct: 318 EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYM 633
A+ +LH+ +++ D+KPENILL + DFGL+K ++ + + GT Y+
Sbjct: 108 ALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT-NTFCGTTEYL 163
Query: 634 APEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNF 666
APE L ++ T D +S G+++ E+ G F
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 37/103 (35%), Positives = 50/103 (48%), Gaps = 9/103 (8%)
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR 627
A +A A+ YLH +++ D+KPENILL ++DFGL K E + S
Sbjct: 102 AAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFC 157
Query: 628 GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG-----SRN 665
GT Y+APE L D + G VL E++ G SRN
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 37/95 (38%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 571 VAR----AIAYLHEECLEWVLHCDIKPENILLG--DDFCPKISDFGLAKL-RKKEDMVSM 623
VAR AI Y+H E ++H DIK EN+L+ +D C + DFG A R
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFH 319
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLE 658
I GT APE L D TP D++S G+V+ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 43/181 (23%), Positives = 80/181 (44%), Gaps = 23/181 (12%)
Query: 488 EVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMS 547
E+ II R+ H N+V+++ G + E V + + + ++ + A +E
Sbjct: 52 EIKIIRRLDHDNIVKVYEVLGPSGSD--LTEDVGSLTELNSVYIVQEYMETDLANVLEQG 109
Query: 548 GVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG-DDFCPKI 606
P+ + R + R + Y+H VLH D+KP N+ + +D KI
Sbjct: 110 ---------PLSEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156
Query: 607 SDFGLAKLRKKE----DMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVS 661
DFGLA++ +S + T+ Y +P L S + T D+++ G + E+++
Sbjct: 157 GDFGLARIVDPHYSHKGYLSEGLV--TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214
Query: 662 G 662
G
Sbjct: 215 G 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 38/120 (31%), Positives = 62/120 (51%), Gaps = 15/120 (12%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYM 633
AI +H+ L +V H DIKP+NIL+ + +++DFG ++ V S GT Y+
Sbjct: 114 AIDSVHQ--LHYV-HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170
Query: 634 APEWLRS-----DQITPKADVYSFGMVLLEIVSGSRNF------EIQGSMMNSDEWY-FP 681
+PE L++ + P+ D +S G+ + E++ G F E G +MN E + FP
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 29/86 (33%), Positives = 47/86 (54%), Gaps = 11/86 (12%)
Query: 586 VLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPE----WLRSD 641
++H D+KP N+ + +D KI DFGLA+ E M+ TR Y APE W+ +
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYN 193
Query: 642 QITPKADVYSFGMVLLEIVSGSRNFE 667
Q D++S G ++ E+++G F+
Sbjct: 194 QTV---DIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYM 633
I +LH ++H D+KP NI++ D KI DFGLA+ M++ + TR Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 192
Query: 634 APEWLRSDQITPKADVYSFGMVLLEIVSG 662
APE + D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 47/226 (20%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWA-----EVTIIARMHHLNLVRLW 504
IG+G FG+V+K ++VA+K K + + E + E+ I+ + H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 505 GFCAEKGERT--------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
C K LV+E+ + LA L S+ + +S +
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL--------SNKNVKFTLSEIK------ 122
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK--- 613
++ + + Y+H +LH D+K NIL+ D K++DFGLA+
Sbjct: 123 ---------KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFS 170
Query: 614 LRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLE 658
L K + T Y PE L + P D++ G ++ E
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-05
Identities = 18/79 (22%), Positives = 30/79 (37%), Gaps = 3/79 (3%)
Query: 269 KNLRNTKFLQLDYVNFSRGNLSDLEADNFSACKANCSANPKCVAFGFKYDGKRYCVLVDQ 328
+ FL+L V S + A + C+ C +N C A+ + C+L +
Sbjct: 7 GDGSTDGFLKLPDVKLPDNA-SAITAISLEECREACLSNCSCTAYAYNNGSGG-CLLWNG 64
Query: 329 LLYGYWSP-GTEMATFLRV 346
LL S +LR+
Sbjct: 65 LLNNLRSLSSGGGTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 63/251 (25%), Positives = 94/251 (37%), Gaps = 60/251 (23%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCL-KNVTGGDAEF---WAEVTIIARMHHLNLVRLW 504
L+G+G G V+ L ++ A+K L K + E I+A + H L L+
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 505 GFCAEKGERTLVYEYVPNGSLADYL-FRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ LV +Y P G L L + G+ S AR
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVAR--------------------- 106
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-- 621
Y A V A+ YLH L +++ D+KPENILL + +SDF L+K E
Sbjct: 107 FY--AAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 622 --------SMSRIR------------------GTRGYMAPEWLRSDQITPKADVYSFGMV 655
S GT Y+APE + D D ++ G++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221
Query: 656 LLEIVSGSRNF 666
L E++ G+ F
Sbjct: 222 LYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 40/233 (17%)
Query: 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKN---VTGGDAE-FWAEVTIIARMHHL 498
F ++G+G FG V E + A+K LK + D E E ++A
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 499 NLVRLWGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
+ C + +R V EYV G L ++ + G+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQ------------------ 102
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
++ Y A ++ + +LH +++ D+K +N++L + KI+DFG+ K
Sbjct: 103 ----AVFY--AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---- 149
Query: 618 EDMVSMSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
E MV R GT Y+APE + D +++G++L E+++G F+
Sbjct: 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 40/121 (33%), Positives = 64/121 (52%), Gaps = 17/121 (14%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR-GTRGY 632
AI +H+ L +V H DIKP+N+LL + +++DFG + LR D S + GT Y
Sbjct: 114 AIDSVHQ--LGYV-HRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDY 169
Query: 633 MAPEWLRS-----DQITPKADVYSFGMVLLEIVSGSRNF------EIQGSMMNSDEWY-F 680
++PE L++ + P+ D +S G+ + E++ G F E G +MN E + F
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQF 229
Query: 681 P 681
P
Sbjct: 230 P 230
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 6/93 (6%)
Query: 571 VARAIAYL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSMSRIRG 628
VA+ +++L + C+ H D+ NILL KI DFGLA+ +R + V R
Sbjct: 223 VAKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 629 TRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+MAPE + + T ++DV+S+G++L EI S
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 66/250 (26%), Positives = 103/250 (41%), Gaps = 46/250 (18%)
Query: 447 FSNLIGRGGFGDV----YKGELTDHRVVAVKCL---KNVTGGDAE-FWAEVTIIARMHHL 498
F +G G FG V YK E D VA+K K + + ++E I+ ++H
Sbjct: 34 FIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
V L+G ++ LV E+V G +L R+ R P+D G
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRF---------------PNDVG--- 133
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
A + YL +++ D+KPEN+LL D K++DFG AK+
Sbjct: 134 ------CFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE- 677
+ GT Y+APE L + AD ++ G+ + EI+ G F ++ +
Sbjct: 185 TYT----LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI 240
Query: 678 ----WYFPKW 683
YFPK+
Sbjct: 241 LEGIIYFPKF 250
|
Length = 340 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 63/258 (24%), Positives = 101/258 (39%), Gaps = 75/258 (29%)
Query: 450 LIGRGGFGDV--YKGELTDHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRL 503
+IGRG FG+V + + T H + A+K L+ A AE I+A + +V+L
Sbjct: 8 VIGRGAFGEVRLVQKKDTGH-IYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 504 WGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+ + + E L + EY+P G + L + E +
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTE-------EET-------------- 103
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK---- 617
R+ IA + AI +H+ L ++ H DIKP+N+LL K+SDFGL KK
Sbjct: 104 --RFYIAETIL-AIDSIHK--LGYI-HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
Query: 618 -------------------EDMVSMSRIR--------------GTRGYMAPEWLRSDQIT 644
+ M S + GT Y+APE
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN 217
Query: 645 PKADVYSFGMVLLEIVSG 662
+ D +S G+++ E++ G
Sbjct: 218 KECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 33/101 (32%), Positives = 46/101 (45%), Gaps = 4/101 (3%)
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-KLRKKEDMVSMSR 625
I + A+AYLH ++H D+K ENI L + + DFG A KL D
Sbjct: 190 IQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
GT +PE L D K D++S G+VL E+ +
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 8e-05
Identities = 29/87 (33%), Positives = 45/87 (51%), Gaps = 5/87 (5%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYM 633
I +LH ++H D+KP NI++ D KI DFGLA+ M++ + TR Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 185
Query: 634 APEWLRSDQITPKADVYSFGMVLLEIV 660
APE + D++S G ++ E+V
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 12/96 (12%)
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR--- 627
+A A+ YLH +++ D+KPENILL ++DFGL K + ++ S
Sbjct: 105 IASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCK-----EGIAQSDTTTTF 156
Query: 628 -GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT Y+APE +R D + G VL E++ G
Sbjct: 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 18/80 (22%), Positives = 30/80 (37%), Gaps = 10/80 (12%)
Query: 174 FSFLNASELVFVSANRSYWNIDDDGNLRIYSYDDNGDRWTVVWQAVQEICTIPDLCGENA 233
+ N S S + +G+L +++ N W + W A ++ C + CG
Sbjct: 38 YRMTNNSIY-------SRLTLSSEGSLERFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYG 90
Query: 234 ICISDGLSRSTSCVCPPGFK 253
C + S C C GF
Sbjct: 91 YCDV---NTSPKCNCIKGFV 107
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 46/233 (19%)
Query: 447 FSNLIGRGGFGDVYKGEL-TDHRVVAVKCLK-NVTGGDAEFWAEVTII-ARMHHLN---- 499
F ++G+G FG V E + A+K LK +V D + E T++ R+ L
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDD--VECTMVEKRVLALPGKPP 61
Query: 500 -LVRLWGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
L +L C + +R V EYV G D ++ +VG +E PH
Sbjct: 62 FLTQLHS-CFQTMDRLYFVMEYVNGG---DLMYHIQQVGK---FKE-------PH----- 102
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
++ Y A +A + +LH + +++ D+K +N++L + KI+DFG+ K
Sbjct: 103 ----AVFY--AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMC----K 149
Query: 618 EDMVSMSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
E++ R GT Y+APE + D ++FG++L E+++G F+
Sbjct: 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 34/94 (36%), Positives = 48/94 (51%), Gaps = 15/94 (15%)
Query: 451 IGRGGFGDVYKGELTDHRV--------VAVKCLKNVTGGDAE---FWAEVTIIARMH-HL 498
+G G FG V E T H + VAVK LK+ T +E +E+ I++ + HL
Sbjct: 45 LGSGAFGRVV--EATAHGLSHSQSTMKVAVKMLKS-TARSSEKQALMSELKIMSHLGPHL 101
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRS 532
N+V L G C + G ++ EY G L DYL R+
Sbjct: 102 NIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRN 135
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 4e-04
Identities = 53/236 (22%), Positives = 91/236 (38%), Gaps = 62/236 (26%)
Query: 496 HHL-----NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVG 550
H L N ++L+ L+ +Y+ +G L D L + G++ E E+
Sbjct: 62 HQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKL------SEAEVK--- 112
Query: 551 PHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKI--SD 608
+I + A+ LH+ ++H DIK EN+L D +I D
Sbjct: 113 ---------------KIIRQLVEALNDLHKH---NIIHNDIKLENVLY-DRAKDRIYLCD 153
Query: 609 FGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEI 668
+GL K+ S GT Y +PE ++ D ++ G++ E+++G F+
Sbjct: 154 YGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
Query: 669 QGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKN----SYDSRVHFDMVNRMVK 720
+ D EE+ +E +L R K S+ D V M+K
Sbjct: 209 -----DED-------------EELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLK 246
|
Length = 267 |
| >gnl|CDD|238010 cd00053, EGF, Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 5e-04
Identities = 13/41 (31%), Positives = 19/41 (46%), Gaps = 6/41 (14%)
Query: 223 CTIPDLCGENAICISDGLSRSTSCVCPPGFKNSTRQDKSCQ 263
C + C C++ S CVCPPG+ D+SC+
Sbjct: 2 CAASNPCSNGGTCVNTP--GSYRCVCPPGY----TGDRSCE 36
|
Length = 36 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 6e-04
Identities = 67/268 (25%), Positives = 102/268 (38%), Gaps = 59/268 (22%)
Query: 432 PKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDH-RVVAVKCLKNVT------GGDAE 484
P ++ E R IG G FG+V+ L H R C K ++ ++
Sbjct: 2 PGKYDDGESRLNEYEVIKKIGNGRFGEVF---LVKHKRTQEFFCWKAISYRGLKEREKSQ 58
Query: 485 FWAEVTIIARMHHLNLVRLWGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAR 542
EV ++ + H N+VR K + L + E+ G L S + +
Sbjct: 59 LVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL-----------SRNIQK 107
Query: 543 EMEMSG-VGPHDGGKPVLDWSIRYRIALGVARAIAYLHE----ECLEWVLHCDIKPENIL 597
+M G + H ++D I + A+AY H E VLH D+KP+NI
Sbjct: 108 CYKMFGKIEEH----AIVD------ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157
Query: 598 LGDDF-----------------CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWL-- 638
L KI DFGL+K E M GT Y +PE L
Sbjct: 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA--HSCVGTPYYWSPELLLH 215
Query: 639 RSDQITPKADVYSFGMVLLEIVSGSRNF 666
+ K+D+++ G ++ E+ SG F
Sbjct: 216 ETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 557 PVLDWSIRYRIALGVARAIAYL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-L 614
P L + + VA + +L + C+ H D+ N+L+ + KI DFGLA+ +
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ + +S +MAPE + ++ T +DV+SFG++L EI +
Sbjct: 290 MRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 47/185 (25%), Positives = 87/185 (47%), Gaps = 43/185 (23%)
Query: 485 FWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREM 544
F+ +++ ++ H ++V L+G C E +V E+V G L ++ R V ++
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP----- 105
Query: 545 EMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG----- 599
W ++++A +A A++YL ++ L +H ++ +NILL
Sbjct: 106 ----------------W--KFKVAKQLASALSYLEDKDL---VHGNVCTKNILLAREGID 144
Query: 600 DDFCP--KISDFG--LAKLRKKEDMVSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGM 654
+ P K+SD G + L ++E + RI ++APE + S ++ AD +SFG
Sbjct: 145 GECGPFIKLSDPGIPITVLSRQE---CVERIP----WIAPECVEDSKNLSIAADKWSFGT 197
Query: 655 VLLEI 659
L EI
Sbjct: 198 TLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 65/270 (24%), Positives = 100/270 (37%), Gaps = 78/270 (28%)
Query: 451 IGRGGFGDVYKGELTDHRVV-AVKCLKN----VTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+G G FG+V D + + A+K L+ + A AE I+A + +VRL+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+K V +Y+P G + L R G + P D R+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMG---------------IFPEDLA--------RF 105
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA------------- 612
IA + A+ +H+ +H DIKP+NIL+ D K++DFGL
Sbjct: 106 YIA-ELTCAVESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 613 --------------------------KLRKKEDMVSMSRIR-------GTRGYMAPEWLR 639
+L+ E + R GT Y+APE L
Sbjct: 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL 221
Query: 640 SDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669
T D +S G++L E++ G F Q
Sbjct: 222 RTGYTQLCDWWSVGVILYEMLVGQPPFLAQ 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 64/267 (23%), Positives = 98/267 (36%), Gaps = 78/267 (29%)
Query: 451 IGRGGFGDVYKGELTD-HRVVAVKCL--KNVTGGD--AEFWAEVTIIARMHHLNLVRLWG 505
+G G FG+V D H + A+K L K+V + A AE I+A + +V+L+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+K V +Y+P G + L R V P + R+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRME---------------VFP--------EVLARF 105
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA------------- 612
IA + AI +H+ +H DIKP+NIL+ D K++DFGL
Sbjct: 106 YIA-ELTLAIESVHKMGF---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161
Query: 613 ---------------------------------KLRKKEDMVSMSRIRGTRGYMAPEWLR 639
+ K+ + GT Y+APE L
Sbjct: 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL 221
Query: 640 SDQITPKADVYSFGMVLLEIVSGSRNF 666
T D +S G++L E++ G F
Sbjct: 222 RKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 60/256 (23%), Positives = 96/256 (37%), Gaps = 66/256 (25%)
Query: 450 LIGRGGFGDVYKGELTDH-RVVAVKCLKNVTGGDAE----FWAEVTIIARMHHLNLVRLW 504
+IGRG FG+V + D V A+K L+ + E AE I+ L +V+++
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+K L+ E++P G + L + + +
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEE-----------------------TQ 104
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK------- 617
+ IA V AI +H+ +H DIKP+N+LL K+SDFGL KK
Sbjct: 105 FYIAETVL-AIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160
Query: 618 -------------EDMVSMSRIR--------------GTRGYMAPEWLRSDQITPKADVY 650
++M S + GT Y+APE D +
Sbjct: 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220
Query: 651 SFGMVLLEIVSGSRNF 666
S G+++ E++ G F
Sbjct: 221 SLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 13/105 (12%)
Query: 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTR 630
VA A+ YLH ++H D+KP+N+L+ ++ K++DFGL+K+ ++ +M I T
Sbjct: 113 VALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNREL-NMMDILTTP 168
Query: 631 GYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675
P+ S TP G VL I S N + S
Sbjct: 169 SMAKPKNDYSR--TP-------GQVLSLISSLGFNTPVGEKDQGS 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 24/126 (19%)
Query: 574 AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK--------------LRKKED 619
A+ YLH ++H D+KP+N+L+ K++DFGL+K + K
Sbjct: 113 ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQGSMM 673
++ GT Y+APE + D ++ G++L E + G F E+ G ++
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229
Query: 674 NSD-EW 678
+ D EW
Sbjct: 230 SDDIEW 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 13/117 (11%)
Query: 450 LIGRGGFGDVYKGE---LTDHR---VVAVKCLKNVTGGDAE--FWAEVTIIARM-HHLNL 500
++G G FG V +G L+ + VAVK LK + +E+ I+ + HLN+
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSS----SPAREMEMSGVGPHD 553
V L G C + G ++ EY G L +YL ++ S P +++++ G+ P D
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPAD 160
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 763 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.88 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.47 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.44 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.37 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.01 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.01 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.99 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.87 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.63 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.62 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.58 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.4 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.36 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.35 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.26 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.22 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.19 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.12 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.03 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.02 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.91 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.89 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.85 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.82 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.67 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.62 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.6 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.56 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.48 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.48 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.43 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.35 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.28 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.04 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.94 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.89 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.83 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.81 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.74 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 96.66 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.56 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 96.51 | |
| PLN02236 | 344 | choline kinase | 96.26 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.23 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.75 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.5 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.43 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.33 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.27 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.18 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.05 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.03 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-54 Score=462.98 Aligned_cols=289 Identities=47% Similarity=0.802 Sum_probs=249.9
Q ss_pred CCccccHHHHHHHhcccc--ccccccccceEEEEEeCCCcEEEEEEeeccCCc-hhhhHHHHHHHhcCCCCccccEEEEE
Q 046586 431 GPKRFTHAELRAATNGFS--NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG-DAEFWAEVTIIARMHHLNLVRLWGFC 507 (763)
Q Consensus 431 ~~~~~~~~el~~~t~~~~--~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~ 507 (763)
....|++.||..||.+|+ ++||+|+||.||+|.+.+++.||||++...... ..+|.+|++++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 567799999999999998 699999999999999999999999998866555 77799999999999999999999999
Q ss_pred eeCC-eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 508 AEKG-ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 508 ~~~~-~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
.+.+ +++||||||++|+|.++|+... .. .++|.+|++||.++|+||+|||+...++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~---------------------~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~i 198 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKK---------------------GE-PLDWETRLKIALGAARGLAYLHEGCPPPI 198 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCC---------------------CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCE
Confidence 9999 5999999999999999997642 11 78999999999999999999999998899
Q ss_pred EecCCCCCceEEcCCCCeEEcccCcccccCCCCccccccc-ccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCC
Q 046586 587 LHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI-RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 587 vHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~-~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
||||||++|||||+++++||+|||+|+..... ....... .||.+|+|||++..+..++|+|||||||+|+||+||+.+
T Consensus 199 iHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~ 277 (361)
T KOG1187|consen 199 IHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKA 277 (361)
T ss_pred ecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcc
Confidence 99999999999999999999999999755431 1111122 899999999999999999999999999999999999988
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccc-cCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKN-SYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
.+...+ .....+..|+...+.++ +..+++|+.+.. .... .++..++.+++.+|++.+|.+||+|.||+++|+
T Consensus 278 ~d~~~~---~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~---~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 278 VDQSRP---RGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPD---EKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred cCCCCC---cccccHHHHHHHHHHCc-chhheeCCCccCCCCCh---HHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 875431 12334888987777766 599999999873 3221 268888999999999999999999999999997
Q ss_pred cCCCC
Q 046586 745 GTVEI 749 (763)
Q Consensus 745 ~~~~~ 749 (763)
.+...
T Consensus 351 ~~~~~ 355 (361)
T KOG1187|consen 351 GILSL 355 (361)
T ss_pred hhccc
Confidence 65544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=417.82 Aligned_cols=268 Identities=29% Similarity=0.467 Sum_probs=232.6
Q ss_pred ccHHHHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 435 FTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 435 ~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
....++.+....+.+.||+|.||.||.|.+++...||+|.++......++|.+|+++|++|+|+|||+++|+|..++.++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 34455666667788999999999999999999889999999987777889999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
||||||+.|+|.+||... .+..+...+.+.++.|||+||+||++++ +|||||.++
T Consensus 278 IVtE~m~~GsLl~yLr~~----------------------~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAAR 332 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTR----------------------EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAAR 332 (468)
T ss_pred EEEEecccCcHHHHhhhc----------------------CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhh
Confidence 999999999999999752 4567889999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
||||+++..+||+|||||+...++.........-+..|.|||.+..++++.|||||||||+||||+| |+.|+....
T Consensus 333 NiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--- 409 (468)
T KOG0197|consen 333 NILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--- 409 (468)
T ss_pred heeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC---
Confidence 9999999999999999999766666555555566789999999999999999999999999999999 888876332
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITE 751 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~~ 751 (763)
..+++. .+...++.+.|..++..++++|..||+.+|++|||+..+...|+...+...
T Consensus 410 --------------------n~ev~~-~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 410 --------------------NEEVLE-LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred --------------------HHHHHH-HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 222222 233445566668899999999999999999999999999999988765443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=406.40 Aligned_cols=254 Identities=33% Similarity=0.554 Sum_probs=212.9
Q ss_pred ccccccccccceEEEEEeCCCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCC-eeeEEEecCCC
Q 046586 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKG-ERTLVYEYVPN 522 (763)
Q Consensus 447 ~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~LV~Ey~~~ 522 (763)
+.+.||+|+||+||+|.+.+...||||++...... .++|.+|+.+|.+++|||||+|+|+|.+.. ...+|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34569999999999999988777999999865433 458999999999999999999999999988 79999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.++|+.. ....+++..+++|+.|||+||.|||+++. |||||||++|||++.++
T Consensus 125 GsL~~~l~~~----------------------~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~ 180 (362)
T KOG0192|consen 125 GSLSVLLHKK----------------------RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKG 180 (362)
T ss_pred CcHHHHHhhc----------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCC
Confidence 9999999753 24579999999999999999999999874 99999999999999998
Q ss_pred -CeEEcccCcccccCCCCcccccccccCCCcccccccc--cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 603 -CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR--SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 603 -~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
++||+|||+++...... ..++...||..|||||.+. ..+|+.|+|||||||+||||+||+.||+.....
T Consensus 181 ~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------- 252 (362)
T KOG0192|consen 181 KTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------- 252 (362)
T ss_pred CEEEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------
Confidence 99999999998765432 2344478999999999999 569999999999999999999999999754320
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.. ...++.. ..+..++.++...+..++.+||+.||+.||++.+++.+|+.+..
T Consensus 253 --~~----------~~~v~~~----~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 253 --QV----------ASAVVVG----GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred --HH----------HHHHHhc----CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 00 1122222 22233334577889999999999999999999999999997653
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=424.46 Aligned_cols=280 Identities=27% Similarity=0.433 Sum_probs=230.0
Q ss_pred cHHHHHHHhccccccccccccceEEEEEeCC------CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEE
Q 046586 436 THAELRAATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFC 507 (763)
Q Consensus 436 ~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~ 507 (763)
...++......+.+.||+|+||.||+|+..+ ...||||.+|+... ...+|++|+++++.++|||||+|+|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 3445666677788999999999999997643 46899999996544 457899999999999999999999999
Q ss_pred eeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 046586 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVL 587 (763)
Q Consensus 508 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~iv 587 (763)
.+++..+||+|||..|||.+||..+.-... ....+ ......|+..+.+.||.|||.||+||.++. +|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~------~~~~g----~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FV 625 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKAD------KLASG----QDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FV 625 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccc------cccCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---cc
Confidence 999999999999999999999976531110 00000 012556999999999999999999999987 99
Q ss_pred ecCCCCCceEEcCCCCeEEcccCcccccCCCCccccc-ccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCC
Q 046586 588 HCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS-RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRN 665 (763)
Q Consensus 588 HrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~-~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p 665 (763)
||||..+|+||.++..|||+||||++.....++.... +-.-+++|||||.+..++|+.+||||||||+|||+++ |+.|
T Consensus 626 HRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QP 705 (774)
T KOG1026|consen 626 HRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQP 705 (774)
T ss_pred ccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCc
Confidence 9999999999999999999999999987776665544 4456789999999999999999999999999999999 8889
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
+.+.. .+++++....+.. ...|+.++.+++.||..||+.+|.+||+++||-..|+.
T Consensus 706 y~glS-----------------------n~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 706 YYGLS-----------------------NQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred ccccc-----------------------hHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 86433 3333333333333 45567899999999999999999999999999999987
Q ss_pred CCCCCCC
Q 046586 746 TVEITEP 752 (763)
Q Consensus 746 ~~~~~~p 752 (763)
..+..+.
T Consensus 762 ~~~~s~~ 768 (774)
T KOG1026|consen 762 WAQASPK 768 (774)
T ss_pred HHhcCcc
Confidence 7665543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=362.31 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=209.3
Q ss_pred ccHHHHHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCC
Q 046586 435 FTHAELRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG 511 (763)
Q Consensus 435 ~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 511 (763)
++..||+. .+.||+|..|+|||+++. +++.+|+|.+.... ...++..+|++++++.+||+||+++|.|....
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 45555543 468999999999999987 57889999995332 23467899999999999999999999999999
Q ss_pred -eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEec
Q 046586 512 -ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE-ECLEWVLHC 589 (763)
Q Consensus 512 -~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHr 589 (763)
...++||||++|||++++... ..+++...-+|+.++++||.|||+ .+ ||||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~------------------------g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHR 203 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRV------------------------GRIPEPVLGKIARAVLRGLSYLHEERK---IIHR 203 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhccC---eeec
Confidence 599999999999999999643 358889999999999999999997 44 9999
Q ss_pred CCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 590 DIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 590 Dlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
||||+|||++..|++||+|||.+..+... ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.|+...
T Consensus 204 DIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 204 DIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred cCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 99999999999999999999999876544 345689999999999999999999999999999999999999999753
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFD-MVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
... .. ...++++....+ .++.+|.+ .+.++.+++..||++||.+||++.|+++
T Consensus 281 ~~~-------~~-----------~~~~Ll~~Iv~~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 281 NPP-------YL-----------DIFELLCAIVDE-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCC-------CC-----------CHHHHHHHHhcC-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 110 00 123333333322 22334444 7889999999999999999999999985
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=396.92 Aligned_cols=260 Identities=25% Similarity=0.452 Sum_probs=222.0
Q ss_pred HHHHHhccccccccccccceEEEEEeCC----CcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCe
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELTD----HRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE 512 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 512 (763)
||..+...+.++||.|.||.|++|+++- ...||||.||... ....+|+.|+.+|.+.+||||++|.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 3444455566799999999999998862 4579999999653 445789999999999999999999999999999
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
..+|.|||+||+|+.||..+ ...+++.+..-++.+||.||.||.+.+ +|||||.
T Consensus 705 vMIiTEyMENGsLDsFLR~~-----------------------DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLA 758 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQN-----------------------DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLA 758 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhc-----------------------CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhh
Confidence 99999999999999999753 235889999999999999999999999 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCccccccc--ccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccc
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI--RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQ 669 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~--~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~ 669 (763)
++|||++.+..+||+||||++.++++.....++. .-+.+|.|||.+...+++.++|||||||+|||.++ |.+||...
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 9999999999999999999998866554333333 34678999999999999999999999999999998 99999633
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
. .++++. .+...++.+.|++++..+.+||+.|||+|-.+||.+.+|+.+|++++.
T Consensus 839 S-----------------------NQdVIk-aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 839 S-----------------------NQDVIK-AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred c-----------------------hHHHHH-HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 2 233332 234456677778999999999999999999999999999999998754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=378.66 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=213.4
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeec----cCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKN----VTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
.+|...+.||+|||+.||.++. ..|+.||+|++.+ .....+...+|+++.+.|+|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5577788999999999999987 7899999999975 3344566889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
|+|++++|..++.+ ++.+++.+++.+..||+.||.|||+.+ |||||||..|++
T Consensus 98 ELC~~~sL~el~Kr------------------------rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlf 150 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR------------------------RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLF 150 (592)
T ss_pred EecCCccHHHHHHh------------------------cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhhee
Confidence 99999999999963 457999999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
|+++.++||+|||||.....++.. ..+.+||+.|+|||++....++..+||||+|||||-|+.|++||+...
T Consensus 151 L~~~~~VKIgDFGLAt~le~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------- 222 (592)
T KOG0575|consen 151 LNENMNVKIGDFGLATQLEYDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------- 222 (592)
T ss_pred ecCcCcEEecccceeeeecCcccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------
Confidence 999999999999999988765443 345799999999999999999999999999999999999999998542
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..+..++....++. +|.....+..+|+..+|+.||.+|||+++|+.
T Consensus 223 ----------------vkety~~Ik~~~Y~--~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 223 ----------------VKETYNKIKLNEYS--MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----------------HHHHHHHHHhcCcc--cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 33333333333333 22456678889999999999999999999993
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=406.51 Aligned_cols=268 Identities=27% Similarity=0.429 Sum_probs=221.9
Q ss_pred HHHHHHhccccccccccccceEEEEEeCC--Cc----EEEEEEeecc--CCchhhhHHHHHHHhcCCCCccccEEEEEee
Q 046586 438 AELRAATNGFSNLIGRGGFGDVYKGELTD--HR----VVAVKCLKNV--TGGDAEFWAEVTIIARMHHLNLVRLWGFCAE 509 (763)
Q Consensus 438 ~el~~~t~~~~~~LG~G~fG~Vy~g~~~~--~~----~VAvK~l~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 509 (763)
.++......+.+.||+|.||.||.|.+.+ +. .||||.++.. .+...+|++|..+|++++|||||+++|+|.+
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 33445566677899999999999998764 32 4899999865 4456789999999999999999999999999
Q ss_pred CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEec
Q 046586 510 KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHC 589 (763)
Q Consensus 510 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHr 589 (763)
....++++|||++|+|..||...+- .......|+....+.++.|||+|+.||+++. .|||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~-----------------~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHR 826 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRP-----------------APFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHR 826 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhccc-----------------ccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCc
Confidence 9999999999999999999987541 1113567899999999999999999999988 9999
Q ss_pred CCCCCceEEcCCCCeEEcccCcccccCCCCcccccc-cccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcc
Q 046586 590 DIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR-IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFE 667 (763)
Q Consensus 590 Dlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~-~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~ 667 (763)
||.++|+||+....|||+|||||+.....++..... ..-+.+|||||.+..+.++.|+|||||||+||||+| |..||.
T Consensus 827 DLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~ 906 (1025)
T KOG1095|consen 827 DLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP 906 (1025)
T ss_pred chhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999999665555433322 245678999999999999999999999999999999 888986
Q ss_pred cccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
... ..+++...+.+. +.+.|..+++.++++|..||+.+|++||++..|++.++.+.
T Consensus 907 ~~~-----------------------n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 907 SRS-----------------------NFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred Ccc-----------------------hHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 433 222222222222 45566889999999999999999999999999999998876
Q ss_pred CC
Q 046586 748 EI 749 (763)
Q Consensus 748 ~~ 749 (763)
..
T Consensus 963 ~~ 964 (1025)
T KOG1095|consen 963 NA 964 (1025)
T ss_pred hh
Confidence 54
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=354.40 Aligned_cols=252 Identities=30% Similarity=0.419 Sum_probs=201.4
Q ss_pred HHHhccccccccccccceEEEEEe-CCCcEEEEEEeeccC--C------chhhhHHHHHHHhcCCCCccccEEEEEeeCC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT--G------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG 511 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~--~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 511 (763)
....|-+++.||+|+||.|-+|.. .+++.||||++++.. . ......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 445677789999999999999965 478999999997432 1 1122469999999999999999999999999
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
..|||||||+||+|.+++...+ .+.......++.|++.|+.|||++| |+||||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk------------------------~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDi 302 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK------------------------YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDI 302 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc------------------------ccccchhHHHHHHHHHHHHHHHHcC---cccccC
Confidence 9999999999999999997653 3455556789999999999999999 999999
Q ss_pred CCCceEEcCC---CCeEEcccCcccccCCCCcccccccccCCCcccccccccCC---CCCccceeehhHHHHHHHhCCCC
Q 046586 592 KPENILLGDD---FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQ---ITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 592 k~~NILl~~~---~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~s~ksDVwS~Gvll~elltG~~p 665 (763)
||+|||+..+ ..+||+|||+|+.... ..-+.+.+||+.|.|||++.++. +..++|+||+||+||-+++|..|
T Consensus 303 KPeNILl~~~~e~~llKItDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 303 KPENILLSNDAEDCLLKITDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred CcceEEeccCCcceEEEecccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 9999999766 8899999999998763 33467789999999999997653 33488999999999999999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
|....... .+ .+.+...... +.+....+..++..+++.+||..||++|||+.|+++
T Consensus 381 FS~~~~~~-----sl-------------~eQI~~G~y~--f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 381 FSEEYTDP-----SL-------------KEQILKGRYA--FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cccccCCc-----cH-------------HHHHhcCccc--ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 97432111 00 1111111111 111222567889999999999999999999999984
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=352.19 Aligned_cols=196 Identities=34% Similarity=0.538 Sum_probs=173.6
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--Cc-hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GG-DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.|.+.++||+|+||+||+|++. ++..||||.+.... .. .+-+..|+.+|+.++|||||+|++++..++..+|||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 3555678999999999999886 47899999996542 22 23467899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
|.+|+|.+|+++. ..++..+...++.|+|.||++||+++ ||||||||.||||+
T Consensus 91 C~gGDLs~yi~~~------------------------~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs 143 (429)
T KOG0595|consen 91 CNGGDLSDYIRRR------------------------GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLS 143 (429)
T ss_pred CCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEec
Confidence 9999999999754 36889999999999999999999999 99999999999997
Q ss_pred CC------CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 600 DD------FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 600 ~~------~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
.. -.+||+|||+|+.+..... ..+.+|++-|||||++...+|+.|+|+||.|+++||+++|+.||+.
T Consensus 144 ~~~~~~~~~~LKIADFGfAR~L~~~~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 144 TTARNDTSPVLKIADFGFARFLQPGSM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred cCCCCCCCceEEecccchhhhCCchhH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 64 5689999999998774432 4467899999999999999999999999999999999999999974
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=338.14 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=208.3
Q ss_pred HHhccccccccccccceEEEEE-eCCCcEEEEEEeec---cCCchhhhHHHHHHHhcCCCCccccEEE-EEeeCCe-eeE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGE-LTDHRVVAVKCLKN---VTGGDAEFWAEVTIIARMHHLNLVRLWG-FCAEKGE-RTL 515 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~-~~~~~~VAvK~l~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~L 515 (763)
.+.+.+.++||+|.||+|||+. +.++..+|.|.++= .....++..+|+.+|++|+|||||++++ -+.+++. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3556677899999999999995 56889999998872 1233456889999999999999999999 5555555 899
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CcEEecCCCCC
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECL-EWVLHCDIKPE 594 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~-~~ivHrDlk~~ 594 (763)
||||+..|+|...++..++ .+..++....+++..|+++||+.+|+.-. ..|+||||||.
T Consensus 98 vmE~c~~GDLsqmIk~~K~--------------------qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPa 157 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKK--------------------QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPA 157 (375)
T ss_pred HHHhhcccCHHHHHHHHHh--------------------ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcch
Confidence 9999999999999987642 56678999999999999999999999431 24999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
||+|+.+|.+||+||||++.+...... ....+||+.||+||.+.+.+|+.|+||||+||++|||..-+.||.+..
T Consensus 158 NIFl~~~gvvKLGDfGL~r~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---- 232 (375)
T KOG0591|consen 158 NIFLTANGVVKLGDFGLGRFLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---- 232 (375)
T ss_pred heEEcCCCceeeccchhHhHhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc----
Confidence 999999999999999999987655332 345789999999999999999999999999999999999999997542
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcch-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVH-FDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
..++-.+.-+.+++ ++| .-.+..+.+++..|+..||+.||+...+++-+.
T Consensus 233 -------------------~~~L~~KI~qgd~~-~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 233 -------------------LLSLCKKIEQGDYP-PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -------------------HHHHHHHHHcCCCC-CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 11222222222232 233 556788999999999999999998555554443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=372.25 Aligned_cols=266 Identities=31% Similarity=0.447 Sum_probs=216.7
Q ss_pred cHHHHHHHhccccccccccccceEEEEEeCC--C--cE-EEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEE
Q 046586 436 THAELRAATNGFSNLIGRGGFGDVYKGELTD--H--RV-VAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGF 506 (763)
Q Consensus 436 ~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~--~--~~-VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~ 506 (763)
..++|......+.++||+|+||.||+|++.. + .. ||||..+.. .....+|++|+++|++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455555666677999999999999998753 2 23 899999842 2345789999999999999999999999
Q ss_pred EeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 507 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
+....++++|||+|+||+|.+||... ...++..+++.++.+.|.||+|||+++ +
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~-----------------------~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~ 283 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKN-----------------------KKSLPTLEKLRFCYDAARGLEYLHSKN---C 283 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHhHHHHHHHCC---C
Confidence 99999999999999999999999753 236899999999999999999999998 9
Q ss_pred EecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCC
Q 046586 587 LHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRN 665 (763)
Q Consensus 587 vHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p 665 (763)
|||||.++|+|++.++.+||+||||++....... ......-+.+|+|||.+..+.|+.++|||||||++||+++ |..|
T Consensus 284 IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~P 362 (474)
T KOG0194|consen 284 IHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEP 362 (474)
T ss_pred cchhHhHHHheecCCCeEEeCccccccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCC
Confidence 9999999999999999999999999985441111 1111245678999999999999999999999999999998 7888
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
|.+.. ..++..+.....++...+...+..+..++..||..+|++||+|.+|.+.|+.
T Consensus 363 y~g~~-----------------------~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~ 419 (474)
T KOG0194|consen 363 YPGMK-----------------------NYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEA 419 (474)
T ss_pred CCCCC-----------------------HHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHH
Confidence 86432 2222222324445555556677888899999999999999999999999987
Q ss_pred CCCCCC
Q 046586 746 TVEITE 751 (763)
Q Consensus 746 ~~~~~~ 751 (763)
+.....
T Consensus 420 ~~~~~~ 425 (474)
T KOG0194|consen 420 LEKKKE 425 (474)
T ss_pred HHhccc
Confidence 665433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=357.91 Aligned_cols=268 Identities=25% Similarity=0.385 Sum_probs=216.2
Q ss_pred HHHHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 437 HAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 437 ~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
..|+.+..-.|.++||+|-||.|.+.....+..||||.++.... ...+|.+|+++|.+++|||||+|+|+|..++.++
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 34555666677899999999999999999989999999986543 4478999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+|+|||++|+|.+||..+. .+.+.-....+|+.|||.||+||.+.. +|||||.++
T Consensus 612 mI~EYmEnGDLnqFl~ahe----------------------apt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~r 666 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHE----------------------LPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATR 666 (807)
T ss_pred HHHHHHhcCcHHHHHHhcc----------------------CcccccchhHHHHHHHHHHHHHHHhhc---hhhcccccc
Confidence 9999999999999997753 122444556789999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh--CCCCcccccC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS--GSRNFEIQGS 671 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt--G~~p~~~~~~ 671 (763)
|+|++.++++||+|||+++-+...+.. ...+.+-+++|||||.+..++++.++|||+||+++||+++ ...||+....
T Consensus 667 NcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 667 NCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred ceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 999999999999999999966555443 3345667889999999999999999999999999999875 7778864321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
+...+. ..++++..-. .-....|.-++..+++++++||..|-++||+++++...|.+.
T Consensus 747 --------------e~vven--~~~~~~~~~~-~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 747 --------------EQVVEN--AGEFFRDQGR-QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred --------------HHHHHh--hhhhcCCCCc-ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111111 1222221111 111123356788999999999999999999999999988653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=363.05 Aligned_cols=266 Identities=25% Similarity=0.414 Sum_probs=230.9
Q ss_pred ccccHHHHHHHhccccccccccccceEEEEEeCC-CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCC
Q 046586 433 KRFTHAELRAATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG 511 (763)
Q Consensus 433 ~~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 511 (763)
+..+.+|+.+....+.++||.|.||.||.|.++. .-.||||.||...-..++|++|+.+|+.++|||+|+|+|+|..+.
T Consensus 257 Pn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 257 PNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred CCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 3457788888888889999999999999998875 457999999988888999999999999999999999999999999
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
..|||.|||.+|+|.+||... .+..++-...+.+|.||+.||+||..++ +|||||
T Consensus 337 PFYIiTEfM~yGNLLdYLRec----------------------nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDL 391 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLREC----------------------NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDL 391 (1157)
T ss_pred CeEEEEecccCccHHHHHHHh----------------------chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhh
Confidence 999999999999999999765 3456777788999999999999999988 999999
Q ss_pred CCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCccccc
Q 046586 592 KPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQG 670 (763)
Q Consensus 592 k~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~ 670 (763)
.++|+|+.++..+||+||||++++..+.+.......-++.|.|||.+..+.++.|+|||+|||+||||.| |..||.+.+
T Consensus 392 AARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 392 AARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred hhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 9999999999999999999999988776654444455788999999999999999999999999999998 888886432
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. .+ ..+++. ..++.+-|+.+++.++++|+.||+++|.+||+++|+-+.+|.+.
T Consensus 472 l--------------Sq------VY~LLE----kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 472 L--------------SQ------VYGLLE----KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred H--------------HH------HHHHHh----ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 1 11 223333 33444555788999999999999999999999999999988765
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=359.10 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=209.7
Q ss_pred cHHHHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCe
Q 046586 436 THAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE 512 (763)
Q Consensus 436 ~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 512 (763)
..+||......+.+.||+|.||+||+|++.+ .||||+++.... ..+.|++|+.++++-+|.||+-++|+|.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 5666766677778999999999999999875 399999985433 34679999999999999999999999998877
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.+|..+|+|-+|..+|+.. +..++..+.+.||.|||+||.|||.++ |||||||
T Consensus 463 -AIiTqwCeGsSLY~hlHv~-----------------------etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLK 515 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ-----------------------ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLK 515 (678)
T ss_pred -eeeehhccCchhhhhccch-----------------------hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhcc
Confidence 9999999999999999753 356888999999999999999999999 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCC-CcccccccccCCCccccccccc---CCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKE-DMVSMSRIRGTRGYMAPEWLRS---DQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
..||++.++++|||+||||+.....- .......-.|...|||||+++. .+|+..+||||||+++|||++|..||..
T Consensus 516 SnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 516 SNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred ccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 99999999999999999999643221 1112223457788999999864 5899999999999999999999999973
Q ss_pred ccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 669 QGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
...+.. ++... ...+.+.+ .....++..+|.+|+..||.+++++||.+.+|+.+|+.+..
T Consensus 596 ~~~dqI-------------ifmVG--rG~l~pd~-----s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 596 QNRDQI-------------IFMVG--RGYLMPDL-----SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred CChhhe-------------EEEec--ccccCccc-----hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 221110 00000 00000000 01114567899999999999999999999999998887664
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=350.29 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=209.0
Q ss_pred cccHHHHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 434 RFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 434 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
.+.+++|.. .+-||.|+.|.||+|++.+ +.||||.++... ..+++-|++|+|+||+.|.|+|......
T Consensus 120 eiPFe~IsE-----LeWlGSGaQGAVF~Grl~n-etVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISE-----LEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhh-----hhhhccCcccceeeeeccC-ceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCcee
Confidence 345555554 3579999999999999976 569999886433 2477889999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
+||||||+.|-|...|.. +..+.......+..+||.||.|||.+. |||||||.
T Consensus 188 CIiMEfCa~GqL~~VLka------------------------~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKS 240 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKA------------------------GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKS 240 (904)
T ss_pred EEeeeccccccHHHHHhc------------------------cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCC
Confidence 999999999999999964 346778888999999999999999987 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
-||||..+..+||+|||-++..... ...-.+.||..|||||+++..+.++|+|||||||+||||+||..||...+.
T Consensus 241 PNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-- 316 (904)
T KOG4721|consen 241 PNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-- 316 (904)
T ss_pred CceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch--
Confidence 9999999999999999999876543 223347899999999999999999999999999999999999999964432
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
..++-..-.+.....+|.++++-+.-|+++||+..|.+||++++|+..|+-..
T Consensus 317 ---------------------sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 317 ---------------------SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred ---------------------heeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 11222222233344556788888999999999999999999999999997543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=345.36 Aligned_cols=265 Identities=23% Similarity=0.307 Sum_probs=205.6
Q ss_pred ccccccccccccceEEEEEe-CCCcEEEEEEeeccC--C-chhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeEEEe
Q 046586 445 NGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT--G-GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTLVYE 518 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~--~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~E 518 (763)
+.-.++||+|.||.||+|+. .+|+.||+|.++-.. . ...-..+|+.+|++|+||||++|.+...+. ..+|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 34456899999999999965 578999999997332 2 234466999999999999999999999887 68999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
||++ +|..++.. ....++..++..++.|++.||+|+|+++ |+|||||.+||||
T Consensus 199 YMdh-DL~GLl~~-----------------------p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLi 251 (560)
T KOG0600|consen 199 YMDH-DLSGLLSS-----------------------PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILI 251 (560)
T ss_pred cccc-hhhhhhcC-----------------------CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEE
Confidence 9988 88888743 3457899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
|.+|.+||+|||||++.........+..+.|++|+|||.+.+ ..|+.++|+||.||||.||+.|+..|.+..+.++.+.
T Consensus 252 dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k 331 (560)
T KOG0600|consen 252 DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK 331 (560)
T ss_pred cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH
Confidence 999999999999999888777777788889999999998876 5899999999999999999999999987654332110
Q ss_pred Cc-------hhHHHHHHHH--hccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WY-------FPKWAFEKVY--EEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~-------~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+ -.-|....+. ...+...-..+.+.+.+ ...+...++|+..+|..||.+|.|+.++++
T Consensus 332 IfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~-----~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 332 IFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETF-----KDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHhCCCChhccccccCCcccccCCCCcccchHHHHh-----ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00 0001100000 00111111111111111 233566788899999999999999999884
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=355.47 Aligned_cols=282 Identities=25% Similarity=0.373 Sum_probs=206.3
Q ss_pred HHHhccccccccccccceEEEEEe------CCCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEeeCC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGEL------TDHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCAEKG 511 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~------~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 511 (763)
....+.+.++||+|+||.||+|.. ..++.||||+++.... ....+.+|+.++..+ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 345677889999999999999974 2346799999975332 235688999999999 8999999999987654
Q ss_pred -eeeEEEecCCCCCHhHHhhhcCCCCCCChhhh----------------------------h-ccc---------CCCCC
Q 046586 512 -ERTLVYEYVPNGSLADYLFRSGRVGSSSPARE----------------------------M-EMS---------GVGPH 552 (763)
Q Consensus 512 -~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~----------------------------~-~~~---------~~~~~ 552 (763)
..++||||+++|+|.+++...+.......... . ... .....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 68899999999999999975432110000000 0 000 00000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCC
Q 046586 553 DGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRG 631 (763)
Q Consensus 553 ~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~ 631 (763)
......+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 001346889999999999999999999988 99999999999999999999999999986533221 12223456778
Q ss_pred cccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcc
Q 046586 632 YMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRV 710 (763)
Q Consensus 632 y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 710 (763)
|+|||.+.+..++.++||||||+++|||++ |..||...... .........+. ....
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~---------~~~~~~~~~~~--------------~~~~ 298 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN---------EEFCQRLKDGT--------------RMRA 298 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc---------HHHHHHHhcCC--------------CCCC
Confidence 999999999999999999999999999997 99998643210 00001111110 0111
Q ss_pred hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 711 HFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 711 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
+...+..+.+++.+||+.||++|||+.||+++|+.+.+
T Consensus 299 ~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 299 PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 13345678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=334.62 Aligned_cols=241 Identities=26% Similarity=0.348 Sum_probs=198.2
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
.....+.++||+|+||.||.++.. .++.+|+|++++.. ...+..++|..+|.+++||.||+++-.|++.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 345567789999999999999765 57899999997542 2345578999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
+||+.||.|..+|.+. ..++...+.-++.+|+.||.|||+.+ ||||||||+||
T Consensus 104 ld~~~GGeLf~hL~~e------------------------g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENI 156 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE------------------------GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENI 156 (357)
T ss_pred EeccCCccHHHHHHhc------------------------CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHe
Confidence 9999999999999754 35777777778889999999999999 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
|||++|+++|+||||++...... ..+.+++||+.|||||++.+..|+..+|.||+|+++|||++|.+||....
T Consensus 157 LLd~~GHi~LtDFgL~k~~~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------ 229 (357)
T KOG0598|consen 157 LLDEQGHIKLTDFGLCKEDLKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------ 229 (357)
T ss_pred eecCCCcEEEeccccchhcccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------
Confidence 99999999999999998543332 33455899999999999999999999999999999999999999997432
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 734 (763)
..++.++.+.... ...+.-...+..+++...++.||++|-
T Consensus 230 -----------------~~~~~~~I~~~k~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 230 -----------------VKKMYDKILKGKL-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----------------HHHHHHHHhcCcC-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1122222222221 111123567788999999999999995
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.92 Aligned_cols=243 Identities=25% Similarity=0.359 Sum_probs=205.5
Q ss_pred cccccccccceEEEEEe-CCCcEEEEEEeeccCCchhh-hHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 448 SNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~-f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
-++||+|+.|.||.+.. ..++.||||++....+..++ .++|+.+|+..+|+|||+++..+...+++++|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 35899999999999954 56789999999877776666 67999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeE
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 605 (763)
.+.+. ...+++.+...|+.++++||+|||.++ |+|||||.+|||++.+|.+|
T Consensus 358 TDvVt-------------------------~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vK 409 (550)
T KOG0578|consen 358 TDVVT-------------------------KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVK 409 (550)
T ss_pred hhhhh-------------------------cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEE
Confidence 99984 345889999999999999999999999 99999999999999999999
Q ss_pred EcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHH
Q 046586 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685 (763)
Q Consensus 606 I~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 685 (763)
|+|||++........ ...+.+||+.|||||......|..|+||||||+|++||+-|..||-...+
T Consensus 410 ltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------------- 474 (550)
T KOG0578|consen 410 LTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------------- 474 (550)
T ss_pred EeeeeeeeccccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--------------
Confidence 999999987655443 44567899999999999999999999999999999999999999852111
Q ss_pred HHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 686 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
+..+..=.-.+..+...+......+.+++.+||+.|+++||++.|+++
T Consensus 475 --------lrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 475 --------LRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred --------HHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 111100001122222333667889999999999999999999999985
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.86 Aligned_cols=260 Identities=30% Similarity=0.482 Sum_probs=222.6
Q ss_pred HHHHHHhccccccccccccceEEEEEeCC---C--cEEEEEEeecc--CCchhhhHHHHHHHhcCCCCccccEEEEEeeC
Q 046586 438 AELRAATNGFSNLIGRGGFGDVYKGELTD---H--RVVAVKCLKNV--TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510 (763)
Q Consensus 438 ~el~~~t~~~~~~LG~G~fG~Vy~g~~~~---~--~~VAvK~l~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 510 (763)
.+|.++...+.++||+|-||.||+|.+.+ | -.||||.-|.. ....+.|+.|..+|++++|||||+|+|+|.+.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 44566666677899999999999998754 2 26899998863 33456799999999999999999999999764
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
..++|||.++-|.|..||+.. +..|+......++.||..+|+|||+.. .||||
T Consensus 464 -P~WivmEL~~~GELr~yLq~n-----------------------k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRD 516 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQN-----------------------KDSLPLRTLTLYCYQICTALAYLESKR---FVHRD 516 (974)
T ss_pred -ceeEEEecccchhHHHHHHhc-----------------------cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhh
Confidence 688999999999999999763 456888899999999999999999988 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQ 669 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~ 669 (763)
|..+|||+...--+|++|||+++....+.....+...-++.|||||.+...+++.++|||.|||.+|||+. |.+||.+.
T Consensus 517 IAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 517 IAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred hhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 99999999999999999999999999888877777777889999999999999999999999999999987 99999743
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
. ..+++. ++...-+.+.|+.++..++.++.+||.+||.+||.+.|+...|+.+.+
T Consensus 597 k-----------------------NsDVI~-~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 597 K-----------------------NSDVIG-HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred c-----------------------ccceEE-EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 2 222222 233444566778999999999999999999999999999988876544
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=339.77 Aligned_cols=244 Identities=21% Similarity=0.312 Sum_probs=197.4
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCch----hhhHHHHHHHhcCCCCccccEEEEEee----CCeeeEEEecC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGD----AEFWAEVTIIARMHHLNLVRLWGFCAE----KGERTLVYEYV 520 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~----~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV~Ey~ 520 (763)
..||+|++|.||+|.+ +++.||||.++...... +.|.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 4799999999999998 57889999997554333 567799999999999999999999977 34688999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCceEEc
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENILLG 599 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NILl~ 599 (763)
++|+|.+++... ..+++...++++.|++.||+|||+. + ++||||||+||+++
T Consensus 105 ~~g~L~~~l~~~------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~ 157 (283)
T PHA02988 105 TRGYLREVLDKE------------------------KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVT 157 (283)
T ss_pred CCCcHHHHHhhC------------------------CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEEC
Confidence 999999999532 3578899999999999999999985 5 78999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCccccccccc--CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS--DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
+++.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------ 227 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------ 227 (283)
T ss_pred CCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------
Confidence 99999999999998654321 23457889999999976 7899999999999999999999999974321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. ++.+...........+...+..+.+++.+||+.||++|||+.||++.|+...
T Consensus 228 ---~--------------~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 228 ---K--------------EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---H--------------HHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0 0111111111111222345678999999999999999999999999998653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.05 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=200.4
Q ss_pred ccccccccccccceEEEEEeCC-CcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCC--eeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG--ERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~LV~Ey~ 520 (763)
....+.||+|+||+||++...+ |...|||.+.... ...+.+.+|+.+|.+++|||||+.+|...... ..+++|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 3446789999999999998764 8899999987442 12455889999999999999999999855444 688999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++|+|.+++.+.+ . .++.........||++||+|||+++ ||||||||+|||++.
T Consensus 99 ~~GsL~~~~~~~g----------------------~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~ 152 (313)
T KOG0198|consen 99 PGGSLSDLIKRYG----------------------G-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDP 152 (313)
T ss_pred CCCcHHHHHHHcC----------------------C-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeC
Confidence 9999999997642 2 6899999999999999999999998 999999999999999
Q ss_pred -CCCeEEcccCcccccCC--CCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 601 -DFCPKISDFGLAKLRKK--EDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 601 -~~~~kI~DFGla~~~~~--~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
++.+||+|||+++.... ..........||+.|||||++..+ ....++||||+||++.||+||+.|+....
T Consensus 153 ~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------ 226 (313)
T KOG0198|consen 153 SNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF------ 226 (313)
T ss_pred CCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc------
Confidence 79999999999987653 222334457899999999999864 33459999999999999999999986320
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
......+..+ .....+.+|...+.+..+++..|++.||++|||+.++++.-
T Consensus 227 -----~~~~~~~~ig-----------~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 227 -----EEAEALLLIG-----------REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -----chHHHHHHHh-----------ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 0001111111 11111244466778899999999999999999999999764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=344.23 Aligned_cols=266 Identities=22% Similarity=0.296 Sum_probs=207.2
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhh--hHHHHHHHhcCC-CCccccEEEEEeeCC-eeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAE--FWAEVTIIARMH-HLNLVRLWGFCAEKG-ERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~--f~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~LV~ 517 (763)
.+|...++||.|.||.||+|+- ..++.||||.+|..-..-++ -++|++.|++|+ |||||+|..++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 4677789999999999999965 46889999999865444444 468999999998 999999999999988 999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
|||+. +|.+.+..+ +..++..++..|+.||.+||+|+|.+| +.|||+||+|||
T Consensus 90 E~Md~-NLYqLmK~R-----------------------~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiL 142 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDR-----------------------NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENIL 142 (538)
T ss_pred Hhhhh-hHHHHHhhc-----------------------CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheE
Confidence 99966 999998653 467999999999999999999999999 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCccccccc-ccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC-
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS- 675 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~- 675 (763)
+..+..+||+|||+||..... ...+..+.|.+|+|||++ +.+-|+.+.||||+|||++||.+-+.-|.+..+..+.
T Consensus 143 i~~~~~iKiaDFGLARev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~ 220 (538)
T KOG0661|consen 143 ISGNDVIKIADFGLAREVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY 220 (538)
T ss_pred ecccceeEecccccccccccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH
Confidence 999999999999999976543 345667889999999976 5689999999999999999999999888654432210
Q ss_pred ------CCCchhHHHHHHHHhccChhhhhc---ccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 676 ------DEWYFPKWAFEKVYEEMKVEDILD---RHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 676 ------~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.......| .++..+...+. +...+..-..+-.....+..+++..|+++||++|||+.+.+++
T Consensus 221 KIc~VLGtP~~~~~-----~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 221 KICEVLGTPDKDSW-----PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhCCCccccc-----hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00000111 11100111111 1111111111223477889999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.29 Aligned_cols=271 Identities=31% Similarity=0.448 Sum_probs=200.3
Q ss_pred cccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHh--cCCCCccccEEEEEeeCC----eeeEEEec
Q 046586 446 GFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIA--RMHHLNLVRLWGFCAEKG----ERTLVYEY 519 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~LV~Ey 519 (763)
++.++||+|+||.||||.+.+ +.||||++.. +..+.|.+|-++.+ .++|+||+++++.-.... +..||+||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 456799999999999999976 7899999963 34556777777755 458999999999877655 88999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCcEEecCCCC
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEEC------LEWVLHCDIKP 593 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~------~~~ivHrDlk~ 593 (763)
.+.|+|.+||. ...++|....+|+..+++||+|||+.- +++|+|||||+
T Consensus 290 h~kGsL~dyL~-------------------------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkS 344 (534)
T KOG3653|consen 290 HPKGSLCDYLK-------------------------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKS 344 (534)
T ss_pred ccCCcHHHHHH-------------------------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccc
Confidence 99999999995 457999999999999999999999753 46799999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccC-CCC-----CccceeehhHHHHHHHhCCCCc
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSD-QIT-----PKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~-~~s-----~ksDVwS~Gvll~elltG~~p~ 666 (763)
+||||.+|+++.|+|||+|..+..... ......+||.+|||||++.+. ++. .+.||||+|.+||||++.-..+
T Consensus 345 kNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 345 KNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred cceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 999999999999999999987764333 233347899999999999764 222 3799999999999999866544
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcch-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVH-----FDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ++... -...|.. .+-+....+++-+-.+..+.++.++ ...+..+.+.+..||..||+-|.|+.-|-+
T Consensus 425 ~~-~~vp~-Yqlpfe~----evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 425 DP-GPVPE-YQLPFEA----EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred cC-CCCCc-ccCchhH----HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 32 11000 0000100 1111111122111111112222111 145677899999999999999999999999
Q ss_pred HhccCCCCC
Q 046586 742 MLEGTVEIT 750 (763)
Q Consensus 742 ~Le~~~~~~ 750 (763)
.+.++....
T Consensus 499 R~~~l~~~~ 507 (534)
T KOG3653|consen 499 RMAELMMLW 507 (534)
T ss_pred HHHHHhccC
Confidence 887766544
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.69 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=204.5
Q ss_pred HHHhccccccccccccceEEEEEeC----CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
....+.+.+.||+|+||.||+|.+. .+..||+|.++.... ....|.+|+.++++++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4566788899999999999999763 356899999985432 2356889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 lv~e~~~~~~L~~~l~~~-----------------------~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~ 136 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH-----------------------EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAH 136 (266)
T ss_pred EEEEeCCCCcHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHh
Confidence 999999999999998542 235789999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
||+++.++.+|++|||.+...............++..|+|||.+.+..++.++||||||+++||+++ |+.||.....
T Consensus 137 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-- 214 (266)
T cd05064 137 KVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-- 214 (266)
T ss_pred hEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--
Confidence 9999999999999999876543222211222345678999999999999999999999999999875 9999864321
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.. ......++ .....+...+..+.+++..||+.+|++||++.+|++.|++.
T Consensus 215 -------~~-~~~~~~~~--------------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 215 -------QD-VIKAVEDG--------------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------HH-HHHHHHCC--------------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 00111000 11112234567889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=330.52 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=208.2
Q ss_pred HHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
....+.+.++||+|+||.||+|...+++.||+|.++......+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 34567778999999999999999888888999998765555678999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||++++
T Consensus 84 ~~~~L~~~l~~~----------------------~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~ 138 (261)
T cd05072 84 AKGSLLDFLKSD----------------------EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSE 138 (261)
T ss_pred CCCcHHHHHHHh----------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecC
Confidence 999999998643 2345788899999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||+++..............++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 139 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-------- 210 (261)
T cd05072 139 SLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-------- 210 (261)
T ss_pred CCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------
Confidence 9999999999998654433222233345678999999998899999999999999999998 9999853211
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
.........+. ..+.....+..+.+++.+|++.+|++||++.++.++|+.
T Consensus 211 --~~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 211 --SDVMSALQRGY--------------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --HHHHHHHHcCC--------------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00011111110 001112344678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=326.96 Aligned_cols=260 Identities=25% Similarity=0.324 Sum_probs=204.8
Q ss_pred HHhccccccccccccceEEEEEe-CCCcEEEEEEeec--cCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 442 AATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKN--VTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
...|++.+.||.|..++||+|+. +.++.||||++.- ......++++|+..|+.++||||++.+..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 35678889999999999999965 4679999999973 23334778899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
||.+||+.+.++..- ...+++..+..|..++++||.|||.+| .||||||+.||||
T Consensus 105 fMa~GS~ldIik~~~----------------------~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi 159 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY----------------------PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILI 159 (516)
T ss_pred hhcCCcHHHHHHHHc----------------------cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEE
Confidence 999999999997642 234888899999999999999999999 8999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCc---ccccccccCCCccccccccc--CCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRS--DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
+++|.+||+|||.+-.+..... ......+||+.|||||++.. ..|+.|+||||||+...||.+|..||....+.
T Consensus 160 ~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm- 238 (516)
T KOG0582|consen 160 DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM- 238 (516)
T ss_pred cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-
Confidence 9999999999998765443322 22256789999999999654 47999999999999999999999999743211
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
-+.-.-.++. ..... ....+.+........+.+++..||++||++|||++++++
T Consensus 239 ---------kvLl~tLqn~-pp~~~----t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 239 ---------KVLLLTLQND-PPTLL----TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ---------HHHHHHhcCC-CCCcc----cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0111111111 10000 001111111334558899999999999999999999984
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=327.62 Aligned_cols=257 Identities=27% Similarity=0.419 Sum_probs=209.1
Q ss_pred HHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+...++.+.+.||+|++|.||+|...+++.||+|.++......+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 44566788899999999999999988888899999986655667899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ....+++..+..++.|++.|++|||+.+ |+|+||||+||+++
T Consensus 83 ~~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~ 137 (261)
T cd05068 83 MKYGSLLEYLQGG----------------------AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVG 137 (261)
T ss_pred ccCCcHHHHHhcc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEc
Confidence 9999999998542 2246789999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~ 678 (763)
+++.+||+|||+++...............+..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 138 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------- 210 (261)
T cd05068 138 ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN------- 210 (261)
T ss_pred CCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-------
Confidence 99999999999998765332221222233457999999999999999999999999999999 8888853211
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
....... .... ....+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 211 ---~~~~~~~----------~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 211 ---AEVLQQV----------DQGY----RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---HHHHHHH----------HcCC----CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0000111 1100 011113345788999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=326.38 Aligned_cols=252 Identities=23% Similarity=0.420 Sum_probs=204.2
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
..+.+.+.||+|+||.||++...++..+|+|.++.......++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 34667789999999999999998888899999876555567899999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++
T Consensus 84 ~~L~~~~~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~ 137 (256)
T cd05114 84 GCLLNYLRQR-----------------------QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTG 137 (256)
T ss_pred CcHHHHHHhC-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCC
Confidence 9999998542 125789999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchh
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~ 681 (763)
.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---------~ 208 (256)
T cd05114 138 VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---------Y 208 (256)
T ss_pred eEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---------H
Confidence 99999999998654333222223345678999999998899999999999999999999 8889863321 0
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
.. .....++. + ...+......+.+++.+||+.+|++||++.++++.|.
T Consensus 209 ~~-~~~i~~~~-------~-------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 209 EV-VEMISRGF-------R-------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HH-HHHHHCCC-------C-------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00 01111110 0 0001123457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=310.00 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=202.6
Q ss_pred ccccccccccccceEEEEEe-CCCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
|.-.++||+|.||.||+|+. ..|+.||||.++.... -.....+|++.|+.++|+||+.|+++|-+.+...||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 44457899999999999976 4689999999984422 2456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+. +|...+.. ....+...+...++.++.+|++|||++. |+||||||.|+|+++
T Consensus 84 ~t-dLe~vIkd-----------------------~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~ 136 (318)
T KOG0659|consen 84 PT-DLEVVIKD-----------------------KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISS 136 (318)
T ss_pred cc-cHHHHhcc-----------------------cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcC
Confidence 77 89988864 3457888999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCC-----
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN----- 674 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~----- 674 (763)
+|.+||+|||+|+.....+..... .+-|.+|+|||.+.+ ..|+..+||||.||++.||+.|.+-|.+..+.++
T Consensus 137 ~g~lKiADFGLAr~f~~p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If 215 (318)
T KOG0659|consen 137 DGQLKIADFGLARFFGSPNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF 215 (318)
T ss_pred CCcEEeecccchhccCCCCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH
Confidence 999999999999988766543333 367999999998876 5899999999999999999999887755432221
Q ss_pred -----CCCCchhHHHHHHHHhccChhhhhcccccccC-CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 675 -----SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSY-DSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 675 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.....++++. .+.+.++-...+.. ...+-........+++..++..||.+|++++|.+++
T Consensus 216 ~~LGTP~~~~WP~~~--------~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 216 RALGTPTPDQWPEMT--------SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHcCCCCcccCcccc--------ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0111111110 01111110000000 000113455677999999999999999999999865
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=327.76 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=207.7
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
....+.+.++||+|+||.||+|... .++.||+|+++.......++.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 3445677889999999999999875 478899999986655567899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 84 ~~~~~L~~~~~~~----------------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~ 138 (263)
T cd05052 84 MTYGNLLDYLREC----------------------NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVG 138 (263)
T ss_pred CCCCcHHHHHHhC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEc
Confidence 9999999998543 2345889999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~ 678 (763)
+++.+||+|||+++...............+..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 139 ~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------- 211 (263)
T cd05052 139 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------- 211 (263)
T ss_pred CCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 99999999999998654433222222334668999999999999999999999999999998 8888863221
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.+ ..... ...... ..+...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 212 --~~-~~~~~----------~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 212 --SQ-VYELL----------EKGYRM----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --HH-HHHHH----------HCCCCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 00 01111 111111 11133456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=346.65 Aligned_cols=281 Identities=24% Similarity=0.348 Sum_probs=206.1
Q ss_pred HHHHhccccccccccccceEEEEEe------CCCcEEEEEEeeccC--CchhhhHHHHHHHhcC-CCCccccEEEEEeeC
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGEL------TDHRVVAVKCLKNVT--GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEK 510 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~------~~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 510 (763)
+....+.+.++||+|+||.||++.. ..+..||||+++... ...+.+.+|+.++..+ +||||++++++|.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3345677789999999999999964 235689999997543 2335688999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCC------------------------hhhhhccc------C------------
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSS------------------------PAREMEMS------G------------ 548 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~------------------------~~~~~~~~------~------------ 548 (763)
+..++||||+++|+|.+++...+...... ........ .
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999997643211000 00000000 0
Q ss_pred ---------CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCC
Q 046586 549 ---------VGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619 (763)
Q Consensus 549 ---------~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~ 619 (763)
..........+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 0000012246889999999999999999999988 9999999999999999999999999998654332
Q ss_pred ccc-ccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhh
Q 046586 620 MVS-MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDI 697 (763)
Q Consensus 620 ~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 697 (763)
... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .-... .
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---------~~~~~----------~ 329 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---------SKFYK----------M 329 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---------HHHHH----------H
Confidence 211 122345678999999999999999999999999999998 88888532110 00001 1
Q ss_pred hcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 698 LDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 698 ~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
+....... .+...+.++.+++.+||+.||++||++.||+++|++.
T Consensus 330 ~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 330 IKEGYRML----SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHhCccCC----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11111000 1112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=334.85 Aligned_cols=279 Identities=24% Similarity=0.347 Sum_probs=204.1
Q ss_pred HHhccccccccccccceEEEEEeCC-----------------CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCcccc
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTD-----------------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVR 502 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~-----------------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~ 502 (763)
...+.+.++||+|+||.||++...+ +..||+|.++.... ...+|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3456778899999999999997532 23699999875432 3356899999999999999999
Q ss_pred EEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 046586 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEEC 582 (763)
Q Consensus 503 l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~ 582 (763)
+++++.+.+..++||||+++|+|.+++............. ...........+++...++++.||+.||+|||+.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN-----DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccc-----cccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999986532111100000 00000113356889999999999999999999988
Q ss_pred CCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh
Q 046586 583 LEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661 (763)
Q Consensus 583 ~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt 661 (763)
|+||||||+|||++.++.+||+|||+++........ ......++..|+|||.+..+.++.++||||||+++|||++
T Consensus 159 ---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 159 ---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred ---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 999999999999999999999999999865433221 2223445788999999998999999999999999999987
Q ss_pred --CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046586 662 --GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739 (763)
Q Consensus 662 --G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eV 739 (763)
+..|+...... ........ ......... ....+..++..+.+++.+||+.||++|||+.+|
T Consensus 236 ~~~~~p~~~~~~~------~~~~~~~~----------~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 236 LCKEQPYGELTDE------QVIENAGE----------FFRDQGRQV-YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred ccCCCCCCcCCHH------HHHHHHHH----------Hhhhccccc-cccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 45566532110 00111100 000000000 000112345678999999999999999999999
Q ss_pred HHHhcc
Q 046586 740 AKMLEG 745 (763)
Q Consensus 740 v~~Le~ 745 (763)
+++|++
T Consensus 299 ~~~l~~ 304 (304)
T cd05096 299 HAFLTE 304 (304)
T ss_pred HHHHhC
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=316.19 Aligned_cols=259 Identities=23% Similarity=0.340 Sum_probs=196.5
Q ss_pred cccccccccceEEEEEeCC-CcEEEEEEeeccCCch---hhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 448 SNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGD---AEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~---~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
..++|+|+||.|||++.++ |+.||||++.+++++. +-.++|+.+|++++|+|+|.|+.+|.....++||+||++.
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh- 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH- 85 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-
Confidence 3579999999999998874 8999999998765532 3478999999999999999999999999999999999987
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
++.+-|... ...++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.
T Consensus 86 TvL~eLe~~-----------------------p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gv 139 (396)
T KOG0593|consen 86 TVLHELERY-----------------------PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGV 139 (396)
T ss_pred HHHHHHHhc-----------------------cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCc
Confidence 444445432 234677888999999999999999998 999999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
+||+|||+|+.+... ....+..+-|.+|+|||.+.+ .+|...+||||.||++.||++|..-+.+..+..+ .+...
T Consensus 140 vKLCDFGFAR~L~~p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ---Ly~I~ 215 (396)
T KOG0593|consen 140 VKLCDFGFARTLSAP-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ---LYLIR 215 (396)
T ss_pred EEeccchhhHhhcCC-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH---HHHHH
Confidence 999999999987642 234566788999999999887 7999999999999999999999987754432211 01111
Q ss_pred HHHHHHHhccChhhhhccc------cccc------CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 683 WAFEKVYEEMKVEDILDRH------IKNS------YDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~------l~~~------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
.....+... ...++... .-+. .+... +....-+.+++..|++.||++|++-++++
T Consensus 216 ktLG~L~pr--hq~iF~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 216 KTLGNLIPR--HQSIFSSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred HHHcccCHH--HHHHhccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 000000000 01111110 0000 00011 23455789999999999999999999988
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=335.63 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=203.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 516 (763)
+++.|.+.||+|+|++|++|+.. .++.+|||++.+.. ...+....|-++|.+| .||.|++|+-.|.+...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 45678899999999999999765 57899999997542 2223456788899999 899999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
+||+++|+|.++|.+.+ .++......++.+|+.||+|||+.| ||||||||+||
T Consensus 153 Le~A~nGdll~~i~K~G------------------------sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENI 205 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYG------------------------SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENI 205 (604)
T ss_pred EEecCCCcHHHHHHHhC------------------------cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhhe
Confidence 99999999999997653 5778888899999999999999999 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcc----------cc--cccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMV----------SM--SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~----------~~--~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~ 664 (763)
|||+|+++||+|||.|+.+...... .. ..++||..|.+||++..+..+..+|+|+|||+||+|+.|.+
T Consensus 206 LLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~P 285 (604)
T KOG0592|consen 206 LLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQP 285 (604)
T ss_pred eEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCC
Confidence 9999999999999999977542221 11 44889999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
||....+ ++ . ...+++- .-. +++..++.+.+|+...|..||.+|+|..+|.+.
T Consensus 286 PFra~Ne-------yl-------i-----FqkI~~l--~y~----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 286 PFRAANE-------YL-------I-----FQKIQAL--DYE----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCccccH-------HH-------H-----HHHHHHh--ccc----CCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 9974421 00 0 1112111 111 223444678888899999999999999998864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=379.75 Aligned_cols=271 Identities=26% Similarity=0.454 Sum_probs=212.7
Q ss_pred cccHHHHHHHhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCe
Q 046586 434 RFTHAELRAATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE 512 (763)
Q Consensus 434 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 512 (763)
.+++.++... ....+.||+|+||.||+|+. .++..||||.++..... ..+|++++++++|||||+++|+|.+.+.
T Consensus 682 ~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~ 757 (968)
T PLN00113 682 SITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKG 757 (968)
T ss_pred hhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence 3455555443 34456899999999999987 47889999998754332 2356889999999999999999999999
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++|+|.+++. .++|.++.+|+.|+|+||+|||....+.|+|||||
T Consensus 758 ~~lv~Ey~~~g~L~~~l~---------------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlk 810 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR---------------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810 (968)
T ss_pred CEEEEeCCCCCcHHHHHh---------------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCC
Confidence 999999999999999983 26899999999999999999997655569999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+||+++.++.+++. ||........ ....+|..|+|||++.+..++.++|||||||++|||++|+.|++...
T Consensus 811 p~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-- 882 (968)
T PLN00113 811 PEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-- 882 (968)
T ss_pred HHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc--
Confidence 999999999988876 6655432211 12367899999999999999999999999999999999999985322
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.......+|+.... +......++++.+..... .+.++..++.+++.+||+.||++||+|+||+++|+++..
T Consensus 883 --~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 883 --GVHGSIVEWARYCY-SDCHLDMWIDPSIRGDVS--VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred --CCCCcHHHHHHHhc-CccchhheeCccccCCCC--ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 12234555554332 222244555555543222 235677789999999999999999999999999998765
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=331.87 Aligned_cols=249 Identities=35% Similarity=0.574 Sum_probs=193.4
Q ss_pred cccccccccccceEEEEEeC-----CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 446 GFSNLIGRGGFGDVYKGELT-----DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~-----~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
++.+.||.|.||.||+|.+. .+..|+||.++.... ..++|.+|++.+++++||||++++|++.+.+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35678999999999999887 246899999975433 24779999999999999999999999998888999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.++|... ....+++.++..|+.||++||+|||+.+ ++|++|+++||++
T Consensus 82 ~~~~g~L~~~L~~~----------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill 136 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK----------------------NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILL 136 (259)
T ss_dssp --TTEBHHHHHHHT----------------------CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE
T ss_pred cccccccccccccc----------------------cccccccccccccccccccccccccccc---ccccccccccccc
Confidence 99999999999764 2356899999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSD 676 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 676 (763)
++++.+||+|||+++....... ...........|+|||.+....++.++||||||+++|||++ |+.|+.....
T Consensus 137 ~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----- 211 (259)
T PF07714_consen 137 DSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----- 211 (259)
T ss_dssp ETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----
Confidence 9999999999999987632222 22223456778999999999999999999999999999999 6788753211
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
.. ....+.++. . ...+...+..+.+++..||+.||++||+|.+|++.|
T Consensus 212 ----~~-~~~~~~~~~----------~----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 212 ----EE-IIEKLKQGQ----------R----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----HH-HHHHHHTTE----------E----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----cc-ccccccccc----------c----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00 011111111 1 111233466788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=346.69 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=208.3
Q ss_pred cccccccccceEEEEEe-CCC----cEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 448 SNLIGRGGFGDVYKGEL-TDH----RVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~-~~~----~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.++||+|+||+||+|.+ +.+ -+||+|++.... +...+++.|+-.|.+++||||++|+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 46999999999999965 344 379999997543 34688999999999999999999999998876 78999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+.|+|.+|++.+ +..+.....+.|+.|||+||.|||++. +|||||..+|||+..
T Consensus 780 P~G~LlDyvr~h-----------------------r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVks 833 (1177)
T KOG1025|consen 780 PLGCLLDYVREH-----------------------RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKS 833 (1177)
T ss_pred ccchHHHHHHHh-----------------------hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecC
Confidence 999999999764 356778889999999999999999987 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCC
Q 046586 601 DFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~ 678 (763)
-..+||.|||+++....+... ......-.+.|||-|.++..+|+.++|||||||.+||++| |..|++.....+
T Consensus 834 P~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----- 908 (1177)
T KOG1025|consen 834 PNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----- 908 (1177)
T ss_pred CCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----
Confidence 999999999999988765543 2333345678999999999999999999999999999999 999987543211
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCC
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEI 749 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~ 749 (763)
+.++++. ..+...|+.+..+++.++..||..|+..||+++++.+.+......
T Consensus 909 ---------------I~dlle~----geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 909 ---------------IPDLLEK----GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ---------------hhHHHhc----cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1122221 122344577889999999999999999999999999888765443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.95 Aligned_cols=282 Identities=25% Similarity=0.339 Sum_probs=206.1
Q ss_pred HHHHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEeeC
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCAEK 510 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 510 (763)
+....+.+.+.||+|+||.||+++.. ++..||+|+++.... ....+.+|+++++.+ +|+||++++++|.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44556778899999999999998742 345799999975432 234588999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChh----------------------------------hhhcc----------
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPA----------------------------------REMEM---------- 546 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~----------------------------------~~~~~---------- 546 (763)
+..++||||+++|+|.+++............ ....+
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999999653211000000 00000
Q ss_pred --cCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcc-cc
Q 046586 547 --SGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-SM 623 (763)
Q Consensus 547 --~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~ 623 (763)
............+++.+.++++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 000000012245889999999999999999999988 999999999999999999999999999765432221 11
Q ss_pred cccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccc
Q 046586 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHI 702 (763)
Q Consensus 624 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 702 (763)
....++..|||||.+.+..++.++||||||+++|||++ |+.||....... . ....+....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------------~------~~~~~~~~~ 332 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------------K------FYKMVKRGY 332 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-------------H------HHHHHHccc
Confidence 22345678999999999999999999999999999997 999986432100 0 001111111
Q ss_pred cccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 703 KNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 703 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
... .+...+.++.+++.+||+.||++|||+.+|+++|++++
T Consensus 333 ~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 333 QMS----RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred Ccc----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 111 11123467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=323.27 Aligned_cols=252 Identities=26% Similarity=0.438 Sum_probs=204.2
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
..+.+.+.||+|+||.||+|+..++..+|+|.++.......+|.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 45677889999999999999988777899999886555567899999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 84 ~~l~~~i~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~ 137 (256)
T cd05113 84 GCLLNYLREH-----------------------GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQG 137 (256)
T ss_pred CcHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCC
Confidence 9999998542 225789999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchh
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~ 681 (763)
.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |..||..... .
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---------~ 208 (256)
T cd05113 138 CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---------S 208 (256)
T ss_pred CEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---------H
Confidence 99999999998654433222222345678999999988889999999999999999998 9888853221 0
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
. ......++. ... .+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 209 ~-~~~~~~~~~----------~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 209 E-TVEKVSQGL----------RLY----RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred H-HHHHHhcCC----------CCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 001111110 000 11223568899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=328.13 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=198.7
Q ss_pred ccccccccccccceEEEEEe-CCCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+...+.||+|+||.||++.. .+++.||+|.+.... .....+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 45668999999999999976 468899999986432 2234578999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 82 ~~~g~L~~~~~~~----------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~ 136 (285)
T cd05631 82 MNGGDLKFHIYNM----------------------GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLD 136 (285)
T ss_pred cCCCcHHHHHHhh----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEEC
Confidence 9999999888543 2235788999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
+++.+||+|||++....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----- 209 (285)
T cd05631 137 DRGHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----- 209 (285)
T ss_pred CCCCEEEeeCCCcEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-----
Confidence 99999999999997653222 22345689999999999999999999999999999999999999975432110
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~ 741 (763)
. ... +..+.. .....+......+.+++.+||+.||++||+ ++++++
T Consensus 210 -~----~~~----------~~~~~~-~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 210 -R----EEV----------DRRVKE-DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -H----HHH----------HHHhhc-ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0 000 000000 001111334567889999999999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=322.11 Aligned_cols=256 Identities=26% Similarity=0.413 Sum_probs=206.3
Q ss_pred HHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
....+.+.++||+|+||.||+|+..+...||+|+++......++|.+|++++++++|+||+++++++.+ +..++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 345688899999999999999988777789999998655556789999999999999999999998754 5678999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++
T Consensus 83 ~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~ 137 (262)
T cd05071 83 SKGSLLDFLKGE----------------------MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGE 137 (262)
T ss_pred CCCcHHHHHhhc----------------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcC
Confidence 999999999642 2235789999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 138 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-------- 209 (262)
T cd05071 138 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------- 209 (262)
T ss_pred CCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------
Confidence 9999999999997654433222223346678999999988899999999999999999999 7878753211
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.........+ .....+.+.+..+.+++.+|++.+|++||++.+++++|++.
T Consensus 210 --~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 210 --REVLDQVERG--------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --HHHHHHHhcC--------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0001111000 01111234567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=322.23 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=203.0
Q ss_pred hccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
.+.+.+.||+|+||.||++...++..+|+|+++.......+|.+|++++++++|+||+++++++.+.+..++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 45677899999999999998887778999998765555667899999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 85 ~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~ 138 (256)
T cd05059 85 CLLNYLRER-----------------------KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNV 138 (256)
T ss_pred CHHHHHHhc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCc
Confidence 999998642 235789999999999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhH
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 682 (763)
+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .
T Consensus 139 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------~ 209 (256)
T cd05059 139 VKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---------E 209 (256)
T ss_pred EEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---------H
Confidence 9999999997654322222222234567999999999999999999999999999999 78888633210 0
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
.......+ .....+...+..+.+++.+||+.+|++|||+.||+++|.
T Consensus 210 -~~~~~~~~--------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 210 -VVESVSAG--------------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred -HHHHHHcC--------------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 00111100 011111234668999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=320.90 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=208.9
Q ss_pred HHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
++...++++.++||+|+||.||+|...+++.+|+|.++.......++.+|+.++++++|+||+++++++. .+..++|||
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 4566788899999999999999999888899999999876666778999999999999999999999874 567899999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||++
T Consensus 81 ~~~~~~L~~~~~~~----------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i 135 (260)
T cd05067 81 YMENGSLVDFLKTP----------------------EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILV 135 (260)
T ss_pred cCCCCCHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEE
Confidence 99999999998543 2346789999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~ 677 (763)
++++.++|+|||++...............++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------ 209 (260)
T cd05067 136 SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN------ 209 (260)
T ss_pred cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh------
Confidence 999999999999997655332222223345678999999998899999999999999999999 9999863321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
+.. .... ..... ...+...+.++.+++.+|++.+|++||++++++++|+.
T Consensus 210 ---~~~-~~~~----------~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 210 ---PEV-IQNL----------ERGYR----MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---HHH-HHHH----------HcCCC----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 000 0011 11000 01112335679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=333.56 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=202.7
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeecc-----C-CchhhhHHHHHHHhcCC-CCccccEEEEEeeCCe
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV-----T-GGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGE 512 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~-----~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~ 512 (763)
....|.+.+.||+|.||.|++|... .++.||+|++... . ...+...+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3456778889999999999999664 6799999977542 1 12344668999999998 9999999999999999
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+.+|+|.+++... ..+.......+..|++.|++|+|+.+ |+|||||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~------------------------g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK 147 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK------------------------GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLK 147 (370)
T ss_pred EEEEEEecCCccHHHHHHHc------------------------CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCC
Confidence 99999999999999999752 35677889999999999999999999 9999999
Q ss_pred CCceEEcCC-CCeEEcccCcccccCCCCcccccccccCCCcccccccccCC-CC-CccceeehhHHHHHHHhCCCCcccc
Q 046586 593 PENILLGDD-FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQ-IT-PKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 593 ~~NILl~~~-~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s-~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
|+|||++.+ +++||+|||++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..
T Consensus 148 ~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 148 PENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred HHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 999999999 999999999998774 2223456679999999999999877 86 7899999999999999999999852
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHH-HHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDM-VNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
. ...+..+.....+. +|... ..++..++.+|+..||.+|+++.+|+
T Consensus 227 ~-----------------------~~~l~~ki~~~~~~--~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 227 N-----------------------VPNLYRKIRKGEFK--IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred c-----------------------HHHHHHHHhcCCcc--CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 2 11111111111111 22223 67889999999999999999999999
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=320.05 Aligned_cols=254 Identities=29% Similarity=0.448 Sum_probs=204.9
Q ss_pred HHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
...+.+.++||+|+||.||++...++..+|+|.++......+++.+|+.++++++|+|++++++++. ....++||||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4457778899999999999999888888999999866555677999999999999999999999885 456889999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++... ....+++.++..++.|++.||+|||+.+ |+||||||+||+++++
T Consensus 84 ~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~ 138 (260)
T cd05070 84 KGSLLDFLKDG----------------------EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDG 138 (260)
T ss_pred CCcHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCC
Confidence 99999998642 2235789999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCch
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~ 680 (763)
+.+||+|||++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------- 209 (260)
T cd05070 139 LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------- 209 (260)
T ss_pred ceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---------
Confidence 999999999998654433222222345678999999988899999999999999999999 8888853211
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
.. ..... .... ..+.+...+..+.+++.+|++.+|++|||+.+++++|+.
T Consensus 210 ~~-~~~~~----------~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 210 RE-VLEQV----------ERGY----RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HH-HHHHH----------HcCC----CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 00111 1100 111123445679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=320.92 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=207.6
Q ss_pred HHhccccccccccccceEEEEEeCCCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
...+.+.++||.|+||.||+|...+++.+++|.++.... ...++.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 345677889999999999999998889999999986544 4567889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ....+++.++..++.|++.||+|||+.+ |+|+||||+||++++
T Consensus 85 ~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~ 139 (261)
T cd05148 85 EKGSLLAFLRSP----------------------EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGE 139 (261)
T ss_pred ccCCHHHHHhcC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcC
Confidence 999999999643 2345789999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||++........ ......++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 140 ~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------- 211 (261)
T cd05148 140 DLVCKVADFGLARLIKEDVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------- 211 (261)
T ss_pred CceEEEccccchhhcCCccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-------
Confidence 99999999999976543222 1223345678999999988899999999999999999998 88888633210
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
..... + .. ......+..+++.+.+++.+||+.||++|||++++++.|+.
T Consensus 212 ---~~~~~---------~-~~----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 212 ---EVYDQ---------I-TA----GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---HHHHH---------H-Hh----CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 00000 0 00 11111223456778999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.32 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=204.7
Q ss_pred HHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
....+.+.++||+|+||.||++...++..+|+|.++......+.+.+|+.++++++|+|++++++++. .+..++||||+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 34567788899999999999999887778999998765555677899999999999999999999875 45688999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++
T Consensus 83 ~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~ 137 (260)
T cd05069 83 GKGSLLDFLKEG----------------------DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGD 137 (260)
T ss_pred CCCCHHHHHhhC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcC
Confidence 999999999642 2235789999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------- 210 (260)
T cd05069 138 NLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------- 210 (260)
T ss_pred CCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------
Confidence 9999999999997654332222222345678999999998999999999999999999999 88888632110
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
-.......+ .....+...+..+.+++.+||+.||++||++.+|+++|+.
T Consensus 211 ---~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 211 ---EVLEQVERG--------------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---HHHHHHHcC--------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000111000 0111123456778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=320.53 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=203.1
Q ss_pred HhccccccccccccceEEEEEeCC----CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD----HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
..+.+.+.||+|+||.||+|.... ...||+|.++.... ...+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 456778899999999999998742 35799999875433 335688999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+|+||||+||
T Consensus 84 ~e~~~~~~L~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~ni 137 (266)
T cd05033 84 TEYMENGSLDKFLREN-----------------------DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNI 137 (266)
T ss_pred EEcCCCCCHHHHHHhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceE
Confidence 9999999999998542 236789999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 674 (763)
++++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--- 214 (266)
T cd05033 138 LVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--- 214 (266)
T ss_pred EEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---
Confidence 999999999999999987652221 12222345678999999999999999999999999999998 9888853210
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.. ......+. ...+.+...+..+.+++.+|++.+|++||++.||+++|+++
T Consensus 215 ------~~-~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 215 ------QD-VIKAVEDG--------------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------HH-HHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 00111000 00011133456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.25 Aligned_cols=267 Identities=29% Similarity=0.460 Sum_probs=206.4
Q ss_pred hccccccccccccceEEEEEeCC------CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
.+.+.+.||+|+||.||+|.... ...|++|.++.... ...+|.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 46677899999999999997643 25799999874432 23568899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
+|||+++++|.+++............ .........+++...+.++.|++.||+|||+.+ ++|+||||+|
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~--------~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~N 154 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAE--------SGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARN 154 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccc--------cccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccce
Confidence 99999999999999754211110000 000112256889999999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
|++++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 155 il~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~- 233 (283)
T cd05048 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ- 233 (283)
T ss_pred EEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence 9999999999999999986543322 22233456788999999998999999999999999999998 99998643210
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
. ..+.+.... ....+...+.++.+++.+||+.||.+||++.||++.|++
T Consensus 234 -------------~------~~~~i~~~~----~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 -------------E------VIEMIRSRQ----LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -------------H------HHHHHHcCC----cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 0 001111111 111224566889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=331.16 Aligned_cols=240 Identities=26% Similarity=0.322 Sum_probs=194.7
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
+.||+|+||.||+++.. +++.||+|+++... .....+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999775 67899999997432 22345788999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|.+++... ..+++.+...++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 81 ~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~ 133 (323)
T cd05571 81 ELFFHLSRE------------------------RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGH 133 (323)
T ss_pred cHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCC
Confidence 999998532 35788999999999999999999998 999999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHH
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~ 683 (763)
+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .
T Consensus 134 ~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---------~-- 201 (323)
T cd05571 134 IKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---------E-- 201 (323)
T ss_pred EEEeeCCCCcccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---------H--
Confidence 9999999997532221 123345799999999999999999999999999999999999999963221 0
Q ss_pred HHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
...+ .+... . ..++.....++.+++.+||+.||++|| ++.++++
T Consensus 202 ---~~~~-----~~~~~----~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 202 ---KLFE-----LILME----E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ---HHHH-----HHHcC----C--CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0000 00000 0 111233456788999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=328.77 Aligned_cols=237 Identities=27% Similarity=0.342 Sum_probs=191.4
Q ss_pred ccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 451 IGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 451 LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
||+|+||.||+++.. +++.||+|+++.. ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4788999999743 22345678899999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeE
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 605 (763)
.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 81 ~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~k 133 (312)
T cd05585 81 FHHLQRE------------------------GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIA 133 (312)
T ss_pred HHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEE
Confidence 9998542 24788899999999999999999988 99999999999999999999
Q ss_pred EcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHH
Q 046586 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685 (763)
Q Consensus 606 I~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 685 (763)
|+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ... .
T Consensus 134 l~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---------~~~-~ 202 (312)
T cd05585 134 LCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---------NEM-Y 202 (312)
T ss_pred EEECcccccCccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---------HHH-H
Confidence 99999997543222 223345789999999999999999999999999999999999999963211 110 0
Q ss_pred HHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH---HHHH
Q 046586 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM---GKVA 740 (763)
Q Consensus 686 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~---~eVv 740 (763)
.. +.. .. ..++......+.+++..||+.||++||++ .|++
T Consensus 203 ~~---------~~~----~~--~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 203 RK---------ILQ----EP--LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HH---------HHc----CC--CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 01 111 10 11123345678899999999999999864 5554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.26 Aligned_cols=243 Identities=27% Similarity=0.400 Sum_probs=206.5
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchh---hhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDA---EFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~---~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
|.+.+.||+|.||.||||+-+ +.+.||+|.+.+....++ ...+|+++++.++|||||.+++.|+...+.++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 456688999999999999765 578999999976655444 3778999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
.+ +|+.+|... ..++..++..|+.++..||.|||+.. |+|||+||.|||++.
T Consensus 84 ~g-~L~~il~~d------------------------~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~ 135 (808)
T KOG0597|consen 84 VG-DLFTILEQD------------------------GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEK 135 (808)
T ss_pred hh-hHHHHHHhc------------------------cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecC
Confidence 77 999999643 46889999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++++|++|||+|+.+... ....+.+.||+.|||||...+.+|+..+|+||+||++||+++|++||-...
T Consensus 136 ~~~~KlcdFg~Ar~m~~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---------- 204 (808)
T KOG0597|consen 136 GGTLKLCDFGLARAMSTN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---------- 204 (808)
T ss_pred CCceeechhhhhhhcccC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----------
Confidence 999999999999976553 334566889999999999999999999999999999999999999995221
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
+.+++...+..... .|.+....++.++...+++||..|.+-.+++.
T Consensus 205 -------------i~~Lv~~I~~d~v~--~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 205 -------------ITQLVKSILKDPVK--PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -------------HHHHHHHHhcCCCC--CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 22333333322221 22577788999999999999999999988873
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=339.97 Aligned_cols=282 Identities=27% Similarity=0.380 Sum_probs=207.1
Q ss_pred HHHhccccccccccccceEEEEEeCC------CcEEEEEEeeccCC--chhhhHHHHHHHhcCC-CCccccEEEEEeeCC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMH-HLNLVRLWGFCAEKG 511 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~ 511 (763)
....+.+.++||+|+||.||+|+... +..||||+++.... ..+.+.+|+++++++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 34566677899999999999997632 34699999975432 2356899999999995 999999999999999
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCC-hh-------------------hhh-----------cccCC-----------
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSS-PA-------------------REM-----------EMSGV----------- 549 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~-~~-------------------~~~-----------~~~~~----------- 549 (763)
..+|||||+++|+|.++|...+...... +. ... .....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999997643110000 00 000 00000
Q ss_pred ---------------C---------------CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 550 ---------------G---------------PHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 550 ---------------~---------------~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
. ........+++.+++.++.|+++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0 00011245889999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDE 677 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~ 677 (763)
+++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~----- 346 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD----- 346 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-----
Confidence 999999999999986543222 12223346788999999999999999999999999999997 88888532110
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
....... .. ......+...+..+.+++.+||+.||++||++.+|+++|+.+.+
T Consensus 347 ----~~~~~~~----------~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 ----STFYNKI----------KS----GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ----HHHHHHH----------hc----CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0000000 00 01111123456788999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=328.88 Aligned_cols=257 Identities=23% Similarity=0.362 Sum_probs=200.8
Q ss_pred HHHhccccccccccccceEEEEEeC-CCc----EEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHR----VVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~----~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
....+...+.||+|+||.||+|+.. +++ .||+|+++... ...+++.+|+.+++.++||||++++|+|... ..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 3456677789999999999999864 333 48999987443 2346788999999999999999999999865 57
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++|+||+++|+|.+++... ...+++...+.++.||+.||+|||+.+ |+||||||
T Consensus 84 ~~v~e~~~~g~l~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp 137 (316)
T cd05108 84 QLITQLMPFGCLLDYVREH-----------------------KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAA 137 (316)
T ss_pred eeeeecCCCCCHHHHHHhc-----------------------cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccch
Confidence 7999999999999998642 235788899999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGS 671 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~ 671 (763)
+|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|++....
T Consensus 138 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~ 217 (316)
T cd05108 138 RNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 217 (316)
T ss_pred hheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999999866533221 1122234678999999999999999999999999999998 9999863210
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
... . .++..... ...+..+...+.+++..||+.+|++||++.+++..|..+..
T Consensus 218 ---------~~~--~---------~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 218 ---------SEI--S---------SILEKGER----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ---------HHH--H---------HHHhCCCC----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 000 0 01111000 01112334578899999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.09 Aligned_cols=250 Identities=26% Similarity=0.325 Sum_probs=200.4
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
|.+.++||+|+||.||+|+.. +++.||+|+++... .....+.+|++++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 567789999999999999886 47899999997432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 83 ~~g~~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~ 135 (333)
T cd05600 83 VPGGDFRTLLNNL------------------------GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLID 135 (333)
T ss_pred CCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEC
Confidence 9999999999532 35788899999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
.++.+||+|||+++.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 136 ~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------- 204 (333)
T cd05600 136 ASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN------- 204 (333)
T ss_pred CCCCEEEEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-------
Confidence 999999999999975433 223457899999999999999999999999999999999999999643210
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.....+... ...+.. .... ........++.+++.+||+.+|++||++.++++.
T Consensus 205 ---~~~~~i~~~---~~~~~~---~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 205 ---ETWENLKYW---KETLQR---PVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---HHHHHHHhc---cccccC---CCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000111100 000000 0000 0002345678899999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.57 Aligned_cols=267 Identities=26% Similarity=0.414 Sum_probs=207.3
Q ss_pred HHhccccccccccccceEEEEEeCC------CcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
..++.+.+.||+|+||.||+|...+ ++.||+|.++..... ..++.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4567778899999999999997643 478999999754433 46799999999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++........... ........+++.++..++.|++.|++|||+.+ ++||||||
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~----------~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp 150 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLK----------SPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLAT 150 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhc----------ccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecccccc
Confidence 999999999999999975431100000 00113456889999999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGS 671 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~ 671 (763)
+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 151 ~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 151 RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred ceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999975433222 11223345778999999999999999999999999999998 9999853321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
. .. ... + .. +.. ...+...+..+.+++..||+.||++||++.||++.|++
T Consensus 231 ~---------~~-~~~---------~-~~---~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 231 E---------EV-IEC---------I-TQ---GRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H---------HH-HHH---------H-Hc---CCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0 00 000 0 00 000 11112345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=332.39 Aligned_cols=281 Identities=27% Similarity=0.375 Sum_probs=204.8
Q ss_pred HHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEeeC-C
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCAEK-G 511 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~ 511 (763)
...+.+.+.||+|+||.||+|... .++.||+|+++.... ..+.+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346778899999999999999643 246899999874332 234577899999999 899999999988754 5
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhh--c-----------------------------c------cCCCCCCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREM--E-----------------------------M------SGVGPHDG 554 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~--~-----------------------------~------~~~~~~~~ 554 (763)
..+++|||+++++|.+++............... . + ........
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999999999998653211000000000 0 0 00000000
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcc
Q 046586 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYM 633 (763)
Q Consensus 555 ~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~ 633 (763)
....++|..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 1247899999999999999999999988 99999999999999999999999999986543322 1222345677899
Q ss_pred cccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchH
Q 046586 634 APEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHF 712 (763)
Q Consensus 634 APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 712 (763)
|||++.+..++.++|||||||++|||++ |..||....... ........+ .. ...+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~----------~~----~~~~~ 299 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---------EFCRRLKEG----------TR----MRAPE 299 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---------HHHHHHhcc----------CC----CCCCc
Confidence 9999999999999999999999999998 999986422100 000011111 00 01112
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 713 DMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 713 ~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
....++.+++.+||+.+|++||++.||+++|+.+++
T Consensus 300 ~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 345678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.63 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=197.5
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45677899999999999999886 57899999997432 23356889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||
T Consensus 98 e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIl 150 (329)
T PTZ00263 98 EFVVGGELFTHLRKA------------------------GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLL 150 (329)
T ss_pred cCCCCChHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEE
Confidence 999999999998542 34677888899999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 151 l~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------ 220 (329)
T PTZ00263 151 LDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------ 220 (329)
T ss_pred ECCCCCEEEeeccCceEcCCC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------
Confidence 999999999999999865432 1235689999999999999999999999999999999999999963221
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~ 741 (763)
....+...+ ... .++.....++.+++..||+.||.+||+ +.++++
T Consensus 221 ----~~~~~~i~~---------~~~------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 221 ----FRIYEKILA---------GRL------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ----HHHHHHHhc---------CCc------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 000111111 110 111223456889999999999999997 677763
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.64 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=206.9
Q ss_pred HHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
++...++.+.++||+|+||.||++...++..+++|.++........|.+|++++++++|+||+++.+++.+ ...+++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 34556788889999999999999998888889999987655556779999999999999999999999887 77899999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||++
T Consensus 81 ~~~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i 135 (260)
T cd05073 81 FMAKGSLLDFLKSD----------------------EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILV 135 (260)
T ss_pred eCCCCcHHHHHHhC----------------------CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEE
Confidence 99999999999542 2235788899999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~ 677 (763)
+.++.+||+|||++...............++..|+|||.+....++.++||||||+++||+++ |+.||......
T Consensus 136 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----- 210 (260)
T cd05073 136 SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----- 210 (260)
T ss_pred cCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence 999999999999997654332222223345678999999998899999999999999999999 88888633210
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
. ......++ .....+...+..+.+++.+|++.+|++||++.+++++|+.
T Consensus 211 ----~-~~~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 211 ----E-VIRALERG--------------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----H-HHHHHhCC--------------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 00111111 0111112345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=318.01 Aligned_cols=266 Identities=26% Similarity=0.375 Sum_probs=200.8
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhc--CCCCccccEEEEEeeCC----eeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIAR--MHHLNLVRLWGFCAEKG----ERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~LV 516 (763)
.+..+.+.||+|.||.||+|++++ +.||||++... +++.+.+|.++.+. |+|+||+.+++.-..+. .++||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrG-e~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRG-EDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred heeEEEEEecCccccceeeccccC-CceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 345567899999999999999975 56999999643 35567788887665 59999999998765543 68899
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCcEEecCC
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE-----ECLEWVLHCDI 591 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-----~~~~~ivHrDl 591 (763)
.+|.++|||.+||. +.+++....++++..+|.||++||- +++|.|.||||
T Consensus 288 TdYHe~GSL~DyL~-------------------------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLN-------------------------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred eecccCCcHHHHHh-------------------------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 99999999999994 4579999999999999999999994 57788999999
Q ss_pred CCCceEEcCCCCeEEcccCcccccCCCCc---ccccccccCCCcccccccccC----CCC--CccceeehhHHHHHHHhC
Q 046586 592 KPENILLGDDFCPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRSD----QIT--PKADVYSFGMVLLEIVSG 662 (763)
Q Consensus 592 k~~NILl~~~~~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~----~~s--~ksDVwS~Gvll~elltG 662 (763)
|+.|||+..++.+.|+|+|||........ ...+..+||.+|||||++... .+. ..+||||||+++||+...
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999975443321 234456899999999999653 111 369999999999999752
Q ss_pred C----------CCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCc-chHHHHHHHHHHHHHccCCCCC
Q 046586 663 S----------RNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSR-VHFDMVNRMVKTAMWCIQDRPE 731 (763)
Q Consensus 663 ~----------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~ 731 (763)
- .||...-+ .+.+ ++.+. .-+-.+.+++..+.+ ...+....+.++|..||..+|.
T Consensus 423 c~~ggi~eey~~Pyyd~Vp----~DPs---------~eeMr-kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~ 488 (513)
T KOG2052|consen 423 CESGGIVEEYQLPYYDVVP----SDPS---------FEEMR-KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPA 488 (513)
T ss_pred hhcCCEehhhcCCcccCCC----CCCC---------HHHHh-cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCch
Confidence 2 23321111 0111 11211 111122222222222 2346788899999999999999
Q ss_pred CCCCHHHHHHHhccCCCCC
Q 046586 732 LRPSMGKVAKMLEGTVEIT 750 (763)
Q Consensus 732 ~RPs~~eVv~~Le~~~~~~ 750 (763)
-|-|+--|.+.|.++.+++
T Consensus 489 aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 489 ARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred hhhHHHHHHHHHHHHhcCh
Confidence 9999999999998887654
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.91 Aligned_cols=257 Identities=29% Similarity=0.463 Sum_probs=208.8
Q ss_pred HHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+....+.+.++||+|+||.||++...+++.+|+|.++.......++.+|+.++++++|+||+++++++......++||||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34456778899999999999999988888899999987666677899999999999999999999999998999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++
T Consensus 83 ~~~~~L~~~i~~~----------------------~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~ 137 (261)
T cd05034 83 MSKGSLLDFLKSG----------------------EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVG 137 (261)
T ss_pred cCCCCHHHHHhcc----------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEc
Confidence 9999999999542 2246889999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~ 678 (763)
+++.+||+|||+++...............+..|+|||.+.+..++.++||||||+++||+++ |+.||.....
T Consensus 138 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------- 210 (261)
T cd05034 138 ENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN------- 210 (261)
T ss_pred CCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence 99999999999998654322222222334568999999998899999999999999999998 9999853211
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
.........+ .....+...+.++.+++.+|++.+|++||++.++++.|+.
T Consensus 211 ---~~~~~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 211 ---REVLEQVERG--------------YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---HHHHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0001111100 0111112335678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=330.72 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=213.0
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+++.+.||.|+-|.|-.|++. .|+.+|||++.+.. .......+|+.+|+.++|||+++|++++++..++|||.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 345678999999999999874 69999999996441 1223467899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|-|.++|... ..+...+..++..||..|+.|+|..+ |+||||||+|+|||
T Consensus 94 v~gGELFdylv~k------------------------G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd 146 (786)
T KOG0588|consen 94 VPGGELFDYLVRK------------------------GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLD 146 (786)
T ss_pred cCCchhHHHHHhh------------------------CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhh
Confidence 9999999999754 46888899999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCC-CccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
..+++||+|||+|.+-.... ...+.+|++.|.|||++++.+|. .++||||.||+||.|++|+.||++..
T Consensus 147 ~~~nIKIADFGMAsLe~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------- 216 (786)
T KOG0588|consen 147 VKNNIKIADFGMASLEVPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------- 216 (786)
T ss_pred cccCEeeeccceeecccCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--------
Confidence 99999999999998654433 34567899999999999999887 58999999999999999999997321
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hccCCCCCCC
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM--LEGTVEITEP 752 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~--Le~~~~~~~p 752 (763)
+..++.+...+.+. +|.+.+.++.+|+.+|+..||+.|.|+.||++. |.+...++.+
T Consensus 217 ---------------ir~LLlKV~~G~f~--MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 217 ---------------IRVLLLKVQRGVFE--MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred ---------------HHHHHHHHHcCccc--CCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 33444444444444 336677889999999999999999999999974 5665554433
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=327.22 Aligned_cols=241 Identities=24% Similarity=0.308 Sum_probs=195.1
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
+.||+|+||.||+++.. +++.||+|+++.. .....++.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 5789999999743 223356788999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|..++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 81 ~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~ 133 (328)
T cd05593 81 ELFFHLSRE------------------------RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGH 133 (328)
T ss_pred CHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCc
Confidence 999888532 35788999999999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHH
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~ 683 (763)
+||+|||+++..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 134 ~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----------- 201 (328)
T cd05593 134 IKITDFGLCKEGITD-AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------- 201 (328)
T ss_pred EEEecCcCCccCCCc-ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----------
Confidence 999999998753222 12233457899999999999999999999999999999999999999633210
Q ss_pred HHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 046586 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAKM 742 (763)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~~ 742 (763)
+......... ..++.....++.+++.+||+.||++|| ++.++++.
T Consensus 202 ------------~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 202 ------------KLFELILMED--IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ------------HHHHHhccCC--ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0000000000 111233456788999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=326.13 Aligned_cols=242 Identities=24% Similarity=0.293 Sum_probs=197.4
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.+.++||+|+||.||++... +++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 566789999999999999876 57899999996432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++
T Consensus 83 ~~~~~L~~~~~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~ 135 (291)
T cd05612 83 VPGGELFSYLRNS------------------------GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLD 135 (291)
T ss_pred CCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEEC
Confidence 9999999998542 35788889999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------- 204 (291)
T cd05612 136 KEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------- 204 (291)
T ss_pred CCCCEEEEecCcchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------
Confidence 9999999999999865432 22356899999999999999999999999999999999999999643210
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAKM 742 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~~ 742 (763)
...... .... ..++......+.+++.+||+.||.+||+ +.++++.
T Consensus 205 ---~~~~~i---------~~~~------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 205 ---GIYEKI---------LAGK------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---HHHHHH---------HhCC------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 000111 1110 0111233557889999999999999995 8888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.89 Aligned_cols=269 Identities=27% Similarity=0.433 Sum_probs=203.8
Q ss_pred HhccccccccccccceEEEEEe-----CCCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-----TDHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-----~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
..+.+.++||+|+||.||+|.. ..++.+++|.++.... ...++.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4566788999999999999975 2457899999974332 23568899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++++|.+++............. .........+++.+.+.++.|++.||+|||+.+ |+||||||+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~n 154 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSS-------DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARN 154 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCcccccc-------ccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccce
Confidence 999999999999986432110000000 000012346889999999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
|++++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-- 232 (283)
T cd05090 155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-- 232 (283)
T ss_pred EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 9999999999999999986543322 12223345678999999988899999999999999999998 8888853210
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
.. ..+.++.... ...+...+.++.+++.+|++.||++||++.+|.++|++
T Consensus 233 --------~~----------~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 --------QE----------VIEMVRKRQL----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --------HH----------HHHHHHcCCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00 0111111000 01112345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.14 Aligned_cols=271 Identities=20% Similarity=0.245 Sum_probs=199.2
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.|.+.+.||+|+||.||+++.. +++.+|+|+++.... ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 3567789999999999999886 578899999975422 235678999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
++++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++
T Consensus 82 ~~~~~l~~~~~------------------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~ 134 (287)
T cd07848 82 VEKNMLELLEE------------------------MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLIS 134 (287)
T ss_pred CCCCHHHHHHh------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEc
Confidence 99876665432 1235788899999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC----
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS---- 675 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~---- 675 (763)
.++.+||+|||+++..............|+..|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (287)
T cd07848 135 HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214 (287)
T ss_pred CCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999999876443333334457899999999999889999999999999999999999999643211000
Q ss_pred -CCCchhHHHHHHHHhccChhhhhcccccc--cCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 -DEWYFPKWAFEKVYEEMKVEDILDRHIKN--SYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 -~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
....++.-................+.... ..........+..+.+++.+||+.||++|||++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 215 KVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000000000000000000 0000011124567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.21 Aligned_cols=264 Identities=23% Similarity=0.363 Sum_probs=202.6
Q ss_pred HHHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCe
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE 512 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 512 (763)
....+.+.++||+|+||.||+|... .+..||+|.++.... ...+|.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456778899999999999999753 246799998864322 34568899999999999999999999999999
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++++|.+++...+..... ......+++..++.++.|++.||+|||+.+ ++|+|||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlk 146 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMEN--------------NPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLA 146 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccc--------------cccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcc
Confidence 99999999999999999653211100 001245788999999999999999999988 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCccccc
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQG 670 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~ 670 (763)
|+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 147 p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~ 226 (277)
T cd05062 147 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS 226 (277)
T ss_pred hheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999999754332221 1112345678999999998999999999999999999999 677875321
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
. .. ..... ..... ...+...+..+.+++.+|++.+|++|||+.|++++|++
T Consensus 227 ~---------~~-~~~~~---------~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 227 N---------EQ-VLRFV---------MEGGL-----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred H---------HH-HHHHH---------HcCCc-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1 00 00000 01000 01112345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.35 Aligned_cols=240 Identities=27% Similarity=0.325 Sum_probs=193.8
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
+.||+|+||.||+++.. +++.||+|+++... .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 67899999997432 23345778999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 81 ~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 133 (323)
T cd05595 81 ELFFHLSRE------------------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGH 133 (323)
T ss_pred cHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCC
Confidence 999888532 35788999999999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHH
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~ 683 (763)
+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 134 ~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----------- 201 (323)
T cd05595 134 IKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----------- 201 (323)
T ss_pred EEecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----------
Confidence 9999999987532221 2223456899999999999999999999999999999999999999643210
Q ss_pred HHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
... ..+... . ..++......+.+++.+||+.||++|| ++.++++
T Consensus 202 ---~~~-----~~~~~~----~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 202 ---RLF-----ELILME----E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ---HHH-----HHHhcC----C--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 000 001110 0 011133456788999999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=327.15 Aligned_cols=266 Identities=21% Similarity=0.288 Sum_probs=201.5
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
...+.+.++||+|+||.||+++.. ++..+|+|+++.... ...++.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 345667789999999999999876 578899999875322 23568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+. |+||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~ 137 (331)
T cd06649 84 HMDGGSLDQVLKEA------------------------KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILV 137 (331)
T ss_pred cCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEE
Confidence 99999999998542 347888999999999999999998532 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.+||+|||++...... ......||..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 138 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----- 209 (331)
T cd06649 138 NSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----- 209 (331)
T ss_pred cCCCcEEEccCccccccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 99999999999999755332 1234568999999999999999999999999999999999999996432100
Q ss_pred chhHHHHHHHHh-----------------------------ccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCC
Q 046586 679 YFPKWAFEKVYE-----------------------------EMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDR 729 (763)
Q Consensus 679 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~d 729 (763)
+.........+ .....+..+.................++.+++.+||+.|
T Consensus 210 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~ 288 (331)
T cd06649 210 -LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKN 288 (331)
T ss_pred -HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCC
Confidence 00000000000 000001111111111111011234567899999999999
Q ss_pred CCCCCCHHHHHHH
Q 046586 730 PELRPSMGKVAKM 742 (763)
Q Consensus 730 P~~RPs~~eVv~~ 742 (763)
|++|||+.|+++.
T Consensus 289 P~~Rpt~~ell~h 301 (331)
T cd06649 289 PAERADLKMLMNH 301 (331)
T ss_pred cccCCCHHHHhcC
Confidence 9999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=311.54 Aligned_cols=246 Identities=30% Similarity=0.464 Sum_probs=197.7
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
++||+|+||.||+|...+++.+|+|.++..... ...+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 469999999999999888899999998754332 346889999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEE
Q 046586 527 DYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKI 606 (763)
Q Consensus 527 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI 606 (763)
+++... ...+++.+++.++.|++.+|.|||+.+ ++|+||||+||++++++.+||
T Consensus 81 ~~~~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l 134 (250)
T cd05085 81 SFLRKK-----------------------KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKI 134 (250)
T ss_pred HHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEE
Confidence 998532 234789999999999999999999988 999999999999999999999
Q ss_pred cccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhHHHH
Q 046586 607 SDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPKWAF 685 (763)
Q Consensus 607 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 685 (763)
+|||++...............++..|+|||++....++.++||||||+++||+++ |..||..... ....
T Consensus 135 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~----------~~~~ 204 (250)
T cd05085 135 SDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN----------QQAR 204 (250)
T ss_pred CCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH----------HHHH
Confidence 9999997543322211122234667999999998899999999999999999998 8889853321 0011
Q ss_pred HHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 686 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
.....+ . ....+...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 205 ~~~~~~----------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 205 EQVEKG----------Y----RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHcC----------C----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 111111 0 01111234568899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.26 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=197.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---------------hhhhHHHHHHHhcCCCCccccEEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---------------DAEFWAEVTIIARMHHLNLVRLWGF 506 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---------------~~~f~~E~~~l~~l~H~niv~l~g~ 506 (763)
..|.+.+.||+|.||.|-+|+.. +++.||||++.+.... .+...+|+.+|++++|||||+|+.+
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 45666789999999999999764 6889999999643211 1357899999999999999999999
Q ss_pred EeeC--CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 046586 507 CAEK--GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLE 584 (763)
Q Consensus 507 ~~~~--~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~ 584 (763)
..+. +.+|||+|||..|.+...= .....+...+++++..++..||+|||.++
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p------------------------~d~~els~~~Ar~ylrDvv~GLEYLH~Qg-- 230 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCP------------------------PDKPELSEQQARKYLRDVVLGLEYLHYQG-- 230 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCC------------------------CCcccccHHHHHHHHHHHHHHHHHHHhcC--
Confidence 8764 5899999999888765421 01223889999999999999999999999
Q ss_pred cEEecCCCCCceEEcCCCCeEEcccCcccccCCC----CcccccccccCCCcccccccccC----CCCCccceeehhHHH
Q 046586 585 WVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE----DMVSMSRIRGTRGYMAPEWLRSD----QITPKADVYSFGMVL 656 (763)
Q Consensus 585 ~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~----~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwS~Gvll 656 (763)
||||||||+|+||+++|++||+|||.+...... ........+||+.|||||...++ ..+.+.||||+||+|
T Consensus 231 -iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTL 309 (576)
T KOG0585|consen 231 -IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTL 309 (576)
T ss_pred -eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhH
Confidence 999999999999999999999999999765221 11223446899999999988763 245689999999999
Q ss_pred HHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 657 LEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 657 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
|.|+.|+.||-... ..++.++........+..+++.+++.++++++|++||+.|.+.
T Consensus 310 YCllfG~~PF~~~~-----------------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l 366 (576)
T KOG0585|consen 310 YCLLFGQLPFFDDF-----------------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITL 366 (576)
T ss_pred HHhhhccCCcccch-----------------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeeh
Confidence 99999999996332 2223333333222222224667889999999999999999999
Q ss_pred HHHHHHh
Q 046586 737 GKVAKML 743 (763)
Q Consensus 737 ~eVv~~L 743 (763)
.+|....
T Consensus 367 ~~ik~Hp 373 (576)
T KOG0585|consen 367 PDIKLHP 373 (576)
T ss_pred hhheecc
Confidence 9998665
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=302.59 Aligned_cols=233 Identities=25% Similarity=0.339 Sum_probs=195.1
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+++.+.||.|+||.|.+++.+ ++..+|+|+++... ...+...+|..+|+.+.||.+++|++.+.+.+.++|||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 345678999999999999886 57899999997432 2234467899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
.+||.|.++|.+.+ .++...+.-+|.||+.||+|||+.+ |++|||||+|||||
T Consensus 126 v~GGElFS~Lrk~~------------------------rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD 178 (355)
T KOG0616|consen 126 VPGGELFSYLRKSG------------------------RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLD 178 (355)
T ss_pred cCCccHHHHHHhcC------------------------CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeec
Confidence 99999999997654 4677777889999999999999999 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
.+|.+||.|||+|+..... +-+.+||+.|+|||.+....|..++|.|||||++|||+.|..||-...+
T Consensus 179 ~~G~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------- 246 (355)
T KOG0616|consen 179 QNGHIKITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------- 246 (355)
T ss_pred cCCcEEEEeccceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------
Confidence 9999999999999876543 5568999999999999999999999999999999999999999964321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCC
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELR 733 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 733 (763)
.++.++.+.... .+|.-....+.+++...++.|-.+|
T Consensus 247 ---------------~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 247 ---------------IQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---------------HHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 122222222222 2334556678888888999999888
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=343.22 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=199.5
Q ss_pred ccccccccccccceEEEEEeC-C-CcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-D-HRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~-~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
|.+.+.||+|+||.||++... + ++.||+|.+..... ....+.+|+.+++.++|||||++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 778899999999999999654 3 56788887653322 23457789999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|.+++..... ....+++.....++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 149 gg~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~ 205 (478)
T PTZ00267 149 GGDLNKQIKQRLK--------------------EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPT 205 (478)
T ss_pred CCCHHHHHHHHHh--------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCC
Confidence 9999998864310 2345788899999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 602 FCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
+.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 206 ~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------- 276 (478)
T PTZ00267 206 GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------- 276 (478)
T ss_pred CcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---------
Confidence 9999999999986543322 123345699999999999999999999999999999999999999863221
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+++...+..... ..+......+.+++..||+.||++||++.++++
T Consensus 277 --------------~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 277 --------------REIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --------------HHHHHHHHhCCCC-CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0111111111111 111234567899999999999999999999864
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=318.38 Aligned_cols=268 Identities=25% Similarity=0.381 Sum_probs=204.1
Q ss_pred HhccccccccccccceEEEEEeCC------CcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
.++.+.++||+|+||.||+|...+ ++.||+|+++..... .+.+.+|+.++..++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 456677899999999999997643 468999999754332 356889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+++||+++++|.+++.......... ...........+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~ 153 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVG--------STDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATR 153 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCcccc--------ccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence 9999999999999996432110000 00001112346889999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
||++++++.+||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..|+.....
T Consensus 154 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~- 232 (283)
T cd05091 154 NVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN- 232 (283)
T ss_pred heEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 99999999999999999986543322 11223345778999999988899999999999999999998 7778753211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
..+ .+. +.+... ...+...+..+.+++..||+.+|++||++.+|++.|+.
T Consensus 233 --------~~~-~~~---------i~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 --------QDV-IEM---------IRNRQV-----LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --------HHH-HHH---------HHcCCc-----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 000 011 111110 01123456778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=326.89 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=198.9
Q ss_pred HHhccccccccccccceEEEEEeCC--CcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTD--HRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~--~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
...+.+.+.||+|+||.||+|.... +..||+|++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3457788999999999999997643 368999998643 2234568899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 109 v~Ey~~~g~L~~~i~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~N 161 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN------------------------KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPEN 161 (340)
T ss_pred EEeCCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHH
Confidence 99999999999998542 35788899999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
||++.++++||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 162 ILl~~~~~ikL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---- 233 (340)
T PTZ00426 162 LLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---- 233 (340)
T ss_pred EEECCCCCEEEecCCCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----
Confidence 99999999999999999865432 2345789999999999998999999999999999999999999964321
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAKM 742 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~~ 742 (763)
......+ ..... . .+......+.+++.+|++.||++|+ ++.++++.
T Consensus 234 ------~~~~~~i---------~~~~~--~----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 234 ------LLIYQKI---------LEGII--Y----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------HHHHHHH---------hcCCC--C----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0011111 11110 0 1122345678999999999999995 89988764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.41 Aligned_cols=239 Identities=26% Similarity=0.365 Sum_probs=200.6
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ 517 (763)
...|..+||+|.||.|+++.+. +++.+|||++|+. .++.+..+.|..++... +||.|+.|+.+|...++++.||
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 4566789999999999999886 4689999999864 33446678888887777 5999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+.||++..+. ....++...+.-+|..|+.||+|||+++ |||||||.+|||
T Consensus 449 ey~~Ggdm~~~~-------------------------~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiL 500 (694)
T KOG0694|consen 449 EYVAGGDLMHHI-------------------------HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLL 500 (694)
T ss_pred EecCCCcEEEEE-------------------------ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheE
Confidence 999999954443 3356888888899999999999999999 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
||.+|++||+||||++.....+. .++++.||+.|||||++.+..|+.++|.|||||+||||+.|..||.+.+
T Consensus 501 LD~eGh~kiADFGlcKe~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd------- 572 (694)
T KOG0694|consen 501 LDTEGHVKIADFGLCKEGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD------- 572 (694)
T ss_pred EcccCcEEecccccccccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-------
Confidence 99999999999999986443332 5678999999999999999999999999999999999999999998654
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
.+++.|..+..+ ...|.-.+.+.+.++.+++..+|++|--+
T Consensus 573 ----------------Eee~FdsI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 573 ----------------EEEVFDSIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----------------HHHHHHHHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 233334333322 12335667888999999999999999876
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.41 Aligned_cols=268 Identities=21% Similarity=0.276 Sum_probs=195.7
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.|.+.++||+|+||.||+|... +++.||+|.++... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 4667789999999999999875 57899999987432 23456789999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++
T Consensus 86 ~~-~l~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~ 138 (288)
T cd07871 86 DS-DLKQYLDNC-----------------------GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINE 138 (288)
T ss_pred Cc-CHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECC
Confidence 75 999988542 235678899999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCC----
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS---- 675 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~---- 675 (763)
++.+||+|||+++....... ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.........
T Consensus 139 ~~~~kl~DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 217 (288)
T cd07871 139 KGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217 (288)
T ss_pred CCCEEECcCcceeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999975433221 2233467899999998865 57899999999999999999999999643211000
Q ss_pred ---CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 ---DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.......| ..............+................++.+++.+|++.||.+|||++|+++
T Consensus 218 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 218 RLLGTPTEETW--PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHhCCCChHHh--hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 00000000000000000000000000123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=316.95 Aligned_cols=254 Identities=25% Similarity=0.353 Sum_probs=196.7
Q ss_pred hccccccccccccceEEEEEeC-CCc----EEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHR----VVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~----~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
.+.+.+.||+|+||.||+|+.. +++ .+++|.+..... ...++..|+..+++++||||+++++++.. ...++|
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 4456689999999999999874 343 477777753322 23567788889999999999999998864 567889
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
+||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 87 ~e~~~~gsL~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~ni 140 (279)
T cd05111 87 TQLSPLGSLLDHVRQH-----------------------RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNI 140 (279)
T ss_pred EEeCCCCcHHHHHHhc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceE
Confidence 9999999999999642 235889999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 674 (763)
++++++.+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.||......
T Consensus 141 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-- 218 (279)
T cd05111 141 LLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-- 218 (279)
T ss_pred EEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 999999999999999986543322 22233457788999999998999999999999999999998 99888643210
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
. ..+++........ +......+.+++.+||..||++|||+.|+++.|+.+..
T Consensus 219 --------~----------~~~~~~~~~~~~~----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 219 --------E----------VPDLLEKGERLAQ----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --------H----------HHHHHHCCCcCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0 0111111000000 11234567889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=325.66 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=196.1
Q ss_pred ccccccccccccceEEEEEe----CCCcEEEEEEeeccC-----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeee
Q 046586 445 NGFSNLIGRGGFGDVYKGEL----TDHRVVAVKCLKNVT-----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~----~~~~~VAvK~l~~~~-----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 514 (763)
+.+.++||+|+||.||+++. .+++.||+|+++... ...+.+.+|+.++..+ +|+||+++++++.+.+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 55678999999999999875 357899999997431 2234578899999999 5999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+
T Consensus 82 lv~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~ 134 (332)
T cd05614 82 LILDYVSGGEMFTHLYQR------------------------DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLE 134 (332)
T ss_pred EEEeCCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHH
Confidence 999999999999998542 35788899999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
|||++.++.+||+|||+++..............||..|+|||.+.+. .++.++|||||||++|||++|+.||.......
T Consensus 135 Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 135 NILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred HeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 99999999999999999986544333333446799999999998765 58899999999999999999999996432211
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
.. ....... .. .....+......+.+++.+||+.||++|| ++.++++
T Consensus 215 -----~~-~~~~~~~-------------~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 215 -----TQ-SEVSRRI-------------LK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -----CH-HHHHHHH-------------hc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 00 0000000 00 01111223456788999999999999999 6677764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=323.77 Aligned_cols=240 Identities=26% Similarity=0.366 Sum_probs=192.7
Q ss_pred ccccccccceEEEEEeC----CCcEEEEEEeeccC-----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 449 NLIGRGGFGDVYKGELT----DHRVVAVKCLKNVT-----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
++||+|+||.||+++.. .++.||+|+++... .....+.+|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999753 57889999997431 2234577899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ..+.+..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 82 ~~~~~L~~~~~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~ 134 (323)
T cd05584 82 LSGGELFMHLERE------------------------GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLD 134 (323)
T ss_pred CCCchHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEC
Confidence 9999999998542 34677888889999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------- 205 (323)
T cd05584 135 AQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------- 205 (323)
T ss_pred CCCCEEEeeCcCCeecccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------
Confidence 999999999999875332221 22345689999999999988999999999999999999999999964321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
.. . ...+.... ..++......+.+++.+||+.||++|| ++.++++
T Consensus 206 -~~-~---------~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 206 -KK-T---------IDKILKGK------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -HH-H---------HHHHHcCC------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 00 0 11111111 111233456788999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=310.76 Aligned_cols=246 Identities=28% Similarity=0.431 Sum_probs=195.2
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
++||+|+||.||+|... +++.+|+|..+.... ....+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 678899998864322 345689999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeE
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 605 (763)
.+++... ...+++.+++.++.|++.||+|||+.+ |+|+||||+||+++.++.+|
T Consensus 81 ~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~k 134 (252)
T cd05084 81 LTFLRTE-----------------------GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLK 134 (252)
T ss_pred HHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEE
Confidence 9998532 235789999999999999999999988 99999999999999999999
Q ss_pred EcccCcccccCCCCcccc-cccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhHH
Q 046586 606 ISDFGLAKLRKKEDMVSM-SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPKW 683 (763)
Q Consensus 606 I~DFGla~~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 683 (763)
|+|||+++.......... .....+..|+|||.+.++.++.++||||||+++|||++ |..|+..... ..
T Consensus 135 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----------~~ 204 (252)
T cd05084 135 ISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----------QQ 204 (252)
T ss_pred ECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----------HH
Confidence 999999975432211111 11123456999999998899999999999999999998 8888753211 00
Q ss_pred HHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
... .+..... ...+...+..+.+++.+|++.+|++|||+.+|.++|+
T Consensus 205 ~~~----------~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 205 TRE----------AIEQGVR----LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHH----------HHHcCCC----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 001 1111111 1112334567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=330.63 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=198.6
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
...+.+.++||+|+||.||+++.. +++.+|+|+++.. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 456777899999999999999875 5789999999742 12334577899999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++|+|.+++.. ..++...+..++.|++.||+|||+.+ |+||||||+||
T Consensus 122 ~Ey~~gg~L~~~l~~-------------------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NI 173 (370)
T cd05596 122 MEYMPGGDLVNLMSN-------------------------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNM 173 (370)
T ss_pred EcCCCCCcHHHHHHh-------------------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence 999999999998843 23667778889999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC----CCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD----QITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|++.++.+||+|||+++..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.....
T Consensus 174 Ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~- 252 (370)
T cd05596 174 LLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL- 252 (370)
T ss_pred EEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-
Confidence 999999999999999986544333233446799999999988643 488999999999999999999999964321
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPEL--RPSMGKVAKM 742 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVv~~ 742 (763)
.. . ...+++.......+. ....+..+.+++..|++.+|.+ ||++.|+++.
T Consensus 253 --------~~-~---------~~~i~~~~~~~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 253 --------VG-T---------YSKIMDHKNSLTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred --------HH-H---------HHHHHcCCCcCCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 0 111111100000110 0134567889999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.49 Aligned_cols=245 Identities=28% Similarity=0.409 Sum_probs=202.6
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeec--cCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKN--VTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
+.-.+.||+|.||.||+|... .++.||+|++.- .....++..+|+.++..++++||.+++|.+..+..+.++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 333478999999999999765 578999999973 34456788999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|++.+.|.... .+......-|..++..|+.|||.++ .+|||||+.|||+..+
T Consensus 95 gGsv~~lL~~~~------------------------~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~ 147 (467)
T KOG0201|consen 95 GGSVLDLLKSGN------------------------ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSES 147 (467)
T ss_pred CcchhhhhccCC------------------------CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEecc
Confidence 999999995432 3355555668899999999999998 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
|.+|++|||.+-......... .+++||+-|||||++....|+.|+||||||++.+||.+|.+|+....+.
T Consensus 148 g~vkl~DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------- 217 (467)
T KOG0201|consen 148 GDVKLADFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------- 217 (467)
T ss_pred CcEEEEecceeeeeechhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------
Confidence 999999999997665544433 6789999999999999999999999999999999999999998644321
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
+..-++.+ ..++.+.......+.+++..||++||+.||+++++++
T Consensus 218 -----------rvlflIpk----~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 218 -----------RVLFLIPK----SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred -----------eEEEeccC----CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 11112222 2222222455677999999999999999999999984
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=318.11 Aligned_cols=276 Identities=27% Similarity=0.408 Sum_probs=204.8
Q ss_pred ccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
+.+.+.||+|+||.||+|... ....+++|.++.... ...++.+|+.+++.++||||+++++.+...+..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 345679999999999999753 235789998875433 235688999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
+||+++++|.+++.............................+++.+++.++.|++.||+|||+.+ |+||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheE
Confidence 999999999999875432111000000000000001112346899999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 674 (763)
++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--- 235 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--- 235 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---
Confidence 9999999999999999865333221 1222345678999999988899999999999999999998 9888853211
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
..... .+...... ..+.....++.+++.+|++.+|++||++.|+++.|+++.
T Consensus 236 -------~~~~~----------~~~~~~~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 236 -------ERLFN----------LLKTGYRM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -------HHHHH----------HHhCCCCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11111 11111111 111334567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=333.69 Aligned_cols=284 Identities=24% Similarity=0.368 Sum_probs=209.1
Q ss_pred HHHHHHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcCC-CCccccEEEEEe
Q 046586 438 AELRAATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMH-HLNLVRLWGFCA 508 (763)
Q Consensus 438 ~el~~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~-H~niv~l~g~~~ 508 (763)
.++....+.+.++||+|+||.||+|+.. .++.||+|+++.... ..+.+.+|++++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4455556667889999999999999864 245799999975422 2346889999999997 999999999999
Q ss_pred eCCeeeEEEecCCCCCHhHHhhhcCCCCCCC-----hhh---------------------------hhccc---------
Q 046586 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSS-----PAR---------------------------EMEMS--------- 547 (763)
Q Consensus 509 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~-----~~~---------------------------~~~~~--------- 547 (763)
+.+..++||||+++|+|.+++...+...... ... .+.+.
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999997643210000 000 00000
Q ss_pred ---------------------------------CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 548 ---------------------------------GVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 548 ---------------------------------~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
...........+++...+.++.|++.||+|||+.+ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 00000012346889999999999999999999987 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999999999999999986432221 12223356788999999998899999999999999999998 8888753211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.+........+ . ....+......+.+++..||+.+|++||++++|++.|+.++
T Consensus 348 --------~~~~~~~~~~~----------~----~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 --------NEQFYNAIKRG----------Y----RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --------hHHHHHHHHcC----------C----CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 00000111111 1 11111234568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=311.25 Aligned_cols=251 Identities=26% Similarity=0.478 Sum_probs=202.5
Q ss_pred hccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
.+.+.+.||+|+||.||++...+++.+|+|.++.......+|.+|++++++++|||++++++++......++||||++++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 45677899999999999998877788999998866556678999999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|.+++... ...+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.
T Consensus 85 ~L~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~ 138 (256)
T cd05112 85 CLSDYLRAQ-----------------------RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQV 138 (256)
T ss_pred cHHHHHHhC-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCe
Confidence 999998542 235788999999999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhH
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 682 (763)
+||+|||+++..............++.+|+|||.+.++.++.++||||||+++|||++ |+.||...... .
T Consensus 139 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---------~ 209 (256)
T cd05112 139 VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---------E 209 (256)
T ss_pred EEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---------H
Confidence 9999999997554332222222335678999999998899999999999999999998 89998632210 0
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
......++ ... ..+......+.+++.+||+.+|++||++.+|+++|.
T Consensus 210 -~~~~~~~~----------~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 210 -VVETINAG----------FRL----YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -HHHHHhCC----------CCC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 00111100 000 001123467999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=317.94 Aligned_cols=273 Identities=26% Similarity=0.395 Sum_probs=207.8
Q ss_pred HHHHhccccccccccccceEEEEEeCC------CcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEeeC
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCAEK 510 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 510 (763)
+....+.+.+.||+|+||.||++...+ ...+|+|.++.... ...++.+|++++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344556778899999999999997642 36799999875322 235688999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
+..++||||+++|+|.+++............. ........+++..++.++.|++.||+|||+.+ |+|||
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~d 157 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPD--------DPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRD 157 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccc--------cccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 99999999999999999997543111111000 01113457899999999999999999999988 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCccc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEI 668 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~ 668 (763)
|||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+..
T Consensus 158 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 158 LAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred cceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 9999999999999999999999865443221 1222345678999999998999999999999999999998 8888753
Q ss_pred ccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 669 QGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
... .. ..... ..... ...+......+.+++.+|++.||++|||+.||++.|+.++
T Consensus 238 ~~~---------~~-~~~~~----------~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 238 IPV---------EE-LFKLL----------KEGYR----MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCH---------HH-HHHHH----------HcCCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 211 00 00111 11000 1111344567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=312.73 Aligned_cols=258 Identities=21% Similarity=0.372 Sum_probs=204.4
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.+.+.++||+|+||.||+|+.. +++.||||.++... .....+.+|+++++.++||||+++++++.+.+..++|+|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 4567789999999999999865 67899999886422 223458899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++..... ....++..+...++.|++.||+|||+.+ ++|+||||+||++
T Consensus 83 ~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~ 139 (267)
T cd08228 83 LADAGDLSQMIKYFKK--------------------QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFI 139 (267)
T ss_pred ecCCCcHHHHHHHhhh--------------------ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEE
Confidence 9999999998854320 2345788899999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....
T Consensus 140 ~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------- 211 (267)
T cd08228 140 TATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------- 211 (267)
T ss_pred cCCCCEEECccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-------
Confidence 9999999999999986543221 12234678899999999888899999999999999999999999853211
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
....+. ..+. ...............+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 212 ~~~~~~-----------~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 212 NLFSLC-----------QKIE---QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred cHHHHH-----------HHHh---cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 000100 0000 01111111234557799999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.23 Aligned_cols=256 Identities=23% Similarity=0.396 Sum_probs=215.1
Q ss_pred ccccHHHHHHHhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCc----hhhhHHHHHHHhcCCCCccccEEEEE
Q 046586 433 KRFTHAELRAATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGG----DAEFWAEVTIIARMHHLNLVRLWGFC 507 (763)
Q Consensus 433 ~~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~----~~~f~~E~~~l~~l~H~niv~l~g~~ 507 (763)
.+-++..-.+.+|.|.+.||+|.||.|-++.. ..|+.||||.+++.... ....++|+++|..|+||||+.++.+|
T Consensus 43 krhhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 43 KRHHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred cccCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 33444444567888999999999999999965 67899999999754332 23478999999999999999999999
Q ss_pred eeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 046586 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVL 587 (763)
Q Consensus 508 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~iv 587 (763)
+..+.+.|||||..+|.|.+|+... ..|+..+..++..||..|+.|+|.+. ++
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer------------------------~~LsErEaRhfFRQIvSAVhYCHknr---Vv 175 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISER------------------------GSLSEREARHFFRQIVSAVHYCHKNR---VV 175 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHh------------------------ccccHHHHHHHHHHHHHHHHHHhhcc---ce
Confidence 9999999999999999999999654 46889999999999999999999988 99
Q ss_pred ecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCC-CccceeehhHHHHHHHhCCCCc
Q 046586 588 HCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 588 HrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwS~Gvll~elltG~~p~ 666 (763)
|||||.+|||+|+|+++||+||||+.++.... -.++++|++.|.+||.+.+.+|. +.+|-||+||+||-|+.|..||
T Consensus 176 HRDLKLENILLD~N~NiKIADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF 253 (668)
T KOG0611|consen 176 HRDLKLENILLDQNNNIKIADFGLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF 253 (668)
T ss_pred ecccchhheeecCCCCeeeeccchhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc
Confidence 99999999999999999999999998765443 35678999999999999998876 6899999999999999999999
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
++.+ ...++.+...+.+.+ ++.+....-++.|||-.+|++|.|+.+|....
T Consensus 254 DG~D-----------------------hk~lvrQIs~GaYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 254 DGRD-----------------------HKRLVRQISRGAYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred CCch-----------------------HHHHHHHhhcccccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 8543 223333333444443 34556778899999999999999999998653
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=329.99 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=200.1
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.++||+|+||.||+++.. +++.||+|+++... .....+.+|++++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 3567789999999999999876 68899999997432 334568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++... ..++...+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 82 ~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll 134 (350)
T cd05573 82 YMPGGDLMNLLIRK------------------------DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILI 134 (350)
T ss_pred CCCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEE
Confidence 99999999999542 35788899999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCC----------------------------cccccccccCCCcccccccccCCCCCcccee
Q 046586 599 GDDFCPKISDFGLAKLRKKED----------------------------MVSMSRIRGTRGYMAPEWLRSDQITPKADVY 650 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~----------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVw 650 (763)
+.++.+||+|||+++...... ........||+.|+|||.+.+..++.++|||
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 214 (350)
T cd05573 135 DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWW 214 (350)
T ss_pred CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeE
Confidence 999999999999998654432 1122335689999999999999999999999
Q ss_pred ehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCC
Q 046586 651 SFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRP 730 (763)
Q Consensus 651 S~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP 730 (763)
||||++|||++|+.||...... .....+... ...+. .+ .....+..+.+++..|++ ||
T Consensus 215 SlG~il~ell~g~~Pf~~~~~~----------~~~~~i~~~-------~~~~~--~p--~~~~~~~~~~~li~~ll~-dp 272 (350)
T cd05573 215 SLGVILYEMLYGFPPFYSDTLQ----------ETYNKIINW-------KESLR--FP--PDPPVSPEAIDLICRLLC-DP 272 (350)
T ss_pred ecchhhhhhccCCCCCCCCCHH----------HHHHHHhcc-------CCccc--CC--CCCCCCHHHHHHHHHHcc-Ch
Confidence 9999999999999999643210 000111100 00010 00 001135678889999998 99
Q ss_pred CCCCC-HHHHHHH
Q 046586 731 ELRPS-MGKVAKM 742 (763)
Q Consensus 731 ~~RPs-~~eVv~~ 742 (763)
.+||+ +.++++.
T Consensus 273 ~~R~~s~~~ll~h 285 (350)
T cd05573 273 EDRLGSFEEIKSH 285 (350)
T ss_pred hhcCCCHHHHhcC
Confidence 99999 9999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=327.88 Aligned_cols=244 Identities=26% Similarity=0.356 Sum_probs=190.1
Q ss_pred cccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 446 GFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
.+.++||+|+||.||+++.. +++.||||++..... ...++.+|+++++.++|+||+++++++.+.+..++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 34678999999999999875 578999999965432 235688999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+.. ......+..++.||+.||+|||+.+ |+||||||+|||+++++
T Consensus 157 ~~L~~~~----------------------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 205 (353)
T PLN00034 157 GSLEGTH----------------------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAK 205 (353)
T ss_pred Ccccccc----------------------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCC
Confidence 9886432 2345677889999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCccccccccc-----CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-----DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
.+||+|||+++...... .......||..|+|||.+.. ...+.++|||||||++|||++|+.||......
T Consensus 206 ~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~----- 279 (353)
T PLN00034 206 NVKIADFGVSRILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG----- 279 (353)
T ss_pred CEEEcccccceeccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----
Confidence 99999999998654322 12234578999999998743 23456899999999999999999999622110
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.|... ... +.. ......+.....++.+++.+||+.||++||++.||++.
T Consensus 280 ----~~~~~--~~~-----~~~-----~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 280 ----DWASL--MCA-----ICM-----SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----cHHHH--HHH-----Hhc-----cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11000 000 000 00111113445678999999999999999999999965
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=318.48 Aligned_cols=271 Identities=24% Similarity=0.408 Sum_probs=207.4
Q ss_pred HHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
...+.+.+.||+|+||.||++... ++..+|+|.++.... ....+.+|++++++++||||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 345667789999999999999752 345689998875433 3457899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++++|.+++.......... ........+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~-----------~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~ 149 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLM-----------AEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR 149 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccc-----------cccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcc
Confidence 9999999999999996542110000 00112345899999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
||++++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 150 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~- 228 (288)
T cd05093 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN- 228 (288)
T ss_pred eEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999986543322 11223345778999999998999999999999999999998 8888853221
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEIT 750 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~ 750 (763)
.. .......+. .. ..+...+..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 229 --------~~-~~~~i~~~~---------~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 229 --------NE-VIECITQGR---------VL-----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred --------HH-HHHHHHcCC---------cC-----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 00 001111110 00 011223457899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=310.87 Aligned_cols=244 Identities=25% Similarity=0.382 Sum_probs=194.3
Q ss_pred cccccccceEEEEEeC---CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 450 LIGRGGFGDVYKGELT---DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~---~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
+||+|+||.||+|.+. +++.+|+|+++.... ..+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999653 567899999874432 2357889999999999999999999885 45678999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 81 ~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~ 133 (257)
T cd05116 81 PLNKFLQKN------------------------KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHY 133 (257)
T ss_pred cHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCe
Confidence 999998532 35788999999999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCccc--ccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCch
Q 046586 604 PKISDFGLAKLRKKEDMVS--MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~ 680 (763)
+||+|||+++......... .....++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 134 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------- 205 (257)
T cd05116 134 AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------- 205 (257)
T ss_pred EEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 9999999998654433211 122234578999999988889999999999999999998 99998633210
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
. ..+.+..... .+.+...+.++.+++.+||+.||++||++.+|++.|++
T Consensus 206 -~-----------~~~~i~~~~~----~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 206 -E-----------VTQMIESGER----MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -H-----------HHHHHHCCCC----CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 0 1111111111 11223455678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=311.16 Aligned_cols=250 Identities=32% Similarity=0.494 Sum_probs=204.0
Q ss_pred HHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
...+.+.+.||+|+||.||++... ++.||+|.++......+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 345677889999999999999875 6789999998665556789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++++
T Consensus 84 ~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~ 138 (256)
T cd05039 84 KGSLVDYLRSR----------------------GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSED 138 (256)
T ss_pred CCcHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCC
Confidence 99999998643 2236899999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCch
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~ 680 (763)
+.+||+|||+++...... .....+..|+|||.+..+.++.++||||||+++||+++ |+.||.....
T Consensus 139 ~~~~l~d~g~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------- 205 (256)
T cd05039 139 LVAKVSDFGLAKEASQGQ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------- 205 (256)
T ss_pred CCEEEccccccccccccc----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---------
Confidence 999999999998653221 12334667999999998899999999999999999997 9888853210
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
.........+ .....+...+..+.+++.+|++.+|++||+++|++++|+.
T Consensus 206 -~~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 206 -KDVVPHVEKG--------------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -HHHHHHHhcC--------------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0001111100 0111123345788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=318.24 Aligned_cols=271 Identities=25% Similarity=0.396 Sum_probs=207.2
Q ss_pred HhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
..+.+.+.||+|+||.||+++.. ++..+++|.++.... ..+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 44667789999999999999753 345688998875443 23568899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++++|.+++........... ..........+++.+++.++.|++.||+|||+.+ |+||||||+|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 153 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILV--------DGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRN 153 (291)
T ss_pred EEecCCCCcHHHHHHhcCccccccc--------ccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcce
Confidence 9999999999999975431100000 0001112345899999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
|+++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 154 il~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-- 231 (291)
T cd05094 154 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-- 231 (291)
T ss_pred EEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999975543322 11223456788999999999999999999999999999999 9999853221
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.. ..+...++ .. ...+...+..+.+++.+||+.+|++||++.+|+++|+.+..
T Consensus 232 -------~~-~~~~~~~~---------~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 232 -------TE-VIECITQG---------RV-----LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -------HH-HHHHHhCC---------CC-----CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 00 00111111 00 01112345678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=317.01 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=192.9
Q ss_pred hccccccccccccceEEEEEeC--CCcEEEEEEeeccCC---chhhhHHHHHHHhcC---CCCccccEEEEEee-----C
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT--DHRVVAVKCLKNVTG---GDAEFWAEVTIIARM---HHLNLVRLWGFCAE-----K 510 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~--~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l---~H~niv~l~g~~~~-----~ 510 (763)
.|.+.+.||+|+||.||+++.. +++.||+|+++.... ....+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 3567789999999999999863 467899999874322 234566788777766 69999999999863 3
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
...++||||++ ++|.+++... ....+++..+..++.|++.||+|||+.+ |+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~----------------------~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~d 135 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV----------------------PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRD 135 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCC
Confidence 56899999996 5999998543 2235788999999999999999999988 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
|||+|||++.++.+||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 136 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 136 LKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred CCHHHEEEcCCCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 9999999999999999999999765433 22334568999999999998899999999999999999999999997543
Q ss_pred CCCCCCCCchhHHHHHHHH----hccC-hhhhhcccccccCCC---cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVY----EEMK-VEDILDRHIKNSYDS---RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~l~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
... .......... +... ............... .........+.+++.+|++.||++|||+.|+++
T Consensus 214 ~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 214 DVD------QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHH------HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 211 0000000000 0000 000000000000000 011223466789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=323.27 Aligned_cols=200 Identities=24% Similarity=0.370 Sum_probs=172.0
Q ss_pred HHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
+....|.+.++||+|+||.||++... ++..+|+|+++.... ...++.+|+++++.++|+||+++++++.+.+..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34566778899999999999999876 578899998875322 235688999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++... ..+++.....++.|++.||+|||+... |+|+||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Ni 135 (333)
T cd06650 82 MEHMDGGSLDQVLKKA------------------------GRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNI 135 (333)
T ss_pred EecCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhE
Confidence 9999999999998542 246788889999999999999998522 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
|++.++.+||+|||++...... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 136 li~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 136 LVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred EEcCCCCEEEeeCCcchhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999754322 12234688999999999988999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=328.32 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=197.2
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
...+.+.++||+|+||.||+++.. +++.+|+|+++.. ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 356777889999999999999876 4788999999642 12334578899999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+||
T Consensus 122 ~Ey~~gg~L~~~l~~-------------------------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NI 173 (370)
T cd05621 122 MEYMPGGDLVNLMSN-------------------------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNM 173 (370)
T ss_pred EcCCCCCcHHHHHHh-------------------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHE
Confidence 999999999999843 23677888999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC----CCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD----QITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+++++.+||+|||+++..............||+.|+|||.+... .++.++||||+||++|||++|+.||......
T Consensus 174 Ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~ 253 (370)
T cd05621 174 LLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253 (370)
T ss_pred EECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999986644333333456799999999998653 3789999999999999999999999643210
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPEL--RPSMGKVAKM 742 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVv~~ 742 (763)
. . ...+++.......+. .......+.+++..|++.++.+ ||++.|+++.
T Consensus 254 ---------~-~---------~~~i~~~~~~~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 254 ---------G-T---------YSKIMDHKNSLNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---------H-H---------HHHHHhCCcccCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 0 111111111111111 1233566778888899866544 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.03 Aligned_cols=246 Identities=26% Similarity=0.367 Sum_probs=194.3
Q ss_pred cccccccceEEEEEeC---CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCC
Q 046586 450 LIGRGGFGDVYKGELT---DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~---~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gs 524 (763)
.||+|+||.||+|.+. ++..||+|+++.... ..++|.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 345799999875432 2356889999999999999999999885 457899999999999
Q ss_pred HhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCe
Q 046586 525 LADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP 604 (763)
Q Consensus 525 L~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 604 (763)
|.+++... ...+++..+++++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 81 L~~~l~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~ 134 (257)
T cd05115 81 LNKFLSGK-----------------------KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYA 134 (257)
T ss_pred HHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcE
Confidence 99998532 236889999999999999999999988 9999999999999999999
Q ss_pred EEcccCcccccCCCCccc--ccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchh
Q 046586 605 KISDFGLAKLRKKEDMVS--MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 605 kI~DFGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~ 681 (763)
||+|||+++......... .....++..|+|||.+....++.++||||||+++||+++ |..||......
T Consensus 135 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------- 205 (257)
T cd05115 135 KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------- 205 (257)
T ss_pred EeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---------
Confidence 999999998554332211 111233578999999988889999999999999999996 99998643210
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
. ... .+.... ....+....+.+.+++..||+.+|++||++.+|.+.|+..
T Consensus 206 ~-~~~----------~~~~~~----~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 206 E-VMS----------FIEQGK----RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred H-HHH----------HHHCCC----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0 001 111111 1112234567888999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=313.22 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=196.8
Q ss_pred ccccccccccceEEEEEeCCCc---EEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeC------Ceee
Q 046586 447 FSNLIGRGGFGDVYKGELTDHR---VVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK------GERT 514 (763)
Q Consensus 447 ~~~~LG~G~fG~Vy~g~~~~~~---~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~ 514 (763)
+.++||+|+||.||+|+..+.. .+|+|.++... ...+++.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 5678999999999999876532 58999887432 2345688999999999999999999988542 2568
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++...+. ......+++.....++.|++.||+|||+.+ |+||||||+
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~ 141 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRL------------------GDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAAR 141 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcc------------------cCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchh
Confidence 99999999999999854321 012345889999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCccc-ccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVS-MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
|||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 142 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 220 (272)
T cd05075 142 NCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN- 220 (272)
T ss_pred heEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 9999999999999999998654332211 122345678999999999999999999999999999999 7888853211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.........+.. ...+...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 221 ---------~~~~~~~~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 221 ---------SEIYDYLRQGNR--------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------HHHHHHHHcCCC--------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001111111110 011123456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.99 Aligned_cols=256 Identities=24% Similarity=0.402 Sum_probs=199.4
Q ss_pred cccccccccccceEEEEEeCC----CcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCe------
Q 046586 446 GFSNLIGRGGFGDVYKGELTD----HRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE------ 512 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------ 512 (763)
.+.+.||+|+||.||+|.... +..||+|+++.... ...++.+|++.++.++|+||+++++++.+...
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 456889999999999998742 36799999875322 23568899999999999999999999876554
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++|+||+++|+|..++...+. ......+++.....++.|++.||+|||+.+ |+|||||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~------------------~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlk 140 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRL------------------GGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLA 140 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhc------------------cCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccc
Confidence 7899999999999999865421 012346889999999999999999999988 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCccc-ccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCccccc
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVS-MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQG 670 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~ 670 (763)
|+||++++++.+||+|||+++......... ......+..|+|||.+....++.++||||||+++|||++ |..||....
T Consensus 141 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~ 220 (273)
T cd05035 141 ARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220 (273)
T ss_pred hheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998654333221 112234678999999988899999999999999999999 888885322
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.. +. .... .+. .....+......+.+++.+||+.||++||++.||++.|+.+
T Consensus 221 ~~---------~~-~~~~---------~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 221 NH---------EI-YDYL---------RHG-----NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HH---------HH-HHHH---------HcC-----CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 00 0111 110 01111234566889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.71 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=202.5
Q ss_pred hccccccccccccceEEEEEeC--CCc--EEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT--DHR--VVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~--~~~--~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
...+.++||+|.||.|++|.+. .|+ .||||.++.... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3445689999999999999775 343 689999985433 56789999999999999999999999988 7888999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
|.++.|||.+.|.+. .+..|-......++.|||.||.||.++. .|||||..+|+|
T Consensus 190 ELaplGSLldrLrka----------------------~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNll 244 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKA----------------------KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLL 244 (1039)
T ss_pred hhcccchHHHHHhhc----------------------cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhhe
Confidence 999999999999762 3456777888899999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCC-CCcccccc-cccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKK-EDMVSMSR-IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~-~~~~~~~~-~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 674 (763)
|...-.+||+||||.+-+.. ++...+.. ..-...|.|||.++..+++.++|||+|||++|||+| |..|+-+....
T Consensus 245 lasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-- 322 (1039)
T KOG0199|consen 245 LASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-- 322 (1039)
T ss_pred ecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--
Confidence 99999999999999997654 33344433 234668999999999999999999999999999999 65665432210
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. +.+.+| .......+..++++++++++.||..+|++|||+..|.+
T Consensus 323 ------------q------IL~~iD----~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 323 ------------Q------ILKNID----AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ------------H------HHHhcc----ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 0 112222 12223344688999999999999999999999999973
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=319.61 Aligned_cols=278 Identities=24% Similarity=0.365 Sum_probs=210.8
Q ss_pred HHHHHhccccccccccccceEEEEEeC--------CCcEEEEEEeeccC--CchhhhHHHHHHHhcC-CCCccccEEEEE
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELT--------DHRVVAVKCLKNVT--GGDAEFWAEVTIIARM-HHLNLVRLWGFC 507 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~--------~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~g~~ 507 (763)
++....+.+.+.||+|+||.||+++.. ++..||+|.++... ....++.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345566778899999999999999742 23579999987432 2345688999999999 899999999999
Q ss_pred eeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 046586 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVL 587 (763)
Q Consensus 508 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~iv 587 (763)
......++||||+++|+|.+++...+.......... .......+++.+++.++.||+.||+|||+.+ |+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---iv 159 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI--------ARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CI 159 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCccccccccc--------ccCCcccccHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 999999999999999999999976432111100000 0012346899999999999999999999988 99
Q ss_pred ecCCCCCceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCC
Q 046586 588 HCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRN 665 (763)
Q Consensus 588 HrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p 665 (763)
||||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 160 H~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 239 (304)
T cd05101 160 HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239 (304)
T ss_pred ecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999865433221 1222345678999999998899999999999999999998 7777
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
+.... ..+ ....+.++. ....+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 240 ~~~~~---------~~~-~~~~~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 240 YPGIP---------VEE-LFKLLKEGH--------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred cccCC---------HHH-HHHHHHcCC--------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 74321 000 111111110 011113445678899999999999999999999999998
Q ss_pred CCCCCC
Q 046586 746 TVEITE 751 (763)
Q Consensus 746 ~~~~~~ 751 (763)
+..+..
T Consensus 296 ~~~~~~ 301 (304)
T cd05101 296 ILTLTT 301 (304)
T ss_pred HHHhhh
Confidence 776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.46 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=199.3
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
+|+..++||+|+||.||++... +++.||+|.++... .....+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3556789999999999999875 67899999987432 223457789999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 81 ~~~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~ 135 (285)
T cd05605 81 LMNGGDLKFHIYNM----------------------GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILL 135 (285)
T ss_pred ccCCCcHHHHHHhc----------------------CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEE
Confidence 99999999888542 2245889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
++++.++|+|||+++...... ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||.......
T Consensus 136 ~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----- 208 (285)
T cd05605 136 DDYGHIRISDLGLAVEIPEGE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----- 208 (285)
T ss_pred CCCCCEEEeeCCCceecCCCC--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-----
Confidence 999999999999997653222 1223468999999999998999999999999999999999999997432110
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAKM 742 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~~ 742 (763)
..+.+ ...+... ....+...+..+.+++..||+.||++|| ++.++++.
T Consensus 209 -----~~~~~------~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 209 -----KREEV------ERRVKED-----QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -----HHHHH------HHHhhhc-----ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00000 0001100 0111234566788999999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=313.10 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=201.3
Q ss_pred HhccccccccccccceEEEEEeCC-C---cEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD-H---RVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~-~---~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
..+...+.||+|+||.||+|+... + ..+++|.++... ...+++.+|++++++++|+||+++.+++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 455667899999999999998752 3 379999987542 2345688999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~e~~~~~~L~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Ni 138 (268)
T cd05063 85 TEYMENGALDKYLRDH-----------------------DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNI 138 (268)
T ss_pred EEcCCCCCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhE
Confidence 9999999999998542 235789999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccc--cccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSM--SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
++++++.+||+|||++........... .....+..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 139 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-- 216 (268)
T cd05063 139 LVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-- 216 (268)
T ss_pred EEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--
Confidence 999999999999999976543222111 11223457999999998899999999999999999997 9999853211
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.+ ....+.+. ... +.+...+..+.+++.+|++.+|++||++.+|++.|++++
T Consensus 217 -------~~-~~~~i~~~----------~~~----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 217 -------HE-VMKAINDG----------FRL----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -------HH-HHHHHhcC----------CCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 00 01111110 000 111234567899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.15 Aligned_cols=265 Identities=25% Similarity=0.379 Sum_probs=199.7
Q ss_pred cccccccccccceEEEEEe-----CCCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeEE
Q 046586 446 GFSNLIGRGGFGDVYKGEL-----TDHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTLV 516 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~-----~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV 516 (763)
.+.+.||+|+||.||++.. .+++.||+|.++.... ....|.+|++++++++||||+++++++.+. ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6678999999999988653 3567899999975432 346788999999999999999999998764 357899
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+|+||||+||
T Consensus 87 ~e~~~~~~l~~~~~~-------------------------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Ni 138 (283)
T cd05080 87 MEYVPLGSLRDYLPK-------------------------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNV 138 (283)
T ss_pred ecCCCCCCHHHHHHH-------------------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheE
Confidence 999999999999843 24889999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+........
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 218 (283)
T cd05080 139 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE 218 (283)
T ss_pred EEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh
Confidence 9999999999999999865432211 11122356679999999988999999999999999999999999754321100
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. ......... ......+.++.... ...+...+..+.+++..||+.+|++|||+++|+++|+.+.
T Consensus 219 ~----~~~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 219 E----MIGPKQGQM-TVVRLIELLERGMR----LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred h----hhccccccc-chhhhhhhhhcCCC----CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0 000000000 00001111111111 1112344578999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=324.13 Aligned_cols=241 Identities=27% Similarity=0.329 Sum_probs=193.4
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
+.||+|+||.||++... +++.||+|+++... ....++..|++++..++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999764 67899999997432 23356778999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCceEEcCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE-ECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDlk~~NILl~~~~ 602 (763)
+|..++... ..+++.++..++.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 81 ~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~ 133 (325)
T cd05594 81 ELFFHLSRE------------------------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDG 133 (325)
T ss_pred cHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCC
Confidence 999888532 357899999999999999999997 56 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 134 ~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---------- 202 (325)
T cd05594 134 HIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------- 202 (325)
T ss_pred CEEEecCCCCeecCCCC-cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----------
Confidence 99999999987533221 1223456899999999999999999999999999999999999999633210
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAKM 742 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~~ 742 (763)
...+ .+.... ..++.....++.+++.+||+.||++|+ ++.++++.
T Consensus 203 ----~~~~-----~i~~~~------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 203 ----KLFE-----LILMEE------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ----HHHH-----HHhcCC------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0000 000000 011123456788999999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.30 Aligned_cols=267 Identities=22% Similarity=0.247 Sum_probs=199.2
Q ss_pred cccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeEEEecCC
Q 046586 448 SNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTLVYEYVP 521 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~Ey~~ 521 (763)
.++|++|.||.||+|+.. +++.||+|+++-... -.-..++|+.+|.+++|||||.+-.+.... +..|||||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 468999999999999875 578999999984332 123467999999999999999999888754 57999999998
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
. +|.+.+... ...+...+..-+..|+++|++|||... |+|||||++|+|++..
T Consensus 161 h-DLksl~d~m-----------------------~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~ 213 (419)
T KOG0663|consen 161 H-DLKSLMETM-----------------------KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHK 213 (419)
T ss_pred h-hHHHHHHhc-----------------------cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccC
Confidence 7 999999654 246788888999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC-c
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW-Y 679 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~-~ 679 (763)
|.+||+|||+|+..+.. ...++..+.|.+|+|||.+.+ ..|+.+.|+||+||++.||+++++.|.+..+..+.+.. .
T Consensus 214 G~lKiaDFGLAR~ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 214 GILKIADFGLAREYGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK 292 (419)
T ss_pred CcEEecccchhhhhcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence 99999999999977654 345677888999999998876 58999999999999999999999988765543221000 0
Q ss_pred hhHHHHHHHHhccChhhhhcc-----cccccCCCcchHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDR-----HIKNSYDSRVHFD-MVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~-----~l~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
......+..+.+......+.. .-....+..++.. ..+.-.+++...+..||.+|.|++|-++.
T Consensus 293 llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 293 LLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred HhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 000000111111111111100 0000111111111 34677889999999999999999998753
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.85 Aligned_cols=243 Identities=26% Similarity=0.341 Sum_probs=191.4
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHH---hcCCCCccccEEEEEeeCCeeeEE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTII---ARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
+.+.+.||+|+||.||++... +++.||||+++... ...+.+..|+.++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 346789999999999999875 57899999997432 2234566666554 567899999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|..++. ...+++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 81 ~E~~~~~~L~~~~~-------------------------~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Ni 132 (324)
T cd05589 81 MEYAAGGDLMMHIH-------------------------TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNL 132 (324)
T ss_pred EcCCCCCcHHHHhh-------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHe
Confidence 99999999998873 235889999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
+++.++.+||+|||+++...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---- 207 (324)
T cd05589 133 LLDTEGFVKIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---- 207 (324)
T ss_pred EECCCCcEEeCcccCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----
Confidence 99999999999999987432221 1233467899999999999999999999999999999999999999643210
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
. ... .+... . ...+......+.+++.+||+.||.+|| ++.++++
T Consensus 208 -----~-~~~---------~i~~~----~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 208 -----E-VFD---------SIVND----E--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----H-HHH---------HHHhC----C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 000 01110 0 011123456788999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.71 Aligned_cols=265 Identities=23% Similarity=0.367 Sum_probs=206.3
Q ss_pred HHHHhccccccccccccceEEEEEeCC------CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCC
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG 511 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 511 (763)
+....+.+.+.||+|+||.||+|...+ +..||+|.+..... ...++.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 344567778899999999999997643 36899999874432 2356889999999999999999999999999
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
..++||||+++++|.+++......... ......+++..++.++.|++.||+|||+.+ |+||||
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di 145 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAEN--------------NPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDL 145 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhh--------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccc
Confidence 999999999999999999654210000 012345789999999999999999999988 999999
Q ss_pred CCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccc
Q 046586 592 KPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQ 669 (763)
Q Consensus 592 k~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~ 669 (763)
||+||+++.++.+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |..||...
T Consensus 146 ~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 225 (277)
T cd05032 146 AARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL 225 (277)
T ss_pred ChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence 99999999999999999999976543322 12233456788999999988899999999999999999998 88888532
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
... -.......+ .....+...+..+.+++..||+.+|++|||+.++++.|+.
T Consensus 226 ~~~----------~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 226 SNE----------EVLKFVIDG--------------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CHH----------HHHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 210 000111000 0111122346788999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=308.22 Aligned_cols=258 Identities=22% Similarity=0.355 Sum_probs=206.2
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.+.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|++++++++|+|++++++++.+.+..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 4667889999999999999887 78899999886321 224568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++..... ....+++.+++.++.|++.||+|||+.+ |+|+||+|+||++
T Consensus 83 ~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~ 139 (267)
T cd08224 83 LADAGDLSRMIKHFKK--------------------QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFI 139 (267)
T ss_pred cCCCCCHHHHHHHhcc--------------------cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEE
Confidence 9999999999864321 2345788999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....
T Consensus 140 ~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------- 211 (267)
T cd08224 140 TATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------- 211 (267)
T ss_pred CCCCcEEEeccceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-------
Confidence 9999999999999876543221 12234578899999999988999999999999999999999999853221
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.... ..+..................+.+++.+||+.+|++||++.+|+++|+++
T Consensus 212 ~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 212 NLYS--------------LCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred cHHH--------------HHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0100 11110001111111124566889999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.09 Aligned_cols=264 Identities=22% Similarity=0.318 Sum_probs=206.1
Q ss_pred HHHhccccccccccccceEEEEEeCC-----CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEee-CCe
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTD-----HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAE-KGE 512 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~-----~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~ 512 (763)
...++.+.+.||+|+||.||+|...+ +..|++|+++.... ....+.+|+.++++++|+||+++++++.+ ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34567788999999999999998765 67899999875432 23568899999999999999999998876 467
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++++||+++++|.+++...+... ......+++.+++.++.|++.||+|||+.+ ++|+|||
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~----------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~ 144 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGE----------------ANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIA 144 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccc----------------cccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccC
Confidence 889999999999999996542110 002356899999999999999999999988 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCccc-ccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCccccc
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVS-MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQG 670 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~ 670 (763)
|+||++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||....
T Consensus 145 p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 145 ARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred HhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 999999999999999999998654332221 122345678999999998899999999999999999999 999986322
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. ..+ ......+ . ....+...++.+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 225 ~---------~~~-~~~~~~~----------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 225 P---------FEM-AAYLKDG----------Y----RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred H---------HHH-HHHHHcC----------C----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1 000 0000000 0 00111234567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.64 Aligned_cols=254 Identities=25% Similarity=0.437 Sum_probs=200.6
Q ss_pred HhccccccccccccceEEEEEeCC-C---cEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD-H---RVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~-~---~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
+.+++.+.||+|+||.||+|.... + ..||+|+++.... ...+|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 456788999999999999998753 2 3699999875322 345799999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~ni 137 (269)
T cd05065 84 TEFMENGALDSFLRQN-----------------------DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNI 137 (269)
T ss_pred EecCCCCcHHHHHhhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheE
Confidence 9999999999998542 235789999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCccc--ccccc--cCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVS--MSRIR--GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGS 671 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~--~~~~~--gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~ 671 (763)
+++.++.+||+|||+++......... ..... .+..|+|||.+.+..++.++||||||+++||+++ |..||.....
T Consensus 138 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 138 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred EEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 99999999999999997654322211 11111 2457999999999999999999999999999886 9999863321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
. . ..... .. ....+.+.+.+..+.+++.+||+.+|++||++.+|+++|++.
T Consensus 218 ~---------~-~~~~i----------~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 218 Q---------D-VINAI----------EQ----DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred H---------H-HHHHH----------Hc----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 00000 00 011111134456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=318.02 Aligned_cols=272 Identities=23% Similarity=0.375 Sum_probs=201.0
Q ss_pred HHHhccccccccccccceEEEEEeCC---------------CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccE
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTD---------------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRL 503 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~---------------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l 503 (763)
....+.+.++||+|+||.||++...+ ...||+|.++.... ...+|.+|++++++++|+||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34567788999999999999987542 13589999875322 23568899999999999999999
Q ss_pred EEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 046586 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECL 583 (763)
Q Consensus 504 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~ 583 (763)
++++...+..++||||+++++|.+++......... ........+++..++.++.|++.||+|||+.+
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~------------~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 149 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTF------------THANNIPSVSIANLLYMAVQIASGMKYLASLN- 149 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccc------------cccccCCcccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 99999999999999999999999999643210000 00112235789999999999999999999988
Q ss_pred CcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-
Q 046586 584 EWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS- 661 (763)
Q Consensus 584 ~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt- 661 (763)
++|+||||+||++++++.+||+|||++......... ......++..|+|||.+..+.++.++||||||+++|||++
T Consensus 150 --i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 150 --FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred --eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 999999999999999999999999999754332221 1222345678999999998899999999999999999998
Q ss_pred -CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 662 -GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 662 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
+..||...... ... ... .+..+....... ...+...+..+.+++.+|++.||++||++.+|+
T Consensus 228 ~~~~p~~~~~~~------~~~----~~~------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 228 CKEQPYSLLSDE------QVI----ENT------GEFFRNQGRQIY-LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred CCCCCCcccChH------HHH----HHH------HHhhhhcccccc-CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 55566532110 000 000 000000000000 000122356899999999999999999999999
Q ss_pred HHhc
Q 046586 741 KMLE 744 (763)
Q Consensus 741 ~~Le 744 (763)
++|+
T Consensus 291 ~~l~ 294 (295)
T cd05097 291 HFLR 294 (295)
T ss_pred HHHh
Confidence 9986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=323.99 Aligned_cols=237 Identities=26% Similarity=0.335 Sum_probs=191.3
Q ss_pred ccccccccceEEEEEe----CCCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 449 NLIGRGGFGDVYKGEL----TDHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~----~~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
+.||+|+||.||+++. .+++.+|+|+++... .....+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 357899999997532 223456789999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++++
T Consensus 82 ~~~L~~~l~~------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 134 (318)
T cd05582 82 GGDLFTRLSK------------------------EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEE 134 (318)
T ss_pred CCcHHHHHHH------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCC
Confidence 9999999853 235789999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
+.+||+|||+++...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 135 ~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------- 204 (318)
T cd05582 135 GHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------- 204 (318)
T ss_pred CcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---------
Confidence 999999999997543321 1223457899999999999889999999999999999999999999643210
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGK 738 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 738 (763)
..... +... . ..++......+.+++.+||+.||++||++.+
T Consensus 205 -~~~~~---------i~~~----~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 205 -ETMTM---------ILKA----K--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -HHHHH---------HHcC----C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 00001 1110 0 0112334567889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.31 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=195.1
Q ss_pred ccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 451 IGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 451 LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
||+|+||.||++... +++.+|+|.+.... ...+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999765 67899999986432 1224577899999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeE
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 605 (763)
..++.... .....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+|
T Consensus 81 ~~~~~~~~--------------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~ 137 (280)
T cd05608 81 RYHIYNVD--------------------EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVR 137 (280)
T ss_pred HHHHHhcc--------------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 98885422 02346889999999999999999999988 99999999999999999999
Q ss_pred EcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHH
Q 046586 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685 (763)
Q Consensus 606 I~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 685 (763)
|+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 138 l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~----------- 205 (280)
T cd05608 138 ISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE----------- 205 (280)
T ss_pred EeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-----------
Confidence 999999976543222 22345789999999999999999999999999999999999999974322110
Q ss_pred HHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 686 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
..+......... ...+...+..+.+++..||+.||++|| ++.++++
T Consensus 206 --------~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 206 --------NKELKQRILNDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred --------HHHHHHhhcccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 000111111110 111234556788999999999999999 7778875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.34 Aligned_cols=241 Identities=27% Similarity=0.369 Sum_probs=192.3
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
++||+|+||.||+|+.. +++.||+|+++.. ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 4789999999743 22334577888888876 899999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 81 ~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~ 133 (321)
T cd05591 81 GDLMFQIQRS------------------------RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEG 133 (321)
T ss_pred CcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCC
Confidence 9999988542 35788899999999999999999998 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 134 ~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---------- 202 (321)
T cd05591 134 HCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---------- 202 (321)
T ss_pred CEEEeecccceecccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH----------
Confidence 99999999997533222 1233456899999999999999999999999999999999999999743210
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-------SMGKVAKM 742 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~eVv~~ 742 (763)
... ..+.. ... ..+.....++.+++..|++.||++|| ++.++++.
T Consensus 203 ----~~~-----~~i~~----~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 203 ----DLF-----ESILH----DDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ----HHH-----HHHHc----CCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 000 01111 000 01122345788999999999999999 77777743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=325.06 Aligned_cols=250 Identities=24% Similarity=0.292 Sum_probs=197.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.+.+.++||+|+||.||+++.. +++.||+|+++.... ....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 3567789999999999999875 578999999985322 33557889999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 82 ~~~~~~L~~~l~~~-----------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll 135 (330)
T cd05601 82 YQPGGDLLSLLNRY-----------------------EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLI 135 (330)
T ss_pred CCCCCCHHHHHHHh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEE
Confidence 99999999999643 235788899999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc------cCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR------SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
+.++.+||+|||++...............||..|+|||.+. ...++.++|||||||++|||++|+.||......
T Consensus 136 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 215 (330)
T cd05601 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215 (330)
T ss_pred CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH
Confidence 99999999999999866544333333456899999999986 457889999999999999999999999643210
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. ....+.... ..+ ..+. .......+.+++..|++ +|.+||++.++++
T Consensus 216 ---------~-~~~~i~~~~-------~~~--~~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 216 ---------K-TYNNIMNFQ-------RFL--KFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ---------H-HHHHHHcCC-------Ccc--CCCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 001111100 000 0010 01235667888889998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.76 Aligned_cols=254 Identities=25% Similarity=0.423 Sum_probs=201.2
Q ss_pred HhccccccccccccceEEEEEeC----CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
..+.+.+.||+|+||.||+|... .+..+|+|.++.... ..+.|.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45677889999999999999763 233799998875332 235688999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~e~~~~~~L~~~~~~~-----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~ni 137 (267)
T cd05066 84 TEYMENGSLDAFLRKH-----------------------DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNI 137 (267)
T ss_pred EEcCCCCCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcE
Confidence 9999999999999542 235788999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccc--cccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSM--SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
+++.++.+||+|||+++.......... ....++..|+|||.+.+..++.++||||||+++||+++ |..||......
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~- 216 (267)
T cd05066 138 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ- 216 (267)
T ss_pred EECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-
Confidence 999999999999999986644322111 12233567999999998899999999999999999886 99998633210
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
+ ......++ ...+.+...+..+.+++.+|++.+|++||+|.++++.|+++
T Consensus 217 --------~-~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 217 --------D-VIKAIEEG--------------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --------H-HHHHHhCC--------------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 00000000 00111123456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.63 Aligned_cols=258 Identities=22% Similarity=0.351 Sum_probs=204.7
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.+.+.+.||+|+||.||++.. .+++.++||.++... ....++.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 355678999999999999986 478899999886432 123568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++.... .....+++.++..++.|+++||+|||+.+ ++|+||||+||++
T Consensus 83 ~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili 139 (267)
T cd08229 83 LADAGDLSRMIKHFK--------------------KQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFI 139 (267)
T ss_pred ecCCCCHHHHHHHhh--------------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 999999999986421 12346889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|||++|..||......
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------ 212 (267)
T cd08229 140 TATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------ 212 (267)
T ss_pred cCCCCEEECcchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------
Confidence 9999999999999876543321 122346788999999999889999999999999999999999998532210
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
. .+.....................+.+++.+||+.||++||||.+|++++++.
T Consensus 213 -~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 213 -L--------------YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -H--------------HHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0 0000000000011111123566889999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.60 Aligned_cols=275 Identities=28% Similarity=0.452 Sum_probs=205.9
Q ss_pred hccccccccccccceEEEEEeCC-C--cEEEEEEeeccC--CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD-H--RVVAVKCLKNVT--GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~-~--~~VAvK~l~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ 517 (763)
.+.+.+.||+|+||.||+|...+ + ..+++|.++... ...+.|.+|++++.++ +||||+++++++.+.+..++|+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 35677899999999999998754 3 247888887432 2345688999999999 7999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++............. ........+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil 151 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFA--------KEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVL 151 (297)
T ss_pred EecCCCcHHHHHHhccccccccccc--------cccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEE
Confidence 9999999999996543211110000 00112346899999999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSD 676 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 676 (763)
+++++.+||+|||++...... ........+..|+|||.+....++.++|||||||++|||++ |..||.....
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~----- 224 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC----- 224 (297)
T ss_pred ECCCCeEEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 999999999999998643211 11111223567999999998899999999999999999997 9999863321
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCCCCCCC
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITEPKKP 755 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~~p~~p 755 (763)
.. ...... +... ...+...+..+.+++.+||+.+|.+||++.+|++.|+.+.+...+.-+
T Consensus 225 ----~~-~~~~~~----------~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~ 284 (297)
T cd05089 225 ----AE-LYEKLP----------QGYR----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVN 284 (297)
T ss_pred ----HH-HHHHHh----------cCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccccc
Confidence 00 011111 1011 111123456788999999999999999999999999887765544443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.89 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=203.1
Q ss_pred HHHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEeeCC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCAEKG 511 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 511 (763)
....+.+.+.||+|+||.||++... .+..||+|+++.... ..+.+.+|+++++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3456777889999999999999742 245799999875432 235688999999999 7999999999999999
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
..++||||+++|+|.+++... ....+++.+...++.|++.||+|||+.+ |+|+||
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~----------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dl 167 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRK----------------------RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDL 167 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 999999999999999998642 1234789999999999999999999988 999999
Q ss_pred CCCceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccc
Q 046586 592 KPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQ 669 (763)
Q Consensus 592 k~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~ 669 (763)
||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 168 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 168 AARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred ccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 999999999999999999999865433221 1122345678999999999999999999999999999998 99998633
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
... .. ..+.+....... .+.....++.+++.+|++.+|++||++.||++.|++.
T Consensus 248 ~~~-------------~~------~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 248 PVD-------------SK------FYKLIKEGYRMA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred Cch-------------HH------HHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 210 00 001111111111 1122346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.14 Aligned_cols=249 Identities=32% Similarity=0.498 Sum_probs=198.5
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEe-eCCeeeEEEecCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCA-EKGERTLVYEYVP 521 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~LV~Ey~~ 521 (763)
..+.+.+.||+|+||.||++... +..+++|.++... ..+.|.+|+.++++++|+|++++++++. +.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 45677889999999999999875 5679999886433 3457899999999999999999999765 4567899999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++++
T Consensus 84 ~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~ 138 (256)
T cd05082 84 KGSLVDYLRSR----------------------GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSED 138 (256)
T ss_pred CCcHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCC
Confidence 99999998643 2345789999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCch
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~ 680 (763)
+.+||+|||+++...... ....++..|+|||++.+..++.++||||||+++|||++ |+.||.... .
T Consensus 139 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---------~ 205 (256)
T cd05082 139 NVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---------L 205 (256)
T ss_pred CcEEecCCccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---------H
Confidence 999999999987543221 12334568999999998899999999999999999998 888885321 1
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
... .... ... .....+...+..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 206 ~~~-~~~~----------~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 206 KDV-VPRV----------EKG----YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHH-HHHH----------hcC----CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 110 0001 010 11111233456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=339.42 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=200.8
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCC-------
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG------- 511 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------- 511 (763)
..|.+.++||+|+||+||+++. .+++.||||+++... .....+.+|+.++..++|+||+++...+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 4677889999999999999976 468899999997432 22345788999999999999999988775433
Q ss_pred -eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 512 -ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 512 -~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ |+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~--------------------~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrD 168 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAK--------------------TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRD 168 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 36799999999999999965321 2346888999999999999999999988 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
|||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 169 LKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred CCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999986543222 2233467999999999999999999999999999999999999999632
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. .++++..+.... ...+...+.++.+++..||+.||.+||++.+++++
T Consensus 249 ~~-----------------------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 249 NM-----------------------EEVMHKTLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CH-----------------------HHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 111111111111 11223456678999999999999999999999864
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.81 Aligned_cols=239 Identities=25% Similarity=0.357 Sum_probs=188.7
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+|+||.||+|+.. +++.||+|+++... ...+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 47789999997432 2234456677777654 899999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|..++... ..++......++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 81 g~L~~~~~~~------------------------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~ 133 (316)
T cd05592 81 GDLMFHIQSS------------------------GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDG 133 (316)
T ss_pred CcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCC
Confidence 9999988542 24788888999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 134 ~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---------- 202 (316)
T cd05592 134 HIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---------- 202 (316)
T ss_pred CEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----------
Confidence 99999999997543222 2233457899999999999999999999999999999999999999643210
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG-KVA 740 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVv 740 (763)
.... .+... ....+.....++.+++..||+.||++||++. +++
T Consensus 203 ----~~~~-----~i~~~------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 203 ----ELFD-----SILND------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ----HHHH-----HHHcC------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0000 00000 0111123445678899999999999999876 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.20 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=210.6
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCe-eeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE-RTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~LV~E 518 (763)
.|...+++|+|+||.++..+.+ +.+.+++|.+.-.. ...+...+|+.++++++|||||.+.+.+.+++. .++||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4556789999999999998775 46788999886332 233457899999999999999999999999988 999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|++||+|.+.+... +...++......+..|++.|+.|||++. |+|||||+.||++
T Consensus 85 Y~eGg~l~~~i~~~----------------------k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifl 139 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQ----------------------KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFL 139 (426)
T ss_pred ecCCCCHHHHHHHH----------------------hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhc
Confidence 99999999999754 3457888999999999999999999877 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.+..+||+|||+|+.+..+.. -...+.||+.||.||.+.+.+|..|+||||+||++|||++-+++|...+
T Consensus 140 tk~~~VkLgDfGlaK~l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-------- 210 (426)
T KOG0589|consen 140 TKDKKVKLGDFGLAKILNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-------- 210 (426)
T ss_pred cccCceeecchhhhhhcCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------
Confidence 9999999999999998876652 3456789999999999999999999999999999999999999997443
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
...++.+..... -.+++.....++..++..|++.+|+.||++.+++.+
T Consensus 211 ---------------m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 211 ---------------MSELILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---------------hHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 233333333332 223446778899999999999999999999999865
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.98 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=190.5
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+|+||.||+++.. +++.+|+|+++... .....+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57889999997532 2234577888888776 899999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 81 ~~L~~~~~~~------------------------~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~ 133 (329)
T cd05618 81 GDLMFHMQRQ------------------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEG 133 (329)
T ss_pred CCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCC
Confidence 9999888532 35788999999999999999999998 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||......... ......
T Consensus 134 ~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~-~~~~~~ 211 (329)
T cd05618 134 HIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-DQNTED 211 (329)
T ss_pred CEEEeeCCccccccCCCC-ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCc-ccccHH
Confidence 999999999975322211 223457899999999999999999999999999999999999999643221110 011111
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
+......+. . ..++......+.+++.+||+.||++||++
T Consensus 212 ~~~~~i~~~---------~------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 212 YLFQVILEK---------Q------IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHhcC---------C------CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111111111 0 11223345678899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.05 Aligned_cols=258 Identities=27% Similarity=0.374 Sum_probs=200.2
Q ss_pred HhccccccccccccceEEEEEeCC------CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
..+.+.+.||+|+||.||+|...+ +..|++|..+.... ....|.+|+.++++++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 345667899999999999998754 46789998864432 2356899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++++|.+++...+... .....+++..++.++.||+.||+|||+.+ ++|+||||+
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~-----------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~ 145 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRP-----------------ERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAAR 145 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecccchh
Confidence 9999999999999996543100 12236899999999999999999999988 999999999
Q ss_pred ceEEcCCC---CeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccc
Q 046586 595 NILLGDDF---CPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQ 669 (763)
Q Consensus 595 NILl~~~~---~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~ 669 (763)
||+++.++ .+||+|||+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 146 nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~ 225 (277)
T cd05036 146 NCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225 (277)
T ss_pred eEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99998765 5999999999865332221 1112233567999999999999999999999999999997 98898632
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
.. .. ..+.+....... .+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 226 ~~---------~~-----------~~~~~~~~~~~~----~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 226 TN---------QE-----------VMEFVTGGGRLD----PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CH---------HH-----------HHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 21 00 011111111111 12334567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=326.44 Aligned_cols=266 Identities=20% Similarity=0.210 Sum_probs=196.3
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
..|.+.++||+|+||.||++... .++.||+|... ...+.+|++++++++||||+++++++......++|+|++.
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 45778899999999999999775 57889999653 2346789999999999999999999999999999999995
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
++|..++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 167 -~~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~ 218 (391)
T PHA03212 167 -TDLYCYLAAK------------------------RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHP 218 (391)
T ss_pred -CCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCC
Confidence 6888887532 35788999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC-CCCch
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS-DEWYF 680 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~-~~~~~ 680 (763)
+.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.|+-........ .....
T Consensus 219 ~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 298 (391)
T PHA03212 219 GDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQ 298 (391)
T ss_pred CCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHH
Confidence 99999999999754332222334467999999999999999999999999999999999999876432211100 00000
Q ss_pred hHHHHHHHHh---------ccChhhhh----ccccc-ccCCC--cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 681 PKWAFEKVYE---------EMKVEDIL----DRHIK-NSYDS--RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 681 ~~~~~~~~~~---------~~~~~~~~----~~~l~-~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.......... .....+.. ..... ..... ......+.++.+++.+||+.||++|||+.|+++
T Consensus 299 l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 299 IKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 00000000 00000 00000 001234567889999999999999999999984
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.23 Aligned_cols=250 Identities=24% Similarity=0.299 Sum_probs=191.3
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.+.++||+|+||.||+|+.. +++.+|+|+++... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 456789999999999999765 57899999997432 2335688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+|||++
T Consensus 83 ~~gg~L~~~l~~~------------------------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~ 135 (381)
T cd05626 83 IPGGDMMSLLIRM------------------------EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILID 135 (381)
T ss_pred CCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEEC
Confidence 9999999998642 34778888899999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCc----------------------------------------------ccccccccCCCcc
Q 046586 600 DDFCPKISDFGLAKLRKKEDM----------------------------------------------VSMSRIRGTRGYM 633 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~----------------------------------------------~~~~~~~gt~~y~ 633 (763)
.++++||+|||+++....... .......||+.|+
T Consensus 136 ~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 215 (381)
T cd05626 136 LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYI 215 (381)
T ss_pred CCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcccc
Confidence 999999999999863311000 0012346999999
Q ss_pred cccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHH
Q 046586 634 APEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFD 713 (763)
Q Consensus 634 APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 713 (763)
|||.+.+..++.++|||||||++|||++|+.||....... . ...++........+. ...
T Consensus 216 aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----------~---------~~~i~~~~~~~~~~~--~~~ 274 (381)
T cd05626 216 APEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE----------T---------QLKVINWENTLHIPP--QVK 274 (381)
T ss_pred CHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHH----------H---------HHHHHccccccCCCC--CCC
Confidence 9999998999999999999999999999999996432100 0 000110000000000 012
Q ss_pred HHHHHHHHHHH--ccCCCCCCCCCHHHHHHH
Q 046586 714 MVNRMVKTAMW--CIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 714 ~~~~l~~l~~~--Cl~~dP~~RPs~~eVv~~ 742 (763)
...++.+++.+ |+..+|..||++.++++.
T Consensus 275 ~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 275 LSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 23455566655 667777789999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=306.07 Aligned_cols=248 Identities=27% Similarity=0.363 Sum_probs=201.3
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
+.+.+.||+|++|.||++... +++.|++|.++.. .....++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 456789999999999999875 5788999998643 233466889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ....+++.++..++.|++.||.|||+.+ |+|+||||+||+++.
T Consensus 82 ~~~~L~~~l~~~----------------------~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~ 136 (256)
T cd08529 82 ENGDLHKLLKMQ----------------------RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDA 136 (256)
T ss_pred CCCcHHHHHHHh----------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeC
Confidence 999999999653 2346888999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.+||+|||+++....... ......++..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 137 ~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------- 206 (256)
T cd08529 137 YDNVKIGDLGVAKLLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------- 206 (256)
T ss_pred CCCEEEcccccceeccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---------
Confidence 99999999999986543322 12334678899999999999999999999999999999999999863321
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
...... .. ... ....+......+.+++.+||+.+|++||++.++++.
T Consensus 207 -~~~~~~---------~~----~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 207 -GALILK---------II----RGV-FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -HHHHHH---------HH----cCC-CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 000000 11 111 111222455788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.85 Aligned_cols=235 Identities=25% Similarity=0.360 Sum_probs=189.0
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
++||+|+||.||+++.. +++.||+|+++.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 5789999999743 22345577888888876 799999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 81 g~L~~~i~~~------------------------~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~ 133 (320)
T cd05590 81 GDLMFHIQKS------------------------RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEG 133 (320)
T ss_pred chHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCC
Confidence 9999988542 35788899999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus 134 ~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---------~ 203 (320)
T cd05590 134 HCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---------D 203 (320)
T ss_pred cEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---------H
Confidence 99999999987532221 1233457899999999999999999999999999999999999999643210 0
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
...... . ... ..+.....++.+++.+|++.||++||++
T Consensus 204 -~~~~i~---------~----~~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 204 -LFEAIL---------N----DEV--VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -HHHHHh---------c----CCC--CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 001111 1 000 0112235678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.56 Aligned_cols=267 Identities=25% Similarity=0.406 Sum_probs=204.9
Q ss_pred HHHHhccccccccccccceEEEEEeCC------CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCC
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG 511 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 511 (763)
+....+.+.++||+|+||.||+|...+ +..||+|.++.... ...++.+|+.+++.++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 345567788999999999999996542 45799998864432 2345788999999999999999999999999
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
..++||||+++|+|.+++........ .......+.+.....++.|++.||+|||+.+ |+||||
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~di 145 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAE--------------NNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDL 145 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccc--------------cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCC
Confidence 99999999999999999975321100 0012345678889999999999999999988 999999
Q ss_pred CCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccc
Q 046586 592 KPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQ 669 (763)
Q Consensus 592 k~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~ 669 (763)
||+||++++++.+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |..||...
T Consensus 146 kp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 146 AARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred ChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999985443222 11222345678999999998999999999999999999998 77787532
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.. .+ .... +.+... ...+...+..+.+++.+|++.||++|||+.++++.|++..
T Consensus 226 ~~---------~~-~~~~---------~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 226 SN---------EQ-VLKF---------VMDGGY-----LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CH---------HH-HHHH---------HHcCCC-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11 00 0000 111100 0111233568999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=291.11 Aligned_cols=246 Identities=26% Similarity=0.391 Sum_probs=203.5
Q ss_pred hccccccccccccceEEEEEeCC-CcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..++.+.||+|-||.||.|+.+. +-.||+|++.+. .+...++.+|+++-..|+||||++++++|.+....||++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 34567899999999999998864 568999999643 3345679999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|.++|+|...|... ....++......++.|+|.||.|+|..+ ||||||||+|+|+
T Consensus 103 ya~~gel~k~L~~~----------------------~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLl 157 (281)
T KOG0580|consen 103 YAPRGELYKDLQEG----------------------RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLL 157 (281)
T ss_pred ecCCchHHHHHHhc----------------------ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhcc
Confidence 99999999999743 2345667777889999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++..||+|||-+.... .....+.+||..|.+||+..+..++.++|+|++|++.||++.|.+||+....
T Consensus 158 g~~~~lkiAdfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~------- 227 (281)
T KOG0580|consen 158 GSAGELKIADFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH------- 227 (281)
T ss_pred CCCCCeeccCCCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-------
Confidence 999999999999986443 2334567899999999999999999999999999999999999999974321
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
...+......++ .+|......+.+++..|+..+|.+|.+..||++.
T Consensus 228 -------~etYkrI~k~~~-----------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 228 -------SETYKRIRKVDL-----------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------HHHHHHHHHccc-----------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111221111111 1224456678899999999999999999998863
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.27 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=194.9
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+|+||.||+++.. +++.||+|+++... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999875 57899999998532 2234577899999988 799999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 81 g~L~~~~~~~------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~ 133 (329)
T cd05588 81 GDLMFHMQRQ------------------------RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEG 133 (329)
T ss_pred CCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCC
Confidence 9999888532 35889999999999999999999998 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||+........ ......
T Consensus 134 ~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~-~~~~~~ 211 (329)
T cd05588 134 HIKLTDYGMCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP-DQNTED 211 (329)
T ss_pred CEEECcCccccccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc-cccchH
Confidence 99999999997432211 1233457899999999999999999999999999999999999999743321110 011111
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC------HHHHHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS------MGKVAK 741 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~eVv~ 741 (763)
+...... ... ..++......+.+++.+||+.||.+||+ +.++++
T Consensus 212 ~~~~~~~---------~~~------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 212 YLFQVIL---------EKQ------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHH---------cCC------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1111111 111 1112234567889999999999999997 667763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=325.13 Aligned_cols=283 Identities=27% Similarity=0.375 Sum_probs=203.7
Q ss_pred HHHHhccccccccccccceEEEEEe------CCCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEeeC
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGEL------TDHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCAEK 510 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~------~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 510 (763)
+....+.+.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3445678889999999999999964 3467899999975332 235688999999999 789999999988754
Q ss_pred -CeeeEEEecCCCCCHhHHhhhcCCCCCCCh-----------------hhhhc----c----------------------
Q 046586 511 -GERTLVYEYVPNGSLADYLFRSGRVGSSSP-----------------AREME----M---------------------- 546 (763)
Q Consensus 511 -~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~-----------------~~~~~----~---------------------- 546 (763)
...++||||+++|+|.+++...+.....-. ..... .
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999999975421100000 00000 0
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccc
Q 046586 547 SGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSR 625 (763)
Q Consensus 547 ~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~ 625 (763)
............+++.++..++.|++.||+|||+.+ |+||||||+||++++++++||+|||+++....... .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 000000001235789999999999999999999988 99999999999999999999999999976432211 12222
Q ss_pred cccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccc
Q 046586 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKN 704 (763)
Q Consensus 626 ~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 704 (763)
..++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ........++. .
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---------~~~~~~~~~~~----------~- 300 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---------EEFCRRLKEGT----------R- 300 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc---------HHHHHHHhccC----------C-
Confidence 345678999999998999999999999999999997 88887532110 00001111110 0
Q ss_pred cCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 705 SYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 705 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
...+......+.+++..||+.||++||++.||++.|+.+.+
T Consensus 301 ---~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 301 ---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00111234568899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=291.52 Aligned_cols=263 Identities=24% Similarity=0.274 Sum_probs=210.2
Q ss_pred HHhccccccccccccceEEEEE-eCCCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCC-----eee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG-----ERT 514 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~-~~~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 514 (763)
..+|.+.++||+|||+-||.++ +.+++.+|+|++.-.. ++.+..++|++.-++++||||+++++++..+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4578888999999999999996 5677889999998554 55677899999999999999999999876543 589
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
|+++|...|+|.+.+..... ++..++..+.++|+.++++||++||+.. ++++||||||.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~--------------------kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~ 158 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKI--------------------KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPA 158 (302)
T ss_pred EEeehhccccHHHHHHHHhh--------------------cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcc
Confidence 99999999999999976542 4567899999999999999999999987 57999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc--------cccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV--------SMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGS 663 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~--------~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~ 663 (763)
|||+.+.+.++|.|||.+......-.. .......|..|+|||.+. +..+++++|||||||+||+|+.|.
T Consensus 159 NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~ 238 (302)
T KOG2345|consen 159 NILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGE 238 (302)
T ss_pred eeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcC
Confidence 999999999999999999754321111 112235789999999885 567889999999999999999999
Q ss_pred CCcccccCCCCCCCCchhHHHHHHHHhccCh-hhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 664 RNFEIQGSMMNSDEWYFPKWAFEKVYEEMKV-EDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 664 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.||+..- .+|.+. ..+....+..... .-.++.+.+++.+|++.||.+||++.+++..
T Consensus 239 sPfe~~~------------------~~GgSlaLAv~n~q~s~P~~----~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 239 SPFERIY------------------QQGGSLALAVQNAQISIPNS----SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CcchHHh------------------hcCCeEEEeeeccccccCCC----CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9997321 122221 1222222221111 1267889999999999999999999999999
Q ss_pred hccCC
Q 046586 743 LEGTV 747 (763)
Q Consensus 743 Le~~~ 747 (763)
++...
T Consensus 297 ~d~Li 301 (302)
T KOG2345|consen 297 LDDLI 301 (302)
T ss_pred HHhhc
Confidence 87653
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=307.34 Aligned_cols=247 Identities=28% Similarity=0.403 Sum_probs=196.1
Q ss_pred ccccccccceEEEEEeCC----CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELTD----HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
++||+|+||.||+|+... +..+|+|.++.... ..+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997632 26899999975544 4567899999999999999999999876 4568999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++... ..+++..++.++.|++.||+|||..+ ++|+||||+||+++.++
T Consensus 80 ~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~ 132 (257)
T cd05060 80 GPLLKYLKKR------------------------REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRH 132 (257)
T ss_pred CcHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCC
Confidence 9999999642 25789999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCccc--ccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCc
Q 046586 603 CPKISDFGLAKLRKKEDMVS--MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 679 (763)
.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 133 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-------- 204 (257)
T cd05060 133 QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-------- 204 (257)
T ss_pred cEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------
Confidence 99999999998654332211 112234568999999999999999999999999999998 9999863321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.. ......+.. ....+...+..+.+++.+|++.+|++||++.+|++.|+++.
T Consensus 205 -~~-~~~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 205 -AE-VIAMLESGE--------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -HH-HHHHHHcCC--------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00 001111110 00111234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=312.33 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=201.7
Q ss_pred HHhccccccccccccceEEEEEeC-CCc----EEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHR----VVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~----~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
...+.+.++||+|+||.||+|+.. +++ .||+|+++.... ...++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 345667789999999999999753 443 489999874332 34568899999999999999999999975 4578
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 85 l~~~~~~~g~l~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~ 138 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN-----------------------KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAAR 138 (279)
T ss_pred EEEEcCCCCCHHHHHhhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 999999999999998542 235889999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||+.....
T Consensus 139 Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 218 (279)
T cd05109 139 NVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR 218 (279)
T ss_pred eEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999999999866433221 1122234678999999998899999999999999999998 88888632210
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITE 751 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~~ 751 (763)
. ....+...... ..+......+.+++..||+.||++||++.++++.|+.....+.
T Consensus 219 ----------~----------~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 219 ----------E----------IPDLLEKGERL----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred ----------H----------HHHHHHCCCcC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 0 01111111000 1112345678899999999999999999999999987765553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.37 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=193.8
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.+.++||+|+||.||+++.. +++.||||+++... .....+.+|++++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 556789999999999999875 57899999997432 2334578899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 83 ~~~g~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~ 135 (364)
T cd05599 83 LPGGDMMTLLMKK------------------------DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLD 135 (364)
T ss_pred CCCcHHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEEC
Confidence 9999999998542 35788999999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcc-------------------------------------cccccccCCCcccccccccCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMV-------------------------------------SMSRIRGTRGYMAPEWLRSDQ 642 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~-------------------------------------~~~~~~gt~~y~APE~l~~~~ 642 (763)
.++.+||+|||+++........ ......||+.|+|||++....
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (364)
T cd05599 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215 (364)
T ss_pred CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC
Confidence 9999999999998754221100 011245899999999999999
Q ss_pred CCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHH
Q 046586 643 ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA 722 (763)
Q Consensus 643 ~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~ 722 (763)
++.++|||||||++|||++|..||...... .......... ..+. .+.. ....+.+.+++
T Consensus 216 ~~~~~DiwSlG~il~el~~G~~Pf~~~~~~----------~~~~~i~~~~-------~~~~--~~~~--~~~s~~~~~li 274 (364)
T cd05599 216 YNKECDWWSLGVIMYEMLVGYPPFCSDNPQ----------ETYRKIINWK-------ETLQ--FPDE--VPLSPEAKDLI 274 (364)
T ss_pred CCCeeeeecchhHHHHhhcCCCCCCCCCHH----------HHHHHHHcCC-------CccC--CCCC--CCCCHHHHHHH
Confidence 999999999999999999999999643210 0001110000 0000 0000 12345677888
Q ss_pred HHccCCCCCCCCC---HHHHHH
Q 046586 723 MWCIQDRPELRPS---MGKVAK 741 (763)
Q Consensus 723 ~~Cl~~dP~~RPs---~~eVv~ 741 (763)
..|+. +|.+|++ +.++++
T Consensus 275 ~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 275 KRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHHcc-CHhhcCCCCCHHHHhc
Confidence 88886 8999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.79 Aligned_cols=198 Identities=26% Similarity=0.424 Sum_probs=167.5
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
..|.+.++||+|+||.||+|+.. +++.||+|+++... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 34667889999999999999876 67899999987433 2234578899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
++ ++|.+++... ...++...+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 85 ~~-~~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~ 137 (303)
T cd07869 85 VH-TDLCQYMDKH-----------------------PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLIS 137 (303)
T ss_pred CC-cCHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 95 6888887542 234778889999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
+++.+||+|||+++...... .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 138 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 138 DTGELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCCCEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999997543222 12233567899999998765 5688999999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.25 Aligned_cols=275 Identities=26% Similarity=0.386 Sum_probs=207.2
Q ss_pred HHHHHhccccccccccccceEEEEEeC--------CCcEEEEEEeeccC--CchhhhHHHHHHHhcC-CCCccccEEEEE
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELT--------DHRVVAVKCLKNVT--GGDAEFWAEVTIIARM-HHLNLVRLWGFC 507 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~--------~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~g~~ 507 (763)
++....+.+.+.||+|+||.||+++.. ....+|+|.++... ....++..|++++.++ +|+||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 444567888999999999999999753 23469999997542 2335688899999999 799999999999
Q ss_pred eeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 046586 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVL 587 (763)
Q Consensus 508 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~iv 587 (763)
.+.+..++||||+++|+|.+++...+........ .........+++.++++++.|++.||+|||+.+ ++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~--------~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~ 162 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCY--------NPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CI 162 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCccccccc--------ccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999764311100000 000012346899999999999999999999988 99
Q ss_pred ecCCCCCceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCC
Q 046586 588 HCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRN 665 (763)
Q Consensus 588 HrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p 665 (763)
||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 163 H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p 242 (307)
T cd05098 163 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242 (307)
T ss_pred cccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999755432211 1122234568999999998899999999999999999998 8888
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
|..... +... +.+.. ......+......+.+++..|++.+|++||+|.+|++.|+.
T Consensus 243 ~~~~~~--------------~~~~------~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 243 YPGVPV--------------EELF------KLLKE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred CCcCCH--------------HHHH------HHHHc----CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 753210 0000 01111 01111223445688899999999999999999999999987
Q ss_pred CCC
Q 046586 746 TVE 748 (763)
Q Consensus 746 ~~~ 748 (763)
+.+
T Consensus 299 ~~~ 301 (307)
T cd05098 299 ILA 301 (307)
T ss_pred HHH
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.49 Aligned_cols=244 Identities=24% Similarity=0.360 Sum_probs=191.8
Q ss_pred ccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 451 IGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 451 LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
||+|+||.||+++.. +++.+|+|.++... .....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 58899999986421 1233456799999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeE
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 605 (763)
.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 81 ~~~~~~~----------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~ 135 (277)
T cd05607 81 KYHIYNV----------------------GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCR 135 (277)
T ss_pred HHHHHhc----------------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEE
Confidence 9888543 2335788999999999999999999988 99999999999999999999
Q ss_pred EcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHH
Q 046586 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685 (763)
Q Consensus 606 I~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 685 (763)
|+|||++....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... ..
T Consensus 136 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-----~~----- 203 (277)
T cd05607 136 LSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-----AK----- 203 (277)
T ss_pred EeeceeeeecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-----hH-----
Confidence 99999997654322 2233468899999999998889999999999999999999999986322100 00
Q ss_pred HHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 686 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. +........... .......++.+++..||+.||++||++.|+++
T Consensus 204 ~~---------~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 204 EE---------LKRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HH---------HHHHhhcccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 00 111111111100 00134567889999999999999999977664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=309.29 Aligned_cols=262 Identities=27% Similarity=0.465 Sum_probs=197.6
Q ss_pred ccccccccceEEEEEeCC-Cc--EEEEEEeeccC--CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELTD-HR--VVAVKCLKNVT--GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~-~~--~VAvK~l~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+|+||.||+|...+ +. .+++|.++... .....+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998754 33 57888887432 2345788999999999 899999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++...+......... ........+++.++..++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~ 149 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFA--------IANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY 149 (270)
T ss_pred CcHHHHHHhccccccccccc--------cccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCC
Confidence 99999997543211110000 00113346889999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchh
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~ 681 (763)
.+||+|||+++..... ........+..|+|||++....++.++||||||+++|||++ |..||..... .
T Consensus 150 ~~kl~dfgl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---------~ 218 (270)
T cd05047 150 VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---------A 218 (270)
T ss_pred eEEECCCCCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---------H
Confidence 9999999998632211 11111233567999999988899999999999999999997 9999853211 0
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.. ......+ . ....+......+.+++.+|++.+|.+|||+.++++.|+.+.
T Consensus 219 ~~-~~~~~~~----------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 EL-YEKLPQG----------Y----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HH-HHHHhCC----------C----CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 0111000 0 00111234457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=334.99 Aligned_cols=262 Identities=23% Similarity=0.286 Sum_probs=209.2
Q ss_pred HhccccccccccccceEEEEEeCCC-cEEEEEEeecc-CCchhhhHHHHHHHhcCC-CCccccEEEE-Eee------CCe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDH-RVVAVKCLKNV-TGGDAEFWAEVTIIARMH-HLNLVRLWGF-CAE------KGE 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~-~~VAvK~l~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~-~~~------~~~ 512 (763)
....+.+.|.+|||+.||.+....+ ..+|+|++-.. +...+..++|+++|++|+ |+|||.+++. ... ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3455678999999999999988776 89999988643 344566889999999996 9999999993 322 136
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.+|.||||.+|+|-+++..+. ...|+..++++|+.|+++|+++||... ++|||||||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rl----------------------q~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLK 173 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRL----------------------QTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLK 173 (738)
T ss_pred EEeehhhccCCcHHHHHHHHH----------------------hccCChHHHHHHHHHHHHHHHHHhcCC-Cccchhhhh
Confidence 789999999999999997542 234899999999999999999999987 789999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCC--ccccc------ccccCCCccccccc---ccCCCCCccceeehhHHHHHHHh
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKED--MVSMS------RIRGTRGYMAPEWL---RSDQITPKADVYSFGMVLLEIVS 661 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~--~~~~~------~~~gt~~y~APE~l---~~~~~s~ksDVwS~Gvll~ellt 661 (763)
-+||||+.+++.||||||.+.-.-... ..... ..--|+.|+|||++ .+.++++|+|||++||+||-|+-
T Consensus 174 iENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy 253 (738)
T KOG1989|consen 174 IENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCY 253 (738)
T ss_pred hhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHH
Confidence 999999999999999999996322111 10000 11358899999987 46799999999999999999999
Q ss_pred CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 662 GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 662 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...||+..+. ..+++ ..+..+..+.....+..|+..||+.||++||++-+|++
T Consensus 254 ~t~PFe~sg~-----------------------laIln----g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 254 FTTPFEESGK-----------------------LAILN----GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred hCCCcCcCcc-----------------------eeEEe----ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 9999985532 12222 23333333578899999999999999999999999999
Q ss_pred HhccCCCCCCCCC
Q 046586 742 MLEGTVEITEPKK 754 (763)
Q Consensus 742 ~Le~~~~~~~p~~ 754 (763)
.+-.+...+.|..
T Consensus 307 ~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 307 EIFELANKPCPIP 319 (738)
T ss_pred HHHHHhcCCCCcc
Confidence 9988776655443
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.56 Aligned_cols=240 Identities=24% Similarity=0.342 Sum_probs=190.5
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+|+||.||+|+.. +++.||+|+++.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 4688999999753 23334566788888764 999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 81 g~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~ 133 (316)
T cd05619 81 GDLMFHIQSC------------------------HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDG 133 (316)
T ss_pred CcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCC
Confidence 9999998532 35788899999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---------- 202 (316)
T cd05619 134 HIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---------- 202 (316)
T ss_pred CEEEccCCcceECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----------
Confidence 99999999987432211 1223456899999999999999999999999999999999999999643210
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG-KVAK 741 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVv~ 741 (763)
.....+... . . ..+......+.+++.+||+.||++||++. ++.+
T Consensus 203 ~~~~~i~~~-------~----~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 203 ELFQSIRMD-------N----P----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHhC-------C----C----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 000000000 0 0 01122345678999999999999999997 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.13 Aligned_cols=267 Identities=25% Similarity=0.389 Sum_probs=202.5
Q ss_pred HhccccccccccccceEEEEEeC------CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
..+.+.++||+|+||.||++... ++..+++|.++... .....+.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 34556789999999999999642 35578999887543 334678999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++++|.+++........... .........+++.+++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~---------~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~n 152 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILA---------GGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRN 152 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhc---------ccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhh
Confidence 9999999999999975431100000 000112346899999999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
|++++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 153 il~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 231 (280)
T cd05092 153 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT- 231 (280)
T ss_pred EEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-
Confidence 9999999999999999975433222 11222345678999999999999999999999999999998 88888532210
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
.. ....... ... ..+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 232 --------~~----------~~~~~~~-~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 232 --------EA----------IECITQG-REL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --------HH----------HHHHHcC-ccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 00 0001000 000 1112345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.06 Aligned_cols=197 Identities=27% Similarity=0.361 Sum_probs=170.0
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.+.++||+|+||+||++... +++.||+|+++... .....+.+|+.++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 456789999999999999765 57899999997432 2234578899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 83 ~~gg~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~ 135 (363)
T cd05628 83 LPGGDMMTLLMKK------------------------DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLD 135 (363)
T ss_pred CCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEEC
Confidence 9999999999542 35788999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCc----------------------------------ccccccccCCCcccccccccCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDM----------------------------------VSMSRIRGTRGYMAPEWLRSDQITP 645 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~----------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ 645 (763)
.++++||+|||+++....... .......||+.|+|||.+.+..++.
T Consensus 136 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~ 215 (363)
T cd05628 136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK 215 (363)
T ss_pred CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC
Confidence 999999999999975432110 0012347999999999999999999
Q ss_pred ccceeehhHHHHHHHhCCCCccc
Q 046586 646 KADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 646 ksDVwS~Gvll~elltG~~p~~~ 668 (763)
++|||||||++|||++|+.||..
T Consensus 216 ~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 216 LCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred chhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.69 Aligned_cols=236 Identities=28% Similarity=0.373 Sum_probs=187.2
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHH-HHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVT-IIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+|+||.||+++.. +++.||+|++.... ....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999875 68899999997431 22234555554 56789999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 81 g~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~ 133 (323)
T cd05575 81 GELFFHLQRE------------------------RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQG 133 (323)
T ss_pred CCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCC
Confidence 9999988542 35778888999999999999999998 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---------~- 202 (323)
T cd05575 134 HVVLTDFGLCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---------A- 202 (323)
T ss_pred cEEEeccCCCcccccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---------H-
Confidence 99999999987532221 223345789999999999999999999999999999999999999964321 0
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
... ..+..... ..+......+.+++.+|++.||.+||++.
T Consensus 203 ----~~~-----~~i~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 203 ----EMY-----DNILNKPL------RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ----HHH-----HHHHcCCC------CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 000 11111111 11123356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=313.79 Aligned_cols=270 Identities=24% Similarity=0.363 Sum_probs=203.7
Q ss_pred HhccccccccccccceEEEEEeCC-----------------CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD-----------------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRL 503 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~-----------------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l 503 (763)
..+.+.++||+|+||.||++...+ +..||+|.++.... ...++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 456778899999999999987643 24589999875432 34678899999999999999999
Q ss_pred EEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 046586 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECL 583 (763)
Q Consensus 504 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~ 583 (763)
++++..++..++|+||+++++|.+++.......... ......+++..++.++.|++.||+|||+.+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~i~~al~~LH~~~- 150 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL-------------ACNSKSLSFSTLLYMATQIASGMRYLESLN- 150 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc-------------cccCCCCCHHHHHHHHHHHHHHHHHHHHcC-
Confidence 999999999999999999999999996542111000 012346899999999999999999999988
Q ss_pred CcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-
Q 046586 584 EWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS- 661 (763)
Q Consensus 584 ~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt- 661 (763)
|+|+||||+||++++++.++|+|||+++........ ......++..|+|||.+....++.++||||||+++|||++
T Consensus 151 --i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 151 --FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred --ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence 999999999999999999999999999765433221 2223456778999999988899999999999999999998
Q ss_pred -CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 662 -GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 662 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
+..|+..... ........+.. ... ........+...+.++.+++.+|++.||++|||+.||+
T Consensus 229 ~~~~p~~~~~~----------~~~~~~~~~~~------~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 229 CREQPYEHLTD----------QQVIENAGHFF------RDD-GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred CCCCCCCCcCh----------HHHHHHHHhcc------ccc-cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 5666642210 11111111110 000 00000011123456899999999999999999999999
Q ss_pred HHhcc
Q 046586 741 KMLEG 745 (763)
Q Consensus 741 ~~Le~ 745 (763)
+.|+.
T Consensus 292 ~~L~~ 296 (296)
T cd05051 292 LFLQR 296 (296)
T ss_pred HHhcC
Confidence 99863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.92 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=196.1
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeC------CeeeE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEK------GERTL 515 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~------~~~~L 515 (763)
.+.+.+.||+|+||.||+|... +++.||+|++........++.+|+.++.++ +|+||+++++++... ...++
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 4556678999999999999875 578899999986666667789999999998 799999999998753 46889
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+|
T Consensus 87 v~e~~~~~~L~~~l~~~----------------------~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~n 141 (272)
T cd06637 87 VMEFCGAGSVTDLIKNT----------------------KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQN 141 (272)
T ss_pred EEEcCCCCcHHHHHHhc----------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHH
Confidence 99999999999998643 2345789999999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
|++++++.+||+|||++....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 142 ili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 142 VLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred EEECCCCCEEEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999999999999999997653322 1223456889999999886 3468889999999999999999999986322
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ......... ..+.. .. ...+..+.+++.+||+.+|.+|||+.+|++
T Consensus 221 ~~----------~~~~~~~~~------~~~~~---~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 221 PM----------RALFLIPRN------PAPRL---KS----KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HH----------HHHHHHhcC------CCCCC---CC----CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 10 000000000 00000 01 123457889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=307.33 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=190.2
Q ss_pred ccccccccceEEEEEeCC---CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELTD---HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~---~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
+.||+|+||.||+|...+ +..+|+|.++.... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998654 35789998875433 2346889999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|.+++...+. .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.+++
T Consensus 81 ~L~~~l~~~~~-------------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~ 138 (269)
T cd05087 81 DLKGYLRSCRK-------------------AELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLT 138 (269)
T ss_pred cHHHHHHHhhh-------------------cccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCc
Confidence 99999965321 01234667888899999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCccc-ccccccCCCcccccccccC-------CCCCccceeehhHHHHHHHh-CCCCcccccCCCC
Q 046586 604 PKISDFGLAKLRKKEDMVS-MSRIRGTRGYMAPEWLRSD-------QITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~-------~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 674 (763)
+||+|||+++......... .....++..|+|||++... .++.++||||||+++|||++ |+.||.......
T Consensus 139 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~- 217 (269)
T cd05087 139 VKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ- 217 (269)
T ss_pred EEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-
Confidence 9999999997543332211 2234567889999988642 46789999999999999996 999986332100
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
.......+. .....++. ......+.+.+++..|+ .+|++|||+.||++.|+
T Consensus 218 ---------~~~~~~~~~-~~~~~~~~--------~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 218 ---------VLTYTVREQ-QLKLPKPR--------LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---------HHHHHhhcc-cCCCCCCc--------cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000000000 00011111 11123446778889999 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.71 Aligned_cols=240 Identities=27% Similarity=0.364 Sum_probs=193.0
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+|+||.||+++.. +++.||+|+++.. ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 4678999999743 22334577888998888 799999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|..++... ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 81 ~~L~~~~~~~------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~ 133 (318)
T cd05570 81 GDLMFHIQRS------------------------GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEG 133 (318)
T ss_pred CCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCC
Confidence 9999988532 35889999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---------- 202 (318)
T cd05570 134 HIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---------- 202 (318)
T ss_pred cEEecccCCCeecCcCC-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----------
Confidence 99999999987432221 1223456899999999999999999999999999999999999999643210
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM-----GKVAK 741 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVv~ 741 (763)
...... ..... ..+......+.+++.+||+.||++||++ .++++
T Consensus 203 ~~~~~i---------~~~~~------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 203 ELFQSI---------LEDEV------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHH---------HcCCC------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 000111 11100 1112345678899999999999999999 87765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=312.76 Aligned_cols=270 Identities=23% Similarity=0.374 Sum_probs=202.1
Q ss_pred HhccccccccccccceEEEEEeC-----------------CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-----------------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRL 503 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-----------------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l 503 (763)
..+.+.++||+|+||.||++... +...+|+|+++.... ...+|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 45677889999999999998532 234689999875432 34578999999999999999999
Q ss_pred EEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 046586 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECL 583 (763)
Q Consensus 504 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~ 583 (763)
++++...+..++||||+++++|.+++......... .......+++.+...++.|++.||+|||+.+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~- 150 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA-------------EKADVVTISYSTLIFMATQIASGMKYLSSLN- 150 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCccccc-------------ccccccccCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 99999999999999999999999999764311100 0113346889999999999999999999988
Q ss_pred CcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCccc-ccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-
Q 046586 584 EWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS-MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS- 661 (763)
Q Consensus 584 ~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt- 661 (763)
++|+||||+||++++++.+||+|||+++......... .....++..|+|||....+.++.++||||||+++|||++
T Consensus 151 --i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~ 228 (296)
T cd05095 151 --FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL 228 (296)
T ss_pred --eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHh
Confidence 9999999999999999999999999997654332211 122334678999999888899999999999999999998
Q ss_pred -CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 662 -GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 662 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
|..|+...... +.. .. ..+.......... ...+..++..+.+++.+||+.||++||++.+|+
T Consensus 229 ~~~~p~~~~~~~---------~~~-~~------~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 229 CKEQPYSQLSDE---------QVI-EN------TGEFFRDQGRQVY-LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred CCCCCccccChH---------HHH-HH------HHHHHhhcccccc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 66777532210 000 00 0000000000000 001123457889999999999999999999999
Q ss_pred HHhcc
Q 046586 741 KMLEG 745 (763)
Q Consensus 741 ~~Le~ 745 (763)
+.|+.
T Consensus 292 ~~l~~ 296 (296)
T cd05095 292 ATLLE 296 (296)
T ss_pred HHHhC
Confidence 99863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.63 Aligned_cols=268 Identities=28% Similarity=0.471 Sum_probs=201.1
Q ss_pred HhccccccccccccceEEEEEeC-CCc--EEEEEEeeccC--CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHR--VVAVKCLKNVT--GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~--~VAvK~l~~~~--~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 516 (763)
..+.+.+.||+|+||.||+|... ++. .+++|.++... ....++.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 45667889999999999999875 343 46777776432 2345688999999999 899999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++............. ........+++.+++.++.|++.||+|||+.+ |+||||||+||
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Ni 155 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFA--------IANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI 155 (303)
T ss_pred EEeCCCCcHHHHHHhccccccccccc--------ccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheE
Confidence 99999999999997643211110000 00112346899999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNS 675 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~ 675 (763)
|+++++.+||+|||+++..... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 230 (303)
T cd05088 156 LVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--- 230 (303)
T ss_pred EecCCCcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---
Confidence 9999999999999998632211 11111234567999999988889999999999999999998 99998533210
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
...+. +.... ....+...+..+.+++.+||+.+|++||++.+++++|+.+.
T Consensus 231 -----------~~~~~------~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 231 -----------ELYEK------LPQGY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred -----------HHHHH------HhcCC----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00110 00000 00111223457889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.30 Aligned_cols=239 Identities=25% Similarity=0.328 Sum_probs=188.1
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHH-HHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVT-IIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+|+||.||+++.. +++.+|+|+++.. .....++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999765 6889999999743 122344556655 46778999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++
T Consensus 81 ~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~ 133 (325)
T cd05604 81 GELFFHLQRE------------------------RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQG 133 (325)
T ss_pred CCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCC
Confidence 9999888532 35788899999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||..... ..
T Consensus 134 ~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---------~~ 203 (325)
T cd05604 134 HVVLTDFGLCKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---------AE 203 (325)
T ss_pred CEEEeecCCcccCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---------HH
Confidence 99999999987532211 123345789999999999999999999999999999999999999964321 00
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
.. ..+....+ ..++.....+.+++..|++.+|.+||++.+.+
T Consensus 204 -----~~-----~~~~~~~~------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 204 -----MY-----DNILHKPL------VLRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -----HH-----HHHHcCCc------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 00 01111111 01122345678899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.03 Aligned_cols=266 Identities=26% Similarity=0.358 Sum_probs=198.3
Q ss_pred hccccccccccccceEEEEEeC-----CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-----DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTL 515 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-----~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~L 515 (763)
.+.+.+.||+|+||.||++... +++.||+|.++.... ..+++.+|++++++++||||+++++++... ...++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4566789999999999999753 477899999875432 345788999999999999999999987543 46889
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
|+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 85 v~e~~~~~~L~~~l~~~-----------------------~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~n 138 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH-----------------------RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRN 138 (284)
T ss_pred EEEecCCCCHHHHHHhc-----------------------CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhh
Confidence 99999999999998542 235789999999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
|++++++++||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++|..+........
T Consensus 139 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~ 218 (284)
T cd05081 139 ILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF 218 (284)
T ss_pred EEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh
Confidence 99999999999999999865432221 1111223456999999998899999999999999999999877653221100
Q ss_pred -C--CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 674 -N--SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 674 -~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
. .......... .. ..+.+.. ......+...+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 219 ~~~~~~~~~~~~~~-~~------~~~~~~~----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 219 MRMMGNDKQGQMIV-YH------LIELLKN----NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhcccccccccch-HH------HHHHHhc----CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0 0000000000 00 0011111 111111233456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.01 Aligned_cols=247 Identities=27% Similarity=0.401 Sum_probs=196.7
Q ss_pred ccccccccceEEEEEeCC--C--cEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELTD--H--RVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~--~--~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
++||+|++|.||+|.... + ..||+|.++.... ..+++.+|+.++++++||||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 2 3689999975433 34678899999999999999999999988 889999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++.... ...+++.....++.|++.||+|||+.+ ++|+||||+||+++.++
T Consensus 80 ~~L~~~l~~~~----------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~ 134 (257)
T cd05040 80 GSLLDRLRKDA----------------------LGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDD 134 (257)
T ss_pred CcHHHHHHhcc----------------------cccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCC
Confidence 99999986531 146789999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCc
Q 046586 603 CPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 679 (763)
.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------- 206 (257)
T cd05040 135 KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-------- 206 (257)
T ss_pred EEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------
Confidence 9999999999866442221 1122456788999999998999999999999999999999 9999853211
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
.+. ...... . ......+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 207 -~~~-~~~~~~---------~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 207 -SQI-LKKIDK---------E----GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -HHH-HHHHHh---------c----CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000 000000 0 0001111234568899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=304.10 Aligned_cols=254 Identities=32% Similarity=0.502 Sum_probs=203.4
Q ss_pred ccccccccceEEEEEeCC----CcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELTD----HRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
++||+|+||.||++.... +..+++|.++..... .+++.+|+++++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998764 778999999865443 56789999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++....... .......+++.++..++.|++.||+|||+.+ |+|+||+|+||++++++
T Consensus 81 ~~L~~~l~~~~~~~---------------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~ 142 (262)
T cd00192 81 GDLLDYLRKSRPVF---------------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDL 142 (262)
T ss_pred CcHHHHHhhccccc---------------cccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCC
Confidence 99999996542100 0001357899999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCch
Q 046586 603 CPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~ 680 (763)
.+||+|||.+........ .......++..|+|||.+....++.++||||+|+++|||++ |..||.....
T Consensus 143 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------- 213 (262)
T cd00192 143 VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------- 213 (262)
T ss_pred cEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---------
Confidence 999999999987654332 22233457889999999988899999999999999999999 6888864311
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
......... ......+...+.++.+++.+|++.+|++|||+.++++.|+
T Consensus 214 -~~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 214 -EEVLEYLRK--------------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -HHHHHHHHc--------------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000111110 1111222344678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=312.08 Aligned_cols=274 Identities=26% Similarity=0.396 Sum_probs=204.3
Q ss_pred HhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
..+.+.+.||+|+||.||++... ++..+|+|+++.... ...++.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 44666789999999999999864 357899999875432 3456889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++............. ..............+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSH--STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccc--cccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 9999999999999997543211111000 00000001112346889999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
||++++++.+||+|||+++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~- 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH- 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999875433222 11222334667999999998899999999999999999998 8778753211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
.+. ......+ .. ...+...+.++.+++.+|++.+|++|||+.||++.|+.
T Consensus 239 --------~~~-~~~~~~~---------~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 --------EEV-IYYVRDG---------NV-----LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --------HHH-HHHHhcC---------CC-----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 010 0111111 00 01112345678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=310.81 Aligned_cols=268 Identities=23% Similarity=0.339 Sum_probs=200.6
Q ss_pred HhccccccccccccceEEEEEeC-----CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeC--Cee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-----DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GER 513 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-----~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 513 (763)
.++.+.++||+|+||.||+++.. ++..||+|.++.... ....+.+|+++++.++||||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34566789999999999999753 467899999874432 335688999999999999999999999875 568
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 84 ~lv~e~~~g~~L~~~l~~~-----------------------~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp 137 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN-----------------------KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAA 137 (284)
T ss_pred EEEEEccCCCCHHHHHHhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccch
Confidence 8999999999999998532 235789999999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++++.|......
T Consensus 138 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 138 RNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred heEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 999999999999999999986543322 112234567789999999888999999999999999999998766432110
Q ss_pred CC-CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 672 MM-NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 672 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.. .........+..... .+.+... .....+...+..+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~------~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRL------VRVLEEG----KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhhhhcccccccccHHHH------HHHHHcC----ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 000000000000000 0000000 01111123467899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=305.85 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=198.0
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
+...+.||+|++|.||++... +++.+|+|.++.... ....+.+|++++++++||||+++++++.+.+..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 456789999999999999764 578999999864321 1245788999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++... ..++......++.|++.||+|||+.+ |+|+||+|+||+
T Consensus 84 e~~~~~~l~~~~~~~------------------------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil 136 (263)
T cd06625 84 EYMPGGSVKDQLKAY------------------------GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANIL 136 (263)
T ss_pred EECCCCcHHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 999999999998542 24678888999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccc--cccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSM--SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
+++++.++|+|||+++.......... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||......
T Consensus 137 v~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--- 213 (263)
T cd06625 137 RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--- 213 (263)
T ss_pred EcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---
Confidence 99999999999999975533221111 2345778999999999999999999999999999999999998532110
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.... .... .......+......+.+++.+||+.+|++|||+.++++.
T Consensus 214 ----------~~~~------~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 214 ----------AAIF------KIAT----QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----------HHHH------HHhc----cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0000 0000 111112223455678899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=323.15 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=196.5
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
....+.+.+.||+|+||.||+++.. +++.+|+|+++... .....+.+|+.+++.++||||+++++.+.+.+..++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3456778899999999999999876 57889999986421 223457789999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+|
T Consensus 121 v~Ey~~gg~L~~~~~~-------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~N 172 (371)
T cd05622 121 VMEYMPGGDLVNLMSN-------------------------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDN 172 (371)
T ss_pred EEcCCCCCcHHHHHHh-------------------------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHH
Confidence 9999999999999843 23677788899999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC----CCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD----QITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
||++.++.+||+|||+++..............||+.|+|||.+... .++.++|||||||++|||++|+.||.....
T Consensus 173 Ill~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 173 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred EEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999986654333333456799999999998653 388999999999999999999999974321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPEL--RPSMGKVAKM 742 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVv~~ 742 (763)
. . . ...++...-..... ........+.+++..|++.++.+ ||++.++++.
T Consensus 253 ~---------~-~---------~~~i~~~~~~~~~~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 253 V---------G-T---------YSKIMNHKNSLTFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred H---------H-H---------HHHHHcCCCcccCC--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0 0 0 01111110000001 11234567788889999854443 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=319.23 Aligned_cols=273 Identities=22% Similarity=0.310 Sum_probs=196.8
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCC-----eeeE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG-----ERTL 515 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~L 515 (763)
|.+.++||+|+||.||+|+.. +++.||||+++... ....++.+|++++++++||||+++++++.... ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 567789999999999999865 57899999987432 23356889999999999999999999886432 5799
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+. ++|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|
T Consensus 82 v~e~~~-~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 133 (338)
T cd07859 82 VFELME-SDLHQVIKAN------------------------DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKN 133 (338)
T ss_pred EEecCC-CCHHHHHHhc------------------------ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999995 6899888532 35789999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCccccccccc--CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRS--DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
||++.++.+||+|||+++....... .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 134 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~ 213 (338)
T cd07859 134 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213 (338)
T ss_pred eEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence 9999999999999999975432221 12234578999999999865 6889999999999999999999999964321
Q ss_pred CCCC------CCCchhHHHHHHHHhccChhhhhcccccccCCCcch---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 672 MMNS------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVH---FDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 672 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.... .......+ ...+... ...+.+... ......... ......+.+++.+||+.||++|||++|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~-~~~i~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 214 VHQLDLITDLLGTPSPET-ISRVRNE-KARRYLSSM-RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHHHHHhCCCCHHH-HHHhhhh-hHHHHHHhh-cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1000 00000000 0000000 001111110 000000000 1234567899999999999999999999953
Q ss_pred --hccCCC
Q 046586 743 --LEGTVE 748 (763)
Q Consensus 743 --Le~~~~ 748 (763)
+++...
T Consensus 291 p~f~~~~~ 298 (338)
T cd07859 291 PYFKGLAK 298 (338)
T ss_pred chhhhcCc
Confidence 554443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.26 Aligned_cols=239 Identities=23% Similarity=0.319 Sum_probs=190.9
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEe
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~E 518 (763)
+.+.+.||+|+||.||+++.. +++.||+|+++... .....+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 456789999999999999876 46789999997432 2234466788888777 68999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 82 ~~~~g~L~~~~~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill 134 (323)
T cd05616 82 YVNGGDLMYQIQQV------------------------GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVML 134 (323)
T ss_pred CCCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEE
Confidence 99999999988542 35788899999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
++++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 135 ~~~~~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------ 207 (323)
T cd05616 135 DSEGHIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ 207 (323)
T ss_pred CCCCcEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------
Confidence 999999999999997543222 1223457899999999999999999999999999999999999999643210
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
.. ...+.... ...+.....++.+++.+|++.||++|++.
T Consensus 208 --------~~-----~~~i~~~~------~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 208 --------EL-----FQSIMEHN------VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --------HH-----HHHHHhCC------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 01111111 01123345678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=316.06 Aligned_cols=239 Identities=24% Similarity=0.297 Sum_probs=189.7
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
++||+|+||.||+++.. +++.||+|+++.. ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 5789999999753 22334567788887755 899999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|..++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 81 g~L~~~i~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~ 133 (316)
T cd05620 81 GDLMFHIQDK------------------------GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDG 133 (316)
T ss_pred CcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCC
Confidence 9999988532 35788889999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||..|+|||.+.+..++.++||||+||++|||++|+.||......
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---------- 202 (316)
T cd05620 134 HIKIADFGMCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---------- 202 (316)
T ss_pred CEEeCccCCCeecccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------
Confidence 99999999987432211 1233467899999999999999999999999999999999999999643210
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG-KVA 740 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVv 740 (763)
...+..... .. ..+.....++.+++.+||+.||++||++. ++.
T Consensus 203 ~~~~~~~~~-----------~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 203 ELFESIRVD-----------TP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHhC-----------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 000111000 00 11122345678899999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=308.42 Aligned_cols=259 Identities=27% Similarity=0.313 Sum_probs=191.1
Q ss_pred cccccccccceEEEEEeCC-CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCC-----eeeEEEecCC
Q 046586 448 SNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG-----ERTLVYEYVP 521 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~LV~Ey~~ 521 (763)
.+++|+|+||.||+|.+.. ++.||||..-..... --+|+++|+++.|||||+|+-+|.... ...|||||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 4699999999999998864 588999987543322 237999999999999999999887543 2347999998
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
. +|.+++..... .+..++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+
T Consensus 106 ~-tL~~~~r~~~~--------------------~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~ 161 (364)
T KOG0658|consen 106 E-TLYRVIRHYTR--------------------ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPD 161 (364)
T ss_pred H-HHHHHHHHHhh--------------------cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCC
Confidence 8 89998864311 2345666667789999999999999988 9999999999999976
Q ss_pred -CCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 602 -FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 602 -~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
|.+||+|||.|+.+...... .....|.-|+|||.+.+ ..|+.+.||||.||++.||+-|+.-|.+.....+
T Consensus 162 tg~LKicDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ----- 234 (364)
T KOG0658|consen 162 TGVLKICDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ----- 234 (364)
T ss_pred CCeEEeccCCcceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH-----
Confidence 99999999999987655433 34567889999998876 5899999999999999999999998876432211
Q ss_pred hhHHHHHHH-------HhccChh--hhhcccccccC-CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 680 FPKWAFEKV-------YEEMKVE--DILDRHIKNSY-DSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~-------~~~~~~~--~~~~~~l~~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.......+ ...+... +.-.+.+.... ..-.......+..+++.++++++|.+|.++.|++.
T Consensus 235 -L~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 235 -LVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred -HHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11100000 0000000 11111111111 01122455678899999999999999999999884
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=317.21 Aligned_cols=239 Identities=22% Similarity=0.308 Sum_probs=190.5
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCC-CccccEEEEEeeCCeeeEEEe
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHH-LNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~LV~E 518 (763)
+.+.+.||+|+||.||+|+.. +++.||+|+++.. ....+.+..|..++..++| ++|+++++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 567789999999999999876 4678999999743 2234567889999999965 568889999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 82 ~~~~g~L~~~~~~~------------------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill 134 (324)
T cd05587 82 YVNGGDLMYHIQQV------------------------GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVML 134 (324)
T ss_pred CCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEE
Confidence 99999999998532 35788899999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.+||+|||+++...... .......||..|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------ 207 (324)
T cd05587 135 DAEGHIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ 207 (324)
T ss_pred cCCCCEEEeecCcceecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------
Confidence 999999999999987432211 1233456899999999999999999999999999999999999999643210
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
... ..+.... ...+......+.+++.+||+.||.+||+.
T Consensus 208 --------~~~-----~~i~~~~------~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 208 --------ELF-----QSIMEHN------VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --------HHH-----HHHHcCC------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 000 0011100 01112345678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=341.67 Aligned_cols=276 Identities=26% Similarity=0.411 Sum_probs=217.5
Q ss_pred HHHHHHHhccccccccccccceEEEEEeCC--------CcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEE
Q 046586 437 HAELRAATNGFSNLIGRGGFGDVYKGELTD--------HRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWG 505 (763)
Q Consensus 437 ~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~--------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g 505 (763)
..|+......+.+.||+|.||.|++|.... ...||||.++.... ..+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 455555555677799999999999997541 35799999986544 356799999999999 6999999999
Q ss_pred EEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 046586 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEW 585 (763)
Q Consensus 506 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ 585 (763)
+|...+..++|.||+..|+|.+||...+.... ....+ ........++..+.+.++.|||.||+||++..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~------~~~~~--~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--- 438 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTES------IDGSG--VFPNERDALTTKDLLSFAYQIANGMEYLASVP--- 438 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhcccccc------ccccC--CCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---
Confidence 99999999999999999999999987650000 00000 00001145999999999999999999999988
Q ss_pred EEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccc--cCCCcccccccccCCCCCccceeehhHHHHHHHh-C
Q 046586 586 VLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR--GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-G 662 (763)
Q Consensus 586 ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~--gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G 662 (763)
+|||||.++|||+.++..+||+|||+|+.....+......-. -+..|||||.+....|+.|+|||||||+||||+| |
T Consensus 439 ~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 439 CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLG 518 (609)
T ss_pred ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCC
Confidence 999999999999999999999999999976655554333222 3567999999999999999999999999999999 8
Q ss_pred CCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 663 SRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 663 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
..||..... ..+++. .+....+...|..+..+++++|+.||+.+|++||+++++++.
T Consensus 519 ~~PYp~~~~----------------------~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~ 575 (609)
T KOG0200|consen 519 GTPYPGIPP----------------------TEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEF 575 (609)
T ss_pred CCCCCCCCc----------------------HHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 888853110 112211 333344444556778899999999999999999999999999
Q ss_pred hccC
Q 046586 743 LEGT 746 (763)
Q Consensus 743 Le~~ 746 (763)
|+.+
T Consensus 576 ~~~~ 579 (609)
T KOG0200|consen 576 FEKH 579 (609)
T ss_pred HHHH
Confidence 9884
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=306.87 Aligned_cols=239 Identities=24% Similarity=0.401 Sum_probs=186.7
Q ss_pred ccccccccceEEEEEeCC-------------CcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 449 NLIGRGGFGDVYKGELTD-------------HRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~-------------~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
+.||+|+||.||+|...+ ...|++|.+..... ....|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997542 22588888764432 3356888999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++++|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 81 lv~e~~~~~~l~~~~~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~ 134 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK-----------------------SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTK 134 (262)
T ss_pred EEEecccCCCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcc
Confidence 999999999999888532 235788999999999999999999988 999999999
Q ss_pred ceEEcCCCC-------eEEcccCcccccCCCCcccccccccCCCcccccccc-cCCCCCccceeehhHHHHHHH-hCCCC
Q 046586 595 NILLGDDFC-------PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIV-SGSRN 665 (763)
Q Consensus 595 NILl~~~~~-------~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvll~ell-tG~~p 665 (763)
|||++.++. +|++|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|
T Consensus 135 Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (262)
T cd05077 135 NILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209 (262)
T ss_pred cEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 999987664 899999998654322 2245778899999886 567899999999999999998 57777
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
+...... . ....... ... .. ......+.+++.+||+.||++||++.+|++.|+
T Consensus 210 ~~~~~~~---------~--~~~~~~~---------~~~--~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 210 LKDKTLA---------E--KERFYEG---------QCM--LV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCCcchh---------H--HHHHHhc---------Ccc--CC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 6532110 0 0011111 000 00 112356889999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.69 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=202.7
Q ss_pred HhccccccccccccceEEEEEeC------CCcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
..+...+.||+|+||.||+|+.. +.+.|++|.+...... ..++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 34455678999999999999864 2467999988754433 467899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++........ ......+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~---------------~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~ 146 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDE---------------KLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAAR 146 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccc---------------cccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccc
Confidence 99999999999999965421000 001236899999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
||+++.++.++|+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 147 Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-- 224 (275)
T cd05046 147 NCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-- 224 (275)
T ss_pred eEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--
Confidence 9999999999999999987544333333334456778999999988889999999999999999998 7778753211
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
... ...... .... ...+...+..+.+++.+||+.+|++||++.+++++|++
T Consensus 225 -------~~~-~~~~~~---------~~~~----~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 225 -------EEV-LNRLQA---------GKLE----LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred -------HHH-HHHHHc---------CCcC----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 000 000000 0000 00112345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=313.15 Aligned_cols=272 Identities=25% Similarity=0.370 Sum_probs=205.3
Q ss_pred HHHhccccccccccccceEEEEEeC--------CCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEee
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT--------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCAE 509 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~--------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 509 (763)
....+.+.++||+|+||.||+++.. ....+|+|+++.... ...++.+|+++++++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3456678899999999999999752 245799999875432 235688999999999 69999999999999
Q ss_pred CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEec
Q 046586 510 KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHC 589 (763)
Q Consensus 510 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHr 589 (763)
.+..++||||+++|+|.+++............. ........+++.+.+.++.|++.||.|||+.+ |+||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~ 158 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD--------ITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHR 158 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCccccccc--------ccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 999999999999999999997643111100000 00012346899999999999999999999988 9999
Q ss_pred CCCCCceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcc
Q 046586 590 DIKPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFE 667 (763)
Q Consensus 590 Dlk~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~ 667 (763)
||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred cccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999865432221 1112234567999999998999999999999999999999 888875
Q ss_pred cccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.... .........+ .....+...+..+.+++.+|++.+|++||++.++++.|++..
T Consensus 239 ~~~~----------~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 239 GIPV----------EELFKLLREG--------------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred CCCH----------HHHHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 3211 0011111111 001111334567889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.97 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=201.9
Q ss_pred HHHhccccccccccccceEEEEEeCC----CcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTD----HRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
...++.+.++||+|+||.||+|...+ ...|++|..+... ...+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34556778899999999999998643 2468999887543 234578999999999999999999999875 5678
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||||+
T Consensus 83 lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~ 136 (270)
T cd05056 83 IVMELAPLGELRSYLQVN-----------------------KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAAR 136 (270)
T ss_pred EEEEcCCCCcHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChh
Confidence 999999999999999542 235789999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
||+++.++.+||+|||+++..............++..|+|||.+....++.++||||||+++||+++ |..||......
T Consensus 137 nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~- 215 (270)
T cd05056 137 NVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN- 215 (270)
T ss_pred eEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-
Confidence 9999999999999999998655443222223344568999999988899999999999999999996 99998643210
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. .......+. ....+...+..+.+++.+|+..+|++|||+.++++.|++..
T Consensus 216 --------~-~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 216 --------D-VIGRIENGE--------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred --------H-HHHHHHcCC--------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 001111110 00112344568899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.77 Aligned_cols=247 Identities=26% Similarity=0.350 Sum_probs=194.3
Q ss_pred cccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 446 GFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.+...||+|+||.||+++-. .|..+|+|+++++. ...+..+.|-.+|...++|.||+|+-.|.+.+.+||||||+
T Consensus 144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence 34569999999999999765 58999999998653 23455788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
|||++..+|.+ ...|+.....-++.+++.|+.-||+.| ||||||||+|+|||.
T Consensus 224 PGGD~mTLL~~------------------------~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~ 276 (550)
T KOG0605|consen 224 PGGDMMTLLMR------------------------KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDA 276 (550)
T ss_pred CCccHHHHHHh------------------------cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecC
Confidence 99999999964 357888888888899999999999999 999999999999999
Q ss_pred CCCeEEcccCcccccCC----------------------CCccc------c------------------cccccCCCccc
Q 046586 601 DFCPKISDFGLAKLRKK----------------------EDMVS------M------------------SRIRGTRGYMA 634 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~----------------------~~~~~------~------------------~~~~gt~~y~A 634 (763)
.|++||+||||+.-+.. .+... . ...+||+.|||
T Consensus 277 ~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiA 356 (550)
T KOG0605|consen 277 KGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIA 356 (550)
T ss_pred CCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccc
Confidence 99999999999953211 00000 0 11369999999
Q ss_pred ccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHH
Q 046586 635 PEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDM 714 (763)
Q Consensus 635 PE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 714 (763)
||++.+..|+..+|.||+|||+|||+.|.+||....+. ..++.+.... ..+..... ...
T Consensus 357 PEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~----------~T~rkI~nwr-------~~l~fP~~----~~~ 415 (550)
T KOG0605|consen 357 PEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ----------ETYRKIVNWR-------ETLKFPEE----VDL 415 (550)
T ss_pred hHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHHHHh-------hhccCCCc----Ccc
Confidence 99999999999999999999999999999999754421 1222221111 01111111 233
Q ss_pred HHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 046586 715 VNRMVKTAMWCIQDRPELRPS---MGKVAK 741 (763)
Q Consensus 715 ~~~l~~l~~~Cl~~dP~~RPs---~~eVv~ 741 (763)
..+..+++.+|+- ||++|-- +.||.+
T Consensus 416 s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 416 SDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred cHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 4778889999998 9999975 555553
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=318.15 Aligned_cols=278 Identities=26% Similarity=0.370 Sum_probs=209.4
Q ss_pred HHHHHHhccccccccccccceEEEEEeC--------CCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEE
Q 046586 438 AELRAATNGFSNLIGRGGFGDVYKGELT--------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGF 506 (763)
Q Consensus 438 ~el~~~t~~~~~~LG~G~fG~Vy~g~~~--------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~ 506 (763)
.++...++.+.+.||+|+||.||++... ....||+|.++.... ...++.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 4555667888999999999999999642 123689998874322 345788999999999 89999999999
Q ss_pred EeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 507 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
+.+.+..++|+||+++|+|.+++............. ........+++.+++.++.|++.||+|||+.+ |
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i 155 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD--------TCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---C 155 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccc--------cccCccccCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 999999999999999999999997542110000000 00013446899999999999999999999988 9
Q ss_pred EecCCCCCceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCC
Q 046586 587 LHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSR 664 (763)
Q Consensus 587 vHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~ 664 (763)
+||||||+||++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..
T Consensus 156 vH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 235 (334)
T cd05100 156 IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235 (334)
T ss_pred eccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999765432211 1122334567999999999999999999999999999998 788
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
||..... .+. ...+..+ .....+......+.+++.+|++.+|++||++.|+++.|+
T Consensus 236 p~~~~~~---------~~~-~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 236 PYPGIPV---------EEL-FKLLKEG--------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred CCCCCCH---------HHH-HHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 8753210 000 0011000 001111234567889999999999999999999999999
Q ss_pred cCCCCC
Q 046586 745 GTVEIT 750 (763)
Q Consensus 745 ~~~~~~ 750 (763)
.+....
T Consensus 292 ~~~~~~ 297 (334)
T cd05100 292 RVLTVT 297 (334)
T ss_pred HHhhhc
Confidence 877443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=316.46 Aligned_cols=236 Identities=28% Similarity=0.353 Sum_probs=186.4
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHH-HHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVT-IIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
++||+|+||.||+++.. +++.||+|++.... ....++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57899999997432 22334555554 57889999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|..++... ..+.......++.||+.||+|||+.+ |+||||||+||+++.++
T Consensus 81 ~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~ 133 (321)
T cd05603 81 GELFFHLQRE------------------------RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQG 133 (321)
T ss_pred CCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCC
Confidence 9999888532 34677888889999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~- 202 (321)
T cd05603 134 HVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---------S- 202 (321)
T ss_pred CEEEccCCCCccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---------H-
Confidence 99999999987532221 123345789999999999999999999999999999999999999964321 0
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
... ..+.... ..++......+.+++.+|++.||.+||++.
T Consensus 203 ----~~~-----~~i~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 203 ----QMY-----DNILHKP------LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ----HHH-----HHHhcCC------CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 001 1111111 111233456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=307.78 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=188.1
Q ss_pred ccccccccceEEEEEeCC---CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELTD---HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~---~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
++||+|+||.||+|...+ ...+++|.++.... ...+|.+|+++++.++|+||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997643 34678887764332 2356889999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|.+++...+.. .....++.....++.||+.||+|||+.+ |+||||||+||++++++.
T Consensus 81 ~L~~~l~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~ 138 (269)
T cd05042 81 DLKNYLRSNRGM-------------------VAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLS 138 (269)
T ss_pred cHHHHHHhcccc-------------------ccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCc
Confidence 999999654210 1223567888999999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCcc-cccccccCCCccccccccc-------CCCCCccceeehhHHHHHHHh-CCCCcccccCCCC
Q 046586 604 PKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRS-------DQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 674 (763)
+||+|||+++........ ......++..|+|||++.. ..++.++||||||+++|||++ |..||......
T Consensus 139 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-- 216 (269)
T cd05042 139 VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-- 216 (269)
T ss_pred EEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--
Confidence 999999998754332221 1122345678999998742 467889999999999999999 77787532110
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
.......... ...+.. ...+......+.+++..|+ .||++|||+++|+++|.
T Consensus 217 --------~~~~~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 217 --------QVLKQVVREQ-DIKLPK--------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --------HHHHHHhhcc-CccCCC--------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000100000 001111 1112334566777888888 49999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=324.06 Aligned_cols=249 Identities=22% Similarity=0.277 Sum_probs=191.2
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
|.+.++||+|+||.||+++.. +++.||+|++.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 556789999999999999764 67899999986432 2235678899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++
T Consensus 83 ~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~ 135 (377)
T cd05629 83 LPGGDLMTMLIKY------------------------DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILID 135 (377)
T ss_pred CCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEC
Confidence 9999999998542 35778888899999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCc-------------c---------------------------------cccccccCCCcc
Q 046586 600 DDFCPKISDFGLAKLRKKEDM-------------V---------------------------------SMSRIRGTRGYM 633 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~-------------~---------------------------------~~~~~~gt~~y~ 633 (763)
.++.+||+|||+++....... . ......||+.|+
T Consensus 136 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 215 (377)
T cd05629 136 RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYI 215 (377)
T ss_pred CCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcccc
Confidence 999999999999963221000 0 001246899999
Q ss_pred cccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHH
Q 046586 634 APEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFD 713 (763)
Q Consensus 634 APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 713 (763)
|||.+.+..++.++|||||||++|||++|+.||...... .......... ..+. .+. ...
T Consensus 216 aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----------~~~~~i~~~~-------~~~~--~p~--~~~ 274 (377)
T cd05629 216 APEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSH----------ETYRKIINWR-------ETLY--FPD--DIH 274 (377)
T ss_pred CHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHH----------HHHHHHHccC-------CccC--CCC--CCC
Confidence 999999999999999999999999999999999643210 0011111000 0000 000 012
Q ss_pred HHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 046586 714 MVNRMVKTAMWCIQDRPELR---PSMGKVAKM 742 (763)
Q Consensus 714 ~~~~l~~l~~~Cl~~dP~~R---Ps~~eVv~~ 742 (763)
...++.+++..|++ +|.+| |++.|+++.
T Consensus 275 ~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 275 LSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 34567788888997 66665 599998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=325.05 Aligned_cols=199 Identities=28% Similarity=0.379 Sum_probs=169.1
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.++||+|+||.||+++.. +++.||+|+++.. ......+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 3567789999999999999875 5789999998642 2234567899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ..++......++.||+.||+|||+.+ |+||||||+|||+
T Consensus 82 ~~~~g~L~~~i~~~------------------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill 134 (376)
T cd05598 82 YIPGGDMMSLLIRL------------------------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILI 134 (376)
T ss_pred CCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEE
Confidence 99999999999542 34677888889999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCC------------------------------------------cccccccccCCCccccc
Q 046586 599 GDDFCPKISDFGLAKLRKKED------------------------------------------MVSMSRIRGTRGYMAPE 636 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~------------------------------------------~~~~~~~~gt~~y~APE 636 (763)
+.++.+||+|||++....... ........||+.|+|||
T Consensus 135 ~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 214 (376)
T cd05598 135 DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE 214 (376)
T ss_pred CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHH
Confidence 999999999999975321000 00012346899999999
Q ss_pred ccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 637 WLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 637 ~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
++.+..++.++|||||||++|||++|+.||...
T Consensus 215 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 215 VLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred HHcCCCCCcceeeeeccceeeehhhCCCCCCCC
Confidence 999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=305.48 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=197.6
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..+.+.++||+|+||.||+|+. .+++.||+|+++... .....+.+|+.++.+++||||+++++.+...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4567788999999999999986 467889999997443 23455788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||+|+||++++
T Consensus 89 ~~~~L~~~~~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~ 141 (267)
T cd06646 89 GGGSLQDIYHVT------------------------GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTD 141 (267)
T ss_pred CCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECC
Confidence 999999988532 35788899999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.+||+|||+++...... .......++..|+|||.+. ...++.++||||||+++|||++|+.|+........
T Consensus 142 ~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--- 217 (267)
T cd06646 142 NGDVKLADFGVAAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--- 217 (267)
T ss_pred CCCEEECcCccceeecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh---
Confidence 9999999999998653221 1122346788999999874 45678899999999999999999999853221100
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
...+........ ........+..+.+++.+||+.+|++||++++|++.|
T Consensus 218 ----------------~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 218 ----------------LFLMSKSNFQPP-KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ----------------heeeecCCCCCC-CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000000000 0000123456788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=316.93 Aligned_cols=240 Identities=25% Similarity=0.345 Sum_probs=187.5
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHH-HHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVT-IIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+|+||.||+++.. +++.+|+|+++... ....++..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 56789999997432 22234444544 56788999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++... ..+.......++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 81 ~~L~~~~~~~------------------------~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~ 133 (325)
T cd05602 81 GELFYHLQRE------------------------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQG 133 (325)
T ss_pred CcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCC
Confidence 9999998542 24667778889999999999999998 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus 134 ~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~ 203 (325)
T cd05602 134 HIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---------E 203 (325)
T ss_pred CEEEccCCCCcccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---------H
Confidence 99999999997532221 1233457899999999999999999999999999999999999999643210 0
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. .. .+..... ..+......+.+++.+|++.||.+||++.+.+.
T Consensus 204 ~-~~---------~i~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 204 M-YD---------NILNKPL------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred H-HH---------HHHhCCc------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0 00 1111101 011234567889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=310.20 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=199.0
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
++.+.+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|+.+++.++|+||+++++.+......++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 5666789999999999999864 67899999987433 344668899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++.. ..+++.++..++.|++.||+|||+.+ |+|+||||+||+++.+
T Consensus 101 ~~~L~~~~~~-------------------------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~ 152 (296)
T cd06654 101 GGSLTDVVTE-------------------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMD 152 (296)
T ss_pred CCCHHHHHHh-------------------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCC
Confidence 9999999842 24678899999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
+.+||+|||++........ ......++..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 153 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------- 223 (296)
T cd06654 153 GSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------- 223 (296)
T ss_pred CCEEECccccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--------
Confidence 9999999999875433221 1223467889999999998889999999999999999999999996432100
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.+... ... .......+......+.+++.+||+.+|++||++.+|++.
T Consensus 224 -----~~~~~-----~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 224 -----ALYLI-----ATN----GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -----hHHHH-----hcC----CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00000 000 000011123445678899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=323.77 Aligned_cols=198 Identities=28% Similarity=0.378 Sum_probs=168.2
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.+.++||+|+||.||+|+.. +++.+|+|++.... .....+.+|++++++++|+||+++++.+.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 456789999999999999875 57889999997432 2335688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++.+. ..++......++.||+.||+|||+.+ |+||||||+|||++
T Consensus 83 ~~gg~L~~~l~~~------------------------~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~ 135 (382)
T cd05625 83 IPGGDMMSLLIRM------------------------GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILID 135 (382)
T ss_pred CCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999998542 24677888899999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCC----------------------------------------------cccccccccCCCcc
Q 046586 600 DDFCPKISDFGLAKLRKKED----------------------------------------------MVSMSRIRGTRGYM 633 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~----------------------------------------------~~~~~~~~gt~~y~ 633 (763)
.++++||+|||+++...... ........||+.|+
T Consensus 136 ~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 215 (382)
T cd05625 136 RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYI 215 (382)
T ss_pred CCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccC
Confidence 99999999999975321000 00012346899999
Q ss_pred cccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 634 APEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 634 APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 216 aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 216 APEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred CHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCC
Confidence 999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=308.62 Aligned_cols=268 Identities=24% Similarity=0.359 Sum_probs=204.5
Q ss_pred HhccccccccccccceEEEEEeC-----CCcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEee--CCee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-----DHRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAE--KGER 513 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-----~~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 513 (763)
..+.+.+.||+|+||.||+++.. .++.+|||+++..... ..+|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34566789999999999999864 3578999999865553 5679999999999999999999999987 5578
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||
T Consensus 84 ~lv~e~~~~~~l~~~l~~~-----------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p 137 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH-----------------------RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAA 137 (284)
T ss_pred EEEEecCCCCCHHHHHHhC-----------------------ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 9999999999999999642 225889999999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....
T Consensus 138 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 217 (284)
T cd05038 138 RNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA 217 (284)
T ss_pred HhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccc
Confidence 9999999999999999999876532211 11123455679999999888999999999999999999999998753221
Q ss_pred CCCC-CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 672 MMNS-DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 672 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.... ............ ..+.+.... ....+..++.++.+++.+||+.+|++||+|.||+++|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~------~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 218 EFLRMIGIAQGQMIVTR------LLELLKEGE----RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred hhccccccccccccHHH------HHHHHHcCC----cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1000 000000000000 111111111 1111233457799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=302.28 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=201.5
Q ss_pred hccccccccccccceEEEEEeCC-CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
.+.+.++||+|+||.||+|...+ ++.+++|.++.... .+++.+|++++++++|+||+++++++.+....++++||+++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 45667899999999999998875 78899999875433 67899999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++
T Consensus 83 ~~L~~~l~~~-----------------------~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~ 136 (256)
T cd06612 83 GSVSDIMKIT-----------------------NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEG 136 (256)
T ss_pred CcHHHHHHhC-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCC
Confidence 9999998542 346889999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......
T Consensus 137 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--------- 206 (256)
T cd06612 137 QAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--------- 206 (256)
T ss_pred cEEEcccccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---------
Confidence 999999999986543321 2223457889999999998899999999999999999999999986432110
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
... .+....... ...+......+.+++.+||+.||++|||+.||++
T Consensus 207 ----~~~-------~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 207 ----AIF-------MIPNKPPPT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ----hhh-------hhccCCCCC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000 000000000 1111334567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.61 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=197.5
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
++||+|+||.||++...+++.|++|.++.... ...++.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987789999999875433 3457899999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEE
Q 046586 527 DYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKI 606 (763)
Q Consensus 527 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI 606 (763)
+++... ...+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.+||
T Consensus 81 ~~l~~~-----------------------~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l 134 (251)
T cd05041 81 TFLRKK-----------------------KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKI 134 (251)
T ss_pred HHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEE
Confidence 998542 235778899999999999999999988 999999999999999999999
Q ss_pred cccCcccccCCCCcccc-cccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhHHH
Q 046586 607 SDFGLAKLRKKEDMVSM-SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPKWA 684 (763)
Q Consensus 607 ~DFGla~~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 684 (763)
+|||+++.......... .....+..|+|||.+.++.++.++||||||+++|||++ |..||...... .
T Consensus 135 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---------~-- 203 (251)
T cd05041 135 SDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---------Q-- 203 (251)
T ss_pred eeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---------H--
Confidence 99999975532211111 12234567999999988899999999999999999999 78887532210 0
Q ss_pred HHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 685 FEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 685 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
..+.+.... ....+...+..+.+++.+|++.+|++||++.||++.|++
T Consensus 204 ---------~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 204 ---------TRERIESGY----RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ---------HHHHHhcCC----CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 000111100 111123445689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=315.55 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=193.7
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.++||+|+||.||+++.. +++.||+|+++... .....+.+|..++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 3567789999999999999876 56789999997421 223457889999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 82 y~~gg~L~~~l~~~-----------------------~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill 135 (331)
T cd05624 82 YYVGGDLLTLLSKF-----------------------EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLL 135 (331)
T ss_pred CCCCCcHHHHHHHh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEE
Confidence 99999999999642 235788888999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-----CCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-----DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
+.++.+||+|||+++..............||+.|+|||.+.+ +.++.++||||||+++|||++|+.||.....
T Consensus 136 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-- 213 (331)
T cd05624 136 DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-- 213 (331)
T ss_pred cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--
Confidence 999999999999997655443333334568999999998865 5688999999999999999999999963321
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPEL--RPSMGKVAKM 742 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVv~~ 742 (763)
.. ... .+.........+... ...++++.+++.+|+..++.+ |+++.++++.
T Consensus 214 -------~~-~~~---------~i~~~~~~~~~p~~~-~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 214 -------VE-TYG---------KIMNHEERFQFPSHI-TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -------HH-HHH---------HHHcCCCcccCCCcc-ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 001 111100000011000 123567778888888765544 5678888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=305.79 Aligned_cols=253 Identities=28% Similarity=0.464 Sum_probs=197.4
Q ss_pred ccccccccceEEEEEeCC-------CcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 449 NLIGRGGFGDVYKGELTD-------HRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~-------~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.||+|+||.||+|+..+ ++.+|+|.+.... ....++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997643 2579999886433 3456789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++....... .....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++
T Consensus 81 ~~~~~L~~~l~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~ 140 (269)
T cd05044 81 MEGGDLLSYLRDARVER-----------------FGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVS 140 (269)
T ss_pred cCCCcHHHHHHHhhhcc-----------------cCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEe
Confidence 99999999997532100 02235789999999999999999999988 99999999999999
Q ss_pred CCC-----CeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 600 DDF-----CPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 600 ~~~-----~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
.+. .+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |+.||.....
T Consensus 141 ~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~- 219 (269)
T cd05044 141 EKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN- 219 (269)
T ss_pred cCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-
Confidence 887 8999999999755433221 1122345678999999999999999999999999999998 9988853211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
... .... .. ......+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 220 --------~~~-~~~~----------~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 220 --------QEV-LQHV----------TA----GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------HHH-HHHH----------hc----CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 0000 00 00111123446778899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.11 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=198.6
Q ss_pred ccccccccccccceEEEEEeCC--CcEEEEEEeeccC-----------CchhhhHHHHHHHhc-CCCCccccEEEEEeeC
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD--HRVVAVKCLKNVT-----------GGDAEFWAEVTIIAR-MHHLNLVRLWGFCAEK 510 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~--~~~VAvK~l~~~~-----------~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~ 510 (763)
+.+.+.||+|+||.||+|.... ++.+|+|.+.... ....++..|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4566789999999999998865 6789999885321 112346778888865 7999999999999999
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEec
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE-ECLEWVLHC 589 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHr 589 (763)
+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+ ++|+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~--------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~ 138 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKE--------------------KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHR 138 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHh--------------------ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeec
Confidence 999999999999999998854210 23468889999999999999999996 45 9999
Q ss_pred CCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 590 DIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 590 Dlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
||+|+||+++.++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 139 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 139 DLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred CCCHHHEEECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 999999999999999999999998654433 233456888999999999889999999999999999999999998632
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
.. .... .. +.+........ ......+.+++.+||+.||++||++.||.++++.
T Consensus 217 ~~---------~~~~-~~---------~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 217 NM---------LSLA-TK---------IVEAVYEPLPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CH---------HHHH-HH---------HhhccCCcCCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 21 0000 01 11111110000 1234678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.77 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=199.2
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeecc--CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV--TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
+.+.++||+|+||.||++... +++.+|+|.++.. ....+.+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 456789999999999999775 5788999998643 2334668899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++... ....++....+.++.|++.||.|||+.+ |+|+||||+||+++++
T Consensus 82 ~~~l~~~~~~~----------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~ 136 (255)
T cd08219 82 GGDLMQKIKLQ----------------------RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQN 136 (255)
T ss_pred CCcHHHHHHhc----------------------cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCC
Confidence 99999988542 2235778889999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
+.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .
T Consensus 137 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---------~ 206 (255)
T cd08219 137 GKVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---------K 206 (255)
T ss_pred CcEEEcccCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---------H
Confidence 9999999999976543222 12235688899999999988999999999999999999999999963221 0
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
... .....+ . ....+......+.+++.+||+.||++||++.+|+..
T Consensus 207 ~~~-~~~~~~-------------~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 207 NLI-LKVCQG-------------S-YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHH-HHHhcC-------------C-CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000 000000 0 011123345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=304.33 Aligned_cols=249 Identities=26% Similarity=0.423 Sum_probs=190.5
Q ss_pred ccccccccceEEEEEeCC----CcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEee-CCeeeEEEecCC
Q 046586 449 NLIGRGGFGDVYKGELTD----HRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAE-KGERTLVYEYVP 521 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~LV~Ey~~ 521 (763)
+.||+|+||.||+|...+ ...+|+|.+.... ...+.+.+|+.+++.++||||+++++++.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999997632 3579999886432 234578899999999999999999998764 556889999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++... ...+.+..++.++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 81 ~~~L~~~~~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~ 134 (262)
T cd05058 81 HGDLRNFIRSE-----------------------THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDES 134 (262)
T ss_pred CCCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCC
Confidence 99999998542 223567788999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcc---cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCC-CCcccccCCCCCCC
Q 046586 602 FCPKISDFGLAKLRKKEDMV---SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS-RNFEIQGSMMNSDE 677 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~-~p~~~~~~~~~~~~ 677 (763)
+.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++|. .|+.....
T Consensus 135 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------ 208 (262)
T cd05058 135 FTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------ 208 (262)
T ss_pred CcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 99999999999754332211 112334577899999998889999999999999999999954 45542110
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.... .....+. ....+...+..+.+++..||+.+|++||++.+|++.|+...
T Consensus 209 ---~~~~-~~~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 209 ---FDIT-VYLLQGR--------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---HHHH-HHHhcCC--------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0000 0011100 00111223457889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=314.00 Aligned_cols=239 Identities=21% Similarity=0.311 Sum_probs=190.9
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEe
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~E 518 (763)
+++.+.||+|+||.||++... +++.||+|+++.. ....+.+..|..++..+. |++|+++.+++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 567789999999999999875 5789999999743 223345778899988885 6778889999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 82 y~~~g~L~~~i~~~------------------------~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill 134 (323)
T cd05615 82 YVNGGDLMYHIQQV------------------------GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVML 134 (323)
T ss_pred CCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEE
Confidence 99999999998532 35889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.+||+|||+++....... ......||..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 135 ~~~~~ikL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------ 207 (323)
T cd05615 135 DSEGHIKIADFGMCKEHMVDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ 207 (323)
T ss_pred CCCCCEEEeccccccccCCCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------
Confidence 9999999999999975432221 223456899999999999999999999999999999999999999643210
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
. . ...+..... ..+.....++.+++.+|++.+|.+|++.
T Consensus 208 ----~----~-----~~~i~~~~~------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 208 ----E----L-----FQSIMEHNV------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----H----H-----HHHHHhCCC------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 0 011111110 1112345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=323.10 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=194.3
Q ss_pred cccccccccccceEEEEEeC-CCcEEEEEEee---c--cCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCe--eeEEE
Q 046586 446 GFSNLIGRGGFGDVYKGELT-DHRVVAVKCLK---N--VTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE--RTLVY 517 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~---~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~--~~LV~ 517 (763)
.|.++||+|+|-+||+|... +|-.||---++ . .....+.|..|+++|+.|+|||||+++..+.+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45679999999999999775 45566633222 1 22233679999999999999999999999988765 77899
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
|.|..|+|+.|+.+++ .++.....+|+.||++||.|||++. |+|||||||.+||+
T Consensus 123 EL~TSGtLr~Y~kk~~------------------------~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIF 177 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR------------------------RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIF 177 (632)
T ss_pred ecccCCcHHHHHHHhc------------------------cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEE
Confidence 9999999999998764 4677889999999999999999988 78999999999999
Q ss_pred EcC-CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 598 LGD-DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 598 l~~-~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
|+. -|.|||+|+|||.+...... ..+.||+.|||||+.. ..|.+.+||||||+.|+||+|+..||..-..
T Consensus 178 inG~~G~VKIGDLGLAtl~r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n----- 248 (632)
T KOG0584|consen 178 VNGNLGEVKIGDLGLATLLRKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN----- 248 (632)
T ss_pred EcCCcCceeecchhHHHHhhcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----
Confidence 976 58999999999997765432 3378999999999887 8999999999999999999999999963321
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..++..+...+..+..+..-...++.+++..|+.. .++|||+.|+++
T Consensus 249 -----------------~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 249 -----------------PAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----------------HHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 12222222222222112222346789999999999 999999999984
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.96 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=186.6
Q ss_pred ccccccccceEEEEEeCCCc---EEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELTDHR---VVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~---~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
++||+|+||.||+|+..++. .+++|.++... ...++|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999765433 45666665432 23467999999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|.+++..... ......+.....++.||+.||+|||+.+ ++||||||+|||++.++.
T Consensus 81 ~L~~~l~~~~~--------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~ 137 (268)
T cd05086 81 DLKSYLSQEQW--------------------HRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLT 137 (268)
T ss_pred cHHHHHHhhhc--------------------ccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCcc
Confidence 99999965321 1234567778899999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCc-ccccccccCCCccccccccc-------CCCCCccceeehhHHHHHHHh-CCCCcccccCCCC
Q 046586 604 PKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRS-------DQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 674 (763)
+||+|||++........ .......++..|+|||++.. ..++.++||||||+++|||++ |..||.....
T Consensus 138 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--- 214 (268)
T cd05086 138 VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--- 214 (268)
T ss_pred EEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 99999999864322211 12233467889999998753 346789999999999999997 4667753211
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
... ......+. ...+.++.+. ......+.+++..|| .+|++||++.+|++.|.
T Consensus 215 ------~~~-~~~~~~~~-~~~~~~~~~~--------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 215 ------REV-LNHVIKDQ-QVKLFKPQLE--------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ------HHH-HHHHHhhc-ccccCCCccC--------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 011 11111111 1111222111 123456778888899 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=299.32 Aligned_cols=267 Identities=21% Similarity=0.245 Sum_probs=197.9
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCc-cccEEEEEeeCC------ee
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLN-LVRLWGFCAEKG------ER 513 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~------~~ 513 (763)
+...++||+|+||+||+|+.. +|+.||+|.++-... ......+|+.++++++|+| ||+|++++...+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 444568999999999999765 678999999974432 3345689999999999999 999999999877 78
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
+||+||++. +|..++..... ....++......+..||++||+|||+++ |+||||||
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~--------------------~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKP 148 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPK--------------------KPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKP 148 (323)
T ss_pred EEEEEeecc-cHHHHHHhccc--------------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCc
Confidence 999999965 99999965431 0034566888999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
.||||+++|.+||+|||+|+...-.. ...++.++|..|+|||.+.+. .|+...||||+||++.||++++.-|.+..+.
T Consensus 149 QNlLi~~~G~lKlaDFGlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~ 227 (323)
T KOG0594|consen 149 QNLLISSSGVLKLADFGLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI 227 (323)
T ss_pred ceEEECCCCcEeeeccchHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH
Confidence 99999999999999999999654332 235567889999999998876 8999999999999999999999888654321
Q ss_pred CCCCCCchhHHHHHHHHhc--cChhh---hhccc--ccccC-CCcchHH---HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEE--MKVED---ILDRH--IKNSY-DSRVHFD---MVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~--l~~~~-~~~~~~~---~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. ......+.+-.. ..... +.+-. ..... ...+... ......+++.+|++.+|.+|.|++..++
T Consensus 228 ~------ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 228 D------QLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred H------HHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 1 111111110000 00000 00000 00000 0011111 1247889999999999999999999998
Q ss_pred H
Q 046586 742 M 742 (763)
Q Consensus 742 ~ 742 (763)
+
T Consensus 302 h 302 (323)
T KOG0594|consen 302 H 302 (323)
T ss_pred C
Confidence 6
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.75 Aligned_cols=199 Identities=25% Similarity=0.352 Sum_probs=170.1
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.+.||+|+||.||+++.. +++.||+|+++.. ......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 3567889999999999999875 5789999999742 2233458889999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ...++...+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 82 ~~~g~~L~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill 135 (331)
T cd05597 82 YYVGGDLLTLLSKF-----------------------EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLL 135 (331)
T ss_pred cCCCCcHHHHHHHh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEE
Confidence 99999999999542 235788889999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-----CCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-----DQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
+.++.+||+|||++...............||+.|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 136 DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 999999999999997654433322233468999999999863 4678899999999999999999999963
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.43 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=192.7
Q ss_pred hccccccccccccceEEEEEeCC-CcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.+.+.++||+|+||.||+++... ++.+|+|++... ......+..|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 35677899999999999998864 678999998642 1223457889999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 82 y~~~g~L~~~l~~~-----------------------~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili 135 (332)
T cd05623 82 YYVGGDLLTLLSKF-----------------------EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILM 135 (332)
T ss_pred ccCCCcHHHHHHHh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEE
Confidence 99999999999642 235788889999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
+.++.+||+|||++...............||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 136 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-- 213 (332)
T cd05623 136 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-- 213 (332)
T ss_pred CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999755433332333457899999999886 35688999999999999999999999964321
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRP--ELRPSMGKVAKM 742 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP--~~RPs~~eVv~~ 742 (763)
... ... +.........+. ........+.+++.+|+..++ ..||++.|+++.
T Consensus 214 -------~~~-~~~---------i~~~~~~~~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 214 -------VET-YGK---------IMNHKERFQFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -------HHH-HHH---------HhCCCccccCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 011 111100000110 012234567777777775444 447899998866
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=338.98 Aligned_cols=267 Identities=25% Similarity=0.329 Sum_probs=202.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.++||+|+||.||+|... .++.||+|+++.... ..++|.+|++++++++||||+++++++.+++..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 4567789999999999999875 578999999974322 23568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++......... .......+++..+++++.||++||+|||+.+ |+||||||+||++
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l-------------~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILL 146 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESL-------------SKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILL 146 (932)
T ss_pred cCCCCCHHHHHHHhhhcccc-------------chhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEE
Confidence 99999999999653211100 0012235678889999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCc-----------------ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh
Q 046586 599 GDDFCPKISDFGLAKLRKKEDM-----------------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~-----------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt 661 (763)
+.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 147 d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT 226 (932)
T PRK13184 147 GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226 (932)
T ss_pred cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999999999999986521110 01123468999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-CHHHHH
Q 046586 662 GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-SMGKVA 740 (763)
Q Consensus 662 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVv 740 (763)
|+.||....... . .... ....+. ......+.+..+.+++.+|++.||++|| ++.+++
T Consensus 227 G~~PF~~~~~~k---------i----~~~~----~i~~P~-----~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 227 LSFPYRRKKGRK---------I----SYRD----VILSPI-----EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred CCCCCCCcchhh---------h----hhhh----hccChh-----hccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999996422100 0 0000 000000 0000023456788899999999999996 677777
Q ss_pred HHhccCCC
Q 046586 741 KMLEGTVE 748 (763)
Q Consensus 741 ~~Le~~~~ 748 (763)
+.|+...+
T Consensus 285 ~~Le~~lq 292 (932)
T PRK13184 285 QDLEPHLQ 292 (932)
T ss_pred HHHHHHHh
Confidence 77766543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=307.68 Aligned_cols=203 Identities=24% Similarity=0.363 Sum_probs=163.0
Q ss_pred cccccccccceEEEEEeC---CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEee--CCeeeEEEecCCC
Q 046586 448 SNLIGRGGFGDVYKGELT---DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAE--KGERTLVYEYVPN 522 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~---~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV~Ey~~~ 522 (763)
.++||+|+||.||+|+.. +++.+|+|.++... ....+.+|+.++++++||||+++++++.. ....++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 358999999999999865 45789999986532 23457889999999999999999998864 4568899999864
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE----
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---- 598 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl---- 598 (763)
+|.+++........ ......+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 85 -~l~~~~~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~ 145 (317)
T cd07868 85 -DLWHIIKFHRASKA---------------NKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEG 145 (317)
T ss_pred -CHHHHHHhcccccc---------------cCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCC
Confidence 88888754321100 012335888999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCc--ccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 599 GDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
+.++.+||+|||+++....... .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 4668999999999986543221 22344678999999998876 468999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.99 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=190.5
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+|+||.||+++.. +++.+|+|+++... .....+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 56889999998532 2234578899999888 699999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 81 ~~L~~~~~~~------------------------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~ 133 (327)
T cd05617 81 GDLMFHMQRQ------------------------RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADG 133 (327)
T ss_pred CcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCC
Confidence 9999888532 35889999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .....
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~---~~~~~ 209 (327)
T cd05617 134 HIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD---MNTED 209 (327)
T ss_pred CEEEeccccceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc---cccHH
Confidence 99999999997432211 122345789999999999999999999999999999999999999964322110 01111
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
+..... ... ...++...+..+.+++.+||+.||++||++
T Consensus 210 ~~~~~~---------~~~------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 210 YLFQVI---------LEK------PIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHH---------HhC------CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 111111 010 011223345667899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.61 Aligned_cols=238 Identities=28% Similarity=0.459 Sum_probs=188.9
Q ss_pred ccccccccceEEEEEeCCCc-----------EEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 449 NLIGRGGFGDVYKGELTDHR-----------VVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~-----------~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
+.||+|+||.||+|...+.. .+++|.++........|.+|+.+++.++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999886433 57888876544446788999999999999999999999988 7889999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+
T Consensus 80 e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nil 133 (259)
T cd05037 80 EYVKFGPLDVFLHRE-----------------------KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNIL 133 (259)
T ss_pred EcCCCCcHHHHHHhh-----------------------ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEE
Confidence 999999999999643 125788999999999999999999988 999999999999
Q ss_pred EcCCC-------CeEEcccCcccccCCCCcccccccccCCCcccccccccC--CCCCccceeehhHHHHHHHh-CCCCcc
Q 046586 598 LGDDF-------CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD--QITPKADVYSFGMVLLEIVS-GSRNFE 667 (763)
Q Consensus 598 l~~~~-------~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwS~Gvll~ellt-G~~p~~ 667 (763)
++.++ .+||+|||++..... .....++..|+|||.+... .++.++||||||+++|||++ |..|+.
T Consensus 134 l~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~ 208 (259)
T cd05037 134 VARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208 (259)
T ss_pred EecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc
Confidence 99888 799999999976433 1123456789999998876 88999999999999999999 466664
Q ss_pred cccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
..... .+ ...+. ... ... ......+.+++..||+.+|++||++.+|++.|+
T Consensus 209 ~~~~~---------~~--~~~~~--------~~~---~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 209 TLSSS---------EK--ERFYQ--------DQH---RLP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCCch---------hH--HHHHh--------cCC---CCC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 32210 00 00000 000 000 011267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=307.31 Aligned_cols=238 Identities=24% Similarity=0.386 Sum_probs=185.0
Q ss_pred cccccccceEEEEEeCC-------------------------CcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccE
Q 046586 450 LIGRGGFGDVYKGELTD-------------------------HRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRL 503 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~~-------------------------~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l 503 (763)
+||+|+||.||+|.+.. ...|++|+++.... ...+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998864332 34568899999999999999999
Q ss_pred EEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 046586 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECL 583 (763)
Q Consensus 504 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~ 583 (763)
++++.+....++||||+++|+|..++... ...+++..++.++.|+++||+|||+.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~- 137 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-----------------------KGRVPVAWKITVAQQLASALSYLEDKN- 137 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHcCC-
Confidence 99999999999999999999999988542 235788899999999999999999988
Q ss_pred CcEEecCCCCCceEEcCCC-------CeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHH
Q 046586 584 EWVLHCDIKPENILLGDDF-------CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMV 655 (763)
Q Consensus 584 ~~ivHrDlk~~NILl~~~~-------~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvl 655 (763)
|+||||||+||+++..+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||++
T Consensus 138 --iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~ 210 (274)
T cd05076 138 --LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTT 210 (274)
T ss_pred --ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHH
Confidence 99999999999997654 3799999988643221 12346778999998865 578999999999999
Q ss_pred HHHHH-hCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 046586 656 LLEIV-SGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734 (763)
Q Consensus 656 l~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 734 (763)
+|||+ +|+.||....... . .... .... ... ......+.+++.+||+.+|++||
T Consensus 211 l~el~~~g~~p~~~~~~~~----------~-~~~~---------~~~~--~~~----~~~~~~~~~li~~cl~~~p~~Rp 264 (274)
T cd05076 211 LLEICFDGEVPLKERTPSE----------K-ERFY---------EKKH--RLP----EPSCKELATLISQCLTYEPTQRP 264 (274)
T ss_pred HHHHHhCCCCCccccChHH----------H-HHHH---------Hhcc--CCC----CCCChHHHHHHHHHcccChhhCc
Confidence 99995 6888886432110 0 0000 1000 001 11234688999999999999999
Q ss_pred CHHHHHHHhc
Q 046586 735 SMGKVAKMLE 744 (763)
Q Consensus 735 s~~eVv~~Le 744 (763)
++.+|++.|+
T Consensus 265 s~~~il~~L~ 274 (274)
T cd05076 265 SFRTILRDLT 274 (274)
T ss_pred CHHHHHHhhC
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=320.68 Aligned_cols=266 Identities=23% Similarity=0.275 Sum_probs=195.6
Q ss_pred cccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCC-----eeeEE
Q 046586 446 GFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG-----ERTLV 516 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~LV 516 (763)
.+.++||+|+||.||++... +++.||+|.+..... ..+++.+|+++++.++|+||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 45678999999999999864 688999999864322 2356889999999999999999999998776 78999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
+||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 83 ~e~~~-~~l~~~~~~------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Ni 134 (372)
T cd07853 83 TELMQ-SDLHKIIVS------------------------PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNL 134 (372)
T ss_pred eeccc-cCHHHHHhc------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHE
Confidence 99996 578887742 235889999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
|++.++.+||+|||+++..............++..|+|||.+.+. .++.++||||+||++|||++|+.||.........
T Consensus 135 li~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 214 (372)
T cd07853 135 LVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214 (372)
T ss_pred EECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 999999999999999986544333333445678999999998764 5899999999999999999999999744321100
Q ss_pred -------CCCchhHHHHHHHHhccChhhhhcccccccCC---CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 676 -------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYD---SRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 676 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.......+.. ..+.. ...+.......... ........+++.+++.+|++.||++|||+.|+++.
T Consensus 215 ~~i~~~~g~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 215 DLITDLLGTPSLEAMRS--ACEGA-RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHcCCCCHHHHHH--hhHHH-HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 00000 00000000000000 00112235678899999999999999999999963
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.21 Aligned_cols=246 Identities=23% Similarity=0.336 Sum_probs=191.8
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
..||+|+||.||+|... ++..|++|.++... ...+.+.+|++++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 58999999999999865 56789999887543 34567889999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC-CCCeE
Q 046586 527 DYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD-DFCPK 605 (763)
Q Consensus 527 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~k 605 (763)
+++.... .....++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+|
T Consensus 94 ~~l~~~~---------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~ 149 (268)
T cd06624 94 ALLRSKW---------------------GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVK 149 (268)
T ss_pred HHHHHhc---------------------ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEE
Confidence 9996431 1111267788899999999999999988 999999999999976 67999
Q ss_pred EcccCcccccCCCCcccccccccCCCcccccccccC--CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHH
Q 046586 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD--QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683 (763)
Q Consensus 606 I~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~ 683 (763)
|+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.|+....... ...+
T Consensus 150 l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~------~~~~ 222 (268)
T cd06624 150 ISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ------AAMF 222 (268)
T ss_pred EecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh------hhHh
Confidence 999999976543222 12234578899999998654 38899999999999999999999986322100 0000
Q ss_pred HHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. ... ......++....+++.+++.+||+.+|++|||+.||++
T Consensus 223 ------~---------~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 223 ------K---------VGM-FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ------h---------hhh-hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 000 00011122345567889999999999999999999886
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.38 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=196.1
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+...+.||+|+||+||++... +++.+|+|.++.... ....+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 345678999999999999775 578999999874321 224477899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++
T Consensus 82 ~~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~ 136 (285)
T cd05632 82 MNGGDLKFHIYNM----------------------GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLD 136 (285)
T ss_pred ccCccHHHHHHHh----------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEC
Confidence 9999999988543 2235899999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
+++.+||+|||++....... ......|+..|+|||.+.+..++.++|+||||+++|||++|..||.......
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~------ 208 (285)
T cd05632 137 DYGHIRISDLGLAVKIPEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV------ 208 (285)
T ss_pred CCCCEEEecCCcceecCCCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence 99999999999997543221 1233568999999999998999999999999999999999999996432100
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~ 741 (763)
....... .+... ... .+......+.+++..|++.||++||+ +.++++
T Consensus 209 ----~~~~~~~-----~~~~~--~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 209 ----KREEVDR-----RVLET--EEV----YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ----HHHHHHH-----hhhcc--ccc----cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0000000 00000 001 11233456788999999999999999 667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.89 Aligned_cols=270 Identities=21% Similarity=0.297 Sum_probs=197.7
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
+|.+.++||+|+||.||+|+.. +++.||+|.++... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 4667789999999999999875 56789999987432 23346789999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 87 ~~-~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~ 139 (309)
T cd07872 87 DK-DLKQYMDDC-----------------------GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINE 139 (309)
T ss_pred CC-CHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 75 888887542 235788889999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCC----
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS---- 675 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~---- 675 (763)
++.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 140 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 140 RGELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred CCCEEECccccceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999999975433221 1223457889999998865 56899999999999999999999999643211000
Q ss_pred ---CCCchhHHHHHHHHhccChhhhhcccccccCC---CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccC
Q 046586 676 ---DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYD---SRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGT 746 (763)
Q Consensus 676 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~ 746 (763)
.......| ..+... .+..+........ .........++.+++.+|++.||.+|||+.|+++ .+++.
T Consensus 219 ~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 219 RLLGTPTEETW--PGISSN---DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred HHhCCCCHHHH--hhhcch---hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 00000000 000000 0000000000000 0000123456789999999999999999999996 45543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.79 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=196.9
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
..+.+.+.||+|+||.||++.. .++.+|+|.++... ....+.+|+.++++++|||++++++++... ..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4567788999999999999975 56779999986432 345788999999999999999999998764 57999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 83 ~~L~~~l~~~----------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~ 137 (254)
T cd05083 83 GNLVNFLRTR----------------------GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDG 137 (254)
T ss_pred CCHHHHHHhc----------------------CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCC
Confidence 9999999643 2335788999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchh
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~ 681 (763)
.+||+|||+++..... ......+..|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 138 ~~kl~Dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---------~ 204 (254)
T cd05083 138 VAKVSDFGLARVGSMG----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---------K 204 (254)
T ss_pred cEEECCCccceecccc----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---------H
Confidence 9999999999754321 112234567999999998899999999999999999998 8888863321 1
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
.. ... +.+.... ..+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 205 ~~-~~~----------~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 205 EV-KEC----------VEKGYRM----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HH-HHH----------HhCCCCC----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 10 011 1111111 1112345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.63 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=202.3
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
....+++.++||+|+||+||++... +++.+|+|++.... ....++.+|+++++.++||||+++++++...+..++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 3455677789999999999999765 57889999886432 23467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCce
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENI 596 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NI 596 (763)
||+++++|.+++... ..+++.....++.+++.||.|||+. + ++|+||+|+||
T Consensus 83 e~~~~~~L~~~~~~~------------------------~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~ni 135 (284)
T cd06620 83 EFMDCGSLDRIYKKG------------------------GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNI 135 (284)
T ss_pred ecCCCCCHHHHHHhc------------------------cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHE
Confidence 999999999988432 3578999999999999999999974 5 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
++++++.++|+|||++...... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 136 l~~~~~~~~l~d~gl~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~- 211 (284)
T cd06620 136 LVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG- 211 (284)
T ss_pred EECCCCcEEEccCCcccchhhh---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh-
Confidence 9999999999999998654221 122356889999999998889999999999999999999999999744321100
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcch-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVH-FDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
.... .. ..+.+........ ..++ .+.+..+.+++.+|++.||++||++.||+++.
T Consensus 212 ~~~~-----~~------~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 212 QDDP-----MG------ILDLLQQIVQEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhhh-----hH------HHHHHHHHhhccC-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000 00 1111111111111 1111 22456788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.04 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=202.8
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..|.+.++||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 4566778999999999999986 468899999997433 33456789999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 99 ~~~~L~~~~~~-------------------------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~ 150 (297)
T cd06656 99 AGGSLTDVVTE-------------------------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGM 150 (297)
T ss_pred CCCCHHHHHHh-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 99999999842 24678899999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus 151 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~------ 223 (297)
T cd06656 151 DGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------ 223 (297)
T ss_pred CCCEEECcCccceEccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh------
Confidence 99999999999975443221 12234578899999999998999999999999999999999999964321110
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccCCC
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGTVE 748 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~~~ 748 (763)
...... ........+......+.+++.+||+.+|++||++.+|++ .++....
T Consensus 224 -------------~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 224 -------------LYLIAT---NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred -------------eeeecc---CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 000000 000011112334566889999999999999999999997 4544333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.63 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=197.5
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.+...+.||+|+||.||+|... +++.||+|.++... ....++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4455678999999999999765 57789999987432 23356889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++.. ..+++..+..++.|+++|++|||+.+ ++|+||+|+||++++
T Consensus 85 ~~~~L~~~~~~-------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~ 136 (277)
T cd06642 85 GGGSALDLLKP-------------------------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSE 136 (277)
T ss_pred CCCcHHHHhhc-------------------------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeC
Confidence 99999998832 34788899999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------- 208 (277)
T cd06642 137 QGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR------- 208 (277)
T ss_pred CCCEEEccccccccccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------
Confidence 99999999999976543321 1223457889999999998899999999999999999999999986322110
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
... .+... .........+..+.+++.+||+.+|++||+|.+|++.
T Consensus 209 ---~~~----------~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 209 ---VLF----------LIPKN----SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---HHh----------hhhcC----CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000 00000 0111113345678899999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=304.04 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=193.9
Q ss_pred ccccccccccccceEEEEEe-CCCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 445 NGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
+.+.++||+|+||.||+|.. .+++.||+|++.... ....++.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 45668999999999999976 467889999986432 233568899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|..+. .+++.....++.|++.||+|||+.+ |+|+||||+||+++.+
T Consensus 83 ~~~l~~~~----------------------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~ 131 (279)
T cd06619 83 GGSLDVYR----------------------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTR 131 (279)
T ss_pred CCChHHhh----------------------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCC
Confidence 99987543 2567788899999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
+.+||+|||++...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......... ....
T Consensus 132 ~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~--~~~~ 206 (279)
T cd06619 132 GQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS--LMPL 206 (279)
T ss_pred CCEEEeeCCcceecccc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc--cchH
Confidence 99999999999755332 123356889999999999989999999999999999999999999643211100 0000
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. ...+.+... ... .......++.+++.+|++.+|++||++.|+++.
T Consensus 207 ~~----------~~~~~~~~~-~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 207 QL----------LQCIVDEDP-PVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HH----------HHHHhccCC-CCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 000000000 000 012234578899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.12 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=196.7
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+...+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 445678999999999999775 578999999864321 224577899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ....+++.++..++.|++.||.|||+.+ |+||||||+||+++
T Consensus 82 ~~g~~L~~~l~~~----------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~ 136 (285)
T cd05630 82 MNGGDLKFHIYHM----------------------GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLD 136 (285)
T ss_pred cCCCcHHHHHHHh----------------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEEC
Confidence 9999999988543 2235788899999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
+++.++|+|||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 137 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~------ 208 (285)
T cd05630 137 DHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI------ 208 (285)
T ss_pred CCCCEEEeeccceeecCCCc--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc------
Confidence 99999999999997543222 1223468999999999999999999999999999999999999997432110
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~ 741 (763)
. .... ....+. ..... +......+.+++..||+.||++||| +.|+++
T Consensus 209 -~---~~~~------~~~~~~-~~~~~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 209 -K---REEV------ERLVKE-VQEEY----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -h---HHHH------Hhhhhh-hhhhc----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 0000 000000 00011 1233456889999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=305.13 Aligned_cols=239 Identities=24% Similarity=0.413 Sum_probs=187.3
Q ss_pred ccccccccceEEEEEeCC--------CcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 449 NLIGRGGFGDVYKGELTD--------HRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~--------~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.||+|+||.||+|.... ...+++|.+.... ...+++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 2348888876433 2345788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++
T Consensus 81 ~~~g~L~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~ 134 (258)
T cd05078 81 VKFGSLDTYLKKN-----------------------KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLI 134 (258)
T ss_pred CCCCcHHHHHhcC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEe
Confidence 9999999999642 235788999999999999999999988 99999999999998
Q ss_pred CCCC--------eEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCC-CCcccc
Q 046586 600 DDFC--------PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGS-RNFEIQ 669 (763)
Q Consensus 600 ~~~~--------~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~-~p~~~~ 669 (763)
.++. ++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+...
T Consensus 135 ~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 135 REEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred cccccccCCCceEEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 7765 599999988654321 23457888999999876 46899999999999999999985 454322
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
... .... ..... . ..+.....++.+++..||+.||++|||++++++.|+
T Consensus 210 ~~~-----------~~~~---------~~~~~--~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 210 DSQ-----------KKLQ---------FYEDR--H----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cHH-----------HHHH---------HHHcc--c----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 110 0000 00100 0 111223356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.82 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=200.9
Q ss_pred HHhccccccccccccceEEEEEeCC-C----cEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTD-H----RVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~-~----~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
...+.+.+.||+|+||.||+|...+ + ..+|+|.++.... ...++.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3456777899999999999998643 3 2589998875433 33568899999999999999999999987 7889
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+
T Consensus 85 ~v~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~ 138 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH-----------------------KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAAR 138 (279)
T ss_pred EEEecCCCCcHHHHHHhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcc
Confidence 999999999999998642 234889999999999999999999987 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
||++++++.+||+|||+++........ ......++..|+|||.+....++.++|+||||+++||+++ |+.||+....
T Consensus 139 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~- 217 (279)
T cd05057 139 NVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA- 217 (279)
T ss_pred eEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-
Confidence 999999999999999999865433221 1111223567999999988899999999999999999998 9999864221
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.++ . ..+..... ...+......+.+++..||..+|.+||++.++++.|+....
T Consensus 218 --------~~~-----~------~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 218 --------VEI-----P------DLLEKGER----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --------HHH-----H------HHHhCCCC----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 010 0 01111000 01112234578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=298.21 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=200.7
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
|.+.+.||.|+||.||.++.. +++.+++|.+... .....++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 567789999999999998764 5788999988643 233456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||+|+||++++
T Consensus 82 ~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~ 136 (256)
T cd08221 82 NGGTLYDKIVRQ----------------------KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTK 136 (256)
T ss_pred CCCcHHHHHHhc----------------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeC
Confidence 999999998643 1345789999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.||+....
T Consensus 137 ~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------- 206 (256)
T cd08221 137 AGLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------- 206 (256)
T ss_pred CCCEEECcCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---------
Confidence 99999999999986544332 22345688999999999888899999999999999999999999863211
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
.... ..+.. ..... .+......+.+++.+||+.+|++||++.++++.+
T Consensus 207 ~~~~----------~~~~~----~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 207 LNLV----------VKIVQ----GNYTP-VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHH----------HHHHc----CCCCC-CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0100 01111 11110 1123456788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.15 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=195.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEe-----eCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCA-----EKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~-----~~~~~~L 515 (763)
.++.+.+.||+|+||.||++... .++.+|+|+++.......++.+|+.+++++ +||||+++++++. .++..++
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 34566789999999999999775 578899999876554556788999999999 7999999999885 3456899
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++++|.+++.... .....+++..+..++.|+++||.|||+.+ |+||||||+|
T Consensus 98 v~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~n 154 (286)
T cd06638 98 VLELCNGGSVTDLVKGFL--------------------KRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNN 154 (286)
T ss_pred EEeecCCCCHHHHHHHhh--------------------ccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHh
Confidence 999999999999885421 02345788899999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-----CCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-----DQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
|++++++.+||+|||+++....... ......|+..|+|||.+.. ..++.++||||+||++|||++|+.|+....
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 155 ILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999976543221 1223468899999998753 457899999999999999999999986332
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. ...... ...... ....+......+.+++.+||+.||++|||+.||++.
T Consensus 234 ~~-------------~~~~~~---~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 234 PM-------------RALFKI---PRNPPP------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hh-------------HHHhhc---cccCCC------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 10 000000 000000 000111234568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=298.21 Aligned_cols=249 Identities=32% Similarity=0.517 Sum_probs=199.7
Q ss_pred cccccccccccceEEEEEeCC-----CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 446 GFSNLIGRGGFGDVYKGELTD-----HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~~-----~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.+.+.||+|+||.||+++..+ +..||+|.++.... ....+..|++++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 356789999999999998764 47899999975543 45678999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++
T Consensus 82 ~~~~~~l~~~~~~~~----------------------~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~ 136 (258)
T smart00219 82 YMEGGDLLDYLRKNR----------------------PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLV 136 (258)
T ss_pred ccCCCCHHHHHHhhh----------------------hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEE
Confidence 999999999986431 112889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~ 677 (763)
++++.++|+|||+++..............++..|+|||.+.+..++.++||||+|++++||++ |+.||.....
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------ 210 (258)
T smart00219 137 GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------ 210 (258)
T ss_pred ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999998665443222222346789999999988899999999999999999998 7788753211
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
... ......+. ....+...+.++.+++.+|++.+|++|||+.+++++|
T Consensus 211 ---~~~-~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 211 ---EEV-LEYLKKGY--------------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---HHH-HHHHhcCC--------------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 00110000 0111123466789999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=302.80 Aligned_cols=249 Identities=21% Similarity=0.293 Sum_probs=195.0
Q ss_pred ccccccccccccceEEEEEeCC-CcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.+.+.||+|+||.||+|.... +..+++|.+.... ...+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 3456789999999999998764 6778899886433 3345688999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 87 ~~l~~~~~~~-----------------------~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~ 140 (282)
T cd06643 87 GAVDAVMLEL-----------------------ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDG 140 (282)
T ss_pred CcHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCC
Confidence 9999887532 235889999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
.+||+|||++....... .......++..|+|||.+. ...++.++|||||||++|||++|+.||......
T Consensus 141 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----- 214 (282)
T cd06643 141 DIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----- 214 (282)
T ss_pred CEEEccccccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----
Confidence 99999999997543221 1223356889999999874 456788999999999999999999998632210
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
+.... ..... .. ....+......+.+++..||+.||++||++.++++.
T Consensus 215 --------~~~~~------~~~~~-~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 215 --------RVLLK------IAKSE-PP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --------HHHHH------HhhcC-CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00000 00 001112345678899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=300.66 Aligned_cols=248 Identities=24% Similarity=0.398 Sum_probs=196.8
Q ss_pred ccccccccccccceEEEEEeCCCcEEEEEEeeccCC-------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 445 NGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG-------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
+...+.||+|+||.||+|...+++.+|+|.++.... ....+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 345678999999999999988889999999874321 1245788999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+
T Consensus 82 e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil 134 (265)
T cd06631 82 EFVPGGSISSILNRF------------------------GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVM 134 (265)
T ss_pred ecCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEE
Confidence 999999999998542 24678888999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCC-----cccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKED-----MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
+++++.+||+|||++....... ........++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 135 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 214 (265)
T cd06631 135 LMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214 (265)
T ss_pred ECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH
Confidence 9999999999999987542211 11122346888999999999889999999999999999999999999633210
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...... ... .......+......+.+++.+||+.+|++||++.++++
T Consensus 215 -------------~~~~~~------~~~---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 215 -------------AAMFYI------GAH---RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------------HHHHHh------hhc---cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 000 00001112334567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.05 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=196.3
Q ss_pred hccccccccccccceEEEEEeC-CCc----EEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHR----VVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~----~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
.+...+.||+|+||.||+|... +++ .+|+|.++.... ...++.+|+.+++.++||||+++++++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 3445678999999999999763 343 478888875432 234688999999999999999999999754 46799
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
+||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||
T Consensus 87 ~e~~~~g~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Ni 140 (303)
T cd05110 87 TQLMPHGCLLDYVHEH-----------------------KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNV 140 (303)
T ss_pred ehhcCCCCHHHHHHhc-----------------------ccCCCHHHHHHHHHHHHHHHHHHhhcC---eecccccccee
Confidence 9999999999998542 235788899999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 674 (763)
++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....
T Consensus 141 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--- 217 (303)
T cd05110 141 LVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--- 217 (303)
T ss_pred eecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999999865432221 1222345678999999999999999999999999999997 8888853210
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
... . +++...... ..+......+.+++..||..+|++||++.++++.|+.+.+
T Consensus 218 -------~~~-~---------~~~~~~~~~----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 218 -------REI-P---------DLLEKGERL----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred -------HHH-H---------HHHHCCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000 0 111110000 0112234578899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.86 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=198.4
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
++.+.++||.|+||.||+|.. .+++.|++|.+.... ...+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 356678999999999999976 468899999987443 334668899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.+
T Consensus 100 ~~~L~~~~~~-------------------------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~ 151 (296)
T cd06655 100 GGSLTDVVTE-------------------------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMD 151 (296)
T ss_pred CCcHHHHHHh-------------------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC
Confidence 9999998842 24789999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
+.+||+|||++........ ......++..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 152 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-------- 222 (296)
T cd06655 152 GSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------- 222 (296)
T ss_pred CCEEEccCccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------
Confidence 9999999999876543322 1223467889999999998899999999999999999999999996432100
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. ........ ......+......+.+++.+||+.||++||++.+|++
T Consensus 223 -~-~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 223 -A-LYLIATNG------------TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -H-HHHHHhcC------------CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0 00000000 0000111234567888999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.52 Aligned_cols=197 Identities=27% Similarity=0.362 Sum_probs=169.4
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.+.+.||+|+||.||+++.. +++.||+|+++.. ......+.+|+.++..++|+||+++++.+.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999875 5789999999743 22335678899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ..++...+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 83 ~~gg~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~ 135 (360)
T cd05627 83 LPGGDMMTLLMKK------------------------DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLD 135 (360)
T ss_pred CCCccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEEC
Confidence 9999999998542 35788889999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCc----------------------------------ccccccccCCCcccccccccCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDM----------------------------------VSMSRIRGTRGYMAPEWLRSDQITP 645 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~----------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ 645 (763)
.++.+||+|||+++....... .......||+.|+|||++.+..++.
T Consensus 136 ~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~ 215 (360)
T cd05627 136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215 (360)
T ss_pred CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC
Confidence 999999999999874422110 0011346899999999999999999
Q ss_pred ccceeehhHHHHHHHhCCCCccc
Q 046586 646 KADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 646 ksDVwS~Gvll~elltG~~p~~~ 668 (763)
++|||||||++|||++|+.||..
T Consensus 216 ~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 216 LCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cceeccccceeeecccCCCCCCC
Confidence 99999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.88 Aligned_cols=251 Identities=33% Similarity=0.501 Sum_probs=198.3
Q ss_pred ccccccccccccceEEEEEeCC-CcEEEEEEeeccCCchhh---hHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAE---FWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~~---f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
|.+.++||+|+||+||+++... ++.+|+|++......... ..+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4577899999999999998875 568999999866543332 356999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ..+++..+..++.|+++||+|||+.+ |+|+||||+||++++
T Consensus 81 ~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~ 133 (260)
T PF00069_consen 81 PGGSLQDYLQKN------------------------KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDE 133 (260)
T ss_dssp TTEBHHHHHHHH------------------------SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEEST
T ss_pred cccccccccccc------------------------cccccccccccccccccccccccccc---ccccccccccccccc
Confidence 999999999632 35789999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccc-cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
++.++|+|||++... ...........++..|+|||.+. +..++.++||||+|+++|+|++|..|+......
T Consensus 134 ~~~~~l~Dfg~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~------- 205 (260)
T PF00069_consen 134 NGEVKLIDFGSSVKL-SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD------- 205 (260)
T ss_dssp TSEEEESSGTTTEES-TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-------
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccch-------
Confidence 999999999999754 12222344567889999999998 889999999999999999999999998743100
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..... ......+........ .......+.+++..||+.||++||++.++++
T Consensus 206 ----~~~~~-----~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 206 ----DQLEI-----IEKILKRPLPSSSQQ--SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ----HHHHH-----HHHHHHTHHHHHTTS--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ----hhhhh-----hhhcccccccccccc--cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 001111111000000 0111378999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=314.55 Aligned_cols=245 Identities=26% Similarity=0.380 Sum_probs=198.9
Q ss_pred cccccccceEEEEEeCCC-cEEEEEEeecc-CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHhH
Q 046586 450 LIGRGGFGDVYKGELTDH-RVVAVKCLKNV-TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLAD 527 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~~~-~~VAvK~l~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 527 (763)
+||+|.||+||.|+..+. ..+|||-+... ....+-+..|+.+.++|+|+|||+++|.|.+++..-+.||-+|||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 899999999999988654 57899988644 3344568899999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc-CCCCeEE
Q 046586 528 YLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG-DDFCPKI 606 (763)
Q Consensus 528 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kI 606 (763)
.|...- +.-.-+..+.--+..||++||.|||++. |||||||-+|||++ -.|.+||
T Consensus 662 LLrskW---------------------GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKI 717 (1226)
T KOG4279|consen 662 LLRSKW---------------------GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKI 717 (1226)
T ss_pred HHHhcc---------------------CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEe
Confidence 996431 1111255666678899999999999988 99999999999996 4789999
Q ss_pred cccCcccccCCCCcccccccccCCCcccccccccC--CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHH
Q 046586 607 SDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD--QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWA 684 (763)
Q Consensus 607 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 684 (763)
+|||-++.+..- ...+.++.||..|||||++..+ .|..++|||||||.+.||.||++||...+...
T Consensus 718 SDFGTsKRLAgi-nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----------- 785 (1226)
T KOG4279|consen 718 SDFGTSKRLAGI-NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----------- 785 (1226)
T ss_pred cccccchhhccC-CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-----------
Confidence 999999865432 2345568899999999999865 68899999999999999999999997544321
Q ss_pred HHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 685 FEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 685 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..++.-.+ -...+++|.+...+...++++|+.+||.+||+++++++
T Consensus 786 ----------AAMFkVGm-yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 786 ----------AAMFKVGM-YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ----------Hhhhhhcc-eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 01111111 11234566889999999999999999999999999874
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.19 Aligned_cols=202 Identities=24% Similarity=0.364 Sum_probs=162.3
Q ss_pred ccccccccceEEEEEeCC---CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEee--CCeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELTD---HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAE--KGERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~---~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV~Ey~~~g 523 (763)
.+||+|+||.||+|+..+ +..||+|.++... ....+.+|++++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 589999999999998753 4689999887543 23467899999999999999999999854 4578899999865
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE----c
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL----G 599 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl----~ 599 (763)
+|.+++........ ......+++..+..++.|++.||+|||+.+ |+||||||+||++ +
T Consensus 85 ~l~~~~~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~ 146 (317)
T cd07867 85 DLWHIIKFHRASKA---------------NKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP 146 (317)
T ss_pred cHHHHHHhhhcccc---------------CCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCC
Confidence 78887754321000 012335889999999999999999999988 9999999999999 5
Q ss_pred CCCCeEEcccCcccccCCCCc--ccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 600 DDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
.++.+||+|||+++....... .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 147 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 147 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 678999999999986543322 22334568999999998876 468999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=296.12 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=197.7
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEee-CCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAE-KGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~LV~Ey 519 (763)
|.+.+.||+|++|.||++... +++.+|+|.++... ...+.+.+|++++++++|+|++++++.+.. ....++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567889999999999999865 46789999986432 233568899999999999999999998764 4467899999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ....+++.++..++.|++.|++|||+.+ |+|+||||+||+++
T Consensus 82 ~~~~~l~~~l~~~----------------------~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~ 136 (257)
T cd08223 82 CEGGDLYHKLKEQ----------------------KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLT 136 (257)
T ss_pred cCCCcHHHHHHHh----------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEe
Confidence 9999999999642 2345789999999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
.++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||++++||++|+.||.....
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------- 207 (257)
T cd08223 137 RTNIIKVGDLGIARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------- 207 (257)
T ss_pred cCCcEEEecccceEEecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------
Confidence 999999999999986543221 22334678899999999999999999999999999999999999863211
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
..... ....+ .+ ...+......+.+++.+|++.+|++||++.++++.
T Consensus 208 -~~~~~-~~~~~---------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 208 -NSLVY-RIIEG---------KL-----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -HHHHH-HHHhc---------CC-----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 01100 01011 00 11123455688999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=296.64 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=200.2
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
|.+.++||+|+||.||++... +++.+|+|.+... .....++.+|+.++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 566789999999999999765 5789999998743 223457889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||+|+||+++.
T Consensus 82 ~~~~l~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~ 136 (256)
T cd08218 82 EGGDLYKKINAQ----------------------RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTK 136 (256)
T ss_pred CCCcHHHHHHhc----------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcC
Confidence 999999988542 1235788899999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.++|+|||++........ ......++..|+|||.+.+..++.++||||||++++||++|+.||.... .
T Consensus 137 ~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---------~ 206 (256)
T cd08218 137 DGTIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN---------M 206 (256)
T ss_pred CCCEEEeeccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC---------H
Confidence 99999999999976543221 1223457889999999998899999999999999999999999986321 0
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
. +.++..+.+.. ...+......+.+++.+||+.+|++||+|.+|++.
T Consensus 207 ~--------------~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 207 K--------------NLVLKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred H--------------HHHHHHhcCCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 11111111111 11223456778999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=318.51 Aligned_cols=271 Identities=20% Similarity=0.214 Sum_probs=199.5
Q ss_pred HHHHHHHhccccccccccccceEEEEEeC---CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 437 HAELRAATNGFSNLIGRGGFGDVYKGELT---DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 437 ~~el~~~t~~~~~~LG~G~fG~Vy~g~~~---~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
...+....|.+.++||+|+||.||++... .++.|++|.+... ..+.+|++++++++||||+++++++......
T Consensus 86 ~~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 86 PASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cchhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34445567888899999999999999754 3467999987642 3456899999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++|||++. ++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||
T Consensus 162 ~lv~e~~~-~~l~~~l~~------------------------~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp 213 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR------------------------SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKT 213 (392)
T ss_pred EEEehhcC-CCHHHHHHh------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCH
Confidence 99999995 688888832 346889999999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
+|||++.++.+||+|||+++....... .......||..|+|||++....++.++|||||||++|||++|+.||......
T Consensus 214 ~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 293 (392)
T PHA03207 214 ENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293 (392)
T ss_pred HHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence 999999999999999999976543322 2223457999999999999999999999999999999999999999654321
Q ss_pred CCCCCCchhHHHHHHHH------hccChhhh------hcccccccCCCc--c-hHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 673 MNSDEWYFPKWAFEKVY------EEMKVEDI------LDRHIKNSYDSR--V-HFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~------~~~~~~~~------~~~~l~~~~~~~--~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
.. ...+.. ....+. .......+ ...........+ + ......++.+++.+|++.||++|||+.
T Consensus 294 ~~--~~~l~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~ 370 (392)
T PHA03207 294 SS--SSQLRS-IIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ 370 (392)
T ss_pred Cc--HHHHHH-HHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHH
Confidence 10 000000 000000 00000000 000000000000 0 011245678899999999999999999
Q ss_pred HHHHH
Q 046586 738 KVAKM 742 (763)
Q Consensus 738 eVv~~ 742 (763)
|++..
T Consensus 371 e~l~~ 375 (392)
T PHA03207 371 DILSL 375 (392)
T ss_pred HHhhC
Confidence 99865
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=298.97 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=199.5
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.+...++||.|+||.||+|... .++.||+|+++... .....+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4555678999999999999875 57889999987432 23456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++.. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.
T Consensus 85 ~~~~L~~~i~~-------------------------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~ 136 (277)
T cd06640 85 GGGSALDLLRA-------------------------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSE 136 (277)
T ss_pred CCCcHHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcC
Confidence 99999998842 24678888999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+.......
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------- 208 (277)
T cd06640 137 QGDVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR------- 208 (277)
T ss_pred CCCEEEcccccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-------
Confidence 99999999999976543322 1223457888999999988899999999999999999999999986332100
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
....+.. ..........+..+.+++.+||+.+|++||++.++++.
T Consensus 209 -------------~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 209 -------------VLFLIPK----NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -------------Hhhhhhc----CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0000000 11122234567788999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=296.91 Aligned_cols=245 Identities=25% Similarity=0.378 Sum_probs=196.6
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
+...+.||+|+||.||+|... +++.|++|.+..... ..+.+.+|+++++.++|+||+++++++.+....++|+
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 345678999999999999876 788999999864321 2356889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+
T Consensus 82 e~~~~~~L~~~~~~~------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~ 134 (258)
T cd06632 82 ELVPGGSLAKLLKKY------------------------GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANIL 134 (258)
T ss_pred EecCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence 999999999998532 24788999999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCC-CCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
++.++.+||+|||++....... ......++..|+|||.+.... ++.++|+||||+++|||++|+.||.....
T Consensus 135 ~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----- 207 (258)
T cd06632 135 VDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----- 207 (258)
T ss_pred ECCCCCEEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----
Confidence 9999999999999997654332 223456788999999987766 89999999999999999999999863221
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...... ..... .....+......+.+++.+||+.+|++||++.++++
T Consensus 208 ----~~~~~~-~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 208 ----VAAVFK-IGRSK-------------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----HHHHHH-HHhcc-------------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000000 00000 001111234567889999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=319.25 Aligned_cols=191 Identities=27% Similarity=0.298 Sum_probs=164.2
Q ss_pred hccccccccccccceEEEEEeCC-CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
.+.+.++||+|+||.||++.... ++.||||... ...+.+|++++++++|+|||++++++...+..++|||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 46677899999999999998864 6789999542 2346789999999999999999999999999999999995
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++... ...+++.+++.|+.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 244 ~~L~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~ 297 (461)
T PHA03211 244 SDLYTYLGAR-----------------------LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPE 297 (461)
T ss_pred CCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCC
Confidence 6898888532 236899999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCc
Q 046586 603 CPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~ 666 (763)
.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 298 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 298 DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 9999999999865432221 122456999999999999999999999999999999999987654
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=323.80 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=188.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeC--------Ceee
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK--------GERT 514 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~ 514 (763)
.|.+.++||+|+||.||+|... .++.||||.+.... ....+|+.+++.++||||+++++++... ...+
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 4677889999999999999875 57899999885432 2345799999999999999999987532 2466
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++ +|.+++.... .....+++.....++.||+.||+|||+.+ |+||||||+
T Consensus 144 lvmE~~~~-~l~~~~~~~~--------------------~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~ 199 (440)
T PTZ00036 144 VVMEFIPQ-TVHKYMKHYA--------------------RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQ 199 (440)
T ss_pred EEEecCCc-cHHHHHHHHh--------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHH
Confidence 89999975 7877775321 03346889999999999999999999988 999999999
Q ss_pred ceEEcCCC-CeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 595 NILLGDDF-CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~-~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|||++.++ .+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|..||......
T Consensus 200 NILl~~~~~~vkL~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 277 (440)
T PTZ00036 200 NLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277 (440)
T ss_pred HEEEcCCCCceeeeccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999664 79999999998654322 1223567999999998865 47999999999999999999999999643211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhh---hcccc-----c----ccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDI---LDRHI-----K----NSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l-----~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
.. +... ...+ +....+. ..+.. . ......++...+.++.+++.+||+.||.+|||+.|++
T Consensus 278 ~~-----~~~i-~~~~--~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 278 DQ-----LVRI-IQVL--GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HH-----HHHH-HHHh--CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00 0000 0000 0000000 00000 0 0000011123456789999999999999999999998
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=299.70 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=197.9
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
|.+.+.||.|+||.||+|+.. +++.+|+|++.... .....+.+|+.+++.++|+||+++++++.+....++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456688999999999999876 57899999987432 234568899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++++
T Consensus 83 ~~~L~~~~~~-------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~ 134 (274)
T cd06609 83 GGSCLDLLKP-------------------------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEE 134 (274)
T ss_pred CCcHHHHHhh-------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCC
Confidence 9999999842 26789999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
+.++|+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 135 ~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------- 204 (274)
T cd06609 135 GDVKLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------- 204 (274)
T ss_pred CCEEEcccccceeecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---------
Confidence 999999999998665432 1223346788999999999888999999999999999999999999643210
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. ..... .......... ...+..+.+++.+||+.+|++||+++++++
T Consensus 205 ~-~~~~~----------~~~~~~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 205 R-VLFLI----------PKNNPPSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred H-HHHHh----------hhcCCCCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 00000 0000011110 114567889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=309.06 Aligned_cols=197 Identities=20% Similarity=0.212 Sum_probs=162.8
Q ss_pred cccccccc--ccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 447 FSNLIGRG--GFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 447 ~~~~LG~G--~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
+.++||+| +|++||++... +++.||+|+++.... ....+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999775 688999999974422 2245678999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 82 ~~~~l~~~~~~~----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~ 136 (327)
T cd08227 82 AYGSAKDLICTH----------------------FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISV 136 (327)
T ss_pred CCCcHHHHHHhh----------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEec
Confidence 999999998543 1234788999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCc-c-----cccccccCCCccccccccc--CCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 601 DFCPKISDFGLAKLRKKEDM-V-----SMSRIRGTRGYMAPEWLRS--DQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~-~-----~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
++.++++||+.......... . ......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 137 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 137 DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred CCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999986543221111 0 0111246678999999876 4689999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.40 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=196.9
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
+.+.++||+|+||.||++... ++..+|+|.++.... ...++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 556789999999999999875 577899998864322 23458899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCceEEcC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NILl~~ 600 (763)
+++|.+++... ..+++..+..++.|++.||+|||+. + ++|+||||+||+++.
T Consensus 83 ~~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~ 135 (308)
T cd06615 83 GGSLDQVLKKA------------------------GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNS 135 (308)
T ss_pred CCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEec
Confidence 99999999542 3578888999999999999999984 5 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.+||+|||++...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 136 ~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~------ 206 (308)
T cd06615 136 RGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL------ 206 (308)
T ss_pred CCcEEEccCCCccccccc---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH------
Confidence 999999999998754322 12335688999999999888899999999999999999999999853321100
Q ss_pred hHHHHHHHHhc-------------------cChhhhhcccccccCCCcch-HHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 681 PKWAFEKVYEE-------------------MKVEDILDRHIKNSYDSRVH-FDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 681 ~~~~~~~~~~~-------------------~~~~~~~~~~l~~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
..+........ ....+..+...... ....+ .....++.+++.+||+.+|++||++.+|+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 285 (308)
T cd06615 207 EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285 (308)
T ss_pred HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 00000000000 00000111100000 00111 12455689999999999999999999998
Q ss_pred HH
Q 046586 741 KM 742 (763)
Q Consensus 741 ~~ 742 (763)
+.
T Consensus 286 ~~ 287 (308)
T cd06615 286 KH 287 (308)
T ss_pred cC
Confidence 65
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.83 Aligned_cols=239 Identities=23% Similarity=0.307 Sum_probs=184.2
Q ss_pred ccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcC---CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 451 IGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARM---HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 451 LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
||+|+||.||+|+.. +++.||+|++.... .....+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 57899999996422 1223355666776655 799999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 81 g~L~~~l~~~------------------------~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~ 133 (330)
T cd05586 81 GELFWHLQKE------------------------GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATG 133 (330)
T ss_pred ChHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCC
Confidence 9999988532 35788899999999999999999998 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
.+||+|||+++...... .......||..|+|||.+.+. .++.++|||||||++|||++|+.||..... .
T Consensus 134 ~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---------~ 203 (330)
T cd05586 134 HIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---------Q 203 (330)
T ss_pred CEEEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---------H
Confidence 99999999997533222 123345789999999998754 589999999999999999999999864321 0
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS----MGKVAK 741 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~eVv~ 741 (763)
. ....+..+ .. .... ......+.+++.+||+.||.+||+ +.++++
T Consensus 204 ~-~~~~i~~~---------~~--~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 204 Q-MYRNIAFG---------KV--RFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred H-HHHHHHcC---------CC--CCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 00111110 00 0000 123457788999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=302.27 Aligned_cols=263 Identities=25% Similarity=0.329 Sum_probs=191.5
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcC---CCCccccEEEEEeeC-----Ce
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARM---HHLNLVRLWGFCAEK-----GE 512 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~-----~~ 512 (763)
|.+.+.||+|+||.||+++.. +++.||+|.++... .....+.+|+++++++ +||||+++++++... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 556789999999999999876 57899999987432 1234566788777665 699999999988652 45
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++ +|.+++... ....+++..+..++.|++.||+|||+.+ |+|||||
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~----------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dik 135 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKV----------------------PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLK 135 (288)
T ss_pred EEEEEccccc-CHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 7899999975 898888542 2235789999999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+||+++.++.+||+|||+++...... ......+|..|+|||.+.+..++.++||||+||++|||++|+.||......
T Consensus 136 p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~ 213 (288)
T cd07863 136 PENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213 (288)
T ss_pred HHHEEECCCCCEEECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH
Confidence 999999999999999999998654322 223456789999999999999999999999999999999999998643211
Q ss_pred CCCCCCchhHHHHHHHH----hccC-hhhhhcccccccCC---CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVY----EEMK-VEDILDRHIKNSYD---SRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~l~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. .+... ..... +... .............. .....+..+.+.+++.+|++.||++|||+.|+++
T Consensus 214 ~-----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 214 D-----QLGKI-FDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred H-----HHHHH-HHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000 00000 0000 00000000000000 0011234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=301.47 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=196.1
Q ss_pred HhccccccccccccceEEEEEeCC-CcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..|.+.++||.|+||.||+|+... ++.+++|.++.... ..+++.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 346677899999999999998864 78899999875432 3456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|..++.+. ...+++..+..++.|++.+|+|||+.+ |+||||||+||+++.
T Consensus 92 ~~~~l~~~~~~~-----------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~ 145 (292)
T cd06644 92 PGGAVDAIMLEL-----------------------DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTL 145 (292)
T ss_pred CCCcHHHHHHhh-----------------------cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcC
Confidence 999999887542 235789999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
++.+||+|||++....... .......++..|+|||.+. ...++.++|||||||++|||++|+.|+......
T Consensus 146 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 221 (292)
T cd06644 146 DGDIKLADFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--- 221 (292)
T ss_pred CCCEEEccCccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---
Confidence 9999999999987533221 1122345788999999884 345788999999999999999999998632210
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.......... .+ ....+.....++.+++.+||+.+|++||++.+|++
T Consensus 222 -------~~~~~~~~~~------~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 222 -------RVLLKIAKSE------PP------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -------HHHHHHhcCC------Cc------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000010000 00 00111234557889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=313.87 Aligned_cols=199 Identities=28% Similarity=0.404 Sum_probs=173.0
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCC-C-----CccccEEEEEeeCCee
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-H-----LNLVRLWGFCAEKGER 513 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~ 513 (763)
...+|.+.+.||+|+||.|-++... +++.||||++++...-..+-..|+.+|..|+ | -|+|+++++|...++.
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 3347888999999999999999654 5899999999987766677788999999996 4 3899999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
+||+|.+.. +|.++|+.. +...++......|+.||+.||..||+.+ |||+||||
T Consensus 264 ciVfELL~~-NLYellK~n----------------------~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKP 317 (586)
T KOG0667|consen 264 CIVFELLST-NLYELLKNN----------------------KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKP 317 (586)
T ss_pred eeeehhhhh-hHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCh
Confidence 999999955 999999765 3456899999999999999999999988 99999999
Q ss_pred CceEEcC--CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 594 ENILLGD--DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 594 ~NILl~~--~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
+||||.+ ...+||+|||.|......-. +...+.-|+|||++.+.+|+.+.||||||||+.||++|.+-|.+.
T Consensus 318 ENILL~~~~r~~vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 318 ENILLKDPKRSRIKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred hheeeccCCcCceeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 9999965 34799999999986554322 456678899999999999999999999999999999998777544
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=297.36 Aligned_cols=251 Identities=23% Similarity=0.297 Sum_probs=196.0
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.+.+.++||+|+||.||+++.. +++.||+|.++.... ....+.+|+.+++.++||||+++++.+...+..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 5566789999999999999765 578999999875432 33457889999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++... ..+++.+...++.|++.||+|||+.+ ++|+||||+||+++.+
T Consensus 90 ~~~L~~~~~~~------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~ 142 (267)
T cd06645 90 GGSLQDIYHVT------------------------GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDN 142 (267)
T ss_pred CCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence 99999998532 35788999999999999999999998 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.+||+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|..|+.......
T Consensus 143 ~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~----- 216 (267)
T cd06645 143 GHVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----- 216 (267)
T ss_pred CCEEECcceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-----
Confidence 999999999987553221 2223456889999999874 4568899999999999999999999985322100
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. ...... ....+..... ...+..+.+++.+|++.+|++||++.+|++.
T Consensus 217 ----~~-~~~~~~----~~~~~~~~~~------~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 217 ----AL-FLMTKS----NFQPPKLKDK------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ----hH-Hhhhcc----CCCCCccccc------CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 000000 0000000000 1234568899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.56 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=197.6
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
|...+.||+|+||.||+|... +++.+++|.++.... ..+++.+|++++++++|+||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 556789999999999999865 678999999985543 3467889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++
T Consensus 82 ~~~~L~~~~~~~------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~ 134 (264)
T cd06626 82 SGGTLEELLEHG------------------------RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDH 134 (264)
T ss_pred CCCcHHHHHhhc------------------------CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 999999998532 24678889999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccc---cccccCCCcccccccccCC---CCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSM---SRIRGTRGYMAPEWLRSDQ---ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~---~~~~gt~~y~APE~l~~~~---~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++.+||+|||++........... ....++..|+|||.+.... ++.++||||||+++||+++|+.||.....
T Consensus 135 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--- 211 (264)
T cd06626 135 NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--- 211 (264)
T ss_pred CCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---
Confidence 99999999999987654333221 1345788999999998766 88999999999999999999999963321
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+......... .....+. .......+.+++.+||+.+|++||++.+++.
T Consensus 212 -------~~~~~~~~~~~---------~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 212 -------EFQIMFHVGAG---------HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -------hHHHHHHHhcC---------CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01000000000 0000000 0123567789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.85 Aligned_cols=268 Identities=21% Similarity=0.268 Sum_probs=195.0
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
|.+.+.||+|++|.||+|+.. +++.||+|.++... .....+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 456789999999999999875 57899999986432 22356889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+ ++|.+++.... ....+++.++..++.|++.||+|||+.+ |+|+||||+||+++.
T Consensus 82 ~-~~l~~~~~~~~---------------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~ 136 (285)
T cd07861 82 S-MDLKKYLDSLP---------------------KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDN 136 (285)
T ss_pred C-CCHHHHHhcCC---------------------CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcC
Confidence 7 68988885432 2346889999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCC----
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS---- 675 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~---- 675 (763)
++.+||+|||++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 137 ~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~ 215 (285)
T cd07861 137 KGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIF 215 (285)
T ss_pred CCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9999999999997554322 11223356888999998765 45789999999999999999999999643211000
Q ss_pred ---CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 ---DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
....-..|........ .............. ........++.+++.+||+.||++|||+.+|++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 216 RILGTPTEDVWPGVTSLPD--YKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhCCCChhhhhcchhhHH--HHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000000 00000000000000 000123567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.34 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=199.5
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.+.+.+.||+|+||.||++... +++.+++|.++... .....+.+|++++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 4667789999999999999875 56789999997543 345678899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++... ...++..++..++.|++.||+|||+.+ |+|+||+|+||+++++
T Consensus 84 ~~~l~~~~~~~-----------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~ 137 (262)
T cd06613 84 GGSLQDIYQVT-----------------------RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTED 137 (262)
T ss_pred CCcHHHHHHhh-----------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCC
Confidence 99999988542 235788899999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccC---CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD---QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.+||+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.|+......
T Consensus 138 ~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~------ 210 (262)
T cd06613 138 GDVKLADFGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM------ 210 (262)
T ss_pred CCEEECccccchhhhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 9999999999976543211 12334678889999998776 8899999999999999999999998643210
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...... ....... .........+..+.+++.+||+.+|.+|||+.+|+.
T Consensus 211 -------~~~~~~------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 211 -------RALFLI------SKSNFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -------HHHHHH------HhccCCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0000000 001112345677899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=298.63 Aligned_cols=256 Identities=22% Similarity=0.355 Sum_probs=196.0
Q ss_pred cccccccccccceEEEEEeC----CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCC------e
Q 046586 446 GFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG------E 512 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~ 512 (763)
.+.+.||+|+||.||+|... .++.||+|+++.... ..+++.+|+.++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45678999999999999764 357899999975422 3456889999999999999999999886543 2
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++++||+++|+|.+++...+.. .....+++.....++.|++.||+|||+.+ |+|||||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~------------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dik 140 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIG------------------EEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLA 140 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhccc------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeecccc
Confidence 46889999999999988543210 01234788899999999999999999988 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCccccc
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQG 670 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~ 670 (763)
|+||++++++.+||+|||+++....... .......++..|++||.+....++.++||||||+++|||++ |+.|+....
T Consensus 141 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~ 220 (273)
T cd05074 141 ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE 220 (273)
T ss_pred hhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999986543221 11222345678999999998899999999999999999999 888875321
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.. . ......... ....+...+..+.+++.+|++.+|++||++.+|++.|+++
T Consensus 221 ~~---------~-~~~~~~~~~--------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 221 NS---------E-IYNYLIKGN--------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HH---------H-HHHHHHcCC--------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 0 000000000 0001123456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.61 Aligned_cols=246 Identities=24% Similarity=0.400 Sum_probs=196.1
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc----------hhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG----------DAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~----------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
+.+...||+|+||.||+|... +++.+|+|.+...... .+.+.+|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 345678999999999999764 5788999988643221 13578899999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|
T Consensus 82 ~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p 134 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY------------------------GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKG 134 (267)
T ss_pred EEEEEecCCCCHHHHHHhc------------------------cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCH
Confidence 9999999999999999542 34678888999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc-----ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM-----VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
+||++++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 135 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 135 ANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred HHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 999999999999999999986642211 111224578899999999988999999999999999999999999963
Q ss_pred ccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 669 QGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.... .... .... ......+......+.+++.+||+.||++||++.+|++
T Consensus 215 ~~~~-------------~~~~------~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 215 CTQL-------------QAIF------KIGE-----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ccHH-------------HHHH------HHhc-----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 2110 0000 0000 0111122345677889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.53 Aligned_cols=253 Identities=25% Similarity=0.324 Sum_probs=196.1
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeC-----CeeeEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEK-----GERTLV 516 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-----~~~~LV 516 (763)
.+.+.+.||+|+||.||++... +++.+|+|++........++.+|+.++.++ +|||++++++++... +..++|
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 4566789999999999999874 678999999976554556788899999999 899999999998754 358999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+||
T Consensus 103 ~ey~~~~sL~~~~~~~~~--------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~ni 159 (291)
T cd06639 103 LELCNGGSVTELVKGLLI--------------------CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNI 159 (291)
T ss_pred EEECCCCcHHHHHHHhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHE
Confidence 999999999998854210 2346789999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-----CCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-----QITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
++++++.+||+|||+++........ .....++..|+|||.+... .++.++|||||||++|||++|+.||.....
T Consensus 160 li~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 160 LLTTEGGVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred EEcCCCCEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 9999999999999999865432221 1234578899999987643 368999999999999999999999863321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
. .- ........ .. . ...+.+....+.+++.+|++.+|++||++.|+++.
T Consensus 239 ~---------~~-~~~~~~~~-~~---------~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 239 V---------KT-LFKIPRNP-PP---------T--LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H---------HH-HHHHhcCC-CC---------C--CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 00 00000000 00 0 00112344578999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=284.01 Aligned_cols=247 Identities=24% Similarity=0.364 Sum_probs=198.6
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc-----h----hhhHHHHHHHhcC-CCCccccEEEEEeeCCee
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG-----D----AEFWAEVTIIARM-HHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~-----~----~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 513 (763)
|.-.+.||+|..+.|-+.... +++..|+|++...... . ++-++|+++|+++ .||+|+.+.++++.+...
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 344578999999999988665 5778999988633211 1 2345799999998 699999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++|+|.|+.|.|.++|. ....++.....+|+.|+.+|++|||..+ ||||||||
T Consensus 99 FlVFdl~prGELFDyLt------------------------s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKp 151 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLT------------------------SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKP 151 (411)
T ss_pred hhhhhhcccchHHHHhh------------------------hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccCh
Confidence 99999999999999995 3457889999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc------cCCCCCccceeehhHHHHHHHhCCCCcc
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR------SDQITPKADVYSFGMVLLEIVSGSRNFE 667 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwS~Gvll~elltG~~p~~ 667 (763)
+|||+|++.++||+|||++..+.... .....+||++|+|||.+. ...|+..+|+|+.||+||-|+.|..||.
T Consensus 152 ENILlddn~~i~isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 152 ENILLDDNMNIKISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred hheeeccccceEEeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 99999999999999999998765543 456689999999999885 3478899999999999999999999996
Q ss_pred cccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.... ....+.+.+| ..+ +..+--.+......+++.+||+.||.+|.|++|+++
T Consensus 230 HRkQ----------mlMLR~ImeG---------kyq--F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 230 HRKQ----------MLMLRMIMEG---------KYQ--FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHH----------HHHHHHHHhc---------ccc--cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 4321 0111111111 111 111111466778899999999999999999999984
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.08 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=189.9
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC------chhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG------GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTL 515 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~L 515 (763)
+...+.||+|+||.||++... .++.+++|.++.... ....+.+|+.++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 455689999999999999775 578999998863321 224578899999999999999999988753 57789
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
++||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+|+||+|+|
T Consensus 84 ~~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~n 136 (266)
T cd06651 84 FMEYMPGGSVKDQLKAY------------------------GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGAN 136 (266)
T ss_pred EEeCCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 99999999999998532 24788888999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
|+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 137 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-- 214 (266)
T cd06651 137 ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-- 214 (266)
T ss_pred EEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--
Confidence 9999999999999999975432111 112234578899999999988999999999999999999999999863211
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ... .... ......++....+.+..++ +|+..+|++||+++||++
T Consensus 215 -------~~----~~~------~~~~----~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 215 -------MA----AIF------KIAT----QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -------HH----HHH------HHhc----CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00 000 0000 0011122233344555665 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=307.34 Aligned_cols=250 Identities=27% Similarity=0.333 Sum_probs=209.0
Q ss_pred HHhccccccccccccceEEEEEeCC-CcEEEEEEeeccCC----chhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTG----GDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~L 515 (763)
...|.+.+.||+|.||.||+++... |+.+|+|++++... ......+|+.+|+++. |||||.+.+++++.+..++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3567778999999999999998875 89999999975432 2357889999999998 9999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
|||++.+|.|.+.+... .++......++.|++.+++|||+.+ |+||||||+|
T Consensus 114 vmEL~~GGeLfd~i~~~-------------------------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN 165 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-------------------------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPEN 165 (382)
T ss_pred EEEecCCchHHHHHHHc-------------------------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHH
Confidence 99999999999999541 2788999999999999999999988 9999999999
Q ss_pred eEEcC----CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 596 ILLGD----DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 596 ILl~~----~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
+|+.. ++.+|++|||++..... .......+||+.|+|||.+....|+..+||||.||++|.|++|..||.....
T Consensus 166 ~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 166 LLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred eeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 99954 35799999999998766 3456678999999999999999999999999999999999999999985542
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
... ...+..... .+..+......+.+.+++..++..||.+|+|+.++++.
T Consensus 244 ~~~-------------------~~~i~~~~~--~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 244 FEI-------------------FLAILRGDF--DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred hHH-------------------HHHHHcCCC--CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 110 111222111 12222224667889999999999999999999999984
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=304.93 Aligned_cols=268 Identities=21% Similarity=0.272 Sum_probs=194.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.|.+.++||+|+||.||+|+.. +++.||+|.++... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 4667789999999999999875 57889999987432 23346788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++
T Consensus 87 ~-~~l~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~ 139 (301)
T cd07873 87 D-KDLKQYLDDC-----------------------GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINE 139 (301)
T ss_pred c-cCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECC
Confidence 7 5899888542 235788899999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC---
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD--- 676 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~--- 676 (763)
++.+||+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........
T Consensus 140 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~ 218 (301)
T cd07873 140 RGELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218 (301)
T ss_pred CCcEEECcCcchhccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999975433221 1223456889999998765 468889999999999999999999996432110000
Q ss_pred ----CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 ----EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
......| ............-.+.................+.+++.+|++.||.+|||+.|+++
T Consensus 219 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 219 RILGTPTEETW--PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHcCCCChhhc--hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 00000000000000000000000001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.38 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=197.5
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.+.+.++||.|+||.||++... +++.+|+|+.+.... ..+.|.+|++++++++|+||+++++.+.+....++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 4566788999999999999875 578999999875432 34568899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.+
T Consensus 86 ~~~L~~~~~~~-----------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~ 139 (280)
T cd06611 86 GGALDSIMLEL-----------------------ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLD 139 (280)
T ss_pred CCcHHHHHHHh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCC
Confidence 99999998542 235888999999999999999999998 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
+.++|+|||++........ ......++..|+|||.+. ...++.++||||||+++|||++|+.||......
T Consensus 140 ~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---- 214 (280)
T cd06611 140 GDVKLADFGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---- 214 (280)
T ss_pred CCEEEccCccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----
Confidence 9999999999875433221 222346888999999874 345788999999999999999999998643210
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
. ......... .+. ...+......+.+++..||+.+|.+||++.+|++.
T Consensus 215 -----~-~~~~~~~~~------~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 215 -----R-VLLKILKSE------PPT------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----H-HHHHHhcCC------CCC------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 000111100 000 00112345678899999999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.58 Aligned_cols=191 Identities=23% Similarity=0.298 Sum_probs=163.0
Q ss_pred HHhccccccccccccceEEEEEeCC-CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
...|.+.+.||+|+||.||+|+... ++.||+|+.... ....|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 3457788999999999999998764 578999975322 2357999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
. ++|.+++... ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 140 ~-~~l~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~ 192 (357)
T PHA03209 140 S-SDLYTYLTKR-----------------------SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFIND 192 (357)
T ss_pred C-CcHHHHHHhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 5 6898888542 346889999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~ 666 (763)
++.+||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 193 ~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 193 VDQVCIGDLGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCCEEEecCccccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999999999997543221 223456899999999999999999999999999999999866554
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.84 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=194.9
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEee------CCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAE------KGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~ 514 (763)
..+.+.+.||+|+||.||+|... +++.+|+|++........++..|+.++.++ +|+||+++++++.. .+..+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 45566789999999999999874 578999999876555556788999999998 79999999999863 45789
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||+|+
T Consensus 96 iv~e~~~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~ 150 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNT----------------------KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQ 150 (282)
T ss_pred EEEEeCCCCcHHHHHHHc----------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH
Confidence 999999999999998643 1234678888999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
||++++++.++|+|||++........ ......++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 151 nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 151 NVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred HEEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99999999999999999875432211 123356888999999875 356888999999999999999999998532
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.... ... ..... ..... .....+..+.+++..||+.||.+||++.||++
T Consensus 230 ~~~~-------------~~~------~~~~~-~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 230 HPMR-------------ALF------LIPRN-PPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHHh-------------hhh------hHhhC-CCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 2100 000 00000 00000 01234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=293.57 Aligned_cols=264 Identities=23% Similarity=0.269 Sum_probs=196.6
Q ss_pred cccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEee-----CCeeeEEEe
Q 046586 448 SNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAE-----KGERTLVYE 518 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~LV~E 518 (763)
.+.||+|+||.|..+... +++.||||.+... ....++-.+|+++|+.++|+||+.+.+++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 568999999999999775 6789999988743 2234567899999999999999999999875 347899999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
+| .-+|...+.. .+.|+......+..|+++||.|+|+.+ |+||||||+|+|+
T Consensus 107 lM-etDL~~iik~------------------------~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~ 158 (359)
T KOG0660|consen 107 LM-ETDLHQIIKS------------------------QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLL 158 (359)
T ss_pred HH-hhHHHHHHHc------------------------CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheee
Confidence 99 4489998853 334788888899999999999999999 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCC-cccccccccCCCcccccccc-cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKED-MVSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
+.+..+||+|||+|+...... ...++..+-|.+|+|||.+. ...|+.+.||||.||++.||++|+.-|.+.+...+..
T Consensus 159 n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 159 NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 999999999999999775431 23456778899999999765 5799999999999999999999999887654322100
Q ss_pred -----CCchhHHHHHHHHhccChhhhhcccccccCCCc---chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 -----EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSR---VHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 -----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
-..........+.... ....+.. +......+ .-+......++++.+||..||.+|+|++|.++
T Consensus 239 lI~~~lGtP~~e~l~~i~s~~-ar~yi~s-lp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 239 LILELLGTPSEEDLQKIRSEK-ARPYIKS-LPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHhcCCCCHHHHHHhccHH-HHHHHHh-CCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000111111110000 1111110 00000000 00234567889999999999999999999985
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.29 Aligned_cols=267 Identities=22% Similarity=0.218 Sum_probs=192.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCC------e
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG------E 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~ 512 (763)
..|.+.+.||+|+||.||++... .++.||+|+++... ....++.+|+.+++.++||||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 45677889999999999999775 57899999996432 23456789999999999999999999986543 5
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~-~l~~~~~~--------------------------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlk 150 (359)
T cd07876 101 VYLVMELMDA-NLCQVIHM--------------------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150 (359)
T ss_pred eEEEEeCCCc-CHHHHHhc--------------------------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 7899999975 56665521 3677888899999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+||+++.++.+||+|||+++..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 151 p~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~ 228 (359)
T cd07876 151 PSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228 (359)
T ss_pred HHHEEECCCCCEEEecCCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999754322 1233456899999999999999999999999999999999999999744211
Q ss_pred CCC------CCCchhHHH---H---HHHHhcc------ChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 046586 673 MNS------DEWYFPKWA---F---EKVYEEM------KVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734 (763)
Q Consensus 673 ~~~------~~~~~~~~~---~---~~~~~~~------~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 734 (763)
... .......+. . ....... ...+........ ............+.+++.+||+.||++||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 307 (359)
T cd07876 229 DQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFP-SESERDKLKTSQARDLLSKMLVIDPDKRI 307 (359)
T ss_pred HHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccc-cccccccccchhHHHHHHHHhccCcccCC
Confidence 000 000000000 0 0000000 000000000000 00001112345688999999999999999
Q ss_pred CHHHHHHH
Q 046586 735 SMGKVAKM 742 (763)
Q Consensus 735 s~~eVv~~ 742 (763)
|+.|+++.
T Consensus 308 t~~e~l~h 315 (359)
T cd07876 308 SVDEALRH 315 (359)
T ss_pred CHHHHhcC
Confidence 99999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.42 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=194.6
Q ss_pred cccccccccccceEEEEEeC-CCcEEEEEEeeccCC---c--------hhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 446 GFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---G--------DAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~--------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
...+.||+|+||.||+|... +++.+|+|.++.... . .+.+.+|+.+++.++|+|++++++++...+..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34578999999999999764 678999998863211 1 13577899999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~ 136 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTY------------------------GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKA 136 (272)
T ss_pred EEEEecCCCCcHHHHHhhc------------------------cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCCh
Confidence 9999999999999998532 35788889999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCC--CCCccceeehhHHHHHHHhCCCCccccc
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQ--ITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
+||+++.++.++|+|||+++....... .......++..|+|||.+.... ++.++||||||+++||+++|..|+....
T Consensus 137 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 137 DNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred hhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 999999999999999999976433211 1123346788999999987654 8899999999999999999999985321
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. ....+ ..................+..+.+++..|++.+|++||++.+|++.
T Consensus 217 ~~-------------~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 217 AI-------------AAMFK------LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hH-------------HHHHH------hhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 10 00000 0001111111111113346788899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.76 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=197.0
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.+++.+.||+|+||.||++... .++.+|+|.++.... ...++.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 3566789999999999999886 678999998874322 2356889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCceEEc
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENILLG 599 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NILl~ 599 (763)
++++|.+++.... ....+++..+..++.|++.||.|||+. + |+|+||||+||+++
T Consensus 82 ~~~~l~~~~~~~~---------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~ 137 (286)
T cd06622 82 DAGSLDKLYAGGV---------------------ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVN 137 (286)
T ss_pred CCCCHHHHHHhcc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEEC
Confidence 9999999885421 123688999999999999999999974 5 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC------CCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD------QITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~------~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
.++.+||+|||++...... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 138 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~- 213 (286)
T cd06622 138 GNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA- 213 (286)
T ss_pred CCCCEEEeecCCcccccCC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-
Confidence 9999999999999754322 12234578899999988544 3588999999999999999999998632110
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ... ...+.+. .....+.....++.+++.+||+.+|++||++.++++
T Consensus 214 --------~~-~~~------~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 214 --------NI-FAQ------LSAIVDG-----DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred --------hH-HHH------HHHHhhc-----CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 00 000 1111111 011222446678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=292.82 Aligned_cols=254 Identities=27% Similarity=0.354 Sum_probs=200.5
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.+.+.+.||.|+||+||+|... ++..+++|++.... .....+.+|+++++.++|+||+++++.+...+..++|+|++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 3567789999999999999864 57889999986432 24467899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++.... ....+++.....++.|++.||+|||+.+ |+|+||+|+||++++
T Consensus 82 ~~~~l~~~~~~~~---------------------~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~ 137 (267)
T cd06610 82 SGGSLLDIMKSSY---------------------PRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGE 137 (267)
T ss_pred CCCcHHHHHHHhc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcC
Confidence 9999999996431 1246789999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcc---cccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 601 DFCPKISDFGLAKLRKKEDMV---SMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
++.+||+|||++......... ......++..|+|||.+... .++.++||||||+++|||++|+.||.......
T Consensus 138 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--- 214 (267)
T cd06610 138 DGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--- 214 (267)
T ss_pred CCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---
Confidence 999999999999765443221 12334688899999998776 78999999999999999999999986432110
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcc-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRV-HFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+ ....... . ....... ....++.+.+++..||+.||++||++.+|++
T Consensus 215 --~~-----~~~~~~~------~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 215 --VL-----MLTLQND------P----PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --hH-----HHHhcCC------C----CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0000000 0 0000000 0244577889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.96 Aligned_cols=249 Identities=25% Similarity=0.331 Sum_probs=197.9
Q ss_pred ccccccccccccceEEEEEeCC-CcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.+.+.||+|+||.||++...+ ++.+|+|.+..... ..+.+..|+++++.++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 5567899999999999998764 88999999975432 335688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+.+++|.+++... ....+++.....++.|++.||+|||+.+ ++|+||||+||+++
T Consensus 83 ~~~~~L~~~~~~~----------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~ 137 (316)
T cd05574 83 CPGGELFRLLQRQ----------------------PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLH 137 (316)
T ss_pred cCCCCHHHHHHhC----------------------CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEc
Confidence 9999999998542 2346888999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCc----------------------------ccccccccCCCcccccccccCCCCCccceee
Q 046586 600 DDFCPKISDFGLAKLRKKEDM----------------------------VSMSRIRGTRGYMAPEWLRSDQITPKADVYS 651 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~----------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS 651 (763)
.++.++|+|||++........ .......|+..|+|||.+.+..++.++||||
T Consensus 138 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s 217 (316)
T cd05574 138 ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWT 217 (316)
T ss_pred CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHH
Confidence 999999999999875422111 0111246788999999999889999999999
Q ss_pred hhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCC
Q 046586 652 FGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPE 731 (763)
Q Consensus 652 ~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 731 (763)
||+++|||++|+.||...... .. ...+...... .. ........+.+++.+|++.||+
T Consensus 218 lG~ll~~l~~g~~pf~~~~~~-------------~~------~~~~~~~~~~--~~--~~~~~~~~~~~li~~~l~~~p~ 274 (316)
T cd05574 218 LGILLYEMLYGTTPFKGSNRD-------------ET------FSNILKKEVT--FP--GSPPVSSSARDLIRKLLVKDPS 274 (316)
T ss_pred HHHHHHHHhhCCCCCCCCchH-------------HH------HHHHhcCCcc--CC--CccccCHHHHHHHHHHccCCHh
Confidence 999999999999998643210 00 1111111111 00 0012567899999999999999
Q ss_pred CCCC----HHHHHH
Q 046586 732 LRPS----MGKVAK 741 (763)
Q Consensus 732 ~RPs----~~eVv~ 741 (763)
+||+ +.|+++
T Consensus 275 ~R~s~~~~~~~ll~ 288 (316)
T cd05574 275 KRLGSKRGAAEIKQ 288 (316)
T ss_pred HCCCchhhHHHHHc
Confidence 9999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=284.20 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=199.3
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeec---cCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKN---VTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..|.+.+.||+|.|+.||+... ..|+.+|+|++.. ...+.+++.+|+.+-+.|+|||||+|.....+....+||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 3456678999999999999855 4678888888752 23356778899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
+|.|++|..-+..+ ...+...+-+.+.||+++|.|.|.++ |||||+||.|+|+
T Consensus 91 ~m~G~dl~~eIV~R------------------------~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllL 143 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR------------------------EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLL 143 (355)
T ss_pred cccchHHHHHHHHH------------------------HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheee
Confidence 99999998777542 24566777889999999999999999 9999999999999
Q ss_pred cC---CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 599 GD---DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 599 ~~---~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
.. .--+|++|||+|.... +....-..+||++|||||+++..+|+..+|||+.||+||-|+.|..||.+...
T Consensus 144 ASK~~~A~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---- 217 (355)
T KOG0033|consen 144 ASKAKGAAVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---- 217 (355)
T ss_pred eeccCCCceeecccceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----
Confidence 53 4568999999998776 22334457899999999999999999999999999999999999999975321
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCC--CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYD--SRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..++++. .++.++ .+.-....++..+++.+||..||.+|.|+.|.++
T Consensus 218 ----------~rlye~I---------~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 218 ----------HRLYEQI---------KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----------HHHHHHH---------hccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2233332 122211 1111345677889999999999999999998773
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=333.38 Aligned_cols=260 Identities=23% Similarity=0.309 Sum_probs=198.1
Q ss_pred cHHHHHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeC-
Q 046586 436 THAELRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK- 510 (763)
Q Consensus 436 ~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~- 510 (763)
...++....|.+.++||+|+||.||++... .++.+|+|+++... .....|..|+.+++.|+|||||++++++.+.
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 334455567888999999999999999875 46789999987432 2335688999999999999999999988653
Q ss_pred -CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----Cc
Q 046586 511 -GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECL----EW 585 (763)
Q Consensus 511 -~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~----~~ 585 (763)
...+|||||+++|+|.++|..... ....+++..++.|+.||+.||+|||+.+. ..
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~--------------------~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~ 145 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYK--------------------MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER 145 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhh--------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence 568999999999999999965320 22468999999999999999999998542 34
Q ss_pred EEecCCCCCceEEcC-----------------CCCeEEcccCcccccCCCCcccccccccCCCccccccccc--CCCCCc
Q 046586 586 VLHCDIKPENILLGD-----------------DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS--DQITPK 646 (763)
Q Consensus 586 ivHrDlk~~NILl~~-----------------~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~k 646 (763)
||||||||+||||+. ...+||+|||++........ .....||+.|+|||++.+ ..++.+
T Consensus 146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~K 223 (1021)
T PTZ00266 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDK 223 (1021)
T ss_pred ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCch
Confidence 999999999999964 34589999999986543221 234578999999998854 468899
Q ss_pred cceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHcc
Q 046586 647 ADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCI 726 (763)
Q Consensus 647 sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl 726 (763)
+|||||||+||||++|+.||..... +... ...+... + ... . ...+..+.+|+..||
T Consensus 224 SDVWSLG~ILYELLTGk~PF~~~~~--------~~ql-i~~lk~~--------p----~lp--i-~~~S~eL~dLI~~~L 279 (1021)
T PTZ00266 224 SDMWALGCIIYELCSGKTPFHKANN--------FSQL-ISELKRG--------P----DLP--I-KGKSKELNILIKNLL 279 (1021)
T ss_pred hHHHHHHHHHHHHHHCCCCCCcCCc--------HHHH-HHHHhcC--------C----CCC--c-CCCCHHHHHHHHHHh
Confidence 9999999999999999999963221 1110 0001000 0 000 0 123467889999999
Q ss_pred CCCCCCCCCHHHHHH
Q 046586 727 QDRPELRPSMGKVAK 741 (763)
Q Consensus 727 ~~dP~~RPs~~eVv~ 741 (763)
+.+|.+||++.+++.
T Consensus 280 ~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 280 NLSAKERPSALQCLG 294 (1021)
T ss_pred cCChhHCcCHHHHhc
Confidence 999999999999983
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.66 Aligned_cols=243 Identities=23% Similarity=0.336 Sum_probs=194.2
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeecc-CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNV-TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
.+||+|+||.||++... +++.||+|.++.. ....+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 47999999999999775 6789999998643 233456889999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEE
Q 046586 527 DYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKI 606 (763)
Q Consensus 527 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI 606 (763)
+++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||
T Consensus 107 ~~~~~-------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL 158 (297)
T cd06659 107 DIVSQ-------------------------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158 (297)
T ss_pred HHHhh-------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEE
Confidence 87732 34788999999999999999999988 999999999999999999999
Q ss_pred cccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHH
Q 046586 607 SDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686 (763)
Q Consensus 607 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 686 (763)
+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...
T Consensus 159 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----------~~~ 227 (297)
T cd06659 159 SDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----------AMK 227 (297)
T ss_pred eechhHhhccccc-ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------HHH
Confidence 9999987543322 12233568899999999998899999999999999999999999986322100 000
Q ss_pred HHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 687 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.+. .. . .... .........+.+++..||+.+|++||++.+|++.
T Consensus 228 ~~~-~~-~----~~~~------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 228 RLR-DS-P----PPKL------KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHh-cc-C----CCCc------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 00 0 0000 0011234568899999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=310.37 Aligned_cols=267 Identities=21% Similarity=0.205 Sum_probs=193.5
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeC------Ce
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK------GE 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 512 (763)
..|.+.+.||+|+||.||++... .++.||||+++... ....++.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 45677889999999999999765 57889999997432 2335678999999999999999999987643 35
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++ +|.+++.. .+++..+..++.|++.||+|||+.+ |+|||||
T Consensus 104 ~~lv~e~~~~-~l~~~~~~--------------------------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlk 153 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQM--------------------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 153 (364)
T ss_pred EEEEEeCCCC-CHHHHHHh--------------------------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCC
Confidence 7999999975 77776632 3677888999999999999999988 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+||+++.++.+||+|||+++...... ......+|..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 154 p~NIll~~~~~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 231 (364)
T cd07875 154 PSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 231 (364)
T ss_pred HHHEEECCCCcEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999998653321 223456899999999999999999999999999999999999999643211
Q ss_pred CCC------CCCchhHHHH------HHHHhccC------hhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 046586 673 MNS------DEWYFPKWAF------EKVYEEMK------VEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734 (763)
Q Consensus 673 ~~~------~~~~~~~~~~------~~~~~~~~------~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 734 (763)
... .....+.+.. ....+... ......... ..............+.+++.+|++.||.+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~ 310 (364)
T cd07875 232 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL-FPADSEHNKLKASQARDLLSKMLVIDASKRI 310 (364)
T ss_pred HHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccc-ccccccccccccHHHHHHHHHhcCcCcccCC
Confidence 000 0000000000 00000000 000000000 0000011112345788999999999999999
Q ss_pred CHHHHHHH
Q 046586 735 SMGKVAKM 742 (763)
Q Consensus 735 s~~eVv~~ 742 (763)
|+.++++.
T Consensus 311 t~~e~L~h 318 (364)
T cd07875 311 SVDEALQH 318 (364)
T ss_pred CHHHHhcC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=293.18 Aligned_cols=250 Identities=22% Similarity=0.370 Sum_probs=197.4
Q ss_pred ccccccccccccceEEEEEe-CCCcEEEEEEeeccCC-------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 445 NGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTG-------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
+...+.||+|+||.||++.. .+++.+|+|.++.... ..+++++|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 34457899999999999976 4678999999874321 235688999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||
T Consensus 82 ~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~ni 134 (268)
T cd06630 82 VEWMAGGSVSHLLSKY------------------------GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANL 134 (268)
T ss_pred EeccCCCcHHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 9999999999998542 25778899999999999999999998 99999999999
Q ss_pred EEcCCC-CeEEcccCcccccCCCCc---ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 597 LLGDDF-CPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 597 Ll~~~~-~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
+++.++ .+||+|||++........ .......++..|+|||.+.+..++.++||||+|++++||++|..||......
T Consensus 135 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 214 (268)
T cd06630 135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214 (268)
T ss_pred EEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Confidence 998776 599999999976543211 1112346788999999998889999999999999999999999998633211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. ... .+............+.....++.+++.+|++.+|++||++.++++
T Consensus 215 ~------~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 215 N------HLA--------------LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred c------hHH--------------HHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0 000 000000111112233456678999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=319.71 Aligned_cols=269 Identities=19% Similarity=0.271 Sum_probs=191.6
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCC------CccccEEEEEeeC-Ceee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHH------LNLVRLWGFCAEK-GERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H------~niv~l~g~~~~~-~~~~ 514 (763)
..|.+.++||+|+||.||++... .++.||||+++.......++..|+++++.++| .+++++++++... .+.+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 45777889999999999999875 57889999997654444556778887777754 4588899988764 5788
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKP 593 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~ 593 (763)
+|||++ +++|.+++... ..+++..+..|+.||+.||+|||++ + ||||||||
T Consensus 209 iv~~~~-g~~l~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP 260 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKH------------------------GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKP 260 (467)
T ss_pred EEEecc-CCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCH
Confidence 999988 77899888542 3578899999999999999999984 6 99999999
Q ss_pred CceEEcCCC----------------CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHH
Q 046586 594 ENILLGDDF----------------CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLL 657 (763)
Q Consensus 594 ~NILl~~~~----------------~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ 657 (763)
+|||++.++ .+||+|||++..... ......||..|+|||++.+..++.++|||||||++|
T Consensus 261 ~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ 336 (467)
T PTZ00284 261 ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336 (467)
T ss_pred HHEEEecCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHH
Confidence 999998765 499999998863221 233467899999999999999999999999999999
Q ss_pred HHHhCCCCcccccCCCC------CCCCchhHHHHHHHHhccChhhhhcccc--cccCC----------Ccc-hHHHHHHH
Q 046586 658 EIVSGSRNFEIQGSMMN------SDEWYFPKWAFEKVYEEMKVEDILDRHI--KNSYD----------SRV-HFDMVNRM 718 (763)
Q Consensus 658 elltG~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~----------~~~-~~~~~~~l 718 (763)
||++|+.||........ ........|......+. ..++.+... ..... ... .......+
T Consensus 337 elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (467)
T PTZ00284 337 ELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEE--ARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLL 414 (467)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchh--HHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHH
Confidence 99999999975432110 00000011110000000 000000000 00000 000 01123567
Q ss_pred HHHHHHccCCCCCCCCCHHHHHH--Hhcc
Q 046586 719 VKTAMWCIQDRPELRPSMGKVAK--MLEG 745 (763)
Q Consensus 719 ~~l~~~Cl~~dP~~RPs~~eVv~--~Le~ 745 (763)
.+|+.+||+.||++|||+.|+++ .|.+
T Consensus 415 ~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 415 CDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred HHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 89999999999999999999996 4443
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=293.86 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=198.6
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCC------eee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKG------ERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~------~~~ 514 (763)
..|.+.+.||+|+||.||+|... +++.+++|+++.......++.+|+.+++++ +|+||+++++++.+.. ..+
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 45667789999999999999885 567899999986666667899999999999 7999999999997654 489
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||+|+
T Consensus 86 lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ 142 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRK--------------------KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQ 142 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhh--------------------cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHH
Confidence 99999999999999864320 2346889999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-----CCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-----DQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
||++++++.+||+|||++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 143 ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 143 NILLTKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred HEEEccCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 9999999999999999987543322 12223457889999998753 35778999999999999999999998632
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
... ....+ +.... ... ...+....+.+.+++.+||+.||++|||+.+|++
T Consensus 222 ~~~-------------~~~~~------~~~~~-~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 222 HPM-------------RALFK------IPRNP-PPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred chH-------------HHHHH------hhccC-CCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 00000 00000 000 0111235678899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=293.06 Aligned_cols=247 Identities=22% Similarity=0.331 Sum_probs=192.5
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC---C---chhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---G---GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTL 515 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~L 515 (763)
+.+.++||+|+||.||+|... +++.||+|.+.... . ..+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 456789999999999999875 57899999886321 1 124578899999999999999999998764 46789
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++++|.+++... ..+++...++++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 v~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~n 136 (265)
T cd06652 84 FMEHMPGGSIKDQLKSY------------------------GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGAN 136 (265)
T ss_pred EEEecCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHH
Confidence 99999999999998542 24678888999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
|+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 137 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~- 215 (265)
T cd06652 137 ILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM- 215 (265)
T ss_pred EEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-
Confidence 9999999999999999975532211 1223345888999999998888999999999999999999999998632100
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
... .+.. ........+......+.+++.+|+. +|++||+++||++.
T Consensus 216 ------------~~~------~~~~----~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 216 ------------AAI------FKIA----TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ------------HHH------HHHh----cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 000 0000 0011112234556677888888885 89999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=292.70 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=198.7
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEee--CCeeeEEEe
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAE--KGERTLVYE 518 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV~E 518 (763)
|++.+.||.|+||.||++... +++.+|+|+++.... ..+++..|++++++++|+||+++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 456789999999999999764 678899999874322 23458889999999999999999998764 346789999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCcEEecCCCC
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH-----EECLEWVLHCDIKP 593 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH-----~~~~~~ivHrDlk~ 593 (763)
|+++++|.+++..... ....+++..++.++.|++.||+||| +.+ ++|+||+|
T Consensus 82 ~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p 138 (265)
T cd08217 82 YCEGGDLAQLIQKCKK--------------------ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKP 138 (265)
T ss_pred hccCCCHHHHHHHHhh--------------------cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCH
Confidence 9999999999965321 2356889999999999999999999 555 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
+||++++++.+||+|||++......... .....++..|+|||.+....++.++||||||+++|+|++|+.||.....
T Consensus 139 ~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-- 215 (265)
T cd08217 139 ANIFLDANNNVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-- 215 (265)
T ss_pred HHEEEecCCCEEEecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--
Confidence 9999999999999999999876543321 2334688999999999988899999999999999999999999864321
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. ..+ .+... .....+......+.+++.+|++.+|++||++.+|+++
T Consensus 216 -------~~-----~~~------~~~~~----~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 -------LQ-----LAS------KIKEG----KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------HH-----HHH------HHhcC----CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 01 000 01110 0112224556788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.09 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=198.3
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
+.+.+.||+|+||.||++... +++.+++|.+.... ....++.+|++++++++||||+++++.+...+..++|+||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 445678999999999999886 57889999987543 234568899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCceEEcC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE-ECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDlk~~NILl~~ 600 (763)
+++|.+++... ...++......++.|++.||+|||+ .+ ++|+||||+||++++
T Consensus 83 ~~~L~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~ 136 (265)
T cd06605 83 GGSLDKILKEV-----------------------QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNS 136 (265)
T ss_pred CCcHHHHHHHc-----------------------cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECC
Confidence 99999998643 1457788889999999999999999 77 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.+||+|||.+........ ....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..
T Consensus 137 ~~~~~l~d~g~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~- 208 (265)
T cd06605 137 RGQIKLCDFGVSGQLVNSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP----DG- 208 (265)
T ss_pred CCCEEEeecccchhhHHHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc----cc-
Confidence 99999999999875532211 11567889999999998999999999999999999999999986432100 00
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFD-MVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..+.+........ ...+.. ....+.+++..||+.+|++|||+.++++
T Consensus 209 -------------~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 209 -------------IFELLQYIVNEPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -------------HHHHHHHHhcCCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0111111111110 111122 5667899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.39 Aligned_cols=275 Identities=22% Similarity=0.286 Sum_probs=200.7
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc------hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG------DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
+.+.+.||+|+||.||+|... +++.|++|.++..... ...+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 456778999999999999875 5789999999754322 345678999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+ +++|.+++... ...+++..+..++.||++||+|||+.+ |+|+||+|+||+
T Consensus 82 e~~-~~~L~~~i~~~-----------------------~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil 134 (298)
T cd07841 82 EFM-ETDLEKVIKDK-----------------------SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLL 134 (298)
T ss_pred ccc-CCCHHHHHhcc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEE
Confidence 999 89999998532 135889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
++.++.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|..+|.......
T Consensus 135 l~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--- 210 (298)
T cd07841 135 IASDGVLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--- 210 (298)
T ss_pred EcCCCCEEEccceeeeeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---
Confidence 99999999999999986544321 2223356778999998854 567899999999999999999977775332110
Q ss_pred CCchhHHHHHHH--------HhccChhhhhcccccccCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcc
Q 046586 677 EWYFPKWAFEKV--------YEEMKVEDILDRHIKNSYD-SRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM--LEG 745 (763)
Q Consensus 677 ~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~--Le~ 745 (763)
.+.. ..... ................... ..........+.+++.+||+.||++|||+.||++. +++
T Consensus 211 --~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 211 --QLGK-IFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred --HHHH-HHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 0000 00000 0000000000000000000 00112345788999999999999999999999985 554
Q ss_pred CCCCCCCC
Q 046586 746 TVEITEPK 753 (763)
Q Consensus 746 ~~~~~~p~ 753 (763)
-.....|.
T Consensus 288 ~~~~~~~~ 295 (298)
T cd07841 288 DPAPTPPS 295 (298)
T ss_pred CCCCCCCC
Confidence 43333333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.27 Aligned_cols=265 Identities=23% Similarity=0.291 Sum_probs=199.1
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
|.+.+.||+|+||.||+|... +++.|++|+++... .....+.+|+.++++++||||+++++++......++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 567789999999999999875 67899999997543 23457889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+++|.+++... ...+++.++..++.|+++||+|||+.+ ++|+||||+||+++.
T Consensus 82 -~~~L~~~~~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~ 134 (286)
T cd07832 82 -PSDLSEVLRDE-----------------------ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISA 134 (286)
T ss_pred -CCCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcC
Confidence 99999998642 245889999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
++.++|+|||++...............++..|+|||.+.+. .++.++||||+|++++||++|..+|.......
T Consensus 135 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~------ 208 (286)
T cd07832 135 DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE------ 208 (286)
T ss_pred CCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH------
Confidence 99999999999987654433233345688999999988654 56899999999999999999987775332100
Q ss_pred hhHHHHHHH--------HhccChhhhhcccccccCC---CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 680 FPKWAFEKV--------YEEMKVEDILDRHIKNSYD---SRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 680 ~~~~~~~~~--------~~~~~~~~~~~~~l~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
........+ .+.....+...-....... .....+....+.+++.+|++.+|++||+++++++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 209 QLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0000000000000000000 00001335788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=301.32 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=197.0
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
++.+.++||+|+||.||++... +++.+|+|++..... ..+.+.+|+++++.++||||+++++++...+..++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 3567789999999999999886 478999999864322 235688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.++... ...+++.+++.++.|++.||+|||+.+ ++|+||+|+||+++
T Consensus 82 ~~~~~l~~~~~~------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~ 134 (286)
T cd07846 82 VDHTVLDDLEKY------------------------PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVS 134 (286)
T ss_pred CCccHHHHHHhc------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEC
Confidence 999988877632 224789999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC--
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD-- 676 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~-- 676 (763)
+++.+||+|||++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~ 213 (286)
T cd07846 135 QSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213 (286)
T ss_pred CCCcEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 99999999999997654332 22233457889999998865 457889999999999999999998886332100000
Q ss_pred ---CCchhHHHHHHHHhccChhhhhcccccccCCC-----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 ---EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDS-----RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...+...... ... ...+.+......... ......+..+.+++.+||+.+|++||++.+|++
T Consensus 214 ~~~~~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 214 IKCLGNLIPRHQE-IFQ---KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHhCCCchhhHH-Hhc---cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000 000 000011100000000 001234677999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=295.83 Aligned_cols=249 Identities=20% Similarity=0.356 Sum_probs=191.2
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHH-HhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTI-IARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
+.+.+.||+|+||.||+++.. +++.||+|+++.... ...++..|+.. ++.++||||+++++++...+..++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456789999999999999876 588999999975432 33456667665 66679999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCceEEc
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENILLG 599 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NILl~ 599 (763)
+ |+|.+++..... ....+++..+..++.|++.||+|||++ + ++||||||+||+++
T Consensus 83 ~-~~l~~~l~~~~~--------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~ 138 (283)
T cd06617 83 D-TSLDKFYKKVYD--------------------KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLIN 138 (283)
T ss_pred c-ccHHHHHHHhcc--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEEC
Confidence 6 689888854321 234689999999999999999999986 6 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCccccccccc----CCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS----DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
.++.+||+|||+++...... ..+...++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.....
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---- 212 (283)
T cd06617 139 RNGQVKLCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT---- 212 (283)
T ss_pred CCCCEEEeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----
Confidence 99999999999997653221 1223457889999998864 4578899999999999999999999853211
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+. .+ ....... ..... ....+..+.+++.+||+.+|++||++.+|++
T Consensus 213 ---~~~-----~~------~~~~~~~-~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 213 ---PFQ-----QL------KQVVEEP-SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---CHH-----HH------HHHHhcC-CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00 0011100 00000 0124567889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=295.06 Aligned_cols=246 Identities=24% Similarity=0.359 Sum_probs=197.7
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.+.+.++||+|+||.||+|... +++.+|+|.+.... .....+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4556678999999999999764 67899999986432 23356889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++.. ..+++.....++.|++.++.|||+.+ ++|+||+|+||+++.
T Consensus 85 ~~~~l~~~i~~-------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~ 136 (277)
T cd06641 85 GGGSALDLLEP-------------------------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSE 136 (277)
T ss_pred CCCcHHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECC
Confidence 99999998832 24788999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+.....
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------- 206 (277)
T cd06641 137 HGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------- 206 (277)
T ss_pred CCCEEEeecccceecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---------
Confidence 99999999999876543221 12234578899999999888899999999999999999999999853211
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.......... .....+...+..+.+++.+||+.+|++||++.++++.
T Consensus 207 -~~~~~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 207 -MKVLFLIPKN--------------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -HHHHHHHhcC--------------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 0111113345678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=306.85 Aligned_cols=268 Identities=22% Similarity=0.207 Sum_probs=193.2
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeC------Ce
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEK------GE 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 512 (763)
..|.+.+.||+|+||.||++... .++.||||.++.... ....+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 35667789999999999999764 578899999974322 235677899999999999999999988643 35
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+|||||
T Consensus 97 ~~lv~e~~~~-~l~~~~~~--------------------------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDik 146 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQM--------------------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 146 (355)
T ss_pred eEEEhhhhcc-cHHHHHhh--------------------------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 7899999965 67666631 3677888999999999999999988 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+|||++.++.+||+|||+++..... .......+|..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 147 p~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 224 (355)
T cd07874 147 PSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224 (355)
T ss_pred hHHEEECCCCCEEEeeCcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999864332 1223457899999999999999999999999999999999999999643211
Q ss_pred CCC------CCCchhHHHH------HHHHhcc-Chhhhhccc-ccc---cCCCcchHHHHHHHHHHHHHccCCCCCCCCC
Q 046586 673 MNS------DEWYFPKWAF------EKVYEEM-KVEDILDRH-IKN---SYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735 (763)
Q Consensus 673 ~~~------~~~~~~~~~~------~~~~~~~-~~~~~~~~~-l~~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 735 (763)
... .....+.+.. ....+.. ....+..+. ... ..+..........+.+++.+|++.||++|||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps 304 (355)
T cd07874 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304 (355)
T ss_pred HHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC
Confidence 000 0000000000 0000000 000000000 000 0000111223467889999999999999999
Q ss_pred HHHHHHH
Q 046586 736 MGKVAKM 742 (763)
Q Consensus 736 ~~eVv~~ 742 (763)
+.|+++.
T Consensus 305 ~~ell~h 311 (355)
T cd07874 305 VDEALQH 311 (355)
T ss_pred HHHHhcC
Confidence 9999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=290.54 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=197.1
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|++++++++||||+++++.+..++..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 556789999999999999774 57889999986432 23456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||+|+||++++
T Consensus 82 ~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~ 136 (256)
T cd08220 82 PGGTLAEYIQKR----------------------CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDK 136 (256)
T ss_pred CCCCHHHHHHHh----------------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 999999999643 2345788999999999999999999988 999999999999985
Q ss_pred C-CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 601 D-FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~-~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
+ ..+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 137 ~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------- 206 (256)
T cd08220 137 HKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-------- 206 (256)
T ss_pred CCCEEEEccCCCceecCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------
Confidence 5 468999999998654322 12234678899999999988899999999999999999999999864321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
...... ..... ....+......+.+++.+||+.+|++|||+.|+++.
T Consensus 207 -~~~~~~----------~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 207 -PALVLK----------IMSGT-----FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -HHHHHH----------HHhcC-----CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111100 00000 001112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=298.32 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=199.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc-CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV-TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.++.+.+.||+|+||.||++... +++.+++|.+... ....+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 45667789999999999999764 6788999998643 334466889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.
T Consensus 99 ~~~~L~~~~~~-------------------------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~ 150 (293)
T cd06647 99 AGGSLTDVVTE-------------------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGM 150 (293)
T ss_pred CCCcHHHHHhh-------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcC
Confidence 99999999843 24678899999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.+||+|||++........ ......++..|+|||.+....++.++||||||+++||+++|+.||........
T Consensus 151 ~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------ 223 (293)
T cd06647 151 DGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------ 223 (293)
T ss_pred CCCEEEccCcceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------
Confidence 99999999999875543322 12234578889999999888899999999999999999999999964321100
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
...+.. .+......+......+.+++.+||+.+|++||++.+++.+
T Consensus 224 -------------~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 224 -------------LYLIAT---NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -------------eeehhc---CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0000001112345678899999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=294.53 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=194.9
Q ss_pred ccccccccccccceEEEEEe-CCCcEEEEEEeecc--CCchhhhHHHHHHHhcCC---CCccccEEEEEeeCCeeeEEEe
Q 046586 445 NGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNV--TGGDAEFWAEVTIIARMH---HLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~--~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~LV~E 518 (763)
|.+.+.||+|+||.||+|.. .+++.+|+|.++.. .....++.+|+.++++++ |||++++++++.++...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 44567899999999999986 46789999998643 233456889999999996 9999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++.. ..+++...+.++.|++.||.|||+.+ |+|+||+|+||++
T Consensus 83 ~~~~~~L~~~~~~-------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i 134 (277)
T cd06917 83 YAEGGSVRTLMKA-------------------------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILV 134 (277)
T ss_pred cCCCCcHHHHHHc-------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEE
Confidence 9999999998832 25789999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++++.++|+|||++........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----- 208 (277)
T cd06917 135 TNTGNVKLCDFGVAALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF----- 208 (277)
T ss_pred cCCCCEEEccCCceeecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----
Confidence 9999999999999986654332 2233468889999998865 45789999999999999999999998643210
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. . ..+.......... .....++.+++.+||+.||++||++.++++
T Consensus 209 ----~~----~-------~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 209 ----RA----M-------MLIPKSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ----hh----h-------hccccCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 00 0 0000000001110 114567889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=296.28 Aligned_cols=263 Identities=23% Similarity=0.325 Sum_probs=196.2
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.|.+.+.||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|+++++.++|+||+++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 3566789999999999999886 578999999874322 234578999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
++++.|..++.. ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++
T Consensus 82 ~~~~~l~~~~~~------------------------~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~ 134 (286)
T cd07847 82 CDHTVLNELEKN------------------------PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILIT 134 (286)
T ss_pred cCccHHHHHHhC------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEc
Confidence 999888877632 235789999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
.++.+||+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---- 209 (286)
T cd07847 135 KQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---- 209 (286)
T ss_pred CCCcEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH----
Confidence 999999999999986644321 1223456788999998876 5688999999999999999999999964321100
Q ss_pred chhHHHHHHHHhcc--Chhhhh------cccccccCCCcc-----hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 679 YFPKWAFEKVYEEM--KVEDIL------DRHIKNSYDSRV-----HFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~--~~~~~~------~~~l~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
........... ...+.. ............ .......+.+++.+||+.+|++||++.|++.
T Consensus 210 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 210 ---LYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ---HHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000000 000000 000000000000 0123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.77 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=197.1
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.+.+.||+|+||.||++... .++.|++|.++... .....+.+|+++++.++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 556789999999999999875 46789999987542 2235678999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++
T Consensus 83 ~~g~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~ 135 (305)
T cd05609 83 VEGGDCATLLKNI------------------------GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLIT 135 (305)
T ss_pred CCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEEC
Confidence 9999999999532 35788889999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCc--------------ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDM--------------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~--------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
.++.+||+|||+++....... .......++..|+|||.+.+..++.++|+||||+++|||++|..|
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~p 215 (305)
T cd05609 136 SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215 (305)
T ss_pred CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999874211100 011124578899999999888999999999999999999999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
|..... .. +.+.........+. .....+..+.+++.+||+.||++||++.++.++|+.
T Consensus 216 f~~~~~---------~~-----~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 216 FFGDTP---------EE-----LFGQVISDDIEWPE--------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCCH---------HH-----HHHHHHhcccCCCC--------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 863211 00 00100000000000 001245678999999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=290.49 Aligned_cols=261 Identities=22% Similarity=0.314 Sum_probs=211.9
Q ss_pred HHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeC-Ce
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEK-GE 512 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~ 512 (763)
+.+...+..+-+|.||.||+|.+. +.+.|.+|.+++.... ...|+.|..++..+.|||+....+++.+. ..
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 334445568999999999999554 4567888988865543 34688999999999999999999999875 46
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.+++|.++.-|+|+.||...+..+. .....++..+...++.|++.||+|||..+ |||.||.
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~----------------~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiA 423 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDP----------------SYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIA 423 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCC----------------ccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhh
Confidence 7788999999999999986542111 14456888899999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCccccccc-ccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCccccc
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI-RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQG 670 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~-~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~ 670 (763)
.+|.+||+...+||+|=.+++.+.+.+.+..... -.+..||+||.+.+..|+.++|||||||+||||+| |+.|+...+
T Consensus 424 aRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID 503 (563)
T KOG1024|consen 424 ARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID 503 (563)
T ss_pred hhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence 9999999999999999999998877776554432 24678999999999999999999999999999998 888986433
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
+. .. ...+...++...|.+++.+++.+|..||..+|++||++++++.-|.+
T Consensus 504 Pf----------Em--------------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 504 PF----------EM--------------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HH----------HH--------------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 21 11 11122233444457889999999999999999999999999988865
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=297.85 Aligned_cols=244 Identities=29% Similarity=0.343 Sum_probs=192.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.+.+.++||+|+||.||+|... +++.||+|.++.... ...++.+|+++++.++||||+++++++.+.+..++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3666789999999999999875 578999999863321 22468899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++
T Consensus 96 ~~~-g~l~~~~~~~-----------------------~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~ 148 (307)
T cd06607 96 YCL-GSASDILEVH-----------------------KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILL 148 (307)
T ss_pred hhC-CCHHHHHHHc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEE
Confidence 997 5777776432 235889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
++++.+||+|||++...... ....++..|+|||.+. .+.++.++||||||+++|||++|+.|+......
T Consensus 149 ~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--- 220 (307)
T cd06607 149 TEPGTVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--- 220 (307)
T ss_pred CCCCCEEEeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---
Confidence 99999999999999754322 2345788899999874 467889999999999999999999998532210
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
. .... +... .............+.+++.+||+.+|++||++.+|+..
T Consensus 221 ------~----~~~~------~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 221 ------S----ALYH------IAQN----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ------H----HHHH------HhcC----CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000 0000 00000112345678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.04 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=199.1
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.+.+.++||+|+||.||+|... +++.|++|.++... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 3667889999999999999876 47899999987432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
++++.+..++.. ...+++.++..++.|++.||+|||+.+ ++|+||+|+||+++
T Consensus 82 ~~~~~l~~~~~~------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~ 134 (288)
T cd07833 82 VERTLLELLEAS------------------------PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVS 134 (288)
T ss_pred CCCCHHHHHHhc------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEC
Confidence 998766655422 234788999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+++.+||+|||++...............++..|+|||++.+. .++.++||||||+++|||++|+.||.......
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~----- 209 (288)
T cd07833 135 ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID----- 209 (288)
T ss_pred CCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 999999999999987655433233445678899999999887 88999999999999999999999986432110
Q ss_pred chhHHHHHHHHhccC--hhhh--hcccccc-----c-----CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 679 YFPKWAFEKVYEEMK--VEDI--LDRHIKN-----S-----YDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~--~~~~--~~~~l~~-----~-----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
..+.......... .... .++.... . .....+...+.++.+++..||+.+|++||++++|+++
T Consensus 210 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 210 --QLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred --HHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000000000 0000 0000000 0 0000112236789999999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=300.84 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=193.6
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
|.+.++||+|+||.||+++.. +++.+|+|.++... .....+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 556789999999999999875 57899999987432 22356788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+ ++|.+++... ...+++..+..++.||++||+|||+.+ |+|+||||+||+++.
T Consensus 82 ~-~~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~ 134 (284)
T cd07839 82 D-QDLKKYFDSC-----------------------NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINK 134 (284)
T ss_pred C-CCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcC
Confidence 7 5888887532 235889999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC--
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE-- 677 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~-- 677 (763)
++.+||+|||+++...... .......++..|+|||.+.+. .++.++||||||+++|||++|..|+...........
T Consensus 135 ~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (284)
T cd07839 135 NGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213 (284)
T ss_pred CCcEEECccchhhccCCCC-CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH
Confidence 9999999999997554322 112234568899999988764 578999999999999999999988643221100000
Q ss_pred ----CchhHHHHHHHHhccChhhhhcccccccCCC-----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 ----WYFPKWAFEKVYEEMKVEDILDRHIKNSYDS-----RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.......+....+ ..+......... ........++.+++.+||+.||.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 214 FRLLGTPTEESWPGVSK------LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHhCCCChHHhHHhhh------cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000000000 000000000000 011234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=293.44 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=199.8
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
+.+.+.||+|+||.||++... +++.+++|+++........+.+|+++++.++|+|++++++.+...+..++|+||++++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 445678999999999999887 5788999999865545667899999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.
T Consensus 101 ~L~~~l~~~-----------------------~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~ 154 (286)
T cd06614 101 SLTDIITQN-----------------------FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGS 154 (286)
T ss_pred cHHHHHHHh-----------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCC
Confidence 999999643 136889999999999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHH
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~ 683 (763)
+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..
T Consensus 155 ~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---------~~ 224 (286)
T cd06614 155 VKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---------RA 224 (286)
T ss_pred EEECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---------HH
Confidence 99999999875443221 122345778999999998889999999999999999999999998632210 00
Q ss_pred HHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...+....... ...+......+.+++.+|++.+|.+||++.+|++
T Consensus 225 ----------~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 225 ----------LFLITTKGIPP---LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----------HHHHHhcCCCC---CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00000000000 0011224567889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=294.63 Aligned_cols=258 Identities=22% Similarity=0.309 Sum_probs=197.2
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~Ey 519 (763)
+.+.++||.|++|.||++... +++.+|+|.+..... ...++.+|++++++++||||+++++++.+. +..++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 455679999999999999885 578899999875433 346689999999999999999999998654 468999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++..... ....++......++.|++.||+|||+.+ ++|+||+|+||+++
T Consensus 83 ~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~ 139 (287)
T cd06621 83 CEGGSLDSIYKKVKK--------------------RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLT 139 (287)
T ss_pred cCCCCHHHHHHHHHh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEe
Confidence 999999998754321 2345788899999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
+++.++|+|||++....... .....++..|+|||.+.+..++.++||||+|+++|||++|..|+....... ..
T Consensus 140 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~ 212 (287)
T cd06621 140 RKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP----LG 212 (287)
T ss_pred cCCeEEEeeccccccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC----CC
Confidence 99999999999987543221 123456788999999999999999999999999999999999997442200 00
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..+. ...... ..... +...... .....+.+.+++.+||+.+|++|||+.||++
T Consensus 213 ~~~~-~~~~~~-~~~~~-----~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 213 PIEL-LSYIVN-MPNPE-----LKDEPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hHHH-HHHHhc-CCchh-----hccCCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0010 000100 00000 0000000 0123567899999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.32 Aligned_cols=243 Identities=26% Similarity=0.367 Sum_probs=193.9
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
..||+|+||.||++... ++..||||.++... ...+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 57999999999999875 57899999986433 33456889999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEE
Q 046586 527 DYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKI 606 (763)
Q Consensus 527 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI 606 (763)
+++.. ..+++.+...++.||+.||+|||+.+ |+||||||+||++++++.+||
T Consensus 108 ~~~~~-------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL 159 (292)
T cd06658 108 DIVTH-------------------------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159 (292)
T ss_pred HHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEE
Confidence 98732 24788899999999999999999988 999999999999999999999
Q ss_pred cccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHH
Q 046586 607 SDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686 (763)
Q Consensus 607 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 686 (763)
+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....
T Consensus 160 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----------~~~~ 228 (292)
T cd06658 160 SDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----------QAMR 228 (292)
T ss_pred ccCcchhhccccc-ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------HHHH
Confidence 9999987543322 1223356888999999998889999999999999999999999998632210 0000
Q ss_pred HHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 687 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. ...+...... .......+..++..|++.||.+|||+.++++.
T Consensus 229 ~~------~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 229 RI------RDNLPPRVKD------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HH------HhcCCCcccc------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 0011111110 01234567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=290.22 Aligned_cols=241 Identities=26% Similarity=0.361 Sum_probs=193.5
Q ss_pred ccccccceEEEEEeCC-CcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 451 IGRGGFGDVYKGELTD-HRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 451 LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
||.|+||.||+++... ++.+++|++.... ...+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999998864 7889999987432 2335688999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeE
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 605 (763)
.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+|
T Consensus 81 ~~~l~~~------------------------~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~ 133 (262)
T cd05572 81 WTILRDR------------------------GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVK 133 (262)
T ss_pred HHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEE
Confidence 9999542 24788899999999999999999988 99999999999999999999
Q ss_pred EcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHH
Q 046586 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685 (763)
Q Consensus 606 I~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 685 (763)
|+|||+++...... ......++..|+|||.+....++.++|+||+|+++|||++|..||...... ....
T Consensus 134 l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~-- 202 (262)
T cd05572 134 LVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-------PMEI-- 202 (262)
T ss_pred EeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-------HHHH--
Confidence 99999998664432 122346788999999998888999999999999999999999999643210 0000
Q ss_pred HHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046586 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAK 741 (763)
Q Consensus 686 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~ 741 (763)
...+.+.. .....+......+.+++..||+.+|++||+ +.|+++
T Consensus 203 --------~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 203 --------YNDILKGN----GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred --------HHHHhccC----CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11111101 111122233678999999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=295.54 Aligned_cols=240 Identities=28% Similarity=0.350 Sum_probs=196.2
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
|.+.+.||+|+||.||++... +++.+|+|.++... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 567789999999999999875 57899999987432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ..++...+..++.|++.||+|||+.+ |+|+||+|+||+++
T Consensus 83 ~~~~~L~~~~~~~------------------------~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~ 135 (290)
T cd05580 83 VPGGELFSHLRKS------------------------GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLD 135 (290)
T ss_pred CCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEC
Confidence 9999999998542 35788899999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
+++.+||+|||+++..... .....+++.|+|||.+.+...+.++||||||+++|||++|+.||.....
T Consensus 136 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------- 203 (290)
T cd05580 136 SDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------- 203 (290)
T ss_pred CCCCEEEeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------
Confidence 9999999999999865443 2334678899999999888899999999999999999999999863321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVA 740 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv 740 (763)
...... +.... ..++......+.+++.+||+.||.+|| ++.|++
T Consensus 204 --~~~~~~---------~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 204 --IQIYEK---------ILEGK------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --HHHHHH---------HhcCC------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 000011 11100 111233456888999999999999999 666666
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=295.15 Aligned_cols=197 Identities=27% Similarity=0.409 Sum_probs=165.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.+.+.+.||+|++|.||+|... +++.||+|.++... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 4566789999999999999876 57899999987432 22345778999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++ +|.+++... ...+++.....++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 86 ~~-~L~~~~~~~-----------------------~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~ 138 (291)
T cd07844 86 DT-DLKQYMDDC-----------------------GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISE 138 (291)
T ss_pred CC-CHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcC
Confidence 85 999988542 235788899999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
++.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..
T Consensus 139 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 139 RGELKLADFGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred CCCEEECccccccccCCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999875432211 1122346788999998865 5689999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=289.30 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=202.2
Q ss_pred ccccccccccccceEEEEEeCC-CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
+++.+.||+|++|.||+++... ++.+++|++..... ...++.+|+..+.+++|+||+++++++...+..++|+||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 4567899999999999998874 88999999875432 45678999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCceEEcC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE-ECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDlk~~NILl~~ 600 (763)
+++|.+++... ..++...++.++.|+++||+|||+ .+ ++|+||+|+||+++.
T Consensus 83 ~~~L~~~l~~~------------------------~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~ 135 (264)
T cd06623 83 GGSLADLLKKV------------------------GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINS 135 (264)
T ss_pred CCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECC
Confidence 99999999542 357889999999999999999999 88 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.++|+|||++......... .....++..|+|||.+....++.++||||||+++|||++|+.|+...... .+
T Consensus 136 ~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~------~~ 208 (264)
T cd06623 136 KGEVKIADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP------SF 208 (264)
T ss_pred CCCEEEccCccceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc------CH
Confidence 999999999999865433222 22446788999999999999999999999999999999999998644310 01
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFD-MVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. . ...+... .....+.. .+..+.+++..|++.+|++||++.++++.
T Consensus 209 ~~-----~-----~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 209 FE-----L-----MQAICDG-----PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HH-----H-----HHHHhcC-----CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 0 0111111 01111123 56789999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=303.97 Aligned_cols=259 Identities=20% Similarity=0.265 Sum_probs=190.6
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeC------Ce
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK------GE 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 512 (763)
..|.+.+.||+|+||.||++... +++.||||.++... .....+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 35666789999999999999764 57889999987432 2235577899999999999999999987643 35
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++++|++ +++|.+++. ...+++..+..++.|++.||+|||+.+ |+|||||
T Consensus 95 ~~~~~~~~-~~~l~~~~~-------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdik 145 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK-------------------------CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLK 145 (343)
T ss_pred EEEEeecC-CCCHHHHHh-------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCC
Confidence 78999988 778988773 235788999999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
|+||++++++.+||+|||+++..... .....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 146 p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 146 PSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred hhhEEECCCCCEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999999865432 234568999999999876 5789999999999999999999999864321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcc-----------cccccCCCc---chHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDR-----------HIKNSYDSR---VHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
... +... ... .+....+.... .+....... ........+.+++.+|++.||++|||+.
T Consensus 222 ~~~-----~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ 293 (343)
T cd07878 222 IDQ-----LKRI--MEV-VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS 293 (343)
T ss_pred HHH-----HHHH--HHH-hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 100 0000 000 00000000000 000000000 0001234578999999999999999999
Q ss_pred HHHHH
Q 046586 738 KVAKM 742 (763)
Q Consensus 738 eVv~~ 742 (763)
|+++.
T Consensus 294 ell~h 298 (343)
T cd07878 294 EALAH 298 (343)
T ss_pred HHhcC
Confidence 99953
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=290.27 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=197.7
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
+.+.+.||+|+||.||++... ++..+|+|.+... ....+.+.+|+++++.++|+||+++++.+.+.+..++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 456789999999999999876 4788999998643 233456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++
T Consensus 82 ~~~~L~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~ 136 (257)
T cd08225 82 DGGDLMKRINRQ----------------------RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSK 136 (257)
T ss_pred CCCcHHHHHHhc----------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcC
Confidence 999999998542 2235789999999999999999999988 999999999999998
Q ss_pred CC-CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 601 DF-CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~-~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
++ .+||+|||.+........ ......|+..|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus 137 ~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------- 206 (257)
T cd08225 137 NGMVAKLGDFGIARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------- 206 (257)
T ss_pred CCCeEEecccccchhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---------
Confidence 85 469999999976543221 1223457889999999988889999999999999999999999986321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
...+... ....... ..+......+.+++.+|++.+|++|||+.+|++.
T Consensus 207 ~~~~~~~----------~~~~~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 207 LHQLVLK----------ICQGYFA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHH----------HhcccCC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111111 1111110 1112344678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=294.69 Aligned_cols=265 Identities=24% Similarity=0.325 Sum_probs=195.2
Q ss_pred cccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeEEEec
Q 046586 446 GFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTLVYEY 519 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~Ey 519 (763)
.+.++||+|+||.||+|+.. +++.+|+|+++... .....+.+|++++++++|+|++++++++.+. +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45678999999999999876 47899999998553 2335688999999999999999999999988 899999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++ +|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++
T Consensus 82 ~~~-~l~~~~~~~-----------------------~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~ 134 (287)
T cd07840 82 MDH-DLTGLLDSP-----------------------EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILIN 134 (287)
T ss_pred ccc-cHHHHHhcc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEc
Confidence 975 888887432 236889999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC--
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD-- 676 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~-- 676 (763)
+++.+||+|||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||+.........
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~ 214 (287)
T cd07840 135 NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214 (287)
T ss_pred CCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999999999998665443222333456788999997764 468899999999999999999999986433110000
Q ss_pred -----CCchhHHH---HHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 -----EWYFPKWA---FEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 -----~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
......|. .....+...........+... ....++..+.+++.+||+.+|++||+++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 215 FELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREF----FKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHhCCCchhhccccccchhhhhccccccchhHHHHH----hcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000 000000000000000000000 00112667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=291.16 Aligned_cols=245 Identities=25% Similarity=0.401 Sum_probs=195.2
Q ss_pred ccccccceEEEEEeCC-CcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 451 IGRGGFGDVYKGELTD-HRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 451 LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
||+|+||.||+++... ++.+++|+++.... ..+.+.+|++++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998874 88999999874432 345688999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeE
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 605 (763)
.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+|
T Consensus 81 ~~~l~~~------------------------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~ 133 (265)
T cd05579 81 ASLLENV------------------------GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLK 133 (265)
T ss_pred HHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEE
Confidence 9998542 25788999999999999999999988 99999999999999999999
Q ss_pred EcccCcccccCCCCc-------ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 606 ISDFGLAKLRKKEDM-------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 606 I~DFGla~~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
|+|||++........ .......++..|+|||.+.....+.++||||||+++|||++|..||.....
T Consensus 134 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------- 206 (265)
T cd05579 134 LTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------- 206 (265)
T ss_pred EEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------
Confidence 999999875433211 122334578899999999888899999999999999999999999863321
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
....+ .+.. ...........+..+.+++.+|++.+|++|||+.+|.+.|+-
T Consensus 207 -------~~~~~-----~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 207 -------EEIFQ-----NILN----GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred -------HHHHH-----HHhc----CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00000 0100 000000001125788999999999999999999777777753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.05 Aligned_cols=243 Identities=25% Similarity=0.345 Sum_probs=194.3
Q ss_pred cccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 448 SNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
.++||+|++|.||++... +++.+++|.++... ...+.+.+|+.+++.++|+||+++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 468999999999999864 67889999886433 2345688999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeE
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 605 (763)
.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++
T Consensus 104 ~~~~~~-------------------------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~ 155 (285)
T cd06648 104 TDIVTH-------------------------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVK 155 (285)
T ss_pred HHHHHh-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEE
Confidence 999843 24788899999999999999999988 99999999999999999999
Q ss_pred EcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHH
Q 046586 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685 (763)
Q Consensus 606 I~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 685 (763)
|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ... .
T Consensus 156 l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---------~~~-~ 224 (285)
T cd06648 156 LSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---------LQA-M 224 (285)
T ss_pred EcccccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---------HHH-H
Confidence 999998875433221 12234578899999999888899999999999999999999999853211 000 0
Q ss_pred HHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 686 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...... ..+... .+......+.+++.+||+.+|++||++.++++
T Consensus 225 ~~~~~~------~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 225 KRIRDN------LPPKLK------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHhc------CCCCCc------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 111000 000000 01224567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=291.01 Aligned_cols=245 Identities=23% Similarity=0.313 Sum_probs=198.0
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
|.+.+.||.|+||.||++... +++.+|+|.+.... ...+.+.+|++++++++||||+++++.+.+.+..++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 566789999999999999876 57889999997432 2346788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ..++..+...++.|+++||+|||+.+ ++|+||+|+||+++
T Consensus 82 ~~~~~L~~~l~~~------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~ 134 (258)
T cd05578 82 LLGGDLRYHLSQK------------------------VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLD 134 (258)
T ss_pred CCCCCHHHHHHhc------------------------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEc
Confidence 9999999998532 35788899999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
+++.++|+|||++....... ......++..|+|||.+....++.++|+||||+++|+|++|+.||......
T Consensus 135 ~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------- 205 (258)
T cd05578 135 EQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------- 205 (258)
T ss_pred CCCCEEEeecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-------
Confidence 99999999999998654432 123356788899999999888999999999999999999999998743211
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM--GKVA 740 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~eVv 740 (763)
...+.. + .... .....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 206 ~~~~~~----~------~~~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 206 IRDQIR----A------KQET-----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHH----H------Hhcc-----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 011100 0 0000 1111223445788899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=285.56 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=203.6
Q ss_pred cccccccccccceEEEEEeCC-CcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 446 GFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
++.+.||.|.-|+||++++.+ +...|+|++.+..- ...+...|-+||+.++||.++.|++.++.++..+||||||
T Consensus 80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 345789999999999999986 48899999975422 2345667999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+||+|+..+++. ....++...+.-++.+++.||+|||-.| ||+|||||+||||.+
T Consensus 160 pGGdL~~LrqkQ----------------------p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvre 214 (459)
T KOG0610|consen 160 PGGDLHSLRQKQ----------------------PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVRE 214 (459)
T ss_pred CCccHHHHHhhC----------------------CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEec
Confidence 999999998754 4567888888889999999999999999 999999999999999
Q ss_pred CCCeEEcccCcccccCC---------------------------------C-Cc---------------------ccccc
Q 046586 601 DFCPKISDFGLAKLRKK---------------------------------E-DM---------------------VSMSR 625 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~---------------------------------~-~~---------------------~~~~~ 625 (763)
+|++.|+||.|+..... . .. .....
T Consensus 215 dGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnS 294 (459)
T KOG0610|consen 215 DGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNS 294 (459)
T ss_pred CCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccc
Confidence 99999999998742100 0 00 00112
Q ss_pred cccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhccccccc
Q 046586 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNS 705 (763)
Q Consensus 626 ~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 705 (763)
++||-.|+|||++.+...+.++|.|+|||++|||+.|..||.+....+. ...++.+.+.-.
T Consensus 295 FVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-------------------l~NIv~~~l~Fp 355 (459)
T KOG0610|consen 295 FVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-------------------LRNIVGQPLKFP 355 (459)
T ss_pred cccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-------------------HHHHhcCCCcCC
Confidence 4689999999999999999999999999999999999999986543221 333333333211
Q ss_pred CCCcchHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH--HhccC
Q 046586 706 YDSRVHFDMVNRMVKTAMWCIQDRPELRPS----MGKVAK--MLEGT 746 (763)
Q Consensus 706 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~eVv~--~Le~~ 746 (763)
.. ++.+..+.+|+...|.+||.+|.- +.||.+ +++++
T Consensus 356 ~~----~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 356 EE----PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred CC----CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence 11 355678899999999999999998 888874 45664
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.21 Aligned_cols=269 Identities=21% Similarity=0.248 Sum_probs=193.2
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
++..+.||+|+||.||+|+.. +++.||||.++.... ....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 455678999999999999875 578999998874322 2346889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
. ++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++
T Consensus 82 ~-~~l~~~~~~~----------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~ 135 (284)
T cd07860 82 H-QDLKKFMDAS----------------------PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINT 135 (284)
T ss_pred c-cCHHHHHHhC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 6 6899888542 2346889999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC--
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE-- 677 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~-- 677 (763)
++.+||+|||+++...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........
T Consensus 136 ~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~ 214 (284)
T cd07860 136 EGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 214 (284)
T ss_pred CCCEEEeeccchhhcccCc-cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9999999999987553321 112233567889999988764 468899999999999999999999864321100000
Q ss_pred ---CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 ---WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.......+............+........ ..........+.+++.+|++.||++||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 215 RTLGTPDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhCCCChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000000000000000000 0000123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=294.39 Aligned_cols=248 Identities=27% Similarity=0.324 Sum_probs=194.3
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+...+.||+|+||.||+++.. +++.+|+|.+..... ...++.+|++++++++|+|++++++++.+.+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 445678999999999999865 578999999864321 224688899999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
++ |+|.+.+... ...+++.++..++.|++.||.|||+.+ |+|+||+|+||+++
T Consensus 107 ~~-g~l~~~~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~ 159 (317)
T cd06635 107 CL-GSASDLLEVH-----------------------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLT 159 (317)
T ss_pred CC-CCHHHHHHHh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEEC
Confidence 97 4888777532 235889999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
.++.+||+|||++...... ....++..|+|||++. .+.++.++||||||+++|||++|+.||......
T Consensus 160 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---- 230 (317)
T cd06635 160 EPGQVKLADFGSASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---- 230 (317)
T ss_pred CCCCEEEecCCCccccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----
Confidence 9999999999998754322 2345788999999873 467899999999999999999999998532110
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. .... +..... ...........+.+++.+||+.+|.+||++.+|++.+--..
T Consensus 231 -----~-~~~~---------~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 231 -----S-ALYH---------IAQNES----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----H-HHHH---------HHhccC----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0 0000 100000 00011234567899999999999999999999998654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=283.60 Aligned_cols=248 Identities=28% Similarity=0.433 Sum_probs=200.1
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
|...+.||+|++|.||++... +++.+++|+++.... ...++.+|++++++++|+|++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 445678999999999999886 678899999975543 556789999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++... ...+++..+..++.|++.+|+|||..+ ++|+||+|+||++++++
T Consensus 82 ~~L~~~~~~~-----------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~ 135 (253)
T cd05122 82 GSLKDLLKST-----------------------NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDG 135 (253)
T ss_pred CcHHHHHhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCC
Confidence 9999998542 146889999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.++|+|||.+........ .....++..|+|||.+....++.++||||||++++||++|+.|+...... .
T Consensus 136 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---------~ 204 (253)
T cd05122 136 EVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---------K 204 (253)
T ss_pred eEEEeecccccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---------H
Confidence 999999999976654332 23456788999999998888999999999999999999999998633210 0
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.... . ......... ........+.+++..||+.||++|||+.++++.
T Consensus 205 ----~~~~------~-~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 205 ----ALFK------I-ATNGPPGLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ----HHHH------H-HhcCCCCcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0 000000000 001225678999999999999999999998863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.80 Aligned_cols=239 Identities=28% Similarity=0.384 Sum_probs=193.7
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccCC-ch---hhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-GD---AEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-~~---~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
+.||.|+||.||.++.. +.+.||||.+.-+.. .. .+.++|+..|.+++|||+|.+.|++......+||||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 47999999999999764 678999999863322 22 458899999999999999999999999999999999994 4
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
|-.+.|.-+ ++++....+..|+.+.+.||+|||+.+ .||||||+.|||+++.|.
T Consensus 111 SAsDlleVh-----------------------kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~ 164 (948)
T KOG0577|consen 111 SASDLLEVH-----------------------KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGL 164 (948)
T ss_pred cHHHHHHHH-----------------------hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCe
Confidence 777777543 457888899999999999999999998 899999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
|||+|||.|.+..+. ..++||+.|||||++. .+.|+-|+||||+|++..||...++|+-...
T Consensus 165 VKLaDFGSAsi~~PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN---------- 229 (948)
T KOG0577|consen 165 VKLADFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---------- 229 (948)
T ss_pred eeeccccchhhcCch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch----------
Confidence 999999999876543 4578999999999763 6899999999999999999999999864221
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
+...+|.-...+ .+.+. ..+-...+++++..||++-|.+|||..++++.
T Consensus 230 ---AMSALYHIAQNe---sPtLq-------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 230 ---AMSALYHIAQNE---SPTLQ-------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ---HHHHHHHHHhcC---CCCCC-------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111122111000 01111 14667889999999999999999999988754
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=289.98 Aligned_cols=243 Identities=25% Similarity=0.343 Sum_probs=191.9
Q ss_pred ccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 451 IGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 451 LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
||+|+||+||++... +++.+|+|.+.... .....+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 57899999986432 2234567899999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeE
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 605 (763)
.+++... ....+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+|
T Consensus 81 ~~~l~~~----------------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~ 135 (277)
T cd05577 81 KYHIYNV----------------------GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVR 135 (277)
T ss_pred HHHHHHc----------------------CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEE
Confidence 9999653 2235789999999999999999999988 99999999999999999999
Q ss_pred EcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHH
Q 046586 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685 (763)
Q Consensus 606 I~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 685 (763)
|+|||++...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .
T Consensus 136 l~dfg~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~----- 203 (277)
T cd05577 136 ISDLGLAVELKGG--KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-----K----- 203 (277)
T ss_pred EccCcchhhhccC--CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-----H-----
Confidence 9999999765432 122234577899999999888899999999999999999999999964332110 0
Q ss_pred HHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 686 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
..+.+. .... ....+......+.+++..||+.||++|| ++.++++
T Consensus 204 ~~~~~~---------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 204 EELKRR---------TLEM--AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHhc---------cccc--cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 011110 0000 1111123456788999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=284.48 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=205.7
Q ss_pred cccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCC
Q 046586 446 GFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gs 524 (763)
.+.++||+|+||.||++.++ .|+.+|||.+.. ....++..+|+.+|++.+.|++|+++|.+.....+++|||||..|+
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 45679999999999999775 589999998864 3456788999999999999999999999999999999999999999
Q ss_pred HhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCe
Q 046586 525 LADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP 604 (763)
Q Consensus 525 L~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 604 (763)
+.+.+..+ +++|...+...++...++||+|||... =||||||+.|||++.+|.+
T Consensus 115 iSDI~R~R-----------------------~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~A 168 (502)
T KOG0574|consen 115 ISDIMRAR-----------------------RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIA 168 (502)
T ss_pred HHHHHHHh-----------------------cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchh
Confidence 99999653 467889999999999999999999977 6899999999999999999
Q ss_pred EEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHH
Q 046586 605 KISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWA 684 (763)
Q Consensus 605 kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 684 (763)
|++|||.|-.+.. ......++.||+.|||||++..-.|..++||||+|+...||..|++||....+..
T Consensus 169 KLADFGVAGQLTD-TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------- 236 (502)
T KOG0574|consen 169 KLADFGVAGQLTD-TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------- 236 (502)
T ss_pred hhhhccccchhhh-hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc-----------
Confidence 9999999965432 2334556889999999999999999999999999999999999999997543211
Q ss_pred HHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 685 FEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 685 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.++.---.+......|++-+.++-+++..||-+.|++|-|+.++++.
T Consensus 237 -----------AIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 237 -----------AIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred -----------eeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11100001111222346778889999999999999999999887753
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=284.25 Aligned_cols=248 Identities=26% Similarity=0.413 Sum_probs=201.3
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeEEEe
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTLVYE 518 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~E 518 (763)
+...+.||+|++|.||+|... +++.|++|+++... ...+.+.+|++++++++|+||+++++.+.+. ...++|+|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 345678999999999999887 68899999987554 3456788999999999999999999999988 89999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++... ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++
T Consensus 82 ~~~~~~L~~~~~~~------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i 134 (260)
T cd06606 82 YVSGGSLSSLLKKF------------------------GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILV 134 (260)
T ss_pred ecCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEE
Confidence 99999999998542 26889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
+.++.+||+|||.+......... ......++..|+|||.+.....+.++||||||+++++|++|+.|+......
T Consensus 135 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----- 209 (260)
T cd06606 135 DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP----- 209 (260)
T ss_pred cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----
Confidence 99999999999999866544321 122346788999999999888999999999999999999999998643210
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. .... .+.. .......+......+.+++.+|++.+|++||++.++++
T Consensus 210 ---~----~~~~------~~~~----~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 210 ---M----AALY------KIGS----SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---H----HHHH------hccc----cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0 0000 0000 01111222344678999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=291.81 Aligned_cols=273 Identities=21% Similarity=0.319 Sum_probs=196.7
Q ss_pred ccccccccccccceEEEEEeCC---CcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeE
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD---HRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTL 515 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~---~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~L 515 (763)
+.+.++||+|+||.||+|.... ++.||+|.++... .....+.+|+.++++++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 5567889999999999998754 6899999997532 2335678899999999999999999999988 78999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++ +|.+++..... .....++......++.|++.||+|||+.+ |+||||||+|
T Consensus 82 v~e~~~~-~l~~~~~~~~~-------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~N 138 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQ-------------------AKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPAN 138 (316)
T ss_pred EEeCCCc-CHHHHHHhhcc-------------------CCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHH
Confidence 9999975 77777754321 01236788899999999999999999988 9999999999
Q ss_pred eEEcC----CCCeEEcccCcccccCCCCc--ccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 596 ILLGD----DFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 596 ILl~~----~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
|+++. ++.+||+|||+++....... .......++..|+|||.+.+ ..++.++||||||++++||++|+.||..
T Consensus 139 il~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 139 ILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred EEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 99999 99999999999986543222 12233567889999998765 4688999999999999999999999975
Q ss_pred ccCCCCCCCCchhHHHHHHHHhcc---------------ChhhhhcccccccCC-Ccc----hH--HHHHHHHHHHHHcc
Q 046586 669 QGSMMNSDEWYFPKWAFEKVYEEM---------------KVEDILDRHIKNSYD-SRV----HF--DMVNRMVKTAMWCI 726 (763)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~~~~-~~~----~~--~~~~~l~~l~~~Cl 726 (763)
.......... +..-....+.+.. ......+........ ... .. ....++.+++.+|+
T Consensus 219 ~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 297 (316)
T cd07842 219 REAKIKKSNP-FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297 (316)
T ss_pred Ccccccccch-hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHh
Confidence 5432210000 0000000000000 000000000000011 000 00 23457899999999
Q ss_pred CCCCCCCCCHHHHHH
Q 046586 727 QDRPELRPSMGKVAK 741 (763)
Q Consensus 727 ~~dP~~RPs~~eVv~ 741 (763)
+.||++|||+.|+++
T Consensus 298 ~~~P~~Rps~~eil~ 312 (316)
T cd07842 298 EYDPTKRITAEEALE 312 (316)
T ss_pred cCCcccCcCHHHHhc
Confidence 999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=290.07 Aligned_cols=241 Identities=23% Similarity=0.286 Sum_probs=186.6
Q ss_pred cccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHh---cCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 450 LIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIA---RMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~---~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.||+|+||.||++... +++.+|+|.++.... ....+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 578999999864321 1223445544433 3479999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++... ..+++.....++.|++.||+|||+.+ |+|+||||+||+++++
T Consensus 81 ~~~L~~~i~~~------------------------~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~ 133 (279)
T cd05633 81 GGDLHYHLSQH------------------------GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEH 133 (279)
T ss_pred CCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCC
Confidence 99999988532 35899999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccc-cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
+.+||+|||++....... .....|+..|+|||.+. +..++.++||||+||++|||++|+.||....... .
T Consensus 134 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~ 204 (279)
T cd05633 134 GHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------K 204 (279)
T ss_pred CCEEEccCCcceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC------H
Confidence 999999999987543221 12346899999999886 4568999999999999999999999996432110 0
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~~ 742 (763)
. ...+. . ......++.....++.+++..|++.||++|| +++|+++.
T Consensus 205 ~-----~~~~~------~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 205 H-----EIDRM------T-----LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred H-----HHHHH------h-----hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0 00000 0 0011112234567888999999999999999 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.39 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=198.6
Q ss_pred ccccccccccccceEEEEEeC----CCcEEEEEEeeccC-----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeee
Q 046586 445 NGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVT-----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~-----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 514 (763)
+.+.+.||+|+||.||+++.. +++.+|||+++... ...+.+.+|++++.++ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 456789999999999998753 56789999987432 2235688999999999 6999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++++|.+++.. ...+++.....++.|+++||+|||+.+ ++|+||+|+
T Consensus 82 lv~e~~~~~~L~~~~~~------------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~ 134 (288)
T cd05583 82 LILDYVNGGELFTHLYQ------------------------REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLE 134 (288)
T ss_pred EEEecCCCCcHHHHHhh------------------------cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 99999999999999853 235788889999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCC--CCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQ--ITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
||+++.++.++|+|||+++..............++..|+|||.+.+.. .+.++||||||+++|||++|..||......
T Consensus 135 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 135 NILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred HeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 999999999999999999865443322223346788999999987654 788999999999999999999998532211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
. ...... + ..... . ...+......+.+++.+||+.||++|||+.++.+.|+-.
T Consensus 215 ~-----~~~~~~-----~-----~~~~~----~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 215 N-----SQSEIS-----R-----RILKS----K--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred c-----hHHHHH-----H-----HHHcc----C--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 001110 0 01110 0 111133446788999999999999999999998888654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.49 Aligned_cols=268 Identities=22% Similarity=0.231 Sum_probs=194.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeEEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTLVY 517 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ 517 (763)
.+.+.+.||+|+||.||+|... +++.+++|.++.... ....+.+|+.++.+++||||+++++++... +..++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4556789999999999999886 578899999974322 223567899999999999999999999887 8999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++ +|.+++... ...+++...+.++.|++.||+|||+.+ ++|+||||+||+
T Consensus 86 e~~~~-~L~~~~~~~-----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nil 138 (293)
T cd07843 86 EYVEH-DLKSLMETM-----------------------KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLL 138 (293)
T ss_pred hhcCc-CHHHHHHhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEE
Confidence 99974 999888542 235889999999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
++.++.+||+|||+++....... ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||..........
T Consensus 139 i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~ 217 (293)
T cd07843 139 LNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN 217 (293)
T ss_pred ECCCCcEEEeecCceeeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999999999986544321 22234568889999988754 56899999999999999999999986432111000
Q ss_pred -------CCchhHHHHHHHHhccChh-hhhcccccccCCCcchHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 -------EWYFPKWAFEKVYEEMKVE-DILDRHIKNSYDSRVHFD-MVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 -------~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
......|.. +.+-.... ..............++.. ....+.+++..||+.+|++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 218 KIFKLLGTPTEKIWPG--FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHhCCCchHHHHH--hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000100 00000000 000000000001111111 3567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=288.69 Aligned_cols=265 Identities=22% Similarity=0.248 Sum_probs=191.7
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCC-CCccccEEEEEeeC--CeeeEEEe
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMH-HLNLVRLWGFCAEK--GERTLVYE 518 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~LV~E 518 (763)
|.+.++||+|+||.||+|... +++.+|+|.++.... ......+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 346788999999999999865 578999999875322 2234567999999885 99999999999987 88999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|++ ++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||+|+||++
T Consensus 81 ~~~-~~l~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l 133 (282)
T cd07831 81 LMD-MNLYELIKGR-----------------------KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILI 133 (282)
T ss_pred cCC-ccHHHHHHhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEE
Confidence 997 5888887532 246889999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc-cCCCCCccceeehhHHHHHHHhCCCCcccccCCCC---
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN--- 674 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~--- 674 (763)
+. +.+||+|||+++....... .....++..|+|||.+. ++.++.++|||||||++|||++|..||........
T Consensus 134 ~~-~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~ 210 (282)
T cd07831 134 KD-DILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK 210 (282)
T ss_pred cC-CCeEEEecccccccccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHH
Confidence 99 9999999999986543222 12345788999999765 45678899999999999999999999964321100
Q ss_pred ---CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 ---SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
........+ ........ ......+..............+..+.+++.+||+.+|++||++.++++
T Consensus 211 ~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 211 IHDVLGTPDAEV-LKKFRKSR-HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHcCCCCHHH-HHhhcccc-cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000011 00000000 000000000000000011244678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=290.35 Aligned_cols=265 Identities=22% Similarity=0.272 Sum_probs=191.6
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.|.+.+.||+|+||.||+|... +++.+|+|+++... .....+.+|+++++.++|+||+++.+++.+.+..++|+||+
T Consensus 6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07870 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85 (291)
T ss_pred eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence 4566789999999999999765 57899999987443 22346789999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+ ++|.+++... ...+.+..+..++.|++.||+|||+.+ |+|+||||+||+++.
T Consensus 86 ~-~~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~ 138 (291)
T cd07870 86 H-TDLAQYMIQH-----------------------PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISY 138 (291)
T ss_pred c-CCHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcC
Confidence 6 6887777432 234677888899999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+...... .
T Consensus 139 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-----~ 212 (291)
T cd07870 139 LGELKLADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-----E 212 (291)
T ss_pred CCcEEEeccccccccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-----H
Confidence 99999999999975433221 1223356889999998875 458889999999999999999999996432110 0
Q ss_pred hhHHHHHHHHh--------ccChhhhhcccccccCCCcch-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 680 FPKWAFEKVYE--------EMKVEDILDRHIKNSYDSRVH-----FDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~--------~~~~~~~~~~~l~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.....+..+.. ..................... ......+.+++.+|++.||.+|||+.|++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 213 QLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000 000000000000000000000 012456788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=288.66 Aligned_cols=266 Identities=24% Similarity=0.267 Sum_probs=193.8
Q ss_pred cccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 446 GFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.+.++||.|++|.||+|... +++.||+|+++... .....+.+|++++++++|||++++++++.+.+..++||||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45678999999999999875 68899999987432 223568899999999999999999999999999999999995
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
++|.+++... ....+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.+
T Consensus 82 -~~l~~~~~~~----------------------~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~ 135 (283)
T cd07835 82 -LDLKKYMDSS----------------------PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDRE 135 (283)
T ss_pred -cCHHHHHhhC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCC
Confidence 6899988543 1236889999999999999999999987 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC---
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE--- 677 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~--- 677 (763)
+.++|+|||+++....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........
T Consensus 136 ~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 214 (283)
T cd07835 136 GALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR 214 (283)
T ss_pred CcEEEeecccccccCCCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999975433221 11223467889999987654 578999999999999999999999864321100000
Q ss_pred --CchhHHHHHHHHhccChhhhhcccccc--cCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 --WYFPKWAFEKVYEEMKVEDILDRHIKN--SYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 --~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.......+..... ..+........ .............+.+++.+|++.||++|||+.|+++
T Consensus 215 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 215 TLGTPDEDVWPGVTS---LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HhCCCChHHhhhhhh---chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000000 00000000000 0000001223467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=315.91 Aligned_cols=202 Identities=22% Similarity=0.256 Sum_probs=159.7
Q ss_pred HHHhccccccccccccceEEEEEeCC--CcEEEEE------------------EeeccCCchhhhHHHHHHHhcCCCCcc
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTD--HRVVAVK------------------CLKNVTGGDAEFWAEVTIIARMHHLNL 500 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~--~~~VAvK------------------~l~~~~~~~~~f~~E~~~l~~l~H~ni 500 (763)
....|.+.++||+|+||.||++.... +...++| .++........+.+|+.++++++|+||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34568888999999999999986542 2222222 222222233568899999999999999
Q ss_pred ccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 046586 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE 580 (763)
Q Consensus 501 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~ 580 (763)
+++++++.+.+..++|+|++. ++|.+++..... .........+...|+.||+.||+|||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------~~~~~~~~~~~~~i~~ql~~aL~yLH~ 285 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAF-------------------DWKDRPLLKQTRAIMKQLLCAVEYIHD 285 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccc-------------------cccccccHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999985 578888754320 011223356677899999999999999
Q ss_pred cCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHH
Q 046586 581 ECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIV 660 (763)
Q Consensus 581 ~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ell 660 (763)
.+ ||||||||+|||++.++.+||+|||+++..............||..|+|||.+.+..++.++|||||||++|||+
T Consensus 286 ~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 362 (501)
T PHA03210 286 KK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362 (501)
T ss_pred CC---eecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 88 999999999999999999999999999876544333333467899999999999999999999999999999999
Q ss_pred hCCCC
Q 046586 661 SGSRN 665 (763)
Q Consensus 661 tG~~p 665 (763)
+|..+
T Consensus 363 ~~~~~ 367 (501)
T PHA03210 363 SHDFC 367 (501)
T ss_pred HCCCC
Confidence 98754
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=285.38 Aligned_cols=248 Identities=25% Similarity=0.364 Sum_probs=200.7
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
+.+.++||+|+||.||+++.. +++.+++|.++... ....++.+|++++++++|+||+++++++.+....++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 456789999999999999765 67889999987432 23456788999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++
T Consensus 82 ~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~ 138 (256)
T cd08530 82 PFGDLSKAISKRKK--------------------KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVA 138 (256)
T ss_pred CCCCHHHHHHHHHh--------------------hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEec
Confidence 99999999865320 2356889999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.+||+|||+++..... ......++..|+|||.+.+..++.++|+||+|+++|||++|+.||.....
T Consensus 139 ~~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------- 206 (256)
T cd08530 139 NDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------- 206 (256)
T ss_pred CCcEEEeeccchhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------
Confidence 999999999999866543 12224578899999999999999999999999999999999999864321
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. ... .+. .. .....+.....++.+++.+|++.+|++||++.++++.
T Consensus 207 ~~-----~~~------~~~---~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 207 QD-----LRY------KVQ---RG-KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HH-----HHH------HHh---cC-CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 000 000 01 1111223556789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=289.74 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=196.1
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
+.+.++||.|++|.||+|+.. +++.||+|.++... .....+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 456789999999999999885 57899999987442 234567789999999999999999999999999999999998
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+ +|.+++.... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++++
T Consensus 82 ~-~l~~~~~~~~---------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~ 136 (284)
T cd07836 82 K-DLKKYMDTHG---------------------VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKR 136 (284)
T ss_pred c-cHHHHHHhcC---------------------CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCC
Confidence 5 8988885432 2345899999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
+.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ..+
T Consensus 137 ~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~ 214 (284)
T cd07836 137 GELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL-KIF 214 (284)
T ss_pred CcEEEeecchhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHH
Confidence 9999999999975433211 1223456888999998865 457899999999999999999999986443210000 000
Q ss_pred ------hHHHHHHHHhccChhhhhcccccccCC---CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 681 ------PKWAFEKVYEEMKVEDILDRHIKNSYD---SRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 681 ------~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..-.+..+.. .... ......... ....+.....+.+++..|++.||.+||++.+|++
T Consensus 215 ~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 215 RIMGTPTESTWPGISQ---LPEY-KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHhCCCChhhHHHHhc---Cchh-cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 0000 000000000 0011234567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=292.51 Aligned_cols=263 Identities=23% Similarity=0.284 Sum_probs=194.5
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCC-----
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG----- 511 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 511 (763)
....+.+.++||+|+||.||+|... +++.||+|.++... .....+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3455677889999999999999886 57899999997432 22345778999999999999999999987655
Q ss_pred -----eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 512 -----ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 512 -----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
..++|+||+++ +|..++.. ....+++..+..++.|++.||+|||+.+ |
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~-----------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 137 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES-----------------------GLVHFSEDHIKSFMKQLLEGLNYCHKKN---F 137 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc-----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 78999999986 77777643 1235889999999999999999999988 9
Q ss_pred EecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCC
Q 046586 587 LHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 587 vHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
+|+||||+||++++++.+||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.|
T Consensus 138 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~ 217 (302)
T cd07864 138 LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217 (302)
T ss_pred ecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998665433222233456778999998764 4678999999999999999999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhc--cChhh----h--------hccc--ccccCCCcchHHHHHHHHHHHHHccCCC
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEE--MKVED----I--------LDRH--IKNSYDSRVHFDMVNRMVKTAMWCIQDR 729 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~----~--------~~~~--l~~~~~~~~~~~~~~~l~~l~~~Cl~~d 729 (763)
|....... .+ +.+.+. ..... + .+.. ....... .....+..+.+++..||+.+
T Consensus 218 ~~~~~~~~-----~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~ 286 (302)
T cd07864 218 FQANQELA-----QL-----ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLD 286 (302)
T ss_pred CCCCChHH-----HH-----HHHHHHhCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCC
Confidence 86432100 00 000000 00000 0 0000 0000000 00123567899999999999
Q ss_pred CCCCCCHHHHHH
Q 046586 730 PELRPSMGKVAK 741 (763)
Q Consensus 730 P~~RPs~~eVv~ 741 (763)
|++||++.+|++
T Consensus 287 P~~Rp~~~~il~ 298 (302)
T cd07864 287 PSKRCTAEEALN 298 (302)
T ss_pred hhhCCCHHHHhc
Confidence 999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=289.16 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=205.4
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.-|.+.+.||+|.|+.|-++++ -.|..||||++.+..-. ...+++|+..|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3466678899999999999965 47899999999765432 3458899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
.-++|+|++|+.++ ...++.....++..||..|+.|.|+.. +|||||||+||.+
T Consensus 98 LGD~GDl~DyImKH-----------------------e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVF 151 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH-----------------------EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVF 151 (864)
T ss_pred ecCCchHHHHHHhh-----------------------hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEE
Confidence 99999999999764 346888899999999999999999988 9999999999988
Q ss_pred c-CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCC-CccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 599 G-DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 599 ~-~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
- .-|-+||.|||++-.+.+.. ..++.+|++.|-|||.+.+..|+ +++||||+||+||.|++|+.||+.....+
T Consensus 152 FEKlGlVKLTDFGFSNkf~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--- 226 (864)
T KOG4717|consen 152 FEKLGLVKLTDFGFSNKFQPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--- 226 (864)
T ss_pred eeecCceEeeeccccccCCCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---
Confidence 5 56889999999997655443 45667899999999999998887 57999999999999999999997433211
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+..++|-.. .+|.-...++.+++.+||..||.+|.+.+||+.
T Consensus 227 ----------------TLTmImDCKY------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 227 ----------------TLTMIMDCKY------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ----------------hhhhhhcccc------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1233333322 233566788999999999999999999999984
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.53 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=190.2
Q ss_pred ccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEecCCC
Q 046586 447 FSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 447 ~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.++||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++. |+||+++++++...+..+++|||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 4568999999999999875 57899999986432 23456889999999996 99999999999999999999999864
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCceEEcCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NILl~~~ 601 (763)
+|.++..... ......+++.....++.|++.||+|||+. + |+||||||+||+++.+
T Consensus 88 -~l~~l~~~~~-------------------~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~ 144 (288)
T cd06616 88 -SLDKFYKYVY-------------------EVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRN 144 (288)
T ss_pred -CHHHHHHHHH-------------------HhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccC
Confidence 6655432110 00234688999999999999999999975 5 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccC---CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD---QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.+||+|||+++....... .....++..|+|||.+... .++.++||||||+++|||++|+.||.....
T Consensus 145 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------- 215 (288)
T cd06616 145 GNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS------- 215 (288)
T ss_pred CcEEEeecchhHHhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------
Confidence 9999999999975443221 1233578899999998766 689999999999999999999999863210
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
......+ ..... ........+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus 216 -----~~~~~~~------~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 216 -----VFDQLTQ------VVKGD-PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -----HHHHHhh------hcCCC-CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111 00000 0011111112356688999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=282.06 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=201.7
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
+.+.+.||+|+||.||++... +++.+++|++.... ....++.+|+++++.++|+|++++++.+...+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 456788999999999999876 57889999997543 23456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++..... ....+++.++..++.+++.||+|||+.+ ++|+||+|+||++++
T Consensus 82 ~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~ 138 (258)
T cd08215 82 DGGDLSQKIKKQKK--------------------EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTS 138 (258)
T ss_pred CCCcHHHHHHHhhc--------------------cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcC
Confidence 99999999965320 2357899999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.++|+|||++....... .......++..|+|||.+....++.++||||+|+++++|++|+.|+.....
T Consensus 139 ~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------- 208 (258)
T cd08215 139 NGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------- 208 (258)
T ss_pred CCcEEECCccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---------
Confidence 9999999999998654433 122334678899999999888999999999999999999999999863321
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.... ........ ..++......+.+++.+||+.+|++||++.++++.
T Consensus 209 ~~~~----------~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 209 LELA----------LKILKGQY-----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHH----------HHHhcCCC-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1100 00111100 11112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=290.37 Aligned_cols=242 Identities=26% Similarity=0.368 Sum_probs=192.8
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
.+||+|+||.||++... +++.||+|.+.... .....+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999874 67899999886433 23456889999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEE
Q 046586 527 DYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKI 606 (763)
Q Consensus 527 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI 606 (763)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|
T Consensus 106 ~~~~~-------------------------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l 157 (292)
T cd06657 106 DIVTH-------------------------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 157 (292)
T ss_pred HHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEE
Confidence 98732 24688899999999999999999988 999999999999999999999
Q ss_pred cccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHH
Q 046586 607 SDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686 (763)
Q Consensus 607 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 686 (763)
+|||++....... .......++..|+|||.+....++.++||||||+++|||++|..||...... ....
T Consensus 158 ~dfg~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~----------~~~~ 226 (292)
T cd06657 158 SDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----------KAMK 226 (292)
T ss_pred cccccceeccccc-ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------HHHH
Confidence 9999987543322 1123346788999999998888999999999999999999999998632210 0000
Q ss_pred HHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 687 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...+. ....+.. .......+.+++.+||+.+|.+||++.+|++
T Consensus 227 ~~~~~------~~~~~~~------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 227 MIRDN------LPPKLKN------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHhh------CCcccCC------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 01000 0111100 0123456788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=288.96 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=194.1
Q ss_pred ccccccccccccceEEEEEe----CCCcEEEEEEeeccC-----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeee
Q 046586 445 NGFSNLIGRGGFGDVYKGEL----TDHRVVAVKCLKNVT-----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~----~~~~~VAvK~l~~~~-----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 514 (763)
+.+.+.||+|+||.||++.. .+++.||+|+++... ...+.+.+|+.++.++ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 45678999999999999976 367899999997432 2235678899999999 6999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++++|.+++... ..+++.....++.|++.||+|||+.+ ++||||+|+
T Consensus 82 lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~ 134 (290)
T cd05613 82 LILDYINGGELFTHLSQR------------------------ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLE 134 (290)
T ss_pred EEEecCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH
Confidence 999999999999998542 34678888899999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc--CCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS--DQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
||++++++.+||+|||+++..............|+..|+|||.+.. ..++.++||||||+++|||++|+.|+......
T Consensus 135 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 214 (290)
T cd05613 135 NILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214 (290)
T ss_pred HeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc
Confidence 9999999999999999998654433333334568899999999875 35778999999999999999999998632211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
..... +.+...... ...+......+.+++.+||+.||++|| ++.++++
T Consensus 215 -----~~~~~--------------~~~~~~~~~--~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 215 -----NSQAE--------------ISRRILKSE--PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----ccHHH--------------HHHHhhccC--CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01111 111100000 111233456788999999999999997 6666664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=283.26 Aligned_cols=247 Identities=22% Similarity=0.333 Sum_probs=193.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc------CCchhhhHHHHHHHhcCCCCccccEEEEEeeC--Ceee
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV------TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERT 514 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 514 (763)
.+.+.+.||+|+||.||+|... +++.+|+|.+... ......+.+|++++++++|+||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 3567789999999999999864 5789999987522 11234688999999999999999999998764 4678
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+
T Consensus 83 ~v~e~~~~~~L~~~~~~~------------------------~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ 135 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAY------------------------GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGA 135 (264)
T ss_pred EEEEeCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 999999999999998532 24778888999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 136 ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~- 214 (264)
T cd06653 136 NILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA- 214 (264)
T ss_pred HEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-
Confidence 99999999999999999986532111 122335688899999999988899999999999999999999999863211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...+. ..........++....+.+.+++.+|++ +|..||+..+++.
T Consensus 215 ---------------------~~~~~-~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 215 ---------------------MAAIF-KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---------------------HHHHH-HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00000 0111111122334556789999999999 5799999998775
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=284.06 Aligned_cols=243 Identities=23% Similarity=0.292 Sum_probs=188.8
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHH-hcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTII-ARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l-~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+|+||.||+|... +++.||+|+++.... ....+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999775 578999999864321 122344555544 455899999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++
T Consensus 82 ~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~ 134 (260)
T cd05611 82 GDCASLIKTL------------------------GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTG 134 (260)
T ss_pred CCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCC
Confidence 9999998532 35778889999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
.+||+|||+++.... .....++..|+|||.+.+..++.++||||||+++|||++|..||..... .
T Consensus 135 ~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----------~ 199 (260)
T cd05611 135 HLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----------D 199 (260)
T ss_pred cEEEeecccceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----------H
Confidence 999999999875432 1234578889999999888899999999999999999999999963321 0
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
-.......+ .. ..........+..+.+++..||+.+|++||++.++.+.|+
T Consensus 200 ~~~~~~~~~---------~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 200 AVFDNILSR---------RI--NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHhc---------cc--CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 001111110 00 0111111235678899999999999999998877766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=294.85 Aligned_cols=269 Identities=22% Similarity=0.298 Sum_probs=194.6
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcC-CCCccccEEEEEeeC--CeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEK--GERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~L 515 (763)
..+.+.+.||+|+||.||+|... +++.+|+|.+... ......+.+|+.+++++ +||||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 45666789999999999999875 5788999988542 22334577899999999 999999999998654 36899
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||||+|
T Consensus 87 v~e~~~-~~L~~~~~~-------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~n 137 (337)
T cd07852 87 VFEYME-TDLHAVIRA-------------------------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSN 137 (337)
T ss_pred Eecccc-cCHHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999997 599888732 25788899999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc----ccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM----VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
|+++.++.+||+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 138 ill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 138 ILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred EEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999986543322 12334568899999998754 568899999999999999999999986432
Q ss_pred CCCCC------CCCchhHHHHHHHHhccChhhhhcccccccCC--CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 671 SMMNS------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYD--SRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 671 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
..... .... ..-....+... ....+++........ .....+....+.+++.+|++.||++|||+.++++.
T Consensus 218 ~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 218 TLNQLEKIIEVIGPP-SAEDIESIKSP-FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hHHHHHHHHHHhCCC-CHHHHHHHHhh-hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 11000 0000 00000000000 011111111000000 00111245678999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=290.98 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=197.4
Q ss_pred HHhccccccccccccceEEEEEeCCCcEEEEEEeeccC---CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVT---GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ 517 (763)
...|.+.++||+||.+.||++...+.+.+|+|.+.... +...-|..|+.+|.+| .|.+||+|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 34456678999999999999999988888888776332 2335699999999999 5999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||=+ -+|..+|.+.. .....| .+..+..|++.++.++|.++ |||.||||.|+|
T Consensus 440 E~Gd-~DL~kiL~k~~----------------------~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFL 492 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKK----------------------SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFL 492 (677)
T ss_pred eccc-ccHHHHHHhcc----------------------CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEE
Confidence 9964 49999997642 223334 67788899999999999999 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCccc-ccccccCCCcccccccccC-----------CCCCccceeehhHHHHHHHhCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVS-MSRIRGTRGYMAPEWLRSD-----------QITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~-----------~~s~ksDVwS~Gvll~elltG~~p 665 (763)
+-. |.+||+|||+|.....+.... ....+||+.||+||.+... +.++++||||+||+||+|+.|+.|
T Consensus 493 lVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktP 571 (677)
T KOG0596|consen 493 LVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTP 571 (677)
T ss_pred EEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCc
Confidence 865 589999999998776554422 2346799999999988532 366899999999999999999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
|.... ..+ .++..+.++...-.++..-.. .+++++|..||+.||.+||+..|+++.
T Consensus 572 f~~~~----------------n~~--aKl~aI~~P~~~Iefp~~~~~---~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 572 FGQII----------------NQI--AKLHAITDPNHEIEFPDIPEN---DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hHHHH----------------HHH--HHHHhhcCCCccccccCCCCc---hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 96321 111 125556666443333321111 228999999999999999999999863
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=297.54 Aligned_cols=268 Identities=21% Similarity=0.201 Sum_probs=193.9
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeC------Ce
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK------GE 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 512 (763)
..|...+.||+|+||.||++... +++.||+|.++... ....++.+|+.++++++|+||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 45667789999999999999765 67899999986432 2234677899999999999999999988643 35
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++ +|.+.+.. .++......++.|++.||+|||+.+ |+|||||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~--------------------------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlk 145 (353)
T cd07850 96 VYLVMELMDA-NLCQVIQM--------------------------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 145 (353)
T ss_pred EEEEEeccCC-CHHHHHhh--------------------------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCC
Confidence 7999999964 88887732 2677888899999999999999988 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+||+++.++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..
T Consensus 146 p~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~ 223 (353)
T cd07850 146 PSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI 223 (353)
T ss_pred HHHEEECCCCCEEEccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 999999999999999999998654322 123345788999999999999999999999999999999999998643211
Q ss_pred CCC------CCCchhHHHH------HHHHhcc------ChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 046586 673 MNS------DEWYFPKWAF------EKVYEEM------KVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734 (763)
Q Consensus 673 ~~~------~~~~~~~~~~------~~~~~~~------~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 734 (763)
... ......++.. ....+.. ...+..............+......+.+++.+||+.||++||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 303 (353)
T cd07850 224 DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI 303 (353)
T ss_pred HHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc
Confidence 000 0000000000 0000000 000000000000000000123466788999999999999999
Q ss_pred CHHHHHHH
Q 046586 735 SMGKVAKM 742 (763)
Q Consensus 735 s~~eVv~~ 742 (763)
|+.|+++.
T Consensus 304 t~~eiL~~ 311 (353)
T cd07850 304 SVDDALQH 311 (353)
T ss_pred CHHHHhcC
Confidence 99999943
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=290.02 Aligned_cols=260 Identities=20% Similarity=0.209 Sum_probs=183.9
Q ss_pred HHHHhccccccccccccceEEEEEeCCC----cEEEEEEeeccCCch------------hhhHHHHHHHhcCCCCccccE
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELTDH----RVVAVKCLKNVTGGD------------AEFWAEVTIIARMHHLNLVRL 503 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~~~----~~VAvK~l~~~~~~~------------~~f~~E~~~l~~l~H~niv~l 503 (763)
+....+.+.++||+|+||.||+|...+. ..+|+|+........ .....+...+..++|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4445678889999999999999987643 456666543221110 012233345666789999999
Q ss_pred EEEEeeCC----eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046586 504 WGFCAEKG----ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH 579 (763)
Q Consensus 504 ~g~~~~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH 579 (763)
++++.... ..++++|++.. ++.+.+... ...++..+..|+.|++.||+|||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH 143 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI------------------------KCKNKKLIKNIMKDMLTTLEYIH 143 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhh------------------------ccCCHHHHHHHHHHHHHHHHHHH
Confidence 99876544 34677887643 566655321 12457778899999999999999
Q ss_pred hcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCc------ccccccccCCCcccccccccCCCCCccceeehh
Q 046586 580 EECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFG 653 (763)
Q Consensus 580 ~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~G 653 (763)
+.+ |+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||
T Consensus 144 ~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG 220 (294)
T PHA02882 144 EHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLG 220 (294)
T ss_pred hCC---eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHH
Confidence 988 99999999999999999999999999986532221 111234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCC
Q 046586 654 MVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELR 733 (763)
Q Consensus 654 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 733 (763)
|++|||++|+.||....... ...... ..+++.+...+.... ...+..+.+++..|++.+|++|
T Consensus 221 ~~l~el~~g~~P~~~~~~~~-----~~~~~~---------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r 283 (294)
T PHA02882 221 YCMLKWAGIKLPWKGFGHNG-----NLIHAA---------KCDFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEK 283 (294)
T ss_pred HHHHHHHhCCCCCCccccch-----HHHHHh---------HHHHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCC
Confidence 99999999999997542111 000000 011111111111110 1235678899999999999999
Q ss_pred CCHHHHHHHhc
Q 046586 734 PSMGKVAKMLE 744 (763)
Q Consensus 734 Ps~~eVv~~Le 744 (763)
|++.++++.|+
T Consensus 284 p~~~~l~~~~~ 294 (294)
T PHA02882 284 PDYDALIKIFD 294 (294)
T ss_pred CCHHHHHHhhC
Confidence 99999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=291.28 Aligned_cols=260 Identities=20% Similarity=0.172 Sum_probs=190.5
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCC
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gs 524 (763)
.+.+|.|+++.||+++. +++.||+|+++.. ......+.+|+++++.++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455566666666655 5789999998743 2233568899999999999999999999999999999999999999
Q ss_pred HhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCe
Q 046586 525 LADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP 604 (763)
Q Consensus 525 L~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 604 (763)
|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 86 l~~~l~~~----------------------~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~ 140 (314)
T cd08216 86 CEDLLKTH----------------------FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKV 140 (314)
T ss_pred HHHHHHHh----------------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCce
Confidence 99999653 1234778888999999999999999988 9999999999999999999
Q ss_pred EEcccCcccccCCCCc------ccccccccCCCccccccccc--CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 605 KISDFGLAKLRKKEDM------VSMSRIRGTRGYMAPEWLRS--DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 605 kI~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
||+|||.+........ .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.......
T Consensus 141 kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--- 217 (314)
T cd08216 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--- 217 (314)
T ss_pred EEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 9999998864432111 11223456778999999875 468899999999999999999999996432110
Q ss_pred CCchhHHHHHHHHhc--------------cChhh----hhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 046586 677 EWYFPKWAFEKVYEE--------------MKVED----ILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGK 738 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~--------------~~~~~----~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 738 (763)
...+..... ..... ..+.................++.+++.+||+.||++|||+.+
T Consensus 218 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 291 (314)
T cd08216 218 ------MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291 (314)
T ss_pred ------HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence 000000000 00000 011111111111222345567899999999999999999999
Q ss_pred HHHH
Q 046586 739 VAKM 742 (763)
Q Consensus 739 Vv~~ 742 (763)
+++.
T Consensus 292 ll~~ 295 (314)
T cd08216 292 LLNH 295 (314)
T ss_pred HhcC
Confidence 9853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=288.05 Aligned_cols=262 Identities=23% Similarity=0.263 Sum_probs=191.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.+.+.+.||+|++|.||+|... +++.||+|.++... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 3566789999999999999875 67899999986432 2235688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
++ ++|.+++... ....+++.....++.||+.||+|||+.+ ++|+||+|+||+++
T Consensus 83 ~~-~~l~~~~~~~----------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~ 136 (294)
T PLN00009 83 LD-LDLKKHMDSS----------------------PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLID 136 (294)
T ss_pred cc-ccHHHHHHhC----------------------CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEE
Confidence 96 5888887432 1223577888899999999999999988 99999999999998
Q ss_pred C-CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 600 D-DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 600 ~-~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
. ++.+||+|||++....... .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.......
T Consensus 137 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---- 211 (294)
T PLN00009 137 RRTNALKLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---- 211 (294)
T ss_pred CCCCEEEEcccccccccCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----
Confidence 5 5679999999997543321 11233456889999998865 468899999999999999999999986432110
Q ss_pred CchhHHHHHHHH-hccChhhhhc--------ccccccCCC----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVY-EEMKVEDILD--------RHIKNSYDS----RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~-~~~~~~~~~~--------~~l~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
....... .+.......+ ......... ........++.+++.+|++.+|++||++.++++
T Consensus 212 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 212 -----ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred -----HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0000000000 000000000 001233567889999999999999999999986
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-33 Score=290.50 Aligned_cols=242 Identities=25% Similarity=0.343 Sum_probs=198.4
Q ss_pred cccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 448 SNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
-++||+||||.||-.+.. .|+.+|.|.+.+. .++..-.+.|-.+|.+++.+.||.|--.++..+.++||+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 469999999999999775 5889999988532 44555678999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|+-+|.+. ..+.++...++-++.+|+.||++||... ||.|||||+|||+|+.|
T Consensus 270 GDLkfHiyn~----------------------g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~G 324 (591)
T KOG0986|consen 270 GDLKFHIYNH----------------------GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHG 324 (591)
T ss_pred CceeEEeecc----------------------CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCC
Confidence 9999999765 3356888888999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
+++|+|.|||..+..... .+..+||.||||||++.++.|+...|.||+||++|||+.|+.||....+
T Consensus 325 hvRISDLGLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke----------- 391 (591)
T KOG0986|consen 325 HVRISDLGLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE----------- 391 (591)
T ss_pred CeEeeccceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-----------
Confidence 999999999987655443 2334899999999999999999999999999999999999999964322
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
.. ..+.+|++.... +...+...+++...+....|++||++|.--.
T Consensus 392 --------Kv-k~eEvdrr~~~~-~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 392 --------KV-KREEVDRRTLED-PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred --------hh-hHHHHHHHHhcc-hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11 111223322211 1223355667788888889999999996433
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=291.24 Aligned_cols=261 Identities=24% Similarity=0.294 Sum_probs=192.5
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeEEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTLVY 517 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ 517 (763)
.+.+.++||+|+||.||+|... +++.||+|.++.... ....+.+|+.++++++|+||+++++++.+. +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4667789999999999999875 588999999874322 123467899999999999999999998765 4689999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++ +|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+||+
T Consensus 88 e~~~~-~l~~~l~~~-----------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil 140 (309)
T cd07845 88 EYCEQ-DLASLLDNM-----------------------PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLL 140 (309)
T ss_pred ecCCC-CHHHHHHhc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99965 888888542 245889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
+++++.+||+|||++....... .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.......
T Consensus 141 ~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--- 216 (309)
T cd07845 141 LTDKGCLKIADFGLARTYGLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--- 216 (309)
T ss_pred ECCCCCEEECccceeeecCCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 9999999999999998654332 12223345788999998865 568999999999999999999999996432110
Q ss_pred CCchhHHHHHHHHhc--cChhhhh---------cc-cccccCCCc---chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 EWYFPKWAFEKVYEE--MKVEDIL---------DR-HIKNSYDSR---VHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~--~~~~~~~---------~~-~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
......+. ....... .. .+....... ........+.+++.+|++.||++|||+.++++
T Consensus 217 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 217 -------QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred -------HHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 0000000 00 000000000 00113566788999999999999999999985
Q ss_pred H
Q 046586 742 M 742 (763)
Q Consensus 742 ~ 742 (763)
.
T Consensus 290 h 290 (309)
T cd07845 290 S 290 (309)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=284.13 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=192.6
Q ss_pred cccccccccccceEEEEEeCC-CcEEEEEEeeccCCc---hhhhHHHHHHHhcC---CCCccccEEEEEeeCCe-----e
Q 046586 446 GFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGG---DAEFWAEVTIIARM---HHLNLVRLWGFCAEKGE-----R 513 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~-----~ 513 (763)
.+.+.||+|+||.||+|+... ++.+|+|+++..... ...+.+|+.++.++ +|+|++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 456789999999999999874 889999999743221 24566788777665 69999999999998776 9
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
+++|||+++ +|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|
T Consensus 82 ~l~~e~~~~-~l~~~l~~~----------------------~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~ 135 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKC----------------------PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKP 135 (287)
T ss_pred EEEehhccc-CHHHHHHHc----------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCh
Confidence 999999975 899888543 1235889999999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
+||+++.++.+||+|||++........ .....++..|+|||.+.+..++.++||||||+++|||++|..||.......
T Consensus 136 ~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~ 213 (287)
T cd07838 136 QNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD 213 (287)
T ss_pred hhEEEccCCCEEEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH
Confidence 999999999999999999976543321 223357888999999999999999999999999999999998886432110
Q ss_pred CCCCCchhHHHHHHHHhccCh-------------hhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKV-------------EDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
. .....+.... ........... ......+....+.+++.+||+.||++||++.+++
T Consensus 214 ---------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 214 ---------Q-LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRS-FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred ---------H-HHHHHHHcCCCChHhcCCCcccchhhcccccccc-hhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 0 0011110000 00000000000 0111124457788999999999999999999987
Q ss_pred H
Q 046586 741 K 741 (763)
Q Consensus 741 ~ 741 (763)
+
T Consensus 283 ~ 283 (287)
T cd07838 283 Q 283 (287)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=289.41 Aligned_cols=246 Identities=26% Similarity=0.311 Sum_probs=192.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
.++...+.||+|+||.||+|+.. +++.+++|.+.... ....++.+|+++++.++|+|++++++++...+..++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 33445678999999999999875 57789999886321 12346788999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+
T Consensus 95 e~~~-~~l~~~~~~~-----------------------~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil 147 (308)
T cd06634 95 EYCL-GSASDLLEVH-----------------------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNIL 147 (308)
T ss_pred EccC-CCHHHHHHHc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEE
Confidence 9996 5888777432 234788899999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++.++.+||+|||++...... ....++..|+|||.+. .+.++.++||||||+++|||++|+.|+......
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-- 220 (308)
T cd06634 148 LSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-- 220 (308)
T ss_pred ECCCCcEEECCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--
Confidence 999999999999998754322 2345788999999874 456888999999999999999999998532110
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
.. ......+. ............+.+++.+||+.+|++||++.+|++..
T Consensus 221 -------~~-~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 221 -------SA-LYHIAQNE-------------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -------HH-HHHHhhcC-------------CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00 00000000 00001123456788999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=291.66 Aligned_cols=267 Identities=19% Similarity=0.237 Sum_probs=189.9
Q ss_pred cccccc--ccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRG--GFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G--~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.||+| +||+||++... .++.||+|+++.... ..+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356776 89999999874 689999999874332 235678899999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 84 ~~l~~~l~~~~----------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~ 138 (328)
T cd08226 84 GSANSLLKTYF----------------------PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDG 138 (328)
T ss_pred CCHHHHHHhhc----------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCC
Confidence 99999986531 234788889999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCccc------ccccccCCCccccccccc--CCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 603 CPKISDFGLAKLRKKEDMVS------MSRIRGTRGYMAPEWLRS--DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~------~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
.+|++||+.+.......... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~ 218 (328)
T cd08226 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM 218 (328)
T ss_pred cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH
Confidence 99999998654322111100 011234567999999876 3578999999999999999999999964321000
Q ss_pred C----CC--------CchhHHHHHHHHhcc-C-----hhhhhc-----ccccccCCCcchHHHHHHHHHHHHHccCCCCC
Q 046586 675 S----DE--------WYFPKWAFEKVYEEM-K-----VEDILD-----RHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPE 731 (763)
Q Consensus 675 ~----~~--------~~~~~~~~~~~~~~~-~-----~~~~~~-----~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 731 (763)
. .. ..++... ....... . .+..+. ..................+.+++.+||+.||+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 297 (328)
T cd08226 219 LLQKLKGPPYSPLDITTFPCEE-SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPE 297 (328)
T ss_pred HHHHhcCCCCCCccccccchhh-hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcc
Confidence 0 00 0000000 0000000 0 000000 00000111112245667899999999999999
Q ss_pred CCCCHHHHHH
Q 046586 732 LRPSMGKVAK 741 (763)
Q Consensus 732 ~RPs~~eVv~ 741 (763)
+|||+.|+++
T Consensus 298 ~Rpta~e~l~ 307 (328)
T cd08226 298 KRPSASSLLS 307 (328)
T ss_pred cCCCHHHHhh
Confidence 9999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=285.42 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=192.2
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcC-CCCccccEEEEEeeCCe-----ee
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGE-----RT 514 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~-----~~ 514 (763)
+.+.+.||+|+||.||+|... +++.||+|.++.... ....+.+|+.+++.+ +|+||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 556789999999999999875 578999998864322 235688999999999 56999999999987665 89
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++ +|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+
T Consensus 83 lv~e~~~~-~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~ 139 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGR-------------------GPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQ 139 (295)
T ss_pred EEeeccCc-CHHHHHHHhcc-------------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChH
Confidence 99999986 89998864321 01346889999999999999999999988 999999999
Q ss_pred ceEEcC-CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 595 NILLGD-DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~-~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
||+++. ++.+||+|||+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||......
T Consensus 140 nil~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~ 218 (295)
T cd07837 140 NLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218 (295)
T ss_pred HEEEecCCCeEEEeecccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 999998 89999999999975433211 1122346788999998865 56799999999999999999999998643211
Q ss_pred CCCCCCchhHHHHHHHHhc--cChhhhhcc----cc---cccCCC----cchHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEE--MKVEDILDR----HI---KNSYDS----RVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~----~l---~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eV 739 (763)
. .... .... ......... .. ...... ...+.....+.+++..||+.||.+||++.|+
T Consensus 219 ~---------~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei 288 (295)
T cd07837 219 Q---------QLLH-IFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA 288 (295)
T ss_pred H---------HHHH-HHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH
Confidence 0 0000 0000 000000000 00 000000 0002345678899999999999999999998
Q ss_pred HH
Q 046586 740 AK 741 (763)
Q Consensus 740 v~ 741 (763)
+.
T Consensus 289 l~ 290 (295)
T cd07837 289 LT 290 (295)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=273.76 Aligned_cols=206 Identities=26% Similarity=0.338 Sum_probs=171.3
Q ss_pred hccccccccccccceEEEEEeCC-----CcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEee-CCeee
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD-----HRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAE-KGERT 514 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~-----~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 514 (763)
.|+...+||+|.||.||+++-.+ .+.+|+|.++.... -....-+|+.+++.++||||+.|..++.+ +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 35667789999999999995432 23789999985533 23557799999999999999999999987 67899
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
|++||.+. +|...++.++.. ....++......|+.||+.|+.|||++- |+||||||.
T Consensus 105 l~fdYAEh-DL~~II~fHr~~-------------------~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPa 161 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRAS-------------------KAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPA 161 (438)
T ss_pred EEehhhhh-hHHHHHHHhccc-------------------hhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcc
Confidence 99999977 899988766421 2346888999999999999999999987 999999999
Q ss_pred ceEEcCC----CCeEEcccCcccccCCCCc--ccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcc
Q 046586 595 NILLGDD----FCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFE 667 (763)
Q Consensus 595 NILl~~~----~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~ 667 (763)
|||+..+ |.|||+|+|+++++...-. .....++.|..|+|||.+.+ ..|+.+.|||+.||++.||++-.+-|.
T Consensus 162 NIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 162 NILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred eEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999877 9999999999997754322 24456788999999998876 589999999999999999999888876
Q ss_pred cccCC
Q 046586 668 IQGSM 672 (763)
Q Consensus 668 ~~~~~ 672 (763)
.....
T Consensus 242 g~E~k 246 (438)
T KOG0666|consen 242 GREEK 246 (438)
T ss_pred chhhh
Confidence 55443
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=294.40 Aligned_cols=269 Identities=21% Similarity=0.245 Sum_probs=195.4
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCC-----eeeE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG-----ERTL 515 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~L 515 (763)
.|.+.++||+|+||.||+|... +++.||+|.++... .....+.+|+.++++++|+||+++++++.... ..++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 4667789999999999999764 67899999986432 23456788999999999999999999876543 5799
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
|+||+++ +|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 86 v~e~~~~-~l~~~~~-------------------------~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~N 136 (336)
T cd07849 86 VQELMET-DLYKLIK-------------------------TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSN 136 (336)
T ss_pred Eehhccc-CHHHHHh-------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence 9999975 8877763 235888999999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcc--cccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+++.++.+||+|||+++........ ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......
T Consensus 137 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~ 216 (336)
T cd07849 137 LLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216 (336)
T ss_pred EEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999765432211 1223467889999998754 57899999999999999999999999643210
Q ss_pred CCCCCCchhHHHHHHHHhcc--Chhhhhccc-------ccccCCCc---chHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEM--KVEDILDRH-------IKNSYDSR---VHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-------l~~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
. ........+.... ....+.+.. ........ ..+....++.+++.+||+.+|++|||+.|++
T Consensus 217 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l 290 (336)
T cd07849 217 H------QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290 (336)
T ss_pred H------HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0 0000000000000 000000000 00000000 0012356789999999999999999999999
Q ss_pred HH--hccCC
Q 046586 741 KM--LEGTV 747 (763)
Q Consensus 741 ~~--Le~~~ 747 (763)
+. ++...
T Consensus 291 ~hp~~~~~~ 299 (336)
T cd07849 291 AHPYLEQYH 299 (336)
T ss_pred cCccccccC
Confidence 76 65544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=288.89 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=190.0
Q ss_pred hccccccccccccceEEEEEeCC-CcEEEEEEeeccC--CchhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVT--GGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.+.+.+.||+|+||.||+|...+ ++.||||.++... ....++..|+.++.+.+ |+||+++++++.+....++||||
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 35667899999999999999875 8899999997543 23345677887777775 99999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCceEE
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENILL 598 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NILl 598 (763)
++ ++|.+++... ...+++..+..++.|++.||+|||+. + |+||||+|+||++
T Consensus 96 ~~-~~l~~l~~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill 148 (296)
T cd06618 96 MS-TCLDKLLKRI-----------------------QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILL 148 (296)
T ss_pred cC-cCHHHHHHHh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEE
Confidence 85 4777776432 23688999999999999999999974 6 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC----CCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD----QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++++.+||+|||++........ .....++..|+|||.+... .++.++||||||+++|||++|+.||......
T Consensus 149 ~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-- 224 (296)
T cd06618 149 DASGNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-- 224 (296)
T ss_pred cCCCCEEECccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--
Confidence 9999999999999975533221 1223467889999998754 3889999999999999999999998632100
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
+ +. ....+..... .... ......++.+++.+||+.||++||++.++++.
T Consensus 225 -----~-----~~------~~~~~~~~~~-~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 225 -----F-----EV------LTKILQEEPP-SLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----H-----HH------HHHHhcCCCC-CCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00 0011111000 0000 01235678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=288.47 Aligned_cols=268 Identities=21% Similarity=0.273 Sum_probs=189.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCC--------
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG-------- 511 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-------- 511 (763)
.|.+.++||+|+||.||++... +++.||||.+.... .....+.+|++++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4677889999999999999875 57899999986432 12334678999999999999999999987654
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
..++||||+.+ +|.+++... ...+++.+...++.|++.||+|||+.+ ++|+||
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl 145 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNK-----------------------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDM 145 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 45999999965 888877432 235789999999999999999999988 999999
Q ss_pred CCCceEEcCCCCeEEcccCcccccCCCCc---ccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcc
Q 046586 592 KPENILLGDDFCPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFE 667 (763)
Q Consensus 592 k~~NILl~~~~~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~ 667 (763)
||+||+++.++.+||+|||++........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 146 ~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 146 KAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred CHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999976543221 112234577889999988664 47889999999999999999999986
Q ss_pred cccCCCCCCCCchhHHHH----HHHHhccChhhhhccc-ccccCCCcc-----hHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 668 IQGSMMNSDEWYFPKWAF----EKVYEEMKVEDILDRH-IKNSYDSRV-----HFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~-l~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
....... ........ ..........+..+.. ......... +......+.+++.+||+.||++|||+.
T Consensus 226 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~ 302 (310)
T cd07865 226 GNTEQHQ---LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDAD 302 (310)
T ss_pred CCCHHHH---HHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHH
Confidence 4321100 00000000 0000000000000000 000000000 001234677899999999999999999
Q ss_pred HHHH
Q 046586 738 KVAK 741 (763)
Q Consensus 738 eVv~ 741 (763)
|+++
T Consensus 303 e~l~ 306 (310)
T cd07865 303 TALN 306 (310)
T ss_pred HHhc
Confidence 9985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=287.14 Aligned_cols=262 Identities=22% Similarity=0.290 Sum_probs=196.8
Q ss_pred cccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 446 GFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.+.+.||+|++|.||++... +++.+++|.++.... ....+.+|++++++++|+||+++++++..++..++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 45678999999999999875 678899999875432 24568889999999999999999999999999999999997
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+ +|.+++... ...+++.++..++.|++.||+|||+.+ |+|+||+|+||+++.+
T Consensus 82 ~-~l~~~l~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~ 134 (283)
T cd05118 82 T-DLYKLIKDR-----------------------QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTE 134 (283)
T ss_pred C-CHHHHHHhh-----------------------cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCC
Confidence 5 888888542 236889999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
+.+||+|||.+....... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||........
T Consensus 135 ~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~------ 207 (283)
T cd05118 135 GVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ------ 207 (283)
T ss_pred CcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH------
Confidence 999999999997665433 122234577889999998776 789999999999999999999999864331100
Q ss_pred hHHHHHHHHhc-----cChhhhhcc---cccccC---CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 681 PKWAFEKVYEE-----MKVEDILDR---HIKNSY---DSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 681 ~~~~~~~~~~~-----~~~~~~~~~---~l~~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.....+.+... ....+.... ...... ......+...++.+++..||+.||.+||++.+++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 208 LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000000 000000000 000000 01112345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=278.77 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=198.6
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
+.+.+.||+|++|.||++... +++.+++|.+..... ....+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 456789999999999999775 578899999975543 3456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.
T Consensus 82 ~~~~L~~~~~~~------------------------~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~ 134 (254)
T cd06627 82 ENGSLRQIIKKF------------------------GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTK 134 (254)
T ss_pred CCCcHHHHHHhc------------------------cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECC
Confidence 999999998532 35889999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.+||+|||++......... .....++..|+|||......++.++|||++|+++|||++|+.|+..... .
T Consensus 135 ~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--------~ 205 (254)
T cd06627 135 DGVVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--------M 205 (254)
T ss_pred CCCEEEeccccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--------H
Confidence 999999999999866543221 2334678899999999888899999999999999999999999863221 0
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ... .... .....+......+.+++.+|++.+|++||++.+++.
T Consensus 206 ~~-----~~~------~~~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 206 AA-----LFR------IVQD-----DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HH-----HHH------Hhcc-----CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00 000 0000 001111234567889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=283.48 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=185.9
Q ss_pred cccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHH---HhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 450 LIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTI---IARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~---l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.||+|+||.||++... .++.||+|.+.... .....+..|..+ ++..+||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999775 57899999986432 112234445443 444579999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.+
T Consensus 81 g~~L~~~l~~------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~ 133 (278)
T cd05606 81 GGDLHYHLSQ------------------------HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEH 133 (278)
T ss_pred CCcHHHHHHh------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCC
Confidence 9999998843 235899999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
+.+||+|||++....... .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........
T Consensus 134 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~------ 204 (278)
T cd05606 134 GHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------ 204 (278)
T ss_pred CCEEEccCcCccccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch------
Confidence 999999999987543221 1234688999999998754 689999999999999999999999964321100
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~~ 742 (763)
...... .. ......+...+..+.+++.+|++.+|.+|| ++.++++.
T Consensus 205 -----~~~~~~------~~-----~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 205 -----HEIDRM------TL-----TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -----HHHHHH------hh-----ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 000000 00 001111223456888999999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=286.16 Aligned_cols=265 Identities=22% Similarity=0.304 Sum_probs=195.2
Q ss_pred ccccccccccccceEEEEEeCC-CcEEEEEEeeccCCc--hhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGG--DAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
+.+.+.||+|+||.||+|+..+ ++.|++|.++..... .....+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 3567889999999999999864 788999998754332 233567999999998 999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+|+|.+++... ....+++.++..++.|++.+|.|||+.+ ++|+||+|+||++++
T Consensus 81 -~~~l~~~~~~~----------------------~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~ 134 (283)
T cd07830 81 -EGNLYQLMKDR----------------------KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSG 134 (283)
T ss_pred -CCCHHHHHHhc----------------------ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcC
Confidence 88999988542 1246799999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccc-cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC----
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS---- 675 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~---- 675 (763)
++.++|+|||++........ .....++..|+|||.+. ...++.++|+||||+++|||++|+.||.........
T Consensus 135 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~ 212 (283)
T cd07830 135 PEVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKIC 212 (283)
T ss_pred CCCEEEeecccceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHH
Confidence 99999999999976543221 22345788899999875 456899999999999999999999988543211000
Q ss_pred ---CCCchhHHHHHHHHhccChhhhhcccccccCCCcc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 676 ---DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRV---HFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 676 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
....-..|.... .....++........... .......+.+++.+|++.+|++||++.|++..
T Consensus 213 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 213 SVLGTPTKQDWPEGY-----KLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HhcCCCChhhhhhHh-----hhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000010000 000111111110000000 01124678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-31 Score=285.35 Aligned_cols=240 Identities=27% Similarity=0.351 Sum_probs=188.5
Q ss_pred cccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 448 SNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
.++||+|+||.||+|+.. +++.|++|.+..... ...++.+|+++++.++|||++++++++.+.+..++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 467999999999999874 578899999864322 22457889999999999999999999999999999999996
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++... ...+++.+++.++.|++.||+|||+.+ |+|+||+|+||++++++
T Consensus 105 ~~l~~~l~~~-----------------------~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~ 158 (313)
T cd06633 105 GSASDLLEVH-----------------------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPG 158 (313)
T ss_pred CCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCC
Confidence 5788777432 235789999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
.+||+|||++..... .....++..|+|||++. ...++.++||||||+++|||++|..|+......
T Consensus 159 ~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------- 226 (313)
T cd06633 159 QVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------- 226 (313)
T ss_pred CEEEeecCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------
Confidence 999999999864321 22356788999999874 467889999999999999999999998533210
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
...... .... . ...........+.+++.+||+.+|.+||++.++++.
T Consensus 227 --~~~~~~-~~~~---------~----~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 227 --SALYHI-AQND---------S----PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --HHHHHH-HhcC---------C----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 0000 0 000011234568889999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=286.83 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=198.3
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEe
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~E 518 (763)
|.+.+.||+|+||.||++... +++.+++|+++.. ......+.+|++++++++ |+||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 566789999999999999875 6889999998752 223356889999999998 9999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++... ..+++.++..++.|++.||+|||+.+ ++|+||+|+||++
T Consensus 83 ~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i 135 (280)
T cd05581 83 YAPNGELLQYIRKY------------------------GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILL 135 (280)
T ss_pred CCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEE
Confidence 99999999998542 26899999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCc-------------------ccccccccCCCcccccccccCCCCCccceeehhHHHHHH
Q 046586 599 GDDFCPKISDFGLAKLRKKEDM-------------------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI 659 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~-------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~el 659 (763)
+.++.++|+|||++........ .......++..|+|||.+....++.++||||||++++|+
T Consensus 136 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l 215 (280)
T cd05581 136 DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQM 215 (280)
T ss_pred CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHH
Confidence 9999999999999986543322 112234578899999999888899999999999999999
Q ss_pred HhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH---
Q 046586 660 VSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM--- 736 (763)
Q Consensus 660 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--- 736 (763)
++|+.|+...... . . .....+ .....+...++.+.+++.+||+.+|++||++
T Consensus 216 ~~g~~p~~~~~~~-------------~-~-----~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 270 (280)
T cd05581 216 LTGKPPFRGSNEY-------------L-T-----FQKILK------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEG 270 (280)
T ss_pred HhCCCCCCCccHH-------------H-H-----HHHHHh------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccC
Confidence 9999998743210 0 0 000110 0111123346778999999999999999999
Q ss_pred -HHHHH
Q 046586 737 -GKVAK 741 (763)
Q Consensus 737 -~eVv~ 741 (763)
.++++
T Consensus 271 ~~~ll~ 276 (280)
T cd05581 271 YDELKA 276 (280)
T ss_pred HHHHhc
Confidence 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=281.09 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=193.2
Q ss_pred ccccccccccccceEEEEEeCC-CcEEEEEEeeccC------CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVT------GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
|.+.++||+|+||.||+++... +..+++|+++... ....++..|+.++++++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5677899999999999997754 3446666665321 22335678999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++..... ....+++.+++.++.|++.||.|||+.+ ++|+||+|+||+
T Consensus 82 e~~~~~~l~~~~~~~~~--------------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nil 138 (260)
T cd08222 82 EYCEGRDLDCKLEELKH--------------------TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIF 138 (260)
T ss_pred EeCCCCCHHHHHHHHhh--------------------cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheE
Confidence 99999999999864321 3356899999999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
+++ +.+||+|||+++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..|+....
T Consensus 139 i~~-~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------- 209 (260)
T cd08222 139 LKN-NLLKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------- 209 (260)
T ss_pred eec-CCEeecccCceeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------
Confidence 975 5699999999976543221 2223457889999999988889999999999999999999999985321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..... .. .... .....+.....++.+++.+|++.+|++||++.|+++
T Consensus 210 --~~~~~-~~---------~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 210 --FLSVV-LR---------IVEG-----PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --HHHHH-HH---------HHcC-----CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00000 00 0000 011122345678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=291.95 Aligned_cols=245 Identities=27% Similarity=0.434 Sum_probs=203.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCch---hhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGD---AEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~---~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..+.+...||+|.|+.|..++.. .+..||+|++++..... +.+.+|+++|..++|||||+++.+......+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 44667789999999999999775 57889999998654332 347899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|..+|.+++||.++.+ .....+..+..|+..+++|||+++ |||||||++||||
T Consensus 136 ya~~ge~~~yl~~~gr------------------------~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL 188 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGR------------------------MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILL 188 (596)
T ss_pred eccCchhHHHHHhccc------------------------chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhccc
Confidence 9999999999987642 333666778899999999999999 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCC-CccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
+.+.++||+|||++..+... ....+..|++.|.|||.+.+.+|. +++|+||+|+++|-|+.|..||++..
T Consensus 189 ~~~mnikIaDfgfS~~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~------- 259 (596)
T KOG0586|consen 189 DENMNIKIADFGFSTFFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN------- 259 (596)
T ss_pred ccccceeeeccccceeeccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-------
Confidence 99999999999999876633 334567899999999999887655 78999999999999999999998542
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
+.++-++.+.+.++ ++.-...++.+++..++-.+|.+|+++.++.+
T Consensus 260 ----------------lk~Lr~rvl~gk~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 260 ----------------LKELRPRVLRGKYR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ----------------cccccchheeeeec--ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 23333334444433 23445667888999999999999999999875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=290.23 Aligned_cols=268 Identities=19% Similarity=0.249 Sum_probs=194.3
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEee----CCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAE----KGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 514 (763)
..+.+.+.||+|+||.||++... +++.||+|+++... .....+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 34566789999999999999765 58899999987532 234567789999999999999999998763 34689
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+. ++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+
T Consensus 85 lv~e~~~-~~l~~~~~~------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~ 136 (334)
T cd07855 85 VVMDLME-SDLHHIIHS------------------------DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPS 136 (334)
T ss_pred EEEehhh-hhHHHHhcc------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 9999995 589888843 234889999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc---cccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV---SMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
||++++++.+||+|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 137 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 137 NLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred HEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 999999999999999999765432221 1223468889999998765 568999999999999999999999996432
Q ss_pred CCCCC------CCCchhHHHHHHHHhccChhhhhcccccccCCCc---chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 671 SMMNS------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSR---VHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 671 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..... ....... ........ ...+..+. ........ .....+..+.+++.+|++.+|++||+++++++
T Consensus 217 ~~~~~~~~~~~~g~~~~~-~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 217 YVHQLKLILSVLGSPSEE-VLNRIGSD-RVRKYIQN-LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hHHHHHHHHHHhCCChhH-hhhhhchh-hHHHHHhh-cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11000 0000000 00000000 00000100 00000000 11234678999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=282.27 Aligned_cols=267 Identities=23% Similarity=0.283 Sum_probs=195.5
Q ss_pred cccccccccccceEEEEEeCC-CcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 446 GFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.+.++||+|+||.||+|+... ++.+|+|+++... ...+.+..|++++++++|+|++++++++.+.+..++|+||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 345789999999999998864 8899999997542 234567899999999999999999999999999999999998
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++++
T Consensus 82 -~~l~~~i~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~ 134 (282)
T cd07829 82 -MDLKKYLDKR-----------------------PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRD 134 (282)
T ss_pred -cCHHHHHHhh-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCC
Confidence 5999998643 135889999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCC-----
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS----- 675 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~----- 675 (763)
+.+||+|||+++....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.........
T Consensus 135 ~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 135 GVLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred CCEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence 9999999999976543221 22233456789999998766 8899999999999999999999998643211000
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.........+....+-................... +.....+.+++..||+.+|++||++.+|+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 214 ILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HhCCCcHHHHHhhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000000000000000000000000000000 123567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=293.94 Aligned_cols=246 Identities=23% Similarity=0.339 Sum_probs=193.8
Q ss_pred ccccccccccceEEEEEeCCCc-EEEEEEeecc-CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCC
Q 046586 447 FSNLIGRGGFGDVYKGELTDHR-VVAVKCLKNV-TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 447 ~~~~LG~G~fG~Vy~g~~~~~~-~VAvK~l~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gs 524 (763)
+...||.|+||.||+++..+.. ..|-|++... ....++|+-|+++|+...||+||+|++.+...+.++++.|||.||-
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGA 115 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGA 115 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCch
Confidence 4457999999999999877544 4456776533 3345779999999999999999999999999999999999999999
Q ss_pred HhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCe
Q 046586 525 LADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP 604 (763)
Q Consensus 525 L~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 604 (763)
++..+... ...|...++.-++.|++.||.|||++. |||||||+.|||++-+|.+
T Consensus 116 VDaimlEL-----------------------~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdi 169 (1187)
T KOG0579|consen 116 VDAIMLEL-----------------------GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDI 169 (1187)
T ss_pred HhHHHHHh-----------------------ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcE
Confidence 99887543 357889999999999999999999988 9999999999999999999
Q ss_pred EEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 605 KISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 605 kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
+|+|||.+-.... .......+.||+.|||||+.. ..+|+.++||||||+.|.||.-+.+|.+.....
T Consensus 170 rLADFGVSAKn~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------- 241 (1187)
T KOG0579|consen 170 RLADFGVSAKNKS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------- 241 (1187)
T ss_pred eeecccccccchh-HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-------
Confidence 9999998853221 111223478999999999874 569999999999999999999999987633211
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+.-.+-... ...++ .|..-...+.+++..||.+||..||+++++++
T Consensus 242 ---RVllKiaKSe-PPTLl-----------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 242 ---RVLLKIAKSE-PPTLL-----------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ---HHHHHHhhcC-CCccc-----------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1111110000 11111 12345667889999999999999999999885
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=291.01 Aligned_cols=270 Identities=19% Similarity=0.244 Sum_probs=192.2
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCC------ee
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG------ER 513 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 513 (763)
.+.+.+.||+|+||.||+|+.. +++.||+|.++... .....+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 3455679999999999999864 68899999986432 22345789999999999999999999987543 46
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++|+||+.. +|..++. ..+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 96 ~lv~e~~~~-~l~~~~~--------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp 145 (342)
T cd07879 96 YLVMPYMQT-DLQKIMG--------------------------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKP 145 (342)
T ss_pred EEEeccccc-CHHHHHc--------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 899999964 6666541 24788899999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
+||+++.++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 146 ~NIll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~ 221 (342)
T cd07879 146 GNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221 (342)
T ss_pred HHEEECCCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999999754321 223467888999998876 56899999999999999999999999743210
Q ss_pred CCC------CCCchhHHHHHHHHhccChhhhhcccccccCCCcc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--
Q 046586 673 MNS------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRV---HFDMVNRMVKTAMWCIQDRPELRPSMGKVAK-- 741 (763)
Q Consensus 673 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~-- 741 (763)
... .....+.+ ............+.. .......+. .+.....+.+++.+||+.||++||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~ 298 (342)
T cd07879 222 DQLTQILKVTGVPGPEF--VQKLEDKAAKSYIKS-LPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHP 298 (342)
T ss_pred HHHHHHHHhcCCCCHHH--HHHhcccchHHHHhh-cCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 000 00000000 000000000000000 000000000 0123456889999999999999999999994
Q ss_pred HhccCCCCC
Q 046586 742 MLEGTVEIT 750 (763)
Q Consensus 742 ~Le~~~~~~ 750 (763)
.+++....+
T Consensus 299 ~f~~~~~~~ 307 (342)
T cd07879 299 YFDSFRDAD 307 (342)
T ss_pred chhhccccc
Confidence 477665443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=288.22 Aligned_cols=270 Identities=21% Similarity=0.255 Sum_probs=195.7
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeC-----Ceee
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK-----GERT 514 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 514 (763)
.|.+.+.||+|+||.||+++.. +++.||||.++.. .....++.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 3566789999999999999764 5789999998743 22345677899999999999999999988654 3579
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+|+||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+
T Consensus 86 lv~e~~~-~~L~~~~~~------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~ 137 (337)
T cd07858 86 IVYELMD-TDLHQIIRS------------------------SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPS 137 (337)
T ss_pred EEEeCCC-CCHHHHHhc------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 9999996 688888743 235888999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
||+++.++.+||+|||+++...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.......
T Consensus 138 Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 216 (337)
T cd07858 138 NLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH 216 (337)
T ss_pred HEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 9999999999999999998654332 12233457889999998765 568999999999999999999999996432100
Q ss_pred CC-------CCCchhHHHHHHHHhccChhhhhcccccccCCC---cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH-
Q 046586 674 NS-------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDS---RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM- 742 (763)
Q Consensus 674 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~- 742 (763)
.. .......+ ... ........+.. ....... ........++.+++.+||+.+|++|||+.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 217 QLKLITELLGSPSEEDL--GFI-RNEKARRYIRS-LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred HHHHHHHHhCCCChHHh--hhc-CchhhhHHHHh-cCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 00 00000000 000 00000000100 0000000 0112345778999999999999999999999966
Q ss_pred -hccC
Q 046586 743 -LEGT 746 (763)
Q Consensus 743 -Le~~ 746 (763)
++..
T Consensus 293 ~~~~~ 297 (337)
T cd07858 293 YLASL 297 (337)
T ss_pred chhhh
Confidence 6554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=288.58 Aligned_cols=271 Identities=21% Similarity=0.254 Sum_probs=200.7
Q ss_pred ccccccccccccceEEEEEeCC-CcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCC-----eeeE
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG-----ERTL 515 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~L 515 (763)
+.+.+.||+|+||.||+++... ++.+|+|.+.... ...+.+.+|+++++.++|+||+++++++...+ ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 5677899999999999998764 7899999987543 23456889999999999999999999998775 7899
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++ +|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+|
T Consensus 82 v~e~~~~-~l~~~l~~------------------------~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~n 133 (330)
T cd07834 82 VTELMET-DLHKVIKS------------------------PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSN 133 (330)
T ss_pred Eecchhh-hHHHHHhC------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 9999984 88888743 236889999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+++.++.++|+|||++........ .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......
T Consensus 134 ili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~ 213 (330)
T cd07834 134 ILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213 (330)
T ss_pred EEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 9999999999999999986554321 123334678899999999887 8999999999999999999999999644321
Q ss_pred CCC-------CCCchhHHHHHHHHhccChhhhhcccccccCCC---cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 673 MNS-------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDS---RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 673 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
... .......+.. .......+.+.. ....... .........+.+++.+||+.+|++||++.++++.
T Consensus 214 ~~~~~i~~~~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 214 DQLNLIVEVLGTPSEEDLKF---ITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred HHHHHHHHhcCCCChhHhhh---ccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 0000000000 000000111110 0000000 0012245678999999999999999999999974
Q ss_pred --hccCC
Q 046586 743 --LEGTV 747 (763)
Q Consensus 743 --Le~~~ 747 (763)
+++..
T Consensus 290 ~~~~~~~ 296 (330)
T cd07834 290 PYLAQLH 296 (330)
T ss_pred ccHHhhc
Confidence 55543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=288.71 Aligned_cols=261 Identities=22% Similarity=0.233 Sum_probs=190.8
Q ss_pred ccccccccccceEEEEEeC-CCcEEEEEEeeccCCch---------------hhhHHHHHHHhcCCCCccccEEEEEeeC
Q 046586 447 FSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGD---------------AEFWAEVTIIARMHHLNLVRLWGFCAEK 510 (763)
Q Consensus 447 ~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~---------------~~f~~E~~~l~~l~H~niv~l~g~~~~~ 510 (763)
+.+.||+|+||.||+|... .++.||+|.++...... ..+.+|+++++.++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3467999999999999865 58899999987432211 2467899999999999999999999999
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
+..++||||++ ++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+|
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~------------------------~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~d 144 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR------------------------KIRLTESQVKCILLQILNGLNVLHKWY---FMHRD 144 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 99999999997 589988843 235788899999999999999999988 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCC-------------cccccccccCCCcccccccccC-CCCCccceeehhHHH
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKED-------------MVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVL 656 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll 656 (763)
|+|+||+++.++.+||+|||+++...... ........++..|+|||.+.+. .++.++||||||+++
T Consensus 145 l~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 224 (335)
T PTZ00024 145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF 224 (335)
T ss_pred ccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHH
Confidence 99999999999999999999997654111 1111223467889999988764 578999999999999
Q ss_pred HHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccC--hhhh--------hcccccccCCCcchHHHHHHHHHHHHHcc
Q 046586 657 LEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMK--VEDI--------LDRHIKNSYDSRVHFDMVNRMVKTAMWCI 726 (763)
Q Consensus 657 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl 726 (763)
|||++|+.||....... .............. .... ......... .........++.+++..|+
T Consensus 225 ~el~tg~~p~~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l 297 (335)
T PTZ00024 225 AELLTGKPLFPGENEID------QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLL 297 (335)
T ss_pred HHHHhCCCCCCCCCHHH------HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHc
Confidence 99999999986443210 00000000000000 0000 000000000 0000123567889999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 046586 727 QDRPELRPSMGKVAKM 742 (763)
Q Consensus 727 ~~dP~~RPs~~eVv~~ 742 (763)
+.+|++||++.|++..
T Consensus 298 ~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 298 KLNPLERISAKEALKH 313 (335)
T ss_pred CCCchhccCHHHHhcC
Confidence 9999999999999953
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=276.61 Aligned_cols=240 Identities=19% Similarity=0.261 Sum_probs=184.8
Q ss_pred cccccc--ccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNL--IGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~--LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
+.+.+. ||+|+||.||++... ++..+|+|.++...... .|+.....+ +||||+++++.+...+..++||||+
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 344454 599999999999764 57889999987532221 123222223 7999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ..+++.++..++.|+++||+|||+.+ ++||||||+||+++.
T Consensus 92 ~~~~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~ 144 (267)
T PHA03390 92 KDGDLFDLLKKE------------------------GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDR 144 (267)
T ss_pred CCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeC
Confidence 999999998532 26889999999999999999999988 999999999999999
Q ss_pred CC-CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 601 DF-CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~-~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
++ .++|+|||+++..... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...
T Consensus 145 ~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~----~~~ 215 (267)
T PHA03390 145 AKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE----ELD 215 (267)
T ss_pred CCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc----hhh
Confidence 98 9999999999765432 1235788999999999989999999999999999999999999732211 111
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-MGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~eVv~ 741 (763)
...+. .. ... ...........+.+++..||+.+|.+||+ ++++++
T Consensus 216 ~~~~~-----~~------~~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 216 LESLL-----KR------QQK------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHH-----Hh------hcc------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11110 00 000 00111245678899999999999999996 688874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=275.51 Aligned_cols=235 Identities=29% Similarity=0.380 Sum_probs=191.1
Q ss_pred ccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 451 IGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 451 LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
||+|+||.||++... +++.+++|+++.... ....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 478999999875432 345788999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeE
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 605 (763)
.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 81 ~~~l~~~------------------------~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~ 133 (250)
T cd05123 81 FSHLSKE------------------------GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIK 133 (250)
T ss_pred HHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEE
Confidence 9998542 25789999999999999999999988 99999999999999999999
Q ss_pred EcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHH
Q 046586 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685 (763)
Q Consensus 606 I~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 685 (763)
|+|||++....... .......++..|+|||...+...+.++|+||||+++||+++|+.||.....
T Consensus 134 l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------------- 198 (250)
T cd05123 134 LTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------------- 198 (250)
T ss_pred EeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------------
Confidence 99999997654432 122345678899999999888899999999999999999999999963321
Q ss_pred HHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 046586 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGK 738 (763)
Q Consensus 686 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 738 (763)
....+ .+.. . ...++......+.+++.+|+..||++||++.+
T Consensus 199 ~~~~~-----~~~~----~--~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 199 KEIYE-----KILK----D--PLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHH-----HHhc----C--CCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 00000 0111 0 01112233567889999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=285.63 Aligned_cols=269 Identities=23% Similarity=0.249 Sum_probs=190.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCC-------
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG------- 511 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------- 511 (763)
..+.+.++||+|+||.||+|... +++.+|+|++..... ....+.+|++++++++|+||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 35667789999999999999875 578899999864322 2345788999999999999999999876543
Q ss_pred -eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 512 -ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 512 -~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
..++|+||+++ +|...+.. ....+++.++..++.|+++||+|||+.+ |+|+|
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~-----------------------~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~d 140 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLEN-----------------------PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRD 140 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhc-----------------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 46899999965 67776643 2235889999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCc----------ccccccccCCCccccccccc-CCCCCccceeehhHHHHHH
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDM----------VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEI 659 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~----------~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~el 659 (763)
|||+||++++++.+||+|||+++....... ...+...++..|+|||.+.+ ..++.++||||||+++|||
T Consensus 141 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el 220 (311)
T cd07866 141 IKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220 (311)
T ss_pred CCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHH
Confidence 999999999999999999999975433221 11123456888999998765 4689999999999999999
Q ss_pred HhCCCCcccccCCCCCCC-----CchhHHHHHHHHhccChhhhhcccccccCCCcc---hHHHHHHHHHHHHHccCCCCC
Q 046586 660 VSGSRNFEIQGSMMNSDE-----WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRV---HFDMVNRMVKTAMWCIQDRPE 731 (763)
Q Consensus 660 ltG~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~ 731 (763)
++|+.||........... .....+.+..... .....+........... .....+.+.+++.+|++.||+
T Consensus 221 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 297 (311)
T cd07866 221 FTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRS---LPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297 (311)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhh---cccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcc
Confidence 999999864322100000 0000000000000 00000000000011000 012336788999999999999
Q ss_pred CCCCHHHHHH
Q 046586 732 LRPSMGKVAK 741 (763)
Q Consensus 732 ~RPs~~eVv~ 741 (763)
+|||+.|+++
T Consensus 298 ~R~t~~ell~ 307 (311)
T cd07866 298 KRLTASDALE 307 (311)
T ss_pred cCcCHHHHhc
Confidence 9999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=296.20 Aligned_cols=197 Identities=30% Similarity=0.474 Sum_probs=170.9
Q ss_pred cccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCC------eeeEEEe
Q 046586 448 SNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG------ERTLVYE 518 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~LV~E 518 (763)
.+.||+|+||.||+|+.+ .|+.||||..+... ...+...+|+++|++++|+|||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 568999999999999964 68999999998643 33455779999999999999999999876544 6789999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
||.+|||+..|.... +...|+..+.+.+..+++.||.|||+++ |+||||||.||++
T Consensus 98 yC~gGsL~~~L~~PE---------------------N~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl 153 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPE---------------------NAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVL 153 (732)
T ss_pred ecCCCcHHHHhcCcc---------------------cccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEE
Confidence 999999999996542 5567999999999999999999999988 9999999999999
Q ss_pred c----CCCCeEEcccCcccccCCCCcccccccccCCCcccccccc-cCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 599 G----DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 599 ~----~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
- ..-..||+|||.|+....+. ..+.+.||..|.+||.+. .+.|+..+|.|||||++||.+||..||....
T Consensus 154 ~~Gedgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 154 QIGEDGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred eecCCCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 3 33357999999999776554 567789999999999998 5899999999999999999999999997554
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=315.83 Aligned_cols=244 Identities=29% Similarity=0.432 Sum_probs=195.1
Q ss_pred ccccccccceEEEEEe-CCCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCC
Q 046586 449 NLIGRGGFGDVYKGEL-TDHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gs 524 (763)
.+||.|.||.||-+.. .+|+..|+|-++-. ........+|+.++..|+|||+|+.+|+-.+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 5899999999999965 56888899987632 2334557789999999999999999999999999999999999999
Q ss_pred HhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCe
Q 046586 525 LADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP 604 (763)
Q Consensus 525 L~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 604 (763)
|.+.+...+ ..+......+..|++.|++|||+++ ||||||||.||+|+.+|.+
T Consensus 1321 La~ll~~gr------------------------i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~i 1373 (1509)
T KOG4645|consen 1321 LASLLEHGR------------------------IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLI 1373 (1509)
T ss_pred HHHHHHhcc------------------------hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcE
Confidence 999996432 3455556677889999999999999 9999999999999999999
Q ss_pred EEcccCcccccCCCCc---ccccccccCCCccccccccc---CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 605 KISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRS---DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 605 kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
|.+|||.|........ .......||+.|||||.+.+ .....+.||||+||++.||+||++|+...+.
T Consensus 1374 K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------- 1446 (1509)
T KOG4645|consen 1374 KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------- 1446 (1509)
T ss_pred EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------
Confidence 9999999987655421 23445689999999999865 3456789999999999999999999864331
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.|+.- + +....-.+++|.....+-.+++.+|++.||++|=++.|+++.
T Consensus 1447 ---e~aIM--y-----------~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1447 ---EWAIM--Y-----------HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---hhHHH--h-----------HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 12111 1 111112234556677888999999999999999777766654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=271.06 Aligned_cols=260 Identities=26% Similarity=0.330 Sum_probs=203.1
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-c---hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-G---DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
..|.++||+|.||.|-+++.+ .++.+|+|++++... . ...-+.|-.+|++.+||.+..|.-.|+..++++.||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 456789999999999999775 588999999985422 2 22345688899999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
..||.|.-+|.+. ..++.....-+...|..||.|||+++ ||.||||.+|.|+|
T Consensus 250 anGGeLf~HLsre------------------------r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLD 302 (516)
T KOG0690|consen 250 ANGGELFFHLSRE------------------------RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLD 302 (516)
T ss_pred ccCceEeeehhhh------------------------hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheec
Confidence 9999999988643 24555555667889999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
.+|++||+|||+++.--. ....+.+++||+.|+|||++....|..++|.|.+||++|||++|+.||-..+.
T Consensus 303 kDGHIKitDFGLCKE~I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-------- 373 (516)
T KOG0690|consen 303 KDGHIKITDFGLCKEEIK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-------- 373 (516)
T ss_pred cCCceEeeecccchhccc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--------
Confidence 999999999999984322 22456778999999999999999999999999999999999999999964321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH--HhccC------
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK--MLEGT------ 746 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~--~Le~~------ 746 (763)
+.+.+- ++.. +..+|.....+...++.-.|.+||.+|. .++||.+ ++.++
T Consensus 374 ------~kLFeL-----Il~e------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~ 436 (516)
T KOG0690|consen 374 ------EKLFEL-----ILME------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATY 436 (516)
T ss_pred ------hHHHHH-----HHhh------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHH
Confidence 111111 1111 1123345566778888889999999995 4555553 22332
Q ss_pred -CCCCCCCCCce
Q 046586 747 -VEITEPKKPTI 757 (763)
Q Consensus 747 -~~~~~p~~p~~ 757 (763)
.++++|-+|.+
T Consensus 437 ~Kki~PPfKPqV 448 (516)
T KOG0690|consen 437 RKKIEPPFKPQV 448 (516)
T ss_pred HhccCCCCCCCc
Confidence 35677777754
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=286.85 Aligned_cols=268 Identities=20% Similarity=0.250 Sum_probs=193.3
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCC------e
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG------E 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~ 512 (763)
.+|.+.+.||+|+||.||++... +++.||||+++.... ....+.+|++++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 34667789999999999999764 688999999864322 2345789999999999999999999987653 4
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|||||
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-------------------------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlk 145 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-------------------------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLK 145 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 58999998 6799888732 35788999999999999999999988 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
|+||+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.....
T Consensus 146 p~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 221 (343)
T cd07880 146 PGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221 (343)
T ss_pred HHHEEEcCCCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999754322 223457889999998875 4688999999999999999999999964321
Q ss_pred CCCC------CCCchhHHHHHHHHhccChhhhhcccccccCCC---cchHHHHHHHHHHHHHccCCCCCCCCCHHHHH--
Q 046586 672 MMNS------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDS---RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA-- 740 (763)
Q Consensus 672 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv-- 740 (763)
.... .......+. ..+... ........ +...... .........+.+++.+|++.||++|||+.+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 222 LDQLMEIMKVTGTPSKEFV-QKLQSE-DAKNYVKK-LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHHHHHhcCCCCHHHH-Hhhcch-hHHHHHHh-ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1000 000000000 000000 00000000 0000000 00112345688999999999999999999999
Q ss_pred HHhccC
Q 046586 741 KMLEGT 746 (763)
Q Consensus 741 ~~Le~~ 746 (763)
..++..
T Consensus 299 ~~~~~~ 304 (343)
T cd07880 299 PYFEEF 304 (343)
T ss_pred ccHhhh
Confidence 445444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=287.61 Aligned_cols=267 Identities=20% Similarity=0.232 Sum_probs=189.5
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeC----------
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK---------- 510 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~---------- 510 (763)
.++.+.+.||.|+||.||+|... +++.||+|.+.... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 45677889999999999999775 57899999986443 3345688999999999999999999776543
Q ss_pred ----CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 511 ----GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 511 ----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
...++||||++ ++|.+++.. ..+++.....++.||+.||.|||+.+ |
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-------------------------~~l~~~~~~~~~~qi~~aL~~LH~~g---i 135 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-------------------------GPLSEEHARLFMYQLLRGLKYIHSAN---V 135 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 35789999997 588887732 24788899999999999999999988 9
Q ss_pred EecCCCCCceEEc-CCCCeEEcccCcccccCCCCcc--cccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhC
Q 046586 587 LHCDIKPENILLG-DDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSG 662 (763)
Q Consensus 587 vHrDlk~~NILl~-~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG 662 (763)
+||||||+||+++ +++.+||+|||+++........ ......++..|+|||.+.. ..++.++|||||||++|||++|
T Consensus 136 vH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 215 (342)
T cd07854 136 LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215 (342)
T ss_pred ccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhC
Confidence 9999999999997 5567899999999765332211 1122357888999997654 5688899999999999999999
Q ss_pred CCCcccccCCCCC------CCCchhHHHHHHHHhccChhhhhcccccccCC--CcchHHHHHHHHHHHHHccCCCCCCCC
Q 046586 663 SRNFEIQGSMMNS------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYD--SRVHFDMVNRMVKTAMWCIQDRPELRP 734 (763)
Q Consensus 663 ~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RP 734 (763)
+.||......... ....... ........ .............. .........++.+++.+|++.||++||
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 292 (342)
T cd07854 216 KPLFAGAHELEQMQLILESVPVVREE-DRNELLNV--IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292 (342)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChH-Hhhhhhhh--hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc
Confidence 9999643211000 0000000 00000000 00000000000000 000112446788999999999999999
Q ss_pred CHHHHHH
Q 046586 735 SMGKVAK 741 (763)
Q Consensus 735 s~~eVv~ 741 (763)
|+.++++
T Consensus 293 t~~ell~ 299 (342)
T cd07854 293 TAEEALM 299 (342)
T ss_pred CHHHHhC
Confidence 9999983
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=282.26 Aligned_cols=265 Identities=22% Similarity=0.229 Sum_probs=188.7
Q ss_pred ccccccccccccceEEEEEeCC---CcEEEEEEeeccCC---chhhhHHHHHHHhcC-CCCccccEEEEEeeC----Cee
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD---HRVVAVKCLKNVTG---GDAEFWAEVTIIARM-HHLNLVRLWGFCAEK----GER 513 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~---~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~~ 513 (763)
+.+.+.||+|+||.||+++... ++.+|+|.++.... ..+.+.+|+++++++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 4567899999999999998753 67899999874322 235678899999999 599999999976533 457
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++++||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 82 ~~~~e~~~-~~L~~~l~~------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp 133 (332)
T cd07857 82 YLYEELME-ADLHQIIRS------------------------GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKP 133 (332)
T ss_pred EEEEeccc-CCHHHHHhc------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCH
Confidence 78899886 589988843 235788999999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc---ccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
+||++++++.+||+|||+++....... .......|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 134 ~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 134 GNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred HHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 999999999999999999986543221 11233568899999998765 57899999999999999999999998643
Q ss_pred cCCCCC------CCCchhHHHHHHHHhccChhhhhcccccccCCCc---chHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 670 GSMMNS------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSR---VHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 670 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
...... .......+ ...+... ........ ........ ........+.+++.+|++.||++|||+.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 214 DYVDQLNQILQVLGTPDEET-LSRIGSP-KAQNYIRS-LPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred CHHHHHHHHHHHhCCCCHHH-HHhhhhh-hHHHHHHh-ccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 210000 00000000 0000000 00000000 00000000 0012346788999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=281.97 Aligned_cols=263 Identities=20% Similarity=0.234 Sum_probs=190.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEee-CCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAE-KGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~LV~E 518 (763)
.|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+++++.++||||+++++++.. ....++|+|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 4566789999999999999765 6889999988642 2234567899999999999999999999876 557889999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+ +++|.+++.. ..+++.....++.|++.||+|||+.+ |+||||+|+||++
T Consensus 91 ~~-~~~L~~~~~~-------------------------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili 141 (328)
T cd07856 91 LL-GTDLHRLLTS-------------------------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILI 141 (328)
T ss_pred hh-ccCHHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeE
Confidence 98 5689888732 24677788899999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCC--
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS-- 675 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~-- 675 (763)
++++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 142 ~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~ 217 (328)
T cd07856 142 NENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217 (328)
T ss_pred CCCCCEEeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999754321 223456888999998765 57899999999999999999999998643210000
Q ss_pred ----CCCchhHHHHHHHHhccChhhhhcccccccCCCcch---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 676 ----DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVH---FDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 676 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
......++.. ...... ..+++.. +......+.. ......+.+++.+|++.+|++||++.+++..
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 218 ITDLLGTPPDDVIN-TICSEN-TLRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhCCCCHHHHH-hccchh-hHHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 000000 0111111 0000000000 1234688999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=258.96 Aligned_cols=252 Identities=22% Similarity=0.391 Sum_probs=193.0
Q ss_pred cccHHHHHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCC-CCccccEEEEEee
Q 046586 434 RFTHAELRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMH-HLNLVRLWGFCAE 509 (763)
Q Consensus 434 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~ 509 (763)
..+..||+ +...||.|..|.|++.++. .|..+|||.+.... .+.++.+..+.++.+-+ .|.||+.+|+|..
T Consensus 88 ~~dindl~-----~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 88 QADINDLE-----NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred ccChHHhh-----hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 34555554 3457999999999999886 47899999997543 23355677777776664 8999999999999
Q ss_pred CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEec
Q 046586 510 KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHC 589 (763)
Q Consensus 510 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHr 589 (763)
+....+-||.|.. .++.+|.+. ...+++...-++...+..||.||.++.. |+||
T Consensus 163 n~dV~IcMelMs~-C~ekLlkri-----------------------k~piPE~ilGk~tva~v~AL~YLKeKH~--viHR 216 (391)
T KOG0983|consen 163 NTDVFICMELMST-CAEKLLKRI-----------------------KGPIPERILGKMTVAIVKALYYLKEKHG--VIHR 216 (391)
T ss_pred CchHHHHHHHHHH-HHHHHHHHh-----------------------cCCchHHhhhhhHHHHHHHHHHHHHhcc--eeec
Confidence 9999999999843 666666543 2357777778899999999999987654 9999
Q ss_pred CCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc---CCCCCccceeehhHHHHHHHhCCCCc
Q 046586 590 DIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS---DQITPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 590 Dlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvll~elltG~~p~ 666 (763)
|+||+|||+|+.|++|++|||++-.+-.. ...++..|-+.|||||.+.- .+|+..+||||||+.|+||.||+.||
T Consensus 217 DvKPSNILlDe~GniKlCDFGIsGrlvdS--kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy 294 (391)
T KOG0983|consen 217 DVKPSNILLDERGNIKLCDFGISGRLVDS--KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPY 294 (391)
T ss_pred ccCccceEEccCCCEEeecccccceeecc--cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCC
Confidence 99999999999999999999999654332 22345678899999999863 57899999999999999999999999
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcc--hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRV--HFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.....+ | +.+.+.+.+. ++.+ +...+..+.+++..||++|+.+||...++++
T Consensus 295 ~~c~td-------F---------------e~ltkvln~e-PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 295 KGCKTD-------F---------------EVLTKVLNEE-PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCcc-------H---------------HHHHHHHhcC-CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 754311 1 1111111111 1111 1235778999999999999999999998875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=281.72 Aligned_cols=264 Identities=21% Similarity=0.250 Sum_probs=188.5
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeC------Cee
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEK------GER 513 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 513 (763)
+|.+.+.||+|+||.||++.. .+++.||+|+++.... ..+.+.+|++++++++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 355567999999999999976 4688999999874322 235678899999999999999999988643 346
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||
T Consensus 98 ~lv~~~~-~~~L~~~~~~-------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp 148 (345)
T cd07877 98 YLVTHLM-GADLNNIVKC-------------------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKP 148 (345)
T ss_pred EEEehhc-ccCHHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCh
Confidence 7888876 7799887732 24788999999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
+||++++++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 149 ~NIll~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 224 (345)
T cd07877 149 SNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224 (345)
T ss_pred HHEEEcCCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999999754322 233467889999998866 57889999999999999999999998543211
Q ss_pred CCCC-----CCchhHHHHHHHHhccChhhh---hcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 673 MNSD-----EWYFPKWAFEKVYEEMKVEDI---LDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 673 ~~~~-----~~~~~~~~~~~~~~~~~~~~~---~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.... ....+......+.... .... +......... ........++.+++.+|++.||.+||++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 225 DQLKLILRLVGTPGAELLKKISSES-ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHHHHhCCCCHHHHhhcccHh-HHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 0000000000000000 0000 0000000000 0001234568899999999999999999998843
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=261.43 Aligned_cols=267 Identities=22% Similarity=0.306 Sum_probs=201.3
Q ss_pred cHHHHHHHhccccccccccccceEEEE-EeCCCcEEEEEEeeccCC-chhhhHHHHHHHhcC-CCCccccEEEEEeeCCe
Q 046586 436 THAELRAATNGFSNLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTG-GDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGE 512 (763)
Q Consensus 436 ~~~el~~~t~~~~~~LG~G~fG~Vy~g-~~~~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 512 (763)
.+.|+.+.| .+.||+|+++.|--+ .+..+..+|||++.+... ...+..+|++++... .|+||+.|+.+|+++..
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 345555544 468999999999887 457889999999976644 345678999999998 59999999999999999
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.|||||-|.||+|..+++++ ..++..++-++..+||.||.+||.++ |.|||||
T Consensus 151 FYLVfEKm~GGplLshI~~~------------------------~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlK 203 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKR------------------------KHFNEREASRVVKDIASALDFLHTKG---IAHRDLK 203 (463)
T ss_pred EEEEEecccCchHHHHHHHh------------------------hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCC
Confidence 99999999999999999754 47888999999999999999999999 9999999
Q ss_pred CCceEEcCCC---CeEEcccCcccccCCCCc------ccccccccCCCcccccccc-----cCCCCCccceeehhHHHHH
Q 046586 593 PENILLGDDF---CPKISDFGLAKLRKKEDM------VSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLE 658 (763)
Q Consensus 593 ~~NILl~~~~---~~kI~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~e 658 (763)
|+|||..+.. -+||+||.|..-...... ....+-+|+..|||||+.. ...|+.+.|.||+||+||-
T Consensus 204 PENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYI 283 (463)
T KOG0607|consen 204 PENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYI 283 (463)
T ss_pred ccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHH
Confidence 9999996544 479999998864322111 2233457888999999763 2478899999999999999
Q ss_pred HHhCCCCcccccCC-CCCCCCchhHHHHHHHHhccChhhhhcccccccCCC--cchHHHHHHHHHHHHHccCCCCCCCCC
Q 046586 659 IVSGSRNFEIQGSM-MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDS--RVHFDMVNRMVKTAMWCIQDRPELRPS 735 (763)
Q Consensus 659 lltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs 735 (763)
|++|..||.+.... -..+......-..+.+.+. ...+.+.. .--...+.+..+++...+..|+.+|-+
T Consensus 284 mLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes---------IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls 354 (463)
T KOG0607|consen 284 MLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES---------IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS 354 (463)
T ss_pred HHhCCCCccCccCCcCCccCCCccHHHHHHHHHH---------HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh
Confidence 99999999766432 1111222222222222222 11122211 111234566677888888899999999
Q ss_pred HHHHHH
Q 046586 736 MGKVAK 741 (763)
Q Consensus 736 ~~eVv~ 741 (763)
+..++.
T Consensus 355 a~~vln 360 (463)
T KOG0607|consen 355 AAQVLN 360 (463)
T ss_pred hhhccC
Confidence 999886
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=303.97 Aligned_cols=143 Identities=29% Similarity=0.406 Sum_probs=126.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.++||+|+||.||+|... +++.||+|+++.... ....+..|+.++..++|+||+++++++...+..+||||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 4567789999999999999876 578999999974322 12567889999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++... ..+++...+.|+.||+.||+|||..+ ||||||||+|||+
T Consensus 85 y~~g~~L~~li~~~------------------------~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl 137 (669)
T cd05610 85 YLIGGDVKSLLHIY------------------------GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLI 137 (669)
T ss_pred CCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEE
Confidence 99999999998542 24678888999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCccc
Q 046586 599 GDDFCPKISDFGLAK 613 (763)
Q Consensus 599 ~~~~~~kI~DFGla~ 613 (763)
+.++.+||+|||+++
T Consensus 138 ~~~g~vkL~DFGls~ 152 (669)
T cd05610 138 SNEGHIKLTDFGLSK 152 (669)
T ss_pred cCCCCEEEEeCCCCc
Confidence 999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.26 Aligned_cols=262 Identities=20% Similarity=0.235 Sum_probs=191.7
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCe------e
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE------R 513 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~ 513 (763)
.|.+.+.||+|+||.||+|+.. +++.||+|+++... ....++.+|+.++++++|+||+++++++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 4566789999999999999886 57889999986432 223557789999999999999999998876554 8
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+.+ |+|+||||
T Consensus 96 ~lv~e~~-~~~L~~~~~-------------------------~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp 146 (343)
T cd07851 96 YLVTHLM-GADLNNIVK-------------------------CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKP 146 (343)
T ss_pred EEEEecC-CCCHHHHHh-------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 9999998 569998883 235889999999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
+||++++++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 147 ~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~ 222 (343)
T cd07851 147 SNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI 222 (343)
T ss_pred HHeEECCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999999999999999999765332 233467888999998865 47889999999999999999999998633211
Q ss_pred CCC------CCCchhHHHHHHHHhccChhhhhcccccccCCCcc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 673 MNS------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRV---HFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 673 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
... .....+.+......+. ....+... ........ .......+.+++.+|++.||++|||+.||++
T Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 223 DQLKRIMNLVGTPDEELLQKISSES--ARNYIQSL-PQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHHHhcCCCCHHHHhhccchh--HHHHHHhc-cccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 0000000000000000 00010000 00000000 0123578999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=274.15 Aligned_cols=269 Identities=24% Similarity=0.352 Sum_probs=207.1
Q ss_pred HHHHHHhccccccccccccceEEEEEeCC-CcEEEEEEeeccC----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCC
Q 046586 438 AELRAATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVT----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKG 511 (763)
Q Consensus 438 ~el~~~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 511 (763)
..|+....+|..+||+|+||.|.++.-++ .+.+|||++++.. ...+--+.|-.+|+.. +-|.++.|..+++.-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 34667778999999999999999997664 5689999998542 2223345677777776 6789999999999999
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
.+|.||||+.+|+|-.++++..+ +....+.-+|.+||-||-+||+++ ||.|||
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~Gk------------------------FKEp~AvFYAaEiaigLFFLh~kg---IiYRDL 476 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGK------------------------FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDL 476 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcc------------------------cCCchhhhhhHHHHHHhhhhhcCC---eeeeec
Confidence 99999999999999999987654 334455668899999999999999 999999
Q ss_pred CCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 592 KPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 592 k~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
|.+||++|.+|++||+|||+++.--.++ ..+.++.||+.|+|||.+...+|+.++|.|||||+||||+.|+.||++.++
T Consensus 477 KLDNvmLd~eGHiKi~DFGmcKEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 477 KLDNVMLDSEGHIKIADFGMCKENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred cccceEeccCCceEeeecccccccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999999999999999999998532222 345678999999999999999999999999999999999999999986543
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH----H-HHH------
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM----G-KVA------ 740 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~-eVv------ 740 (763)
.+ + ...+.+... . .|...+.+.+.+....+.+.|.+|.-. + +|-
T Consensus 556 ~e--------------l-----F~aI~ehnv--s----yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR 610 (683)
T KOG0696|consen 556 DE--------------L-----FQAIMEHNV--S----YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFR 610 (683)
T ss_pred HH--------------H-----HHHHHHccC--c----CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchh
Confidence 11 1 122222211 1 224556677788888899999988522 1 221
Q ss_pred ----HHhccCCCCCCCCCCceecc
Q 046586 741 ----KMLEGTVEITEPKKPTIYFL 760 (763)
Q Consensus 741 ----~~Le~~~~~~~p~~p~~~~~ 760 (763)
+.|| ..++++|-+|.+=.+
T Consensus 611 ~iDWek~E-~~eiqPPfkPk~k~~ 633 (683)
T KOG0696|consen 611 RIDWEKLE-RREIQPPFKPKIKCG 633 (683)
T ss_pred hccHHHHh-hccCCCCCCCccccC
Confidence 1221 246778888876443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=272.55 Aligned_cols=258 Identities=26% Similarity=0.361 Sum_probs=197.4
Q ss_pred HHHHHhccccccccccccceEEEEE-eCCCcEEEEEEeeccCCc---h-----hhhHHHHHHHhcCCCCccccEEEEEee
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGG---D-----AEFWAEVTIIARMHHLNLVRLWGFCAE 509 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~-~~~~~~VAvK~l~~~~~~---~-----~~f~~E~~~l~~l~H~niv~l~g~~~~ 509 (763)
-....+|-+.++||+|||+.||++. +...+.||||+-.-.... . +...+|..+.+.|.||.||++++++.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3445556667899999999999994 566789999997533222 2 225679999999999999999999874
Q ss_pred -CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 046586 510 -KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLH 588 (763)
Q Consensus 510 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 588 (763)
.+..+-|+||++|-+|+-||..+ +.++..++..|+.||..||.||.+.. ++|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQh------------------------klmSEKEARSIiMQiVnAL~YLNEik-pPIIH 593 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQH------------------------KLMSEKEARSIIMQIVNALKYLNEIK-PPIIH 593 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhh------------------------hhhhHHHHHHHHHHHHHHHHHHhccC-CCeee
Confidence 56778899999999999999765 35778899999999999999999876 78999
Q ss_pred cCCCCCceEEc---CCCCeEEcccCcccccCCCCcc------cccccccCCCccccccccc----CCCCCccceeehhHH
Q 046586 589 CDIKPENILLG---DDFCPKISDFGLAKLRKKEDMV------SMSRIRGTRGYMAPEWLRS----DQITPKADVYSFGMV 655 (763)
Q Consensus 589 rDlk~~NILl~---~~~~~kI~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~----~~~s~ksDVwS~Gvl 655 (763)
-||||.|||+- .-|.+||.||||++++..+... .++...||.+|++||.+.- .+++.|+||||.||+
T Consensus 594 YDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVI 673 (775)
T KOG1151|consen 594 YDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVI 673 (775)
T ss_pred eccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehh
Confidence 99999999994 4588999999999988765442 3445689999999998853 478899999999999
Q ss_pred HHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC
Q 046586 656 LLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735 (763)
Q Consensus 656 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 735 (763)
+|..+-|+.||...... ..+.+...+..... -.++. .+....+...++.+||++..++|..
T Consensus 674 FyQClYGrKPFGhnqsQ-------------QdILqeNTIlkAtE----VqFP~--KPvVsseAkaFIRRCLaYRKeDR~D 734 (775)
T KOG1151|consen 674 FYQCLYGRKPFGHNQSQ-------------QDILQENTILKATE----VQFPP--KPVVSSEAKAFIRRCLAYRKEDRID 734 (775)
T ss_pred hhhhhccCCCCCCchhH-------------HHHHhhhchhccee----ccCCC--CCccCHHHHHHHHHHHHhhhhhhhh
Confidence 99999999999744321 11111111111111 01111 1344567788999999999999987
Q ss_pred HHHHH
Q 046586 736 MGKVA 740 (763)
Q Consensus 736 ~~eVv 740 (763)
.-++.
T Consensus 735 V~qLA 739 (775)
T KOG1151|consen 735 VQQLA 739 (775)
T ss_pred HHHHc
Confidence 66654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=299.09 Aligned_cols=155 Identities=26% Similarity=0.433 Sum_probs=112.9
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccC-----------------CCCcccc
Q 046586 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK-----------------KEDMVSM 623 (763)
Q Consensus 561 ~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~-----------------~~~~~~~ 623 (763)
....+++..+|+.||+|+|+++ ||||||||.||++|++..|||+|||+|.... .......
T Consensus 696 ~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~ 772 (1351)
T KOG1035|consen 696 RDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDL 772 (1351)
T ss_pred hHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccc
Confidence 4556889999999999999999 9999999999999999999999999998621 0011134
Q ss_pred cccccCCCcccccccccC---CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcc
Q 046586 624 SRIRGTRGYMAPEWLRSD---QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDR 700 (763)
Q Consensus 624 ~~~~gt~~y~APE~l~~~---~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (763)
+..+||.-|+|||.+.+. +|+.|+|+||+||+++||+. ||...- ..... +..+-+.
T Consensus 773 Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-------------ERa~i-----L~~LR~g 831 (1351)
T KOG1035|consen 773 TSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-------------ERASI-----LTNLRKG 831 (1351)
T ss_pred ccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH-------------HHHHH-----HHhcccC
Confidence 557899999999998753 69999999999999999985 343211 00111 1111111
Q ss_pred cccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 701 HIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 701 ~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+... ..+.......-.+++.|+++.||.+|||+.|++.
T Consensus 832 ~iP~~--~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 832 SIPEP--ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred CCCCC--cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11111 1122334445568899999999999999999885
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=264.96 Aligned_cols=220 Identities=21% Similarity=0.182 Sum_probs=175.6
Q ss_pred cccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHhHHhhhc
Q 046586 454 GGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRS 532 (763)
Q Consensus 454 G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~ 532 (763)
|.+|.||+++.. +++.+|+|.++... ++..|...+....||||+++++++.+.+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 889999999775 57889999987543 2344555566667999999999999999999999999999999998542
Q ss_pred CCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcc
Q 046586 533 GRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612 (763)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla 612 (763)
..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++
T Consensus 80 ------------------------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~ 132 (237)
T cd05576 80 ------------------------LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRW 132 (237)
T ss_pred ------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccch
Confidence 24789999999999999999999988 999999999999999999999999988
Q ss_pred cccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhcc
Q 046586 613 KLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEM 692 (763)
Q Consensus 613 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 692 (763)
...... .....++..|+|||.+....++.++||||+|+++|||++|+.|+......
T Consensus 133 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------------- 188 (237)
T cd05576 133 SEVEDS----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------------- 188 (237)
T ss_pred hccccc----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------------------
Confidence 654332 12234567799999998888999999999999999999999876421100
Q ss_pred ChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 693 KVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 693 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
.. .. ....++......+.+++.+|++.||++||++.
T Consensus 189 -~~----~~----~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 189 -IN----TH----TTLNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred -cc----cc----cccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 00 00 00011123456788999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=261.32 Aligned_cols=264 Identities=25% Similarity=0.356 Sum_probs=195.6
Q ss_pred CccccHHHHHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhc-CCCCccccEEEEE
Q 046586 432 PKRFTHAELRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIAR-MHHLNLVRLWGFC 507 (763)
Q Consensus 432 ~~~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~-l~H~niv~l~g~~ 507 (763)
...|+...|+.. ..||.|+||+|+|-.++ .|+..|||+++... ...++++.|+++..+ -+.||||+++|.+
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 445666666543 47999999999998775 58999999998543 345678899987544 4899999999999
Q ss_pred eeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 046586 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVL 587 (763)
Q Consensus 508 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~iv 587 (763)
..++..++-||.|+- ||+.+....- .-....+++...-+|..-+.+||.||...-. ||
T Consensus 133 F~EGdcWiCMELMd~-SlDklYk~vy-------------------~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iI 190 (361)
T KOG1006|consen 133 FSEGDCWICMELMDI-SLDKLYKRVY-------------------SVQKSRIPENILGHITVATVDALDYLKEELK--II 190 (361)
T ss_pred hcCCceeeeHHHHhh-hHHHHHHHHH-------------------HHHhccCcHhhhhheeeeehhHHHHHHHHhh--hh
Confidence 999999999999954 7776653210 0134567788888889999999999987654 99
Q ss_pred ecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc--CCCCCccceeehhHHHHHHHhCCCC
Q 046586 588 HCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS--DQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 588 HrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
|||+||+|||++..|.+||+|||++-.+.. +...+.-.|-..|||||.+.. ..|+.++||||+|++|+|+.||+.|
T Consensus 191 HRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fP 268 (361)
T KOG1006|consen 191 HRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFP 268 (361)
T ss_pred hccCChhheEEecCCCEeeecccchHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCC
Confidence 999999999999999999999999964432 223344567888999999864 3589999999999999999999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
+.. |.. +.++ +..++......-....-..+....++.++..|+.+|...||...++.++
T Consensus 269 yr~--------------w~s--vfeq--l~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 269 YRK--------------WDS--VFEQ--LCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cch--------------HHH--HHHH--HHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 862 211 2221 1111111000000000013456789999999999999999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=281.28 Aligned_cols=238 Identities=25% Similarity=0.322 Sum_probs=191.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..|.+...+|.|+|+.|-.+... .++..++|++.... .+-.+|+.++... +||||+++.+.+.+..+.++|||.+
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 34566678999999999998664 56789999997652 2234677666665 7999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE-c
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-G 599 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl-~ 599 (763)
.++-|.+.+... +... ..+..|+.+|+.++.|||+++ ||||||||+|||+ +
T Consensus 399 ~g~ell~ri~~~------------------------~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~ 450 (612)
T KOG0603|consen 399 DGGELLRRIRSK------------------------PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDG 450 (612)
T ss_pred cccHHHHHHHhc------------------------chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecC
Confidence 999888877432 1223 777889999999999999998 9999999999999 6
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
+.++++|+|||.++..... ..+-+-|..|.|||.+....|++++|+||||++||+|++|+.||......
T Consensus 451 ~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------- 519 (612)
T KOG0603|consen 451 SAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------- 519 (612)
T ss_pred CCCcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------
Confidence 9999999999999876554 22234578899999999999999999999999999999999999743210
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.++..+...+.+. ...+....+++.+||+.||.+||+|.++..
T Consensus 520 ---------------~ei~~~i~~~~~s----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 520 ---------------IEIHTRIQMPKFS----ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---------------HHHHHhhcCCccc----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1222222222222 455678899999999999999999999874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=259.28 Aligned_cols=236 Identities=27% Similarity=0.396 Sum_probs=190.6
Q ss_pred ccceEEEEEeCC-CcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHhHHhhh
Q 046586 455 GFGDVYKGELTD-HRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFR 531 (763)
Q Consensus 455 ~fG~Vy~g~~~~-~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~ 531 (763)
+||.||+|+..+ ++.+++|++...... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998874 889999999754332 57899999999999999999999999999999999999999999999854
Q ss_pred cCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCc
Q 046586 532 SGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL 611 (763)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGl 611 (763)
. ..+++..+..++.+++.+++|||+.+ ++|+||+|+||++++++.++|+|||.
T Consensus 81 ~------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~ 133 (244)
T smart00220 81 R------------------------GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGL 133 (244)
T ss_pred c------------------------cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccc
Confidence 2 12788999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhc
Q 046586 612 AKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEE 691 (763)
Q Consensus 612 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (763)
+....... ......++..|++||.+....++.++||||||++++||++|..|+...... ..
T Consensus 134 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-------------~~---- 194 (244)
T smart00220 134 ARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-------------LE---- 194 (244)
T ss_pred eeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-------------HH----
Confidence 98665432 233456788999999998888999999999999999999999998642110 00
Q ss_pred cChhhhhcccccccCCCcchH-HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 692 MKVEDILDRHIKNSYDSRVHF-DMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 692 ~~~~~~~~~~l~~~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..+.+.. ......... ....++.+++.+|+..+|++||++.++++
T Consensus 195 --~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 195 --LFKKIGK---PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred --HHHHHhc---cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0000110 000000001 14568899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=271.87 Aligned_cols=240 Identities=26% Similarity=0.431 Sum_probs=188.1
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCC
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gs 524 (763)
+.||+|.||+||-|+++ .|+.||||++.+. ..++.++++|+.+|++++||.||.|.-.|+..+..++|||-+ +|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 69999999999999875 6899999999754 345567899999999999999999999999999999999999 557
Q ss_pred HhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC---
Q 046586 525 LADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD--- 601 (763)
Q Consensus 525 L~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~--- 601 (763)
+.+.+... .+..|+...-.-++.||+.||.|||.++ |||+||||+|||+.+.
T Consensus 649 MLEMILSs----------------------EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~F 703 (888)
T KOG4236|consen 649 MLEMILSS----------------------EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPF 703 (888)
T ss_pred HHHHHHHh----------------------hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCC
Confidence 76666443 3446777777778899999999999999 9999999999999654
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
-.+||+|||+|++...... ...++||+.|+|||+++.+.|...-|+||.||++|.-++|..||....+.
T Consensus 704 PQvKlCDFGfARiIgEksF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--------- 772 (888)
T KOG4236|consen 704 PQVKLCDFGFARIIGEKSF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--------- 772 (888)
T ss_pred Cceeeccccceeecchhhh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch---------
Confidence 4689999999998875443 23478999999999999999999999999999999999999999743211
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eV 739 (763)
.++....+++- +...-.+.....++++...||..=.+|-|...-
T Consensus 773 -------ndQIQNAaFMy-------Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 773 -------NDQIQNAAFMY-------PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred -------hHHhhcccccc-------CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 01100111111 111113455566677777777777777665544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=281.30 Aligned_cols=282 Identities=21% Similarity=0.176 Sum_probs=182.9
Q ss_pred HhccccccccccccceEEEEEe-----------------CCCcEEEEEEeeccCCc-h--------------hhhHHHHH
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-----------------TDHRVVAVKCLKNVTGG-D--------------AEFWAEVT 490 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-----------------~~~~~VAvK~l~~~~~~-~--------------~~f~~E~~ 490 (763)
..+.+.++||+|+||.||+|.. ..++.||||+++...+. . +.+..|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 3456678999999999999964 23467999998743321 1 22345777
Q ss_pred HHhcCCCCcc-----ccEEEEEee--------CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCC
Q 046586 491 IIARMHHLNL-----VRLWGFCAE--------KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557 (763)
Q Consensus 491 ~l~~l~H~ni-----v~l~g~~~~--------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 557 (763)
++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+.............+.............
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7788876654 678888764 356899999999999999997532111111111110000000111234
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccc
Q 046586 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEW 637 (763)
Q Consensus 558 ~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~ 637 (763)
.++|..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..............+++.|+|||.
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 5788999999999999999999988 9999999999999999999999999997544322222222234789999998
Q ss_pred cccCCC----------------------CCccceeehhHHHHHHHhCCC-CcccccCCCC---CCCCchhHHHHHHHHhc
Q 046586 638 LRSDQI----------------------TPKADVYSFGMVLLEIVSGSR-NFEIQGSMMN---SDEWYFPKWAFEKVYEE 691 (763)
Q Consensus 638 l~~~~~----------------------s~ksDVwS~Gvll~elltG~~-p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 691 (763)
+..... ..+.||||+||+++||++|.. |+........ ........|.
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r------- 454 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR------- 454 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-------
Confidence 754321 234799999999999999875 6542211000 0000001110
Q ss_pred cChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 046586 692 MKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRP---ELRPSMGKVAKM 742 (763)
Q Consensus 692 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~eVv~~ 742 (763)
.......+........+...+++..++..+| .+|+|++|+++.
T Consensus 455 --------~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 455 --------MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --------hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0000111111112345677888888998766 689999999853
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=253.51 Aligned_cols=258 Identities=20% Similarity=0.259 Sum_probs=197.7
Q ss_pred cccc-ccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEee----CCeeeEEE
Q 046586 445 NGFS-NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAE----KGERTLVY 517 (763)
Q Consensus 445 ~~~~-~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~LV~ 517 (763)
|.++ ++||-|-.|.|-....+ .++.+|+|+|.+. ...++|+++.-.. .|||||.+++++.. ...+.+||
T Consensus 63 Y~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 63 YSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred heehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 3443 68999999999998664 6788999998753 3456888886665 69999999998864 34677899
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
|.|+||.|.+.++.. ....++..++-.|..||+.|+.|||+.+ |.||||||+|+|
T Consensus 139 E~meGGeLfsriq~~----------------------g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLL 193 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDR----------------------GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLL 193 (400)
T ss_pred ecccchHHHHHHHHc----------------------ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhhee
Confidence 999999999999765 3567899999999999999999999998 999999999999
Q ss_pred Ec---CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LG---DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~---~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
.. .|-.+||+|||+|+..... ....+-+-|+.|.|||++...+|+...|+||+||++|-|++|.+||-......
T Consensus 194 yt~t~~na~lKLtDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a- 270 (400)
T KOG0604|consen 194 YTTTSPNAPLKLTDFGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA- 270 (400)
T ss_pred eecCCCCcceEecccccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-
Confidence 96 4667999999999865432 23445677999999999999999999999999999999999999996443211
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccCCCCC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGTVEIT 750 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~~~~~ 750 (763)
+..+++ ..+.... -.++.+--.+.++...+++..+|+.+|++|.|+.+++. .+.+...+|
T Consensus 271 -------------ispgMk-~rI~~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 271 -------------ISPGMK-RRIRTGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred -------------CChhHH-hHhhccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 011110 0010000 11121112456777889999999999999999999985 344433343
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=294.11 Aligned_cols=252 Identities=25% Similarity=0.305 Sum_probs=198.8
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
.+..+.+.+.||+|+||.|..++.. .++.+|.|++.+. .....-|+.|-.+|..-+.+-|+.|.-.|.++.++||
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3556677889999999999999886 5788999999762 3344568899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
|||||+||+|...+.+. ..++..-+.-++..|..||.-||+.| +|||||||+|
T Consensus 153 VMdY~pGGDlltLlSk~------------------------~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDN 205 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKF------------------------DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDN 205 (1317)
T ss_pred EEecccCchHHHHHhhc------------------------CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcce
Confidence 99999999999999643 25777777777888999999999999 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc----c-CCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR----S-DQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~----~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
||||..|++||+|||.+-.+..++.-.....+|||.|++||++. + +.|+..+|.||+||++|||+.|..||....
T Consensus 206 vLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 206 VLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred eEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 99999999999999999877766666666678999999999985 3 689999999999999999999999996321
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS---MGKVAK 741 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~eVv~ 741 (763)
- .+. ...+++- ...+..+...+.++...+++...+. +|+.|-. +.++-.
T Consensus 286 l-------------veT------Y~KIm~h--k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 286 L-------------VET------YGKIMNH--KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred H-------------HHH------HHHHhch--hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1 011 1111111 0111111113355666777776665 7888877 777764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-31 Score=256.75 Aligned_cols=264 Identities=23% Similarity=0.329 Sum_probs=191.0
Q ss_pred cccccccccceEEEEEeCC-CcEEEEEEee--c-cCCchhhhHHHHHHHhcCCCCccccEEEEEeeC--------CeeeE
Q 046586 448 SNLIGRGGFGDVYKGELTD-HRVVAVKCLK--N-VTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK--------GERTL 515 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~--~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~~~~L 515 (763)
..+||+|.||.||+++..+ ++.||+|+.- . ...-....++|+.+|..|+|+|++.++..|... ...+|
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 4589999999999998764 6778887653 1 122234568999999999999999999888642 35899
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
|+++++. +|...|.+ ....++..++.++..++..||.|+|... |+|||+|+.|
T Consensus 102 Vf~~ceh-DLaGlLsn-----------------------~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaN 154 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSN-----------------------RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAAN 154 (376)
T ss_pred eHHHhhh-hHHHHhcC-----------------------ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhh
Confidence 9999977 88888854 2356888999999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc---ccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
+||+.++.+||+|||+++.+...+. ...+..+.|..|++||.+.+ ..|+++.|||+-||++.||.++.+-+++..+
T Consensus 155 vLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 155 VLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred EEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 9999999999999999986654333 23344567999999998765 6899999999999999999999988865433
Q ss_pred CCCC----------CCCchhHHHHHHHHhccChhhhhccc---ccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 046586 672 MMNS----------DEWYFPKWAFEKVYEEMKVEDILDRH---IKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGK 738 (763)
Q Consensus 672 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 738 (763)
..+. ....+|....-.+++....+.+.... +..... +.-...+..+++..++..||.+||++++
T Consensus 235 qqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~k---p~~kd~~a~dLle~ll~~DP~kR~~ad~ 311 (376)
T KOG0669|consen 235 QQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLK---PYVKDDEALDLLEKLLKLDPTKRIDADQ 311 (376)
T ss_pred HHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcc---cccCChhHHHHHHHHhccCcccCcchHh
Confidence 2210 01111111111222222111111100 000000 0112346778889999999999999998
Q ss_pred HHH
Q 046586 739 VAK 741 (763)
Q Consensus 739 Vv~ 741 (763)
++.
T Consensus 312 aln 314 (376)
T KOG0669|consen 312 ALN 314 (376)
T ss_pred hhc
Confidence 874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=259.96 Aligned_cols=281 Identities=21% Similarity=0.307 Sum_probs=208.3
Q ss_pred CCccccHHHHHHHhccccccccccccceEEEEEeCC-CcEEEEEEeeccCCchhhhHHHHHHHhcCCC--C----ccccE
Q 046586 431 GPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARMHH--L----NLVRL 503 (763)
Q Consensus 431 ~~~~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H--~----niv~l 503 (763)
|.-.+...+....+|.+..+||+|.||.|-...... +..||||+++....-.+..+-|+++++++.+ | -+|.+
T Consensus 77 GH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 77 GHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred ceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 334567777778889999999999999999986653 6889999999877666777889999999932 2 36778
Q ss_pred EEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 046586 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECL 583 (763)
Q Consensus 504 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~ 583 (763)
.++|.-.++.++|+|.| |-|+.++|... +-..++..+...|+.|+++++++||+..
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N----------------------~y~~fpi~~ir~m~~QL~~sv~fLh~~k- 212 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKEN----------------------NYIPFPIDHIRHMGYQLLESVAFLHDLK- 212 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccC----------------------CccccchHHHHHHHHHHHHHHHHHHhcc-
Confidence 88899999999999998 55999999654 3456788999999999999999999988
Q ss_pred CcEEecCCCCCceEEcC--------------------CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCC
Q 046586 584 EWVLHCDIKPENILLGD--------------------DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI 643 (763)
Q Consensus 584 ~~ivHrDlk~~NILl~~--------------------~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 643 (763)
++|-||||+|||+-+ +..+||+|||.|..-.... +.++.|..|+|||++.+-.+
T Consensus 213 --l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGw 286 (415)
T KOG0671|consen 213 --LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGW 286 (415)
T ss_pred --eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCc
Confidence 999999999999932 3468999999998654333 45677899999999999999
Q ss_pred CCccceeehhHHHHHHHhCCCCcccccCCC-----CCCCCchhHHHHHHH-----HhccChh--hh-hcccccccCCCc-
Q 046586 644 TPKADVYSFGMVLLEIVSGSRNFEIQGSMM-----NSDEWYFPKWAFEKV-----YEEMKVE--DI-LDRHIKNSYDSR- 709 (763)
Q Consensus 644 s~ksDVwS~Gvll~elltG~~p~~~~~~~~-----~~~~~~~~~~~~~~~-----~~~~~~~--~~-~~~~l~~~~~~~- 709 (763)
+.++||||+||+|.|+.+|..-|...+..+ +..-..+|....... ....+++ +. ..+.+....+..
T Consensus 287 S~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ck 366 (415)
T KOG0671|consen 287 SQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCK 366 (415)
T ss_pred CCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCc
Confidence 999999999999999999999886544211 000011111111111 0000000 00 000000000000
Q ss_pred -------chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 710 -------VHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 710 -------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
....+..++.+|+..||.+||.+|+|++|++.
T Consensus 367 pl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 367 PLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred cHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 11356678999999999999999999999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=274.61 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=204.3
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEee-----CCeeeEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAE-----KGERTLV 516 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~-----~~~~~LV 516 (763)
+..|.+.||.|.+|.||+++.. +++.+|+|++.......++...|.++++.. +|||++.++|++.. ++.++||
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 4567789999999999999764 688999999998888888889999999988 79999999999875 4689999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
||||.+||..+.+... ....+.|.....|+..++.|+++||... ++|||||-.||
T Consensus 100 MEfC~gGSVTDLVKn~----------------------~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~Ni 154 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNT----------------------KGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNV 154 (953)
T ss_pred eeccCCccHHHHHhhh----------------------cccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceE
Confidence 9999999999999654 2456889999999999999999999987 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-----CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-----DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
|++.++.+|+.|||.+..+... .....+..||+.|||||++.. ..|+..+|+||+|++..||--|.+|+-...+
T Consensus 155 LLT~e~~VKLvDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 155 LLTENAEVKLVDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred EEeccCcEEEeeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 9999999999999999754322 223445789999999999863 3677899999999999999999999854322
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. ..++.-.-.+......+..-.+++.+++..||.+|-++||++.++++
T Consensus 234 m----------------------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 234 M----------------------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred h----------------------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1 11111101111112223667889999999999999999999998875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=281.78 Aligned_cols=279 Identities=17% Similarity=0.134 Sum_probs=169.8
Q ss_pred HhccccccccccccceEEEEEeCC-----CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEE------EeeCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD-----HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF------CAEKG 511 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~-----~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~------~~~~~ 511 (763)
..+.+.++||+|+||.||+|++.+ +..||+|.++..... +.+..| .+....+.+++.++.. +.+..
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 356677899999999999998854 578999987643221 111111 1222223333222221 24566
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
..+|||||+++++|.+++........ ...... ................+..++.|++.||+|||+.+ |+||||
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~--v~~~l~--~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYN--VEPYLL--GKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchh--HHHHhc--cchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 89999999999999999865321000 000000 00000001112234456689999999999999988 999999
Q ss_pred CCCceEEcC-CCCeEEcccCcccccCCCCcccccccccCCCcccccccccC----------------------CCCCccc
Q 046586 592 KPENILLGD-DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD----------------------QITPKAD 648 (763)
Q Consensus 592 k~~NILl~~-~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------------------~~s~ksD 648 (763)
||+|||+++ ++.+||+|||+++..............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 68999999999986544333344556789999999965322 2445679
Q ss_pred eeehhHHHHHHHhCCCCcccccCC----CCCCCCchhHHHHHHHHhccChhhhhcccccccCCC--cchHHHHHHHHHHH
Q 046586 649 VYSFGMVLLEIVSGSRNFEIQGSM----MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDS--RVHFDMVNRMVKTA 722 (763)
Q Consensus 649 VwS~Gvll~elltG~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~l~~l~ 722 (763)
||||||+||||+++..+.+..... .......+..|.. .+.+........ ...........+|+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRK-----------LVEPRASPDLRRGFEVLDLDGGAGWELL 430 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHH-----------hhccccchhhhhhhhhccccchHHHHHH
Confidence 999999999999976654321000 0000011111110 001100000000 00001123456899
Q ss_pred HHccCCCCCCCCCHHHHHHH
Q 046586 723 MWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 723 ~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.+||+.||++|||+.++++.
T Consensus 431 ~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHccCCcccCCCHHHHhCC
Confidence 99999999999999999964
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=258.52 Aligned_cols=290 Identities=23% Similarity=0.265 Sum_probs=216.2
Q ss_pred hcCccccCCCCCccccHHHHHH-HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcCC--
Q 046586 421 TLGLELLPAGGPKRFTHAELRA-ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-- 496 (763)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~el~~-~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-- 496 (763)
.++......++.+.+...|+.. ++|.+.++||-|-|++||++.. ++.+.||+|+.|....-.+..+.|+++|++++
T Consensus 55 qE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 55 QEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG 134 (590)
T ss_pred ccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence 3444556678889999999888 8999999999999999999965 46789999999976665667789999999983
Q ss_pred ---C---CccccEEEEEeeC----CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHH
Q 046586 497 ---H---LNLVRLWGFCAEK----GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566 (763)
Q Consensus 497 ---H---~niv~l~g~~~~~----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 566 (763)
| ..||+|+++|... .+.+||+|++ |-+|..++.... -..++...+.+
T Consensus 135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~----------------------YrGlpl~~VK~ 191 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN----------------------YRGLPLSCVKE 191 (590)
T ss_pred CCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC----------------------CCCCcHHHHHH
Confidence 2 3699999999864 4899999999 669999997653 34578899999
Q ss_pred HHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC-----------C---------------------------------
Q 046586 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDD-----------F--------------------------------- 602 (763)
Q Consensus 567 ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~-----------~--------------------------------- 602 (763)
|+.||+.||.|||.++. |||-||||+|||+..+ +
T Consensus 192 I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~ 269 (590)
T KOG1290|consen 192 ICRQVLTGLDYLHRECG--IIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSK 269 (590)
T ss_pred HHHHHHHHHHHHHHhcC--ccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhh
Confidence 99999999999999985 9999999999999210 0
Q ss_pred --------------------------------------------------------------------------------
Q 046586 603 -------------------------------------------------------------------------------- 602 (763)
Q Consensus 603 -------------------------------------------------------------------------------- 602 (763)
T Consensus 270 ~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl 349 (590)
T KOG1290|consen 270 FKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSL 349 (590)
T ss_pred HHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccc
Confidence
Q ss_pred ------------------------------------------CeEEcccCcccccCCCCcccccccccCCCccccccccc
Q 046586 603 ------------------------------------------CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS 640 (763)
Q Consensus 603 ------------------------------------------~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~ 640 (763)
++||+|||-|...... .+.-..|..|+|||++.+
T Consensus 350 ~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllG 425 (590)
T KOG1290|consen 350 PESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLG 425 (590)
T ss_pred cchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeec
Confidence 0233333333322211 112235778999999999
Q ss_pred CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHH--------HHhccChhhhhcccc----------
Q 046586 641 DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEK--------VYEEMKVEDILDRHI---------- 702 (763)
Q Consensus 641 ~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l---------- 702 (763)
..|+..+||||++|++|||+||...|+......-..+........+. ...|....++++++-
T Consensus 426 sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~ 505 (590)
T KOG1290|consen 426 SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKP 505 (590)
T ss_pred CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCC
Confidence 99999999999999999999999999765433322222222222221 122222334444321
Q ss_pred -------cccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 703 -------KNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 703 -------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+.+ .++.++..++.+++.-||+.+|++|||+.+.++
T Consensus 506 WpL~~VL~eKY--~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 506 WPLYEVLIEKY--EWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred CcHHHHHHHHh--CCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 1111 245788899999999999999999999999884
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=230.02 Aligned_cols=192 Identities=28% Similarity=0.400 Sum_probs=162.1
Q ss_pred cccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 448 SNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
.++||+|.||+|++|+.. .++.||+|+++-... -....++|+-+++.++|+|||+++++...+..+-||+||+..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 468999999999999875 478899999973322 235678999999999999999999999999999999999955
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|..|.... ...++......++.|+.+||.+.|++. +.|||+||.|.||+.||+
T Consensus 86 dlkkyfdsl-----------------------ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~nge 139 (292)
T KOG0662|consen 86 DLKKYFDSL-----------------------NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGE 139 (292)
T ss_pred HHHHHHHhc-----------------------CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCc
Confidence 888877432 235778888999999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHh-CCCCcc
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVS-GSRNFE 667 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~ellt-G~~p~~ 667 (763)
.|++|||+++.++-.- ...+..+.|..|++|.++.+ .-|+...|+||-||++.|+.. |++.|.
T Consensus 140 lkladfglarafgipv-rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 140 LKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred EEecccchhhhcCCce-EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 9999999999766442 23344567899999999887 468999999999999999987 555454
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-29 Score=275.65 Aligned_cols=241 Identities=27% Similarity=0.332 Sum_probs=181.2
Q ss_pred ccccccccce-EEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 449 NLIGRGGFGD-VYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 449 ~~LG~G~fG~-Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
+.+|.|+.|+ ||+|.+. ++.||||++-... ..-..+|+..|+.- +|||||++++.-.+....|+..|.|.. +|.
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~ 590 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQ 590 (903)
T ss_pred HHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHH
Confidence 5899999975 6999985 4789999885322 12346899998888 699999999999999999999999955 999
Q ss_pred HHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC-----C
Q 046586 527 DYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD-----D 601 (763)
Q Consensus 527 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~-----~ 601 (763)
+++..... ......-...+.+..|++.||++||+.+ ||||||||.||||+. .
T Consensus 591 dlie~~~~--------------------d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~ 647 (903)
T KOG1027|consen 591 DLIESSGL--------------------DVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGT 647 (903)
T ss_pred HHHhcccc--------------------chhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcc
Confidence 99965310 0001111345678899999999999988 999999999999975 3
Q ss_pred CCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhC-CCCcccccCCCCCCCC
Q 046586 602 FCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG-SRNFEIQGSMMNSDEW 678 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG-~~p~~~~~~~~~~~~~ 678 (763)
.+++|+|||+++.+..... .......||-||+|||.+....-+.++||||+||++|+.++| .+||...-..+
T Consensus 648 ~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----- 722 (903)
T KOG1027|consen 648 LRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----- 722 (903)
T ss_pred eeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-----
Confidence 5799999999987655433 234557799999999999998888999999999999999985 88996432110
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
.++..+.. .+ . .+. .+...+..+++.+|++++|..||++.+|+
T Consensus 723 -------~NIl~~~~--~L-~-~L~--------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 723 -------ANILTGNY--TL-V-HLE--------PLPDCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -------hhhhcCcc--ce-e-eec--------cCchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 11111110 00 0 000 11111788999999999999999999997
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=246.92 Aligned_cols=267 Identities=23% Similarity=0.303 Sum_probs=196.9
Q ss_pred cccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCC-----eeeEEEe
Q 046586 448 SNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG-----ERTLVYE 518 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~LV~E 518 (763)
.+-||.|+||.||....+ +|+.||.|.+.+.-+ ..+.+.+|+++|+-.+|.|++..+++-.-.. ++|+|.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 467999999999998764 789999998875433 3467889999999999999999988776543 5778899
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
.|.. +|++.+.. ...++-....-+..||++||.|||+.+ |.||||||.|.|+
T Consensus 138 LmQS-DLHKIIVS------------------------PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLV 189 (449)
T KOG0664|consen 138 LMQS-DLHKIIVS------------------------PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLV 189 (449)
T ss_pred HHHh-hhhheecc------------------------CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEe
Confidence 8865 78887753 235666667778999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC-
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD- 676 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~- 676 (763)
+.|...||+|||+++..+.++...++..+.|-.|+|||.+++ ..|+.+.||||.||++.||+..+..|+...+.++-+
T Consensus 190 NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l 269 (449)
T KOG0664|consen 190 NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM 269 (449)
T ss_pred ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH
Confidence 999999999999999988888888888888999999999887 589999999999999999999888886544322100
Q ss_pred ----CCchhHHHHHHHHhccChhhhhcccccc-cCC----CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 677 ----EWYFPKWAFEKVYEEMKVEDILDRHIKN-SYD----SRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 677 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
-......+.+..-|+.+ ..++....+. ... ..-+...-.+.+.+...++..||++|.+..+.+..+
T Consensus 270 ItdLLGTPs~EaMr~ACEGAk-~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 270 IIDLLGTPSQEAMKYACEGAK-NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHhCCCcHHHHHHHhhhhH-HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00000111122222221 1122221111 100 000112233456777888999999999988887665
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=242.13 Aligned_cols=245 Identities=23% Similarity=0.337 Sum_probs=192.8
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEe
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..+..+||+|+|+.|..+++. ..+.+|+|++|+.- ....-...|-.+.... +||.+|.|..+|.....+++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 445679999999999999886 46789999998532 2223355677777776 79999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|--++++. ..|+...+.-+..+|..||.|||+.+ ||.||||.+|||+
T Consensus 332 yv~ggdlmfhmqrq------------------------rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvll 384 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQ------------------------RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLL 384 (593)
T ss_pred EecCcceeeehhhh------------------------hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEE
Confidence 99999998877643 35677777778889999999999999 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
|..|++|+.|+|+++.--.+. ..++++.||+.|+|||.+++..|...+|.|++||+++||+.|+.||+..+.... +.
T Consensus 385 daeghikltdygmcke~l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~--d~ 461 (593)
T KOG0695|consen 385 DAEGHIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP--DM 461 (593)
T ss_pred ccCCceeecccchhhcCCCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCc--cc
Confidence 999999999999998643332 245678999999999999999999999999999999999999999986553221 11
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 734 (763)
+-.++.. +-++.+.+ ++|...+.+...++..-+++||.+|.
T Consensus 462 ntedylf---------qvilekqi------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 462 NTEDYLF---------QVILEKQI------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred chhHHHH---------HHHhhhcc------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 1111111 11222222 12345566777888889999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=228.81 Aligned_cols=195 Identities=26% Similarity=0.403 Sum_probs=161.6
Q ss_pred cccccccccceEEEEEe-CCCcEEEEEEeecc--CCchhhhHHHHHHHhc-CCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 448 SNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNV--TGGDAEFWAEVTIIAR-MHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~--~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
...||+|++|.|-+-++ ++|+..|+|+++.. .+..++.++|+.+..+ ...|.+|.++|........++.||.|+.
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 45799999999988866 47899999999854 3344567888887554 4899999999999999999999999965
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
||+.+-...-+ ....+++...-+||..+..||.|||++-. |||||+||+|||++.+|+
T Consensus 130 Sldkfy~~v~~--------------------~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~Gq 187 (282)
T KOG0984|consen 130 SLDKFYRKVLK--------------------KGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQ 187 (282)
T ss_pred hHHHHHHHHHh--------------------cCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCc
Confidence 88887654211 45578888889999999999999999764 999999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCccccccccc----CCCCCccceeehhHHHHHHHhCCCCcc
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS----DQITPKADVYSFGMVLLEIVSGSRNFE 667 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~s~ksDVwS~Gvll~elltG~~p~~ 667 (763)
+||+|||++-++.+.- ..+...|-..|||||.+.. ..|+.|+||||+|+.+.||.+++.||+
T Consensus 188 VKiCDFGIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 188 VKICDFGISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred EEEcccccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 9999999997654321 2222457778999998853 479999999999999999999999996
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=229.41 Aligned_cols=210 Identities=35% Similarity=0.568 Sum_probs=182.4
Q ss_pred ccccccceEEEEEeCC-CcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHhH
Q 046586 451 IGRGGFGDVYKGELTD-HRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLAD 527 (763)
Q Consensus 451 LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~ 527 (763)
||+|.+|.||++...+ ++.+++|++...... ...+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998875 788999999865442 5678999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC-CCCeEE
Q 046586 528 YLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD-DFCPKI 606 (763)
Q Consensus 528 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~kI 606 (763)
++... ...+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|
T Consensus 81 ~~~~~-----------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l 134 (215)
T cd00180 81 LLKEN-----------------------EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKL 134 (215)
T ss_pred HHHhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEE
Confidence 98542 135788999999999999999999998 999999999999999 899999
Q ss_pred cccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHH
Q 046586 607 SDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685 (763)
Q Consensus 607 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 685 (763)
+|||.+........ ......+...|++||.+... .++.+.|+|++|+++++|
T Consensus 135 ~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------- 187 (215)
T cd00180 135 ADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------- 187 (215)
T ss_pred ecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------
Confidence 99999986544321 12234567889999998877 888999999999999998
Q ss_pred HHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 686 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 ------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4677888999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-28 Score=258.45 Aligned_cols=236 Identities=24% Similarity=0.329 Sum_probs=191.3
Q ss_pred cccccccccceEEEEEeCCCc-EEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 448 SNLIGRGGFGDVYKGELTDHR-VVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~-~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
...||-|+||.|=+.+..... ..|+|++++.. ...+....|-.+|...+.|.||+|+-.+.+....|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 347999999999999887544 38889887532 2334467899999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|.|...|..+. .++..+..-++..+.+|++|||+++ ||+|||||+|.++|.+|
T Consensus 505 GElWTiLrdRg------------------------~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~G 557 (732)
T KOG0614|consen 505 GELWTILRDRG------------------------SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRG 557 (732)
T ss_pred chhhhhhhhcC------------------------CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCC
Confidence 99999996543 4555566667888999999999999 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhH
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~ 682 (763)
-+||.|||+|+...... .+-+++||+.|.|||.+.+...+.++|.||+|+++|||++|.+||...++..
T Consensus 558 y~KLVDFGFAKki~~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk--------- 626 (732)
T KOG0614|consen 558 YLKLVDFGFAKKIGSGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK--------- 626 (732)
T ss_pred ceEEeehhhHHHhccCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---------
Confidence 99999999999776543 4557899999999999999999999999999999999999999998665321
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 735 (763)
....+..+. |. ..+|........+++++..+.+|.+|.-
T Consensus 627 -tYn~ILkGi------d~-------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 627 -TYNLILKGI------DK-------IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -HHHHHHhhh------hh-------hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 112222221 11 1122344566778888889999999976
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=247.09 Aligned_cols=209 Identities=29% Similarity=0.420 Sum_probs=169.4
Q ss_pred cHHHHHHHhcc---c--cccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEE
Q 046586 436 THAELRAATNG---F--SNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWG 505 (763)
Q Consensus 436 ~~~el~~~t~~---~--~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g 505 (763)
.|..|+++... | .+.||-|+||.|.+++-. ....+|.|.|++. .......++|-.||+....+-||+|+-
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 44455555432 2 357999999999999554 4567899988643 223345778999999999999999999
Q ss_pred EEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 046586 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEW 585 (763)
Q Consensus 506 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ 585 (763)
.|.+.+.+|+||||++||++-.+|.+.. .+.+..+.-++.+++.|+++.|..|
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrmg------------------------IFeE~LARFYIAEltcAiesVHkmG--- 749 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRMG------------------------IFEEDLARFYIAELTCAIESVHKMG--- 749 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHhc------------------------cCHHHHHHHHHHHHHHHHHHHHhcc---
Confidence 9999999999999999999999997543 5666666677778999999999999
Q ss_pred EEecCCCCCceEEcCCCCeEEcccCcccccC---------CCCcc--------------------------------ccc
Q 046586 586 VLHCDIKPENILLGDDFCPKISDFGLAKLRK---------KEDMV--------------------------------SMS 624 (763)
Q Consensus 586 ivHrDlk~~NILl~~~~~~kI~DFGla~~~~---------~~~~~--------------------------------~~~ 624 (763)
.|||||||+|||||.+|++||.||||+.-+. ..+.. ...
T Consensus 750 FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ah 829 (1034)
T KOG0608|consen 750 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAH 829 (1034)
T ss_pred ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhh
Confidence 9999999999999999999999999985221 00000 001
Q ss_pred ccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 625 ~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
..+||+.|+|||++....|+...|.||.||+||||+.|+.||.....
T Consensus 830 slvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 830 SLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTP 876 (1034)
T ss_pred hhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCC
Confidence 14699999999999999999999999999999999999999976544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=246.25 Aligned_cols=193 Identities=25% Similarity=0.332 Sum_probs=164.0
Q ss_pred ccccccccccccceEEEEEeCC-CcEEEEEEeeccCCchh---------hhHHHHHHHhcCC---CCccccEEEEEeeCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDA---------EFWAEVTIIARMH---HLNLVRLWGFCAEKG 511 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~---------~f~~E~~~l~~l~---H~niv~l~g~~~~~~ 511 (763)
|...+.||+|+||.|+.+.++. ...|+||.+.+.+--.. ..-.|+.+|..++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 4445789999999999998864 56789998875432211 2446999999997 999999999999999
Q ss_pred eeeEEEecC-CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 512 ERTLVYEYV-PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 512 ~~~LV~Ey~-~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
..||++|-. ++-+|.+++.. ++.+++.+...|..|++.|+++||+++ |||||
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~------------------------kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrd 695 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEF------------------------KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRD 695 (772)
T ss_pred eeEEEecCCCCCcchhhhhhc------------------------cCccchHHHHHHHHHHHhccccccccC---ceecc
Confidence 999999987 45689999853 456888899999999999999999999 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCC-ccceeehhHHHHHHHhCCCCcc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITP-KADVYSFGMVLLEIVSGSRNFE 667 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~-ksDVwS~Gvll~elltG~~p~~ 667 (763)
||-+||.++.+|-+||+|||.+.+.... ....++||.+|.|||++.+.+|-- .-|||++|++||-++-...||-
T Consensus 696 ikdenvivd~~g~~klidfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 696 IKDENVIVDSNGFVKLIDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cccccEEEecCCeEEEeeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999999999999999876543 234578999999999999987764 5899999999999998888873
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=225.17 Aligned_cols=197 Identities=34% Similarity=0.547 Sum_probs=169.9
Q ss_pred cccccccccccceEEEEEeCC-CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 446 GFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
.+.+.||+|++|.||++...+ ++.+++|.+..... ....+.+|++.+++++|+|++++++++......++++||+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 456789999999999998875 78899999975443 356788999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++.... ..+++.....++.+++.++.+||+.+ ++|+||+++||+++.++
T Consensus 82 ~~L~~~~~~~~-----------------------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~ 135 (225)
T smart00221 82 GDLFDYLRKKG-----------------------GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDG 135 (225)
T ss_pred CCHHHHHHhcc-----------------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 99999986431 11788999999999999999999987 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCccccccc-ccCCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
.++|+|||++...............++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 136 LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999999999986654321122335677889999998 677888899999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=242.91 Aligned_cols=212 Identities=25% Similarity=0.322 Sum_probs=180.9
Q ss_pred CCCccccHHHHHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCC------CCcccc
Q 046586 430 GGPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMH------HLNLVR 502 (763)
Q Consensus 430 ~~~~~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~------H~niv~ 502 (763)
.+.-++.+.|+....|.+.-..|+|-|++|-.|... .|+.||||++.+.+--.+.=++|+++|++|+ .-+.++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 345678889999999999999999999999999776 3679999999876544444568999999995 347899
Q ss_pred EEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 046586 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEEC 582 (763)
Q Consensus 503 l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~ 582 (763)
|+-.|...++++||+|-+ ..+|.+.|...+ ....|....+..++.|+..||..|-..+
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG---------------------~nvGL~ikaVRsYaqQLflALklLK~c~ 556 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYG---------------------RNVGLHIKAVRSYAQQLFLALKLLKKCG 556 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhC---------------------cccceeehHHHHHHHHHHHHHHHHHhcC
Confidence 999999999999999988 459999998764 4456788889999999999999999988
Q ss_pred CCcEEecCCCCCceEEcCC-CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh
Q 046586 583 LEWVLHCDIKPENILLGDD-FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661 (763)
Q Consensus 583 ~~~ivHrDlk~~NILl~~~-~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt 661 (763)
|+|.||||+|||+++. ..+||+|||.|....... .+.+..+..|.|||.+.+-+|+...|+||.||.||||.|
T Consensus 557 ---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYt 630 (752)
T KOG0670|consen 557 ---VLHADIKPDNILVNESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYT 630 (752)
T ss_pred ---eeecccCccceEeccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeec
Confidence 9999999999999875 568999999998665443 334445667999999999999999999999999999999
Q ss_pred CCCCcccc
Q 046586 662 GSRNFEIQ 669 (763)
Q Consensus 662 G~~p~~~~ 669 (763)
|+..|.+.
T Consensus 631 GkIlFpG~ 638 (752)
T KOG0670|consen 631 GKILFPGR 638 (752)
T ss_pred cceecCCC
Confidence 99988643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=220.02 Aligned_cols=264 Identities=19% Similarity=0.281 Sum_probs=188.5
Q ss_pred hccccccccccccceEEEEE-eCCCcEEEEEEeeccCCchhhhHHHHHHHhcCC-CCccccEEEEEeeCC--eeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKG--ERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~-~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~LV~Ey 519 (763)
.|++.+++|+|.++.|+.|. ..+.+.++||+++... .+...+|+.+|..|. ||||++|+++..+.. ...||+||
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 45667899999999999995 4567889999998654 356789999999996 999999999998754 56799999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+.+.+..... ++++-......+.++++||.|+|+.| |+|||+||.|++||
T Consensus 117 v~n~Dfk~ly---------------------------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmId 166 (338)
T KOG0668|consen 117 VNNTDFKQLY---------------------------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMID 166 (338)
T ss_pred hccccHHHHh---------------------------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeec
Confidence 9998776654 35677788889999999999999999 99999999999998
Q ss_pred C-CCCeEEcccCcccccCCCCcccccccccCCCcccccccc-cCCCCCccceeehhHHHHHHHhCCCCcccccC-CCC--
Q 046586 600 D-DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSGSRNFEIQGS-MMN-- 674 (763)
Q Consensus 600 ~-~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~-~~~-- 674 (763)
. .-.++|+|+|+|.+........ -.+.+.-|..||.+- ...|+.+-|+|||||++.+|+..+.||-.... ..+
T Consensus 167 h~~rkLrlIDWGLAEFYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV 244 (338)
T KOG0668|consen 167 HELRKLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 244 (338)
T ss_pred hhhceeeeeecchHhhcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH
Confidence 5 4579999999998765443322 123455678899875 46789999999999999999999999842211 000
Q ss_pred -----CCCCchhHHHHHH-HHhccChhhhhcccccccCCCcchH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 -----SDEWYFPKWAFEK-VYEEMKVEDILDRHIKNSYDSRVHF----DMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 -----~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~~~----~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
-....+....... +.-.....+++.+..+..+....+. -...+.++++...|..|-.+|||++|.+.
T Consensus 245 kIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 245 KIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0000000000000 0000112223333222222111111 12367889999999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-25 Score=221.18 Aligned_cols=271 Identities=22% Similarity=0.248 Sum_probs=188.0
Q ss_pred cccccccceEEEEEe-CCCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeC------CeeeEEEec
Q 046586 450 LIGRGGFGDVYKGEL-TDHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK------GERTLVYEY 519 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~LV~Ey 519 (763)
.+|.|.- .|-.+.. -.++.||+|.+... ....+...+|..++..++|+||++++.++.-. .+.|+|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4566665 4444422 24678999887532 23345677899999999999999999998743 367899999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
|.. +|...+.. .++-.+...|..|++.|+.|||+.+ |+||||||+||++.
T Consensus 103 m~~-nl~~vi~~--------------------------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~ 152 (369)
T KOG0665|consen 103 MDA-NLCQVILM--------------------------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVN 152 (369)
T ss_pred hhh-HHHHHHHH--------------------------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceec
Confidence 954 88888752 2556677899999999999999999 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC-----
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN----- 674 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~----- 674 (763)
.+..+||.|||+|+..... ..++..+.|..|.|||.+.+-.+.+++||||.||++.||++|+.-|.+.+...+
T Consensus 153 ~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~ 230 (369)
T KOG0665|consen 153 SDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKII 230 (369)
T ss_pred chhheeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHH
Confidence 9999999999999854433 456778899999999999887899999999999999999999987764332111
Q ss_pred ----CCCCchhH---HHHHHHHhcc------Chhhhhcc-cccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 675 ----SDEWYFPK---WAFEKVYEEM------KVEDILDR-HIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 675 ----~~~~~~~~---~~~~~~~~~~------~~~~~~~~-~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
.-+..|-+ -..+.+.+.. ...+.+.. ...... +.+......+.+++.+||-.||++|.++.+++
T Consensus 231 ~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~--e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 231 EQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVL--EGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccc--cCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 00000000 0001111100 00000000 000000 11123445678899999999999999999999
Q ss_pred HH--hc---cCCCCCCCCCC
Q 046586 741 KM--LE---GTVEITEPKKP 755 (763)
Q Consensus 741 ~~--Le---~~~~~~~p~~p 755 (763)
+. ++ ...+++.|+.+
T Consensus 309 ~HPY~~vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 309 RHPYIKVWYDPDEVEAPPPE 328 (369)
T ss_pred cCCeeeeecccccccCCCCc
Confidence 64 33 33344444444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-25 Score=266.84 Aligned_cols=196 Identities=15% Similarity=0.228 Sum_probs=139.9
Q ss_pred hcCCC-CccccEEEEE-------eeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHH
Q 046586 493 ARMHH-LNLVRLWGFC-------AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564 (763)
Q Consensus 493 ~~l~H-~niv~l~g~~-------~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 564 (763)
+.++| .||+++++.| .+....++++||+ +++|.++|.. ....+++.++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-----------------------~~~~~~~~~~ 82 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-----------------------PDRSVDAFEC 82 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-----------------------ccccccHHHH
Confidence 34556 6888899887 2334567789988 5599999953 2245889999
Q ss_pred HHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC-------------------CCCeEEcccCcccccCCCCc-----
Q 046586 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD-------------------DFCPKISDFGLAKLRKKEDM----- 620 (763)
Q Consensus 565 ~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~-------------------~~~~kI~DFGla~~~~~~~~----- 620 (763)
+.++.||++||+|||+++ |+||||||+||||+. ++.+||+|||+++.......
T Consensus 83 ~~i~~qi~~al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~ 159 (793)
T PLN00181 83 FHVFRQIVEIVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEK 159 (793)
T ss_pred HHHHHHHHHHHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhh
Confidence 999999999999999988 999999999999954 45667777777754211000
Q ss_pred ----------ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHh
Q 046586 621 ----------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYE 690 (763)
Q Consensus 621 ----------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 690 (763)
.......||+.|||||++.+..++.++|||||||+||||++|..|+..... ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~------------~~~~~~~ 227 (793)
T PLN00181 160 LEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR------------TMSSLRH 227 (793)
T ss_pred hhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH------------HHHHHHH
Confidence 001123578889999999999999999999999999999998887642110 0000100
Q ss_pred ccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 691 EMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 691 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. .+.+ .. .........++.+||+.+|.+||+|.||++
T Consensus 228 ~-----~~~~----~~-----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 228 R-----VLPP----QI-----LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred h-----hcCh----hh-----hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0 0000 00 112334567888999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-25 Score=241.18 Aligned_cols=250 Identities=21% Similarity=0.282 Sum_probs=192.1
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.|.....+|.|.+|.|||++.. .++..|+|+++-.. ....-..+|+-+++..+|||||.++|.+...+...+.|||+.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 3556679999999999999764 68899999998443 333446689999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|.+.-+- ...++..+...+++...+||+|||+.+ =+|||||-.|||+++.
T Consensus 96 ggslQdiy~~------------------------TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~ 148 (829)
T KOG0576|consen 96 GGSLQDIYHV------------------------TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDE 148 (829)
T ss_pred CCcccceeee------------------------cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeeccc
Confidence 9999987653 236788889999999999999999998 5899999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
|.+|++|||.+-.+... ......+.||+.|||||+.. .+.|..++|||+.|+...|+-.-..|.-...
T Consensus 149 gDvklaDfgvsaqitat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-------- 219 (829)
T KOG0576|consen 149 GDVKLADFGVSAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-------- 219 (829)
T ss_pred CceeecccCchhhhhhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--------
Confidence 99999999998543221 12234468999999999773 5689999999999999999977666542111
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..+.++ ++.+.........-...-.+.+.++++.|+.++|.+||++..++.
T Consensus 220 -----pmr~l~-------LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 220 -----PMRALF-------LMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -----hHHHHH-------HhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111111 111111111111111344567888999999999999999987663
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-25 Score=215.12 Aligned_cols=248 Identities=21% Similarity=0.352 Sum_probs=193.4
Q ss_pred ccccccccccccceEEEEEeCCCcEEEEEEeec---cCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKN---VTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.++..+|.+...|..|+|+++++. +++|+++. .....++|..|.-.|+...||||+.++|.|....++.+|..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 345568999999999999998766 56677753 23445789999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
.|||...|+.. ....++..++.+++.++|+||+|||+.. +-|.---|.++.|++|++
T Consensus 271 ~gslynvlhe~----------------------t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmided 327 (448)
T KOG0195|consen 271 FGSLYNVLHEQ----------------------TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDED 327 (448)
T ss_pred chHHHHHHhcC----------------------ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecch
Confidence 99999999653 4456788899999999999999999976 334455789999999999
Q ss_pred CCeEEc--ccCcccccCCCCcccccccccCCCcccccccccCCCC---CccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 602 FCPKIS--DFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQIT---PKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 602 ~~~kI~--DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s---~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
.+++|+ |--++. ......-.+.||+||.+...+-+ .++|+|||.+++|||.|...||....+.+
T Consensus 328 ltarismad~kfsf--------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme--- 396 (448)
T KOG0195|consen 328 LTARISMADTKFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME--- 396 (448)
T ss_pred hhhheecccceeee--------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---
Confidence 999885 221111 00111235779999999765443 57999999999999999999996433211
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
-++ +...+..+..+|+.....+.+++.-|...||.+||.+..|+-+||+..
T Consensus 397 -------------cgm-------kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 397 -------------CGM-------KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -------------hhh-------hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 111 111233344455777889999999999999999999999999998753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-24 Score=210.16 Aligned_cols=250 Identities=18% Similarity=0.344 Sum_probs=182.0
Q ss_pred hccccccccccccceEEEEEeCC-CcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEE-EeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGF-CAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~LV~Ey~ 520 (763)
.|++.+.||+|.||.+-+++++. .+.+++|.+.......++|.+|..---.| .|.||+.-+.+ |+..+..+.++||+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 45677899999999999998875 56899999987777788999999875555 69999987764 56677888999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE--
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-- 598 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl-- 598 (763)
|.|+|.+-+.. ..+......+++.|++.||.|+|+++ +||||||.+||||
T Consensus 105 P~gdL~snv~~-------------------------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~ 156 (378)
T KOG1345|consen 105 PRGDLRSNVEA-------------------------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFD 156 (378)
T ss_pred ccchhhhhcCc-------------------------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEec
Confidence 99999987733 34666777899999999999999999 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-----CCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-----QITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
.+..++|++|||+.+..+.. .....-+..|.+||..... ...+.+|||.||++++.++||..|++....
T Consensus 157 ~df~rvKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-- 230 (378)
T KOG1345|consen 157 ADFYRVKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-- 230 (378)
T ss_pred CCccEEEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc--
Confidence 34458999999999754321 1112235568999977532 455789999999999999999999973221
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.+..+ |.+..+..+. .. .+...+. -..+.+.++..+-+..+|++|=-..++.++
T Consensus 231 --~d~~Y--~~~~~w~~rk-~~-----~~P~~F~-----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 231 --MDKPY--WEWEQWLKRK-NP-----ALPKKFN-----PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred --cCchH--HHHHHHhccc-Cc-----cCchhhc-----ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 12222 2333333221 21 1111111 123455566667788888888555555544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=205.26 Aligned_cols=156 Identities=22% Similarity=0.256 Sum_probs=117.0
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccc
Q 046586 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPE 636 (763)
Q Consensus 557 ~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE 636 (763)
..+++.+++.|+.|++.||+|||+.+ ||+|||++.++.+|+ ||+++...... ..||+.|||||
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~~~y~aPE 74 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVDPYFMAPE 74 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------CCCcccccChH
Confidence 46899999999999999999999865 999999999999999 99998654322 25789999999
Q ss_pred ccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHH
Q 046586 637 WLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVN 716 (763)
Q Consensus 637 ~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 716 (763)
++.+..++.++|||||||++|||++|+.||....... .. ...+.... ...... ....+.....
T Consensus 75 ~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--------~~-~~~~~~~~------~~~~~~--~~~~~~~~~~ 137 (176)
T smart00750 75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--------AI-LEILLNGM------PADDPR--DRSNLESVSA 137 (176)
T ss_pred HhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--------HH-HHHHHHHh------ccCCcc--ccccHHHHHh
Confidence 9999999999999999999999999999986332110 00 01111110 000000 0011122333
Q ss_pred --HHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 717 --RMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 717 --~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
++.+++.+||+.+|++||++.|+++.+...
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 699999999999999999999999987643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=215.36 Aligned_cols=192 Identities=27% Similarity=0.393 Sum_probs=158.7
Q ss_pred ccccccccccccceEEEEEeC----CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+...++||+|.|++||++.+. ..+.||+|.+.... ......+|+++|..+ .+.||+++.+++..++...+|+||
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 445679999999999999664 35789999886433 234578999999999 599999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
++.....+++. .++..+.......+..||+++|..| ||||||||+|+|.+
T Consensus 117 ~~H~~f~~l~~---------------------------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n 166 (418)
T KOG1167|consen 117 FEHDRFRDLYR---------------------------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYN 166 (418)
T ss_pred cCccCHHHHHh---------------------------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccc
Confidence 99999888874 3567888899999999999999999 99999999999997
Q ss_pred C-CCCeEEcccCcccccCCCC----------------------------------cc---------cccccccCCCcccc
Q 046586 600 D-DFCPKISDFGLAKLRKKED----------------------------------MV---------SMSRIRGTRGYMAP 635 (763)
Q Consensus 600 ~-~~~~kI~DFGla~~~~~~~----------------------------------~~---------~~~~~~gt~~y~AP 635 (763)
. .+.-.|.|||+|....... .. ......||+||.||
T Consensus 167 ~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaP 246 (418)
T KOG1167|consen 167 RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAP 246 (418)
T ss_pred cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCch
Confidence 4 5778999999997210000 00 00124699999999
Q ss_pred cccc-cCCCCCccceeehhHHHHHHHhCCCCcc
Q 046586 636 EWLR-SDQITPKADVYSFGMVLLEIVSGSRNFE 667 (763)
Q Consensus 636 E~l~-~~~~s~ksDVwS~Gvll~elltG~~p~~ 667 (763)
|++. ....+.++||||.||+++-+++++.||-
T Consensus 247 EvL~k~~~QttaiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 247 EVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred HHHhhccCcCCccceeeccceeehhhccccccc
Confidence 9875 5678899999999999999999999984
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=183.88 Aligned_cols=106 Identities=30% Similarity=0.472 Sum_probs=89.9
Q ss_pred CCCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCC
Q 046586 41 NQNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPN 120 (763)
Q Consensus 41 ~~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst 120 (763)
.++++|+|+++.|++|||.+.. ...++.+|||.+++ .++||+||++.|. .....+.++.||+|+|.|.+|.+||++
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~~-q~~dgnlv~~~~~~--~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 5 SSGQTLVSSGSLFELGFFKLIM-QSRDYNLILYKGSS--RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred CCCCEEEeCCCcEEEecccCCC-CCCeEEEEEEeCCC--CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 4578999999999999998643 32488999998876 6889999999994 455778899999999999999999999
Q ss_pred CCCCCCCCCceeEEEccCCCeeee------cccccCCC
Q 046586 121 PKTATGNPNSTRLFLQDAGNLVYG------NWQSFNLP 152 (763)
Q Consensus 121 ~~~~~~~~~~~~~~lld~GNlvl~------~WqSFd~P 152 (763)
+... ......|+|+|+|||||+ +|||||||
T Consensus 81 ~~~~--~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTR--VNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred cccC--CCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 8542 245678999999999998 49999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-23 Score=187.36 Aligned_cols=86 Identities=40% Similarity=0.646 Sum_probs=60.7
Q ss_pred CEEEEEeCCCCCCCCC--CccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee------cccccCC
Q 046586 80 TTVIWSANDKFPVAGN--GSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------NWQSFNL 151 (763)
Q Consensus 80 ~tvvW~Anr~~p~~~~--~~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------~WqSFd~ 151 (763)
+||||+|||+.|+.+. ...|.+..||||+|.|..|+.||+++.+.........|.|+|+|||||+ +||||||
T Consensus 2 ~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~ 81 (114)
T PF01453_consen 2 RTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFDY 81 (114)
T ss_dssp --------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTTS
T ss_pred cccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecCC
Confidence 7999999999999643 3789999999999999999999999432211115789999999999998 4999999
Q ss_pred CCccccCCCccCCC
Q 046586 152 PTDTILPNQTLNGP 165 (763)
Q Consensus 152 Ptdtllpg~~l~~~ 165 (763)
||||+||||+|+..
T Consensus 82 ptdt~L~~q~l~~~ 95 (114)
T PF01453_consen 82 PTDTLLPGQKLGDG 95 (114)
T ss_dssp SS-EEEEEET--TS
T ss_pred CccEEEeccCcccC
Confidence 99999999998643
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=209.95 Aligned_cols=163 Identities=20% Similarity=0.180 Sum_probs=126.4
Q ss_pred HHHhccccccccccccceEEEEEeC--CCcEEEEEEeeccC------CchhhhHHHHHHHhcCCCCccccEEEEEeeCCe
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT--DHRVVAVKCLKNVT------GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE 512 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~--~~~~VAvK~l~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 512 (763)
....|.+.+.||+|+||.||+|... +++.+|||++.... ...+.|.+|+++|++++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3456778899999999999999775 57778999875321 123458899999999999999863332 246
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC-
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI- 591 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl- 591 (763)
.+|||||+++++|.. +.. .. ...++.+++++|+|||+.+ |+||||
T Consensus 93 ~~LVmE~~~G~~L~~-~~~------------------------~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~ 138 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-ARP------------------------HG------DPAWFRSAHRALRDLHRAG---ITHNDLA 138 (365)
T ss_pred cEEEEEccCCCCHHH-hCc------------------------cc------hHHHHHHHHHHHHHHHHCC---CeeCCCC
Confidence 899999999999962 210 00 1357889999999999988 999999
Q ss_pred CCCceEEcCCCCeEEcccCcccccCCCCc-------ccccccccCCCccccccccc
Q 046586 592 KPENILLGDDFCPKISDFGLAKLRKKEDM-------VSMSRIRGTRGYMAPEWLRS 640 (763)
Q Consensus 592 k~~NILl~~~~~~kI~DFGla~~~~~~~~-------~~~~~~~gt~~y~APE~l~~ 640 (763)
||+|||++.++.+||+|||+++....... ...+...+++.|+|||.+..
T Consensus 139 KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 139 KPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999999999999999999986654321 11245678889999999864
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-21 Score=173.16 Aligned_cols=104 Identities=32% Similarity=0.474 Sum_probs=88.7
Q ss_pred CCCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCC
Q 046586 41 NQNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPN 120 (763)
Q Consensus 41 ~~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst 120 (763)
..+++|+|+++.|++|||.+. ...++.+|||.+.+ .++||+|||+.|+.++ ..+.+..||+|+|.|.+|.+||+|
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~--~q~dgnlV~~~~~~--~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 5 SSGQTLVSGNSLFELGFFTLI--MQNDYNLILYKSSS--RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred CCCCEEecCCCcEeeeccccC--CCCCEEEEEEECCC--CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEEe
Confidence 357899999999999999864 33678999999875 6789999999998654 778888999999999999999999
Q ss_pred CCCCCCCCCceeEEEccCCCeeee------cccccCC
Q 046586 121 PKTATGNPNSTRLFLQDAGNLVYG------NWQSFNL 151 (763)
Q Consensus 121 ~~~~~~~~~~~~~~lld~GNlvl~------~WqSFd~ 151 (763)
+.. .......++|+|+|||||+ +||||||
T Consensus 80 ~t~--~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 80 NTT--GANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred ccc--CCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 743 2345678999999999997 4999997
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.1e-20 Score=197.59 Aligned_cols=258 Identities=23% Similarity=0.248 Sum_probs=190.1
Q ss_pred hccccccccccccceEEEEEeCCC--cEEEEEEeeccCC-chhhhHHHHHHHhcCCC----CccccEEEEE-eeCCeeeE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDH--RVVAVKCLKNVTG-GDAEFWAEVTIIARMHH----LNLVRLWGFC-AEKGERTL 515 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~--~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~L 515 (763)
.+.+.++||+|+||.||++..... ..+|+|....... ....+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 577789999999999999987653 4788888875432 22367889999999873 5888899888 47778999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||+.+ |.+|.++.... ....++..+.++|+.|++.+|.+||+.+ ++||||||.|
T Consensus 99 VM~l~-G~sL~dl~~~~----------------------~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N 152 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN----------------------PPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPEN 152 (322)
T ss_pred EEecc-CccHHHHHHhC----------------------CCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHH
Confidence 99988 77999977443 2356888999999999999999999999 9999999999
Q ss_pred eEEcCC-----CCeEEcccCccc--ccCCCCc---c---c-ccccccCCCcccccccccCCCCCccceeehhHHHHHHHh
Q 046586 596 ILLGDD-----FCPKISDFGLAK--LRKKEDM---V---S-MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661 (763)
Q Consensus 596 ILl~~~-----~~~kI~DFGla~--~~~~~~~---~---~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt 661 (763)
+++... ..+.|.|||+++ ....... . . ....+||..|.+++...+...+.+.|+||++.++.|++.
T Consensus 153 ~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~ 232 (322)
T KOG1164|consen 153 FVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLK 232 (322)
T ss_pred eeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhc
Confidence 999765 469999999998 3222211 1 1 223569999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 662 GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 662 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
|..|+........ .....+. ........ .....+..+.++...+-..+..++|....+.+
T Consensus 233 g~LPW~~~~~~~~----------~~~~~~~-~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 233 GSLPWEALEMTDL----------KSKFEKD-PRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred CCCCCccccccch----------HHHHHHH-hhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 9988753321110 0000000 00001110 00122345555555566689999999999998
Q ss_pred HhccCC
Q 046586 742 MLEGTV 747 (763)
Q Consensus 742 ~Le~~~ 747 (763)
.|++..
T Consensus 293 ~l~~~~ 298 (322)
T KOG1164|consen 293 LLKDVF 298 (322)
T ss_pred HHHHHH
Confidence 886654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.7e-19 Score=187.90 Aligned_cols=260 Identities=31% Similarity=0.421 Sum_probs=194.6
Q ss_pred ccccccccccccceEEEEEeCCCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCC-ccccEEEEEeeCCeeeEEEec
Q 046586 445 NGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHL-NLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.+.+.||.|+||.||++... ..+++|.+..... ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 345678999999999999887 7799999975432 256789999999999888 799999999777778999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+.++++.+++..... ...+.......+..|++.++.|+|+.+ ++|||+||+||+++
T Consensus 80 ~~~~~l~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~ 135 (384)
T COG0515 80 VDGGSLEDLLKKIGR---------------------KGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLD 135 (384)
T ss_pred CCCCcHHHHHHhccc---------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeec
Confidence 999999976643210 025778889999999999999999998 99999999999999
Q ss_pred CCC-CeEEcccCcccccCCCCcc-----cccccccCCCccccccccc---CCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 600 DDF-CPKISDFGLAKLRKKEDMV-----SMSRIRGTRGYMAPEWLRS---DQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 600 ~~~-~~kI~DFGla~~~~~~~~~-----~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
... .+++.|||+++........ ......|+..|+|||.+.+ ..++...|+||+|++++++++|..|+....
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 136 RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 998 7999999999855443322 2355689999999999987 688999999999999999999999965332
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. .........+...... .................+.+++..|+..+|..|.++.+....
T Consensus 216 ~~------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 216 NS------SATSQTLKIILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cc------ccHHHHHHHHHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 0001111111111100 000011100001223567888889999999999999887754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=180.31 Aligned_cols=200 Identities=23% Similarity=0.306 Sum_probs=167.3
Q ss_pred hccccccccccccceEEEEE-eCCCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~-~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.+.+.++||+|.||.++.|+ +-+++.||||.-. ......+++.|....+.| ..++|...+-+-.++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 46678999999999999995 5678999999753 334456678888888888 5789999998888888999999998
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC-
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD- 600 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~- 600 (763)
|-||.++..- -...++..+.+-||.|+..-++|+|++. +|.|||||+|+||..
T Consensus 107 GPSLEDLFD~-----------------------CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp 160 (449)
T KOG1165|consen 107 GPSLEDLFDL-----------------------CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRP 160 (449)
T ss_pred CcCHHHHHHH-----------------------hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCC
Confidence 7799887743 2457889999999999999999999998 999999999999964
Q ss_pred ----CCCeEEcccCcccccCCCCc------ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 601 ----DFCPKISDFGLAKLRKKEDM------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 601 ----~~~~kI~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
...+.|+|||+|+...+... .......||.+||+-....+.+.+...|+-|+|-|+.+.+.|..|+++..
T Consensus 161 ~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 161 GTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred CCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 34689999999987654332 12234569999999999999999999999999999999999999998654
Q ss_pred C
Q 046586 671 S 671 (763)
Q Consensus 671 ~ 671 (763)
.
T Consensus 241 A 241 (449)
T KOG1165|consen 241 A 241 (449)
T ss_pred C
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-20 Score=213.54 Aligned_cols=251 Identities=22% Similarity=0.265 Sum_probs=183.8
Q ss_pred ccccccccccceEEEEEeC-CCcEEEEEEeec---cCCchh----hhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 447 FSNLIGRGGFGDVYKGELT-DHRVVAVKCLKN---VTGGDA----EFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 447 ~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~---~~~~~~----~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..+.+|.|++|.|+..... ..+..+.|..+. ...... .+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3568999999977776443 333333332220 111111 14567777788899999888887777777777799
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++ +|..++... ..+....+..+..|+..|+.|||+.+ |.|||+|++|+++
T Consensus 402 ~~~~-Dlf~~~~~~------------------------~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~ 453 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN------------------------GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLV 453 (601)
T ss_pred cccH-HHHHHHhcc------------------------cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEE
Confidence 9999 999998532 25677788889999999999999999 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCc---ccccccccCCCcccccccccCCCCC-ccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRSDQITP-KADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~s~-ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
..++.+||+|||.+........ .......|+..|+|||.+....|.+ ..||||.|+++..|++|+.|+........
T Consensus 454 ~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 454 TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 9999999999999986654333 3455678999999999999999887 59999999999999999999864322110
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+ .+ ..-.+..-......++-...+.+...++.++|+.||.+|.|+.+|++
T Consensus 534 ----~~--------~~----~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 534 ----SF--------KT----NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ----ch--------hh----hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00 00 00000001111122233566778899999999999999999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=176.47 Aligned_cols=139 Identities=19% Similarity=0.174 Sum_probs=107.6
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeeccCC---c-------hhhh-----------------HHHHHHHhcCCCCcc
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG---G-------DAEF-----------------WAEVTIIARMHHLNL 500 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~---~-------~~~f-----------------~~E~~~l~~l~H~ni 500 (763)
...||+|+||.||+|...+|+.||||+++.... . ...| ..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999988899999999975321 1 1122 249999999988776
Q ss_pred ccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-H
Q 046586 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYL-H 579 (763)
Q Consensus 501 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yL-H 579 (763)
.....+.. ...+|||||++++++...... ...++..+...++.|++.+|.|| |
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~------------------------~~~~~~~~~~~i~~qi~~~L~~l~H 135 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK------------------------DAPLSESKARELYLQVIQIMRILYQ 135 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 44333222 234899999998776654321 23577888999999999999999 6
Q ss_pred hcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccC
Q 046586 580 EECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK 616 (763)
Q Consensus 580 ~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~ 616 (763)
+.+ |+||||||+|||++ ++.++|+|||+|....
T Consensus 136 ~~g---iiHrDlkP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 136 DCR---LVHADLSEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred hCC---cccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence 877 99999999999998 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.5e-19 Score=178.83 Aligned_cols=172 Identities=13% Similarity=0.085 Sum_probs=133.4
Q ss_pred HHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhh----------hHHHHHHHhcCCCCccccEEEEEe
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAE----------FWAEVTIIARMHHLNLVRLWGFCA 508 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~----------f~~E~~~l~~l~H~niv~l~g~~~ 508 (763)
++....+...+.||.|+||.||.... ++..+|+|+++......+. +.+|+..+.+++|++|.....++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34567788889999999999999766 5667999999754333322 578999999999999999998866
Q ss_pred eC--------CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 046586 509 EK--------GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE 580 (763)
Q Consensus 509 ~~--------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~ 580 (763)
.. ...+|||||++|.+|.++.. ++. ....+++.+|..+|.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------------------------~~~----~~~~~i~~~l~~lH~ 153 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----------------------------ISE----DVKAKIKASIESLHQ 153 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh----------------------------ccH----HHHHHHHHHHHHHHH
Confidence 43 35789999999999987641 111 245689999999999
Q ss_pred cCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHH
Q 046586 581 ECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIV 660 (763)
Q Consensus 581 ~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ell 660 (763)
.+ ++|||+||+||+++.++ ++|+|||.......+.... .+.....+..++|+|+||+.+..+.
T Consensus 154 ~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 154 HG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 99 99999999999999988 9999999887543221111 1334455678999999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.7e-19 Score=173.17 Aligned_cols=203 Identities=24% Similarity=0.296 Sum_probs=167.2
Q ss_pred HHHHhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcCCC-CccccEEEEEeeCCeeeEEE
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHH-LNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~LV~ 517 (763)
|....|.+.++||.|+||.+|.|.. .+|+.||||+-+... ...++..|..+.+.|+| ..|..+..+..+.+.-.|||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 3455688899999999999999954 678999999875432 34567789999999964 67888888899999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
|.+ +.||.+...-. ...++..+.+-++-|+..-++|+|.++ .|||||||+|.|
T Consensus 91 dLL-GPsLEdLfnfC-----------------------~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFL 143 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC-----------------------SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFL 143 (341)
T ss_pred ecc-CccHHHHHHHH-----------------------hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCcccee
Confidence 998 77999887543 235778889999999999999999999 999999999999
Q ss_pred EcCC---CCeEEcccCcccccCCCCc------ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 598 LGDD---FCPKISDFGLAKLRKKEDM------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 598 l~~~---~~~kI~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
..-+ ..+.++|||+|+...+... .......||.+|.+-....+...+...|+-|+|.+|.++-.|..|+++
T Consensus 144 MGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 144 MGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred eccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 9644 5688999999985433211 123346799999999888888889999999999999999999999986
Q ss_pred cc
Q 046586 669 QG 670 (763)
Q Consensus 669 ~~ 670 (763)
..
T Consensus 224 lk 225 (341)
T KOG1163|consen 224 LK 225 (341)
T ss_pred cc
Confidence 54
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=170.83 Aligned_cols=140 Identities=21% Similarity=0.139 Sum_probs=109.8
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeeccCCc---------------------------hhhhHHHHHHHhcCCCCcc
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG---------------------------DAEFWAEVTIIARMHHLNL 500 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~---------------------------~~~f~~E~~~l~~l~H~ni 500 (763)
...||+|+||.||+|...+|+.||||+++..... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999888999999999754211 0113578899999999987
Q ss_pred ccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 046586 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE 580 (763)
Q Consensus 501 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~ 580 (763)
.....+... ..+|||||++++++...... ...++......++.|++.++.+||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~------------------------~~~~~~~~~~~i~~~l~~~l~~lH~ 135 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK------------------------DVPLEEEEAEELYEQVVEQMRRLYQ 135 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh------------------------hccCCHHHHHHHHHHHHHHHHHHHH
Confidence 554444333 34899999998855443211 1235677889999999999999999
Q ss_pred -cCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCC
Q 046586 581 -ECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617 (763)
Q Consensus 581 -~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~ 617 (763)
.+ |+||||||+||+++ ++.++|+|||++.....
T Consensus 136 ~~g---ivHrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 136 EAG---LVHGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hCC---EecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 88 99999999999999 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=191.06 Aligned_cols=218 Identities=25% Similarity=0.412 Sum_probs=162.1
Q ss_pred HhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHH
Q 046586 492 IARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGV 571 (763)
Q Consensus 492 l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qi 571 (763)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...++|.....+..+|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-----------------------~~~~d~~F~~s~~rdi 57 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-----------------------DIKLDYFFILSFIRDI 57 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-----------------------ccCccHHHHHHHHHHH
Confidence 45789999999999999999999999999999999999652 3468899999999999
Q ss_pred HHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCC-cccccccccCCCcccccccccC-------CC
Q 046586 572 ARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED-MVSMSRIRGTRGYMAPEWLRSD-------QI 643 (763)
Q Consensus 572 a~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~-------~~ 643 (763)
+.||+|||.... -.|+.++++|.++|..+.+||+|||+........ ........-..-|.|||.++.. ..
T Consensus 58 ~~Gl~ylh~s~i--~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~ 135 (484)
T KOG1023|consen 58 SKGLAYLHNSPI--GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESAL 135 (484)
T ss_pred HHHHHHHhcCcc--eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccc
Confidence 999999998662 2999999999999999999999999998764311 1111112234569999998763 24
Q ss_pred CCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHH
Q 046586 644 TPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAM 723 (763)
Q Consensus 644 s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~ 723 (763)
+.+.||||||++++|+++.+.||......... +.....+..+ ....+.+.+... .+..+++..++.
T Consensus 136 ~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~------~eii~~~~~~--~~~~~rP~i~~~------~e~~~~l~~l~~ 201 (484)
T KOG1023|consen 136 TQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP------DEIILRVKKG--GSNPFRPSIELL------NELPPELLLLVA 201 (484)
T ss_pred cccCCeehHHHHHHHHHhccCccccccccCCh------HHHHHHHHhc--CCCCcCcchhhh------hhcchHHHHHHH
Confidence 67899999999999999999999754322210 1111111110 111111111110 134447899999
Q ss_pred HccCCCCCCCCCHHHHHHHhccCCC
Q 046586 724 WCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 724 ~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.||..+|++||++..|-..++....
T Consensus 202 ~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 202 RCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HhcccChhhCccHHHHHhhhhhhcc
Confidence 9999999999999999998876654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-19 Score=204.25 Aligned_cols=249 Identities=23% Similarity=0.248 Sum_probs=180.9
Q ss_pred ccccccccccccceEEEEEeCCCcEEEEEEeeccC--CchhhhHHHHHH--HhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 445 NGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVT--GGDAEFWAEVTI--IARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~--~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..+.+.||++.|=.|.+++.+.|. |+||++-+.. ..-+.|.++++- ...++|||.+++.-+-......|||-+|.
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 456689999999999999999988 8899885433 233455554444 44558999999888877777888888888
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
.+ +|.+.|. .++.+...+...|+.|++.|+.-.|..+ |.|+|||.+||||+.
T Consensus 104 kh-nLyDRlS------------------------TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTS 155 (1431)
T KOG1240|consen 104 KH-NLYDRLS------------------------TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITS 155 (1431)
T ss_pred hh-hhhhhhc------------------------cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEee
Confidence 55 8888874 4567888899999999999999999999 999999999999999
Q ss_pred CCCeEEcccCcccccC--CCCcccccc----cccCCCccccccccc----------C-CCCCccceeehhHHHHHHHh-C
Q 046586 601 DFCPKISDFGLAKLRK--KEDMVSMSR----IRGTRGYMAPEWLRS----------D-QITPKADVYSFGMVLLEIVS-G 662 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~--~~~~~~~~~----~~gt~~y~APE~l~~----------~-~~s~ksDVwS~Gvll~ellt-G 662 (763)
=.=+.|+||..-+... .++....+- ...-..|+|||.+.. . ..+++-||||.||++.||++ |
T Consensus 156 WNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg 235 (1431)
T KOG1240|consen 156 WNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEG 235 (1431)
T ss_pred echhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcC
Confidence 8889999998776432 222222211 122346999998743 1 26678999999999999998 7
Q ss_pred CCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 663 SRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 663 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
+++|+...- . -|.... .......+..- +...++++++.|++.||++|.++.+.++.
T Consensus 236 ~PlF~LSQL---------~------aYr~~~-~~~~e~~Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 236 RPLFTLSQL---------L------AYRSGN-ADDPEQLLEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CCcccHHHH---------H------hHhccC-ccCHHHHHHhC--------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 888863221 0 011110 11111111110 12367899999999999999999999987
Q ss_pred hccC
Q 046586 743 LEGT 746 (763)
Q Consensus 743 Le~~ 746 (763)
-.|.
T Consensus 292 yrG~ 295 (1431)
T KOG1240|consen 292 YRGL 295 (1431)
T ss_pred hhcc
Confidence 6553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.1e-18 Score=166.77 Aligned_cols=184 Identities=16% Similarity=0.104 Sum_probs=138.4
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeeccCCchh-----hhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEecCC
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDA-----EFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~-----~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
...|++|+||+||.+.- ++.+++.+.++......+ .|.+|+++|++|+ |+++++++++ +..+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46899999999997766 567788787775544222 4789999999994 5889999886 45699999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC-CCCceEEcC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI-KPENILLGD 600 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl-k~~NILl~~ 600 (763)
|.+|...+.. ....+..|++++|.++|+.+ |+|||| ||.|||++.
T Consensus 82 G~~L~~~~~~-------------------------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~ 127 (218)
T PRK12274 82 GAAMYQRPPR-------------------------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQE 127 (218)
T ss_pred CccHHhhhhh-------------------------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcC
Confidence 9888654310 01346789999999999999 999999 799999999
Q ss_pred CCCeEEcccCcccccCCCCc-------cccc-----ccccCCCcccccccccC-CCC-CccceeehhHHHHHHHhCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDM-------VSMS-----RIRGTRGYMAPEWLRSD-QIT-PKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~-------~~~~-----~~~gt~~y~APE~l~~~-~~s-~ksDVwS~Gvll~elltG~~p~ 666 (763)
++.++|+|||++........ .... ....++.|++|+...-- ..+ ...+.++-|..+|.++|++.+.
T Consensus 128 ~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 128 DGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred CCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 99999999999985443321 0000 12357778888855432 333 5677889999999999999887
Q ss_pred cccc
Q 046586 667 EIQG 670 (763)
Q Consensus 667 ~~~~ 670 (763)
....
T Consensus 208 ~~~~ 211 (218)
T PRK12274 208 WEDN 211 (218)
T ss_pred cccC
Confidence 5443
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.9e-17 Score=148.70 Aligned_cols=81 Identities=35% Similarity=0.803 Sum_probs=67.4
Q ss_pred ceeeecCceeeee------ecCeeEEEEecCCceEEEEEecCCCceEEEecccccCcCCCCCCCCCcccccCCCCCCccc
Q 046586 173 KFSFLNASELVFV------SANRSYWNIDDDGNLRIYSYDDNGDRWTVVWQAVQEICTIPDLCGENAICISDGLSRSTSC 246 (763)
Q Consensus 173 ~~~~~~~~~~~~~------~~~~~~~~l~~~G~~~~~~~~~~~~~w~~~~~~~~~~c~~~~~CG~~g~C~~~~~~~~~~C 246 (763)
.|.|..+.++++. .....+++||.+|++|+|.|++..++|...|.+|.|+||+|+.||+||+|+.+ ..+.|
T Consensus 24 ~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~Cd~y~~CG~~g~C~~~---~~~~C 100 (110)
T PF00954_consen 24 NYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQCDVYGFCGPNGICNSN---NSPKC 100 (110)
T ss_pred EEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCCCCccccCCccEeCCC---CCCce
Confidence 4555544444332 23356889999999999999999999999999999999999999999999754 37899
Q ss_pred cCCCCccccC
Q 046586 247 VCPPGFKNST 256 (763)
Q Consensus 247 ~C~~Gf~~~~ 256 (763)
.||+||+|++
T Consensus 101 ~Cl~GF~P~n 110 (110)
T PF00954_consen 101 SCLPGFEPKN 110 (110)
T ss_pred ECCCCcCCCc
Confidence 9999999985
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-18 Score=187.75 Aligned_cols=224 Identities=27% Similarity=0.316 Sum_probs=171.8
Q ss_pred cccccccceEEEEE----eCCCcEEEEEEeeccCC---chhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEecCC
Q 046586 450 LIGRGGFGDVYKGE----LTDHRVVAVKCLKNVTG---GDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~----~~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.+|+|.||.|+..+ .+.+..+|.|++++... .......|-.++...+ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999998863 23467788888864322 1124556888888886 9999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|...+... ...+.....-....+|-+++.+|+.+ |+|||+|++||+++.+
T Consensus 81 gg~lft~l~~~------------------------~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~ 133 (612)
T KOG0603|consen 81 GGDLFTRLSKE------------------------VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLE 133 (612)
T ss_pred cchhhhccccC------------------------CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeeccc
Confidence 99999887543 34455555666778999999999999 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
|++|+.|||+++..-.... .+||..|||||.+. .....+|-||||++++||++|..||..
T Consensus 134 Ghi~~tdfglske~v~~~~-----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------- 193 (612)
T KOG0603|consen 134 GHIKLTDFGLSKEAVKEKI-----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------- 193 (612)
T ss_pred CccccCCchhhhHhHhhhh-----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------------
Confidence 9999999999986543322 17899999999988 678899999999999999999999863
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
+++...+... ...|.+....+.+++..+...+|.+|--.
T Consensus 194 --------------~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 --------------DTMKRILKAE--LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --------------HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1111111111 12235556666666777777777777644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=158.75 Aligned_cols=133 Identities=17% Similarity=0.304 Sum_probs=101.9
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeecc-CCchhhhHHHHHHHhcC-----CCCccccEEEEEeeCC---e-eeEEE
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNV-TGGDAEFWAEVTIIARM-----HHLNLVRLWGFCAEKG---E-RTLVY 517 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~-~~~~~~f~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~LV~ 517 (763)
.+.||+|+||.||. +++....+||+.... ....+++.+|+.+++.+ .||||++++|++.++. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 35899999999996 433333468887643 33456789999999999 5799999999998874 3 33789
Q ss_pred ec--CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCcEEecCCCCC
Q 046586 518 EY--VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAI-AYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 518 Ey--~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL-~yLH~~~~~~ivHrDlk~~ 594 (763)
|| +++++|.+++.+. .++.. ..++.+++.++ +|||+++ |+||||||+
T Consensus 85 e~~G~~~~tL~~~l~~~-------------------------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~ 134 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC-------------------------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQ 134 (210)
T ss_pred cCCCCcchhHHHHHHcc-------------------------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHH
Confidence 99 5689999999532 23333 35577888777 9999998 999999999
Q ss_pred ceEEcC----CCCeEEcccCcc
Q 046586 595 NILLGD----DFCPKISDFGLA 612 (763)
Q Consensus 595 NILl~~----~~~~kI~DFGla 612 (763)
|||++. +..++|+||+.+
T Consensus 135 NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 135 NILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HEEEeccCCCCCcEEEEECCCC
Confidence 999974 348999995544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-16 Score=165.15 Aligned_cols=196 Identities=24% Similarity=0.295 Sum_probs=138.3
Q ss_pred CCCccccEEEEEee---------------------------CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccC
Q 046586 496 HHLNLVRLWGFCAE---------------------------KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSG 548 (763)
Q Consensus 496 ~H~niv~l~g~~~~---------------------------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~ 548 (763)
+|||||++.++|.+ ...+||||..++. +|+++|..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----------------- 335 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----------------- 335 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----------------
Confidence 68899888887753 2357889988865 89999843
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE--cCCC--CeEEcccCcccccCCCCc----
Q 046586 549 VGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL--GDDF--CPKISDFGLAKLRKKEDM---- 620 (763)
Q Consensus 549 ~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl--~~~~--~~kI~DFGla~~~~~~~~---- 620 (763)
...+...+.-|+.|+++|..|||.++ |.|||+|++|||+ |+|+ ...|+|||.+---+....
T Consensus 336 --------~~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy 404 (598)
T KOG4158|consen 336 --------RHRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPY 404 (598)
T ss_pred --------CCCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeecccccccccc
Confidence 35667778889999999999999999 9999999999999 4444 468999998853222111
Q ss_pred -ccccccccCCCcccccccccC--C----CCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccC
Q 046586 621 -VSMSRIRGTRGYMAPEWLRSD--Q----ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMK 693 (763)
Q Consensus 621 -~~~~~~~gt~~y~APE~l~~~--~----~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 693 (763)
...-...|....||||..... + .-.|+|.|+.|.+.||+++...||-..++..-+. +. |++.
T Consensus 405 ~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~---------r~-Yqe~- 473 (598)
T KOG4158|consen 405 ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT---------RT-YQES- 473 (598)
T ss_pred ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech---------hh-hhhh-
Confidence 111223577789999987532 1 2258999999999999999999997644321100 00 1111
Q ss_pred hhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 694 VEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 694 ~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
--+.++..++..+.+++...++.||++||+..-....|
T Consensus 474 ------------qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 474 ------------QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred ------------hCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 11122344566788889999999999999976555444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=165.22 Aligned_cols=233 Identities=21% Similarity=0.258 Sum_probs=146.2
Q ss_pred ccccccccccceEEEEEeCC-CcEEEEEEeeccC----CchhhhHHHHHHHhcCCC----------CccccEEEEEe---
Q 046586 447 FSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVT----GGDAEFWAEVTIIARMHH----------LNLVRLWGFCA--- 508 (763)
Q Consensus 447 ~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H----------~niv~l~g~~~--- 508 (763)
..+.||.|+++.||.++..+ ++.+|+|+..... ...+++++|.-.+..+.+ -.++.-++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 35689999999999998875 7899999986332 233557777666655432 12222222221
Q ss_pred ------eCC--------eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q 046586 509 ------EKG--------ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARA 574 (763)
Q Consensus 509 ------~~~--------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~g 574 (763)
... ..+++|+-+ .++|.+++..-.... .....+....++.+..|+.+.
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~-----------------~~~~~l~~~arl~lT~Q~I~l 157 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA-----------------QTHSPLAFAARLSLTVQMIRL 157 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT-----------------TTSHHHHHHHHHHHHHHHHHH
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc-----------------cccchhHHHHHHHHHHHHHHH
Confidence 111 235677777 458888764211000 011234556778888999999
Q ss_pred HHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc--------CCCCCc
Q 046586 575 IAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS--------DQITPK 646 (763)
Q Consensus 575 L~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~k 646 (763)
+++||+.+ +||+||+|+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+
T Consensus 158 vA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~ 230 (288)
T PF14531_consen 158 VANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFA 230 (288)
T ss_dssp HHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HH
T ss_pred HHHHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeec
Confidence 99999999 999999999999999999999999877644322111 234567999997643 257889
Q ss_pred cceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHcc
Q 046586 647 ADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCI 726 (763)
Q Consensus 647 sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl 726 (763)
.|.|++|+++|.|.+++.||......... +. .+. ... +.++.+..++..+|
T Consensus 231 ~DaW~LG~~ly~lWC~~lPf~~~~~~~~~--------------------~~-------~f~-~C~-~~Pe~v~~LI~~lL 281 (288)
T PF14531_consen 231 TDAWQLGITLYSLWCGRLPFGLSSPEADP--------------------EW-------DFS-RCR-DMPEPVQFLIRGLL 281 (288)
T ss_dssp HHHHHHHHHHHHHHHSS-STCCCGGGSTS--------------------GG-------GGT-TSS----HHHHHHHHHHT
T ss_pred cCHHHHHHHHHHHHHccCCCCCCCccccc--------------------cc-------cch-hcC-CcCHHHHHHHHHHc
Confidence 99999999999999999999754322110 00 111 111 56778889999999
Q ss_pred CCCCCCC
Q 046586 727 QDRPELR 733 (763)
Q Consensus 727 ~~dP~~R 733 (763)
+.||++|
T Consensus 282 ~~~~~~R 288 (288)
T PF14531_consen 282 QRNPEDR 288 (288)
T ss_dssp -SSGGGS
T ss_pred cCCcccC
Confidence 9999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-16 Score=185.15 Aligned_cols=201 Identities=23% Similarity=0.306 Sum_probs=159.4
Q ss_pred cHHHHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCC---CCccccEEEEEeeCCe
Q 046586 436 THAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH---HLNLVRLWGFCAEKGE 512 (763)
Q Consensus 436 ~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~ 512 (763)
+.-++....+.+.+.||+|+||.||+|...+++.||+|+-+.....+ |.-=.+++.+|+ -+-|..+.....-.+.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 34445566777889999999999999999899999999987654432 222223344444 2334445555556677
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
-+||+||.+.|+|.+++. ..+.++|...+.++.|+++-+..||..+ |||+|||
T Consensus 769 S~lv~ey~~~Gtlld~~N------------------------~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiK 821 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN------------------------TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIK 821 (974)
T ss_pred ceeeeeccccccHHHhhc------------------------cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCC
Confidence 889999999999999995 3356889999999999999999999998 9999999
Q ss_pred CCceEEc-------CCCCeEEcccCcccccCC-CCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCC
Q 046586 593 PENILLG-------DDFCPKISDFGLAKLRKK-EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 593 ~~NILl~-------~~~~~kI~DFGla~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~ 664 (763)
|+|.||. ++..++|+|||.+-.+.. .+.......++|-++-.+|+..+.+++.+.|-|.+..+++-|+.|+.
T Consensus 822 PDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 822 PDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999994 356789999999854321 22245566788999999999999999999999999999999999986
Q ss_pred C
Q 046586 665 N 665 (763)
Q Consensus 665 p 665 (763)
.
T Consensus 902 ~ 902 (974)
T KOG1166|consen 902 M 902 (974)
T ss_pred H
Confidence 4
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.6e-16 Score=155.38 Aligned_cols=133 Identities=20% Similarity=0.293 Sum_probs=112.2
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCc---------hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG---------DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~---------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.||+|++|.||+|.. ++..+++|+....... ...+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4799999999999988 5567888976532211 13477899999999999998888888788889999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... .+ .+..++.+++.+|++||+.+ ++|+|++|+||+++
T Consensus 81 ~~G~~L~~~~~~~---------------------------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~ 129 (211)
T PRK14879 81 IEGEPLKDLINSN---------------------------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS 129 (211)
T ss_pred eCCcCHHHHHHhc---------------------------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE
Confidence 9999999988432 11 77899999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccc
Q 046586 600 DDFCPKISDFGLAKL 614 (763)
Q Consensus 600 ~~~~~kI~DFGla~~ 614 (763)
++.++|+|||++..
T Consensus 130 -~~~~~liDf~~a~~ 143 (211)
T PRK14879 130 -GGKIYLIDFGLAEF 143 (211)
T ss_pred -CCCEEEEECCcccC
Confidence 78999999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.8e-16 Score=157.19 Aligned_cols=141 Identities=17% Similarity=0.125 Sum_probs=107.8
Q ss_pred ccccccccccccceEEEEE--eCCCcEEEEEEeeccCCc-------------------------hhhhHHHHHHHhcCCC
Q 046586 445 NGFSNLIGRGGFGDVYKGE--LTDHRVVAVKCLKNVTGG-------------------------DAEFWAEVTIIARMHH 497 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~--~~~~~~VAvK~l~~~~~~-------------------------~~~f~~E~~~l~~l~H 497 (763)
+.+.+.||+|+||.||+|. ..+|+.||+|+++..... ...+..|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999998 568899999999743210 0124679999999975
Q ss_pred Cc--cccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 046586 498 LN--LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAI 575 (763)
Q Consensus 498 ~n--iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL 575 (763)
.. +.+.++. ...++||||+++.+|...... ...+...+...++.|++.++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~------------------------~~~~~~~~~~~i~~qi~~~l 161 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK------------------------DVEPEEEEEFELYDDILEEM 161 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccc------------------------cCCcchHHHHHHHHHHHHHH
Confidence 33 3444442 235899999999888765421 11234456678999999999
Q ss_pred HHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccC
Q 046586 576 AYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK 616 (763)
Q Consensus 576 ~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~ 616 (763)
++||+.+. |+||||||+||+++ ++.++|+|||++....
T Consensus 162 ~~LH~~g~--iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 162 RKLYKEGE--LVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred HHHHhcCC--EEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999763 99999999999999 8899999999997544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.1e-17 Score=174.20 Aligned_cols=174 Identities=30% Similarity=0.403 Sum_probs=130.4
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
.+++.|+++...+|.+||.+.+ .....++...+.++.|++.|+.| ++ .+|+|+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~---------------------~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdl 382 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR---------------------TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDL 382 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC---------------------cccccchhHHHHHHHhhccchhh---cc---chhhhc
Confidence 5788999999999999997543 34556788899999999999999 55 899999
Q ss_pred CCCceEEcCCCCeEEcccCcccccCCCC-----cccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCC
Q 046586 592 KPENILLGDDFCPKISDFGLAKLRKKED-----MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRN 665 (763)
Q Consensus 592 k~~NILl~~~~~~kI~DFGla~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p 665 (763)
||.||....+..+||.|||+........ ....+...||..||+||.+.+..|+.|+||||+|++|+|++. =...
T Consensus 383 kp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~ 462 (516)
T KOG1033|consen 383 KPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQ 462 (516)
T ss_pred cccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccH
Confidence 9999999999999999999987655443 235566789999999999999999999999999999999987 2222
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eV 739 (763)
++-.. ...++-+..+.+.+- ..-..-+.++.+++...|.+||++.++
T Consensus 463 ~er~~----------------------t~~d~r~g~ip~~~~-----~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 463 FERIA----------------------TLTDIRDGIIPPEFL-----QDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHHH----------------------hhhhhhcCCCChHHh-----hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 22110 011222222211111 111233567889999999999955443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=151.81 Aligned_cols=136 Identities=19% Similarity=0.152 Sum_probs=107.4
Q ss_pred ccccccccccccceEEEEEeCCCcEEEEEEeeccCCc-----------------------hhhhHHHHHHHhcCCCC--c
Q 046586 445 NGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG-----------------------DAEFWAEVTIIARMHHL--N 499 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~-----------------------~~~f~~E~~~l~~l~H~--n 499 (763)
+.+.+.||+|+||.||++...+++.||||+++..... ...+..|..++..+.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 5667899999999999999888999999987643211 11256788889988877 4
Q ss_pred cccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046586 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH 579 (763)
Q Consensus 500 iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH 579 (763)
+++.++. ...++||||+++++|...... .....++.+++.++.++|
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------------------------------~~~~~~~~~i~~~l~~lh 142 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL------------------------------EDPEEVLDEILEEIVKAY 142 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc------------------------------ccHHHHHHHHHHHHHHHH
Confidence 4555442 355899999999988764310 223578899999999999
Q ss_pred hcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCC
Q 046586 580 EECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617 (763)
Q Consensus 580 ~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~ 617 (763)
+.+ |+|+||||+||++++++.++|+|||++.....
T Consensus 143 ~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 143 KHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred HCC---CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 988 99999999999999999999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=175.31 Aligned_cols=133 Identities=24% Similarity=0.318 Sum_probs=109.6
Q ss_pred ccccccccccceEEEEEeCCCcEEEEEEeecc-CC-------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNV-TG-------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 447 ~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~-~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..++||+|+||.||+|.+.+...++.+.+... .. ..+.+.+|++++..++|++++....++......++|||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 46799999999999998876554433333221 11 12457899999999999999998888888788899999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++. ....++.+++++|+|||+.+ ++||||||+|||+
T Consensus 417 ~~~g~~L~~~l~--------------------------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl 461 (535)
T PRK09605 417 YIGGKDLKDVLE--------------------------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV 461 (535)
T ss_pred ecCCCcHHHHHH--------------------------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE
Confidence 999999999872 34578999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCccccc
Q 046586 599 GDDFCPKISDFGLAKLR 615 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~ 615 (763)
+++.++|+|||+++..
T Consensus 462 -~~~~~~liDFGla~~~ 477 (535)
T PRK09605 462 -RDDRLYLIDFGLGKYS 477 (535)
T ss_pred -ECCcEEEEeCcccccC
Confidence 6789999999999753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=151.44 Aligned_cols=129 Identities=21% Similarity=0.310 Sum_probs=106.0
Q ss_pred cccccccceEEEEEeCCCcEEEEEEeeccC--C-------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 450 LIGRGGFGDVYKGELTDHRVVAVKCLKNVT--G-------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~--~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.||+|+||.||+|.. ++..+++|...... . ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 45778999865321 1 1245678999999999888766666666777789999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++.... ..++.+++.+|++||+.+ ++|+|++|+||+++
T Consensus 80 ~g~~l~~~~~~~~-------------------------------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~- 124 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------------------------------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR- 124 (199)
T ss_pred CCccHHHHHhhcH-------------------------------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-
Confidence 9999998874310 078999999999999998 99999999999999
Q ss_pred CCCeEEcccCcccc
Q 046586 601 DFCPKISDFGLAKL 614 (763)
Q Consensus 601 ~~~~kI~DFGla~~ 614 (763)
++.+++.|||++..
T Consensus 125 ~~~~~liDfg~a~~ 138 (199)
T TIGR03724 125 DDKLYLIDFGLGKY 138 (199)
T ss_pred CCcEEEEECCCCcC
Confidence 89999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.1e-14 Score=142.25 Aligned_cols=136 Identities=20% Similarity=0.145 Sum_probs=97.7
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeeccCCch---hhh----------------------HHHHHHHhcCCCC--cc
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGD---AEF----------------------WAEVTIIARMHHL--NL 500 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~---~~f----------------------~~E~~~l~~l~H~--ni 500 (763)
.+.||+|+||.||+|...+++.||||+++...... ..+ ..|...+..+++. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998888999999987532211 111 2455556555433 24
Q ss_pred ccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 046586 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE 580 (763)
Q Consensus 501 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~ 580 (763)
.+.+++ ...++||||++++.+........ ... .....++.+++.++.++|.
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------------------------~~~-~~~~~~~~~~~~~l~~lh~ 132 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------------------------RLL-EDPEELYDQILELMRKLYR 132 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh------------------------hhc-ccHHHHHHHHHHHHHHHhh
Confidence 444443 24689999999965432211100 000 4567899999999999999
Q ss_pred -cCCCcEEecCCCCCceEEcCCCCeEEcccCcccccC
Q 046586 581 -ECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK 616 (763)
Q Consensus 581 -~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~ 616 (763)
.+ |+|+||||+||+++ ++.++|+|||.+....
T Consensus 133 ~~~---ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 133 EAG---LVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred ccC---cCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 77 99999999999999 9999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.1e-13 Score=140.20 Aligned_cols=134 Identities=20% Similarity=0.231 Sum_probs=103.2
Q ss_pred cccc-ccccceEEEEEeCCCcEEEEEEeecc-------C-------CchhhhHHHHHHHhcCCCCcc--ccEEEEEeeCC
Q 046586 449 NLIG-RGGFGDVYKGELTDHRVVAVKCLKNV-------T-------GGDAEFWAEVTIIARMHHLNL--VRLWGFCAEKG 511 (763)
Q Consensus 449 ~~LG-~G~fG~Vy~g~~~~~~~VAvK~l~~~-------~-------~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~~ 511 (763)
..|| .|+.|+||+.... +..++||+++.. . .....+.+|++++.+|+|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4787 8999999999886 456888887521 0 122457889999999998875 67777754432
Q ss_pred ----eeeEEEecCCC-CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 512 ----ERTLVYEYVPN-GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 512 ----~~~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
..++|+|++++ .+|.+++... .++. ....+++.+|.+||+.+ |
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-------------------------~l~~----~~~~~i~~~l~~lH~~G---I 163 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-------------------------PLSE----EQWQAIGQLIARFHDAG---V 163 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-------------------------CCCH----HHHHHHHHHHHHHHHCC---C
Confidence 23599999997 6898887421 1222 23568999999999999 9
Q ss_pred EecCCCCCceEEcCCCCeEEcccCccccc
Q 046586 587 LHCDIKPENILLGDDFCPKISDFGLAKLR 615 (763)
Q Consensus 587 vHrDlk~~NILl~~~~~~kI~DFGla~~~ 615 (763)
+|+||||.|||++.++.++|+|||.+...
T Consensus 164 ~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 164 YHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred CCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 99999999999999999999999999753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.7e-13 Score=128.37 Aligned_cols=134 Identities=24% Similarity=0.228 Sum_probs=112.8
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCC--CccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHH--LNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
.+.||+|.++.||++...+ ..+++|..+.... ..++.+|+.++..++| .++++++++....+..+++|||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 3579999999999999866 6799999865443 5678899999999976 5899999988888889999999988665
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeE
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~k 605 (763)
..+ +......++.++++++++||......++|+|++|+||++++.+.++
T Consensus 81 ~~~-------------------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~ 129 (155)
T cd05120 81 DEV-------------------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILG 129 (155)
T ss_pred ccC-------------------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEE
Confidence 432 3456677899999999999986444599999999999999999999
Q ss_pred EcccCcccc
Q 046586 606 ISDFGLAKL 614 (763)
Q Consensus 606 I~DFGla~~ 614 (763)
+.|||.+..
T Consensus 130 l~Df~~~~~ 138 (155)
T cd05120 130 IIDWEYAGY 138 (155)
T ss_pred EEecccccC
Confidence 999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.6e-14 Score=164.10 Aligned_cols=138 Identities=23% Similarity=0.363 Sum_probs=103.2
Q ss_pred HHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCC-------c-------ccccccccCCCccccc
Q 046586 571 VARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED-------M-------VSMSRIRGTRGYMAPE 636 (763)
Q Consensus 571 ia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~-------~-------~~~~~~~gt~~y~APE 636 (763)
++.+++|||+.+ |+|||+||+|.+|..-|++|+.|||+++...... . ..-..++||+.|+|||
T Consensus 152 mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 152 MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 378999999998 9999999999999999999999999997432110 0 1123467999999999
Q ss_pred ccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhccccccc--CCCcchHHH
Q 046586 637 WLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNS--YDSRVHFDM 714 (763)
Q Consensus 637 ~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~~ 714 (763)
++....|...+|.|++|+++||.+-|..||.+... ++++...+... +++. ....
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-----------------------eelfg~visd~i~wpE~-dea~ 284 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----------------------EELFGQVISDDIEWPEE-DEAL 284 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-----------------------HHHHhhhhhhhcccccc-CcCC
Confidence 99999999999999999999999999999975432 11111111100 0000 1334
Q ss_pred HHHHHHHHHHccCCCCCCCCC
Q 046586 715 VNRMVKTAMWCIQDRPELRPS 735 (763)
Q Consensus 715 ~~~l~~l~~~Cl~~dP~~RPs 735 (763)
..++.+++.+.|+.+|..|--
T Consensus 285 p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhcc
Confidence 567778888899999999963
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.2e-13 Score=111.36 Aligned_cols=62 Identities=18% Similarity=0.375 Sum_probs=52.8
Q ss_pred cccCceeeEeeeeeccCCccccc-cccchHHHHHHccCCCceeeEEEee-CCccceE-Eeeeccc
Q 046586 270 NLRNTKFLQLDYVNFSRGNLSDL-EADNFSACKANCSANPKCVAFGFKY-DGKRYCV-LVDQLLY 331 (763)
Q Consensus 270 C~~~~~f~~~~~~~~~~~~~~~~-~~~~~~~C~~~Cl~nCsC~a~~~~~-~~~~~C~-~~~~l~~ 331 (763)
|+.+|+|+++++|++|++..... .+.++++|++.||+||||+||+|.. .++++|+ |.++|++
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 45789999999999999865543 5689999999999999999999973 3678999 8888876
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.2e-13 Score=158.95 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=177.4
Q ss_pred hccccccccccccceEEEEEeCC--CcEEEEEEeeccCCch---hhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD--HRVVAVKCLKNVTGGD---AEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~--~~~VAvK~l~~~~~~~---~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~ 517 (763)
.+++.+.||+|.|+.|-...... ...+|+|.+....... +....|..+-..+. |+|++++++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 45566779999999998876543 3456666665433222 22334666666675 999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcEEecCCCCCce
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH-EECLEWVLHCDIKPENI 596 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH-~~~~~~ivHrDlk~~NI 596 (763)
+|..++++.+.+... .....+....-....|+..++.|+| ..+ +.||||||+|.
T Consensus 101 ~~s~g~~~f~~i~~~----------------------~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~ 155 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP----------------------DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNS 155 (601)
T ss_pred CcccccccccccccC----------------------CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccc
Confidence 999999998877311 1112233344567889999999999 777 99999999999
Q ss_pred EEcCCC-CeEEcccCcccccCC-CCc-cccccccc-CCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 597 LLGDDF-CPKISDFGLAKLRKK-EDM-VSMSRIRG-TRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 597 Ll~~~~-~~kI~DFGla~~~~~-~~~-~~~~~~~g-t~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
+++..+ ..|++|||+|..... ... .......| ++.|+|||...+ ....+..|+||.|+++.-+++|..|.+....
T Consensus 156 ~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 156 LLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred hhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 999999 999999999986655 222 33344567 999999999887 4566789999999999999999998764432
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
.. ..+..|... ....... ..........++...++..+|..|.+.+++.
T Consensus 236 ~~----~~~~~~~~~--------~~~~~~~--------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 236 KD----GRYSSWKSN--------KGRFTQL--------PWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cc----ccceeeccc--------ccccccC--------ccccCChhhhhcccccccCCchhcccccccc
Confidence 21 111111000 0000000 0122334566677778889999999988765
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.2e-12 Score=108.24 Aligned_cols=79 Identities=20% Similarity=0.321 Sum_probs=62.5
Q ss_pred ccccccC---ceeeEeeeeeccCCccccccccchHHHHHHccCCCceeeEEEeeCCccceE-EeeecccceecCCCCCeE
Q 046586 267 ELKNLRN---TKFLQLDYVNFSRGNLSDLEADNFSACKANCSANPKCVAFGFKYDGKRYCV-LVDQLLYGYWSPGTEMAT 342 (763)
Q Consensus 267 ~l~C~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~C~-~~~~l~~~~~~~~~~~~~ 342 (763)
+++|... ++|++++++++|+..+.. ...++++|++.|++||+|+||+|. +++++|+ |...+.+.......+..+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~-~~~~~C~~~~~~~~~~~~~~~~~~~~ 79 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYN-NGSGGCLLWNGLLNNLRSLSSGGGTL 79 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeec-CCCCeEEEEeceecceEeecCCCcEE
Confidence 4566543 799999999999876555 677999999999999999999998 5678999 556666655544445899
Q ss_pred EEEee
Q 046586 343 FLRVD 347 (763)
Q Consensus 343 ylk~~ 347 (763)
|||++
T Consensus 80 yiKv~ 84 (84)
T cd01098 80 YLRLA 84 (84)
T ss_pred EEEeC
Confidence 99984
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.6e-12 Score=130.43 Aligned_cols=152 Identities=22% Similarity=0.326 Sum_probs=117.0
Q ss_pred HhcCCCCccccEEEEEeeC-----CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHH
Q 046586 492 IARMHHLNLVRLWGFCAEK-----GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566 (763)
Q Consensus 492 l~~l~H~niv~l~g~~~~~-----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 566 (763)
|-.+.|.|||+++.|+.+. .+..++.|||..|+|..+|++.++ ....+......+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--------------------~~~a~~~~~wkk 180 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--------------------NQKALFQKAWKK 180 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--------------------hhhhhhHHHHHH
Confidence 4455799999999998754 357789999999999999987542 345677778889
Q ss_pred HHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCccccc---CCCCcccccccccCCCcccccccccCCC
Q 046586 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR---KKEDMVSMSRIRGTRGYMAPEWLRSDQI 643 (763)
Q Consensus 567 ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~---~~~~~~~~~~~~gt~~y~APE~l~~~~~ 643 (763)
++-||..||.|||+.. ++|+|+++..+.|++..++-+||.----.... ............+-++|.|||+-...+.
T Consensus 181 w~tqIlsal~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~ 259 (458)
T KOG1266|consen 181 WCTQILSALSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT 259 (458)
T ss_pred HHHHHHhhhhhhhccC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc
Confidence 9999999999999976 78999999999999999999988632211100 0000011222346789999998877788
Q ss_pred CCccceeehhHHHHHHHhCCC
Q 046586 644 TPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 644 s~ksDVwS~Gvll~elltG~~ 664 (763)
+.++|||+||+..+||.-+..
T Consensus 260 ~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 260 TGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred ccchhhhhhhHHHHHHHHhee
Confidence 889999999999999977653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.29 E-value=7.5e-12 Score=139.83 Aligned_cols=140 Identities=21% Similarity=0.222 Sum_probs=99.3
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCch-----------------------------------------hhhHH
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGD-----------------------------------------AEFWA 487 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~-----------------------------------------~~f~~ 487 (763)
+.||.|++|.||+|++.+|+.||||+.+...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4799999999999999999999999986431100 02445
Q ss_pred HHHHHhcC----CCCccccEEEEEe-eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHH
Q 046586 488 EVTIIARM----HHLNLVRLWGFCA-EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562 (763)
Q Consensus 488 E~~~l~~l----~H~niv~l~g~~~-~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 562 (763)
|+..+.++ +|.+-+..-.++. .....+|||||++|++|.++..... ...
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-----------------------~~~--- 256 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-----------------------AGL--- 256 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-----------------------cCC---
Confidence 55555554 2333233333332 2446799999999999988764211 011
Q ss_pred HHHHHHHHHHH-HHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCC
Q 046586 563 IRYRIALGVAR-AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617 (763)
Q Consensus 563 ~~~~ia~qia~-gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~ 617 (763)
.+.+++..++. .+..+|..+ ++|+|+||.||+++.++++++.|||++.....
T Consensus 257 ~~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 257 DRKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CHHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 23456666666 467889888 99999999999999999999999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.6e-11 Score=115.54 Aligned_cols=130 Identities=18% Similarity=0.096 Sum_probs=97.2
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccc-cEEEEEeeCCeeeEEEecCCCCCHhH
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLV-RLWGFCAEKGERTLVYEYVPNGSLAD 527 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~LV~Ey~~~gsL~~ 527 (763)
+.|+.|.++.||++... ++.+++|+..........+.+|+.+++.+.+.+++ +++.+. ....++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 46889999999999876 56799998865433334567899999998665554 444443 334689999999987653
Q ss_pred HhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEecCCCCCceEEcCCCCeE
Q 046586 528 YLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEEC--LEWVLHCDIKPENILLGDDFCPK 605 (763)
Q Consensus 528 ~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~--~~~ivHrDlk~~NILl~~~~~~k 605 (763)
.. .....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++
T Consensus 81 ~~--------------------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~ 127 (170)
T cd05151 81 ED--------------------------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLW 127 (170)
T ss_pred cc--------------------------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEE
Confidence 20 001245678999999999976 23369999999999999 66899
Q ss_pred EcccCcccc
Q 046586 606 ISDFGLAKL 614 (763)
Q Consensus 606 I~DFGla~~ 614 (763)
++|||.+..
T Consensus 128 liDf~~a~~ 136 (170)
T cd05151 128 LIDWEYAGM 136 (170)
T ss_pred EEecccccC
Confidence 999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=3e-11 Score=100.48 Aligned_cols=69 Identities=12% Similarity=0.121 Sum_probs=58.0
Q ss_pred ccCceeeEeeeeeccCCccccccccchHHHHHHccC---CCceeeEEEeeCCccceE-Eeeec-ccceecCCCCCeEEEE
Q 046586 271 LRNTKFLQLDYVNFSRGNLSDLEADNFSACKANCSA---NPKCVAFGFKYDGKRYCV-LVDQL-LYGYWSPGTEMATFLR 345 (763)
Q Consensus 271 ~~~~~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~~~~~~~C~-~~~~l-~~~~~~~~~~~~~ylk 345 (763)
..+.+|+++.+|++|++.. .++++|+++|++ ||||+||+|.. .+++|+ |.+++ .+.++....+.++|+|
T Consensus 6 ~~~g~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~-~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 6 KSAGTTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAK-ARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred ecCCeEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccC-CCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 4567899999999997654 689999999999 99999999973 346899 88888 7877766678899998
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.3e-10 Score=128.32 Aligned_cols=251 Identities=22% Similarity=0.228 Sum_probs=177.2
Q ss_pred HHHHHHHhccccccccc--cccceEEEEEe---CCCcEEEEEEeeccCC---chhhhHHHHHHHhcC-CCCccccEEEEE
Q 046586 437 HAELRAATNGFSNLIGR--GGFGDVYKGEL---TDHRVVAVKCLKNVTG---GDAEFWAEVTIIARM-HHLNLVRLWGFC 507 (763)
Q Consensus 437 ~~el~~~t~~~~~~LG~--G~fG~Vy~g~~---~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l-~H~niv~l~g~~ 507 (763)
..+....+.++.+.+|. |.+|.||++.. .++..+|+|.-+.... ....=.+|+....++ .|+|.++....+
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence 33455666777889999 99999999977 3567889888553222 222334677777777 599999999999
Q ss_pred eeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCC
Q 046586 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVAR----AIAYLHEECL 583 (763)
Q Consensus 508 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~----gL~yLH~~~~ 583 (763)
.+.+..++=.|++. .+|.++..... ..++......+..+..+ |+..+|...
T Consensus 188 e~~~~lfiqtE~~~-~sl~~~~~~~~-----------------------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~- 242 (524)
T KOG0601|consen 188 EGSGILFIQTELCG-ESLQSYCHTPC-----------------------NFLPDNLLWNSLRDWLSRDVTALSHLHSNN- 242 (524)
T ss_pred ccCCcceeeecccc-chhHHhhhccc-----------------------ccCCchhhhhHHhhhhhcccccccccCCCc-
Confidence 99999999999885 68887775422 22344445555666666 999999988
Q ss_pred CcEEecCCCCCceEEcCC-CCeEEcccCcccccCCCCccc----ccccccCCCcccccccccCCCCCccceeehhHHHHH
Q 046586 584 EWVLHCDIKPENILLGDD-FCPKISDFGLAKLRKKEDMVS----MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLE 658 (763)
Q Consensus 584 ~~ivHrDlk~~NILl~~~-~~~kI~DFGla~~~~~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~e 658 (763)
++|-|+||.||++..+ ...+++|||+...+....... ..+..|...|++||... +-++.++|+|++|.+..|
T Consensus 243 --~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~ 319 (524)
T KOG0601|consen 243 --IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILE 319 (524)
T ss_pred --ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHh
Confidence 9999999999999999 889999999998776554321 12235677899999765 567889999999999999
Q ss_pred HHhCCCCcccc--cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 659 IVSGSRNFEIQ--GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 659 lltG~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
..++....... ....+ +.+.....+..+ ....++......+++.+|-.|++.
T Consensus 320 ~~l~~~~~~~g~~~~W~~-------------~r~~~ip~e~~~-------------~~s~~l~~~~~~~~d~~~~~~~~~ 373 (524)
T KOG0601|consen 320 AILGSHLPSVGKNSSWSQ-------------LRQGYIPLEFCE-------------GGSSSLRSVTSQMLDEDPRLRLTA 373 (524)
T ss_pred hHhhcccccCCCCCCccc-------------cccccCchhhhc-------------CcchhhhhHHHHhcCcchhhhhHH
Confidence 99987765432 11111 000000111111 112334447888999999999998
Q ss_pred HHHHH
Q 046586 737 GKVAK 741 (763)
Q Consensus 737 ~eVv~ 741 (763)
.++..
T Consensus 374 q~~~~ 378 (524)
T KOG0601|consen 374 QILTA 378 (524)
T ss_pred HHHhc
Confidence 77654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-09 Score=110.14 Aligned_cols=141 Identities=20% Similarity=0.221 Sum_probs=100.0
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCC--chhhhHHHHHHHhcCCC--CccccEEEEEeeCC---eeeEEEecCC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHH--LNLVRLWGFCAEKG---ERTLVYEYVP 521 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~LV~Ey~~ 521 (763)
+.|+.|..+.||++...+|+.+++|+...... ...++..|+++++.+++ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999887777899999865432 34578899999999975 45677888776643 5689999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-------------------- 581 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-------------------- 581 (763)
+.++.+.+.. ..++..++..++.+++++|+.||+.
T Consensus 84 G~~l~~~~~~-------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~ 138 (223)
T cd05154 84 GRVLRDRLLR-------------------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQ 138 (223)
T ss_pred CEecCCCCCC-------------------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHH
Confidence 9888765421 1122333333344444444444321
Q ss_pred ---------------------------------CCCcEEecCCCCCceEEcC--CCCeEEcccCcccc
Q 046586 582 ---------------------------------CLEWVLHCDIKPENILLGD--DFCPKISDFGLAKL 614 (763)
Q Consensus 582 ---------------------------------~~~~ivHrDlk~~NILl~~--~~~~kI~DFGla~~ 614 (763)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 139 VARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.5e-09 Score=117.97 Aligned_cols=166 Identities=17% Similarity=0.211 Sum_probs=123.1
Q ss_pred EeCCCcEEEEEEeeccCCch-hhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChh
Q 046586 463 ELTDHRVVAVKCLKNVTGGD-AEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPA 541 (763)
Q Consensus 463 ~~~~~~~VAvK~l~~~~~~~-~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~ 541 (763)
+..++.+|.|...+...... ....+-++.|+.++||||++++....+.+..|||+|.+ ..|..++...
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l--------- 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL--------- 101 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh---------
Confidence 44567889998887554422 33567788899999999999999999999999999987 3566666432
Q ss_pred hhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcc
Q 046586 542 REMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621 (763)
Q Consensus 542 ~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~ 621 (763)
.-......+.||+.||.+||..+. ++|++|....|+++..|..||++|.++........
T Consensus 102 ------------------~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~- 160 (690)
T KOG1243|consen 102 ------------------GKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA- 160 (690)
T ss_pred ------------------HHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-
Confidence 234455678899999999997765 99999999999999999999999988854332211
Q ss_pred cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhC
Q 046586 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662 (763)
Q Consensus 622 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG 662 (763)
......--..|..|+.+.... -..|.|.||++++|++.|
T Consensus 161 ~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 000011112366676554332 457999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.01 E-value=4e-09 Score=104.01 Aligned_cols=136 Identities=16% Similarity=0.114 Sum_probs=97.4
Q ss_pred ccccccccceEEEEEeCC-------CcEEEEEEeeccCC----------ch-------------hhh----HHHHHHHhc
Q 046586 449 NLIGRGGFGDVYKGELTD-------HRVVAVKCLKNVTG----------GD-------------AEF----WAEVTIIAR 494 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~-------~~~VAvK~l~~~~~----------~~-------------~~f----~~E~~~l~~ 494 (763)
..||.|--+.||.|.-.+ +..+|||+.+.... +. ..+ .+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 47899999863211 01 012 278888998
Q ss_pred CCC--CccccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHH
Q 046586 495 MHH--LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVA 572 (763)
Q Consensus 495 l~H--~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia 572 (763)
+.. -++.+.+++ ...+|||||+.+..+..-.. ....++..+...+..+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L------------------------kd~~~~~~~~~~i~~~i~ 134 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL------------------------KDAKLNDEEMKNAYYQVL 134 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh------------------------hccccCHHHHHHHHHHHH
Confidence 853 466667764 46789999997654322111 011233445667889999
Q ss_pred HHHHHH-HhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccC
Q 046586 573 RAIAYL-HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK 616 (763)
Q Consensus 573 ~gL~yL-H~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~ 616 (763)
.+|..| |..+ |||+||++.||+++ ++.+.|+|||.+....
T Consensus 135 ~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 135 SMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999 7877 99999999999997 4689999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.7e-09 Score=122.42 Aligned_cols=141 Identities=18% Similarity=0.167 Sum_probs=90.0
Q ss_pred ccccccccceEEEEEeCC-CcEEEEEEeeccCCc-----------------------------------h------hhhH
Q 046586 449 NLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGG-----------------------------------D------AEFW 486 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~-----------------------------------~------~~f~ 486 (763)
+.||+|++|.||+|++.+ |+.||||+++..... . -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 479999999999999987 999999999743100 0 1244
Q ss_pred HHHHHHhcCC----CCccccEEEEEee-CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCH
Q 046586 487 AEVTIIARMH----HLNLVRLWGFCAE-KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561 (763)
Q Consensus 487 ~E~~~l~~l~----H~niv~l~g~~~~-~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 561 (763)
+|+.-+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.++-.... .+ .....+..
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g-----------------~d~~~la~ 266 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AG-----------------TDMKLLAE 266 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cC-----------------CCHHHHHH
Confidence 4554444442 3444443333332 456789999999999987431110 00 00011112
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC----CeEEcccCcccccCC
Q 046586 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF----CPKISDFGLAKLRKK 617 (763)
Q Consensus 562 ~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~----~~kI~DFGla~~~~~ 617 (763)
.....+..| ++..+ ++|+|+||.||+++.++ .+++.|||++.....
T Consensus 267 ~~v~~~~~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 267 RGVEVFFTQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 222222223 33455 99999999999999988 999999999976644
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.9e-09 Score=98.49 Aligned_cols=130 Identities=22% Similarity=0.280 Sum_probs=100.9
Q ss_pred cccccccceEEEEEeCCCcEEEEEEe-eccCCc--------hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 450 LIGRGGFGDVYKGELTDHRVVAVKCL-KNVTGG--------DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~~~~~VAvK~l-~~~~~~--------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.+++|+-+.+|.+.+.+.. +++|.- ++.... ...-.+|+.+|.+++--.|..-.-+..+.+...|+|||.
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775544 555543 332111 123568999999997666666666777888889999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++..|.+.+... +..++..+-.-+.-||..+ |||+||.++||++..
T Consensus 82 ~G~~lkd~l~~~-------------------------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~ 127 (204)
T COG3642 82 EGELLKDALEEA-------------------------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSG 127 (204)
T ss_pred CChhHHHHHHhc-------------------------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeC
Confidence 999999888431 2467777888888999999 999999999999988
Q ss_pred CCCeEEcccCccccc
Q 046586 601 DFCPKISDFGLAKLR 615 (763)
Q Consensus 601 ~~~~kI~DFGla~~~ 615 (763)
.. +.++||||+...
T Consensus 128 ~~-i~~IDfGLg~~s 141 (204)
T COG3642 128 GR-IYFIDFGLGEFS 141 (204)
T ss_pred Cc-EEEEECCccccc
Confidence 75 999999999743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.7e-09 Score=119.59 Aligned_cols=242 Identities=24% Similarity=0.227 Sum_probs=168.1
Q ss_pred ccccccccccccceEEEEEeC--CCcEEEEEEeeccCCch---hhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEe
Q 046586 445 NGFSNLIGRGGFGDVYKGELT--DHRVVAVKCLKNVTGGD---AEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~--~~~~VAvK~l~~~~~~~---~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.++...||.|.|+.|++...+ ++..+++|.+.+..... ..-+.|+.+...+ .|.++++....+......++=-|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 344568999999999998654 56788888887543322 1234566666666 58888888888888888889999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|++++++...+.- ...++...++++..|++.++.++|+.. ++|+|+||+||++
T Consensus 347 ~~~~~s~~l~~~~------------------------~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i 399 (524)
T KOG0601|consen 347 FCEGGSSSLRSVT------------------------SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILI 399 (524)
T ss_pred hhcCcchhhhhHH------------------------HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceee
Confidence 9999988776621 224556677889999999999999988 9999999999999
Q ss_pred cCC-CCeEEcccCcccccCCCCcccccccccCCCc-ccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 599 GDD-FCPKISDFGLAKLRKKEDMVSMSRIRGTRGY-MAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 599 ~~~-~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y-~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
..+ +..+++|||.+..+... ...-...+..| .+|+......+-.+.|++|||.-+.|.+++..--+....
T Consensus 400 ~~~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----- 471 (524)
T KOG0601|consen 400 SNDGFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----- 471 (524)
T ss_pred ccchhhhhcccccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----
Confidence 886 88899999998632111 11111122233 356666778899999999999999999988653221100
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
...+..... ... ......+..++..+...++..||.+.++..+.+
T Consensus 472 -----------------~~~i~~~~~-p~~-----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 472 -----------------SLTIRSGDT-PNL-----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -----------------ceeeecccc-cCC-----CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 001101000 011 122255666677788999999999888776554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.1e-08 Score=93.94 Aligned_cols=142 Identities=18% Similarity=0.272 Sum_probs=103.1
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeeccCC--------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG--------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~--------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
...|-+|+-+.|+++...+...+..++..+... .....++|+..+.+++--.|.--.-++.+...-.|+|||
T Consensus 12 l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred ceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 357889999999999987654343333332211 124567899999998766666666677777788899999
Q ss_pred CCC-CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 520 VPN-GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 520 ~~~-gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
.++ .++.+++...-. ....-......+..|-+.+.-||..+ |+|+||..+||++
T Consensus 92 ~~g~~~vk~~i~~~~~----------------------~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill 146 (229)
T KOG3087|consen 92 IDGASTVKDFILSTME----------------------DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILL 146 (229)
T ss_pred ccchhHHHHHHHHHcc----------------------CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEE
Confidence 977 488888865321 11111222678888999999999998 9999999999999
Q ss_pred cCCC---CeEEcccCcccc
Q 046586 599 GDDF---CPKISDFGLAKL 614 (763)
Q Consensus 599 ~~~~---~~kI~DFGla~~ 614 (763)
..++ .+.++|||++..
T Consensus 147 ~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 147 RSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ecCCCcCceEEEeecchhc
Confidence 6543 458999999964
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=6.4e-08 Score=104.75 Aligned_cols=179 Identities=17% Similarity=0.232 Sum_probs=130.5
Q ss_pred ceEEEEEe-CCCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEee----CCeeeEEEecCCC-CCHhHHh
Q 046586 457 GDVYKGEL-TDHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAE----KGERTLVYEYVPN-GSLADYL 529 (763)
Q Consensus 457 G~Vy~g~~-~~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV~Ey~~~-gsL~~~L 529 (763)
.+.||+.. .||..+++|+++.... ....-..-++..+++.|.|+|+|..++.. +..+++||+|.|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57899865 4788999999953221 11123456788999999999999998873 3478899999986 5787776
Q ss_pred hhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEccc
Q 046586 530 FRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDF 609 (763)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DF 609 (763)
+........... ........++....+.++.|++.||.++|+.| ..-+-|.+++||++.+.+++|+..
T Consensus 370 F~~~~~t~~~n~---------~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 370 FANPPFTKRTNS---------FYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred ccCCcccccccc---------ccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecc
Confidence 654321110000 01113456788899999999999999999999 777999999999999999999999
Q ss_pred CcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCC
Q 046586 610 GLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 610 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
|...+...+.... +. --.+-|.=.||.+++.|.+|...
T Consensus 438 ~i~Dvl~~d~~~~---------------le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 438 GIMDVLQEDPTEP---------------LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cceeeecCCCCcc---------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 9887765543111 11 12356777899999999999654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.1e-07 Score=91.55 Aligned_cols=125 Identities=23% Similarity=0.219 Sum_probs=81.7
Q ss_pred eEEEEEeCCCcEEEEEEeeccCCc------------h---------------hhhHHHHHHHhcCCCC--ccccEEEEEe
Q 046586 458 DVYKGELTDHRVVAVKCLKNVTGG------------D---------------AEFWAEVTIIARMHHL--NLVRLWGFCA 508 (763)
Q Consensus 458 ~Vy~g~~~~~~~VAvK~l~~~~~~------------~---------------~~f~~E~~~l~~l~H~--niv~l~g~~~ 508 (763)
.||.|...++..+|+|+.+..... . ....+|.+.|.++... ++.+.+.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999999999999998632110 0 1256799999999765 566666543
Q ss_pred eCCeeeEEEecCC--CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCc
Q 046586 509 EKGERTLVYEYVP--NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAY-LHEECLEW 585 (763)
Q Consensus 509 ~~~~~~LV~Ey~~--~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~y-LH~~~~~~ 585 (763)
.-.|||||++ +..+...... .++......++.+++..+.. +|..+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~--------------------------~~~~~~~~~~~~~il~~~~~~~~~~g--- 127 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV--------------------------DLSPEEPKELLEEILEEIIKMLHKAG--- 127 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC--------------------------GGGGSTHHHHHHHHHHHHHHHHHCTT---
T ss_pred ---CCEEEEEecCCCccchhhHHhc--------------------------cccchhHHHHHHHHHHHHHHHHHhcC---
Confidence 4579999998 5444443211 11123345677788886666 46777
Q ss_pred EEecCCCCCceEEcCCCCeEEcccCcccccC
Q 046586 586 VLHCDIKPENILLGDDFCPKISDFGLAKLRK 616 (763)
Q Consensus 586 ivHrDlk~~NILl~~~~~~kI~DFGla~~~~ 616 (763)
|||+||.+.||+++++ .+.|+|||.+....
T Consensus 128 ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 128 IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 9999999999999988 99999999986544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.3e-07 Score=93.42 Aligned_cols=132 Identities=18% Similarity=0.112 Sum_probs=95.1
Q ss_pred ceEEEEEeCCCcEEEEEEeeccCC------------chhhhHHHHHHHhcCCCC--ccccEEEEEee-----CCeeeEEE
Q 046586 457 GDVYKGELTDHRVVAVKCLKNVTG------------GDAEFWAEVTIIARMHHL--NLVRLWGFCAE-----KGERTLVY 517 (763)
Q Consensus 457 G~Vy~g~~~~~~~VAvK~l~~~~~------------~~~~f~~E~~~l~~l~H~--niv~l~g~~~~-----~~~~~LV~ 517 (763)
..|.+..+ +|+.+.||....... ....+.+|...+.++... ..+..+++... ....+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34666665 456799997643221 112477899998888533 34455666543 23578999
Q ss_pred ecCCCC-CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 518 EYVPNG-SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 518 Ey~~~g-sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|++++- +|.+++.... ....+...+..++.+++..++-||..+ |+|+|++++||
T Consensus 115 e~l~~~~sL~~~~~~~~----------------------~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~Ni 169 (268)
T PRK15123 115 EDLAPTISLEDYCADWA----------------------TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHF 169 (268)
T ss_pred eeCCCCccHHHHHHhhc----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhE
Confidence 999886 8998874321 122345567789999999999999999 99999999999
Q ss_pred EEcC-------CCCeEEcccCcccc
Q 046586 597 LLGD-------DFCPKISDFGLAKL 614 (763)
Q Consensus 597 Ll~~-------~~~~kI~DFGla~~ 614 (763)
|++. +..+.++||+.++.
T Consensus 170 Ll~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 170 LLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred EEeccccCCCCCceEEEEECCcccc
Confidence 9975 57899999998863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.3e-08 Score=118.18 Aligned_cols=240 Identities=20% Similarity=0.236 Sum_probs=150.6
Q ss_pred ccccccccceEEEEEeCC-CcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELTD-HRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
+-+-+|.++.++.+.-.. +...+.|+.+.. ....+..+.+-.++-..+||-++...--+.-....+||++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 356677787777664322 222233332211 111122222322332334565555444444566889999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|...|+... ..+..-.......+.+.++|||... ++|+|++|.|+++..+++
T Consensus 890 ~~~Skl~~~~------------------------~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh 942 (1205)
T KOG0606|consen 890 DLPSKLHNSG------------------------CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGH 942 (1205)
T ss_pred CchhhhhcCC------------------------CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCC
Confidence 9999987643 1111122234456788999999976 899999999999999999
Q ss_pred eEEcccCcccccCC------C---------------C---c------ccccccccCCCcccccccccCCCCCccceeehh
Q 046586 604 PKISDFGLAKLRKK------E---------------D---M------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFG 653 (763)
Q Consensus 604 ~kI~DFGla~~~~~------~---------------~---~------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~G 653 (763)
.+++|||....... . . . .......+|+.|.+||.+.+......+|.|+.|
T Consensus 943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen 943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence 99999984321100 0 0 0 011224689999999999999999999999999
Q ss_pred HHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCC
Q 046586 654 MVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELR 733 (763)
Q Consensus 654 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 733 (763)
+.++|.++|..||....... . .+.++....... ..+.+...++.++....+..+|.+|
T Consensus 1023 ~~l~e~l~g~pp~na~tpq~--------------~-----f~ni~~~~~~~p---~g~~~~s~~aq~~~~~ll~~~~~qr 1080 (1205)
T KOG0606|consen 1023 VCLFEVLTGIPPFNAETPQQ--------------I-----FENILNRDIPWP---EGPEEGSYEAQDLINRLLTEEPTQR 1080 (1205)
T ss_pred hhhhhhhcCCCCCCCcchhh--------------h-----hhccccCCCCCC---CCccccChhhhhhhhhhhccCchhc
Confidence 99999999999997443211 0 111222211110 1123445566677777888889888
Q ss_pred CCHH
Q 046586 734 PSMG 737 (763)
Q Consensus 734 Ps~~ 737 (763)
-.|.
T Consensus 1081 ~~a~ 1084 (1205)
T KOG0606|consen 1081 LGAK 1084 (1205)
T ss_pred cCcc
Confidence 7765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.6e-06 Score=91.89 Aligned_cols=264 Identities=14% Similarity=0.130 Sum_probs=152.5
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEE------e-eCCeeeEEEec
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFC------A-EKGERTLVYEY 519 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~------~-~~~~~~LV~Ey 519 (763)
+..||+|+-+.+|-.-.-.+ .+-|+.+......+ .+.++.|.+. .||-+-.-+.+= - .....-+.|..
T Consensus 16 gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchhhc--hhheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 46799999999996422222 23466654322211 1223334444 565443311110 0 11124455666
Q ss_pred CCCC-CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 520 VPNG-SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 520 ~~~g-sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
+++. .+..++.... ....-+..+|...++.+..+|.+.+-||..| .+-+|+.++|+|+
T Consensus 92 v~g~~pI~~~y~p~t------------------RRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lV 150 (637)
T COG4248 92 VSGKEPIHMIYSPAT------------------RRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLV 150 (637)
T ss_pred CCCccchhhhcCchh------------------hcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceee
Confidence 6553 2222221100 0113456899999999999999999999999 7889999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhC-CCCcccccCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSG-SRNFEIQGSM 672 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG-~~p~~~~~~~ 672 (763)
.+++.+.+.|-..-.+.... .....-+|...|.+||.-. +-.-+...|-|.+||++++++.| ++||.+....
T Consensus 151 sd~~~V~LVdsDsfqi~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~ 228 (637)
T COG4248 151 SDDSKVVLVDSDSFQINANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI 228 (637)
T ss_pred ecCceEEEEcccceeeccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc
Confidence 99999999986655433221 1222346788899999654 34566789999999999999875 9999754321
Q ss_pred CCCCCCchh-HHHHHHHHhccChhhhhc--ccccccCCCcch-HHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHhccC
Q 046586 673 MNSDEWYFP-KWAFEKVYEEMKVEDILD--RHIKNSYDSRVH-FDMVNRMVKTAMWCIQDR--PELRPSMGKVAKMLEGT 746 (763)
Q Consensus 673 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~-~~~~~~l~~l~~~Cl~~d--P~~RPs~~eVv~~Le~~ 746 (763)
... ...+. +.+ .+. ....-+ +.+.. .+...| .-.+..+.-+..+|+... +.-|||++..+..|...
T Consensus 229 ~~a-p~p~E~~Ia-----~g~-f~ya~~~~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 229 SDA-PNPLETDIA-----HGR-FAYASDQRRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred CCC-CCcchhhhh-----cce-eeechhccCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 110 00000 000 000 000000 00110 011112 223445666667787543 67899999999888654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.3e-07 Score=106.07 Aligned_cols=150 Identities=20% Similarity=0.346 Sum_probs=99.8
Q ss_pred HHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcc-----cc---cccccCCCcccccccc
Q 046586 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-----SM---SRIRGTRGYMAPEWLR 639 (763)
Q Consensus 568 a~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~-----~~---~~~~gt~~y~APE~l~ 639 (763)
+.+++.||.|+|...+ +||++|.|++|.++.++..||+.|+.+......... .. .-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456699999998764 999999999999999999999999988644331111 00 1123456799999999
Q ss_pred cCCCCCccceeehhHHHHHHHhCCC-CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHH
Q 046586 640 SDQITPKADVYSFGMVLLEIVSGSR-NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRM 718 (763)
Q Consensus 640 ~~~~s~ksDVwS~Gvll~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l 718 (763)
+...+.++|+||+|+++|-+..|.. -+...+.... .. .....+..-...+. .+.+.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---~~--------------~~~~~~~~~~~~~s----~~~p~el 241 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---YS--------------FSRNLLNAGAFGYS----NNLPSEL 241 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch---hh--------------hhhccccccccccc----ccCcHHH
Confidence 9889999999999999999995444 3332221110 00 00000000001111 2345566
Q ss_pred HHHHHHccCCCCCCCCCHHHHH
Q 046586 719 VKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 719 ~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
.+=+...+..++..||++.++.
T Consensus 242 ~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 242 RESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHHHHHhcCCcccCcchhhhh
Confidence 6666778999999999777665
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.9e-06 Score=85.88 Aligned_cols=136 Identities=21% Similarity=0.159 Sum_probs=95.2
Q ss_pred ccccccccccccceEEEEEeCCCcEEEEEEeeccCCc-----------------------hhhhHHHHHHHhcCCCC--c
Q 046586 445 NGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG-----------------------DAEFWAEVTIIARMHHL--N 499 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~-----------------------~~~f~~E~~~l~~l~H~--n 499 (763)
+.+.++||.|--+.||.|..+.|.++|||.-+..... .....+|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567899999999999999999999999986521110 01256788999999644 6
Q ss_pred cccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046586 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH 579 (763)
Q Consensus 500 iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH 579 (763)
+.+.+++ +...+||||.++-.|...- ++....-.|+..|++-+.-+-
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----------------------------~~~en~~~il~~il~~~~~~~ 219 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----------------------------LDVENPDEILDKILEEVRKAY 219 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----------------------------CcccCHHHHHHHHHHHHHHHH
Confidence 6666554 3557999999886554321 112222334444444444444
Q ss_pred hcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccC
Q 046586 580 EECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK 616 (763)
Q Consensus 580 ~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~ 616 (763)
..| |||+|+.+-||+++++|.+.++||--+....
T Consensus 220 ~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 220 RRG---IVHGDLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred HcC---ccccCCchheEEEecCCCEEEEeCcccccCC
Confidence 556 9999999999999999999999997665433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=8.6e-06 Score=80.71 Aligned_cols=137 Identities=19% Similarity=0.146 Sum_probs=102.1
Q ss_pred ccccccceEEEEEeCCCcEEEEEEeecc-------CCchhhhHHHHHHHhcCCC--CccccEEEEEe-eC----CeeeEE
Q 046586 451 IGRGGFGDVYKGELTDHRVVAVKCLKNV-------TGGDAEFWAEVTIIARMHH--LNLVRLWGFCA-EK----GERTLV 516 (763)
Q Consensus 451 LG~G~fG~Vy~g~~~~~~~VAvK~l~~~-------~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~-~~----~~~~LV 516 (763)
-|+||-+.|++-.+.+. .+-+|.-.+. ..+...|.+|...|.+|.. -.+.+.+ ++. .. ..-+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46799999999877655 5888876521 2255679999999999853 3344444 332 21 246789
Q ss_pred EecCCC-CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 517 YEYVPN-GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 517 ~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
+|-+++ .+|.+++... .....+...+..+..++++.++-||+.+ +.|+|+.+.|
T Consensus 104 Te~L~g~~~L~~~l~~~----------------------~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~kh 158 (216)
T PRK09902 104 TEDMAGFISIADWYAQH----------------------AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRH 158 (216)
T ss_pred EEeCCCCccHHHHHhcC----------------------CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhh
Confidence 997754 5898888542 1234566777899999999999999999 9999999999
Q ss_pred eEEcCCCC--eEEcccCcccc
Q 046586 596 ILLGDDFC--PKISDFGLAKL 614 (763)
Q Consensus 596 ILl~~~~~--~kI~DFGla~~ 614 (763)
|+++.++. ++++||.-++.
T Consensus 159 Ill~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 159 IYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eeecCCCCeeEEEEEhhccch
Confidence 99986667 99999987753
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.2e-06 Score=71.49 Aligned_cols=72 Identities=17% Similarity=0.355 Sum_probs=52.2
Q ss_pred CceeeEeeeeeccCCccccccccchHHHHHHccC-CCceeeEEEeeCCccceEEee--ecccceecCCCCCeEEEE
Q 046586 273 NTKFLQLDYVNFSRGNLSDLEADNFSACKANCSA-NPKCVAFGFKYDGKRYCVLVD--QLLYGYWSPGTEMATFLR 345 (763)
Q Consensus 273 ~~~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~~~~~~~C~~~~--~l~~~~~~~~~~~~~ylk 345 (763)
...|.+++++.+++.........++++|++.|++ +|+|.||.|.. +++.|+++. .+.+....+....+.|.|
T Consensus 3 ~~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~-~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNN-GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred CceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcC-CCCEEEEeeCCccccceecccCCceeEEe
Confidence 4569999999998655443455699999999999 99999999975 678999544 445544334444455544
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.8e-05 Score=79.68 Aligned_cols=107 Identities=25% Similarity=0.299 Sum_probs=84.3
Q ss_pred hhhhHHHHHHHhcCC--CCccccEEEEEeeCC----eeeEEEecCCCC-CHhHHhhhcCCCCCCChhhhhcccCCCCCCC
Q 046586 482 DAEFWAEVTIIARMH--HLNLVRLWGFCAEKG----ERTLVYEYVPNG-SLADYLFRSGRVGSSSPAREMEMSGVGPHDG 554 (763)
Q Consensus 482 ~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~----~~~LV~Ey~~~g-sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (763)
.....+|...+..|+ .-...+.+++..... ..+||+|++++. +|.+++....
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--------------------- 113 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--------------------- 113 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---------------------
Confidence 345778888888874 344566777766532 457999999884 8999886421
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC---CeEEcccCccccc
Q 046586 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF---CPKISDFGLAKLR 615 (763)
Q Consensus 555 ~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~---~~kI~DFGla~~~ 615 (763)
..+......++.++++.++-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 114 ---~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 114 ---QLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred ---ccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 1445667889999999999999999 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=6.5e-06 Score=92.94 Aligned_cols=140 Identities=21% Similarity=0.206 Sum_probs=91.1
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCch-------------------------------h----------hhHH
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGD-------------------------------A----------EFWA 487 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~-------------------------------~----------~f~~ 487 (763)
+-|+.++-|.||+|++.+|+.||||+.+..-... + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 4789999999999999999999999986432110 0 1344
Q ss_pred HHHHHhcC----CCCccccEEEEEe-eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHH
Q 046586 488 EVTIIARM----HHLNLVRLWGFCA-EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562 (763)
Q Consensus 488 E~~~l~~l----~H~niv~l~g~~~-~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 562 (763)
|..-+.++ ++..-++.-.++. -.....|+|||++|-.+.+...... ...+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-----------------------~g~d-- 265 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-----------------------AGID-- 265 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-----------------------cCCC--
Confidence 44444443 2222233333333 3567889999999998888753211 1222
Q ss_pred HHHHHHHHHHHHH-HHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCC
Q 046586 563 IRYRIALGVARAI-AYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617 (763)
Q Consensus 563 ~~~~ia~qia~gL-~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~ 617 (763)
+..++..++++. .-+-..+ ++|.|.+|.||+++.++++.+.|||+......
T Consensus 266 -~k~ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 266 -RKELAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -HHHHHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 223333333331 1222234 89999999999999999999999999976544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.4e-05 Score=78.70 Aligned_cols=72 Identities=17% Similarity=0.250 Sum_probs=53.6
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCc--cccEEEEEeeCCeeeEEEecCCCCC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLN--LVRLWGFCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~LV~Ey~~~gs 524 (763)
..||+|..+.||+. .+...++|...... ...+..+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 47899999999983 23456788876432 3445688999999986443 4677888877778889999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.6e-06 Score=96.38 Aligned_cols=184 Identities=17% Similarity=0.137 Sum_probs=136.1
Q ss_pred ccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCc-cccEEEEEeeCCeeeEEEecCCCC-C
Q 046586 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLN-LVRLWGFCAEKGERTLVYEYVPNG-S 524 (763)
Q Consensus 447 ~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~LV~Ey~~~g-s 524 (763)
+-+-+++|+.+.++|.+-...+....+.+... .+..-++++|.+++||| .+..++-+..++...++++++..+ +
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 34568899999999987765555556655432 44567899999999999 777777777777888899998776 1
Q ss_pred HhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCe
Q 046586 525 LADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP 604 (763)
Q Consensus 525 L~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 604 (763)
-..... .....+...+...+...-+++++|||+.. =+|+| ||+..+ +..
T Consensus 322 ~~~~~~-----------------------~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~ 370 (829)
T KOG0576|consen 322 SALEMT-----------------------VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEV 370 (829)
T ss_pred ccccCC-----------------------hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccc
Confidence 111110 01223455666777788889999999864 38998 776665 688
Q ss_pred EEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcc
Q 046586 605 KISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667 (763)
Q Consensus 605 kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~ 667 (763)
|..||+....+.... ..+...+|..|+|||....+.+..+.|+|+.|+-..++--|..|-.
T Consensus 371 ~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 371 KLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 999999887654433 3445678999999999999999999999999998777777776653
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.8e-05 Score=89.02 Aligned_cols=142 Identities=20% Similarity=0.137 Sum_probs=89.9
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCch--------------------------------------hhhHHHHH
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGD--------------------------------------AEFWAEVT 490 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~--------------------------------------~~f~~E~~ 490 (763)
+-||..+.|.||+|++.+|+.||||+.+..-... -+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999987432111 02455554
Q ss_pred HHhc----CCCCc---cccEEEEEe-eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHH
Q 046586 491 IIAR----MHHLN---LVRLWGFCA-EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562 (763)
Q Consensus 491 ~l~~----l~H~n---iv~l~g~~~-~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 562 (763)
=..+ +.|-+ -|..-.++. -...+.|+||||+|..+.+.-.-. +..++..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-----------------------~~gi~~~ 303 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-----------------------KRGISPH 303 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-----------------------HcCCCHH
Confidence 3333 34555 111222222 234789999999999887764321 1123333
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC----CCCeEEcccCcccccCCC
Q 046586 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD----DFCPKISDFGLAKLRKKE 618 (763)
Q Consensus 563 ~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~----~~~~kI~DFGla~~~~~~ 618 (763)
....-+.++..-+-+-| | .+|+|-+|.||++.. ++.+.+-|||+.......
T Consensus 304 ~i~~~l~~~~~~qIf~~--G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 304 DILNKLVEAYLEQIFKT--G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHHHHHHHHHHHhc--C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 33333333222222222 3 899999999999983 678999999999866543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.91 E-value=3.5e-05 Score=76.12 Aligned_cols=104 Identities=26% Similarity=0.338 Sum_probs=82.4
Q ss_pred HHHHHHhcCCC-CccccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHH
Q 046586 487 AEVTIIARMHH-LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565 (763)
Q Consensus 487 ~E~~~l~~l~H-~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 565 (763)
.|.-+++.+++ +++++++|+| ..++|.||.+.+++...-... ..-...+|..|.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l---------------------~~~~~~~w~~R~ 62 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPL---------------------SQFLQSPWEQRA 62 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccc---------------------ccccccCHHHHH
Confidence 57888888876 6999999999 347789999877654220000 011246899999
Q ss_pred HHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCccccc
Q 046586 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615 (763)
Q Consensus 566 ~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~ 615 (763)
+||.++++.+.+|+......+...|++++|+-+++++++|+.|...+...
T Consensus 63 ~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 63 KIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999999999876666888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00012 Score=75.59 Aligned_cols=75 Identities=16% Similarity=0.176 Sum_probs=54.6
Q ss_pred cccccc-ceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEecCCCCCHhHH
Q 046586 451 IGRGGF-GDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYEYVPNGSLADY 528 (763)
Q Consensus 451 LG~G~f-G~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 528 (763)
|-.|.. ..||+....+ ..+.+|+..... ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 7889987654 678888875433 345678999988883 44566778877766678999999999888654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00017 Score=71.81 Aligned_cols=138 Identities=15% Similarity=0.138 Sum_probs=86.9
Q ss_pred HHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhh----------hHHHHHHHhcCC---CCccccEEEE
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAE----------FWAEVTIIARMH---HLNLVRLWGF 506 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~----------f~~E~~~l~~l~---H~niv~l~g~ 506 (763)
+....+...+.+-.....-|.+-..++ +..++|..+......++ ..+++..+.+++ -.....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~-~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDG-KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECC-cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 344445555666666666666666644 66888887643322221 223333333332 2333333333
Q ss_pred Eee-----CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 046586 507 CAE-----KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE 581 (763)
Q Consensus 507 ~~~-----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~ 581 (763)
... ....+|||||++|..|.+... ++. .++..+++++.-||..
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----------------------------i~e----~~~~ki~~~ikqlH~~ 154 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----------------------------IDE----DLAEKIVEAIKQLHKH 154 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----------------------------cCH----HHHHHHHHHHHHHHHc
Confidence 332 234568999999987766541 111 3556688889999999
Q ss_pred CCCcEEecCCCCCceEEcCCCCeEEcccCcccc
Q 046586 582 CLEWVLHCDIKPENILLGDDFCPKISDFGLAKL 614 (763)
Q Consensus 582 ~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~ 614 (763)
| ++|+|.+|.|+++++++ +++.||+..+.
T Consensus 155 G---~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 155 G---FYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred C---CccCCCCcCcEEEECCc-EEEEECccccc
Confidence 9 99999999999999654 99999987753
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00017 Score=72.67 Aligned_cols=135 Identities=24% Similarity=0.219 Sum_probs=90.8
Q ss_pred cccccccceEEEEEeCCCcEEEEEEeeccCCch----------hh---------------hHHHHHHHhcCC--CCcccc
Q 046586 450 LIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGD----------AE---------------FWAEVTIIARMH--HLNLVR 502 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~----------~~---------------f~~E~~~l~~l~--H~niv~ 502 (763)
.|.+|--+.||+|.-.++..+|||+.+.....- .. ..+|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 677788889999998889999999997543211 11 234555566652 344445
Q ss_pred EEEEEeeCCeeeEEEecCCCCC-HhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 046586 503 LWGFCAEKGERTLVYEYVPNGS-LADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE- 580 (763)
Q Consensus 503 l~g~~~~~~~~~LV~Ey~~~gs-L~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~- 580 (763)
-+++. +-.|||||+.... -.-.| ....+.......+..++.+.|.-|-.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~L-------------------------kDv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRL-------------------------KDVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCc-------------------------ccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 55544 3469999985531 00000 11122222566677788888888776
Q ss_pred cCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCC
Q 046586 581 ECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617 (763)
Q Consensus 581 ~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~ 617 (763)
.+ +||+||+.=|||+. ++.+.|+|+|-|....+
T Consensus 186 a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 186 AG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred cC---cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 44 99999999999999 88999999999975553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00037 Score=70.96 Aligned_cols=77 Identities=19% Similarity=0.311 Sum_probs=56.9
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCC--ccccEEEEEeeC---CeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHL--NLVRLWGFCAEK---GERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~LV~Ey~~~g 523 (763)
+.|+.|..+.||+....+ ..+++|+.... ....+..+|+.+++.+... .+.+++...... ...+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 468899999999999988 57889987654 3456677899998888533 356777655433 3568999999998
Q ss_pred CHhH
Q 046586 524 SLAD 527 (763)
Q Consensus 524 sL~~ 527 (763)
.+..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 8887
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00053 Score=83.51 Aligned_cols=78 Identities=12% Similarity=0.250 Sum_probs=56.8
Q ss_pred cccccccccceEEEEEeCCC---cEEEEEEeeccC--CchhhhHHHHHHHhcCC-CCcc--ccEEEEEeeC---CeeeEE
Q 046586 448 SNLIGRGGFGDVYKGELTDH---RVVAVKCLKNVT--GGDAEFWAEVTIIARMH-HLNL--VRLWGFCAEK---GERTLV 516 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~---~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~LV 516 (763)
.+.|+.|.+..+|+....++ ..+++|+..... .....+.+|+++++.+. |.++ .+.+++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 35788999999999877654 356666654322 23356889999999995 6665 7888888764 467899
Q ss_pred EecCCCCCH
Q 046586 517 YEYVPNGSL 525 (763)
Q Consensus 517 ~Ey~~~gsL 525 (763)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988654
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.61 E-value=7e-05 Score=61.71 Aligned_cols=53 Identities=34% Similarity=0.667 Sum_probs=42.4
Q ss_pred eeEeeeeeccCCccccccccchHHHHHHccCCCceeeEEEeeCCccceEEeeec
Q 046586 276 FLQLDYVNFSRGNLSDLEADNFSACKANCSANPKCVAFGFKYDGKRYCVLVDQL 329 (763)
Q Consensus 276 f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~C~~~~~l 329 (763)
|..+++++++..+.......+.++|+..|+.||+|.||.|. .+.+.|+++...
T Consensus 6 ~~~~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~-~~~~~C~lk~~~ 58 (73)
T cd01100 6 FRQGSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYN-TKSKKCFLKSSE 58 (73)
T ss_pred ccccCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEE-CCCCeEEcccCC
Confidence 44456788877766555556999999999999999999998 557889987764
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00065 Score=69.68 Aligned_cols=74 Identities=20% Similarity=0.233 Sum_probs=48.9
Q ss_pred ccccccccceEEEEEeCC--CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCcc-ccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 449 NLIGRGGFGDVYKGELTD--HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL-VRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~--~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
+.|..|-...+|+....+ ++.+++|+.........+..+|+.++..+...++ +++++.+. ..+||||+++.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 456778888999988764 5678899776433222334578888888854344 44444332 2479999998776
Q ss_pred h
Q 046586 526 A 526 (763)
Q Consensus 526 ~ 526 (763)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 4
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0011 Score=70.69 Aligned_cols=75 Identities=9% Similarity=0.103 Sum_probs=57.8
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCC---CccccEEEEEeeC---CeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHH---LNLVRLWGFCAEK---GERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~LV~Ey~~~ 522 (763)
+.||.|..+.||+....+++ +++|..+. ......|.+|.+.|+.|.- ..+.+.++++... +..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 47999999999999877665 66777543 2234578899999998843 4688889888643 668999999998
Q ss_pred CCH
Q 046586 523 GSL 525 (763)
Q Consensus 523 gsL 525 (763)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 766
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0006 Score=70.08 Aligned_cols=74 Identities=12% Similarity=0.128 Sum_probs=46.2
Q ss_pred ccccccccc-eEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCC---ccccEEEEEeeCC---eeeEEEecCC
Q 046586 449 NLIGRGGFG-DVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHL---NLVRLWGFCAEKG---ERTLVYEYVP 521 (763)
Q Consensus 449 ~~LG~G~fG-~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~LV~Ey~~ 521 (763)
+.|+.|+.. .||+. +..+++|+.+. .....++.+|++++..+... .+.+.++.....+ ..++||++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 356777766 58874 23466776554 22345788999999888532 3444454443322 3478999999
Q ss_pred CCCHhH
Q 046586 522 NGSLAD 527 (763)
Q Consensus 522 ~gsL~~ 527 (763)
|.++.+
T Consensus 78 G~~l~~ 83 (235)
T cd05155 78 GETATA 83 (235)
T ss_pred CCCCCc
Confidence 977754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0015 Score=64.98 Aligned_cols=126 Identities=21% Similarity=0.310 Sum_probs=86.4
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccC-----------------CchhhhHHHHHHHhcCC------CCccccEEE
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVT-----------------GGDAEFWAEVTIIARMH------HLNLVRLWG 505 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~-----------------~~~~~f~~E~~~l~~l~------H~niv~l~g 505 (763)
..||+|+.-.||. +++.....||+.+... ....++.+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4799999999995 5555567888887544 22355667776655554 889999999
Q ss_pred EEeeCCeeeEEEecCC------CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046586 506 FCAEKGERTLVYEYVP------NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH 579 (763)
Q Consensus 506 ~~~~~~~~~LV~Ey~~------~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH 579 (763)
+..++...-+|+|.+. ..+|.+++... .++. . +...+-+-..||-
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-------------------------~~~~-~---~~~~L~~f~~~l~ 135 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG-------------------------GLTE-E---LRQALDEFKRYLL 135 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC-------------------------CccH-H---HHHHHHHHHHHHH
Confidence 9999988888888863 23567776322 2333 2 2333334455666
Q ss_pred hcCCCcEEecCCCCCceEEcCCC----CeEEcc
Q 046586 580 EECLEWVLHCDIKPENILLGDDF----CPKISD 608 (763)
Q Consensus 580 ~~~~~~ivHrDlk~~NILl~~~~----~~kI~D 608 (763)
+.. |+.+|++|.||++..+. .+.|.|
T Consensus 136 ~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 136 DHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 666 99999999999995432 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0013 Score=62.94 Aligned_cols=130 Identities=22% Similarity=0.241 Sum_probs=86.6
Q ss_pred ccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 447 ~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
..+.|++|.+|.||+|.+.++ .+|+|+-+.. .....+..|+++|..++--++-+=+-.+- .-++.|||..|.+|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~L~ 100 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhcccccEEEEeeccCc-eEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcchh
Confidence 346899999999999998765 6888876532 23456789999999998766644332222 223459999888887
Q ss_pred HHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC--CceEEcCCCCe
Q 046586 527 DYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP--ENILLGDDFCP 604 (763)
Q Consensus 527 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~--~NILl~~~~~~ 604 (763)
+.-... +- +-...+++.-.-|...+ |-|+.|.- .||++.++ .+
T Consensus 101 ~~~~~~---------------------------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~-~~ 145 (201)
T COG2112 101 KLEIGG---------------------------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDR-DV 145 (201)
T ss_pred hhhhcc---------------------------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCC-cE
Confidence 754210 11 22334455544455666 88888874 45555554 99
Q ss_pred EEcccCcccccC
Q 046586 605 KISDFGLAKLRK 616 (763)
Q Consensus 605 kI~DFGla~~~~ 616 (763)
.|+||..|+...
T Consensus 146 ~iIDFd~At~k~ 157 (201)
T COG2112 146 YIIDFDSATFKK 157 (201)
T ss_pred EEEEccchhhcc
Confidence 999999997443
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0014 Score=59.07 Aligned_cols=90 Identities=28% Similarity=0.450 Sum_probs=58.9
Q ss_pred cCCCCCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEe-CCCCCCCCCCccEEEccCCcEEEecCCCCe
Q 046586 38 WLPNQNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSA-NDKFPVAGNGSLAIAATTGQLRLLNSSNSN 116 (763)
Q Consensus 38 ~~~~~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~A-nr~~p~~~~~~~~~~~~~g~L~l~~~~~~~ 116 (763)
|+.+..+.+.+.+|.+.|-|-..+ -|-| |.. ..+++|.. +....-. ....+.+..||||||.|.++.+
T Consensus 6 W~an~~~p~~~~s~~~~L~l~~dG------nLvl-~~~---~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~ 74 (114)
T PF01453_consen 6 WVANRNSPLTSSSGNYTLILQSDG------NLVL-YDS---NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNV 74 (114)
T ss_dssp ----TTEEEEECETTEEEEEETTS------EEEE-EET---TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEE
T ss_pred cccccccccccccccccceECCCC------eEEE-EcC---CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceE
Confidence 455666677776689999997543 2444 432 24669999 4333322 4567888899999999999999
Q ss_pred ecCCCCCCCCCCCceeEEEcc--CCCee
Q 046586 117 LWPNPKTATGNPNSTRLFLQD--AGNLV 142 (763)
Q Consensus 117 vwst~~~~~~~~~~~~~~lld--~GNlv 142 (763)
||++. ..+..+.+..++ .||++
T Consensus 75 lW~Sf----~~ptdt~L~~q~l~~~~~~ 98 (114)
T PF01453_consen 75 LWQSF----DYPTDTLLPGQKLGDGNVT 98 (114)
T ss_dssp EEEST----TSSS-EEEEEET--TSEEE
T ss_pred EEeec----CCCccEEEeccCcccCCCc
Confidence 99884 234566777777 88888
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0017 Score=67.61 Aligned_cols=71 Identities=13% Similarity=0.056 Sum_probs=46.3
Q ss_pred ccccccceEEEEEeCCCcEEEEEEeeccCCch-hhhHHHHHHHhcCCCCcc-ccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGD-AEFWAEVTIIARMHHLNL-VRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 451 LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~-~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
+..|-...+|+... +++.+++|+........ ....+|.++++.+....+ .++++... ..+||||++|..+.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 45677789998874 45668888765432221 245789999888864433 34444432 36899999987654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0067 Score=59.94 Aligned_cols=131 Identities=27% Similarity=0.445 Sum_probs=89.5
Q ss_pred ccccHHHHHHHhcccccccccccc-ceEEEEEeCCCcEEEEEEeec-----c-------CC----------chhhhHHHH
Q 046586 433 KRFTHAELRAATNGFSNLIGRGGF-GDVYKGELTDHRVVAVKCLKN-----V-------TG----------GDAEFWAEV 489 (763)
Q Consensus 433 ~~~~~~el~~~t~~~~~~LG~G~f-G~Vy~g~~~~~~~VAvK~l~~-----~-------~~----------~~~~f~~E~ 489 (763)
.+|+. .....+|.+.||.|.- |.||+.++.+ +.+|+|+.+. . .. -...|..|.
T Consensus 30 ~~F~~---h~~~I~flefLg~g~~~~~V~kv~I~g-~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 30 EPFTH---HGDDIEFLEFLGHGSHDGYVFKVEIDG-RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CCcCC---CCCcEeeeeecCCCCceeEEEEEEECC-eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 34555 2267788899999999 9999999965 5899999431 0 00 012377898
Q ss_pred HHHhcCC---CCcc--ccEEEEEeeCC------------------eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcc
Q 046586 490 TIIARMH---HLNL--VRLWGFCAEKG------------------ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEM 546 (763)
Q Consensus 490 ~~l~~l~---H~ni--v~l~g~~~~~~------------------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~ 546 (763)
....+|+ +.++ |+.+|+..-.. .+.+|.||.+...
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------------- 163 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------------- 163 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------------
Confidence 8877774 4456 88888874220 1234555553321
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcc
Q 046586 547 SGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612 (763)
Q Consensus 547 ~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla 612 (763)
....+-+.+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 164 ---------------~~~~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 164 ---------------PLQIRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---------------ccchhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 112234556778888999998 999999999986 5689999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0049 Score=65.90 Aligned_cols=74 Identities=26% Similarity=0.353 Sum_probs=49.5
Q ss_pred cccccccceEEEEEeCC-------CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCcc-ccEEEEEeeCCeeeEEEecCC
Q 046586 450 LIGRGGFGDVYKGELTD-------HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL-VRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~~-------~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.|..|-...+|+....+ ++.+++|+.........+..+|.+++..+....+ .++++++.. .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeC
Confidence 45556667899887765 4778899976544443456788888888853333 455555532 35899999
Q ss_pred CCCHhH
Q 046586 522 NGSLAD 527 (763)
Q Consensus 522 ~gsL~~ 527 (763)
|..+..
T Consensus 81 G~~l~~ 86 (302)
T cd05156 81 SRTLTT 86 (302)
T ss_pred CCcCCH
Confidence 877654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.005 Score=65.58 Aligned_cols=155 Identities=14% Similarity=0.094 Sum_probs=86.7
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCc--cccEEEE------EeeCCeeeEEEecC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLN--LVRLWGF------CAEKGERTLVYEYV 520 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~LV~Ey~ 520 (763)
+.|..|....+|+....++ .+++|+... ....+...|++++..+++.+ +.+.+.. ....+..++|++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~~~-~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 20 EGISAGIENTNYFVTTDSG-RYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred ecccCccccceEEEEeCCC-cEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 4677787789999876555 577888764 33455667888888885332 4444432 22345678999999
Q ss_pred CCCCHhH----HhhhcCCCCCCChhhhhccc----CCCCCCCCCCCCCHHHHH----------HHHHHHHHHHHHHHhc-
Q 046586 521 PNGSLAD----YLFRSGRVGSSSPAREMEMS----GVGPHDGGKPVLDWSIRY----------RIALGVARAIAYLHEE- 581 (763)
Q Consensus 521 ~~gsL~~----~L~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~----------~ia~qia~gL~yLH~~- 581 (763)
+|..+.. .+.... +....+. .............|.... .....+...+.++...
T Consensus 97 ~G~~~~~~~~~~~~~lg-------~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 97 AGEHLTRPTAAHCRQIG-------EALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred CCCCCCCCCHHHHHHHH-------HHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 9877532 000000 0000000 000000011112232211 1112233445555431
Q ss_pred ---CCCcEEecCCCCCceEEcCCCCeEEcccCccc
Q 046586 582 ---CLEWVLHCDIKPENILLGDDFCPKISDFGLAK 613 (763)
Q Consensus 582 ---~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~ 613 (763)
....++|+|+.|.||+++++..+.|.||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 12348999999999999998778999998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0082 Score=63.35 Aligned_cols=72 Identities=17% Similarity=0.280 Sum_probs=48.1
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCC---CCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH---HLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
+.|+.|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 478889999999988 667789999876 334456788888888773 456778898888777889999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.017 Score=63.58 Aligned_cols=79 Identities=16% Similarity=0.107 Sum_probs=54.9
Q ss_pred ccccccccceEEEEEeCCC-cEEEEEEeecc--------CCchhhhHHHHHHHhcCC---CCccccEEEEEeeCCeeeEE
Q 046586 449 NLIGRGGFGDVYKGELTDH-RVVAVKCLKNV--------TGGDAEFWAEVTIIARMH---HLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~-~~VAvK~l~~~--------~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~LV 516 (763)
+.||.|.+..||+....+| +.++||.-... ....+.+..|.+.|..+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4789999999999999877 47999975311 112345677888888762 2456667766 34567899
Q ss_pred EecCCCCC-HhHHh
Q 046586 517 YEYVPNGS-LADYL 529 (763)
Q Consensus 517 ~Ey~~~gs-L~~~L 529 (763)
|||+++.. +++.|
T Consensus 110 ME~L~~~~~lr~~L 123 (401)
T PRK09550 110 MEDLSDHKILRKGL 123 (401)
T ss_pred EecCCCccHHHHHH
Confidence 99998643 44443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0036 Score=75.03 Aligned_cols=195 Identities=17% Similarity=0.164 Sum_probs=131.4
Q ss_pred HHHHHHHhcCCCCccccEEEEEeeCCeee----EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCH
Q 046586 486 WAEVTIIARMHHLNLVRLWGFCAEKGERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561 (763)
Q Consensus 486 ~~E~~~l~~l~H~niv~l~g~~~~~~~~~----LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 561 (763)
.-|.+.+.++.|+|++.++.+-.+....- +..|++...++...+.. -..++.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~------------------------v~~i~~ 285 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS------------------------VGSIPL 285 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh------------------------ccccCH
Confidence 34677788899999999999887654322 34566666677666643 235677
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC---ceEEcCCCCeEEc--ccCcccccCCCCcccccccccCCCccccc
Q 046586 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPE---NILLGDDFCPKIS--DFGLAKLRKKEDMVSMSRIRGTRGYMAPE 636 (763)
Q Consensus 562 ~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~---NILl~~~~~~kI~--DFGla~~~~~~~~~~~~~~~gt~~y~APE 636 (763)
.+.+.+..++..||+|+|+.. ..|.=+..+ +-..+..+.+.++ ||+.++........ .....+..+.|||
T Consensus 286 ~~~r~~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e 360 (1351)
T KOG1035|consen 286 ETLRILHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADE 360 (1351)
T ss_pred HHHHHHHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCcccccccc
Confidence 888889999999999999975 444444444 5555677788888 99888755433221 1123345688888
Q ss_pred ccccCCCCC--ccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHH
Q 046586 637 WLRSDQITP--KADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDM 714 (763)
Q Consensus 637 ~l~~~~~s~--ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 714 (763)
......+.. ..|+|.+|..+..+..|..+-.... ....+++...
T Consensus 361 ~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~----------------------~~~~~l~~~~------------ 406 (1351)
T KOG1035|consen 361 DLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA----------------------VPVSLLDVLS------------ 406 (1351)
T ss_pred ccccccchhhhhhHHHHHHHHHhhhhhcCccccccc----------------------chhhhhcccc------------
Confidence 887665554 4799999999999988765432110 0111111111
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 715 VNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 715 ~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
...+......|+..++++|+++.+++...
T Consensus 407 ~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 407 TSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred chhhhhhhhhhcchhhhhccchhhhhhch
Confidence 11456667789999999999999998765
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0019 Score=58.24 Aligned_cols=47 Identities=32% Similarity=0.429 Sum_probs=35.0
Q ss_pred EccCCcEEEecCC-CCeecCCCCCCCCCCCceeEEEccCCCeeee------cccc
Q 046586 101 AATTGQLRLLNSS-NSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------NWQS 148 (763)
Q Consensus 101 ~~~~g~L~l~~~~-~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------~WqS 148 (763)
...||+||+.+.. +.+||+++...+.. ....+.|.++|||||+ +|+|
T Consensus 26 ~q~dgnlV~~~~~~~~~vW~snt~~~~~-~~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 26 MQNDYNLILYKSSSRTVVWVANRDNPVS-DSCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred CCCCEEEEEEECCCCcEEEECCCCCCCC-CCEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 3468999998765 57999998543322 2367889999999997 3776
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.025 Score=60.63 Aligned_cols=159 Identities=14% Similarity=0.151 Sum_probs=82.1
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCC--ccccEEEEE------eeCCeeeEEEecC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHL--NLVRLWGFC------AEKGERTLVYEYV 520 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~------~~~~~~~LV~Ey~ 520 (763)
+.++.|....+|+....+++ +++|+.+... ...+...|++++..|... .+.+.+... ...+..++++||+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~~-~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVGR-YILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCCc-EEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 45677777899998766664 6678765422 234455677777777422 244444421 1235678999999
Q ss_pred CCCCHhHH----hhhcCC--CCCCChhhhhcccCCCCCCCCCCCCCHHHHH------------HHHHHHHHHHHHHHh--
Q 046586 521 PNGSLADY----LFRSGR--VGSSSPAREMEMSGVGPHDGGKPVLDWSIRY------------RIALGVARAIAYLHE-- 580 (763)
Q Consensus 521 ~~gsL~~~----L~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~------------~ia~qia~gL~yLH~-- 580 (763)
+|..+... .....+ ...+.... .+.. ........-.|.... .....+.+.++++..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~--~~~~--~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGA--HFPE--NRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhc--cCCC--CCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 88654210 000000 00000000 0000 000000011121110 111223344555543
Q ss_pred --cCCCcEEecCCCCCceEEcCCCCeEEcccCccc
Q 046586 581 --ECLEWVLHCDIKPENILLGDDFCPKISDFGLAK 613 (763)
Q Consensus 581 --~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~ 613 (763)
.....++|+|+++.||++++++...|.||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 122459999999999999998877899999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0027 Score=57.50 Aligned_cols=44 Identities=32% Similarity=0.479 Sum_probs=34.2
Q ss_pred CCcEEEecCC-CCeecCCCCCCCCCCCceeEEEccCCCeeeec------ccc
Q 046586 104 TGQLRLLNSS-NSNLWPNPKTATGNPNSTRLFLQDAGNLVYGN------WQS 148 (763)
Q Consensus 104 ~g~L~l~~~~-~~~vwst~~~~~~~~~~~~~~lld~GNlvl~~------WqS 148 (763)
||+|++.+.. +++||+++...+ ......+.|.++|||||++ |||
T Consensus 30 dgnlv~~~~~~~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 30 DYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred eEEEEEEeCCCCeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 8999998765 579999985433 3456678899999999973 776
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.035 Score=60.44 Aligned_cols=73 Identities=16% Similarity=0.091 Sum_probs=46.6
Q ss_pred cccccccceEEEEEeCC-----CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCcc-ccEEEEEeeCCeeeEEEecCCCC
Q 046586 450 LIGRGGFGDVYKGELTD-----HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL-VRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~~-----~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
.|-.|-.-.+|+....+ ++.+++|+........-.-.+|..++..+...++ .++++.+..+ .|+||+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 34446667889887542 3578888876543332234678888888854444 3556665332 589999876
Q ss_pred CHh
Q 046586 524 SLA 526 (763)
Q Consensus 524 sL~ 526 (763)
+|.
T Consensus 119 ~l~ 121 (344)
T PLN02236 119 TLS 121 (344)
T ss_pred CCC
Confidence 664
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.029 Score=60.38 Aligned_cols=74 Identities=5% Similarity=-0.047 Sum_probs=45.0
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCC--ccccEEE------EEeeCCeeeEEEecC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHL--NLVRLWG------FCAEKGERTLVYEYV 520 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g------~~~~~~~~~LV~Ey~ 520 (763)
+.|+.|....+|+....++ .+++|+.. .....+...|+.++..|... .+.+.+. +....+..++++||+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 3566777789999887666 47788875 22233444566666665322 2333332 122345678999999
Q ss_pred CCCCH
Q 046586 521 PNGSL 525 (763)
Q Consensus 521 ~~gsL 525 (763)
+|..+
T Consensus 105 ~G~~~ 109 (319)
T PRK05231 105 EGKWP 109 (319)
T ss_pred CCCCC
Confidence 98754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.046 Score=57.55 Aligned_cols=32 Identities=28% Similarity=0.476 Sum_probs=26.5
Q ss_pred CcEEecCCCCCceEEcCCCC-eEEcccCccccc
Q 046586 584 EWVLHCDIKPENILLGDDFC-PKISDFGLAKLR 615 (763)
Q Consensus 584 ~~ivHrDlk~~NILl~~~~~-~kI~DFGla~~~ 615 (763)
+.++|+|+++.||+++++++ .-|.||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999997555 469999998643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.012 Score=61.51 Aligned_cols=131 Identities=20% Similarity=0.185 Sum_probs=88.8
Q ss_pred ccccccccccccceEEEEEeCCCcEEEEEEeecc-----------------CCch------hhhHHHHHHHhcCC-C-Cc
Q 046586 445 NGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNV-----------------TGGD------AEFWAEVTIIARMH-H-LN 499 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~-----------------~~~~------~~f~~E~~~l~~l~-H-~n 499 (763)
+.+.++||-|--+.||.+...+|++.++|.-+-. ..+. -...+|...|+.|. | --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 4567899999999999999999998888864310 0010 12456888888884 2 23
Q ss_pred cccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046586 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH 579 (763)
Q Consensus 500 iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH 579 (763)
+.+.+++ +..++|||++.+-.|...-+ ..+..+.. ..+..-+--|.
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~---------------------------v~d~~~ly---~~lm~~Iv~la 219 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRH---------------------------VEDPPTLY---DDLMGLIVRLA 219 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeee---------------------------cCChHHHH---HHHHHHHHHHH
Confidence 4444444 35678999998866654321 12223332 33333444566
Q ss_pred hcCCCcEEecCCCCCceEEcCCCCeEEcccCcc
Q 046586 580 EECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612 (763)
Q Consensus 580 ~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla 612 (763)
.+| +||+|..--||+++++..++++||--.
T Consensus 220 ~~G---lIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 220 NHG---LIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred HcC---ceecccchheeEEecCCCEEEeechHh
Confidence 667 999999999999999999999999644
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.0009 Score=81.52 Aligned_cols=160 Identities=14% Similarity=0.031 Sum_probs=108.2
Q ss_pred HHHHHHHhcCCCCccccEEEEEe--eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHH
Q 046586 486 WAEVTIIARMHHLNLVRLWGFCA--EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563 (763)
Q Consensus 486 ~~E~~~l~~l~H~niv~l~g~~~--~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 563 (763)
..|...++...|+++.....-.. +..+.+.+++|+..|.+.+.+.+.-. ..+.++..-
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~e--------------------e~~~ld~~~ 1336 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLE--------------------ESPDLDRSP 1336 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccc--------------------cCCcchhch
Confidence 34555566678888765554333 23467788999999999999865421 112222222
Q ss_pred HHHHHHHHHHHHHHHHh--cCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC
Q 046586 564 RYRIALGVARAIAYLHE--ECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD 641 (763)
Q Consensus 564 ~~~ia~qia~gL~yLH~--~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 641 (763)
....-.+......-.|+ ......+|+++|+-|.+|..+..+|++++|+.++..+. ........+++-|++|+....-
T Consensus 1337 v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~i 1415 (2724)
T KOG1826|consen 1337 VHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEI 1415 (2724)
T ss_pred HHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHH
Confidence 22222222333333332 23355799999999999999999999999999843322 2223345677789999988888
Q ss_pred CCCCccceeehhHHHHHHHhCCCCc
Q 046586 642 QITPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 642 ~~s~ksDVwS~Gvll~elltG~~p~ 666 (763)
+++.++|+|..|+.+|+.-.|..+|
T Consensus 1416 k~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1416 KFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhHHHHHHHHHHHHHHhcccHHH
Confidence 8999999999999999998877665
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.033 Score=56.06 Aligned_cols=55 Identities=15% Similarity=0.073 Sum_probs=33.9
Q ss_pred CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCcc-ccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 467 HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL-VRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 467 ~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
.+.|+||+........-....|..+++.+...++ .++++++.++ +|+||+++..|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEeccccc
Confidence 3568888887665555566789999888865444 4556654332 57799876654
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.13 Score=55.72 Aligned_cols=72 Identities=17% Similarity=0.199 Sum_probs=46.0
Q ss_pred cccccccceEEEEEeCC----CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCcc-ccEEEEEeeCCeeeEEEecCCCCC
Q 046586 450 LIGRGGFGDVYKGELTD----HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL-VRLWGFCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~~~gs 524 (763)
.|..|-.-.+|+....+ +..+++|+........-.-.+|..+++.+...++ .++++++. ++ +|.+|+++..
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCC
Confidence 44446667788886653 2378888876543333334678888888865555 45666653 22 5899997766
Q ss_pred H
Q 046586 525 L 525 (763)
Q Consensus 525 L 525 (763)
|
T Consensus 97 l 97 (330)
T PLN02421 97 L 97 (330)
T ss_pred C
Confidence 5
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.15 Score=54.59 Aligned_cols=141 Identities=19% Similarity=0.223 Sum_probs=93.2
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeeccC----------Cchhh-----------------hHHHHHHHhcCCCCcc
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNVT----------GGDAE-----------------FWAEVTIIARMHHLNL 500 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~----------~~~~~-----------------f~~E~~~l~~l~H~ni 500 (763)
...|..|--+.||.+.-.+|..+|||+++.+- .+... ..+|+.-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34888999999999999999999999987431 11111 2346666777754443
Q ss_pred ccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 046586 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE 580 (763)
Q Consensus 501 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~ 580 (763)
..---+.. ....|||+|+.... + ..|.. ....++...+...-.|++.-|.-|-.
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdg---w---------~aPkL------------Kd~~ls~~ka~~~Y~~~v~~MR~lY~ 282 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDG---W---------AAPKL------------KDASLSTSKARELYQQCVRIMRRLYQ 282 (520)
T ss_pred CCCCceee--ecceEeeeeccCCC---C---------cCccc------------ccccCChHHHHHHHHHHHHHHHHHHH
Confidence 32111111 12458999984211 1 01100 22345666778888889999988888
Q ss_pred cCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCC
Q 046586 581 ECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617 (763)
Q Consensus 581 ~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~ 617 (763)
.+. +||.||.--|+|+.+ |.+.|+|.+-+.....
T Consensus 283 ~c~--LVHADLSEfN~Lyhd-G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 283 KCR--LVHADLSEFNLLYHD-GKLYIIDVSQSVEHDH 316 (520)
T ss_pred Hhc--eeccchhhhhheEEC-CEEEEEEccccccCCC
Confidence 775 999999999998865 5889999988764443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.26 Score=54.31 Aligned_cols=81 Identities=14% Similarity=0.061 Sum_probs=53.3
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeec-----cC---CchhhhHHHHHHHhcCC---CCccccEEEEEeeCCeeeEE
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKN-----VT---GGDAEFWAEVTIIARMH---HLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~-----~~---~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~LV 516 (763)
.+.||.|..-.||+.... ++.++||.-.. .. .....-..|++.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 357899999999998764 44588887651 11 12233345566666553 357888888887 446789
Q ss_pred EecCCC--CCHhHHhhh
Q 046586 517 YEYVPN--GSLADYLFR 531 (763)
Q Consensus 517 ~Ey~~~--gsL~~~L~~ 531 (763)
||++++ ..+++.+..
T Consensus 114 ME~L~~~~~ilr~~Ll~ 130 (418)
T PLN02756 114 MRYLEPPHIILRKGLIA 130 (418)
T ss_pred EeecCCcceehhhhhcc
Confidence 999977 356555543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.19 Score=53.66 Aligned_cols=148 Identities=20% Similarity=0.251 Sum_probs=81.1
Q ss_pred CcEEEEEEeec---cCCchhhhHHHHHHHhcCC--CCccccEEEEEeeCC--eeeEEEecCCCCCHhHHhhhcCCCCCCC
Q 046586 467 HRVVAVKCLKN---VTGGDAEFWAEVTIIARMH--HLNLVRLWGFCAEKG--ERTLVYEYVPNGSLADYLFRSGRVGSSS 539 (763)
Q Consensus 467 ~~~VAvK~l~~---~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~--~~~LV~Ey~~~gsL~~~L~~~~~~~~~~ 539 (763)
++..++. ... .........+|..+|+.+. -.-+.+.++.|.++. ..+.||+|.++..+.+.+...... ..
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~--~~ 124 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLG--RQ 124 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccch--HH
Confidence 5556666 221 1112234567888888874 334556677887776 678999999885444333221100 00
Q ss_pred hhh--------------hhcccCCCCCC--CCCCCCCHHHHHHHH--------HHHHHHHHHHHhcC-----CCcEEecC
Q 046586 540 PAR--------------EMEMSGVGPHD--GGKPVLDWSIRYRIA--------LGVARAIAYLHEEC-----LEWVLHCD 590 (763)
Q Consensus 540 ~~~--------------~~~~~~~~~~~--~~~~~l~~~~~~~ia--------~qia~gL~yLH~~~-----~~~ivHrD 590 (763)
... .........+. ..++.-.|...++.+ -....-..||+... .+.++|+|
T Consensus 125 ~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD 204 (321)
T COG3173 125 FALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGD 204 (321)
T ss_pred HHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCC
Confidence 000 00000111000 112223333333211 12333456666543 35699999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCC
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKK 617 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~ 617 (763)
+++.|++++.+.-+=|.||+++.+-.+
T Consensus 205 ~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 205 YRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred cccCCEEEeCCCeeEEEeccccccCCc
Confidence 999999999998899999999976443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.23 Score=53.48 Aligned_cols=157 Identities=20% Similarity=0.209 Sum_probs=84.5
Q ss_pred ccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCc------cccEEE----EEeeCCeeeEEEecCCCCC
Q 046586 455 GFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLN------LVRLWG----FCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 455 ~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g----~~~~~~~~~LV~Ey~~~gs 524 (763)
.--.+|+....+++. ++|+.+.. ....+...|+..|..|.-.. +..+=| ....+...+-|++|++|..
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~ 114 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP 114 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence 446789988888886 88988766 55666677888887773211 222222 1111136778999999988
Q ss_pred HhH------------H---hhhcC-CCC--CCChhhhhccc--CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 046586 525 LAD------------Y---LFRSG-RVG--SSSPAREMEMS--GVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLE 584 (763)
Q Consensus 525 L~~------------~---L~~~~-~~~--~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~ 584 (763)
+.. . |+... ... .+......... ............++..+..+...+..-++.+-..-..
T Consensus 115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~ 194 (331)
T COG2334 115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194 (331)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence 773 0 11110 011 00000000000 0000000011122223444444444444444333222
Q ss_pred c---EEecCCCCCceEEcCCCC-eEEcccCccc
Q 046586 585 W---VLHCDIKPENILLGDDFC-PKISDFGLAK 613 (763)
Q Consensus 585 ~---ivHrDlk~~NILl~~~~~-~kI~DFGla~ 613 (763)
. +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2 899999999999999885 8999999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 763 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-57 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-56 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-35 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-21 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-20 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-20 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 397 bits (1023), Expect = e-133
Identities = 126/324 (38%), Positives = 187/324 (57%), Gaps = 32/324 (9%)
Query: 427 LPAGGPKRFTHAELRAATNGFS--NLIGRGGFGDVYKGELTDHRVVAVKCLK--NVTGGD 482
+ G KRF+ EL+ A++ FS N++GRGGFG VYKG L D +VAVK LK GG+
Sbjct: 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE 71
Query: 483 AEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAR 542
+F EV +I+ H NL+RL GFC ER LVY Y+ NGS+A L
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE----------- 120
Query: 543 EMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602
+P LDW R RIALG AR +AYLH+ C ++H D+K NILL ++F
Sbjct: 121 ---------RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 603 CPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ DFGLAKL +D V+ + +RGT G++APE+L + + + K DV+ +G++LLE+++
Sbjct: 172 EAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
Query: 662 GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKT 721
G R F++ + N D+ W + +E K+E ++D ++ +Y + V ++++
Sbjct: 231 GQRAFDL-ARLANDDDVMLLDWVK-GLLKEKKLEALVDVDLQGNYKD----EEVEQLIQV 284
Query: 722 AMWCIQDRPELRPSMGKVAKMLEG 745
A+ C Q P RP M +V +MLEG
Sbjct: 285 ALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 351 bits (904), Expect = e-116
Identities = 117/333 (35%), Positives = 162/333 (48%), Gaps = 50/333 (15%)
Query: 427 LPAGGPKRFTHAELRAATNGFS--------NLIGRGGFGDVYKGELTDHRVVAVKCLK-- 476
+ F+ EL+ TN F N +G GGFG VYKG + ++ VAVK L
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65
Query: 477 ---NVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSG 533
+F E+ ++A+ H NLV L GF ++ + LVY Y+PNGSL D L
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL- 124
Query: 534 RVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593
G P L W +R +IA G A I +LHE +H DIK
Sbjct: 125 --------------------DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKS 161
Query: 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMS-RIRGTRGYMAPEWLRSDQITPKADVYSF 652
NILL + F KISDFGLA+ +K M+ RI GT YMAPE LR +ITPK+D+YSF
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSF 220
Query: 653 GMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHF 712
G+VLLEI++G + + + E EE +ED +D+ + + DS
Sbjct: 221 GVVLLEIITGLPAVD-----EHREPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTS-- 272
Query: 713 DMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745
V M A C+ ++ RP + KV ++L+
Sbjct: 273 --VEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 348 bits (894), Expect = e-114
Identities = 103/325 (31%), Positives = 157/325 (48%), Gaps = 37/325 (11%)
Query: 433 KRFTHAELRAATNGFS--NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG-GDAEFWAEV 489
R +L ATN F LIG G FG VYKG L D VA+K + G EF E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 490 TIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGV 549
++ H +LV L GFC E+ E L+Y+Y+ NG+L +L+ S
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL--------------- 131
Query: 550 GPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDF 609
+ W R I +G AR + YLH ++H D+K NILL ++F PKI+DF
Sbjct: 132 -----PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183
Query: 610 GLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
G++K + D +S + ++GT GY+ PE+ ++T K+DVYSFG+VL E++
Sbjct: 184 GISKKGTELDQTHLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQ 727
+ +WA + + ++E I+D ++ + + + TA+ C+
Sbjct: 243 QSLP---REMVNLAEWA-VESHNNGQLEQIVDPNLADKIRPES----LRKFGDTAVKCLA 294
Query: 728 DRPELRPSMGKVAKMLEGTVEITEP 752
E RPSMG V LE + + E
Sbjct: 295 LSSEDRPSMGDVLWKLEYALRLQES 319
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 4e-74
Identities = 75/332 (22%), Positives = 122/332 (36%), Gaps = 53/332 (15%)
Query: 435 FTHAELRAATNGFS--NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTII 492
L + + RG FG V+K +L + VAVK + EV +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 493 ARMHHLNLVRLWGFCAE----KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSG 548
M H N+++ G + L+ + GSL+D+L
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----------------- 115
Query: 549 VGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEW-------VLHCDIKPENILLGDD 601
V+ W+ IA +AR +AYLHE+ + H DIK +N+LL ++
Sbjct: 116 --------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167
Query: 602 FCPKISDFGLAK-LRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMV 655
I+DFGLA + GTR YMAPE L + D+Y+ G+V
Sbjct: 168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227
Query: 656 LLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMK---VEDILDRHIKNSYDSRVHF 712
L E+ S + G + + + E+M+ V +++ +
Sbjct: 228 LWELASRCTAAD--GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKH--- 282
Query: 713 DMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744
+ + +T C E R S G V + +
Sbjct: 283 AGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-63
Identities = 85/352 (24%), Positives = 124/352 (35%), Gaps = 62/352 (17%)
Query: 435 FTHAELRAATNGFS--NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTI- 491
+E + LIGRG +G VYKG L D R VAVK F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS--FANRQNFINEKNIY 59
Query: 492 -IARMHHLNLVRLWGFCAEKGERT-----LVYEYVPNGSLADYLFRSGRVGSSSPAREME 545
+ M H N+ R LV EY PNGSL YL
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-------------- 105
Query: 546 MSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEW------VLHCDIKPENILLG 599
DW R+A V R +AYLH E + H D+ N+L+
Sbjct: 106 -----------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK 154
Query: 600 DDFCPKISDFGLAKL-------RKKEDMVSMSRIRGTRGYMAPEWLRS-------DQITP 645
+D ISDFGL+ R E+ + GT YMAPE L +
Sbjct: 155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214
Query: 646 KADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRH---I 702
+ D+Y+ G++ EI + S+ + + +E+M+V ++
Sbjct: 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKF 274
Query: 703 KNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITEPKK 754
++ + V + +T C E R + + + + I E K
Sbjct: 275 PEAWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-57
Identities = 75/305 (24%), Positives = 120/305 (39%), Gaps = 58/305 (19%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDA---EFWAEVTIIARMHHLNLVRL 503
IG G FG V++ E VAVK L EF EV I+ R+ H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
G + ++V EY+ GSL L +SG + LD
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA---------------------REQLDERR 138
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
R +A VA+ + YLH ++H ++K N+L+ + K+ DFGL++L K +S
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSS 196
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683
GT +MAPE LR + K+DVYSFG++L E+ +
Sbjct: 197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL--------------------- 235
Query: 684 AFEKVYEEMKVEDILDRHIKNSY----DSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739
++ + + ++ ++ + + C + P RPS +
Sbjct: 236 --QQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG----CWTNEPWKRPSFATI 289
Query: 740 AKMLE 744
+L
Sbjct: 290 MDLLR 294
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 7e-57
Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 52/299 (17%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
++GRG FG V K + + VA+K +++ F E+ ++R++H N+V+L+G
Sbjct: 12 VEEVVGRGAFGVVCKAKWRA-KDVAIKQIES-ESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
C LV EY GSL + L + P +
Sbjct: 70 CLNP--VCLVMEYAEGGSLYNVLHGAEP---------------------LPYYTAAHAMS 106
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF-CPKISDFGLAKLRKKEDMVSMSR 625
L ++ +AYLH + ++H D+KP N+LL KI DFG A + M+
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTN 162
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685
+G+ +MAPE + K DV+S+G++L E+++ + F+
Sbjct: 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD------------------ 204
Query: 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744
E ++ + + + + + M + C P RPSM ++ K++
Sbjct: 205 EIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR----CWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 4e-53
Identities = 84/345 (24%), Positives = 129/345 (37%), Gaps = 84/345 (24%)
Query: 422 LGLELLPAGGPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDH-RVVAVKCLKNVTG 480
+G P E+ + IG+GGFG V+KG L VVA+K L
Sbjct: 3 MGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57
Query: 481 GD--------AEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRS 532
EF EV I++ ++H N+V+L+G +V E+VP G L L
Sbjct: 58 EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRL--- 112
Query: 533 GRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592
D P + WS++ R+ L +A I Y+ ++H D++
Sbjct: 113 -------------------LDKAHP-IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLR 151
Query: 593 PENILL-----GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWL--RSDQITP 645
NI L C K++DFGL++ S+S + G +MAPE + + T
Sbjct: 152 SPNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTE 207
Query: 646 KADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNS 705
KAD YSF M+L I++G E ++E I ++
Sbjct: 208 KADTYSFAMILYTILTG-----------------------EGPFDEYSYGKIKFINMIRE 244
Query: 706 YDSR------VHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744
R + N + C P+ RP + K L
Sbjct: 245 EGLRPTIPEDCPPRLRNVIEL----CWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 1e-52
Identities = 70/315 (22%), Positives = 112/315 (35%), Gaps = 73/315 (23%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDA-----EFWAEVTIIARMHHLNLV 501
+IG GGFG VY+ VAVK ++ D E + A + H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L G C ++ LV E+ G L L +
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVL----------------------S---GKRIPP 104
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP--------KISDFGLAK 613
I A+ +AR + YLH+E + ++H D+K NIL+ KI+DFGLA+
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 614 LRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673
+ +S G +MAPE +R+ + +DV+S+G++L E+++G
Sbjct: 165 EWHRTTKMSA---AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG----------- 210
Query: 674 NSDEWYFPKWAFEKVYEEMK----VEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDR 729
E + + + + S M C
Sbjct: 211 ------------EVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMED----CWNPD 254
Query: 730 PELRPSMGKVAKMLE 744
P RPS + L
Sbjct: 255 PHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-51
Identities = 69/309 (22%), Positives = 106/309 (34%), Gaps = 63/309 (20%)
Query: 451 IGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGD-AEFWAEVTIIARMHHLNLVRLWGFCA 508
+G+G FG K V+ +K L F EV ++ + H N+++ G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
+ + EY+ G+L + WS R A
Sbjct: 78 KDKRLNFITEYIKGGTLRGII----------------------KSMDSQ-YPWSQRVSFA 114
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL-------------R 615
+A +AYLH ++H D+ N L+ ++ ++DFGLA+L
Sbjct: 115 KDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 616 KKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675
KK D + G +MAPE + K DV+SFG+VL EI+
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-DYLPRTM 230
Query: 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735
D + V LDR+ + + C PE RPS
Sbjct: 231 D-------------FGLNVRGFLDRYCPPNCPPSFF--------PITVRCCDLDPEKRPS 269
Query: 736 MGKVAKMLE 744
K+ LE
Sbjct: 270 FVKLEHWLE 278
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 56/308 (18%), Positives = 105/308 (34%), Gaps = 65/308 (21%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDA---EFWAEVTIIARMHHLNLVRL 503
F + G+++KG + VK LK +F E + H N++ +
Sbjct: 14 FLTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 504 WGFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
G C + ++P GSL + L H+G V+D
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVL----------------------HEGTNFVVDQ 110
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
S + AL +AR +A+LH + + ++++ +D +IS +
Sbjct: 111 SQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------ 163
Query: 622 SMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678
++APE L+ D AD++SF ++L E+V+
Sbjct: 164 QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR---------------- 207
Query: 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHF--DMVNRMVKTAMWCIQDRPELRPSM 736
E + ++ +I + R + + K C+ + P RP
Sbjct: 208 -------EVPFADLSNMEIGMKVALEGL--RPTIPPGISPHVSKLMKICMNEDPAKRPKF 258
Query: 737 GKVAKMLE 744
+ +LE
Sbjct: 259 DMIVPILE 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 3e-51
Identities = 73/320 (22%), Positives = 115/320 (35%), Gaps = 55/320 (17%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG+G +G+V+ G+ VAVK E+ M H N++
Sbjct: 41 MVKQIGKGRYGEVWMGKWRG-EKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 507 CAEKGERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ L+ +Y NGSL DYL LD
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL-------------------------KSTTLDAK 134
Query: 563 IRYRIALGVARAIAYLHEECLEW-----VLHCDIKPENILLGDDFCPKISDFGLAKL--- 614
++A + +LH E + H D+K +NIL+ + I+D GLA
Sbjct: 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194
Query: 615 -RKKEDMVSMSRIRGTRGYMAPEWL------RSDQITPKADVYSFGMVLLEIVSGSRNFE 667
+ D+ +R+ GT+ YM PE L Q AD+YSFG++L E+ +
Sbjct: 195 DTNEVDIPPNTRV-GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
Query: 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRH---IKNSYDSRVHFDMVNRMVKTAMW 724
I Y + YE+M+ + + N + S + + +M K
Sbjct: 254 IVEEYQLP---YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD---ECLRQMGKLMTE 307
Query: 725 CIQDRPELRPSMGKVAKMLE 744
C P R + +V K L
Sbjct: 308 CWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 7e-51
Identities = 69/321 (21%), Positives = 116/321 (36%), Gaps = 57/321 (17%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG+G FG+V++G+ VAVK + AE+ + H N++
Sbjct: 46 LQESIGKGRFGEVWRGKWRG-EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 507 CAEKGERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ LV +Y +GSL DYL + +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL-------------------------NRYTVTVE 139
Query: 563 IRYRIALGVARAIAYLHEECLEW-----VLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
++AL A +A+LH E + + H D+K +NIL+ + I+D GLA
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199
Query: 618 EDM---VSMSRIRGTRGYMAPEWLRSDQITP------KADVYSFGMVLLEIVSGSRNFEI 668
++ + GT+ YMAPE L +AD+Y+ G+V EI I
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
Query: 669 QGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSY-----DSRVHFDMVNRMVKTAM 723
E Y + ++ V + VE++ + + + + M K
Sbjct: 260 -------HEDYQLPY-YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 311
Query: 724 WCIQDRPELRPSMGKVAKMLE 744
C R + ++ K L
Sbjct: 312 ECWYANGAARLTALRIKKTLS 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 70/322 (21%), Positives = 122/322 (37%), Gaps = 59/322 (18%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTI--IARMHHLNLVRLW 504
+G+G +G+V++G VAVK + + ++ E + + H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQG-ENVAVKIFS--SRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 505 GFCAEKGERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+ L+ Y GSL DYL LD
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL-------------------------QLTTLD 103
Query: 561 WSIRYRIALGVARAIAYLHEECLEW-----VLHCDIKPENILLGDDFCPKISDFGLAKL- 614
RI L +A +A+LH E + H D+K +NIL+ + I+D GLA +
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 615 ---RKKEDMVSMSRIRGTRGYMAPEWLRSDQITP------KADVYSFGMVLLEIVSGSRN 665
+ D+ + R+ GT+ YMAPE L + D+++FG+VL E+ +
Sbjct: 164 SQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222
Query: 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRH---IKNSYDSRVHFDMVNRMVKTA 722
I ++ + +E+M+ +D+ I N + S + + K
Sbjct: 223 NGIVEDYK---PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSD---PTLTSLAKLM 276
Query: 723 MWCIQDRPELRPSMGKVAKMLE 744
C P R + ++ K L
Sbjct: 277 KECWYQNPSARLTALRIKKTLT 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 55/301 (18%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGD---AEFWAEVTIIARMHHLNLVRLWGFC 507
IG G FG VYKG+ VAVK L F EV ++ + H+N++ G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+ +V ++ SL +L H + + I
Sbjct: 90 -TAPQLAIVTQWCEGSSLYHHL----------------------HAS-ETKFEMKKLIDI 125
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS-MSRI 626
A AR + YLH + ++H D+K NI L +D KI DFGLA + + ++
Sbjct: 126 ARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182
Query: 627 RGTRGYMAPEWLRSDQITP---KADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683
G+ +MAPE +R P ++DVY+FG+VL E+++G + ++ N D+
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQ------ 233
Query: 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743
E V D+ ++++ R+ M C++ + + RPS ++ +
Sbjct: 234 IIEMVGRGSLSPDLSK--VRSNCPKRMKRLM--------AECLKKKRDERPSFPRILAEI 283
Query: 744 E 744
E
Sbjct: 284 E 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-48
Identities = 62/314 (19%), Positives = 108/314 (34%), Gaps = 68/314 (21%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDA---EFWAEVTIIARMHHLNLVRL 503
LIG+G FG VY G H VA++ + + F EV + H N+V
Sbjct: 37 IGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
G C ++ +L + D K VLD +
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVV----------------------RD-AKIVLDVNK 131
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS- 622
+IA + + + YLH + +LH D+K +N+ + I+DFGL +
Sbjct: 132 TRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRR 187
Query: 623 ---MSRIRGTRGYMAPEWLRSDQI---------TPKADVYSFGMVLLEIVSGSRNFEIQG 670
+ G ++APE +R + +DV++ G + E+ +
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE------- 240
Query: 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRP 730
+P ++ E I+ + + M + ++C
Sbjct: 241 ---------WP-------FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQ 284
Query: 731 ELRPSMGKVAKMLE 744
E RP+ K+ MLE
Sbjct: 285 EERPTFTKLMDMLE 298
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-39
Identities = 76/316 (24%), Positives = 128/316 (40%), Gaps = 69/316 (21%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+G+G FG+V+ G VA+K LK T F E ++ ++ H LV+L+
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+E+ +V EY+ GSL D+L + + ++M
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDM-------------------- 285
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
A +A +AY+ +H D++ NIL+G++ K++DFGLA+L + + +
Sbjct: 286 -AAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 341
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686
+ + APE + T K+DV+SFG++L E+ + R
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR---------------------- 379
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRM---------VKTAM-WCIQDRPELRPSM 736
Y M ++LD ++ Y RM + M C + PE RP+
Sbjct: 380 VPYPGMVNREVLD-QVERGY----------RMPCPPECPESLHDLMCQCWRKEPEERPTF 428
Query: 737 GKVAKMLEGTVEITEP 752
+ LE TEP
Sbjct: 429 EYLQAFLEDYFTSTEP 444
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-39
Identities = 71/312 (22%), Positives = 113/312 (36%), Gaps = 81/312 (25%)
Query: 451 IGRGGFGDVYKGELTDHRV-VAVKCLKNVTGGD--AEFWAEVTIIARMHHLNLVRLWGFC 507
IGRG FG+V+ G L VAVK + D A+F E I+ + H N+VRL G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+K +V E V G +L R+ L ++
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-RTEG----------------------ARLRVKTLLQM 218
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR-- 625
A + YL +C +H D+ N L+ + KISDFG+++ +
Sbjct: 219 VGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLR 275
Query: 626 ---IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682
++ + APE L + + ++DV+SFG++L E S G+ P
Sbjct: 276 QVPVK----WTAPEALNYGRYSSESDVWSFGILLWETFSL-------GAS--------P- 315
Query: 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRM---------VKTAM-WCIQDRPEL 732
Y + + ++ R+ V M C P
Sbjct: 316 ------YPNLSNQQTR-EFVEKGG----------RLPCPELCPDAVFRLMEQCWAYEPGQ 358
Query: 733 RPSMGKVAKMLE 744
RPS + + L+
Sbjct: 359 RPSFSTIYQELQ 370
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-38
Identities = 76/316 (24%), Positives = 128/316 (40%), Gaps = 69/316 (21%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+G+G FG+V+ G VA+K LK T F E ++ ++ H LV+L+
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+E+ +V EY+ GSL D+L + + ++M
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDM-------------------- 368
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
A +A +AY+ +H D++ NIL+G++ K++DFGLA+L + + +
Sbjct: 369 -AAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686
+ + APE + T K+DV+SFG++L E+ + R
Sbjct: 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR---------------------- 462
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRM---------VKTAM-WCIQDRPELRPSM 736
Y M ++LD ++ Y RM + M C + PE RP+
Sbjct: 463 VPYPGMVNREVLD-QVERGY----------RMPCPPECPESLHDLMCQCWRKEPEERPTF 511
Query: 737 GKVAKMLEGTVEITEP 752
+ LE TEP
Sbjct: 512 EYLQAFLEDYFTSTEP 527
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 61/223 (27%), Positives = 91/223 (40%), Gaps = 32/223 (14%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWA----EVTIIARMHHLNLVRLW 504
L+GRGG GDVY+ E R+VA+K + D F E R+ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
F G+ + + LA L R G + +P R +
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPL---APPRAV-------------------- 137
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
I + A+ H H D+KPENIL+ D + DFG+A E + +
Sbjct: 138 -AIVRQIGSALDAAHAAGA---THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG 193
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
GT YMAPE T +AD+Y+ VL E ++GS ++
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-37
Identities = 72/317 (22%), Positives = 131/317 (41%), Gaps = 69/317 (21%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRV-VAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+ +G G +G+VY+G + + VAVK LK T EF E ++ + H NLV+L G
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
C + ++ E++ G+L DYL R S + M
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYM------------------- 323
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
A ++ A+ YL ++ +H ++ N L+G++ K++DFGL++L + + +
Sbjct: 324 --ATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685
+ + APE L ++ + K+DV++FG++L EI + + P
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------P---- 419
Query: 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRM---------VKTAM-WCIQDRPELRPS 735
Y + + + + ++ Y RM V M C Q P RPS
Sbjct: 420 ---YPGIDLSQVYE-LLEKDY----------RMERPEGCPEKVYELMRACWQWNPSDRPS 465
Query: 736 MGKVAKMLEGTVEITEP 752
++ + E + +
Sbjct: 466 FAEIHQAFETMFQESSI 482
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 32/223 (14%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWA----EVTIIARMHHLNLVRLW 504
+G GG VY E + VA+K + E EV +++ H N+V +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
E LV EY+ +L++Y+ G + ++
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGPL----SVDT--------------AIN---- 115
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
+ I + H+ ++H DIKP+NIL+ + KI DFG+AK + + +
Sbjct: 116 --FTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
+ GT Y +PE + + D+YS G+VL E++ G F
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-36
Identities = 71/316 (22%), Positives = 128/316 (40%), Gaps = 69/316 (21%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+G G FG+V+ H VAVK +K + F AE ++ + H LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
++ ++ E++ GSL D+L +S + ++
Sbjct: 252 VTKEPIY-IITEFMAKGSLLDFL-KSDEGSKQPLPKLIDF-------------------- 289
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+ +A +A++ + +H D++ NIL+ KI+DFGLA++ + + +
Sbjct: 290 -SAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 345
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686
+ + APE + T K+DV+SFG++L+EIV+ R P
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI---------------P----- 385
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRM---------VKTAM-WCIQDRPELRPSM 736
Y M +++ R ++ Y RM + M C ++RPE RP+
Sbjct: 386 --YPGMSNPEVI-RALERGY----------RMPRPENCPEELYNIMMRCWKNRPEERPTF 432
Query: 737 GKVAKMLEGTVEITEP 752
+ +L+ TE
Sbjct: 433 EYIQSVLDDFYTATES 448
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 81/320 (25%), Positives = 135/320 (42%), Gaps = 77/320 (24%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+G G FG+V+ G H VAVK LK + F AE ++ ++ H LVRL+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
++ ++ EY+ NGSL D+L ++ + + ++M
Sbjct: 77 VTQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDM-------------------- 114
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR- 625
A +A +A++ E +H D++ NIL+ D KI+DFGLA+L + + +
Sbjct: 115 -AAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
Query: 626 ---IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPK 682
I+ + APE + T K+DV+SFG++L EIV+ R P
Sbjct: 171 KFPIK----WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI---------------P- 210
Query: 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA----------MWCIQDRPEL 732
Y M +++ +++ Y RMV+ C ++RPE
Sbjct: 211 ------YPGMTNPEVIQ-NLERGY----------RMVRPDNCPEELYQLMRLCWKERPED 253
Query: 733 RPSMGKVAKMLEGTVEITEP 752
RP+ + +LE TE
Sbjct: 254 RPTFDYLRSVLEDFFTATEG 273
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 73/335 (21%), Positives = 125/335 (37%), Gaps = 76/335 (22%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR-----VVAVKCLKNVTGGDA--EFWAEVTIIARMHHLN 499
+G G FG V +VAVK LK G + E+ I+ ++H +
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 500 LVRLWGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
+++ G C + G + LV EYVP GSL DYL +G
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGL------------------AQ 135
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRK 616
+L + A + +AYLH + +H D+ N+LL +D KI DFGLAK + +
Sbjct: 136 LLLF------AQQICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186
Query: 617 KEDMVSMSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671
+ + + + APE L+ + +DV+SFG+ L E+++
Sbjct: 187 GHEYYRVREDGDSPVF----WYAPECLKEYKFYYASDVWSFGVTLYELLTH-------CD 235
Query: 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA--------- 722
S F + +M V + ++ R+ +
Sbjct: 236 SSQSPPTKFLELIGIA-QGQMTVLRLT-ELLERGE----------RLPRPDKCPAEVYHL 283
Query: 723 -MWCIQDRPELRPSMGKVAKMLEGTVEITEPKKPT 756
C + RP+ + +L+ E + + P+
Sbjct: 284 MKNCWETEASFRPTFENLIPILKTVHEKYQGQAPS 318
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 65/322 (20%), Positives = 122/322 (37%), Gaps = 72/322 (22%)
Query: 447 FSNLIGRGGFGDVYKGELT-----DHRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLN 499
+G G FG V VAVK LK +GG+ + E+ I+ ++H N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 500 LVRLWGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
+V+ G C E G L+ E++P+GSL +YL + + ++++
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNK-NKINLKQQLKY----------- 131
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRK 616
A+ + + + YL +H D+ N+L+ + KI DFGL K +
Sbjct: 132 ----------AVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
Query: 617 KEDMVSMSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQG 670
++ ++ + + APE L + +DV+SFG+ L E+++ +
Sbjct: 179 DKEYYTVKDDRDSPVF----WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234
Query: 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSY--------DSRVHFDMVNRMVKTA 722
+ + +M V +++ +K V+ M
Sbjct: 235 LFLKMIGPT---------HGQMTVTRLVNT-LKEGKRLPCPPNCPDEVYQLMRK------ 278
Query: 723 MWCIQDRPELRPSMGKVAKMLE 744
C + +P R S + + E
Sbjct: 279 --CWEFQPSNRTSFQNLIEGFE 298
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 42/231 (18%)
Query: 450 LIGRGGFGDVYKGELTDH---RVVAVKCLKNVTGGDAEFWA----EVTIIARMHHLNLVR 502
++G GG +V+ D R VAVK L+ D F+ E A ++H +V
Sbjct: 19 ILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 503 L--WGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
+ G +V EYV +L D + G + +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM----TPKR--------------A 118
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK--LRK 616
++ + +A+ + H+ + +H D+KP NI++ K+ DFG+A+
Sbjct: 119 IE------VIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADS 169
Query: 617 KEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
+ + + GT Y++PE R D + ++DVYS G VL E+++G F
Sbjct: 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 34/219 (15%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
F IG G FG V+ G + VA+K ++ + +F E ++ ++ H LV+L+G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
C E+ LV E++ +G L+DYL R+ R G + + M
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYL-RTQR-GLFAAETLLGM-------------------- 109
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR- 625
L V +AYL E C V+H D+ N L+G++ K+SDFG+ + + S +
Sbjct: 110 -CLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165
Query: 626 ---IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
++ + +PE + + K+DV+SFG+++ E+ S
Sbjct: 166 KFPVK----WASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
F +G G FG V G+ VA+K +K + + EF E ++ + H LV+L+G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
C ++ ++ EY+ NG L +YL R R + +EM
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYL-REMR-HRFQTQQLLEM-------------------- 125
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR- 625
V A+ YL + LH D+ N L+ D K+SDFGL++ ++ S
Sbjct: 126 -CKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 181
Query: 626 ---IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+R + PE L + + K+D+++FG+++ EI S
Sbjct: 182 KFPVR----WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 70/320 (21%), Positives = 122/320 (38%), Gaps = 68/320 (21%)
Query: 447 FSNLIGRGGFGDVYKGELT-----DHRVVAVKCLKNVTGGD-AEFWAEVTIIARMHHLNL 500
F +G+G FG V VVAVK L++ T +F E+ I+ + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 501 VRLWGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
V+ G C G R L+ EY+P GSL DYL + + + ++
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHK-ERIDHIKLLQY------------ 119
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
+ + + YL + +H D+ NIL+ ++ KI DFGL K+ ++
Sbjct: 120 ---------TSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQD 167
Query: 619 DMVSMSR------IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672
+ I + APE L + + +DV+SFG+VL E+ + + +
Sbjct: 168 KEFFKVKEPGESPIF----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223
Query: 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSY--------DSRVHFDMVNRMVKTAMW 724
+M V +++ +KN+ ++ M
Sbjct: 224 FMRMIGNDK-------QGQMIVFHLIEL-LKNNGRLPRPDGCPDEIYMIMTE-------- 267
Query: 725 CIQDRPELRPSMGKVAKMLE 744
C + RPS +A ++
Sbjct: 268 CWNNNVNQRPSFRDLALRVD 287
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+G G FG V G+ VAVK +K + + EF+ E + ++ H LV+ +G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
C+++ +V EY+ NG L +YL RS P++ +EM
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL-RSHG-KGLEPSQLLEM-------------------- 109
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR- 625
V +A+L +H D+ N L+ D C K+SDFG+ + + VS
Sbjct: 110 -CYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGT 165
Query: 626 ---IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
++ + APE + + K+DV++FG+++ E+ S
Sbjct: 166 KFPVK----WSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 70/327 (21%), Positives = 123/327 (37%), Gaps = 68/327 (20%)
Query: 447 FSNLIGRGGFGDVYKGELT-----DHRVVAVKCLKNVTGGD-AEFWAEVTIIARMHHLNL 500
F +G+G FG V VVAVK L++ T +F E+ I+ + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 501 VRLWGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
V+ G C G R L+ EY+P GSL DYL + + + ++
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHK-ERIDHIKLLQY------------ 150
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
+ + + YL + +H D+ NIL+ ++ KI DFGL K+ ++
Sbjct: 151 ---------TSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQD 198
Query: 619 DMVSMSR------IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672
+ I + APE L + + +DV+SFG+VL E+ + + +
Sbjct: 199 KEYYKVKEPGESPIF----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 254
Query: 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSY--------DSRVHFDMVNRMVKTAMW 724
+M V +++ +KN+ ++ M
Sbjct: 255 FMRMIGNDK-------QGQMIVFHLIEL-LKNNGRLPRPDGCPDEIYMIMTE-------- 298
Query: 725 CIQDRPELRPSMGKVAKMLEGTVEITE 751
C + RPS +A ++ +
Sbjct: 299 CWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 76/321 (23%), Positives = 130/321 (40%), Gaps = 63/321 (19%)
Query: 447 FSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTGGD--AEFWAEVTIIARMHHL 498
+G G FG V K + VAVK LK + +E ++ +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
++++L+G C++ G L+ EY GSL +L S +VG + +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
L A +++ + YL ++ V H D+ NIL+ + KISDFGL++ +E
Sbjct: 147 LTMGDLISFAWQISQGMQYL--AEMKLV-HRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 619 DMVSMSRIRGTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673
D ++ ++G +MA E L T ++DV+SFG++L EIV+ G
Sbjct: 204 DSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT-------LGGN- 251
Query: 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA----------M 723
P Y + E + +K + RM + +
Sbjct: 252 -------P-------YPGIPPERLF-NLLKTGH----------RMERPDNCSEEMYRLML 286
Query: 724 WCIQDRPELRPSMGKVAKMLE 744
C + P+ RP ++K LE
Sbjct: 287 QCWKQEPDKRPVFADISKDLE 307
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 68/335 (20%), Positives = 124/335 (37%), Gaps = 71/335 (21%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR-----VVAVKCLK-NVTGGDAEFWAEVTIIARMHHLNL 500
+ + +G+G FG V +VAVK L+ + +F E+ I+ +H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 501 VRLWGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
V+ G G ++ LV EY+P+G L D+L + R +
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHR----------------ARLDASRL 129
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
L + + + + + YL +H D+ NIL+ + KI+DFGLAKL +
Sbjct: 130 LLY------SSQICKGMEYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLD 180
Query: 619 DMVSMSR------IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGS 671
+ R I + APE L + + ++DV+SFG+VL E+ + ++
Sbjct: 181 KDYYVVREPGQSPIF----WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236
Query: 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSY--------DSRVHFDMVNRMVKTAM 723
+ + +L+ ++ + VH M
Sbjct: 237 FLRMMGCERD---------VPALSRLLEL-LEEGQRLPAPPACPAEVHELMKL------- 279
Query: 724 WCIQDRPELRPSMGKVAKMLEGTVEITEPKKPTIY 758
C P+ RPS + L+ + + +
Sbjct: 280 -CWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 313
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 68/317 (21%), Positives = 120/317 (37%), Gaps = 80/317 (25%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR-----VVAVKCLKNVTGGDA--EFWAEVTIIARMHHLN 499
++G G FG VYKG VA+K L+ T A E E ++A + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+ RL G C L+ + +P G L DY+ R + + +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYV-REHK-DNIGSQYLLNW------------- 122
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
+ +A+ + YL + L +H D+ N+L+ KI+DFGLAKL E+
Sbjct: 123 --------CVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 620 MVSMSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673
+ I+ +MA E + T ++DV+S+G+ + E+++ GS+
Sbjct: 172 KEYHAEGGKVPIK----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--------- 218
Query: 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVH------FDMVNRMVKTAMWCIQ 727
P Y+ + +I ++ R+ D+ M K C
Sbjct: 219 -------P-------YDGIPASEISS-ILEKGE--RLPQPPICTIDVYMIMRK----CWM 257
Query: 728 DRPELRPSMGKVAKMLE 744
+ RP ++
Sbjct: 258 IDADSRPKFRELIIEFS 274
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 73/320 (22%), Positives = 132/320 (41%), Gaps = 77/320 (24%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRV-VAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+ +G G +G+VY+G + + VAVK LK T EF E ++ + H NLV+L G
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
C + ++ E++ G+L DYL R S + M
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYM------------------- 116
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
A ++ A+ YL ++ +H D+ N L+G++ K++DFGL++L + + +
Sbjct: 117 --ATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 626 ----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681
I+ + APE L ++ + K+DV++FG++L EI + + P
Sbjct: 172 AKFPIK----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------P 212
Query: 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVK---------TAM-WCIQDRPE 731
Y + + + + ++ Y RM + M C Q P
Sbjct: 213 -------YPGIDLSQVYE-LLEKDY----------RMERPEGCPEKVYELMRACWQWNPS 254
Query: 732 LRPSMGKVAKMLEGTVEITE 751
RPS ++ + E + +
Sbjct: 255 DRPSFAEIHQAFETMFQESS 274
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-34
Identities = 81/311 (26%), Positives = 129/311 (41%), Gaps = 79/311 (25%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG+G FGDV G+ ++V AVKC+KN F AE +++ ++ H NLV+L G
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKV-AVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 507 CAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E+ +V EY+ GSL DYL G+ VL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYL----------------------RSRGRSVLGGDCLL 292
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ +L V A+ YL +H D+ N+L+ +D K+SDFGL ++ +
Sbjct: 293 KFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGK 347
Query: 626 --IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683
++ + APE LR + + K+DV+SFG++L EI S R P
Sbjct: 348 LPVK----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---------------P-- 386
Query: 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRM---------VKTAM-WCIQDRPELR 733
Y + ++D++ ++ Y +M V M C R
Sbjct: 387 -----YPRIPLKDVVP-RVEKGY----------KMDAPDGCPPAVYDVMKNCWHLDAATR 430
Query: 734 PSMGKVAKMLE 744
P+ ++ + LE
Sbjct: 431 PTFLQLREQLE 441
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 53/227 (23%), Positives = 100/227 (44%), Gaps = 43/227 (18%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR-----VVAVKCLKNVTGGDA--EFWAEVTIIARMHHLN 499
++G G FG V+KG V +K +++ +G + + I + H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+VRL G C LV +Y+P GSL D++ R R G+ P +
Sbjct: 77 IVRLLGLCPGS-SLQLVTQYLPLGSLLDHV-RQHR-GALGPQLLLNW------------- 120
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
+ +A+ + YL E + +H ++ N+LL +++DFG+A L +D
Sbjct: 121 --------GVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
Query: 620 MVSMSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ I+ +MA E + + T ++DV+S+G+ + E+++
Sbjct: 170 KQLLYSEAKTPIK----WMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 85/317 (26%), Positives = 135/317 (42%), Gaps = 68/317 (21%)
Query: 447 FSNLIGRGGFGDVYKGELTDH---RVVAVKCLK-NVTGGD-AEFWAEVTIIARM-HHLNL 500
F ++IG G FG V K + A+K +K + D +F E+ ++ ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+ L G C +G L EY P+G+L D+L R RV + PA + + L
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIA-------NSTASTLS 140
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
A VAR + YL ++ +H D+ NIL+G+++ KI+DFGL+ R +E
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLS--RGQEVY 195
Query: 621 VSMSR----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNS 675
V + +R +MA E L T +DV+S+G++L EIVS G
Sbjct: 196 VKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----------- 240
Query: 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSY--------DSRVHFDMVNRMVKTAMWCIQ 727
P Y M ++ + Y D V+ M C +
Sbjct: 241 -----P-------YCGMTCAELY-EKLPQGYRLEKPLNCDDEVYDLM--------RQCWR 279
Query: 728 DRPELRPSMGKVAKMLE 744
++P RPS ++ L
Sbjct: 280 EKPYERPSFAQILVSLN 296
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 69/309 (22%), Positives = 119/309 (38%), Gaps = 70/309 (22%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE---FWAEVTIIARMHHLNLVR 502
F IGRG F VYKG + VA L++ +E F E ++ + H N+VR
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 503 LWGFC--AEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
+ KG++ + V E + +G+L YL R
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------------------------ 125
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-GDDFCPKISDFGLAKLRKK 617
+ + + + + +LH ++H D+K +NI + G KI D GLA L++
Sbjct: 126 MKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
++ GT +MAPE + ++ DVY+FGM +LE+ + E S +
Sbjct: 185 SFAKAV---IGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATS----EYPYSECQN-- 234
Query: 678 WYFPKWAFEKVYEEMK---VEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734
+ +V +K + + +K +++ CI+ + R
Sbjct: 235 ---AAQIYRRVTSGVKPASFDKVAIPEVK---------EIIEG-------CIRQNKDERY 275
Query: 735 SMGKVAKML 743
S K L
Sbjct: 276 S----IKDL 280
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 49/229 (21%)
Query: 450 LIGRGGFGDVYKGE--LTDHRVVAVKCLKNVTGGDAEFWA----EVTIIARMHHLNLVRL 503
I GG G +Y + R V +K L + GDAE A E +A + H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVH--SGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 504 WGFCAEKGERT-----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
+ F +V EYV SL G K
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------------------------GQKLP 180
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
+ +I L + A++YLH L ++ D+KPENI+L ++ K+ D G
Sbjct: 181 VAEAI--AYLLEILPALSYLHSIGL---VYNDLKPENIMLTEEQ-LKLIDLGAVSR---- 230
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
+ S + GT G+ APE +R+ T D+Y+ G L +
Sbjct: 231 -INSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRN 277
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 79/329 (24%), Positives = 131/329 (39%), Gaps = 63/329 (19%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR------VVAVKCLK-NVTGGD-AEFWAEVTIIARMHHL 498
+ IG G FG V++ +VAVK LK + A+F E ++A +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
N+V+L G CA L++EY+ G L ++L S + + G P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
L + + IA VA +AYL ++V H D+ N L+G++ KI+DFGL++
Sbjct: 171 LSCAEQLCIARQVAAGMAYL--SERKFV-HRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 619 D---MVSMSR--IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673
D IR +M PE + ++ T ++DV+++G+VL EI S G
Sbjct: 228 DYYKADGNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS-------YGLQ- 275
Query: 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA----------M 723
P Y M E+++ ++++ +
Sbjct: 276 -------P-------YYGMAHEEVI-YYVRDGN----------ILACPENCPLELYNLMR 310
Query: 724 WCIQDRPELRPSMGKVAKMLEGTVEITEP 752
C P RPS + ++L+ E E
Sbjct: 311 LCWSKLPADRPSFCSIHRILQRMCERAEG 339
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 67/231 (29%), Positives = 99/231 (42%), Gaps = 26/231 (11%)
Query: 447 FSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTGGD--AEFWAEVTIIARM-HH 497
F ++G G FG V VAVK LK +E+ ++ ++ H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
N+V L G C G L++EY G L +YL RS R S E E +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL-RSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL--- 614
VL + A VA+ + +L E V H D+ N+L+ KI DFGLA+
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL--EFKSCV-HRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 615 ----RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ + + ++ +MAPE L T K+DV+S+G++L EI S
Sbjct: 225 DSNYVVRGN--ARLPVK----WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 57/275 (20%), Positives = 104/275 (37%), Gaps = 57/275 (20%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCA 508
++G+G FG V K D R A+K +++ + +EV ++A ++H +VR +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 509 EKGERT-------------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGG 555
E+ + EY NG+L D +
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW------------- 119
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
R+ + A++Y+H + ++H D+KP NI + + KI DFGLAK
Sbjct: 120 ----------RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 616 KKEDMVS-------------MSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVS 661
+ + ++ GT Y+A E L + K D+YS G++ E++
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
Query: 662 GSRNFEIQGSMMN---SDEWYFPKWAFEKVYEEMK 693
+ +++ S FP + + K
Sbjct: 227 PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEK 261
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 27/227 (11%)
Query: 447 FSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTGGD-AEFWAEVTIIARMHHLN 499
+G G FG V+ E + +VAVK LK+ T +F E ++ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+V+ +G C + +V+EY+ +G L +L R+ + + G K L
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFL-RAHG-------PDAMILVDGQPRQAKGEL 130
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
S IA +A + YL +V H D+ N L+G + KI DFG+++ D
Sbjct: 131 GLSQMLHIASQIASGMVYL--ASQHFV-HRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 620 MVSMSRIRGTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ G +M PE + + T ++DV+SFG++L EI +
Sbjct: 188 YYRV----GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-33
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 41/225 (18%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRV----VAVKCLKNVTGGDA--EFWAEVTIIARMHHLNL 500
+ ++G G FG+VY+G T+H+ VAVK K D +F +E I+ + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
V+L G E+ ++ E P G L YL + S +
Sbjct: 76 VKLIGII-EEEPTWIIMELYPYGELGHYL-ERNK-NSLKVLTLVLY-------------- 118
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
+L + +A+AYL +H DI NIL+ C K+ DFGL++ + ED
Sbjct: 119 -------SLQICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168
Query: 621 VSMSR----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
S I+ +M+PE + + T +DV+ F + + EI+S
Sbjct: 169 YKASVTRLPIK----WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 27/229 (11%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR------VVAVKCLKNVTGGD--AEFWAEVTIIARM-HH 497
F +G G FG V + VAVK LK +E+ +++ + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
+N+V L G C G ++ EY G L ++L R R + + + +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFL-RRKR-----DSFICSKTSPAIMEDDEL 140
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
LD + VA+ +A+L + +H D+ NILL KI DFGLA+ K
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 618 EDMVSMSRIRGTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ + + +MAPE + + T ++DV+S+G+ L E+ S
Sbjct: 198 DS----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 50/298 (16%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEF----WAEVTIIARMHHLNLVRLW 504
IGRG F +VY+ L D VA+K ++ DA+ E+ ++ +++H N+++ +
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
E E +V E G L+ + + P R V + ++
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT--------------VWKYFVQ 144
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
+ A+ ++H V+H DIKP N+ + K+ D GL + + + S
Sbjct: 145 ------LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWA 684
+ GT YM+PE + + K+D++S G +L E+ + F + S
Sbjct: 196 LV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--------L 246
Query: 685 FEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742
+K+ E+ + H S + R +VN CI PE RP + V +
Sbjct: 247 CKKI-EQCDYPPLPSDHY--SEELR---QLVN-------MCINPDPEKRPDVTYVYDV 291
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 82/309 (26%), Positives = 129/309 (41%), Gaps = 75/309 (24%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG+G FGDV G+ ++V AVKC+KN F AE +++ ++ H NLV+L G
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 507 C-AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
EKG +V EY+ GSL DYL RS ++
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKF------------------- 122
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+L V A+ YL +H D+ N+L+ +D K+SDFGL ++ +
Sbjct: 123 --SLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGK 175
Query: 626 --IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683
++ + APE LR + + K+DV+SFG++L EI S R P
Sbjct: 176 LPVK----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---------------P-- 214
Query: 684 AFEKVYEEMKVEDILDRHIKNSY--------DSRVHFDMVNRMVKTAMWCIQDRPELRPS 735
Y + ++D++ ++ Y V+ M C +RPS
Sbjct: 215 -----YPRIPLKDVVP-RVEKGYKMDAPDGCPPAVYEVM--------KNCWHLDAAMRPS 260
Query: 736 MGKVAKMLE 744
++ + LE
Sbjct: 261 FLQLREQLE 269
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 28/227 (12%)
Query: 447 FSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTGGD-AEFWAEVTIIARMHHLN 499
+G G FG V+ E + +VAVK LK + +F E ++ + H +
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+VR +G C E +V+EY+ +G L +L G D L
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH---------GPDAKLLAGGEDVAPGPL 155
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
+A VA + YL +H D+ N L+G KI DFG+++ D
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 620 MVSMSRIRGTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ G R +M PE + + T ++DV+SFG+VL EI +
Sbjct: 213 YYRV----GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 61/229 (26%), Positives = 88/229 (38%), Gaps = 45/229 (19%)
Query: 447 FSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHL 498
+G G FG V +GE VAVKCLK +F EV + + H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
NL+RL+G +V E P GSL D L R + G
Sbjct: 82 NLIRLYGVVLTPP-MKMVTELAPLGSLLDRL-RKHQ-GHFLLGTLSRY------------ 126
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKK 617
A+ VA + YL + +H D+ N+LL KI DFGL + L +
Sbjct: 127 ---------AVQVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174
Query: 618 EDMVSMSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+D M + APE L++ + +D + FG+ L E+ +
Sbjct: 175 DDHYVMQEHRKVPFA----WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR----VVAVKCLKNVTGGD--AEFWAEVTIIARMHHLNL 500
+IG+G FG VY GE D A+K L +T F E ++ ++H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 501 VRLWGFCAEKGERTL-VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+ L G + Y+ +G L ++ RS +
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQ----------------------RNP 121
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
L VAR + YL E+ +H D+ N +L + F K++DFGLA+ +
Sbjct: 122 TVKDLISFGLQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDILDRE 178
Query: 620 MVSMSRIRGTR---GYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
S+ + R R + A E L++ + T K+DV+SFG++L E+++
Sbjct: 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 52/226 (23%), Positives = 94/226 (41%), Gaps = 29/226 (12%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVK--CLKNVTGGDAEF-WAEVTIIARMHHLNLVRLWG 505
IG G +G K +D +++ K ++T + + +EV ++ + H N+VR +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 506 FCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
++ TL V EY G LA + + + + +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV----------------LRV 116
Query: 564 RYRIALGVARAIAYLHEECLEW--VLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
++ L A+ H VLH D+KP N+ L K+ DFGLA++ +
Sbjct: 117 MTQLTL----ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
+ + + GT YM+PE + K+D++S G +L E+ + F
Sbjct: 173 AKTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 43/227 (18%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR-----VVAVKCLKNVTGGDA--EFWAEVTIIARMHHLN 499
++G G FG VYKG VA+K L+ T A E E ++A + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+ RL G C L+ + +P G L DY+ R + + +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYV-REHK-DNIGSQYLLNW------------- 122
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
+ +A+ + YL + L +H D+ N+L+ KI+DFGLAKL E+
Sbjct: 123 --------CVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171
Query: 620 MVSMSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ I+ +MA E + T ++DV+S+G+ + E+++
Sbjct: 172 KEYHAEGGKVPIK----WMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 76/331 (22%), Positives = 131/331 (39%), Gaps = 74/331 (22%)
Query: 447 FSNLIGRGGFGDVYKGELTD--------HRVVAVKCLK-NVTGGD-AEFWAEVTIIARM- 495
+G G FG V E VAVK LK + T D ++ +E+ ++ +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 496 HHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGG 555
H N++ L G C + G ++ EY G+L +YL R+ R + + +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYD-------INRVP 196
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
+ + + +AR + YL + + H D+ N+L+ ++ KI+DFGLA+
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDI 253
Query: 616 KKEDMVSMSRIRGTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670
D + T G +MAPE L T ++DV+SFG+++ EI + G
Sbjct: 254 NNID----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL-------G 302
Query: 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA-------- 722
P Y + VE++ +K + RM K A
Sbjct: 303 GS--------P-------YPGIPVEELFK-LLKEGH----------RMDKPANCTNELYM 336
Query: 723 --MWCIQDRPELRPSMGKVAKMLEGTVEITE 751
C P RP+ ++ + L+ + +T
Sbjct: 337 MMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 451 IGRGGFGDVYKGELTDHR----VVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVRLW 504
IG G FGDV++G VA+K KN T +F E + + H ++V+L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
G E ++ E G L +L + + S A +
Sbjct: 83 GVITEN-PVWIIMELCTLGELRSFL-QVRK-YSLDLASLILY------------------ 121
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
A ++ A+AYL + +H DI N+L+ + C K+ DFGL++ + S
Sbjct: 122 ---AYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 175
Query: 625 R----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ I+ +MAPE + + T +DV+ FG+ + EI+
Sbjct: 176 KGKLPIK----WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 44/223 (19%)
Query: 451 IGRGGFGDVYKGELTDHRV---VAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLW 504
+G G FG V KG +V VAVK LKN E AE ++ ++ + +VR+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
G C + LV E G L YL ++ V + +++
Sbjct: 85 GICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKN------------------IIEL--- 122
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
V+ + YL E +H D+ N+LL KISDFGL+K + ++ +
Sbjct: 123 ---VHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176
Query: 625 R------IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ ++ + APE + + + K+DV+SFG+++ E S
Sbjct: 177 QTHGKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 52/279 (18%), Positives = 98/279 (35%), Gaps = 43/279 (15%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL-KNVTGGDAEFWA-EVTIIARMHHLNLVRL 503
S+++G+G +V++G + A+K + E ++ +++H N+V+L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 504 WGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+ E R L+ E+ P GSL L E E
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFL-------------- 115
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP----KISDFGLAKLRKK 617
+ V + +L E ++H +IKP NI+ K++DFG A+ +
Sbjct: 116 ----IVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQI--------TPKADVYSFGMVLLEIVSGSRNFEIQ 669
++ + GT Y+ P+ + D++S G+ +GS F
Sbjct: 169 DEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDS 708
+ E + + V+ + I S D
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 447 FSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTGGD--AEFWAEVTIIARM-HH 497
F +G G FG V + VAVK LK+ D +E+ I++ + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
N+V L G C G ++ EY G L ++L R RV + PA + S D
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD---- 165
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
+ VA+ +A+L + +H D+ N+LL + KI DFGLA+
Sbjct: 166 ------LLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 618 EDMVSMSRIRGTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ I +MAPE + T ++DV+S+G++L EI S
Sbjct: 217 DSNY----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 42/222 (18%)
Query: 451 IGRGGFGDVYKGELTDHRV---VAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVRLWG 505
+G G FG V +G + VA+K LK T E E I+ ++ + +VRL G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
C + LV E G L +L + E+
Sbjct: 78 VCQAE-ALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAEL------------------- 115
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
V+ + YL E+ +H D+ N+LL + KISDFGL+K +D +R
Sbjct: 116 --LHQVSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170
Query: 626 ------IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
++ + APE + + + ++DV+S+G+ + E +S
Sbjct: 171 SAGKWPLK----WYAPECINFRKFSSRSDVWSYGVTMWEALS 208
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 68/325 (20%), Positives = 117/325 (36%), Gaps = 85/325 (26%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR----VVAVKCLKNVTGGDAE---FWAEVTIIARMHHLN 499
++G G FG V +G L VAVK +K E F +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 500 LVRLWGFCAEKGERT-----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDG 554
++RL G C E + ++ ++ G L YL R +
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSR-----------------LET 139
Query: 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL 614
G + + + +A + YL LH D+ N +L DD ++DFGL+K
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKK 196
Query: 615 RKKEDMVSMSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669
D R ++ ++A E L T K+DV++FG+ + EI + +
Sbjct: 197 IYSGDYYRQGRIAKMPVK----WIAIESLADRVYTSKSDVWAFGVTMWEIAT-------R 245
Query: 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVK--------- 720
G P Y ++ ++ D ++ + + R+ +
Sbjct: 246 GMT--------P-------YPGVQNHEMYD-YLLHGH----------RLKQPEDCLDELY 279
Query: 721 TAMW-CIQDRPELRPSMGKVAKMLE 744
M+ C + P RP+ + LE
Sbjct: 280 EIMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 74/331 (22%), Positives = 124/331 (37%), Gaps = 83/331 (25%)
Query: 447 FSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNL 500
+IG G G+V G L VA+K LK +F +E +I+ + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+RL G +V EY+ NGSL +L R+ G + + + M
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHD-GQFTIMQLVGM-------------- 156
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKED 619
GV + YL + +H D+ N+L+ + K+SDFGL++ L D
Sbjct: 157 -------LRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 620 MVSMSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673
+ IR + APE + + +DV+SFG+V+ E+++ G R
Sbjct: 207 AAYTTTGGKIPIR----WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER--------- 253
Query: 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSY--------DSRVHFDMVNRMVKTAMWC 725
P Y M D++ ++ Y +H M + C
Sbjct: 254 -------P-------YWNMTNRDVI-SSVEEGYRLPAPMGCPHALHQLM--------LDC 290
Query: 726 IQDRPELRPSMGKVAKMLEGTVEITEPKKPT 756
RP ++ +L+ + E + T
Sbjct: 291 WHKDRAQRPRFSQIVSVLDALIRSPESLRAT 321
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-31
Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 40/231 (17%)
Query: 447 FSNLIGRGGFGDVYKGE--LTDHRVVAVKCL-KNVTGGDAEFWA-EVTIIARMHHLNLVR 502
+G GGFG V + T +V A+K + ++ + E W E+ I+ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQV-AIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 503 L------WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
A L EY G L YL + +E
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGP----------- 122
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAK 613
IR + ++ A+ YLHE ++H D+KPENI+L KI D G AK
Sbjct: 123 ------IR-TLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172
Query: 614 LRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664
+ ++ + GT Y+APE L + T D +SFG + E ++G R
Sbjct: 173 ELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 36/225 (16%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR----VVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNL 500
F+ +IGRG FG VY G L D+ AVK L +T +F E I+ H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 501 VRLWGFCAEKGERTL-VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+ L G C L V Y+ +G L +++ R+
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNET----------------------HNP 125
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
L VA+ + YL + +H D+ N +L + F K++DFGLA+ ++
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
Query: 620 MVSMSRIRGTR---GYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
S+ G + +MA E L++ + T K+DV+SFG++L E+++
Sbjct: 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 61/228 (26%), Positives = 98/228 (42%), Gaps = 28/228 (12%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR------VVAVKCLKNVTGGDA--EFWAEVTIIARMHHL 498
F +G FG VYKG L VA+K LK+ G EF E + AR+ H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
N+V L G + ++++ Y +G L ++L P ++ +
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL-VMRS-----PHSDVGSTDDDRTVKSA-- 124
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
L+ + +A + YL V H D+ N+L+ D KISD GL +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL--SSHHVV-HKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 619 D---MVSMSR--IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
D ++ S IR +MAPE + + + +D++S+G+VL E+ S
Sbjct: 182 DYYKLLGNSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 77/331 (23%), Positives = 132/331 (39%), Gaps = 74/331 (22%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR--------VVAVKCLK-NVTGGD-AEFWAEVTIIARM- 495
+G G FG V E VAVK LK + T D ++ +E+ ++ +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 496 HHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGG 555
H N++ L G C + G ++ EY G+L +YL R+ R + + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYD-------INRVP 150
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
+ + + +AR + YL + +H D+ N+L+ ++ KI+DFGLA+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 616 KKEDMVSMSRIRGTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670
D + T G +MAPE L T ++DV+SFG+++ EI + G
Sbjct: 208 NNID----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL-------G 256
Query: 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA-------- 722
P Y + VE++ +K + RM K A
Sbjct: 257 GS--------P-------YPGIPVEELFK-LLKEGH----------RMDKPANCTNELYM 290
Query: 723 -MW-CIQDRPELRPSMGKVAKMLEGTVEITE 751
M C P RP+ ++ + L+ + +T
Sbjct: 291 MMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 43/224 (19%)
Query: 451 IGRGGFGDVYKGELTDHRV-----VAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVRL 503
IG G FG+VYKG L VA+K LK +F E I+ + H N++RL
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
G ++ ++ EY+ NG+L +L R G S + + M
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL-REKD-GEFSVLQLVGM----------------- 152
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
G+A + YL +H D+ NIL+ + K+SDFGL+++ + + +
Sbjct: 153 ----LRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205
Query: 624 SR------IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ IR + APE + + T +DV+SFG+V+ E+++
Sbjct: 206 TTSGGKIPIR----WTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 68/230 (29%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 447 FSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTGGD--AEFWAEVTIIARM-HH 497
+GRG FG V + + R VAVK LK +E+ I+ + HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 498 LNLVRLWGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
LN+V L G C + G ++ E+ G+L+ YL RS R E D K
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-RSKRNEFVPYKVAPE-------DLYK 142
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK 616
L + VA+ + +L +H D+ NILL + KI DFGLA+
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 617 KEDMVSMSRIRGTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
K+ +R +MAPE + T ++DV+SFG++L EI S
Sbjct: 200 KDP----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 61/245 (24%), Positives = 99/245 (40%), Gaps = 40/245 (16%)
Query: 449 NLIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAE--FWAEVTIIARMHHLNLVRL 503
+G+G FG+VY E ++A+K L + E EV I + + H N++RL
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+G+ + L+ EY P G++ L + +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKF-DEQRTA--------------------- 112
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
+A A++Y H + V+H DIKPEN+LLG KI+DFG + +
Sbjct: 113 --TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL 167
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM-----NSDEW 678
GT Y+ PE + K D++S G++ E + G FE + E+
Sbjct: 168 C---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 224
Query: 679 YFPKW 683
FP +
Sbjct: 225 TFPDF 229
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-31
Identities = 83/336 (24%), Positives = 135/336 (40%), Gaps = 74/336 (22%)
Query: 451 IGRGGFGDVYKGELTD--------HRVVAVKCLK-NVTGGD-AEFWAEVTIIARM-HHLN 499
+G G FG V E VAVK LK + T D ++ +E+ ++ + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
++ L G C + G ++ EY G+L +YL ++ R + P + L
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYS-------YNPSHNPEEQL 188
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
A VAR + YL + + H D+ N+L+ +D KI+DFGLA+ D
Sbjct: 189 SSKDLVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 620 MVSMSRIRGTRG-----YMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674
+ T G +MAPE L T ++DV+SFG++L EI + G
Sbjct: 246 YY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-------LGGS-- 292
Query: 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA---------MW- 724
P Y + VE++ + +K + RM K + M
Sbjct: 293 ------P-------YPGVPVEELF-KLLKEGH----------RMDKPSNCTNELYMMMRD 328
Query: 725 CIQDRPELRPSMGKVAKMLEGTVEITEPKKPTIYFL 760
C P RP+ ++ + L+ V +T ++ Y
Sbjct: 329 CWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHH 364
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 46/233 (19%), Positives = 88/233 (37%), Gaps = 43/233 (18%)
Query: 447 FSNLIGRGGFGDVYKGELTDH----RVVAVKCLKNVTGGDAE---FWAEVTIIARMHHLN 499
++G+G FG V + +L VAVK LK ++ F E + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 500 LVRLWGFCAEKGERT------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHD 553
+ +L G + ++ ++ +G L +L + R
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASR-----------------IG 128
Query: 554 GGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK 613
L R + +A + YL +H D+ N +L +D ++DFGL++
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 614 LRKKEDMVSMSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
D ++ ++A E L + T +DV++FG+ + EI++
Sbjct: 186 KIYSGDYYRQGCASKLPVK----WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 66/312 (21%), Positives = 120/312 (38%), Gaps = 76/312 (24%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFC 507
LIG GGFG V+K + D + +K +K + + EV +A++ H+N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY---NNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 508 AEKGERT----------------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGP 551
+ E+ G+L ++ + ++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR----RGEKLDKVLA----- 124
Query: 552 HDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL 611
+ +I GV Y+H + +++ D+KP NI L D KI DFGL
Sbjct: 125 ---------LELFEQITKGV----DYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGL 168
Query: 612 AKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671
K + +R +GT YM+PE + S + D+Y+ G++L E++
Sbjct: 169 VTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT------ 220
Query: 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPE 731
AFE D+ D I + +D + ++ ++ + +PE
Sbjct: 221 ------------AFET---SKFFTDLRDGIISDIFDKKEK-TLLQKL-------LSKKPE 257
Query: 732 LRPSMGKVAKML 743
RP+ ++ + L
Sbjct: 258 DRPNTSEILRTL 269
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 52/279 (18%), Positives = 98/279 (35%), Gaps = 43/279 (15%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL-KNVTGGDAEFWA-EVTIIARMHHLNLVRL 503
S+++G+G +V++G + A+K + E ++ +++H N+V+L
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 504 WGFCAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+ E R L+ E+ P GSL L E E
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFL-------------- 115
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG----DDFCPKISDFGLAKLRKK 617
+ V + +L E ++H +IKP NI+ K++DFG A+ +
Sbjct: 116 ----IVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQI--------TPKADVYSFGMVLLEIVSGSRNFEIQ 669
++ + GT Y+ P+ + D++S G+ +GS F
Sbjct: 169 DEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDS 708
+ E + + V+ + I S D
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 34/228 (14%)
Query: 447 FSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHL 498
S +G+G FG VY+G VA+K + EF E +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
++VRL G ++ ++ E + G L YL RS R + ++
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMA-------------NNPVLAP 134
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
S ++A +A +AYL+ +H D+ N ++ +DF KI DFG+ + +
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191
Query: 619 DMVSMSR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
D +R +M+PE L+ T +DV+SFG+VL EI +
Sbjct: 192 DYYRKGGKGLLPVR----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 49/233 (21%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRV--------VAVKCLKNVTGGDAE-FWAEVTIIARMHH 497
F+ +G+G F ++KG + V +K L +E F+ ++++++ H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
+LV +G C E LV E+V GSL YL + + + ++E+
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNK-NCINILWKLEV----------- 118
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL--------GDDFCPKISDF 609
A +A A+ +L E L +H ++ +NILL G+ K+SD
Sbjct: 119 ----------AKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165
Query: 610 GLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVS 661
G++ +D++ RI ++ PE + + + D +SFG L EI S
Sbjct: 166 GISITVLPKDILQE-RIP----WVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 59/233 (25%), Positives = 86/233 (36%), Gaps = 42/233 (18%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE---FWAEVTIIARM-HHLNLVRLW 504
+G G +G+V+K D R+ AVK + G + AEV ++ H VRL
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
E G L E SL + G E ++ W
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGA-----SLPEAQV--------------WGYL 163
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
L +A +LH + ++H D+KP NI LG K+ DFGL ++ +
Sbjct: 164 RDTLLALA----HLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLV-----ELGTAG 211
Query: 625 RIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674
G YMAPE L+ ADV+S G+ +LE+ G
Sbjct: 212 AGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPH-GGEGWQ 262
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 69/326 (21%), Positives = 119/326 (36%), Gaps = 82/326 (25%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR----VVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNL 500
IG G FGDV++G VA+K KN T +F E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
V+L G E ++ E G L +L + + S A +
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFL-QVRK-FSLDLASLILY-------------- 496
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
A ++ A+AYL + +H DI N+L+ + C K+ DFGL++ +
Sbjct: 497 -------AYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546
Query: 621 VSMSR----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNS 675
S+ I+ +MAPE + + T +DV+ FG+ + EI+ G
Sbjct: 547 YKASKGKLPIK----WMAPESINFRRFTSASDVWMFGVCMWEILMHG------------- 589
Query: 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSY--------DSRVHFDMVNRMVKTAMWCIQ 727
K ++ +K D++ I+N ++ M C
Sbjct: 590 ----------VKPFQGVKNNDVI-GRIENGERLPMPPNCPPTLYSLM--------TKCWA 630
Query: 728 DRPELRPSMGKVAKMLEGTVEITEPK 753
P RP ++ L +E + +
Sbjct: 631 YDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 42/223 (18%)
Query: 451 IGRGGFGDVYKGELT----DHRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVRLW 504
+G G FG+V G L VA+K LK +F E +I+ + H N++RL
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
G + +V EY+ NGSL +L R + + + M
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL-RKHD-AQFTVIQLVGM------------------ 152
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSM 623
G+A + YL + +H D+ NIL+ + K+SDFGL + L +
Sbjct: 153 ---LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 624 SR-----IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+R IR + +PE + + T +DV+S+G+VL E++S
Sbjct: 207 TRGGKIPIR----WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVK--CLKNVTGGDAEF-WAEVTIIARMHHLNLVRLWG 505
IG G FG + D R +K + ++ + E EV ++A M H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E G +V +Y G L + +E + +LDW ++
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKG----VLFQEDQ------------ILDWFVQ- 133
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ A+ ++H+ +LH DIK +NI L D ++ DFG+A++ ++ +
Sbjct: 134 -----ICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
I GT Y++PE + K+D+++ G VL E+ + FE
Sbjct: 186 I-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 50/222 (22%), Positives = 85/222 (38%), Gaps = 37/222 (16%)
Query: 449 NLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFC 507
+GRG FG+V++ + AVK ++ + E E+ A + +V L+G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVE---ELVACAGLSSPRIVPLYGAV 119
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
E + E + GSL + + G E Y
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMG------CLPEDR-----------------ALY-Y 155
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP-KISDFGLAK----LRKKEDMVS 622
+ YLH +LH D+K +N+LL D + DFG A + +++
Sbjct: 156 LGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 623 MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664
I GT +MAPE + K D++S ++L +++G
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 63/231 (27%), Positives = 89/231 (38%), Gaps = 40/231 (17%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR------VVAVKCLKNVTGGDA--EFWAEVTIIARMHHL 498
+G G FG+VY+G+++ VAVK L V +F E II++ +H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
N+VR G + R ++ E + G L +L R R P
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETR----------------PRPSQPSS 136
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLR 615
L +A +A YL E +H DI N LL G KI DFG+A+
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
Query: 616 KKEDMVSMSRIRGTRGY-----MAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+ +G M PE T K D +SFG++L EI S
Sbjct: 194 YRASYYR----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 36/225 (16%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR----VVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNL 500
F+ +IGRG FG VY G L D+ AVK L +T +F E I+ H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 501 VRLWGFCAEKGERTL-VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+ L G C L V Y+ +G L +++ R+
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNET----------------------HNP 189
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
L VA+ + +L + +H D+ N +L + F K++DFGLA+ ++
Sbjct: 190 TVKDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
Query: 620 MVSMSRIRGTR---GYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
S+ G + +MA E L++ + T K+DV+SFG++L E+++
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 63/312 (20%), Positives = 113/312 (36%), Gaps = 76/312 (24%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVK--CLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+GRGGFG V++ + D A+K L N + EV +A++ H +VR +
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 507 CAEKGE---------RTLVY---EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDG 554
EK + +Y + +L D++
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC--------------------- 110
Query: 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL 614
+ S+ I L +A A+ +LH + ++H D+KP NI D K+ DFGL
Sbjct: 111 TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167
Query: 615 RKKEDMVSMSRIR-----------GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS 663
+++ GT+ YM+PE + + + K D++S G++L E++
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--- 224
Query: 664 RNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAM 723
+ F E ++ + R++K + MV+
Sbjct: 225 -------------------YPFSTQMERVRTLTDV-RNLKFPPLFTQKYPCEYVMVQ--- 261
Query: 724 WCIQDRPELRPS 735
+ P RP
Sbjct: 262 DMLSPSPMERPE 273
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 5e-30
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 42/222 (18%)
Query: 451 IGRGGFGDVYKGELTDHRV---VAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVRLWG 505
+G G FG V +G + VA+K LK T E E I+ ++ + +VRL G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
C + LV E G L +L + E+
Sbjct: 404 VCQAE-ALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAEL------------------- 441
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
V+ + YL E+ +H ++ N+LL + KISDFGL+K +D +R
Sbjct: 442 --LHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496
Query: 626 ------IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
++ + APE + + + ++DV+S+G+ + E +S
Sbjct: 497 SAGKWPLK----WYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 61/250 (24%), Positives = 101/250 (40%), Gaps = 33/250 (13%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKC-----LKNVTGGDAE-FWAEVTIIARMHHLN 499
IG+G +G V E + A+K ++ + D E EV ++ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+ RL+ ++ LV E G L D L + A ++ + + P
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 560 DWSIRY------------RIALGVAR----AIAYLHEECLEWVLHCDIKPENILLG--DD 601
+ ++ + R A+ YLH + + H DIKPEN L
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKS 206
Query: 602 FCPKISDFGLAKL---RKKEDMVSMSRIRGTRGYMAPEWLRSDQ--ITPKADVYSFGMVL 656
F K+ DFGL+K + M+ GT ++APE L + PK D +S G++L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 657 LEIVSGSRNF 666
++ G+ F
Sbjct: 267 HLLLMGAVPF 276
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 58/244 (23%), Positives = 99/244 (40%), Gaps = 40/244 (16%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAE--FWAEVTIIARMHHLNLVRLW 504
+G+G FG+VY E + ++A+K L + E E+ I + + H N++R++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+ ++ L+ E+ P G L L + GR +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRF-DEQRSA---------------------- 117
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
+A A+ Y HE V+H DIKPEN+L+G KI+DFG + +M
Sbjct: 118 -TFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC 173
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM-----NSDEWY 679
GT Y+ PE + K D++ G++ E + G F+ + +
Sbjct: 174 ---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK 230
Query: 680 FPKW 683
FP +
Sbjct: 231 FPPF 234
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 45/244 (18%), Positives = 92/244 (37%), Gaps = 42/244 (17%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCL--------KNVTGGDAEFWA----------EVTII 492
+ +G F + E ++ A+K ++ T + + + E+ II
Sbjct: 39 LNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 493 ARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPH 552
+ + + G E ++YEY+ N S+ + + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI------- 150
Query: 553 DGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612
V + +Y+H E + + H D+KP NIL+ + K+SDFG +
Sbjct: 151 -------QVIKCI--IKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 613 KLRKKEDMVSMSRIRGTRGYMAPEWLRSDQIT--PKADVYSFGMVLLEIVSGSRNFEIQG 670
+ + + RGT +M PE+ ++ K D++S G+ L + F ++
Sbjct: 200 EYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
Query: 671 SMMN 674
S++
Sbjct: 257 SLVE 260
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGFC 507
++G+G +G VY G +L++ +A+K + ++ E+ + + H N+V+ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+E G + E VP GSL+ L GP + I
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKW----------------GPLKDNEQT----IG-FY 127
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLG-DDFCPKISDFGLAKLRKKEDMVSMSRI 626
+ + YLH+ ++H DIK +N+L+ KISDFG +K + + +
Sbjct: 128 TKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-F 183
Query: 627 RGTRGYMAPEWLRSDQI--TPKADVYSFGMVLLEIVSGSR 664
GT YMAPE + AD++S G ++E+ +G
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 64/319 (20%), Positives = 108/319 (33%), Gaps = 76/319 (23%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLVRLWGF 506
+G GGF V E L D A+K + E E + +H N++RL +
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 507 CAEKGERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
C + L+ + G+L + + R G+ + +L
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ--------------IL--- 137
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
+ LG+ R + +H + H D+KP NILLGD+ P + D G S
Sbjct: 138 ---WLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 623 MSRIR--------GTRGYMAPEWL---RSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671
+ T Y APE I + DV+S G VL ++ G +++
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 672 MMNS------DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWC 725
+S ++ P+ + S + ++N M
Sbjct: 252 KGDSVALAVQNQLSIPQS--------------------PRHSSALW-QLLNSM------- 283
Query: 726 IQDRPELRPSMGKVAKMLE 744
+ P RP + + LE
Sbjct: 284 MTVDPHQRPHIPLLLSQLE 302
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 48/231 (20%), Positives = 86/231 (37%), Gaps = 46/231 (19%)
Query: 449 NLIGRGGFGDVYKGELTDHRVVAVKC--LKNVTGGDAE-FWAEVTIIARMHHLNL--VRL 503
IG GG V++ ++ A+K L+ + + E+ + ++ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ + +V E N L +L + +D
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS------------------------IDPWE 128
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVS 622
R + A+ +H+ ++H D+KP N L+ D K+ DFG+A ++ V
Sbjct: 129 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 184
Query: 623 MSRIRGTRGYMAPE-----------WLRSDQITPKADVYSFGMVLLEIVSG 662
GT YM PE +I+PK+DV+S G +L + G
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 77/325 (23%), Positives = 112/325 (34%), Gaps = 85/325 (26%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR------VVAVKCLKNVTGGD--AEFWAEVTIIARMHHL 498
+G G FG+VY+G+++ VAVK L V +F E II++ +H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
N+VR G + R ++ E + G L +L R R P
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETR----------------PRPSQPSS 177
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLR 615
L +A +A YL E +H DI N LL G KI DFG+A+
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 616 KKEDMVSMSRIRGTRGY-----MAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQ 669
+ G M PE T K D +SFG++L EI S G
Sbjct: 235 YRAGYYRK----GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM----- 285
Query: 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA------- 722
P Y +++L + + RM
Sbjct: 286 -----------P-------YPSKSNQEVL-EFVTSGG----------RMDPPKNCPGPVY 316
Query: 723 --MW-CIQDRPELRPSMGKVAKMLE 744
M C Q +PE RP+ + + +E
Sbjct: 317 RIMTQCWQHQPEDRPNFAIILERIE 341
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 54/247 (21%), Positives = 92/247 (37%), Gaps = 43/247 (17%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAE--FWAEVTIIARMHHLNLVRLW 504
L+G+G F VY+ + VA+K + K + EV I ++ H +++ L+
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+ + LV E NG + YL + S + AR
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR---------------------- 115
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
+ + YLH +LH D+ N+LL + KI+DFGLA K
Sbjct: 116 -HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH----E 167
Query: 625 RIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM-----NSD 676
+ GT Y++PE ++DV+S G + ++ G F+
Sbjct: 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227
Query: 677 EWYFPKW 683
++ P +
Sbjct: 228 DYEMPSF 234
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 30/288 (10%), Positives = 68/288 (23%), Gaps = 35/288 (12%)
Query: 425 ELLPAGGPKRF-THAELRAATNGFSNLIGRGGFGDVYKG-ELTDHRVVAVKCL---KNVT 479
+ P + + G V+ ++ A+K +
Sbjct: 43 TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102
Query: 480 GGDAE-FWAEVTIIARMHHLNLVRLWGFCAEKGERTLV-YEYVPNGSLADYLFRSGRVGS 537
+ E AR+ + V + P + V +
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 538 S---SPAREMEMSGVGPHDGGKPV----LDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590
PA +++ + V + + + R A L + ++H
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219
Query: 591 IKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD--QITPKAD 648
P+N+ + D + D + Y E+L + T +
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSAL----WKVGTRGPASSVPVTYAPREFLNASTATFTHALN 275
Query: 649 VYSFGMVLLEIVSGSRNFEIQGSM------------MNSDEWYFPKWA 684
+ G+ + + F + +D F
Sbjct: 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCT 323
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 60/305 (19%), Positives = 106/305 (34%), Gaps = 63/305 (20%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWG 505
+++G G G + + D+R VAVK + A+ EV ++ H N++R +
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRYFC 85
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
++ + + E +L +Y+ +
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPIT---------------------- 122
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGD-----DFCPKISDFGLAKLRKKED- 619
+ +A+LH ++H D+KP NIL+ ISDFGL K
Sbjct: 123 -LLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178
Query: 620 -MVSMSRIRGTRGYMAPEWLRSDQI---TPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675
S + GT G++APE L D T D++S G V ++S
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEG------------ 226
Query: 676 DEWYFPKWA-FEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734
P ++ + LD ++ + +++ +M I P+ RP
Sbjct: 227 ---SHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKM-------IAMDPQKRP 276
Query: 735 SMGKV 739
S V
Sbjct: 277 SAKHV 281
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 39/262 (14%), Positives = 75/262 (28%), Gaps = 31/262 (11%)
Query: 425 ELLPAGGPKRFTHAEL--RAATNGFSNLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGG 481
L G P R +EL R T ++G+ + V
Sbjct: 59 SLWNTGQPFRV-ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP 117
Query: 482 DAEFWA----EVTIIAR----------MHHLNLVRLWGFCAEKGERTL--VYEYVPNGSL 525
+ EV + HL + + + ++ + V + +
Sbjct: 118 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 177
Query: 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEW 585
F R+ S+ + L R ++ L V R +A LH
Sbjct: 178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHK---SLVHHARLQLTLQVIRLLASLHHYG--- 231
Query: 586 VLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQ--- 642
++H ++P +I+L ++ F + + R A L Q
Sbjct: 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHP 291
Query: 643 --ITPKADVYSFGMVLLEIVSG 662
+T D ++ G+ + I
Sbjct: 292 TLMTFAFDTWTLGLAIYWIWCA 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 49/231 (21%), Positives = 87/231 (37%), Gaps = 46/231 (19%)
Query: 449 NLIGRGGFGDVYKGELTDHRVVAVKC--LKNVTGGDAE-FWAEVTIIARM--HHLNLVRL 503
IG GG V++ ++ A+K L+ + + E+ + ++ H ++RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ + +V E N L +L + +D
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS------------------------IDPWE 109
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVS 622
R + A+ +H+ ++H D+KP N L+ D K+ DFG+A ++ V
Sbjct: 110 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 165
Query: 623 MSRIRGTRGYMAPE-----------WLRSDQITPKADVYSFGMVLLEIVSG 662
GT YM PE +I+PK+DV+S G +L + G
Sbjct: 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 40/264 (15%), Positives = 82/264 (31%), Gaps = 51/264 (19%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR------VVAVKCLKNVTGGDAEFWAEVTIIARM---HH 497
+L+G G F VY+ D +K K EF+ ++ R+
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW--EFYIGTQLMERLKPSMQ 126
Query: 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
++ + + LV E G+L + +
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK------------------- 167
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP-----------KI 606
V+ + A+ + I +H+ ++H DIKP+N +LG+ F +
Sbjct: 168 VMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224
Query: 607 SDFGLAK-LRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS-- 663
D G + ++ + T G+ E L + + D + + ++ G+
Sbjct: 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
Query: 664 ----RNFEIQGSMMNSDEWYFPKW 683
E + + + W
Sbjct: 285 KVKNEGGECKPEGLFRRLPHLDMW 308
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 55/249 (22%), Positives = 88/249 (35%), Gaps = 54/249 (21%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE---FWAEVTIIARM-HHLNLVRLW 504
IG G FG V+K + D + A+K K G + EV A + H ++VR +
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
AE + EY GSLAD + + R+ S E E+ +
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK--EAEL--------------KDLL 121
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP-------------------K 605
++ G+ Y+H ++H DIKP NI + P K
Sbjct: 122 LQVGRGLR----YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSR 664
I D G + G ++A E L+ + PKAD+++ + ++
Sbjct: 175 IGDLGHVTRISSPQVE-----EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229
Query: 665 NFEIQGSMM 673
G
Sbjct: 230 LPR-NGDQW 237
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 62/336 (18%), Positives = 114/336 (33%), Gaps = 79/336 (23%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKC--LKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+GRGGFG V++ + D A+K L N + EV +A++ H +VR +
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDG------------ 554
E E + S A +++ + P
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 555 ------------------------GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590
+ + I + +A A+ +LH + ++H D
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRD 189
Query: 591 IKPENILLGDDFCPKISDFGLAK-----------LRKKEDMVSMSRIRGTRGYMAPEWLR 639
+KP NI D K+ DFGL L + + GT+ YM+PE +
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249
Query: 640 SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILD 699
+ + K D++S G++L E++ ++F E +++ +
Sbjct: 250 GNNYSHKVDIFSLGLILFELL----------------------YSFSTQMERVRIITDV- 286
Query: 700 RHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735
R++K + + MV+ + P RP
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPE 319
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 47/231 (20%), Positives = 85/231 (36%), Gaps = 46/231 (19%)
Query: 449 NLIGRGGFGDVYKGELTDHRVVAVKC--LKNVTGGDAE-FWAEVTIIARMHHLNL--VRL 503
IG GG V++ ++ A+K L+ + + E+ + ++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ + +V E N L +L + +D
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS------------------------IDPWE 156
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVS 622
R + A+ +H+ ++H D+KP N L+ D K+ DFG+A ++ V
Sbjct: 157 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 212
Query: 623 MSRIRGTRGYMAPE-----------WLRSDQITPKADVYSFGMVLLEIVSG 662
G YM PE +I+PK+DV+S G +L + G
Sbjct: 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 52/226 (23%), Positives = 85/226 (37%), Gaps = 39/226 (17%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAE--FWAEVTIIARMHHLNLVRLW 504
+G+GGF ++ + V A K + + E++I + H ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
GF + +V E SL + R + + AR
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKAL-TEPEAR---------------------- 144
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
+ YLH V+H D+K N+ L +D KI DFGLA + +
Sbjct: 145 -YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----E 196
Query: 625 RIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
R + GT Y+APE L + + DV+S G ++ ++ G FE
Sbjct: 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 52/226 (23%), Positives = 85/226 (37%), Gaps = 39/226 (17%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAE--FWAEVTIIARMHHLNLVRLW 504
+G+GGF ++ + V A K + + E++I + H ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
GF + +V E SL + R + + AR
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKAL-TEPEAR---------------------- 118
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
+ YLH V+H D+K N+ L +D KI DFGLA + +
Sbjct: 119 -YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----E 170
Query: 625 RIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
R + GT Y+APE L + + DV+S G ++ ++ G FE
Sbjct: 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAE-FWAEVTIIARMHHLNLVR 502
+G G +G+V + H A+K + +V+ EV ++ + H N+++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L+ F +K LV E G L D + + E++ +
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF------NEVDAA--------------- 139
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKED 619
I V + YLH+ ++H D+KPEN+LL D KI DFGL+ + + +
Sbjct: 140 ---VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
M GT Y+APE LR + K DV+S G++L +++G F
Sbjct: 194 --KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAE-FWAEVTIIARMHHLNLVR 502
++G+G FG+V K + + AVK + + D EV ++ ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L+ + +V E G L D + + R E + +
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS------EHDAA--------------- 124
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKED 619
RI V I Y+H+ ++H D+KPENILL D KI DFGL+ ++
Sbjct: 125 ---RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
M GT Y+APE LR K DV+S G++L ++SG+ F
Sbjct: 179 K--MKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPF 222
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 36/217 (16%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAE-FWAEVTIIARMHHLNLVR 502
+G+G F V + T A K + K ++ D + E I ++ H N+VR
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L E+ LV++ V G L + + S + A
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SEADASHC------------------ 110
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKED 619
I+ + +IAY H ++H ++KPEN+LL K++DFGLA +
Sbjct: 111 IQQ-----ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVL 656
GT GY++PE L+ D + D+++ G++L
Sbjct: 163 A--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 63/271 (23%), Positives = 110/271 (40%), Gaps = 55/271 (20%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLK--------------NVTGGDAEFWAEVTI 491
+G G +G+V E H A+K +K N+ E + E+++
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 492 IARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGP 551
+ + H N+++L+ +K LV E+ G L + + + E + +
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF------DECDAA---- 149
Query: 552 HDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISD 608
I + I YLH+ ++H DIKPENILL KI D
Sbjct: 150 --------------NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD 192
Query: 609 FGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF-- 666
FGL+ K+ + GT Y+APE L+ + K DV+S G+++ ++ G F
Sbjct: 193 FGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGG 249
Query: 667 ----EIQGSMMNSDEWYFPKWAFEKVYEEMK 693
+I + ++YF ++ + +E K
Sbjct: 250 QNDQDIIKKVEKG-KYYFDFNDWKNISDEAK 279
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 38/228 (16%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAE--FWAEVTIIARMHHLNLV 501
++G+G FG+V + + AVK + + V + EV ++ ++ H N++
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+L+ F +KG LV E G L D + R E++ +
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF------SEVDAA-------------- 129
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKE 618
RI V I Y+H+ ++H D+KPEN+LL D +I DFGL+ +
Sbjct: 130 ----RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
M GT Y+APE L K DV+S G++L ++SG F
Sbjct: 183 K--KMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPF 227
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL-KNVTGGDAEFWAEVTIIARMHHLNLVRLW 504
F ++G G F +V+ + ++ A+KC+ K+ D+ E+ ++ ++ H N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
LV + V G L D + G + A + I+
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVY-TEKDASLV------------------IQ 113
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKEDMV 621
V A+ YLHE ++H D+KPEN+L ++ I+DFGL+K+ + M
Sbjct: 114 Q-----VLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVL 656
+ GT GY+APE L + D +S G++
Sbjct: 166 TAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 60/325 (18%), Positives = 113/325 (34%), Gaps = 82/325 (25%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCL--KNVTGGDAEFWAEVTIIARM-HHLNLVRL 503
++G G G V R VAVK + E+ ++ H N++R
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPNVIRY 74
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVG-SSSPAREMEMSGVGPHDGGKPVLDWS 562
+ + E N +L D + + +E
Sbjct: 75 YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI--------------- 118
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-------------GDDFCPKISDF 609
+ +A +A+LH ++H D+KP+NIL+ ++ ISDF
Sbjct: 119 ---SLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 610 GLAKLRKKEDMVSMSRIR---GTRGYMAPEWLRSD-------QITPKADVYSFGMVLLEI 659
GL K + + GT G+ APE L ++T D++S G V I
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 660 VSGSR-----NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDM 714
+S + + + +++ ++ +++ + DR + ++ D+
Sbjct: 233 LSKGKHPFGDKYSRESNIIR------------GIFSLDEMKCLHDRSL--IAEAT---DL 275
Query: 715 VNRMVKTAMWCIQDRPELRPSMGKV 739
+++M I P RP+ KV
Sbjct: 276 ISQM-------IDHDPLKRPTAMKV 293
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 35/289 (12%), Positives = 71/289 (24%), Gaps = 74/289 (25%)
Query: 425 ELLPAGGPKRF-THAELRAATNGFSNLIGRGGFGDVYKG-ELTDHRVVAVKCL---KNVT 479
L G P R + R T ++G+ + + V +
Sbjct: 54 SLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 113
Query: 480 GGDAE--------------------------FWAEVTIIARMHHLNLVRLWGFCAEKGER 513
+ F ++ ++R+ +
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173
Query: 514 TLVYEY----VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIAL 569
+ + Y + + L S R ++ L
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA--------------------RLQLTL 213
Query: 570 GVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGT 629
V R +A LH ++H ++P +I+L ++ F +
Sbjct: 214 QVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS 265
Query: 630 RGYMAPEWL-----------RSDQITPKADVYSFGMVLLEIVSGSRNFE 667
RG+ PE R +T D ++ G+V+ I
Sbjct: 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 43/243 (17%)
Query: 428 PAGGPKRFTHAELRAATNG-------FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL--KN 477
GG + +E + +G+G F V + T A K + K
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 478 VTGGDAE-FWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVG 536
++ D + E I ++ H N+VRL E+ LV++ V G L + +
Sbjct: 67 LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY- 125
Query: 537 SSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596
S + A I+ + +IAY H ++H ++KPEN+
Sbjct: 126 SEADASHC------------------IQQ-----ILESIAYCHSNG---IVHRNLKPENL 159
Query: 597 LL---GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFG 653
LL K++DFGLA + GT GY++PE L+ D + D+++ G
Sbjct: 160 LLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 217
Query: 654 MVL 656
++L
Sbjct: 218 VIL 220
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 49/226 (21%), Positives = 85/226 (37%), Gaps = 41/226 (18%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKC-----LKNVTGGDAE-FWAEVTIIARMHHLN 499
+IG+G F V + + AVK + G E E +I + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVG---SSSPAREMEMSGVGPHDGGK 556
+V L + G +V+E++ L + + G S + A
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY------------ 135
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAK 613
+R + A+ Y H+ ++H D+KP +LL + K+ FG+A
Sbjct: 136 ------MRQ-----ILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 614 LRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI 659
+ +V GT +MAPE ++ + DV+ G V+L I
Sbjct: 182 QLGESGLV-AGGRVGTPHFMAPEVVKREPYGKPVDVWGCG-VILFI 225
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 41/218 (18%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLK------NVTGGDAE-FWAEVTIIARMHHLNLVR 502
+G G F V K E + A K +K + G E EV+I+ ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L + + L+ E V G L D+L + + E E +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESL------SEEEATSF------------- 120
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP----KISDFGLAKLRKKE 618
I+ + + YLH + + H D+KPENI+L D P K+ DFGLA + E
Sbjct: 121 IKQ-----ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE 170
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVL 656
D V I GT ++APE + + + +AD++S G++
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 35/217 (16%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAE-FWAEVTIIARMHHLNLVR 502
+G+G F V + ++ + A + K ++ D + E I + H N+VR
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L +E+G L+++ V G L + + E + S
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS------EADASHC------------- 115
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKED 619
I+ + A+ + H+ V+H ++KPEN+LL K++DFGLA + E
Sbjct: 116 IQQ-----ILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVL 656
GT GY++PE LR D D+++ G++L
Sbjct: 168 QA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 37/217 (17%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAE-FWAEVTIIARMHHLNLVR 502
++G+G FG+V K + + AVK + + D EV ++ ++ H N+++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L+ + +V E G L D + + R E + + +
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS------EHDAARI------------- 126
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKED 619
I+ V I Y+H+ ++H D+KPENILL D KI DFGL+ ++
Sbjct: 127 IKQ-----VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVL 656
M GT Y+APE LR K DV+S G++L
Sbjct: 179 K--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 34/227 (14%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL-KNVTGGDAE-FWAEVTIIARMHHLNLVRL 503
F +G G FGDV+ E + +K + K+ + E AE+ ++ + H N++++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLF-RSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ + +V E G L + + R + S E ++ +
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS---EGYVAEL------------- 129
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKED 619
++ + A+AY H + V+H D+KPENIL KI DFGLA+L K ++
Sbjct: 130 MKQ-----MMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
+ GT YMAPE + D +T K D++S G+V+ +++G F
Sbjct: 182 H--STNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPF 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 42/221 (19%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLK------NVTGGDAE-FWAEVTIIARMHHLNLVR 502
+G G F V K + + A K +K + G E EV I+ + H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L K + L+ E V G L D+L + E E +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLT------EDEATQF------------- 113
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP----KISDFGLAKLRKKE 618
++ + + YLH + + H D+KPENI+L D P K+ DFG+A +
Sbjct: 114 LKQ-----ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI 659
+ I GT ++APE + + + +AD++S G V+ I
Sbjct: 166 NE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYI 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 42/221 (19%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLK-------NVTGGDAEFWAEVTIIARMHHLNLVR 502
+G G F V K E + A K +K E EV+I+ ++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L + + L+ E V G L D+L + + E E +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESL------SEEEATSF------------- 120
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP----KISDFGLAKLRKKE 618
I+ + + YLH + + H D+KPENI+L D P K+ DFGLA + E
Sbjct: 121 IKQ-----ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA--HEIE 170
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI 659
D V I GT ++APE + + + +AD++S G V+ I
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYI 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 62/253 (24%), Positives = 99/253 (39%), Gaps = 39/253 (15%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGFCA 508
+G G FG V++ E RV K + D E++I+ ++HH L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
+K E L+ E++ G L D + S + M + +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-M---------RQACE-------- 160
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLG--DDFCPKISDFGLAKLRKKEDMVSMSRI 626
+ ++HE ++H DIKPENI+ KI DFGLA K +
Sbjct: 161 -----GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLA--TKLNPDEIVKVT 210
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI-VSGSRNF--EIQGSMMN---SDEWYF 680
T + APE + + + D+++ G VL + +SG F E + +W F
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 269
Query: 681 PKWAFEKVYEEMK 693
+ AF V E K
Sbjct: 270 DEDAFSSVSPEAK 282
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 50/228 (21%), Positives = 90/228 (39%), Gaps = 47/228 (20%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKC-----LKNVTGGDAE-----FWAEVTIIARM 495
++GRG V + + AVK + + + + EV I+ ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 496 -HHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDG 554
H N+++L LV++ + G L DYL + S R++
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL-SEKETRKI---------- 129
Query: 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL 614
+R + I LH+ ++H D+KPENILL DD K++DFG +
Sbjct: 130 --------MRA-----LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQI------TPKADVYSFGMVL 656
+ + + GT Y+APE + + D++S G+++
Sbjct: 174 LDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 53/256 (20%), Positives = 100/256 (39%), Gaps = 38/256 (14%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+ +GRG FG V++ E + + K +K E++I+ H N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E +++E++ + + + S + + V +
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-V---------HQVCE----- 113
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLG--DDFCPKISDFGLAKLRKKEDMVSM 623
A+ +LH + H DI+PENI+ KI +FG A+ K D
Sbjct: 114 --------ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--F 160
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI-VSGSRNF--EIQGSMMN---SDE 677
+ Y APE + D ++ D++S G L+ + +SG F E ++ + E
Sbjct: 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSGINPFLAETNQQIIENIMNAE 219
Query: 678 WYFPKWAFEKVYEEMK 693
+ F + AF+++ E
Sbjct: 220 YTFDEEAFKEISIEAM 235
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 48/221 (21%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLK--NVTGGDAE-FWAEVTIIARM-HHLNLVRLWG 505
+GRG F V + + + A K LK E+ ++ ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E L+ EY G + + + +
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLC----------------------------LPELAEMV 128
Query: 566 --RIALGVAR----AIAYLHEECLEWVLHCDIKPENILLG--DDFCP-KISDFGLAKLRK 616
+ + + + YLH+ ++H D+KP+NILL KI DFG++ RK
Sbjct: 129 SENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMS--RK 183
Query: 617 KEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLL 657
+ I GT Y+APE L D IT D+++ G ++
Sbjct: 184 IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIG-IIA 223
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 60/225 (26%), Positives = 90/225 (40%), Gaps = 42/225 (18%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLK------NVTGGDAE-FWAEVTIIARMHHL 498
+G G F V K E + A K +K + G E EV+I+ + H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
N++ L K + L+ E V G L D+L + + K +
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL-----------KQI 123
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP----KISDFGLAKL 614
L+ + YLH + H D+KPENI+L D P KI DFGLA
Sbjct: 124 LN-------------GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA-- 165
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI 659
K + I GT ++APE + + + +AD++S G V+ I
Sbjct: 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYI 209
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 27/225 (12%), Positives = 50/225 (22%), Gaps = 66/225 (29%)
Query: 450 LIGRGGFGDVYKGELTD---HRVVAVKCLKNVTGGDAEFWA----EVTIIARMHHLNLVR 502
G ++ D R VA+ + + ++R+ + R
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ + +V E++ GSL + + P
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA----------------DTSPSPVGA-------- 131
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
R +A A H V P + + D G L
Sbjct: 132 --IRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSID--------GDVVL-------- 170
Query: 623 MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
M P+ D+ G L ++
Sbjct: 171 -----AYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLP 203
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 59/225 (26%), Positives = 89/225 (39%), Gaps = 35/225 (15%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL-KNVTGGDAEFWAEVTIIARMHHLNLVRLW 504
N IGRG +G+V + A K + K F E+ I+ + H N++RL+
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+ + LV E G L + + E + +
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFR------ESDAA----------------- 109
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKEDMV 621
RI V A+AY H+ V H D+KPEN L D K+ DFGLA K M
Sbjct: 110 -RIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM- 164
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666
M GT Y++P+ L P+ D +S G+++ ++ G F
Sbjct: 165 -MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPF 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 65/258 (25%), Positives = 109/258 (42%), Gaps = 39/258 (15%)
Query: 446 GFSNLIGRGGFGDVYKG-ELTDHRVVAVKCL-KNVTGGDAEFWAEVTIIARMHHLNLVRL 503
+ ++G G FG V+K E +A K + E E++++ ++ H NL++L
Sbjct: 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ K + LV EYV G L D + + M K + +
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-M---------KQICE--- 198
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG--DDFCPKISDFGLAKLRKKEDMV 621
I ++H+ ++LH D+KPENIL D KI DFGLA+ K +
Sbjct: 199 ----------GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI-VSGSRNF--EIQGSMMN---S 675
+ GT ++APE + D ++ D++S G V+ + +SG F + +N +
Sbjct: 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVG-VIAYMLLSGLSPFLGDNDAETLNNILA 302
Query: 676 DEWYFPKWAFEKVYEEMK 693
W F+ + EE K
Sbjct: 303 CRWDLEDEEFQDISEEAK 320
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 34/214 (15%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+ +GRG VY+ + + A+K LK T E+ ++ R+ H N+++L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKK-TVDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E +LV E V G L D + G S A + ++
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYY-SERDAADA------------------VKQ 156
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKEDMVS 622
+ A+AYLHE ++H D+KPEN+L D KI+DFGL+K+ + + +
Sbjct: 157 -----ILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-- 206
Query: 623 MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVL 656
M + GT GY APE LR P+ D++S G++
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 53/247 (21%), Positives = 89/247 (36%), Gaps = 46/247 (18%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVK-CLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGF 506
++ GGF VY+ + + R A+K L N + EV + ++ H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 507 CAEKGERT-------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+ E + L+ + G L ++L + G S VL
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT---------------VL 139
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
+I RA+ ++H ++H D+K EN+LL + K+ DFG A
Sbjct: 140 ------KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 620 MVSMSRI-----------RGTRGYMAPE---WLRSDQITPKADVYSFGMVLLEIVSGSRN 665
S S T Y PE + I K D+++ G +L +
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
Query: 666 FEIQGSM 672
FE +
Sbjct: 253 FEDGAKL 259
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 61/257 (23%), Positives = 96/257 (37%), Gaps = 39/257 (15%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLW 504
+G G FG V++ E A K + D E E+ ++ + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+ E ++YE++ G L + + S A E +R
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY------------------MR 262
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP--KISDFGLAKLRKKEDMVS 622
V + + ++HE +H D+KPENI+ K+ DFGL + S
Sbjct: 263 Q-----VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 312
Query: 623 MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI-VSGSRNF--EIQGSMMN---SD 676
+ GT + APE + D++S G VL I +SG F E + S
Sbjct: 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYILLSGLSPFGGENDDETLRNVKSC 371
Query: 677 EWYFPKWAFEKVYEEMK 693
+W AF + E+ K
Sbjct: 372 DWNMDDSAFSGISEDGK 388
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 41/219 (18%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGFCA 508
IG G G V E R VAVK + E + EV I+ H N+V ++
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
E ++ E++ G+L D + S E +++ +
Sbjct: 113 VGEELWVLMEFLQGGALTDIV-------SQVRLNEEQIA------------------TVC 147
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-----KLRKKEDMVSM 623
V +A+AYLH + V+H DIK ++ILL D K+SDFG + K++ +V
Sbjct: 148 EAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-- 202
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE + + D++S G++++E+V G
Sbjct: 203 ----GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 69/249 (27%), Positives = 102/249 (40%), Gaps = 46/249 (18%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCL---KNVTGGDAEFWA----EVTIIARMH----H 497
L+G+GGFG V+ G LTD VA+K + + + EV ++ ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 498 LNLVRLWGFCAEKGERTLVYEY-VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
++RL + + LV E +P L DY+ G + P+R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPL-GEGPSR-------------- 142
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-GDDFCPKISDFGLAKLR 615
V AI + H V+H DIK ENIL+ C K+ DFG L
Sbjct: 143 ---------CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
Query: 616 KKEDMVSMSRIRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674
E GTR Y PEW+ Q A V+S G++L ++V G FE ++
Sbjct: 191 HDEPYTDFD---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE 247
Query: 675 SDEWYFPKW 683
+ E +FP
Sbjct: 248 A-ELHFPAH 255
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 44/247 (17%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCL---KNVTGGDAEFWA----EVTIIARMHHL--N 499
L+G GGFG VY G ++D+ VA+K + + G+ EV ++ ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 500 LVRLWGFCAEKGERTLVYEYV-PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
++RL + L+ E P L D++ G + AR
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL-QEELAR---------------- 152
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-GDDFCPKISDFGLAKLRKK 617
V A+ + H VLH DIK ENIL+ + K+ DFG L K
Sbjct: 153 -------SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676
GTR Y PEW+R + A V+S G++L ++V G FE ++
Sbjct: 203 TVYTDFD---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG- 258
Query: 677 EWYFPKW 683
+ +F +
Sbjct: 259 QVFFRQR 265
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 68/345 (19%), Positives = 134/345 (38%), Gaps = 69/345 (20%)
Query: 451 IGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEF---WAEVTIIARMHHLNLVRLWGF 506
+G G G V+K V+A K + ++ A E+ ++ + +V +G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
GE ++ E++ GSL L ++GR+ E + +
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIP------EQILG------------------K 135
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+++ V + + YL E+ ++H D+KP NIL+ K+ DFG++ + D ++ S +
Sbjct: 136 VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV 191
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS--RNFEIQGSMMNSDEWYFPKWA 684
GTR YM+PE L+ + ++D++S G+ L+E+ G + A
Sbjct: 192 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250
Query: 685 FEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVK-------TAMW----------CIQ 727
E L++ +S F++++ +V + ++ C+
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 310
Query: 728 DRPELRPSMGK----------------VAKMLEGTVEITEPKKPT 756
P R + + A L T+ + +P PT
Sbjct: 311 KNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIGLNQPSTPT 355
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 41/219 (18%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGFCA 508
IG+G G VY ++ + VA++ + E E+ ++ + N+V
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
E +V EY+ GSL D + + + E +++ +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV-------TETCMDEGQIA------------------AVC 122
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-----KLRKKEDMVSM 623
+A+ +LH V+H DIK +NILLG D K++DFG + K+ MV
Sbjct: 123 RECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-- 177
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE + PK D++S G++ +E++ G
Sbjct: 178 ----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 50/227 (22%), Positives = 91/227 (40%), Gaps = 46/227 (20%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLK---------NVTGGDAEFWAEVTIIARMH 496
++IGRG V + AVK ++ + E I+ ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 497 -HLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGG 555
H +++ L LV++ + G L DYL + S R +
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL-SEKETRSI----------- 205
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
+R + A+++LH ++H D+KPENILL D+ ++SDFG +
Sbjct: 206 -------MRS-----LLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250
Query: 616 KKEDMVSMSRIRGTRGYMAPEWLRSDQI------TPKADVYSFGMVL 656
+ + + + GT GY+APE L+ + D+++ G++L
Sbjct: 251 EPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 54/226 (23%), Positives = 95/226 (42%), Gaps = 46/226 (20%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL---KNVTGGDAE------FWAEVTIIARMH 496
S +G G G+V E + VA++ + K G E E+ I+ +++
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 497 HLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
H ++++ F + + +V E + G L D + + R+ + +
Sbjct: 199 HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL-KEATCK-------------- 242
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAK 613
+ A+ YLHE ++H D+KPEN+LL +D KI+DFG +K
Sbjct: 243 ---------LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
Query: 614 LRKKEDMVSMSRIRGTRGYMAPEWLRSDQI---TPKADVYSFGMVL 656
+ + + M + GT Y+APE L S D +S G++L
Sbjct: 291 ILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 36/223 (16%)
Query: 451 IGRGGFGDVYKGE--LTDHRVVAVKCLKNVTGGDAEFWA---EVTIIARMHHLNLVRLWG 505
IG+G F V LT V A+K + EV I+ ++H N+V+L+
Sbjct: 23 IGKGNFAKVKLARHILTGREV-AIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ L+ EY G + DYL GR+ AR
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRM-KEKEAR----------------------- 117
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ A+ Y H++ ++H D+K EN+LL D KI+DFG + +
Sbjct: 118 SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF- 173
Query: 626 IRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFE 667
G Y APE + + P+ DV+S G++L +VSGS F+
Sbjct: 174 -CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 71/272 (26%), Positives = 103/272 (37%), Gaps = 64/272 (23%)
Query: 447 FSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTGGD--AEFWAEVTI-IARMHH 497
+GRG FG V + + R VAVK LK +E+ I I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 498 LNLVRLWGFCAEKGERTLV-YEYVPNGSLADYLFR------------------------- 531
LN+V L G C + G +V E+ G+L+ YL
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 532 ----SGRVGSSSPAREMEMSGVG-------------PHDGGKPVLDWSIRYRIALGVARA 574
R+ S + ++ SG P D K L + VA+
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 575 IAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRG--- 631
+ +L +H D+ NILL + KI DFGLA+ K+ +R
Sbjct: 206 MEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLP 258
Query: 632 --YMAPEWLRSDQITPKADVYSFGMVLLEIVS 661
+MAPE + T ++DV+SFG++L EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 46/226 (20%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL---KNVTGGDAE------FWAEVTIIARMH 496
S +G G G+V E + VA+K + K G E E+ I+ +++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 497 HLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
H ++++ F + + +V E + G L D + + R+ + +
Sbjct: 74 HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRL-KEATCKLY------------ 119
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAK 613
+ A+ YLHE ++H D+KPEN+LL +D KI+DFG +K
Sbjct: 120 ------FYQ-----MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 614 LRKKEDMVSMSRIRGTRGYMAPEWLRSDQI---TPKADVYSFGMVL 656
+ + + M + GT Y+APE L S D +S G++L
Sbjct: 166 ILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 61/256 (23%), Positives = 97/256 (37%), Gaps = 56/256 (21%)
Query: 450 LIGRGGFGDVYKGE--LTDHRVVAVKCL--KNVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+G G +G+V +T+ V AVK + K E+ I ++H N+V+ +G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAV-AVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E + L EY G L D + + E +
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGM------PEPD-------------------- 106
Query: 566 RIALGVAR--------AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
A+ + YLH + H DIKPEN+LL + KISDFGLA + +
Sbjct: 107 ------AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 618 EDMVSMSRIR-GTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFEIQGSMMN- 674
+ + GT Y+APE L+ + DV+S G+VL +++G ++
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
Query: 675 -----SDEWYFPKWAF 685
+ Y W
Sbjct: 218 YSDWKEKKTYLNPWKK 233
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGD--AEFWAEVTIIARMHHLNLVRLWGFC 507
IG+G FG+V+KG + +VVA+K + D + E+T++++ + + +G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+ + ++ EY+ GS D L G P E + I I
Sbjct: 90 LKDTKLWIIMEYLGGGSALD-LLEPG------PLDETQ-----------------IAT-I 124
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-----LRKKEDMVS 622
+ + + YLH E +H DIK N+LL + K++DFG+A K+ V
Sbjct: 125 LREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV- 180
Query: 623 MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE ++ KAD++S G+ +E+ G
Sbjct: 181 -----GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 50/224 (22%), Positives = 98/224 (43%), Gaps = 44/224 (19%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGFCA 508
+G G FG VYK + A K ++ + + E + E+ I+A H +V+L G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
G+ ++ E+ P G++ + R E + I+ +
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQ-----------------IQV-VC 123
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-----KLRKKEDMVSM 623
+ A+ +LH + ++H D+K N+L+ + +++DFG++ L+K++ +
Sbjct: 124 RQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-- 178
Query: 624 SRIRGTRGYMAPE-----WLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE ++ KAD++S G+ L+E+
Sbjct: 179 ----GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 50/211 (23%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCA 508
+G G F K ++ AVK + + + E+T + H N+V+L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--KEITALKLCEGHPNIVKLHEVFH 76
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
++ LV E + G L + + + E E S + +R
Sbjct: 77 DQLHTFLVMELLNGGELFERIKKKKHFS------ETEASYI-------------MRK--- 114
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ A++++H+ V+H D+KPEN+L D+ KI DFG A+L+ ++ +
Sbjct: 115 --LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKT 168
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVL 656
T Y APE L + D++S G++L
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 49/218 (22%), Positives = 81/218 (37%), Gaps = 41/218 (18%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCL--KNVTGGDAEFWAEVTIIARM-HHLNLVR 502
IG G + + + AVK + + E+ I+ R H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQHPNIIT 80
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L + +V E + G L D + R E E S
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS------EREAS--------------- 119
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL----GDDFCPKISDFGLAKLRKKE 618
+ + + + YLH + V+H D+KP NIL G+ +I DFG AK + E
Sbjct: 120 ---AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVL 656
+ + + T ++APE L D++S G++L
Sbjct: 174 NGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 39/220 (17%)
Query: 449 NLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFC 507
+G G +G VYK ++VA+K + V E E++I+ + ++V+ +G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+ + +V EY GS++D + + E E++ I
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIA------------------TI 130
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-----KLRKKEDMVS 622
+ + YLH +H DIK NILL + K++DFG+A + K+ ++
Sbjct: 131 LQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI- 186
Query: 623 MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE ++ AD++S G+ +E+ G
Sbjct: 187 -----GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 44/216 (20%), Positives = 79/216 (36%), Gaps = 41/216 (18%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIAR-MHHLNLVRLWGFC 507
++G G G V + + A+K L + + EV + ++V +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVY 91
Query: 508 AEKGERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
++ E + G L + G + E E +
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT----EREAA---------------- 131
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKEDM 620
I + AI +LH + H D+KPEN+L D K++DFG AK + +
Sbjct: 132 --EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVL 656
+ T Y+APE L ++ D++S G+++
Sbjct: 187 QTPC---YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 29/221 (13%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGD--AEFWAEVTIIARMHHLNLVRLWGFC 507
IG G V VA+K + E E+ +++ HH N+V +
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
K E LV + + GS+ D + G E + I I
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST---------------IAT-I 126
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL-AKLRKKEDMVSMSRI 626
V + YLH+ +H D+K NILLG+D +I+DFG+ A L D+
Sbjct: 127 LREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV- 182
Query: 627 R----GTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSG 662
R GT +MAPE + + KAD++SFG+ +E+ +G
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 61/256 (23%), Positives = 97/256 (37%), Gaps = 56/256 (21%)
Query: 450 LIGRGGFGDVYKGE--LTDHRVVAVKCL--KNVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+G G +G+V +T+ V AVK + K E+ I ++H N+V+ +G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAV-AVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E + L EY G L D + + E +
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGM------PEPD-------------------- 106
Query: 566 RIALGVAR--------AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
A+ + YLH + H DIKPEN+LL + KISDFGLA + +
Sbjct: 107 ------AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 618 EDMVSMSRIR-GTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFEIQGSMMN- 674
+ + GT Y+APE L+ + DV+S G+VL +++G ++
Sbjct: 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
Query: 675 -----SDEWYFPKWAF 685
+ Y W
Sbjct: 218 YSDWKEKKTYLNPWKK 233
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 43/230 (18%)
Query: 451 IGRGGFGDVYKGE--LTDHRVVAVKC-----LKNVTGGDAEFWA----EVTIIARMHHLN 499
+G G FG V+ + V VK + + E+ I++R+ H N
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEV-VVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN 90
Query: 500 LVRLWGFCAEKGERTLVYE-YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
++++ +G LV E + L ++ R R+ E S
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL------DEPLAS----------- 133
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
I + A+ YL + ++H DIK ENI++ +DF K+ DFG A ++
Sbjct: 134 -------YIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNFE 667
+ GT Y APE L + P+ +++S G+ L +V F
Sbjct: 184 KL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 53/230 (23%), Positives = 100/230 (43%), Gaps = 49/230 (21%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWG--- 505
+G G +G VYKG + ++ A+K + + E E+ ++ + HH N+ +G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 506 ---FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ LV E+ GS+ D + + + +E
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEW----------------- 130
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-----KLRKK 617
I Y I + R +++LH+ V+H DIK +N+LL ++ K+ DFG++ + ++
Sbjct: 131 IAY-ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQIT-----PKADVYSFGMVLLEIVSG 662
+ GT +MAPE + D+ K+D++S G+ +E+ G
Sbjct: 187 NTFI------GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 53/233 (22%)
Query: 450 LIGRGGFGDVYKGE--LTDHRVVAVKCL---KNVTGGDAE-FWAEVTIIARMHHLNLVRL 503
+G G FG V GE LT H+V AVK L K + E+ + H ++++L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKV-AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ + + +V EYV G L DY+ + GRV EME
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRV------EEME------------------ 112
Query: 564 RYRIALGVAR--------AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
AR A+ Y H V+H D+KPEN+LL KI+DFGL+ +
Sbjct: 113 --------ARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161
Query: 616 KKEDMVSMSRIRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFE 667
+ + S G+ Y APE + P+ D++S G++L ++ G+ F+
Sbjct: 162 SDGEFLRTS--CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 41/222 (18%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLW 504
S ++G G G V + A+K L++ + EV + R ++VR+
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 121
Query: 505 GFCAEKGERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+V E + G L + G + E E S
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT----EREAS------------- 164
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKK 617
I + AI YLH + H D+KPEN+L + K++DFG AK
Sbjct: 165 -----EIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEI 659
+ S++ T Y+APE L ++ D++S G V++ I
Sbjct: 217 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG-VIMYI 255
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 50/227 (22%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCL-KNVTGGDAEFWAEVTIIARMHHL----NLVRL 503
++G G V L + AVK + K + + EV + ++ N++ L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEM---LYQCQGHRNVLEL 76
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
F E+ LV+E + GS+ ++ + E+E S V +
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN------ELEASVV-------------V 117
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAKLRKKEDM 620
+ VA A+ +LH + + H D+KPENIL KI DF L K
Sbjct: 118 QD-----VASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 621 VSMSRIR------GTRGYMAPEWLRSDQIT-----PKADVYSFGMVL 656
S G+ YMAPE + + + D++S G++L
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 5e-21
Identities = 43/227 (18%), Positives = 76/227 (33%), Gaps = 41/227 (18%)
Query: 451 IGRG--GFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFW----AEVTIIARMHHLNLVRL 503
IG+G V V V+ + N+ E E+ + +H N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
E +V ++ GS D + E+ I
Sbjct: 92 RATFIADNELWVVTSFMAYGSAKDLI----CTHFMDGMNELA-----------------I 130
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA------KLRKK 617
Y I GV +A+ Y+H +H +K +IL+ D +S R++
Sbjct: 131 AY-ILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQI--TPKADVYSFGMVLLEIVSG 662
+++PE L+ + K+D+YS G+ E+ +G
Sbjct: 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 59/231 (25%), Positives = 82/231 (35%), Gaps = 51/231 (22%)
Query: 450 LIGRGGFGDVYKGE--LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFC 507
IG G FG LT V AVK ++ D E+ + H N+VR
Sbjct: 27 DIGSGNFGVARLMRDKLTKELV-AVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
++ EY G L + + +GR E E
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRF------SEDE---------------------- 117
Query: 568 ALGVAR--------AIAYLHEECLEWVLHCDIKPENILLGDDFCP--KISDFGLAKLRKK 617
AR ++Y H + H D+K EN LL P KI DFG +K
Sbjct: 118 ----ARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFE 667
+ GT Y+APE L + ADV+S G+ L ++ G+ FE
Sbjct: 171 HSQPKST--VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 42/221 (19%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWA----EVTIIARMHHLNLVRLWG 505
IG G FG VY ++ + VVA+K + E W EV + ++ H N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ LV EY GS +D L + P +E+E I
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKK-----PLQEVE-----------------IAA 158
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL-AKLRKKEDMVSMS 624
+ G + +AYLH ++H D+K NILL + K+ DFG + + V
Sbjct: 159 -VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV--- 211
Query: 625 RIRGTRGYMAPE---WLRSDQITPKADVYSFGMVLLEIVSG 662
GT +MAPE + Q K DV+S G+ +E+
Sbjct: 212 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 41/223 (18%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWA---EVTIIARMH-HLNLVRLWG 505
+G G G V+K V+AVK + +G E ++ ++ + H +V+ +G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ + E + + G + E +
Sbjct: 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIP------ERILG------------------ 127
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL-AKLRKKEDMVSMS 624
++ + + +A+ YL E+ V+H D+KP NILL + K+ DFG+ +L D +
Sbjct: 128 KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKD 182
Query: 625 RIRGTRGYMAPEWLRSDQI-----TPKADVYSFGMVLLEIVSG 662
R G YMAPE + +ADV+S G+ L+E+ +G
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 36/222 (16%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEF---WAEVTIIARM-HHLNLVRLWG 505
IGRG +G V K +++AVK + T + E ++ ++ R +V+ +G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+G+ + E + + S ++ E +
Sbjct: 89 ALFREGDCWICMELM-STSFDK-FYKYVYSVLDDVIPEEILG------------------ 128
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGL-AKLRKKEDMVSMS 624
+I L +A+ +L E ++H DIKP NILL K+ DFG+ +L D ++ +
Sbjct: 129 KITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKT 183
Query: 625 RIRGTRGYMAPEWLRSDQITP----KADVYSFGMVLLEIVSG 662
R G R YMAPE + ++DV+S G+ L E+ +G
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-20
Identities = 77/312 (24%), Positives = 123/312 (39%), Gaps = 78/312 (25%)
Query: 423 GLELLPAGGPKRFTHAELRAATNGFS--------NLIGRGGFGDVYKGELTDHRVVAVKC 474
G++L P P + G +IG G FG V++ +L + VA+K
Sbjct: 12 GVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK 71
Query: 475 LKNVTGGDAEFWA-EVTIIARMHHLNLVRLWGFCAEKGERT------LVYEYVPNGSLAD 527
+ D F E+ I+ + H N+V L F G++ LV EYVP ++
Sbjct: 72 VLQ----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYR 126
Query: 528 YLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVL 587
++ + P ++ Y++ R++AY+H +
Sbjct: 127 ASRHYAKLKQTMPMLLIK----------------LYMYQLL----RSLAYIHSI---GIC 163
Query: 588 HCDIKPENILLGDDFCP--KISDFGLAK-LRKKEDMVS-MSRIRGTRGYMAPEW-LRSDQ 642
H DIKP+N+LL D K+ DFG AK L E VS + +R Y APE +
Sbjct: 164 HRDIKPQNLLL-DPPSGVLKLIDFGSAKILIAGEPNVSYIC----SRYYRAPELIFGATN 218
Query: 643 ITPKADVYSFGMVLLEIVSG-------------SRNFEIQGS-------MMNSD--EWYF 680
T D++S G V+ E++ G ++ G+ MN + E F
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKF 278
Query: 681 PKWA---FEKVY 689
P+ F KV+
Sbjct: 279 PQIRPHPFSKVF 290
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 8e-20
Identities = 60/233 (25%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 450 LIGRGGFGDVYKGE--LTDHRVVAVKCLKNVTGGDAEFWA----EVTIIARMHHLNLVRL 503
+G G FG V G+ LT H+V AVK L + E+ + H ++++L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKV-AVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ + + +V EYV G L DY+ ++GR+ E E
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRL------DEKE------------------ 117
Query: 564 RYRIALGVAR--------AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
+R + Y H V+H D+KPEN+LL KI+DFGL+ +
Sbjct: 118 --------SRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 166
Query: 616 KKEDMVSMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNFE 667
+ + S G+ Y APE + P+ D++S G++L ++ G+ F+
Sbjct: 167 SDGEFLRTS--CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 54/233 (23%)
Query: 450 LIGRGGFGDVYKGE--LTDHRVVAVKCLKNVTGGDAEFWA----EVTIIARMHHLNLVRL 503
+G G FG V T +V A+K + ++ E++ + + H ++++L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKV-ALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ + +V EY G L DY+ R+ E E
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRM------TEDE------------------ 109
Query: 564 RYRIALGVAR--------AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
R AI Y H ++H D+KPEN+LL D+ KI+DFGL+ +
Sbjct: 110 --------GRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM 158
Query: 616 KKEDMVSMSRIRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFE 667
+ + S G+ Y APE + P+ DV+S G+VL ++ G F+
Sbjct: 159 TDGNFLKTS--CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 35/221 (15%)
Query: 451 IGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEF---WAEVTIIARM-HHLNLVRLWG 505
+GRG +G V K +++AVK + T E ++ I R V +G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+G+ + E + + SL + + G + P E +
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP--EDILG------------------ 112
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+IA+ + +A+ +LH + V+H D+KP N+L+ K+ DFG++ D V+
Sbjct: 113 KIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDVAKDI 168
Query: 626 IRGTRGYMAPE----WLRSDQITPKADVYSFGMVLLEIVSG 662
G + YMAPE L + K+D++S G+ ++E+
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 59/238 (24%), Positives = 90/238 (37%), Gaps = 55/238 (23%)
Query: 450 LIGRGGFGDVYKGE--LTDHRVVAVK-----CLKNVTGGDAEFWAEVTIIARMHHLNLVR 502
L+G G +G V + T R AVK L+ + G+A E+ ++ R+ H N+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRR-AVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 503 LWG--FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
L + EK + +V EY G +EM LD
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGM-----------------QEM--------------LD 99
Query: 561 WSIRYRIALGVAR--------AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA 612
R + A + YLH + ++H DIKP N+LL KIS G+A
Sbjct: 100 SVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156
Query: 613 KLRKKEDMVSMSRIR-GTRGYMAPEWLRSDQI--TPKADVYSFGMVLLEIVSGSRNFE 667
+ R G+ + PE K D++S G+ L I +G FE
Sbjct: 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 8e-19
Identities = 58/249 (23%), Positives = 103/249 (41%), Gaps = 40/249 (16%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLK--NVTGGDAEFWA--EVTIIARMHHLNLVRLW 504
++GRGGFG+V+ ++ ++ A K L + A E I+A++H +V L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL- 250
Query: 505 GFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ E LV + G + + V +P + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDI---RYHIYNVDEDNPGFQEPRA---------------- 291
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
+ A + + +LH+ +++ D+KPEN+LL DD +ISD GLA K +
Sbjct: 292 IFYTA-QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY---- 679
GT G+MAPE L ++ D ++ G+ L E+++ F +G + + E
Sbjct: 348 GYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406
Query: 680 -----FPKW 683
+P
Sbjct: 407 EQAVTYPDK 415
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 64/276 (23%), Positives = 102/276 (36%), Gaps = 75/276 (27%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCL-KNVTGGDAEFWA-------------------- 487
IG+G +G V D+ A+K L K A F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 488 ------EVTIIARMHHLNLVRL---WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSS 538
E+ I+ ++ H N+V+L + +V+E V G + + +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLD-DPNEDHLYMVFELVNQGPVMEVP-------TL 131
Query: 539 SPAREMEMSGVGPHDGGKPVLDWSIRY--RIALGVARAIAYLHEECLEWVLHCDIKPENI 596
P E + + Y + G+ YLH + ++H DIKP N+
Sbjct: 132 KPLSEDQ----------------ARFYFQDLIKGIE----YLHYQK---IIHRDIKPSNL 168
Query: 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQIT---PKADVYSFG 653
L+G+D KI+DFG++ K D + +S GT +MAPE L + DV++ G
Sbjct: 169 LVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG 227
Query: 654 MVLLEIVSGSRNFEIQGSMMN------SDEWYFPKW 683
+ L V G F + +M S FP
Sbjct: 228 VTLYCFVFGQCPFMDE-RIMCLHSKIKSQALEFPDQ 262
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 70/223 (31%), Positives = 102/223 (45%), Gaps = 42/223 (18%)
Query: 451 IGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWA-EVTIIARMHHLNLVRLWGFCA 508
IG G FG VY+ +L D +VA+K + D F E+ I+ ++ H N+VRL F
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 509 EKGERT------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
GE+ LV +YVP ++ R + P ++
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVK----------------L 160
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP-KISDFGLAK-LRKKEDM 620
Y++ R++AY+H + H DIKP+N+LL D K+ DFG AK L + E
Sbjct: 161 YMYQLF----RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 621 VSMSRIRGTRGYMAPEW-LRSDQITPKADVYSFGMVLLEIVSG 662
V S I +R Y APE + T DV+S G VL E++ G
Sbjct: 214 V--SYI-CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLKN---VTGGDAEF-WAEVTIIARMHHLNLV 501
F ++G G F V EL R A+K L+ + + E +++R+ H V
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAR----EMEMSGVGPHDGGKP 557
+L+ + + Y NG L Y+ + G + R E
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF-DETCTRFYTAE-------------- 138
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
+ A+ YLH + ++H D+KPENILL +D +I+DFG AK+
Sbjct: 139 -------------IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 182
Query: 618 EDMVSMSR-IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
E + + GT Y++PE L +D+++ G ++ ++V+G
Sbjct: 183 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-18
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 42/223 (18%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLK--NVTGGDAEFWA--EVTIIARMHHLNLVRLW 504
++G+GGFG+V ++ ++ A K L+ + E A E I+ +++ +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 505 GFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ E + LV + G L +++ G+ G
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA----------------------- 286
Query: 564 RYRI-ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
R A + + LH E +++ D+KPENILL D +ISD GLA +
Sbjct: 287 RAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAV-----HVPE 338
Query: 623 MSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
I+ GT GYMAPE +++++ T D ++ G +L E+++G
Sbjct: 339 GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 44/227 (19%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLKN---VTGGDAE-FWAEVTIIARMHHLNLVRLW 504
+IGRG FG+V +L + +V A+K L + + F E ++ + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAR----EMEMSGVGPHDGGKPVLD 560
+ LV +Y G L L + AR EM V+
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM-------------VI- 186
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
AI +H+ +H DIKP+NIL+ + +++DFG ++
Sbjct: 187 -------------AIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
Query: 621 VSMSRIRGTRGYMAPEWLRSDQI-----TPKADVYSFGMVLLEIVSG 662
V S GT Y++PE L++ + P+ D +S G+ + E++ G
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 54/230 (23%), Positives = 85/230 (36%), Gaps = 48/230 (20%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCL-KNVTGGDAE---FWAEVTIIARMHHLNLVRLW 504
+IGRG F +V ++ +V A+K + K E F E ++ + +L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 505 GFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAR----EMEMSGVGPHDGGKPVL 559
F + LV EY G L L + G + AR E+ V+
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI-------------VM 173
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
AI +H +H DIKP+NILL +++DFG + +
Sbjct: 174 --------------AIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQITPKADVY-------SFGMVLLEIVSG 662
V GT Y++PE L++ P Y + G+ E+ G
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 49/225 (21%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWA------EVTIIARMHHLNLVRL 503
IG G +G V+K ++VA+K K + D E+ ++ ++ H NLV L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIK--KFLESEDDP-VIKKIALREIRMLKQLKHPNLVNL 67
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
K LV+EY + ++ L R R + SI
Sbjct: 68 LEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-------------------SI 107
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-----KLRKKE 618
++ +A+ + H+ +H D+KPENIL+ K+ DFG A +
Sbjct: 108 TWQT----LQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160
Query: 619 DMVSMSRIRGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSG 662
D V+ TR Y +PE L Q P DV++ G V E++SG
Sbjct: 161 DEVA------TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 49/227 (21%)
Query: 449 NLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWA------EVTIIARMHHLNLV 501
L+G G +G V K R+VA+K D + E+ ++ ++ H NLV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLE---SDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L C +K LV+E+V + ++ D +E+ G LD+
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDH-TILDD---------------LELFPNG--------LDY 123
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLA-----KLRK 616
+ + + I + H ++H DIKPENIL+ K+ DFG A
Sbjct: 124 QVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180
Query: 617 KEDMVSMSRIRGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSG 662
+D V+ TR Y APE L + DV++ G ++ E+ G
Sbjct: 181 YDDEVA------TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 451 IGRGGFGDVYKG---ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFC 507
+GRG +G VYK + D + A+K ++ TG E+ ++ + H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG-TGISMSACREIALLRELKHPNVISLQKVF 87
Query: 508 AEKGER--TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+R L+++Y + L + ++ ++ V K S+ Y
Sbjct: 88 LSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMV------K-----SLLY 135
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF----CPKISDFGLAKLRKKEDMV 621
+I I YLH WVLH D+KP NIL+ + KI+D G A R +
Sbjct: 136 QI----LDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA--RLFNSPL 186
Query: 622 -SMSRIRG---TRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSG 662
++ + T Y APE L + T D+++ G + E+++
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 55/232 (23%), Positives = 101/232 (43%), Gaps = 41/232 (17%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLK--NVTGGDAEFW--AEVTIIARMHHLNLVRLW 504
IG+G FG V + D ++ A+K + + E+ I+ + H LV LW
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 505 GFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ + E +V + + G L +L ++ + ++
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-----------------------EETV 117
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVS 622
+ I + A+ YL + ++H D+KP+NILL + I+DF +A L ++ + +
Sbjct: 118 KLFIC-ELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173
Query: 623 MSRIRGTRGYMAPEWLRSDQI---TPKADVYSFGMVLLEIVSGSRNFEIQGS 671
M+ GT+ YMAPE S + + D +S G+ E++ G R + I+ S
Sbjct: 174 MA---GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 451 IGRGGFGDVYKGELTD-HRVVAVK-CLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCA 508
G+G FG V G+ VA+K +++ + E + +A +HH N+V+L +
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPNIVQLQSYFY 89
Query: 509 EKGERT-------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
GER +V EYVP+ +L R + P ++
Sbjct: 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK---------------- 132
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP-KISDFGLAK-LRKKED 619
+++ R+I LH + V H DIKP N+L+ + K+ DFG AK L E
Sbjct: 133 VFLFQLI----RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 620 MVSMSRIRGTRGYMAPEW-LRSDQITPKADVYSFGMVLLEIVSG 662
V+ I +R Y APE + T D++S G + E++ G
Sbjct: 188 NVAY--I-CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-15
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLK----NVTGGDAEFWAEVTIIARMHHLN---LV 501
+IGRGGFG+VY D ++ A+KCL + G+ E +++ + + +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 502 RLWGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+ + ++ + + + G L +L + G S A
Sbjct: 256 CMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEAD------------------ 293
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
+R+ A + + ++H V++ D+KP NILL + +ISD GLA K+
Sbjct: 294 --MRFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 621 VSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSG 662
+ GT GYMAPE L+ AD +S G +L +++ G
Sbjct: 348 HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 57/232 (24%)
Query: 450 LIGRGGFGDVYK-GELTDHRVVAVKCLKN---VTGGDAE-FWAEVTIIARMHHLNLVRLW 504
+IGRG FG+V + +V A+K L + D+ FW E I+A + +V+L+
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 505 GFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
A + +R L V EY+P G L + +
Sbjct: 136 --YAFQDDRYLYMVMEYMPGGDLVNLM--------------------------------- 160
Query: 563 IRYRIALGVAR--------AIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL 614
Y + AR A+ +H +H D+KP+N+LL K++DFG
Sbjct: 161 SNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 217
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQI----TPKADVYSFGMVLLEIVSG 662
KE MV GT Y++PE L+S + D +S G+ L E++ G
Sbjct: 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAE---FWA--EVTIIARMHHLNLVRLWG 505
+G G +G VYK + + R+VA+K ++ + E A E++++ +HH N+V L
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIR--LDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ TLV+E++ L L D K L S
Sbjct: 87 VIHSERCLTLVFEFMEK-DLKKVL-----------------------DENKTGLQDSQIK 122
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ R +A+ H+ +LH D+KP+N+L+ D K++DFGLA+ + S +
Sbjct: 123 IYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARA-FGIPVRSYTH 178
Query: 626 IRGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSG 662
T Y AP+ L S + + D++S G + E+++G
Sbjct: 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 35/220 (15%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE----FWA--EVTIIARMHHLNLVRL 503
+G G + VYKG T VA+K +K D+E A E++++ + H N+VRL
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKL----DSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ + + TLV+E++ N L Y M+ VG G L+ ++
Sbjct: 69 YDVIHTENKLTLVFEFMDN-DLKKY---------------MDSRTVGNTPRG---LELNL 109
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
+ + +A+ HE +LH D+KP+N+L+ K+ DFGLA+ + +
Sbjct: 110 VKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARA-FGIPVNTF 165
Query: 624 SRIRGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSG 662
S T Y AP+ L S + D++S G +L E+++G
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG 205
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 68/301 (22%), Positives = 112/301 (37%), Gaps = 67/301 (22%)
Query: 451 IGRGGFGDVYKGELTDH-RVVAVKCLKNVTGGDAEFWA-EVTIIARMHHLNLVRLWGF-- 506
+G G FG V + + + A+K + D + E+ I+ + H+N+++L +
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ----DPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 507 -CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPARE--------ME-MSGVGPHDGGK 556
++ + N + S ME + P K
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV----PDTLHK 126
Query: 557 PVLDWSIRYRIALGVA----------RAIAYLHEECLEWVLHCDIKPENILLGDDFCP-K 605
VL IR ++ + RA+ ++H + H DIKP+N+L+ K
Sbjct: 127 -VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLK 182
Query: 606 ISDFGLAK-LRKKEDMVSMSRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSG- 662
+ DFG AK L E V+ I +R Y APE L + + TP D++S G V E++ G
Sbjct: 183 LCDFGSAKKLIPSEPSVAY--I-CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 663 ------------SRNFEIQGS-------MMNSD--EWYFPKWA---FEKVYEEMKVEDIL 698
R +I G+ MN E FP + K+ E +
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 699 D 699
D
Sbjct: 300 D 300
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 6e-15
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 36/218 (16%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAE---FWA--EVTIIARMHHLNLVRLWG 505
IG G +G VYK + A+K ++ + E E++I+ + H N+V+L+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
K LV+E++ L L D + L+
Sbjct: 68 VIHTKKRLVLVFEHLDQ-DLKKLL-----------------------DVCEGGLESVTAK 103
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
L + IAY H+ VLH D+KP+N+L+ + KI+DFGLA+ + +
Sbjct: 104 SFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTH 159
Query: 626 IRGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSG 662
T Y AP+ L S + + D++S G + E+V+G
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 8e-15
Identities = 61/229 (26%), Positives = 94/229 (41%), Gaps = 43/229 (18%)
Query: 449 NLIGRGGFGDVYKG-ELTDHRVVAVKCLK--NVTGGDAEFWA----EVTIIARMH---HL 498
IG G +G VYK + VA+K ++ N GG EV ++ R+ H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 499 NLVRLWGFCAEKGER-----TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHD 553
N+VRL CA TLV+E+V L YL +P + +
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL-------DKAPPPGLPAETI---- 122
Query: 554 GGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK 613
K + + R + +LH ++H D+KPENIL+ K++DFGLA
Sbjct: 123 --K-----DLMRQF----LRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLA- 167
Query: 614 LRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
R ++++ + T Y APE L D++S G + E+
Sbjct: 168 -RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 48/250 (19%), Positives = 95/250 (38%), Gaps = 51/250 (20%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHL---------- 498
+G G F V+ + + ++ VA+K ++ E+ ++ R++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 499 -NLVRLWGFCAEKGERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHD 553
++++L KG +V+E V +L + + G
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIY------------ 132
Query: 554 GGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP------KIS 607
++ +I+ + + Y+H C ++H DIKPEN+L+ P KI+
Sbjct: 133 ---------VK-QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIA 180
Query: 608 DFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
D G A + + TR Y +PE L AD++S ++ E+++G FE
Sbjct: 181 DLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
Query: 668 IQGSMMNSDE 677
+ +
Sbjct: 237 PDEGHSYTKD 246
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 36/218 (16%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLKN---VTGGDAE-FWAEVTIIARMHHLNLVRLW 504
+G G FG V + + A+K L V E E I+ ++ LV+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+ +V EYV G + +L R GR S AR
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHAR---------------------F 145
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
Y A + YLH +++ D+KPEN+L+ +++DFG AK
Sbjct: 146 Y--AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTW 196
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ GT +APE + S D ++ G+++ E+ +G
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 39/222 (17%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE---FWA--EVTIIARMHHLNLVRLW 504
IG G +G V+K H +VA+K ++ D E A E+ ++ + H N+VRL
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+ TLV+E+ L Y D LD I
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYF-----------------------DSCNGDLDPEIV 103
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED-MVSM 623
+ + + + H VLH D+KP+N+L+ + K+++FGLA R +
Sbjct: 104 KSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLA--RAFGIPVRCY 158
Query: 624 SRIRGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSGSR 664
S T Y P+ L + + D++S G + E+ + R
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 62/250 (24%), Positives = 99/250 (39%), Gaps = 49/250 (19%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLK--NVTGGDAEFW--AEVTIIARMHHLNLVRLW 504
L+G+G FG V + R A+K LK + D E ++ H L L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 505 GFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ + +R V EY G L +L R
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------------------------- 248
Query: 564 RYRI-ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
R R + A+ YLH E + V++ D+K EN++L D KI+DFGL KE +
Sbjct: 249 RARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLC----KEGIKD 302
Query: 623 MSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQGSMM 673
+ ++ GT Y+APE L + D + G+V+ E++ G F ++ ++
Sbjct: 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362
Query: 674 NSDEWYFPKW 683
+E FP+
Sbjct: 363 M-EEIRFPRT 371
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 38/221 (17%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE----FWA--EVTIIARMHHLNLVRL 503
+G G F VYK + +++VA+K +K +A+ A E+ ++ + H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
K +LV++++ L + + + S + K
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVII--------KDNSLVLTPSHI------K------- 115
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-S 622
L + + YLH+ W+LH D+KP N+LL ++ K++DFGLA + +
Sbjct: 116 --AYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA--KSFGSPNRA 168
Query: 623 MSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSG 662
+ TR Y APE L + D+++ G +L E++
Sbjct: 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 40/182 (21%), Positives = 66/182 (36%), Gaps = 40/182 (21%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLW 504
S ++G G G V + A+K L++ + EV + R ++VR+
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIV 77
Query: 505 GFCAEKGERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+V E + G L + G + E E S +
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT----EREASEI----------- 122
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL---GDDFCPKISDFGLAK--LR 615
++ + AI YLH + H D+KPEN+L + K++DFG AK
Sbjct: 123 --MKS-----IGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG 172
Query: 616 KK 617
+K
Sbjct: 173 EK 174
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVK--CLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFC 507
+G G + VYKG +VA+K L++ G EV+++ + H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+ TLV+EY+ L YL + M V K +++
Sbjct: 70 HTEKSLTLVFEYLDK-DLKQYL--------DDCGNIINMHNV------K-----LFLFQL 109
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRI 626
R +AY H + VLH D+KP+N+L+ + K++DFGLA R K +
Sbjct: 110 ----LRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLA--RAKSIPTKTYDNE 160
Query: 627 RGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSG 662
T Y P+ L S + + D++ G + E+ +G
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 8e-14
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 447 FSNLIGRGGFGDVYKGELTD-HRVVAVKCLKN---VTGGDAE-FWAEVTIIARMHHLNLV 501
+G G FG V+ R A+K LK V E E +++ + H ++
Sbjct: 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAR----EMEMSGVGPHDGGKP 557
R+WG + + ++ +Y+ G L L +S R + A+ E
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-PNPVAKFYAAE-------------- 114
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
+ L A+ YLH + +++ D+KPENILL + KI+DFG AK
Sbjct: 115 ---------VCL----ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK---- 154
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ GT Y+APE + + D +SFG+++ E+++G
Sbjct: 155 YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 62/249 (24%), Positives = 96/249 (38%), Gaps = 48/249 (19%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCL-KNVTGGDAEFW---AEVTIIARMHHLNLVRLW 504
L+G+G FG V R A+K L K V E E ++ H L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 505 GFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
+ + +R V EY G L +L R + +
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFT----------------------EERAR 108
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
Y + A+ YLH V++ DIK EN++L D KI+DFGL K E +
Sbjct: 109 FY--GAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDG 159
Query: 624 SRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQGSMMN 674
+ ++ GT Y+APE L + D + G+V+ E++ G F + ++
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 675 SDEWYFPKW 683
+E FP+
Sbjct: 220 -EEIRFPRT 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 57/252 (22%), Positives = 107/252 (42%), Gaps = 52/252 (20%)
Query: 450 LIGRGGFGDVY----KGELTDHRVVAVKCLKN---VTGGDAEFWAEVTIIARMHHLNLVR 502
++G+G FG V+ ++ A+K LK E I+ ++H +V+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 503 LWGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAR----EMEMSGVGPHDGGKP 557
L + + + L+ +++ G L L + + + E
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-TEEDVKFYLAE-------------- 134
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
+AL A+ +LH +++ D+KPENILL ++ K++DFGL+K
Sbjct: 135 ---------LAL----ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQGS 671
+ + S GT YMAPE + T AD +SFG+++ E+++G+ F E
Sbjct: 179 HEKKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 237
Query: 672 MMNSDEWYFPKW 683
++ + P++
Sbjct: 238 ILK-AKLGMPQF 248
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 54/234 (23%), Positives = 90/234 (38%), Gaps = 55/234 (23%)
Query: 449 NLIGRGGFGDVYKG--ELTDHRVVAVKCLK--------NVTGGDAEFWA--EVTIIARMH 496
IG G +G V+K R VA+K ++ ++ EV ++ +
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS-------TIREVAVLRHLE 69
Query: 497 ---HLNLVRL-----WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSG 548
H N+VRL + + TLV+E+V L YL
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL------------------- 109
Query: 549 VGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISD 608
+P + + + R + +LH V+H D+KP+NIL+ K++D
Sbjct: 110 ---DKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 163
Query: 609 FGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
FGLA R ++++ + T Y APE L D++S G + E+
Sbjct: 164 FGLA--RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 51/232 (21%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-----FWA--EVTIIARMHHLNLVR 502
IG+G FG+V+K + VA+K + + E A E+ I+ + H N+V
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLM----ENEKEGFPITALREIKILQLLKHENVVN 80
Query: 503 LWGFCAEKGERT--------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDG 554
L C K LV+++ + LA L S+ + +S +
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--------SNVLVKFTLSEI----- 126
Query: 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK- 613
K R+ + + Y+H +LH D+K N+L+ D K++DFGLA+
Sbjct: 127 -K---------RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 614 --LRKKEDMVSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSG 662
L K + T Y PE L P D++ G ++ E+ +
Sbjct: 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 8e-13
Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 5/90 (5%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
I +LH ++H D+KP NI++ D KI DFGLA R M+ TR Y
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYVVTRYY 192
Query: 633 MAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
APE + D++S G ++ E++ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 8e-13
Identities = 60/254 (23%), Positives = 102/254 (40%), Gaps = 51/254 (20%)
Query: 447 FSNLIGRGGFGDVYKGELTD-HRVVAVKCLKN---VTGGDAEF-WAEVTIIAR-MHHLNL 500
F ++G+G FG V E + AVK LK + D E E ++A L
Sbjct: 345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 501 VRLWGFCAEKGER-TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+L C + +R V EYV G L ++ + GR
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP--------------------- 442
Query: 560 DWSIRYRI-ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
A +A + +L + +++ D+K +N++L + KI+DFG+ K E
Sbjct: 443 ----HAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK----E 491
Query: 619 DMVSMSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQ 669
++ + GT Y+APE + D ++FG++L E+++G F E+
Sbjct: 492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
Query: 670 GSMMNSDEWYFPKW 683
S+M +PK
Sbjct: 552 QSIME-HNVAYPKS 564
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 53/257 (20%), Positives = 93/257 (36%), Gaps = 59/257 (22%)
Query: 428 PAGGPKRFTHAELRAATN--GFSNL--IGRGGFGDVYKG-ELTDHRVVAVKCLK------ 476
GP + + +AT+ + + +G G +G+VYK + + VA+K ++
Sbjct: 15 QTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE 74
Query: 477 --NVTGGDAEFWA--EVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRS 532
T A EV+++ + H N++ L L++EY N L Y+ ++
Sbjct: 75 GVPGT-------AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN 126
Query: 533 GRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592
V + + + + H LH D+K
Sbjct: 127 PDVSMRVIKSFLYQ------------------------LINGVNFCHSR---RCLHRDLK 159
Query: 593 PENILLGDDFCP-----KISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWL-RSDQITP 645
P+N+LL KI DFGLA R + + T Y PE L S +
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLA--RAFGIPIRQFTHEIITLWYRPPEILLGSRHYST 217
Query: 646 KADVYSFGMVLLEIVSG 662
D++S + E++
Sbjct: 218 SVDIWSIACIWAEMLMK 234
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 43/226 (19%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWA---EVTIIARMHHL------ 498
+LIG+G FG V K + VA+K +KN A EV ++ M+
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
+V L + LV+E + + +L D L + G S
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNL----------------- 158
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP--KISDFGLAKLRK 616
R + A + A+ +L L ++HCD+KPENILL + KI DFG +
Sbjct: 159 ----TR-KFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212
Query: 617 KEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ + + +R Y +PE L D++S G +L+E+ +G
Sbjct: 213 QR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 60/250 (24%), Positives = 104/250 (41%), Gaps = 49/250 (19%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLKN---VTGGDAEF-WAEVTIIARM-HHLNLVRL 503
++G+G FG V E + AVK LK + D E E ++A L +L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 504 WGFCAEKGER-TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
C + +R V EYV G L ++ + GR +
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----------------------EPHA 123
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
+ Y A +A + +L + +++ D+K +N++L + KI+DFG+ K E++
Sbjct: 124 VFY--AAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK----ENIWD 174
Query: 623 MSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQGSMM 673
+ GT Y+APE + D ++FG++L E+++G F E+ S+M
Sbjct: 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234
Query: 674 NSDEWYFPKW 683
+PK
Sbjct: 235 E-HNVAYPKS 243
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 64/242 (26%), Positives = 104/242 (42%), Gaps = 50/242 (20%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLK--NVTGGDAEFW--AEVTIIAR-MHHLNLVRL 503
+IGRG + V L R+ A+K +K V + W E + + +H LV L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 504 WGFCAEKGER-TLVYEYVPNGSLADYLFRSGRVGSSSPAR----EMEMSGVGPHDGGKPV 558
C + R V EYV G L ++ R ++ AR E
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKL-PEEHARFYSAE--------------- 118
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
I+L A+ YLHE +++ D+K +N+LL + K++D+G+ K E
Sbjct: 119 --------ISL----ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK----E 159
Query: 619 DMVSMSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675
+ GT Y+APE LR + D ++ G+++ E+++G F+I GS N
Sbjct: 160 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 219
Query: 676 DE 677
D+
Sbjct: 220 DQ 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 56/260 (21%), Positives = 102/260 (39%), Gaps = 58/260 (22%)
Query: 450 LIGRGGFGDVY---KGELTDH-RVVAVKCLKN---VTGGDAEFW--AEVTIIARM-HHLN 499
++G G +G V+ K D ++ A+K LK V E ++ +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 500 LVRLWGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAR----EMEMSGVGPHDG 554
LV L + + + L+ +Y+ G L +L + R + + E
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERF-TEHEVQIYVGE----------- 167
Query: 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL 614
I L A+ +LH+ +++ DIK ENILL + ++DFGL+K
Sbjct: 168 ------------IVL----ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 208
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQI--TPKADVYSFGMVLLEIVSGSRNFEIQGSM 672
++ GT YMAP+ +R D +S G+++ E+++G+ F + G
Sbjct: 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268
Query: 673 MNSDEWY---------FPKW 683
+ E +P+
Sbjct: 269 NSQAEISRRILKSEPPYPQE 288
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 63/242 (26%), Positives = 104/242 (42%), Gaps = 50/242 (20%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLK--NVTGGDAEFW--AEVTIIAR-MHHLNLVRL 503
+IGRG + V L R+ A++ +K V + W E + + +H LV L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 504 WGFCAEKGER-TLVYEYVPNGSLADYLFRSGRVGSSSPAR----EMEMSGVGPHDGGKPV 558
C + R V EYV G L ++ R ++ AR E
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKL-PEEHARFYSAE--------------- 161
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
I+L A+ YLHE +++ D+K +N+LL + K++D+G+ K E
Sbjct: 162 --------ISL----ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK----E 202
Query: 619 DMVSMSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675
+ GT Y+APE LR + D ++ G+++ E+++G F+I GS N
Sbjct: 203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 262
Query: 676 DE 677
D+
Sbjct: 263 DQ 264
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 30/90 (33%), Positives = 43/90 (47%), Gaps = 5/90 (5%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
I +LH ++H D+KP NI++ D KI DFGLA R M+ TR Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA--RTAGTSFMMTPYVVTRYY 229
Query: 633 MAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
APE + D++S G ++ E+V
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 51/251 (20%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLK--NVTGGDAEFW--AEVTIIAR-MHHLNLVRL 503
++G+G FG V+ E ++ A+K LK V D E +++ H L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 504 WGFCAEKGER-TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ + E V EY+ G L ++ + L +
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----------------------LSRA 120
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD-FCPKISDFGLAKLRKKEDMV 621
Y A + + +LH + +++ D+K +NILL D KI+DFG+ K E+M+
Sbjct: 121 TFY--AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHI-KIADFGMCK----ENML 170
Query: 622 SMSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQGSM 672
++ GT Y+APE L + D +SFG++L E++ G F E+ S+
Sbjct: 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230
Query: 673 MNSDEWYFPKW 683
D ++P+W
Sbjct: 231 RM-DNPFYPRW 240
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 49/222 (22%), Positives = 94/222 (42%), Gaps = 39/222 (17%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHL------NLVR 502
+IG+G FG V K H+ VA+K ++N + E+ I+ + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ + + +E + + +L + + ++ G S P
Sbjct: 164 MLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPL--------------------- 201
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP--KISDFGLAKLRKKEDM 620
+R + A + + + LH+ + +HCD+KPENILL K+ DFG + +
Sbjct: 202 VR-KFAHSILQCLDALHKNRI---IHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-- 255
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG 662
+ +R Y APE + + D++S G +L E+++G
Sbjct: 256 --VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 61/250 (24%), Positives = 111/250 (44%), Gaps = 49/250 (19%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLKN---VTGGDAEF-WAEVTIIAR-MHHLNLVRL 503
++G+G FG V + + + AVK LK + D E E I++ +H L +L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 504 WGFCAEKGER-TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ C + +R V E+V G L ++ +S R +
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----------------------EARA 126
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
Y A + A+ +LH++ +++ D+K +N+LL + K++DFG+ K E + +
Sbjct: 127 RFY--AAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK----EGICN 177
Query: 623 MSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQGSMM 673
GT Y+APE L+ P D ++ G++L E++ G F ++ +++
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
Query: 674 NSDEWYFPKW 683
N DE +P W
Sbjct: 238 N-DEVVYPTW 246
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 44/218 (20%), Positives = 87/218 (39%), Gaps = 40/218 (18%)
Query: 451 IGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCA 508
+GRG + +V++ +T++ V VK LK V + E+ I+ + N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVK 101
Query: 509 EKGERTLVY--EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ RT E+V N + + D+ IR+
Sbjct: 102 DPVSRTPALVFEHVNNTDFKQLY--------------------------QTLTDYDIRFY 135
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP-KISDFGLAKLRKKEDMVSMSR 625
+ + +A+ Y H ++H D+KP N+++ + ++ D+GLA +
Sbjct: 136 M-YEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYHPGQEYNV 189
Query: 626 IRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSG 662
+R + PE L Q+ D++S G +L ++
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 8e-12
Identities = 60/257 (23%), Positives = 105/257 (40%), Gaps = 60/257 (23%)
Query: 450 LIGRGGFGDVY---KGELTD-HRVVAVKCLKN---VTGGDAEFW--AEVTIIARMHHLNL 500
++G+GG+G V+ K + ++ A+K LK V AE I+ + H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 501 VRLWGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAR----EMEMSGVGPHDGG 555
V L + + G + L+ EY+ G L L R G A E
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIF-MEDTACFYLAE------------ 129
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615
I++ A+ +LH++ +++ D+KPENI+L K++DFGL K
Sbjct: 130 -----------ISM----ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-- 169
Query: 616 KKEDMVSMSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------ 666
E + + GT YMAPE L D +S G ++ ++++G+ F
Sbjct: 170 --ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227
Query: 667 EIQGSMMNSDEWYFPKW 683
+ ++ + P +
Sbjct: 228 KTIDKILK-CKLNLPPY 243
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 1e-11
Identities = 33/211 (15%), Positives = 57/211 (27%), Gaps = 31/211 (14%)
Query: 431 GPKRFTHAELRAATNGFSNL--IGRGGFGDVYKGELTDHRVVAVKCL---------KNVT 479
GP F+H T IG G FG+V++ DH VA+K + +
Sbjct: 9 GPVPFSHC---LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQ 64
Query: 480 GGDAEFWAEVTI---------IARMHHLNLVRLWGFCAEKGERT----LVYEYVPNGSLA 526
E E+ I + L +G +++ + +
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 527 DYLFRSGRVGSSSPAR-EMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEW 585
E E G+ + + I + ++A
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR-- 182
Query: 586 VLHCDIKPENILLGDDFCPKISDFGLAKLRK 616
H D+ N+LL K+ K
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 6/91 (6%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
+ LHE V+H D+ P NILL D+ I DF LA R+ + + R Y
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLA--REDTADANKTHYVTHRWY 199
Query: 633 MAPE-WLRSDQITPKADVYSFGMVLLEIVSG 662
APE ++ T D++S G V+ E+ +
Sbjct: 200 RAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 8/91 (8%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
+ + Y+H ++H D+KP N+ + +D KI DFGLA R+ + M+ TR Y
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA--RQADS--EMTGYVVTRWY 191
Query: 633 MAPE-WLRSDQITPKADVYSFGMVLLEIVSG 662
APE L + T D++S G ++ E+++G
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 60/250 (24%), Positives = 96/250 (38%), Gaps = 49/250 (19%)
Query: 450 LIGRGGFGDVYKGELTD-HRVVAVKCLKN---VTGGDAEF-WAEVTIIAR-MHHLNLVRL 503
+IG+G FG V AVK L+ + + + +E ++ + + H LV L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 504 WGFCAEKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
F + ++ V +Y+ G L +L R +
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFL----------------------EPRA 141
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS 622
Y A +A A+ YLH +++ D+KPENILL ++DFGL K E++
Sbjct: 142 RFY--AAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEH 192
Query: 623 MSRIR---GTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF------EIQGSMM 673
S GT Y+APE L D + G VL E++ G F E+ +++
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252
Query: 674 NSDEWYFPKW 683
N
Sbjct: 253 N-KPLQLKPN 261
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 34/93 (36%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVS--MSRIRGTR 630
R + Y+H VLH D+KP N+LL KI DFGLA++ + + ++ TR
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 631 GYMAPE-WLRSDQITPKADVYSFGMVLLEIVSG 662
Y APE L S T D++S G +L E++S
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
+ + Y+H V+H D+KP N+ + +D KI DFGLA R + M+ TR Y
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA--RHADA--EMTGYVVTRWY 189
Query: 633 MAPE-WLRSDQITPKADVYSFGMVLLEIVSG 662
APE L D++S G ++ E+++G
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 7/94 (7%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCP-KISDFGLAKLRKKEDMVS--MSRIRGT 629
R + Y+H VLH D+KP N+ + + KI DFGLA++ +S T
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 630 RGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSG 662
+ Y +P L + T D+++ G + E+++G
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 8/91 (8%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGY 632
R + Y+H ++H D+KP N+ + +D KI DFGLA R D M+ TR Y
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA--RHTADE--MTGYVATRWY 195
Query: 633 MAPE-WLRSDQITPKADVYSFGMVLLEIVSG 662
APE L D++S G ++ E+++G
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 52/229 (22%), Positives = 85/229 (37%), Gaps = 47/229 (20%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLV-RLWGFCA 508
IG G FG +++G L +++ VA+K + E + + ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLLAGCTGIPNVYYFGQ 76
Query: 509 EKGERTLVYEYVPNG-SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
E LV + + G SL D L GR S K V
Sbjct: 77 EGLHNVLVIDLL--GPSLEDLLDLCGRKFSV-----------------KTVA------MA 111
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK-----ISDFGLAKLRKKEDMVS 622
A + + +HE+ L ++ DIKP+N L+G + DFG+ K D V+
Sbjct: 112 AKQMLARVQSIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK--FYRDPVT 166
Query: 623 MSRI--------RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS 663
I GT YM+ + + + D+ + G V + + GS
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 13/100 (13%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRG---- 628
RA+ LH V+H D+KP N+L+ + K+ DFGLA++ + +
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 629 -----TRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSG 662
TR Y APE L S + + DV+S G +L E+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 50/228 (21%), Positives = 82/228 (35%), Gaps = 45/228 (19%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAE 509
IG G FG++ G+ L + VA+K + + +++ F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76
Query: 510 KGERTLVYEYVPNG-SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
+V E + G SL D R S K VL IA
Sbjct: 77 GKYNAMVLELL--GPSLEDLFDLCDRTFSL-----------------KTVL------MIA 111
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK-----ISDFGLAKLRKKEDMVSM 623
+ + + Y+H + L ++ D+KPEN L+G I DF LAK + D +
Sbjct: 112 IQLISRMEYVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK--EYIDPETK 166
Query: 624 SRI--------RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS 663
I GT YM+ + + + D+ + G + + + GS
Sbjct: 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 50/248 (20%), Positives = 82/248 (33%), Gaps = 73/248 (29%)
Query: 450 LIGRGGFGDVYKG--ELTDHRVVAVKCLKNVTGGDAEFWA---EVTIIARMHHL------ 498
+G G FG V + VA+K ++NV A E+ ++ ++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKF 82
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
V + + G + +E + + ++L + P
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPH----------------- 124
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
+R +A + A+ +LHE L H D+KPENIL + + + + K
Sbjct: 125 ----VR-HMAYQLCHALRFLHENQL---THTDLKPENILFVNSEFETLYNEHKSCEEKS- 175
Query: 619 DMVSMSRIR----G--------------TRGYMAPE------WLRSDQITPKADVYSFGM 654
V + IR G TR Y PE W DV+S G
Sbjct: 176 --VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGC 227
Query: 655 VLLEIVSG 662
+L E G
Sbjct: 228 ILFEYYRG 235
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 28/187 (14%), Positives = 55/187 (29%), Gaps = 51/187 (27%)
Query: 451 IGRGGFGDVYKGE---------LTDHRVVAVKCLKNVTGGDAEF-----------WAEVT 490
R G +Y+ + ++K E +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 491 IIARMHHLNLVRLWGFCAEKGE-RTLVYEYVPNG-SLADYLFRSGRVGSSSPAREMEMSG 548
+ L + GF + + R LV + G SL L S + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPK-------HVLSERS 160
Query: 549 VGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKI-- 606
V ++A + A+ +LHE +H ++ ENI + + ++
Sbjct: 161 V---------------LQVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTL 202
Query: 607 SDFGLAK 613
+ +G A
Sbjct: 203 AGYGFAF 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 55/248 (22%), Positives = 92/248 (37%), Gaps = 73/248 (29%)
Query: 450 LIGRGGFGDVYKG--ELTDHRVVAVKCLKNVTGGDAEFWA---EVTIIARMHHL------ 498
+G G FG V + R VAVK +KNV D A E+ ++ ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
V++ + G +V+E + S D++ +G +
Sbjct: 78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDH----------------- 119
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
IR ++A + +++ +LH L H D+KPENIL ++ K+++ E
Sbjct: 120 ----IR-KMAYQICKSVNFLHSNKL---THTDLKPENILFVQ---SDYTEAYNPKIKRDE 168
Query: 619 DMVSMSRIR----G--------------TRGYMAPE------WLRSDQITPKADVYSFGM 654
+ I+ G TR Y APE W + DV+S G
Sbjct: 169 RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGC 222
Query: 655 VLLEIVSG 662
+L+E G
Sbjct: 223 ILIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 54/249 (21%), Positives = 92/249 (36%), Gaps = 71/249 (28%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWA---EVTIIARM-----HHLNL 500
+G G FG V + + + + AVK ++N+ + E I+ ++ ++ N+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNI 98
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
V+ G L++E SL + + R+ G
Sbjct: 99 VKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIED------------------- 138
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
I+ + + +A+ YL + L H D+KPENILL D + K K+
Sbjct: 139 --IK-LYCIEILKALNYLRKMSL---THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192
Query: 621 VSM---SRIR----G--------------TRGYMAPE------WLRSDQITPKADVYSFG 653
+ + I+ G TR Y APE W +D++SFG
Sbjct: 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFG 246
Query: 654 MVLLEIVSG 662
VL E+ +G
Sbjct: 247 CVLAELYTG 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 59/227 (25%), Positives = 82/227 (36%), Gaps = 45/227 (19%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLV-RLWGFCA 508
IG G FGD+Y G + VA+K V + E I M + + A
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 509 EKGERTLVYEYVPNG-SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
E +V E + G SL D R S K VL +
Sbjct: 76 EGDYNVMVMELL--GPSLEDLFNFCSRKFSL-----------------KTVL------LL 110
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK---ISDFGLAKLRKKEDMVSMS 624
A + I Y+H + +H D+KP+N L+G I DFGLAK K D +
Sbjct: 111 ADQMISRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRDARTHQ 165
Query: 625 RI--------RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS 663
I GT Y + + + + D+ S G VL+ GS
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 38/183 (20%), Positives = 56/183 (30%), Gaps = 66/183 (36%)
Query: 555 GKPVLDWSIRYR-----------IALGVARAIAYLHEECLEWVLHCDIKPENILLG---- 599
G +L W I+ I V + + YLH +C ++H DIKPENILL
Sbjct: 128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQ 185
Query: 600 ---------------------------------------------DDFCPKISDFGLAKL 614
+ KI+D G A
Sbjct: 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW 245
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674
K + TR Y + E L AD++S + E+ +G FE
Sbjct: 246 VHKHF----TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
Query: 675 SDE 677
+ +
Sbjct: 302 TRD 304
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 35/111 (31%), Positives = 50/111 (45%), Gaps = 24/111 (21%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRG---- 628
+ I YLH +LH D+KP NILL + K++DFGL++ V+ +
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 629 ----------------TRGYMAPEW-LRSDQITPKADVYSFGMVLLEIVSG 662
TR Y APE L S + T D++S G +L EI+ G
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 29/114 (25%), Positives = 46/114 (40%), Gaps = 25/114 (21%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRG---- 628
++HE ++H D+KP N LL D K+ DFGLA+ E ++
Sbjct: 140 LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 629 -----------------TRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSGSR 664
TR Y APE L + T D++S G + E+++ +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 36/189 (19%), Positives = 62/189 (32%), Gaps = 53/189 (28%)
Query: 450 LIGRGGFGDVYKG------ELTDHRVVAVKCLKNVTG------------GDAEFWAEVTI 491
IG+GGFG +Y + VK + G E +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 492 IARMHHLNLVRLWGFCAEKGE----RTLVYEYVPNG-SLADYLFRSGRVGSSSPAREMEM 546
++ +L + + WG R ++ + G L + + S
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSR-------- 151
Query: 547 SGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKI 606
K VL +++L + + Y+HE +H DIK N+LL ++
Sbjct: 152 ---------KTVL------QLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQV 193
Query: 607 --SDFGLAK 613
D+GLA
Sbjct: 194 YLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 57/227 (25%), Positives = 84/227 (37%), Gaps = 45/227 (19%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLV-RLWGFCA 508
IG G FG++Y G + + VA+K V + E I + + + F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLEN-VKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 509 EKGERTLVYEYVPNG-SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
E LV + + G SL D R S K VL +
Sbjct: 74 EGDYNVLVMDLL--GPSLEDLFNFCSRKLSL-----------------KTVL------ML 108
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPK---ISDFGLAKLRKKEDMVSMS 624
A + + ++H + LH DIKP+N L+G I DFGLAK K D +
Sbjct: 109 ADQMINRVEFVHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAK--KYRDTSTHQ 163
Query: 625 RI--------RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS 663
I GT Y + + + + D+ S G VL+ + GS
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 36/176 (20%), Positives = 65/176 (36%), Gaps = 30/176 (17%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCA 508
IG GGFG +Y A +K + ++E+ R+ + ++ W
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKW---- 99
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPA-REMEMSGVGP------HDGGKPVLDW 561
+ L Y +P + SG + R M M +G G +
Sbjct: 100 -IERKQLDYLGIPL------FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT----F 148
Query: 562 SIR--YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKI--SDFGLAK 613
++ + + + Y+HE +H DIK N+LLG ++ +D+GL+
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-07
Identities = 29/113 (25%), Positives = 41/113 (36%), Gaps = 19/113 (16%)
Query: 45 ILLSPNSTFAAGFLPKPNSRNLFTFS-----VWYHNLSEPTTVIWSANDKFPVAGNGSLA 99
L SPNS F L V Y + +W++N G+G
Sbjct: 3 SLSSPNSLFTGHSLE-VGPSYRLIMQGDCNFVLYDS----GKPVWASNT--GGLGSGCRL 55
Query: 100 IAATTGQLRLLNSSNSNLWPNPKTAT-GNPNSTRLFLQDAGNLV-YGN--WQS 148
G L + + SN +W +T T G + L LQ N+V YG W +
Sbjct: 56 TLHNNGNLVIYDQSNRVIW---QTKTNGKEDHYVLVLQQDRNVVIYGPVVWAT 105
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 6e-07
Identities = 88/626 (14%), Positives = 162/626 (25%), Gaps = 222/626 (35%)
Query: 189 RSYWNIDDDGNLRIYSYDDNGDR----WTVVWQAVQEICTIPDLCGENAICISDGLSRST 244
R +W + + + + R + + ++ P + I D L
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKF--LMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 245 SCVCPPGFKNSTRQDKSCQRKIELKNLRNTKFLQLDYVNFSRGNL----SDLEADNFSAC 300
N +R + + L LR K + +D G L + + D C
Sbjct: 124 QVFAK---YNVSRLQPYLKLRQALLELRPAKNVLID------GVLGSGKTWVALD---VC 171
Query: 301 KANCSANPKCVAFGFK--------YDGKRYCVLVDQLLYGYWSPGTE------MATFLRV 346
S +C FK + + + Q L P LR+
Sbjct: 172 L---SYKVQC-KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 347 DESEN-------------------DVSN------FTGMTNLLVTT--------------- 366
+ +V N F +L+TT
Sbjct: 228 HSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 367 --CPVNISLPLPPDES-STTARNIAI---------------IVTLFAAELISGA--WFFW 406
+ S+ L PDE S + + +++ A + G W W
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 407 AFLKKYIKYRDMARTLG--LELLPAGGPKRFTHAELRAATNGFSNLIGRGGFGDVYKGEL 464
K++ + + L +L P AE R ++ L
Sbjct: 348 ----KHVNCDKLTTIIESSLNVLE---P-----AEYR----------------KMFD-RL 378
Query: 465 TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGS 524
+V F I + L +W + +V + S
Sbjct: 379 ------SV------------FPPSAHIPTIL----LSLIWFDVIKSDVMVVVNKLH-KYS 415
Query: 525 LADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLE 584
L + ++ + S + Y LH ++
Sbjct: 416 LVE--------------KQPKESTISIPS----------IYLELKVKLENEYALHRSIVD 451
Query: 585 WVLHCDIKPENILLGDDFCPKISD------FG--LAKLRKKEDMVSMSRIRGTRGYMAPE 636
P+ DD P D G L + E M + ++
Sbjct: 452 ----HYNIPKT-FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV-----FLDFR 501
Query: 637 WLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN--SDEWYFPKWAFEK--VYEEM 692
+L K I S + GS++N ++ + + YE +
Sbjct: 502 FLEQ-----K------------IRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERL 544
Query: 693 KVEDILD---RHIKNSYDSRVHFDMV 715
V ILD + +N S+ + D++
Sbjct: 545 -VNAILDFLPKIEENLICSK-YTDLL 568
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 29/116 (25%), Positives = 44/116 (37%), Gaps = 30/116 (25%)
Query: 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRG---- 628
+ Y+H +LH D+KP N L+ D K+ DFGLA+ + +
Sbjct: 167 VGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 629 ----------------------TRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVS 661
TR Y APE L + T DV+S G + E+++
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-06
Identities = 28/122 (22%), Positives = 42/122 (34%), Gaps = 22/122 (18%)
Query: 36 SPWLPNQNRILLSPNSTFAAGFLPKPNSRNLFTFS-----VWYHNLSEPTTVIWSANDKF 90
N +IL + S + F V Y N IW+ N
Sbjct: 7 KQPDDNHPQILHATESLE----ILFGTHVYRFIMQTDCNLVLYDN----NNPIWATNT-- 56
Query: 91 PVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTAT-GNPNSTRLFLQDAGNLV-YGN--W 146
GNG A+ G L ++ + N +W ++ G L LQ N+V YG+ W
Sbjct: 57 GGLGNGCRAVLQPDGVLVVITNENVTVW---QSPVAGKAGHYVLVLQPDRNVVIYGDALW 113
Query: 147 QS 148
+
Sbjct: 114 AT 115
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-06
Identities = 28/113 (24%), Positives = 48/113 (42%), Gaps = 14/113 (12%)
Query: 44 RILLSPNSTFAAG-FLPKPNSRNLFTFS---VWYHNLSEPTTVIWSANDKFPVAGNGSLA 99
R LL+ AG L + V Y + +T +W++N + G A
Sbjct: 1 RNLLTNGEGLYAGQSLDVEPYHFIMQEDCNLVLYDH----STSVWASN-TGILGKKGCKA 55
Query: 100 IAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLV-YGN--WQSF 149
+ + G + ++ +LW + + GN N L LQ+ GN+V YG+ W +
Sbjct: 56 VLQSDGNFVVYDAEGRSLWAS-HSVRGNGNY-VLVLQEDGNVVIYGSDIWSTG 106
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 Length = 264 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 36/222 (16%), Positives = 55/222 (24%), Gaps = 37/222 (16%)
Query: 418 MARTLGLEL-LPAGGPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLK 476
M GL PA +R + T G S+ V++ V+ VK
Sbjct: 1 MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSD-------AAVFRLSAQGRPVLFVKTDL 53
Query: 477 NVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVG 536
+ + + A + + E G L+ VP L
Sbjct: 54 SGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKV 113
Query: 537 SSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH--------------EEC 582
S + + P D ++RI R A L E
Sbjct: 114 SIMADAMRRLHTLDPATCP---FDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170
Query: 583 LEW------------VLHCDIKPENILLGDDFCPKISDFGLA 612
V H D NI++ + D G
Sbjct: 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-05
Identities = 23/117 (19%), Positives = 38/117 (32%), Gaps = 17/117 (14%)
Query: 39 LPNQNRILLSPNSTFAAGFLPKPNSRNLFTFS---VWYHNLSEPTTVIWSANDKFPVAGN 95
+P N +L S + G L N + + V Y W +N G
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTAKNHQLVMQGDCNLVLYGG-----KYGWQSNT--HGNGE 54
Query: 96 GSLAIAATTGQLRLLNSSNSNLWPNPKTAT-GNPNSTRLFLQDAGNLV-YGN--WQS 148
G+L + + +W + + L LQD G V YG +++
Sbjct: 55 HCFLRLNHKGELIIKDDDFKTIW---SSRSSSKQGEYVLILQDDGFGVIYGPAIFET 108
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 1e-04
Identities = 26/112 (23%), Positives = 38/112 (33%), Gaps = 21/112 (18%)
Query: 47 LSPNSTFAAG-FLPKPNSRNLFTFS-----VWYHNLSEPTTVIWSANDKFPVAGNGSLAI 100
L T + G FL N R +F V Y IW+ N
Sbjct: 4 LYSGETLSPGEFLN--NGRYVFIMQEDCNLVLYDV----DKPIWATNT--GGLDRRCHLS 55
Query: 101 AATTGQLRLLNSSNSNLWPNPKTAT-GNPNSTRLFLQDAGNLV-YGN--WQS 148
+ G L + + N+ +W + T G + LQ N+V YG W +
Sbjct: 56 MQSDGNLVVYSPRNNPIW---ASNTGGENGNYVCVLQKDRNVVIYGTARWAT 104
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 1e-04
Identities = 21/120 (17%), Positives = 37/120 (30%), Gaps = 20/120 (16%)
Query: 39 LPNQNRILLSPNSTFAAGFLPKPNSR-------NLFTFSVWYHNLSEPTTVIWSANDKFP 91
+P +L S + L + NL V T ++W +
Sbjct: 2 IPRVRNVLFSSQVMYDNAQLATRDYSLVMRDDCNL----VLTKG--SKTNIVWESG--TS 53
Query: 92 VAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLV-YGN--WQS 148
G +G+L + + + ++ T + L LQ G V YG W +
Sbjct: 54 GRGQHCFMRLGHSGELDITDDRLNTVF-VSNTVGQEGDY-VLILQINGQAVVYGPAVWST 111
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.5 bits (101), Expect = 1e-04
Identities = 45/228 (19%), Positives = 67/228 (29%), Gaps = 56/228 (24%)
Query: 30 SFSSSDSPWLPN-----QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIW 84
F+ + LP + LLSPN F N V N +W
Sbjct: 8 PFNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-------LVIQDN----GATVW 56
Query: 85 SANDKFPVAG------NGSLAIAATTGQLRLLNSSNS---NLWPNPKTATGNPNSTRLFL 135
AN++ P + + L + S + T+ N T L L
Sbjct: 57 VANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVL 116
Query: 136 QDAGNLVYGNWQSF------------NLPTDTILPNQTLN-GPPLVSKNGKFSFLNASEL 182
QD GN+V + + + + + P L G + K F L
Sbjct: 117 QDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGNL 176
Query: 183 VFVSAN-RSYWN------------IDDDGNLRIYSYDDNGDRWTVVWQ 217
V N + WN DGNL +Y + V+W
Sbjct: 177 VAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNA-----VLWH 219
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.3 bits (98), Expect = 3e-04
Identities = 21/148 (14%), Positives = 41/148 (27%), Gaps = 10/148 (6%)
Query: 6 FFFFIFILSPSPSLQQQQKPQYMSSFSSSDSPWLPNQNRILLSPNSTFAAGFLPKPNSRN 65
+ +L ++ + + + +L + S+
Sbjct: 109 WNRTHLVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKL 168
Query: 66 LFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTAT 125
+F W+A + A+ G L + + N+ LW + T
Sbjct: 169 VFQGDGNLVAYGPNGAATWNAGTQ---GKGAVRAVFQGDGNLVVYGAGNAVLW---HSHT 222
Query: 126 GNPNSTRLFLQDAGNLV-YGN---WQSF 149
G S L LQ G++ W F
Sbjct: 223 GGHASAVLRLQANGSIAILDEKPVWARF 250
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 763 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.72 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.66 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.63 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.55 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.44 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.43 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.22 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.2 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.02 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 98.89 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 98.85 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 98.75 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 98.73 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.67 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.65 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.64 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.45 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.33 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.32 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.3 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.22 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.18 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.13 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.03 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.95 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 97.9 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.68 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.54 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.45 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 97.43 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.02 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.97 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.94 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.89 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.69 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.65 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.81 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.88 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 91.01 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.09 | |
| 3hms_A | 101 | Hepatocyte growth factor; HGF/SF, hormone/growth f | 84.73 | |
| 4a5v_A | 161 | MIC4, micronemal protein 4; adhesion; NMR {Toxopla | 80.41 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-54 Score=456.41 Aligned_cols=280 Identities=24% Similarity=0.337 Sum_probs=220.1
Q ss_pred ccHHHHHHHhccccccccccccceEEEEEeC------CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEE
Q 046586 435 FTHAELRAATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGF 506 (763)
Q Consensus 435 ~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~ 506 (763)
.++.|+..++.+|.++||+|+||.||+|++. +++.||||+++... ...++|.+|+.++++++|||||+++|+
T Consensus 18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 3444556677889999999999999999873 46789999997543 234679999999999999999999999
Q ss_pred EeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 507 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
|.+.+..+||||||++|+|.++|............. ........++|.++++|+.|||+||+|||+.+ |
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---i 166 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD--------DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---V 166 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-------------CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccc--------cccccccCCCHHHHHHHHHHHHHHHHHHHhCC---C
Confidence 999999999999999999999997643211110000 00112356999999999999999999999988 9
Q ss_pred EecCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCC
Q 046586 587 LHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSR 664 (763)
Q Consensus 587 vHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~ 664 (763)
|||||||+||||++++++||+|||+|+.....+. .......||+.|||||.+.++.|+.++|||||||+||||+| |+.
T Consensus 167 iHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~ 246 (308)
T 4gt4_A 167 VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 246 (308)
T ss_dssp CCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654333 23445679999999999999999999999999999999998 899
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
||..... ......+.. ....+.+.+++..+.+++.+||+.||++||||+||++.|+
T Consensus 247 Pf~~~~~----------~~~~~~i~~--------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 247 PYCGYSN----------QDVVEMIRN--------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp TTTTCCH----------HHHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCH----------HHHHHHHHc--------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9964321 001111111 1112233456778999999999999999999999999998
Q ss_pred cCCCC
Q 046586 745 GTVEI 749 (763)
Q Consensus 745 ~~~~~ 749 (763)
....+
T Consensus 303 a~~nl 307 (308)
T 4gt4_A 303 AWGNL 307 (308)
T ss_dssp TSCC-
T ss_pred hccCC
Confidence 75543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=454.20 Aligned_cols=272 Identities=25% Similarity=0.375 Sum_probs=208.2
Q ss_pred HhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
....+.++||+|+||.||+|++. +++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34566789999999999999874 467899999975432 34679999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
|||||++|+|.++|...+........ ........++|.++++|+.|||+||+|||+.+ ||||||||+|
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~---------~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~N 188 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAG---------GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRN 188 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC--------------------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEcCCCCcHHHHHHhcCcccccccc---------cccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhh
Confidence 99999999999999765321110000 00113457999999999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
|||++++++||+|||+|+.....+. .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.....
T Consensus 189 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-- 266 (329)
T 4aoj_A 189 CLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-- 266 (329)
T ss_dssp EEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--
T ss_pred EEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--
Confidence 9999999999999999987654433 23345679999999999999999999999999999999999 8999964321
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEIT 750 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~ 750 (763)
......+.++ .+.+.|..+++++.+++.+||+.||++||||+||+++|+.+.+.|
T Consensus 267 --------~~~~~~i~~g--------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 267 --------TEAIDCITQG--------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp --------HHHHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred --------HHHHHHHHcC--------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 0111111111 112223455678999999999999999999999999999877654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=447.60 Aligned_cols=270 Identities=24% Similarity=0.398 Sum_probs=213.7
Q ss_pred HHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
...+.+.++||+|+||.||+|++. +++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 345667899999999999999874 367899999975433 3467999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
||||||++|+|.++|...+... .. .........++|.++++|+.|||+||+|||+++ ||||||||+
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~------~~-----~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~ 157 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDA------VL-----MAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR 157 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHH------HH-----C----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEEEcCCCCcHHHHHHhcCccc------cc-----ccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHh
Confidence 9999999999999997642100 00 000113457999999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
||||++++++||+|||+|+.....+.. ......||+.|||||.+.++.|+.++|||||||++|||+| |+.||.....
T Consensus 158 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~- 236 (299)
T 4asz_A 158 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN- 236 (299)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred hEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 999999999999999999866544332 2334579999999999999999999999999999999999 8999964321
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEI 749 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~ 749 (763)
......+.++ ...+.|..+++++.+++.+||+.||++||||+||+++|+.+.+.
T Consensus 237 ---------~~~~~~i~~~--------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 237 ---------NEVIECITQG--------------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ---------HHHHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------HHHHHHHHcC--------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 0111111111 11122345567899999999999999999999999999886543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=441.22 Aligned_cols=261 Identities=27% Similarity=0.407 Sum_probs=203.5
Q ss_pred HHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
||......+.++||+|+||+||+|++.+ .||||+++.... ..++|.+|++++++++|||||+++|++.+ +..+|
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 3444556778999999999999998764 599999975432 23569999999999999999999999865 56899
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
|||||++|+|.++|... ...++|.++++|+.|||+||+|||+++ ||||||||+|
T Consensus 109 VmEy~~gGsL~~~l~~~-----------------------~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~N 162 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQ-----------------------ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNN 162 (307)
T ss_dssp EEECCSSCBHHHHHHTS-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSS
T ss_pred EEEcCCCCCHHHHHhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHH
Confidence 99999999999999642 346899999999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCC-cccccccccCCCccccccccc---CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKED-MVSMSRIRGTRGYMAPEWLRS---DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
|||++++++||+|||+|+...... ........||+.|||||++.+ ++|+.++|||||||+||||+||+.||.....
T Consensus 163 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 163 IFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp EEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 999999999999999998765432 233455789999999999863 4699999999999999999999999964321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. .........+. ..+. ....+.+++..+.+++.+||+.||++||||.||++.|+.+.
T Consensus 243 ~---------~~~~~~~~~~~-----~~p~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 243 R---------DQIIFMVGRGY-----ASPD-----LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp H---------HHHHHHHHTTC-----CCCC-----STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred H---------HHHHHHHhcCC-----CCCC-----cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 0 11111111111 0110 11122455678999999999999999999999999997643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=431.24 Aligned_cols=274 Identities=25% Similarity=0.295 Sum_probs=201.9
Q ss_pred hccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCC----eeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG----ERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~LV~Ey 519 (763)
++.+.++||+|+||+||+|++ +|+.||||+++........+.+|+..+.+++|||||+++|+|.+.+ ..+|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 456678999999999999998 4788999999754333333445666778899999999999998764 57999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCcEEecCCCCC
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEEC-----LEWVLHCDIKPE 594 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~-----~~~ivHrDlk~~ 594 (763)
|++|+|.++|... .++|..+++|+.|+|+||+|||++. .++||||||||+
T Consensus 83 ~~~gsL~~~l~~~-------------------------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~ 137 (303)
T 3hmm_A 83 HEHGSLFDYLNRY-------------------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp CTTCBHHHHHHHC-------------------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGG
T ss_pred CCCCcHHHHHHhC-------------------------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcc
Confidence 9999999999542 4889999999999999999999872 234999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc---cccccccCCCcccccccccC------CCCCccceeehhHHHHHHHhCCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV---SMSRIRGTRGYMAPEWLRSD------QITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~------~~s~ksDVwS~Gvll~elltG~~p 665 (763)
||||+.++++||+|||+|+........ ......||+.|||||++.+. .++.++|||||||+||||+||+.|
T Consensus 138 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~ 217 (303)
T 3hmm_A 138 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217 (303)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred cEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCC
Confidence 999999999999999999876543321 22346799999999998754 467899999999999999999988
Q ss_pred cccccCCCCC-CCCchhHHHHHHHHhccChhhhhcccccccCCCcc-hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 046586 666 FEIQGSMMNS-DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRV-HFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743 (763)
Q Consensus 666 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~L 743 (763)
+......... ............. ...+.++.+.+..+... ..+.+..+.+++.+||+.||++||||.||+++|
T Consensus 218 ~~~~~~~~~p~~~~~~~~~~~~~~-----~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 292 (303)
T 3hmm_A 218 GGIHEDYQLPYYDLVPSDPSVEEM-----RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHH-----HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred CCccccccccchhcccccchHHHH-----HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 7543221110 0000000000000 01111222222222111 135677899999999999999999999999999
Q ss_pred ccCCC
Q 046586 744 EGTVE 748 (763)
Q Consensus 744 e~~~~ 748 (763)
+.+.+
T Consensus 293 ~~l~~ 297 (303)
T 3hmm_A 293 SQLSQ 297 (303)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=440.08 Aligned_cols=278 Identities=27% Similarity=0.373 Sum_probs=217.8
Q ss_pred HHHHHHHhccccccccccccceEEEEEeCC------CcEEEEEEeeccCC--chhhhHHHHHHHhcCC-CCccccEEEEE
Q 046586 437 HAELRAATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMH-HLNLVRLWGFC 507 (763)
Q Consensus 437 ~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~-H~niv~l~g~~ 507 (763)
.+|+....+.+.++||+|+||.||+|++.+ ++.||||+++.... ..++|.+|+++|.+++ |||||+++|+|
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 356777788899999999999999998643 36799999975433 2356999999999995 59999999999
Q ss_pred eeC-CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 508 AEK-GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 508 ~~~-~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
.+. +..+||||||++|+|.++|...+........ .........++|.+++.|+.|||+||+|||+++ |
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~--------~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---i 206 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV--------APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 206 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC---------------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccccccc--------cchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---e
Confidence 765 5789999999999999999764321110000 001113457999999999999999999999988 9
Q ss_pred EecCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCC
Q 046586 587 LHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSR 664 (763)
Q Consensus 587 vHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~ 664 (763)
|||||||+|||+++++++||+|||+|+....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 9999999999999999999999999987654433 33445679999999999999999999999999999999998 999
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
||...... ......+.++ .+...|...+.++.+++.+||+.||++||||+||++.|+
T Consensus 287 Pf~~~~~~---------~~~~~~i~~g--------------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 287 PYPGVKID---------EEFCRRLKEG--------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp SSTTCCCS---------HHHHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHH---------HHHHHHHHcC--------------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 99643211 1111111111 122233445678899999999999999999999999998
Q ss_pred cCCC
Q 046586 745 GTVE 748 (763)
Q Consensus 745 ~~~~ 748 (763)
.+++
T Consensus 344 ~llq 347 (353)
T 4ase_A 344 NLLQ 347 (353)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=413.51 Aligned_cols=245 Identities=26% Similarity=0.373 Sum_probs=196.4
Q ss_pred cccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEee----CCeeeEEE
Q 046586 446 GFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAE----KGERTLVY 517 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV~ 517 (763)
.|.++||+|+||.||+|... +++.||+|++..... ..+.|.+|++++++++|||||++++++.+ .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56778999999999999875 578999999975432 23568999999999999999999999875 34689999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
|||++|+|.+++.+. ..+++..+..|+.||+.||+|||+++ ++||||||||+|||
T Consensus 109 Ey~~gg~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NIL 163 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF------------------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIF 163 (290)
T ss_dssp ECCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEE
T ss_pred eCCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhhee
Confidence 999999999999653 35889999999999999999999976 45999999999999
Q ss_pred Ec-CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 598 LG-DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 598 l~-~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
|+ .++.+||+|||+|+..... ......||+.|||||++.+ +|+.++|||||||++|||++|+.||......
T Consensus 164 l~~~~g~vKl~DFGla~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~---- 235 (290)
T 3fpq_A 164 ITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---- 235 (290)
T ss_dssp ESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----
T ss_pred EECCCCCEEEEeCcCCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----
Confidence 98 4899999999999864332 2345689999999998864 6999999999999999999999999633210
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
......+..+ ..+...+...++++.+++.+||+.||++|||+.|+++
T Consensus 236 -----~~~~~~i~~~-------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 236 -----AQIYRRVTSG-------------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----HHHHHHHTTT-------------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHHcC-------------CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011111111 1111112223456889999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=423.56 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=199.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.|.+.++||+|+||.||+|+.. +++.||||+++.... ..+.|.+|+++|++++|||||++++++.+++..||||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4777899999999999999875 689999999975432 235689999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.++|... ....+++.+++.|+.||+.||+|||+++ ||||||||+||||+
T Consensus 105 ~~gg~L~~~i~~~----------------------~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~ 159 (350)
T 4b9d_A 105 CEGGDLFKRINAQ----------------------KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLT 159 (350)
T ss_dssp CTTCBHHHHHHHT----------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEEC
T ss_pred CCCCcHHHHHHHc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEEC
Confidence 9999999999653 2345788899999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
.++.+||+|||+|+...... ...+...||+.|||||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 160 ~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------- 230 (350)
T 4b9d_A 160 KDGTVQLGDFGIARVLNSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------- 230 (350)
T ss_dssp TTCCEEECSTTEESCCCHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------
T ss_pred CCCCEEEcccccceeecCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------
Confidence 99999999999998664321 223456799999999999999999999999999999999999999974321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+++.+.+....+ ..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 231 ---------------~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 231 ---------------KNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---------------HHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------------HHHHHHHHcCCCC-CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111111 112344567899999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=419.78 Aligned_cols=250 Identities=21% Similarity=0.212 Sum_probs=201.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
.+.+.++||+|+||.||+|+.. +++.||||+++... .+.+|+.++++++|||||++++++.+++..+||||||++
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 3456678999999999999875 58899999997532 235799999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.++|... ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++
T Consensus 135 g~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g 187 (336)
T 4g3f_A 135 GSLGQLIKQM------------------------GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDG 187 (336)
T ss_dssp CBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTS
T ss_pred CcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCC
Confidence 9999999653 35889999999999999999999998 99999999999999988
Q ss_pred -CeEEcccCcccccCCCCcc----cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 603 -CPKISDFGLAKLRKKEDMV----SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 603 -~~kI~DFGla~~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++||+|||+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.......
T Consensus 188 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---- 263 (336)
T 4g3f_A 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---- 263 (336)
T ss_dssp CCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----
T ss_pred CEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----
Confidence 6999999999876543321 2234579999999999999999999999999999999999999997433211
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.+ ..+..+. .. ...++...+..+.+++.+||+.||++|||+.||++.|...
T Consensus 264 -~~-----~~i~~~~---------~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 264 -LC-----LKIASEP---------PP---IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp -CH-----HHHHHSC---------CG---GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HH-----HHHHcCC---------CC---chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 00 0111110 00 0112234567888999999999999999999999887654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=418.60 Aligned_cols=247 Identities=24% Similarity=0.325 Sum_probs=205.3
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc-CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV-TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.|.+.++||+|+||.||+|+.. +|+.||||+++.. ....+.+.+|+++|++++|||||++++++.+.+..|||||||+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 4677789999999999999875 6899999999744 3345668899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.+
T Consensus 155 gg~L~~~l~~-------------------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~ 206 (346)
T 4fih_A 155 GGALTDIVTH-------------------------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHD 206 (346)
T ss_dssp TEEHHHHHHH-------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred CCcHHHHHHc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCC
Confidence 9999999854 24789999999999999999999998 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
+++||+|||+|+....... ..+..+||+.|||||++.+..|+.++||||+||++|||++|+.||......
T Consensus 207 g~vKl~DFGla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------- 276 (346)
T 4fih_A 207 GRVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------- 276 (346)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------
T ss_pred CCEEEecCcCceecCCCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---------
Confidence 9999999999987654322 345578999999999999999999999999999999999999999643210
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.....+.+. ... ........+.++.+++.+||+.||++|||+.|+++
T Consensus 277 -~~~~~i~~~----------~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 277 -KAMKMIRDN----------LPP--RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -HHHHHHHHS----------SCC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHHHHcC----------CCC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011111111 000 11111344567889999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=411.15 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=205.4
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.++||+|+||.||+++.. +++.||||+++.. ....+.+.+|+++|++++|||||++++++.+.+..|||||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999875 6889999999742 3345678999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++.+. ..+++.++..++.||+.||+|||+++ ||||||||+|||+
T Consensus 113 y~~gG~L~~~i~~~------------------------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl 165 (311)
T 4aw0_A 113 YAKNGELLKYIRKI------------------------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILL 165 (311)
T ss_dssp CCTTEEHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cCCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEE
Confidence 99999999999653 35889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
+.++.+||+|||+|+....... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.....
T Consensus 166 ~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------ 239 (311)
T 4aw0_A 166 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------ 239 (311)
T ss_dssp CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 9999999999999997654332 334567899999999999999999999999999999999999999964321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eV 739 (763)
.+++.+.+.... .++...+.++.+++.+||+.||++|||+.|+
T Consensus 240 -----------------~~~~~~i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 240 -----------------GLIFAKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp -----------------HHHHHHHHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred -----------------HHHHHHHHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 111111111111 1123345678899999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=419.57 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=205.0
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.|.+.++||+|+||.||+|+.. +|+.||||+++... ...+.+.+|+.+|+.++|||||++++++.+.+..|||||||+
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 4677889999999999999875 58999999997543 344568899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|.+++... .+++.++..|+.||+.||+|||+++ ||||||||+||||+.+
T Consensus 232 gG~L~~~i~~~-------------------------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~ 283 (423)
T 4fie_A 232 GGALTDIVTHT-------------------------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHD 283 (423)
T ss_dssp TEEHHHHHHHS-------------------------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTT
T ss_pred CCcHHHHHhcc-------------------------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCC
Confidence 99999998532 4789999999999999999999998 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
+.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||......
T Consensus 284 g~vKl~DFGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------- 353 (423)
T 4fie_A 284 GRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------- 353 (423)
T ss_dssp CCEEECCCTTCEECCSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------
T ss_pred CCEEEecCccceECCCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---------
Confidence 999999999998765432 2345578999999999999999999999999999999999999999643210
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.....+.... ...+ ......+.++.+|+.+||+.||++|||+.|+++
T Consensus 354 -~~~~~i~~~~------~~~~------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 354 -KAMKMIRDNL------PPRL------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -HHHHHHHHSC------CCCC------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHHHHHHcCC------CCCC------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111111110 0000 111234567889999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=406.69 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=195.7
Q ss_pred HhccccccccccccceEEEEEeC----CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
..|.+.++||+|+||.||+|+.. .++.||||+++... .....+.+|+++|++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45888999999999999999763 46789999997432 233468899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++|+|.+++.+. ..+++.++..++.||+.||+|||+++ ||||||||+|
T Consensus 104 vmEy~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~N 156 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE------------------------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPEN 156 (304)
T ss_dssp EECCCTTCEEHHHHHHH------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGG
T ss_pred EEEcCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 99999999999999653 35889999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
||++.++.+||+|||+|+...... .......||+.|||||.+.+..|+.++||||+||++|||++|+.||.....
T Consensus 157 ILl~~~g~vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---- 231 (304)
T 3ubd_A 157 ILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---- 231 (304)
T ss_dssp EEECTTSCEEEESSEEEEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred eEEcCCCCEEecccccceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH----
Confidence 999999999999999998654332 223456899999999999999999999999999999999999999974321
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM-----GKVAK 741 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVv~ 741 (763)
.+++........ .++...+.++.+++.+||+.||++|||+ .|+++
T Consensus 232 -------------------~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 232 -------------------KETMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -------------------HHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -------------------HHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111111111111 1223345678899999999999999984 67764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=395.85 Aligned_cols=244 Identities=23% Similarity=0.380 Sum_probs=189.1
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..|.+.+.||+|+||.||+|+.. +++.||||+++... .....+.+|++++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 35788899999999999999875 68999999997432 23356889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+ +|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||
T Consensus 93 Ey~-~g~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NIL 144 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR------------------------DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLL 144 (275)
T ss_dssp ECC-CEEHHHHHHHS------------------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEE
T ss_pred eCC-CCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeE
Confidence 999 68999999643 35889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCC-CCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
+++++++||+|||+|+...... ......||+.|||||.+.+..+ +.++||||+||++|||++|+.||.....
T Consensus 145 l~~~~~vkl~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----- 217 (275)
T 3hyh_A 145 LDEHLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----- 217 (275)
T ss_dssp ECTTCCEEECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred ECCCCCEEEeecCCCeecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----
Confidence 9999999999999998654332 2345689999999999998876 5799999999999999999999964321
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ....+..+ .. .++...++++.+++.+||+.||++|||+.|+++
T Consensus 218 ----~~-~~~~i~~~-------------~~--~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 218 ----PV-LFKNISNG-------------VY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----HH-HHHHHHHT-------------CC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----HH-HHHHHHcC-------------CC--CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 01111111 11 111234567889999999999999999999986
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=394.96 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=189.2
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCC---------
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG--------- 511 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--------- 511 (763)
.|.+.+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 4778899999999999999875 688999999975433 2356889999999999999999999997654
Q ss_pred ---eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 046586 512 ---ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLH 588 (763)
Q Consensus 512 ---~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 588 (763)
..++||||+++|+|.+++.... ......+..++.|+.||+.||+|||+++ |||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~---------------------~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiH 141 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRC---------------------TIEERERSVCLHIFLQIAEAVEFLHSKG---LMH 141 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCC---------------------SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcC---------------------CCChhHHHHHHHHHHHHHHHHHHHHHCc---Ccc
Confidence 3689999999999999996542 1223567778999999999999999998 999
Q ss_pred cCCCCCceEEcCCCCeEEcccCcccccCCCCcc-----------cccccccCCCcccccccccCCCCCccceeehhHHHH
Q 046586 589 CDIKPENILLGDDFCPKISDFGLAKLRKKEDMV-----------SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLL 657 (763)
Q Consensus 589 rDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~-----------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ 657 (763)
|||||+|||++.++.+||+|||+|+........ ..+..+||+.|||||.+.+..|+.++|||||||++|
T Consensus 142 RDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvily 221 (299)
T 4g31_A 142 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILF 221 (299)
T ss_dssp CCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred ccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHH
Confidence 999999999999999999999999876543221 123457999999999999999999999999999999
Q ss_pred HHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 658 EIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 658 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
||++ ||..... .... ...+. ....+ +...+....+.+++.+||+.||++|||+.
T Consensus 222 ell~---Pf~~~~~------------~~~~------~~~~~----~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 275 (299)
T 4g31_A 222 ELLY---PFSTQME------------RVRT------LTDVR----NLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAI 275 (299)
T ss_dssp HHHS---CCSSHHH------------HHHH------HHHHH----TTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHcc---CCCCccH------------HHHH------HHHHh----cCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHH
Confidence 9996 6642110 0000 00111 11111 12234455677899999999999999999
Q ss_pred HHHH--Hhcc
Q 046586 738 KVAK--MLEG 745 (763)
Q Consensus 738 eVv~--~Le~ 745 (763)
|+++ .+++
T Consensus 276 eil~h~~~~~ 285 (299)
T 4g31_A 276 NIIENAVFED 285 (299)
T ss_dssp HHHTSGGGCC
T ss_pred HHhcCHhhCC
Confidence 9987 4543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=385.35 Aligned_cols=267 Identities=19% Similarity=0.228 Sum_probs=199.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEee------CCee
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAE------KGER 513 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 513 (763)
.|.+.++||+|+||.||+|+.. +|+.||||+++..... .+.+.+|+++|+.++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 4778899999999999999875 6899999999754332 3458899999999999999999999864 3578
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
|||||||+ |+|.+++.. ...+++.++..++.||+.||+|||+++ ||||||||
T Consensus 135 ~ivmE~~~-g~L~~~i~~------------------------~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP 186 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHS------------------------SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKP 186 (398)
T ss_dssp EEEEECCS-EEHHHHHTS------------------------SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCG
T ss_pred EEEEeCCC-CCHHHHHHh------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCc
Confidence 99999996 689999853 346899999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCC---cccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKED---MVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~---~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
+|||++.++.+||+|||+|+...... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...
T Consensus 187 ~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 187 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp GGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred cccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 99999999999999999998654322 1234557899999999998764 6799999999999999999999999754
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcc-----------cccccCCCc---chHHHHHHHHHHHHHccCCCCCCCCC
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDR-----------HIKNSYDSR---VHFDMVNRMVKTAMWCIQDRPELRPS 735 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs 735 (763)
.... ........ .+....+.... .+....... .......++.+|+.+||+.||++|||
T Consensus 267 ~~~~------~l~~I~~~--~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 338 (398)
T 4b99_A 267 NYVH------QLQLIMMV--LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS 338 (398)
T ss_dssp SHHH------HHHHHHHH--HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC
T ss_pred CHHH------HHHHHHHh--cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC
Confidence 3110 00000000 00000000000 000000000 00123467889999999999999999
Q ss_pred HHHHHH--HhccC
Q 046586 736 MGKVAK--MLEGT 746 (763)
Q Consensus 736 ~~eVv~--~Le~~ 746 (763)
+.|+++ .|.+.
T Consensus 339 a~e~L~Hp~f~~~ 351 (398)
T 4b99_A 339 AAAALRHPFLAKY 351 (398)
T ss_dssp HHHHTTSGGGTTT
T ss_pred HHHHhcCHhhCcC
Confidence 999986 45443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=374.58 Aligned_cols=292 Identities=42% Similarity=0.739 Sum_probs=233.1
Q ss_pred CCCccccHHHHHHHhccc--cccccccccceEEEEEeCCCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEE
Q 046586 430 GGPKRFTHAELRAATNGF--SNLIGRGGFGDVYKGELTDHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWG 505 (763)
Q Consensus 430 ~~~~~~~~~el~~~t~~~--~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g 505 (763)
+....++..++...+.++ .+.||+|+||.||+|+..+++.||||+++... .....+.+|+++++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 445678888888776555 57999999999999998889999999997543 23346899999999999999999999
Q ss_pred EEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 046586 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEW 585 (763)
Q Consensus 506 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ 585 (763)
++.+.+..++||||+++|+|.+++..... ....+++..+..|+.|++.||+|||+...+.
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ 154 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPE--------------------SQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCST--------------------TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999975421 3456899999999999999999999982223
Q ss_pred EEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCC
Q 046586 586 VLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 586 ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
|+||||||+|||++.++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus 155 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 234 (326)
T 3uim_A 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234 (326)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCS
T ss_pred eEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCc
Confidence 99999999999999999999999999987765544445556799999999999989999999999999999999999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
|+...... ........|...... ......+.+..+. ...+.+.+..+.+++.+||+.||++|||+.||+++|++
T Consensus 235 f~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 235 FDLARLAN-DDDVMLLDWVKGLLK-EKKLEALVDVDLQ----GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp BCHHHHTT-TSCSBHHHHHTTTTS-SCCSTTSSCTTCT----TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred cccccccc-ccchhHHHHHHHHhh-chhhhhhcChhhc----cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 96432111 112233333222211 1113333333333 33447888999999999999999999999999999987
Q ss_pred CC
Q 046586 746 TV 747 (763)
Q Consensus 746 ~~ 747 (763)
..
T Consensus 309 ~~ 310 (326)
T 3uim_A 309 DG 310 (326)
T ss_dssp SS
T ss_pred cc
Confidence 54
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=375.96 Aligned_cols=195 Identities=24% Similarity=0.330 Sum_probs=166.7
Q ss_pred HhccccccccccccceEEEEEeC----CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..|.+.++||+|+||.||+|+.. .++.||+|++.... ...++.+|+++|..+ +|||||++++++.+.++.+|||
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 35778899999999999999753 46789999986543 345678999999998 6999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++. .+++.++..++.||+.||+|||+++ ||||||||+|||
T Consensus 100 E~~~g~~L~~~~~---------------------------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiL 149 (361)
T 4f9c_A 100 PYLEHESFLDILN---------------------------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFL 149 (361)
T ss_dssp ECCCCCCHHHHHT---------------------------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred eCCCcccHHHHHc---------------------------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeE
Confidence 9999999999882 3678899999999999999999999 999999999999
Q ss_pred EcCC-CCeEEcccCcccccCCCCc---------------------------ccccccccCCCcccccccccC-CCCCccc
Q 046586 598 LGDD-FCPKISDFGLAKLRKKEDM---------------------------VSMSRIRGTRGYMAPEWLRSD-QITPKAD 648 (763)
Q Consensus 598 l~~~-~~~kI~DFGla~~~~~~~~---------------------------~~~~~~~gt~~y~APE~l~~~-~~s~ksD 648 (763)
++.+ +.+||+|||+|+....... ...+..+||+.|||||++.+. .|+.++|
T Consensus 150 l~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~D 229 (361)
T 4f9c_A 150 YNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAID 229 (361)
T ss_dssp EETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHH
T ss_pred EeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccc
Confidence 9877 7999999999975433211 112345799999999998765 5899999
Q ss_pred eeehhHHHHHHHhCCCCccc
Q 046586 649 VYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 649 VwS~Gvll~elltG~~p~~~ 668 (763)
|||+||++|||++|+.||..
T Consensus 230 iWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 230 MWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHHHHHHHTCSSSSC
T ss_pred hhhhHHHHHHHHHCCCCCCC
Confidence 99999999999999999953
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=368.10 Aligned_cols=277 Identities=35% Similarity=0.589 Sum_probs=223.9
Q ss_pred hccccccccccccceEEEEEeCCCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
.+.+.+.||+|+||.||+|+..+++.||||++.... ...+++.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 119 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTT
T ss_pred ccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCC
Confidence 345567999999999999998889999999987543 3456789999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++.... .....+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 120 ~~L~~~l~~~~--------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~ 176 (321)
T 2qkw_B 120 GNLKRHLYGSD--------------------LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENF 176 (321)
T ss_dssp CBTGGGSSSSC--------------------CCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTC
T ss_pred CcHHHHHhccC--------------------CCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCC
Confidence 99999986432 12346899999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 603 CPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....
T Consensus 177 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~---~~~~~ 253 (321)
T 2qkw_B 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE---MVNLA 253 (321)
T ss_dssp CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS---CCCHH
T ss_pred CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH---HHHHH
Confidence 999999999986543222 22334568999999999999999999999999999999999999997543321 22333
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCCC
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITE 751 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~~ 751 (763)
.|.......+ .....+++.+. ...+.+.+..+.+++.+||+.||++|||+.||++.|+.+.++.+
T Consensus 254 ~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 254 EWAVESHNNG-QLEQIVDPNLA----DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp HHTHHHHTTT-CCCSSSSSSCT----TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred HHhhhccccc-cHHHhcChhhc----cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 4433322222 13333443332 23347888999999999999999999999999999998765543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=395.11 Aligned_cols=249 Identities=19% Similarity=0.265 Sum_probs=204.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.|.+.+.||+|+||.||+++.. +|+.||+|+++.... ..+.+.+|+++|+.++|||||++++++.+.+..+||||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 5788899999999999999875 688999999975433 34568899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|.++|... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 238 gg~L~~~i~~~-----------------------~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~ 291 (573)
T 3uto_A 238 GGELFEKVADE-----------------------HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTK 291 (573)
T ss_dssp CCBHHHHHTCT-----------------------TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSS
T ss_pred CCcHHHHHHHh-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCC
Confidence 99999998532 246889999999999999999999998 9999999999999854
Q ss_pred --CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 602 --FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 602 --~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
+.+||+|||+|+...... ......||+.|||||++.+..|+.++||||+||++|||++|+.||......
T Consensus 292 ~~~~vKl~DFG~a~~~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------- 362 (573)
T 3uto_A 292 RSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------- 362 (573)
T ss_dssp SCCCEEECCCSSCEECCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------
T ss_pred CCCCEEEeeccceeEccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------
Confidence 899999999998765443 234568999999999999999999999999999999999999999743210
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.....+... . ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus 363 ---~~~~~i~~~---------~--~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 363 ---ETLRNVKSC---------D--WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ---HHHHHHHTT---------C--CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHHhC---------C--CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111111 0 01111112234567889999999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=367.38 Aligned_cols=266 Identities=29% Similarity=0.431 Sum_probs=202.2
Q ss_pred HHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
...+.+.++||+|+||.||+|+. .++.||||++...... .+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45677789999999999999987 5678999999754332 2468899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||||+||++
T Consensus 115 ~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll 172 (309)
T 3p86_A 115 YLSRGSLYRLLHKSG---------------------AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLV 172 (309)
T ss_dssp CCTTCBHHHHHHSTT---------------------HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEE
T ss_pred cCCCCcHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEE
Confidence 999999999996432 1224889999999999999999999976 459999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 173 ~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~------- 244 (309)
T 3p86_A 173 DKKYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP------- 244 (309)
T ss_dssp CTTCCEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-------
T ss_pred eCCCcEEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------
Confidence 999999999999997543322 223345789999999999999999999999999999999999999964321
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCCCCCC
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITEPKK 754 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~~p~~ 754 (763)
.... ... .. .......+......+.+++.+||+.||++|||+.+|++.|+.+.+...|+.
T Consensus 245 --~~~~-~~~---------~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 245 --AQVV-AAV---------GF----KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp --HHHH-HHH---------HH----SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred --HHHH-HHH---------Hh----cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 0000 000 00 001111223445678899999999999999999999999999876544443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=390.53 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=197.5
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHH---HHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWA---EVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~---E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
.+.+.++||+|+||.||+++.. +++.||+|+++.. ........+ ++.+++.++|||||++++++.+.+..||
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 4677899999999999999875 5889999999742 222233333 4667778899999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||++||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+|
T Consensus 270 VmEy~~GGdL~~~l~~~------------------------~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeN 322 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQH------------------------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPAN 322 (689)
T ss_dssp EECCCCSCBHHHHHHHH------------------------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGG
T ss_pred EEecCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHH
Confidence 99999999999999653 35889999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
|||+.+|++||+|||+|+...... ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||.......
T Consensus 323 ILld~~G~vKL~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~- 398 (689)
T 3v5w_A 323 ILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD- 398 (689)
T ss_dssp EEECTTSCEEECCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-
T ss_pred eEEeCCCCEEecccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-
Confidence 999999999999999998765432 345689999999999964 589999999999999999999999997432211
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~ 741 (763)
..++....+... ..++...+.++.+++..||+.||.+|++ +.||++
T Consensus 399 -------------------~~~i~~~i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 399 -------------------KHEIDRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -------------------HHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -------------------HHHHHHhhcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 001111111111 1122334567889999999999999998 677763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=390.25 Aligned_cols=263 Identities=25% Similarity=0.431 Sum_probs=219.3
Q ss_pred HHHHHHhccccccccccccceEEEEEeCC-CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 438 AELRAATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 438 ~el~~~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
.++....+.+.++||+|+||.||+|+... +..||||+++......++|.+|+.+|++++||||++++++|.+.+..++|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 44556678888999999999999999875 78999999987666778899999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++|+|.+++... ....+++..++.|+.||+.||+|||+.+ |+||||||+||
T Consensus 295 ~E~~~~g~L~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NI 349 (495)
T 1opk_A 295 TEFMTYGNLLDYLREC----------------------NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNC 349 (495)
T ss_dssp EECCTTCBHHHHHHHS----------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred EEccCCCCHHHHHHhc----------------------CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhE
Confidence 9999999999999753 2345889999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNS 675 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~ 675 (763)
|++.++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 350 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-- 427 (495)
T 1opk_A 350 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-- 427 (495)
T ss_dssp EECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred EECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999998765444333334456789999999999999999999999999999999 999986432110
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCC
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEI 749 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~ 749 (763)
..+.+... .....+..++..+.+++.+||+.||++|||+.+|+++|+.+.+.
T Consensus 428 ------------------~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 428 ------------------VYELLEKD----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ------------------HHHHHHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred ------------------HHHHHHcC----CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 11111111 11122234567889999999999999999999999999987643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=386.93 Aligned_cols=261 Identities=25% Similarity=0.424 Sum_probs=215.0
Q ss_pred HHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
++....+.+.++||+|+||.||+|...++..||||+++......++|.+|+.++++++||||+++++++. .+..++|||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 4455677888999999999999999988889999999876666788999999999999999999999986 667899999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 263 ~~~~g~L~~~l~~~----------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill 317 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD----------------------EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILV 317 (454)
T ss_dssp CCTTCBHHHHHHSH----------------------HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEE
T ss_pred ecCCCcHHHHHHhc----------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 99999999999643 1224788899999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~ 677 (763)
+.++.+||+|||+++..............+|..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 318 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------ 391 (454)
T 1qcf_A 318 SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------ 391 (454)
T ss_dssp CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999998765433222333456788999999999999999999999999999999 9999964321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCC
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEI 749 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~ 749 (763)
.. ....+..+ .....+...+..+.+++.+||+.||++|||+.+|+++|+.+...
T Consensus 392 ---~~-~~~~i~~~--------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 392 ---PE-VIRALERG--------------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ---HH-HHHHHHHT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ---HH-HHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 00 11111111 11112234567899999999999999999999999999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.61 Aligned_cols=255 Identities=26% Similarity=0.479 Sum_probs=213.3
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
..+.+.+.||+|+||.||++...+++.||+|+++......+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 46777899999999999999998888999999987766778899999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 90 ~~L~~~l~~~-----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~ 143 (269)
T 4hcu_A 90 GCLSDYLRTQ-----------------------RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQ 143 (269)
T ss_dssp CBHHHHHHTT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGG
T ss_pred CcHHHHHHhc-----------------------CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCC
Confidence 9999999642 245889999999999999999999998 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchh
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~ 681 (763)
.+||+|||+++..............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.....
T Consensus 144 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---------- 213 (269)
T 4hcu_A 144 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---------- 213 (269)
T ss_dssp CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------
T ss_pred CEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----------
Confidence 99999999998665443333444567788999999999999999999999999999999 9999864321
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.........+ . ....+...+..+.+++..||+.||++|||+.++++.|+++.
T Consensus 214 ~~~~~~~~~~----------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 214 SEVVEDISTG----------F----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp HHHHHHHHTT----------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhcC----------c----cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 0011111111 0 11111233567889999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.66 Aligned_cols=259 Identities=25% Similarity=0.418 Sum_probs=215.3
Q ss_pred HHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
....+.+.+.||+|+||.||+++..++..||+|+++......+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 34567788999999999999999998889999999877667788999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 86 ~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~ 139 (268)
T 3sxs_A 86 SNGCLLNYLRSH-----------------------GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDR 139 (268)
T ss_dssp TTCBHHHHHHHH-----------------------GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECT
T ss_pred CCCcHHHHHHHc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECC
Confidence 999999999653 235889999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 140 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------- 212 (268)
T 3sxs_A 140 DLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------- 212 (268)
T ss_dssp TCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------
T ss_pred CCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-------
Confidence 9999999999998765554444444556778999999999899999999999999999999 99998643210
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCC
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEI 749 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~ 749 (763)
. .......+. ....+...+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 213 --~-~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 213 --E-VVLKVSQGH--------------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --H-HHHHHHTTC--------------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --H-HHHHHHcCC--------------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0 011111110 0011122345788999999999999999999999999987653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=384.12 Aligned_cols=263 Identities=27% Similarity=0.418 Sum_probs=210.2
Q ss_pred HHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
++....+.+.++||+|+||.||+|...++..||||+++......++|.+|++++++++||||+++++++.+ +..++|||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 34456677889999999999999999888889999998766667789999999999999999999999876 67899999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 259 ~~~~gsL~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill 313 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE----------------------TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 313 (452)
T ss_dssp CCTTCBHHHHHSHH----------------------HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred hhcCCCHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEE
Confidence 99999999999642 1235789999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~ 677 (763)
+.++.+||+|||+++..............++..|+|||.+.++.++.++||||||+++|||++ |+.||.....
T Consensus 314 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------ 387 (452)
T 1fmk_A 314 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------ 387 (452)
T ss_dssp CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------
T ss_pred CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999998765433333334457889999999999999999999999999999999 9999864321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCCC
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITE 751 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~~ 751 (763)
......+..+ .....+...++.+.+++.+||+.||++|||+.+|+++|+.+.....
T Consensus 388 ----~~~~~~i~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 388 ----REVLDQVERG--------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp ----HHHHHHHHTT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ----HHHHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 0011111111 1112224456788999999999999999999999999999875433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.74 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=209.0
Q ss_pred HHHhccccccccccccceEEEEEeC----CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
....+.+.++||+|+||.||+|+.. .+..||||+++.... ..++|.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3456777899999999999999885 345699999985432 3456899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~ 180 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH-----------------------DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAAR 180 (325)
T ss_dssp EEEECCTTCBHHHHHHTT-----------------------TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EEeeCCCCCcHHHHHHhc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcc
Confidence 999999999999999542 235889999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGS 671 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~ 671 (763)
|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 181 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 181 NVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp GEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred eEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999876543221 2223456778999999999999999999999999999999 9999864321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITE 751 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~~ 751 (763)
. .......++ .....+...+..+.+++..||+.||++|||+.+|+++|+.+.+.++
T Consensus 261 ~----------~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 261 R----------DVISSVEEG--------------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp H----------HHHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred H----------HHHHHHHcC--------------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0 001111111 1111223455788999999999999999999999999998775544
Q ss_pred C
Q 046586 752 P 752 (763)
Q Consensus 752 p 752 (763)
.
T Consensus 317 ~ 317 (325)
T 3kul_A 317 S 317 (325)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=359.13 Aligned_cols=257 Identities=26% Similarity=0.374 Sum_probs=207.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..+.+.++||+|+||.||++... +++.||+|++.... ...+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 45677889999999999999875 58899999886433 34467899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++|+|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 90 ~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~ 143 (310)
T 3s95_A 90 KGGTLRGIIKSM-----------------------DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRE 143 (310)
T ss_dssp TTCBHHHHHHHC-----------------------CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECT
T ss_pred CCCcHHHHHHhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECC
Confidence 999999999653 245899999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCccc-------------ccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVS-------------MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~-------------~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~ 667 (763)
++.+||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~ 223 (310)
T 3s95_A 144 NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223 (310)
T ss_dssp TSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSST
T ss_pred CCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCc
Confidence 9999999999998654332211 114579999999999999999999999999999999999999886
Q ss_pred cccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
............ .....+.... ...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 224 ~~~~~~~~~~~~--------------~~~~~~~~~~--------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 224 DYLPRTMDFGLN--------------VRGFLDRYCP--------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp TTSCBCTTSSBC--------------HHHHHHHTCC--------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhhhHHHHhhh--------------hhccccccCC--------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 433221111111 1111111111 223456889999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=350.99 Aligned_cols=281 Identities=41% Similarity=0.651 Sum_probs=225.2
Q ss_pred CCccccHHHHHHHhcccc--------ccccccccceEEEEEeCCCcEEEEEEeeccC-----CchhhhHHHHHHHhcCCC
Q 046586 431 GPKRFTHAELRAATNGFS--------NLIGRGGFGDVYKGELTDHRVVAVKCLKNVT-----GGDAEFWAEVTIIARMHH 497 (763)
Q Consensus 431 ~~~~~~~~el~~~t~~~~--------~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~-----~~~~~f~~E~~~l~~l~H 497 (763)
..+.|++.++..++.+|. ++||+|+||.||+|.. +++.||||++.... ...+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 356799999999999886 4599999999999987 56789999986432 224568899999999999
Q ss_pred CccccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 046586 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAY 577 (763)
Q Consensus 498 ~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~y 577 (763)
|||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||+|
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~ 148 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD---------------------GTPPLSWHMRCKIAQGAANGINF 148 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG---------------------GCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc---------------------CCCCCCHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999996432 23468999999999999999999
Q ss_pred HHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHH
Q 046586 578 LHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVL 656 (763)
Q Consensus 578 LH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll 656 (763)
||+.+ |+||||||+||+++.++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++
T Consensus 149 lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il 224 (307)
T 2nru_A 149 LHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVL 224 (307)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHH
T ss_pred HhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHH
Confidence 99998 99999999999999999999999999986544322 22334578999999998764 588999999999999
Q ss_pred HHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 657 LEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 657 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
|||++|+.||....... ....+............+.+++.+. ..+...+..+.+++.+||+.||.+|||+
T Consensus 225 ~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~ 294 (307)
T 2nru_A 225 LEIITGLPAVDEHREPQ-----LLLDIKEEIEDEEKTIEDYIDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDI 294 (307)
T ss_dssp HHHHHCCCSBCTTBSSS-----BTTHHHHHHHTTSCCHHHHSCSSCS-----CCCHHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHCCCCcccCcchH-----HHHHHHHHhhhhhhhhhhhcccccc-----ccchHHHHHHHHHHHHHcCCCcccCcCH
Confidence 99999999997543211 1122221111112223334443321 2336778899999999999999999999
Q ss_pred HHHHHHhccCC
Q 046586 737 GKVAKMLEGTV 747 (763)
Q Consensus 737 ~eVv~~Le~~~ 747 (763)
.+|+++|+++.
T Consensus 295 ~~l~~~L~~l~ 305 (307)
T 2nru_A 295 KKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHHHh
Confidence 99999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=366.24 Aligned_cols=272 Identities=24% Similarity=0.355 Sum_probs=211.7
Q ss_pred HHhccccccccccccceEEEEEeC--------CCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEeeC
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT--------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCAEK 510 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~--------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 510 (763)
...+.+.+.||+|+||.||+|+.. ++..||||+++.... ..+++.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 356778899999999999999762 345799999975433 235689999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
+..++||||+++|+|.+++...+.......... .......+++.+++.++.||+.||+|||+.+ |+|||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 228 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDI--------NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRD 228 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccc--------cccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 999999999999999999976542111000000 0012346899999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCccc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEI 668 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~ 668 (763)
|||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp CCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999986554332 22334567889999999999999999999999999999999 9999864
Q ss_pred ccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 669 QGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
..... ....+..+ .....+......+.+++.+||+.||++||++.||++.|+.+++
T Consensus 309 ~~~~~----------~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 309 IPVEE----------LFKLLKEG--------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp CCGGG----------HHHHHHTT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH----------HHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 32100 00111111 1111223456688999999999999999999999999988654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.00 Aligned_cols=258 Identities=23% Similarity=0.389 Sum_probs=211.7
Q ss_pred HHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+....+.+.++||+|+||.||+++..++..||+|+++......+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 44567788899999999999999999888999999987766778899999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+||+++
T Consensus 101 ~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~ 154 (283)
T 3gen_A 101 MANGCLLNYLREM-----------------------RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVN 154 (283)
T ss_dssp CTTCBHHHHHHCG-----------------------GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEEC
T ss_pred cCCCcHHHHHHHh-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEc
Confidence 9999999999642 235889999999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~ 678 (763)
.++.+||+|||+++..............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.....
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------- 227 (283)
T 3gen_A 155 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------- 227 (283)
T ss_dssp TTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------
T ss_pred CCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-------
Confidence 99999999999998665443333334456788999999999999999999999999999998 9999864321
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
......+.++ .... .+....+.+.+++.+||+.||++|||+.++++.|+++.
T Consensus 228 ---~~~~~~~~~~----------~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 228 ---SETAEHIAQG----------LRLY----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp ---HHHHHHHHTT----------CCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---hHHHHHHhcc----------cCCC----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 0011111111 1111 11223467889999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=363.28 Aligned_cols=269 Identities=27% Similarity=0.349 Sum_probs=207.1
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCC----eeeEEEe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG----ERTLVYE 518 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~LV~E 518 (763)
..+.+.++||+|+||.||+|+.. ++.||||+++........+.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 45777889999999999999886 688999999765555566778999999999999999999998754 4699999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCcEEe
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE----------CLEWVLH 588 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~----------~~~~ivH 588 (763)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+. + |+|
T Consensus 103 ~~~~g~L~~~l~~-------------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH 154 (322)
T 3soc_A 103 FHEKGSLSDFLKA-------------------------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISH 154 (322)
T ss_dssp CCTTCBHHHHHHH-------------------------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EEC
T ss_pred cCCCCCHHHHHHh-------------------------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEe
Confidence 9999999999954 2488999999999999999999998 6 999
Q ss_pred cCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCccccccccc-----CCCCCccceeehhHHHHHHHhC
Q 046586 589 CDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRS-----DQITPKADVYSFGMVLLEIVSG 662 (763)
Q Consensus 589 rDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvll~elltG 662 (763)
|||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|
T Consensus 155 ~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg 234 (322)
T 3soc_A 155 RDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence 99999999999999999999999976544332 22334578999999999876 3556689999999999999999
Q ss_pred CCCcccccCCCCCCCCchhHHHHHHHHhccChhhhh----cccccccCCCc-chHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 663 SRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDIL----DRHIKNSYDSR-VHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 663 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
+.||........ ..+... ........++. ........... .....+..+.+++.+||+.||++|||+.
T Consensus 235 ~~pf~~~~~~~~---~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 307 (322)
T 3soc_A 235 CTAADGPVDEYM---LPFEEE----IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307 (322)
T ss_dssp BTTSSSCCCCCC---CTTHHH----HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCcchhc---cchhhh----hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHH
Confidence 999975432111 011000 00000011111 11111111111 1135667799999999999999999999
Q ss_pred HHHHHhccCC
Q 046586 738 KVAKMLEGTV 747 (763)
Q Consensus 738 eVv~~Le~~~ 747 (763)
||++.|+.+.
T Consensus 308 ell~~L~~l~ 317 (322)
T 3soc_A 308 CVGERITQMQ 317 (322)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=352.38 Aligned_cols=248 Identities=23% Similarity=0.315 Sum_probs=203.9
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeecc-CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNV-TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..|.+.++||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 4567788999999999999986 46889999999744 334566889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++|+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~L~~~~~~~-------------------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~ 151 (297)
T 3fxz_A 100 AGGSLTDVVTET-------------------------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGM 151 (297)
T ss_dssp TTCBHHHHHHHS-------------------------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CCCCHHHHHhhc-------------------------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECC
Confidence 999999999542 4788999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 152 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------- 222 (297)
T 3fxz_A 152 DGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------- 222 (297)
T ss_dssp TCCEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------
T ss_pred CCCEEEeeCCCceecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------
Confidence 99999999999986554332 234467999999999999999999999999999999999999999643210
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ........ ......+...+..+.+++.+||+.||++|||+.|+++
T Consensus 223 -~~-~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 223 -RA-LYLIATNG------------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -HH-HHHHHHHC------------SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HH-HHHHHhCC------------CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 00010000 0011112345567889999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=352.65 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=209.6
Q ss_pred ccccHHHHHHHhc------------cccccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCC
Q 046586 433 KRFTHAELRAATN------------GFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHL 498 (763)
Q Consensus 433 ~~~~~~el~~~t~------------~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~ 498 (763)
..+++.+++.++. .+.++||+|+||.||+|+.. +++.||||+++... ...+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 4578888877764 34468999999999999886 68999999997543 3456688999999999999
Q ss_pred ccccEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 046586 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYL 578 (763)
Q Consensus 499 niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yL 578 (763)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||+||
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------------------------~~l~~~~~~~i~~qi~~~L~~L 157 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-------------------------VRLNEEQIATVCEAVLQALAYL 157 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-------------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999832 3588999999999999999999
Q ss_pred HhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHH
Q 046586 579 HEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLE 658 (763)
Q Consensus 579 H~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~e 658 (763)
|+.+ |+||||||+||+++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++||
T Consensus 158 H~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~e 233 (321)
T 2c30_A 158 HAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233 (321)
T ss_dssp HHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHH
Confidence 9988 99999999999999999999999999986554322 2344679999999999999999999999999999999
Q ss_pred HHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 046586 659 IVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGK 738 (763)
Q Consensus 659 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 738 (763)
|++|+.||..... ......+.... .+.+ ......+..+.+++.+||+.||++|||+.|
T Consensus 234 l~~g~~pf~~~~~----------~~~~~~~~~~~------~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 234 MVDGEPPYFSDSP----------VQAMKRLRDSP------PPKL------KNSHKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp HHHSSCTTTTSCH----------HHHHHHHHHSS------CCCC------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHhCCCCCCCCCH----------HHHHHHHhcCC------CCCc------CccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999964321 01111111110 0000 011233467889999999999999999999
Q ss_pred HHHH
Q 046586 739 VAKM 742 (763)
Q Consensus 739 Vv~~ 742 (763)
+++.
T Consensus 292 ll~h 295 (321)
T 2c30_A 292 LLDH 295 (321)
T ss_dssp HHTS
T ss_pred HhcC
Confidence 9873
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=353.75 Aligned_cols=264 Identities=25% Similarity=0.433 Sum_probs=219.8
Q ss_pred ccHHHHHHHhccccccccccccceEEEEEeCC-CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 435 FTHAELRAATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 435 ~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
+...++....+.+.++||+|+||.||+|.... ++.||+|+++......+++.+|++++++++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 44445566778888999999999999998864 78899999987666678899999999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||
T Consensus 85 ~~v~e~~~~~~L~~~~~~~----------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp 139 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC----------------------NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAA 139 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC----------------------CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSG
T ss_pred EEEEEcCCCCcHHHHHHhc----------------------ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCc
Confidence 9999999999999999653 2346889999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
+||+++.++.+||+|||++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 140 ~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~ 219 (288)
T 3kfa_A 140 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 219 (288)
T ss_dssp GGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999998766554444445567889999999999999999999999999999999 99998643211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. ..+.+...... ..+...++.+.+++..||+.||++|||+.+|++.|+...
T Consensus 220 ~--------------------~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 220 Q--------------------VYELLEKDYRM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp G--------------------HHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--------------------HHHHHhccCCC----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 0 11111111111 112334567899999999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=369.82 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=208.7
Q ss_pred HHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
+....+.+.++||+|+||.||+|+.. +++.||||+++.... ...+|.+|++++++++||||+++++++.+.+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34456778899999999999999986 688999999975432 235689999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 191 ~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Ni 244 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE-----------------------GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNC 244 (377)
T ss_dssp EECCTTCBHHHHHHHH-----------------------GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred EEcCCCCCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHE
Confidence 9999999999999643 235789999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccc-cccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSM-SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 674 (763)
|++.++.+||+|||+++.......... ....++..|+|||.+.++.++.++||||||+++|||++ |+.||.....
T Consensus 245 l~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--- 321 (377)
T 3cbl_A 245 LVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--- 321 (377)
T ss_dssp EECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---
T ss_pred EEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999986443222111 12245778999999999999999999999999999998 9999864321
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
..... .+... .....+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 322 -------~~~~~----------~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 322 -------QQTRE----------FVEKG----GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp -------HHHHH----------HHHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHHH----------HHHcC----CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 00111 11111 111122334567889999999999999999999999998653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=386.95 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=215.4
Q ss_pred HHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
++....+.+.++||+|+||.||+|...++..||||+++......++|.+|+++|++++||||+++++++.+ +..+||||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 34556677889999999999999999988889999998766667789999999999999999999999976 67899999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.++|... ....+++.+++.|+.||+.||+|||+.+ |+||||||+|||+
T Consensus 342 ~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll 396 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE----------------------TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILV 396 (535)
T ss_dssp CCTTEEHHHHHSHH----------------------HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred hhcCCcHHHHHhhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEE
Confidence 99999999999642 1235789999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~ 677 (763)
++++.+||+|||+++..............++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 397 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------ 470 (535)
T 2h8h_A 397 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------ 470 (535)
T ss_dssp CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------
T ss_pred cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999998765432222333456788999999999999999999999999999999 8999864321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCC
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEIT 750 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~ 750 (763)
......+..+ .....+..++..+.+++.+||+.||++|||+.+|+++|+.+....
T Consensus 471 ----~~~~~~i~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 471 ----REVLDQVERG--------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ----HHHHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ----HHHHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 0011111111 111122345678899999999999999999999999999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=348.86 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=207.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc----hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG----DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~----~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..|.+.++||+|+||.||+++.. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 45778899999999999999875 6789999998643322 246889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+
T Consensus 91 e~~~g~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil 143 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH------------------------GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNIL 143 (294)
T ss_dssp ECCCSCBHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred eCCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence 999999999999643 25889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 144 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------ 217 (294)
T 4eqm_A 144 IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------ 217 (294)
T ss_dssp ECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------
T ss_pred ECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------
Confidence 99999999999999987655444444456799999999999999999999999999999999999999964321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhccCCCCCCCCC
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-SMGKVAKMLEGTVEITEPKK 754 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVv~~Le~~~~~~~p~~ 754 (763)
........ ... ... ...... ...+..+.+++.+|++.||++|| ++.++.+.|+..........
T Consensus 218 ---~~~~~~~~-~~~-~~~-----~~~~~~----~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 218 ---VSIAIKHI-QDS-VPN-----VTTDVR----KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp ---HHHHHHHH-SSC-CCC-----HHHHSC----TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred ---HHHHHHHh-hcc-CCC-----cchhcc----cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 11111111 000 000 000111 23456788999999999999998 99999999998775544433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=345.39 Aligned_cols=255 Identities=26% Similarity=0.477 Sum_probs=211.8
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
..+.+.+.||+|+||.||++...+++.||+|+++......+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 45777899999999999999998888999999987666677899999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++
T Consensus 88 ~~L~~~~~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~ 141 (267)
T 3t9t_A 88 GCLSDYLRTQ-----------------------RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQ 141 (267)
T ss_dssp CBHHHHHHHT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGG
T ss_pred CcHHHHHhhC-----------------------cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCC
Confidence 9999999653 235789999999999999999999998 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchh
Q 046586 603 CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~ 681 (763)
.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 142 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~ 212 (267)
T 3t9t_A 142 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---------S 212 (267)
T ss_dssp CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---------H
T ss_pred CEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---------H
Confidence 99999999998654433223334457788999999998999999999999999999999 8999864321 0
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. ....+..+ . ....+...+..+.+++.+||+.||++||++.++++.|+++.
T Consensus 213 ~-~~~~i~~~----------~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 213 E-VVEDISTG----------F----RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp H-HHHHHHTT----------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-HHHHHhcC----------C----cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 11111111 0 01111233567889999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=370.45 Aligned_cols=251 Identities=31% Similarity=0.458 Sum_probs=205.4
Q ss_pred HHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCC-eeeEEEecC
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG-ERTLVYEYV 520 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~LV~Ey~ 520 (763)
...+.+.++||+|+||.||+|... ++.||||+++... ..++|.+|+.++++++||||+++++++.+.. ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 345667789999999999999986 5789999998543 5677999999999999999999999988765 789999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 270 ~~g~L~~~l~~~----------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~ 324 (450)
T 1k9a_A 270 AKGSLVDYLRSR----------------------GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSE 324 (450)
T ss_dssp TTCBHHHHHHHH----------------------CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred CCCcHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECC
Confidence 999999999754 2334788999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||+++..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 325 ~~~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------ 394 (450)
T 1k9a_A 325 DNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------ 394 (450)
T ss_dssp TSCEEECCCTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT------
T ss_pred CCCEEEeeCCCccccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------
Confidence 999999999999854322 122357889999999999999999999999999999998 999996432110
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
....+..+ .....+..++..+.+++..||+.||++|||+.+|++.|+.+.
T Consensus 395 ----~~~~i~~~--------------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 395 ----VVPRVEKG--------------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp ----HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHcC--------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00111111 111222445678899999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=367.46 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=196.4
Q ss_pred HHhccccccccccccceEEEEEeC----CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
...+.+.+.||+|+||.||+|+.. ++..||||+++.... ..++|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 456777889999999999999875 467899999975432 33569999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++|+|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|
T Consensus 124 v~e~~~~~sL~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 177 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH-----------------------DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARN 177 (373)
T ss_dssp EEECCTTCBHHHHHHTT-----------------------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEeCCCCCcHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcce
Confidence 99999999999999642 245889999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCccc--ccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVS--MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 178 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~- 256 (373)
T 2qol_A 178 ILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN- 256 (373)
T ss_dssp EEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-
T ss_pred EEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999998765433221 122345778999999999999999999999999999998 9999863321
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.. ....+....... .+...+..+.+++.+||+.||++||++.+|+++|+.+.
T Consensus 257 --------~~-----------~~~~i~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 257 --------QD-----------VIKAVDEGYRLP----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp --------HH-----------HHHHHHTTEECC----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------HH-----------HHHHHHcCCCCC----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 00 011111111111 11344577899999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=352.97 Aligned_cols=245 Identities=26% Similarity=0.418 Sum_probs=202.4
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.|.+.+.||+|+||.||+|+. .+++.||||+++.... ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 467788999999999999987 5789999999975432 234588999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 96 ~~~~~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~ 148 (328)
T 3fe3_A 96 ASGGEVFDYLVAH------------------------GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLD 148 (328)
T ss_dssp CTTCBHHHHHHHH------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred CCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEc
Confidence 9999999999653 24788999999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCC-CccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
.++.+||+|||+++...... ......||+.|+|||.+.+..+. .++||||+||++|||++|+.||.....
T Consensus 149 ~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------- 219 (328)
T 3fe3_A 149 ADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------- 219 (328)
T ss_dssp TTSCEEECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------
T ss_pred CCCCEEEeeccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------
Confidence 99999999999998654432 23456799999999999888775 799999999999999999999974321
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. +......... ..+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 220 --~~--------------~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 220 --KE--------------LRERVLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --HH--------------HHHHHHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --HH--------------HHHHHHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 1111111111 1112345678899999999999999999999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=344.79 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=195.2
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccC-----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVT-----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.++||+|+||.||+|... ++.||||+++... ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 35677889999999999999986 7889999987432 22366889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++. ...+++..+..++.|++.||+|||+.+..+|+||||||+||+
T Consensus 86 e~~~~~~L~~~~~-------------------------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil 140 (271)
T 3dtc_A 86 EFARGGPLNRVLS-------------------------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNIL 140 (271)
T ss_dssp ECCTTEEHHHHHT-------------------------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEE
T ss_pred EcCCCCCHHHHhh-------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEE
Confidence 9999999999983 235889999999999999999999988556899999999999
Q ss_pred EcC--------CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 598 LGD--------DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 598 l~~--------~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
++. ++.+||+|||+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 141 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (271)
T 3dtc_A 141 ILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217 (271)
T ss_dssp ESSCCSSSCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred EecccccccccCcceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 986 7789999999997654322 22356899999999999999999999999999999999999999643
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
... .. ........ .....+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 218 ~~~---------~~----------~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 218 DGL---------AV----------AYGVAMNK----LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CHH---------HH----------HHHHHTSC----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CHH---------HH----------HHhhhcCC----CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 210 00 00011111 11112234456789999999999999999999999999853
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=357.69 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=199.9
Q ss_pred HHhccccccccccccceEEEEEeC-CCc----EEEEEEeecc--CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHR----VVAVKCLKNV--TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~----~VAvK~l~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
...+.+.++||+|+||.||+|+.. +++ .||+|.++.. ....++|.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 456777899999999999999864 333 4688887643 234567999999999999999999999998764 78
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+|+||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~ 146 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH-----------------------KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146 (327)
T ss_dssp EEEECCTTCBHHHHHHHS-----------------------TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred EEEEecCCCcHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChh
Confidence 999999999999999753 246889999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
|||++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 147 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 226 (327)
T 3poz_A 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp GEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred eEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence 99999999999999999986644332 22233456889999999999999999999999999999999 99999643211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. ....+...... ..+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 227 ~--------------------~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 227 E--------------------ISSILEKGERL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp G--------------------HHHHHHTTCCC----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred H--------------------HHHHHHcCCCC----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 11111111111 112334567889999999999999999999999997653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.03 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=211.3
Q ss_pred HHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
...++.+.+.||+|+||.||+|...+++.||+|+++......+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 34567888999999999999999988889999999876666788999999999999999999999986 45689999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++
T Consensus 90 ~~~~L~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~ 144 (279)
T 1qpc_A 90 ENGSLVDFLKTP----------------------SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSD 144 (279)
T ss_dssp TTCBHHHHTTSH----------------------HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred CCCCHHHHHhcC----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcC
Confidence 999999998532 1125889999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 145 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------- 216 (279)
T 1qpc_A 145 TLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------- 216 (279)
T ss_dssp TSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------
T ss_pred CCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------
Confidence 9999999999998765544333344567889999999998899999999999999999999 8999864321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.. ....+..+ .. ...+...+..+.+++..|++.||++|||+.++++.|+...
T Consensus 217 -~~-~~~~~~~~----------~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 217 -PE-VIQNLERG----------YR----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp -HH-HHHHHHTT----------CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HH-HHHHHhcc----------cC----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 00 01111111 01 1111234567899999999999999999999999998865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=364.54 Aligned_cols=285 Identities=27% Similarity=0.376 Sum_probs=212.0
Q ss_pred HHHHHHHhccccccccccccceEEEEEe------CCCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEE
Q 046586 437 HAELRAATNGFSNLIGRGGFGDVYKGEL------TDHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFC 507 (763)
Q Consensus 437 ~~el~~~t~~~~~~LG~G~fG~Vy~g~~------~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~ 507 (763)
..++....+.+.++||+|+||.||+|+. .+++.||||+++.... ..+.+.+|++++.++ +||||+++++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 3445566788889999999999999974 2457899999975433 235689999999999 899999999999
Q ss_pred eeCC-eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcc----------------------------------------
Q 046586 508 AEKG-ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEM---------------------------------------- 546 (763)
Q Consensus 508 ~~~~-~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~---------------------------------------- 546 (763)
.+.+ ..++||||+++|+|.+++................+
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8865 48999999999999999986542110000000000
Q ss_pred --cCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccc
Q 046586 547 --SGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSM 623 (763)
Q Consensus 547 --~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~ 623 (763)
............+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 000000011334899999999999999999999998 99999999999999999999999999986543322 233
Q ss_pred cccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccc
Q 046586 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHI 702 (763)
Q Consensus 624 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 702 (763)
....||+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .........+
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---------~~~~~~~~~~----------- 312 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---------EEFCRRLKEG----------- 312 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---------HHHHHHHHHT-----------
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh---------HHHHHHHHcC-----------
Confidence 44678999999999999999999999999999999998 99999643211 1111111111
Q ss_pred cccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 703 KNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 703 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.....+......+.+++..||+.||++|||+.||+++|+.++
T Consensus 313 ---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 313 ---TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111111234567889999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=349.37 Aligned_cols=249 Identities=21% Similarity=0.340 Sum_probs=197.6
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCC--------
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG-------- 511 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-------- 511 (763)
..|.+.++||+|+||.||+|+.. +++.||||+++... ...+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45777899999999999999886 78899999997433 34467899999999999999999999987654
Q ss_pred -------------------------------------------------eeeEEEecCCCCCHhHHhhhcCCCCCCChhh
Q 046586 512 -------------------------------------------------ERTLVYEYVPNGSLADYLFRSGRVGSSSPAR 542 (763)
Q Consensus 512 -------------------------------------------------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~ 542 (763)
..++||||+++++|.+++....
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------- 156 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--------- 156 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC---------
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc---------
Confidence 2789999999999999997543
Q ss_pred hhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCc--
Q 046586 543 EMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-- 620 (763)
Q Consensus 543 ~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-- 620 (763)
......+..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 157 ------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~ 221 (332)
T 3qd2_B 157 ------------SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221 (332)
T ss_dssp ------------SGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC----
T ss_pred ------------CccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhc
Confidence 2234567788999999999999999998 99999999999999999999999999987654321
Q ss_pred ---------ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhc
Q 046586 621 ---------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEE 691 (763)
Q Consensus 621 ---------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 691 (763)
.......||+.|+|||.+.+..++.++||||||+++|||++|..|+.... ..
T Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----------------~~--- 282 (332)
T 3qd2_B 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----------------RI--- 282 (332)
T ss_dssp ----------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----------------HH---
T ss_pred cccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----------------HH---
Confidence 12233569999999999999999999999999999999999877653110 00
Q ss_pred cChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 692 MKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 692 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...... . ............+.+++.+||+.||++|||+.|+++
T Consensus 283 --~~~~~~----~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 283 --ITDVRN----L-KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp --HHHHHT----T-CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred --HHHhhc----c-CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 000000 0 111122345567789999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=350.05 Aligned_cols=259 Identities=24% Similarity=0.334 Sum_probs=197.5
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhc--CCCCccccEEEEEeeC----CeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIAR--MHHLNLVRLWGFCAEK----GERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~LV 516 (763)
..+.+.++||+|+||.||+|+. +++.||||+++.. ....+..|.+++.. ++||||+++++++.+. ...++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 4577789999999999999988 5788999998643 34456667777666 7999999999997653 468899
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCcEEe
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH--------EECLEWVLH 588 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH--------~~~~~~ivH 588 (763)
|||+++|+|.+++. ...+++..++.++.|++.||+||| +.+ |+|
T Consensus 85 ~e~~~~g~L~~~l~-------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH 136 (301)
T 3q4u_A 85 THYHEMGSLYDYLQ-------------------------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAH 136 (301)
T ss_dssp ECCCTTCBHHHHHT-------------------------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EEC
T ss_pred hhhccCCCHHHHHh-------------------------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eec
Confidence 99999999999993 235889999999999999999999 666 999
Q ss_pred cCCCCCceEEcCCCCeEEcccCcccccCCCCcc---cccccccCCCcccccccccC------CCCCccceeehhHHHHHH
Q 046586 589 CDIKPENILLGDDFCPKISDFGLAKLRKKEDMV---SMSRIRGTRGYMAPEWLRSD------QITPKADVYSFGMVLLEI 659 (763)
Q Consensus 589 rDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~------~~s~ksDVwS~Gvll~el 659 (763)
|||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+. .++.++||||||+++|||
T Consensus 137 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el 216 (301)
T 3q4u_A 137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216 (301)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred CCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHH
Confidence 999999999999999999999999765443322 12334789999999999876 455799999999999999
Q ss_pred HhC----------CCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCC-CcchHHHHHHHHHHHHHccCC
Q 046586 660 VSG----------SRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYD-SRVHFDMVNRMVKTAMWCIQD 728 (763)
Q Consensus 660 ltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~l~~~Cl~~ 728 (763)
++| +.||...... ...+...... .. ......... ...+...+..+.+++.+||+.
T Consensus 217 ~tg~~~~~~~~~~~~pf~~~~~~----~~~~~~~~~~-~~---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 282 (301)
T 3q4u_A 217 ARRMVSNGIVEDYKPPFYDVVPN----DPSFEDMRKV-VC---------VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQ 282 (301)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCS----SCCHHHHHHH-HT---------TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCS
T ss_pred HhhhcCccccccccccccccCCC----CcchhhhhHH-Hh---------ccCCCCCCChhhccCccHHHHHHHHHHHhhc
Confidence 999 6666432211 1111111000 00 000001111 112245778899999999999
Q ss_pred CCCCCCCHHHHHHHhccC
Q 046586 729 RPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 729 dP~~RPs~~eVv~~Le~~ 746 (763)
||++|||+.+|++.|+++
T Consensus 283 dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 283 NPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SGGGSCCHHHHHHHHHHH
T ss_pred ChhhCCCHHHHHHHHhcc
Confidence 999999999999999853
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=363.57 Aligned_cols=277 Identities=27% Similarity=0.379 Sum_probs=216.0
Q ss_pred HHHHHhccccccccccccceEEEEEeC--------CCcEEEEEEeeccCCc--hhhhHHHHHHHhcC-CCCccccEEEEE
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELT--------DHRVVAVKCLKNVTGG--DAEFWAEVTIIARM-HHLNLVRLWGFC 507 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~--------~~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l-~H~niv~l~g~~ 507 (763)
++....+.+.++||+|+||.||+|+.. .+..||||+++..... ..++.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 445567888899999999999999862 2357999999754332 35688999999999 999999999999
Q ss_pred eeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 046586 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVL 587 (763)
Q Consensus 508 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~iv 587 (763)
.+.+..++||||+++|+|.+++........... ..........+++.+++.|+.||+.||+|||+.+ |+
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~--------~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv 213 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYS--------YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CI 213 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSC--------CCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccc--------cccccccccccCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 999999999999999999999976542111000 0011123456999999999999999999999998 99
Q ss_pred ecCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCC
Q 046586 588 HCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRN 665 (763)
Q Consensus 588 HrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p 665 (763)
||||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 214 H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p 293 (382)
T 3tt0_A 214 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293 (382)
T ss_dssp CSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986654332 22334567889999999999999999999999999999999 9999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
|..... ......+.++ ... ..+.....++.+++.+||+.||++|||+.||++.|+.
T Consensus 294 ~~~~~~----------~~~~~~~~~~----------~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 349 (382)
T 3tt0_A 294 YPGVPV----------EELFKLLKEG----------HRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349 (382)
T ss_dssp STTCCH----------HHHHHHHHTT----------CCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCH----------HHHHHHHHcC----------CCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 864321 0111111111 111 1112345678999999999999999999999999998
Q ss_pred CCCCC
Q 046586 746 TVEIT 750 (763)
Q Consensus 746 ~~~~~ 750 (763)
+....
T Consensus 350 ~~~~~ 354 (382)
T 3tt0_A 350 IVALT 354 (382)
T ss_dssp HHHHS
T ss_pred HHHHH
Confidence 76443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.39 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=204.5
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
..|.+.+.||+|+||.||++... +++.+|+|+++........+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 35677889999999999999876 57899999998655555678899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC-
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD- 600 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~- 600 (763)
+|+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 85 g~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~ 138 (321)
T 1tki_A 85 GLDIFERINTS-----------------------AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTR 138 (321)
T ss_dssp CCBHHHHHTSS-----------------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSS
T ss_pred CCCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccC
Confidence 99999999532 235889999999999999999999998 999999999999987
Q ss_pred -CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 601 -DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 -~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 139 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------- 208 (321)
T 1tki_A 139 RSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------- 208 (321)
T ss_dssp SCCCEEECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------
T ss_pred CCCCEEEEECCCCeECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------
Confidence 7899999999998765432 23345789999999999998899999999999999999999999964321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ....+..+ .. ..........+.++.+++.+||+.||++|||+.|+++
T Consensus 209 -~~-~~~~i~~~---------~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 209 -QQ-IIENIMNA---------EY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HH-HHHHHHHT---------CC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HH-HHHHHHcC---------CC--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 01111111 00 0010011234567899999999999999999999996
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.05 Aligned_cols=252 Identities=24% Similarity=0.263 Sum_probs=198.2
Q ss_pred cccHHHHHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCch---hhhHHHHHHHhcC-CCCccccEEEEEe
Q 046586 434 RFTHAELRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGD---AEFWAEVTIIARM-HHLNLVRLWGFCA 508 (763)
Q Consensus 434 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~---~~f~~E~~~l~~l-~H~niv~l~g~~~ 508 (763)
.....++....+.+.++||+|+||+||+|+.. +++.||||++....... .++..|+..+.++ +||||+++++++.
T Consensus 48 p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~ 127 (311)
T 3p1a_A 48 PSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127 (311)
T ss_dssp TTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence 34445566778889999999999999999886 68999999987543322 3355566665555 8999999999999
Q ss_pred eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 046586 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLH 588 (763)
Q Consensus 509 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 588 (763)
+.+..++||||+ +++|.+++... ...+++..++.|+.|++.||+|||+.+ |+|
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~~-----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 180 (311)
T 3p1a_A 128 EGGILYLQTELC-GPSLQQHCEAW-----------------------GASLPEAQVWGYLRDTLLALAHLHSQG---LVH 180 (311)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHH-----------------------CSCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred eCCEEEEEEecc-CCCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---Eec
Confidence 999999999999 67999998653 235899999999999999999999988 999
Q ss_pred cCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 589 CDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 589 rDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
|||||+|||++.++.+||+|||++....... ......||+.|+|||.+.+ .++.++||||||+++|||++|..|+..
T Consensus 181 ~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp CCCSGGGEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CCCCHHHEEECCCCCEEEccceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999997654332 2334568999999998875 799999999999999999999776542
Q ss_pred ccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 669 QGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ....+..+. .....+......+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~-------------~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 258 GE-------------GWQQLRQGY-------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HH-------------HHHHHTTTC-------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc-------------HHHHHhccC-------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 011111111 111112234567899999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=354.90 Aligned_cols=281 Identities=26% Similarity=0.380 Sum_probs=209.8
Q ss_pred HHhccccccccccccceEEEEEeCC------CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
...+.+.+.||+|+||.||+|+..+ ++.||||+++.... ..+++.+|+.++++++||||+++++++.+.+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 3566778899999999999998753 47899999975433 235689999999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++|+|.+++.............................+++.+++.++.||+.||+|||+.+ |+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCc
Confidence 999999999999999976432110000000000000000012357899999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGS 671 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~ 671 (763)
+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 999999999999999999976543322 22234567889999999999999999999999999999999 9999864321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEI 749 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~ 749 (763)
........++ .. ...+...+..+.+++.+||+.||++||++.+|+++|+.+.+-
T Consensus 283 ----------~~~~~~~~~~---------~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 283 ----------EEVIYYVRDG---------NI-----LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp ----------HHHHHHHHTT---------CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred ----------HHHHHHHhCC---------Cc-----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 0011111111 00 111233456789999999999999999999999999987753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=361.36 Aligned_cols=263 Identities=26% Similarity=0.343 Sum_probs=208.7
Q ss_pred HHHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCe
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE 512 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 512 (763)
....+.+.++||+|+||.||+|+.. +++.||||+++.... ...++.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3456778899999999999999853 356899999975432 33568899999999999999999999999999
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++|+|.+++...+... .....+++.+++.++.||+.||+|||+.+ |+|||||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~-----------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlk 208 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRP-----------------SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIA 208 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCS-----------------SSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred CEEEEEeCCCCCHHHHHHhhcccc-----------------CccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCC
Confidence 999999999999999997653211 12346899999999999999999999998 9999999
Q ss_pred CCceEEcCCC---CeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcc
Q 046586 593 PENILLGDDF---CPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFE 667 (763)
Q Consensus 593 ~~NILl~~~~---~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~ 667 (763)
|+|||++.++ .+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus 209 p~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~ 288 (367)
T 3l9p_A 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288 (367)
T ss_dssp GGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred hhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999555 599999999975432221 22334567899999999999999999999999999999998 999986
Q ss_pred cccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
..... ........+ . ....+...+..+.+++.+||+.||++|||+.+|++.|+...
T Consensus 289 ~~~~~----------~~~~~i~~~----------~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 289 SKSNQ----------EVLEFVTSG----------G----RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TCCHH----------HHHHHHHTT----------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHH----------HHHHHHHcC----------C----CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 43210 001111111 0 11111334567889999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=349.82 Aligned_cols=275 Identities=22% Similarity=0.329 Sum_probs=210.5
Q ss_pred cHHHHHHHhccccccccccccceEEEEEe-----CCCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEe
Q 046586 436 THAELRAATNGFSNLIGRGGFGDVYKGEL-----TDHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCA 508 (763)
Q Consensus 436 ~~~el~~~t~~~~~~LG~G~fG~Vy~g~~-----~~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 508 (763)
+...+....+.+.++||+|+||.||++++ .+++.||+|+++... ...+.+.+|++++++++||||+++++++.
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 33344456678889999999999999984 357899999997443 33467899999999999999999999998
Q ss_pred eC--CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 509 EK--GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 509 ~~--~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
+. ...++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i 147 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKN-----------------------KNKINLKQQLKYAVQICKGMDYLGSRQ---Y 147 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHH-----------------------TTTCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhc-----------------------cccCCHHHHHHHHHHHHHHHHHhhcCC---c
Confidence 76 6689999999999999999643 235889999999999999999999998 9
Q ss_pred EecCCCCCceEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCC
Q 046586 587 LHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 587 vHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~ 664 (763)
+||||||+||+++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++|..
T Consensus 148 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (302)
T 4e5w_A 148 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227 (302)
T ss_dssp ECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC
T ss_pred ccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccC
Confidence 9999999999999999999999999987654432 22334567888999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCCchhHHHHHHH--HhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKV--YEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
|+...... . .... ..+......+...+........+...++.+.+++.+||+.||++|||+.+|++.
T Consensus 228 p~~~~~~~----------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 228 SDSSPMAL----------F-LKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp GGGSHHHH----------H-HHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCcchhhH----------H-hhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 86422100 0 0000 000000001111111111222234456789999999999999999999999999
Q ss_pred hccCC
Q 046586 743 LEGTV 747 (763)
Q Consensus 743 Le~~~ 747 (763)
|+.++
T Consensus 297 L~~ll 301 (302)
T 4e5w_A 297 FEALL 301 (302)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 98654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=354.89 Aligned_cols=270 Identities=25% Similarity=0.347 Sum_probs=204.5
Q ss_pred HHHhccccccccccccceEEEEEe-----CCCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeC--Ce
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGEL-----TDHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GE 512 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~-----~~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~ 512 (763)
....+.+.++||+|+||.||++++ .+++.||||+++.... ..+++.+|++++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 346678889999999999999985 2578999999975433 335688999999999999999999999654 56
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+|||||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dik 141 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH-----------------------KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLA 141 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC-----------------------GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEeCCCCCHHHHHHhc-----------------------ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCC
Confidence 89999999999999999653 234889999999999999999999988 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
|+||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+....
T Consensus 142 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 221 (295)
T 3ugc_A 142 TRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 221 (295)
T ss_dssp GGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH
T ss_pred HhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh
Confidence 9999999999999999999987644322 12223456778999999999999999999999999999999999875321
Q ss_pred CCCCCCCCchhHHHHHHHHhccC---hhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMK---VEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.. . ......... ....+...+........+...+..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 222 ~~----------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 222 AE----------F-MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HH----------H-HHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----------H-HhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 10 0 000000000 000000111111122223455678999999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=348.04 Aligned_cols=246 Identities=26% Similarity=0.320 Sum_probs=203.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.+.||+|+||.||+++.. +++.||+|+++.. ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 35677889999999999999876 5889999999743 334567889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 85 E~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIl 137 (337)
T 1o6l_A 85 EYANGGELFFHLSRE------------------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLM 137 (337)
T ss_dssp ECCTTCBHHHHHHHH------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEE
T ss_pred eCCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEE
Confidence 999999999999643 25788999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 138 l~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------ 210 (337)
T 1o6l_A 138 LDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ 210 (337)
T ss_dssp ECTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred ECCCCCEEEeeccchhhcccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------
Confidence 9999999999999998543222 223456799999999999999999999999999999999999999964321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
.. .... +.... ..++.....++.+++.+||+.||++|| ++.||++
T Consensus 211 ---~~-~~~~---------i~~~~------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 211 ---ER-LFEL---------ILMEE------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---HH-HHHH---------HHHCC------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---HH-HHHH---------HHcCC------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 00 0011 11110 011223456788999999999999999 8999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=347.80 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=195.1
Q ss_pred HHHhccccccccccccceEEEEEeCC----CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTD----HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
....+.+.+.||+|+||.||+|.... +..||+|+++.... ..+.+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34677888999999999999998753 45799999875433 2356889999999999999999999984 56789
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 92 lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 145 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR-----------------------KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAAR 145 (281)
T ss_dssp EEEECCTTEEHHHHHHHT-----------------------TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEEecCCCCCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHH
Confidence 999999999999999642 235889999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
|||++.++.+||+|||+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 146 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~ 225 (281)
T 1mp8_A 146 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225 (281)
T ss_dssp GEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred HEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence 9999999999999999998765443333344557789999999999999999999999999999996 999986432110
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
....+..+. ....+...+..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 226 ----------~~~~i~~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 226 ----------VIGRIENGE--------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ----------HHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------HHHHHHcCC--------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001111110 01122344567889999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=370.19 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=203.0
Q ss_pred HhccccccccccccceEEEEEeCC-CcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.++||+|+||.||+++... ++.||+|+++.. ......+.+|..++..++||||+++++++.+.+..+|||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 345667899999999999998865 788999999742 223345889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ||||||||+|||
T Consensus 154 Ey~~gg~L~~~l~~~-----------------------~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NIL 207 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKF-----------------------EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNIL 207 (437)
T ss_dssp CCCTTCBHHHHHHTT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred ecCCCCcHHHHHHHc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHee
Confidence 999999999999642 245889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
++.++.+||+|||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||......
T Consensus 208 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 287 (437)
T 4aw2_A 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287 (437)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred EcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh
Confidence 999999999999999876555444445568999999999987 567999999999999999999999999743210
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPEL--RPSMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVv~ 741 (763)
..... ++........+.. .......+.+++.+||+.+|++ ||++.|+++
T Consensus 288 ----------~~~~~---------i~~~~~~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 288 ----------ETYGK---------IMNHKERFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ----------HHHHH---------HHTHHHHCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ----------HHHHh---------hhhccccccCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00111 1110000011100 0123567888999999888888 999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=356.13 Aligned_cols=283 Identities=24% Similarity=0.330 Sum_probs=209.8
Q ss_pred HHHHhccccccccccccceEEEEEe------CCCcEEEEEEeecc--CCchhhhHHHHHHHhcC-CCCccccEEEEEeeC
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGEL------TDHRVVAVKCLKNV--TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEK 510 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~------~~~~~VAvK~l~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 510 (763)
+....+.+.+.||+|+||.||+|.. .+++.||+|+++.. ....+.+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3456778889999999999999986 23568999999743 23446789999999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
+..++||||+++|+|.+++................ ............+++..++.++.||+.||+|||+.+ |+|||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN-QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC----------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhh-hcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 99999999999999999997653211100000000 000000112345899999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCccc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEI 668 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~ 668 (763)
|||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999986544332 22334567889999999999999999999999999999998 9999964
Q ss_pred ccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 669 QGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.... ..... .+.... ....+...+..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 278 ~~~~---------~~~~~----------~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 278 IPVD---------ANFYK----------LIQNGF----KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCCS---------HHHHH----------HHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCcH---------HHHHH----------HHhcCC----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 3211 00011 111111 111123345678999999999999999999999999988664
Q ss_pred C
Q 046586 749 I 749 (763)
Q Consensus 749 ~ 749 (763)
.
T Consensus 335 ~ 335 (344)
T 1rjb_A 335 D 335 (344)
T ss_dssp -
T ss_pred H
Confidence 3
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=348.56 Aligned_cols=279 Identities=25% Similarity=0.323 Sum_probs=205.6
Q ss_pred ccHHHHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcC--CCCccccEEEEEeeC--
Q 046586 435 FTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM--HHLNLVRLWGFCAEK-- 510 (763)
Q Consensus 435 ~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l--~H~niv~l~g~~~~~-- 510 (763)
....+.....+.+.++||+|+||.||+|+.. ++.||||++.... ...+..|.+++..+ +||||+++++++.+.
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 3444555678899999999999999999986 7889999996443 33445566655554 999999999999987
Q ss_pred --CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----C
Q 046586 511 --GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEEC-----L 583 (763)
Q Consensus 511 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~-----~ 583 (763)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. .
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~ 160 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-------------------------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-------------------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB
T ss_pred CCCceEEEEeccCCCcHHHHhhc-------------------------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence 789999999999999999953 24889999999999999999999881 1
Q ss_pred CcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcc---cccccccCCCcccccccccCCCCCc------cceeehhH
Q 046586 584 EWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV---SMSRIRGTRGYMAPEWLRSDQITPK------ADVYSFGM 654 (763)
Q Consensus 584 ~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~k------sDVwS~Gv 654 (763)
+.|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||.+.+.....+ +||||||+
T Consensus 161 ~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 240 (337)
T 3mdy_A 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGL 240 (337)
T ss_dssp CCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHH
T ss_pred CCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHH
Confidence 12999999999999999999999999999765433221 1224578999999999988777665 99999999
Q ss_pred HHHHHHhCCCCcccccCCCC------CCCCchhHHHHHHHHhccChhhhhcccccccCCCc-chHHHHHHHHHHHHHccC
Q 046586 655 VLLEIVSGSRNFEIQGSMMN------SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSR-VHFDMVNRMVKTAMWCIQ 727 (763)
Q Consensus 655 ll~elltG~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~l~~l~~~Cl~ 727 (763)
++|||++|..|+........ .....+... .. .............. ...++++++.+++.+||+
T Consensus 241 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~--~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 310 (337)
T 3mdy_A 241 ILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM--RE--------IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310 (337)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH--HH--------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSC
T ss_pred HHHHHHhccCcccccccccccHhhhcCCCCchhhh--HH--------HHhhhccCccccccchhhHHHHHHHHHHHHhhh
Confidence 99999999554432111000 001111111 00 01111111111111 123678889999999999
Q ss_pred CCCCCCCCHHHHHHHhccCCCCCC
Q 046586 728 DRPELRPSMGKVAKMLEGTVEITE 751 (763)
Q Consensus 728 ~dP~~RPs~~eVv~~Le~~~~~~~ 751 (763)
.||++|||+.+|++.|+.+.+..+
T Consensus 311 ~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 311 HNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hChhhCCCHHHHHHHHHHHHhhcc
Confidence 999999999999999998765544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.25 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=193.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---------------------------chhhhHHHHHHHhc
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---------------------------GDAEFWAEVTIIAR 494 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---------------------------~~~~f~~E~~~l~~ 494 (763)
..|.+.+.||+|+||.||+|+.. +++.||||+++.... ..+++.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 35777899999999999999875 578999999974321 12468899999999
Q ss_pred CCCCccccEEEEEee--CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHH
Q 046586 495 MHHLNLVRLWGFCAE--KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVA 572 (763)
Q Consensus 495 l~H~niv~l~g~~~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia 572 (763)
++||||+++++++.+ .+..++||||+++++|.+++ ....+++.++..++.|++
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------------------------~~~~~~~~~~~~~~~qi~ 147 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-------------------------TLKPLSEDQARFYFQDLI 147 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-------------------------CSSCCCHHHHHHHHHHHH
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-------------------------hcCCCCHHHHHHHHHHHH
Confidence 999999999999987 56889999999999998765 234688999999999999
Q ss_pred HHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCC---CCCccce
Q 046586 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQ---ITPKADV 649 (763)
Q Consensus 573 ~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~s~ksDV 649 (763)
.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||
T Consensus 148 ~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 223 (298)
T 2zv2_A 148 KGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDV 223 (298)
T ss_dssp HHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHH
T ss_pred HHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhh
Confidence 9999999998 99999999999999999999999999986654322 233457899999999997765 4788999
Q ss_pred eehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCC
Q 046586 650 YSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDR 729 (763)
Q Consensus 650 wS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~d 729 (763)
||||+++|||++|+.||..... ... ....... ...... ....++.+.+++.+||+.|
T Consensus 224 ~slG~~l~~l~~g~~pf~~~~~---------~~~-~~~~~~~---------~~~~~~----~~~~~~~l~~li~~~l~~d 280 (298)
T 2zv2_A 224 WAMGVTLYCFVFGQCPFMDERI---------MCL-HSKIKSQ---------ALEFPD----QPDIAEDLKDLITRMLDKN 280 (298)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSH---------HHH-HHHHHHC---------CCCCCS----SSCCCHHHHHHHHHHTCSC
T ss_pred HhHHHHHHHHHHCCCCCCCccH---------HHH-HHHHhcc---------cCCCCC----ccccCHHHHHHHHHHhhcC
Confidence 9999999999999999964321 111 1111111 010000 1223467889999999999
Q ss_pred CCCCCCHHHHHH
Q 046586 730 PELRPSMGKVAK 741 (763)
Q Consensus 730 P~~RPs~~eVv~ 741 (763)
|++|||+.|+++
T Consensus 281 p~~R~s~~e~l~ 292 (298)
T 2zv2_A 281 PESRIVVPEIKL 292 (298)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhhCCCHHHHhc
Confidence 999999999874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=349.08 Aligned_cols=279 Identities=27% Similarity=0.380 Sum_probs=210.6
Q ss_pred HHhccccccccccccceEEEEEe------CCCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGEL------TDHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~------~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
...+.+.+.||+|+||.||++.. .+++.||||+++.... ..+++.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45677789999999999999976 2457899999975432 235688999999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++.............................+++.+++.++.|++.||+|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999986542111000000000000000012345899999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGS 671 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~ 671 (763)
+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986644332 22233457888999999999999999999999999999999 9999864321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.. .......+ . ....+...++.+.+++.+||+.||++||++.+|++.|+++.
T Consensus 259 ~~----------~~~~~~~~----------~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 ER----------LFNLLKTG----------H----RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GG----------HHHHHHTT----------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----------HHHHhhcC----------C----cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 00111111 1 11112344567899999999999999999999999998754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=343.26 Aligned_cols=272 Identities=18% Similarity=0.276 Sum_probs=211.4
Q ss_pred HhccccccccccccceEEEEEeCC-CcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCC--eeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG--ERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~LV~ 517 (763)
..|.+.++||+|+||.||+|+... ++.||||+++... ...+.+.+|++++++++||||+++++++.+.. ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 356778999999999999998864 8899999997532 34567889999999999999999999998765 779999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 89 e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 144 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPS---------------------NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIM 144 (319)
T ss_dssp ECCTTCBHHHHHHSGG---------------------GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred eCCCCCCHHHHHHHhc---------------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEE
Confidence 9999999999997542 2234899999999999999999999998 999999999999
Q ss_pred E----cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc--------cCCCCCccceeehhHHHHHHHhCCCC
Q 046586 598 L----GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR--------SDQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 598 l----~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
+ +.++.+||+|||+++....... .....||..|+|||.+. +..++.++||||||+++|||++|+.|
T Consensus 145 l~~~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~p 222 (319)
T 4euu_A 145 RVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222 (319)
T ss_dssp EEECTTSCEEEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred EeccCCCCceEEEccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9 8888999999999986654332 23456899999999886 57899999999999999999999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcc-------cc----cccCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDR-------HI----KNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~l----~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 734 (763)
|........ ... .......+.. ...... .. .-.....+.......+.+++.+||+.||++||
T Consensus 223 f~~~~~~~~-----~~~-~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~ 295 (319)
T 4euu_A 223 FRPFEGPRR-----NKE-VMYKIITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW 295 (319)
T ss_dssp EECTTCGGG-----CHH-HHHHHHHHCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred CCCCCccch-----hHH-HHHHHhcCCC-cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc
Confidence 974332111 111 1111111111 000000 00 00111234467888899999999999999999
Q ss_pred CHHHHHHHhccCC
Q 046586 735 SMGKVAKMLEGTV 747 (763)
Q Consensus 735 s~~eVv~~Le~~~ 747 (763)
|+.|+++...+..
T Consensus 296 s~~ell~h~~d~~ 308 (319)
T 4euu_A 296 GFDQFFAETSDIL 308 (319)
T ss_dssp CHHHHHHHHHHHT
T ss_pred cHHHhhhccHHHh
Confidence 9999999887543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=349.54 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=202.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
..|.+.+.||+|+||.||+++.. +++.||+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 35778899999999999999876 588999999975432 2356889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+
T Consensus 92 lv~e~~~gg~L~~~l~~------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~ 144 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ------------------------KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPE 144 (361)
T ss_dssp EEEECCCSCBHHHHHTT------------------------CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred EEEEcCCCCcHHHHHHh------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH
Confidence 99999999999999953 235889999999999999999999998 999999999
Q ss_pred ceEEcCCC----CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 595 NILLGDDF----CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 595 NILl~~~~----~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
|||++.++ .+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|..||....
T Consensus 145 NIll~~~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 145 NIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp GEEESCTTSSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred HEEEeCCCCCccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998877 79999999998665432 2344679999999999999999999999999999999999999996432
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. . ....+... . ..++.......+..+.+++..||+.||++|||+.|+++
T Consensus 223 ~~---------~-~~~~i~~~---------~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 223 KQ---------E-TLANITAV---------S--YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HH---------H-HHHHHHTT---------C--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH---------H-HHHHHHhc---------C--CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 0 00111111 0 01111111233567889999999999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=348.75 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=199.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.|.+.++||+|+||.||+++.. +++.||||+++... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 4677899999999999999876 68899999996432 23466889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 88 ~~~~L~~~l~~------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~ 140 (323)
T 3tki_A 88 SGGELFDRIEP------------------------DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDE 140 (323)
T ss_dssp TTEEGGGGSBT------------------------TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECT
T ss_pred CCCcHHHHHhh------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeC
Confidence 99999999843 235889999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCC-CCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 601 DFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
++.+||+|||+++....... .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .
T Consensus 141 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~ 216 (323)
T 3tki_A 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----Q 216 (323)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS----H
T ss_pred CCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH----H
Confidence 99999999999986543322 22345679999999999987765 779999999999999999999997443211 0
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.+ ....... . ...........+.+++.+||+.||++|||+.|+++.
T Consensus 217 ~~-----~~~~~~~---------~----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 217 EY-----SDWKEKK---------T----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HH-----HHHHTTC---------T----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HH-----HHHhccc---------c----cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 0111110 0 000012334677899999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=347.89 Aligned_cols=267 Identities=28% Similarity=0.429 Sum_probs=198.4
Q ss_pred cccHHHHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeC
Q 046586 434 RFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEK 510 (763)
Q Consensus 434 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 510 (763)
.++..|+....+.+.++||+|+||.||+|+..+ .||+|+++..... .+.|.+|+.++++++||||+++++++ ..
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 344456667788889999999999999998754 5999999754332 35688999999999999999999965 55
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+|||
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~D 145 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHAS-----------------------ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRD 145 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC--------------------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CccEEEEEecCCCcHHHHHhhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 6789999999999999999542 345889999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCC-cccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCCCc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKED-MVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~p~ 666 (763)
|||+||+++.++.+||+|||+++...... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||
T Consensus 146 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp CCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence 99999999999999999999997654322 22334467899999999886 667889999999999999999999999
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
...... .........+. . ... ........+..+.+++.+||+.||++|||+.+|+++|+++
T Consensus 226 ~~~~~~---------~~~~~~~~~~~-~----~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 226 SNINNR---------DQIIEMVGRGS-L----SPD-----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp SSCCCH---------HHHHHHHHHTS-C----CCC-----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cccchH---------HHHHHHhcccc-c----Ccc-----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 643211 11111111111 0 000 0111134457899999999999999999999999999987
Q ss_pred CC
Q 046586 747 VE 748 (763)
Q Consensus 747 ~~ 748 (763)
.+
T Consensus 287 ~~ 288 (289)
T 3og7_A 287 AR 288 (289)
T ss_dssp TC
T ss_pred hh
Confidence 54
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.54 Aligned_cols=253 Identities=31% Similarity=0.503 Sum_probs=201.2
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc--------hhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG--------DAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~--------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
..+.+.+.||+|+||.||+|+.. +++.||+|++...... .+++.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 46777899999999999999875 6889999998643221 156889999999999999999999997654
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ .+|+||||||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp 152 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK-----------------------AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRS 152 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT-----------------------TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSG
T ss_pred eEEEEecCCCCHHHHHhcc-----------------------cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCc
Confidence 6999999999999988642 346899999999999999999999976 4499999999
Q ss_pred CceEEcCCCC-----eEEcccCcccccCCCCcccccccccCCCccccccc--ccCCCCCccceeehhHHHHHHHhCCCCc
Q 046586 594 ENILLGDDFC-----PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWL--RSDQITPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 594 ~NILl~~~~~-----~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l--~~~~~s~ksDVwS~Gvll~elltG~~p~ 666 (763)
+||+++.++. +||+|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||
T Consensus 153 ~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 228 (287)
T 4f0f_A 153 PNIFLQSLDENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228 (287)
T ss_dssp GGEEESCCCTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ceEEEeccCCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 9999988776 99999999974433 23346789999999998 4556889999999999999999999999
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
....... .... . ..... ......+...+..+.+++..||+.||++|||+.||++.|+++
T Consensus 229 ~~~~~~~-------~~~~-~---------~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 229 DEYSYGK-------IKFI-N---------MIREE----GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp TTCCCCH-------HHHH-H---------HHHHS----CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccccccH-------HHHH-H---------HHhcc----CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 6432110 0000 0 01111 111122234457889999999999999999999999999863
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.25 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=202.8
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~LV~ 517 (763)
..+.+.++||+|+||.||+|+.. ++.||||+++.... ..++|.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 45777899999999999999986 78899999975432 235689999999999999999999999887 7889999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ....+++.+++.++.|++.||+|||+.+ ..|+||||||+||+
T Consensus 89 e~~~~~~L~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil 145 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG----------------------TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVM 145 (271)
T ss_dssp ECCTTCBHHHHHHSC----------------------SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEE
T ss_pred cccCCCcHHHHHhhc----------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEE
Confidence 999999999999643 2335899999999999999999999876 45999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCC---ccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITP---KADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~---ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++.++.++|+|||++..... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||.....
T Consensus 146 ~~~~~~~~l~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--- 216 (271)
T 3kmu_A 146 IDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--- 216 (271)
T ss_dssp ECTTSCEEEEGGGSCCTTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---
T ss_pred EcCCcceeEEeccceeeecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---
Confidence 99999999999988754322 2346789999999998765554 79999999999999999999964321
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.... ...... ......+...+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 217 ------~~~~----------~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 217 ------MEIG----------MKVALE----GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ------HHHH----------HHHHHS----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ------HHHH----------HHHHhc----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0100 011111 1111122344567899999999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=351.76 Aligned_cols=251 Identities=24% Similarity=0.281 Sum_probs=194.6
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
..|.+.++||+|+||.||+++.. +++.||||+++......+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 45778899999999999999886 68899999998766666788999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 100 ~~~L~~~l~~~------------------------~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~ 152 (361)
T 3uc3_A 100 GGELYERICNA------------------------GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGS 152 (361)
T ss_dssp SCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSS
T ss_pred CCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCC
Confidence 99999999643 25889999999999999999999998 9999999999999877
Q ss_pred CC--eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCc-cceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 602 FC--PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPK-ADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 602 ~~--~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~k-sDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+. +||+|||+++...... ......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||.......
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----- 225 (361)
T 3uc3_A 153 PAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR----- 225 (361)
T ss_dssp SSCCEEECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-----
T ss_pred CCceEEEeecCccccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-----
Confidence 65 9999999997433221 2234569999999999988887766 899999999999999999997543211
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+.... ..+... ....+........+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~----------~~~~~~----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 226 DYRKTI----------QRILSV----KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CHHHHH----------HHHHTT----CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHH----------HHHhcC----CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 111110 111111 1111111123467889999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.24 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=202.9
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
..|.+.+.||+|+||.||++... +++.||+|+++.... ..+++.+|+.++++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56788899999999999999876 588999999975322 2456889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 91 lv~e~~~~~~L~~~l~~------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~ 143 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE------------------------KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPE 143 (326)
T ss_dssp EEEECCCSCBHHHHHTT------------------------SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred EEEEcCCCCCHHHHHHh------------------------cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHH
Confidence 99999999999999953 235889999999999999999999998 999999999
Q ss_pred ceEEcCCC----CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 595 NILLGDDF----CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 595 NILl~~~~----~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
|||++.++ .+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 144 NIll~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 144 NIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp GEEESCSSSSSCCEEECCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred HEEEecCCCCCCCEEEEECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 99999887 89999999998664332 2334579999999999999999999999999999999999999996432
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. . ......... ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~---------~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 222 KQ---------E-TLANVSAVN-----------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HH---------H-HHHHHHHTC-----------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HH---------H-HHHHHHhcC-----------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 10 0 001111100 00111111233567889999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.05 Aligned_cols=277 Identities=25% Similarity=0.366 Sum_probs=212.6
Q ss_pred HHHHHhccccccccccccceEEEEEe------CCCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEee
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGEL------TDHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCAE 509 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~------~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 509 (763)
++....+.+.+.||+|+||.||+|+. .+++.||+|+++.... ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34456788889999999999999975 3467899999975433 335688999999999 99999999999999
Q ss_pred CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEec
Q 046586 510 KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHC 589 (763)
Q Consensus 510 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHr 589 (763)
.+..++||||+++|+|.+++.............. .........+++..++.++.|++.||+|||+.+ |+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 169 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP------AIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR 169 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccc------cccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecC
Confidence 9999999999999999999976542111000000 000112346899999999999999999999998 9999
Q ss_pred CCCCCceEEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcc
Q 046586 590 DIKPENILLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFE 667 (763)
Q Consensus 590 Dlk~~NILl~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~ 667 (763)
||||+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 170 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544332 2233457889999999999999999999999999999999 999986
Q ss_pred cccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
..... ........+. .... .+...+..+.+++.+||+.||.+|||+.||+++|++..
T Consensus 250 ~~~~~---------~~~~~~~~~~----------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 250 GMPVD---------SKFYKMIKEG----------FRML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp TCCSS---------HHHHHHHHHT----------CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccch---------hHHHHHhccC----------CCCC----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 43211 0111111111 1111 11234567899999999999999999999999998765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=349.33 Aligned_cols=255 Identities=19% Similarity=0.270 Sum_probs=203.9
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeecc------CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV------TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
....|.+.+.||+|+||.||++... +++.||||+++.. ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467888999999999999999875 6889999998632 12356789999999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp 158 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRAD--------------------AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKP 158 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHH--------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred EEEEeCCCCCCHHHHHHHhcc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCh
Confidence 999999999999988865320 2345789999999999999999999998 99999999
Q ss_pred CceEEcCCCC---eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 594 ENILLGDDFC---PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 594 ~NILl~~~~~---~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
+|||++.++. +||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 159 HCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp GGEEECSSSTTCCEEECCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred HHeEEecCCCCCcEEEecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 9999987655 99999999986654322 2334579999999999999999999999999999999999999996421
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. .....+..+. . ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~-----------~~~~~i~~~~---------~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 238 E-----------RLFEGIIKGK---------Y--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp H-----------HHHHHHHHTC---------C--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H-----------HHHHHHHcCC---------C--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0011111110 0 0000000123567889999999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=352.88 Aligned_cols=266 Identities=17% Similarity=0.208 Sum_probs=204.3
Q ss_pred HHhccccccccccccceEEEEEeCC------CcEEEEEEeeccCCc------------hhhhHHHHHHHhcCCCCccccE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTGG------------DAEFWAEVTIIARMHHLNLVRL 503 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~~------------~~~f~~E~~~l~~l~H~niv~l 503 (763)
...|.+.++||+|+||.||+|.... ++.||||++...... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 3467788999999999999998865 478999998754321 1124456667778899999999
Q ss_pred EEEEeeC----CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046586 504 WGFCAEK----GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH 579 (763)
Q Consensus 504 ~g~~~~~----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH 579 (763)
++++.+. ...+|||||+ +++|.+++... ...+++.+++.|+.||+.||+|||
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-----------------------~~~l~~~~~~~i~~qi~~~l~~lH 169 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-----------------------AKRFSRKTVLQLSLRILDILEYIH 169 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-----------------------TSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999875 4589999999 99999999653 246899999999999999999999
Q ss_pred hcCCCcEEecCCCCCceEEc--CCCCeEEcccCcccccCCCCcc------cccccccCCCcccccccccCCCCCccceee
Q 046586 580 EECLEWVLHCDIKPENILLG--DDFCPKISDFGLAKLRKKEDMV------SMSRIRGTRGYMAPEWLRSDQITPKADVYS 651 (763)
Q Consensus 580 ~~~~~~ivHrDlk~~NILl~--~~~~~kI~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS 651 (763)
+.+ |+||||||+|||++ .++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||
T Consensus 170 ~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 246 (364)
T 3op5_A 170 EHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEI 246 (364)
T ss_dssp HTT---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred HCC---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHH
Confidence 998 99999999999999 8999999999999865433221 113345999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCC
Q 046586 652 FGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPE 731 (763)
Q Consensus 652 ~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 731 (763)
|||++|||++|+.||...... ............ ....+++++.+.. ...+.++.+++..||+.||+
T Consensus 247 lG~~l~el~~g~~Pf~~~~~~-----~~~~~~~~~~~~--~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~ 312 (364)
T 3op5_A 247 LGYCMIQWLTGHLPWEDNLKD-----PKYVRDSKIRYR--ENIASLMDKCFPA-------ANAPGEIAKYMETVKLLDYT 312 (364)
T ss_dssp HHHHHHHHHHSCCTTGGGTTC-----HHHHHHHHHHHH--HCHHHHHHHHSCT-------TCCCHHHHHHHHHHHTCCTT
T ss_pred HHHHHHHHHhCCCCccccccC-----HHHHHHHHHHhh--hhHHHHHHHhccc-------ccCHHHHHHHHHHHhcCCCC
Confidence 999999999999999743211 111111111111 1133344333221 12346788999999999999
Q ss_pred CCCCHHHHHHHhccCCC
Q 046586 732 LRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 732 ~RPs~~eVv~~Le~~~~ 748 (763)
+||++.+|+++|+.+.+
T Consensus 313 ~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 313 EKPLYENLRDILLQGLK 329 (364)
T ss_dssp CCCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHH
Confidence 99999999999987653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=345.65 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=196.1
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
..+.+.+.||+|+||.||+++.. ++.||+|+++.. ...+.|.+|++++++++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 45667889999999999999986 578999998643 34567899999999999999999999887 458999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++.... ....+++..++.++.|+++||+|||+.+...|+||||||+||+++.++
T Consensus 84 ~~L~~~l~~~~---------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~ 142 (307)
T 2eva_A 84 GSLYNVLHGAE---------------------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG 142 (307)
T ss_dssp CBHHHHHHCSS---------------------SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTT
T ss_pred CCHHHHHhccC---------------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCC
Confidence 99999996532 223478889999999999999999993322399999999999999888
Q ss_pred C-eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 603 C-PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 603 ~-~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
. +||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .
T Consensus 143 ~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~ 211 (307)
T 2eva_A 143 TVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-------F 211 (307)
T ss_dssp TEEEECCCCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-------H
T ss_pred CEEEEcccccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-------H
Confidence 7 799999999754322 233468999999999999999999999999999999999999996432110 0
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
... .....+ .....+...+..+.+++.+||+.||++|||+.+|+++|+.+.+
T Consensus 212 ~~~-~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 212 RIM-WAVHNG--------------TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHH-HHHHTT--------------CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HHH-HHHhcC--------------CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 000 000000 0011112345678899999999999999999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=351.51 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=198.0
Q ss_pred HHHHhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCee
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 513 (763)
+....+.+.++||+|+||.||+++.. +++.||+|+++.. ....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44456788899999999999999876 5789999999743 23345678899999988 799999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 100 ~lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp 152 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS------------------------RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKL 152 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCG
T ss_pred EEEEeCCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCH
Confidence 9999999999999999653 35889999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
+|||++.++++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 153 ~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~- 230 (353)
T 3txo_A 153 DNVLLDHEGHCKLADFGMCKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED- 230 (353)
T ss_dssp GGEEECTTSCEEECCCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred HHEEECCCCCEEEccccceeecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-
Confidence 99999999999999999998533222 2334567999999999999989999999999999999999999999743210
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM------GKVAK 741 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~eVv~ 741 (763)
..... +..... ..+......+.+++..||+.||++||++ .||++
T Consensus 231 ---------~~~~~---------i~~~~~------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 231 ---------DLFEA---------ILNDEV------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---------HHHHH---------HHHCCC------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---------HHHHH---------HHcCCC------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 00111 111111 1112345678899999999999999998 67764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=360.38 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=203.2
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.++||+|+||.||+++.. +++.||+|+++.. ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 45667789999999999999886 5789999999742 234456889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 149 E~~~gg~L~~~l~~~-------------------------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NIL 200 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNY-------------------------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNML 200 (410)
T ss_dssp CCCTTEEHHHHHHHC-------------------------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred eCCCCCcHHHHHHcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHee
Confidence 999999999998542 4788899999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCC----CCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQ----ITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
++.++++||+|||+++..............||+.|+|||++.+.. ++.++|||||||++|||++|+.||......
T Consensus 201 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~- 279 (410)
T 3v8s_A 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV- 279 (410)
T ss_dssp ECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-
T ss_pred ECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-
Confidence 999999999999999876655444445678999999999997655 889999999999999999999999743210
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPEL--RPSMGKVAKM 742 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~eVv~~ 742 (763)
.. ...++........+. ....+..+.+++.+||+.+|.+ ||++.||++.
T Consensus 280 ---------~~---------~~~i~~~~~~~~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 280 ---------GT---------YSKIMNHKNSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---------HH---------HHHHHTHHHHCCCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---------hH---------HHHHHhccccccCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00 111111100001110 0123567889999999999998 9999999963
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=345.00 Aligned_cols=259 Identities=17% Similarity=0.211 Sum_probs=204.9
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..+.+.++||+|+||.||+|+. .+++.||||+++... ...++.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 3467788999999999999986 568899999987543 345688999999999 9999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 88 -~~~L~~~~~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~ 140 (330)
T 2izr_A 88 -GPSLEDLFDLC-----------------------DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGR 140 (330)
T ss_dssp -CCBHHHHHHHT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECC
T ss_pred -CCCHHHHHHHc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecc
Confidence 99999999652 246899999999999999999999998 999999999999999
Q ss_pred CCC-----eEEcccCcccccCCCCcc------cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 601 DFC-----PKISDFGLAKLRKKEDMV------SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 601 ~~~-----~kI~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
++. +||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 141 ~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 141 PGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp GGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 887 999999999865433221 124567999999999999999999999999999999999999999754
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.... .. .....+.+.. ... .........+ ++.+++..||+.||.+||++.+|++.|+.+.
T Consensus 221 ~~~~------~~-~~~~~i~~~~---------~~~-~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 221 KADT------LK-ERYQKIGDTK---------RAT-PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp CCSS------HH-HHHHHHHHHH---------HHS-CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cccc------HH-HHHHHHHhhh---------ccC-CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 2111 00 0001110000 000 0000001123 8999999999999999999999999997643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.47 Aligned_cols=264 Identities=23% Similarity=0.281 Sum_probs=199.3
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
..|.+.++||+|+||.||+++..+++.||+|+++.... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 45677889999999999999998899999999974322 235688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 101 ~~~-~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~ 153 (311)
T 3niz_A 101 MEK-DLKKVLDEN-----------------------KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLIN 153 (311)
T ss_dssp CSE-EHHHHHHTC-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred CCC-CHHHHHHhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEEC
Confidence 985 888888542 245889999999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
.++.+||+|||+++...... .......+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||.......
T Consensus 154 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----- 227 (311)
T 3niz_A 154 SDGALKLADFGLARAFGIPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD----- 227 (311)
T ss_dssp TTCCEEECCCTTCEETTSCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-----
T ss_pred CCCCEEEccCcCceecCCCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-----
Confidence 99999999999998654322 22334568999999999876 578999999999999999999999997543211
Q ss_pred chhHHHHHHHHhcc--------ChhhhhcccccccCCC----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 679 YFPKWAFEKVYEEM--------KVEDILDRHIKNSYDS----RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~--------~~~~~~~~~l~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+. .......... ........... .... ........++.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 228 QLP-KIFSILGTPNPREWPQVQELPLWKQRTFQ-VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHH-HHHHHHCCCCTTTSGGGTTSHHHHSCCCC-CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHH-HHHHHHCCCChHHhhhhhccchhhhcccc-cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 010 0000000000 00000000000 0000 001123467889999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=349.08 Aligned_cols=255 Identities=21% Similarity=0.330 Sum_probs=200.1
Q ss_pred HhccccccccccccceEEEEEeC-CCc----EEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHR----VVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~----~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
..+.+.++||+|+||.||+|+.. +++ .||+|.+.... ....++.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 35667789999999999999875 344 37888875432 33456889999999999999999999986 567889
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 92 v~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~N 145 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-----------------------RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARN 145 (325)
T ss_dssp EEECCTTCBSHHHHHSS-----------------------GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTT
T ss_pred EEEeCCCCCHHHHHHHc-----------------------cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchhe
Confidence 99999999999999642 235788899999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
||++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 146 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 225 (325)
T 3kex_A 146 VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225 (325)
T ss_dssp EEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH
T ss_pred EEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH
Confidence 9999999999999999987654433 22344567889999999999999999999999999999999 999997432110
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
....+..+ .... .+......+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 226 ----------~~~~~~~~----------~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 226 ----------VPDLLEKG----------ERLA----QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ----------HHHHHHTT----------CBCC----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ----------HHHHHHcC----------CCCC----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00111111 0011 112234467889999999999999999999999987643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=339.35 Aligned_cols=261 Identities=18% Similarity=0.249 Sum_probs=208.2
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..|.+.+.||+|+||.||+|.. .+++.||||+++... ...++.+|+.+++.+ +|+|++++++++.+....++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 4577789999999999999986 568899999986433 345688999999999 8999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 89 -~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 141 (298)
T 1csn_A 89 -GPSLEDLLDLC-----------------------GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGR 141 (298)
T ss_dssp -CCBHHHHHHHT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECC
T ss_pred -CCCHHHHHHHh-----------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecc
Confidence 99999999653 235889999999999999999999988 999999999999987
Q ss_pred CCC-----eEEcccCcccccCCCCcc------cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 601 DFC-----PKISDFGLAKLRKKEDMV------SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 601 ~~~-----~kI~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
++. +||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 142 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 142 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp SSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred CCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 776 999999999866543221 234457999999999999999999999999999999999999999754
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.... .......+.+.. . .... .......++.+.+++.+||+.||++||++.+|++.|+.+.+
T Consensus 222 ~~~~-------~~~~~~~~~~~~-~----~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 222 KAAT-------NKQKYERIGEKK-Q----STPL-----RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp CSCC-------HHHHHHHHHHHH-H----HSCH-----HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hccc-------cHHHHHHHHhhc-c----CccH-----HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 3211 011111111110 0 0000 00001235688999999999999999999999999988764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.09 Aligned_cols=266 Identities=25% Similarity=0.340 Sum_probs=206.4
Q ss_pred ccccccccccccceEEEEEeC-----CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeC--CeeeE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-----DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEK--GERTL 515 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-----~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~L 515 (763)
+.+.++||+|+||.||++.+. +++.||||+++.... ..+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377899999999999998753 578899999985432 235689999999999999999999999884 57899
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 113 v~e~~~~~~L~~~l~~-------------------------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~N 164 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-------------------------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARN 164 (318)
T ss_dssp EECCCTTCBHHHHGGG-------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEecccCCcHHHHHhh-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchhe
Confidence 9999999999999953 23889999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
|+++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 165 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~ 244 (318)
T 3lxp_A 165 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244 (318)
T ss_dssp EEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred EEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh
Confidence 9999999999999999987654332 12233467888999999999999999999999999999999999986321100
Q ss_pred C-CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 674 N-SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 674 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
. ............ ...+.+.... ....+...+..+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 245 ~~~~~~~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 245 LELIGIAQGQMTVL------RLTELLERGE----RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHCSCCHHHHHH------HHHHHHHTTC----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhcccccchhHH------HHHHHHhccc----CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 0 000000000000 0111122211 122224456789999999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.89 Aligned_cols=251 Identities=22% Similarity=0.317 Sum_probs=202.8
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
...|.+.+.||+|+||.||++... +++.||+|+++..... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457888899999999999999875 5789999999754332 346889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 108 e~~~gg~L~~~l~~------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIl 160 (362)
T 2bdw_A 108 DLVTGGELFEDIVA------------------------REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLL 160 (362)
T ss_dssp CCCCSCBHHHHHTT------------------------CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEE
T ss_pred ecCCCCCHHHHHHH------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEE
Confidence 99999999999853 235889999999999999999999998 999999999999
Q ss_pred EcCC---CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LGDD---FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~~~---~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++.+ +.+||+|||++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 161 l~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--- 235 (362)
T 2bdw_A 161 LASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--- 235 (362)
T ss_dssp ESCSSTTCCEEECCCTTCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred EecCCCCCCEEEeecCcceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---
Confidence 9865 459999999998665332 23346799999999999999999999999999999999999999964321
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
. .....+..+. . ..+.......+..+.+++.+||+.||++||++.++++.
T Consensus 236 ------~-~~~~~i~~~~---------~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 236 ------H-RLYAQIKAGA---------Y--DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ------H-HHHHHHHHTC---------C--CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ------H-HHHHHHHhCC---------C--CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0111111110 0 00111112345678899999999999999999999853
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=353.04 Aligned_cols=274 Identities=25% Similarity=0.357 Sum_probs=210.3
Q ss_pred HHHHHHhccccccccccccceEEEEEeCC------CcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEe
Q 046586 438 AELRAATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCA 508 (763)
Q Consensus 438 ~el~~~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 508 (763)
.++....+.+.+.||+|+||.||+|.... ...||+|+++.... ..+.+.+|+.+++.+ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34455667788999999999999998753 24799999975433 335688999999999 8999999999999
Q ss_pred eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 046586 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLH 588 (763)
Q Consensus 509 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 588 (763)
+.+..++||||+++|+|.+++............ .......+++..++.++.|++.||+|||+.+ |+|
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH 187 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA----------FAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIH 187 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhccccccccc----------ccccccccCHHHHHHHHHHHHHHHHHHhcCC---ccc
Confidence 999999999999999999999754211000000 0001346899999999999999999999998 999
Q ss_pred cCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCc
Q 046586 589 CDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNF 666 (763)
Q Consensus 589 rDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~ 666 (763)
|||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 188 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 267 (333)
T 2i1m_A 188 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267 (333)
T ss_dssp SCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999986543322 22233557889999999999999999999999999999998 98998
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
...... .........+ ... ..+...+..+.+++..||+.||.+|||+.+|+++|+..
T Consensus 268 ~~~~~~---------~~~~~~~~~~----------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 268 PGILVN---------SKFYKLVKDG----------YQM----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp TTCCSS---------HHHHHHHHHT----------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccchh---------HHHHHHHhcC----------CCC----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 643211 0011111111 111 11122356788999999999999999999999999865
Q ss_pred C
Q 046586 747 V 747 (763)
Q Consensus 747 ~ 747 (763)
.
T Consensus 325 ~ 325 (333)
T 2i1m_A 325 A 325 (333)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.67 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=200.3
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.+.||+|+||.||+|.. .+++.||+|+++.. ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 567789999999999999987 46889999999742 2334578899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+ +|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 90 ~~-~g~l~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll 141 (336)
T 3h4j_B 90 YA-GGELFDYIVEK------------------------KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLL 141 (336)
T ss_dssp CC-CEEHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEE
T ss_pred CC-CCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEE
Confidence 99 78999998643 35889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCC-CCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++++.+||+|||++....... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......
T Consensus 142 ~~~~~~kl~DFG~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---- 215 (336)
T 3h4j_B 142 DDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---- 215 (336)
T ss_dssp CTTCCEEECCSSCTBTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----
T ss_pred cCCCCEEEEEeccceeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----
Confidence 999999999999998654432 2344579999999999988776 689999999999999999999997432111
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
+........ ...+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 216 -------------------~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 216 -------------------LFKKVNSCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -------------------CBCCCCSSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -------------------HHHHHHcCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111111110 1112334567889999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=347.30 Aligned_cols=262 Identities=21% Similarity=0.341 Sum_probs=194.0
Q ss_pred HHhccccccccccccceEEEEEeCCCc----EEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCee-
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTDHR----VVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER- 513 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~~~----~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~- 513 (763)
...+.+.+.||+|+||.||+|+..... .||||+++.. ....+++.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 456778899999999999999876432 7999999753 22346789999999999999999999999887655
Q ss_pred -----eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 046586 514 -----TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLH 588 (763)
Q Consensus 514 -----~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 588 (763)
++||||+++|+|.+++..... ......+++.+++.++.|++.||+|||+.+ |+|
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH 160 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRI------------------GENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIH 160 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhc------------------cccccccCHHHHHHHHHHHHHHHHHHHcCC---ccc
Confidence 899999999999999965421 012235899999999999999999999998 999
Q ss_pred cCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCc
Q 046586 589 CDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNF 666 (763)
Q Consensus 589 rDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~ 666 (763)
|||||+|||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 161 ~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~ 240 (323)
T 3qup_A 161 RDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240 (323)
T ss_dssp SCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999986544332 22223456788999999999999999999999999999999 89998
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
....... .......+. ....+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 241 ~~~~~~~----------~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 241 AGIENAE----------IYNYLIGGN--------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp TTCCGGG----------HHHHHHTTC--------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccChHH----------HHHHHhcCC--------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 6432110 001111110 1111234456789999999999999999999999999986
Q ss_pred CC
Q 046586 747 VE 748 (763)
Q Consensus 747 ~~ 748 (763)
++
T Consensus 297 l~ 298 (323)
T 3qup_A 297 LG 298 (323)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.15 Aligned_cols=243 Identities=26% Similarity=0.350 Sum_probs=201.9
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.+.||+|+||.||+++.. +++.||+|+++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 35677899999999999999875 6889999999743 234466789999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 86 e~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIl 138 (318)
T 1fot_A 86 DYIEGGELFSLLRKS------------------------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENIL 138 (318)
T ss_dssp CCCCSCBHHHHHHHT------------------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEE
T ss_pred eCCCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEE
Confidence 999999999999643 35788999999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 139 l~~~g~~kL~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------ 208 (318)
T 1fot_A 139 LDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------ 208 (318)
T ss_dssp ECTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------
T ss_pred EcCCCCEEEeecCcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------
Confidence 999999999999999865432 2345799999999999999999999999999999999999999964321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
.. . ...++.... .++.....++.+++.+||+.||++|| ++.||++
T Consensus 209 ---~~-~---------~~~i~~~~~------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 209 ---MK-T---------YEKILNAEL------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---HH-H---------HHHHHHCCC------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---HH-H---------HHHHHhCCC------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00 0 111111111 11123456788999999999999999 8899883
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=353.59 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=201.7
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
...|.+.++||+|+||.||++... +++.+|+|+++.... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 356888899999999999999764 688999999975432 2355889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 90 E~~~gg~L~~~i~~~------------------------~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIl 142 (444)
T 3soa_A 90 DLVTGGELFEDIVAR------------------------EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLL 142 (444)
T ss_dssp CCCBCCBHHHHHHHC------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEE
T ss_pred EeCCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEE
Confidence 999999999998643 35889999999999999999999998 999999999999
Q ss_pred Ec---CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LG---DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~---~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++ .++.+||+|||+++....... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.....
T Consensus 143 l~~~~~~~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--- 218 (444)
T 3soa_A 143 LASKLKGAAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--- 218 (444)
T ss_dssp ESBSSTTCCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred EeccCCCCcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---
Confidence 98 568899999999986654322 23446799999999999999999999999999999999999999964321
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
......+..+. .. .+.......+..+.+++..||+.||++|||+.|+++
T Consensus 219 -------~~~~~~i~~~~---------~~--~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 219 -------HRLYQQIKAGA---------YD--FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -------HHHHHHHHHTC---------CC--CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -------HHHHHHHHhCC---------CC--CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00111111110 00 000001234567889999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=347.55 Aligned_cols=275 Identities=24% Similarity=0.365 Sum_probs=211.6
Q ss_pred HHHHhccccccccccccceEEEEEeC--------CCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEe
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELT--------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCA 508 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~--------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 508 (763)
+....+.+.+.||+|+||.||+|+.. +++.||+|+++.... ...++.+|+++++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 44567888899999999999999873 467899999975433 235688999999999 8999999999999
Q ss_pred eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 046586 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLH 588 (763)
Q Consensus 509 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 588 (763)
+.+..++||||+++|+|.+++............. ........+++..++.++.||+.||+|||+.+ |+|
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 180 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD--------INRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIH 180 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC----------------CCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCceEEEEECCCCCcHHHHHHHhcccccccccc--------ccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeC
Confidence 9999999999999999999997653211100000 00012345899999999999999999999998 999
Q ss_pred cCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCc
Q 046586 589 CDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNF 666 (763)
Q Consensus 589 rDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~ 666 (763)
|||||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999986654332 22333457889999999998999999999999999999999 99998
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
..... .. ....+..+. ....+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 261 ~~~~~---------~~-~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 261 PGIPV---------EE-LFKLLKEGH--------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp TTCCH---------HH-HHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCCH---------HH-HHHHHhcCC--------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 64321 00 111111110 0111133456789999999999999999999999999987
Q ss_pred CCC
Q 046586 747 VEI 749 (763)
Q Consensus 747 ~~~ 749 (763)
.+.
T Consensus 317 ~~~ 319 (334)
T 2pvf_A 317 LTL 319 (334)
T ss_dssp HHH
T ss_pred Hhc
Confidence 643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=346.30 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=198.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 516 (763)
..+.+.++||+|+||.||+++.. +++.||+|+++... .....+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 45777899999999999999876 47889999997542 2234578899999887 899999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 132 ~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NI 184 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ------------------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNV 184 (396)
T ss_dssp EECCTTCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGE
T ss_pred EEcCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHE
Confidence 9999999999999653 35889999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
|++.++++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........
T Consensus 185 Ll~~~g~ikL~DFGla~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~ 263 (396)
T 4dc2_A 185 LLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263 (396)
T ss_dssp EECTTSCEEECCCTTCBCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----
T ss_pred EECCCCCEEEeecceeeecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc
Confidence 99999999999999998533222 23445689999999999999999999999999999999999999997543221100
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
. .......... ... . ..++.....++.+++..||+.||++||++
T Consensus 264 ~-~~~~~~~~~i---------~~~----~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 264 Q-NTEDYLFQVI---------LEK----Q--IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --CCHHHHHHHH---------HHC----C--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred h-hhHHHHHHHH---------hcc----c--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0 0001111111 111 1 11223445678899999999999999995
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=348.23 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=199.4
Q ss_pred HHhccccccccccccceEEEEEeCC-----CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTD-----HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~-----~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
...+.+.+.||+|+||.||+|.... +..||||+++.... ...++.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3456667899999999999997643 23699999975433 2346889999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 123 lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~ 176 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK-----------------------DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAAR 176 (333)
T ss_dssp EEEECCTTEEHHHHHHHT-----------------------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred EEEeCCCCCcHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChh
Confidence 999999999999999642 245889999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGS 671 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~ 671 (763)
||+++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 177 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 177 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp GEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999866543221 1222346788999999999999999999999999999999 9999863321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
......+.++ .....+...+..+.+++.+||+.||++||++.+|+++|+.+.
T Consensus 257 ----------~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 257 ----------HEVMKAINDG--------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ----------HHHHHHHHTT--------------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----------HHHHHHHHCC--------------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0011111111 011111344567899999999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=348.71 Aligned_cols=272 Identities=24% Similarity=0.320 Sum_probs=208.7
Q ss_pred HHhccccccccccccceEEEEEe-----CCCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEe--eCCee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGEL-----TDHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCA--EKGER 513 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~-----~~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 513 (763)
...+.+.++||+|+||.||++++ .+++.||||+++.... ..+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35677889999999999999985 3578999999975433 3356899999999999999999999987 45678
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp 155 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH-----------------------RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAA 155 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH-----------------------GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred EEEEeecCCCCHHHHHHhc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCh
Confidence 9999999999999999653 135889999999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
+||+++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.....
T Consensus 156 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 156 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp GGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred hhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 999999999999999999987654332 122334678889999999999999999999999999999999999863321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
... ..............+...+........+...+..+.+++..||+.||++|||+.||++.|+.+..
T Consensus 236 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 236 EFL---------RMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHH---------HHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hhh---------hhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 000 00000000000000111111111222234556789999999999999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=372.11 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=198.0
Q ss_pred cccccccceEEEEEeC---CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCC
Q 046586 450 LIGRGGFGDVYKGELT---DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~---~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gs 524 (763)
+||+|+||.||+|.+. ++..||||+++... ...++|.+|+++|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999774 45679999998542 345779999999999999999999999976 56899999999999
Q ss_pred HhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCe
Q 046586 525 LADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP 604 (763)
Q Consensus 525 L~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~ 604 (763)
|.+++.. ....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 422 L~~~l~~-----------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~v 475 (613)
T 2ozo_A 422 LHKFLVG-----------------------KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYA 475 (613)
T ss_dssp HHHHHTT-----------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEE
T ss_pred HHHHHhh-----------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcE
Confidence 9999954 2346899999999999999999999998 9999999999999999999
Q ss_pred EEcccCcccccCCCCccc--ccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchh
Q 046586 605 KISDFGLAKLRKKEDMVS--MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 605 kI~DFGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~ 681 (763)
||+|||+++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 476 kL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------- 546 (613)
T 2ozo_A 476 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------- 546 (613)
T ss_dssp EECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---------
T ss_pred EEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---------
Confidence 999999998765433221 122345689999999999999999999999999999998 99999743210
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.....+..+ .....+..++..+.+++..||+.||++||++.+|++.|+...
T Consensus 547 -~~~~~i~~~--------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 547 -EVMAFIEQG--------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp -HHHHHHHTT--------------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHcC--------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011111111 111222445678999999999999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.25 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=204.7
Q ss_pred Hhccccc-cccccccceEEEEEeC---CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSN-LIGRGGFGDVYKGELT---DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~-~LG~G~fG~Vy~g~~~---~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
..+.+.+ .||+|+||.||+|... ++..||+|+++.... ..+++.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3444555 8999999999999864 567899999986432 345688999999999999999999999 56678999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 88 ~e~~~~~~L~~~l~~-----------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 141 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG-----------------------KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNV 141 (287)
T ss_dssp EECCTTEEHHHHHTT-----------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred EEeCCCCCHHHHHHh-----------------------CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheE
Confidence 999999999999953 2345889999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 142 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~- 220 (287)
T 1u59_A 142 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP- 220 (287)
T ss_dssp EEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-
T ss_pred EEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence 9999999999999999876543322 1223456889999999998899999999999999999998 99999643210
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. ....+..+ . ....+...+..+.+++..||+.||++||++.+|++.|+.+.
T Consensus 221 --------~-~~~~i~~~----------~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 221 --------E-VMAFIEQG----------K----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp --------H-HHHHHHTT----------C----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------H-HHHHHhcC----------C----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 00111111 0 11122345678899999999999999999999999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.27 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=206.0
Q ss_pred HHHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEee--------
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAE-------- 509 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-------- 509 (763)
......+.+.+.||+|+||.||+++.. +++.||+|+++... ..+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 344567888899999999999999886 68899999997532 467899999999999999999998864
Q ss_pred --------CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 046586 510 --------KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE 581 (763)
Q Consensus 510 --------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~ 581 (763)
....++||||+++++|.+++... ....+++..++.++.|++.||+|||+.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~ 141 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR----------------------RGEKLDKVLALELFEQITKGVDYIHSK 141 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG----------------------GGSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc----------------------cCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 44588999999999999999653 224588999999999999999999999
Q ss_pred CCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh
Q 046586 582 CLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661 (763)
Q Consensus 582 ~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt 661 (763)
+ |+|+||||+||+++.++.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++
T Consensus 142 ~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 216 (284)
T 2a19_B 142 K---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216 (284)
T ss_dssp T---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHS
T ss_pred C---eeeccCCHHHEEEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHh
Confidence 8 99999999999999999999999999986654322 234568999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 662 GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 662 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
|..|+.... .. ...+....+ . ...+..+.+++.+||+.||++|||+.|+++
T Consensus 217 ~~~~~~~~~----------------~~-----~~~~~~~~~----~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 267 (284)
T 2a19_B 217 VCDTAFETS----------------KF-----FTDLRDGII----S----DIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267 (284)
T ss_dssp CCSSHHHHH----------------HH-----HHHHHTTCC----C----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCcchhHH----------------HH-----HHHhhcccc----c----ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 998764210 00 001111111 1 122356788999999999999999999999
Q ss_pred HhccCCCCCCCC
Q 046586 742 MLEGTVEITEPK 753 (763)
Q Consensus 742 ~Le~~~~~~~p~ 753 (763)
.|+...+.+...
T Consensus 268 ~l~~~~~~~~~~ 279 (284)
T 2a19_B 268 TLTVWKKSPEKN 279 (284)
T ss_dssp HHHHHTC-----
T ss_pred HHHHHhhCCCcc
Confidence 998876654443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=348.20 Aligned_cols=245 Identities=26% Similarity=0.352 Sum_probs=194.5
Q ss_pred cccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 448 SNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
.+.||+|+||.||+|... +++.||+|+++... ...+++.+|++++++++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 468999999999999875 68899999998543 3456789999999999999999999999999999999999999999
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE--cCCCC
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL--GDDFC 603 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl--~~~~~ 603 (763)
.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.
T Consensus 174 ~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 227 (373)
T 2x4f_A 174 FDRIIDE-----------------------SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQ 227 (373)
T ss_dssp HHHHHHT-----------------------GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTE
T ss_pred HHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCc
Confidence 9998642 235789999999999999999999998 9999999999999 67789
Q ss_pred eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHH
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~ 683 (763)
+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus 228 ~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---------~- 295 (373)
T 2x4f_A 228 IKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---------E- 295 (373)
T ss_dssp EEECCCSSCEECCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---------H-
T ss_pred EEEEeCCCceecCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---------H-
Confidence 99999999987654322 23346899999999999999999999999999999999999999643210 0
Q ss_pred HHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
....+... .. ...........+.+.+++.+||+.||++|||+.|+++
T Consensus 296 ~~~~i~~~---------~~--~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 296 TLNNILAC---------RW--DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHT---------CC--CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhc---------cC--CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01111111 00 0011111234567899999999999999999999996
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.05 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=198.4
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc----hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG----DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~----~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..|.+.++||+|+||.||++... +++.||+|+++..... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 45778899999999999999875 6789999999754322 256889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+
T Consensus 114 e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl 166 (309)
T 2h34_A 114 RLINGVDLAAMLRRQ------------------------GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENIL 166 (309)
T ss_dssp ECCCCEEHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred EecCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEE
Confidence 999999999999643 25789999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++.+||+|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------ 240 (309)
T 2h34_A 167 VSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------ 240 (309)
T ss_dssp ECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------
T ss_pred EcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------
Confidence 99999999999999986654443334456789999999999999999999999999999999999999964321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhccCCCCCCCC
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-SMGKVAKMLEGTVEITEPK 753 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVv~~Le~~~~~~~p~ 753 (763)
............. ....+...+..+.+++.+||+.||++|| ++.++++.|+.......+.
T Consensus 241 ----~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 241 ----SVMGAHINQAIPR------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp ----HHHHHHHHSCCCC------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred ----HHHHHHhccCCCC------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 0111111111000 0011123456788999999999999999 9999999999887654443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=342.36 Aligned_cols=243 Identities=21% Similarity=0.247 Sum_probs=202.3
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.+.||+|+||.||+++.. +++.||+|+++.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45777899999999999999876 5889999999743 234467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 121 e~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIl 173 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI------------------------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLL 173 (350)
T ss_dssp ECCTTCBHHHHHHHH------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred cCCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEE
Confidence 999999999999653 24788999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 174 l~~~g~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------ 243 (350)
T 1rdq_E 174 IDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------ 243 (350)
T ss_dssp ECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred ECCCCCEEEcccccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------
Confidence 999999999999999865432 2345799999999999999999999999999999999999999964321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~ 741 (763)
......+ ..... .++......+.+++.+||+.||++||+ +.||++
T Consensus 244 ----~~~~~~i---------~~~~~------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 244 ----IQIYEKI---------VSGKV------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----HHHHHHH---------HHCCC------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----HHHHHHH---------HcCCC------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0011111 11111 111234567889999999999999998 888874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=343.35 Aligned_cols=268 Identities=24% Similarity=0.359 Sum_probs=210.0
Q ss_pred HHHHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCC
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG 511 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 511 (763)
+....+.+.+.||+|+||.||+|+.. .++.||+|+++.... ...++.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 101 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 101 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence 34456788899999999999999764 367899999975433 2346889999999999999999999999999
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
..++||||+++|+|.+++...+... . .......+++..++.++.|++.||+|||+.+ |+||||
T Consensus 102 ~~~lv~e~~~~~~L~~~l~~~~~~~--------~------~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di 164 (322)
T 1p4o_A 102 PTLVIMELMTRGDLKSYLRSLRPAM--------A------NNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDL 164 (322)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHH--------H------HCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCC
T ss_pred ccEEEEEeCCCCcHHHHHHHhchhh--------c------cCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCC
Confidence 9999999999999999996532000 0 0001245789999999999999999999998 999999
Q ss_pred CCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccc
Q 046586 592 KPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQ 669 (763)
Q Consensus 592 k~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~ 669 (763)
||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 165 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 244 (322)
T 1p4o_A 165 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244 (322)
T ss_dssp SGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence 99999999999999999999986543322 22233457889999999999999999999999999999999 88888643
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.. . .......++ .. ...+...+..+.+++.+||+.||++|||+.|+++.|++..+
T Consensus 245 ~~---------~-~~~~~~~~~---------~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 245 SN---------E-QVLRFVMEG---------GL-----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CH---------H-HHHHHHHTT---------CC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CH---------H-HHHHHHHcC---------Cc-----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 21 0 001111111 00 01113345678899999999999999999999999988654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=342.29 Aligned_cols=272 Identities=24% Similarity=0.328 Sum_probs=210.1
Q ss_pred CccccHHHHHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhc--CCCCccccEEEEEee
Q 046586 432 PKRFTHAELRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIAR--MHHLNLVRLWGFCAE 509 (763)
Q Consensus 432 ~~~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~ 509 (763)
...+...+.....+.+.+.||+|+||.||+|+.. ++.||||+++.. ....+.+|++++.. ++||||+++++++..
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 3445556667788999999999999999999984 788999999643 34567888888887 799999999999988
Q ss_pred CC----eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH------
Q 046586 510 KG----ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH------ 579 (763)
Q Consensus 510 ~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH------ 579 (763)
.. ..++||||+++|+|.+++... .+++.+++.++.|++.||+|||
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~ 162 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-------------------------TVTVEGMIKLALSTASGLAHLHMEIVGT 162 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC-------------------------CBCHHHHHHHHHHHHHHHHHHHCCBCST
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc-------------------------CccHHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 76 789999999999999999542 4789999999999999999999
Q ss_pred --hcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcc---cccccccCCCcccccccccC------CCCCccc
Q 046586 580 --EECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV---SMSRIRGTRGYMAPEWLRSD------QITPKAD 648 (763)
Q Consensus 580 --~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~------~~s~ksD 648 (763)
+.+ |+||||||+||+++.++++||+|||+++........ ......||+.|+|||.+.+. .++.++|
T Consensus 163 ~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~D 239 (342)
T 1b6c_B 163 QGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 239 (342)
T ss_dssp TCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHH
T ss_pred cccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCccc
Confidence 666 999999999999999999999999999765443321 23345789999999998765 2336899
Q ss_pred eeehhHHHHHHHhC----------CCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCc-chHHHHHH
Q 046586 649 VYSFGMVLLEIVSG----------SRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSR-VHFDMVNR 717 (763)
Q Consensus 649 VwS~Gvll~elltG----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~ 717 (763)
|||||+++|||++| ..||...... ......+. . .+............ ...+....
T Consensus 240 i~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~----~~~~~~~~-~---------~~~~~~~~~~~~~~~~~~~~~~~ 305 (342)
T 1b6c_B 240 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS----DPSVEEMR-K---------VVCEQKLRPNIPNRWQSCEALRV 305 (342)
T ss_dssp HHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS----SCCHHHHH-H---------HHTTSCCCCCCCGGGGTSHHHHH
T ss_pred HHHHHHHHHHHHhccCcCCcccccccCccccCcC----cccHHHHH-H---------HHHHHHhCCCCcccccchhHHHH
Confidence 99999999999999 5555432211 11111111 0 01111111111111 12367788
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 718 MVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 718 l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 306 l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 306 MAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.89 Aligned_cols=247 Identities=24% Similarity=0.351 Sum_probs=193.2
Q ss_pred HHhccccccccccccceEEEEEe----CCCcEEEEEEeeccC-----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCe
Q 046586 442 AATNGFSNLIGRGGFGDVYKGEL----TDHRVVAVKCLKNVT-----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE 512 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~----~~~~~VAvK~l~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 512 (763)
...+.+.++||+|+||.||+++. .+++.||+|+++... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45678889999999999999987 468899999997532 233457889999999999999999999999999
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlk 148 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE------------------------GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLK 148 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCC
Confidence 99999999999999999643 24788899999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 149 p~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~- 226 (327)
T 3a62_A 149 PENIMLNHQGHVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR- 226 (327)
T ss_dssp TTTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred HHHeEECCCCcEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-
Confidence 999999999999999999997543222 123345789999999999999999999999999999999999999964321
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
.. .... +..... .++......+.+++.+||+.||++|| ++.|+++
T Consensus 227 --------~~-~~~~---------i~~~~~------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 227 --------KK-TIDK---------ILKCKL------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --------HH-HHHH---------HHHTCC------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --------HH-HHHH---------HHhCCC------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 00 0111 111111 11123456788999999999999999 7778875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=342.04 Aligned_cols=265 Identities=24% Similarity=0.362 Sum_probs=196.8
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCc----hhhhHHHHHHHhcCCCCccccEEEEEeeCCe----e
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGG----DAEFWAEVTIIARMHHLNLVRLWGFCAEKGE----R 513 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~----~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----~ 513 (763)
..|.+.++||+|+||.||+++. .+++.||||+++..... ...+.+|+.++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 4577889999999999999987 56889999999754322 2458899999999999999999999887653 3
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||
T Consensus 92 ~lv~e~~~g~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp 144 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE------------------------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKP 144 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCG
T ss_pred EEEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCH
Confidence 9999999999999999643 25889999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 145 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp GGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999999986544322 223345689999999999999999999999999999999999999964321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH-HHhccCCCCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA-KMLEGTVEIT 750 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv-~~Le~~~~~~ 750 (763)
................ ......+.++.+++.+||+.||++||++.+++ +.|.......
T Consensus 225 ---------~~~~~~~~~~~~~~~~------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 225 ---------VSVAYQHVREDPIPPS------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp ---------HHHHHHHHHCCCCCHH------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred ---------HHHHHHHhcCCCCCcc------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 1111111111100000 00012456788999999999999999666554 4554443333
Q ss_pred CCCCC
Q 046586 751 EPKKP 755 (763)
Q Consensus 751 ~p~~p 755 (763)
+|..|
T Consensus 284 ~~~~~ 288 (311)
T 3ork_A 284 PPEAP 288 (311)
T ss_dssp CCSSC
T ss_pred CCCCC
Confidence 33333
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.49 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=201.3
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeee
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 514 (763)
....+.+.+.||+|+||.||+++.. +++.||+|+++.. ......+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 3456777899999999999999886 5789999999753 33455678899999877 9999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+
T Consensus 95 lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~ 147 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC------------------------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLD 147 (345)
T ss_dssp EEEECCTTCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG
T ss_pred EEEeCCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChh
Confidence 999999999999999643 25788999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
|||++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 148 NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--- 223 (345)
T 1xjd_A 148 NILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--- 223 (345)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred hEEECCCCCEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---
Confidence 9999999999999999998543222 223456799999999999999999999999999999999999999964321
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG-KVA 740 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVv 740 (763)
......+..+ . ...+......+.+++.+||+.||++||++. +|+
T Consensus 224 -------~~~~~~i~~~-------------~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 224 -------EELFHSIRMD-------------N--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------HHHHHHHHHC-------------C--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------HHHHHHHHhC-------------C--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0001111111 0 011123456788999999999999999997 665
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=346.79 Aligned_cols=279 Identities=18% Similarity=0.179 Sum_probs=203.1
Q ss_pred Hhcccccccccc--ccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRG--GFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G--~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
..|.+.++||+| +||.||+++.. +++.||||+++..... .+.+.+|+.+++.++|||||++++++.+.+..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 467888999999 99999999886 6889999999754322 24577899999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~----------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NI 159 (389)
T 3gni_B 105 TSFMAYGSAKDLICTH----------------------FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHI 159 (389)
T ss_dssp EECCTTCBHHHHHHHT----------------------CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred EEccCCCCHHHHHhhh----------------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 9999999999999654 2345889999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCc------ccccccccCCCccccccccc--CCCCCccceeehhHHHHHHHhCCCCccc
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDM------VSMSRIRGTRGYMAPEWLRS--DQITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
|++.++.+||+|||++........ .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 160 LISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999865432211 11122468899999999987 6899999999999999999999999965
Q ss_pred ccCCCCCC---CCchhHHH------HHHHHhc-------cChhhhhcc-----cccccCCCcchHHHHHHHHHHHHHccC
Q 046586 669 QGSMMNSD---EWYFPKWA------FEKVYEE-------MKVEDILDR-----HIKNSYDSRVHFDMVNRMVKTAMWCIQ 727 (763)
Q Consensus 669 ~~~~~~~~---~~~~~~~~------~~~~~~~-------~~~~~~~~~-----~l~~~~~~~~~~~~~~~l~~l~~~Cl~ 727 (763)
........ ....+... ....... ....+.+.. ..........+......+.+++.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 319 (389)
T 3gni_B 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319 (389)
T ss_dssp CCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTC
T ss_pred CCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhh
Confidence 33211000 00000000 0000000 000000000 000000111223445779999999999
Q ss_pred CCCCCCCCHHHHHHH--hccC
Q 046586 728 DRPELRPSMGKVAKM--LEGT 746 (763)
Q Consensus 728 ~dP~~RPs~~eVv~~--Le~~ 746 (763)
.||++|||+.|+++. +++.
T Consensus 320 ~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 320 RNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp SCTTTSCCHHHHTTSGGGGGC
T ss_pred cCcccCCCHHHHhcCHHHHHH
Confidence 999999999999854 5443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=354.09 Aligned_cols=252 Identities=22% Similarity=0.270 Sum_probs=200.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.++||+|+||.||+++.. +++.||+|+++.. ......+.+|..++..++||||+++++++.+.+..+|||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 45666789999999999999885 6899999999742 223345889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 141 E~~~gg~L~~~l~~~-----------------------~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NIL 194 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKF-----------------------GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNIL 194 (412)
T ss_dssp CCCCSCBHHHHHHHH-----------------------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred cCCCCCcHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHee
Confidence 999999999999653 235889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc-------cCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-------SDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-------~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
++.++++||+|||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 195 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 195 LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 999999999999999876554443344568999999999987 4678999999999999999999999996432
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELR---PSMGKVAK 741 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~eVv~ 741 (763)
.. ..... ++........+ ..+...+.++.+++.+||+ +|++| |++.||++
T Consensus 275 ~~----------~~~~~---------i~~~~~~~~~p-~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 275 TA----------ETYGK---------IVHYKEHLSLP-LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HH----------HHHHH---------HHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HH----------HHHHH---------HHhcccCcCCC-ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 10 00011 11100000000 0112345678899999999 99998 68999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=336.09 Aligned_cols=254 Identities=27% Similarity=0.377 Sum_probs=200.6
Q ss_pred HhccccccccccccceEEEEEeCC----CcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD----HRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
..+.+.+.||+|+||.||+|+..+ +..||+|+++.... ..+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 467778999999999999998643 23699999975432 34668999999999999999999999865 457899
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 91 ~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Ni 144 (281)
T 3cc6_A 91 MELYPYGELGHYLERN-----------------------KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNI 144 (281)
T ss_dssp EECCTTCBHHHHHHHH-----------------------TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGE
T ss_pred EecCCCCCHHHHHHhc-----------------------cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceE
Confidence 9999999999999653 235789999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNS 675 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~ 675 (763)
+++.++.+||+|||++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 145 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-- 222 (281)
T 3cc6_A 145 LVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-- 222 (281)
T ss_dssp EEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--
T ss_pred EECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--
Confidence 99999999999999998765544333344567889999999999999999999999999999998 999986332110
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. ...+..+. . ...+...++.+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 223 ----~----~~~~~~~~----------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 223 ----V----IGVLEKGD----------R----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ----H----HHHHHHTC----------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----H----HHHHhcCC----------C----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 0 01111110 0 0111234567889999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=344.46 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=187.3
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
..+.+.++||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 34677889999999999999886 47889999998543 34568899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC-
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD- 600 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~- 600 (763)
+++|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 132 ~~~L~~~l~~------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~ 184 (349)
T 2w4o_A 132 GGELFDRIVE------------------------KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATP 184 (349)
T ss_dssp SCBHHHHHTT------------------------CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSS
T ss_pred CCCHHHHHHh------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecC
Confidence 9999999853 235889999999999999999999998 999999999999975
Q ss_pred --CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 601 --DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 601 --~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 185 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------ 256 (349)
T 2w4o_A 185 APDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------ 256 (349)
T ss_dssp STTCCEEECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------
T ss_pred CCCCCEEEccCccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------
Confidence 8999999999998654322 233457899999999999999999999999999999999999999643210
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
......+... ... .......+....+.+++.+||+.||++|||+.|+++.
T Consensus 257 ---~~~~~~i~~~---------~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 257 ---QFMFRRILNC---------EYY--FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---HHHHHHHHTT---------CCC--CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---HHHHHHHHhC---------CCc--cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111 000 0011112345678899999999999999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=351.49 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=192.2
Q ss_pred ccccccccccccceEEEEEeC--CC--cEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEee-CCeeeEEE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT--DH--RVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAE-KGERTLVY 517 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~--~~--~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~LV~ 517 (763)
+.+.++||+|+||.||+|... ++ ..||+|.++.... ..++|.+|+.++++++||||+++++++.+ .+..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 456789999999999999764 22 3689999875432 34678999999999999999999999765 45789999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 171 e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 224 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNE-----------------------THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCM 224 (373)
T ss_dssp ECCTTCBHHHHHHCT-----------------------TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred ECCCCCCHHHHHhhc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEE
Confidence 999999999999642 245788999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcc---cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMV---SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 225 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~ 304 (373)
T 3c1x_A 225 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304 (373)
T ss_dssp ECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC
T ss_pred ECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH
Confidence 999999999999999865433221 2233457788999999999999999999999999999999 666775432111
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.. ....++. ....+...+..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 305 ------~~----~~~~~~~--------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 305 ------IT----VYLLQGR--------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp ------HH----HHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HH----HHHHcCC--------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 1111111 011112345678999999999999999999999999988653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=344.25 Aligned_cols=249 Identities=21% Similarity=0.325 Sum_probs=194.0
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCC--CccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHH--LNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~LV~ 517 (763)
..|.+.++||+|+||.||++...+++.||||+++..... .+.+.+|+.++.+++| +||+++++++.+.+..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 346778999999999999999988999999999754332 2568899999999976 99999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
| +.+++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||
T Consensus 89 e-~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIl 140 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKK------------------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFL 140 (343)
T ss_dssp C-CCSEEHHHHHHHS------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred e-CCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEE
Confidence 9 5688999999643 35788999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcc-cccccccCCCccccccccc-----------CCCCCccceeehhHHHHHHHhCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRS-----------DQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
++ ++.+||+|||+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.|
T Consensus 141 l~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 219 (343)
T 3dbq_A 141 IV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219 (343)
T ss_dssp EE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred EE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCc
Confidence 97 578999999999876543322 2334679999999999864 6789999999999999999999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
|...... ... ....++.......+ ......+.+++..||+.||.+|||+.|+++.
T Consensus 220 f~~~~~~--------~~~----------~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 220 FQQIINQ--------ISK----------LHAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp TTTCCSH--------HHH----------HHHHHCTTSCCCCC----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhhH--------HHH----------HHHHhcCCcccCCc----ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 9632110 000 11222222211111 2234578899999999999999999999853
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=344.36 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=201.4
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.+.||+|+||.||+++.. +++.||+|+++.. ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45778899999999999999876 4789999999743 334467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 95 e~~~gg~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIl 147 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN------------------------VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNIL 147 (384)
T ss_dssp CCCTTEEHHHHHHTT------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred ecCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeE
Confidence 999999999999642 35889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc---CCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS---DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++.++.+||+|||+++...... ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||.......
T Consensus 148 l~~~g~vkL~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~- 224 (384)
T 4fr4_A 148 LDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS- 224 (384)
T ss_dssp ECTTSCEEECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-
T ss_pred ECCCCCEEEeccceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-
Confidence 9999999999999998654332 2345679999999999864 468999999999999999999999997433211
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-MGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~eVv~ 741 (763)
... ...... .. ....+......+.+++..||+.||.+||+ +.+|.+
T Consensus 225 -----~~~-~~~~~~---------~~------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 225 -----SKE-IVHTFE---------TT------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----HHH-HHHHHH---------HC------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----HHH-HHHHHh---------hc------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 000 000000 00 01111334567899999999999999998 777764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.99 Aligned_cols=255 Identities=23% Similarity=0.354 Sum_probs=197.6
Q ss_pred HhccccccccccccceEEEEEeC-CCc----EEEEEEeecc--CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHR----VVAVKCLKNV--TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~----~VAvK~l~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
..+.+.++||+|+||.||+|... +++ .||+|.++.. ....+++.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 45777899999999999999864 344 3577777543 334567999999999999999999999998764 789
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 94 v~~~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~N 147 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH-----------------------KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARN 147 (327)
T ss_dssp EECCCSSCBHHHHHHHT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEecCCCcHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHH
Confidence 99999999999999653 245889999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 673 (763)
||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 148 Il~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 227 (327)
T 3lzb_A 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp EEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999999999999986643322 22233456788999999999999999999999999999999 999997432110
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
....+..... ...+......+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 228 --------------------~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 228 --------------------ISSILEKGER----LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --------------------HHHHHHTTCC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --------------------HHHHHHcCCC----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111111111 11113345678899999999999999999999999987654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=332.08 Aligned_cols=264 Identities=22% Similarity=0.243 Sum_probs=196.3
Q ss_pred hccccccccccccceEEEEEeCCCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.|.+.++||+|+||.||+|+..+++.||+|+++.... ....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 4667889999999999999998899999999964332 2366889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 83 ~~-~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~ 135 (288)
T 1ob3_A 83 DQ-DLKKLLDVC-----------------------EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINR 135 (288)
T ss_dssp SE-EHHHHHHTS-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred CC-CHHHHHHhc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcC
Confidence 85 999988542 235788999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||+++...... .......+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||.......
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------ 208 (288)
T 1ob3_A 136 EGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD------ 208 (288)
T ss_dssp TSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------
T ss_pred CCCEEEeECccccccCccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence 9999999999997654321 12234568999999999875 468999999999999999999999996432110
Q ss_pred hhHHHHHHHHhcc--Chhh-----hhcccccccCC---CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 680 FPKWAFEKVYEEM--KVED-----ILDRHIKNSYD---SRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~--~~~~-----~~~~~l~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
............. .... ..++....... ........+.+.+++.+||+.||++|||+.|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000000 0000 00000000000 0011224567889999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.67 Aligned_cols=263 Identities=23% Similarity=0.271 Sum_probs=203.8
Q ss_pred HHhccccccccccccceEEEEEe-CCCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEee----CCeeeE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAE----KGERTL 515 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~L 515 (763)
...|.+.+.||+|+||.||+++. .+++.||||++.... ...+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 34677889999999999999987 568899999986533 334668899999999999999999999873 347889
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+.+ |+||||||+|
T Consensus 108 v~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~N 164 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKD--------------------KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTN 164 (317)
T ss_dssp EEECCTTCBHHHHHHHHHT--------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEEeCCCCcHHHHHHHHHh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 9999999999999975321 2356899999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcc--------cccccccCCCcccccccccCC---CCCccceeehhHHHHHHHhCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMV--------SMSRIRGTRGYMAPEWLRSDQ---ITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~--------~~~~~~gt~~y~APE~l~~~~---~s~ksDVwS~Gvll~elltG~~ 664 (763)
|+++.++.+||+|||++......... ......||+.|+|||.+.... ++.++||||||+++|||++|+.
T Consensus 165 Il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 244 (317)
T 2buj_A 165 ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244 (317)
T ss_dssp EEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSC
T ss_pred EEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999998754321110 112345799999999987553 7899999999999999999999
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
||....... ......+....... .+...+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 245 p~~~~~~~~------------------~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 245 PYDMVFQKG------------------DSVALAVQNQLSIP----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp TTHHHHHTT------------------SCHHHHHHCC--CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Chhhhhccc------------------chhhHHhhccCCCC----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 986321100 00111111111111 11234567899999999999999999999999999
Q ss_pred cCCCC
Q 046586 745 GTVEI 749 (763)
Q Consensus 745 ~~~~~ 749 (763)
.+...
T Consensus 303 ~~~~~ 307 (317)
T 2buj_A 303 ALQPP 307 (317)
T ss_dssp HTCCC
T ss_pred hcCCC
Confidence 76543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=348.43 Aligned_cols=270 Identities=29% Similarity=0.394 Sum_probs=195.6
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHH--HHhcCCCCccccEEEEEee-----CCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVT--IIARMHHLNLVRLWGFCAE-----KGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~--~l~~l~H~niv~l~g~~~~-----~~~~~L 515 (763)
..+.+.++||+|+||.||+|+. +++.||||+++... ...+..|.+ .+..++||||+++++.+.. ....++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 4567788999999999999987 56889999997543 233444444 4556899999999986653 235689
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCcE
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE---------CLEWV 586 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~---------~~~~i 586 (763)
||||+++|+|.+++... ..++..+..++.|++.||+|||+. + |
T Consensus 90 v~e~~~~g~L~~~l~~~-------------------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---i 141 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLH-------------------------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---I 141 (336)
T ss_dssp EECCCTTCBHHHHHHHC-------------------------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---E
T ss_pred EEecCCCCcHHHHHhhc-------------------------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---e
Confidence 99999999999999543 347889999999999999999998 6 9
Q ss_pred EecCCCCCceEEcCCCCeEEcccCcccccCCCCc-------ccccccccCCCccccccccc-------CCCCCccceeeh
Q 046586 587 LHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-------VSMSRIRGTRGYMAPEWLRS-------DQITPKADVYSF 652 (763)
Q Consensus 587 vHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-------~~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwS~ 652 (763)
+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+ ..++.++|||||
T Consensus 142 vH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 221 (336)
T 3g2f_A 142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221 (336)
T ss_dssp ECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHH
T ss_pred eecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHH
Confidence 9999999999999999999999999986543221 12234569999999999876 456678999999
Q ss_pred hHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccCh---hhh-hcccccccCCCc--chHHHHHHHHHHHHHcc
Q 046586 653 GMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKV---EDI-LDRHIKNSYDSR--VHFDMVNRMVKTAMWCI 726 (763)
Q Consensus 653 Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~l~~~~~~~--~~~~~~~~l~~l~~~Cl 726 (763)
|+++|||++|..|+........... .+.. ........ ... .........+.. .....+..+.+++.+||
T Consensus 222 G~il~ell~g~~p~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (336)
T 3g2f_A 222 GLIYWEIFMRCTDLFPGESVPEYQM-AFQT----EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCW 296 (336)
T ss_dssp HHHHHHHHTTBGGGSTTSCCCCCCC-TTHH----HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHS
T ss_pred HHHHHHHHhcCCcCCCccchhHHHH-hhhc----ccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHh
Confidence 9999999999887743322111000 0000 00000000 000 000111111110 11346778999999999
Q ss_pred CCCCCCCCCHHHHHHHhccCCC
Q 046586 727 QDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 727 ~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
+.||++|||+.||++.|+++++
T Consensus 297 ~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 297 DQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCChhhCcchHHHHHHHHHHHH
Confidence 9999999999999999988764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=342.78 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=200.7
Q ss_pred HHHhccccccccccccceEEEEEeCC-C-------cEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTD-H-------RVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG 511 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~-~-------~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 511 (763)
....+.+.+.||+|+||.||+|+... + ..||+|+++... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 34567788999999999999997653 2 469999997543 34567899999999999999999999999999
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dl 139 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN-----------------------KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNV 139 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT-----------------------GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred CCEEEEECCCCCCHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCc
Confidence 999999999999999999653 234789999999999999999999998 999999
Q ss_pred CCCceEEcCCCC--------eEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhC
Q 046586 592 KPENILLGDDFC--------PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSG 662 (763)
Q Consensus 592 k~~NILl~~~~~--------~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG 662 (763)
||+|||++.++. +||+|||++...... ....+|..|+|||.+.+ ..++.++||||||+++|||++|
T Consensus 140 kp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 214 (289)
T 4fvq_A 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214 (289)
T ss_dssp CGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTT
T ss_pred CcceEEEecCCcccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcC
Confidence 999999998887 999999999754322 23457889999999987 7899999999999999999996
Q ss_pred CCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 663 SRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 663 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
..|+..... .. ........ . .... .....++.+++..||+.||++|||+.++++.
T Consensus 215 ~~~~~~~~~--------~~--~~~~~~~~--------~---~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 215 GDKPLSALD--------SQ--RKLQFYED--------R---HQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCTTTTSC--------HH--HHHHHHHT--------T---CCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCccccc--------hH--HHHHHhhc--------c---CCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 554431110 00 00000000 0 0011 1123467899999999999999999999999
Q ss_pred hccCCC
Q 046586 743 LEGTVE 748 (763)
Q Consensus 743 Le~~~~ 748 (763)
|+.+..
T Consensus 270 l~~l~~ 275 (289)
T 4fvq_A 270 LNSLFT 275 (289)
T ss_dssp HHTCC-
T ss_pred HHHhcC
Confidence 998775
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=373.04 Aligned_cols=246 Identities=26% Similarity=0.376 Sum_probs=196.5
Q ss_pred ccccccccceEEEEEeC---CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELT---DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~---~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
++||+|+||.||+|.+. .++.||||+++.... ..+++.+|++++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 457899999985432 2467999999999999999999999996 4568899999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++... ..+++.+++.|+.||+.||+|||+.+ ||||||||+|||++.++
T Consensus 454 g~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~ 506 (635)
T 4fl3_A 454 GPLNKYLQQN------------------------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQH 506 (635)
T ss_dssp EEHHHHHHHC------------------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETT
T ss_pred CCHHHHHhhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCC
Confidence 9999999643 35889999999999999999999998 99999999999999999
Q ss_pred CeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCc
Q 046586 603 CPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 679 (763)
.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 507 ~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------- 578 (635)
T 4fl3_A 507 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------- 578 (635)
T ss_dssp EEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------
T ss_pred CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------
Confidence 999999999987654332 22233456789999999999999999999999999999998 9999964321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
..... .+.... ....+..++.++.+++..||+.||++||++.+|++.|+..
T Consensus 579 --~~~~~----------~i~~~~----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 579 --SEVTA----------MLEKGE----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp --HHHHH----------HHHTTC----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --HHHHH----------HHHcCC----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 00111 111111 1112234567899999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=343.92 Aligned_cols=274 Identities=28% Similarity=0.390 Sum_probs=209.8
Q ss_pred HHHHhccccccccccccceEEEEEe------CCCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEeeC
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGEL------TDHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCAEK 510 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~------~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 510 (763)
+....+.+.+.||+|+||.||+|+. .+++.||||+++.... ..+.+.+|+.++.++ +||||+++++++.+.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 3456778889999999999999974 3467899999975433 235688999999999 799999999999876
Q ss_pred C-eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEec
Q 046586 511 G-ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHC 589 (763)
Q Consensus 511 ~-~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHr 589 (763)
+ ..++||||+++++|.+++............ .........+++..++.++.|++.||+|||+.+ |+||
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV--------APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC---------------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccc--------cchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 5 589999999999999999764321000000 000012344889999999999999999999998 9999
Q ss_pred CCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcc
Q 046586 590 DIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFE 667 (763)
Q Consensus 590 Dlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~ 667 (763)
||||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999986544322 22334567889999999999999999999999999999998 999986
Q ss_pred cccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
..... .........+. ....+......+.+++.+||+.||.+|||+.||++.|+.+.
T Consensus 253 ~~~~~---------~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 253 GVKID---------EEFCRRLKEGT--------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp TCCCS---------HHHHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchh---------HHHHHHhccCc--------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 43211 11111111111 01111233567889999999999999999999999998765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.80 Aligned_cols=265 Identities=17% Similarity=0.180 Sum_probs=198.9
Q ss_pred HHHhccccccccccccceEEEEEeC----CCcEEEEEEeeccCCc------------hhhhHHHHHHHhcCCCCccccEE
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVTGG------------DAEFWAEVTIIARMHHLNLVRLW 504 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~~~------------~~~f~~E~~~l~~l~H~niv~l~ 504 (763)
....|.+.++||+|+||.||+|... .+..+|+|+....... ...+.+|+..+..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3456778899999999999999886 4678999998754321 12366788899999999999999
Q ss_pred EEEee----CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 046586 505 GFCAE----KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE 580 (763)
Q Consensus 505 g~~~~----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~ 580 (763)
+++.+ ....++||||+ +++|.+++... ..+++.+++.++.||+.||+|||+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~ 169 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN------------------------GTFKKSTVLQLGIRMLDVLEYIHE 169 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG------------------------GBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99988 67899999999 99999998542 268899999999999999999999
Q ss_pred cCCCcEEecCCCCCceEEcCCC--CeEEcccCcccccCCCCc------ccccccccCCCcccccccccCCCCCccceeeh
Q 046586 581 ECLEWVLHCDIKPENILLGDDF--CPKISDFGLAKLRKKEDM------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSF 652 (763)
Q Consensus 581 ~~~~~ivHrDlk~~NILl~~~~--~~kI~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~ 652 (763)
.+ |+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+..++.++|||||
T Consensus 170 ~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 246 (345)
T 2v62_A 170 NE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEIL 246 (345)
T ss_dssp TT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHH
T ss_pred CC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHH
Confidence 98 99999999999999887 999999999986543221 11234578999999999999999999999999
Q ss_pred hHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCC
Q 046586 653 GMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPEL 732 (763)
Q Consensus 653 Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~ 732 (763)
|+++|||++|+.||....... ............. ....+...... ...+..+.+++..||+.||++
T Consensus 247 G~il~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~~--~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~ 312 (345)
T 2v62_A 247 GYCMLRWLCGKLPWEQNLKDP-----VAVQTAKTNLLDE--LPQSVLKWAPS-------GSSCCEIAQFLVCAHSLAYDE 312 (345)
T ss_dssp HHHHHHHHHSSCTTGGGTTCH-----HHHHHHHHHHHHT--TTHHHHHHSCT-------TSCCHHHHHHHHHHHTCCTTC
T ss_pred HHHHHHHHhCCCCcccccccc-----HHHHHHHHhhccc--ccHHHHhhccc-------cccHHHHHHHHHHHhhcCccc
Confidence 999999999999996421110 0000001111110 11111110000 133568899999999999999
Q ss_pred CCCHHHHHHHhccCC
Q 046586 733 RPSMGKVAKMLEGTV 747 (763)
Q Consensus 733 RPs~~eVv~~Le~~~ 747 (763)
||++.+|++.|+...
T Consensus 313 Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 313 KPNYQALKKILNPHG 327 (345)
T ss_dssp CCCHHHHHHHHCTTC
T ss_pred CCCHHHHHHHHhccC
Confidence 999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=334.41 Aligned_cols=265 Identities=26% Similarity=0.344 Sum_probs=198.7
Q ss_pred HHHHHhccccccccccccceEEEEEe-CCCcEEEEEEeeccCC------chhhhHHHHHHHhcCC---CCccccEEEEEe
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTG------GDAEFWAEVTIIARMH---HLNLVRLWGFCA 508 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~------~~~~f~~E~~~l~~l~---H~niv~l~g~~~ 508 (763)
++....|.+.++||+|+||.||+|+. .+++.||+|+++.... ....+.+|++++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 34456788889999999999999987 4688999999974321 2346778888877775 999999999998
Q ss_pred eCC-----eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 046586 509 EKG-----ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECL 583 (763)
Q Consensus 509 ~~~-----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~ 583 (763)
... ..++||||++ ++|.+++... ....+++.++..++.|++.||+|||+.+
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----------------------~~~~~~~~~~~~i~~qi~~al~~lH~~~- 140 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA----------------------PPPGLPAETIKDLMRQFLRGLDFLHANC- 140 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTC----------------------CTTCSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhc----------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 765 5789999997 5999999653 2234899999999999999999999998
Q ss_pred CcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCC
Q 046586 584 EWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS 663 (763)
Q Consensus 584 ~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~ 663 (763)
|+||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+
T Consensus 141 --ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 216 (308)
T 3g33_A 141 --IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216 (308)
T ss_dssp --CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSS
T ss_pred --cccCCCCHHHEEEcCCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998654332 234567899999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCchhHHHHHHHHhc--cChhhhhc-------ccccccCCC---cchHHHHHHHHHHHHHccCCCCC
Q 046586 664 RNFEIQGSMMNSDEWYFPKWAFEKVYEE--MKVEDILD-------RHIKNSYDS---RVHFDMVNRMVKTAMWCIQDRPE 731 (763)
Q Consensus 664 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-------~~l~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~ 731 (763)
.||....... ......+. ....+... ......... ....+..+.+.+++.+||+.||+
T Consensus 217 ~pf~~~~~~~----------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 286 (308)
T 3g33_A 217 PLFCGNSEAD----------QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPH 286 (308)
T ss_dssp CSCCCSSHHH----------HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTT
T ss_pred CCCCCCCHHH----------HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCc
Confidence 9996432110 00111100 00000000 000000000 01123456788999999999999
Q ss_pred CCCCHHHHHH
Q 046586 732 LRPSMGKVAK 741 (763)
Q Consensus 732 ~RPs~~eVv~ 741 (763)
+|||+.|+++
T Consensus 287 ~R~t~~e~l~ 296 (308)
T 3g33_A 287 KRISAFRALQ 296 (308)
T ss_dssp TSCCHHHHHT
T ss_pred cCCCHHHHhc
Confidence 9999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=346.91 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=203.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..|.+.++||+|+||.||+|... +++.||+|++..... ....+.+|+++++.++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 35778899999999999999875 578999999975432 3456889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 131 ~gg~L~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~ 184 (387)
T 1kob_A 131 SGGELFDRIAAE-----------------------DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCET 184 (387)
T ss_dssp CCCBHHHHTTCT-----------------------TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESS
T ss_pred CCCcHHHHHHhh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEec
Confidence 999999998532 235889999999999999999999998 999999999999974
Q ss_pred --CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 601 --DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 601 --~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
++.+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 185 ~~~~~vkL~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------ 256 (387)
T 1kob_A 185 KKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ 256 (387)
T ss_dssp TTCCCEEECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------
T ss_pred CCCCceEEEecccceecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------
Confidence 57899999999987654332 23347899999999999999999999999999999999999999743210
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
. ........ .. ..+.......+.++.+++.+||+.||++|||+.|+++.
T Consensus 257 ---~-~~~~i~~~---------~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 257 ---E-TLQNVKRC---------DW--EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---H-HHHHHHHC---------CC--CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---H-HHHHHHhC---------CC--CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 00111110 00 01111112345678899999999999999999999973
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=329.34 Aligned_cols=246 Identities=24% Similarity=0.353 Sum_probs=181.1
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.+.+.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 467788999999999999987 46889999999743 2234678899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 92 ~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili 145 (278)
T 3cok_A 92 MCHNGEMNRYLKNR-----------------------VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLL 145 (278)
T ss_dssp CCTTEEHHHHHHTC-----------------------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEE
T ss_pred cCCCCcHHHHHhhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 99999999999642 246889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----- 219 (278)
T 3cok_A 146 TRNMNIKIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN----- 219 (278)
T ss_dssp CTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------
T ss_pred cCCCCEEEEeecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----
Confidence 9999999999999986543222 1223568999999999999999999999999999999999999997432111
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+........ ..+......+.+++.+||+.||++|||+.++++
T Consensus 220 ------------------~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 220 ------------------TLNKVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----------------------CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------------------HHHHHhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0000000000 111234567889999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=331.96 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=197.5
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.|.+.++||+|+||+||+|+.. +++.||+|+++.... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 4667889999999999999885 578999999974432 235688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 83 ~~~-~l~~~~~~~-----------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~ 135 (292)
T 3o0g_A 83 CDQ-DLKKYFDSC-----------------------NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLIN 135 (292)
T ss_dssp CSE-EHHHHHHHT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCC-CHHHHHHhC-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc
Confidence 975 666666432 245889999999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCC-CCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++||||||+++|||++|..|+......
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~------ 208 (292)
T 3o0g_A 136 RNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV------ 208 (292)
T ss_dssp TTSCEEECCCTTCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH------
T ss_pred CCCCEEEeecccceecCCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH------
Confidence 99999999999998654322 2233457899999999987765 899999999999999999998886322110
Q ss_pred chhHHHHHHHHh--ccChhhhhcccc------------cccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 679 YFPKWAFEKVYE--EMKVEDILDRHI------------KNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~--~~~~~~~~~~~l------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ......+ +....+...... ...............+.+++.+||+.||++|||+.|+++
T Consensus 209 --~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 209 --DD-QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp --HH-HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --HH-HHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 0011110 000000000000 000000111234567889999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=342.44 Aligned_cols=200 Identities=28% Similarity=0.368 Sum_probs=175.5
Q ss_pred HHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCC-----CCccccEEEEEeeCCee
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-----HLNLVRLWGFCAEKGER 513 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-----H~niv~l~g~~~~~~~~ 513 (763)
+....|.+.++||+|+||.||+|+.. +++.||||+++........+..|+.+++.++ ||||+++++++...+..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 34566788899999999999999884 6789999999865555567888999999986 99999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 112 ~lv~e~~-~~~L~~~~~~~----------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp 165 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRN----------------------NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKP 165 (360)
T ss_dssp EEEECCC-CCBHHHHHHHT----------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred EEEEcCC-CCCHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCc
Confidence 9999999 99999999754 2335889999999999999999999998 99999999
Q ss_pred CceEEcC-------------------------CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccc
Q 046586 594 ENILLGD-------------------------DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKAD 648 (763)
Q Consensus 594 ~NILl~~-------------------------~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksD 648 (763)
+|||++. ++.+||+|||+++..... .....||+.|+|||.+.+..++.++|
T Consensus 166 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~D 241 (360)
T 3llt_A 166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSD 241 (360)
T ss_dssp GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccc
Confidence 9999975 889999999999864432 23457899999999999999999999
Q ss_pred eeehhHHHHHHHhCCCCcccc
Q 046586 649 VYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 649 VwS~Gvll~elltG~~p~~~~ 669 (763)
||||||++|||++|+.||...
T Consensus 242 iwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 242 MWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHHHHHSSCSCCCS
T ss_pred hHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=342.58 Aligned_cols=245 Identities=25% Similarity=0.308 Sum_probs=197.4
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCc----hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGG----DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~----~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+...+.||+|+||.||+|+. .+++.||||+++..... .+++.+|++++++++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4467778999999999999986 56889999999754322 246889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||++ |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||
T Consensus 134 e~~~-g~l~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 186 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH-----------------------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNIL 186 (348)
T ss_dssp ECCS-EEHHHHHHHH-----------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEE
T ss_pred ecCC-CCHHHHHHHh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEE
Confidence 9997 6888888542 235889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++.++.+||+|||+++..... ....||+.|+|||.+. .+.++.++||||||+++|||++|+.||.....
T Consensus 187 l~~~~~~kL~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--- 258 (348)
T 1u5q_A 187 LSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--- 258 (348)
T ss_dssp EETTTEEEECCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---
T ss_pred ECCCCCEEEeeccCceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---
Confidence 999999999999999865432 2357899999999884 57899999999999999999999999863321
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.... ....... .+.. .+...+..+.+++.+||+.||++|||+.++++.
T Consensus 259 ------~~~~-~~~~~~~------~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 259 ------MSAL-YHIAQNE------SPAL-------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ------HHHH-HHHHHSC------CCCC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------HHHH-HHHHhcC------CCCC-------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 0111110 0000 012234568899999999999999999999853
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=334.77 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=200.9
Q ss_pred Hhccccc-cccccccceEEEEEeC---CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSN-LIGRGGFGDVYKGELT---DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~-~LG~G~fG~Vy~g~~~---~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
..+.+.+ .||+|+||.||+|... .++.||||+++.... ..+++.+|+.+++.++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 9999999999999653 367899999975432 245789999999999999999999999 6678899
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 95 v~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~N 147 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN------------------------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARN 147 (291)
T ss_dssp EEECCTTEEHHHHHHHC------------------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEeCCCCCHHHHHHhC------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcce
Confidence 99999999999999643 24788999999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
|+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 148 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~- 226 (291)
T 1xbb_A 148 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG- 226 (291)
T ss_dssp EEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-
T ss_pred EEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 99999999999999999876543322 1222346788999999998899999999999999999999 9999864321
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
......+..+ . ....+...+..+.+++..||+.||++||++.+|++.|+.+.
T Consensus 227 ---------~~~~~~~~~~----------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 227 ---------SEVTAMLEKG----------E----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ---------HHHHHHHHTT----------C----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---------HHHHHHHHcC----------C----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0001111111 0 11112344578899999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=341.32 Aligned_cols=281 Identities=22% Similarity=0.285 Sum_probs=201.5
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeecc------CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV------TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
...|.+.++||+|+||.||+|... +++.||+|+++.. ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 356888999999999999999875 5788999999643 234467899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhc--------------ccC--CCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREME--------------MSG--VGPHDGGKPVLDWSIRYRIALGVARAIAYL 578 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~--------------~~~--~~~~~~~~~~l~~~~~~~ia~qia~gL~yL 578 (763)
+||||+++|+|.+++................ ... ..........+++..+..|+.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999995321110000000000 000 000000122345677889999999999999
Q ss_pred HhcCCCcEEecCCCCCceEEcCCC--CeEEcccCcccccCCCC---cccccccccCCCccccccccc--CCCCCccceee
Q 046586 579 HEECLEWVLHCDIKPENILLGDDF--CPKISDFGLAKLRKKED---MVSMSRIRGTRGYMAPEWLRS--DQITPKADVYS 651 (763)
Q Consensus 579 H~~~~~~ivHrDlk~~NILl~~~~--~~kI~DFGla~~~~~~~---~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS 651 (763)
|+.+ |+||||||+||+++.++ .+||+|||+++...... ........||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 9998 99999999999998776 89999999998653322 122345679999999999865 68899999999
Q ss_pred hhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCC
Q 046586 652 FGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPE 731 (763)
Q Consensus 652 ~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 731 (763)
||+++|||++|+.||...... . .... ++..... ............+.+++..||+.||.
T Consensus 262 lG~il~el~~g~~pf~~~~~~---------~-~~~~---------~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDA---------D-TISQ---------VLNKKLC--FENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHH---------H-HHHH---------HHHCCCC--TTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHCCCCCCCCChH---------H-HHHH---------HHhcccc--cCCcccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999643210 1 0111 1111110 01111122456788999999999999
Q ss_pred CCCCHHHHHH--HhccC
Q 046586 732 LRPSMGKVAK--MLEGT 746 (763)
Q Consensus 732 ~RPs~~eVv~--~Le~~ 746 (763)
+||++.++++ .+++.
T Consensus 321 ~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 321 ERFDAMRALQHPWISQF 337 (345)
T ss_dssp TSCCHHHHHHSHHHHTT
T ss_pred HCCCHHHHhcChhhccC
Confidence 9999999986 44443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=342.87 Aligned_cols=248 Identities=23% Similarity=0.318 Sum_probs=201.8
Q ss_pred HHHhccccccccccccceEEEEEeCC-CcEEEEEEeecc----CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeee
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNV----TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 514 (763)
....+.+.+.||+|+||.||+++... ++.||+|+++.. ....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34567788999999999999998864 788999999743 23446688999999988 8999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+
T Consensus 98 lv~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~ 150 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV------------------------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLD 150 (353)
T ss_dssp EEEECCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG
T ss_pred EEEeCCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHH
Confidence 999999999999999653 25788999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
|||++.++++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 151 NIll~~~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--- 226 (353)
T 2i0e_A 151 NVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--- 226 (353)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred HEEEcCCCcEEEEeCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---
Confidence 9999999999999999998543222 223456799999999999999999999999999999999999999964321
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~ 741 (763)
.. ... .++.... .++...+.++.+++..||+.||++||+ +.+|++
T Consensus 227 ------~~-~~~---------~i~~~~~------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 227 ------DE-LFQ---------SIMEHNV------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------HH-HHH---------HHHHCCC------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------HH-HHH---------HHHhCCC------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00 011 1111111 112334567889999999999999995 467764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=336.42 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=200.8
Q ss_pred ccccccccccccceEEEEEeCC-C---cEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCee-eEEE
Q 046586 445 NGFSNLIGRGGFGDVYKGELTD-H---RVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER-TLVY 517 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~-~---~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-~LV~ 517 (763)
+...++||+|+||.||+|...+ + ..+|+|+++.... ..+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 3445899999999999997632 2 3799999975433 235688999999999999999999999877655 8999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+.+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+
T Consensus 103 e~~~~~~L~~~~~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil 156 (298)
T 3pls_A 103 PYMCHGDLLQFIRSP-----------------------QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCM 156 (298)
T ss_dssp CCCTTCBHHHHHHCT-----------------------TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred ecccCCCHHHHHhcc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEE
Confidence 999999999999642 345789999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCc---ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++.++.+||+|||+++....... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+.......
T Consensus 157 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~- 235 (298)
T 3pls_A 157 LDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF- 235 (298)
T ss_dssp ECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-
T ss_pred EcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-
Confidence 99999999999999986543322 12233567889999999999999999999999999999999666543211100
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
. ....+..... ...+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 236 ----~--------------~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 236 ----D--------------LTHFLAQGRR----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp ----G--------------HHHHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----H--------------HHHHhhcCCC----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 0111111111 11112345678999999999999999999999999988753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=355.49 Aligned_cols=246 Identities=27% Similarity=0.331 Sum_probs=192.9
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.++||+|+||.||+++.. +++.||||+++.. ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 35677889999999999999875 5889999999742 233456789999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEEecCCCCCce
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE-ECLEWVLHCDIKPENI 596 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~ivHrDlk~~NI 596 (763)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+||
T Consensus 228 e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NI 280 (446)
T 4ejn_A 228 EYANGGELFFHLSRE------------------------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENL 280 (446)
T ss_dssp CCCSSCBHHHHHHHH------------------------SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGE
T ss_pred eeCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHE
Confidence 999999999999643 358899999999999999999998 77 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
|++.++.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 281 ll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----- 354 (446)
T 4ejn_A 281 MLDKDGHIKITDFGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----- 354 (446)
T ss_dssp EECSSSCEEECCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred EECCCCCEEEccCCCceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----
Confidence 99999999999999998543322 233456799999999999999999999999999999999999999964321
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
... ... +..... .++......+.+++..||+.||.+|| ++.|+++
T Consensus 355 ----~~~-~~~---------i~~~~~------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 355 ----EKL-FEL---------ILMEEI------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----HHH-HHH---------HHHCCC------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----HHH-HHH---------HHhCCC------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 000 011 111100 11123456788999999999999999 9999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.00 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=201.0
Q ss_pred HhccccccccccccceEEEEEeCC-CcEEEEEEeecc-CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNV-TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..|.+.++||+|+||.||+|.... +..+|+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 467888999999999999998764 678999999754 345577999999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE--
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-- 598 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl-- 598 (763)
++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 89 ~~~~L~~~~~~~------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~ 141 (277)
T 3f3z_A 89 TGGELFERVVHK------------------------RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLT 141 (277)
T ss_dssp CSCBHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESS
T ss_pred CCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEec
Confidence 999999998643 35789999999999999999999998 9999999999999
Q ss_pred -cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 599 -GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 -~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
+.++.+||+|||++....... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.....
T Consensus 142 ~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 212 (277)
T 3f3z_A 142 DSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD------ 212 (277)
T ss_dssp SSTTCCEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred CCCCCcEEEEecccceeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH------
Confidence 888999999999998655432 2334568999999998865 489999999999999999999999964321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
........++. . ..........+..+.+++.+||+.||++|||+.++++
T Consensus 213 ----~~~~~~~~~~~---------~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 213 ----SEVMLKIREGT---------F--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ----HHHHHHHHHCC---------C--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----HHHHHHHHhCC---------C--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111111110 0 0000000123567899999999999999999999984
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=345.36 Aligned_cols=245 Identities=25% Similarity=0.334 Sum_probs=191.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHH-HhcCCCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTI-IARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
..+.+.+.||+|+||.||+++.. +++.||+|+++... .....+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 45778899999999999999886 47889999997542 223446677776 5778999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 118 ~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NI 170 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE------------------------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENI 170 (373)
T ss_dssp EECCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred EeCCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHE
Confidence 9999999999999653 24778889999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
|++.++++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 171 ll~~~g~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----- 244 (373)
T 2r5t_A 171 LLDSQGHIVLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----- 244 (373)
T ss_dssp EECTTSCEEECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----
T ss_pred EECCCCCEEEeeCccccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----
Confidence 99999999999999998533221 234456899999999999999999999999999999999999999964321
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
. .... .++.... .++......+.+++..||+.||.+||++.+.+
T Consensus 245 ----~-~~~~---------~i~~~~~------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 245 ----A-EMYD---------NILNKPL------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp ----H-HHHH---------HHHHSCC------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ----H-HHHH---------HHHhccc------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 0 0011 1111111 11123446788999999999999999985433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=337.33 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=184.2
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
++||+|+||.||++... +++.||||+++.. ....+.+|+.+++.++ ||||+++++++.+....++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 68999999999999885 5789999999743 3456789999999997 999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC---C
Q 046586 527 DYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF---C 603 (763)
Q Consensus 527 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~---~ 603 (763)
+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .
T Consensus 95 ~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 147 (325)
T 3kn6_A 95 ERIKKK------------------------KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLE 147 (325)
T ss_dssp HHHHHC------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CE
T ss_pred HHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCccc
Confidence 999643 35889999999999999999999998 99999999999997765 8
Q ss_pred eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHH
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~ 683 (763)
+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 148 ~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--------- 217 (325)
T 3kn6_A 148 IKIIDFGFARLKPPDN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT--------- 217 (325)
T ss_dssp EEECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----------------
T ss_pred EEEeccccceecCCCC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc---------
Confidence 9999999998654332 223345689999999999999999999999999999999999999975432110
Q ss_pred HHHHHHhccChhhhhcccccccC--CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccCCCCC
Q 046586 684 AFEKVYEEMKVEDILDRHIKNSY--DSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGTVEIT 750 (763)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~~~~~ 750 (763)
.....+++........ ........+.++.+++.+||+.||++|||++|+++ .+.+....+
T Consensus 218 -------~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~ 281 (325)
T 3kn6_A 218 -------CTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281 (325)
T ss_dssp -------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred -------cccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence 0001111222111111 11111234678899999999999999999999984 455544433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=336.83 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=198.9
Q ss_pred hccccccccccccceEEEEEeCCC----cEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEee-CCeeeEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDH----RVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAE-KGERTLV 516 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~----~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~LV 516 (763)
.+.+.++||+|+||.||+|...+. ..+|+|.++.... ..+.+.+|+.++++++||||+++++++.+ ++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 466778999999999999986532 3689999875433 23568899999999999999999999754 5578999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 106 ~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Ni 159 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNE-----------------------THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNC 159 (298)
T ss_dssp EECCTTCBHHHHHHCT-----------------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred EeCCCCCCHHHHHHhc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheE
Confidence 9999999999999642 345788999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCc---ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhC-CCCcccccCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSG-SRNFEIQGSM 672 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG-~~p~~~~~~~ 672 (763)
+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..|+......
T Consensus 160 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~ 239 (298)
T 3f66_A 160 MLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239 (298)
T ss_dssp EECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT
T ss_pred EECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 999999999999999986644332 122334678899999999999999999999999999999995 4555432211
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
. . .....++. . ...+...+..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 240 ~------~----~~~~~~~~----------~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 240 D------I----TVYLLQGR----------R----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp T------H----HHHHHTTC----------C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H------H----HHHHhcCC----------C----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 0 00111110 0 01112234678899999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.00 Aligned_cols=261 Identities=22% Similarity=0.351 Sum_probs=196.8
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..|.+.+.||+|+||.||+|.. .+++.||+|+++.... ...++.+|+.++++++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 3577889999999999999987 4688999999974321 2356889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ |+|+||||+||+
T Consensus 112 e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl 168 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKK--------------------QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVF 168 (310)
T ss_dssp ECCCSCBHHHHHHHHHH--------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ecCCCCCHHHHHHHhcc--------------------cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEE
Confidence 99999999999964310 2346889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 169 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------ 241 (310)
T 2wqm_A 169 ITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------ 241 (310)
T ss_dssp ECTTSCEEECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------
T ss_pred EcCCCCEEEEeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------
Confidence 99999999999999986543321 22345689999999999999999999999999999999999999864321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
..... ....... ..........+..+.+++.+||+.||++|||+.+|+++|+.+..
T Consensus 242 -~~~~~-~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 242 -NLYSL-CKKIEQC-------------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -CHHHH-HHHHHTT-------------CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hHHHH-HHHhhcc-------------cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 00010 0111110 00000112335678899999999999999999999999988754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=344.42 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=202.6
Q ss_pred HhccccccccccccceEEEEEe----CCCcEEEEEEeecc-----CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL----TDHRVVAVKCLKNV-----TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGE 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~----~~~~~VAvK~l~~~-----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 512 (763)
..|.+.++||+|+||.||+++. .+++.||||+++.. ....+.+.+|++++.++ +||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4577889999999999999987 36889999998643 23345678899999999 69999999999999999
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlk 186 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR------------------------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIK 186 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred EEEEeecCCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 99999999999999999643 25788999999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc--CCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS--DQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
|+|||++.++.+||+|||+++..............||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 187 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 187 LENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp GGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred HHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 999999999999999999998665444444455679999999999985 457899999999999999999999997443
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAKML 743 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~~L 743 (763)
... ...... ... ... ....+.+....+.+++.+||+.||++|| ++.|+++..
T Consensus 267 ~~~-----~~~~~~-~~~-------------~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 267 EKN-----SQAEIS-RRI-------------LKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp SCC-----CHHHHH-HHH-------------HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ccc-----hHHHHH-HHH-------------hcc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 211 111110 000 000 0111233456788999999999999999 999998643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.95 Aligned_cols=250 Identities=23% Similarity=0.315 Sum_probs=203.3
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-------chhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
...|.+.+.||+|+||.||+++.. +++.||+|+++.... ..+++.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999876 588999999975422 245689999999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 91 ~lv~e~~~~~~L~~~l~~------------------------~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp 143 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ------------------------KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKP 143 (321)
T ss_dssp EEEECCCCSCBHHHHHHT------------------------CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEEcCCCCcHHHHHHh------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCh
Confidence 999999999999999953 235788999999999999999999998 99999999
Q ss_pred CceEEcCCC----CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 594 ENILLGDDF----CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 594 ~NILl~~~~----~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
+||+++.++ .+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 144 ~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 221 (321)
T 2a2a_A 144 ENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221 (321)
T ss_dssp GGEEESCTTSSSCCEEECCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred HHEEEecCCCCcCCEEEccCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence 999999888 79999999998654432 223456899999999999999999999999999999999999999643
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
... . ....+.... ...+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~---------~-~~~~i~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 222 TKQ---------E-TLANITSVS-----------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp SHH---------H-HHHHHHTTC-----------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CHH---------H-HHHHHHhcc-----------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 210 0 001111100 01111111233467889999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.86 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=201.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
..+.+.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46788899999999999999876 68899999997432 3346788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++
T Consensus 87 ~~~~~L~~~l~~------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~ 139 (276)
T 2yex_A 87 CSGGELFDRIEP------------------------DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLD 139 (276)
T ss_dssp CTTEEGGGGSBT------------------------TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred cCCCcHHHHHhh------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEc
Confidence 999999998843 235889999999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCC-CCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
.++.+||+|||++........ .......||..|+|||.+.+..+ +.++||||||+++|||++|+.||.......
T Consensus 140 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---- 215 (276)
T 2yex_A 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---- 215 (276)
T ss_dssp TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS----
T ss_pred cCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH----
Confidence 999999999999986543322 22344578999999999987665 779999999999999999999997533211
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..+ ..+..... ...........+.+++.+||+.||++|||+.|+++
T Consensus 216 ~~~-----~~~~~~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 216 QEY-----SDWKEKKT-------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHH-----HHHHTTCT-------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHH-----HHhhhccc-------------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001 11111100 00001233467889999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.46 Aligned_cols=241 Identities=25% Similarity=0.384 Sum_probs=200.6
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---------chhhhHHHHHHHhcCCCCccccEEEEEeeCC
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG 511 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 511 (763)
...|.+.+.||+|+||.||+|+.. +++.||||+++.... ....+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 356778899999999999999864 678999999975432 2346889999999999999999999999999
Q ss_pred eeeEEEecCCCC-CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 512 ERTLVYEYVPNG-SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 512 ~~~LV~Ey~~~g-sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
..++||||+.+| +|.+++... ..+++..+..|+.|++.||+|||+.+ |+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 155 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH------------------------PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRD 155 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred EEEEEEEeCCCCccHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEec
Confidence 999999999777 999998542 35889999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCC-CCccceeehhHHHHHHHhCCCCcccc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
|||+|||++.++.+||+|||+++....... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 156 lkp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 156 IKDENIVIAEDFTIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred cCHHHEEEcCCCcEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 999999999999999999999986654322 334578999999999988776 78999999999999999999999632
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. ........ + ......+.+++..||+.||++|||+.++++.
T Consensus 234 ~~-------------------------~~~~~~~~--~----~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 234 EE-------------------------TVEAAIHP--P----YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp GG-------------------------GTTTCCCC--S----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HH-------------------------HHhhccCC--C----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 11111110 0 1234578899999999999999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.29 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=200.3
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 516 (763)
..+.+.+.||+|+||.||+++.. +++.||+|+++.... ..+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 35677889999999999999886 578999999975432 224577899999988 899999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 89 ~e~~~gg~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NI 141 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ------------------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNV 141 (345)
T ss_dssp ECCCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGE
T ss_pred EeCCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHE
Confidence 9999999999999643 25789999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
|++.++++||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........
T Consensus 142 ll~~~g~~kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 220 (345)
T 3a8x_A 142 LLDSEGHIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220 (345)
T ss_dssp EECTTSCEEECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----
T ss_pred EECCCCCEEEEeccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc
Confidence 99999999999999998543222 22345679999999999999999999999999999999999999996432211100
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH------HHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM------GKVA 740 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~eVv 740 (763)
. .........+ .... ..++......+.+++.+||+.||++||++ .|++
T Consensus 221 ~-~~~~~~~~~i---------~~~~------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~ 274 (345)
T 3a8x_A 221 Q-NTEDYLFQVI---------LEKQ------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 274 (345)
T ss_dssp ---CHHHHHHHH---------HHCC------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHH
T ss_pred c-ccHHHHHHHH---------HcCC------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHh
Confidence 0 0001111111 1111 11223345678899999999999999995 5666
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=347.50 Aligned_cols=247 Identities=21% Similarity=0.330 Sum_probs=194.1
Q ss_pred hccccccccccccceEEEEEeCCCcEEEEEEeeccCC---chhhhHHHHHHHhcCC--CCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG---GDAEFWAEVTIIARMH--HLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.++||+|+||.||++...+++.||||+++.... ..+++.+|+.++.+++ ||||+++++++...+..++|||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E 136 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence 4777889999999999999988899999999975432 2356889999999996 5999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
+.+++|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 137 -~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll 188 (390)
T 2zmd_A 137 -CGNIDLNSWLKKK------------------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI 188 (390)
T ss_dssp -CCSEEHHHHHHHC------------------------SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEE
T ss_pred -cCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEE
Confidence 5688999999643 25788899999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCc-ccccccccCCCccccccccc-----------CCCCCccceeehhHHHHHHHhCCCCc
Q 046586 599 GDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRS-----------DQITPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwS~Gvll~elltG~~p~ 666 (763)
+ ++.+||+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 189 ~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf 267 (390)
T 2zmd_A 189 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267 (390)
T ss_dssp S-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred E-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcc
Confidence 5 58999999999987654332 22344679999999999865 47899999999999999999999999
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...... ... ...+++.......+ ......+.+++.+||+.||++|||+.||++
T Consensus 268 ~~~~~~--------~~~----------~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 268 QQIINQ--------ISK----------LHAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp TTCCCH--------HHH----------HHHHHCTTSCCCCC----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhHH--------HHH----------HHHHhCccccCCCC----ccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 632110 000 11222222111111 122457889999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=349.07 Aligned_cols=274 Identities=19% Similarity=0.274 Sum_probs=211.8
Q ss_pred HhccccccccccccceEEEEEeCC-CcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCC--eeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG--ERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~LV~ 517 (763)
..|.+.++||+|+||.||+|+... ++.||||+++... ...+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 356778999999999999998864 8899999997532 34467889999999999999999999998765 779999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 89 e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 144 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPS---------------------NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIM 144 (396)
T ss_dssp CCCTTEEHHHHTTSGG---------------------GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred ecCCCCCHHHHHHhhh---------------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEE
Confidence 9999999999996432 2234899999999999999999999998 999999999999
Q ss_pred E----cCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc--------CCCCCccceeehhHHHHHHHhCCCC
Q 046586 598 L----GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS--------DQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 598 l----~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
+ +.++.+||+|||+++...... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.|
T Consensus 145 l~~~~~~~~~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~P 222 (396)
T 4eut_A 145 RVIGEDGQSVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222 (396)
T ss_dssp EEECTTSCEEEEECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred EeecCCCceeEEEecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9 788889999999998654432 2334578999999998864 5678899999999999999999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhh------hcccc----cccCCCcchHHHHHHHHHHHHHccCCCCCCCCC
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDI------LDRHI----KNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~l----~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 735 (763)
|........ ... .......+.....+ ..... .......+.......+.+++..||+.||++||+
T Consensus 223 f~~~~~~~~-----~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s 296 (396)
T 4eut_A 223 FRPFEGPRR-----NKE-VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296 (396)
T ss_dssp EECTTCTTT-----CHH-HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC
T ss_pred CCCCCcccc-----hHH-HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc
Confidence 975332111 111 11112222111000 00000 001112334678889999999999999999999
Q ss_pred HHHHHHHhccCCC
Q 046586 736 MGKVAKMLEGTVE 748 (763)
Q Consensus 736 ~~eVv~~Le~~~~ 748 (763)
+.++++.++.+++
T Consensus 297 ~~e~l~~l~~il~ 309 (396)
T 4eut_A 297 FDQFFAETSDILH 309 (396)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhh
Confidence 9999999987654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.53 Aligned_cols=250 Identities=32% Similarity=0.479 Sum_probs=196.4
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeC-CeeeEEEecCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK-GERTLVYEYVP 521 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~LV~Ey~~ 521 (763)
..+.+.+.||+|+||.||+++.. ++.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 98 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence 46778899999999999999885 6889999997543 456789999999999999999999997655 47899999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.+
T Consensus 99 ~~~L~~~l~~~~----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 153 (278)
T 1byg_A 99 KGSLVDYLRSRG----------------------RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSED 153 (278)
T ss_dssp TEEHHHHHHHHH----------------------HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred CCCHHHHHHhcc----------------------cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCC
Confidence 999999996431 123788899999999999999999998 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCch
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~ 680 (763)
+.+||+|||+++..... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 154 ~~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------- 222 (278)
T 1byg_A 154 NVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------- 222 (278)
T ss_dssp SCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------
T ss_pred CcEEEeecccccccccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 99999999999754332 123357889999999999999999999999999999998 999986432100
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
....+... .....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 223 -------------~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 223 -------------VVPRVEKG----YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp -------------HHHHHTTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------------HHHHHhcC----CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 00001111 111122344567899999999999999999999999998753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=330.76 Aligned_cols=261 Identities=21% Similarity=0.261 Sum_probs=201.8
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEE-eeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFC-AEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~LV~Ey~ 520 (763)
..|.+.+.||+|+||.||+|+. .+++.||||++.... ...++.+|+++++.++|++++..++.+ .+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 4677889999999999999987 568899999876433 234688999999999888877766665 5677889999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE--
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-- 598 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl-- 598 (763)
+++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 88 -~~~L~~~~~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~ 140 (296)
T 4hgt_A 88 -GPSLEDLFNFC-----------------------SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGL 140 (296)
T ss_dssp -CCBHHHHHHHT-----------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECC
T ss_pred -CCCHHHHHHHh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeec
Confidence 99999999642 235899999999999999999999998 9999999999999
Q ss_pred -cCCCCeEEcccCcccccCCCCc------ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 599 -GDDFCPKISDFGLAKLRKKEDM------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 599 -~~~~~~kI~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
++++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 141 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 141 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 7899999999999986654322 122345789999999999999999999999999999999999999975432
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
... ...+........ .. .... .....+..+.+++..||+.||++|||+.+|++.|+.+.+
T Consensus 221 ~~~--~~~~~~~~~~~~-~~--~~~~------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 221 ATK--RQKYERISEKKM-ST--PIEV------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp SSS--SSHHHHHHHHHH-HS--CHHH------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhh--hhhhhhhhcccc-cc--hhhh------------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 211 111111100000 00 0000 001224678999999999999999999999999988653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=331.32 Aligned_cols=261 Identities=21% Similarity=0.254 Sum_probs=203.8
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEE-eeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFC-AEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~LV~Ey~ 520 (763)
..|.+.+.||+|+||.||+|+. .+++.||||++.... ...++.+|+.+++.++|++++..+..+ .+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 3567788999999999999987 578899999987543 345688999999999988877666655 5667889999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE--
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-- 598 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl-- 598 (763)
+++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||++
T Consensus 88 -~~~L~~~~~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~ 140 (296)
T 3uzp_A 88 -GPSLEDLFNFC-----------------------SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGL 140 (296)
T ss_dssp -CCBHHHHHHHT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECC
T ss_pred -CCCHHHHHHhh-----------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEec
Confidence 99999999642 235889999999999999999999998 9999999999999
Q ss_pred -cCCCCeEEcccCcccccCCCCcc------cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 599 -GDDFCPKISDFGLAKLRKKEDMV------SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 599 -~~~~~~kI~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
+.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 141 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 58899999999999866543321 12345789999999999999999999999999999999999999975432
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
... ...+........ .. ... ......+..+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 221 ~~~--~~~~~~~~~~~~-~~--~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 221 ATK--RQKYERISEKKM-ST--PIE------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp SSS--SSHHHHHHHHHH-HS--CHH------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhh--hhhhhhhccccc-CC--chH------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 211 111111100000 00 000 0001234678999999999999999999999999988653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.00 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=203.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..|.+.+.||+|+||.||+|+.. +++.||||+++.. ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35777889999999999999886 6899999999743 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 96 E~~~gg~L~~~l~~------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIl 148 (476)
T 2y94_A 96 EYVSGGELFDYICK------------------------NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVL 148 (476)
T ss_dssp ECCSSEEHHHHTTS------------------------SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEE
T ss_pred eCCCCCcHHHHHHh------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEE
Confidence 99999999999853 235889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCC-CCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
++.++.+||+|||+++...... ......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||.....
T Consensus 149 l~~~~~vkL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~----- 221 (476)
T 2y94_A 149 LDAHMNAKIADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV----- 221 (476)
T ss_dssp ECTTCCEEECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----
T ss_pred EecCCCeEEEeccchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----
Confidence 9999999999999998765432 2334579999999999988765 6899999999999999999999974321
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--Hhcc
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEG 745 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~ 745 (763)
.. ....+. +... ..+......+.+++.+||+.||++|||+.||++ .+..
T Consensus 222 ----~~-~~~~i~---------~~~~------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 222 ----PT-LFKKIC---------DGIF------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ----HH-HHHHHH---------TTCC------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ----HH-HHHHHh---------cCCc------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 00 011111 1111 011223457889999999999999999999996 4554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=335.41 Aligned_cols=266 Identities=22% Similarity=0.323 Sum_probs=189.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
..+.+.++||+|+||.||+|... +++.||+|+++... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 34667789999999999999875 57899999997433 2346788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
++ |+|.+++..... ......+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 85 ~~-~~L~~~l~~~~~------------------~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~ 142 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTV------------------GNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLIN 142 (317)
T ss_dssp CC-CBHHHHHHHHHS------------------SSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred cC-CCHHHHHHhccc------------------cccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEc
Confidence 98 599999865321 012345889999999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
.++.+||+|||+++....... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......
T Consensus 143 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----- 216 (317)
T 2pmi_A 143 KRGQLKLGDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE----- 216 (317)
T ss_dssp TTCCEEECCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----
T ss_pred CCCCEEECcCccceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----
Confidence 999999999999986543221 2234568999999999876 478999999999999999999999996432110
Q ss_pred chhHHHHHHHHh--ccChhhh---------hcccccccCCCc--------chHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046586 679 YFPKWAFEKVYE--EMKVEDI---------LDRHIKNSYDSR--------VHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739 (763)
Q Consensus 679 ~~~~~~~~~~~~--~~~~~~~---------~~~~l~~~~~~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eV 739 (763)
....+.+ +...... ..+......... ........+.+++.+||+.||++|||+.|+
T Consensus 217 -----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 291 (317)
T 2pmi_A 217 -----QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291 (317)
T ss_dssp -----HHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred -----HHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 0011100 0000000 000000000000 001234578999999999999999999999
Q ss_pred HH
Q 046586 740 AK 741 (763)
Q Consensus 740 v~ 741 (763)
++
T Consensus 292 l~ 293 (317)
T 2pmi_A 292 LH 293 (317)
T ss_dssp TT
T ss_pred hC
Confidence 85
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=338.99 Aligned_cols=269 Identities=28% Similarity=0.472 Sum_probs=203.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcE--EEEEEeecc--CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRV--VAVKCLKNV--TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~--VAvK~l~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 516 (763)
..+.+.+.||+|+||.||+++.. ++.. +|+|.++.. ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56778899999999999999875 4553 599998743 23446689999999999 999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++...+.......... .......+++.+++.++.|++.||+|||+.+ |+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NI 173 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAI--------ANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI 173 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHH--------HTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred EecCCCCCHHHHHHhcccccccccccc--------cccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceE
Confidence 999999999999965420000000000 0012346899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNS 675 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~ 675 (763)
+++.++.+||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 174 l~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---- 247 (327)
T 1fvr_A 174 LVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---- 247 (327)
T ss_dssp EECGGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH----
T ss_pred EEcCCCeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH----
Confidence 9999999999999999743221 12223456889999999998899999999999999999998 9999964321
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
. .....+ ... .....+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 248 -----~-~~~~~~----------~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 248 -----A-ELYEKL----------PQG----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp -----H-HHHHHG----------GGT----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----H-HHHHHh----------hcC----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 000111 111 1111123345678999999999999999999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=336.68 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=197.1
Q ss_pred HHHhccccccccccccceEEEEEeC----CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCC--
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKG-- 511 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-- 511 (763)
....+.+.+.||+|+||.||+|... .++.||+|+++..... .+++.+|+.++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3456777889999999999999764 2457999999754322 356889999999999999999999998765
Q ss_pred ---eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 046586 512 ---ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLH 588 (763)
Q Consensus 512 ---~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 588 (763)
..++||||+++++|.+++..... ......+++..++.++.|++.||+|||+.+ |+|
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 170 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRL------------------ETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLH 170 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTB------------------TTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhh------------------hcCCccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 34999999999999999965321 013456899999999999999999999988 999
Q ss_pred cCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCc
Q 046586 589 CDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNF 666 (763)
Q Consensus 589 rDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~ 666 (763)
|||||+||+++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 171 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 250 (313)
T 3brb_A 171 RDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY 250 (313)
T ss_dssp CCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999986544322 22233457889999999999999999999999999999999 88888
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
....... .......+ .....+...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 251 ~~~~~~~----------~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 251 PGVQNHE----------MYDYLLHG--------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp TTCCGGG----------HHHHHHTT--------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCHHH----------HHHHHHcC--------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 6432110 00111111 01111234456789999999999999999999999999876
Q ss_pred C
Q 046586 747 V 747 (763)
Q Consensus 747 ~ 747 (763)
.
T Consensus 307 ~ 307 (313)
T 3brb_A 307 L 307 (313)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.98 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=196.2
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
..+.+.++||+|+||.||+++.. +++.+|+|++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56888899999999999999875 57899999997543 3446789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE-
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL- 598 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl- 598 (763)
+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 102 ~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~ 158 (285)
T 3is5_A 102 CEGGELLERIVSAQA--------------------RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQ 158 (285)
T ss_dssp CSCCBHHHHHHHHHH--------------------HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEES
T ss_pred CCCCcHHHHHHhhhh--------------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEe
Confidence 999999999865310 2346889999999999999999999998 9999999999999
Q ss_pred --cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 599 --GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 599 --~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
+.++.+||+|||+++...... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||.....
T Consensus 159 ~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~----- 230 (285)
T 3is5_A 159 DTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL----- 230 (285)
T ss_dssp SSSTTCCEEECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred cCCCCCCEEEEeeecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----
Confidence 556889999999998654332 233456899999999875 5789999999999999999999999964321
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.... ...... ........ ......+.+++.+||+.||++|||+.||++
T Consensus 231 ----~~~~-~~~~~~-------~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 231 ----EEVQ-QKATYK-------EPNYAVEC-----RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----HHHH-HHHHHC-------CCCCCC-------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----HHHH-hhhccC-------Cccccccc-----CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 000000 00000000 112457789999999999999999999985
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.29 Aligned_cols=250 Identities=20% Similarity=0.257 Sum_probs=189.4
Q ss_pred cccc-ccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHh-cCCCCccccEEEEEee----CCeeeEEE
Q 046586 445 NGFS-NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIA-RMHHLNLVRLWGFCAE----KGERTLVY 517 (763)
Q Consensus 445 ~~~~-~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~----~~~~~LV~ 517 (763)
|.+. ++||+|+||.||++... +++.||||+++. ...+.+|++++. ..+||||+++++++.. ....+|||
T Consensus 63 y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 3443 68999999999999875 578999999963 345778888874 4589999999999876 56789999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ....+++..+..|+.||+.||+|||+.+ |+||||||+|||
T Consensus 139 E~~~gg~L~~~l~~~----------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nil 193 (400)
T 1nxk_A 139 ECLDGGELFSRIQDR----------------------GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLL 193 (400)
T ss_dssp ECCCSEEHHHHHHCC-------------------------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred EeCCCCcHHHHHHHh----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEE
Confidence 999999999999643 2346899999999999999999999988 999999999999
Q ss_pred EcC---CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LGD---DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~~---~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 194 l~~~~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 271 (400)
T 1nxk_A 194 YTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271 (400)
T ss_dssp ESSSSTTCCEEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS
T ss_pred EecCCCCccEEEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 997 7899999999998654322 23456789999999999999999999999999999999999999975432211
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
. ... ...+..+. . ............++.+++..||+.||++|||+.||++.
T Consensus 272 ~--~~~----~~~i~~~~---------~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 272 S--PGM----KTRIRMGQ---------Y--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C--CSH----HHHHHHTC---------C--CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c--HHH----HHHHHcCc---------c--cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000 00111110 0 00000002345678899999999999999999999963
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.24 Aligned_cols=254 Identities=21% Similarity=0.300 Sum_probs=203.1
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..|.+.++||+|+||.||+|... +++.||+|+++..... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 35677889999999999999875 5789999999754332 3557899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 86 ~~~~~~l~~~~~~~------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~ 138 (284)
T 3kk8_A 86 LVTGGELFEDIVAR------------------------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLL 138 (284)
T ss_dssp CCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred cCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEE
Confidence 99999999988643 35789999999999999999999998 9999999999999
Q ss_pred cCCCC---eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 599 GDDFC---PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 599 ~~~~~---~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
+.++. +||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 139 ~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--- 213 (284)
T 3kk8_A 139 ASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--- 213 (284)
T ss_dssp SSSSTTCCEEECCCTTCEECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred ecCCCCCcEEEeeceeeEEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---
Confidence 86655 9999999997654332 223457899999999999999999999999999999999999999643210
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccC
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGT 746 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~ 746 (763)
........+. .. ............+.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 214 -------~~~~~~~~~~---------~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (284)
T 3kk8_A 214 -------RLYAQIKAGA---------YD--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268 (284)
T ss_dssp -------HHHHHHHHTC---------CC--CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred -------HHHHHHHhcc---------cc--CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence 0011111110 00 000011233567889999999999999999999986 45443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.08 Aligned_cols=244 Identities=25% Similarity=0.420 Sum_probs=197.3
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..|.+.+.||+|+||.||++... +++.||+|++... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 34667889999999999999876 4678999998643 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+
T Consensus 89 e~~~~~~l~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nil 141 (279)
T 3fdn_A 89 EYAPLGTVYRELQKL------------------------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLL 141 (279)
T ss_dssp CCCTTEEHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEE
T ss_pred ecCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEE
Confidence 999999999999653 24788999999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++.+||+|||++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 142 i~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------ 212 (279)
T 3fdn_A 142 LGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------ 212 (279)
T ss_dssp ECTTSCEEECSCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------
T ss_pred EcCCCCEEEEeccccccCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------
Confidence 999999999999998654332 22345789999999999999999999999999999999999999964321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ........ ....+......+.+++..||+.||++|||+.||++
T Consensus 213 ---~~-~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 213 ---QE-TYKRISRV---------------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ---HH-HHHHHHHT---------------CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---HH-HHHHHHhC---------------CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 00111000 00111234567889999999999999999999995
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.37 Aligned_cols=250 Identities=23% Similarity=0.327 Sum_probs=200.2
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-------chhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
...|.+.+.||+|+||.||+++.. +++.||+|+++.... ..+++.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356788899999999999999886 588999999974321 246689999999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p 136 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK------------------------ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKP 136 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred EEEEeecCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCh
Confidence 9999999999999999643 25789999999999999999999998 99999999
Q ss_pred CceEEcCCC----CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 594 ENILLGDDF----CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 594 ~NILl~~~~----~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
+||+++.++ .+||+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 137 ~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 214 (283)
T 3bhy_A 137 ENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214 (283)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred HHEEEecCCCCCCceEEEecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence 999998877 89999999998654332 223456899999999999999999999999999999999999999643
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
... .......... ...........+..+.+++.+||+.||++|||+.++++
T Consensus 215 ~~~----------~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 215 TKQ----------ETLTNISAVN-----------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp SHH----------HHHHHHHTTC-----------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chH----------HHHHHhHhcc-----------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 210 0001111000 00111111233567889999999999999999999996
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.79 Aligned_cols=264 Identities=26% Similarity=0.353 Sum_probs=204.6
Q ss_pred HHHHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCC
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG 511 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 511 (763)
+....+.+.+.||+|+||.||+|+.. +++.||||+++.... ...++.+|+.++++++||||+++++++.+.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34567888899999999999999843 467899999974332 3456889999999999999999999999999
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
..++||||+++++|.+++....... .....+++..++.++.|++.||+|||+.+ |+||||
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~-----------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dl 166 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRP-----------------SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDI 166 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCS-----------------SSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccc-----------------cccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcC
Confidence 9999999999999999997653111 12346899999999999999999999998 999999
Q ss_pred CCCceEEcC---CCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCc
Q 046586 592 KPENILLGD---DFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNF 666 (763)
Q Consensus 592 k~~NILl~~---~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~ 666 (763)
||+|||++. +..+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 167 kp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 246 (327)
T 2yfx_A 167 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246 (327)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999984 45699999999975433222 22234567889999999999999999999999999999998 98998
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
..... . ........+ .. ...+...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus 247 ~~~~~---------~-~~~~~~~~~----------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 247 PSKSN---------Q-EVLEFVTSG----------GR----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTCCH---------H-HHHHHHHTT----------CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcCH---------H-HHHHHHhcC----------CC----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 64321 0 001111111 00 111123456788999999999999999999999999875
Q ss_pred C
Q 046586 747 V 747 (763)
Q Consensus 747 ~ 747 (763)
.
T Consensus 303 ~ 303 (327)
T 2yfx_A 303 T 303 (327)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=335.39 Aligned_cols=279 Identities=21% Similarity=0.263 Sum_probs=196.3
Q ss_pred hcccc-ccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFS-NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~-~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.|.+. +.||+|+||.||++... +++.||||+++... .....+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 35553 68999999999999864 68899999997543 3456789999999885 799999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 93 ~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~ 145 (316)
T 2ac3_A 93 MRGGSILSHIHKR------------------------RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCE 145 (316)
T ss_dssp CTTCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEES
T ss_pred CCCCcHHHHHhcc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEc
Confidence 9999999999653 25788999999999999999999998 99999999999999
Q ss_pred CCCC---eEEcccCcccccCCCCc------ccccccccCCCccccccccc-----CCCCCccceeehhHHHHHHHhCCCC
Q 046586 600 DDFC---PKISDFGLAKLRKKEDM------VSMSRIRGTRGYMAPEWLRS-----DQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 600 ~~~~---~kI~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
.++. +||+|||+++....... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.|
T Consensus 146 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 225 (316)
T 2ac3_A 146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225 (316)
T ss_dssp CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCC
Confidence 8776 99999999976542211 11223468999999999875 5688999999999999999999999
Q ss_pred cccccCCCCCC--CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--
Q 046586 666 FEIQGSMMNSD--EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK-- 741 (763)
Q Consensus 666 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~-- 741 (763)
|.......... ....+.. ...+. ..+..... ..+..........+.+++.+||+.||++|||+.|+++
T Consensus 226 f~~~~~~~~~~~~~~~~~~~-~~~~~-----~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 226 FVGRCGSDCGWDRGEACPAC-QNMLF-----ESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp CCCCCCSCSCC----CCHHH-HHHHH-----HHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred CcccccccccccccccchhH-HHHHH-----HHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 97543221100 0000000 00000 00111000 0010000123567899999999999999999999997
Q ss_pred HhccCCCCCCCCCCce
Q 046586 742 MLEGTVEITEPKKPTI 757 (763)
Q Consensus 742 ~Le~~~~~~~p~~p~~ 757 (763)
.+.+.......+.|.+
T Consensus 298 ~~~~~~~~~~~~~~~~ 313 (316)
T 2ac3_A 298 WVQGCAPENTLPTPMV 313 (316)
T ss_dssp TCC-------------
T ss_pred hhcCCCCcccCCCccc
Confidence 4555444444444443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.42 Aligned_cols=254 Identities=16% Similarity=0.194 Sum_probs=203.5
Q ss_pred HHhccccccccccccceEEEEE------eCCCcEEEEEEeeccCCchhhhHHHHHHHhcCC---CCccccEEEEEeeCCe
Q 046586 442 AATNGFSNLIGRGGFGDVYKGE------LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH---HLNLVRLWGFCAEKGE 512 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~------~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~ 512 (763)
...|.+.++||+|+||.||+|. ...++.||||+++.. ...++..|++++.+++ |+||+++++++.+.+.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 3556778899999999999994 446789999999743 4567888998888886 9999999999999999
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++|+|.+++...+. .....+++..++.|+.||+.||+|||+.+ |||||||
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiK 199 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKN-------------------TPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIK 199 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHT-------------------STTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCS
T ss_pred cEEEEeccCCCcHHHHHHHhhc-------------------ccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCC
Confidence 9999999999999999975321 02346899999999999999999999988 9999999
Q ss_pred CCceEEcC-----------CCCeEEcccCcccccCC-CCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHH
Q 046586 593 PENILLGD-----------DFCPKISDFGLAKLRKK-EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIV 660 (763)
Q Consensus 593 ~~NILl~~-----------~~~~kI~DFGla~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ell 660 (763)
|+|||++. ++.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 200 p~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 279 (365)
T 3e7e_A 200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279 (365)
T ss_dssp GGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHH
T ss_pred HHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHH
Confidence 99999998 89999999999975432 2223345567999999999999999999999999999999999
Q ss_pred hCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCC-CCHHHH
Q 046586 661 SGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELR-PSMGKV 739 (763)
Q Consensus 661 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~eV 739 (763)
+|+.||....... ..+...+... ...+.+.+++..|++.+|.+| |++.++
T Consensus 280 tg~~pf~~~~~~~----------------------~~~~~~~~~~-------~~~~~~~~~~~~~l~~~p~~r~~~~~~l 330 (365)
T 3e7e_A 280 FGTYMKVKNEGGE----------------------CKPEGLFRRL-------PHLDMWNEFFHVMLNIPDCHHLPSLDLL 330 (365)
T ss_dssp HSSCCCEEEETTE----------------------EEECSCCTTC-------SSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred hCCCccccCCCCc----------------------eeechhcccc-------CcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence 9999986432110 0011111110 114456778888999999999 688888
Q ss_pred HHHhccCCC
Q 046586 740 AKMLEGTVE 748 (763)
Q Consensus 740 v~~Le~~~~ 748 (763)
.+.|++..+
T Consensus 331 ~~~l~~~l~ 339 (365)
T 3e7e_A 331 RQKLKKVFQ 339 (365)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 888877553
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.23 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=195.0
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEee----CCeeeEE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAE----KGERTLV 516 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV 516 (763)
+.+.++||+|+||.||+|... ++..||+|+++.... ..+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 556779999999999999875 577899999975432 23568899999999999999999999876 3568999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ .+|+||||||+||
T Consensus 108 ~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Ni 162 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF------------------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNI 162 (290)
T ss_dssp EECCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGE
T ss_pred EEecCCCCHHHHHHHc------------------------cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHE
Confidence 9999999999999643 35788999999999999999999976 3499999999999
Q ss_pred EEc-CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 597 LLG-DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 597 Ll~-~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
+++ .++.+||+|||++....... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||......
T Consensus 163 l~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--- 235 (290)
T 1t4h_A 163 FITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--- 235 (290)
T ss_dssp EESSTTSCEEECCTTGGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---
T ss_pred EEECCCCCEEEeeCCCcccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH---
Confidence 997 88999999999997544332 23456899999999876 56999999999999999999999999643211
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.........+. .....+...+..+.+++..||+.||++|||+.|+++
T Consensus 236 ------~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 236 ------AQIYRRVTSGV-------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------HHHHHHHTTTC-------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------HHHHHHHhccC-------------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00111111110 111111223457899999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.41 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=195.3
Q ss_pred HHhccccccccccccceEEEEEeC--CCc--EEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT--DHR--VVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~--~~~--~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
...+.+.++||+|+||.||+|+.. +++ .||+|+++... ...+++.+|++++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 356778899999999999999863 333 68999987432 23456889999999999999999999998765 8
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||
T Consensus 96 ~~v~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp 149 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH-----------------------QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAA 149 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH-----------------------GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred eeeEecccCCCHHHHHHhc-----------------------cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCch
Confidence 8999999999999999653 235789999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCccccc
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQG 670 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~ 670 (763)
+||+++.++.+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 150 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 150 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp GGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 9999999999999999999876543321 2233457888999999998899999999999999999999 999986432
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
. ... .... .. .......+...+..+.+++.+||+.||++|||+.++++.|++...
T Consensus 230 ~---------~~~-~~~~---------~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 230 G---------SQI-LHKI---------DK----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp H---------HHH-HHHH---------HT----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred H---------HHH-HHHH---------Hc----cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1 000 0011 00 011111123445788999999999999999999999999987653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.82 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=201.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.+.+.++||+|+||.||+|... +++.||+|+++... ...+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 4667789999999999999865 68899999997542 34467899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++. ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.
T Consensus 103 ~~~~L~~~~~-------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~ 154 (303)
T 3a7i_A 103 GGGSALDLLE-------------------------PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSE 154 (303)
T ss_dssp TTEEHHHHHT-------------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CCCcHHHHHh-------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECC
Confidence 9999999983 235889999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------- 224 (303)
T 3a7i_A 155 HGEVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------- 224 (303)
T ss_dssp TSCEEECCCTTCEECBTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---------
T ss_pred CCCEEEeecccceecCcccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---------
Confidence 99999999999976544322 22345789999999999999999999999999999999999999863321
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. ........ ...... ...+..+.+++..||+.||++|||+.++++.
T Consensus 225 ~~-~~~~~~~~----------~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 225 MK-VLFLIPKN----------NPPTLE----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HH-HHHHHHHS----------CCCCCC----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HH-HHHHhhcC----------CCCCCc----cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00111111 001111 2334578899999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.14 Aligned_cols=270 Identities=24% Similarity=0.339 Sum_probs=206.4
Q ss_pred HHhccccccccccccceEEEEEe-----CCCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCC--ee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGEL-----TDHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG--ER 513 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~-----~~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 513 (763)
...+.+.++||+|+||.||+++. .+++.||||+++.... ..+++.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45577889999999999999984 3578999999975433 3457899999999999999999999987654 78
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||
T Consensus 120 ~lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp 173 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH-----------------------KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLAT 173 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS-----------------------TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred EEEEECCCCCCHHHHHHhc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCc
Confidence 9999999999999999653 235889999999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+.....
T Consensus 174 ~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 253 (326)
T 2w1i_A 174 RNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253 (326)
T ss_dssp GGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH
T ss_pred ceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH
Confidence 9999999999999999999876543321 12234567789999999988999999999999999999999998753210
Q ss_pred CC-C-CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 672 MM-N-SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 672 ~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.. . ........+.... ..+.+.. ......+...+.++.+++.+||+.||++|||+.||++.|+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~------~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 254 EFMRMIGNDKQGQMIVFH------LIELLKN----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHCTTCCTHHHHHH------HHHHHHT----TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhccccchhhhHHH------HHHHhhc----CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 0 0000000000000 0111111 1111222345678999999999999999999999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=355.40 Aligned_cols=251 Identities=25% Similarity=0.311 Sum_probs=204.1
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.+.||+|+||.||+++.. +++.||+|+++.. ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 45667789999999999999885 6889999999742 334566889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 264 Ey~~gg~L~~~l~~~----------------------~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNIL 318 (576)
T 2acx_A 264 TLMNGGDLKFHIYHM----------------------GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENIL 318 (576)
T ss_dssp CCCCSCBHHHHHHSS----------------------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred EcCCCCcHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEE
Confidence 999999999999653 2335889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++++||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 319 ld~~g~vKL~DFGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--- 393 (576)
T 2acx_A 319 LDDHGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--- 393 (576)
T ss_dssp ECTTSCEEECCCTTCEECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC---
T ss_pred EeCCCCeEEEecccceecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh---
Confidence 9999999999999998664332 22345799999999999999999999999999999999999999975432110
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
........... ...++......+.+++..||+.||++|| ++.||++
T Consensus 394 ---~~~i~~~i~~~---------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 394 ---REEVERLVKEV---------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---HHHHHHHHHHC---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---HHHHHHHhhcc---------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00011111000 0111123456788999999999999999 7888874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=363.97 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=203.6
Q ss_pred HHHHhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCee
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 513 (763)
+....+.+.++||+|+||.||+++.. +++.||||+++.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 33456777889999999999999876 5788999999742 33456688899999988 799999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
+|||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ ||||||||
T Consensus 418 ~lV~E~~~gg~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp 470 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV------------------------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKL 470 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCS
T ss_pred EEEEeCcCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCCh
Confidence 9999999999999999653 25889999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
+||||+.++++||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 471 ~NILl~~~g~ikL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~- 548 (674)
T 3pfq_A 471 DNVMLDSEGHIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED- 548 (674)
T ss_dssp TTEEECSSSCEEECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-
T ss_pred hhEEEcCCCcEEEeecceeeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-
Confidence 99999999999999999998543322 2344568999999999999999999999999999999999999999743210
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM-----GKVAK 741 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVv~ 741 (763)
.. ...++... ..++.....++.+++..||+.||++||++ .||++
T Consensus 549 ---------~~---------~~~i~~~~------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 549 ---------EL---------FQSIMEHN------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---------HH---------HHHHHSSC------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---------HH---------HHHHHhCC------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 00 11111111 11223456778999999999999999998 77763
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.13 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=194.6
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
..||+|+||.||+|... +++.||+|.++... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 48999999999999874 57899999997543 33567899999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC-CCCeE
Q 046586 527 DYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD-DFCPK 605 (763)
Q Consensus 527 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~-~~~~k 605 (763)
+++.... ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++. ++.+|
T Consensus 108 ~~l~~~~---------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~k 163 (295)
T 2clq_A 108 ALLRSKW---------------------GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLK 163 (295)
T ss_dssp HHHHHTT---------------------CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEE
T ss_pred HHHHhhc---------------------cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEE
Confidence 9997542 2335678889999999999999999998 999999999999987 89999
Q ss_pred EcccCcccccCCCCcccccccccCCCcccccccccC--CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHH
Q 046586 606 ISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD--QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683 (763)
Q Consensus 606 I~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~ 683 (763)
|+|||+++....... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... ..
T Consensus 164 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~ 233 (295)
T 2clq_A 164 ISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---------QA 233 (295)
T ss_dssp ECCTTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---------HH
T ss_pred EeecccccccCCCCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---------hH
Confidence 999999986543221 22345689999999998764 3889999999999999999999999643210 00
Q ss_pred HHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..... . . . ......+......+.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~--~-----~--~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 234 AMFKV--G-----M--F----KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHH--H-----H--H----CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHhh--c-----c--c----cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000 0 0 0 0111122344567889999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=328.83 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=204.4
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
...|.+.+.||+|+||.||+++.. +++.||+|+++.... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 356788899999999999999875 688999999985432 345688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE-
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL- 598 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl- 598 (763)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 88 ~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~ 140 (304)
T 2jam_A 88 VSGGELFDRILER------------------------GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYL 140 (304)
T ss_dssp CCSCBHHHHHHHH------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEES
T ss_pred CCCccHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEe
Confidence 9999999998643 24788999999999999999999998 9999999999999
Q ss_pred --cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 599 --GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 599 --~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
++++.+||+|||+++..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 141 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----- 212 (304)
T 2jam_A 141 TPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----- 212 (304)
T ss_dssp SSSTTCCEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----
T ss_pred cCCCCCCEEEccCCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----
Confidence 78899999999999754332 22345689999999999999999999999999999999999999964321
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccCC
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGTV 747 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~~ 747 (763)
......+.++. . ..........+..+.+++.+||+.||++|||+.|+++ .+++..
T Consensus 213 -----~~~~~~i~~~~---------~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 213 -----SKLFEKIKEGY---------Y--EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp -----HHHHHHHHHCC---------C--CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred -----HHHHHHHHcCC---------C--CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 00111111110 0 0111111234567899999999999999999999996 555543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.51 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=198.4
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEec
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
...|.+.+.||+|+||.||++... +++.||+|+++.... .+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 356788899999999999999876 578999999975432 345788888888 799999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+.
T Consensus 98 ~~gg~L~~~i~~~------------------------~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~ 150 (342)
T 2qr7_A 98 MKGGELLDKILRQ------------------------KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYV 150 (342)
T ss_dssp CCSCBHHHHHHTC------------------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEES
T ss_pred CCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEe
Confidence 9999999999642 35889999999999999999999998 99999999999985
Q ss_pred CC----CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 600 DD----FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 600 ~~----~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
++ +.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--- 226 (342)
T 2qr7_A 151 DESGNPESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--- 226 (342)
T ss_dssp SSSCSGGGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS---
T ss_pred cCCCCcCeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC---
Confidence 43 3599999999986544322 233457899999999998888999999999999999999999999743211
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ......+..+. .. .........+..+.+++.+||+.||++||++.++++
T Consensus 227 ---~~-~~~~~~i~~~~---------~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 227 ---TP-EEILARIGSGK---------FS--LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CH-HHHHHHHHHCC---------CC--CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CH-HHHHHHHccCC---------cc--cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11 11111111110 00 011111234567889999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=341.10 Aligned_cols=269 Identities=21% Similarity=0.293 Sum_probs=202.3
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
...+.+.++||+|+||.||++... +++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 456777889999999999999886 678999999975432 23568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCceE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENIL 597 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NIL 597 (763)
|+++++|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+||+
T Consensus 112 ~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil 164 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA------------------------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNIL 164 (360)
T ss_dssp CCTTCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEE
T ss_pred CCCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEE
Confidence 99999999999653 2478899999999999999999996 7 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC---
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN--- 674 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~--- 674 (763)
++.++.+||+|||++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 165 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 241 (360)
T 3eqc_A 165 VNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241 (360)
T ss_dssp ECTTCCEEECCCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH
T ss_pred ECCCCCEEEEECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999754321 22345789999999999999999999999999999999999999964321100
Q ss_pred ------CCCC-----------chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 675 ------SDEW-----------YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 675 ------~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
.... .+..+.. .........+.++...............+..+.+++.+||+.||++|||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 320 (360)
T 3eqc_A 242 FGCQVEGDAAETPPRPRTPGRPLNKFGM-DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320 (360)
T ss_dssp HC-------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred hcccccccCCCCCCCcccCCCccccccc-CCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHH
Confidence 0000 0000000 000000011122221111111111122456789999999999999999999
Q ss_pred HHHH
Q 046586 738 KVAK 741 (763)
Q Consensus 738 eVv~ 741 (763)
|+++
T Consensus 321 ell~ 324 (360)
T 3eqc_A 321 QLMV 324 (360)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9984
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=328.87 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=201.9
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEee--CCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAE--KGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV 516 (763)
..|.+.+.||+|+||.||+++.. +++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 35677889999999999999875 688999999975432 23568899999999999999999998854 5688999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCcEEecCCCCC
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEEC--LEWVLHCDIKPE 594 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~--~~~ivHrDlk~~ 594 (763)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~ 145 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTK--------------------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145 (279)
T ss_dssp EECCTTEEHHHHHHHHHH--------------------TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGG
T ss_pred EeCCCCCCHHHHHHhhcc--------------------cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchh
Confidence 999999999999975321 2345899999999999999999999976 234999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
||+++.++.+||+|||+++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 146 NIl~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--- 221 (279)
T 2w5a_A 146 NVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--- 221 (279)
T ss_dssp GEEECSSSCEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred hEEEcCCCCEEEecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---
Confidence 99999999999999999986543321 22345689999999999999999999999999999999999999864321
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
......+.++. . ...+...+..+.+++.+||+.||++||++.||++.+..
T Consensus 222 -------~~~~~~i~~~~---------~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 222 -------KELAGKIREGK---------F-----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -------HHHHHHHHHTC---------C-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------HHHHHHHhhcc---------c-----ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 00111111111 0 01112345678999999999999999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=342.89 Aligned_cols=262 Identities=18% Similarity=0.151 Sum_probs=203.7
Q ss_pred HhccccccccccccceEEEEEeCC---------CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCcccc-----------
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD---------HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVR----------- 502 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~---------~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~----------- 502 (763)
..|.+.+.||+|+||.||+|+... ++.||+|+++.. ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 467788999999999999998764 788999999753 46889999999999999988
Q ss_pred ----EEEEEee-CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 046586 503 ----LWGFCAE-KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAY 577 (763)
Q Consensus 503 ----l~g~~~~-~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~y 577 (763)
+++++.. ....++||||+ +++|.+++... ....+++.+++.++.||+.||+|
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----------------------~~~~l~~~~~~~i~~qi~~~L~~ 174 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS----------------------PKHVLSERSVLQVACRLLDALEF 174 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS----------------------GGGCCCHHHHHHHHHHHHHHHHH
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC----------------------CcCCCCHHHHHHHHHHHHHHHHH
Confidence 6788876 67899999999 99999999753 12468999999999999999999
Q ss_pred HHhcCCCcEEecCCCCCceEEcCCC--CeEEcccCcccccCCCCcc------cccccccCCCcccccccccCCCCCccce
Q 046586 578 LHEECLEWVLHCDIKPENILLGDDF--CPKISDFGLAKLRKKEDMV------SMSRIRGTRGYMAPEWLRSDQITPKADV 649 (763)
Q Consensus 578 LH~~~~~~ivHrDlk~~NILl~~~~--~~kI~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDV 649 (763)
||+.+ |+||||||+|||++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||
T Consensus 175 LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 251 (352)
T 2jii_A 175 LHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDL 251 (352)
T ss_dssp HHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred HHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhH
Confidence 99998 99999999999999998 9999999999865533221 1233578999999999999999999999
Q ss_pred eehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCC
Q 046586 650 YSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDR 729 (763)
Q Consensus 650 wS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~d 729 (763)
||||+++|||++|+.||....... ...... ....... ...+....... ...+..+.+++.+||+.|
T Consensus 252 ~slG~il~el~~g~~pf~~~~~~~----~~~~~~-~~~~~~~--~~~~~~~~~~~-------~~~~~~l~~li~~~l~~d 317 (352)
T 2jii_A 252 QSLGYCMLKWLYGFLPWTNCLPNT----EDIMKQ-KQKFVDK--PGPFVGPCGHW-------IRPSETLQKYLKVVMALT 317 (352)
T ss_dssp HHHHHHHHHHHHSCCTTGGGTTCH----HHHHHH-HHHHHHS--CCCEECTTSCE-------ECCCHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHhCCCCcccCCcCH----HHHHHH-HHhccCC--hhhhhhhcccc-------CCCcHHHHHHHHHHHhCC
Confidence 999999999999999997542110 000000 0000000 11111110000 122467899999999999
Q ss_pred CCCCCCHHHHHHHhccCCC
Q 046586 730 PELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 730 P~~RPs~~eVv~~Le~~~~ 748 (763)
|++|||+.+|+++|+++.+
T Consensus 318 p~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 318 YEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp TTCCCCHHHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHHHH
Confidence 9999999999999988763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=348.76 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=203.3
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.+.||+|+||.||+++.. +++.||+|+++.. ......+.+|+.++++++||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 34556689999999999999885 5899999999743 234466889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 265 E~~~gg~L~~~l~~~~~--------------------~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NIL 321 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDE--------------------DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVL 321 (543)
T ss_dssp CCCTTCBHHHHHHTSST--------------------TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred EeccCCCHHHHHHHhhc--------------------ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEE
Confidence 99999999999965421 2346899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++++||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 322 l~~~g~vkL~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~---- 396 (543)
T 3c4z_A 322 LDDDGNVRISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---- 396 (543)
T ss_dssp ECTTSCEEECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC----
T ss_pred EeCCCCEEEeecceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch----
Confidence 99999999999999986543322 2334579999999999999999999999999999999999999997543211
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH-----HHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM-----GKVA 740 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~eVv 740 (763)
..... .... .... ...+...+..+.+++..||+.||++||++ .+|+
T Consensus 397 -~~~~~-~~~i---------~~~~------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 397 -ENKEL-KQRV---------LEQA------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp -CHHHH-HHHH---------HHCC------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred -hHHHH-HHHH---------hhcc------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 00110 1111 1110 01123345678899999999999999975 5666
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.68 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=197.3
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 516 (763)
...|.+.++||+|+||.||++... +++.||+|+++... ....++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356778899999999999999886 68899999998542 2345688999999999 999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 90 ~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NI 146 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR--------------------IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNI 146 (289)
T ss_dssp EECCTTCBHHHHHHHHHH--------------------HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred EEecCCCcHHHHHHhhcc--------------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHE
Confidence 999999999999965320 1246889999999999999999999998 99999999999
Q ss_pred EEcC-------------------CCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHH
Q 046586 597 LLGD-------------------DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVL 656 (763)
Q Consensus 597 Ll~~-------------------~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll 656 (763)
+++. ...+||+|||++....... ...||..|+|||.+.+. .++.++||||||+++
T Consensus 147 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 221 (289)
T 1x8b_A 147 FISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTV 221 (289)
T ss_dssp EEC--------------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHH
T ss_pred EEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHH
Confidence 9984 4489999999998654432 23589999999998765 667899999999999
Q ss_pred HHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 657 LEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 657 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
|||++|..++.... ....+.++ .. . ..+......+.+++.+||+.||++|||+
T Consensus 222 ~~l~~~~~~~~~~~-------------~~~~~~~~---------~~-~----~~~~~~~~~~~~li~~~l~~dp~~Rps~ 274 (289)
T 1x8b_A 222 VCAAGAEPLPRNGD-------------QWHEIRQG---------RL-P----RIPQVLSQEFTELLKVMIHPDPERRPSA 274 (289)
T ss_dssp HHHTTCCCCCSSSH-------------HHHHHHTT---------CC-C----CCSSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHhcCCCCCcchh-------------HHHHHHcC---------CC-C----CCCcccCHHHHHHHHHHhCCCcccCCCH
Confidence 99999987754211 01111111 11 1 1112345678899999999999999999
Q ss_pred HHHHH
Q 046586 737 GKVAK 741 (763)
Q Consensus 737 ~eVv~ 741 (763)
.|+++
T Consensus 275 ~~ll~ 279 (289)
T 1x8b_A 275 MALVK 279 (289)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=344.60 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=190.3
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC---------CchhhhHHHHHHHhcCCCCccccEEEEEeeC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---------GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 510 (763)
....|.+.++||+|+||.||+|... +++.||||+++... .....+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4457888899999999999999875 57899999997431 11235889999999999999999999975 4
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrD 264 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG------------------------NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRD 264 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS------------------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEEcCCCCcHHHHHhc------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 568999999999999998853 235889999999999999999999998 99999
Q ss_pred CCCCceEEcCC---CCeEEcccCcccccCCCCcccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCC
Q 046586 591 IKPENILLGDD---FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 591 lk~~NILl~~~---~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~ 664 (763)
|||+|||++.+ ..+||+|||+++..... .......||+.|+|||.+. ...++.++||||||+++|||++|+.
T Consensus 265 lkp~NIll~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 265 LKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp CCGGGEEESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred CChHhEEEecCCCcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999754 45999999999876432 2234567999999999985 3678899999999999999999999
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
||....... .+. .....+. ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 343 pf~~~~~~~-----~~~----~~i~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 343 PFSEHRTQV-----SLK----DQITSGK-----------YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SSCCCSSSC-----CHH----HHHHTTC-----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCcchH-----HHH----HHHhcCC-----------CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 996432211 000 0111110 00010111234567899999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=343.80 Aligned_cols=282 Identities=20% Similarity=0.227 Sum_probs=208.3
Q ss_pred CCCccccHHHHHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCC--------CCcc
Q 046586 430 GGPKRFTHAELRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMH--------HLNL 500 (763)
Q Consensus 430 ~~~~~~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~--------H~ni 500 (763)
++...+...++....|.+.++||+|+||.||+|+.. +++.||||+++......+.+.+|+.+++.++ |+||
T Consensus 24 ~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 24 GGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp --CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred CCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 344445555555677889999999999999999764 5789999999865445567889999999985 7889
Q ss_pred ccEEEEEe----eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 046586 501 VRLWGFCA----EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIA 576 (763)
Q Consensus 501 v~l~g~~~----~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~ 576 (763)
+++++++. +....++||||+ +++|.+++... ....+++..++.|+.||+.||+
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----------------------~~~~~~~~~~~~i~~qi~~aL~ 160 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS----------------------NYQGLPLPCVKKIIQQVLQGLD 160 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT----------------------TTSCCCHHHHHHHHHHHHHHHH
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhc----------------------ccCCCCHHHHHHHHHHHHHHHH
Confidence 99999998 456899999999 66777777543 2245889999999999999999
Q ss_pred HHHhc-CCCcEEecCCCCCceEEcCCC-------------------------------------------------CeEE
Q 046586 577 YLHEE-CLEWVLHCDIKPENILLGDDF-------------------------------------------------CPKI 606 (763)
Q Consensus 577 yLH~~-~~~~ivHrDlk~~NILl~~~~-------------------------------------------------~~kI 606 (763)
|||++ + |+||||||+|||++.++ .+||
T Consensus 161 ~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl 237 (397)
T 1wak_A 161 YLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237 (397)
T ss_dssp HHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEE
T ss_pred HHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEe
Confidence 99998 7 99999999999999775 8999
Q ss_pred cccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHH
Q 046586 607 SDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686 (763)
Q Consensus 607 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 686 (763)
+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....................
T Consensus 238 ~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 313 (397)
T 1wak_A 238 ADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313 (397)
T ss_dssp CCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHH
T ss_pred cccccccccccc----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHH
Confidence 999999865432 2345789999999999999999999999999999999999999975432211000000000000
Q ss_pred HH--------HhccChhhhhcccc-----ccc----------CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 687 KV--------YEEMKVEDILDRHI-----KNS----------YDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 687 ~~--------~~~~~~~~~~~~~l-----~~~----------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ..+....+...... ... .....+.+....+.+++.+||+.||++|||+.|+++
T Consensus 314 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 314 LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 00000000000000 000 001123677888999999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=333.78 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=200.4
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---------hhhhHHHHHHHhcC-CCCccccEEEEEeeC
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---------DAEFWAEVTIIARM-HHLNLVRLWGFCAEK 510 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---------~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 510 (763)
...|.+.+.||+|+||.||+|+.. +|+.||||+++..... .+.+.+|+.+++++ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 456777899999999999999986 6899999999754321 24578899999999 899999999999999
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
...++||||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+|+|
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~D 225 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK------------------------VALSEKETRSIMRSLLEAVSFLHANN---IVHRD 225 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred CEEEEEEEeCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9999999999999999999643 35889999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc------CCCCCccceeehhHHHHHHHhCCC
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS------DQITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~s~ksDVwS~Gvll~elltG~~ 664 (763)
|||+||+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.
T Consensus 226 lkp~NIl~~~~~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 226 LKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEECCCCCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 99999999999999999999998665432 2334678999999998863 368899999999999999999999
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
||..... ......+..+. .. .........+..+.+++.+||+.||++|||+.++++
T Consensus 304 pf~~~~~----------~~~~~~i~~~~---------~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 304 PFWHRRQ----------ILMLRMIMEGQ---------YQ--FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SSCCSSH----------HHHHHHHHHTC---------CC--CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCH----------HHHHHHHHhCC---------CC--CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9964321 00011111110 00 000000123457889999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=342.22 Aligned_cols=199 Identities=28% Similarity=0.419 Sum_probs=159.5
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCC-CCccccEEEEEeeCC--eee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMH-HLNLVRLWGFCAEKG--ERT 514 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~ 514 (763)
...|.+.++||+|+||.||+|... +++.||||++..... ....+.+|+.++..+. ||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 356788899999999999999875 688999999864322 2345778999999997 999999999998654 789
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 88 lv~e~~~-~~L~~~~~~-------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~ 138 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA-------------------------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPS 138 (388)
T ss_dssp EEEECCS-EEHHHHHHH-------------------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred EEecccC-cCHHHHHHc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHH
Confidence 9999997 589998853 25788899999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCC--------------------CcccccccccCCCccccccccc-CCCCCccceeehh
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKE--------------------DMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFG 653 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~--------------------~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~G 653 (763)
|||++.++.+||+|||+++..... .....+...||+.|+|||.+.+ ..++.++||||+|
T Consensus 139 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 218 (388)
T 3oz6_A 139 NILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218 (388)
T ss_dssp GEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred HeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHH
Confidence 999999999999999999865321 1112344679999999999876 6899999999999
Q ss_pred HHHHHHHhCCCCcccc
Q 046586 654 MVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 654 vll~elltG~~p~~~~ 669 (763)
|++|||++|+.||...
T Consensus 219 ~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 219 CILGEILCGKPIFPGS 234 (388)
T ss_dssp HHHHHHHHSSCSCCCS
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=332.29 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=206.6
Q ss_pred ccccHHHHHHHhcccc-ccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcC-CCCccccEEEE
Q 046586 433 KRFTHAELRAATNGFS-NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARM-HHLNLVRLWGF 506 (763)
Q Consensus 433 ~~~~~~el~~~t~~~~-~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l-~H~niv~l~g~ 506 (763)
..|...+.....|.+. ++||+|+||.||++... +++.||+|+++.... ...++.+|+.++..+ +||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3466666777777776 89999999999999876 588999999975322 346788999999999 57999999999
Q ss_pred EeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 507 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
+.+.+..++||||+++|+|.+++... ....+++.+++.++.|++.||+|||+.+ |
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~----------------------~~~~~~~~~~~~i~~ql~~~L~~LH~~g---i 152 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE----------------------LAEMVSENDVIRLIKQILEGVYYLHQNN---I 152 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC----------------------C-CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh----------------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 99999999999999999999998532 2356899999999999999999999998 9
Q ss_pred EecCCCCCceEEcC---CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCC
Q 046586 587 LHCDIKPENILLGD---DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS 663 (763)
Q Consensus 587 vHrDlk~~NILl~~---~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~ 663 (763)
+||||||+||+++. ++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+
T Consensus 153 vH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 230 (327)
T 3lm5_A 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT 230 (327)
T ss_dssp ECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999998 7899999999998664332 223457899999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 664 RNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 664 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.||...... ......... ...............+.+++.+||+.||++|||+.++++.
T Consensus 231 ~pf~~~~~~----------~~~~~i~~~-----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 231 SPFVGEDNQ----------ETYLNISQV-----------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CSSCCSSHH----------HHHHHHHHT-----------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCch----------HHHHHHHhc-----------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 999643210 000111110 0011111112345678899999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=327.75 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=198.9
Q ss_pred HHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.....+.+.+.||+|+||.||+|... +++.||+|+++... ...++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 34456778899999999999999886 48899999997543 45678999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++
T Consensus 105 ~~~~~~L~~~~~~~-----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~ 158 (314)
T 3com_A 105 YCGAGSVSDIIRLR-----------------------NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILL 158 (314)
T ss_dssp CCTTEEHHHHHHHH-----------------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred cCCCCCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEE
Confidence 99999999998632 245889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.+||+|||++....... .......||..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------ 231 (314)
T 3com_A 159 NTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------ 231 (314)
T ss_dssp CTTCCEEECCCTTCEECBTTB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred CCCCCEEEeecccchhhhhhc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------
Confidence 999999999999997654322 1233456899999999999999999999999999999999999999643210
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ........ .. ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 232 ---~~-~~~~~~~~----------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 232 ---RA-IFMIPTNP----------PP--TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---HH-HHHHHHSC----------CC--CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---HH-HHHHhcCC----------Cc--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00 00000000 00 00111233567889999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=330.47 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=194.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.|.+.++||+|+||.||+++.. +++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 4667889999999999999886 4889999998654332 35578999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++
T Consensus 84 ~~~~~l~~~~~~------------------------~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~ 136 (311)
T 4agu_A 84 CDHTVLHELDRY------------------------QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILIT 136 (311)
T ss_dssp CSEEHHHHHHHT------------------------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCCchHHHHHhh------------------------hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEc
Confidence 999999988753 235889999999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCC---
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS--- 675 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~--- 675 (763)
.++.+||+|||+++....... ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 215 (311)
T 4agu_A 137 KHSVIKLCDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215 (311)
T ss_dssp TTSCEEECCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEeeCCCchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999986543322 2234578999999999876 67899999999999999999999999644321100
Q ss_pred ---CCCchhHHHHHHHHhccChhhhhcccccccCC--Ccc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 ---DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYD--SRV---HFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.....+.+. . ..... ............ ... ....+..+.+++..||+.||++|||++|+++
T Consensus 216 ~~~~~~~~~~~~-~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 216 RKTLGDLIPRHQ-Q-VFSTN---QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHCSCCHHHH-H-HHHTC---GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred HHHhcccccccc-c-ccccc---cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000 0 00000 000000000000 000 0134566889999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=335.61 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=197.0
Q ss_pred HHhccccccccccccceEEEEEeCCCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
...+.+.+.||+|+||.||+|+..+ .+|+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 3456778999999999999998864 49999987432 234568899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+||++
T Consensus 110 ~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~ 163 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA-----------------------KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFY 163 (319)
T ss_dssp CCCSEEHHHHTTSS-----------------------CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEE
T ss_pred cccCCcHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEE
Confidence 99999999999532 235888999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCc----ccccccccCCCccccccccc---------CCCCCccceeehhHHHHHHHhCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDM----VSMSRIRGTRGYMAPEWLRS---------DQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~----~~~~~~~gt~~y~APE~l~~---------~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
+ ++.+||+|||+++....... .......||..|+|||.+.. ..++.++||||||+++|||++|+.|
T Consensus 164 ~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 242 (319)
T 2y4i_B 164 D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242 (319)
T ss_dssp C---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred e-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 8 67999999999875432111 12233458999999998864 4588999999999999999999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
|..... .........+. .+... . ...+..+.+++..||+.||++|||+.+|+++|+.
T Consensus 243 ~~~~~~----------~~~~~~~~~~~------~~~~~---~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 299 (319)
T 2y4i_B 243 FKTQPA----------EAIIWQMGTGM------KPNLS---Q----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299 (319)
T ss_dssp SSSCCH----------HHHHHHHHTTC------CCCCC---C----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTT
T ss_pred CCCCCH----------HHHHHHhccCC------CCCCC---c----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 964321 00111111110 01000 0 1234568899999999999999999999999999
Q ss_pred CCCC
Q 046586 746 TVEI 749 (763)
Q Consensus 746 ~~~~ 749 (763)
+.+.
T Consensus 300 l~~~ 303 (319)
T 2y4i_B 300 LPKR 303 (319)
T ss_dssp C---
T ss_pred HHHh
Confidence 8754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=347.31 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=201.2
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
...|.+.++||+|+||.||+++.. +++.||||+++.. ......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999876 6889999999632 334567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 101 e~~~~~~L~~~~~~~------------------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil 153 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR------------------------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENIL 153 (486)
T ss_dssp CCCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EcCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEE
Confidence 999999999998643 35889999999999999999999998 999999999999
Q ss_pred Ec---CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LG---DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~---~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++ .++.+||+|||+++...... ......||+.|+|||.+.+ .++.++||||+||++|||++|+.||......
T Consensus 154 ~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-- 228 (486)
T 3mwu_A 154 LESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-- 228 (486)
T ss_dssp ESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred EecCCCCCCEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 95 56689999999998654332 2334579999999999875 5999999999999999999999999643210
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.....+..+. . ....+.....+..+.+++.+||+.||++|||+.++++.
T Consensus 229 --------~~~~~i~~~~---------~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 229 --------DILKRVETGK---------Y--AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --------HHHHHHHHTC---------C--CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --------HHHHHHHhCC---------C--CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011111110 0 00111112345678899999999999999999999963
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=323.00 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=203.6
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..+.+.+.||+|+||.||+++.. +++.||+|++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 45777899999999999999876 5778999999643 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+
T Consensus 94 e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil 146 (284)
T 2vgo_A 94 EFAPRGELYKELQKH------------------------GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLL 146 (284)
T ss_dssp CCCTTEEHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEE
T ss_pred EeCCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEE
Confidence 999999999999653 24788999999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++.+||+|||++....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 147 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----- 218 (284)
T 2vgo_A 147 MGYKGELKIADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT----- 218 (284)
T ss_dssp ECTTCCEEECCCTTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----
T ss_pred EcCCCCEEEecccccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----
Confidence 9999999999999997554321 23456899999999999999999999999999999999999999643210
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccC
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGT 746 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~ 746 (763)
. .... +.... ...+......+.+++.+||+.||++||++.++++ .+...
T Consensus 219 ----~-~~~~---------~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 219 ----E-THRR---------IVNVD------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ----H-HHHH---------HHTTC------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ----H-HHHH---------Hhccc------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 0 0011 11110 0111234567889999999999999999999985 55443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=329.90 Aligned_cols=252 Identities=19% Similarity=0.285 Sum_probs=185.2
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCch--h-hhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGD--A-EFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~--~-~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
...+.+.++||+|+||.||+++.. +++.||+|+++...... . .+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 356778899999999999999874 68899999997543322 2 2444555688889999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCce
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENI 596 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NI 596 (763)
||++ |+|.+++..... ....+++..+..++.|++.||+|||+. + |+||||||+||
T Consensus 86 e~~~-~~l~~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Ni 141 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVID--------------------KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNV 141 (290)
T ss_dssp ECCS-EEHHHHHHHHHH--------------------TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGC
T ss_pred ehhc-cchHHHHHHHHh--------------------cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHE
Confidence 9997 589888754210 335689999999999999999999998 8 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccc----ccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWL----RSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
+++.++.+||+|||+++....... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||......
T Consensus 142 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 219 (290)
T 3fme_A 142 LINALGQVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219 (290)
T ss_dssp EECTTCCEEBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH
T ss_pred EECCCCCEEEeecCCccccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch
Confidence 999999999999999986544322 2234689999999996 5668899999999999999999999999632210
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
..... ..+....... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 220 ---------~~~~~---------~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 220 ---------FQQLK---------QVVEEPSPQL----PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---------HHHHH---------HHHHSCCCCC----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------HHHHH---------HHhccCCCCc----ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00001 1111111110 11234567889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=349.10 Aligned_cols=243 Identities=14% Similarity=0.111 Sum_probs=188.1
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeecc----CCchhhhHHHHH---HHhcCCCCccccEE-------EEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNV----TGGDAEFWAEVT---IIARMHHLNLVRLW-------GFCA 508 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~----~~~~~~f~~E~~---~l~~l~H~niv~l~-------g~~~ 508 (763)
.+.+.+.||+|+||.||+|+. .+++.||||+++.. ....+.+.+|++ ++++++|||||+++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 455678999999999999986 46899999999743 223466889994 55556899999998 7766
Q ss_pred eCC-----------------eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHH
Q 046586 509 EKG-----------------ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGV 571 (763)
Q Consensus 509 ~~~-----------------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qi 571 (763)
+.+ ..++||||+ +|+|.+++....... .....+++..++.|+.||
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~qi 215 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS-----------------STHKSLVHHARLQLTLQV 215 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT-----------------TTTHHHHHHHHHHHHHHH
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc-----------------cccccccHHHHHHHHHHH
Confidence 553 278999999 689999997542110 012345678899999999
Q ss_pred HHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC----------
Q 046586 572 ARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD---------- 641 (763)
Q Consensus 572 a~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~---------- 641 (763)
+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||.+.+.
T Consensus 216 ~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~ 287 (377)
T 3byv_A 216 IRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRR 287 (377)
T ss_dssp HHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCE
T ss_pred HHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhccccccccccccc
Confidence 99999999998 99999999999999999999999999985332 2334567 999999999887
Q ss_pred -CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHH
Q 046586 642 -QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVK 720 (763)
Q Consensus 642 -~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~ 720 (763)
.++.++|||||||++|||++|+.||........ ...+... . ...+..+.+
T Consensus 288 ~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~-------------------~~~~~~~------~----~~~~~~~~~ 338 (377)
T 3byv_A 288 TLMTFSFDAWALGLVIYWIWCADLPITKDAALGG-------------------SEWIFRS------C----KNIPQPVRA 338 (377)
T ss_dssp EECCHHHHHHHHHHHHHHHHHSSCCC------CC-------------------SGGGGSS------C----CCCCHHHHH
T ss_pred ccCChhhhHHHHHHHHHHHHHCCCCCcccccccc-------------------hhhhhhh------c----cCCCHHHHH
Confidence 899999999999999999999999964321110 1111110 0 122457889
Q ss_pred HHHHccCCCCCCCCCHHHHHH
Q 046586 721 TAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 721 l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
++.+||+.||++|||+.++++
T Consensus 339 li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 339 LLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHcCCCchhCCCHHHHhh
Confidence 999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.83 Aligned_cols=246 Identities=22% Similarity=0.315 Sum_probs=201.3
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..|.+.+.||+|+||.||++... +++.+|+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 45667889999999999999886 478899999875421 2356889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+
T Consensus 95 e~~~~~~L~~~~~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil 147 (294)
T 2rku_A 95 ELCRRRSLLELHKRR------------------------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLF 147 (294)
T ss_dssp ECCTTCBHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred ecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEE
Confidence 999999999988643 35889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 220 (294)
T 2rku_A 148 LNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------ 220 (294)
T ss_dssp ECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------
T ss_pred EcCCCCEEEEeccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence 99999999999999986543222 22345689999999999999999999999999999999999999964321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ...... ... ...+......+.+++.+||+.||++|||+.++++
T Consensus 221 ---~~-~~~~~~---------~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 221 ---KE-TYLRIK---------KNE------YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---HH-HHHHHH---------TTC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---HH-HHHHHh---------hcc------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 001110 000 0111233457889999999999999999999996
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=350.33 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=203.2
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
....|.+.++||+|+||.||+++.. +++.||||++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467888999999999999999886 6889999999643 2345678999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|
T Consensus 104 v~e~~~~~~L~~~~~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~N 156 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR------------------------KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPEN 156 (484)
T ss_dssp EECCCCSCBHHHHHHTC------------------------SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHH
Confidence 99999999999998642 35889999999999999999999998 9999999999
Q ss_pred eEE---cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 596 ILL---GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 596 ILl---~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
||+ +.++.+||+|||+++...... ......||+.|+|||.+.+ .++.++||||+||++|||++|+.||......
T Consensus 157 il~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 233 (484)
T 3nyv_A 157 LLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY 233 (484)
T ss_dssp EEESSSSTTCCEEECCTTHHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEecCCCCCcEEEEeeeeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH
Confidence 999 567899999999998654432 2334579999999998875 7999999999999999999999999743210
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.....+..+. . ....+.....++.+.+++.+||+.||++|||+.|+++
T Consensus 234 ----------~~~~~i~~~~---------~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 234 ----------DILKKVEKGK---------Y--TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ----------HHHHHHHHCC---------C--CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------HHHHHHHcCC---------C--CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0111111110 0 0111111234567889999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=333.28 Aligned_cols=246 Identities=22% Similarity=0.317 Sum_probs=201.4
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..|.+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 45667889999999999999886 47889999997542 12356889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+
T Consensus 121 e~~~~~~L~~~~~~~------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl 173 (335)
T 2owb_A 121 ELCRRRSLLELHKRR------------------------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLF 173 (335)
T ss_dssp CCCTTCBHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred ecCCCCCHHHHHhcc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEE
Confidence 999999999988643 35889999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++.++.+||+|||+++....... ......||..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 174 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------ 246 (335)
T 2owb_A 174 LNEDLEVKIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------ 246 (335)
T ss_dssp ECTTCCEEECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------
T ss_pred EcCCCCEEEeeccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------
Confidence 99999999999999986543322 22345689999999999999999999999999999999999999964321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
... ....... .. ..+......+.+++.+||+.||++|||+.|+++
T Consensus 247 ---~~~-~~~~~~~---------~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 247 ---KET-YLRIKKN---------EY------SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---HHH-HHHHHHT---------CC------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---HHH-HHHHhcC---------CC------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0111110 00 011223457888999999999999999999996
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=347.56 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=197.2
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
...|.+.++||+|+||.||+++.. +++.||+|+++.. ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356888899999999999999886 5789999999753 234567899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 116 e~~~~g~L~~~~~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil 168 (494)
T 3lij_A 116 ECYKGGELFDEIIHR------------------------MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLL 168 (494)
T ss_dssp ECCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred ecCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEE
Confidence 999999999988643 35788999999999999999999998 999999999999
Q ss_pred EcC---CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LGD---DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~~---~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++. ++.+||+|||+++...... ......||+.|+|||.+. +.++.++||||+||++|||++|+.||.....
T Consensus 169 ~~~~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--- 242 (494)
T 3lij_A 169 LESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--- 242 (494)
T ss_dssp ESCSSTTCCEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred EeCCCCCCcEEEEECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---
Confidence 976 4559999999998765432 234457999999999876 5799999999999999999999999974321
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
......+..+. . ..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 243 -------~~~~~~i~~~~---------~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 243 -------QEILRKVEKGK---------Y--TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -------HHHHHHHHHTC---------C--CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------HHHHHHHHhCC---------C--CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00111111110 0 0011111234567889999999999999999999984
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.65 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=194.5
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEee------CCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAE------KGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~------~~~~~ 514 (763)
..|.+.+.||+|+||.||+|+.. +++.||||+++.......++.+|+.+++++ +||||+++++++.. .+..+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 34667789999999999999874 688999999987666678899999999999 89999999999987 46889
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+
T Consensus 104 lv~e~~~~~~L~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~ 158 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNT----------------------KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQ 158 (326)
T ss_dssp EEEECCTTEEHHHHHHHS----------------------GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGG
T ss_pred EEEEcCCCCcHHHHHHhc----------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHH
Confidence 999999999999999653 1235788999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
||+++.++.+||+|||++....... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 159 NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 159 NVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp GEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred HEEEcCCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999997654321 1223456899999999986 567899999999999999999999998633
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
... . ......... . +.. .. ...+..+.+++.+||+.||++||++.++++
T Consensus 238 ~~~---------~-~~~~~~~~~-~-----~~~---~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 238 HPM---------R-ALFLIPRNP-A-----PRL---KS----KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CHH---------H-HHHHHHHSC-C-----CCC---SC----SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cHH---------H-HHHHhhcCc-c-----ccC---Cc----cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 210 0 000111110 0 000 01 123467889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.70 Aligned_cols=268 Identities=22% Similarity=0.289 Sum_probs=195.6
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
+|.+.++||+|+||.||+|+.. +++.||+|+++.... ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 4667789999999999999886 688999999974332 2235678999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+ |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 83 ~-~~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~ 135 (324)
T 3mtl_A 83 D-KDLKQYLDDC-----------------------GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINE 135 (324)
T ss_dssp S-EEHHHHHHHT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECT
T ss_pred c-cCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECC
Confidence 7 5999998653 245889999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||+++...... .......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||.......
T Consensus 136 ~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------ 208 (324)
T 3mtl_A 136 RGELKLADFGLARAKSIPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE------ 208 (324)
T ss_dssp TCCEEECSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------
T ss_pred CCCEEEccCcccccccCCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------
Confidence 9999999999997554322 22334568999999998876 678999999999999999999999996432110
Q ss_pred hhHHHHHHHHhccChhhhhccccc---------ccCCC----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--Hhc
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIK---------NSYDS----RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLE 744 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~---------~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le 744 (763)
......... +....+....... ..... .........+.+++.+||+.||++|||+.|+++ .+.
T Consensus 209 ~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 286 (324)
T 3mtl_A 209 QLHFIFRIL--GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286 (324)
T ss_dssp HHHHHHHHH--CCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred HHHHHHHHh--CCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence 000000000 0000000000000 00000 001123467889999999999999999999986 455
Q ss_pred cCC
Q 046586 745 GTV 747 (763)
Q Consensus 745 ~~~ 747 (763)
+..
T Consensus 287 ~~~ 289 (324)
T 3mtl_A 287 SLG 289 (324)
T ss_dssp GGC
T ss_pred hcc
Confidence 443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=337.54 Aligned_cols=256 Identities=22% Similarity=0.274 Sum_probs=186.5
Q ss_pred HHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-chhhhHHHHHHHhcCC-CCccccEEEEEe--------eC
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMH-HLNLVRLWGFCA--------EK 510 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~-H~niv~l~g~~~--------~~ 510 (763)
...+.+.++||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.++.++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 346778899999999999999875 678999999865432 3456889999999996 999999999994 33
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
...++||||++ |+|.+++.... ....+++.+++.++.||+.||+|||+.+ ++|+|||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~D 163 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKME---------------------SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRD 163 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHH---------------------TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhh---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEcc
Confidence 45789999996 79999986532 2346899999999999999999999976 3499999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCcc-----------cccccccCCCccccccc---ccCCCCCccceeehhHHH
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDMV-----------SMSRIRGTRGYMAPEWL---RSDQITPKADVYSFGMVL 656 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~~-----------~~~~~~gt~~y~APE~l---~~~~~s~ksDVwS~Gvll 656 (763)
|||+|||++.++.+||+|||+++........ ......||+.|+|||.+ .+..++.++||||||+++
T Consensus 164 ikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il 243 (337)
T 3ll6_A 164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243 (337)
T ss_dssp CCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHH
T ss_pred CCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHH
Confidence 9999999999999999999999876543221 11134589999999998 567889999999999999
Q ss_pred HHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 657 LEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 657 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
|||++|+.||...... .++......... ......+.+++..||+.||++|||+
T Consensus 244 ~el~~g~~p~~~~~~~-----------------------~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~ 296 (337)
T 3ll6_A 244 YLLCFRQHPFEDGAKL-----------------------RIVNGKYSIPPH----DTQYTVFHSLIRAMLQVNPEERLSI 296 (337)
T ss_dssp HHHHHSSCCC-----------------------------------CCCCTT----CCSSGGGHHHHHHHSCSSGGGSCCH
T ss_pred HHHHhCCCCCcchhHH-----------------------HhhcCcccCCcc----cccchHHHHHHHHHccCChhhCcCH
Confidence 9999999999633211 011111110111 1123457889999999999999999
Q ss_pred HHHHHHhccCC
Q 046586 737 GKVAKMLEGTV 747 (763)
Q Consensus 737 ~eVv~~Le~~~ 747 (763)
.|+++.|+.+.
T Consensus 297 ~e~l~~l~~~~ 307 (337)
T 3ll6_A 297 AEVVHQLQEIA 307 (337)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99999998765
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=364.93 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=203.6
Q ss_pred HHHHHhccccccccccccceEEEEEeCC----CcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeCCe
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELTD----HRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEKGE 512 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 512 (763)
++....+.+.+.||+|+||.||+|.... +..||+|.++..... .+.|.+|+.++++++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445677888999999999999998743 457999998754332 356899999999999999999999985 457
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+|||||
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~-----------------------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDik 518 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVR-----------------------KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIA 518 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHT-----------------------TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEcCCCCcHHHHHHhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccc
Confidence 89999999999999999643 235889999999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGS 671 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~ 671 (763)
|+|||++.++.+||+|||+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 519 p~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 519 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp GGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred hHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 999999999999999999998765544333344567889999999999999999999999999999997 9999864321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
. . ....+..+. ....+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 599 ~---------~-~~~~i~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 599 N---------D-VIGRIENGE--------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp H---------H-HHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---------H-HHHHHHcCC--------------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0 0 011111110 11122344578899999999999999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=321.01 Aligned_cols=246 Identities=25% Similarity=0.416 Sum_probs=193.3
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..|.+.+.||+|+||.||+|+.. +++.||+|+++.. ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 45677889999999999999886 6889999999743 233457889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+
T Consensus 91 e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil 143 (276)
T 2h6d_A 91 EYVSGGELFDYICKH------------------------GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVL 143 (276)
T ss_dssp ECCCSCBHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEE
T ss_pred eccCCCcHHHHHhcc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEE
Confidence 999999999999653 24788999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCC-CCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
++.++.+||+|||++........ .....+|+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....
T Consensus 144 ~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----- 216 (276)
T 2h6d_A 144 LDAHMNAKIADFGLSNMMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----- 216 (276)
T ss_dssp ECTTSCEEECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred ECCCCCEEEeecccccccCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----
Confidence 99999999999999986544321 233468999999999987765 6899999999999999999999964221
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. ....+..+. ...+......+.+++.+||+.||++|||+.+|++.
T Consensus 217 ----~~-~~~~~~~~~---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 217 ----PT-LFKKIRGGV---------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----HH-HHHHHHHCC---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----HH-HHHHhhcCc---------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 111111110 00112234678899999999999999999999973
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=348.36 Aligned_cols=246 Identities=25% Similarity=0.354 Sum_probs=197.5
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--------------CchhhhHHHHHHHhcCCCCccccEEEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--------------GGDAEFWAEVTIIARMHHLNLVRLWGFC 507 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--------------~~~~~f~~E~~~l~~l~H~niv~l~g~~ 507 (763)
..|.+.++||+|+||.||+++.. +++.||+|+++... ...+++.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45777899999999999999876 57899999997532 2245688999999999999999999999
Q ss_pred eeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 046586 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVL 587 (763)
Q Consensus 508 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~iv 587 (763)
.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 168 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINR------------------------HKFDECDAANIMKQILSGICYLHKHN---IV 168 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 9999999999999999999998643 35889999999999999999999998 99
Q ss_pred ecCCCCCceEEcCCC---CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCC
Q 046586 588 HCDIKPENILLGDDF---CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 588 HrDlk~~NILl~~~~---~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~ 664 (763)
||||||+|||++.++ .+||+|||+++...... ......||+.|+|||.+. +.++.++||||+||++|||++|+.
T Consensus 169 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~ 245 (504)
T 3q5i_A 169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP 245 (504)
T ss_dssp CSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCC
Confidence 999999999998775 69999999998665432 234457999999999887 569999999999999999999999
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCc--chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSR--VHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
||..... ......+.. ...... .....+..+.+++.+||+.||.+|||+.|+++
T Consensus 246 pf~~~~~----------~~~~~~i~~-------------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 246 PFGGQND----------QDIIKKVEK-------------GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp SSCCSSH----------HHHHHHHHH-------------CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCH----------HHHHHHHHc-------------CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9974321 001111111 111100 00123567899999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=332.14 Aligned_cols=264 Identities=21% Similarity=0.241 Sum_probs=197.0
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEee--------C
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAE--------K 510 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------~ 510 (763)
..|.+.++||+|+||.||+|+. .+++.||+|++.... .....+.+|+.+++.++||||+++++++.+ .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4677889999999999999988 468899999986432 234568899999999999999999999987 4
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
+..++||||+++ +|.+.+... ...+++.++..++.|++.||+|||+.+ |+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 149 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV-----------------------LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRD 149 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT-----------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred ceEEEEEeccCC-CHHHHHhhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCC
Confidence 468999999975 788877542 235889999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCc---ccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~ 666 (763)
|||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 150 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 150 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999986543221 22344578999999998876 56899999999999999999999999
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhh---------hhccccc-ccCCCcchHH-----HHHHHHHHHHHccCCCCC
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVED---------ILDRHIK-NSYDSRVHFD-----MVNRMVKTAMWCIQDRPE 731 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~l~-~~~~~~~~~~-----~~~~l~~l~~~Cl~~dP~ 731 (763)
....... ....... .. +....+ ..+.... .......... ....+.+++.+||+.||+
T Consensus 230 ~~~~~~~------~~~~i~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 301 (351)
T 3mi9_A 230 QGNTEQH------QLALISQ-LC-GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 301 (351)
T ss_dssp CCSSHHH------HHHHHHH-HH-CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGG
T ss_pred CCCChHH------HHHHHHH-Hh-CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChh
Confidence 7532110 0000000 00 000000 0000000 0000011111 135688999999999999
Q ss_pred CCCCHHHHHH
Q 046586 732 LRPSMGKVAK 741 (763)
Q Consensus 732 ~RPs~~eVv~ 741 (763)
+|||+.|+++
T Consensus 302 ~R~t~~e~l~ 311 (351)
T 3mi9_A 302 QRIDSDDALN 311 (351)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhC
Confidence 9999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=335.58 Aligned_cols=266 Identities=20% Similarity=0.268 Sum_probs=201.7
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCc----h--------------hhhHHHHHHHhcCCCCccccEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG----D--------------AEFWAEVTIIARMHHLNLVRLW 504 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~----~--------------~~f~~E~~~l~~l~H~niv~l~ 504 (763)
..|.+.+.||+|+||.||++.. +++.||+|++...... . +.+.+|+.++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4577789999999999999999 8899999999743111 1 7789999999999999999999
Q ss_pred EEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCC
Q 046586 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE-ECL 583 (763)
Q Consensus 505 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~ 583 (763)
+++.+.+..++||||+++++|.+++...... .......+++..+..++.|++.||+|||+ .+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l----------------~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~- 172 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVL----------------DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN- 172 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESS----------------CSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC-
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhh----------------hhccccCCCHHHHHHHHHHHHHHHHHHhccCC-
Confidence 9999999999999999999999984321000 00024578999999999999999999999 88
Q ss_pred CcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCC-ccceeehhHHHHHHHh
Q 046586 584 EWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITP-KADVYSFGMVLLEIVS 661 (763)
Q Consensus 584 ~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~-ksDVwS~Gvll~ellt 661 (763)
|+|+||||+||+++.++.+||+|||++...... ......||..|+|||.+.+. .++. ++||||||+++|||++
T Consensus 173 --i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 247 (348)
T 2pml_X 173 --ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247 (348)
T ss_dssp --EECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred --EeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999865433 23445789999999999877 6766 9999999999999999
Q ss_pred CCCCcccccCCCCCCCCchhHHHHHHHHhccC-hhh----hhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 662 GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMK-VED----ILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 662 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
|+.||....... .....+..+.. ... ...+.. ...........+..+.+++.+||+.||++|||+
T Consensus 248 g~~pf~~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~ 317 (348)
T 2pml_X 248 NVVPFSLKISLV---------ELFNNIRTKNIEYPLDRNHFLYPLT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317 (348)
T ss_dssp SSCSSCCSSCSH---------HHHHHHTSCCCCCCCSSSSSTTTTC-C--------CCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCCCCCCcHH---------HHHHHHhccCcCCccchhhhhcccc-ccccccchhhcCHHHHHHHHHHccCChhhCCCH
Confidence 999997443210 01111111100 000 000000 000000112345678999999999999999999
Q ss_pred HHHHH
Q 046586 737 GKVAK 741 (763)
Q Consensus 737 ~eVv~ 741 (763)
.|+++
T Consensus 318 ~e~l~ 322 (348)
T 2pml_X 318 EDALK 322 (348)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=341.30 Aligned_cols=197 Identities=23% Similarity=0.361 Sum_probs=171.3
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcC------CCCccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARM------HHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l------~H~niv~l~g~~~~~~~~~L 515 (763)
..|.+.++||+|+||.||+|... +++.||||+++.......++.+|+.+++.+ +|+||+++++++...+..++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 45778899999999999999775 578999999986544456678888888777 57799999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+. ++|.+++... ....+++..+..|+.||+.||+|||+.+ |+||||||+|
T Consensus 177 v~e~~~-~~L~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~N 230 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKN----------------------KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPEN 230 (429)
T ss_dssp EECCCC-CBHHHHHHHT----------------------TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGG
T ss_pred EEeccC-CCHHHHHHhc----------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999996 6999998654 2345889999999999999999999998 9999999999
Q ss_pred eEEcCCCC--eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 596 ILLGDDFC--PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 596 ILl~~~~~--~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
||++.++. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 231 ILl~~~~~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 231 ILLKQQGRSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEccCCCcceEEeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999987 999999999754332 23457899999999999999999999999999999999999999654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=345.57 Aligned_cols=267 Identities=21% Similarity=0.221 Sum_probs=192.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeC------Ce
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK------GE 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 512 (763)
..|.+.++||+|+||.||++... +++.||||++.... ...+++.+|+.+++.++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 35677889999999999999765 57899999997532 2235688999999999999999999999754 35
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 142 ~~lv~E~~~~-~l~~~~~--------------------------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlk 191 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQ--------------------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 191 (464)
T ss_dssp EEEEEECCSE-EHHHHHT--------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred EEEEEeCCCC-CHHHHHh--------------------------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 7999999976 4666662 13788999999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+|||++.++.+||+|||+++..... ...+...||+.|+|||.+.+..++.++||||+||++|||++|+.||......
T Consensus 192 p~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~ 269 (464)
T 3ttj_A 192 PSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 269 (464)
T ss_dssp GGGEEECTTSCEEECCCCCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hHhEEEeCCCCEEEEEEEeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999865432 2234568999999999999999999999999999999999999999754311
Q ss_pred CCCC------CCchhHH------HHHHHHhcc------ChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 046586 673 MNSD------EWYFPKW------AFEKVYEEM------KVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734 (763)
Q Consensus 673 ~~~~------~~~~~~~------~~~~~~~~~------~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 734 (763)
.... ....+.+ ......+.. .........+. .............+.+++.+||+.||++||
T Consensus 270 ~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 348 (464)
T 3ttj_A 270 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF-PADSEHNKLKASQARDLLSKMLVIDPAKRI 348 (464)
T ss_dssp HHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGS-CCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccc-ccccccccccCHHHHHHHHHHcCCChhhCC
Confidence 0000 0000000 000000000 00000000000 001111123367899999999999999999
Q ss_pred CHHHHHHH
Q 046586 735 SMGKVAKM 742 (763)
Q Consensus 735 s~~eVv~~ 742 (763)
|+.|+++.
T Consensus 349 ta~e~L~H 356 (464)
T 3ttj_A 349 SVDDALQH 356 (464)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.98 Aligned_cols=253 Identities=23% Similarity=0.285 Sum_probs=197.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc-----CCchhhhHHHHHHHhcCCCCccccEEEEEe--eCCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV-----TGGDAEFWAEVTIIARMHHLNLVRLWGFCA--EKGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 514 (763)
..|.+.+.||+|+||.||++... +++.||+|+++.. ......+.+|++++++++||||+++++++. +....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 35777899999999999999875 5789999999743 234567899999999999999999999984 456889
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||++++ |.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 85 lv~e~~~~~-l~~~~~~~----------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~ 138 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSV----------------------PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPG 138 (305)
T ss_dssp EEEECCSEE-HHHHHHHS----------------------TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred EEehhccCC-HHHHHHhC----------------------cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcc
Confidence 999999876 77777543 2346889999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCC-cccccccccCCCcccccccccCC--CCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKED-MVSMSRIRGTRGYMAPEWLRSDQ--ITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
||+++.++.+||+|||++....... ........||..|+|||.+.+.. ++.++||||||+++|||++|+.||.....
T Consensus 139 NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (305)
T 2wtk_C 139 NLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218 (305)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Confidence 9999999999999999998654322 12233456899999999987644 47799999999999999999999974321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGT 746 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~ 746 (763)
.. ....+..+ . ...+......+.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 219 ---------~~-~~~~i~~~---------~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 219 ---------YK-LFENIGKG---------S------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ---------HH-HHHHHHHC---------C------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ---------HH-HHHHHhcC---------C------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 00 01111111 0 0111234567889999999999999999999995 45543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=332.74 Aligned_cols=270 Identities=24% Similarity=0.349 Sum_probs=196.5
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..|.+.+.||+|+||.||+++.. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 35677789999999999999886 4889999998754433 2457899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 105 ~~~~~~l~~~~~~------------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~ 157 (331)
T 4aaa_A 105 FVDHTILDDLELF------------------------PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILV 157 (331)
T ss_dssp CCSEEHHHHHHHS------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred cCCcchHHHHHhh------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEE
Confidence 9999999887643 235889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCC--
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS-- 675 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~-- 675 (763)
+.++.+||+|||+++....... ......||..|+|||.+.+. .++.++||||||+++|||++|+.||.........
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 236 (331)
T 4aaa_A 158 SQSGVVKLCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236 (331)
T ss_dssp CTTSCEEECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cCCCcEEEEeCCCceeecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 9999999999999976543222 22345689999999998775 7899999999999999999999999643211000
Q ss_pred ----CCCchhHHHHHHHHhccChhhhhcccccccCC-CcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 ----DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYD-SRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.....+.+ ...+...........+....... .......++.+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 237 IMMCLGNLIPRH-QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHCSCCHHH-HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHhCCCChhh-hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 00000000000000000000000 0001234678999999999999999999999885
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.95 Aligned_cols=251 Identities=11% Similarity=0.013 Sum_probs=178.7
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC----chhhhHHHHHHHhcC--CCCccccEE-------EEEee
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----GDAEFWAEVTIIARM--HHLNLVRLW-------GFCAE 509 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----~~~~f~~E~~~l~~l--~H~niv~l~-------g~~~~ 509 (763)
++.+.++||+|+||.||+|+.. +++.||||+++.... ..+.+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 3667789999999999999875 688999999986443 234567785544444 699988755 55543
Q ss_pred C-----------------CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHH------HH
Q 046586 510 K-----------------GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR------YR 566 (763)
Q Consensus 510 ~-----------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------~~ 566 (763)
. ...++||||++ |+|.+++.... ..+.+..+ +.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------------------~~~~~~~~~~~~vk~~ 198 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----------------------FVYVFRGDEGILALHI 198 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----------------------HSCCCCHHHHHHHHHH
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----------------------cccchhhhhhhhhHHH
Confidence 3 23799999999 89999997532 12344445 78
Q ss_pred HHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc--CCCC
Q 046586 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS--DQIT 644 (763)
Q Consensus 567 ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s 644 (763)
++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++
T Consensus 199 i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~ 271 (371)
T 3q60_A 199 LTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFT 271 (371)
T ss_dssp HHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECC
T ss_pred HHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcC
Confidence 8899999999999998 999999999999999999999999999865422 113456799999999987 7899
Q ss_pred CccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHH
Q 046586 645 PKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMW 724 (763)
Q Consensus 645 ~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~ 724 (763)
.++|||||||++|||++|+.||.......... ......... .............+..+.+++.+
T Consensus 272 ~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~ 335 (371)
T 3q60_A 272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS------------WKRPSLRVP----GTDSLAFGSCTPLPDFVKTLIGR 335 (371)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC------------CCBCCTTSC----CCCSCCCTTSSCCCHHHHHHHHH
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCcCcccccc------------hhhhhhhhc----cccccchhhccCCCHHHHHHHHH
Confidence 99999999999999999999997553221100 000000000 00111111112345688999999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 046586 725 CIQDRPELRPSMGKVAK 741 (763)
Q Consensus 725 Cl~~dP~~RPs~~eVv~ 741 (763)
||+.||++|||+.++++
T Consensus 336 ~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 336 FLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HTCSSTTTCCCHHHHTT
T ss_pred HcCCChhhCCCHHHHhc
Confidence 99999999999999974
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=343.63 Aligned_cols=260 Identities=22% Similarity=0.287 Sum_probs=203.6
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcCCC-CccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHH-LNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..|.+.++||+|+||.||+|+. .+++.||||+++... ...++.+|+++++.++| +++..+..++.+.+..+|||||+
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 3567789999999999999986 568899999887443 33468899999999976 56666777778888999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE--
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-- 598 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl-- 598 (763)
+++|.+++... ...+++.+++.|+.||+.||+|||+.+ ||||||||+||||
T Consensus 86 -g~sL~~ll~~~-----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~ 138 (483)
T 3sv0_A 86 -GPSLEDLFNFC-----------------------SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGL 138 (483)
T ss_dssp -CCBHHHHHHHT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECC
T ss_pred -CCCHHHHHHhh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEec
Confidence 99999999642 235899999999999999999999998 9999999999999
Q ss_pred -cCCCCeEEcccCcccccCCCCcc------cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 599 -GDDFCPKISDFGLAKLRKKEDMV------SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 599 -~~~~~~kI~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
+.++.+||+|||+++........ ......||..|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 139 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 68899999999999866543321 12356799999999999999999999999999999999999999975432
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
... ......+.+.. ....+.. +....+.++.+++..||+.||++||++.+|+++|+.+.
T Consensus 219 ~~~-------~~~~~~i~~~~-~~~~~~~---------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 219 GTK-------KQKYEKISEKK-VATSIEA---------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp SSH-------HHHHHHHHHHH-HHSCHHH---------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred hhH-------HHHHHHHhhcc-ccccHHH---------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 110 00001111100 0000000 01123467899999999999999999999999998763
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=343.60 Aligned_cols=194 Identities=26% Similarity=0.389 Sum_probs=152.4
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeC-----Cee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEK-----GER 513 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 513 (763)
..|.+.++||+|+||.||+|+.. +++.||||++..... ..+.+.+|++++++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 35778899999999999999875 678999999975432 235688999999999999999999999543 578
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+.+ ||||||||
T Consensus 133 ~lv~e~~-~~~L~~~~~~------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp 184 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT------------------------PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKP 184 (458)
T ss_dssp EEEECCC-SEEHHHHHHS------------------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCG
T ss_pred EEEEecc-ccchhhhccc------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCCh
Confidence 9999998 5699998853 235889999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc--------------------------ccccccccCCCccccccc-ccCCCCCc
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM--------------------------VSMSRIRGTRGYMAPEWL-RSDQITPK 646 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~--------------------------~~~~~~~gt~~y~APE~l-~~~~~s~k 646 (763)
+|||++.++.+||+|||+++....... ...+...||+.|+|||++ ....++.+
T Consensus 185 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~ 264 (458)
T 3rp9_A 185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA 264 (458)
T ss_dssp GGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTH
T ss_pred hhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcH
Confidence 999999999999999999986543211 123445789999999976 56789999
Q ss_pred cceeehhHHHHHHHhCCC
Q 046586 647 ADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 647 sDVwS~Gvll~elltG~~ 664 (763)
+|||||||++|||++|..
T Consensus 265 ~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 265 IDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp HHHHHHHHHHHHHHTTST
T ss_pred hHHHHHHHHHHHHHHhcc
Confidence 999999999999999433
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=326.97 Aligned_cols=250 Identities=21% Similarity=0.313 Sum_probs=195.9
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc-CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV-TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..|.+.+.||+|+||.||+|+.. +++.||+|+++.. ....+++.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 45777889999999999999886 4789999998744 334577899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.
T Consensus 99 ~~~~l~~~~~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~ 152 (302)
T 2j7t_A 99 PGGAVDAIMLEL-----------------------DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTL 152 (302)
T ss_dssp TTEEHHHHHHHH-----------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECT
T ss_pred CCCcHHHHHHhh-----------------------ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECC
Confidence 999999998653 235889999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccc-----ccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWL-----RSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l-----~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
++.+||+|||++...... ........||..|+|||.+ ....++.++||||||+++|||++|+.||.....
T Consensus 153 ~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---- 227 (302)
T 2j7t_A 153 EGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---- 227 (302)
T ss_dssp TSCEEECCCHHHHHHHHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----
T ss_pred CCCEEEEECCCCcccccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----
Confidence 999999999997532211 1112234689999999988 467889999999999999999999999864321
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
... ........ . .....+...+..+.+++.+||+.||++|||+.++++
T Consensus 228 -----~~~-~~~~~~~~-~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 228 -----MRV-LLKIAKSD-P-----------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----HHH-HHHHHHSC-C-----------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----HHH-HHHHhccC-C-----------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000 01111110 0 000111334567889999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.19 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=202.1
Q ss_pred HHhccccccccccccceEEEEEe--CCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCc------cccEEEEEeeCCee
Q 046586 442 AATNGFSNLIGRGGFGDVYKGEL--TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLN------LVRLWGFCAEKGER 513 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~--~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~~ 513 (763)
...|.+.++||+|+||.||++.. .+++.||||+++......+.+.+|+++++.++|+| ++++++++.+.+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 35678889999999999999986 36789999999865545567889999999987664 99999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+ +++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 93 ~lv~e~~-~~~l~~~l~~~----------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 146 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKEN----------------------GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKP 146 (339)
T ss_dssp EEEEECC-CCBHHHHHHHT----------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred EEEEcCC-CCCHHHHHHhc----------------------CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCH
Confidence 9999999 88999999653 2245789999999999999999999998 99999999
Q ss_pred CceEEcC-------------------CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhH
Q 046586 594 ENILLGD-------------------DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGM 654 (763)
Q Consensus 594 ~NILl~~-------------------~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gv 654 (763)
+|||++. ++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+
T Consensus 147 ~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 222 (339)
T 1z57_A 147 ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGC 222 (339)
T ss_dssp GGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHH
T ss_pred HHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHH
Confidence 9999987 678999999999864432 23457899999999999999999999999999
Q ss_pred HHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhc-----------------------------cccccc
Q 046586 655 VLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILD-----------------------------RHIKNS 705 (763)
Q Consensus 655 ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~l~~~ 705 (763)
++|||++|+.||....... ... ......... ...+.. +.+...
T Consensus 223 il~el~~g~~pf~~~~~~~------~~~-~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (339)
T 1z57_A 223 ILIEYYLGFTVFPTHDSKE------HLA-MMERILGPL-PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF 294 (339)
T ss_dssp HHHHHHHSSCSCCCSCHHH------HHH-HHHHHHCSC-CHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred HHHHHHhCCCCCCCCChHH------HHH-HHHHHhCCC-CHHHHhhccchhHHhhccccccccccccchhhhcCcchhhh
Confidence 9999999999996432110 000 000000000 000000 000000
Q ss_pred CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 706 YDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 706 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
........+.+.+++.+||+.||++|||+.|+++
T Consensus 295 --~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 295 --MLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp --CSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 0011356788999999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=331.27 Aligned_cols=260 Identities=20% Similarity=0.277 Sum_probs=190.2
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..|.+.++||+|+||.||+++.. +++.||||+++.... ....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 113 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE 113 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence 45777899999999999999865 688999999974332 23567899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++ +|.+++... ..+++..+..|+.||+.||+|||+.+ |+||||||+|||+
T Consensus 114 ~~~~-~L~~~~~~~------------------------~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll 165 (329)
T 3gbz_A 114 YAEN-DLKKYMDKN------------------------PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLL 165 (329)
T ss_dssp CCSE-EHHHHHHHC------------------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred cCCC-CHHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEE
Confidence 9984 999999643 34889999999999999999999998 9999999999999
Q ss_pred c-----CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 599 G-----DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 599 ~-----~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
+ .++.+||+|||+++...... .......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 244 (329)
T 3gbz_A 166 SVSDASETPVLKIGDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI 244 (329)
T ss_dssp EC-----CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ecCCCCccceEEECcCCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence 4 55569999999998654322 223345679999999998774 5899999999999999999999999643211
Q ss_pred CCCCCCchhHHHHHHHHhc--cChhhhh---------cccccccCCC----cchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 673 MNSDEWYFPKWAFEKVYEE--MKVEDIL---------DRHIKNSYDS----RVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~--~~~~~~~---------~~~l~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
. . .....+. ....... .......... ..+.....++.+++.+||+.||++|||+.
T Consensus 245 ~---------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 314 (329)
T 3gbz_A 245 D---------Q-LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314 (329)
T ss_dssp H---------H-HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred H---------H-HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHH
Confidence 0 0 0000000 0000000 0000000000 00112346788999999999999999999
Q ss_pred HHHH
Q 046586 738 KVAK 741 (763)
Q Consensus 738 eVv~ 741 (763)
|+++
T Consensus 315 e~l~ 318 (329)
T 3gbz_A 315 NALE 318 (329)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 9986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.70 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=195.6
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC---------CchhhhHHHHHHHhcCCCCccccEEEEEeeC
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT---------GGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~---------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 510 (763)
....|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3457888999999999999999875 57899999986432 1224588999999999999999999998765
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
+ .++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 139 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG------------------------NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRD 139 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST------------------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred c-eEEEEecCCCCcHHHHHhc------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 4 8999999999999998853 235889999999999999999999998 99999
Q ss_pred CCCCceEEcCCCC---eEEcccCcccccCCCCcccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHhCCC
Q 046586 591 IKPENILLGDDFC---PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 591 lk~~NILl~~~~~---~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~elltG~~ 664 (763)
|||+||+++.++. +||+|||+++...... ......||+.|+|||.+. ...++.++||||||+++|||++|+.
T Consensus 140 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 140 LKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp CSGGGEEESSSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEEecCCCCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999987665 9999999998654322 223456899999999874 5678999999999999999999999
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
||....... .+. ..+..+. . ..........+..+.+++.+||+.||++||++.++++
T Consensus 218 pf~~~~~~~-----~~~----~~~~~~~-~----------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 218 PFSEHRTQV-----SLK----DQITSGK-Y----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SSCSTTCSS-----CHH----HHHHHTC-C----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccchHH-----HHH----HHHHhCc-c----------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 996432211 110 1111110 0 0000111233567899999999999999999999984
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=323.68 Aligned_cols=261 Identities=19% Similarity=0.265 Sum_probs=197.5
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcCC-CCccccEEEEEee--CCeeeEEEe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-HLNLVRLWGFCAE--KGERTLVYE 518 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~LV~E 518 (763)
..|.+.++||+|+||.||+|+. .+++.||||+++. ...+.+.+|++++++++ ||||+++++++.+ ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 4577789999999999999976 4688999999974 33567899999999997 9999999999998 667899999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++. .++...+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 114 ~~~~~~l~~~~~---------------------------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~ 163 (330)
T 3nsz_A 114 HVNNTDFKQLYQ---------------------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMI 163 (330)
T ss_dssp CCCCCCHHHHGG---------------------------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred ccCchhHHHHHH---------------------------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEE
Confidence 999999999873 2678889999999999999999998 9999999999999
Q ss_pred cCCC-CeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 599 GDDF-CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 599 ~~~~-~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
+.++ .+||+|||+++....... .....+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 164 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-- 239 (330)
T 3nsz_A 164 DHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-- 239 (330)
T ss_dssp ETTTTEEEECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--
T ss_pred cCCCCEEEEEeCCCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--
Confidence 9776 899999999986544322 234568899999999876 6799999999999999999999999953221100
Q ss_pred CCchhHHH--------HHHHHhcc-C----hhhhhccccc----ccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046586 677 EWYFPKWA--------FEKVYEEM-K----VEDILDRHIK----NSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739 (763)
Q Consensus 677 ~~~~~~~~--------~~~~~~~~-~----~~~~~~~~l~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eV 739 (763)
.+.... ...+.... . ..+....... .......+......+.+++.+||+.||++|||++|+
T Consensus 240 --~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~ 317 (330)
T 3nsz_A 240 --QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317 (330)
T ss_dssp --HHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred --HHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 000000 00000000 0 0000000000 001111112246788999999999999999999999
Q ss_pred HH
Q 046586 740 AK 741 (763)
Q Consensus 740 v~ 741 (763)
++
T Consensus 318 l~ 319 (330)
T 3nsz_A 318 ME 319 (330)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=323.73 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=191.9
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEee------------
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAE------------ 509 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------------ 509 (763)
..+.+.+.||+|+||.||+|+.. +++.||||+++......+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 46778899999999999999875 68899999997655555778999999999999999999999865
Q ss_pred -CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 046586 510 -KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLH 588 (763)
Q Consensus 510 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 588 (763)
.+..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H 139 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSE-----------------------NLNQQRDEYWRLFRQILEALSYIHSQG---IIH 139 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHS-----------------------CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCCHHHhhhcc-----------------------ccccchHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 35688999999999999999653 234678889999999999999999998 999
Q ss_pred cCCCCCceEEcCCCCeEEcccCcccccCCCC-------------cccccccccCCCcccccccccC-CCCCccceeehhH
Q 046586 589 CDIKPENILLGDDFCPKISDFGLAKLRKKED-------------MVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGM 654 (763)
Q Consensus 589 rDlk~~NILl~~~~~~kI~DFGla~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gv 654 (763)
|||||+||+++.++.+||+|||+++...... ........||..|+|||.+.+. .++.++||||||+
T Consensus 140 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (303)
T 1zy4_A 140 RDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHH
T ss_pred ccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHH
Confidence 9999999999999999999999998654321 1122345689999999998764 7999999999999
Q ss_pred HHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 046586 655 VLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734 (763)
Q Consensus 655 ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 734 (763)
++|||++ |+.... ......+. +... ....+...+...+..+.+++.+||+.||++||
T Consensus 220 il~~l~~---p~~~~~-------------~~~~~~~~-----~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (303)
T 1zy4_A 220 IFFEMIY---PFSTGM-------------ERVNILKK-----LRSV--SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276 (303)
T ss_dssp HHHHHHS---CCSSHH-------------HHHHHHHH-----HHST--TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHh---ccCCch-------------hHHHHHHh-----cccc--ccccCccccccchHHHHHHHHHHHhcCcccCc
Confidence 9999998 442110 00000000 0000 01111222234556788999999999999999
Q ss_pred CHHHHHHH
Q 046586 735 SMGKVAKM 742 (763)
Q Consensus 735 s~~eVv~~ 742 (763)
|+.++++.
T Consensus 277 s~~~ll~h 284 (303)
T 1zy4_A 277 GARTLLNS 284 (303)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhCC
Confidence 99999873
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.25 Aligned_cols=264 Identities=21% Similarity=0.270 Sum_probs=194.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCC------e
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKG------E 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~ 512 (763)
..|.+.+.||+|+||.||+|... +++.||||++...... .+++.+|+++++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 35677889999999999999874 6889999999643322 356889999999999999999999998753 4
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 105 ~~lv~e~~-~~~L~~~~~~-------------------------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlk 155 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH-------------------------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLK 155 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH-------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred EEEEEecC-CCCHHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcC
Confidence 69999999 8899999853 24788899999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
|+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.....
T Consensus 156 p~NIll~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 156 PGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHEEEcCCCCEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999865432 334578999999999877 7899999999999999999999999974431
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhccc-----------ccccCC---CcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRH-----------IKNSYD---SRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------l~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
.. ....... ..+....+.+... +..... ..........+.+++.+||+.||++|||+.
T Consensus 232 ~~------~l~~i~~--~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~ 303 (367)
T 1cm8_A 232 LD------QLKEIMK--VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 303 (367)
T ss_dssp HH------HHHHHHH--HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HH------HHHHHHH--hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHH
Confidence 10 0000000 0000011111000 000000 001123456788999999999999999999
Q ss_pred HHHH--HhccCC
Q 046586 738 KVAK--MLEGTV 747 (763)
Q Consensus 738 eVv~--~Le~~~ 747 (763)
|+++ .++...
T Consensus 304 e~l~hp~f~~~~ 315 (367)
T 1cm8_A 304 EALAHPYFESLH 315 (367)
T ss_dssp HHHHSGGGTTTC
T ss_pred HHhcChHHHhhc
Confidence 9997 465543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=332.02 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=196.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
..|.+.+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 45777899999999999999885 588999999974321 12468899999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 90 v~e~~~~-~l~~~~~~~-----------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 142 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDN-----------------------SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNN 142 (346)
T ss_dssp EEECCSE-EHHHHHTTC-----------------------CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred EEEcCCC-CHHHHHHhc-----------------------CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHH
Confidence 9999986 898888542 235778889999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
||++.++.+||+|||+++...... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|..||......
T Consensus 143 il~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-- 219 (346)
T 1ua2_A 143 LLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-- 219 (346)
T ss_dssp EEECTTCCEEECCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred EEEcCCCCEEEEecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--
Confidence 999999999999999998654332 22334578999999999865 45899999999999999999999998643211
Q ss_pred CCCCchhHHHHHHHHhc--cChhhh-------hcccccccCCC----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEE--MKVEDI-------LDRHIKNSYDS----RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~--~~~~~~-------~~~~l~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. ....+.+. ....+. .+......... .........+.+++.+||+.||++|||+.|+++
T Consensus 220 -------~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 220 -------D-QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp -------H-HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -------H-HHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00111110 000000 00000000000 001223468899999999999999999999997
Q ss_pred H
Q 046586 742 M 742 (763)
Q Consensus 742 ~ 742 (763)
.
T Consensus 292 h 292 (346)
T 1ua2_A 292 M 292 (346)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=320.83 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=199.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC----------chhhhHHHHHHHhcCC-CCccccEEEEEeeC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG----------GDAEFWAEVTIIARMH-HLNLVRLWGFCAEK 510 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~----------~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~ 510 (763)
..|.+.+.||+|+||.||++... +++.||||+++.... ..+.+.+|++++++++ ||||+++++++.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 45677889999999999999886 578999999975431 1245789999999995 99999999999999
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+|
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 149 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEK------------------------VTLSEKETRKIMRALLEVICALHKLN---IVHRD 149 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred CeEEEEEeccCCCcHHHHHhcc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 9999999999999999999643 35789999999999999999999998 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc------cCCCCCccceeehhHHHHHHHhCCC
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR------SDQITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwS~Gvll~elltG~~ 664 (763)
|||+||+++.++.+||+|||++....... ......+++.|+|||.+. ...++.++||||||+++|||++|+.
T Consensus 150 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 227 (298)
T 1phk_A 150 LKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227 (298)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCcceEEEcCCCcEEEecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCC
Confidence 99999999999999999999998654332 233456899999999885 4578899999999999999999999
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
||..... ......+..+ ... .........+..+.+++.+||+.||++|||+.|+++
T Consensus 228 p~~~~~~----------~~~~~~~~~~---------~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 228 PFWHRKQ----------MLMLRMIMSG---------NYQ--FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SSCCSSH----------HHHHHHHHHT---------CCC--CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcCccH----------HHHHHHHhcC---------Ccc--cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 9964321 0011111111 000 000111234567899999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.87 Aligned_cols=206 Identities=23% Similarity=0.353 Sum_probs=155.8
Q ss_pred ccc-cccccccccceEEEEEeC---CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEee--CCeeeEEEe
Q 046586 445 NGF-SNLIGRGGFGDVYKGELT---DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAE--KGERTLVYE 518 (763)
Q Consensus 445 ~~~-~~~LG~G~fG~Vy~g~~~---~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV~E 518 (763)
+.+ .++||+|+||.||+|+.. +++.||||+++... ....+.+|+.++++++||||+++++++.. ....++|||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 444 458999999999999875 46789999997533 34568899999999999999999999965 678999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|++ ++|.+++...+.... ......+++..+..|+.||+.||+|||+.+ |+||||||+|||+
T Consensus 101 ~~~-~~l~~~~~~~~~~~~---------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll 161 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKA---------------NKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILV 161 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC----------------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred CCC-CCHHHHHHHhccccc---------------cccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEE
Confidence 996 488888864321000 002235899999999999999999999998 9999999999999
Q ss_pred ----cCCCCeEEcccCcccccCCCCc--ccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 599 ----GDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 599 ----~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
+.++.+||+|||+++....... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 162 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 162 MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 7789999999999987643221 23345678999999999887 459999999999999999999999997544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=318.44 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=201.9
Q ss_pred HHHHHHhccccccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 438 AELRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 438 ~el~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
.......|.+.++||+|+||.||+++.. +++.||+|+++.. ......+.+|++++++++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3345568889999999999999999886 6889999999743 23456788999999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+|+||||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p 149 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR------------------------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKP 149 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred EEEEEccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCh
Confidence 9999999999999998643 25789999999999999999999998 99999999
Q ss_pred CceEEcCC---CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 594 ENILLGDD---FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 594 ~NILl~~~---~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
+||+++.+ +.+||+|||++....... ......+|+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 150 ~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 150 ENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp GGEEESCSSTTCCEEECSTTGGGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhEEEecCCCcccEEEeccCcceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 99999764 479999999998654332 2233458899999998875 58999999999999999999999996432
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. . ....+..+. .. .+.......+..+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~---------~-~~~~~~~~~---------~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 227 EY---------D-ILKRVETGK---------YA--FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HH---------H-HHHHHHHCC---------CC--CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH---------H-HHHHHHcCC---------CC--CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 10 0 011111110 00 001111234567889999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=327.29 Aligned_cols=268 Identities=24% Similarity=0.327 Sum_probs=186.1
Q ss_pred HHHHhccccccccccccceEEEEEeC-CCcEEEEEEeecc--CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV--TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
+....+.+.+.||+|+||.||++... +++.||||++... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 33456778899999999999999864 6789999998643 23346788999999999999999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++++|.+++....... ......+++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Ni 152 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKG----------------EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNI 152 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTT----------------TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGE
T ss_pred ehhccCCchHHHHHHHhhcc----------------ccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhE
Confidence 99999999999996421100 012346899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCc----ccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDM----VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
+++.++.+||+|||++........ .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 153 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 232 (303)
T 2vwi_A 153 LLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232 (303)
T ss_dssp EECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred EEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence 999999999999999976543221 11234568999999999875 5789999999999999999999999974321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. .... ..... .............. ......+.+++.+||+.||.+|||+.++++
T Consensus 233 ~~---------~~~~-~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 233 MK---------VLML-TLQND-PPSLETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp GG---------HHHH-HHTSS-CCCTTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hh---------HHHH-HhccC-CCccccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 10 0000 11110 00000000000011 123457889999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.43 Aligned_cols=278 Identities=19% Similarity=0.258 Sum_probs=205.3
Q ss_pred HHHhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcCC-----------CCccccEEEEEe
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-----------HLNLVRLWGFCA 508 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~ 508 (763)
....|.+.++||+|+||.||+|+. .+++.||||+++........+.+|+.++++++ |+||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 345688889999999999999987 46889999999755445567889999999886 899999999998
Q ss_pred eCC----eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CC
Q 046586 509 EKG----ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CL 583 (763)
Q Consensus 509 ~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~ 583 (763)
..+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ +
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~----------------------~~~~~~~~~~~~i~~qi~~aL~~lH~~~~- 152 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY----------------------EHRGIPLIYVKQISKQLLLGLDYMHRRCG- 152 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT----------------------TTSCCCHHHHHHHHHHHHHHHHHHHHTTC-
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh----------------------hccCCcHHHHHHHHHHHHHHHHHHHhcCC-
Confidence 654 789999999 88999999754 223588999999999999999999998 7
Q ss_pred CcEEecCCCCCceEEc------CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHH
Q 046586 584 EWVLHCDIKPENILLG------DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLL 657 (763)
Q Consensus 584 ~~ivHrDlk~~NILl~------~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ 657 (763)
|+||||||+|||++ ..+.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|
T Consensus 153 --ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 226 (373)
T 1q8y_A 153 --IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 226 (373)
T ss_dssp --EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHH
T ss_pred --EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHH
Confidence 99999999999994 4458999999999865432 23357899999999999999999999999999999
Q ss_pred HHHhCCCCcccccCCCCCCCCchhHHHHHHH--------HhccChhhhhcc-----------------cccccCCCcchH
Q 046586 658 EIVSGSRNFEIQGSMMNSDEWYFPKWAFEKV--------YEEMKVEDILDR-----------------HIKNSYDSRVHF 712 (763)
Q Consensus 658 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-----------------~l~~~~~~~~~~ 712 (763)
||++|+.||.....................+ .........+.. .+.. ....+.
T Consensus 227 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 304 (373)
T 1q8y_A 227 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSK 304 (373)
T ss_dssp HHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCH
T ss_pred HHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCc
Confidence 9999999997543211000000000000000 000000000000 0000 112346
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccCCCCC
Q 046586 713 DMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGTVEIT 750 (763)
Q Consensus 713 ~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~~~~~ 750 (763)
.....+.+++.+||+.||++|||+.||++ .+.+.....
T Consensus 305 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344 (373)
T ss_dssp HHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred chHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCcc
Confidence 77889999999999999999999999997 566655443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=328.24 Aligned_cols=266 Identities=21% Similarity=0.219 Sum_probs=189.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCC------e
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKG------E 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~ 512 (763)
..|.+.+.||+|+||.||+|... +++.||||+++..... ...+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 35677889999999999999865 5789999999754322 345889999999999999999999998665 7
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+++ +|.+++.. .+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 105 ~~lv~e~~~~-~l~~~~~~--------------------------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlk 154 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM--------------------------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 154 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS--------------------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred eEEEEEcCCC-CHHHHHhh--------------------------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCC
Confidence 8999999975 78887732 3778899999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+|||++.++.+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 155 p~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 232 (371)
T 2xrw_A 155 PSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 232 (371)
T ss_dssp GGGEEECTTSCEEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHHEEEcCCCCEEEEEeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999998654321 233457899999999999999999999999999999999999999754311
Q ss_pred CC------CCCCchhHHH------HHHHHhcc------ChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC
Q 046586 673 MN------SDEWYFPKWA------FEKVYEEM------KVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734 (763)
Q Consensus 673 ~~------~~~~~~~~~~------~~~~~~~~------~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 734 (763)
.. ......+.+. .....+.. .......... ..............+.+++.+||+.||++||
T Consensus 233 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 311 (371)
T 2xrw_A 233 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL-FPADSEHNKLKASQARDLLSKMLVIDASKRI 311 (371)
T ss_dssp HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGG-SCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhccccc-CcccccccccccHHHHHHHHHHCcCChhhCC
Confidence 00 0000000000 00000000 0000000000 0011112234467899999999999999999
Q ss_pred CHHHHHH
Q 046586 735 SMGKVAK 741 (763)
Q Consensus 735 s~~eVv~ 741 (763)
|+.|+++
T Consensus 312 t~~e~l~ 318 (371)
T 2xrw_A 312 SVDEALQ 318 (371)
T ss_dssp CHHHHHH
T ss_pred CHHHHhC
Confidence 9999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=323.92 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=198.3
Q ss_pred HhccccccccccccceEEEEEe--CCCcEEEEEEeeccC---CchhhhHHHHHHHhcC---CCCccccEEEEEe-----e
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL--TDHRVVAVKCLKNVT---GGDAEFWAEVTIIARM---HHLNLVRLWGFCA-----E 509 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~--~~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l---~H~niv~l~g~~~-----~ 509 (763)
..|.+.+.||+|+||.||+++. .+++.||+|+++... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 4567789999999999999987 467899999997432 2234577888887776 8999999999997 4
Q ss_pred CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEec
Q 046586 510 KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHC 589 (763)
Q Consensus 510 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHr 589 (763)
....++||||++ |+|.+++... ....+++..+..++.|++.||+|||+.+ |+||
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~----------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~ 144 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKV----------------------PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHR 144 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHS----------------------CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred CceEEEEEecCC-CCHHHHHHhc----------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 567899999998 6999999654 2235889999999999999999999998 9999
Q ss_pred CCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 590 DIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 590 Dlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
||||+||+++.++.+||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 145 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 145 DLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp CCCGGGEEECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCHHHeEEcCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999998654322 233457899999999999999999999999999999999999999743
Q ss_pred cCCCCCCCCchhHHHHHHHHhc--cChhhhh-------cccccc---cCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEE--MKVEDIL-------DRHIKN---SYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-------~~~l~~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
.... ....+.+. ....+.. ...... .............+.+++.+||+.||++|||+.
T Consensus 223 ~~~~----------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 292 (326)
T 1blx_A 223 SDVD----------QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 292 (326)
T ss_dssp SHHH----------HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CHHH----------HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHH
Confidence 2110 00111100 0000000 000000 000011123456788999999999999999999
Q ss_pred HHHH
Q 046586 738 KVAK 741 (763)
Q Consensus 738 eVv~ 741 (763)
|+++
T Consensus 293 e~l~ 296 (326)
T 1blx_A 293 SALS 296 (326)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9994
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.70 Aligned_cols=262 Identities=21% Similarity=0.285 Sum_probs=193.7
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeC-----------
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK----------- 510 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----------- 510 (763)
..|.+.++||+|+||.||+|.. .+++.||||++.... ....+|+++++.++||||+++++++...
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 4577889999999999999987 468999999987442 2334799999999999999999998543
Q ss_pred ---------------------------CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHH
Q 046586 511 ---------------------------GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563 (763)
Q Consensus 511 ---------------------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 563 (763)
...++||||++ |+|.+.+..... ....+++..
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--------------------~~~~l~~~~ 142 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR--------------------SGRSIPMNL 142 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHH--------------------TTCCCCHHH
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh--------------------cCCCCCHHH
Confidence 34889999998 588888764210 335689999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc-CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-
Q 046586 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG-DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD- 641 (763)
Q Consensus 564 ~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~-~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~- 641 (763)
+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+.
T Consensus 143 ~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~ 217 (383)
T 3eb0_A 143 ISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGAT 217 (383)
T ss_dssp HHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCS
T ss_pred HHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCC
Confidence 9999999999999999988 99999999999998 689999999999986543322 2345689999999988764
Q ss_pred CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccC-hhhhh--ccc--------c-cccCCCc
Q 046586 642 QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMK-VEDIL--DRH--------I-KNSYDSR 709 (763)
Q Consensus 642 ~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~--------l-~~~~~~~ 709 (763)
.++.++||||+|+++|||++|+.||........ +.. .... .+.. .+.+. ++. . .......
T Consensus 218 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~-i~~~--~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (383)
T 3eb0_A 218 EYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ-----LVR-IIQI--MGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKI 289 (383)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHH-HHHH--HCCCCHHHHHHHCTTC--CCCCCCCCCCHHHH
T ss_pred CCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH-----HHH-HHHH--hCCCCHHHHHHhCcccccccCCccCcccHHhh
Confidence 599999999999999999999999975321100 000 0000 0000 00000 000 0 0000001
Q ss_pred chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 710 VHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 710 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
++...+..+.+++.+||+.||++|||+.|+++
T Consensus 290 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 290 LPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp SCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12234567899999999999999999999983
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=331.04 Aligned_cols=262 Identities=21% Similarity=0.253 Sum_probs=197.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeC-----Ceee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEK-----GERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 514 (763)
..|.+.++||+|+||.||++... +++.||||+++..... ...+.+|++++++++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 35778899999999999999875 6788999999754332 25688999999999999999999999765 3689
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||++ |+|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+
T Consensus 107 iv~e~~~-~~L~~~l~~-------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~ 157 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKT-------------------------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPS 157 (364)
T ss_dssp EEEECCS-EEHHHHHHH-------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred EEEcccC-cCHHHHHHh-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChH
Confidence 9999997 599998853 24889999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccc-cCCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
|||++.++.+||+|||+++........ ......||+.|+|||.+. ...++.++||||||+++|||++|+.||.....
T Consensus 158 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 237 (364)
T 3qyz_A 158 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237 (364)
T ss_dssp GEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG
T ss_pred hEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh
Confidence 999999999999999999866543221 234457999999999865 45689999999999999999999999965432
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhccc-----------ccccCCC---cchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRH-----------IKNSYDS---RVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------l~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
.. ........ . +....+.+... ....... .........+.+++.+||+.||++|||+.
T Consensus 238 ~~------~~~~i~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 309 (364)
T 3qyz_A 238 LD------QLNHILGI-L-GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309 (364)
T ss_dssp GG------HHHHHHHH-H-CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HH------HHHHHHHH-h-CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 11 00000000 0 00000000000 0000000 00112346788999999999999999999
Q ss_pred HHHH
Q 046586 738 KVAK 741 (763)
Q Consensus 738 eVv~ 741 (763)
|+++
T Consensus 310 e~l~ 313 (364)
T 3qyz_A 310 QALA 313 (364)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9996
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.76 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=192.8
Q ss_pred HHhccccccccccccceEEEEEeCCCcEEEEEEeeccCC---chhhhHHHHHHHhcCC--CCccccEEEEEeeCCeeeEE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG---GDAEFWAEVTIIARMH--HLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~LV 516 (763)
...|.+.+.||+|+||.||++...+++.||||+++.... ....+.+|++++.+++ |+||+++++++.+.+..++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 345777889999999999999998899999999975432 2356889999999997 59999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|| +.+++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||
T Consensus 107 ~e-~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NI 158 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKK------------------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANF 158 (313)
T ss_dssp EC-CCSEEHHHHHHHC------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred Ee-cCCCcHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccE
Confidence 99 5688999999643 35788999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcc-cccccccCCCccccccccc-----------CCCCCccceeehhHHHHHHHhCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRS-----------DQITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwS~Gvll~elltG~~ 664 (763)
++++ +.+||+|||+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.
T Consensus 159 l~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (313)
T 3cek_A 159 LIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237 (313)
T ss_dssp EEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred EEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCC
Confidence 9965 89999999999865443221 2234568999999999865 478889999999999999999999
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
||...... ... ....++........ ......+.+++.+||+.||++||++.|+++
T Consensus 238 pf~~~~~~--------~~~----------~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 238 PFQQIINQ--------ISK----------LHAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp TTTTCCSH--------HHH----------HHHHHCTTSCCCCC----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhHHHH--------HHH----------HHHHHhcccccCCc----ccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 99632210 000 11122221111111 222457889999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=336.81 Aligned_cols=197 Identities=26% Similarity=0.369 Sum_probs=165.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeC-----Cee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEK-----GER 513 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 513 (763)
..|.+.+.||+|+||.||+|+.. +++.||||+++..... .+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 46778899999999999999875 5788999999754332 35688999999999999999999999876 578
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 106 ~lv~e~~~-~~L~~~~~~------------------------~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp 157 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKT------------------------PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKP 157 (432)
T ss_dssp EEEEECCS-EEHHHHHHS------------------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred EEEEecCC-cCHHHHHhc------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCH
Confidence 99999986 599999853 235899999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCc---------------------ccccccccCCCccccccc-ccCCCCCccceee
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDM---------------------VSMSRIRGTRGYMAPEWL-RSDQITPKADVYS 651 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~---------------------~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwS 651 (763)
+|||++.++.+||+|||+++....... ...+...||+.|+|||.+ ....++.++||||
T Consensus 158 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwS 237 (432)
T 3n9x_A 158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237 (432)
T ss_dssp GGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred HHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccch
Confidence 999999999999999999987643321 123556799999999986 5677999999999
Q ss_pred hhHHHHHHHhCCCCcc
Q 046586 652 FGMVLLEIVSGSRNFE 667 (763)
Q Consensus 652 ~Gvll~elltG~~p~~ 667 (763)
+||++|||++|..|+.
T Consensus 238 lG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 238 TGCIFAELLNMLQSHI 253 (432)
T ss_dssp HHHHHHHHHTTCTTTC
T ss_pred HHHHHHHHHhcccccc
Confidence 9999999998766654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.14 Aligned_cols=263 Identities=22% Similarity=0.236 Sum_probs=190.6
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCc------------hhhhHHHHHHHhcCCCCccccEEEEEeeC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG------------DAEFWAEVTIIARMHHLNLVRLWGFCAEK 510 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~------------~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 510 (763)
..|.+.+.||+|+||.||+|...+++.||||++...... .+.+.+|++++++++||||+++++++...
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 356667899999999999999888999999999643221 15688999999999999999999999543
Q ss_pred -----CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 046586 511 -----GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEW 585 (763)
Q Consensus 511 -----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ 585 (763)
...++||||++ |+|.+++.. ....+++..+..++.||+.||+|||+.+
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~-----------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~--- 154 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHD-----------------------QRIVISPQHIQYFMYHILLGLHVLHEAG--- 154 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHC-----------------------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHh-----------------------cccCCCHHHHHHHHHHHHHHHHHHHHCc---
Confidence 36799999998 689888853 2346889999999999999999999998
Q ss_pred EEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCC
Q 046586 586 VLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 586 ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~ 664 (763)
|+||||||+||+++.++.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.
T Consensus 155 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 155 VVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CEecCCChHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 9999999999999999999999999997543322 2334568999999998876 789999999999999999999999
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccC-----------hhhhhcccccccCCC---cchHHHHHHHHHHHHHccCCCC
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMK-----------VEDILDRHIKNSYDS---RVHFDMVNRMVKTAMWCIQDRP 730 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~~~~~---~~~~~~~~~l~~l~~~Cl~~dP 730 (763)
||....... ........ ..... ..+.+.......... .........+.+++.+||+.||
T Consensus 233 pf~~~~~~~------~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 305 (362)
T 3pg1_A 233 LFRGSTFYN------QLNKIVEV-VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305 (362)
T ss_dssp SCCCSSHHH------HHHHHHHH-HCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred CCCCCCHHH------HHHHHHHH-cCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCCh
Confidence 997432110 00000000 00000 001111111110000 0112335678899999999999
Q ss_pred CCCCCHHHHHH
Q 046586 731 ELRPSMGKVAK 741 (763)
Q Consensus 731 ~~RPs~~eVv~ 741 (763)
++|||+.|+++
T Consensus 306 ~~Rpt~~ell~ 316 (362)
T 3pg1_A 306 QRRISTEQALR 316 (362)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHHc
Confidence 99999999996
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.96 Aligned_cols=271 Identities=21% Similarity=0.262 Sum_probs=191.0
Q ss_pred HhccccccccccccceEEEEEeCC-CcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEe------------
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCA------------ 508 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~------------ 508 (763)
..|.+.+.||+|+||.||+|.... ++.||+|+++... ...+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 356677899999999999998864 8899999987543 23466889999999999999999999874
Q ss_pred --eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 509 --EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 509 --~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i 141 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-------------------------GPLLEEHARLFMYQLLRGLKYIHSAN---V 141 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-------------------------CCccHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 3467899999997 699999832 35788999999999999999999998 9
Q ss_pred EecCCCCCceEEc-CCCCeEEcccCcccccCCCCc--ccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhC
Q 046586 587 LHCDIKPENILLG-DDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSG 662 (763)
Q Consensus 587 vHrDlk~~NILl~-~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG 662 (763)
+||||||+||+++ +++.+||+|||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|
T Consensus 142 ~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g 221 (320)
T 2i6l_A 142 LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221 (320)
T ss_dssp BCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHS
T ss_pred ecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhC
Confidence 9999999999997 577999999999986643221 12234567899999998865 7899999999999999999999
Q ss_pred CCCcccccCCCCCC-----CCchhHHHHHHHHhccChhhhhcccccccCC--CcchHHHHHHHHHHHHHccCCCCCCCCC
Q 046586 663 SRNFEIQGSMMNSD-----EWYFPKWAFEKVYEEMKVEDILDRHIKNSYD--SRVHFDMVNRMVKTAMWCIQDRPELRPS 735 (763)
Q Consensus 663 ~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 735 (763)
+.||.......... ............... ....+......... .......+..+.+++.+||+.||++|||
T Consensus 222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 299 (320)
T 2i6l_A 222 KTLFAGAHELEQMQLILESIPVVHEEDRQELLSV--IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299 (320)
T ss_dssp SCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTT--SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhc--CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence 99997433110000 000000000000000 00000000000000 0001224577899999999999999999
Q ss_pred HHHHHH--Hhc
Q 046586 736 MGKVAK--MLE 744 (763)
Q Consensus 736 ~~eVv~--~Le 744 (763)
+.|+++ .+.
T Consensus 300 ~~ell~hp~~~ 310 (320)
T 2i6l_A 300 AEEALSHPYMS 310 (320)
T ss_dssp HHHHHTSHHHH
T ss_pred HHHHhCCcccc
Confidence 999986 454
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=326.62 Aligned_cols=267 Identities=24% Similarity=0.231 Sum_probs=187.8
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCe-------
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE------- 512 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------- 512 (763)
.-..|.+.++||+|+||.||+|+.. +++.||||++.........+.+|++.+..++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 3446777899999999999999885 58899999997665556667888999999999999999999976443
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCcEEecC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLH--EECLEWVLHCD 590 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH--~~~~~~ivHrD 590 (763)
.++||||+++ +|...+.... .....+++..+..++.|++.||.||| +.+ |+|||
T Consensus 101 ~~lv~e~~~~-~l~~~~~~~~--------------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~D 156 (360)
T 3e3p_A 101 LNVVMEYVPD-TLHRCCRNYY--------------------RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRD 156 (360)
T ss_dssp EEEEEECCSC-BHHHHHHHHH--------------------TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSC
T ss_pred EEEEeecccc-cHHHHHHHHh--------------------hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCc
Confidence 7899999986 5555543211 03456788999999999999999999 877 99999
Q ss_pred CCCCceEEcC-CCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCccc
Q 046586 591 IKPENILLGD-DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEI 668 (763)
Q Consensus 591 lk~~NILl~~-~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~ 668 (763)
|||+|||++. ++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 157 lkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 157 IKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp CCGGGEEEETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCHHHEEEeCCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 9999999997 89999999999986654322 2345689999999988654 589999999999999999999999975
Q ss_pred ccCCCCCCCCchhHHHHHHHHhccChhhhhccccc--------ccC-------CCcchHHHHHHHHHHHHHccCCCCCCC
Q 046586 669 QGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIK--------NSY-------DSRVHFDMVNRMVKTAMWCIQDRPELR 733 (763)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--------~~~-------~~~~~~~~~~~l~~l~~~Cl~~dP~~R 733 (763)
..... .+... ... .+....+.+..... ... ...........+.+++.+||+.||++|
T Consensus 235 ~~~~~-----~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 306 (360)
T 3e3p_A 235 DNSAG-----QLHEI-VRV--LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306 (360)
T ss_dssp SSHHH-----HHHHH-HHH--HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGS
T ss_pred CChHH-----HHHHH-HHH--cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCcccc
Confidence 32110 00000 000 00000011000000 000 000112246789999999999999999
Q ss_pred CCHHHHHH
Q 046586 734 PSMGKVAK 741 (763)
Q Consensus 734 Ps~~eVv~ 741 (763)
||+.|+++
T Consensus 307 pt~~e~l~ 314 (360)
T 3e3p_A 307 MKPYEALC 314 (360)
T ss_dssp CCHHHHTT
T ss_pred CCHHHHhc
Confidence 99999996
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=334.22 Aligned_cols=261 Identities=24% Similarity=0.292 Sum_probs=191.5
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeC----C--eeeEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK----G--ERTLV 516 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----~--~~~LV 516 (763)
.|.+.++||+|+||.||+|+.. +++.||||++.... ..+.+|++++++++||||+++++++... + ..++|
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 4667889999999999999886 58899999986432 2345799999999999999999998642 1 36789
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++ +|.+.+..... ....+++..+..++.||++||+|||+.+ |+||||||+||
T Consensus 132 ~e~~~~-~l~~~~~~~~~--------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NI 187 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSR--------------------AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNL 187 (420)
T ss_dssp EECCCE-EHHHHHHHHHH--------------------TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGE
T ss_pred hhcccc-cHHHHHHHHhh--------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhE
Confidence 999986 67666643210 3456899999999999999999999988 99999999999
Q ss_pred EEcCC-CCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 597 LLGDD-FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 597 Ll~~~-~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
|++.+ +.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 188 Ll~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~- 264 (420)
T 1j1b_A 188 LLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD- 264 (420)
T ss_dssp EEETTTTEEEECCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred EEeCCCCeEEeccchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 99965 6789999999986543322 2345789999999998764 79999999999999999999999997532110
Q ss_pred CCCCchhHHHHHHHHhccChhhhh---ccccc----ccCCC-----cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDIL---DRHIK----NSYDS-----RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~----~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+.... .. -+....+.+ .+... ..... .++.....++.+|+.+||+.||++|||+.|+++
T Consensus 265 ----~l~~i~-~~--lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 265 ----QLVEII-KV--LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp ----HHHHHH-HH--HCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----HHHHHH-HH--hCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000000 00 000000000 00000 00000 011233568899999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=335.61 Aligned_cols=267 Identities=22% Similarity=0.265 Sum_probs=194.0
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCe------eeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE------RTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~LV 516 (763)
..|.+.++||+|+||.||+|+...+..+|+|++..... ...+|+++++.++||||+++++++..... .++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 35777899999999999999998777799988864322 23479999999999999999999976443 7899
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||++++.+........ ....+++..+..++.||++||+|||+.+ |+||||||+||
T Consensus 117 ~e~~~~~l~~~~~~~~~---------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Ni 172 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAK---------------------LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNL 172 (394)
T ss_dssp EECCSEEHHHHHHHHHH---------------------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred eeccCccHHHHHHHHHh---------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHE
Confidence 99998754433322111 2346889999999999999999999998 99999999999
Q ss_pred EEc-CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 597 LLG-DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 597 Ll~-~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
|++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......
T Consensus 173 ll~~~~~~~kL~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~- 249 (394)
T 4e7w_A 173 LLDPPSGVLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID- 249 (394)
T ss_dssp EEETTTTEEEECCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred EEcCCCCcEEEeeCCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999 899999999999986543322 2345689999999988764 69999999999999999999999997543110
Q ss_pred CCCCchhHHHHHHHHhccChh--------hhhcccccccCCCc----chHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVE--------DILDRHIKNSYDSR----VHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.+... ... -+.... .............. ++.....++.+++.+||+.||++|||+.|+++.
T Consensus 250 ----~l~~i-~~~--~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 250 ----QLVEI-IKV--LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp ----HHHHH-HHH--HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ----HHHHH-HHH--hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000 000 000000 00000000000000 112245688999999999999999999999963
Q ss_pred --hccC
Q 046586 743 --LEGT 746 (763)
Q Consensus 743 --Le~~ 746 (763)
++++
T Consensus 323 p~f~~~ 328 (394)
T 4e7w_A 323 PFFDEL 328 (394)
T ss_dssp GGGSTT
T ss_pred hhhhhh
Confidence 5543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=328.12 Aligned_cols=199 Identities=28% Similarity=0.359 Sum_probs=168.6
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCC-CC-----ccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-HL-----NLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~~~~~~L 515 (763)
..|.+.++||+|+||.||+|... +++.||||+++.......++..|+.+++.++ |+ +|+++++++...+..++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 46777899999999999999876 5788999999855444566788998888884 44 49999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||++ ++|.+++... ....+++..+..++.|++.||+|||++. ..|+||||||+|
T Consensus 134 v~e~~~-~~L~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~N 189 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNT----------------------NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPEN 189 (382)
T ss_dssp EEECCC-CBHHHHHHHT----------------------TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGG
T ss_pred EEecCC-CCHHHHHhhc----------------------CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCccc
Confidence 999996 5999999754 2235889999999999999999999531 229999999999
Q ss_pred eEEc--CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 596 ILLG--DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 596 ILl~--~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
||++ .++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 190 Ill~~~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 190 ILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEecCCCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9994 5788999999999865432 23457899999999999999999999999999999999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=335.13 Aligned_cols=252 Identities=23% Similarity=0.271 Sum_probs=185.1
Q ss_pred ccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 447 ~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
..++||+|+||+||.+...+++.||||++... ..+.+.+|++++.++ +||||+++++++.+.+..++||||++ |+|
T Consensus 19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 35789999999998777778899999998643 235678999999876 89999999999999999999999995 699
Q ss_pred hHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC----
Q 046586 526 ADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD---- 601 (763)
Q Consensus 526 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~---- 601 (763)
.+++........ ......+..++.++.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 96 ~~~l~~~~~~~~-----------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~ 155 (434)
T 2rio_A 96 QDLVESKNVSDE-----------------NLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFT 155 (434)
T ss_dssp HHHHHTC-----------------------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHH
T ss_pred HHHHhccCCCch-----------------hhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccc
Confidence 999975431000 0111233456789999999999999998 9999999999999754
Q ss_pred ---------CCeEEcccCcccccCCCCcc---cccccccCCCccccccccc-------CCCCCccceeehhHHHHHHHh-
Q 046586 602 ---------FCPKISDFGLAKLRKKEDMV---SMSRIRGTRGYMAPEWLRS-------DQITPKADVYSFGMVLLEIVS- 661 (763)
Q Consensus 602 ---------~~~kI~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwS~Gvll~ellt- 661 (763)
+.+||+|||+++........ ......||+.|+|||.+.+ ..++.++|||||||++|||++
T Consensus 156 ~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~ 235 (434)
T 2rio_A 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235 (434)
T ss_dssp SCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhC
Confidence 48999999999876543321 2234579999999999865 678999999999999999999
Q ss_pred CCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 662 GSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 662 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
|+.||...... . .....+. .. ............+.++.+++.+||+.||++|||+.+|++
T Consensus 236 g~~Pf~~~~~~---------~---~~i~~~~-----~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 236 GKHPFGDKYSR---------E---SNIIRGI-----FS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp SCCTTCSTTTH---------H---HHHHHTC-----CC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCchhh---------H---HHHhcCC-----CC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 99998632210 0 1111110 00 000011112466788999999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.89 Aligned_cols=259 Identities=20% Similarity=0.250 Sum_probs=180.5
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeC------Ce
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEK------GE 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 512 (763)
..|.+.+.||+|+||.||+|... +++.||||+++.... ..+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 45677889999999999999864 688999999975432 235688999999999999999999999754 56
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+|||||
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-------------------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlk 159 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-------------------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLK 159 (367)
T ss_dssp CEEEEECC-CEECC------------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred EEEEeccc-CCCHHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCC
Confidence 79999999 6799888732 35889999999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
|+|||++.++.+||+|||+++..... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||.....
T Consensus 160 p~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 160 PSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp GGGEEECTTCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HhhEEECCCCCEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999864432 344678999999999876 7899999999999999999999999975431
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhccc-----------ccccCCCcc---hHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRH-----------IKNSYDSRV---HFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------l~~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
.. ........ -+....+.+... +.......+ .......+.+++.+||+.||++|||+.
T Consensus 236 ~~------~l~~i~~~--~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~ 307 (367)
T 2fst_X 236 ID------QLKLILRL--VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307 (367)
T ss_dssp HH------HHHHHHHH--HCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred HH------HHHHHHHH--hCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHH
Confidence 10 00000000 000011111100 000000000 012346788999999999999999999
Q ss_pred HHHHH
Q 046586 738 KVAKM 742 (763)
Q Consensus 738 eVv~~ 742 (763)
|+++.
T Consensus 308 e~L~h 312 (367)
T 2fst_X 308 QALAH 312 (367)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=324.82 Aligned_cols=263 Identities=20% Similarity=0.259 Sum_probs=200.5
Q ss_pred HHHhccccccccccccceEEEEEeC-CC-cEEEEEEeeccCCchhhhHHHHHHHhcCCCCc------cccEEEEEeeCCe
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DH-RVVAVKCLKNVTGGDAEFWAEVTIIARMHHLN------LVRLWGFCAEKGE 512 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~-~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 512 (763)
....|.+.+.||+|+||.||++... ++ +.||+|+++......+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 3457888899999999999999875 33 68999999865555567889999999998766 9999999999999
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+ +++|.+++... ....+++.++..++.||+.||+|||+.+ |+|||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlk 150 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN----------------------NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLK 150 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT----------------------TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCC
T ss_pred EEEEEecc-CCChHHHHHhc----------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 99999999 66788877543 2346889999999999999999999988 9999999
Q ss_pred CCceEE-------------------cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehh
Q 046586 593 PENILL-------------------GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFG 653 (763)
Q Consensus 593 ~~NILl-------------------~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~G 653 (763)
|+|||+ +.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||
T Consensus 151 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 226 (355)
T 2eu9_A 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIG 226 (355)
T ss_dssp GGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHH
T ss_pred HHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHH
Confidence 999999 67889999999999864332 2345789999999999999999999999999
Q ss_pred HHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhccc--------------------------ccc-cC
Q 046586 654 MVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRH--------------------------IKN-SY 706 (763)
Q Consensus 654 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------l~~-~~ 706 (763)
+++|||++|+.||....... .... ..... +.....+.... ... ..
T Consensus 227 ~il~el~~g~~pf~~~~~~~------~~~~-~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (355)
T 2eu9_A 227 CILFEYYRGFTLFQTHENRE------HLVM-MEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298 (355)
T ss_dssp HHHHHHHHSSCSCCCSSHHH------HHHH-HHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGG
T ss_pred HHHHHHHhCCCCCCCCCHHH------HHHH-HHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccc
Confidence 99999999999997432110 0000 00000 00000000000 000 00
Q ss_pred CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 707 DSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 707 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...........+.+++.+||+.||++|||+.|+++
T Consensus 299 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp GCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00011344668999999999999999999999984
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=322.87 Aligned_cols=260 Identities=20% Similarity=0.262 Sum_probs=176.6
Q ss_pred Hhcccc-ccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHH-HHHhcCCCCccccEEEEEee----CCeeeE
Q 046586 443 ATNGFS-NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEV-TIIARMHHLNLVRLWGFCAE----KGERTL 515 (763)
Q Consensus 443 ~t~~~~-~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~-~~l~~l~H~niv~l~g~~~~----~~~~~L 515 (763)
..|.+. +.||+|+||.||++... +++.||||++.... ...+|+ ..++.++||||+++++++.. ....++
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 356664 46999999999999886 68899999997532 223333 34667799999999999976 445899
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++|+|.+++... ....+++.+++.++.|++.||+|||+.+ |+||||||+|
T Consensus 104 v~e~~~gg~L~~~l~~~----------------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~N 158 (336)
T 3fhr_A 104 IMECMEGGELFSRIQER----------------------GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPEN 158 (336)
T ss_dssp EEECCTTEEHHHHHHTC-----------------------CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEeccCCCCHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 99999999999999653 2346899999999999999999999998 9999999999
Q ss_pred eEEcC---CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 596 ILLGD---DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 596 ILl~~---~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|+++. ++.+||+|||+++..... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 159 Ill~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 159 LLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp EEESCSSTTCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred EEEEecCCCceEEEeccccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 99976 455999999999865432 223456899999999999889999999999999999999999999643321
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccCCCCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGTVEIT 750 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~~~~~ 750 (763)
... ... ...+..... ..........+..+.+++.+||+.||++|||+.|+++ .+.+....+
T Consensus 236 ~~~--------------~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 298 (336)
T 3fhr_A 236 AIS--------------PGM-KRRIRLGQY--GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298 (336)
T ss_dssp --------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred hhh--------------hhH-HHhhhcccc--ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence 100 000 000000000 0010111234567889999999999999999999997 666544443
Q ss_pred C
Q 046586 751 E 751 (763)
Q Consensus 751 ~ 751 (763)
.
T Consensus 299 ~ 299 (336)
T 3fhr_A 299 Q 299 (336)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=325.45 Aligned_cols=267 Identities=19% Similarity=0.256 Sum_probs=197.7
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeC-----Ceee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEK-----GERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 514 (763)
..+.+.+.||+|+||.||+|+.. +++.||||+++.... ...++.+|++++++++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 35677889999999999999876 588999999974433 235678999999999999999999998764 6789
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 91 lv~e~~~-~~L~~~~~~-------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~ 141 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVIST-------------------------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPS 141 (353)
T ss_dssp EEECCCS-EEHHHHHHH-------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred EEEeccC-ccHHHHHhh-------------------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 9999997 599998853 24789999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc---------cccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV---------SMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSR 664 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~---------~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~ 664 (763)
|||++.++.+||+|||+++........ ......||+.|+|||.+.. ..++.++||||||+++|||++|+.
T Consensus 142 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 221 (353)
T 2b9h_A 142 NLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221 (353)
T ss_dssp GEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred HeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999865432211 1223568999999998764 789999999999999999999999
Q ss_pred CcccccCCCCCCCCchhHHHHHHHHhccC------------hhhhhcccccccCCC---cchHHHHHHHHHHHHHccCCC
Q 046586 665 NFEIQGSMMNSDEWYFPKWAFEKVYEEMK------------VEDILDRHIKNSYDS---RVHFDMVNRMVKTAMWCIQDR 729 (763)
Q Consensus 665 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~~~~~---~~~~~~~~~l~~l~~~Cl~~d 729 (763)
||....... ....... ...... ..+.+... ...... .........+.+++.+||+.|
T Consensus 222 pf~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 2b9h_A 222 IFPGRDYRH------QLLLIFG-IIGTPHSDNDLRCIESPRAREYIKSL-PMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293 (353)
T ss_dssp SCCCSSHHH------HHHHHHH-HHCCCCSTTTTTTCCCHHHHHHHHTS-CCCCCCCHHHHSTTSCHHHHHHHHHHSCSS
T ss_pred CCCCCCcHH------HHHHHHH-HhCCCchhccccccccchhhHHhhcc-cCCCCcchhhhcccCCHHHHHHHHHhcCcC
Confidence 997442100 0000000 000000 00000000 000000 001234567889999999999
Q ss_pred CCCCCCHHHHHH--HhccC
Q 046586 730 PELRPSMGKVAK--MLEGT 746 (763)
Q Consensus 730 P~~RPs~~eVv~--~Le~~ 746 (763)
|++|||+.|+++ .+...
T Consensus 294 P~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 294 PAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp GGGSCCHHHHHTSGGGTTT
T ss_pred cccCCCHHHHhcCcccccc
Confidence 999999999996 45543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=321.31 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=177.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHH-HHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVT-IIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..+.+.+.||+|+||.||++... +++.||||+++.... ...++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 45666789999999999999885 688999999975433 2344566666 6777899999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCceE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENIL 597 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NIL 597 (763)
|+++ +|.+++..... .....+++..+..++.|++.||+|||+. + |+||||||+||+
T Consensus 102 ~~~~-~l~~~~~~~~~-------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIl 158 (327)
T 3aln_A 102 LMST-SFDKFYKYVYS-------------------VLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNIL 158 (327)
T ss_dssp CCSE-EHHHHHHHHHH-------------------TTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEE
T ss_pred ecCC-ChHHHHHHHHh-------------------hhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEE
Confidence 9985 88888753210 0234688999999999999999999998 8 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCccccccc----ccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWL----RSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
++.++.+||+|||+++...... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||.......
T Consensus 159 l~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (327)
T 3aln_A 159 LDRSGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236 (327)
T ss_dssp EETTTEEEECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----
T ss_pred EcCCCCEEEccCCCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH
Confidence 9999999999999997654322 22334689999999998 46679999999999999999999999996432110
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. . ...++... ...............+.+++.+||+.||++|||+.+|++
T Consensus 237 ~------------~------~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 237 D------------Q------LTQVVKGD-PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---------------------CCCCCSC-CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred H------------H------HHHHhcCC-CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 0 00111100 000111011234567899999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=323.32 Aligned_cols=241 Identities=27% Similarity=0.429 Sum_probs=197.8
Q ss_pred HHHHhccccccccccccceEEEEEe-CCCcEEEEEEeeccCC-------chhhhHHHHHHHhcCC--CCccccEEEEEee
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTG-------GDAEFWAEVTIIARMH--HLNLVRLWGFCAE 509 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~-------~~~~f~~E~~~l~~l~--H~niv~l~g~~~~ 509 (763)
.....|.+.+.||+|+||.||+|+. .+++.||||+++.... ....+.+|+.++++++ |+||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3445678889999999999999976 4678999999975432 2356789999999996 5999999999999
Q ss_pred CCeeeEEEecCCC-CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 046586 510 KGERTLVYEYVPN-GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLH 588 (763)
Q Consensus 510 ~~~~~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 588 (763)
.+..++|+|++.+ ++|.+++... ..+++..+..++.|++.||+|||+.+ |+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH 172 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER------------------------GALQEELARSFFWQVLEAVRHCHNCG---VLH 172 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEe
Confidence 9999999999976 8999999643 35788999999999999999999998 999
Q ss_pred cCCCCCceEEc-CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCC-CCccceeehhHHHHHHHhCCCCc
Q 046586 589 CDIKPENILLG-DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 589 rDlk~~NILl~-~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvll~elltG~~p~ 666 (763)
|||||+|||++ +++.+||+|||+++...... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||
T Consensus 173 ~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 249 (320)
T 3a99_A 173 RDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249 (320)
T ss_dssp CCCSGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCCHHHEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC
Confidence 99999999999 78999999999998665332 234568999999999887665 68899999999999999999998
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.... ..... .. ... ...+.++.+++.+||+.||++|||+.||++
T Consensus 250 ~~~~----------------~~~~~---------~~--~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 250 EHDE----------------EIIRG---------QV--FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CSHH----------------HHHHC---------CC--CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CChh----------------hhhcc---------cc--ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 6321 00111 00 011 123457889999999999999999999997
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=323.11 Aligned_cols=257 Identities=19% Similarity=0.257 Sum_probs=193.2
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCCee-----
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKGER----- 513 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~----- 513 (763)
..|.+.+.||+|+||.||+|... +++.||||+++..... ...+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 35667789999999999999875 5889999999754332 35688999999999999999999999887655
Q ss_pred -eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 514 -TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 514 -~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
++||||++ ++|.+++. ..+++..+..++.|++.||+|||+.+ |+|||||
T Consensus 122 ~~lv~e~~~-~~l~~~~~--------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 171 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG--------------------------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLK 171 (371)
T ss_dssp CEEEEECCC-EEHHHHTT--------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred EEEEEcccc-ccHHHHhh--------------------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcC
Confidence 99999997 58888762 23789999999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
|+|||++.++.+||+|||+++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 172 p~NIll~~~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 247 (371)
T 4exu_A 172 PGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 247 (371)
T ss_dssp GGGEEECTTCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHHeEECCCCCEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999999999855332 334578999999999877 7899999999999999999999999974321
Q ss_pred CCCCCCCchhHHHHHHHH-hccChhhhhcc-----------cccccCCCc---chHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 672 MMNSDEWYFPKWAFEKVY-EEMKVEDILDR-----------HIKNSYDSR---VHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----------~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
. ........ .+....+.... .+....... ........+.+++.+||+.||++|||+
T Consensus 248 ~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 318 (371)
T 4exu_A 248 L---------DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 318 (371)
T ss_dssp H---------HHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred H---------HHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH
Confidence 1 00000000 00000000000 000000000 011235788999999999999999999
Q ss_pred HHHHHH
Q 046586 737 GKVAKM 742 (763)
Q Consensus 737 ~eVv~~ 742 (763)
.|+++.
T Consensus 319 ~ell~h 324 (371)
T 4exu_A 319 AQALTH 324 (371)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=318.49 Aligned_cols=243 Identities=29% Similarity=0.444 Sum_probs=190.8
Q ss_pred HHHHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-------chhhhHHHHHHHhcC----CCCccccEEE
Q 046586 438 AELRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-------GDAEFWAEVTIIARM----HHLNLVRLWG 505 (763)
Q Consensus 438 ~el~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-------~~~~f~~E~~~l~~l----~H~niv~l~g 505 (763)
.+.....|.+.++||+|+||.||+|+.. +++.||||+++.... ....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4455677888999999999999999874 678999999974422 234567899999998 8999999999
Q ss_pred EEeeCCeeeEEEec-CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 046586 506 FCAEKGERTLVYEY-VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLE 584 (763)
Q Consensus 506 ~~~~~~~~~LV~Ey-~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~ 584 (763)
++.+.+..++|+|| +++++|.+++... ..+++..++.++.|++.||+|||+.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~-- 159 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK------------------------GPLGEGPSRCFFGQVVAAIQHCHSRG-- 159 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 99999999999999 7899999999653 25789999999999999999999998
Q ss_pred cEEecCCCCCceEEc-CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCC-CccceeehhHHHHHHHhC
Q 046586 585 WVLHCDIKPENILLG-DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQIT-PKADVYSFGMVLLEIVSG 662 (763)
Q Consensus 585 ~ivHrDlk~~NILl~-~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwS~Gvll~elltG 662 (763)
|+||||||+||+++ .++.+||+|||+++...... .....||..|+|||.+.+..+. .++||||||+++|||++|
T Consensus 160 -i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 235 (312)
T 2iwi_A 160 -VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235 (312)
T ss_dssp -EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHS
T ss_pred -eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHC
Confidence 99999999999999 89999999999998765432 2345689999999998876664 589999999999999999
Q ss_pred CCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 663 SRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 663 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
+.||.... . +..... . .+......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~pf~~~~----------------~---------~~~~~~--~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 236 DIPFERDQ----------------E---------ILEAEL--H----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp SCSCCSHH----------------H---------HHHTCC--C----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCChH----------------H---------Hhhhcc--C----CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99986321 0 011100 0 11233457889999999999999999999997
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=329.55 Aligned_cols=247 Identities=24% Similarity=0.253 Sum_probs=183.5
Q ss_pred hccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
.+.+.++||+|+||+|+.....+++.||||++.... ...+.+|+++++.+ +|||||++++++.+....++||||++
T Consensus 25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 455668999999999776666678999999986432 23467899999999 89999999999999999999999996
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC--
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD-- 600 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~-- 600 (763)
|+|.+++.... ..+....+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 102 g~L~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~ 155 (432)
T 3p23_A 102 ATLQEYVEQKD-----------------------FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPN 155 (432)
T ss_dssp EEHHHHHHSSS-----------------------CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCB
T ss_pred CCHHHHHHhcC-----------------------CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCC
Confidence 59999996532 12233345789999999999999998 999999999999943
Q ss_pred ---CCCeEEcccCcccccCCCCc--ccccccccCCCcccccccc---cCCCCCccceeehhHHHHHHHh-CCCCcccccC
Q 046586 601 ---DFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVS-GSRNFEIQGS 671 (763)
Q Consensus 601 ---~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~ 671 (763)
...+||+|||+++....... .......||+.|+|||.+. ...++.++|||||||++|||++ |..||.....
T Consensus 156 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~ 235 (432)
T 3p23_A 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235 (432)
T ss_dssp TTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred CCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH
Confidence 34688999999986653321 2334467999999999987 4677889999999999999999 8889853211
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. . .... .......... ........+.+++.+||+.||++|||+.+|++
T Consensus 236 ~----------~-~~~~---------~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 236 R----------Q-ANIL---------LGACSLDCLH--PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp H----------H-HHHH---------TTCCCCTTSC--TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred H----------H-HHHH---------hccCCccccC--ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0 0000 0000000001 11234566889999999999999999999983
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=321.55 Aligned_cols=256 Identities=19% Similarity=0.263 Sum_probs=192.4
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCCe------
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKGE------ 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------ 512 (763)
.+|.+.+.||+|+||.||+|... +++.||||+++..... ...+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 35667789999999999999875 6889999999754332 3568899999999999999999999987654
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||++ ++|.+++. ..+++..+..++.||+.||+|||+.+ |+|||||
T Consensus 104 ~~lv~e~~~-~~l~~~~~--------------------------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlk 153 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG--------------------------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLK 153 (353)
T ss_dssp CEEEEECCS-EEGGGTTT--------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCC
T ss_pred EEEEecccc-CCHHHHhc--------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 499999997 58877662 23789999999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
|+||+++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 154 p~NIl~~~~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 229 (353)
T 3coi_A 154 PGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229 (353)
T ss_dssp GGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH
T ss_pred HHHEeECCCCcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999864322 234578999999998876 7899999999999999999999999974321
Q ss_pred CCCCCCCchhHHHHHHHH-hccChhhhhcc-----------cccccCC---CcchHHHHHHHHHHHHHccCCCCCCCCCH
Q 046586 672 MMNSDEWYFPKWAFEKVY-EEMKVEDILDR-----------HIKNSYD---SRVHFDMVNRMVKTAMWCIQDRPELRPSM 736 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----------~l~~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 736 (763)
. ........ .+....+.... .+..... ..........+.+++.+||+.||++|||+
T Consensus 230 ~---------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~ 300 (353)
T 3coi_A 230 L---------DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 300 (353)
T ss_dssp H---------HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred H---------HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH
Confidence 1 00000000 00000000000 0000000 01112446788999999999999999999
Q ss_pred HHHHH
Q 046586 737 GKVAK 741 (763)
Q Consensus 737 ~eVv~ 741 (763)
.++++
T Consensus 301 ~e~l~ 305 (353)
T 3coi_A 301 AQALT 305 (353)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=312.86 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=175.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCch--hh-hHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGD--AE-FWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~--~~-f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..+.+.+.||+|+||.||+++.. +++.||||+++...... .+ +..+..+++.++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 35667789999999999999886 68899999997544322 22 3445556888899999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCceE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENIL 597 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NIL 597 (763)
|+ ++.+..+.... ...+++..+..++.|++.||+|||+. + |+|+||||+||+
T Consensus 105 ~~-~~~~~~l~~~~-----------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil 157 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM-----------------------QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNIL 157 (318)
T ss_dssp CC-SEEHHHHHHHH-----------------------TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEE
T ss_pred cc-CCcHHHHHHHh-----------------------ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEE
Confidence 99 44555444321 23578999999999999999999995 7 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
++.++.+||+|||++....... ......+|+.|+|||.+. ...++.++||||||+++|||++|+.||......
T Consensus 158 ~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (318)
T 2dyl_A 158 LDERGQIKLCDFGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235 (318)
T ss_dssp ECTTSCEEECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred ECCCCCEEEEECCCchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Confidence 9999999999999997654322 223456899999999984 567889999999999999999999999642210
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. .......+. ...+.. ....+..+.+++.+||+.||.+||++.+|++
T Consensus 236 --------~~-~~~~~~~~~------~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 236 --------FE-VLTKVLQEE------PPLLPG------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --------HH-HHHHHHHSC------CCCCCS------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --------HH-HHHHHhccC------CCCCCc------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 111111110 000000 0123467889999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=341.77 Aligned_cols=265 Identities=24% Similarity=0.285 Sum_probs=196.0
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEee------CCee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAE------KGER 513 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 513 (763)
..|.+.++||+|+||.||+|... +++.||||+++.... ..+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 56888999999999999999874 588999999875422 24568899999999999999999999765 6778
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++|+|.+++.... ....+++..+..|+.|++.||+|||+.+ |+||||||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~---------------------~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP 149 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE---------------------NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKP 149 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS---------------------CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCS
T ss_pred EEEEEeCCCCCHHHHHHhcc---------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCH
Confidence 99999999999999997542 2335788899999999999999999988 99999999
Q ss_pred CceEEcCCCC---eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 594 ENILLGDDFC---PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 594 ~NILl~~~~~---~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
+||+++.++. +||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 150 ~NILl~~~g~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~ 227 (676)
T 3qa8_A 150 ENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227 (676)
T ss_dssp TTEEEECCSSSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred HHeEeecCCCceeEEEccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence 9999997765 9999999998664432 2234578999999999999999999999999999999999999996432
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhccccc----ccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIK----NSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGK 738 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 738 (763)
........... .........+....... ...........+..+.+++..||+.||++|||+.+
T Consensus 228 ~~~~~~~~i~~-----~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 228 QPVQWHGKVRE-----KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp HHHHSSTTCC-----------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred chhhhhhhhhc-----ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 10000000000 00000000000111000 00111233456788999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=303.80 Aligned_cols=230 Identities=14% Similarity=0.105 Sum_probs=182.7
Q ss_pred HHHhccccccccccccceEEEEEeCC-CcEEEEEEeeccCCch----hhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGD----AEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~----~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
....|.+.+.||+|+||.||+|.... ++.||||+++...... +++.+|+.++.+++||||+++++++.+.+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 34567888999999999999998864 8899999998554332 678999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++++|.+++... ....+..+|+.|++.||+|||+.+ |+||||||+|
T Consensus 109 v~e~~~g~~L~~~l~~~--------------------------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~N 159 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--------------------------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSR 159 (286)
T ss_dssp EEECCCEEEHHHHHTTC--------------------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGG
T ss_pred EEEecCCCCHHHHHhcC--------------------------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCccc
Confidence 99999999999998321 244567889999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
||++.++.+||++++ |++ +++.++||||||+++|||++|+.||........
T Consensus 160 Ill~~~g~~kl~~~~---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~- 210 (286)
T 3uqc_A 160 VRVSIDGDVVLAYPA---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG- 210 (286)
T ss_dssp EEEETTSCEEECSCC---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-
T ss_pred EEEcCCCCEEEEecc---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-
Confidence 999999999998543 333 368899999999999999999999975432110
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCC--cchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDS--RVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
. ....+........ ......+..+.+++.+||+.||++| |+.|+++.|+....
T Consensus 211 ------------------~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 211 ------------------L-APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp ------------------S-EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ------------------h-HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0 0000000000000 0112345678999999999999999 99999999987543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.56 Aligned_cols=238 Identities=18% Similarity=0.268 Sum_probs=182.5
Q ss_pred cccc-ccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHH-hcCCCCccccEEEEEee----CCeeeEEE
Q 046586 445 NGFS-NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTII-ARMHHLNLVRLWGFCAE----KGERTLVY 517 (763)
Q Consensus 445 ~~~~-~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~LV~ 517 (763)
|.+. +.||+|+||.||++... +++.||+|+++. ...+.+|++++ +.++||||+++++++.. ....++||
T Consensus 19 y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred hhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 4444 68999999999999874 678999999964 34577899887 66699999999999987 67889999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+
T Consensus 95 e~~~~~~L~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil 149 (299)
T 3m2w_A 95 ECLDGGELFSRIQDR----------------------GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLL 149 (299)
T ss_dssp CCCCSCBHHHHHHHC----------------------TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred eecCCCcHHHHHHhc----------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 999999999999753 2346889999999999999999999998 999999999999
Q ss_pred EcC---CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LGD---DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~~---~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++. ++.+||+|||++.... +..++.++||||||+++|||++|+.||........
T Consensus 150 ~~~~~~~~~~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 206 (299)
T 3m2w_A 150 YTSKRPNAILKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206 (299)
T ss_dssp ESSSSTTCCEEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred EecCCCCCcEEEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence 998 7899999999986432 24567899999999999999999999964322110
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCc--chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccCCCCC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSR--VHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGTVEIT 750 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~~~~~ 750 (763)
................ .....+..+.+++.+||+.||++|||+.|+++ .+.+....+
T Consensus 207 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 207 -------------------SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp --------------------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred -------------------hHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 0000000001111100 00234567899999999999999999999996 455544444
Q ss_pred CCC
Q 046586 751 EPK 753 (763)
Q Consensus 751 ~p~ 753 (763)
.++
T Consensus 268 ~~~ 270 (299)
T 3m2w_A 268 QTP 270 (299)
T ss_dssp CCB
T ss_pred CCC
Confidence 433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=337.39 Aligned_cols=237 Identities=23% Similarity=0.296 Sum_probs=190.5
Q ss_pred HhccccccccccccceEEEEEeC--CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCe-----e
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT--DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGE-----R 513 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~--~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----~ 513 (763)
..|.+.++||+|+||.||++... +++.||||++..... ....+.+|+.++++++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 56788899999999999999875 578999999875432 23468899999999999999999999988765 7
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
+|||||+++++|.+++. ..+++.+++.|+.||+.||+|||+.+ ||||||||
T Consensus 160 ~lv~E~~~g~~L~~~~~--------------------------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp 210 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG--------------------------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKP 210 (681)
T ss_dssp EEEEECCCCEECC------------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEEeCCCCcHHHHHh--------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccCh
Confidence 99999999999988762 15889999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
+|||++.+ .+||+|||+++..... ....||+.|+|||.+.++. +.++|||||||++|||++|..|+.......
T Consensus 211 ~NIll~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~ 283 (681)
T 2pzi_A 211 ENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG 283 (681)
T ss_dssp GGEEECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS
T ss_pred HHeEEeCC-cEEEEecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc
Confidence 99999986 9999999999865432 3457899999999987654 889999999999999999988875321100
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHhccC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-MGKVAKMLEGT 746 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~eVv~~Le~~ 746 (763)
.. ...........+.+++.+||+.||++||+ +.++.+.|.+.
T Consensus 284 --------------------~~-----------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 284 --------------------LP-----------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp --------------------CC-----------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------------------cc-----------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 00011233467889999999999999995 56666665543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=315.27 Aligned_cols=241 Identities=13% Similarity=0.069 Sum_probs=175.7
Q ss_pred ccccccccccccceEEEEEe-CCCcEEEEEEeeccC----CchhhhHHHHHHHhcCCC-Ccc---------cc-------
Q 046586 445 NGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT----GGDAEFWAEVTIIARMHH-LNL---------VR------- 502 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H-~ni---------v~------- 502 (763)
+...+.||+|+||.||+|+. .+++.||||+++... ...+.|.+|+.+++.++| +|. +.
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 34457999999999999985 468899999997322 234678999999999977 221 11
Q ss_pred -----EEEEEee-----CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHH
Q 046586 503 -----LWGFCAE-----KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVA 572 (763)
Q Consensus 503 -----l~g~~~~-----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia 572 (763)
+..+... ....+++|+++ +++|.+++...... ......+++..++.|+.||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~-----------------~~~~~~l~~~~~~~i~~qi~ 221 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH-----------------SSTHKSLVHHARLQLTLQVI 221 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHH-----------------TTTSHHHHHHHHHHHHHHHH
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc-----------------cccCCCCCHHHHHHHHHHHH
Confidence 1111111 12456677765 67999988532100 00234578889999999999
Q ss_pred HHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccc----------ccCC
Q 046586 573 RAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWL----------RSDQ 642 (763)
Q Consensus 573 ~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l----------~~~~ 642 (763)
+||+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....| +.|+|||.+ ....
T Consensus 222 ~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 293 (413)
T 3dzo_A 222 RLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTL 293 (413)
T ss_dssp HHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEE
T ss_pred HHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcC
Confidence 9999999998 999999999999999999999999999764432 334567 999999998 5557
Q ss_pred CCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHH
Q 046586 643 ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA 722 (763)
Q Consensus 643 ~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~ 722 (763)
++.++|||||||++|||++|+.||....... ..+..+.... ..++.+.+++
T Consensus 294 ~~~~~DvwSlGvil~elltg~~Pf~~~~~~~-----------------------~~~~~~~~~~------~~~~~~~~li 344 (413)
T 3dzo_A 294 MTFAFDTWTLGLAIYWIWCADLPNTDDAALG-----------------------GSEWIFRSCK------NIPQPVRALL 344 (413)
T ss_dssp ECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS-----------------------CSGGGGSSCC------CCCHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCCcchhh-----------------------hHHHHHhhcc------cCCHHHHHHH
Confidence 8889999999999999999999996432111 1111111110 1236788999
Q ss_pred HHccCCCCCCCCCHHHHH
Q 046586 723 MWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 723 ~~Cl~~dP~~RPs~~eVv 740 (763)
..||+.||++||++.+++
T Consensus 345 ~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 345 EGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHTCSSGGGSCCHHHHT
T ss_pred HHHccCChhhCcCHHHHH
Confidence 999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=307.97 Aligned_cols=242 Identities=16% Similarity=0.161 Sum_probs=186.2
Q ss_pred HHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCC---------chhhhHHHHHHHhcCC---------CCccc
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG---------GDAEFWAEVTIIARMH---------HLNLV 501 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~---------~~~~f~~E~~~l~~l~---------H~niv 501 (763)
+....|.+.++||+|+||.||+|+. +++.||||+++.... ..+.+.+|+.+++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3356678889999999999999998 678999999975421 1266889999988885 88888
Q ss_pred cEEEEEe------------------------------eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCC
Q 046586 502 RLWGFCA------------------------------EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGP 551 (763)
Q Consensus 502 ~l~g~~~------------------------------~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~ 551 (763)
++.+++. +.+..+|||||+++|++.+.+.+
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------------------- 155 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------------------- 155 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------------------
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------------------
Confidence 8877653 26789999999999987776632
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCcEEecCCCCCceEEcCCC--------------------CeEEcccC
Q 046586 552 HDGGKPVLDWSIRYRIALGVARAIAYLH-EECLEWVLHCDIKPENILLGDDF--------------------CPKISDFG 610 (763)
Q Consensus 552 ~~~~~~~l~~~~~~~ia~qia~gL~yLH-~~~~~~ivHrDlk~~NILl~~~~--------------------~~kI~DFG 610 (763)
..+++.++..|+.||+.||+||| +.+ |+||||||+|||++.++ .+||+|||
T Consensus 156 -----~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG 227 (336)
T 2vuw_A 156 -----KLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT 227 (336)
T ss_dssp -----TCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCT
T ss_pred -----cCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeecc
Confidence 35789999999999999999999 888 99999999999999887 89999999
Q ss_pred cccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHH-HHHHHhCCCCcccccCCCCCCCCchhHHHHHHHH
Q 046586 611 LAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMV-LLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVY 689 (763)
Q Consensus 611 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvl-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 689 (763)
+|+..... ...||+.|+|||.+.+.. +.++||||++++ .+++++|..||... .|... .
T Consensus 228 ~a~~~~~~------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------------~~~~~-~- 286 (336)
T 2vuw_A 228 LSRLERDG------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------------LWLHY-L- 286 (336)
T ss_dssp TCBEEETT------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------------HHHHH-H-
T ss_pred ccEecCCC------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------------hhhhH-H-
Confidence 99865432 347999999999998766 889999998777 77788899888521 01000 0
Q ss_pred hccChhhhhcc-cccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 690 EEMKVEDILDR-HIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 690 ~~~~~~~~~~~-~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
...++.. ..............+.++.+++.+||+.| |+.|++
T Consensus 287 ----~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 287 ----TDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp ----HHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ----HHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 1111111 11111222334577889999999999976 899888
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=270.70 Aligned_cols=108 Identities=25% Similarity=0.351 Sum_probs=90.5
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCC----CccEEEccCCcEEE--ecCCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGN----GSLAIAATTGQLRL--LNSSNS 115 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~----~~~~~~~~~g~L~l--~~~~~~ 115 (763)
.+++|||++|+|+||||. + + ++|| |+ + .+ |||+||||+||.++ ++.|.++.||+|+| .|++|+
T Consensus 25 ~~~~l~S~~g~F~lgf~~-~-~--~~~l---y~--~-~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~Lvl~~~~~~~~ 93 (276)
T 3m7h_A 25 AGQYLLSPNQRFKLLLQG-D-G--NLVI---QD--N-GA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRR 93 (276)
T ss_dssp TTCEEECTTSSEEEEECT-T-S--CEEE---EE--T-TE-EEEECSTTSTTEEEEECCCTTCCSEEEESSSEEEEEGGGT
T ss_pred CCCEEEcCCCcEEEEEEC-C-C--CeEE---EC--C-CC-eEEECCCCCCcCCcccccceEEEEeCCCcEEEEEeCCCCC
Confidence 478999999999999994 2 2 4566 76 6 46 99999999999874 77899999999999 888899
Q ss_pred eecCCCCCCCC---CCCceeEEEccCCCeeee----cccccCCCCccccCCCcc
Q 046586 116 NLWPNPKTATG---NPNSTRLFLQDAGNLVYG----NWQSFNLPTDTILPNQTL 162 (763)
Q Consensus 116 ~vwst~~~~~~---~~~~~~~~lld~GNlvl~----~WqSFd~Ptdtllpg~~l 162 (763)
+||||+.+.+. ...++.|+|+|+|||||+ +||| ||||||||||++
T Consensus 94 ~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~~~~lWqS--~ptdtlLpg~~~ 145 (276)
T 3m7h_A 94 RVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDSLALWNG--TPAIPLVPGAID 145 (276)
T ss_dssp EEEEECCCCCCCTTHHHHEEEEECTTSCEEEEEEEEEEES--CTTSCCCCSCTT
T ss_pred EEEEeCCCcccccccCCceEEEEeCCCCEEecCCceeeCc--cccccccccccc
Confidence 99999854211 034678999999999998 5999 999999999994
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=273.87 Aligned_cols=185 Identities=14% Similarity=0.082 Sum_probs=129.8
Q ss_pred cccccccceEEEE-EeCCCcEEEEEEeeccC-----------CchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEE
Q 046586 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVT-----------GGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 450 ~LG~G~fG~Vy~g-~~~~~~~VAvK~l~~~~-----------~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV 516 (763)
..+.|++|.+..+ +..-|+.+++|++.... ...++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4566666666554 23357889999997432 1124699999999999 799999999999999999999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||++|++|.++|... ..++. .+|+.||+.||+|||+++ ||||||||+||
T Consensus 321 MEyv~G~~L~d~i~~~------------------------~~l~~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNI 370 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG------------------------EEIDR---EKILGSLLRSLAALEKQG---FWHDDVRPWNV 370 (569)
T ss_dssp EECCCSEEHHHHHHTT------------------------CCCCH---HHHHHHHHHHHHHHHHTT---CEESCCCGGGE
T ss_pred EecCCCCcHHHHHHhC------------------------CCCCH---HHHHHHHHHHHHHHHHCC---ceeccCchHhE
Confidence 9999999999999643 23443 358999999999999999 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCc
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~ 666 (763)
|+++++++||+|||+|+...... .......||++|||||.+.+ .+..++|+||+|++++++.++..++
T Consensus 371 LL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 371 MVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp EECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred EECCCCCEEEeecccCeeCCCCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 99999999999999998665432 23445689999999999875 5677899999999999887776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.9e-25 Score=251.36 Aligned_cols=181 Identities=17% Similarity=0.229 Sum_probs=144.8
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeeccCCc---------hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG---------DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~---------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.++||+|+||.||++... ++.+++|........ .+.+.+|++++++++||||+++..++...+..+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 468999999999999554 567888876432211 2347899999999999999977777778888899999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||+
T Consensus 420 ~~~ggsL~~~l~~--------------------------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl 464 (540)
T 3en9_A 420 YINGKLAKDVIED--------------------------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIF 464 (540)
T ss_dssp CCCSEEHHHHSTT--------------------------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEE
T ss_pred CCCCCCHHHHHHH--------------------------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEE
Confidence 9999999999842 3579999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCccc------ccccccCCCccccccccc--CCCCCccceeehhHHHHHHHhCCCCc
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVS------MSRIRGTRGYMAPEWLRS--DQITPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~------~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvll~elltG~~p~ 666 (763)
+. ++||+|||+++......... .....||+.|||||++.. ..|+.+.|+|+..+-..+-+.++.+|
T Consensus 465 ~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 465 DK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp SS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99 99999999999765432211 235679999999999976 67888999999999999988887766
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=5.4e-23 Score=209.99 Aligned_cols=144 Identities=16% Similarity=0.269 Sum_probs=100.1
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.+++| ++|.|+|||+.+++ +. +|.. .||||+|||+.| .++.+.+..||||||.|++|++||+|+
T Consensus 19 ~g~~l--~~g~f~l~f~~~gn------l~-ly~~----~~~vW~an~~~~---~~~~l~l~~dGnLvl~d~~~~~vW~s~ 82 (236)
T 1dlp_A 19 AAQSL--ELSSFRFTMQSDCN------LV-LFDS----DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSG 82 (236)
T ss_dssp TTCEE--CSTTEEEEECTTSC------EE-EEES----SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCCC
T ss_pred CCCEE--EcCCEEEEECCCCc------EE-EEEC----CEEEEECCCCCC---CCeEEEEcCCCcEEEEcCCCcEEEeCC
Confidence 46788 59999999985432 22 4442 688999999998 457788999999999999999999998
Q ss_pred CCCCCCCCceeEEEccCCCeeee---cccccCCCCccc----------cCCCccCCC--CCCCC----CCceeee--cCc
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYG---NWQSFNLPTDTI----------LPNQTLNGP--PLVSK----NGKFSFL--NAS 180 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~---~WqSFd~Ptdtl----------lpg~~l~~~--~l~s~----~g~~~~~--~~~ 180 (763)
... ......|+|+|+|||||+ +||||||||||+ +|||+++.+ .|++. +|.|++. ...
T Consensus 83 ~~~--~~~~~~~~l~d~Gnlvl~~~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~d~s~G~~~l~l~~dG 160 (236)
T 1dlp_A 83 TKG--SIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDC 160 (236)
T ss_dssp CCC--CSSCCEEEECSSSCEEEECSEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSCCCBCSSCEEEEETTT
T ss_pred ccc--cCCcEEEEEeCCCCEEEecCCEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCcEeecCcEEEEECCCC
Confidence 432 223458999999999997 599999998655 777755422 23222 5777775 111
Q ss_pred ee-eeeecCe-------------eEEEEecCCceEEEE
Q 046586 181 EL-VFVSANR-------------SYWNIDDDGNLRIYS 204 (763)
Q Consensus 181 ~~-~~~~~~~-------------~~~~l~~~G~~~~~~ 204 (763)
.+ ++.+ .. .+..|+.+|++.+|.
T Consensus 161 ~LvL~~~-~~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~ 197 (236)
T 1dlp_A 161 NLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLT 197 (236)
T ss_dssp EEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEE
T ss_pred cEEEEcC-CEeEEeCCCcCCCCceEEEECCCCcEEEEe
Confidence 22 2221 11 234678888887775
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-21 Score=206.42 Aligned_cols=141 Identities=15% Similarity=0.078 Sum_probs=113.8
Q ss_pred cccccccccccceEEEEEeCCCcEEEEEEeeccCC-------------------chhhhHHHHHHHhcCCCCccccEEEE
Q 046586 446 GFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG-------------------GDAEFWAEVTIIARMHHLNLVRLWGF 506 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~-------------------~~~~f~~E~~~l~~l~H~niv~l~g~ 506 (763)
.+.+.||+|+||.||+|...+++.||+|+++.... ....+.+|++++++++| +++.++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~ 169 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKV 169 (282)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCE
T ss_pred EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeE
Confidence 35589999999999999987789999999963221 13458899999999994 555554
Q ss_pred EeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 507 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
+.. +..++||||+++++|.+ +.. .....++.|++.||+|||+.+ |
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~------------------------------~~~~~i~~qi~~~l~~lH~~g---i 214 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRV------------------------------ENPDEVLDMILEEVAKFYHRG---I 214 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCC------------------------------SCHHHHHHHHHHHHHHHHHTT---E
T ss_pred Eec-cceEEEEEecCCCcHHH-cch------------------------------hhHHHHHHHHHHHHHHHHHCC---C
Confidence 433 56699999999999998 421 113469999999999999998 9
Q ss_pred EecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccc
Q 046586 587 LHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR 639 (763)
Q Consensus 587 vHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~ 639 (763)
+||||||+|||++ ++.+||+|||+++. +..++|||++.
T Consensus 215 iHrDlkp~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 215 VHGDLSQYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp ECSCCSTTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EeCCCCHHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 9999999999999 99999999999963 33478899875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=8e-18 Score=174.42 Aligned_cols=135 Identities=19% Similarity=0.162 Sum_probs=104.5
Q ss_pred ccccccccccccceEEEEEe-CCCcE--EEEEEeeccCCc-------------------------hhhhHHHHHHHhcCC
Q 046586 445 NGFSNLIGRGGFGDVYKGEL-TDHRV--VAVKCLKNVTGG-------------------------DAEFWAEVTIIARMH 496 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~-~~~~~--VAvK~l~~~~~~-------------------------~~~f~~E~~~l~~l~ 496 (763)
+.+.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 34668999999999999988 67888 999997643111 125788999999998
Q ss_pred CCcc--ccEEEEEeeCCeeeEEEecCCC-C----CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHH
Q 046586 497 HLNL--VRLWGFCAEKGERTLVYEYVPN-G----SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIAL 569 (763)
Q Consensus 497 H~ni--v~l~g~~~~~~~~~LV~Ey~~~-g----sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~ 569 (763)
|+++ ...++. +..+|||||+.+ | +|.++... .++.....++.
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------------------------~~~~~~~~i~~ 177 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------------------------LKELDVEGIFN 177 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------------------------GGGSCHHHHHH
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------------------------cChHHHHHHHH
Confidence 8764 444442 357899999942 4 66655421 11334678999
Q ss_pred HHHHHHHHHH-hcCCCcEEecCCCCCceEEcCCCCeEEcccCccccc
Q 046586 570 GVARAIAYLH-EECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLR 615 (763)
Q Consensus 570 qia~gL~yLH-~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~ 615 (763)
|++.||.||| +.+ |+||||||+|||+++ .++|+|||+|...
T Consensus 178 qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 178 DVVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999 887 999999999999998 9999999999754
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.66 E-value=5.9e-16 Score=136.21 Aligned_cols=91 Identities=21% Similarity=0.372 Sum_probs=73.5
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.|++|+| |.|.|.|...+ .|.++. ..++||+|||+.|..+ +..+.+..||||+|.|++|++||+|+
T Consensus 12 ~g~~L~s--g~y~l~~q~Dg------NLvly~-----~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~~~~vWss~ 77 (105)
T 4h3o_A 12 AGQSLDV--EPYHFIMQDDC------NLVLYD-----HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSSGRSLWASH 77 (105)
T ss_dssp TTCEEEE--TTEEEEECTTS------CEEEEE-----TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECTTCCEEEECC
T ss_pred CCCEEEE--CCEEEEECCCC------eEEEEE-----CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECCCcEEEEEec
Confidence 5778887 88999998644 265654 2678999999999764 46789999999999999999999998
Q ss_pred CCCCCCCCceeEEEccCCCeeee---cccc
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYG---NWQS 148 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~---~WqS 148 (763)
.. .......|+|+|+|||||+ +|||
T Consensus 78 t~--~~~~~~~l~L~ddGNlVly~~~~W~S 105 (105)
T 4h3o_A 78 ST--RGSGNYILILQDDGNVIIYGSDIWST 105 (105)
T ss_dssp CC--CCSSCEEEEECTTSCEEEEESEEEEC
T ss_pred CC--CCCCCEEEEEeCCCeEEEECCcEecC
Confidence 43 2334568999999999998 4997
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.63 E-value=1.6e-15 Score=136.74 Aligned_cols=92 Identities=25% Similarity=0.394 Sum_probs=74.9
Q ss_pred CCceEe--cCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecC
Q 046586 42 QNRILL--SPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWP 119 (763)
Q Consensus 42 ~~~~l~--S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vws 119 (763)
++++|+ |++|.|+|+|+.+++ + +||++ .++||+||++.| +.+..+.+..||||||.|.+|.+||+
T Consensus 19 ~g~~l~~~S~~g~~~L~~~~dgn----l---vly~~----~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~d~~~~~lW~ 85 (119)
T 1b2p_A 19 ATESLEILFGTHVYRFIMQTDCN----L---VLYDN----NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQ 85 (119)
T ss_dssp TTCEEEEEETTEEEEEEECTTSC----E---EEEET----TEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEEE
T ss_pred CCCEEEEeCCCCCEEEEEecCCC----E---EEEEC----CEEEEeCCCccC--CCceEEEEccCCEEEEEeCCCcEEEc
Confidence 577999 999999999996542 2 57864 689999999977 34567899999999999999999999
Q ss_pred CCCCCCCCCCceeEEEccCCCeeee---cccc
Q 046586 120 NPKTATGNPNSTRLFLQDAGNLVYG---NWQS 148 (763)
Q Consensus 120 t~~~~~~~~~~~~~~lld~GNlvl~---~WqS 148 (763)
+.... ..+...++|+|+|||||+ .|||
T Consensus 86 S~~~~--~~g~~~l~l~~~Gnlvl~~~~~W~S 115 (119)
T 1b2p_A 86 SPVAG--KAGHYVLVLQPDRNVVIYGDALWAT 115 (119)
T ss_dssp CSCCC--CSSCEEEEECTTSCEEEEESEEEEC
T ss_pred CCCCC--CCCCEEEEEECCCcEEEECccEeCC
Confidence 87432 234568999999999997 4887
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.7e-15 Score=134.75 Aligned_cols=95 Identities=22% Similarity=0.324 Sum_probs=77.3
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.+++|+ ++|.|+|+|+..++ | |+|+ . .++||+||++.|- .+..+.+..||||||.|.+|.+||+|.
T Consensus 12 ~g~~l~-~~~~~~l~~~~dGn------l-vl~~--~--~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~~~~~W~S~ 77 (110)
T 3a0c_A 12 TGHSLE-VGPSYRLIMQGDCN------F-VLYD--S--GKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQSNRVIWQTK 77 (110)
T ss_dssp TTCEEE-ETTTEEEEECTTSC------E-EEEE--T--TEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred CCCEEE-ECCCEEEEEcCCCc------E-EEEE--C--CEEEEECCCCCCC--CcEEEEEeCCCCEEEECCCCcEEEecC
Confidence 578999 99999999986432 2 6776 2 6889999998773 346788889999999999999999988
Q ss_pred CCCCCCCCceeEEEccCCCeeee---cccccCCC
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYG---NWQSFNLP 152 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~---~WqSFd~P 152 (763)
... ..+...++|+|+|||||+ .||||+||
T Consensus 78 t~~--~~g~~~l~l~~dGnlvl~~~~~W~S~~~~ 109 (110)
T 3a0c_A 78 TNG--KEDHYVLVLQQDRNVVIYGPVVWATGSGP 109 (110)
T ss_dssp CCC--SSSCCEEEECTTSCEEEECSEEEECSCCC
T ss_pred CCC--CCCCEEEEEeCCccEEEECCCEecCCCcC
Confidence 432 224557999999999997 59999998
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=7.7e-16 Score=166.35 Aligned_cols=137 Identities=14% Similarity=0.061 Sum_probs=97.7
Q ss_pred ccccccccccccceEEEEEeCCCcEEEEEEeeccCC------c---------hhh--------hHHHHHHHhcCCCCccc
Q 046586 445 NGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG------G---------DAE--------FWAEVTIIARMHHLNLV 501 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~------~---------~~~--------f~~E~~~l~~l~H~niv 501 (763)
|.+.++||+|+||.||+|...+|+.||||+++.... . ... ..+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 567789999999999999999999999999863210 0 011 12355556666444432
Q ss_pred cEEEEEeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 046586 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE 581 (763)
Q Consensus 502 ~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~ 581 (763)
...-+... ..+|||||+++++|..+... .....++.|++.+|.|||+.
T Consensus 177 vp~p~~~~--~~~LVME~i~G~~L~~l~~~------------------------------~~~~~l~~qll~~l~~lH~~ 224 (397)
T 4gyi_A 177 VPEPIAQS--RHTIVMSLVDALPMRQVSSV------------------------------PDPASLYADLIALILRLAKH 224 (397)
T ss_dssp CCCEEEEE--TTEEEEECCSCEEGGGCCCC------------------------------SCHHHHHHHHHHHHHHHHHT
T ss_pred CCeeeecc--CceEEEEecCCccHhhhccc------------------------------HHHHHHHHHHHHHHHHHHHC
Confidence 21111111 23799999999887654310 12346789999999999998
Q ss_pred CCCcEEecCCCCCceEEcCCC----------CeEEcccCcccccC
Q 046586 582 CLEWVLHCDIKPENILLGDDF----------CPKISDFGLAKLRK 616 (763)
Q Consensus 582 ~~~~ivHrDlk~~NILl~~~~----------~~kI~DFGla~~~~ 616 (763)
+ ||||||||.|||+++++ .+.|+||+-+....
T Consensus 225 g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 225 G---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp T---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred C---CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 8 99999999999998876 38999999886443
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=2.2e-14 Score=128.65 Aligned_cols=96 Identities=19% Similarity=0.277 Sum_probs=75.8
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.+++|+ +|.|+|+|+..+ +. ++|+ . .++||+||++.|. .+..+.+..+|||||.|.++.+||+++
T Consensus 13 ~g~~L~--~g~~~L~~~~dg----nl---vly~--~--~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~~~~vW~S~ 77 (115)
T 2dpf_A 13 ADHSLQ--AGAYTLTIQNKC----NL---VKYQ--N--GRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHNNNDVWGSA 77 (115)
T ss_dssp TTEEEE--ETTEEEEECTTS----CE---EEEE--T--TEEEEECSCTTSC--SSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred CCCEEE--CCCEEEEEcCCC----cE---EEEe--C--CEEEEeCCCCCCC--CceEEEECCCCcEEEECCCceEEEEcC
Confidence 467888 899999998543 23 2364 2 6889999999883 356788999999999999899999987
Q ss_pred CCCCCCCCceeEEEccCCCeeee---cccccCCCCc
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYG---NWQSFNLPTD 154 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~---~WqSFd~Ptd 154 (763)
... ......++|+|+|||||+ .||||.+++.
T Consensus 78 ~~~--~~g~~~l~l~~dGnlvl~~~~~W~S~~~~~~ 111 (115)
T 2dpf_A 78 CWG--DNGKYALVLQKDGRFVIYGPVLWSLGPNGCR 111 (115)
T ss_dssp CCC--SSSCCEEEECTTSCEEEECSEEECSSTTCBC
T ss_pred CCC--CCCCEEEEEeCCCeEEEECCCEEECCCCCCc
Confidence 431 233567999999999998 5999998764
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=4.9e-13 Score=118.63 Aligned_cols=90 Identities=18% Similarity=0.295 Sum_probs=69.9
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.+++|+ +|.|+|+|+..++ .+| |.. .++||++|++.+ +.+..+.+..||||||.|.++.++|+++
T Consensus 12 ~g~~L~--~g~~~L~~q~dGn----Lvl---y~~----~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~~~~W~S~ 76 (109)
T 3dzw_A 12 PGEFLN--NGRYVFIMQEDCN----LVL---YDV----DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRNNPIWASN 76 (109)
T ss_dssp TTCEEE--ETTEEEEECTTSC----EEE---EET----TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTSCEEEECC
T ss_pred CCCEEE--CCCEEEEEcCCCc----EEE---EeC----CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCCCEEEECC
Confidence 467786 7999999986432 322 653 478999999876 3456788999999999999999999987
Q ss_pred CCCCCCCCceeEEEccCCCeeee---cccc
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYG---NWQS 148 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~---~WqS 148 (763)
... ......|+|+|+|||||+ +|||
T Consensus 77 t~~--~~~~~~~~L~ddGNlvly~~~~W~s 104 (109)
T 3dzw_A 77 TGG--ENGNYVCVLQKDRNVVIYGTARWAT 104 (109)
T ss_dssp CCC--SSSCEEEEECTTSCEEEEESCCCCC
T ss_pred CCC--CCCCEEEEEeCCCEEEEECCCEEeC
Confidence 432 223467999999999998 4988
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.43 E-value=3.6e-13 Score=120.19 Aligned_cols=93 Identities=17% Similarity=0.318 Sum_probs=72.2
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.+++| ++|.|+|+|+.+++ . +||++ .++||+||++.+ +.+..+.+..+|||||.| ++.+||++.
T Consensus 12 ~g~~L--~~~~~~L~~~~dgn----l---vl~~~----~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~~~~~W~S~ 75 (112)
T 1xd5_A 12 TGGSL--AEGGYLFIIQNDCN----L---VLYDN----NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-GSRAIWASN 75 (112)
T ss_dssp TTCEE--EETTEEEEECTTSC----E---EEEET----TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-TTEEEEECC
T ss_pred CCCEE--eCCCEEEEEcCCCc----E---EEEEC----CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-CCEEEEECC
Confidence 46778 58999999986542 2 35764 578999999864 345678899999999999 888999987
Q ss_pred CCCCCCCCceeEEEccCCCeeee------cccccCCC
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYG------NWQSFNLP 152 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~------~WqSFd~P 152 (763)
... ......++|+++|||||+ .||||++.
T Consensus 76 ~~~--~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 76 TNR--QNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp CCC--SCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred ccC--CCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 431 223567999999999997 39999974
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.22 E-value=6.7e-11 Score=105.42 Aligned_cols=92 Identities=15% Similarity=0.260 Sum_probs=68.4
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.++.|. +|.|.|-|...++ |.++ .... .++||.+|++.+ +.+..+.+..||||||.|.++++||+++
T Consensus 17 ~g~~L~--~g~~~L~~q~dGN------LvL~-~~~~--~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d~~~~~iW~S~ 83 (113)
T 3mez_B 17 DNAQLA--TRDYSLVMRDDCN------LVLT-KGSK--TNIVWESGTSGR--GQHCFMRLGHSGELDITDDRLNTVFVSN 83 (113)
T ss_dssp TTCEEE--ETTEEEEECTTSC------EEEE-ETTT--TEEEEECCCTTS--CSSCEEEECTTSCEEEECTTSCEEEECS
T ss_pred CCCEeE--cCCEEEEEcCCCE------EEEE-ECCC--CEEEEECCcccC--CcCEEEEEeCCCcEEEECCCCCEEEECC
Confidence 355665 4889999975432 5554 3222 678999999876 2356788999999999999999999998
Q ss_pred CCCCCCCCceeEEEccCCCeeee---cccc
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYG---NWQS 148 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~---~WqS 148 (763)
... ......|+|+|+|||||+ +|+|
T Consensus 84 t~~--~~~~~~~~L~~dGnlvly~~~~W~s 111 (113)
T 3mez_B 84 TVG--QEGDYVLILQINGQAVVYGPAVWST 111 (113)
T ss_dssp CCC--SSSCCEEEECTTSCEEEECSEEEES
T ss_pred CcC--CCCCEEEEEcCCceEEEecCCEecC
Confidence 432 223468999999999998 4876
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.20 E-value=5e-11 Score=105.61 Aligned_cols=89 Identities=16% Similarity=0.229 Sum_probs=65.7
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.++.|+| |.|.|-|...+ + |.+ |.. .+||++|++.. +.+..+.+..||||||.|.+|.++|+++
T Consensus 17 ~g~~L~s--g~~~L~~q~dG----n--Lvl-~~~-----~~vW~snt~~~--~~~~~l~l~~dGNLvl~d~~~~~iW~S~ 80 (110)
T 3r0e_B 17 GDGRLTA--KNHQLVMQGDC----N--LVL-YGG-----KYGWQSNTHGN--GEHCFLRLNHKGELIIKDDDFKTIWSSR 80 (110)
T ss_dssp TTEEEEC--SSCEEEECTTS----C--EEE-ECS-----SSCEECCCTTS--SSSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred CCCEEEe--CCEEEEEcCCC----e--EEE-ECC-----eEEEECCCcCC--CcCEEEEEeCCCcEEEEeCCCCEEEEcC
Confidence 4778887 45888765322 2 444 643 25899999863 3346788999999999999999999988
Q ss_pred CCCCCCCCceeEEEccCCCeeeec---ccc
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYGN---WQS 148 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~~---WqS 148 (763)
... ......|+|+|+|||||+. |+|
T Consensus 81 t~~--~~~~~~~~L~~dGNlvly~~~~W~t 108 (110)
T 3r0e_B 81 SSS--KQGEYVLILQDDGFGVIYGPAIFET 108 (110)
T ss_dssp CCC--SSSCCEEEECTTSCEEEECSEEEES
T ss_pred CcC--CCCCEEEEEcCCccEEEecCCEecC
Confidence 432 2234689999999999984 776
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=1.6e-10 Score=119.41 Aligned_cols=139 Identities=15% Similarity=0.050 Sum_probs=109.4
Q ss_pred ccccccccccccceEEEEEeCCCcEEEEEEeeccC-CchhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEecCCC
Q 046586 445 NGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVT-GGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
+.+...++.|+.+.||+.... ++.+++|+..... .....+.+|+++++.+. |.++.++++++.+.+..++||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 456677888888999999765 5779999987432 33456889999999984 77888999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEEC-------------------- 582 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~-------------------- 582 (763)
.+|.+.+.. ......++.+++++|+.||+..
T Consensus 95 ~~l~~~~~~-----------------------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~ 145 (263)
T 3tm0_A 95 VLCSEEYED-----------------------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL 145 (263)
T ss_dssp EEHHHHCCT-----------------------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHH
T ss_pred eehhhccCC-----------------------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHH
Confidence 998876411 0112467888999999999811
Q ss_pred ------------------------------------CCcEEecCCCCCceEEcCCCCeEEcccCccc
Q 046586 583 ------------------------------------LEWVLHCDIKPENILLGDDFCPKISDFGLAK 613 (763)
Q Consensus 583 ------------------------------------~~~ivHrDlk~~NILl~~~~~~kI~DFGla~ 613 (763)
...++|+|+++.||+++++..+.|+||+.+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999887667799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=6.4e-10 Score=114.24 Aligned_cols=128 Identities=19% Similarity=0.075 Sum_probs=93.6
Q ss_pred cccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCc--cccEEEEEeeCCeeeEEEecCCCCCHhHHh
Q 046586 452 GRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLN--LVRLWGFCAEKGERTLVYEYVPNGSLADYL 529 (763)
Q Consensus 452 G~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L 529 (763)
+.|..+.||+....+|+.+++|+.... ....+.+|+.+++.+++.+ +.+++++...++..++||||++|.+|. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 455669999998877888999997643 3356789999999986544 566889888888899999999998874 2
Q ss_pred hhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------
Q 046586 530 FRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEEC--------------------------- 582 (763)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~--------------------------- 582 (763)
.. . ....++.++++.|+.||+..
T Consensus 105 ~~---------------------------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (264)
T 1nd4_A 105 SH---------------------------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVD 154 (264)
T ss_dssp SC---------------------------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCC
T ss_pred Cc---------------------------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCcc
Confidence 10 0 01134455555555555422
Q ss_pred ----------------------------CCcEEecCCCCCceEEcCCCCeEEcccCccc
Q 046586 583 ----------------------------LEWVLHCDIKPENILLGDDFCPKISDFGLAK 613 (763)
Q Consensus 583 ----------------------------~~~ivHrDlk~~NILl~~~~~~kI~DFGla~ 613 (763)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 155 QDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887777899999885
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.02 E-value=5.6e-10 Score=98.68 Aligned_cols=93 Identities=18% Similarity=0.270 Sum_probs=68.3
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.++.| .+|.|.|.|...++ |- .|. . +|.+|+..+ ..+..+.+..||||+|.|.++.++|+++
T Consensus 14 ~g~~L--~~g~~~L~~q~dGN------Lv-l~~--~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d~~~~~vWss~ 75 (109)
T 3r0e_A 14 TEGHL--KNGDFDLVMQDDCN------LV-LYN--G-----NWQSNTANN--GRDCKLTLTDYGELVIKNGDGSTVWKSG 75 (109)
T ss_dssp TTCEE--EETTEEEEECTTSC------EE-EET--T-----TEECCCTTS--CSSCEEEECTTSCEEEECTTSCEEEECC
T ss_pred CCCEe--ECCCEEEEEecCCe------EE-EEe--C-----eEEcCCCCC--CCcEEEEEcCCCeEEEEeCCCCEEEcCC
Confidence 35566 57999999975432 22 243 1 599998865 3456789999999999999999999987
Q ss_pred CCCCCCCCceeEEEccCCCeeee---cccccCCCCccccCC
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYG---NWQSFNLPTDTILPN 159 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~---~WqSFd~Ptdtllpg 159 (763)
... ......|+|+|+|||||+ +|+| .|.+||
T Consensus 76 t~~--~~~~~~~~L~~dGNlvly~~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 76 AQS--VKGNYAAVVHPDGRLVVFGPSVFKI-----DPWVRG 109 (109)
T ss_dssp CCC--SSSCCEEEEETTTEEEEECSEEEEE-----CTTSCC
T ss_pred CcC--CCcCEEEEEcCCCeEEEEecCEECC-----CCccCC
Confidence 431 233568999999999998 4987 555554
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.92 E-value=2.6e-09 Score=94.69 Aligned_cols=91 Identities=14% Similarity=0.207 Sum_probs=65.6
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCC-eecCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNS-NLWPN 120 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~-~vwst 120 (763)
.++.| .+|.|.|.|...++ |-+ |.. .. ||.+|+..+ ..+..+.+..||||||.|.++. +||++
T Consensus 13 ~g~~L--~~g~~~L~~q~dGn------Lvl-~~~----~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~~~~~vW~S 76 (111)
T 3mez_A 13 TDNQL--SYESAAFVMQGDCN------LVL-YNE----AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSANSNTPVWVY 76 (111)
T ss_dssp TTCEE--EETTEEEEECTTSC------EEE-ECS----SC-CEECCCTTS--CSSCEEEECTTSCEEEECSSCSSCSEEE
T ss_pred CCCEE--ecCCEEEEEccCCe------EEE-ECC----CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCCCCEEEEEe
Confidence 45667 47899999975432 323 542 23 899999876 2346788999999999999876 59998
Q ss_pred CCCCCCCCCceeEEEccCCCeeee---cccc
Q 046586 121 PKTATGNPNSTRLFLQDAGNLVYG---NWQS 148 (763)
Q Consensus 121 ~~~~~~~~~~~~~~lld~GNlvl~---~WqS 148 (763)
+...........+.|+|+|||||+ .|+|
T Consensus 77 ~t~~~~~~~~~~l~Lq~dGNlvly~~~~W~s 107 (111)
T 3mez_A 77 PRSVNTVRGNYAATLGPDQHVTIYGPAIWST 107 (111)
T ss_dssp SSSCCCCSSCCEEEECTTSCEEEECSEEEEC
T ss_pred ccccCCCCcCEEEEECCCCeEEEeccCEEcc
Confidence 742222334568999999999998 4776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=5.6e-09 Score=113.04 Aligned_cols=139 Identities=17% Similarity=0.248 Sum_probs=104.8
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEee--ccC--CchhhhHHHHHHHhcCC--CCccccEEEEEeeC---CeeeEEEec
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLK--NVT--GGDAEFWAEVTIIARMH--HLNLVRLWGFCAEK---GERTLVYEY 519 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~--~~~--~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~LV~Ey 519 (763)
+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.++ +..+.++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 578999999999998765 457778765 322 22356788999999996 56688999998876 458999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEEC----------------- 582 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~----------------- 582 (763)
+++..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~--------------------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3dxp_A 123 VSGRVLWDQS--------------------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQ 176 (359)
T ss_dssp CCCBCCCCTT--------------------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHH
T ss_pred cCCeecCCCc--------------------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchH
Confidence 9987664311 123567788899999999999999731
Q ss_pred --------------------------------------CCcEEecCCCCCceEEcCCCC--eEEcccCcccc
Q 046586 583 --------------------------------------LEWVLHCDIKPENILLGDDFC--PKISDFGLAKL 614 (763)
Q Consensus 583 --------------------------------------~~~ivHrDlk~~NILl~~~~~--~kI~DFGla~~ 614 (763)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 177 RQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999999874
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=98.89 E-value=2.4e-09 Score=95.26 Aligned_cols=62 Identities=26% Similarity=0.343 Sum_probs=47.9
Q ss_pred CCCCCCCCccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee-----cccccCCCC
Q 046586 89 KFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG-----NWQSFNLPT 153 (763)
Q Consensus 89 ~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~-----~WqSFd~Pt 153 (763)
+.|+.+....|.+..||||+|.+. +++||+++... ......|+|+|+|||||+ +||||+.|.
T Consensus 13 g~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~--~~~~~~l~l~~~GNLvl~d~~~~~W~S~~~~~ 79 (112)
T 1xd5_A 13 GGSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNG--KASGCVLKMQNDGNLVIYSGSRAIWASNTNRQ 79 (112)
T ss_dssp TCEEEETTEEEEECTTSCEEEEET-TEEEEECCCTT--SCSSEEEEECTTSCEEEEETTEEEEECCCCCS
T ss_pred CCEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcC--CCCCEEEEEeCCCCEEEEcCCEEEEECCccCC
Confidence 345544557788999999999987 78999998432 223568999999999997 499997653
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=5.3e-09 Score=92.59 Aligned_cols=55 Identities=24% Similarity=0.314 Sum_probs=43.8
Q ss_pred CCccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee------cccccCCC
Q 046586 95 NGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------NWQSFNLP 152 (763)
Q Consensus 95 ~~~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------~WqSFd~P 152 (763)
....|.+..||||+|.+ .+++||+++.... .....++|+|+|||||+ +||||..|
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~~~~~W~S~t~~ 80 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQSNRVIWQTKTNG 80 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEEECCCCC
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECCCCcEEEecCCCC
Confidence 34678888999999998 5789999985322 23568999999999998 49999654
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=1.5e-08 Score=90.45 Aligned_cols=55 Identities=20% Similarity=0.250 Sum_probs=43.5
Q ss_pred CccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee------cccccCCCC
Q 046586 96 GSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------NWQSFNLPT 153 (763)
Q Consensus 96 ~~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------~WqSFd~Pt 153 (763)
...|.+..||||+|.+ .+++||+++...+ .....++|+|+|||||+ +|||||+|.
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~~ 81 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHNNNDVWGSACWGD 81 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTTCCEEEECCCCCS
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCCceEEEEcCCCCC
Confidence 3567788899999998 5789999984322 23468999999999997 499999853
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=98.73 E-value=2.3e-08 Score=89.71 Aligned_cols=53 Identities=30% Similarity=0.326 Sum_probs=42.5
Q ss_pred ccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee------cccccCCC
Q 046586 97 SLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------NWQSFNLP 152 (763)
Q Consensus 97 ~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------~WqSFd~P 152 (763)
..|.+..||||+|.+. +++||+++.... .....++|+|+|||||+ +||||..|
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~d~~~~~lW~S~~~~ 90 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAG 90 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEEECSCCC
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccC--CCceEEEEccCCEEEEEeCCCcEEEcCCCCC
Confidence 4577888999999987 889999985322 23468999999999998 49999655
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=3.3e-08 Score=102.28 Aligned_cols=97 Identities=21% Similarity=0.310 Sum_probs=67.6
Q ss_pred CCceEecCCCeEEEeeecCCC-CCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPN-SRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPN 120 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~-~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst 120 (763)
.++.|+|+ ..++.|+|...- ....++ + |.+ ..+++|.+++..+ +. ..+.+..+|+|++.|.++.++|++
T Consensus 151 ~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~---~~~~yW~Sgt~~~--~~-~~l~l~~dGnLvl~d~~~~~vWsS 220 (276)
T 3m7h_A 151 PGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGP---NGAATWNAGTQGK--GA-VRAVFQGDGNLVVYGAGNAVLWHS 220 (276)
T ss_dssp SSEEECTT-CEEEETTEEEEECTTSCEE--E-ECT---TSSEEEECCCTTT--TC-CEEEECTTSCEEEECTTSCEEEEC
T ss_pred cCcccccC-CCCCCceEEEeecCCceEE--E-EeC---CCeEEEECCCCCC--cc-EEEEEcCCCeEEEEeCCCcEEEEe
Confidence 35566554 455555554311 111233 3 432 1467899999876 22 678889999999999988999998
Q ss_pred CCCCCCCCCceeEEEccCCCeeee----cccccCC
Q 046586 121 PKTATGNPNSTRLFLQDAGNLVYG----NWQSFNL 151 (763)
Q Consensus 121 ~~~~~~~~~~~~~~lld~GNlvl~----~WqSFd~ 151 (763)
+.. ......|+|+++||||++ +||||||
T Consensus 221 ~t~---~~~~~rl~Ld~dGnLvly~~~~~Wqsf~~ 252 (276)
T 3m7h_A 221 HTG---GHASAVLRLQANGSIAILDEKPVWARFGF 252 (276)
T ss_dssp SCT---TCTTCEEEECTTSCEEEEEEEEEEESSSC
T ss_pred cCC---CCCCEEEEEcCCccEEEEcCCCeEEccCc
Confidence 843 223578999999999998 4999997
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.65 E-value=1.1e-08 Score=108.00 Aligned_cols=183 Identities=19% Similarity=0.219 Sum_probs=115.6
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcC-CCCc--cccEEEEEeeCC---eeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLN--LVRLWGFCAEKG---ERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l-~H~n--iv~l~g~~~~~~---~~~LV~Ey~~~ 522 (763)
+.++.|....||+.. ..+++|+.... .....+.+|+++++.+ ++.. +.+.+......+ ..++|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458899999999853 45888876432 2345688999999887 3333 445555543333 35789999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE--------------------- 581 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~--------------------- 581 (763)
.+|...... .++..++..++.++++.|+.||+.
T Consensus 101 ~~l~~~~~~--------------------------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~ 154 (304)
T 3sg8_A 101 VPLTPLLLN--------------------------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDN 154 (304)
T ss_dssp EECCHHHHH--------------------------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHH
T ss_pred eECCccccc--------------------------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHH
Confidence 887653321 234455556666666666666641
Q ss_pred ----------------------------------CCCcEEecCCCCCceEEcC--CCCeEEcccCcccccCCCCcccccc
Q 046586 582 ----------------------------------CLEWVLHCDIKPENILLGD--DFCPKISDFGLAKLRKKEDMVSMSR 625 (763)
Q Consensus 582 ----------------------------------~~~~ivHrDlk~~NILl~~--~~~~kI~DFGla~~~~~~~~~~~~~ 625 (763)
....++|+|+++.||++++ +..+.|+||+.+........ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D--l~~ 232 (304)
T 3sg8_A 155 KKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND--FIS 232 (304)
T ss_dssp HHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH--HHT
T ss_pred HHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH--HHH
Confidence 1235899999999999998 56688999999875322111 000
Q ss_pred cccCCCc---ccccccc-----cCCC---------CCccceeehhHHHHHHHhCCCCcc
Q 046586 626 IRGTRGY---MAPEWLR-----SDQI---------TPKADVYSFGMVLLEIVSGSRNFE 667 (763)
Q Consensus 626 ~~gt~~y---~APE~l~-----~~~~---------s~ksDVwS~Gvll~elltG~~p~~ 667 (763)
.... ..|+... .+.. ....+.|+++.++|++.+|..++.
T Consensus 233 ---~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 233 ---LMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp ---TCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred ---HHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0001 1222111 0111 112578999999999999987763
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.64 E-value=4e-08 Score=87.30 Aligned_cols=59 Identities=15% Similarity=0.206 Sum_probs=45.7
Q ss_pred CCCCCCCCCccEEEccCCcEEEecC-CCCeecCCCCCCCCCCCceeEEEccCCCeeeec------ccc
Q 046586 88 DKFPVAGNGSLAIAATTGQLRLLNS-SNSNLWPNPKTATGNPNSTRLFLQDAGNLVYGN------WQS 148 (763)
Q Consensus 88 r~~p~~~~~~~~~~~~~g~L~l~~~-~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~~------WqS 148 (763)
.++|+.+....|.+..||||||.+. .+++||+++... ......++|+|+|||||++ |||
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~--~~~~~~l~l~~dGNLVl~d~~~~~iW~S 82 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVS 82 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTT--SCSSCEEEECTTSCEEEECTTSCEEEEC
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCccc--CCcCEEEEEeCCCcEEEECCCCCEEEEC
Confidence 4566665567889999999999998 488999998432 1234689999999999973 776
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.45 E-value=3.8e-07 Score=80.67 Aligned_cols=57 Identities=14% Similarity=0.126 Sum_probs=42.8
Q ss_pred CCCCCCCCccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee-------ccccc
Q 046586 89 KFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG-------NWQSF 149 (763)
Q Consensus 89 ~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~-------~WqSF 149 (763)
+.++++....|.+..||||||.+.++ +|+++... ......++|+|+|||||+ +|||.
T Consensus 14 g~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~--~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~ 77 (111)
T 3mez_A 14 DNQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYP 77 (111)
T ss_dssp TCEEEETTEEEEECTTSCEEEECSSC--CEECCCTT--SCSSCEEEECTTSCEEEECSSCSSCSEEES
T ss_pred CCEEecCCEEEEEccCCeEEEECCCC--EEECCccc--CCcCEEEEEcCCCcEEEEeCCCCEEEEEec
Confidence 44455445678899999999998877 99988432 123468999999999997 37775
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.3e-06 Score=76.89 Aligned_cols=51 Identities=24% Similarity=0.337 Sum_probs=39.9
Q ss_pred CccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee------ccccc
Q 046586 96 GSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------NWQSF 149 (763)
Q Consensus 96 ~~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------~WqSF 149 (763)
...|.+..||||+|.+. +++||+++.... .....++|+|+|||||+ +|||.
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~~~~~W~S~ 76 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPRNNPIWASN 76 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTS--SSSCEEEECTTSCEEEECTTSCEEEECC
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccC--CCCEEEEEeCCCCEEEECCCCCEEEECC
Confidence 35688889999999987 789999984321 23468899999999997 38874
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.30 E-value=1.4e-06 Score=76.91 Aligned_cols=50 Identities=20% Similarity=0.273 Sum_probs=38.7
Q ss_pred CccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee------ccccc
Q 046586 96 GSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------NWQSF 149 (763)
Q Consensus 96 ~~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------~WqSF 149 (763)
...|.+..||||+|.+. +++|+++... ......++|+|+|||||+ +|||-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~--~~~~~~l~l~~dGNLvl~d~~~~~iW~S~ 80 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHG--NGEHCFLRLNHKGELIIKDDDFKTIWSSR 80 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTT--SSSSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcC--CCcCEEEEEeCCCcEEEEeCCCCEEEEcC
Confidence 46678889999999876 5899988432 223468999999999997 38874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=9.8e-06 Score=83.46 Aligned_cols=78 Identities=14% Similarity=0.104 Sum_probs=58.8
Q ss_pred cccccccc-eEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 450 LIGRGGFG-DVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 450 ~LG~G~fG-~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
.+..|..| .||+.... ++..+++|+-... ...++.+|...|+.+. +-.+.++++++.+.+..++|||++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 45556665 68987765 4567888886532 3456788999998884 445788999999999999999999998877
Q ss_pred HHh
Q 046586 527 DYL 529 (763)
Q Consensus 527 ~~L 529 (763)
+..
T Consensus 109 ~~~ 111 (272)
T 4gkh_A 109 QVL 111 (272)
T ss_dssp HHH
T ss_pred ccc
Confidence 654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.3e-05 Score=84.53 Aligned_cols=75 Identities=15% Similarity=0.114 Sum_probs=54.0
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCC---ccccEEEEEe-eCCeeeEEEecCCCCC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHL---NLVRLWGFCA-EKGERTLVYEYVPNGS 524 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~LV~Ey~~~gs 524 (763)
+.++.|....||+. +..+++|+-.. ......+.+|+++|+.+.+. .+.+.+.+.. ..+..++||||++|..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788888899987 45578887532 12345688999999999642 3566777764 3456789999999988
Q ss_pred HhHH
Q 046586 525 LADY 528 (763)
Q Consensus 525 L~~~ 528 (763)
|.+.
T Consensus 100 l~~~ 103 (306)
T 3tdw_A 100 LGED 103 (306)
T ss_dssp CHHH
T ss_pred Cchh
Confidence 8763
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.03 E-value=9.9e-06 Score=71.21 Aligned_cols=51 Identities=22% Similarity=0.252 Sum_probs=38.5
Q ss_pred CCCCCCCCCccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee
Q 046586 88 DKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG 144 (763)
Q Consensus 88 r~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~ 144 (763)
.+.|+++....|.+..||||||.++ +|+++... ......++|+++|||||+
T Consensus 14 ~g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~--~~~~~~l~l~~dGnLvl~ 64 (109)
T 3r0e_A 14 TEGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTAN--NGRDCKLTLTDYGELVIK 64 (109)
T ss_dssp TTCEEEETTEEEEECTTSCEEEETT----TEECCCTT--SCSSCEEEECTTSCEEEE
T ss_pred CCCEeECCCEEEEEecCCeEEEEeC----eEEcCCCC--CCCcEEEEEcCCCeEEEE
Confidence 4455554556788899999999984 89998432 123567899999999997
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=1.6e-05 Score=85.42 Aligned_cols=79 Identities=9% Similarity=0.029 Sum_probs=57.1
Q ss_pred ccc-cccccceEEEEEeC-------CCcEEEEEEeeccC---C-chhhhHHHHHHHhcCC-C--CccccEEEEEeeC---
Q 046586 449 NLI-GRGGFGDVYKGELT-------DHRVVAVKCLKNVT---G-GDAEFWAEVTIIARMH-H--LNLVRLWGFCAEK--- 510 (763)
Q Consensus 449 ~~L-G~G~fG~Vy~g~~~-------~~~~VAvK~l~~~~---~-~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~--- 510 (763)
+.| +.|....+|+.... +++.+++|+..... . ....+.+|+.+++.+. + ..+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 467 78888999998764 25678888765422 1 2356788999998884 3 3577888887665
Q ss_pred CeeeEEEecCCCCCHhH
Q 046586 511 GERTLVYEYVPNGSLAD 527 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~ 527 (763)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=97.90 E-value=2.5e-05 Score=68.09 Aligned_cols=47 Identities=19% Similarity=0.267 Sum_probs=36.0
Q ss_pred ccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeeec
Q 046586 97 SLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYGN 145 (763)
Q Consensus 97 ~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~~ 145 (763)
-.|.+..||||||.+ .+++||+++...+ ......+.|.++|||||++
T Consensus 21 y~l~~q~DgNLvly~-~~~~vW~ant~~~-~~~~~~L~l~~dGnLvL~d 67 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYD-HSTSTWASNTEIG-GKSGCSAVLQSDGNFVVYD 67 (105)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCT-TCCSCEEEECTTSCEEEEC
T ss_pred EEEEECCCCeEEEEE-CCEEEEEecCCCC-CCccEEEEEeCCccEEEEC
Confidence 457788999999987 4678999984322 2334578999999999973
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00021 Score=77.98 Aligned_cols=73 Identities=15% Similarity=0.077 Sum_probs=49.1
Q ss_pred ccccccccceEEEEEeC-CCcEEEEEEeeccC--------CchhhhHHHHHHHhcCCC--Cc-cccEEEEEeeCCeeeEE
Q 046586 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--------GGDAEFWAEVTIIARMHH--LN-LVRLWGFCAEKGERTLV 516 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--------~~~~~f~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~LV 516 (763)
+.||.|.++.||++... +++.++||...... .....+..|.++++.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57899999999999764 46789999865321 123456789998887732 33 4455544 34567899
Q ss_pred EecCCCC
Q 046586 517 YEYVPNG 523 (763)
Q Consensus 517 ~Ey~~~g 523 (763)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00024 Score=75.39 Aligned_cols=72 Identities=11% Similarity=0.180 Sum_probs=42.5
Q ss_pred cccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCC--CccccEEE------EEeeCCeeeEEEecCC
Q 046586 450 LIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHH--LNLVRLWG------FCAEKGERTLVYEYVP 521 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g------~~~~~~~~~LV~Ey~~ 521 (763)
.|+.|..+.||+....+++ +++|+.... ..++..|+.+++.|.. -.+.+++. +....+..++||||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~~-~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGA-VCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTEE-EEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCCC-EEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 4666778999999876655 888888642 2344456666655531 12333332 1234567889999999
Q ss_pred CCCH
Q 046586 522 NGSL 525 (763)
Q Consensus 522 ~gsL 525 (763)
|..+
T Consensus 115 G~~~ 118 (346)
T 2q83_A 115 GRPF 118 (346)
T ss_dssp CBCC
T ss_pred CccC
Confidence 8655
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00054 Score=72.05 Aligned_cols=74 Identities=18% Similarity=0.211 Sum_probs=59.4
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCC---CCccccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH---HLNLVRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
+.|+.|....+|+.... +..+++|+.... ....+..|++.|+.|. ...+.+.++++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 46899999999998864 566888887642 3456888999988883 36788899998888899999999998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00057 Score=70.97 Aligned_cols=73 Identities=25% Similarity=0.241 Sum_probs=54.0
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCC-chhhhHHHHHHHhcCC-C--CccccEEEEEeeCCeeeEEEecCCCCC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTG-GDAEFWAEVTIIARMH-H--LNLVRLWGFCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~LV~Ey~~~gs 524 (763)
+.+|.|..+.||+.++.||+.+++|+...... ....|..|+..|+.|. . --+.+.+++. ..++||||++.+.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 57899999999999999999999998764332 2345788999988884 2 2345555542 3478999998765
Q ss_pred H
Q 046586 525 L 525 (763)
Q Consensus 525 L 525 (763)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00036 Score=70.37 Aligned_cols=72 Identities=25% Similarity=0.367 Sum_probs=52.8
Q ss_pred ccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee------cccccCCCCccccCCCccCCCCCCCC
Q 046586 97 SLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------NWQSFNLPTDTILPNQTLNGPPLVSK 170 (763)
Q Consensus 97 ~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------~WqSFd~Ptdtllpg~~l~~~~l~s~ 170 (763)
-.+.++.+|+|+|.+.+ .++|+++... ......++|+++||||++ .||||.+..
T Consensus 152 ~~l~l~~dG~LvL~~~~-~~~W~s~~~~--~~~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~----------------- 211 (236)
T 1dlp_A 152 YRLSMETDCNLVLFDRD-DRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRS----------------- 211 (236)
T ss_dssp CEEEEETTTEEEEEBTT-BCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEEECCCCCS-----------------
T ss_pred EEEEECCCCcEEEEcCC-EeEEeCCCcC--CCCceEEEECCCCcEEEEeCCCcEEEEeCCCCC-----------------
Confidence 46788899999999765 6899987421 123457889999999997 499985320
Q ss_pred CCceeeecCceeeeeecCeeEEEEecCCceEEEE
Q 046586 171 NGKFSFLNASELVFVSANRSYWNIDDDGNLRIYS 204 (763)
Q Consensus 171 ~g~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~ 204 (763)
.| ..+++||+||++++|.
T Consensus 212 ~~----------------~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 212 AG----------------RYVFVLQPDRNLAIYG 229 (236)
T ss_dssp SS----------------CCEEEECSSSCEEEEC
T ss_pred CC----------------CEEEEEcCCCcEEEeC
Confidence 01 2356899999999994
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.002 Score=70.71 Aligned_cols=78 Identities=8% Similarity=0.016 Sum_probs=47.5
Q ss_pred CCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccc--cCCCcccccccccCC---CCCccceeehhHHHH
Q 046586 583 LEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIR--GTRGYMAPEWLRSDQ---ITPKADVYSFGMVLL 657 (763)
Q Consensus 583 ~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~--gt~~y~APE~l~~~~---~s~ksDVwS~Gvll~ 657 (763)
...++|+|+++.||+++.++ ++|+||+.+........ ..... -...|.+|+...... -....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 35599999999999998876 99999999875432111 11100 112356666543111 111244557777888
Q ss_pred HHHhCC
Q 046586 658 EIVSGS 663 (763)
Q Consensus 658 elltG~ 663 (763)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00062 Score=73.58 Aligned_cols=161 Identities=17% Similarity=0.195 Sum_probs=84.0
Q ss_pred ccccccccceEEEEEeCC--------CcEEEEEEeeccCCchhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEec
Q 046586 449 NLIGRGGFGDVYKGELTD--------HRVVAVKCLKNVTGGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~--------~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
+.|..|-...+|+....+ ++.+++|+..........+.+|..+++.|. +.-..++++++.+ -+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 356667778899988752 467889886443334556678999988884 3223567776643 289999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHH-------------------HHHHHH--
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVA-------------------RAIAYL-- 578 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia-------------------~gL~yL-- 578 (763)
++|..|..--................+.............-|.+..++..++. +.+..|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 99866542110000000000001111111111111111112344444443332 123333
Q ss_pred --Hhc-CCCcEEecCCCCCceEEcCC----CCeEEcccCccc
Q 046586 579 --HEE-CLEWVLHCDIKPENILLGDD----FCPKISDFGLAK 613 (763)
Q Consensus 579 --H~~-~~~~ivHrDlk~~NILl~~~----~~~kI~DFGla~ 613 (763)
... ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 22358999999999999876 789999999885
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.002 Score=67.23 Aligned_cols=72 Identities=8% Similarity=-0.016 Sum_probs=45.7
Q ss_pred cccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCcc-ccEEEEEeeCCeeeEEEecC-CCCCH
Q 046586 448 SNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL-VRLWGFCAEKGERTLVYEYV-PNGSL 525 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~-~~gsL 525 (763)
.+.|+.|....+|+. +.+++|+............+|+.+++.+...++ .+++++. .+..++|+||+ ++..|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 356888999999998 458888876432222234578888877743333 4565543 44467899999 66555
Q ss_pred h
Q 046586 526 A 526 (763)
Q Consensus 526 ~ 526 (763)
.
T Consensus 96 ~ 96 (301)
T 3dxq_A 96 S 96 (301)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0025 Score=70.71 Aligned_cols=73 Identities=14% Similarity=0.081 Sum_probs=48.3
Q ss_pred ccccccccceEEEEEeCC-CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCcc-ccEEEEEeeCCeeeEEEecCCCCCH
Q 046586 449 NLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL-VRLWGFCAEKGERTLVYEYVPNGSL 525 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~Ey~~~gsL 525 (763)
+.|+.|-...+|+....+ ++.+++|+.........+..+|..+++.|...++ .++++++. + .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 467888889999998876 4678888875332222223589999998865444 56777763 2 259999987555
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0032 Score=66.69 Aligned_cols=77 Identities=4% Similarity=-0.012 Sum_probs=42.7
Q ss_pred cccccccce-EEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCC--CccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 450 LIGRGGFGD-VYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHH--LNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 450 ~LG~G~fG~-Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
.|+.|.... +|+....+++.+++|...... ..++..|+.+++.+.. -.+.+++.+..+. .++|||++.+..+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcchH
Confidence 455554443 667765445667777544321 1345677777777742 2356677764333 37899999887777
Q ss_pred HHhh
Q 046586 527 DYLF 530 (763)
Q Consensus 527 ~~L~ 530 (763)
+++.
T Consensus 101 ~~l~ 104 (333)
T 3csv_A 101 EVIN 104 (333)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 6654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.003 Score=66.55 Aligned_cols=75 Identities=15% Similarity=0.086 Sum_probs=50.0
Q ss_pred cccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCC--ccccEEEE-----EeeCCeeeEEEecCCC
Q 046586 450 LIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHL--NLVRLWGF-----CAEKGERTLVYEYVPN 522 (763)
Q Consensus 450 ~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~LV~Ey~~~ 522 (763)
.|+ |....||+....+|+.+++|+.........++..|+.++..+... .+++.+.. ....+..++||++++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 455 777899998777777799999874433455677788888777422 23444432 1224566789999987
Q ss_pred CCH
Q 046586 523 GSL 525 (763)
Q Consensus 523 gsL 525 (763)
..+
T Consensus 112 ~~~ 114 (328)
T 1zyl_A 112 RQF 114 (328)
T ss_dssp EEC
T ss_pred CCC
Confidence 543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0018 Score=71.43 Aligned_cols=72 Identities=21% Similarity=0.312 Sum_probs=50.2
Q ss_pred ccccccccceEEEEEeCC--------CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCcc-ccEEEEEeeCCeeeEEEec
Q 046586 449 NLIGRGGFGDVYKGELTD--------HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL-VRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~--------~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~Ey 519 (763)
+.|+.|....+|+....+ ++.+++|+.... .....+..|+.+++.+...++ .++++.+.+ .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 467788889999998763 467889988432 111566789999888853344 667776542 289999
Q ss_pred CCCCCH
Q 046586 520 VPNGSL 525 (763)
Q Consensus 520 ~~~gsL 525 (763)
+++..|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0046 Score=64.97 Aligned_cols=150 Identities=12% Similarity=0.103 Sum_probs=80.5
Q ss_pred ccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCc--cccEEEE------EeeCCeeeEEEecC
Q 046586 449 NLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLN--LVRLWGF------CAEKGERTLVYEYV 520 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~LV~Ey~ 520 (763)
+.|+.|....+|+....++ .+++|+.... ....++..|+.++..+...+ +.+++.. ....+..++|++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3567788889999988766 4778887642 12345667888877774222 2333321 12245678999999
Q ss_pred CCCCHhH--------------HhhhcCC-CCCCChhhhhcccCCCCCCCCCCCCCHHHHHH------------HHHHHHH
Q 046586 521 PNGSLAD--------------YLFRSGR-VGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR------------IALGVAR 573 (763)
Q Consensus 521 ~~gsL~~--------------~L~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~------------ia~qia~ 573 (763)
+|..+.. .++.... ..... ........|...+. +...+.+
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~-------------~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~ 172 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKR-------------PNALSVDGWKVLWDKSEERADEVEKGLREEIRP 172 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCC-------------BCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcc-------------cCccChHHHHHHHHHHHHHHHhhhhhhHHHHHH
Confidence 9865421 0111100 00000 00000112322110 0112444
Q ss_pred HHHHHHhc----CCCcEEecCCCCCceEEcCCCCeEEcccCccc
Q 046586 574 AIAYLHEE----CLEWVLHCDIKPENILLGDDFCPKISDFGLAK 613 (763)
Q Consensus 574 gL~yLH~~----~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~ 613 (763)
.++.++.. ....++|+|+++.||+++++..+.|+||+.+.
T Consensus 173 ~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 173 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 55566532 12458999999999999987666899999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0042 Score=66.82 Aligned_cols=73 Identities=12% Similarity=0.094 Sum_probs=44.9
Q ss_pred ccccccccceEEEEEeCC---------CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCc-cccEEEEEeeCCeeeEEEe
Q 046586 449 NLIGRGGFGDVYKGELTD---------HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLN-LVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~---------~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~LV~E 518 (763)
+.|+.|..-.+|+....+ ++.+++|+.........+...|.++++.+...+ ..++++.. . -.+|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 357778888999988764 257888887543222223467888888885334 34666554 2 368999
Q ss_pred cCCCCCH
Q 046586 519 YVPNGSL 525 (763)
Q Consensus 519 y~~~gsL 525 (763)
|+++..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.81 E-value=0.03 Score=59.40 Aligned_cols=68 Identities=12% Similarity=0.093 Sum_probs=43.5
Q ss_pred cccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCC---CccccEEEE------EeeCCeeeEEEecCCC
Q 046586 452 GRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHH---LNLVRLWGF------CAEKGERTLVYEYVPN 522 (763)
Q Consensus 452 G~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~------~~~~~~~~LV~Ey~~~ 522 (763)
|.|....||+....++ .+++|+...... ..|+.++..|.. |.+++.+.. ....+..++||+|++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 3344679999988777 788998765431 356666665521 224444432 2335677899999998
Q ss_pred CCH
Q 046586 523 GSL 525 (763)
Q Consensus 523 gsL 525 (763)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 766
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.42 E-value=0.033 Score=60.83 Aligned_cols=73 Identities=11% Similarity=0.138 Sum_probs=48.0
Q ss_pred ccccccccceEEEEEeCC--------CcEEEEEEeeccCCchhhhHHHHHHHhcCCCCc-cccEEEEEeeCCeeeEEEec
Q 046586 449 NLIGRGGFGDVYKGELTD--------HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLN-LVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~--------~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~LV~Ey 519 (763)
+.|..|-...+|+....+ ++.+++|+.........+..+|..+++.+...+ ..++++.+. -.+||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 456677788999988763 577888886543222223467888888884333 355665432 3789999
Q ss_pred CCCCCH
Q 046586 520 VPNGSL 525 (763)
Q Consensus 520 ~~~gsL 525 (763)
++|..|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.88 E-value=0.18 Score=49.29 Aligned_cols=91 Identities=9% Similarity=0.039 Sum_probs=58.5
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccc
Q 046586 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAP 635 (763)
Q Consensus 556 ~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~AP 635 (763)
..+++..+++.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.+...+ ..+. .....+.||
T Consensus 43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~~~~~~p 106 (229)
T 2yle_A 43 NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-------------AGEPPPVAG 106 (229)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------------------
T ss_pred CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-------------ccccCCCCh
Confidence 45899999999999999998776221111 1333456899999999998764 2111 112235688
Q ss_pred cccccCCCCCccceeehhHHHHHHHhCC
Q 046586 636 EWLRSDQITPKADVYSFGMVLLEIVSGS 663 (763)
Q Consensus 636 E~l~~~~~s~ksDVwS~Gvll~elltG~ 663 (763)
|... ...+.+.-|||+|+++|.-+--.
T Consensus 107 e~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 107 KLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred hhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 8663 45567888999999999988633
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=91.01 E-value=0.26 Score=39.99 Aligned_cols=38 Identities=21% Similarity=0.476 Sum_probs=31.6
Q ss_pred ccccchHHHHHHccCCCceeeEEEeeCCccceEEeeecc
Q 046586 292 LEADNFSACKANCSANPKCVAFGFKYDGKRYCVLVDQLL 330 (763)
Q Consensus 292 ~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~C~~~~~l~ 330 (763)
...+++++|+..|+.+=.|+||.|. .....|++++...
T Consensus 27 ~~~~sl~~Cq~aC~a~~~C~aFTyN-~~s~~CflKs~~~ 64 (82)
T 2ll3_A 27 KRASSLSECRARCQAEKECSHYTYN-VKSGLCYPKRGKP 64 (82)
T ss_dssp EECSSHHHHHHHHHHCTTEEEEEEE-TTTTEEEEEESSC
T ss_pred ccCCCHHHHHHHhhccCCCCeEEec-cCCCceEcccCCC
Confidence 3456899999999999999999997 5667899887643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.09 E-value=2.9 Score=45.00 Aligned_cols=29 Identities=28% Similarity=0.346 Sum_probs=24.8
Q ss_pred EEecCCCCCceEE------cCCCCeEEcccCcccc
Q 046586 586 VLHCDIKPENILL------GDDFCPKISDFGLAKL 614 (763)
Q Consensus 586 ivHrDlk~~NILl------~~~~~~kI~DFGla~~ 614 (763)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998863
|
| >3hms_A Hepatocyte growth factor; HGF/SF, hormone/growth factor, disulfide bond, glycoprotein, kringle, pyrrolidone carboxylic acid, serine protea homolog; 1.70A {Homo sapiens} SCOP: g.10.1.1 PDB: 3hmt_A 2hgf_A 3hmr_A | Back alignment and structure |
|---|
Probab=84.73 E-value=0.89 Score=38.39 Aligned_cols=54 Identities=17% Similarity=0.388 Sum_probs=39.2
Q ss_pred ceeeEeeeeeccCCcc----ccccccchHHHHHHccCC----CceeeEEEeeCCccceEEeee
Q 046586 274 TKFLQLDYVNFSRGNL----SDLEADNFSACKANCSAN----PKCVAFGFKYDGKRYCVLVDQ 328 (763)
Q Consensus 274 ~~f~~~~~~~~~~~~~----~~~~~~~~~~C~~~Cl~n----CsC~a~~~~~~~~~~C~~~~~ 328 (763)
++|.+..++.+...+. ......+.++|.+.|.++ =.|.||.|. ..+..|.|...
T Consensus 15 ~~y~kTeg~~L~~~~~~~~~~~~~~~s~eeCA~kC~~~~~~~F~CRAF~y~-~k~q~C~ll~~ 76 (101)
T 3hms_A 15 HEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFD-KARKQCLWFPF 76 (101)
T ss_dssp GGEEEEEEEEEEECCTTCCCEEEECSCHHHHHHHHHHCTTCSSCCCEEEEE-TTTTEEEEESC
T ss_pred HHhhhcCCeEEeccCCCccceeeccCCHHHHHHHHHhccCCCcceeeeEEe-cCCCcEEECCC
Confidence 5688888888864322 123345899999999995 689999997 44558997554
|
| >4a5v_A MIC4, micronemal protein 4; adhesion; NMR {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=80.41 E-value=1.5 Score=40.68 Aligned_cols=51 Identities=18% Similarity=0.413 Sum_probs=39.8
Q ss_pred EeeeeeccCCcc-ccccccchHHHHHHccCCCceeeEEEeeCCccceEEeeec
Q 046586 278 QLDYVNFSRGNL-SDLEADNFSACKANCSANPKCVAFGFKYDGKRYCVLVDQL 329 (763)
Q Consensus 278 ~~~~~~~~~~~~-~~~~~~~~~~C~~~Cl~nCsC~a~~~~~~~~~~C~~~~~l 329 (763)
..+|+.+-.+++ ......+.++|+..|..+=.|.+|.|. .....|+++...
T Consensus 13 ~~~n~~~~g~~i~~~~~~~s~~~Cq~~C~~~p~C~~fTf~-~~~~~C~LK~s~ 64 (161)
T 4a5v_A 13 HSDNKGSRAPTIGEPVPDVSLEQCAAQCKAVDGCTHFTYN-DDSKMCHVKEGK 64 (161)
T ss_dssp CCSSEEECSCBCSCCBTTCCHHHHHHHHHHSTTCSEEEEE-TTTCCEEEECSS
T ss_pred cCCCccccCCCeeeeecCCCHHHHHHHCcCCCCCcEEEEE-CCCCEEEEeCCC
Confidence 456677766666 445556899999999999999999998 456789988753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 763 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-37 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 4e-09 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 0.003 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 5e-05 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 0.003 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 8e-05 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 9e-66
Identities = 76/305 (24%), Positives = 128/305 (41%), Gaps = 49/305 (16%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+G G FG+V+ G H VAVK LK + F AE ++ ++ H LVRL+
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ ++ EY+ NGSL D+L L +
Sbjct: 77 V-TQEPIYIITEYMENGSLVDFL----------------------KTPSGIKLTINKLLD 113
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+A +A +A++ E +H D++ NIL+ D KI+DFGLA+L + + +
Sbjct: 114 MAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686
+ + APE + T K+DV+SFG++L EIV+ R
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-------------------- 210
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746
Y M +++ ++++ Y + + + C ++RPE RP+ + +LE
Sbjct: 211 --YPGMTNPEVI-QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
Query: 747 VEITE 751
TE
Sbjct: 268 FTATE 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 3e-64
Identities = 71/312 (22%), Positives = 115/312 (36%), Gaps = 47/312 (15%)
Query: 451 IGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK 510
IG+G FG+V++G+ VAVK + AE+ + H N++ +
Sbjct: 11 IGKGRFGEVWRGKWRG-EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 511 GERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
LV +Y +GSL DYL R + +
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYT-------------------------VTVEGMIK 104
Query: 567 IALGVARAIAYLHEECLEW-----VLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM- 620
+AL A +A+LH E + + H D+K +NIL+ + I+D GLA
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 621 --VSMSRIRGTRGYMAPEWLRSD------QITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672
++ + GT+ YMAPE L + +AD+Y+ G+V EI I
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPEL 732
P + ++ E L +I N + S + + M K C
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC---EALRVMAKIMRECWYANGAA 281
Query: 733 RPSMGKVAKMLE 744
R + ++ K L
Sbjct: 282 RLTALRIKKTLS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (546), Expect = 3e-64
Identities = 74/311 (23%), Positives = 126/311 (40%), Gaps = 35/311 (11%)
Query: 447 FSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTGGD--AEFWAEVTIIARMHHL 498
+ IG G FG V++ +VAVK LK D A+F E ++A +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
N+V+L G CA L++EY+ G L ++L S + + G P
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKK 617
L + + IA VA +AYL E +H D+ N L+G++ KI+DFGL++ +
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
+ + +M PE + ++ T ++DV+++G+VL EI S
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP----------- 242
Query: 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737
Y M E+++ + + + + C P RPS
Sbjct: 243 -----------YYGMAHEEVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRPSFC 290
Query: 738 KVAKMLEGTVE 748
+ ++L+ E
Sbjct: 291 SIHRILQRMCE 301
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 1e-63
Identities = 69/305 (22%), Positives = 125/305 (40%), Gaps = 55/305 (18%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGD---AEFWAEVTIIARMHHLNLVRL 503
IG G FG VYKG+ H VAVK L F EV ++ + H+N++
Sbjct: 12 VGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
G+ + +V ++ SL +L + +
Sbjct: 70 MGYS-TAPQLAIVTQWCEGSSLYHHLHII-----------------------ETKFEMIK 105
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VS 622
IA A+ + YLH + ++H D+K NI L +D KI DFGLA ++ +
Sbjct: 106 LIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
Query: 623 MSRIRGTRGYMAPEWLR---SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679
++ G+ +MAPE +R + + ++DVY+FG+VL E+++G + +N+ +
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQI 218
Query: 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739
++ R + S+V + M + C++ + + RP ++
Sbjct: 219 I---------------FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI 263
Query: 740 AKMLE 744
+E
Sbjct: 264 LASIE 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 9e-62
Identities = 67/302 (22%), Positives = 122/302 (40%), Gaps = 49/302 (16%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
F IG G FG V+ G + VA+K ++ + +F E ++ ++ H LV+L+G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
C E+ LV+E++ +G L+DYL + +
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLRTQ-----------------------RGLFAAETLLG 105
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+ L V +AYL E C V+H D+ N L+G++ K+SDFG+ + + S +
Sbjct: 106 MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686
+ + +PE + + K+DV+SFG+++ E+ S + S
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------------ 210
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746
+ I + + + C ++RPE RP+ ++ + L
Sbjct: 211 -----------VVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
Query: 747 VE 748
E
Sbjct: 260 AE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-61
Identities = 61/298 (20%), Positives = 111/298 (37%), Gaps = 49/298 (16%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
F +G G FG V G+ VA+K +K + + EF E ++ + H LV+L+G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
C ++ ++ EY+ NG L +YL +
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREM-----------------------RHRFQTQQLLE 104
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+ V A+ YL + LH D+ N L+ D K+SDFGL++ ++ S
Sbjct: 105 MCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686
+ + PE L + + K+D+++FG+++ EI S +
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-------------------- 201
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744
YE + + HI ++ C ++ + RP+ + +
Sbjct: 202 --YERFTNSETAE-HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-61
Identities = 71/308 (23%), Positives = 122/308 (39%), Gaps = 49/308 (15%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
+G+G FG+V+ G VA+K LK T F E ++ ++ H LV+L+
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ +V EY+ GSL D+ L
Sbjct: 81 V-SEEPIYIVTEYMSKGSLLDF----------------------LKGETGKYLRLPQLVD 117
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+A +A +AY+ +H D++ NIL+G++ K++DFGLA+L + + +
Sbjct: 118 MAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 174
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686
+ + APE + T K+DV+SFG++L E+ + R
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-------------------- 214
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746
Y M ++LD+ ++ Y + + C + PE RP+ + LE
Sbjct: 215 --YPGMVNREVLDQ-VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
Query: 747 VEITEPKK 754
TEP+
Sbjct: 272 FTSTEPQY 279
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 6e-60
Identities = 72/308 (23%), Positives = 112/308 (36%), Gaps = 36/308 (11%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR------VVAVKCLKNV--TGGDAEFWAEVTIIARM-HH 497
F ++G G FG V VAVK LK + +E+ ++ ++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
N+V L G C G L++EY G L +YL S + +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRK 616
L + A VA+ + +L + +H D+ N+L+ KI DFGLA+ +
Sbjct: 161 -LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 617 KEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676
+ V R +MAPE L T K+DV+S+G++L EI S N
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP---------- 266
Query: 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
Y + V+ + I+N + F + C RPS
Sbjct: 267 ------------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314
Query: 737 GKVAKMLE 744
+ L
Sbjct: 315 PNLTSFLG 322
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 6e-60
Identities = 82/299 (27%), Positives = 125/299 (41%), Gaps = 55/299 (18%)
Query: 447 FSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGF 506
IG+G FGDV G+ VAVKC+KN F AE +++ ++ H NLV+L G
Sbjct: 11 LLQTIGKGEFGDVMLGDYRG-NKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 507 CAE-KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E KG +V EY+ GSL DYL G+ VL
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYL----------------------RSRGRSVLGGDCLL 106
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ +L V A+ YL +H D+ N+L+ +D K+SDFGL K +
Sbjct: 107 KFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----TQDT 159
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685
+ + APE LR + + K+DV+SFG++L EI S R
Sbjct: 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP------------------- 200
Query: 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744
Y + ++D++ R ++ Y + + C +RPS ++ + LE
Sbjct: 201 ---YPRIPLKDVVPR-VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 8e-60
Identities = 72/312 (23%), Positives = 120/312 (38%), Gaps = 41/312 (13%)
Query: 447 FSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVT--GGDAEFWAEVTIIARM-HH 497
F +G G FG V + VAVK LK +E+ +++ + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
+N+V L G C G ++ EY G L ++L R S M + +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM------EDDEL 140
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRK 616
LD + VA+ +A+L + +H D+ NILL KI DFGLA+ ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 617 KEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676
+ V R +MAPE + + T ++DV+S+G+ L E+ S +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---------- 247
Query: 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
Y M V+ + IK + M C P RP+
Sbjct: 248 ------------YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295
Query: 737 GKVAKMLEGTVE 748
++ +++E +
Sbjct: 296 KQIVQLIEKQIS 307
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (510), Expect = 2e-59
Identities = 69/299 (23%), Positives = 127/299 (42%), Gaps = 49/299 (16%)
Query: 447 FSNLIGRGGFGDVYKGELTDH-RVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+ +G G +G+VY+G + VAVK LK T EF E ++ + H NLV+L G
Sbjct: 21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
C + ++ E++ G+L DYL R + +
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLRECNR----------------------QEVSAVVLL 118
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+A ++ A+ YL ++ +H D+ N L+G++ K++DFGL++L + + +
Sbjct: 119 YMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAF 685
+ + APE L ++ + K+DV++FG++L EI + + +P
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------------YPGIDL 222
Query: 686 EKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744
+VYE ++ Y ++ + C Q P RPS ++ + E
Sbjct: 223 SQVYE----------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-59
Identities = 82/317 (25%), Positives = 138/317 (43%), Gaps = 45/317 (14%)
Query: 447 FSNLIGRGGFGDVYKGELTD---HRVVAVKCLKNVTGGDA--EFWAEVTIIARM-HHLNL 500
F ++IG G FG V K + A+K +K D +F E+ ++ ++ HH N+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+ L G C +G L EY P+G+L D+L +S RV + PA + S L
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKS-RVLETDPAFAIANSTAST-------LS 125
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
A VAR + YL ++ +H D+ NIL+G+++ KI+DFGL++ + E
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQ--EVY 180
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680
V + R +MA E L T +DV+S+G++L EIVS
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-------------- 226
Query: 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740
Y M ++ ++ + Y + + + C +++P RPS ++
Sbjct: 227 --------YCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277
Query: 741 KMLEGTVEITEPKKPTI 757
L + E +K +
Sbjct: 278 VSLN---RMLEERKTYV 291
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 2e-59
Identities = 69/335 (20%), Positives = 131/335 (39%), Gaps = 70/335 (20%)
Query: 435 FTHAELRAATNGFS-----------NLIGRGGFGDVYKGELT----DHRVVAVKCLKN-- 477
FT + A F+ +IG G FG+V G L VA+K LK+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 478 VTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGS 537
+F +E +I+ + H N++ L G + ++ E++ NGSL +L ++ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 538 SSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597
+ G+A + YL + +H D+ NIL
Sbjct: 127 -----------------------VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNIL 160
Query: 598 LGDDFCPKISDFGLAKLRKKED----MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFG 653
+ + K+SDFGL++ + + S + + APE ++ + T +DV+S+G
Sbjct: 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYG 220
Query: 654 MVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFD 713
+V+ E++S + Y +M +D+++ I+ Y D
Sbjct: 221 IVMWEVMSYGE----------------------RPYWDMTNQDVINA-IEQDYRLPPPMD 257
Query: 714 MVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748
+ + + + C Q RP G++ L+ +
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-58
Identities = 60/321 (18%), Positives = 114/321 (35%), Gaps = 53/321 (16%)
Query: 440 LRAATNGFS--NLIGRGGFGDVYKGE-LTDHRVVAVKCLK--NVTGGDAEFWAEVTIIAR 494
+ + F + +G G G V+K V+A K + + E+ ++
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 495 MHHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDG 554
+ +V +G GE ++ E++ GSL L ++GR
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-------------------- 100
Query: 555 GKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL 614
+ I ++++ V + + YL E+ ++H D+KP NIL+ K+ DFG++
Sbjct: 101 ----IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE------- 667
+ GTR YM+PE L+ + ++D++S G+ L+E+ G
Sbjct: 155 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211
Query: 668 --IQGSMMNSDEWYFPKWA----------FEKVYEEMKVEDILDRHIKNSYDSRVHFDMV 715
+ G + D P M + ++LD +
Sbjct: 212 ELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 271
Query: 716 NRMVKTAMWCIQDRPELRPSM 736
C+ P R +
Sbjct: 272 LEFQDFVNKCLIKNPAERADL 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 7e-56
Identities = 67/308 (21%), Positives = 122/308 (39%), Gaps = 59/308 (19%)
Query: 447 FSNLIGRGGFGDVYKGELTDHR----VVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNL 500
F+ +IGRG FG VY G L D+ AVK L +T G ++F E I+ H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 501 VRLWGFCAE-KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
+ L G C +G +V Y+ +G L ++
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNF-----------------------IRNETHNP 127
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
L VA+ + + +H D+ N +L + F K++DFGLA+ ++
Sbjct: 128 TVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 620 MVS---MSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676
S + + +MA E L++ + T K+DV+SFG++L E+++
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---------- 234
Query: 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
Y ++ DI ++ + + + + + + C + E+RPS
Sbjct: 235 ------------YPDVNTFDITVYLLQGRRLLQPEY-CPDPLYEVMLKCWHPKAEMRPSF 281
Query: 737 GKVAKMLE 744
++ +
Sbjct: 282 SELVSRIS 289
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-55
Identities = 65/301 (21%), Positives = 112/301 (37%), Gaps = 57/301 (18%)
Query: 451 IGRGGFGDVYKGEL---TDHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWG 505
+G G FG V +G VA+K LK T E E I+ ++ + +VRL G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
C + LV E G L +L + + S
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGK-----------------------REEIPVSNVA 112
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED--MVSM 623
+ V+ + YL E+ +H D+ N+LL + KISDFGL+K +D +
Sbjct: 113 ELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683
S + + APE + + + ++DV+S+G+ + E +S + P
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KP-- 212
Query: 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743
Y++MK +++ I+ + + C + E RP V + +
Sbjct: 213 -----YKKMKGPEVM-AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
Query: 744 E 744
Sbjct: 267 R 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-55
Identities = 62/299 (20%), Positives = 113/299 (37%), Gaps = 53/299 (17%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAE---FWAEVTIIARMHHLNLVRLW 504
IG G +G K +D +++ K L + +AE +EV ++ + H N+VR +
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 505 GFCAEKGERTL--VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
++ TL V EY G LA + + + + LD
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTK--------------------ERQYLDEE 109
Query: 563 IRYRIALGVARAIAYLHE--ECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
R+ + A+ H + VLH D+KP N+ L K+ DFGLA++ D
Sbjct: 110 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDT 168
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680
GT YM+PE + K+D++S G +L E+ + F
Sbjct: 169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-------------- 214
Query: 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739
+++ + I+ R+ + + + + + + RPS+ ++
Sbjct: 215 ---------TAFSQKELAGK-IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 5e-55
Identities = 68/304 (22%), Positives = 107/304 (35%), Gaps = 59/304 (19%)
Query: 449 NLIGRGGFGDVYKGELTDH---RVVAVKCLKNVTGGDA---EFWAEVTIIARMHHLNLVR 502
+G G FG V KG + VAVK LKN A E AE ++ ++ + +VR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
+ G C E LV E G L YL ++ +
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH------------------------VKDK 107
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-- 620
+ V+ + YL E +H D+ N+LL KISDFGL+K + ++
Sbjct: 108 NIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680
+ + + + APE + + + K+DV+SFG+++ E S +
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP-------------- 210
Query: 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740
Y MK ++ ++ M C E RP V
Sbjct: 211 --------YRGMKGSEVTAM-LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVE 261
Query: 741 KMLE 744
L
Sbjct: 262 LRLR 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 6e-55
Identities = 81/313 (25%), Positives = 125/313 (39%), Gaps = 44/313 (14%)
Query: 447 FSNLIGRGGFGDVYKG------ELTDHRVVAVKCLK--NVTGGDAEFWAEVTIIARM-HH 497
+GRG FG V + + R VAVK LK +E+ I+ + HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 498 LNLVRLWGFCAEKGER-TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
LN+V L G C + G ++ E+ G+L+ YL E V P D K
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN--------EFVPYKVAPEDLYK 128
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LR 615
L + VA+ + +L +H D+ NILL + KI DFGLA+ +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 185
Query: 616 KKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675
K D V R +MAPE + T ++DV+SFG++L EI S +
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------- 236
Query: 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735
Y +K+++ R +K R M +T + C P RP+
Sbjct: 237 -------------YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 283
Query: 736 MGKVAKMLEGTVE 748
++ + L ++
Sbjct: 284 FSELVEHLGNLLQ 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 9e-55
Identities = 68/322 (21%), Positives = 122/322 (37%), Gaps = 58/322 (18%)
Query: 447 FSNLIGRGGFGDVYKGELTD-----HRVVAVKCLKN--VTGGDAEFWAEVTIIARMHHLN 499
+IG G FG+VYKG L VA+K LK +F E I+ + H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
++RL G ++ ++ EY+ NG+L +
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKF-----------------------LREKDGEF 107
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK--K 617
+ G+A + YL +H D+ NIL+ + K+SDFGL+++ +
Sbjct: 108 SVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
E + S + + APE + + T +DV+SFG+V+ E+++
Sbjct: 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP----------- 213
Query: 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737
Y E+ +++ + I + + D + + + M C Q RP
Sbjct: 214 -----------YWELSNHEVM-KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFA 261
Query: 738 KVAKMLEGTVEITEPKKPTIYF 759
+ +L+ + + K F
Sbjct: 262 DIVSILDKLIRAPDSLKTLADF 283
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 6e-54
Identities = 65/302 (21%), Positives = 108/302 (35%), Gaps = 60/302 (19%)
Query: 447 FSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAE---FWAEVTIIARMHHLNLVR 502
F IGRG F VYKG T+ VA L++ +E F E ++ + H N+VR
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 503 LWGFCAEKGERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
+ + LV E + +G+L YL R
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------------------------ 108
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-GDDFCPKISDFGLAKLRKK 617
+ + + + + +LH ++H D+K +NI + G KI D GLA L++
Sbjct: 109 MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
+ GT +MAPE ++ DVY+FGM +LE+ + +
Sbjct: 168 S---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPY----------- 212
Query: 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737
E I R + + + + CI+ + R S+
Sbjct: 213 -----------SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIK 261
Query: 738 KV 739
+
Sbjct: 262 DL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (472), Expect = 1e-53
Identities = 61/299 (20%), Positives = 95/299 (31%), Gaps = 63/299 (21%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAE----FWAEVTIIARMHHLNLVRL 503
IG G FG VY + + VVA+K + E EV + ++ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
G + LV EY + L
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP------------------------LQEVE 116
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
+ G + +AYLH ++H D+K NILL + K+ DFG A + M
Sbjct: 117 IAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----MAPA 168
Query: 624 SRIRGTRGYMAPEWLRSD---QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680
+ GT +MAPE + + Q K DV+S G+ +E+
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-------------- 214
Query: 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739
M L +N + C+Q P+ RP+ +
Sbjct: 215 ---------FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-52
Identities = 63/298 (21%), Positives = 108/298 (36%), Gaps = 60/298 (20%)
Query: 447 FSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLV 501
+G+G FG+VY ++A+K L G + + EV I + + H N++
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
RL+G+ + L+ EY P G++ L + + D
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK------------------------FDE 105
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
+A A++Y H + V+H DIKPEN+LLG KI+DFG +
Sbjct: 106 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159
Query: 622 SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681
+ + GT Y+ PE + K D++S G++ E + G F
Sbjct: 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------------- 204
Query: 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739
E ++ R + + ++ P RP + +V
Sbjct: 205 --------EANTYQETYKRISRVEFTFPDFVT--EGARDLISRLLKHNPSQRPMLREV 252
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-52
Identities = 70/304 (23%), Positives = 107/304 (35%), Gaps = 59/304 (19%)
Query: 451 IGRGGFGDVYKGELT----DHRVVAVKCLKNVTGGDAE----FWAEVTIIARMHHLNLVR 502
+G G FG V +GE VAVKCLK E F EV + + H NL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 503 LWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWS 562
L+G + +V E P GSL D L + +
Sbjct: 76 LYGVVLTPPMK-MVTELAPLGSLLDRLRKH-----------------------QGHFLLG 111
Query: 563 IRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED--M 620
R A+ VA + YL + +H D+ N+LL KI DFGL + + D
Sbjct: 112 TLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680
V + + APE L++ + +D + FG+ L E+ + +
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP-------------- 214
Query: 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740
+ + IL + K D + + C +PE RP+ +
Sbjct: 215 --------WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
Query: 741 KMLE 744
L
Sbjct: 267 DFLL 270
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-52
Identities = 73/316 (23%), Positives = 124/316 (39%), Gaps = 46/316 (14%)
Query: 447 FSNLIGRGGFGDVYKGELT--------DHRVVAVKCLKN--VTGGDAEFWAEVTIIARM- 495
+G G FG V E VAVK LK+ ++ +E+ ++ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 496 HHLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGG 555
H N++ L G C + G ++ EY G+L +YL G P
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN--------PSHNP 128
Query: 556 KPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-L 614
+ L A VAR + YL + +H D+ N+L+ +D KI+DFGLA+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 615 RKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674
+ + R +MAPE L T ++DV+SFG++L EI + +
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-------- 237
Query: 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734
Y + VE++ + +K + + N + C P RP
Sbjct: 238 --------------YPGVPVEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP 282
Query: 735 SMGKVAKMLEGTVEIT 750
+ ++ + L+ V +T
Sbjct: 283 TFKQLVEDLDRIVALT 298
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 9e-52
Identities = 57/299 (19%), Positives = 108/299 (36%), Gaps = 58/299 (19%)
Query: 449 NLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGF 506
+G G FG VYK + + + A K + + + E + E+ I+A H N+V+L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
+ ++ E+ G++ + R L S
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER-----------------------PLTESQIQV 114
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+ A+ YLH+ ++H D+K NIL D K++DFG++ + +
Sbjct: 115 VCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSF 170
Query: 627 RGTRGYMAPEWLRSDQ-----ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681
GT +MAPE + + KADV+S G+ L+E+
Sbjct: 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH--------------- 215
Query: 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAM-WCIQDRPELRPSMGKV 739
E+ +L + K+ + + K + C++ + R + ++
Sbjct: 216 --------HELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-51
Identities = 66/322 (20%), Positives = 128/322 (39%), Gaps = 50/322 (15%)
Query: 447 FSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHL 498
S +G+G FG VY+G VA+K + EF E +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
++VRL G ++ ++ E + G L YL +++P
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL--------------AP 129
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
S ++A +A +AYL+ +H D+ N ++ +DF KI DFG+ + +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 619 D-MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
D + +M+PE L+ T +DV+SFG+VL EI + +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----------- 235
Query: 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737
Y+ + E +L ++ + + + + + C Q P++RPS
Sbjct: 236 -----------YQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFL 283
Query: 738 KVAKMLEGTVEITEPKKPTIYF 759
++ ++ +E ++ + Y+
Sbjct: 284 EIISSIKEEME-PGFREVSFYY 304
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 5e-51
Identities = 62/299 (20%), Positives = 104/299 (34%), Gaps = 56/299 (18%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCL--KNVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+G G +G+V VAVK + K E+ I ++H N+V+ +G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
E + L EY G L D + +
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG------------------------MPEPDAQ 106
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK-LRKKEDMVSMS 624
R + + YLH + H DIKPEN+LL + KISDFGLA R ++
Sbjct: 107 RFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163
Query: 625 RIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683
++ GT Y+APE L+ + DV+S G+VL +++G +
Sbjct: 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW----------------- 206
Query: 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAM-WCIQDRPELRPSMGKVAK 741
++ K + ++ + + + P R ++ + K
Sbjct: 207 ------DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 7e-50
Identities = 64/301 (21%), Positives = 111/301 (36%), Gaps = 56/301 (18%)
Query: 450 LIGRGGFGDVYKGELTDH----RVVAVKCLKNVTGGD--AEFWAEVTIIARMHHLNLVRL 503
IG G FGDV++G VA+K KN T +F E + + H ++V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
G + ++ E G L + K LD +
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSF-----------------------LQVRKYSLDLAS 109
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
A ++ A+AYL + +H DI N+L+ + C K+ DFGL++ +
Sbjct: 110 LILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 166
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683
S+ + +MAPE + + T +DV+ FG+ + EI+
Sbjct: 167 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP----------------- 209
Query: 684 AFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKML 743
++ +K D++ R I+N + + + C P RP ++ L
Sbjct: 210 -----FQGVKNNDVIGR-IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 263
Query: 744 E 744
Sbjct: 264 S 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 6e-49
Identities = 58/304 (19%), Positives = 107/304 (35%), Gaps = 58/304 (19%)
Query: 449 NLIGRGGFGDVYKGELTDH-----RVVAVKCLKNVTGGDA--EFWAEVTIIARMHHLNLV 501
++G G FG VYKG VA+K L+ T A E E ++A + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
RL G C + L+ + +P G L DY+
Sbjct: 75 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG-----------------------S 110
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED-M 620
+ +A+ + YL + ++H D+ N+L+ KI+DFGLAKL E+
Sbjct: 111 QYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680
+ +MA E + T ++DV+S+G+ + E+++
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-------------- 213
Query: 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740
Y+ + +I ++ + + C + RP ++
Sbjct: 214 --------YDGIPASEISSI-LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264
Query: 741 KMLE 744
Sbjct: 265 IEFS 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 9e-49
Identities = 60/294 (20%), Positives = 105/294 (35%), Gaps = 55/294 (18%)
Query: 449 NLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGF 506
IG+G G VY ++ + VA++ + E E+ ++ + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYR 566
E +V EY+ GSL D + + D
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCM-------------------------DEGQIAA 120
Query: 567 IALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRI 626
+ +A+ +LH V+H DIK +NILLG D K++DFG E S +
Sbjct: 121 VCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686
GT +MAPE + PK D++S G++ +E++ G +
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY-------------------- 216
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAM-WCIQDRPELRPSMGKV 739
L N + + ++ + + + C+ E R S ++
Sbjct: 217 ---LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-46
Identities = 64/309 (20%), Positives = 107/309 (34%), Gaps = 68/309 (22%)
Query: 447 FSNLIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGD----AEFWAEVTIIARMHHLNLV 501
F ++G G F V EL R A+K L+ E +++R+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
+L+ + + Y NG L Y+ + G D
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------------------------FDE 107
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED-M 620
+ + A+ YLH + ++H D+KPENILL +D +I+DFG AK+ E
Sbjct: 108 TCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680
+ GT Y++PE L +D+++ G ++ ++V+G F
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-------------- 210
Query: 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHF-----DMVNRMVKTAMWCIQDRPELRPS 735
I + IK YD F D+V + + R
Sbjct: 211 ---------RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK-------LLVLDATKRLG 254
Query: 736 MGKVAKMLE 744
++
Sbjct: 255 CEEMEGYGP 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (420), Expect = 5e-46
Identities = 56/296 (18%), Positives = 100/296 (33%), Gaps = 63/296 (21%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGFC 507
+G G FG V++ E A K + D E E+ ++ + H LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+ E ++YE++ G L + + +
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK-----------------------MSEDEAVEY 129
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP--KISDFGLAKLRKKEDMVSMSR 625
V + + ++HE +H D+KPENI+ K+ DFGL + S+
Sbjct: 130 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT--AHLDPKQSVKV 184
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM-----MNSDEWYF 680
GT + APE + D++S G++ ++SG F + + S +W
Sbjct: 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM 244
Query: 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
AF + E+ K D + + + P R ++
Sbjct: 245 DDSAFSGISEDGK--DFIRK------------------------LLLADPNTRMTI 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (405), Expect = 5e-44
Identities = 60/296 (20%), Positives = 107/296 (36%), Gaps = 63/296 (21%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-FWAEVTIIARMHHLNLVRLWGFC 507
+G G FG V++ E RV K + D E++I+ ++HH L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 508 AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+K E L+ E++ G L D + + +
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK-----------------------MSEAEVINY 132
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP--KISDFGLAKLRKKEDMVSMSR 625
+ ++HE ++H DIKPENI+ KI DFGLA +++ +
Sbjct: 133 MRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--VKV 187
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM-----MNSDEWYF 680
T + APE + + + D+++ G++ ++SG F + + + +W F
Sbjct: 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 247
Query: 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
+ AF V E K D + +Q P R ++
Sbjct: 248 DEDAFSSVSPEAK--DFIKN------------------------LLQKEPRKRLTV 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 56/295 (18%), Positives = 106/295 (35%), Gaps = 62/295 (21%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCA 508
+GRG FG V++ E + + K +K E++I+ H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
E +++E++ + + + S L+
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFE-----------------------LNEREIVSYV 108
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP--KISDFGLAKLRKKEDMVSMSRI 626
V A+ +LH + H DI+PENI+ KI +FG A+ K D +
Sbjct: 109 HQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLL 163
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM-----MNSDEWYFP 681
Y APE + D ++ D++S G ++ ++SG F + + + + E+ F
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
+ AF+++ E D +DR + + R +
Sbjct: 224 EEAFKEISIEAM--DFVDR------------------------LLVKERKSRMTA 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 2e-43
Identities = 60/295 (20%), Positives = 105/295 (35%), Gaps = 54/295 (18%)
Query: 447 FSNLIGRGGFGDVYKGE-LTDHRVVAVKCLK--NVTGGDAEFWAEVTIIARMHHLNLVRL 503
F +++G G F +V E ++VA+KC+ + G + E+ ++ ++ H N+V L
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
G L+ + V G L D + G
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKGF------------------------YTERD 108
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
R+ V A+ YLH+ + L +D ISDFGL+K+ + +
Sbjct: 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--L 166
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKW 683
S GT GY+APE L + D +S G++ ++ G F
Sbjct: 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF----------------- 209
Query: 684 AFEKVYEEMKVEDILDRHIKNSY--DSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
+ + ++ +K Y DS D+ + ++ PE R +
Sbjct: 210 ------YDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTC 258
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (389), Expect = 1e-42
Identities = 62/309 (20%), Positives = 112/309 (36%), Gaps = 64/309 (20%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAE----FWAEVTIIARMHHLNLVRLW 504
++G GG +V+ L HR VAVK L+ D F E A ++H +V ++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 505 GFCAEKGERT----LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
+ +V EYV +L D + G +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------------------------MT 109
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED- 619
+ +A+ + H+ ++H D+KP NI++ K+ DFG+A+
Sbjct: 110 PKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166
Query: 620 -MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678
+ + + GT Y++PE R D + ++DVYS G VL E+++G F
Sbjct: 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------------ 214
Query: 679 YFPKWAFEKVYEEMKVEDILDRHIKNSY--DSRVHFDMVNRMVKTAMWCIQDRPELRP-S 735
+ +H++ S H + + + + PE R +
Sbjct: 215 -----------TGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 263
Query: 736 MGKVAKMLE 744
++ L
Sbjct: 264 AAEMRADLV 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (378), Expect = 4e-41
Identities = 61/314 (19%), Positives = 112/314 (35%), Gaps = 78/314 (24%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGD----------AEFWAEVTIIARMH- 496
++GRG V + + AVK + GG EV I+ ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 497 HLNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
H N+++L LV++ + G L DYL
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------------------- 106
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRK 616
L +I + I LH+ ++H D+KPENILL DD K++DFG +
Sbjct: 107 --LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161
Query: 617 KEDMVSMSRIRGTRGYMAPEWLRSDQ------ITPKADVYSFGMVLLEIVSG-----SRN 665
+ + + GT Y+APE + + D++S G+++ +++G R
Sbjct: 162 PGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219
Query: 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWC 725
+ M+ S + F ++ + +K D++ R
Sbjct: 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVK--DLVSR------------------------F 253
Query: 726 IQDRPELRPSMGKV 739
+ +P+ R + +
Sbjct: 254 LVVQPQKRYTAEEA 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-40
Identities = 62/306 (20%), Positives = 108/306 (35%), Gaps = 53/306 (17%)
Query: 449 NLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAE------FWAEVTIIARMHHLNLV 501
+ +G G F VYK +++VA+K +K +A+ E+ ++ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L K +LV++++ S L
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV------------------------LTP 99
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMV 621
S L + + YLH+ W+LH D+KP N+LL ++ K++DFGLAK
Sbjct: 100 SHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNR 155
Query: 622 SMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNFE----------IQG 670
+ + TR Y APE L + D+++ G +L E++ I
Sbjct: 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215
Query: 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRP 730
++ E +P Y K + H S D++ P
Sbjct: 216 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG-------LFLFNP 268
Query: 731 ELRPSM 736
R +
Sbjct: 269 CARITA 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 57/248 (22%), Positives = 97/248 (39%), Gaps = 39/248 (15%)
Query: 447 FSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAE----FWAEVTIIAR-MHHLNL 500
++G+G FG V+ E ++ A+K LK + E +++ H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
++ K V EY+ G L ++ + D
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK------------------------FD 101
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
S A + + +LH + +++ D+K +NILL D KI+DFG+ K D
Sbjct: 102 LSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG-----SMMNS 675
+ GT Y+APE L + D +SFG++L E++ G F Q +
Sbjct: 159 -KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217
Query: 676 DEWYFPKW 683
D ++P+W
Sbjct: 218 DNPFYPRW 225
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (375), Expect = 7e-40
Identities = 58/301 (19%), Positives = 109/301 (36%), Gaps = 61/301 (20%)
Query: 447 FSNLIGRGGFGDVYKGELTD-HRVVAVKCLK----NVTGGDAEFWAEVTIIARMHHL--- 498
+IGRGGFG+VY D ++ A+KCL + G+ E +++ +
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
+V + + + + + + G L +L + G
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----------------------- 104
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
+ A + + ++H +V++ D+KP NILL + +ISD GLA K+
Sbjct: 105 -SEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
GT GYMAPE L+ AD +S G +L +++ G
Sbjct: 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG--------------H 203
Query: 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737
F + + +E ++ + + +S+ + ++ +Q R
Sbjct: 204 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR-SLLEG-------LLQRDVNRRLGCL 255
Query: 738 K 738
Sbjct: 256 G 256
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 59/305 (19%), Positives = 103/305 (33%), Gaps = 75/305 (24%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGFC 507
++G G G V + A+K L++ + EV + R ++VR+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 508 ----AEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
A + +V E + G L + D G
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRI----------------------QDRGDQAFTERE 112
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP---KISDFGLAKLRKKEDM 620
I + AI YLH + H D+KPEN+L K++DFG AK +
Sbjct: 113 ASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 168
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY- 679
S++ T Y+APE L ++ D++S G+++ ++ G F + S
Sbjct: 169 -SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227
Query: 680 --------FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPE 731
FP + +V EE+K ++ ++ P
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVK--MLIRN------------------------LLKTEPT 261
Query: 732 LRPSM 736
R ++
Sbjct: 262 QRMTI 266
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-38
Identities = 64/302 (21%), Positives = 104/302 (34%), Gaps = 40/302 (13%)
Query: 447 FSNLIGRGGFGDVYKGELTD-HRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
+ +IG G FG VY+ +L D +VA+K + E+ I+ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 506 FCAEKGERT------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
F GE+ LV +YVP + K L
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARH---------------------YSRAKQTL 119
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-GDDFCPKISDFGLAKLRKKE 618
+ R++AY+H + H DIKP+N+LL D K+ DFG AK +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF----EIQGSMMN 674
+ +S I + T DV+S G VL E++ G F + +
Sbjct: 177 EPN-VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI 235
Query: 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP 734
P + E + + + + ++ P R
Sbjct: 236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
Query: 735 SM 736
+
Sbjct: 296 TP 297
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (360), Expect = 1e-38
Identities = 53/306 (17%), Positives = 92/306 (30%), Gaps = 56/306 (18%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCA 508
IG G FGD+Y G + VA+K V + E I M + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 509 EKGERT-LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRI 567
+G+ +V E + + F S + +
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRK------------------------FSLKTVLLL 108
Query: 568 ALGVARAIAYLHEECLEWVLHCDIKPENIL---LGDDFCPKISDFGLAKLRKKED----- 619
A + I Y+H + +H D+KP+N L I DFGLAK +
Sbjct: 109 ADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165
Query: 620 -MVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678
+ GT Y + + + + D+ S G VL+ GS + +
Sbjct: 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW----------QG 215
Query: 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGK 738
+K + + + +N C R + +P
Sbjct: 216 LKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF-------CRSLRFDDKPDYSY 268
Query: 739 VAKMLE 744
+ ++
Sbjct: 269 LRQLFR 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 58/298 (19%), Positives = 104/298 (34%), Gaps = 33/298 (11%)
Query: 449 NLIGRGGFGDVYKGE--LTDHRVVAVKCLKNVTGGDA---EFWAEVTI---IARMHHLNL 500
IG G +G V+K R VA+K ++ TG + EV + + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 501 VRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLD 560
VRL+ C + + L +P +
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY------------------LDKVPEPGVP 114
Query: 561 WSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDM 620
+ + R + +LH V+H D+KP+NIL+ K++DFGLA++
Sbjct: 115 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQ 169
Query: 621 VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE-WY 679
++++ + T Y APE L D++S G + E+ F + +
Sbjct: 170 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229
Query: 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAM-WCIQDRPELRPSM 736
E+ + H K++ ++ + K + C+ P R S
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 66/302 (21%), Positives = 108/302 (35%), Gaps = 72/302 (23%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGD-------AEFWAEVTIIARMH--HLN 499
L+G GGFG VY G ++D+ VA+K ++ D EV ++ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 500 LVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
++RL + L+ E + L
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE-----------------------RGAL 107
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL-GDDFCPKISDFGLAKLRKKE 618
+ V A+ + H VLH DIK ENIL+ + K+ DFG L K
Sbjct: 108 QEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 164
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
GTR Y PEW+R + A V+S G++L ++V G FE ++ +
Sbjct: 165 VYTDF---DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-GQ 220
Query: 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737
+F ++V E + ++ WC+ RP RP+
Sbjct: 221 VFFR----QRVSSECQ--HLI------------------------RWCLALRPSDRPTFE 250
Query: 738 KV 739
++
Sbjct: 251 EI 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (354), Expect = 8e-38
Identities = 46/307 (14%), Positives = 99/307 (32%), Gaps = 56/307 (18%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCA 508
IG G FG +++G L +++ VA+K + E + + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
++G ++ + SL D L GR A
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLCGRK-----------------------FSVKTVAMAA 107
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP-----KISDFGLAKL------RKK 617
+ + +HE+ +++ DIKP+N L+G + DFG+ K ++
Sbjct: 108 KQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677
+ GT YM+ + + + D+ + G V + + GS + QG +++
Sbjct: 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW--QGLKAATNK 222
Query: 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737
+ + +K + + ++ K + + P
Sbjct: 223 QKYERIGEKK--QSTPLRELCA-------------GFPEEFYKYMHYARNLAFDATPDYD 267
Query: 738 KVAKMLE 744
+ +
Sbjct: 268 YLQGLFS 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 139 bits (350), Expect = 3e-37
Identities = 59/295 (20%), Positives = 100/295 (33%), Gaps = 34/295 (11%)
Query: 449 NLIGRGGFGDVYKGELTDHRVVAVKCL---KNVTGGDAEFWAEVTIIARMHHLNLVRLWG 505
IG G +G VYK + A+K + K G + E++I+ + H N+V+L+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
K LV+E++ G L+
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG------------------------LESVTAK 103
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
L + IAY H+ VLH D+KP+N+L+ + KI+DFGLA+
Sbjct: 104 SFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF----EIQGSMMNSDEWYFP 681
I + S + + D++S G + E+V+G+ F E M P
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220
Query: 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
E+ D + + + ++ P R +
Sbjct: 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 64/304 (21%), Positives = 104/304 (34%), Gaps = 72/304 (23%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE-------FWAEVTIIARMHHLNLV 501
+G G F V K E + A K +K + EV+I+ + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 502 RLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDW 561
L K + L+ E V G L D+L L
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES------------------------LTE 112
Query: 562 SIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP----KISDFGLAKLRKK 617
+ + YLH + H D+KPENI+L D P KI DFGLA
Sbjct: 113 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM----- 672
+ I GT ++APE + + + +AD++S G++ ++SG+ F
Sbjct: 170 GN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 227
Query: 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPEL 732
+++ + F F K D + R + P+
Sbjct: 228 VSAVNYEFEDEYFSNTSALAK--DFIRR------------------------LLVKDPKK 261
Query: 733 RPSM 736
R ++
Sbjct: 262 RMTI 265
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-37
Identities = 56/300 (18%), Positives = 100/300 (33%), Gaps = 36/300 (12%)
Query: 449 NLIGRGGFGDVYKG-ELTDHRVVAVKCLKNV--TGGDAEFWAEVTIIARMHHLNLVRLWG 505
+ IG G +G V + + VA+K + E+ I+ R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ Y+ + L++ + L
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---------------------LSNDHIC 112
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKL--RKKEDMVSM 623
+ R + Y+H VLH D+KP N+LL KI DFGLA++ + +
Sbjct: 113 YFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 169
Query: 624 SRIRGTRGYMAPEWL-RSDQITPKADVYSFGMVLLEIVSG-----SRNFEIQGSMMNSDE 677
+ TR Y APE + S T D++S G +L E++S +++ Q + +
Sbjct: 170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229
Query: 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKT-AMWCIQDRPELRPSM 736
+ + +L KN F + + P R +
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (351), Expect = 5e-37
Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 41/255 (16%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAE----FWAEVTIIARMHHLNLVRL 503
+G G FG V+ + R A+K LK + E +++ + H ++R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
WG + + ++ +Y+ G L L +S R +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF------------------------PNPV 105
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
A V A+ YLH + +++ D+KPENILL + KI+DFG AK
Sbjct: 106 AKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----T 158
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM-----MNSDEW 678
+ GT Y+APE + + D +SFG+++ E+++G F +M + + E
Sbjct: 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 218
Query: 679 YFPKWAFEKVYEEMK 693
FP + E V + +
Sbjct: 219 RFPPFFNEDVKDLLS 233
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-36
Identities = 61/297 (20%), Positives = 107/297 (36%), Gaps = 36/297 (12%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLW 504
IG G +G VYK VVA+K ++ T G + E++++ ++H N+V+L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+ + LV+E++ + L ++ S G + +
Sbjct: 68 DVIHTENKLYLVFEFL-HQDLKKFMDASALTG----------------------IPLPLI 104
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
+ + +A+ H VLH D+KP+N+L+ + K++DFGLA+
Sbjct: 105 KSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
Query: 625 RIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNF----EIQGSMMNSDEWY 679
+ T Y APE L + + D++S G + E+V+ F EI
Sbjct: 162 EV-VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 220
Query: 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSM 736
P M S+V + + P R S
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 1e-34
Identities = 59/314 (18%), Positives = 109/314 (34%), Gaps = 56/314 (17%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLK---NVTGGDAEFWAEVTIIARMHHLNLVRLW 504
IG+G FG+V+K + VA+K + G E+ I+ + H N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 505 GFCAEKGERT--------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGK 556
C K LV+++ + +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---------------------- 113
Query: 557 PVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAK--- 613
S R+ + + Y+H +LH D+K N+L+ D K++DFGLA+
Sbjct: 114 --FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFS 168
Query: 614 LRKKEDMVSMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNFE----- 667
L K + T Y PE L ++ P D++ G ++ E+ + S +
Sbjct: 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228
Query: 668 -----IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA 722
I + +P ++YE++++ R +K+ + V ++
Sbjct: 229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID-- 286
Query: 723 MWCIQDRPELRPSM 736
+ P R
Sbjct: 287 -KLLVLDPAQRIDS 299
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 56/224 (25%), Positives = 80/224 (35%), Gaps = 33/224 (14%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGD----AEFWAEVTIIARMHHLNLVRL 503
L+G+G FG V R A+K L+ A E ++ H L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 504 WGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSI 563
V EY G L +L R + V
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSR------------------------ERVFTEER 106
Query: 564 RYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSM 623
+ A+ YLH V++ DIK EN++L D KI+DFGL K + +M
Sbjct: 107 ARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 162
Query: 624 SRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFE 667
GT Y+APE L + D + G+V+ E++ G F
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-33
Identities = 54/307 (17%), Positives = 104/307 (33%), Gaps = 50/307 (16%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDA---EFWAEVTIIARMHHLNLVRLWG 505
+G G +G V + VA+K L + + E+ ++ M H N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 506 FCAEKGERT------LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVL 559
LV ++ G+ L + + L
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK------------------------L 118
Query: 560 DWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKED 619
+ + + + Y+H ++H D+KP N+ + +D KI DFGLA+ E
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE- 174
Query: 620 MVSMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNF-----EIQGSMM 673
M+ TR Y APE + + T D++S G ++ E+++G F Q +
Sbjct: 175 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
Query: 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAM-WCIQDRPEL 732
P +++ + + D + + + + E
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291
Query: 733 RPSMGKV 739
R + G+
Sbjct: 292 RVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (320), Expect = 1e-32
Identities = 51/253 (20%), Positives = 90/253 (35%), Gaps = 41/253 (16%)
Query: 451 IGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAE----FWAEVTIIARMHHLNLVRLWG 505
+G G FG V + A+K L + E I+ ++ LV+L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ +V EYV G + +L R GR
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR------------------------FSEPHAR 144
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
A + YLH +++ D+KPEN+L+ +++DFG A K
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFA----KRVKGRTWT 197
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM-----MNSDEWYF 680
+ GT +APE + S D ++ G+++ E+ +G F + + S + F
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 681 PKWAFEKVYEEMK 693
P + + ++
Sbjct: 258 PSHFSSDLKDLLR 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 2e-32
Identities = 50/297 (16%), Positives = 102/297 (34%), Gaps = 36/297 (12%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLK---NVTGGDAEFWAEVTIIARMHHLNLVRLW 504
IG G +G V+K + H +VA+K ++ + G + E+ ++ + H N+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+ TLV+E+ + +G + D I
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL------------------------DPEIV 103
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
+ + + + H VLH D+KP+N+L+ + K+++FGLA+ +
Sbjct: 104 KSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWA 684
+ + + D++S G + E+ + R + + + F
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 685 FEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA-----MWCIQDRPELRPSM 736
+ + + D Y + V + ++ P R S
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (312), Expect = 8e-32
Identities = 55/307 (17%), Positives = 113/307 (36%), Gaps = 53/307 (17%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARM-HHLNLVRLWGF 506
+GRG + +V++ +T++ V VK LK V + E+ I+ + N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADI 98
Query: 507 CAEKGERT--LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+ RT LV+E+V N + + D+ IR
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY--------------------------QTLTDYDIR 132
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCP-KISDFGLAKLRKKEDMVSM 623
+ +A+ Y H ++H D+KP N+++ + ++ D+GLA+
Sbjct: 133 -FYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EY 186
Query: 624 SRIRGTRGYMAPE-WLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN-------- 674
+ +R + PE + D++S G +L ++ F +
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
Query: 675 -SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTA----MWCIQDR 729
E + + + + DIL RH + ++ VH + + + A ++
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
Query: 730 PELRPSM 736
+ R +
Sbjct: 307 HQSRLTA 313
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-29
Identities = 52/255 (20%), Positives = 95/255 (37%), Gaps = 39/255 (15%)
Query: 449 NLIGRGGFGDVYKGELTDH----RVVAVKCLKNVTGGD-----AEFWAEVTIIARM-HHL 498
++G G +G V+ ++ A+K LK T E ++ +
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 499 NLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPV 558
LV L + + L+ +Y+ G L +L + R
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER------------------------ 125
Query: 559 LDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKE 618
+ A+ +LH+ +++ DIK ENILL + ++DFGL+K +
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182
Query: 619 DMVSMSRIRGTRGYMAPEWLRSDQ--ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676
+ GT YMAP+ +R D +S G+++ E+++G+ F + G +
Sbjct: 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA 242
Query: 677 EWYFPKWAFEKVYEE 691
E E Y +
Sbjct: 243 EISRRILKSEPPYPQ 257
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 6e-29
Identities = 46/272 (16%), Positives = 101/272 (37%), Gaps = 13/272 (4%)
Query: 450 LIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCA 508
+G G F V+ + + ++ VA+K ++ E+ ++ R++ + + A
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIA 568
+ L + + + +G + A + G +I+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI--------PLIYVKQIS 131
Query: 569 LGVARAIAYLHEECLEWVLHCDIKPENILL-GDDFCPKISDFGLAKLRK-KEDMVSMSRI 626
+ + Y+H C ++H DIKPEN+L+ D + +A L +
Sbjct: 132 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 627 RGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFPKWAFE 686
TR Y +PE L AD++S ++ E+++G FE + + E
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 687 KVYEEMKVEDILDRHIKNSYDSRVHFDMVNRM 718
+ E ++ + ++SR ++++
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (287), Expect = 2e-28
Identities = 59/308 (19%), Positives = 95/308 (30%), Gaps = 47/308 (15%)
Query: 450 LIGRGGFGDVYKG-ELTDHRVVAVKCLKNVTGGDAE---FWAEVTIIARMHHLNLVRLWG 505
IG G G V + R VA+K L + E+ ++ ++H N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 506 FCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRY 565
+ + YL ME+ + LD
Sbjct: 84 VFTPQKTLEEFQDV--------YLV-------------MELMDANLCQVIQMELDHERMS 122
Query: 566 RIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSR 625
+ + I +LH ++H D+KP NI++ D KI DFGLA+ M M+
Sbjct: 123 YLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTP 177
Query: 626 IRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF-------------EIQGSM 672
TR Y APE + D++S G ++ E+V F E G+
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAM----WCIQD 728
V K + + + A +
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 729 RPELRPSM 736
P R S+
Sbjct: 298 DPAKRISV 305
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 5e-26
Identities = 49/298 (16%), Positives = 89/298 (29%), Gaps = 36/298 (12%)
Query: 449 NLIGRGGFGDVYKGE-LTDHRVVAVKCLKNVTGGDAE---FWAEVTIIARMHHLNLVRLW 504
+ +G G +G V VAVK L + E+ ++ M H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 505 GFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIR 564
+ YL M + L
Sbjct: 84 DVFTPARSLEEFNDV--------YLV------------THLMGADLNNIVKCQKLTDDHV 123
Query: 565 YRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMS 624
+ + R + Y+H ++H D+KP N+ + +D KI DFGLA+ D
Sbjct: 124 QFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTG 177
Query: 625 RIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNF-----EIQGSMMNSDEWY 679
+ L D++S G ++ E+++G F Q ++
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAM-WCIQDRPELRPSM 736
+K+ E I + F N + + + + R +
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 90.6 bits (224), Expect = 2e-21
Identities = 34/231 (14%), Positives = 55/231 (23%), Gaps = 66/231 (28%)
Query: 449 NLIGRGGFGDVYKGELTDHRVVAVKCLK-----------NVTGGDAEFWAEVTIIARMHH 497
L+G G V+ VK K GD F AR
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 498 LNLVRLWGFCAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKP 557
L +L G K VY + N L +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMEL----------------------IDAKELY 98
Query: 558 VLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFCPKISDFGLAKLRKK 617
+ + + +A + ++H D+ N+L+ + I DF +
Sbjct: 99 RVRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQS----- 149
Query: 618 EDMVSMSRIRGTRGYMAPEWLRSD----------QITPKADVYSFGMVLLE 658
E L D + D+ S +L+
Sbjct: 150 ---------VEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 52.7 bits (126), Expect = 4e-09
Identities = 20/109 (18%), Positives = 42/109 (38%), Gaps = 9/109 (8%)
Query: 45 ILLSPNSTFAAGFLPKPNSRNLFTFSVWYH-NLSEPTTVIWSANDKFPVAGNGSLAIAAT 103
+L + +A L F + L + +T +W++N + +
Sbjct: 3 LLTNGEGLYAGQSLD--VEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQ-S 59
Query: 104 TGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLV-YGN--WQSF 149
G + ++ +LW + + + L LQ+ GN+V YG+ W +
Sbjct: 60 DGNFVVYDAEGRSLWASH--SVRGNGNYVLVLQEDGNVVIYGSDIWSTG 106
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 36.1 bits (83), Expect = 0.003
Identities = 13/79 (16%), Positives = 22/79 (27%), Gaps = 20/79 (25%)
Query: 154 DTILPNQTLN-GPPLVSKNGKFSFLNASELVFVSANRSYWN--------------IDDDG 198
+ + + L G L + F LV + S W + DG
Sbjct: 2 NLLTNGEGLYAGQSLDVEPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDG 61
Query: 199 NLRIYSYDDNGDRWTVVWQ 217
N +Y + +W
Sbjct: 62 NFVVYDAEGR-----SLWA 75
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 41.1 bits (96), Expect = 5e-05
Identities = 22/142 (15%), Positives = 35/142 (24%), Gaps = 45/142 (31%)
Query: 70 SVWYHNLSEPTTVIWSAN-DKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNP 128
S+ Y + + + L++ T L L + + N G
Sbjct: 11 SILYSTQGNDNHP-QTLHATQSLQLSPYRLSME-TDCNLVLFDRDDRVWSTN---TAGKG 65
Query: 129 NSTRLFLQDAGNLVYGN------WQSFNLPTDTILPNQTLNGPPLVSKNGKFSFLNASEL 182
R LQ G + W S N G++ F+
Sbjct: 66 TGCRAVLQPNGRMDVLTNQNIAVWTSGN-----------------SRSAGRYVFV----- 103
Query: 183 VFVSANRSYWNIDDDGNLRIYS 204
+ D NL IY
Sbjct: 104 -----------LQPDRNLAIYG 114
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 36.1 bits (83), Expect = 0.003
Identities = 13/98 (13%), Positives = 29/98 (29%), Gaps = 23/98 (23%)
Query: 133 LFLQDAGNLVYGNWQSFNLPTDTILPNQTLNGPPLVSKNGKFSFLNASELVFVSANRSYW 192
+ + + GN + + Q + T+ Q+L + S LV + W
Sbjct: 3 VVVANNGNSILYSTQGNDNHPQTLHATQSLQ-----LSPYRLSMETDCNLVLFDRDDRVW 57
Query: 193 -------------NIDDDGNLRIYSYDDNGDRWTVVWQ 217
+ +G + + + + VW
Sbjct: 58 STNTAGKGTGCRAVLQPNGRMDVLTNQNI-----AVWT 90
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 40.4 bits (94), Expect = 8e-05
Identities = 16/77 (20%), Positives = 24/77 (31%), Gaps = 7/77 (9%)
Query: 76 LSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFL 135
L + IW+ N G + L+ + SN G + L
Sbjct: 33 LYDVDKPIWATNTG----GLSRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCIL 88
Query: 136 QDAGNLV-YGN--WQSF 149
Q N+V YG W +
Sbjct: 89 QKDRNVVIYGTDRWATG 105
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 763 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.61 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.58 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.52 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.4 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.26 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.08 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.0 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.66 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.14 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.03 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 97.88 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 97.86 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 97.81 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.77 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.9 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.01 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.82 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 86.03 | |
| d2qj2a1 | 91 | Hepatocyte growth factor {Human (Homo sapiens) [Ta | 85.16 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 84.59 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 81.72 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 81.18 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=423.72 Aligned_cols=254 Identities=26% Similarity=0.484 Sum_probs=201.5
Q ss_pred hccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
.+.+.++||+|+||+||+|++.+++.||||+++......++|.+|++++++++|||||+++|+|.+.+..++||||+++|
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 45678899999999999999998889999999877777788999999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|.+++... ...+++..++.|+.|||+||+|||+.+ |+||||||+|||+++++.
T Consensus 86 ~L~~~l~~~-----------------------~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~ 139 (263)
T d1sm2a_ 86 CLSDYLRTQ-----------------------RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQV 139 (263)
T ss_dssp BHHHHHHTT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGC
T ss_pred cHHHHhhcc-----------------------ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCC
Confidence 999998642 346889999999999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCC-CcccccCCCCCCCCchhH
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR-NFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~-p~~~~~~~~~~~~~~~~~ 682 (763)
+||+|||+++..............||+.|+|||.+.+..++.++|||||||++|||+|+.. |+.... ...
T Consensus 140 ~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---------~~~ 210 (263)
T d1sm2a_ 140 IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---------NSE 210 (263)
T ss_dssp EEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---------HHH
T ss_pred eEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---------HHH
Confidence 9999999998766554444445678999999999999999999999999999999999544 443211 000
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
....+..+ .....+..+++++.+++.+||+.||++||||+||++.|+++.
T Consensus 211 -~~~~i~~~--------------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 211 -VVEDISTG--------------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp -HHHHHHHT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHhc--------------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 11111111 111122344568899999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-50 Score=426.54 Aligned_cols=266 Identities=25% Similarity=0.415 Sum_probs=222.5
Q ss_pred ccHHHHHHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCee
Q 046586 435 FTHAELRAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGER 513 (763)
Q Consensus 435 ~~~~el~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 513 (763)
++.+||....+.+.++||+|+||+||+|++. +++.||||+++......++|.+|+++|++++|||||+++|+|.+++..
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 4445666677888999999999999999886 478999999987777778899999999999999999999999999999
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+++|+|.+++... ....+++..++.|+.|||.||+|||+++ |+||||||
T Consensus 89 ~iv~E~~~~g~l~~~l~~~----------------------~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp 143 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLREC----------------------NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAA 143 (287)
T ss_dssp EEEEECCTTCBHHHHHHHS----------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEeecccCcchHHHhhhc----------------------cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCcccc
Confidence 9999999999999999654 3457899999999999999999999988 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
+|||+++++++||+|||+|+..............||+.|+|||.+.++.++.++|||||||++|||++|..|+.....
T Consensus 144 ~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-- 221 (287)
T d1opja_ 144 RNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-- 221 (287)
T ss_dssp GGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred CeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--
Confidence 999999999999999999997766555445556789999999999999999999999999999999997776642211
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.. - ..+.+... ...+.+...++++.+++..||+.||++||||+||++.|+.+.+
T Consensus 222 ------~~-~----------~~~~i~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 222 ------LS-Q----------VYELLEKD----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ------HH-H----------HHHHHHTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ------HH-H----------HHHHHhcC----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00 0 11111211 1122224456789999999999999999999999999987654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=423.13 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=212.9
Q ss_pred HHHHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
|....+.+.++||+|+||.||+|++++++.||||+++......++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 4445678889999999999999999988899999998777777889999999999999999999998865 567999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++... ....+++.++++|+.|||+||+|||+.+ |+||||||+||||+
T Consensus 89 ~~~g~L~~~~~~~----------------------~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~ 143 (272)
T d1qpca_ 89 MENGSLVDFLKTP----------------------SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVS 143 (272)
T ss_dssp CTTCBHHHHTTSH----------------------HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC
T ss_pred CCCCcHHHHHhhc----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeee
Confidence 9999999988542 2235899999999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
+++.+||+|||+|+..............||+.|||||.+.++.++.++|||||||++|||+||..|+.....
T Consensus 144 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------- 215 (272)
T d1qpca_ 144 DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------- 215 (272)
T ss_dssp TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------
T ss_pred cccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--------
Confidence 999999999999998766555455566789999999999999999999999999999999997665432111
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
. ......+..+ .+...+...++++.+++.+||+.||++||||+||+++|+..
T Consensus 216 ~-~~~~~~i~~~--------------~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 216 N-PEVIQNLERG--------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp H-HHHHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-HHHHHHHHhc--------------CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 0 0011111111 11112234456789999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=409.00 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=214.8
Q ss_pred hccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPNG 523 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~g 523 (763)
.+.|.++||+|+||+||+|++++++.||||+++......++|++|++++++++|||||+++|+|.+++..++||||+++|
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 35678999999999999999998889999999987777789999999999999999999999999999999999999999
Q ss_pred CHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCCC
Q 046586 524 SLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDFC 603 (763)
Q Consensus 524 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~~ 603 (763)
+|..++... ...+++..+++++.|+|+||+|||+.+ |+||||||+|||+++++.
T Consensus 85 ~l~~~~~~~-----------------------~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~ 138 (258)
T d1k2pa_ 85 CLLNYLREM-----------------------RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGV 138 (258)
T ss_dssp EHHHHHHSG-----------------------GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCC
T ss_pred cHHHhhhcc-----------------------ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCc
Confidence 999997543 346789999999999999999999988 999999999999999999
Q ss_pred eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCchhH
Q 046586 604 PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYFPK 682 (763)
Q Consensus 604 ~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 682 (763)
+||+|||+++..............||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .
T Consensus 139 ~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---------~- 208 (258)
T d1k2pa_ 139 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---------S- 208 (258)
T ss_dssp EEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---------H-
T ss_pred EEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---------H-
Confidence 9999999998766555544555678999999999999999999999999999999998 8989864321 0
Q ss_pred HHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 683 WAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.....+.++ .....+...++++.+++.+||+.||++|||+.||++.|.++
T Consensus 209 ~~~~~i~~~--------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 209 ETAEHIAQG--------------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHHHTT--------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHHhC--------------CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 011111111 11122234456889999999999999999999999998653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=417.71 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=201.5
Q ss_pred HHhccccccccccccceEEEEEeCCCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
...+.+.++||+|+||+||+|+..+ .||||+++.. ....++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4456778999999999999998754 5999999743 2334678999999999999999999999865 56899999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ...+++.+++.|+.|||+||+|||+++ ||||||||+|||+
T Consensus 84 y~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl 137 (276)
T d1uwha_ 84 WCEGSSLYHHLHII-----------------------ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFL 137 (276)
T ss_dssp CCCEEEHHHHHHTS-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred cCCCCCHHHHHhhc-----------------------cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEE
Confidence 99999999999643 245899999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCc-ccccccccCCCccccccccc---CCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRS---DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
+.++.+||+|||+|+....... .......||+.|||||.+.+ +.|+.++|||||||++|||+||+.||......
T Consensus 138 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-- 215 (276)
T d1uwha_ 138 HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-- 215 (276)
T ss_dssp ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--
T ss_pred cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--
Confidence 9999999999999987654332 33455689999999999864 46899999999999999999999999743211
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
.........+. ..+.+ ...+.+.++++.+++.+||+.||++||||+||++.|+.+.
T Consensus 216 -------~~~~~~~~~~~-----~~p~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 216 -------DQIIFMVGRGY-----LSPDL-----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp -------HHHHHHHHHTS-----CCCCG-----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHHHHHhcCC-----CCCcc-----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11111111111 01111 1112345678999999999999999999999999998765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=417.47 Aligned_cols=263 Identities=27% Similarity=0.401 Sum_probs=209.7
Q ss_pred HHhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
...+.+.+.||+|+||.||+|+..+++.||||+++......++|.+|+.++++++|||||+++|+|.+ +..++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 45688899999999999999999988899999998777777889999999999999999999999854 56889999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|..++... ....++|.+++.|+.|||.||+|||+.+ |+||||||+||||+++
T Consensus 95 ~g~l~~~~~~~----------------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~ 149 (285)
T d1fmka3 95 KGSLLDFLKGE----------------------TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN 149 (285)
T ss_dssp TCBHHHHHSHH----------------------HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred CCchhhhhhhc----------------------ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCC
Confidence 99999998653 2346899999999999999999999998 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
+++||+|||+++..............||+.|+|||.+..+.++.++||||||+++|||++|..|+...... .
T Consensus 150 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--------~ 221 (285)
T d1fmka3 150 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------R 221 (285)
T ss_dssp GCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------H
T ss_pred CcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--------H
Confidence 99999999999876554444445567899999999999999999999999999999999977665422110 0
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCCCCC
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEITEPK 753 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~~p~ 753 (763)
. ....+.... ..+.+...++++.+++.+||+.||++||||.+|+++|+.......|+
T Consensus 222 ~-----------~~~~i~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~ 278 (285)
T d1fmka3 222 E-----------VLDQVERGY----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278 (285)
T ss_dssp H-----------HHHHHHTTC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred H-----------HHHHHHhcC----CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence 0 011111111 11222455678999999999999999999999999999877544443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-49 Score=420.04 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=196.7
Q ss_pred hccccccccccccceEEEEEeCC-C---cEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD-H---RVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~-~---~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
.+.+.++||+|+||+||+|++.. + ..||||.+..... ..++|.+|+++|++++|||||+++|++.+.+..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 34455789999999999998753 2 3688998865433 3357999999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ...++|.+++.|+.|||+||+|||+.+ |+||||||+|||
T Consensus 107 Ey~~~g~L~~~~~~~-----------------------~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NIL 160 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQN-----------------------DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNIL 160 (299)
T ss_dssp ECCTTEEHHHHHHTT-----------------------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred EecCCCcceeeeccc-----------------------cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEE
Confidence 999999999988642 346899999999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcc----cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMV----SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSM 672 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 672 (763)
|+.++++||+|||+++........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.....
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~- 239 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN- 239 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999876543321 1222457899999999999999999999999999999998 8999864321
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.. ... .+.. ....+.+.+.++.+.+++.+||+.||++||||.||++.|+.+++
T Consensus 240 --------~~-~~~----------~i~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 240 --------QD-VIN----------AIEQ----DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp --------HH-HHH----------HHHT----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------HH-HHH----------HHHc----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 00 001 1111 11122234556789999999999999999999999999987654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=411.20 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=201.5
Q ss_pred HhccccccccccccceEEEEEeCCC-----cEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDH-----RVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~-----~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
..+.+.++||+|+||.||+|.+.+. ..||||+++.... ...+|++|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3456678999999999999987542 3799999975433 23568999999999999999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+.++++.+++... ...++|.++++++.||+.||+|||+.+ |+||||||+|
T Consensus 87 v~e~~~~~~l~~~~~~~-----------------------~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~N 140 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK-----------------------DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARN 140 (283)
T ss_dssp EEECCTTEEHHHHHHHT-----------------------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEecccCcchhhhhcc-----------------------cccccHHHHHHHHHHHHHhhhhccccc---cccCccccce
Confidence 99999999999988643 346899999999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
|||+.++.+||+|||+++....... .......||+.|||||.+.++.++.++|||||||++|||++|..|+.....
T Consensus 141 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-- 218 (283)
T d1mqba_ 141 ILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-- 218 (283)
T ss_dssp EEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred EEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--
Confidence 9999999999999999987654332 223345689999999999999999999999999999999997666532211
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVEIT 750 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~~~ 750 (763)
. .-.... +... ...+.+.+.+.++.+++.+||+.||++||||.||+++|+.+++.|
T Consensus 219 ------~-~~~~~~----------i~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 219 ------N-HEVMKA----------INDG----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp ------H-HHHHHH----------HHTT----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ------H-HHHHHH----------Hhcc----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 0 001111 1111 112222445678999999999999999999999999999876654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=405.74 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=203.6
Q ss_pred ccccc-cccccccceEEEEEeC---CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 445 NGFSN-LIGRGGFGDVYKGELT---DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 445 ~~~~~-~LG~G~fG~Vy~g~~~---~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
..+.+ +||+|+||.||+|.+. ++..||||+++.... ..++|.+|+++|++++|||||+++|++.+ +..+||||
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE 88 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 88 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence 34455 5999999999999764 345799999975432 34679999999999999999999999865 56899999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++.. .+..+++.+++.|+.|||.||+|||+++ |+||||||+|||+
T Consensus 89 ~~~~g~L~~~l~~-----------------------~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill 142 (285)
T d1u59a_ 89 MAGGGPLHKFLVG-----------------------KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLL 142 (285)
T ss_dssp CCTTEEHHHHHTT-----------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred eCCCCcHHHHhhc-----------------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheee
Confidence 9999999999854 2346899999999999999999999988 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNS 675 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~ 675 (763)
+.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.....
T Consensus 143 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---- 218 (285)
T d1u59a_ 143 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---- 218 (285)
T ss_dssp EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----
T ss_pred ccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999876554332 2234568999999999999999999999999999999998 8999964321
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.+ ....+..+ ...+.+...+.++.+++.+||+.||++||||.+|++.|+..
T Consensus 219 -----~~-~~~~i~~~--------------~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 219 -----PE-VMAFIEQG--------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -----HH-HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HH-HHHHHHcC--------------CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 00 11111111 11223345567889999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=400.17 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=200.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.|.+.++||+|+||+||+|+.. +++.||||+++... ...+++.+|++++++++|||||++++++.+.+..+|||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 4677899999999999999875 68899999997432 33456899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++
T Consensus 86 ~gg~L~~~l~~------------------------~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~ 138 (271)
T d1nvra_ 86 SGGELFDRIEP------------------------DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDE 138 (271)
T ss_dssp TTEEGGGGSBT------------------------TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred CCCcHHHHHhc------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECC
Confidence 99999999853 346889999999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCC-CCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 601 DFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
++.+||+|||+|+....... ...+...||+.|||||.+.+..+ +.++||||+||++|||++|+.||.......
T Consensus 139 ~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~----- 213 (271)
T d1nvra_ 139 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----- 213 (271)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----
T ss_pred CCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----
Confidence 99999999999987654332 23445689999999999988776 578999999999999999999996432211
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. ........ . ........++++.+++.+||+.||++|||+.|+++
T Consensus 214 --~~--~~~~~~~~---------~----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 214 --QE--YSDWKEKK---------T----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --HH--HHHHHTTC---------T----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HH--HHHHhcCC---------C----CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 00011110 0 00011233467788999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=415.10 Aligned_cols=279 Identities=25% Similarity=0.346 Sum_probs=209.5
Q ss_pred HHHHHhccccccccccccceEEEEEeCC------CcEEEEEEeecc--CCchhhhHHHHHHHhcC-CCCccccEEEEEee
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELTD------HRVVAVKCLKNV--TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAE 509 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~~------~~~VAvK~l~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 509 (763)
|+....+.+.++||+|+||+||+|+... ...||||.+... ......|.+|+.+|.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 3444567888999999999999998643 136999998643 33446789999999998 89999999999999
Q ss_pred CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEec
Q 046586 510 KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHC 589 (763)
Q Consensus 510 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHr 589 (763)
.+..++||||+++|+|.++|...+............ ............+++..++.|+.||++||+|||+++ ||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN-QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC----------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhcc-ccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 999999999999999999997654322111110000 000001113356899999999999999999999988 9999
Q ss_pred CCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcc
Q 046586 590 DIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFE 667 (763)
Q Consensus 590 Dlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~ 667 (763)
||||+|||++.++++||+|||+|+....... .......||+.|||||.+.++.++.++|||||||++|||++ |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986554333 23345678999999999999999999999999999999998 899996
Q ss_pred cccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 046586 668 IQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLE 744 (763)
Q Consensus 668 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le 744 (763)
...... . ...++.. ....+.+...++++.+++.+||+.||++||||+||+++|.
T Consensus 269 ~~~~~~---------~----------~~~~~~~----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDA---------N----------FYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSH---------H----------HHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHH---------H----------HHHHHhc----CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 432110 0 1111111 1222233445678999999999999999999999999995
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=402.63 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=197.0
Q ss_pred ccccccccceEEEEEeCC---CcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 449 NLIGRGGFGDVYKGELTD---HRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~---~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
++||+|+||+||+|.+.+ ++.||||+++.... ..++|.+|+++|++++|||||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998753 46899999974322 23569999999999999999999999964 567899999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCCC
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDDF 602 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~~ 602 (763)
|+|.+++... ..+++.+++.|+.|||.||+|||+.+ ||||||||+|||++.++
T Consensus 92 g~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~ 144 (277)
T d1xbba_ 92 GPLNKYLQQN------------------------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQH 144 (277)
T ss_dssp EEHHHHHHHC------------------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred CcHHHHHhhc------------------------cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccC
Confidence 9999998643 35899999999999999999999988 99999999999999999
Q ss_pred CeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCc
Q 046586 603 CPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 603 ~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~ 679 (763)
.+||+|||+++........ ......||+.|||||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 145 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------- 216 (277)
T d1xbba_ 145 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------- 216 (277)
T ss_dssp EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------
T ss_pred cccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------
Confidence 9999999999876544332 2334578999999999999999999999999999999998 8999964321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
...... +.+. ...+.+...+.++.+++.+||+.||++||||++|+++|+.
T Consensus 217 --~~~~~~----------i~~~----~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 217 --SEVTAM----------LEKG----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp --HHHHHH----------HHTT----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --HHHHHH----------HHcC----CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 001111 1111 1122224456788999999999999999999999998864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=394.63 Aligned_cols=243 Identities=26% Similarity=0.416 Sum_probs=203.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.+.||+|+||.||+|+.. +++.||+|+++.. ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 4778899999999999999885 5789999998632 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||+
T Consensus 87 y~~~g~L~~~l~~~------------------------~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill 139 (263)
T d2j4za1 87 YAPLGTVYRELQKL------------------------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLL 139 (263)
T ss_dssp CCTTCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred ecCCCcHHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeecccccee
Confidence 99999999999653 35889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.+||+|||+|+..... ......||+.|||||.+.+..++.++|||||||++|||++|+.||+....
T Consensus 140 ~~~~~~kl~DFG~a~~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------- 209 (263)
T d2j4za1 140 GSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------- 209 (263)
T ss_dssp CTTSCEEECCCCSCSCCCCC---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------
T ss_pred cCCCCEeecccceeeecCCC---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------
Confidence 99999999999999765433 23446799999999999999999999999999999999999999964321
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
......+. ... ..++...++++.+++.+||+.||++|||+.|+++
T Consensus 210 ---~~~~~~i~-------------~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 210 ---QETYKRIS-------------RVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---HHHHHHHH-------------TTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHH-------------cCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 00111111 111 1112334567889999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=399.70 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=204.6
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccC-CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT-GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.|.+.++||+|+||+||+|+.. +++.||||+++... ...+.+.+|++++++++|||||++++++.+.+..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 4777889999999999999874 68999999997543 345678999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|.+++.. ..++..++..++.||+.||+|||+++ ||||||||+|||++.+
T Consensus 101 gg~L~~~~~~-------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~ 152 (293)
T d1yhwa1 101 GGSLTDVVTE-------------------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMD 152 (293)
T ss_dssp TCBHHHHHHH-------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred CCcHHHHhhc-------------------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCC
Confidence 9999998743 24889999999999999999999998 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCchh
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYFP 681 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~~ 681 (763)
+++||+|||+|+....... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||......
T Consensus 153 ~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------- 222 (293)
T d1yhwa1 153 GSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------- 222 (293)
T ss_dssp CCEEECCCTTCEECCSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---------
T ss_pred CcEeeccchhheeeccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH---------
Confidence 9999999999987654332 234567999999999999999999999999999999999999999643210
Q ss_pred HHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 682 KWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
... ...... .......+...+..+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~-~~~~~~------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 223 RAL-YLIATN------------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHH-HHHHHH------------CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHH-HHHHhC------------CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000 01111222345678899999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=392.52 Aligned_cols=246 Identities=26% Similarity=0.367 Sum_probs=196.2
Q ss_pred ccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEee----CCeeeEE
Q 046586 445 NGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAE----KGERTLV 516 (763)
Q Consensus 445 ~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~LV 516 (763)
+.|.++||+|+||+||+|... +++.||+|.++.... ..+.|.+|+++|++++|||||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356778999999999999875 578999999975432 23568899999999999999999999875 3467899
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++|+|.+++... ..+++..+..++.||++||+|||+++ .+|+||||||+||
T Consensus 91 mE~~~~g~L~~~l~~~------------------------~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NI 145 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF------------------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNI 145 (270)
T ss_dssp EECCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGE
T ss_pred EeCCCCCcHHHHHhcc------------------------ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhc
Confidence 9999999999999653 35889999999999999999999976 4599999999999
Q ss_pred EEc-CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCC
Q 046586 597 LLG-DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNS 675 (763)
Q Consensus 597 Ll~-~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 675 (763)
|++ +++.+||+|||+|+..... ......||+.|||||.+.+ +++.++|||||||++|||++|+.||......
T Consensus 146 Ll~~~~~~~Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--- 218 (270)
T d1t4ha_ 146 FITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--- 218 (270)
T ss_dssp EESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---
T ss_pred eeeCCCCCEEEeecCcceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH---
Confidence 996 5899999999999864433 2345689999999998865 6999999999999999999999999633210
Q ss_pred CCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 676 DEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
......+..+ ..+...+....+++.+++.+||+.||++|||+.|+++
T Consensus 219 ------~~~~~~i~~~-------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 219 ------AQIYRRVTSG-------------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------HHHHHHHTTT-------------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------HHHHHHHHcC-------------CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0011111111 1111112233456889999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=399.61 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=192.9
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEee--CCeeeEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAE--KGERTLV 516 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~LV 516 (763)
..|.+.+.||+|+||.||+|+.. +++.||||+++..... .+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 35778899999999999999875 6889999999754322 3458899999999999999999999965 4568999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC--CcEEecCCCCC
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECL--EWVLHCDIKPE 594 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~--~~ivHrDlk~~ 594 (763)
|||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+. .+||||||||+
T Consensus 84 mEy~~~g~L~~~i~~~~~--------------------~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~ 143 (269)
T d2java1 84 MEYCEGGDLASVITKGTK--------------------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 143 (269)
T ss_dssp EECCTTEEHHHHHHHHHH--------------------HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGG
T ss_pred EecCCCCcHHHHHHhccc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchh
Confidence 999999999999865321 23568999999999999999999998752 34999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
|||++.++.+||+|||+++....... ......||+.|||||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 144 NIll~~~~~vkl~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--- 219 (269)
T d2java1 144 NVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--- 219 (269)
T ss_dssp GEEECTTSCEEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred hcCcCCCCcEEEeeccceeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---
Confidence 99999999999999999987654322 23456899999999999999999999999999999999999999964321
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
. .....+.++ .. ...+...++++.+++.+||+.||++|||+.|+++
T Consensus 220 ------~-~~~~~i~~~---------~~-----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 220 ------K-ELAGKIREG---------KF-----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------H-HHHHHHHHT---------CC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------H-HHHHHHHcC---------CC-----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 011111111 11 1122334567899999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-47 Score=406.05 Aligned_cols=279 Identities=26% Similarity=0.367 Sum_probs=209.4
Q ss_pred HhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
..+.+.++||+|+||+||+|+.. +++.||||+++.... ..++|.+|++++++++||||++++++|.+.+..+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 45677899999999999999864 357899999975433 2356999999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++.............................+++..++.|+.|+|.||+|||+.+ ||||||||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~ 169 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATR 169 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEccc
Confidence 99999999999999976543222111111111111111223456899999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCC-CCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS-RNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~-~p~~~~~~~ 672 (763)
|||++.++++||+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||++|. .||.....
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~- 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH-
Confidence 99999999999999999986544332 2334467889999999999999999999999999999999986 56653221
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.+ ....+.++ .....+...+.++.+++.+||+.||++||||.||+++|+.+.+
T Consensus 249 --------~e-~~~~v~~~--------------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 249 --------EE-VIYYVRDG--------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp --------HH-HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --------HH-HHHHHHcC--------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00 01111111 1112223455688999999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-47 Score=396.34 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=203.0
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc-CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV-TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.|.+.++||+|+||.||+|+.. +++.||||+++.. ....+.|.+|+++|++++|||||++++++.+.+..++||||++
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 3677889999999999999875 6889999999754 3445679999999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 93 ~g~L~~~~~~~-----------------------~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~ 146 (288)
T d2jfla1 93 GGAVDAVMLEL-----------------------ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLD 146 (288)
T ss_dssp TEEHHHHHHHH-----------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred CCcHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCC
Confidence 99999998643 235899999999999999999999998 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccc-----cCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLR-----SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
+++||+|||+|+...... .......||+.|||||++. ...|+.++|||||||++|||++|+.||.......
T Consensus 147 ~~~Kl~DFG~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--- 222 (288)
T d2jfla1 147 GDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--- 222 (288)
T ss_dssp SCEEECCCTTCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---
T ss_pred CCEEEEechhhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---
Confidence 999999999997543221 1233467999999999884 4578999999999999999999999997432110
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.......+. ......+...++++.+++.+||+.||++|||+.|+++
T Consensus 223 -------~~~~i~~~~------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 223 -------VLLKIAKSE------------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -------HHHHHHHSC------------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------HHHHHHcCC------------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111110 0011112345678899999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=397.10 Aligned_cols=245 Identities=23% Similarity=0.355 Sum_probs=201.0
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.+.||+|+||.||+|+.. +++.||||+++.. ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 5788899999999999999875 6889999999732 3344678999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ||||||||+|||+
T Consensus 89 y~~gg~L~~~~~~~------------------------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll 141 (288)
T d1uu3a_ 89 YAKNGELLKYIRKI------------------------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILL 141 (288)
T ss_dssp CCTTEEHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred ccCCCCHHHhhhcc------------------------CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCcccccc
Confidence 99999999998643 35889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
++++.+||+|||+|+....... .......||+.|||||++.+..++.++||||+||++|||++|+.||.....
T Consensus 142 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------ 215 (288)
T d1uu3a_ 142 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------ 215 (288)
T ss_dssp CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------
Confidence 9999999999999987654332 233456799999999999999999999999999999999999999974321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
.++......... .++...++++.+++.+||+.||++|||++|++
T Consensus 216 -----------------~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 216 -----------------YLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -----------------HHHHHHHHTTCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -----------------HHHHHHHHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 001111111111 11233456788999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-47 Score=403.36 Aligned_cols=271 Identities=21% Similarity=0.285 Sum_probs=203.0
Q ss_pred HHHhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 441 RAATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 441 ~~~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
....|.+.++||+|+||+||+|+.. +++.||+|+++... ....++.+|+.+|++++|||||+++++|.+.++.++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3456778899999999999999875 68899999997542 23467899999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCcEEecCCCCCce
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEE-CLEWVLHCDIKPENI 596 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~-~~~~ivHrDlk~~NI 596 (763)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||++ + |+||||||+||
T Consensus 84 Ey~~gg~L~~~l~~~------------------------~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NI 136 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA------------------------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNI 136 (322)
T ss_dssp ECCTTEEHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGE
T ss_pred EcCCCCcHHHHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHe
Confidence 999999999999653 2588999999999999999999974 7 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCC--
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN-- 674 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~-- 674 (763)
|+++++++||+|||+|+..... ......||+.|||||++.+.+|+.++||||+||++|||++|+.||........
T Consensus 137 Ll~~~~~vkl~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~ 213 (322)
T d1s9ja_ 137 LVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213 (322)
T ss_dssp EECTTCCEEECCCCCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred eECCCCCEEEeeCCCccccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999999999999999865322 23456899999999999999999999999999999999999999965432100
Q ss_pred -------CCCC---chhHHHHHH----HHh---ccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 675 -------SDEW---YFPKWAFEK----VYE---EMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 675 -------~~~~---~~~~~~~~~----~~~---~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
.... ....+.... ... .....+..+.......+.......+.++.+++.+||+.||++|||+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp HC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 0000 000000000 000 00001111111110000000012346788999999999999999999
Q ss_pred HHHH
Q 046586 738 KVAK 741 (763)
Q Consensus 738 eVv~ 741 (763)
|+++
T Consensus 294 e~L~ 297 (322)
T d1s9ja_ 294 QLMV 297 (322)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=392.91 Aligned_cols=249 Identities=32% Similarity=0.486 Sum_probs=197.2
Q ss_pred HhccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeC-CeeeEEEecCC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK-GERTLVYEYVP 521 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~LV~Ey~~ 521 (763)
..+.+.++||+|+||.||+|++. ++.||||+++.. ...++|.+|++++++++||||++++|+|.+. +..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 34667899999999999999985 578999999753 3457799999999999999999999999654 56899999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcCC
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGDD 601 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~~ 601 (763)
+|+|.++|... ....++|..+++|+.||+.||+|||+.+ |+||||||+|||++.+
T Consensus 85 ~g~L~~~l~~~----------------------~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~ 139 (262)
T d1byga_ 85 KGSLVDYLRSR----------------------GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSED 139 (262)
T ss_dssp TEEHHHHHHHH----------------------HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred CCCHHHHHHhc----------------------CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCC
Confidence 99999999653 1235899999999999999999999988 9999999999999999
Q ss_pred CCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCCCCCCch
Q 046586 602 FCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 602 ~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~~~~~ 680 (763)
+.+||+|||+++..... .....+|..|+|||.+.++.++.++||||||+++|||+| |+.|+.......
T Consensus 140 ~~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~------- 208 (262)
T d1byga_ 140 NVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------- 208 (262)
T ss_dssp SCEEECCCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------
T ss_pred CCEeecccccceecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-------
Confidence 99999999999865432 233467889999999999999999999999999999998 677765322100
Q ss_pred hHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
....+.. ....+++...+.++.+++.+||+.||++||||.+|+++|+.+
T Consensus 209 -------------~~~~i~~----~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 209 -------------VVPRVEK----GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -------------HHHHHTT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------HHHHHHc----CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111111 112223344557889999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=394.66 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=196.1
Q ss_pred HHhccccccccccccceEEEEEeCC----CcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 442 AATNGFSNLIGRGGFGDVYKGELTD----HRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 442 ~~t~~~~~~LG~G~fG~Vy~g~~~~----~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
...+.+.+.||+|+||.||+|++.. +..||||.++..... .+.|.+|++++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4567888999999999999998753 346889988654332 356999999999999999999999996 467899
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|
T Consensus 85 v~E~~~~g~l~~~~~~~-----------------------~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~N 138 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR-----------------------KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARN 138 (273)
T ss_dssp EEECCTTEEHHHHHHHT-----------------------TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEEeccCCcHHhhhhcc-----------------------CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhh
Confidence 99999999999988642 346899999999999999999999988 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 674 (763)
|+++.++.+||+|||+++..............||+.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 139 Ill~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~- 217 (273)
T d1mp8a_ 139 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND- 217 (273)
T ss_dssp EEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-
T ss_pred eeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-
Confidence 999999999999999998766555445556678999999999999999999999999999999998 888886432110
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
....+.++ ...+.+...++.+.+++..||+.||++|||+.||++.|+.++
T Consensus 218 ---------~~~~i~~~--------------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 218 ---------VIGRIENG--------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ---------HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------HHHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 00111111 111223455678999999999999999999999999998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-46 Score=393.95 Aligned_cols=244 Identities=25% Similarity=0.300 Sum_probs=198.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc----hhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEE
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG----DAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~----~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
..|...++||+|+||.||+|+.. +++.||||+++..... .+++.+|+++|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34677889999999999999864 6889999999754322 245889999999999999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|..++.. ...+++.++..++.||+.||+|||+++ ||||||||+|||
T Consensus 95 E~~~~g~l~~~~~~------------------------~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NIL 147 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH------------------------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNIL 147 (309)
T ss_dssp ECCSEEHHHHHHHH------------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEE
T ss_pred EecCCCchHHHHHh------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEE
Confidence 99999999877643 236899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc---CCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS---DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
++.++++||+|||+|+.... .....||+.|||||++.+ +.|+.++|||||||++|||++|+.||......
T Consensus 148 l~~~~~~Kl~DFG~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-- 220 (309)
T d1u5ra_ 148 LSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-- 220 (309)
T ss_dssp EETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--
T ss_pred ECCCCCEEEeecccccccCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--
Confidence 99999999999999986543 234579999999999863 56899999999999999999999999633210
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
........+ ......+...++.+.+++.+||+.||++|||+.|+++
T Consensus 221 --------~~~~~i~~~-------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 221 --------SALYHIAQN-------------ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --------HHHHHHHHS-------------CCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------HHHHHHHhC-------------CCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 001111111 1111111234567899999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-46 Score=392.10 Aligned_cols=254 Identities=27% Similarity=0.445 Sum_probs=191.6
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccC--CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVT--GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
..|.+.+.||+|+||+||+|+.. +++.||||+++... .....+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34788899999999999999875 58899999997432 3345688999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+.
T Consensus 89 ~~gg~L~~~l~~------------------------~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~ 141 (307)
T d1a06a_ 89 VSGGELFDRIVE------------------------KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYY 141 (307)
T ss_dssp CCSCBHHHHHHT------------------------CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEES
T ss_pred cCCCcHHHhhhc------------------------ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeec
Confidence 999999999964 236899999999999999999999998 99999999999994
Q ss_pred ---CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCC
Q 046586 600 ---DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSD 676 (763)
Q Consensus 600 ---~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 676 (763)
+++.+||+|||+++...... ......||+.|||||.+.+..|+.++||||+||++|||++|+.||......
T Consensus 142 ~~~~~~~vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---- 215 (307)
T d1a06a_ 142 SLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---- 215 (307)
T ss_dssp SSSTTCCEEECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred ccCCCceEEEeccceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH----
Confidence 57899999999998654332 234467999999999999999999999999999999999999999643210
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HhccC
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEGT 746 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~~ 746 (763)
..... +..... ..........++++.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 216 ------~~~~~---------i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 216 ------KLFEQ---------ILKAEY--EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ------HHHHH---------HHTTCC--CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ------HHHHH---------HhccCC--CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 00111 111111 1111122344567899999999999999999999998 45543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=394.00 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=204.1
Q ss_pred hccccccccccccceEEEEEeCCC----cEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeC-CeeeEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDH----RVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEK-GERTLV 516 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~----~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~LV 516 (763)
+.+|.++||+|+||+||+|++.++ ..||||+++.... ..++|.+|++++++++|||||+++|++.+. +..++|
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 446678999999999999988542 2689999974333 336799999999999999999999998764 588999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||+++|+|.+++... ...+++..+++++.|+|.||.|||+.+ |+||||||+||
T Consensus 108 ~E~~~~g~l~~~~~~~-----------------------~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NI 161 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE-----------------------THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNC 161 (311)
T ss_dssp EECCTTCBHHHHHHCT-----------------------TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred EEEeecCchhhhhccc-----------------------cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhE
Confidence 9999999999998642 345778899999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcc---cccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMV---SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
|+++++.+||+|||+++........ ......||..|+|||.+..+.++.++||||||+++|||++|+.|+.......
T Consensus 162 Ll~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~ 241 (311)
T d1r0pa_ 162 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241 (311)
T ss_dssp EECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----
T ss_pred eECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 9999999999999999876543322 2334578999999999999999999999999999999999888875322110
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.. ...+.++. ....+...+..+.+++.+||+.||++||+|.||++.|+++.+
T Consensus 242 -----~~----~~~i~~g~--------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 242 -----DI----TVYLLQGR--------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ------C----HHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HH----HHHHHcCC--------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00 01111111 111123345678999999999999999999999999988753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=391.56 Aligned_cols=254 Identities=27% Similarity=0.383 Sum_probs=195.7
Q ss_pred HhccccccccccccceEEEEEeCC--C--cEEEEEEeeccC----CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELTD--H--RVVAVKCLKNVT----GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~~--~--~~VAvK~l~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
..+.+.+.||+|+||.||+|++.. + ..||||+++... ...++|.+|+++|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 457788999999999999998642 2 368999987432 223579999999999999999999999965 4678
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+||||+++|+|.+++... ...+++..++.++.|||+||+|||+++ |+||||||+
T Consensus 87 lv~e~~~~~~l~~~~~~~-----------------------~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~ 140 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH-----------------------QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAAR 140 (273)
T ss_dssp EEEECCTTCBHHHHHHHH-----------------------GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred eeeeeecCcchhhhhhcc-----------------------cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHH
Confidence 999999999999988653 235899999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcc--cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMV--SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGS 671 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~ 671 (763)
|||++.++.+||+|||+++........ ......||..|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 141 NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~ 220 (273)
T d1u46a_ 141 NLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220 (273)
T ss_dssp GEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred HhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence 999999999999999999976544332 2234567889999999999999999999999999999998 8999964321
Q ss_pred CCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 672 MMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 672 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
.+.+..........+.+...+..+.+++.+||+.||++||||.||+++|++.
T Consensus 221 -----------------------~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 221 -----------------------SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----------------------HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------------------HHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111111111112222234556789999999999999999999999999753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=396.04 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=200.2
Q ss_pred hccccccccccccceEEEEEeC-CCc----EEEEEEeecc--CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHR----VVAVKCLKNV--TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~----~VAvK~l~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV 516 (763)
.|++.++||+|+||+||+|... +++ +||+|.++.. ....++|.+|++++++++|||||+++|+|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 4677899999999999999875 333 6899988643 33457799999999999999999999999875 56788
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
+||+.+|+|.+++... ...+++..+++++.|||.||+|||+++ ||||||||+||
T Consensus 89 ~e~~~~~~l~~~~~~~-----------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NI 142 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREH-----------------------KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNV 142 (317)
T ss_dssp EECCTTCBHHHHHHHT-----------------------SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred EEeccCCccccccccc-----------------------ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcc
Confidence 9999999999988653 356899999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCcc-cccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCcccccCCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDMV-SMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNFEIQGSMMN 674 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 674 (763)
|++.++++||+|||+++........ ......||+.|||||.+.++.++.++|||||||++|||+| |..||+......
T Consensus 143 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~- 221 (317)
T d1xkka_ 143 LVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE- 221 (317)
T ss_dssp EEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-
T ss_pred eeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-
Confidence 9999999999999999876544332 2344578999999999999999999999999999999998 788886432110
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
....+... .....+...+.++.+++.+||+.||++|||+.||++.|+.+
T Consensus 222 -------------------~~~~i~~~----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 222 -------------------ISSILEKG----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -------------------HHHHHHHT----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------------HHHHHHcC----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11111111 11122234567889999999999999999999999988764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=395.17 Aligned_cols=269 Identities=25% Similarity=0.287 Sum_probs=200.4
Q ss_pred hccccccccccccceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCC----eeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKG----ERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~LV~Ey 519 (763)
++-+.++||+|+||.||+|++ +|+.||||+++........+..|+..+..++|||||+++|+|.+.+ ..++||||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 455678999999999999997 4688999999754332222344555667789999999999998764 57899999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCcEEecCCCCC
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEEC-----LEWVLHCDIKPE 594 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~-----~~~ivHrDlk~~ 594 (763)
|++|+|.++|.+ ..++|.++++++.|+|.||+|||+.. ...||||||||+
T Consensus 83 ~~~g~L~~~l~~-------------------------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~ 137 (303)
T d1vjya_ 83 HEHGSLFDYLNR-------------------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 137 (303)
T ss_dssp CTTCBHHHHHHH-------------------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGG
T ss_pred ccCCCHHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCcc
Confidence 999999999954 25889999999999999999999742 134999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCc---ccccccccCCCcccccccccCC------CCCccceeehhHHHHHHHhCCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRSDQ------ITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~------~s~ksDVwS~Gvll~elltG~~p 665 (763)
||||+.++++||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||+||||+||..|
T Consensus 138 NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~ 217 (303)
T d1vjya_ 138 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217 (303)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCB
T ss_pred ceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCC
Confidence 99999999999999999987644332 1234467999999999987542 56789999999999999999988
Q ss_pred cccccCCCCCC------CCchhHHHHHHHHhccChhhhhcccccccCCCc-chHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 046586 666 FEIQGSMMNSD------EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSR-VHFDMVNRMVKTAMWCIQDRPELRPSMGK 738 (763)
Q Consensus 666 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 738 (763)
+.......... .... ..... ...+..+.+..+.. .+.+....+.+++.+||+.||++||||.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~-~~~~~---------~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 287 (303)
T d1vjya_ 218 GGIHEDYQLPYYDLVPSDPSV-EEMRK---------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp TTBCCCCCCTTTTTSCSSCCH-HHHHH---------HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred CCcccccccchhhcccccchH-HHHHH---------HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 75433221100 0011 11111 11111222222111 12456778999999999999999999999
Q ss_pred HHHHhccCCC
Q 046586 739 VAKMLEGTVE 748 (763)
Q Consensus 739 Vv~~Le~~~~ 748 (763)
|++.|+.+.+
T Consensus 288 i~~~L~~i~~ 297 (303)
T d1vjya_ 288 IKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999987654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=395.23 Aligned_cols=277 Identities=27% Similarity=0.367 Sum_probs=201.9
Q ss_pred HHHHHHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEe
Q 046586 438 AELRAATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCA 508 (763)
Q Consensus 438 ~el~~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 508 (763)
+|+....+.+.++||+|+||.||+|+.. +++.||||+++.... ..+++.+|...+.++ +|+|||.+++++.
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 3455567888999999999999999863 246899999975432 345678888888777 7999999999987
Q ss_pred eCC-eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEE
Q 046586 509 EKG-ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVL 587 (763)
Q Consensus 509 ~~~-~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~iv 587 (763)
+.+ ..++||||+++|+|.+++...+......... ........+++.+++.++.||++||+|||+++ ||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iv 156 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA--------PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 156 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-------------------CBCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccc--------hhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---Cc
Confidence 654 6899999999999999997643211100000 00113456899999999999999999999988 99
Q ss_pred ecCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCC-CC
Q 046586 588 HCDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS-RN 665 (763)
Q Consensus 588 HrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~-~p 665 (763)
||||||+||||++++++||+|||+|+....... .......||+.|||||.+.++.++.++|||||||++|||++|. .|
T Consensus 157 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp CSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence 999999999999999999999999986554333 2344567999999999999999999999999999999999975 56
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEG 745 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~ 745 (763)
|...... ......+.++ .....+...++++.+++.+||+.||++||||.||+++|+.
T Consensus 237 ~~~~~~~---------~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 237 YPGVKID---------EEFCRRLKEG--------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp STTCCCS---------HHHHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHH---------HHHHHHHhcC--------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 7532211 1111111111 1112223445678999999999999999999999999987
Q ss_pred CCC
Q 046586 746 TVE 748 (763)
Q Consensus 746 ~~~ 748 (763)
+++
T Consensus 294 ilq 296 (299)
T d1ywna1 294 LLQ 296 (299)
T ss_dssp HHH
T ss_pred HHh
Confidence 653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=392.67 Aligned_cols=278 Identities=24% Similarity=0.346 Sum_probs=213.7
Q ss_pred HHHHHHhccccccccccccceEEEEEe------CCCcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEe
Q 046586 438 AELRAATNGFSNLIGRGGFGDVYKGEL------TDHRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCA 508 (763)
Q Consensus 438 ~el~~~t~~~~~~LG~G~fG~Vy~g~~------~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 508 (763)
+|+....+.+.++||+|+||.||+|++ ..++.||||+++.... ...+|.+|+.+++++ +|||||+++|+|.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 345567888899999999999999976 2456899999975433 334689999999999 7999999999999
Q ss_pred eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 046586 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLH 588 (763)
Q Consensus 509 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 588 (763)
+.+..++||||+++|+|.+++.............. .........+++..+++++.||++||+|||+++ |||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~------~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivH 168 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP------AIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIH 168 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhcccccccccccc------ccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 99999999999999999999987543211111000 001123457999999999999999999999998 999
Q ss_pred cCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCC-Cc
Q 046586 589 CDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR-NF 666 (763)
Q Consensus 589 rDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~-p~ 666 (763)
|||||+||+++.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+++.. |+
T Consensus 169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654333 33345678999999999999999999999999999999999544 44
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
...... .. ..++++...... .+...+..+.+|+.+||+.||++||||.+|+++|++.
T Consensus 249 ~~~~~~---------~~----------~~~~i~~~~~~~----~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 249 PGMPVD---------SK----------FYKMIKEGFRML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp TTCCSS---------HH----------HHHHHHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCHH---------HH----------HHHHHhcCCCCC----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 322110 00 111222211111 2233457899999999999999999999999999865
Q ss_pred C
Q 046586 747 V 747 (763)
Q Consensus 747 ~ 747 (763)
+
T Consensus 306 i 306 (311)
T d1t46a_ 306 I 306 (311)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.5e-45 Score=392.72 Aligned_cols=250 Identities=19% Similarity=0.272 Sum_probs=204.6
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.|.+.+.||+|+||.||+|+.. +|+.||||+++.... ..+.+.+|+.+|++++|||||++++++.+.+..+|||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 5788899999999999999875 688999999975433 34568899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc--
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG-- 599 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~-- 599 (763)
+|+|.+++... ...+++..+..|+.||+.||+|||+++ ||||||||+|||++
T Consensus 107 gg~L~~~l~~~-----------------------~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~ 160 (350)
T d1koaa2 107 GGELFEKVADE-----------------------HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTK 160 (350)
T ss_dssp SCBHHHHHTCT-----------------------TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESST
T ss_pred CCCHHHHHHhh-----------------------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccC
Confidence 99999998532 235899999999999999999999998 99999999999995
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
.++.+||+|||+++...... ......||+.|||||++.+..++.++||||+||++|||++|+.||.....
T Consensus 161 ~~~~vkL~DFG~a~~~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------- 230 (350)
T d1koaa2 161 RSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------- 230 (350)
T ss_dssp TSCCEEECCCTTCEECCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------
T ss_pred CCCeEEEeecchheeccccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------
Confidence 46889999999998765433 23446799999999999999999999999999999999999999964321
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
.. ....+... . ...........++++.+++.+||+.||++|||++|+++.
T Consensus 231 -~~-~~~~i~~~---------~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 231 -DE-TLRNVKSC---------D--WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -HH-HHHHHHHT---------C--CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -HH-HHHHHHhC---------C--CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 01111111 0 011111112345678899999999999999999999984
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=381.53 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=203.5
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeee
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERT 514 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 514 (763)
..|.+.+.||+|+||.||+|+.. +|+.||||+++.... ..+.+.+|+++|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35788899999999999999875 688999999964321 2356899999999999999999999999999999
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
|||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 90 iv~E~~~gg~L~~~i~~~------------------------~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~ 142 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK------------------------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPE 142 (293)
T ss_dssp EEEECCCSCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred EEEEcCCCccccchhccc------------------------cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccc
Confidence 999999999999999643 35889999999999999999999998 999999999
Q ss_pred ceEEcCCC----CeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 595 NILLGDDF----CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 595 NILl~~~~----~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
|||++.++ .+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 143 Nill~~~~~~~~~vkl~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 143 NIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp GEEESCSSSSSCCEEECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eEEEecCCCcccceEecchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 99998776 49999999998764432 2344578999999999999999999999999999999999999997432
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.. .....+.... .......+...+..+.+++.+||+.||++|||+.|+++
T Consensus 221 ~~----------~~~~~i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 221 KQ----------ETLANVSAVN-----------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HH----------HHHHHHHTTC-----------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HH----------HHHHHHHhcC-----------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 0111111110 01111111234567889999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.6e-45 Score=391.10 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=206.4
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~ 521 (763)
.|.+.++||+|+||.||+|+.. +++.||||+++.... ....+.+|+++|++++|||||++++++.+++..+|||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4788899999999999999874 689999999975432 34567899999999999999999999999999999999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc--
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG-- 599 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~-- 599 (763)
+|+|.+++.. ....+++.++..|+.||+.||+|||+.+ ||||||||+|||++
T Consensus 110 gg~L~~~~~~-----------------------~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~ 163 (352)
T d1koba_ 110 GGELFDRIAA-----------------------EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETK 163 (352)
T ss_dssp CCBHHHHTTC-----------------------TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESST
T ss_pred CChHHHHHHh-----------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccccccccccccc
Confidence 9999988743 2346899999999999999999999998 99999999999998
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
.++.+||+|||+|+...... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||......
T Consensus 164 ~~~~vkL~DFGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------- 234 (352)
T d1koba_ 164 KASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------- 234 (352)
T ss_dssp TCCCEEECCCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------
T ss_pred CCCeEEEeecccceecCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------
Confidence 67899999999998765443 234467899999999999999999999999999999999999999643210
Q ss_pred hhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcc
Q 046586 680 FPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM--LEG 745 (763)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~--Le~ 745 (763)
. ........ .. ..+.......+.++.+++.+||+.||++|||+.|+++. +++
T Consensus 235 --~-~~~~i~~~---------~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 235 --E-TLQNVKRC---------DW--EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp --H-HHHHHHHC---------CC--CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred --H-HHHHHHhC---------CC--CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0 00111111 00 11111123445678899999999999999999999873 544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=387.48 Aligned_cols=268 Identities=26% Similarity=0.445 Sum_probs=204.8
Q ss_pred hccccccccccccceEEEEEeCC-Cc--EEEEEEeecc--CCchhhhHHHHHHHhcC-CCCccccEEEEEeeCCeeeEEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTD-HR--VVAVKCLKNV--TGGDAEFWAEVTIIARM-HHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~-~~--~VAvK~l~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~LV~ 517 (763)
.+.+.++||+|+||.||+|++.+ +. .||||.++.. ....++|.+|+++|+++ +|||||+++|+|.+++..++||
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 45677899999999999998754 33 5788888643 33456799999999999 7999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.++|+............ ........+++.++++++.|||+||.|||+.+ |+||||||+|||
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~--------~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL 159 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFA--------IANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL 159 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHH--------HHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred EecCCCcHHHHHhhccccccchhhh--------ccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEE
Confidence 9999999999997542100000000 00113467999999999999999999999988 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCC-CcccccCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSR-NFEIQGSMMNSD 676 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~-p~~~~~~~~~~~ 676 (763)
++.++.+||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. ||....
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------ 231 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------ 231 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------
T ss_pred EcCCCceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------
Confidence 9999999999999997543322 2234568999999999999999999999999999999999765 554221
Q ss_pred CCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 677 EWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
..++++... ...+.+.+...++++.+++.+||+.||++||||+||++.|+++.+
T Consensus 232 -----------------~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 232 -----------------CAELYEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -----------------HHHHHHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------------HHHHHHHHH-hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111111111 111222334556789999999999999999999999999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=387.39 Aligned_cols=269 Identities=23% Similarity=0.341 Sum_probs=212.1
Q ss_pred HHHHHhccccccccccccceEEEEEeC------CCcEEEEEEeeccCCc--hhhhHHHHHHHhcCCCCccccEEEEEeeC
Q 046586 439 ELRAATNGFSNLIGRGGFGDVYKGELT------DHRVVAVKCLKNVTGG--DAEFWAEVTIIARMHHLNLVRLWGFCAEK 510 (763)
Q Consensus 439 el~~~t~~~~~~LG~G~fG~Vy~g~~~------~~~~VAvK~l~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 510 (763)
||....+.+.++||+|+||+||+|.+. +++.||||+++..... ...|.+|++++++++|||||+++|+|...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 344456778899999999999999764 2578999999754332 24589999999999999999999999999
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
+..++||||+++|+|.+++...+... . .......+++..+.+++.|+|+||+|||+.+ |+|||
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~--------~------~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrD 158 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAM--------A------NNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 158 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHH--------H------HCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSC
T ss_pred CceeEEEeecCCCCHHHHHHhccccc--------c------cccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeece
Confidence 99999999999999999986532100 0 0012345789999999999999999999988 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCC-CCccc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGS-RNFEI 668 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~-~p~~~ 668 (763)
|||+|||+++++++||+|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||+||+ .|+..
T Consensus 159 lk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 159 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp CSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred EcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999986654333 2233456899999999999999999999999999999999985 56642
Q ss_pred ccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 046586 669 QGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTVE 748 (763)
Q Consensus 669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~~ 748 (763)
.. .... ... +.+. .....+...+..+.+++.+||+.||++||||.+|+++|++.++
T Consensus 239 ~~---------~~~~-~~~---------i~~~-----~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 239 LS---------NEQV-LRF---------VMEG-----GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp SC---------HHHH-HHH---------HHTT-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CC---------HHHH-HHH---------HHhC-----CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 21 1110 111 1111 1111223455789999999999999999999999999998654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=387.62 Aligned_cols=274 Identities=27% Similarity=0.373 Sum_probs=207.6
Q ss_pred HHHHhccccccccccccceEEEEEeCC--------CcEEEEEEeeccCC--chhhhHHHHHHHhcC-CCCccccEEEEEe
Q 046586 440 LRAATNGFSNLIGRGGFGDVYKGELTD--------HRVVAVKCLKNVTG--GDAEFWAEVTIIARM-HHLNLVRLWGFCA 508 (763)
Q Consensus 440 l~~~t~~~~~~LG~G~fG~Vy~g~~~~--------~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 508 (763)
|....+.+.+.||+|+||.||+|+... +..||||+++.... ...++.+|+..+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 445577888999999999999997632 24799999975443 346788999999888 8999999999999
Q ss_pred eCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEe
Q 046586 509 EKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLH 588 (763)
Q Consensus 509 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivH 588 (763)
+++..++||||+++|+|.++|...+........ .........+++.+++.++.||+.||+|||+.+ |||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~--------~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivH 158 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSY--------NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 158 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCcccccc--------ccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEe
Confidence 999999999999999999999765321111000 011123467999999999999999999999998 999
Q ss_pred cCCCCCceEEcCCCCeEEcccCcccccCCCCc-ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh-CCCCc
Q 046586 589 CDIKPENILLGDDFCPKISDFGLAKLRKKEDM-VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS-GSRNF 666 (763)
Q Consensus 589 rDlk~~NILl~~~~~~kI~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt-G~~p~ 666 (763)
|||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.++.|+.++||||||+++|||++ |..||
T Consensus 159 rDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 159 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238 (299)
T ss_dssp SCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred eeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence 99999999999999999999999987654333 23344678999999999999999999999999999999998 67787
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
..... ......+..+ .. ...+...+.++.+++.+||+.||++|||+.||+++|+.+
T Consensus 239 ~~~~~----------~~~~~~i~~~----------~~----~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 239 PGVPV----------EELFKLLKEG----------HR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp TTCCH----------HHHHHHHHTT----------CC----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCH----------HHHHHHHHcC----------CC----CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 53221 1111111111 11 112233456789999999999999999999999999876
Q ss_pred CC
Q 046586 747 VE 748 (763)
Q Consensus 747 ~~ 748 (763)
+.
T Consensus 295 ~a 296 (299)
T d1fgka_ 295 VA 296 (299)
T ss_dssp HH
T ss_pred hh
Confidence 53
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-44 Score=380.62 Aligned_cols=242 Identities=24% Similarity=0.334 Sum_probs=202.5
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 4678899999999999999875 6899999999742 3345678999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|..++... ..+++..+..++.||+.||+|||+++ ||||||||+|||+
T Consensus 85 ~~~gg~l~~~~~~~------------------------~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl 137 (316)
T d1fota_ 85 YIEGGELFSLLRKS------------------------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILL 137 (316)
T ss_dssp CCCSCBHHHHHHHT------------------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEE
T ss_pred ecCCcccccccccc------------------------ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeE
Confidence 99999999988643 35678888999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.+||+|||+|+..... .....||+.|||||.+.+..|+.++||||+||++|||++|+.||.....
T Consensus 138 ~~~g~vkL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------- 206 (316)
T d1fota_ 138 DKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------- 206 (316)
T ss_dssp CTTSCEEECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------
T ss_pred cCCCCEEEecCccceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------
Confidence 99999999999999876433 2346899999999999999999999999999999999999999974321
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
.++..+.+.... ..+...++++.+++.+||+.||.+|| |++++++
T Consensus 207 ----------------~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 207 ----------------MKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----------------HHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------------HHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 111111111111 11233456788999999999999996 8999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=382.23 Aligned_cols=245 Identities=25% Similarity=0.313 Sum_probs=203.6
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.+.||+|+||.||+++.. +++.||||+++.. ....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 4778899999999999999874 6899999999742 3345678899999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+++|+|.+++... ..++...+..++.||+.||+|||+++ ||||||||+|||+
T Consensus 86 y~~gg~L~~~~~~~------------------------~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl 138 (337)
T d1o6la_ 86 YANGGELFFHLSRE------------------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLML 138 (337)
T ss_dssp CCTTCBHHHHHHHH------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEE
T ss_pred ccCCCchhhhhhcc------------------------cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEe
Confidence 99999999998654 35788889999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++.+||+|||+|+...... .......||+.|+|||.+.+..|+.++||||+||++|||++|+.||.....
T Consensus 139 ~~~g~vkl~DFG~a~~~~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------- 210 (337)
T d1o6la_ 139 DKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------- 210 (337)
T ss_dssp CTTSCEEECCCTTCBCSCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------
T ss_pred cCCCCEEEeecccccccccCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-------
Confidence 999999999999998654332 234456899999999999999999999999999999999999999974321
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~ 741 (763)
.++........ ..++...+.++.+++.+||+.||++||+ +.|+++
T Consensus 211 ----------------~~~~~~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 211 ----------------ERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----------------HHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----------------HHHHHHHhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 01111111111 1122344567889999999999999995 778875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.9e-44 Score=372.38 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=196.9
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeeccCCc----hhhhHHHHHHHhcCCCCccccEEEEEeeCC----eee
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGG----DAEFWAEVTIIARMHHLNLVRLWGFCAEKG----ERT 514 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~----~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 514 (763)
+|.+.+.||+|+||.||+|+. .+++.||||+++..... ...|.+|+++++.++|||||++++++...+ ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 477889999999999999987 46889999999754322 245889999999999999999999998754 378
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
|||||+++++|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+
T Consensus 88 lvmE~~~g~~L~~~~~~~------------------------~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~ 140 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTE------------------------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 140 (277)
T ss_dssp EEEECCCEEEHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred EEEECCCCCEehhhhccc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCc
Confidence 999999999999988653 35889999999999999999999988 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
|||++.++..+|+|||.+........ .......||+.|||||.+.+..++.++||||+||++|||++|+.||.....
T Consensus 141 NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~- 219 (277)
T d1o6ya_ 141 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP- 219 (277)
T ss_dssp GEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred ccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-
Confidence 99999999999999999976543322 234456799999999999999999999999999999999999999964321
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHhcc
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-SMGKVAKMLEG 745 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~eVv~~Le~ 745 (763)
.+............ ........++++.+++.+||+.||++|| |++++++.|..
T Consensus 220 --------~~~~~~~~~~~~~~------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 220 --------VSVAYQHVREDPIP------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp --------HHHHHHHHHCCCCC------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --------HHHHHHHHhcCCCC------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11111111111000 0001123456788999999999999999 89999888764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-43 Score=380.00 Aligned_cols=242 Identities=21% Similarity=0.238 Sum_probs=202.8
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEe
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYE 518 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~E 518 (763)
.|.+.++||+|+||.||+|+.. +|+.||||+++.. ....+.+.+|+.+|+.++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 5778899999999999999875 6899999999632 2344668999999999999999999999999999999999
Q ss_pred cCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEE
Q 046586 519 YVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILL 598 (763)
Q Consensus 519 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl 598 (763)
|+.+|+|.+++... ..+++..+..++.||+.||.|||+.+ ||||||||+|||+
T Consensus 122 ~~~~g~l~~~l~~~------------------------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl 174 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRI------------------------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLI 174 (350)
T ss_dssp CCTTCBHHHHHHHH------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred cccccchhhhHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHccc
Confidence 99999999999653 25889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 599 GDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 599 ~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
+.++++||+|||+|+..... .....||+.|||||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 175 ~~~g~ikL~DFG~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------- 243 (350)
T d1rdqe_ 175 DQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------- 243 (350)
T ss_dssp CTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------
T ss_pred CCCCCEEeeeceeeeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------
Confidence 99999999999999876532 2346799999999999999999999999999999999999999964321
Q ss_pred chhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRP-----SMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~eVv~ 741 (763)
......+..+ .. ..+...+.++.+++.+||+.||.+|+ |+.++++
T Consensus 244 ---~~~~~~i~~~-------------~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 244 ---IQIYEKIVSG-------------KV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---HHHHHHHHHC-------------CC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---HHHHHHHhcC-------------CC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0111111111 11 11133456788999999999999994 8999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-43 Score=369.61 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=202.5
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeeccCCc----------hhhhHHHHHHHhcCC-CCccccEEEEEeeCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGG----------DAEFWAEVTIIARMH-HLNLVRLWGFCAEKG 511 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~----------~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~ 511 (763)
.|.+.++||+|+||+||+++. .+++.||||+++..... .+.+.+|+.++++++ |||||++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 467789999999999999987 46889999999754321 134789999999996 999999999999999
Q ss_pred eeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 512 ERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 512 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
..+|||||+++|+|.++|... ..+++.+++.++.||++||+|||+.+ |+||||
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDl 136 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEK------------------------VTLSEKETRKIMRALLEVICALHKLN---IVHRDL 136 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred ceEEEEEcCCCchHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcC---Cccccc
Confidence 999999999999999999643 35899999999999999999999998 999999
Q ss_pred CCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc------CCCCCccceeehhHHHHHHHhCCCC
Q 046586 592 KPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS------DQITPKADVYSFGMVLLEIVSGSRN 665 (763)
Q Consensus 592 k~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~s~ksDVwS~Gvll~elltG~~p 665 (763)
||+|||++.++.+||+|||+++...... ..+...||..|+|||++.+ ..++.++||||+||++|||++|+.|
T Consensus 137 kp~Nill~~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~P 214 (277)
T d1phka_ 137 KPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214 (277)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccceEEEcCCCCeEEccchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCC
Confidence 9999999999999999999998765432 2344679999999998853 4578899999999999999999999
Q ss_pred cccccCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 046586 666 FEIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM 742 (763)
Q Consensus 666 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~ 742 (763)
|..... ......+..+. .. .........++++.+++.+||+.||++|||+.||++.
T Consensus 215 f~~~~~----------~~~~~~i~~~~---------~~--~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 215 FWHRKQ----------MLMLRMIMSGN---------YQ--FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp SCCSSH----------HHHHHHHHHTC---------CC--CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCH----------HHHHHHHHhCC---------CC--CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 974321 11111111111 10 1111123456789999999999999999999999763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=376.65 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=203.6
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecCCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYVPN 522 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~~~ 522 (763)
.|.+.+.||+|+||+||+|... +++.||||+++........+.+|+++|+.++|||||++++++.+.+..+|||||+++
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 4678899999999999999875 678999999986655556788999999999999999999999999999999999999
Q ss_pred CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC--
Q 046586 523 GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD-- 600 (763)
Q Consensus 523 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~-- 600 (763)
|+|.+++... ...+++.++..|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 86 g~L~~~i~~~-----------------------~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~ 139 (321)
T d1tkia_ 86 LDIFERINTS-----------------------AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRR 139 (321)
T ss_dssp CBHHHHHTSS-----------------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSS
T ss_pred CcHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCC
Confidence 9999999532 235899999999999999999999998 999999999999985
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCch
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWYF 680 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~~ 680 (763)
...+||+|||+++....... .....+|+.|+|||.+.+..++.++||||+||++|||++|+.||.....
T Consensus 140 ~~~ikl~DFG~~~~~~~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------- 208 (321)
T d1tkia_ 140 SSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------- 208 (321)
T ss_dssp CCCEEECCCTTCEECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---------
T ss_pred ceEEEEcccchhhccccCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---------
Confidence 45899999999986644322 3345789999999999999999999999999999999999999964321
Q ss_pred hHHHHHHHHhccChhhhhcccccccC--CCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 681 PKWAFEKVYEEMKVEDILDRHIKNSY--DSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
.+++...+.... +.......+.++.+++.+||+.||++|||+.|+++
T Consensus 209 --------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 209 --------------QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --------------HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --------------HHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111111111 11111134567889999999999999999999997
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=378.03 Aligned_cols=245 Identities=24% Similarity=0.329 Sum_probs=200.4
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHHHHHHh-cCCCCccccEEEEEeeCCeeeEEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAEVTIIA-RMHHLNLVRLWGFCAEKGERTLVY 517 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~LV~ 517 (763)
.|.+.++||+|+||+||+|+.. +++.||||+++.. ....+.+..|..++. .++|||||++++++.+++..++||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 4678899999999999999875 6889999999742 334456777777765 689999999999999999999999
Q ss_pred ecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceE
Q 046586 518 EYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENIL 597 (763)
Q Consensus 518 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NIL 597 (763)
||+++|+|.+++... ..++..++..++.||+.||+|||+++ |+||||||+|||
T Consensus 83 Ey~~~g~L~~~i~~~------------------------~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL 135 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSC------------------------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNIL 135 (320)
T ss_dssp ECCTTCBHHHHHHHH------------------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEE
T ss_pred eecCCCcHHHHhhcc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCccccee
Confidence 999999999999654 24788899999999999999999998 999999999999
Q ss_pred EcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 598 LGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 598 l~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
+++++++||+|||+++...... ...+...||+.|+|||.+.+..++.++||||+||++|||++|+.||.....
T Consensus 136 ~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------ 208 (320)
T d1xjda_ 136 LDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------ 208 (320)
T ss_dssp ECTTSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred ecCCCceeccccchhhhccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------
Confidence 9999999999999998654332 233446799999999999999999999999999999999999999974321
Q ss_pred CchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 046586 678 WYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG-KVAK 741 (763)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-eVv~ 741 (763)
......... .. ...+...+.++.+++.+||+.||++||++. +|++
T Consensus 209 ----~~~~~~i~~-------------~~--~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 209 ----EELFHSIRM-------------DN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----HHHHHHHHH-------------CC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----HHHHHHHHc-------------CC--CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 011111111 11 112233456788999999999999999995 6763
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=377.33 Aligned_cols=257 Identities=20% Similarity=0.273 Sum_probs=201.6
Q ss_pred hcccc-ccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhc-CCCCccccEEEEEee----CCeeeEE
Q 046586 444 TNGFS-NLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIAR-MHHLNLVRLWGFCAE----KGERTLV 516 (763)
Q Consensus 444 t~~~~-~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~LV 516 (763)
.|.+. +.||+|+||.||+|+. .+++.||||+++. ...+.+|++++.+ .+|||||++++++.+ ....++|
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 45655 4699999999999987 4688999999964 3567789998665 489999999999875 4578999
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
||||++|+|.++|... ....+++.++..|+.||+.||+|||+.+ |+||||||+||
T Consensus 88 mEy~~gg~L~~~i~~~----------------------~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NI 142 (335)
T d2ozaa1 88 MECLDGGELFSRIQDR----------------------GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENL 142 (335)
T ss_dssp EECCCSEEHHHHHHSC----------------------SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred EECCCCCcHHHHHHhc----------------------CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccc
Confidence 9999999999999643 2346899999999999999999999998 99999999999
Q ss_pred EEcC---CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 597 LLGD---DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 597 Ll~~---~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
|+++ ++.+||+|||+|+...... ......||+.|||||.+.+..|+.++|||||||++|||++|+.||.......
T Consensus 143 ll~~~~~~~~~Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 143 LYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp EESCSSTTCCEEECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred ccccccccccccccccceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence 9985 5679999999998665433 2344679999999999999999999999999999999999999997543221
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhccccccc--CCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--hccCCCC
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILDRHIKNS--YDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM--LEGTVEI 749 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~--Le~~~~~ 749 (763)
. ...+........ .+.......++++.+++.+||+.||++|||+.|+++. +.+..+.
T Consensus 221 ~-------------------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 281 (335)
T d2ozaa1 221 I-------------------SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281 (335)
T ss_dssp --------------------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSS
T ss_pred H-------------------HHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCC
Confidence 1 001111111111 1112223556789999999999999999999999972 4444443
Q ss_pred C
Q 046586 750 T 750 (763)
Q Consensus 750 ~ 750 (763)
+
T Consensus 282 ~ 282 (335)
T d2ozaa1 282 P 282 (335)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.4e-43 Score=378.25 Aligned_cols=246 Identities=23% Similarity=0.299 Sum_probs=196.6
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeecc----CCchhhhHHH---HHHHhcCCCCccccEEEEEeeCCeeeE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV----TGGDAEFWAE---VTIIARMHHLNLVRLWGFCAEKGERTL 515 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~----~~~~~~f~~E---~~~l~~l~H~niv~l~g~~~~~~~~~L 515 (763)
.|.+.++||+|+||.||+|+.. +|+.||||++... ......+.+| +.+++.++|||||++++++.+.+..++
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 4677899999999999999875 6899999998632 2223334444 667778899999999999999999999
Q ss_pred EEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCc
Q 046586 516 VYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPEN 595 (763)
Q Consensus 516 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~N 595 (763)
||||+++|+|.++|... ..+++..+..++.||+.||+|||+.+ ||||||||+|
T Consensus 85 vmE~~~gg~L~~~l~~~------------------------~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~N 137 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQH------------------------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPAN 137 (364)
T ss_dssp EECCCCSCBHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEEecCCCcHHHHHHhc------------------------ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccce
Confidence 99999999999999653 35778899999999999999999998 9999999999
Q ss_pred eEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 596 ILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 596 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
||++.++.+||+|||+|+...... .....||+.|+|||++.. ..|+.++|||||||++|||++|+.||.......
T Consensus 138 ILl~~~g~iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~- 213 (364)
T d1omwa3 138 ILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD- 213 (364)
T ss_dssp EEECSSSCEEECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-
T ss_pred eEEcCCCcEEEeeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 999999999999999998665432 344679999999999864 578999999999999999999999997533211
Q ss_pred CCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046586 675 SDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~ 741 (763)
..++....... ....+...++++.+++.+||+.||++||| +.|+++
T Consensus 214 -------------------~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 214 -------------------KHEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------------------HHHHHHHSSSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------------------HHHHHHhcccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00111111111 11111234567889999999999999999 688874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=367.19 Aligned_cols=260 Identities=22% Similarity=0.286 Sum_probs=194.9
Q ss_pred cccccccccceEEEEEeC-CCcEEEEEEeeccCC------chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 448 SNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG------GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 448 ~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.++||+|+||+||+|+.. +++.||||+++.... ..+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 368999999999999875 588999999964321 1246889999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+++++..... ....+++.++..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 83 ~~~~~~~~~~------------------------~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~ 135 (299)
T d1ua2a_ 83 ETDLEVIIKD------------------------NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDE 135 (299)
T ss_dssp SEEHHHHHTT------------------------CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred cchHHhhhhh------------------------cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecC
Confidence 9887766553 2345778889999999999999999998 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||+++....... ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||.......
T Consensus 136 ~~~~KL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~------ 208 (299)
T d1ua2a_ 136 NGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD------ 208 (299)
T ss_dssp TCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------
T ss_pred CCccccccCccccccCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH------
Confidence 99999999999986554332 2334578999999998865 568999999999999999999999996432110
Q ss_pred hhHHHHHHHHhc--cChhhhhcc-------cccccCC-Cc---chHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--Hhc
Q 046586 680 FPKWAFEKVYEE--MKVEDILDR-------HIKNSYD-SR---VHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLE 744 (763)
Q Consensus 680 ~~~~~~~~~~~~--~~~~~~~~~-------~l~~~~~-~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le 744 (763)
....+.+. ....+.... ....... .. ......+++.+++.+||+.||++|||++|+++ .|.
T Consensus 209 ----~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~ 284 (299)
T d1ua2a_ 209 ----QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 284 (299)
T ss_dssp ----HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred ----HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhC
Confidence 00111100 000000000 0000000 00 00123467899999999999999999999997 465
Q ss_pred c
Q 046586 745 G 745 (763)
Q Consensus 745 ~ 745 (763)
.
T Consensus 285 ~ 285 (299)
T d1ua2a_ 285 N 285 (299)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=360.50 Aligned_cols=242 Identities=26% Similarity=0.431 Sum_probs=196.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCC-------chhhhHHHHHHHhcCC--CCccccEEEEEeeCCe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG-------GDAEFWAEVTIIARMH--HLNLVRLWGFCAEKGE 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~-------~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~ 512 (763)
..|.+.++||+|+||.||+|+.. +++.||||+++.... ...++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 45788899999999999999875 689999999974321 1244789999999986 9999999999999999
Q ss_pred eeEEEecCCC-CCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCC
Q 046586 513 RTLVYEYVPN-GSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDI 591 (763)
Q Consensus 513 ~~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDl 591 (763)
.++||||+.+ +++.+++... ..+++.++..++.||+.||+|||+.+ |+||||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~------------------------~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDi 136 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER------------------------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDI 136 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH------------------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred EEEEEEeccCcchHHHHHhcc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccC
Confidence 9999999976 6788877543 35889999999999999999999998 999999
Q ss_pred CCCceEEcC-CCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCC-CCccceeehhHHHHHHHhCCCCcccc
Q 046586 592 KPENILLGD-DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQI-TPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 592 k~~NILl~~-~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
||+|||++. ++.+||+|||+|+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||...
T Consensus 137 Kp~NIll~~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 137 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccceEEecCCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 999999985 579999999999865433 2345679999999999987765 56799999999999999999999632
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--Hhcc
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK--MLEG 745 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~--~Le~ 745 (763)
. ....+ .. ..+ ...++++.+++.+||+.||++|||+.|+++ .|++
T Consensus 214 ~----------------~i~~~---------~~--~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 260 (273)
T d1xwsa_ 214 E----------------EIIRG---------QV--FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260 (273)
T ss_dssp H----------------HHHHC---------CC--CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred h----------------HHhhc---------cc--CCC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 1 11111 00 111 123467889999999999999999999987 3544
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=356.65 Aligned_cols=266 Identities=21% Similarity=0.265 Sum_probs=198.7
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.|.+.++||+|+||+||+|+. .+++.||||+++... ...+++.+|++++++++|||||++++++.+.+..++||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 466778999999999999987 468999999996432 2346789999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+.+ ++.+++... ....+++..+..++.||+.||+|||+++ ||||||||+|||++
T Consensus 83 ~~~-~~~~~~~~~----------------------~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~ 136 (298)
T d1gz8a_ 83 LHQ-DLKKFMDAS----------------------ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLIN 136 (298)
T ss_dssp CSE-EHHHHHHHT----------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred cCC-chhhhhhhh----------------------cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeec
Confidence 975 555555332 3456899999999999999999999998 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCC-CCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQ-ITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
.++.+||+|||+|+...... .......||+.|+|||.+.... ++.++||||+||++|||++|+.||.......
T Consensus 137 ~~~~~kl~DFG~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~----- 210 (298)
T d1gz8a_ 137 TEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----- 210 (298)
T ss_dssp TTSCEEECSTTHHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----
T ss_pred ccCcceeccCCcceeccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-----
Confidence 99999999999998654432 2234457999999999877654 5789999999999999999999996432110
Q ss_pred chhHHHHHHHHhccChhhhhccc------cccc----CCCcc---hHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--h
Q 046586 679 YFPKWAFEKVYEEMKVEDILDRH------IKNS----YDSRV---HFDMVNRMVKTAMWCIQDRPELRPSMGKVAKM--L 743 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~~~~~~~~~------l~~~----~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~--L 743 (763)
.............+...+. .... ..... ......++.+++.+||+.||++|||+.|+++. |
T Consensus 211 ----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff 286 (298)
T d1gz8a_ 211 ----QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286 (298)
T ss_dssp ----HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred ----HHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence 0000000000000000000 0000 00000 01234678899999999999999999999974 6
Q ss_pred cc
Q 046586 744 EG 745 (763)
Q Consensus 744 e~ 745 (763)
++
T Consensus 287 ~~ 288 (298)
T d1gz8a_ 287 QD 288 (298)
T ss_dssp TT
T ss_pred cc
Confidence 53
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=356.45 Aligned_cols=266 Identities=23% Similarity=0.308 Sum_probs=197.5
Q ss_pred HhccccccccccccceEEEEEeC-C-CcEEEEEEeeccC---CchhhhHHHHHHHhcC---CCCccccEEEEEee-----
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-D-HRVVAVKCLKNVT---GGDAEFWAEVTIIARM---HHLNLVRLWGFCAE----- 509 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~-~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~----- 509 (763)
..|.+.++||+|+||+||+|+.. + ++.||||+++... .....+.+|+.+++.| +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 45778899999999999999874 3 6789999997432 2234577888887766 79999999999863
Q ss_pred CCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEec
Q 046586 510 KGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHC 589 (763)
Q Consensus 510 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHr 589 (763)
....+++|||++++.+...... ....+++.....++.|++.||+|||+++ ||||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHr 140 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKV-----------------------PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHR 140 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHS-----------------------CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred CceEEEEEEeccCCchhhhhhc-----------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEec
Confidence 2478899999988776654432 3456889999999999999999999998 9999
Q ss_pred CCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 590 DIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 590 Dlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
||||+|||++.++.+||+|||+++..... .......||+.|+|||.+.+.+|+.++||||+||++|||++|+.||...
T Consensus 141 DiKp~NILi~~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 141 DLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCccEEEEcCCCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999865432 2344568999999999999999999999999999999999999999743
Q ss_pred cCCCCCCCCchhHHHHHHHHh--ccChhhhhc-------cc---ccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHH
Q 046586 670 GSMMNSDEWYFPKWAFEKVYE--EMKVEDILD-------RH---IKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMG 737 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-------~~---l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 737 (763)
.... ......+ +........ .. ..............+.+.+|+.+||+.||++|||+.
T Consensus 219 ~~~~----------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~ 288 (305)
T d1blxa_ 219 SDVD----------QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288 (305)
T ss_dssp SHHH----------HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CHHH----------HHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 2110 0000000 000000000 00 000000111123456788999999999999999999
Q ss_pred HHHHH--hccC
Q 046586 738 KVAKM--LEGT 746 (763)
Q Consensus 738 eVv~~--Le~~ 746 (763)
|+++. |+++
T Consensus 289 e~L~Hpff~~i 299 (305)
T d1blxa_ 289 SALSHPYFQDL 299 (305)
T ss_dssp HHHTSGGGTTC
T ss_pred HHhcChhhcCc
Confidence 99863 5443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.2e-41 Score=352.02 Aligned_cols=264 Identities=22% Similarity=0.241 Sum_probs=196.4
Q ss_pred hccccccccccccceEEEEEeCCCcEEEEEEeeccC---CchhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEecC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVT---GGDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
.|.+.++||+|+||+||+|+..+++.||||+++... ...+.+.+|+.+|++++|||||++++++.+.+..++++||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 466778999999999999999999999999996432 23467899999999999999999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
.++.+..+.. ....++...+..++.||+.||+|||+.+ ||||||||+|||++.
T Consensus 83 ~~~~~~~~~~------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~ 135 (286)
T d1ob3a_ 83 DQDLKKLLDV------------------------CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINR 135 (286)
T ss_dssp SEEHHHHHHT------------------------STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred hhhhHHHHHh------------------------hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcC
Confidence 8876666653 2346899999999999999999999988 999999999999999
Q ss_pred CCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCCc
Q 046586 601 DFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEWY 679 (763)
Q Consensus 601 ~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~~ 679 (763)
++.+||+|||++........ ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.......
T Consensus 136 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~------ 208 (286)
T d1ob3a_ 136 EGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD------ 208 (286)
T ss_dssp TSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------
T ss_pred CCCEEecccccceecccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH------
Confidence 99999999999986544322 2233468899999998875 567999999999999999999999996432110
Q ss_pred hhHHHHHHHHhcc--C---hhhh--hccccc---ccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 680 FPKWAFEKVYEEM--K---VEDI--LDRHIK---NSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 680 ~~~~~~~~~~~~~--~---~~~~--~~~~l~---~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...-......... . .... ...... ..............+.+++.+||+.||++|||++|+++
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000 0 0000 000000 00000111233567889999999999999999999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=352.46 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=200.5
Q ss_pred HhccccccccccccceEEEEEeC----CCcEEEEEEeecc-----CCchhhhHHHHHHHhcCCC-CccccEEEEEeeCCe
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT----DHRVVAVKCLKNV-----TGGDAEFWAEVTIIARMHH-LNLVRLWGFCAEKGE 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~----~~~~VAvK~l~~~-----~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~ 512 (763)
..|.+.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 34888899999999999999762 4789999998632 2234668899999999966 899999999999999
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+.+|+|.+++...+ .+.......++.||+.||+|||+.+ |||||||
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~------------------------~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiK 156 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE------------------------RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIK 156 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS------------------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred eeeeeecccccHHHHHHHhcc------------------------cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCC
Confidence 999999999999999997542 4567788899999999999999988 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC--CCCCccceeehhHHHHHHHhCCCCccccc
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD--QITPKADVYSFGMVLLEIVSGSRNFEIQG 670 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwS~Gvll~elltG~~p~~~~~ 670 (763)
|+|||++.++.+||+|||+++..............|++.|+|||.+.+. .++.++||||+||+||||++|+.||....
T Consensus 157 p~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 157 LENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp GGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred ccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987655444444556799999999998754 57889999999999999999999997543
Q ss_pred CCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 046586 671 SMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS-----MGKVAK 741 (763)
Q Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~eVv~ 741 (763)
.... . ..+....... ....+...+.++.+++.+||+.||++||| ++|+++
T Consensus 237 ~~~~-----~--------------~~i~~~~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 237 EKNS-----Q--------------AEISRRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCCC-----H--------------HHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHH-----H--------------HHHHHhcccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 2211 1 1111111111 11122345678899999999999999994 788886
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-40 Score=347.97 Aligned_cols=258 Identities=21% Similarity=0.250 Sum_probs=195.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCcccc-EEEEEeeCCeeeEEEecCC
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVR-LWGFCAEKGERTLVYEYVP 521 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~-l~g~~~~~~~~~LV~Ey~~ 521 (763)
+|.+.++||+|+||.||+|+.. +++.||||+++... ...++..|+++++.++|+|++. +.++..+.+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 4778899999999999999874 68899999987543 3456889999999998776555 555667788899999999
Q ss_pred CCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc--
Q 046586 522 NGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG-- 599 (763)
Q Consensus 522 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~-- 599 (763)
+++|...+.. ....+++..++.++.|++.||+|||+++ ||||||||+|||++
T Consensus 86 ~~~l~~~~~~-----------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~ 139 (299)
T d1ckia_ 86 GPSLEDLFNF-----------------------CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLG 139 (299)
T ss_dssp CCBHHHHHHH-----------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCG
T ss_pred CCchhhhhhh-----------------------ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhcccccc
Confidence 5577766643 2346899999999999999999999998 99999999999985
Q ss_pred -CCCCeEEcccCcccccCCCCc------ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCC
Q 046586 600 -DDFCPKISDFGLAKLRKKEDM------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSM 672 (763)
Q Consensus 600 -~~~~~kI~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~ 672 (763)
.+..+||+|||+|+....... .......||+.|||||.+.+..++.++|||||||++|||++|+.||......
T Consensus 140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp GGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred CCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 456799999999987654322 1234467999999999999999999999999999999999999999754321
Q ss_pred CCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 046586 673 MNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGT 746 (763)
Q Consensus 673 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~ 746 (763)
... ........... ..... ......++++.+++..||+.+|++||+++++.+.|+..
T Consensus 220 ~~~--~~~~~~~~~~~--~~~~~-------------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 220 TKR--QKYERISEKKM--STPIE-------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -------HHHHHHHHH--HSCHH-------------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HHH--HHHHHhhcccC--CCChh-------------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 110 00000000000 00000 00112346788999999999999999999999888764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=345.32 Aligned_cols=265 Identities=20% Similarity=0.231 Sum_probs=192.6
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeecc---CCchhhhHHHHHHHhcCCCCccccEEEEEee--------C
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNV---TGGDAEFWAEVTIIARMHHLNLVRLWGFCAE--------K 510 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------~ 510 (763)
..|.+.++||+|+||+||+|+.. +++.||||+++.. .....++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 46778899999999999999874 7899999998633 2334668899999999999999999999865 3
Q ss_pred CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecC
Q 046586 511 GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCD 590 (763)
Q Consensus 511 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrD 590 (763)
+..++||||++++.+..+.. ....++......++.|++.||+|||+.+ |+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~------------------------~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrD 142 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN------------------------VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRD 142 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC------------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred ceEEEEEeccCCCccchhhh------------------------cccccccHHHHHHHHHHHHHHHHhccCC---EEecC
Confidence 46889999998876665442 2345778889999999999999999998 99999
Q ss_pred CCCCceEEcCCCCeEEcccCcccccCCCCc---ccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCc
Q 046586 591 IKPENILLGDDFCPKISDFGLAKLRKKEDM---VSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNF 666 (763)
Q Consensus 591 lk~~NILl~~~~~~kI~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~ 666 (763)
|||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||
T Consensus 143 lKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 143 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence 999999999999999999999976554332 122335689999999998754 7899999999999999999999999
Q ss_pred ccccCCCCCCCCchhHHHHHHHHhccChhhhhcc--------ccc--ccCCCcch-----HHHHHHHHHHHHHccCCCCC
Q 046586 667 EIQGSMMNSDEWYFPKWAFEKVYEEMKVEDILDR--------HIK--NSYDSRVH-----FDMVNRMVKTAMWCIQDRPE 731 (763)
Q Consensus 667 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~l~--~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~ 731 (763)
....... ..... .... +....+.... ... ........ ......+.+++.+||+.||+
T Consensus 223 ~~~~~~~------~~~~i-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~ 294 (318)
T d3blha1 223 QGNTEQH------QLALI-SQLC-GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294 (318)
T ss_dssp CCSSHHH------HHHHH-HHHH-CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT
T ss_pred CCCCHHH------HHHHH-HHhc-CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChh
Confidence 6432110 00000 0000 0000000000 000 00000010 11234667899999999999
Q ss_pred CCCCHHHHHHH
Q 046586 732 LRPSMGKVAKM 742 (763)
Q Consensus 732 ~RPs~~eVv~~ 742 (763)
+|||++|+++.
T Consensus 295 ~R~sa~elL~H 305 (318)
T d3blha1 295 QRIDSDDALNH 305 (318)
T ss_dssp TSCCHHHHHHS
T ss_pred HCcCHHHHHcC
Confidence 99999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=352.48 Aligned_cols=262 Identities=25% Similarity=0.287 Sum_probs=191.1
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCccccEEEEEeeC------CeeeEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNLVRLWGFCAEK------GERTLV 516 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~~LV 516 (763)
+|+..++||+|+||+||+|+.. +++.||||+++... ..+.+|+++|++++||||+++++++... .+.+||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc---hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 5667789999999999999885 58999999997543 2345799999999999999999998653 357899
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
|||++++.+........ ....+++.++..++.||+.||+|||+++ |+||||||+||
T Consensus 98 ~Ey~~~~~~~~l~~~~~---------------------~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NI 153 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSR---------------------AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNL 153 (350)
T ss_dssp EECCSEEHHHHHHHHHH---------------------TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGE
T ss_pred EeccCCccHHHHHhhhh---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceE
Confidence 99998754443332111 3456899999999999999999999988 99999999999
Q ss_pred EEcCCC-CeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccCCCC
Q 046586 597 LLGDDF-CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGSMMN 674 (763)
Q Consensus 597 Ll~~~~-~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~ 674 (763)
|++.++ .+||+|||+++....... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||........
T Consensus 154 Ll~~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~ 231 (350)
T d1q5ka_ 154 LLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231 (350)
T ss_dssp EECTTTCCEEECCCTTCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH
T ss_pred EEecCCCceeEecccchhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH
Confidence 999775 899999999986654332 234578999999998765 5799999999999999999999999964321100
Q ss_pred CCCCchhHHHH-------HHHHhccChhhhhcccccc----cCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 675 SDEWYFPKWAF-------EKVYEEMKVEDILDRHIKN----SYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 675 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
+..... +.+.... ....+..... ...........+++.+|+.+||+.||++|||+.|+++
T Consensus 232 -----l~~i~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 232 -----LVEIIKVLGTPTREQIREMN--PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp -----HHHHHHHHCCCCHHHHHHHC--C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHhCCChHHhhhhhc--cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0000000 0000000000 0000011234567889999999999999999999995
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.5e-40 Score=344.70 Aligned_cols=260 Identities=18% Similarity=0.250 Sum_probs=203.9
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCchhhhHHHHHHHhcCCC-CccccEEEEEeeCCeeeEEEecC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGGDAEFWAEVTIIARMHH-LNLVRLWGFCAEKGERTLVYEYV 520 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~LV~Ey~ 520 (763)
..|.+.++||+|+||.||+|+.. +++.||||+++... ...++.+|+++++.++| +|++.+++++.++...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 35778899999999999999875 68899999986432 34567889999999965 89999999999999999999999
Q ss_pred CCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEcC
Q 046586 521 PNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLGD 600 (763)
Q Consensus 521 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~~ 600 (763)
+++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 84 -~~~l~~~~~~~-----------------------~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~ 136 (293)
T d1csna_ 84 -GPSLEDLLDLC-----------------------GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGR 136 (293)
T ss_dssp -CCBHHHHHHHT-----------------------TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECC
T ss_pred -CCCHHHHHHhh-----------------------ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecC
Confidence 68999988653 346889999999999999999999998 999999999999974
Q ss_pred -----CCCeEEcccCcccccCCCCc------ccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccc
Q 046586 601 -----DFCPKISDFGLAKLRKKEDM------VSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQ 669 (763)
Q Consensus 601 -----~~~~kI~DFGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~ 669 (763)
++.+||+|||+|+....... .......||+.|||||.+.+..++.++||||||+++|||++|+.||...
T Consensus 137 ~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 137 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp SSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 57899999999987643321 1233467999999999999999999999999999999999999999744
Q ss_pred cCCCCCCCCchhHHHHHHHHhccChhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 046586 670 GSMMNSDEWYFPKWAFEKVYEEMKVEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAKMLEGTV 747 (763)
Q Consensus 670 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~~Le~~~ 747 (763)
..... ........+.. ...... .+....++++.+++..|++.+|++||+++.+.+.|++++
T Consensus 217 ~~~~~-------~~~~~~i~~~~-~~~~~~---------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 217 KAATN-------KQKYERIGEKK-QSTPLR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp CSCCH-------HHHHHHHHHHH-HHSCHH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cchhH-------HHHHHHHHhcc-CCCChH---------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 32110 00111111110 000000 000123457888999999999999999999999887654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=350.74 Aligned_cols=268 Identities=20% Similarity=0.269 Sum_probs=192.8
Q ss_pred HhccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeCC------e
Q 046586 443 ATNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEKG------E 512 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~ 512 (763)
.+|.+.++||+|+||+||+|... +++.||||+++..... .+.+.+|+++|+.++|||||++++++...+ +
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 35777889999999999999875 6899999999754332 346889999999999999999999998654 5
Q ss_pred eeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCC
Q 046586 513 RTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIK 592 (763)
Q Consensus 513 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk 592 (763)
.++||||+ +.+|..++.. ..+++..+..++.||+.||+|||+++ |+|||||
T Consensus 98 ~~lv~e~~-~~~l~~~~~~-------------------------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiK 148 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH-------------------------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLK 148 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH-------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred EEEEEecc-cccHHHHHHh-------------------------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccC
Confidence 79999999 5577776632 35899999999999999999999998 9999999
Q ss_pred CCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCccccccccc-CCCCCccceeehhHHHHHHHhCCCCcccccC
Q 046586 593 PENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRS-DQITPKADVYSFGMVLLEIVSGSRNFEIQGS 671 (763)
Q Consensus 593 ~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvll~elltG~~p~~~~~~ 671 (763)
|+|||++.++.+||+|||+|+..... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.....
T Consensus 149 p~NIL~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 149 PGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cchhhcccccccccccccceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 99999999999999999999865433 345678999999998875 5678999999999999999999999964421
Q ss_pred CCCCCCCchhHHHH------HHHHhccChh--hhhcccc---cccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 046586 672 MMNSDEWYFPKWAF------EKVYEEMKVE--DILDRHI---KNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVA 740 (763)
Q Consensus 672 ~~~~~~~~~~~~~~------~~~~~~~~~~--~~~~~~l---~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv 740 (763)
... +..... ....+..... ......+ ...............+.+|+.+||+.||++|||+.|++
T Consensus 225 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL 299 (346)
T d1cm8a_ 225 LDQ-----LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299 (346)
T ss_dssp HHH-----HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHH-----HHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 100 000000 0000000000 0000000 00000011123345778999999999999999999999
Q ss_pred HH--hccCCC
Q 046586 741 KM--LEGTVE 748 (763)
Q Consensus 741 ~~--Le~~~~ 748 (763)
+. |+++.+
T Consensus 300 ~Hp~f~~~~~ 309 (346)
T d1cm8a_ 300 AHPYFESLHD 309 (346)
T ss_dssp HSGGGTTTC-
T ss_pred cChhhCcCCC
Confidence 74 766543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=351.68 Aligned_cols=267 Identities=21% Similarity=0.235 Sum_probs=194.6
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeeccCC--chhhhHHHHHHHhcCCCCccccEEEEEeeCC----eeeEE
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTG--GDAEFWAEVTIIARMHHLNLVRLWGFCAEKG----ERTLV 516 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~LV 516 (763)
.|.+.++||+|+||+||+|+. .+++.||||+++.... ..+.+++|+++|+.++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 467789999999999999976 4789999999975432 2356889999999999999999999997653 23455
Q ss_pred EecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCce
Q 046586 517 YEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENI 596 (763)
Q Consensus 517 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NI 596 (763)
++|+.+|+|.+++... .+++..+..++.|++.||+|||+++ ||||||||+||
T Consensus 89 ~~~~~~g~L~~~l~~~-------------------------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NI 140 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ-------------------------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNL 140 (345)
T ss_dssp EEECCCEEHHHHHHHC-------------------------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred EEeecCCchhhhhhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceE
Confidence 5667799999999532 4889999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEcccCcccccCCCCc--ccccccccCCCcccccccc-cCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 597 LLGDDFCPKISDFGLAKLRKKEDM--VSMSRIRGTRGYMAPEWLR-SDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 597 Ll~~~~~~kI~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
|+++++.+||+|||+++....... .......||+.|+|||.+. ...++.++||||+||++|||++|+.||.......
T Consensus 141 Ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~ 220 (345)
T d1pmea_ 141 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220 (345)
T ss_dssp EECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH
Confidence 999999999999999986544322 2234567899999999884 4577899999999999999999999996432110
Q ss_pred CCCCCchhHHHHHHHHhccChh-----------hhhcccccccCCCc---chHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVE-----------DILDRHIKNSYDSR---VHFDMVNRMVKTAMWCIQDRPELRPSMGKV 739 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eV 739 (763)
. .+............ ..... ........ .......++.+++.+||+.||++|||+.|+
T Consensus 221 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~ 292 (345)
T d1pmea_ 221 Q-------LNHILGILGSPSQEDLNCIINLKARNYLLS-LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292 (345)
T ss_dssp H-------HHHHHHHHCSCCHHHHHTCCCHHHHHHHHT-SCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred H-------HHHHhhhccCCChhhhhhhhhhhhhccccc-CCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 0 00000000000000 00000 00000000 001223578899999999999999999999
Q ss_pred HHH--hccC
Q 046586 740 AKM--LEGT 746 (763)
Q Consensus 740 v~~--Le~~ 746 (763)
++. |+..
T Consensus 293 L~hpf~~~~ 301 (345)
T d1pmea_ 293 LAHPYLEQY 301 (345)
T ss_dssp HTSGGGTTT
T ss_pred hcCHhhccC
Confidence 974 5543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-39 Score=337.37 Aligned_cols=265 Identities=20% Similarity=0.221 Sum_probs=198.9
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCC---chhhhHHHHHHHhcCCCCccccEEEEEeeCCeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTG---GDAEFWAEVTIIARMHHLNLVRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~LV~Ey 519 (763)
.|++.++||+|+||+||+|+.. +++.||||+++.... ...++.+|+.+++.++||||+++++++.+.+..++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 4667889999999999999874 688999999974432 246788999999999999999999999999999999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+.+++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++
T Consensus 83 ~~~~~l~~~~~~~------------------------~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~ 135 (292)
T d1unla_ 83 CDQDLKKYFDSCN------------------------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLIN 135 (292)
T ss_dssp CSEEHHHHHHHTT------------------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred ccccccccccccc------------------------cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccc
Confidence 9999988877532 35788899999999999999999988 99999999999999
Q ss_pred CCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCCC
Q 046586 600 DDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDEW 678 (763)
Q Consensus 600 ~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~~ 678 (763)
.++.+||+|||.++....... ......++..|+|||.+... .++.++||||+||++|||++|+.||.......
T Consensus 136 ~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~----- 209 (292)
T d1unla_ 136 RNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----- 209 (292)
T ss_dssp TTCCEEECCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-----
T ss_pred cCCceeeeecchhhcccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH-----
Confidence 999999999999987654332 22234567889999988765 46899999999999999999999974221110
Q ss_pred chhHHHHHHHHhccC-----hhhhhcc-----cccccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 679 YFPKWAFEKVYEEMK-----VEDILDR-----HIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 679 ~~~~~~~~~~~~~~~-----~~~~~~~-----~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
....-.......... .....+. ...............+.+.+++.+||+.||.+|||++||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000000 0000000 00000111122344567889999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.3e-39 Score=342.96 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=194.5
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcCC-CCccccEEEEEeeC--CeeeEEEec
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-HLNLVRLWGFCAEK--GERTLVYEY 519 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~LV~Ey 519 (763)
.|.+.++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 578889999999999999987 46889999999743 3567889999999995 99999999999754 568999999
Q ss_pred CCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCCceEEc
Q 046586 520 VPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPENILLG 599 (763)
Q Consensus 520 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~NILl~ 599 (763)
+++++|..+. ..++...+..++.||+.||+|||+++ ||||||||+|||++
T Consensus 114 ~~~~~L~~~~---------------------------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~ 163 (328)
T d3bqca1 114 VNNTDFKQLY---------------------------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMID 163 (328)
T ss_dssp CCSCBGGGTT---------------------------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE
T ss_pred cCCCcHHHHh---------------------------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEc
Confidence 9999987653 24788999999999999999999998 99999999999998
Q ss_pred CCC-CeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCCCCCC
Q 046586 600 DDF-CPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMMNSDE 677 (763)
Q Consensus 600 ~~~-~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~~ 677 (763)
.++ .+||+|||+|+....... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......... .
T Consensus 164 ~~~~~vkl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~-~ 240 (328)
T d3bqca1 164 HEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-L 240 (328)
T ss_dssp TTTTEEEECCGGGCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-H
T ss_pred CCCCeeeecccccceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH-H
Confidence 655 699999999986654322 3445789999999988764 5799999999999999999999999643211000 0
Q ss_pred CchhHH----HHHHHHhcc--C----hhhhhcccc----cccCCCcchHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 046586 678 WYFPKW----AFEKVYEEM--K----VEDILDRHI----KNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPSMGKVAK 741 (763)
Q Consensus 678 ~~~~~~----~~~~~~~~~--~----~~~~~~~~l----~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~eVv~ 741 (763)
...... ......... . ......... ..............++.+|+.+||+.||++|||++|+++
T Consensus 241 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000000000 0 000000000 000111111234567889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=342.91 Aligned_cols=266 Identities=22% Similarity=0.209 Sum_probs=187.7
Q ss_pred hccccccccccccceEEEEEeC-CCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEee------CCee
Q 046586 444 TNGFSNLIGRGGFGDVYKGELT-DHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAE------KGER 513 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~~-~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 513 (763)
.|.+.++||+|+||+||+|+.. +++.||||+++..... ..++.+|+.++++++|||||++++++.. ....
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 3667789999999999999875 6899999999754332 2458899999999999999999999964 3688
Q ss_pred eEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCC
Q 046586 514 TLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKP 593 (763)
Q Consensus 514 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~ 593 (763)
++||||+.++ +.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||
T Consensus 98 ~iv~Ey~~~~-l~~~~~--------------------------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP 147 (355)
T d2b1pa1 98 YLVMELMDAN-LCQVIQ--------------------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 147 (355)
T ss_dssp EEEEECCSEE-HHHHHT--------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred EEEEeccchH-HHHhhh--------------------------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCc
Confidence 9999999765 444442 24688999999999999999999998 99999999
Q ss_pred CceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 594 ENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 594 ~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
+|||++.++.+|++|||+++...... ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||.......
T Consensus 148 ~Nil~~~~~~~kl~df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 148 SNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp GGEEECTTCCEEECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cccccccccceeeechhhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH
Confidence 99999999999999999988654322 2344578999999999999999999999999999999999999996432110
Q ss_pred CC------CCCchhHH------HHHHHHhcc-C-----hhhhhcccccccCCCcchHHHHHHHHHHHHHccCCCCCCCCC
Q 046586 674 NS------DEWYFPKW------AFEKVYEEM-K-----VEDILDRHIKNSYDSRVHFDMVNRMVKTAMWCIQDRPELRPS 735 (763)
Q Consensus 674 ~~------~~~~~~~~------~~~~~~~~~-~-----~~~~~~~~l~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 735 (763)
.. .....+++ ......... . ......... ..............+.+|+.+||+.||++|||
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 304 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSL-FPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304 (355)
T ss_dssp HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGG-SCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCcccccccccccccccc-ccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence 00 00000000 000000000 0 000110000 11112223456778999999999999999999
Q ss_pred HHHHHHH
Q 046586 736 MGKVAKM 742 (763)
Q Consensus 736 ~~eVv~~ 742 (763)
++|+++.
T Consensus 305 a~elL~H 311 (355)
T d2b1pa1 305 VDDALQH 311 (355)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-38 Score=340.56 Aligned_cols=264 Identities=19% Similarity=0.232 Sum_probs=193.5
Q ss_pred hccccccccccccceEEEEEe-CCCcEEEEEEeeccCCc---hhhhHHHHHHHhcCCCCccccEEEEEeeC-----Ceee
Q 046586 444 TNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGG---DAEFWAEVTIIARMHHLNLVRLWGFCAEK-----GERT 514 (763)
Q Consensus 444 t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 514 (763)
+|.+.++||+|+||+||+|+. .+++.||||+++..... .+++.+|+++|+.++|||||++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 477789999999999999986 46899999999754332 24578999999999999999999999643 3456
Q ss_pred EEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcEEecCCCCC
Q 046586 515 LVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWVLHCDIKPE 594 (763)
Q Consensus 515 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~ivHrDlk~~ 594 (763)
+|++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+
T Consensus 99 ~i~~~~~gg~L~~~~~~-------------------------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~ 150 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-------------------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPS 150 (348)
T ss_dssp EEEEECCSEEHHHHHTT-------------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred EEEEeecCCchhhhccc-------------------------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCc
Confidence 77888889999999832 35889999999999999999999998 999999999
Q ss_pred ceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccC-CCCCccceeehhHHHHHHHhCCCCcccccCCC
Q 046586 595 NILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSD-QITPKADVYSFGMVLLEIVSGSRNFEIQGSMM 673 (763)
Q Consensus 595 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvll~elltG~~p~~~~~~~~ 673 (763)
|||++.++.+|++|||++...... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......
T Consensus 151 NILi~~~~~~kl~dfg~a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~ 226 (348)
T d2gfsa1 151 NLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226 (348)
T ss_dssp GEEECTTCCEEECCC----CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccccccccccchhcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999999754322 3345788999999986654 57899999999999999999999996432110
Q ss_pred CCCCCchhHHHHHHHHhccChhhhhc-----------ccccccCCCcc---hHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 046586 674 NSDEWYFPKWAFEKVYEEMKVEDILD-----------RHIKNSYDSRV---HFDMVNRMVKTAMWCIQDRPELRPSMGKV 739 (763)
Q Consensus 674 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~l~~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~eV 739 (763)
......... +....+... ..+........ ......++.+|+.+||+.||++|||+.|+
T Consensus 227 ------~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el 298 (348)
T d2gfsa1 227 ------QLKLILRLV--GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298 (348)
T ss_dssp ------HHHHHHHHH--CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ------HHHHHHHhc--CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence 000000000 000000000 00000000000 01234678899999999999999999999
Q ss_pred HH--HhccCC
Q 046586 740 AK--MLEGTV 747 (763)
Q Consensus 740 v~--~Le~~~ 747 (763)
++ .|.+..
T Consensus 299 L~Hp~f~~~~ 308 (348)
T d2gfsa1 299 LAHAYFAQYH 308 (348)
T ss_dssp HTSGGGTTTC
T ss_pred hcCHhhCCCC
Confidence 97 566543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-35 Score=317.50 Aligned_cols=288 Identities=19% Similarity=0.208 Sum_probs=199.6
Q ss_pred HhccccccccccccceEEEEEe-CCCcEEEEEEeeccCCchhhhHHHHHHHhcCC-----------CCccccEEEEEeeC
Q 046586 443 ATNGFSNLIGRGGFGDVYKGEL-TDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH-----------HLNLVRLWGFCAEK 510 (763)
Q Consensus 443 ~t~~~~~~LG~G~fG~Vy~g~~-~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~~ 510 (763)
.+|.+.++||+|+||+||+|+. .+++.||||+++......+.+.+|+.+++.++ |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4588899999999999999987 46899999999865444566788999888875 57899999988653
Q ss_pred --CeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCcEE
Q 046586 511 --GERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHE-ECLEWVL 587 (763)
Q Consensus 511 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~-~~~~~iv 587 (763)
...+++++++..+.......... ....++...+..++.||+.||+|||+ .+ |+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~i~~i~~qil~al~~lh~~~~---Iv 148 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKY---------------------EHRGIPLIYVKQISKQLLLGLDYMHRRCG---II 148 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHT---------------------TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EE
T ss_pred cccceeeeeeecccccccccccccc---------------------cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cc
Confidence 45667777765554433332221 34567888999999999999999998 66 99
Q ss_pred ecCCCCCceEEcCCCC------eEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHHHHHHh
Q 046586 588 HCDIKPENILLGDDFC------PKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVLLEIVS 661 (763)
Q Consensus 588 HrDlk~~NILl~~~~~------~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll~ellt 661 (763)
||||||+|||++.++. +|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++
T Consensus 149 HrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 224 (362)
T d1q8ya_ 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224 (362)
T ss_dssp CSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccCChhHeeeeccCcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHH
Confidence 9999999999986654 999999999754332 234578999999999999999999999999999999999
Q ss_pred CCCCcccccCCCCCCCCc-hhHHHH-------HHHHhccChhhhhcc-----ccccc----------CCCcchHHHHHHH
Q 046586 662 GSRNFEIQGSMMNSDEWY-FPKWAF-------EKVYEEMKVEDILDR-----HIKNS----------YDSRVHFDMVNRM 718 (763)
Q Consensus 662 G~~p~~~~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~~~~-----~l~~~----------~~~~~~~~~~~~l 718 (763)
|+.||............. +..... .............+. ..... ...........++
T Consensus 225 g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (362)
T d1q8ya_ 225 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304 (362)
T ss_dssp SSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHH
T ss_pred CCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHH
Confidence 999997543211100000 000000 000000000000000 00000 0111235677889
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH--hccCC---CCCCCCCCcee
Q 046586 719 VKTAMWCIQDRPELRPSMGKVAKM--LEGTV---EITEPKKPTIY 758 (763)
Q Consensus 719 ~~l~~~Cl~~dP~~RPs~~eVv~~--Le~~~---~~~~p~~p~~~ 758 (763)
.+|+.+||+.||++|||++|+++. +++.. ++..|+.|..-
T Consensus 305 ~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 305 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp HHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccCC
Confidence 999999999999999999999974 65443 45555555443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=5.1e-22 Score=193.98 Aligned_cols=168 Identities=14% Similarity=0.117 Sum_probs=119.5
Q ss_pred cccccccccccceEEEEEeCCCcEEEEEEeeccCCc-------------------hhhhHHHHHHHhcCCCCccccEEEE
Q 046586 446 GFSNLIGRGGFGDVYKGELTDHRVVAVKCLKNVTGG-------------------DAEFWAEVTIIARMHHLNLVRLWGF 506 (763)
Q Consensus 446 ~~~~~LG~G~fG~Vy~g~~~~~~~VAvK~l~~~~~~-------------------~~~f~~E~~~l~~l~H~niv~l~g~ 506 (763)
.+.++||+|+||+||+|+..+|+.||||+++..... .....+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 457899999999999999989999999987632110 0124568888999999999998866
Q ss_pred EeeCCeeeEEEecCCCCCHhHHhhhcCCCCCCChhhhhcccCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCcE
Q 046586 507 CAEKGERTLVYEYVPNGSLADYLFRSGRVGSSSPAREMEMSGVGPHDGGKPVLDWSIRYRIALGVARAIAYLHEECLEWV 586 (763)
Q Consensus 507 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~qia~gL~yLH~~~~~~i 586 (763)
. ..++||||+++..+.+ +.......++.|++++|+|||+.+ |
T Consensus 83 ~----~~~lvme~~~~~~~~~-------------------------------l~~~~~~~i~~ql~~~l~~lH~~g---i 124 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------------------------------VRVENPDEVLDMILEEVAKFYHRG---I 124 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------------------------------CCCSCHHHHHHHHHHHHHHHHHTT---E
T ss_pred c----CCEEEEEeeccccccc-------------------------------hhhHHHHHHHHHHHHHHHHHhhCC---E
Confidence 4 2379999998755432 222334678999999999999998 9
Q ss_pred EecCCCCCceEEcCCCCeEEcccCcccccCCCCcccccccccCCCcccccccccCCCCCccceeehhHHH
Q 046586 587 LHCDIKPENILLGDDFCPKISDFGLAKLRKKEDMVSMSRIRGTRGYMAPEWLRSDQITPKADVYSFGMVL 656 (763)
Q Consensus 587 vHrDlk~~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvll 656 (763)
+||||||+|||++++ .++|+|||+|.....+.....-.. ... .-.|. ..++|+.++|+||..--+
T Consensus 125 iHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~r--d~~-~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 125 VHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILER--DVR-NIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHH--HHH-HHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHH--HHH-HHHHH-HcCCCCCcccHHHHHHHH
Confidence 999999999999976 489999999976543322110000 000 00111 135778899999976544
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.61 E-value=1.3e-15 Score=132.57 Aligned_cols=93 Identities=20% Similarity=0.288 Sum_probs=74.2
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.|++|. +|.|.|.|+..++ |.||. ..++||.||++.|- .+..+.+..+|+|+|.|++|.+|||++
T Consensus 12 ~G~~l~--ng~~~l~~q~DGN------Lvly~-----~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~g~~vWsS~ 76 (108)
T d1jpca_ 12 TGEFLN--YGSFVFIMQEDCN------LVLYD-----VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPSNKPIWASN 76 (108)
T ss_dssp TTCEEE--ETTEEEEECTTSC------EEEEE-----TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEEECC
T ss_pred CCCEEE--cCCEEEEECCCCe------EEEEe-----CCceeeEeCCCCCC--CccEEEEeccceEEEECCCccceEEcc
Confidence 467784 6999999997543 66764 25679999999883 345788899999999999999999997
Q ss_pred CCCCCCCCceeEEEccCCCeeee---cccccCC
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYG---NWQSFNL 151 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~---~WqSFd~ 151 (763)
.. .......|+|+|+|||||+ .||||+|
T Consensus 77 t~--~~~~~~~l~L~ddGNlVly~~~~W~S~t~ 107 (108)
T d1jpca_ 77 TG--GQNGNYVCILQKDRNVVIYGTDRWATGTH 107 (108)
T ss_dssp CC--CSCSCEEEEECTTSCEEEEECCCCCCCCC
T ss_pred cc--CCCCcEEEEEcCCCCEEEeCCCcccCCCC
Confidence 43 2233557899999999998 5999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.58 E-value=4.3e-15 Score=129.36 Aligned_cols=94 Identities=18% Similarity=0.328 Sum_probs=73.7
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.+++|. +|.|.|+|...++ |.++. ..++||+||++.|... +..+.++.||+|+|.|++|++||+|+
T Consensus 12 ~g~~l~--~g~~~l~~q~dgn------Lvl~~-----~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~s~ 77 (109)
T d1kj1a_ 12 AGQSLD--VEPYHFIMQEDCN------LVLYD-----HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDAEGRSLWASH 77 (109)
T ss_dssp TTCEEE--ETTEEEEECTTSC------EEEEE-----TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECSSSCEEEECC
T ss_pred CCCEEE--eCCEEEEecCCCe------EEEEe-----CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCCCcEEEEEe
Confidence 466775 5889999986432 54543 2577999999999764 46688999999999999999999998
Q ss_pred CCCCCCCCceeEEEccCCCeeeec---ccccCC
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYGN---WQSFNL 151 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~~---WqSFd~ 151 (763)
.+ .......|+|+|+|||||+. |||+-|
T Consensus 78 t~--~~~~~~~l~L~ddGNlvly~~~~W~S~t~ 108 (109)
T d1kj1a_ 78 SV--RGNGNYVLVLQEDGNVVIYGSDIWSTGTY 108 (109)
T ss_dssp CC--CCSSCCEEEECTTSCEEEECCEEEECCCC
T ss_pred eE--CCCCCEEEEEeCCCcEEEECCCEecCCCc
Confidence 43 23345689999999999984 999854
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.52 E-value=1.9e-14 Score=126.35 Aligned_cols=95 Identities=14% Similarity=0.261 Sum_probs=73.7
Q ss_pred CCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCC
Q 046586 42 QNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNP 121 (763)
Q Consensus 42 ~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~ 121 (763)
.+++|+ +|.|.|+|...++ |.|++ ..++||.||++.|.. ++.+.+..||+|+|.|. +..+|+++
T Consensus 12 ~g~~l~--~g~~~l~~q~DGN------Lvly~-----~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~-~~~~w~s~ 75 (112)
T d1xd5a_ 12 TGGSLA--EGGYLFIIQNDCN------LVLYD-----NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG-SRAIWASN 75 (112)
T ss_dssp TTCEEE--ETTEEEEECTTSC------EEEEE-----TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET-TEEEEECC
T ss_pred CCCEEE--ECCEEEEEcCCCC------EEEEc-----CCcEEEEccCccCCC--CcEEEEeccccEEEEec-CCeEEEEe
Confidence 477887 4999999986542 55654 267899999998843 46789999999999996 45677766
Q ss_pred CCCCCCCCceeEEEccCCCeeee------cccccCCCCc
Q 046586 122 KTATGNPNSTRLFLQDAGNLVYG------NWQSFNLPTD 154 (763)
Q Consensus 122 ~~~~~~~~~~~~~lld~GNlvl~------~WqSFd~Ptd 154 (763)
.+ ...+...|+|+|+|||||+ +|||+.+|+|
T Consensus 76 t~--~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 76 TN--RQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp CC--CSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred ec--cCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 32 2334568999999999998 4999999986
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.40 E-value=2.1e-13 Score=120.48 Aligned_cols=76 Identities=17% Similarity=0.229 Sum_probs=61.6
Q ss_pred EEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee------
Q 046586 71 VWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------ 144 (763)
Q Consensus 71 iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------ 144 (763)
|||.++++ ++.+|++|++.|+....-.|.+..||||+|.+. +.+||+++.. .......|+|+|+|||||+
T Consensus 12 il~~~~~~-~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~~~~ 87 (120)
T d1dlpa2 12 ILYSTQGN-DNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQNIA 87 (120)
T ss_dssp ECCCC--C-CCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCC--SSCSSCEEEEETTTEEEEEETTTEE
T ss_pred EEEcCCCC-CCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccc--cCCCcEEEEEeCCeeEEEEcCCCCE
Confidence 89998884 788899999999986667899999999999985 6789998742 2234568999999999998
Q ss_pred cccccC
Q 046586 145 NWQSFN 150 (763)
Q Consensus 145 ~WqSFd 150 (763)
+||||.
T Consensus 88 lW~S~t 93 (120)
T d1dlpa2 88 VWTSGN 93 (120)
T ss_dssp EEECCC
T ss_pred EEEeCC
Confidence 499984
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.26 E-value=1.7e-11 Score=107.64 Aligned_cols=90 Identities=23% Similarity=0.381 Sum_probs=70.0
Q ss_pred EecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCCCCCC
Q 046586 46 LLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTAT 125 (763)
Q Consensus 46 l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~~~~~ 125 (763)
+.+..|.|.|.|...++ |.+ |. ..++||.||+..+- .+..+.+..||+|+|.|.+|.+||+++..
T Consensus 25 ~~~~~~~y~l~mQ~DGN------LVL-y~----~~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d~~g~~vWsS~t~-- 89 (119)
T d1b2pa_ 25 ILFGTHVYRFIMQTDCN------LVL-YD----NNNPIWATNTGGLG--NGCRAVLQPDGVLVVITNENVTVWQSPVA-- 89 (119)
T ss_dssp EEETTEEEEEEECTTSC------EEE-EE----TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTTCCEEEECSCC--
T ss_pred EecCCceEEEEECCCCc------EEE-EE----CCeEEEEecCCCCC--cceEEEEEeCCCEEEECCCCcEEEECCCc--
Confidence 46678999999986543 434 43 26789999998774 34678999999999999999999998742
Q ss_pred CCCCceeEEEccCCCeeee---cccccC
Q 046586 126 GNPNSTRLFLQDAGNLVYG---NWQSFN 150 (763)
Q Consensus 126 ~~~~~~~~~lld~GNlvl~---~WqSFd 150 (763)
.......++|+|+|||||+ +|||-.
T Consensus 90 ~~~~~~~l~Lq~DGNlvlYg~~~W~S~T 117 (119)
T d1b2pa_ 90 GKAGHYVLVLQPDRNVVIYGDALWATQT 117 (119)
T ss_dssp CCSSCEEEEECTTSCEEEEESEEEECCC
T ss_pred CCCCceEEEEcCCCCEEEECCCEeccCC
Confidence 2234557899999999998 599853
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.08 E-value=3.4e-11 Score=104.89 Aligned_cols=75 Identities=17% Similarity=0.202 Sum_probs=61.0
Q ss_pred EEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee------
Q 046586 71 VWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------ 144 (763)
Q Consensus 71 iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------ 144 (763)
|||.-.+ +.+..|..+.++++.+....|.+..||||+|.+ .+.++|+++ +.+..+..+.|+|+|||||+
T Consensus 3 ~~~~~~~-~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~---t~~~~~~~l~l~~dGNLvl~d~~~~~ 77 (115)
T d1dlpa1 3 ILFGLSH-EGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASN---TAGATGCRAVLQSDGLLVILTAQNTI 77 (115)
T ss_dssp CCBCSSS-SSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCC---CCSCSCCBCCBCSSSCBCCBCTTTCC
T ss_pred EEEecCC-CCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcc---cCCCCceEEEEeccCCEEEEccCCCE
Confidence 6776555 466679999999998766789999999999987 577899987 33455778999999999998
Q ss_pred cccccC
Q 046586 145 NWQSFN 150 (763)
Q Consensus 145 ~WqSFd 150 (763)
+|||+-
T Consensus 78 vWsS~t 83 (115)
T d1dlpa1 78 RWSSGT 83 (115)
T ss_dssp SCCCCC
T ss_pred EEEcCC
Confidence 499874
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.00 E-value=5e-10 Score=97.38 Aligned_cols=95 Identities=21% Similarity=0.298 Sum_probs=70.8
Q ss_pred CcCCCCCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCe
Q 046586 37 PWLPNQNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSN 116 (763)
Q Consensus 37 ~~~~~~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~ 116 (763)
+.+...++.| .+|.|.|.|...++ |.++. + ..+||.+|...+ .+..+.+..+|||+|.|.++.+
T Consensus 14 ~~tl~~~~~l--~~g~~~l~~q~DGN------LvL~~---~--~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~ 77 (115)
T d1dlpa1 14 PQTLHAAQSL--ELSSFRFTMQSDCN------LVLFD---S--DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTI 77 (115)
T ss_dssp CSCCCTTCEE--CSTTEEEEECTTSC------EEEEE---S--SSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCC
T ss_pred cceecCCCcE--EcCCEEEEECCCCe------EEEEc---C--CeeEEEcccCCC---CceEEEEeccCCEEEEccCCCE
Confidence 3445667778 57889999986543 65654 2 456899997542 3467888899999999999999
Q ss_pred ecCCCCCCCCCCCceeEEEccCCCeeee---ccccc
Q 046586 117 LWPNPKTATGNPNSTRLFLQDAGNLVYG---NWQSF 149 (763)
Q Consensus 117 vwst~~~~~~~~~~~~~~lld~GNlvl~---~WqSF 149 (763)
||++.... ......++|+++|||||+ .|+|-
T Consensus 78 vWsS~t~~--~~g~y~l~Lq~DGNlvlY~~~~Wssg 111 (115)
T d1dlpa1 78 RWSSGTKG--SIGNYVLVLQPDRTVTIYGPGLWDSG 111 (115)
T ss_dssp SCCCCCCC--CSSCCEEEECSSSCEEEECSEEEECS
T ss_pred EEEcCCCC--CCCCEEEEECCCCcEEEeCCCeecCC
Confidence 99987432 234557899999999998 48874
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.66 E-value=3e-08 Score=86.74 Aligned_cols=93 Identities=18% Similarity=0.339 Sum_probs=64.7
Q ss_pred CCCCCceEecCCCeEEEeeecCCCCCCceEEEEEEecCCCCCEEEEEeCCCCCCCCCCccEEEccCCcEEEecCCCCeec
Q 046586 39 LPNQNRILLSPNSTFAAGFLPKPNSRNLFTFSVWYHNLSEPTTVIWSANDKFPVAGNGSLAIAATTGQLRLLNSSNSNLW 118 (763)
Q Consensus 39 ~~~~~~~l~S~~g~f~lgF~~~~~~~~~~~l~iw~~~~~~~~tvvW~Anr~~p~~~~~~~~~~~~~g~L~l~~~~~~~vw 118 (763)
+.+.++.| ..|.|.|.|-..+ .|.|+.. ..+||.+|-.. ......+.+..+|||+|.|.++.+||
T Consensus 25 ~l~~~q~l--~~g~y~L~~q~DG------NLvL~~~-----~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 25 TLHATQSL--QLSPYRLSMETDC------NLVLFDR-----DDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp EECSSCCC--BCSSCEEEEETTT------EEEEEBT-----TBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred EEcCCCee--EcCCEEEEEcCCC------cEEEecC-----CcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 33445555 3577888886543 3666532 34579988433 33445688889999999999999999
Q ss_pred CCCCCCCCCCCceeEEEccCCCeeee---cccc
Q 046586 119 PNPKTATGNPNSTRLFLQDAGNLVYG---NWQS 148 (763)
Q Consensus 119 st~~~~~~~~~~~~~~lld~GNlvl~---~WqS 148 (763)
+++.. .......+.|+++|||||+ .|.|
T Consensus 90 ~S~t~--~~~~~~~l~Lq~DGnlvlY~~~~W~t 120 (120)
T d1dlpa2 90 TSGNS--RSAGRYVFVLQPDRNLAIYGGALWTT 120 (120)
T ss_dssp ECCCC--CSSSCCEEEECSSSCEEEECCCCCBC
T ss_pred EeCCC--CCCCcEEEEECCCCcEEEeCCCcccC
Confidence 98743 2234557899999999998 3754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.14 E-value=7.6e-06 Score=81.33 Aligned_cols=76 Identities=13% Similarity=0.080 Sum_probs=55.2
Q ss_pred ccccceEEEEEeCCCcEEEEEEeecc-CCchhhhHHHHHHHhcCC-CCccccEEEEEeeCCeeeEEEecCCCCCHhHHh
Q 046586 453 RGGFGDVYKGELTDHRVVAVKCLKNV-TGGDAEFWAEVTIIARMH-HLNLVRLWGFCAEKGERTLVYEYVPNGSLADYL 529 (763)
Q Consensus 453 ~G~fG~Vy~g~~~~~~~VAvK~l~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L 529 (763)
.++...||+....+ +.+++|+.... ......+.+|...+..+. +--+.+++.+..+++..++||+++++..+.+..
T Consensus 24 G~s~~~v~rv~~~~-~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 24 GMSPAKVYKLVGEN-ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CCSSSEEEEEECSS-CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCCcEEEEEeCC-CeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 34446899887544 45677877543 334455778998888773 545678888888889999999999998886654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.03 E-value=6.8e-06 Score=71.12 Aligned_cols=44 Identities=32% Similarity=0.379 Sum_probs=34.7
Q ss_pred cEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee
Q 046586 98 LAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG 144 (763)
Q Consensus 98 ~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~ 144 (763)
.|.+..||||||.+. +.+||+++.. .....+.+.|.++|||||+
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~--~~~~~~~l~l~~dGnLvL~ 76 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTG--GLGNGCRAVLQPDGVLVVI 76 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCT--TSCSSCEEEECTTSCEEEE
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCC--CCCcceEEEEEeCCCEEEE
Confidence 567889999999865 5689999843 2233578999999999997
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=97.88 E-value=1.7e-05 Score=67.89 Aligned_cols=86 Identities=24% Similarity=0.410 Sum_probs=57.8
Q ss_pred ccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeeec-----ccccCCCCccccCCCccCCCCCCCCC
Q 046586 97 SLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYGN-----WQSFNLPTDTILPNQTLNGPPLVSKN 171 (763)
Q Consensus 97 ~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~~-----WqSFd~Ptdtllpg~~l~~~~l~s~~ 171 (763)
-.|.+..||||+|.+ .+.+||+++... ....+.+.|..+|||||+. |-|= | ..
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~--~~~~~~l~l~~dGnLvl~~~~~~~w~s~---t--------------~~-- 78 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYD-NNRAVWASGTNG--KASGCVLKMQNDGNLVIYSGSRAIWASN---T--------------NR-- 78 (112)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTT--SCSSEEEEECTTSCEEEEETTEEEEECC---C--------------CC--
T ss_pred EEEEEcCCCCEEEEc-CCcEEEEccCcc--CCCCcEEEEeccccEEEEecCCeEEEEe---e--------------cc--
Confidence 467788999999986 567999988432 2345679999999999973 4330 0 00
Q ss_pred CceeeecCceeeeeecCeeEEEEecCCceEEEEEecCCCceEEEecccccCc
Q 046586 172 GKFSFLNASELVFVSANRSYWNIDDDGNLRIYSYDDNGDRWTVVWQAVQEIC 223 (763)
Q Consensus 172 g~~~~~~~~~~~~~~~~~~~~~l~~~G~~~~~~~~~~~~~w~~~~~~~~~~c 223 (763)
.....+.+|+.||++++|.- .....|+...+.|
T Consensus 79 --------------~~~~~~l~L~ddGNlvly~~-----~~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 79 --------------QNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNVG 111 (112)
T ss_dssp --------------SCCCCEEEECTTSCEEEECT-----TSCEEEECCCCCC
T ss_pred --------------CCCceEEEEcCCCCEEEECC-----CCcEEecCCCccC
Confidence 01224678999999999842 2245677665554
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=97.86 E-value=1.4e-05 Score=68.06 Aligned_cols=49 Identities=27% Similarity=0.356 Sum_probs=37.4
Q ss_pred ccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee------cccc
Q 046586 97 SLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------NWQS 148 (763)
Q Consensus 97 ~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------~WqS 148 (763)
-.+.+..||||||.+ .+.+||+++... ......+.|.++|||||+ +|+|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~--~~~~~~l~l~~~Gnlvl~~~~g~~vWsS 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGG--LSRSCFLSMQTDGNLVVYNPSNKPIWAS 75 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTT--SCSSCEEEECTTSCEEEECTTCCEEEEC
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCC--CCCccEEEEeccceEEEECCCccceEEc
Confidence 457778999999987 567899988432 223457999999999997 3776
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=97.81 E-value=2.3e-05 Score=66.68 Aligned_cols=50 Identities=22% Similarity=0.355 Sum_probs=37.4
Q ss_pred ccEEEccCCcEEEecCCCCeecCCCCCCCCCCCceeEEEccCCCeeee------cccc
Q 046586 97 SLAIAATTGQLRLLNSSNSNLWPNPKTATGNPNSTRLFLQDAGNLVYG------NWQS 148 (763)
Q Consensus 97 ~~~~~~~~g~L~l~~~~~~~vwst~~~~~~~~~~~~~~lld~GNlvl~------~WqS 148 (763)
-.+.+..||||+|.+ .+.+||+++...+ ......+.|.++|||||+ +|+|
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~s 76 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGIL-GKKGCKAVLQSDGNFVVYDAEGRSLWAS 76 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCT-TCCCCEEEECTTSCEEEECSSSCEEEEC
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCC-CceeEEEEEcCCceEEEEeCCCcEEEEE
Confidence 456777899999986 5678999874322 233567899999999997 3776
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.77 E-value=5e-05 Score=74.75 Aligned_cols=76 Identities=17% Similarity=0.127 Sum_probs=55.3
Q ss_pred ccccccc-ceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCC--CCccccEEEEEeeCCeeeEEEecCCCCCHh
Q 046586 450 LIGRGGF-GDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMH--HLNLVRLWGFCAEKGERTLVYEYVPNGSLA 526 (763)
Q Consensus 450 ~LG~G~f-G~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~LV~Ey~~~gsL~ 526 (763)
.+..|.. +.||+....++..+++|...... ..++..|+..++.+. .-.+.+++++..+.+..++||+++++.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3444544 68999998888888899865432 334677888887773 334677888888888899999999886654
Q ss_pred H
Q 046586 527 D 527 (763)
Q Consensus 527 ~ 527 (763)
+
T Consensus 95 ~ 95 (255)
T d1nd4a_ 95 S 95 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.11 E-value=0.0012 Score=69.26 Aligned_cols=75 Identities=16% Similarity=0.104 Sum_probs=48.0
Q ss_pred ccccccccceEEEEEeCC-CcEEEEEEeecc--------CCchhhhHHHHHHHhcCC-C--CccccEEEEEeeCCeeeEE
Q 046586 449 NLIGRGGFGDVYKGELTD-HRVVAVKCLKNV--------TGGDAEFWAEVTIIARMH-H--LNLVRLWGFCAEKGERTLV 516 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~-~~~VAvK~l~~~--------~~~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~LV 516 (763)
+.||.|....||+....+ ++.++||.-... .....+...|++.|+.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998764 567888865321 112234556888887662 2 345556654 45567899
Q ss_pred EecCCCCCH
Q 046586 517 YEYVPNGSL 525 (763)
Q Consensus 517 ~Ey~~~gsL 525 (763)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999977543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.43 E-value=0.006 Score=61.88 Aligned_cols=68 Identities=15% Similarity=0.093 Sum_probs=48.0
Q ss_pred ceEEEEEeCCCcEEEEEEeeccCCchhhhHHHHHHHhcCCCCcc--ccEE-----EEEeeCCeeeEEEecCCCCC
Q 046586 457 GDVYKGELTDHRVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL--VRLW-----GFCAEKGERTLVYEYVPNGS 524 (763)
Q Consensus 457 G~Vy~g~~~~~~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~ni--v~l~-----g~~~~~~~~~LV~Ey~~~gs 524 (763)
=.||+....+|+.+++|+.+......+++..|+..+..|....+ +..+ ......+..+.++++++|..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 47999999999999999988766667778889988888743222 1111 12234567788999987643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.90 E-value=0.011 Score=61.51 Aligned_cols=73 Identities=21% Similarity=0.317 Sum_probs=49.1
Q ss_pred ccccccccceEEEEEeCCC--------cEEEEEEeeccCCchhhhHHHHHHHhcCCCCcc-ccEEEEEeeCCeeeEEEec
Q 046586 449 NLIGRGGFGDVYKGELTDH--------RVVAVKCLKNVTGGDAEFWAEVTIIARMHHLNL-VRLWGFCAEKGERTLVYEY 519 (763)
Q Consensus 449 ~~LG~G~fG~Vy~g~~~~~--------~~VAvK~l~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~LV~Ey 519 (763)
+.|+.|-.=.+|+....++ +.|.+++.-. ........+|..+++.+.-.++ .++++++.+ .+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4677777789999987543 4566666653 3333455689999888843344 577777743 589999
Q ss_pred CCCCCHh
Q 046586 520 VPNGSLA 526 (763)
Q Consensus 520 ~~~gsL~ 526 (763)
+++..|.
T Consensus 123 i~g~~l~ 129 (395)
T d1nw1a_ 123 IPSRPLS 129 (395)
T ss_dssp CCEEECC
T ss_pred eccccCC
Confidence 9875543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.01 E-value=0.2 Score=49.47 Aligned_cols=29 Identities=28% Similarity=0.356 Sum_probs=26.5
Q ss_pred cEEecCCCCCceEEcCCCCeEEcccCccc
Q 046586 585 WVLHCDIKPENILLGDDFCPKISDFGLAK 613 (763)
Q Consensus 585 ~ivHrDlk~~NILl~~~~~~kI~DFGla~ 613 (763)
.+||+|+.++||+++.+...-|.||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 49999999999999998878899999885
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.82 E-value=0.026 Score=35.44 Aligned_cols=34 Identities=26% Similarity=0.698 Sum_probs=27.3
Q ss_pred cCcCCCCCCCCCcccccCCCCCCccccCCCCccccCC
Q 046586 221 EICTIPDLCGENAICISDGLSRSTSCVCPPGFKNSTR 257 (763)
Q Consensus 221 ~~c~~~~~CG~~g~C~~~~~~~~~~C~C~~Gf~~~~~ 257 (763)
|.|.+-..|| +|.|++-- ..-.|.|-+||+|...
T Consensus 2 dECsignpCG-nGTCtNvi--GgFec~C~~GFepgpm 35 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVI--GGFECTCEEGFEPGPM 35 (39)
T ss_dssp CGGGTTCSSS-SSCEEECS--SSEEECCSSSSCCCSS
T ss_pred CccccCCccC-Cceeeecc--cceEEeecCCcCCCcc
Confidence 7899999998 79997532 3568999999998753
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.03 E-value=0.14 Score=34.21 Aligned_cols=33 Identities=24% Similarity=0.687 Sum_probs=25.6
Q ss_pred cCcCC-CCCCCCCcccccCCCCCCccccCCCCcccc
Q 046586 221 EICTI-PDLCGENAICISDGLSRSTSCVCPPGFKNS 255 (763)
Q Consensus 221 ~~c~~-~~~CG~~g~C~~~~~~~~~~C~C~~Gf~~~ 255 (763)
|+|.. ...|..+|.|.... .+..|.|++||+-.
T Consensus 4 deC~~~~~pC~n~g~C~n~~--g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTL--GSFECQCLQGYTGP 37 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECS--SSEEEECCTTEEST
T ss_pred ccccCCCCCCCCCcEeECCC--CCEEeECCCCCcCC
Confidence 56765 46899999998643 46799999999743
|
| >d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Hairpin loop containing domain-like superfamily: Hairpin loop containing domain-like family: Hairpin loop containing domain domain: Hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.16 E-value=0.41 Score=37.84 Aligned_cols=54 Identities=17% Similarity=0.394 Sum_probs=37.5
Q ss_pred ceeeEeeeeeccCCccc----cccccchHHHHHHccCC----CceeeEEEeeCCccceEEeee
Q 046586 274 TKFLQLDYVNFSRGNLS----DLEADNFSACKANCSAN----PKCVAFGFKYDGKRYCVLVDQ 328 (763)
Q Consensus 274 ~~f~~~~~~~~~~~~~~----~~~~~~~~~C~~~Cl~n----CsC~a~~~~~~~~~~C~~~~~ 328 (763)
++|.+..++.+...+.. .....+.++|..+|+++ =.|.+|.|. ...+.|.+...
T Consensus 5 ~dy~kt~~~~L~~~~~~~~~~~~~~~s~eeCA~rC~~~~~~~f~CrSF~y~-~~~~~C~Ls~~ 66 (91)
T d2qj2a1 5 HEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFD-KARKQCLWFPF 66 (91)
T ss_dssp GGEEEETTEEEEECSTTCCCEEEECSCHHHHHHHHHTTTTCSSCCCEEEEE-TTTTEEEEESS
T ss_pred HhhhhcCCceEeccCccccccccccCCHHHHHHHHHccCCCCceEEeEEEE-CCCCeEEEccc
Confidence 46888888777533221 22234899999999884 469999997 45567997554
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.59 E-value=0.22 Score=33.51 Aligned_cols=39 Identities=26% Similarity=0.701 Sum_probs=26.3
Q ss_pred cCcCCCC-CCCCCcccccCCCCCCccccCCCCccccCCCCCCc
Q 046586 221 EICTIPD-LCGENAICISDGLSRSTSCVCPPGFKNSTRQDKSC 262 (763)
Q Consensus 221 ~~c~~~~-~CG~~g~C~~~~~~~~~~C~C~~Gf~~~~~~~~GC 262 (763)
|+|.... .| .++.|.+.. .+-.|.|++||+...+..+.|
T Consensus 4 dEC~~~~~~C-~~~~C~Nt~--Gsy~C~C~~Gy~~~~~~g~~C 43 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNTP--GDFECKCDEGYESGFMMMKNC 43 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEET--TEEEECCCSSEEECTTTSSSE
T ss_pred cccCCCCCCC-CCCEeEcCC--CCeEEeCCCCCccCCCCCCcC
Confidence 6786644 45 478998754 367999999998643322444
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.72 E-value=0.38 Score=31.42 Aligned_cols=32 Identities=22% Similarity=0.635 Sum_probs=24.3
Q ss_pred cCcCCCCCCCCCcccccCCCCCCccccCCCCcccc
Q 046586 221 EICTIPDLCGENAICISDGLSRSTSCVCPPGFKNS 255 (763)
Q Consensus 221 ~~c~~~~~CG~~g~C~~~~~~~~~~C~C~~Gf~~~ 255 (763)
|+|. ...|...|.|.... ....|.|++||+-.
T Consensus 1 D~C~-~~PC~ngg~C~~~~--~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGL--GEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTT-TCCCCSSCEECCCS--SSCCEECCTTEETT
T ss_pred CcCC-CCCCCCCcEEECCC--CCEEEECCCCCCcC
Confidence 4565 46799999997543 46799999999754
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.18 E-value=0.53 Score=31.40 Aligned_cols=32 Identities=31% Similarity=0.691 Sum_probs=24.6
Q ss_pred ccCcCCCCCCCCCcccccCCCCCCccccCCCCccc
Q 046586 220 QEICTIPDLCGENAICISDGLSRSTSCVCPPGFKN 254 (763)
Q Consensus 220 ~~~c~~~~~CG~~g~C~~~~~~~~~~C~C~~Gf~~ 254 (763)
-|+|.... |+..+.|.+.. .+-.|.|++||+.
T Consensus 5 idEC~~~~-~~~~~~C~Nt~--Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKEPD-VCKHGQCINTD--GSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSSTT-SCSSSCCCCCS--SCCCCCCCTTEEE
T ss_pred eeccCCcC-CCCCCEeECCC--CCeEeECCCCccc
Confidence 37887654 55789998754 4779999999975
|